<SEC-DOCUMENT>0001628280-23-011123.txt : 20230407
<SEC-HEADER>0001628280-23-011123.hdr.sgml : 20230407
<ACCEPTANCE-DATETIME>20230407170806
ACCESSION NUMBER:		0001628280-23-011123
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		121
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230407
DATE AS OF CHANGE:		20230407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUTERA INC
		CENTRAL INDEX KEY:			0001162461
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770492262
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50644
		FILM NUMBER:		23809201

	BUSINESS ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		94005

	MAIL ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTUS MEDICAL INC
		DATE OF NAME CHANGE:	20011119
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cutr-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f,d:62f386bfb76443f0a57b663f9bc3fcbb--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:cutr="http://cutera.com/20221231" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cutr-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityCentralIndexKey" id="f-32">0001162461</ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:AmendmentFlag" id="f-33">false</ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="f-35">2022</ix:nonNumeric><ix:nonNumeric contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231" name="cutr:ExtendedServiceContractOptionOneTerm" id="f-470">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i07b7b9884af54beba53177415e5ee110_I20221231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="f-475">P2Y</ix:nonNumeric><ix:nonFraction unitRef="reporting_unit" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportingUnits" scale="0" id="f-545">1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="0" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="0" id="f-546">0</ix:nonFraction><ix:nonNumeric contextRef="i3d329e32bed04599a6821d1b1a10a95b_D20220101-20221231" name="cutr:ExtendedServiceContractTerm" id="f-656">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i0697b2b0d3684173ba373c05bd2a350c_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-712">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i38375ff36c734db9af8789f600457e7c_D20220101-20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-958">25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i4d3740b151434c4f9e44cbd4fadbf958_D20220101-20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-959">50</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i11097d39ff414e72bbef9a4dcb529f5c_D20220101-20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-960">50</ix:nonFraction><ix:nonNumeric contextRef="iebd28db3d2e64dce9fe6cfe6eac074bd_D20220101-20221231" name="cutr:LesseeLeasesRemainingTerm" id="f-1264">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1270">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-1271">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1282">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1283">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1286">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1287">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1335">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1336">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="i4db954fe033847e2b53b08a387423de3_D20210101-20211231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1339">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1340">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1343">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1344">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="f-1502">0.0301427</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531" decimals="6" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="f-1503">0.018986</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i907329613e904271948adfa043a3fa61_D20221201-20221231" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="f-1504">0.0171378</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cutr-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4254762331b5400eafbadf6adc174e06_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i0eb77ba8cb414b3998c3a159344980fd_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i22c2b0a369614a47bb4d25533345f31f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>cutr:country</xbrli:measure></xbrli:unit><xbrli:context id="id98fc580362c485a9aa22ac1e8f9841d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b771e0f32854640adb37fcb81cf460b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34b1b427465407d9a74c3746d642f8d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id024b9170dda414581e1c92eebe3bd2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf23510a12f84fca9925a26e5d1b065d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60f899800144726a0adde4f7415072f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba8742059574d5d885b961563cd6219_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1d9a6f8016476496ef409fccdcff79_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ee0d6962ab14de7be6135cd2e7b9249_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f908a491e314b5c86c9269bde35f991_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3b036d16fce44ae9da1d4c718443132_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ea7b28b3844cd4a1155d9f70e04574_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8b09c7fe8e9430bb8f6a8a02974f27f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i866a04e8824b4dbf9ff659afa11d7000_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676902d8b941452fb791a00f1146c1bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9285aaa84b6421b90e1c1305b5a251b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b00ad12fcec4fafb066d792a4d074fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebb11d45b894f9db048b1331f35f200_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24f897f06eb54a918841c6272f8b6949_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e2bd56525ca43019f62289ecfa3967e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i691b0e7ec5e74c68a82b35523edcdf7a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6b601d31324e1a930073ea52076b8f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib52bee5d91bb42b28334013f49e33682_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e448c55c1e49beac9e5d5156d2d3c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b270930e93e45fd9058c41b81f26c8e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12f50874bc174d76a3c5aa9d3d3d0590_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i768f5c2bba054cc9b135fa68bf4eaa0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f9e1bcaffa47f6a881fcaf76d33c60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6422ac28260743888cffc10f5e601c76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd264fa35e046aca3397b855df0cab9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07b7b9884af54beba53177415e5ee110_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869ee720a299437f94a3f4ee6b7220c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabc624c81f7f4b68aa9384952bc72b52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdcec047f47949518eae3be472c59560_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79f8334ee431491ea8a7102ddfe49fd8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ad808c733c48d59c4363b7215cd797_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie26d7981afe04301908853ba61c5d641_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i693768b6a7e945bdb951b75a87c2e03b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7ef2fd159c48529daf7452defc65e0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2743a40780d64a419e4084b9eb8cc1e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb65f4a3b1046d69abf37f63e36005e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84291aab4fff4efe9c464193a3d89fbd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if730726557904a0e8129172982f3fa0f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2a89ad78ae47bf9c76026b524514ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7870599153e64b0fa7a3ebb5df62f415_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b739e3ad9964dbf98889c162108b1f8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cde67dc1f864753bb385d33cbe1b6aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1332d0d5ac433fabf234a1e2f746ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6506c5c97e94b878215a956808ec764_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cutr:segment</xbrli:measure></xbrli:unit><xbrli:context id="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>cutr:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i2ac7a7e554464f1d8c996aff630afeb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic57b91ff7d8c4faea9f96493ed40332c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ca02c2f35d427c969131afb737148e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac9e761079e46d09f596d92d01d71b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3f7fca92974b8aba97f327669fb368_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7081fb323837425eb325cf18993c3f13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43de6969b39446da9d7aa3def0715785_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id720e09c88e443f2809964bf360c8189_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8340bed1b672419cbaface1d8b4809cb_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221c5f5bf1c048b58ad83bbe86effde5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be7dc17e6d2432fbb9a56dfd5b44ffe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46ca417d3e2946ceb0aaf60b4425ef5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605a89e30db34ee5b4f659a4a45e8f1d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a962cbab39448a1a2946df5cccfff51_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b2c4567c63458dbf8d418f20083383_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5296be68503d4aac9ffe8a6e86065dcc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a44bf842a0d40fa904345e182ab2a54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5baea4532648c7a0de553581dd9364_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157789288079499a8a2a1e6fa6177625_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd22553f7fc24f4399f493cc7a5b0c69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib97937e36112460f905b590a698c2662_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e0968e414b4cce9b5df6a4573b4de2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70000ea7bfe4aa091134520e36adee3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d329e32bed04599a6821d1b1a10a95b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i627fb423930e40d5904d10ac994e9b22_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6174e841cf8942359f88304752a651ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae3e0055764457a9c1f55592c65d687_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cbf6cae62846b4918bd5c16022a51e_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:UnderwriterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08530b13979643b789fbf75b8ddb226a_I19981231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3435c591f64b3798ada0cae4b3cb6b_I20041231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2004-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56956846a75c43d6beae2d01dad8e79e_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56053101176e4eee83b23bfb85a4c018_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2fdd272272b45deb78651a9217686d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46004954bc984936a1ba499adac7a1fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c18e28a9c3b4ac891e9d2b6fea59279_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic54be2ac79324b2f8eb1e0feef2c9f6c_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a45faa2dad7441e9750fb1049202ddb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93eb16b5a06840968cbc9875832fe5e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c2d12e9c8744b01846c152372849986_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0fc73b5fb954186bdecf4e03ab50a44_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f8b1beeb3b46d6896264075a0f642c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31476d551c22406289d5d7e70159145a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56d977f3237048fd8f92c1754156e659_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0697b2b0d3684173ba373c05bd2a350c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAnnualGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30021351cc7642de9f7e7a753727c538_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a873e55daf4d1096b17ed6d286c540_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6c6ee7693f44fbbc190082fa49573c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b5675f4b3c4a44b1e6ca6d6528fc07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i675d69b502a848bc9f2401845e49adfc_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce66ed419804b35a387a3a2298ae2b4_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>cutr:tranche</xbrli:measure></xbrli:unit><xbrli:context id="ibe4bf8f916284b378c9dfccf341f2e0e_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718cf9e3833d4cbe824fb83ef9b96dd7_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d864291f7042989243b040cd710241_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica8f35fa7fcb453b85159c8316392bdc_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98655c3b6d21446ea2a5d6fface14f08_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic000f7fad27f41da8a1b11411e5199d4_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-01-12</xbrli:startDate><xbrli:endDate>2004-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85b6c70335ab468995fd22f87f7dea79_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cbfe8553003474dbea4fbe1cb946be5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259a5ef49c174b599bbd8e82d8d4cd67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5fd5162e3749dda52119ea03e417b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f46393f84249579bf1f0ecda83cecf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i115c28e37fe341eebe4c63199b303d29_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70779460b35645a8ae14d35ecd7316dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieff965b22673420b9ac95034349a3a3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2821e1c3f34e6d88ea2da034cb653f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa282846e30940929a3b644c6b61c15d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a6913c1f23c4c2183eb2a516465a2d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i895e42cc37a4468982700f81c2a36726_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7dfdf16b051484fbfef1d9db4f028d5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595dfc44c26342479914423f899ffd41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f809c30032e4095af4562f984e79643_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3ed95613494914aa350bfdca948d59_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd90507e569a4a009155cc0c1d41eb33_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib971e664547449019e686dfcda7d726f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eaa18236bf541fd9be0327591bddadb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c95c2271944120adfe82eb5cc72bed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9eb37cd2f843bcb2780db55cc261c7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida56af569414409888521b3e5deceb5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38c559feb1b74bcda18168292816e21d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a14495444114a1b95d8e60d66bcef2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if574d6c9139942fcae8b73ef1132adce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2af1fdd05cd445a0ae8d99f2546c9649_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedb3fa0d043f42818e6ba795391d99b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb210668bb0d40229989bb9910942dc6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i393abfeabcec4e439702c6fb89a55f9b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950f3f1cbe644accb57140891f583a57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a78a9a76abb4ea692915c784e8c9154_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i831c2cc741324fff9890a07923f079f9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1334e42d4dd14b4ba4c5edf93302f4b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a919cae1df94161b1b26d4d2c036cd7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38375ff36c734db9af8789f600457e7c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3740b151434c4f9e44cbd4fadbf958_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11097d39ff414e72bbef9a4dcb529f5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9dea9e779424bb0b81869578a5eb41a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa86cedc4f743a89628f54d6c8ddd3f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a8180f361034cc0a7ddd4675321f231_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b1494dda634811b284b9faa38d0601_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45dca5694694e9eaafbe4a6234d3b92_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if11b725ce1af4a30b46852703abf3192_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d82e33152c849b3b7b22e9850693bc7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2718ea9e3df24ae9919f09e3a9bd8d2d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d2af5d0d40240728bbaf7100364c888_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica33e5e0a8d149e08222f5657ba8f9bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1222f8a294044704aaca365b5961f91f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9973a1bb092c40f8b6352bebbf706d79_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i666467d2ee8b4706828ce53f22a78ef9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icacb09d5d4564041b646ac2fea6f291f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0099f611054142b44663a4d35bd018_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435b3ba5e879438ab1c9c925dc8a1ba6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c63a15d54b4af684d1b7b298377b14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65060ead42404852b4696510b4327f7a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3883679f5dd14bd58d3bdc2f35fc8b3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1afd2b598094e77a995de1beb182fc0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70b796e7c79344caa2cc64d5b0a40019_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf71e1c04fa42eb8e5bcab09ec61552_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80255a5d1504da7ac5a65f6a26a95f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64feb72e527a4ddeba367f7807175c19_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ddee769932a4350a14cc2d6333a6757_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76980ed1a1534046811d38eed346f857_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3786902aa814d6781382d2a734de748_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i846ac160c48140659c8ff08589c1559c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9be98d2423634757af936bba4482f104_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af2f3a0df564393908ceb31eb4f5771_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i057d976e50f54bb5b4029b6e8eed833d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab29b34be6724c94945ef58bbfbbbe24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabd1a6a576ea4d019bb8ce898cadf674_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id51d133a94594ab68d99649b2087f195_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e56fbd57d240fc8787786a963035f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71acb76f8254ab48b6267e153db44c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3011f822b64b65b4850bdaf7aee0ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia90a17929a2c47458119f913368da54d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43b61bed02d4fce96d758963f8ca202_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c171c7b5cbf4b489415ee212fd357c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b0cfbd65e4486580c0b2d539204abc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32af68888229429c86c1f6d4e66c39d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc0bee4a202b46a886d4dac9c6a0465c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b100c928a264c0780179352a51b0551_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bcc961f86c4d37ad3553546f5a6370_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864a42f1b9474cd3bf43681344389c54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b4e54ccf702485ebea23892a41e90d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79cb131a331f444aaec8d0b8104c73b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5b1f1666e8c420ba4cde97cf41fb662_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105738620d9448cd86de0b72566e2192_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ac813d49b5749bdbb352b5de5d1604c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc14c23d98b5459bbca583cda98d027e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112b7a48420c4a4a815d9a7348d931fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b2c7662fd449d0afe5418656bb70be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc6629fab6b94f3ab926f0814d6fd0d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea513a253ca34fe9a2a2acdd9000fbc5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd67954cb584428b5eb9b700919da0a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce4b410a9a94845afb82c481a9282d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d978e3d81f43a4920268bc4873fd78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib45100873e384627a7d0d4ae1bee0f3d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04aff51169d478787e0b3b3998d9c0a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3183169f49b0407497637750803e56cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79831062395d48ff9827b5dd62714018_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i570cc80078864aeba21c2158c1c81d44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i438a7e3fe616461bb35aac62f1dd3281_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfd4323e38a42f380d911aaae444128_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b446bf3d14c44a595ac3dfcbab2b828_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f95e00759c5463c8accbe2d58291bdd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id82a22a9886c4a319a7f2dcb4b5cbdbd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97f0dbf965b43738ea95b5b2200e359_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806a9486ff1043a2abc3ab0f1747be03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd28db3d2e64dce9fe6cfe6eac074bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseLicenseFeeRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseLicenseFeeRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db954fe033847e2b53b08a387423de3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseRecurringRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseRecurringRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia982b914a1b146c5a1cab988d0bd6cca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:AviClearDeviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease_term"><xbrli:measure>cutr:lease_term</xbrli:measure></xbrli:unit><xbrli:context id="i4d7a93cebb0445b3adc4fdbd8bcad826_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc8691977a17471e888e8008855e2dec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e56eaab24a348b69456952d07cd3e95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a5220685f0420ab867e7dfb9c2cf00_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796773bebe7e43e7bcecf719e525f796_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e1b769004c940138fbdcc25ec85a289_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a0cca728a634df5a5f6d19439a8e76f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7719fc175b6482682d41fed2b2280cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc01ef124dcd4432926e7fafc9179e82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc2557870e243c2a5677cb7decf7012_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4fabcd0c6b145328c06480322497ceb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f3d4babfce840a2b159fd70abd4be03_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42551caee064e72b3e0bb899ff817f7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i311a3952ceef49ac9b09d68b91ee185d_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:VoceCapitalManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f9433f295c4816bc3f161b64e8c985_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcee2bc0609d4e29aba04556ae20c3bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17fbfe26ef264a34b2c3bbbd999e5121_I20220601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c543a80fb3441f29a2f3497b9785ec9_I20220524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>cutr:day</xbrli:measure></xbrli:unit><xbrli:context id="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5360b54f8bd047afbb77191b00d60ec7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1261edff6b94c0eabe87de89ca47291_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27566a6eb1a14a6da1bcb731ccfcad08_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028FirstConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028SecondConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb3d4792c6144be88746b11a2ee39995_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dd175c6046b46988a2632db59313ec8_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i003fc45e98c843a98b06a88ed0a0f62d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723997427a13498fb7414de5cf577325_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib99c5a3203694570b12bf45da9728932_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerItem"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>cutr:item</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib2840cd98ca143cd8b20996a137ad641_I20210304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i560132f058e647e7836489cdaa020a99_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5adbe42165d747f9b1a502754f152e1c_I20210304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601beccbd0004b92931f1016a7656cf5_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0739d3b24f09440ba3de580700fa75f8_I20210304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca4ca09a78d4f1db1fbfc595409a42c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ed4f6c46564823a197c54da88e53aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae49b5f0167c4c098a4473073d17fb51_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51590e3866c44f098a65564cb2ec8b38_I20220524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib581b45783164777b7e88b6c201257fc_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f3386c03a84affa91cabbfd26c26e5_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4c7536ce80e4e06b2517e9f76b4751f_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907329613e904271948adfa043a3fa61_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f427bfbfd74894b34c8a26f7658e98_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cutr:USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6b6a127ff244979a92a75f9e174aed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cutr:CashSweepInvestmentFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c9297e011c43528e40adc29971dc4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic72b182a81cf43ee99eb4e8a9d3ec1a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7debaf31c58640479aa03b97de9695a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i488403d682ba4e59b493908691cb1e8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib21545b587824019adbfef02bb41d281_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dec51418121482fbdb4c18abe975265_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d09091e9bde4c10a1ae5c4f5f4d6337_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">trademark</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For fiscal year ended <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ____ to ____</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityFileNumber" id="f-6">000-50644</ix:nonNumeric></span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityRegistrantName" id="f-7">CUTERA, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="f-9">77-0492262</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="f-10">3240 Bayshore Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="f-11">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">California</ix:nonNumeric> <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="f-13">94005</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:CityAreaCode" id="f-14">415</ix:nonNumeric>) <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:LocalPhoneNumber" id="f-15">657-5500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:Security12bTitle" id="f-16"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:Security12bTitle" id="f-17">Common Stock ($0.001 par value)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:TradingSymbol" id="f-18">CUTR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market, LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="f-25">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-26">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-27">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by checkmark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes &#9744; No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">x</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock, held by non-affiliates of the registrant as of June 30, 2022 (which is the last business day of registrant&#8217;s most recently completed second fiscal quarter) based upon the closing price of such stock on the NASDAQ Global Select Market on June 30, 2022, was approximately $<ix:nonFraction unitRef="usd" contextRef="i4254762331b5400eafbadf6adc174e06_I20220630" decimals="-6" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="f-29">670</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of Registrant&#8217;s common stock issued and outstanding as of April&#160;4, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was <ix:nonFraction unitRef="shares" contextRef="i0eb77ba8cb414b3998c3a159344980fd_I20230404" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">19,788,358</ix:nonFraction></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true">Part III incorporates by reference certain information from the registrant&#8217;s definitive proxy statement for the 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2022.</ix:nonNumeric></span></div><div style="text-indent:6.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_13">PART&#160;I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_19">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_19">Risk&#160;Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_19">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_22">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_22">Unresolved&#160;Staff&#160;Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_22">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_25">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_25">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_28">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_28">Legal&#160;Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_28">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_31">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_31">Mine&#160;Safety&#160;Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_31">54</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_34">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_37">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_37">Market&#160;for&#160;Registrant&#8217;s&#160;Common&#160;Equity,&#160;Related&#160;Stockholder&#160;Matters&#160;and&#160;Issuer&#160;Purchases&#160;of&#160;Equity&#160;Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_37">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_40">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_40">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_40">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_43">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_43">Management&#8217;s&#160;Discussion&#160;and&#160;Analysis&#160;of&#160;Financial&#160;Condition&#160;and&#160;Results&#160;of&#160;Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_43">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_67">Item&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_67">Quantitative&#160;and&#160;Qualitative&#160;Disclosures&#160;About&#160;Market&#160;Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_67">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_70">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_70">Financial&#160;Statements&#160;and&#160;Supplementary&#160;Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_70">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_148">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_148">Changes&#160;in&#160;and&#160;Disagreements&#160;with&#160;Accountants&#160;on&#160;Accounting&#160;and&#160;Financial&#160;Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_148">119</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_151">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_151">Controls&#160;and&#160;Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_151">119</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_154">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_154">Other&#160;Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_154">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_157">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_154">121</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_160">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_163">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_163">Directors,&#160;Executive&#160;Officers&#160;and&#160;Corporate&#160;Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_163">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_166">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_166">Executive&#160;Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_166">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_169">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_169">Security&#160;Ownership&#160;of&#160;Certain&#160;Beneficial&#160;Owners&#160;and&#160;Management&#160;and&#160;Related&#160;Stockholder&#160;Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_169">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_172">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_172">Certain&#160;Relationships&#160;and&#160;Related&#160;Transactions,&#160;and&#160;Director&#160;Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_172">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_175">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_175">Principal&#160;Accounting&#160;Fees&#160;and&#160;Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_175">122</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_178">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_181">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_181">Exhibits,&#160;Financial&#160;Statement&#160;Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_181">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_184">Item&#160;16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_184">Form&#160;10K&#160;Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_184">125</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; that involve risks and uncertainties. The Company&#8217;s actual results could differ materially from those discussed in the forward-looking statements. The statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements are often identified by the use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;might,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or variations of these terms and similar expressions, or the negative of these terms or similar expressions intended to identify forward-looking statements. Forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. Forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled &#8220;Risk Factors&#8221; included under Part I, Item 1A below. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with and are qualified in their entirety by reference to the discussions included in Item 1A - Risk Factors, Item 7 - Management&#8217;s Discussion &amp; Analysis of Financial Condition and Results of Operations, and elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report on Form 10-K, unless the context otherwise requires, references to the &#8220;Company,&#8221; &#8220;Cutera,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;the Company&#8217;s&#8221; refers to Cutera, Inc.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report on Form 10-K, &#8220;Cutera,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;the Company&#8217;s&#8221; refer to Cutera, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Background</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera was formed in 1998 as a Delaware corporation and is a global provider of aesthetic and dermatology solutions for medical practitioners worldwide. The Company develops, manufactures, and markets energy-based product platforms for use by medical practitioners, enabling them to offer safe and effective treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following key platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear, enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel, truSculpt, Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; each of which enables medical practitioners to perform safe and effective procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The Company&#8217;s ongoing research and development activities primarily focus on developing new products and improving and enhancing the Company&#8217;s portfolio of existing products within dermatology and aesthetics. The Company also explores ways to expand the Company&#8217;s product offerings through alternative arrangements with other companies, such as distribution arrangements for third party developed products, as well as through mergers, acquisitions and investments. The Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in January 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten SR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in April 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in July 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in February 2019 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in June 2019, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in July 2020, and a product extension of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the fourth quarter of 2020. In 2021, the Company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truFlex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes. In March 2022, the Company received 510(k) clearance from the U.S. Food and Drug Administration for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> acne treatment device ("AviClear"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a laser treatment that offers a safe, prescription-free solution for acne.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s trademarks include: &#8220;CUTERA&#174;,&#8221; &#8220;AVI360&#174;,&#8221; &#8220;AVICARE&#174;," &#8220;AVICLEAR&#174;," &#8220;AVICOOL&#174;, "ACUTIP 500&#174;," &#8220;COOLGLIDE&#174;,&#8221; &#8220;CUCF&#174;,&#8221; &#8220;CUTERA UNIVERSITY CLINICAL FORUM&#174;,&#8221; &#8220;ENLIGHTEN&#174;,&#8221; &#8220;EXCEL HR&#174;,&#8221; &#8220;EXCEL V&#174;,&#8221; &#8220;EXCEL V+&#8482;,&#8221; &#8220;GENESIS&#174;,&#8221; &#8220;LASER GENESIS&#174;,&#8221; &#8220;LIMELIGHT&#174;,&#8221; "MYQ&#174;," &#8220;PEARL&#174;,&#8221; &#8220;PICO GENESIS&#174;,&#8221; &#8220;PROWAVE 770&#174;,&#8221; &#8220;SOLERA&#174;,&#8221; &#8220;TITAN&#174;,&#8221; &#8220;TRUBODY&#174;,&#8221; &#8220;TRUFLEX&#8482;,&#8221; &#8220;TRUSCULPT&#174;,&#8221; &#8220;TRUSCULPT ID&#174;,&#8221; &#8220;TRUSCULPT FLEX&#174;,&#8221; &#8220;VANTAGE&#174;,&#8221; and &#8220;XEO&#174;.&#8221; The Company&#8217;s logo and other Company trade names, trademarks, and service marks appearing in this document are the Company&#8217;s property. Other trade names, trademarks, and service marks appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, the Company&#8217;s trade names, trademarks and service marks referred to in this Annual Report on Form 10-K appear without the &#174; or TM symbols, but those references are not intended to indicate, in any way, that the Company will not assert, to the fullest extent under applicable law, the Company&#8217;s rights, or the right of the applicable licensor to these trade names, trademarks, and service marks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A description of each of the Company&#8217;s devices and a summary of the features of the Company&#8217;s primary platforms are as follows:</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In March 2022, AviClear was cleared by the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) for the treatment of mild, moderate, and severe inflammatory acne vulgaris. AviClear significantly eliminates acne in three, 30-minute treatments. AviClear treats active acne and helps prevent future acne by suppressing the sebaceous glands. AviClear was designed with the AviCool&#8482; contact cooling technology that allows for a safe and comfortable treatment experience. AviClear offers a long-term durable solution for all severities of acne.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In 2020, the Company expanded its distribution of the Secret PRO device. Secret PRO features two proven technologies &#8211; RF microneedling and fractional CO2. Secret PRO utilizes fractional CO2 for skin resurfacing and radio frequency microneedling for deep dermal remodeling. The pairing of technologies provides practitioners the ability to tailor each treatment for a patient's individual skin concerns. Used individually or in combination for best outcomes with minimal downtime. Each time a procedure is performed, the physician must use a new handpiece tip. The sale of the replacement tip results in recurring revenue.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In June 2019, the Company introduced the truFlex for the muscle-sculpting market. This product is a bio-electrical muscle stimulation device designed to strengthen, firm and tone the abdomen, buttocks and thighs, and can treat patients at all fitness levels. The truFlex delivers Multi-Direction Stimulation with truControl, inducing muscle hypertrophy and hyperplasia. Johari Digital Healthcare Ltd. (the Company&#8217;s contract manufacturing organization) received 510(k) clearance from the FDA for muscle conditioning in 2013. It is sold in the USA, Canada, Japan, certain Asia Pacific markets, and the European Union (&#8220;EU&#8221;) and is expected to be sold to a broader international customer base upon required regulatory approvals. The truFlex includes a consumable handpiece that needs to be "refilled" after a set number of treatments are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performed, resulting in recurring revenue. In 2021, the company introduced truFlex+, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In February 2019, the Company introduced the excel V+, a new iteration of the excel V vascular platform originally introduced in 2011. Excel V+, is a high-performance, vascular and benign pigmented lesion treatment platform explicitly designed for the market of dermatologists and plastic surgeons. The excel V+ has 50% more power than its predecessor and provides a greater range of parameters for faster, more customizable treatments. The excel V and excel V+ are solid-state laser platforms providing a combination of the 532 nanometers (&#8220;nm&#8221;) green laser with 1064 nm Nd:YAG technology to provide a single, compact and efficient system that treats the entire range of cosmetic vascular and benign pigmented lesion conditions. In Q4 of 2020, the Company introduced a product extension to its excel V+ platform, which included a new, 1 mm Dermastat handpiece and expanded specifications. The new excel V+, expanded treatment capabilities and provided dermatologists and aesthetic providers a higher level of precision and versatility for vascular and pigmented lesions. The excel V+ continues to boast 50% more power than its predecessor (excel V) and provides a greater range of parameters for faster, more customizable treatments. excel V+ is a solid-state laser platform combining the 532 nanometers (&#8220;nm&#8221;) green laser with 1064 nm Nd:YAG technology to provide a single, compact and efficient system that treats the entire range of cosmetic vascular and benign pigmented lesion conditions. The excel V+ device includes Cutera&#8217;s signature laser genesis treatment, and introduced the &#8216;green genesis&#8217; treatment &#8211; a micro-pulsed 532 treatment.  </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In July 2018, the Company introduced a hands-free version of the Company&#8217;s truSculpt platform, the truSculpt, for the non-surgical body sculpting market. It includes consumable cycles that need to be ordered by the practitioner after a set number of treatments are performed, resulting in recurring revenue. This product is a high-powered radio frequency (&#8220;RF&#8221;) system designed for circumferential reduction, lipolysis, and deep tissue heating and can treat all body and skin types. The truSculpt delivers targeted energy at 2 MHz, causing subcutaneous adipose tissue lipolysis. The Company received 510(k) clearance from the FDA for lipolysis of abdominal fat in 2018. Prior truSculpt platforms include the truSculpt 3D, a 2 MHz device for tissue heating and circumferential reduction of fat in the abdomen and flank, and the original truSculpt platform launched in August 2012 and delivered treatments at 1 MHz. In December 2016, the Company received 510(k) clearance from the FDA to market the truSculpt platform for the temporary reduction in circumference of the abdomen. The truSculpt 3D includes a consumable handpiece that needs to be &#8220;refilled&#8221; after a set number of treatments are performed, resulting in recurring revenue.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In January 2018, the Company introduced a new fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy. The targeted energy revitalizes the tissue, via hemostasis, and coagulation of the tissue, minimizing downtime. Each time a procedure is performed, the physician must use a new handpiece tip. The sale of the replacement tip results in recurring revenue. The Company is the distributor of Secret RF.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">enlighten </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; In December 2014, the Company introduced the enlighten laser platform with a dual wavelength (1064 nm + 532 nm). In December 2016, the Company introduced a three wavelength model (1064 nm + 532 nm + 670 nm), enlighten III. The enlighten system is a dual pulse duration (750 picoseconds, or &#8220;ps,&#8221; and two nanoseconds, or &#8220;ns&#8221;) laser system cleared for multi-colored tattoo removal and the treatment of benign pigmented lesions and acne scars. In 2018, the Company introduced an expanded performance enlighten III, and in April 2018, the Company introduced enlighten SR, a lighter version of enlighten with reduced optical performance. Clinical studies were conducted to support an FDA clearance in October 2018 for treatment of acne scars on patients with Fitzpatrick skin types II-V when used with the PICO Genesis FX Micro Lens Array (&#8220;MLA&#8221;) handpiece attachment.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In June 2014, the Company introduced the excel HR platform, a premium hair removal solution for all skin types, combining the Company&#8217;s proven long-pulse 1064 nm Nd:YAG laser and a high-power 755 nm Alexandrite laser with sapphire contact cooling.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In 2003, the Company introduced the xeo platform, which combines intense pulsed light technology with laser applications in a single system. The xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above-mentioned primary systems, the Company generates revenue from the distribution of skincare products, which are manufactured by ZO Skin Health, Inc. (&#8220;ZO&#8221;), and sold in the Japanese market. The Company also generates revenue from the sale of post-warranty services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers its customers the ability to select the systems and applications that best fit their practice and subsequently upgrade their systems to add new applications. This upgrade path allows the Company&#8217;s customers to cost-effectively build their aesthetic practices and provides the Company with a source of incremental revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Market for Non-Surgical Aesthetic Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes several factors are contributing to the global growth of aesthetic treatment procedures and aesthetic laser equipment sales, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Growing Improvement in Economic Environment, Aesthetic Accessibility, and Expanded Practitioner Base</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The last decade has seen an increased demand for aesthetic procedures, which has resulted in an expanding practitioner base to satisfy the demand. Despite worsening recent economic conditions, underlying market feedback continues to support steady patient traffic. An expanding practitioner base paired with digital and mobile advancements has led to a broader range of accessibility options for potential patients.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Aging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Demographics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industrialized</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Countries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The aging population of industrialized countries, the amount of discretionary income available to the &#8220;baby boomer&#8221; demographic segment &#9472; ages 59 to 77 as of 2023 &#9472; and their desire to retain a youthful appearance contribute to the increased demand for aesthetic procedures. With millennials entering their 40's the demand and preference for non-invasive aesthetic treatments are also rising. Millennials who are currently entering their 30's, including those in their 30's, have been earlier adopters of aesthetic treatments in comparison to older generations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Broader</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Range</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treatments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Technical developments and an increase in treatable conditions due to new product introductions, have led to safe, effective, easy-to-use, and low-cost treatments with fewer side effects, resulting in broader adoption of aesthetic procedures by practitioners. In addition, technical advancements enable practitioners to offer a broader range of treatments. These technical developments reduce treatment and recovery times, leading to greater patient demand.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Broader</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Base</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Managed care and government payor reimbursement restrictions motivate physicians to establish or expand their elective aesthetic practices with procedures paid for directly by patients. As a result, in addition to core practitioners such as dermatologists and plastic surgeons, many other practitioners, such as gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners (&#8220;non-core practitioners&#8221;) expanded their practices to offer aesthetic procedures.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Reductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Due partly to increased competition in the aesthetic market, the cost per procedure has decreased in the past few years. This attracts a broader base of customers and patients seeking aesthetic procedures.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Wide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acceptance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aesthetic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Increased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Focus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Image</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to the American Society for Aesthetic Plastic Surgery survey in 2019, both surgical and non-surgical procedures increased compared to 2015. Surgical procedures increased by 6.2%, while non-surgical procedures increased by 13.3% over this four-year period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Surgical Aesthetic Procedures for Improving the Body and/or Skin&#8217;s Appearance and Their Limitations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many alternative therapies are available for improving a person&#8217;s appearance by treating specific structures within the skin. These procedures utilize injections or abrasive agents to reach different depths of the dermis and the epidermis. In addition, non-invasive and minimally invasive treatments have been developed that employ laser and other energy-based technologies to achieve similar therapeutic results. Some of these common aesthetic procedures and their limitations are described below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acne &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treatments for acne include over-the-counter ("OTC") and prescription topicals, washes, oral antibiotics, and oral isotretinoin. Acne affects an estimated 50 million Americans according to the American Academy of Dermatology. Previously, lasers have been used to treat acne albeit with varying levels of success. Many treatments have not demonstrated a durable response, while new approaches like AviClear, which target the sebaceous gland, offer renewed promise for treating acne at its source.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contouring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Treatments for non-invasive body sculpting can be done utilizing a variety of technologies, including radio frequency, laser, cooling, and ultrasound. Procedures address the reduction of unwanted fat on the abdomen, flanks, arms, thighs, submentum, and back and can require one or more treatments. Systems with the ability to induce non-invasive lipolysis (breakdown of fat) offer a more permanent solution with an average fat reduction of more than 20%. Common side effects of this approach may include paradoxical hyperplasia with cooling devices, and nodules which typically resolve over time and the risk of burning the treatment area with radiofrequency devices. In June 2019, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a bio-electrical muscle stimulation device designed to strengthen, firm, and tone the abdomen, buttocks, and thighs. In 2021 the Company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truFlex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tattoo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The most effective way to remove tattoos on the body is to utilize laser systems that deliver very short pulse durations with high peak power in order to break up the ink particles that comprise tattoos.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global tattoo removal market was valued at $122.8&#160;million in 2019&#160;and is projected to reach $219.0 million by 2026. According to market research, people tend to remove their tattoos due to career choices, social conditions, personal situations, and more, which have been the key drivers for the tattoo removal market. Despite the effectiveness of lasers for tattoo removal, common complaints concerning laser tattoo removal include a low rate of complete clearance (sometimes no better than 50% after several treatments) as well as the high number of treatments for satisfactory clearance (often 10 or more treatments spaced four to eight weeks apart). However, the latest generation of tattoo removal lasers produce picosecond pulse durations, (a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trillionth of a second) and thereby, can meaningfully improve tattoo clearance and reduce the total number of treatments. The Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system, a dual pulse duration laser system, that was cleared for multi-colored tattoo removal.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hair Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Techniques for hair removal include waxing, depilatories, tweezing, shaving, electrolysis, laser as well as other energy-based hair removal modalities. The only techniques that provide a long-lasting solution are electrolysis, laser, and other energy-based technology such as Intense Pulsed Light (&#8220;IPL&#8221;). Electrolysis is usually painful, time-consuming and expensive for large areas, but is the most common method for removing light-colored hair. During electrolysis, an electrologist inserts a needle directly into a hair follicle and activates an electric current in the needle. Since electrolysis only treats one hair follicle at a time, the treatment of an area as small as an upper lip may require numerous visits and many hours of treatment. In addition, electrolysis can cause blemishes and infection related to needle use. In comparison, lasers can quickly treat large areas with a high degree of safety and efficacy. In 2003, the Company introduced the xeo system platform utilized for hair removal, which combines intense pulse light technology with laser applications in a single system. In 2014, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, a premium hair removal solution for all skin types, combining the Company&#8217;s proven long-pulse 1064 nm Nd:YAG laser and a high-power 755 nm Alexandrite laser with sapphire contact cooling.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Skin revitalization treatments include a broad range of popular alternatives, including Botox and collagen injections, chemical peels, microdermabrasion, radio frequency treatment and laser and other energy-based treatments. With these treatments, patients hope to improve overall skin tone and texture, reduce pore size, tighten skin and remove other signs of aging, including mottled pigmentation, diffuse redness and wrinkles. All of these procedures are temporary solutions and must be repeated within several weeks or months to sustain their effect, thereby increasing the cost and inconvenience to patients. For example, the body absorbs Botox and collagen, and patients require supplemental injections every three to six months to maintain the benefits of these treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other skin revitalization treatments, such as chemical peels and microdermabrasion, can have undesirable side effects. Chemical peels use acidic or caustic solutions to peel away the epidermis, and microdermabrasion generally utilizes sand crystals to resurface the skin. These techniques can lead to stinging, redness, irritation and scabbing. In addition, more serious complications, such as changes in skin color, can result from deeper chemical peels.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With many modalities available today for skin revitalization and resurfacing, the Company has developed a range of clinically proven solutions uniquely paired with a patient&#8217;s lifestyle and skin concerns, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which utilizes fractional CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for skin resurfacing and radio frequency microneedling for deep dermal remodeling and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a novel fractional RF microneedling system for tissue coagulation and hemostasis designed to stimulate and remodel collagen and address the common signs of aging.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RF Microneedling</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Also known as collagen induction therapy, microneedling is a minimally invasive revitalization treatment that involves using fine needles to create hundreds of tiny, invisible puncture wounds in the top layer of the skin, which stimulates the body's natural wound healing processes, resulting in cell turnover and increased collagen and elastin production via hemostasis and tissue coagulation. In January 2018, the Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product, a RF fractional microneedling system. In 2020, the Company released the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which included the dual modality treatment options of RF microneedling and CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> laser.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Veins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Current aesthetic treatment methods for leg and facial veins include sclerotherapy, as well as laser and other energy-based treatments. With these treatments, patients seek to eliminate visible veins, and improve overall skin appearance. Sclerotherapy requires a skilled practitioner to inject a saline or detergent-based solution into the target vein, which breaks down the vessel causing it to collapse and be absorbed into the body. The need to correctly position the needle on the inside of the vein makes it difficult to treat smaller veins, which limits the treatment of facial vessels and small leg veins. In 2019, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a high-performance, vascular and benign pigmented lesion treatment platform designed specifically for the core-market of dermatologists and plastic surgeons, which treats the entire range of cosmetic vascular and benign pigmented lesion conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laser and other energy-based non-surgical treatments for hair removal, veins, skin revitalization and body contouring are discussed in the following section.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laser and Other Energy-Based Aesthetic Treatments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laser and other energy-based aesthetic treatments can achieve therapeutic results by affecting structures within the skin. The development of safe and effective aesthetic treatments has resulted in a well-established market for these procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Practitioners can use laser and other energy-based technologies to selectively target hair follicles, veins, melanin as well as other chromophores within the epidermis and dermis, without damaging surrounding tissue. Practitioners can also use these </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">technologies to safely remove portions of the epidermis and deliver heat to the dermis as a means of generating new collagen growth. Ablative skin resurfacing improves the appearance of the skin by removing the outer layers of the skin. Ablative skin resurfacing procedures are considered invasive or minimally invasive, depending on how much of the epidermis is removed during a treatment. Non-ablative skin resurfacing improves the appearance of the skin by treating the underlying structure of the skin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Safe and effective laser and energy-based treatments require an appropriate combination of four parameters:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Energy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the amount of light or radio frequency emitted to heat a target;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Pulse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Duration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the time interval over which the energy is delivered;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Spot Size</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrode</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Size</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the diameter of the energy beam, which affects treatment depth and area; and</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the position in the electromagnetic spectrum which impacts the absorption and the effective depth of the energy delivered.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in the case of hair removal, by utilizing the correct combination of these parameters, a practitioner can use a laser or other light source to selectively target melanin within the hair follicle to absorb the laser energy and destroy the follicle, without damaging other delicate structures in the surrounding tissue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Technology and Design of the Company&#8217;s Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel, Secret PRO, Secret RF, truSculpt and xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms provide the long-lasting benefits of laser and other energy- based aesthetic treatments. The Company&#8217;s technology allows for a wide variety of applications in a single system. Key features of the Company&#8217;s solutions include:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Multiple</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Applications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Single</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Many of the Company&#8217;s platforms feature multiple-applications that enable practitioners to perform a variety of aesthetic procedures using a single device. These procedures include hair removal, vascular treatments and skin revitalization, which address discoloration, fine lines, and uneven texture. Because practitioners can use the Company&#8217;s systems for multiple indications, the investment in a unit is spread across a greater number of patients and procedures, and the acquisition cost may be more rapidly recovered.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Design</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leadership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s innovative laser technology combines multiple wavelengths, adjustable energy levels, variable spot sizes and a wide range of pulse durations, allowing practitioners to customize treatments for each patient and condition. The Company&#8217;s proprietary pulsed light hand pieces for the treatment of discoloration, hair removal and vascular treatments optimize the wavelength used for treatments and incorporate a monitoring system to increase safety. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece utilizes a novel light source not previously used for aesthetic treatments. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, with proprietary YSGG technology, represent the first application of the 2790 nm wavelength for minimally invasive cosmetic dermatology.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Upgradeable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo, excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products allow the Company&#8217;s customers to upgrade their system to the Company&#8217;s newest technologies or add new applications to their system, each of which provide the Company with a source of incremental revenue. The Company believes that product upgradeability allows customers to take advantage of the Company&#8217;s latest product offerings and provide additional treatment options to their patients, thereby expanding the opportunities for their aesthetic practices.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Treatments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Range</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Types</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For hair removal, the Company&#8217;s products are safe and effective on patients of all skin types, including harder-to-treat patients with dark or tanned skin. In addition, the wide parameter range of the Company&#8217;s systems allows practitioners to effectively treat patients with both fine and coarse hair. Practitioners may use the Company&#8217;s products to treat spider veins on the leg; to treat facial veins; and perform skin revitalization procedures for discoloration, texture, fine lines and wrinkles on any type of skin. The ability to customize treatment parameters based on skin type enables practitioners to offer safe and effective therapies to a broad base of their patients.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Ease of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company designs its products to be easy to use. The Company&#8217;s proprietary hand pieces are lightweight and ergonomic, minimize user fatigue, and facilitate clear views of the treatment area, reducing the possibility of unintended damage and increasing the speed of application. The Company&#8217;s control console contains an intuitive user interface with simple, independently adjustable controls from which to select a wide range of treatment parameters to suit each patient&#8217;s profile. For instance, the clinical navigation user interface on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform provides recommended clinical treatment parameter ranges based on patient criteria entered. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces include a scanner </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with multiple scan patterns to allow simple and fast treatments of the face. Finally, the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> embodies the best of many of the above features. Unlike other body sculpting treatments on the market that require certain body types, or pinchable fat, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is &#8220;body agnostic&#8221; with the ability to customize treatments to the patient's needs and body type. In addition, the Company&#8217;s proprietary algorithms and navigation enable the practitioner to treat a 300cm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> area in only 15 minutes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s vision and mission is to continue developing innovative solutions that harness the power of science and nature to advance health, beauty, and wellness. To achieve this goal, the Company plans on executing a strategic plan encompassing the following opportunities:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Capture Market Share in Acne and Capitalize on the Building Momentum in AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In March 2022, the FDA announced the 510(k) clearance of AviClear, the first energy-based device receiving designation for the treatment of mild, moderate, and severe acne. In the US, there are an estimated 50 million acne sufferers with only about 6.5 million seeking physician treatment. As a revolutionary first-mover solution, AviClear is well-positioned to disrupt the large and growing acne market with its robust clinical findings and promising positive results to-date. The Company announced official launch in November 2022 after a limited commercial release in April 2022. The device is now available broadly in the US as well as in Canada where Health Canada has approved the device for the treatment of mild, moderate, and severe acne along with additional approval in Canada for the treatment of acne scars. As of December 31, 2022, the Company has performed over 5,000 AviClear acne treatments. The Company has also introduced Avi360, a partnership-driven offering with tools, support, and education, and a rewards program for customers and expanded financing options for patients. These efforts are intended to drive support and increase access to care for both customers and patients. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Continue to Expand the Company&#8217;s Product Portfolio with Innovative Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Though the Company believes that its current portfolio of products is comprehensive, the Company&#8217;s research and development group has a pipeline of potential products under development. The Company launched excel V in 2011, truSculpt in 2012, ProWave LX in 2013, and excel HR and enlighten in 2014. In addition, the Company continues to expand offerings on the Company&#8217;s current platforms with further enhancement such as the enlighten III launched in 2016, truSculpt 3D launched in 2017, enlighten SR launched in April 2018, truSculpt launched in July 2018, excel V+ launched in February 2019 and truFlex launched in June 2019. The Company also introduced Secret RF, in January 2018, and Secret PRO, a fractional CO2 and RF microneedling device, in September 2020. In 2021, the company introduced truSculpt flex+, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes. More recently, in March 2022, the Company launched AviClear to treat mild, moderate, and severe acne. The Company&#8217;s research and development strategy remains focused on developing innovative, first-mover solutions to solve unmet and evolving needs of customers across the aesthetic and dermatologic fields while ensuring adequate updates and upgrades of current portfolio offerings to maintain high-quality products and outcomes for customers and patients.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Focus on Continued Investment of Clinical, Commercial Excellence, and Training Expertise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company believes one of its differentiators and contributors to the Company&#8217;s leading position in the aesthetic and dermatology industry is its commitment and continued investment in its clinical and regulatory capabilities, medical education, and customer success teams. The Company&#8217;s product portfolio is supported by robust and thoughtful clinical research, an internal clinic at the Company's headquarters for clinical studies, and targeted digital marketing strategies such as direct-to-patient and consumer marketing, tradeshows and workshops, clinical forums and symposiums, Cutera University, and webinars. In addition, the Company is committed to the commercial excellence of the customers through collaboration with key opinion leaders and expert customers around the world to foster valued partnerships and stay apprised of the latest trends and development in the industry.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Leverage Comprehensive Portfolio for Cross-Selling Opportunities and Deepen Customer Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company has a track record of 20 years delivering innovation, which has contributed to its robust and comprehensive portfolio offerings across several main franchises such as face and skin, body contouring, and medical dermatology. With the introduction of enlighten, excel V, excel HR, xeo, truSculpt, SecretPro, Secret RF, and AviClear, the Company can effectively offer additional platforms into the existing installed base. In addition, each of these platforms allows for potential future upgrades that offer additional capabilities. The Company believes the expansive breadth and depth of the Company&#8217;s portfolio offerings is a one-stop shop for customers seeking a range of treatments that can be performed in their practices. Practitioner customers can increase their patient&#8217;s wallet share, stickiness, and satisfaction with each visit while the Company can generate additional revenue through cross-selling products to existing customers. The Company believes this aligned value proposition will help grow the Company&#8217;s categorical leadership and gain market share while deepening relationships with current and new customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Expand the Company&#8217;s Global Presence and Footprint in Existing and Attractive New Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company currently serves over 40 countries and 10,000 customers with a global installed base of over 12,000 units through the Company&#8217;s clinically-focused and robust sales infrastructure of direct sales and distribution networks. While the Company is continuing to strengthen its leadership position in the US, there presents significant opportunities abroad in areas such as APAC, particularly Japan, Europe, New Zealand, Australia, and other intercontinental locations. The Company believes that the market for aesthetic systems will continue to grow and offer whitespace opportunities in these geographic regions. As a result, the Company will continue to build brand recognition through new product introductions, invest in commercial infrastructure, and grow and optimize international sales channels and distribution networks to increase global footprint and revenue. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Increase Revenue and Improve Productivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company believes that there is a significant opportunity to grow revenue across its core and recurring revenue segments. With a comprehensive aesthetic and dermatologic portfolio, the Company has the opportunity to cross-sell to drive greater repeat repurchases from the current installed base. As the Company grows its leadership position in current and new therapeutic areas, the Company can accelerate market share gains across franchises and product categories. The Company&#8217;s innovative business model with AviClear represents a driver of more predictable and consistent revenue generation. The attractive financial profile &#8211; high recurring revenue and profitability margins &#8211; associated with this business model can serve to mitigate against any potential macroeconomic and industry headwinds and volatility. The Company also plans to generate increased recurring revenue from services and refillable, consumable, and hand pieces. The Company&#8217;s Titan, truSculpt 3D, truSculpt and truFlex cycle and pulsed-light handpieces are refillable products, while the Company&#8217;s single use disposable tips applicable to Secret PRO, and Secret RF are consumable products. Each provides the Company with the opportunity for greater participation in the `economics of high volume-based procedures from the Company&#8217;s existing customers. The Company also offers post-warranty services to its customers either through extended service contracts to cover preventive maintenance or through direct billing for parts and labor. These post-warranty services serve as additional sources of revenue. In addition, the Company generates revenue from distribution of third-party manufactured skincare products in Japan. These skincare products are purchased from a third-party manufacturer and sold to licensed physicians and other end users. Along with a focus on increasing operating efficiencies, gross margin expansion, and other financial improvements, the Company believes that this will build a foundation for a highly scalable business with strong top-line and bottom-line growth and increased long-term profitability.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Strategically Engage in Attractive and Synergistic Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company plans to explore opportunities that can augment and differentiate the Company&#8217;s product portfolio and research and development strategy, expand current leadership position, strengthen competitive positioning, penetrate new or adjacent markets, and present long-term financial benefits. Such opportunities may include, but are not limited to, acquisitions, strategic partnerships, licensing, or collaboration of competitive, commercial, distributor, supplier, or manufacturer relationships.  With a global brand, footprint, and commercial expertise, the Company can be a key strategic partner on various opportunities that can bring significant growth and value creation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo platforms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allow for the delivery of laser light and/or RF energy for aesthetic applications from a single system. With the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, practitioners can purchase customized systems with a variety of the Company&#8217;s multi-technology applications. Each of the Company&#8217;s products consists of a control console and one or more hand pieces, depending on the model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table lists the Company&#8217;s currently offered products. Each checked box represents the applications included in the product in the years noted.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applications:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skin Revitalization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noninvasive<br/>Body<br/>Contouring*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">System<br/>Platforms</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Energy<br/>Source</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hair<br/>Removal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vascular<br/>Lesions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BPL&#8217;s<br/>Dyschromia<br/>&amp; Melasma</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Texture,<br/>Lines and<br/>Wrinkles</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acne Scars</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tattoo<br/>Removal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lipolysis*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">xeo</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Nd:YAG</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">ProWave 770</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">AcuTip 500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Titan XL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">LimeLight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Pearl</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Pearl Fractional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">ProWave LX</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel V</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">enlighten(dual wavelength)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">enlighten III&#160;(MLA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt 3D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Secret RF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x*</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truFlex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x*</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel V+</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">PRO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(k)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(l)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Energy Sources:</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Visible</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">near-infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pulsed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Light;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pulsed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Light;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">2790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Er:YSGG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Combined</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency-doubled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&amp;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mono-polar</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Combined</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alexandrite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Dual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">picosecond</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Three</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">picosecond</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mono-polar; and</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bi-polar.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">1726nm wavelength</span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">allows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">it</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Union,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">certain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">countries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">outside</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reduction,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">shaping</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">contouring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">has</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">510(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">clearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reduction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">circumference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">abdomen,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">non-invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">lipolysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(breakdown</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fat)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">abdomen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">elevating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tissue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">temperature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">treatment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">such</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">relief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pain,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">muscle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">spasms,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">local</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">circulation,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">temporary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">improvement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">appearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cellulite.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">** Via Hemostasis and Coagulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Upgrades</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo, excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products, are designed to allow customers to cost-effectively upgrade to the Company&#8217;s newest technologies or add applications to their system, each of which provides the Company with a source of additional revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Extended Contract Services and Support</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for terms of one to four years. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company&#8217;s installed product base.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are engineered to enable quick and efficient service and support. There are several separate components of the Company&#8217;s products, each of which can be removed and replaced. The Company believes that quick and effective delivery of service is important to its customers. As of December&#160;31, 2022, the Company had 56 Field Service employees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In countries where the Company is represented by distribution partners, customers are serviced through the distributor. Distributors are generally provided warranty coverage for parts only, with labor customarily provided to the end customer by the distributor. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces generally include a warranty for a set number of shots, rather than for a period of time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers, except system sales through distributors, include training on the use of the system to be provided within 180 days of purchase. Training is also sold separately from systems. The Company recognizes revenue for training once the training has been provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumables (Other accessories)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as replacement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, as consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products have single use disposable tips, which must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applications and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are designed to allow the practitioner to select an appropriate combination of energy level, spot size and pulse duration for each treatment. The ability to manipulate the combinations of these parameters allows the Company&#8217;s customers to treat the broadest range of conditions available with a single energy-based system.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contouring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology allows practitioners to apply a hand piece directly to the skin and deliver high-powered RF energy that results in the deep and uniform heating of the subcutaneous fat tissue at sustained therapeutic temperatures. This heating can cause selective destruction of fat cells, which are eliminated from the treatment area through the body&#8217;s natural wound healing processes. The treatment takes approximately 15 minutes and two or more treatments may be required to obtain the desired aesthetic results. The Company&#8217;s CE Mark allows the Company to market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU, Australia and certain other countries outside the U.S. for fat reduction, body shaping, body contouring and circumferential reduction. In the U.S., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has 510(k) clearance for topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation. Additionally, the 2 MHz setting for the 40 cm2 hand piece is indicated for reduction in circumference of the abdomen and non-invasive lipolysis (breakdown of fat) of the abdomen. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> massage device is intended to provide a temporary reduction in the appearance of cellulite.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tattoo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> systems, delivering picosecond or dual picosecond and nanosecond pulse durations are used for tattoo removal, the treatment of benign pigmented lesions, and a laser skin toning procedure that the Company refers to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PICO Genesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hair</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has two platforms, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which address hair removal for all skin types as well as hair thicknesses. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform allows practitioners to select between the 1064 nm mode for darker, course hair, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProWave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece designed to address finer, vellus hair. Contact cooling is present on both hand pieces for epidermal protection. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs both a 1064 nm Nd:YAG as well as a 755 nm Alexandrite for hair removal. Like the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the 1064 nm wavelength addresses darker, course hair while the 755 nm wavelength is used for finer, lighter hair. Both wavelengths are transmitted through the same </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoolView</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece with spot sizes up to 18 mm for the 755 nm wavelength and up to 18 mm for the 1064 nm wavelength. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoolView</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece employs sapphire as a means of contact cooling &#8211; epidermal protection. Both platforms are cleared for treating all skin types.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vascular</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lesions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Both the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V and excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms are capable of treating a wide range of aesthetic vein conditions, including spider and reticular veins, and small facial veins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece for addressing small veins as well as vascular lesions while the Nd:YAG is appropriate for deeper, larger vessels. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a fixed spot size IPL while the Nd:YAG has adjustable spot sizes up to 10mm. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">devices are is a dual wavelength laser &#8211; 1064 nm and 532 nm &#8211; with adjustable spot sizes ranging from 2 mm to 12 mm for excel V and 1 mm - 16 mm for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 532 nm and 1064 wavelength can be used to treat over 20 conditions ranging from small veins and vessels to a variety of vascular lesions. For both of these devices, patients receive on average between one and six treatments, with six weeks or longer between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and enlighten platforms, utilizing an Nd:YAG laser, allow the Company&#8217;s customers to perform non-invasive and minimally-invasive treatments that reduce redness, dyschromia, fine lines, improve skin texture, and treat other aesthetic conditions. When using a 1064 nm Nd:YAG laser to improve skin texture and treat fine lines, cooling is not applied and the hand piece is held directly above the skin. A large number of pulses are directed at the treatment site, repeatedly covering an area, such as the cheek. By delivering many pulses of laser light to a treatment area, a gentle heating of the dermis occurs and collagen growth is stimulated to rejuvenate the skin and reduce wrinkles. Patients typically receive four to six treatments for this procedure. The treatment typically takes less than a half hour with a spacing of two to four weeks between treatments. Skin revitalization was expanded with introduction of 'green genesis', a micro-pulsed 532 nm treatment on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excelV+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texture,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lines</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wrinkles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform can address fine lines and wrinkles using the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces. When treating fine lines, texture and wrinkles with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece, the hand piece is held at a controlled distance from the skin and the scanner delivers a preset pattern of spots to the treatment area. Cooling is not applied to the epidermis during the treatment. The energy delivered by the hand piece ablates a portion of the epidermis while leaving a coagulated portion that will gently peel off over the course of a few days. Heat is also delivered into the dermis, which can result in the production of new collagen. Treatment of the full face can usually be performed in approximately 15 to 30 minutes. Patients receive on average between one and three treatments at monthly intervals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms feature Radio Frequency microneedling device that employs fractionated RF energy (2 MHz) delivered at different pre-programmed depths in the dermis to produce new collagen. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> come with four treatment tips: a 25-pin tip, both insulated and semi-insulated, and a semi-insulated 64-pin tip. The treatment has minimal side effects, negligible downtime and results in improved skin tone and texture as well as improvement in acne scars.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dyschromia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s pulsed-light technologies allow the Company&#8217;s customers to safely and effectively treat red and brown dyschromia (skin discoloration), benign pigmented lesions, and rosacea. The practitioner delivers a narrow spectrum of light to the surface of the skin through the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces. These hand pieces include one of the Company&#8217;s proprietary wavelength filters, which reduce the energy level required for therapeutic effect and minimize the risk of skin injury.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 532 nm wavelength green laser option of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> systems, as well as the 755 nm infrared wavelength of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> can be used to treat benign pigmented lesions in substantially the same way.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In treating benign pigmented lesions, the hand piece is placed directly on the skin and then the pulse is triggered. The cells forming the pigmented lesion absorb the light energy, darken and then flake off over the course of two to three weeks. Several treatments may be required to completely remove the lesion. The treatment takes a few minutes per area treated and there are typically three to four weeks between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Practitioners can also treat dyschromia and other skin conditions with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece. During these treatments, the heat delivered by the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece will remove the outer layer of the epidermis while coagulating a portion of the epidermis. That coagulated portion will gently peel off over the course of a few days, revealing a new layer of skin underneath. Treatment of the full face can usually be performed in 15 to 30 minutes. Patients receive on average between one and three treatments at monthly intervals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology allows the Company&#8217;s customers to use deep dermal heating to tighten lax skin. The practitioner delivers a spectrum of light to the skin through the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece. This hand piece includes the Company&#8217;s proprietary light source and wavelength filter which tailors the delivered spectrum of light to provide heating at the desired depth in the skin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In treating compromised skin, the hand piece is placed directly on the skin and then the light pulse is triggered. A sustained pulse causes significant heating in the dermis. This heating can cause immediate collagen contraction while also stimulating </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-term collagen regrowth. Several treatments may be required to obtain the desired degree of tightening of the skin. The treatment of a full face can take over an hour and there are typically four weeks between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s CE Mark allows the Company to market the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU, Australia and certain other countries outside the U.S. for the treatment of wrinkles through skin tightening. However, in the U.S. the Company has a 510(k) clearance only for deep dermal heating.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acne</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s acne solution, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is a prescription-free, drug-free laser treatment that is safe for all skin types and tones and FDA-cleared for the treatment of mild to severe acne. The device can provide lasting clearance without significant side effects in three 30-minute treatment sessions. Acne forms when sebum, the oily substance on skin, combines with dead skin cells and clogs pores. The Company&#8217;s treatment uses a 100-watt laser device with a 1726 nm wavelength to treat acne at the source by selectively targeting and down-regulating the sebaceous glands. Research has indicated that at 1726 nm, pure sebum absorbs twice as much energy as compared to water. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selectively targets this exact frequency to damage the sebocytes and down-regulate sebum production. Additionally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is equipped with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviCool&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sapphire skin cooling and smart sensory controls that maintain the skin&#8217;s temperature during treatment for a more comfortable and safe experience. After an AviClear treatment, patients can resume activities immediately. In addition, patients will produce less oil, helping improve the acne, and experience shorter breakouts with fewer and less intense flare-ups. Acne clearance results are expected to continue to improve over time, demonstrating the long-term efficacy of this treatment. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets, sells, and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland and the United Kingdom. International sales and services outside of these direct markets are made through a network of distributors in over 37 countries, as well as a direct international sales force. The Company internally manages its U.S. and Canadian sales organization as one North American sales region.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells certain items like hand piece refills, cycle refills, consumable tips, and marketing brochures through the Company&#8217;s web site www.mycutera.com.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers generally demand quality, performance, ease of use and high productivity in relation to the cost of ownership. The Company responds to these customer demands by introducing new products focused on these requirements in the markets it serves. Specifically, the Company believes it introduces new products and applications that are innovative, address the specific aesthetic procedures in demand, and are upgradeable on its customers&#8217; existing systems. In addition, the Company provides attractive upgrade pricing to new product families. To increase market penetration, the Company also markets to non-core practitioners in addition to the Company&#8217;s core specialties of plastic surgeons and dermatologists.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to establish strong ongoing relationships with its customers through the upgradeability of the Company&#8217;s products, sales of extended service contracts, hand piece refills and replacement disposable tips, ongoing training and support, and by distributing skincare products in Japan. The Company primarily targets its marketing efforts to practitioners through office visits, workshops, trade shows, webinars and trade journals. The Company also markets to potential patients through brochures, workshops and its website. In addition, the Company offers clinical forums with recognized expert panelists to promote advanced treatment techniques using the Company&#8217;s products to further enhance customer loyalty and uncover new sales opportunities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry in which the Company operates is subject to intense competition. The Company&#8217;s products compete against conventional non-energy-based treatments, such as electrolysis, Botox and collagen injections, chemical peels, microdermabrasion and sclerotherapy. The products also compete against laser and other energy-based products offered by other public companies, such as Abbvie (acquired Allergan and its division Zeltiq), Bausch Health (formerly Valeant Pharmaceuticals), Vieve, Soliton, InMode and Lutronic, as well as private companies, including Sisram, Candela (formerly Syneron Candela, acquired in 2017 by an affiliate of private equity funds advised by Apax Partners), Sciton, BTL Industries and several others. In late 2019, Clayton, Dubilier &amp; Rice entered into an agreement under which its managed funds acquired Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. Cynosure develops, manufactures, and markets medical aesthetic treatment systems for dermatologists, plastic surgeons, medical spas and other healthcare practitioners, with sales and distribution worldwide. In early 2020, the affiliated private equity funds of Baring Private Equity Asia completed the acquisition of Lumenis, a provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology, with an international presence. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition among providers of laser and other energy-based devices for the aesthetic market is characterized by extensive research and development efforts, and innovative technology. While the Company attempts to protect its products through patents and other intellectual property rights, there are few barriers to entry that would prevent new entrants or existing competitors from developing products that would compete directly with the Company. There are many companies, both public and private, that are developing devices that use both energy-based and alternative technologies. Some of these competitors have greater resources than the Company does or product applications for certain sub-markets in which the Company does not participate. Additional competitors may enter the market, and the Company is likely to compete with new companies in the future. To compete effectively, the Company has to demonstrate that the Company&#8217;s products are attractive alternatives to other devices and treatments by differentiating the Company&#8217;s products on the basis of performance, brand name, service and price. The Company has encountered, and expects to continue to encounter, potential customers who, due to existing relationships with the Company&#8217;s competitors, are committed to, or prefer, the products offered by these competitors. Competitive pressures may result in price reductions and reduced margins for the Company&#8217;s products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells skincare products in Japan under the exclusive distribution agreement with ZO which granted the Company the exclusive right to promote, market, sell, and distribute the products produced by ZO in Japan. ZO&#8217;s skincare products compete against other Physician-dispensed skincare brands developed and marketed by other companies, such as Environ, Navision and Revision Skincare, among others.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company focuses its research and development efforts on innovation and improvement for products and services that align with its mission. The Company consistently strives to understand its customers&#8217; expectations for total excellence. The Company accomplishes this by its commitment to continuous improvement in design, manufacturing, and service, which the Company believes provides for superior products and services to ensure on going customer satisfaction, trust and loyalty. The Company seeks to comply with all applicable domestic and international regulations to maintain the highest quality.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s research and development activities are conducted by employees with a broad base of experience in lasers, optoelectronics, software, and other related disciplines. The Company develops working relationships with outside contract engineering and design consultants, giving the Company&#8217;s team additional technical and creative breadth. The Company works closely with thought leaders and customers, to understand unmet needs and emerging applications in aesthetic medicine.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Investments, and Distribution Agreements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s strategy of providing a broad range of therapeutic capabilities requires a wide variety of technologies, products, and capabilities. The rapid pace of technological development in the aesthetic device industry and the specialized expertise required in different areas make it challenging for the Company to develop a broad portfolio of technological solutions. In addition to internally generated growth through research and development efforts, the Company has considered, and expects to continue to consider, acquisitions, investments, and distribution agreements to provide access to new products and technologies in both new and existing markets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to further the Company&#8217;s strategic objectives and strengthen its existing businesses by making future acquisitions and investments, or by entering into new distribution agreements in areas that the Company believes it can acquire or stimulate the development of new technologies and products. Mergers and acquisitions of medical technology companies, as well as distribution relationships, are inherently risky and no assurance can be given that any acquisition will be successful or will not materially adversely affect the Company&#8217;s consolidated operations, financial condition and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures its products with components and subassemblies supplied by vendors and assembles and tests each of its products at the Brisbane, California facility, and at third-party contract manufacturers&#8217; facilities. Quality control, cost reduction and inventory management are top priorities of the manufacturing operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components, subassemblies, and assembled systems from a limited number of suppliers. All Secret RF systems are manufactured by Ilooda Co. Ltd, who also manages all related regulatory activities. The Company has flexibility with its suppliers to adjust the number of components and subassemblies as well as the delivery schedules. The forecasts are based on historical demands and sales projections. Lead times for components and subassemblies may vary significantly depending on the size of the order, time required to fabricate and test the components or subassemblies, specific supplier requirements and current market demand for the components and subassemblies. The potential for disruption of supply is reduced by maintaining sufficient inventories and identifying additional suppliers. The time required to qualify new suppliers </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for some components, or to redesign them, could cause delays in the Company&#8217;s manufacturing. To date, the Company has not experienced significant delays in obtaining any of its components or subassemblies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Patents and Proprietary Technology</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company relies on a combination of patent, copyright, trademark and trade secret laws, and non-disclosure, confidentiality, and invention assignment agreements to protect the Company&#8217;s intellectual property rights. As of March 8, 2023, the Company had 29 issued and unexpired U.S. patents, 10 pending U.S. patent applications, and 4 pending international applications under the Patent Cooperation Treaty (PCT) or other national or regional patent offices. The Company intends to file for additional patents and trademarks to continue to strengthen the Company&#8217;s intellectual property rights. Patents typically have a 20-year term from the application filing date. There can be no assurance that pending patent applications will result in the issuance of patents, that patents issued to or licensed by the Company will not be challenged or circumvented by competitors, or that these patents will be found to be valid or sufficiently broad to protect the Company&#8217;s technology or to provide the Company with a competitive advantage. The Company has also obtained certain trademarks and trade names for the Company&#8217;s products and maintain certain details about the Company&#8217;s processes, products, and strategies as trade secrets. In the U.S. and several foreign countries, the Company registers its Company name and certain of its product names as trademarks, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cutera, AVI360, AviCare, AviClear, AviCool, AcuTip 500, CoolGlide, CUCF, Cutera University Clinical Forum, Enlighten, Excel HR, Excel V, Genesis, Laser Genesis, LimeLight, myQ, Pearl, PICO Genesis, ProWave 770, Solera, Titan, truBody, truSculpt, truSculpt iD, truSculpt Flex, Vantage,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company may have common law rights in other product names, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">truFlex.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company relies on non-disclosure and non-competition agreements with employees, technical consultants, and other parties to protect, in part, trade secrets and other proprietary technology. The Company also requires them to agree to disclose and assign to the Company all inventions conceived in connection with the relationship. There can be no assurance that these agreements will not be breached, that the Company will have adequate remedies for any breach, that others will not independently develop equivalent proprietary information or that third parties will not otherwise gain access to the Company&#8217;s trade secrets and proprietary knowledge.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, please refer to Item 1A. Risk Factors of this Annual Report on Form 10-K, under the section entitled &#8220;Risk Factors - Intellectual property rights may not provide adequate protection for some or all of the Company&#8217;s products, which may permit third parties to compete against the Company more effectively, and the Company may be involved in future costly intellectual property litigation, which could impact the Company&#8217;s future business and financial performance.&#8221;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are medical devices subject to regulation by numerous government agencies, including the FDA and counterpart agencies outside the U.S. To varying degrees, each of these agencies require the Company to comply with laws and regulations governing the research, development, testing, manufacturing, labeling, pre-market clearance or approval, marketing, distribution, advertising, promotion, record keeping, reporting, tracking, and importing and exporting of medical devices. In the U.S., FDA regulations govern the following activities that the Company performs and will continue to perform to ensure that medical products distributed domestically or exported internationally are safe and effective for their intended uses:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product design and development;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product testing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product manufacturing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product safety;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product labeling;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product storage;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">record keeping;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">pre-market clearance or approval;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">advertising and promotion;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">production;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product sales and distribution; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">complaint handling.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA&#8217;s Pre-market Clearance Requirements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, each medical device the Company wishes to commercially distribute in the U.S. will require either prior 510(k) clearance, or de novo approval from the FDA. The FDA classifies medical devices into one of three classes. Devices deemed to pose lower risks are placed in either Class I or II. For Class II, the manufacturer must submit to the FDA a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pre-market notification requesting permission to commercially distribute the device. This process is known as 510(k) clearance. Some low risk devices are exempted from this requirement. Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously cleared 510(k) device, are placed in Class III, requiring more rigorous pre-market approval. All of the Company&#8217;s current products are Class II devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">510(k) Clearance Pathway</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When 510(k) clearance is required, the Company must submit a pre-market notification demonstrating that the Company&#8217;s proposed device is substantially equivalent to a previously cleared 510(k) device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of Pre-Market Approval, or "PMA", applications. By regulation, the FDA is required to clear or deny 510(k), pre-market notification within 90 days of submission of the application. As a practical matter, clearance may take significantly longer, as FDA may require additional information. Laser devices used for aesthetic procedures, such as hair removal, have generally qualified for clearance under 510(k) procedures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the indications for which the Company received a 510(k) clearance for the Company&#8217;s products and when these clearances were received.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:83.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FDA Marketing Clearances:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Received:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laser-based products:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- treatment of vascular lesions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June&#160;1999</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- hair removal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- permanent hair reduction</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January&#160;2001</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- treatment of benign pigmented lesions and pseudo folliculitis barbae, commonly referred to as razor bumps, and for the reduction of red pigmentation in scars</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June&#160;2002</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- treatment of wrinkles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- treatment to increase clear nail in patients with onychomycosis</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- expanded spot size to 5 mm for clear nail in patients with onychomycosis</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- addition of Alexandrite 755 nm laser wavelength for hair removal, permanent hair reduction, treatment of vascular, benign pigmented lesions and treatment of wrinkles</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- addition of treatment of mild to moderate inflammatory acne vulgaris</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-  enlighten picosecond and nanosecond 532/1064 nm for the treatment of benign pigmented lesions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten picosecond and nanosecond 532/1064 nm for multi-colored tattoo removal</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- enlighten III picosecond and nanosecond 532/1064 nm for multi-colored tattoo removal and treatment of benign pigmented lesion and picosecond 670 nm for benign pigmented lesions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten III higher performance specifications for 532/1064 nm; addition of nanosecond mode for 670nm</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- enlighten III addition of tattoo removal for lighter colored inks (green and blue) for 670 nm</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten Micro Lens Array (MLA) for treatment of acne scars</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- treatment of acne</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pulsed-light technologies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- treatment of pigmented lesions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2003</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- hair removal and vascular treatments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2005</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for deep dermal heating for the temporary relief of minor muscle and joint pain and for the temporary increase in local circulation where applied</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;2004</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Solera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">tabletop console:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- for use with the Titan hand piece</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;2004</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- for use with the Company&#8217;s pulsed-light hand pieces</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January&#160;2005</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">product for the treatment of wrinkles</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2007</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">product for skin resurfacing and coagulation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2008</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">radio frequency product:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- for topical heating to elevate tissue temperature for the treatment of selected medical conditions such as relief of pain and muscle spasms and increase in local circulation; massage device for temporary reduction in the appearance of cellulite</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Temporary reduction in circumference of the abdomen</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Reduction in circumference of the abdomen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- truSculpt: For non-invasive lipolysis of the abdomen and for reduction in circumference of the abdomen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- truFlex: For improvement of abdominal tone, strengthening of abdominal muscles, and development of firmer abdomen; and strengthening, toning, and firming of buttocks and thighs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Modifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to FDA regulations, after a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, labeling and biocompatibility, requires a new clearance. The FDA requires manufacturers to make this determination initially, but the FDA can review any such decision and may disagree with a manufacturer&#8217;s determination. To date, the Company has modified aspects of the Company&#8217;s products after receiving regulatory clearance and determined that new 510(k) clearances are not required for these modifications. If the FDA disagrees with the Company&#8217;s determination not to seek a new 510(k) clearance, the FDA may retroactively require the Company to seek 510(k) clearance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Trials</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When FDA approval of a Class II device requires human clinical trials, only approval from the Institutional Review Board (&#8220;IRB&#8221;) is required to proceed with the planned and IRB approved clinical trial/study.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to manufacture the Company&#8217;s products in compliance with the FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;) and the international quality management standard for medical systems ISO 13485:2016. The QSR and ISO 13485 cover the methods and documentation of the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of the Company&#8217;s products. Since 2017, the Company has been enrolled in the Medical Device Single Audit Program (&#8220;MDSAP&#8221;). The MDSAP allows a single audit of a medical device manufacturer&#8217;s Quality Management System (&#8220;QMS&#8221;), which satisfies the requirements of five&#160;regulatory jurisdictions (FDA - US, Health Canada - Canada, Therapeutic Goods Administration (&#8220;TGA&#8221;) - Australia, Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) - Japan, and Ag&#234;ncia Nacional de Vigilancia Sanit&#225;ria (&#8220;ANVISA&#8221;) - Brazil); and for the EU under Europ&#228;ische Norm (&#8220;EN&#8221;) International Standards Organization (&#8220;ISO&#8221;) 13485:2016 and Medical Device Directive (MDD)/EU Medical Device Regulation ("MDR&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MDSAP re-certification occurs every three years with a surveillance audit taking place annually. Major findings during these audits or an increase in field reportable events could trigger regulatory enforcement action including by the FDA. The Company&#8217;s manufacturing facility is ISO 13485 certified. The Company had a successful MDSAP re-certification audit in January 2021. There were no significant findings or observations as a result of this audit. However, the Company&#8217;s failure to maintain compliance with the QSR requirements could result in the shutdown of the Company&#8217;s manufacturing operations and the recall of the Company&#8217;s products, which would have a material adverse effect on the Company&#8217;s business. In the event that one of the Company&#8217;s suppliers fails to maintain compliance with specified quality requirements, the Company may have to qualify a new supplier and could experience manufacturing delays as a result. The Company has opted to maintain quality assurance and quality management certifications to enable the Company to market the Company&#8217;s products in the U.S., the member states of the EU, the European Free Trade Association and countries which have entered into Mutual Recognition Agreements with the EU.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pervasive and Continuing Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply. These include:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Quality system regulations, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Labeling regulations and FDA prohibitions against the promotion of products for un-cleared, unapproved or &#8220;off-label&#8221; uses;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has broad post-market and regulatory enforcement powers. The Company is subject to unannounced inspections by the FDA and the Food and Drug Branch of the California Department of Health Services (or &#8220;CDHS&#8221;), to determine the Company&#8217;s compliance with the QSR and other applicable regulations, which may include the manufacturing facilities of the Company&#8217;s subcontractors. In the past, the Company&#8217;s current manufacturing facility has been inspected by the FDA and the CDHS. The FDA and the CDHS noted observations, but there were no findings that involved a material violation of regulatory requirements. The Company&#8217;s responses to those observations have been accepted by the FDA and CDHS.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also regulated under the Radiation Control for Health and Safety Act, which requires laser products to comply with performance standards, including design and operation requirements, and manufacturers to certify in product labeling and in reports to the FDA that their products comply with all such standards. The regulations also require laser manufacturers to file </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new product and annual reports, maintain manufacturing, testing and sales records, and report product defects. Various warning labels must be affixed and certain protective devices installed, depending on the class of the product.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Repair, replacement, recall or seizure of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Operating restrictions or partial suspension or total shutdown of production;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Refusing the Company&#8217;s requests for 510(k) clearance of new products, new intended uses, or modifications to existing products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Withdrawing 510(k) clearance that have already been granted; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Criminal prosecution and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also has the authority to require the Company to repair, replace or refund the cost of any medical device that it has manufactured or distributed. If any of these events were to occur, they could have a material adverse effect on the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to a wide range of federal, state and local laws and regulations, including those related to the environment, health and safety, land use and quality assurance. The Company believes that compliance with these laws and regulations as currently in effect will not have a material adverse effect on the Company&#8217;s capital expenditures, earnings and competitive and financial position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices are subject to foreign governmental regulations, which vary substantially from country to country. The time required to obtain clearance or approval by a foreign country may be different than that required for FDA clearance. And the clearance or approval requirements may be different from those in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Japan, the Company is actively seeking approvals for products to supplement the Company&#8217;s existing approvals for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten III,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Economic Area (&#8220;EEA&#8221;), which is composed of the 27 Member States of the EU plus Norway, Liechtenstein and Iceland, a single regulatory approval process exists, and conformity with the legal requirements is represented by the CE mark. The Company&#8217;s products are regulated in the EU as medical devices per the EU Medical Devices Regulation (&#8220;MDR&#8221;). The Company's current CE marks on systems sold in the EU are set to expire on April 15, 2023, and a new CE marking under the MDR designation is required after April 15, 2023. The Company intends to obtain MDR certification for its principal products sold in the EU ahead of the April 15, 2023 expiration date. From January 1, 2021, the UK Conformity Assessed (UKCA) mark replaced the CE mark as the new product conformity marking requirement in England, Wales, and Scotland. Medical devices will have until July 1, 2024, to comply. The CE mark continues to be required for goods sold in Northern Ireland. Other countries, such as Switzerland, have entered into Mutual Recognition Agreements and allow the marketing of medical devices that meet EU requirements. The EU has adopted numerous directives and European Standardization Committees have promulgated voluntary standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. Devices that comply with the requirements of a relevant directive will be entitled to bear CE conformity marking, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the EEA and countries which have entered into a Mutual Recognition Agreement. The method of assessing conformity varies depending on the type and class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a Notified Body, an independent and neutral institution appointed by a country to conduct the conformity assessment. This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s device. An assessment by a Notified Body in one member state of the EEA, or one country which has entered into a Mutual Recognition Agreement is required in order for a manufacturer to commercially distribute the product throughout these countries. ISO 9001 and ISO 13845 certification are voluntary harmonized standards. Compliance establishes the presumption of conformity with the essential requirements for a CE Marking. In February 2000, the Company&#8217;s facility was awarded the ISO 9001 and EN 46001 certification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company conducted the Company&#8217;s recertification audit to the requirements of ISO 13485:2003 under the MDSAP for the five regulatory jurisdictions signatory to MDSAP (FDA - US, Health Canada - Canada, TGA - Australia, PMDA - Japan, and ANVISA - Brazil); and for the EU under EN ISO 13485:2016 and MDD 93/42/EEC. In January 2021, the Company passed the recertification audit re-confirming compliance with ISO13485:2016 and MDSAP. The MDSAP and EU </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certification can be used to demonstrate compliance with GMP/QSR/QMS requirements for all five regulatory jurisdictions, replacing routine audits from each regulatory jurisdiction. For cause audits can still occur.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Applicability of Anti-Corruption Laws and Regulations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s worldwide business is subject to the U.S. Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;), the United Kingdom Bribery Act of 2010 (the &#8220;UK Bribery Act&#8221;) and other anti-corruption laws and regulations applicable in the jurisdictions where the Company operates. The FCPA can be used to prosecute companies in the U.S. for arrangements with physicians, or other parties outside the U.S., if the physician or party is a government official of another country and the arrangement violates the law of that country. The UK Bribery Act prohibits both domestic and international bribery, as well as bribery across both public and private sectors. There are similar laws and regulations applicable to the Company outside the U.S., all of which are subject to evolving interpretations. For additional information, please refer to Item 1A. Risk Factors of this Annual Report on Form 10-K, under the sections entitled &#8220;Risk Factors &#8211; the Company&#8217;s failure to comply with rules relating to bribery, foreign corrupt practices and privacy and security laws may subject the Company to penalties and adversely impact the Company&#8217;s reputation and business operations.&#8221;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Privacy and Security Laws</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various laws worldwide protect the confidentiality of certain patient health and other consumer information, including patient medical records, and restrict the use and disclosure of patient health information by healthcare providers. Privacy standards in Europe and Asia are becoming increasingly strict, enforcement action and financial penalties related to privacy in the EU are growing, and new laws and restrictions are being passed. The management of cross-border transfers of information among and outside of EU member countries is becoming more complex, which may complicate the Company&#8217;s clinical research and commercial activities, as well as product offerings that involve transmission or use of data. The Company will continue its efforts to comply with those requirements and to adapt the Company&#8217;s business processes to those standards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology and Clinical Health Act (&#8220;HITECH&#8221;) and their respective implementing regulations, including the final omnibus rule published on January 25, 2013, imposes specified requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys new general authority to file civil actions for damages or injunctions in federal court to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways, thus complicating compliance efforts. The Company potentially operates as a business associate to covered entities in a limited number of instances. In those cases, the patient data that the Company receives may include protected health information, as defined under HIPAA. Enforcement actions can be costly and interrupt regular operations of its business. While the Company has not been named in any such actions, if a substantial breach or loss of data from the Company&#8217;s records were to occur, the Company could become a target of such litigation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, Regulation 2016/679 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (&#8220;General Data Protection Regulation&#8221; or &#8220;GDPR&#8221;) came into effect on May 25, 2018. The GDPR replaces Directive 95/46/EC (&#8220;Data Protection Directive&#8221;). While many of the principles of the GDPR reflect those of the Data Protection Directive, for example in relation to the requirements relating to the privacy, security and transmission of individually identifiable health information, there are a number of changes. In particular: (1) pro-active compliance measures are introduced, such as the requirement to carry out a Privacy Impact Assessment and to appoint a Data Protection Officer where health data is processed on a &#8220;large scale;&#8221; and (2) the administrative fines that can be levied are significantly increased, the maximum being the higher of &#8364;20 million, or 4%, of the total worldwide annual turnover of the group in the previous financial year. The Company will continue its efforts to comply with the GDPR requirements and to adapt the Company&#8217;s business processes to those requirements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Health and Safety Laws</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to various environmental health and safety laws and regulations worldwide. Like other medical device companies, the Company&#8217;s manufacturing and other operations involve the use and transportation of substances regulated under environmental health and safety laws including those related to the transportation of hazardous materials. To the best of the Company&#8217;s knowledge at this time, the Company does not expect that compliance with environmental protection laws will have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees and Human Capital</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had 540 employees, compared to 461 employees as of December 31, 2021. The Company believes that its future success will depend in part on the Company&#8217;s continued ability to attract, hire and retain qualified personnel. None of the Company&#8217;s employees are represented by a labor union, and the Company believes its employee relations are good.&#160;The Company is committed to fostering a diverse and inclusive workplace that attracts and retains exceptional talent. Through ongoing employee development, comprehensive compensation and benefits, and a focus on health, safety and employee well-being, the Company strives to help its employees in all aspects of their lives so they can do their best work.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is committed to create and maintain a diverse and safe work environment to capture the ideas and perspectives that fuel innovation and enable its workforce, customers, and communities to succeed in creating the future of medical aesthetics. The Company strives to create an inclusive workplace where people can design, manufacture, and market a comprehensive portfolio of aesthetic laser and energy-based products that enable its customers (the practitioner) to provide safe and effective treatments.&#160;Its commitment to diversity and inclusion starts at the highest levels of the Company.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Engagement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly collects feedback to better understand and improve the employee experience and identify opportunities to continually strengthen its culture. The Company wants to know what is working well, what the Company can do better and how well its employees understand and practice the Company's cultural values. In 2022, nearly 97% of its employees participated in its annual employee survey.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leadership development and training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's leaders learn with Cutera, grow with Cutera and reach their potential through challenging job experiences. The Company provides learning opportunities by offering valuable training resources for employees in order to ensure its people have everything they need to succeed both personally and professionally. The Company&#8217;s employees are encouraged to take responsibility for their own development and create learning plans that best fit their needs and development goals. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The physical health, financial well-being, life balance and mental health of its employees is vital to its success. The Company sponsors wellness initiatives designed to enhance physical, financial, and mental well-being for all employees. The Company has successfully implemented a number of safety and social distancing measures within its premises to protect the health and safety of associates who are required to be on-premise to support its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes its periodic and current reports, including the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports, filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as well as its charters for the Company's Audit, Compensation, Nominating and Corporate Governance, and Enterprise Risk Committees and its Code of Ethics, Corporate Governance Guidelines, By-Laws, and Certificate of Incorporation, available free of charge, on the Company&#8217;s website as soon as practicable after such material is electronically filed or furnished with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company&#8217;s website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.cutera.com </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the reports are filed under &#8220;SEC Filings,&#8221; under &#8220;Financials&#8221; on the Investor Relations portion of the Company&#8217;s website. These reports and other information concerning the Company may be accessed through the SEC&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a rapidly changing economic and technological environment that presents numerous risks, many of which are driven by factors that the Company cannot control or predict. The Company&#8217;s business, financial condition and results of operations may be impacted by a number of factors. In addition to the factors discussed elsewhere in this report, the following risks and uncertainties could materially harm the Company&#8217;s business, financial condition or results of operations, including causing the Company&#8217;s actual results to differ materially from those projected in any forward-looking statements. The following list of significant risk factors is not all-inclusive or necessarily in order of importance. Additional risks and uncertainties not presently known to the Company, or that the Company currently deems immaterial, also may materially adversely affect the Company in future periods. You should carefully consider these risks and uncertainties before investing in the Company&#8217;s securities.</span></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business, financial condition, operating results and cash flows are subject to numerous risks and uncertainties that are summarized below. The below summary of risk factors should be read together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Company&#8217;s Business and its Industry</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Global supply chain disruptions and inflation may have a material adverse effect on the Company's business, financial condition and results of operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The increase in sales of skincare products in Japan in 2020 and 2021 may have been temporary, and sales of skincare products may continue to decline in the future.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The trading price of the Company&#8217;s common stock may fluctuate substantially.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company has a relatively limited number of shares of common stock outstanding, which could result in an increase in volatility of its stock price.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s ability to report timely and accurate information could be negatively impacted by its recent implementation of a new accounting and enterprise resource planning (&#8220;ERP&#8221;) system.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Reliance on contract manufacturers increases the risk that the Company will not have sufficient supply or that such supply will not be available to the Company at an acceptable cost.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s annual and quarterly operating results may fluctuate in the future, which may cause the Company&#8217;s trading </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price to decline.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Any defects in the design, material or workmanship of its products, defective design, material or workmanship or misuse of its products will cause additional costs, including product recalls and product liability suits, and harm the Company&#8217;s reputation.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The success and continuing development of the Company&#8217;s products depends, in part, upon maintaining strong relationships with physicians and other healthcare professionals.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Failure in hiring, training and retaining sales professionals and skilled and experienced personnel, or changes to management could adversely affect the Company&#8217;s operations and financial results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company depends on skilled and experienced personnel to operate its global business effectively.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Inability for the Company's new energy-based solution for the treatment of Acne to be widely adopted by customers or their patients.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The aesthetic equipment market is characterized by rapid innovation and high competition, which may adversely affect the Company if it does not continue to innovate and develop new products and applications.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company competes against companies that offer alternative solutions to its products, have greater resources, or have a larger customer base and broader product offerings than the Company&#8217;s offerings.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s business is subject to regulatory requirements, laser performance standards, federal regulatory reforms, FDA and other government agencies&#8217; regulation and oversight which may negatively affect its business, financial condition and results of operations if the Company fails to comply with them.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company's products may cause or contribute to adverse medical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events or be subject to failures or malfunctions that would be subject to sanctions that could harm its reputation, business, financial condition and results of operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company may be unable to obtain or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maintain international regulatory qualifications or approvals for its current or future products and indications, which could harm its business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Failure in international expansion and economic and other risks associated with international sales and operations could adversely affect the Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Some of the Company&#8217;s manufacturing operations are dependent upon third-party suppliers, making it vulnerable to supply shortages and price fluctuations, which could harm its business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Reduction or interruption in supply and an inability to develop alternative sources for supply may adversely affect the Company&#8217;s manufacturing operations and related product sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.8pt">If the Company fails to maintain or renew any of its distribution agreements before they expire, its revenues and cash flow may be adversely affected.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">To successfully market and sell third-party products internationally, the Company must address many issues that are unique to the related distribution arrangements, which could reduce the Company&#8217;s available cash reserves and negatively impact the Company&#8217;s profitability.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s distribution agreement with ZO requires certain economic requirements to be met by the Company. If the Company does not meet these minimum requirements, the Company could lose the distribution rights to the skincare products.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If customers are not trained and/or the Company&#8217;s products are used by non-licensed practitioners, it could result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation, result in product liability litigation, distract management and result in additional costs, all of which could harm the Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s products are sometimes subject to clinical trial processes which are lengthy and expensive and have uncertain outcomes. Delays or failures in the Company's clinical trials will prevent it from commercializing any modified or new products.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Intellectual property rights may not provide adequate protection for some or all the Company&#8217;s products, or the Company may be involved in future costly intellectual property litigation.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The expense and potential unavailability of insurance coverage for the Company&#8217;s customers could adversely affect its ability to sell its products, and therefore adversely affect its financial condition.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Any acquisitions that the Company makes could result in operating difficulties, dilution, and other consequences that may adversely impact the Company&#8217;s business and results of operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Adverse developments affecting the banking industry, such as actual events or concerns involving liquidity, defaults or non-performance, could adversely affect the Company's operations and liquidity. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Cash, cash equivalents and marketable securities could be adversely affected by the failure of Silicon Valley Bank or other financial institutions.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Inability to access credit on favorable terms for the funding of the Company&#8217;s operations and capital projects may be limited due to changes in credit markets.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Security breaches, cyber-security incidents and other disruptions could compromise the Company&#8217;s information and impact the Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Macroeconomic political and market conditions, and catastrophic events may adversely affect the Company&#8217;s business, results of operations, financial condition and the trading price of the Company&#8217;s stock.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Disaster or other similar events could cause damage to the Company&#8217;s facilities and equipment, which may require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Income tax audits or similar proceedings or changes in accounting standards may have a material adverse effect on the Company&#8217;s results of operations and financial position.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company may be adversely affected by changes in U.S. tax laws, importation taxes and other changes that may be imposed by the current administration.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Changes in accounting standards and estimates could have a material adverse effect on the Company&#8217;s results of operations and financial position.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company has identified a material weakness in its internal control over financial reporting related to information technology general controls ("ITGCs"), inventory controls, and accounting for expense related to equity-based awards, which could, if not remediated, result in material misstatements in the Company's financial statements.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Economic and other risks associated with international sales and operations could adversely affect the Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company offers credit terms to some qualified customers and also to leasing companies to finance the purchase of its products. In the event that any of these customers default on the amounts payable to the Company, its earnings may be adversely affected.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s ability to effectively compete and generate additional revenue from new and existing products depends upon the Company&#8217;s ability to distinguish the Company and its products from the competitors and their products, and to develop and effectively market new and existing products. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If there is not sufficient consumer demand for the procedures performed with the Company&#8217;s products, practitioner demand for its products could be inhibited, resulting in unfavorable operating results and reduced growth potential.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If the Company modifies one of its&#160;FDA-cleared&#160;devices, it may need to seek a new clearance, which, if not granted, would prevent the Company from selling its modified products or cause it to redesign its products.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If the Company cannot obtain and maintain Medical Device Regulation approvals, the Company will not be able to sell its products in the European Union. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Any defects in the design, material or workmanship of its products may not be discovered prior to shipment to customers, which could materially increase its expenses, adversely impact profitability and harm its business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company's products may in the future be subject to product recalls that could harm its&#160;reputation, business and financial results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The results of the Company's&#160;clinical trials may not support its&#160;products claims or may result in the discovery of adverse side effects.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Product liability suits could be brought against the Company due to a defective design, material or workmanship or misuse of its products and could result in expensive and time-consuming litigation, payment of substantial damages and an increase in its insurance rates.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Certain of the Company&#8217;s product platforms such as Enlighten and excel HR are only capable of being produced at the single site in Brisbane, and as such the occurrence of a catastrophic disaster or other similar event could cause damage to its facilities and equipment, which might require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company may be involved in future costly intellectual property litigation, which could impact its future business and financial performance.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company&#8217;s failure to comply with rules relating to bribery, foreign corrupt practices, and privacy and security laws may subject the Company to penalties and adversely impact its reputation and business operations.</span></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Convertible Notes</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Servicing the Company&#8217;s debt, including the notes, may require a significant amount of cash, and the Company may not have sufficient cash flow from its business to pay its indebtedness.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company may not have the ability to raise the funds necessary to settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and its future debt may contain limitations on its ability to pay cash upon conversion or repurchase of the notes.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The conditional conversion feature of the notes, if triggered, may adversely affect the Company's financial condition and operating results.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Transactions relating to the notes may affect the value of the Company&#8217;s common stock.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company is subject to counterparty risk with respect to the capped call transactions.</span></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of the Company's Common Stock</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Anti-takeover provisions contained in the Company's amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company's business could be negatively affected by activist shareholders.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, its market or its competitors, or if they adversely change their recommendations regarding the Company's common stock, the market price and trading volume of its common stock could decline.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company does not expect to declare any dividends on its common stock in the foreseeable future.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">If the Company raises additional capital through the sale of shares of the Company&#8217;s common stock, convertible securities or debt in the future, its stockholders&#8217; ownership in the Company could be diluted and restrictions could be imposed on the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company has implemented &#8220;sell-to-cover&#8221; in which shares of its common stock are sold into the market on behalf of RSU and PSU holders upon vesting of RSUs and PSUs to cover tax withholding liabilitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s and such sales will result in dilution to its stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to&#160;the Company&#8217;s Business and its Industry</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global supply chain disruptions and inflation may have a material adverse effect on the Company's business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recent disruptions to the global economy have impeded global supply chains and resulted in longer lead times and increased component costs and freight expenses. In some instances, the Company depends on a sole source supplier arrangement, and alternative suppliers may not be readily available. The supply of these components is critical to the Company's manufacturing needs. There can be no assurances that unforeseen future events in the global supply chain, and inflationary pressures, will not have a material adverse effect on its business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The increase in sales of skincare products in Japan in 2020 and 2021 may have been temporary, and sales of skincare products may continue to decline in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2020 and 2021, the Company experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO, which allows the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales may have been the result of changes in customers&#8217; spending habits to purchase more aesthetic treatments which could be applied at home due to limitations on in-person aesthetic procedures, social distancing and mask wearing requirements resulting from the COVID-19 pandemic. In 2022, the Company experienced a decrease in skincare revenue, mainly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">as a result of a significant weakening of the Japanese Yen. Future growth in sales of skincare products depends on the customers&#8217; spending habits, which may revert to original spending habits after the COVID-19 pandemic, and strengthening of the Yen. If sales in Japan do not recover to their previous levels, the Company&#8217;s revenue, operating results and cash flows will be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of the Company&#8217;s common stock may fluctuate substantially due to several factors, some of which are outside of its control. Further, the Company has a relatively limited number of shares of common stock outstanding, a large portion of which is held by a small number of investors, which could result in the increase in volatility of its stock price.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been recent volatility in the price of the Company&#8217;s common stock. The Company believes this is due in part to the overall impact of COVID-19 on the aesthetic industry and its partial recovery, and other factors discussed below. As a result of the Company&#8217;s relatively limited public float, its common stock may be less liquid than the stock of companies with broader public ownership. Among other things, trading of a relatively small volume of the Company&#8217;s common stock may have a greater impact on the trading price for the Company&#8217;s shares than would be the case if the Company&#8217;s public float were larger. The public market price of the Company&#8217;s common stock has in the past fluctuated substantially and, due to the current concentration of stockholders, the trading price of the common stock may continue to do so in the future. The market price for the Company&#8217;s common stock could also be affected by a number of other factors, including the general market conditions unrelated to the Company&#8217;s operating performance, including market volatility as a result of the COVID-19 outbreak.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price for the Company&#8217;s common stock could also be affected by a number of other factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the general market conditions unrelated to the Company&#8217;s operating performance;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">sales of large blocks of the Company&#8217;s common stock, including sales by the Company&#8217;s executive officers, directors and large institutional investors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">quarterly variations in the Company&#8217;s, or the Company&#8217;s competitors&#8217;, results of operations;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">actual or anticipated changes or fluctuations in the Company&#8217;s results of operations;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">actual or anticipated changes in analysts&#8217; estimates, investors&#8217; perceptions, recommendations by securities analysts or the Company&#8217;s failure to achieve analysts &#8216;estimates;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the announcement of new products, service enhancements, distributor relationships or acquisitions by the Company;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the announcement of the departure of a key employee or executive officer by the Company or the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulatory developments or delays concerning the Company&#8217;s, or the Company&#8217;s competitors&#8217; products; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the initiation of any litigation by the Company or against the Company, including the lawsuit initiated by the Company on January 31, 2020 in Federal District Court in California against Lutronic Aesthetics, Inc. as previously disclosed on February 3, 2020, or against the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual or perceived instability or volatility in the Company&#8217;s stock price could reduce demand from potential buyers of the Company&#8217;s stock, thereby causing the trading price of the Company&#8217;s notes and stock to either remain depressed or to decline further. In addition, if the market for medical-device company stocks or the stock market in general experiences a loss of investor confidence, the trading price of the Company&#8217;s notes and stock could decline for reasons unrelated to the Company&#8217;s business, results of operations or financial condition. The trading price of the Company&#8217;s notes and common stock might also decline in reaction to events that affect other companies in the Company&#8217;s industry even if these events do not directly affect us. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Any future securities litigation could result in substantial costs and divert the Company&#8217;s management&#8217;s attention and resources from the Company&#8217;s business, which could have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to report timely and accurate information could be negatively impacted by its recently implemented accounting and enterprise resource planning (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ERP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">) system.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recently completed the implementation of a new accounting and ERP system. If aspects of the implementation were not executed successfully, then the Company's ability to report timely and accurate information could be negatively impacted. Such events could have a material adverse effect on the Company&#8217;s consolidated financial position and results of operation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company relie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s on third-party contract manufacturers (&#8220;CMs&#8221;) to produce certain systems. This reliance on CMs increases the risk that the Company will not have sufficient supply or that such supply will not be available to it at an acceptable cost, which may have a material adverse effect on its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into arrangements with third-party contract manufacturers to produce and deliver fully assembled systems ready for direct shipment to its customers. The Company may experience supply shortfalls or delays in shipping products </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to its customers if its contract manufacturers experience delays, disruptions, quality control problems in their manufacturing operations, or if the Company has to change or add manufacturers or contract manufacturing locations. Even if products are available, the Company may be unable to obtain sufficient quantities at an acceptable cost or quality. The Company may not have adequate time to transition all of its manufacturing needs to an alternative manufacturer under comparable commercial terms. Additionally, a significant portion of the Company's manufacturing is performed in foreign countries and is therefore subject to risks associated with doing business outside of the U.S., including import restrictions, export restrictions, disruptions to its supply chain, cyberattacks, pandemics, regional climate-related events, or regional conflicts. The failure by the Company or its CMs to produce sufficient quantities at acceptable cost and quality may have a material adverse effect on its business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company&#8217;s annual and quarterly operating results may fluctuate in the future, which may cause the Company&#8217;s trading&#160;price for the shares to&#160;decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net sales, expenses and operating results may vary significantly from year to year and quarter to quarter for several reasons, including, without limitation:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the ability of the Company&#8217;s sales force to effectively market and promote the Company&#8217;s products, and the extent to which those products gain market acceptance;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the inability to meet the Company&#8217;s debt repayment obligations under its senior credit facility due to insufficient cash;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the possibility that cybersecurity breaches, data breaches, and other disruptions could compromise the Company&#8217;s information or result in the unauthorized disclosure of confidential information;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the existence and timing of any product approvals or changes;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the rate and size of expenditures incurred on the Company&#8217;s clinical, manufacturing, sales, marketing, and product development efforts;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company&#8217;s ability to attract and retain personnel;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the availability of key components, materials and contract services, which depends on the Company&#8217;s ability to forecast sales, among other things;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">investigations of the Company&#8217;s business and business-related activities by regulatory or other governmental authorities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">variations in timing and quantity of product orders;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">temporary manufacturing interruptions or disruptions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the timing and success of new product and new market introductions, as well as delays in obtaining domestic or foreign regulatory approvals for such introductions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased competition, patent expirations or new technologies or treatments;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product recalls or safety alerts;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">litigation, including product liability, patent, employment, securities class action, stockholder derivative, general commercial and other lawsuits;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">volatility in the global market and worldwide economic conditions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws, including changes domestically and internationally, or exposure to additional income tax liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the impact of the EU privacy regulations (GDPR) on the Company&#8217;s resources;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the financial health of the Company&#8217;s customers and their ability to purchase the Company&#8217;s products in the current economic environment;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">other unusual or non-operating expenses, such as expenses related to mergers or acquisitions, may cause operating results to vary; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">an epidemic or pandemic, such as the COVID-19&#160;pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of any of these factors, the Company&#8217;s consolidated results of operations may fluctuate significantly, which may in turn cause the&#160;trading price&#160;of the shares to fluctuate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If defects are discovered in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, the Company may incur additional unforeseen costs, customers may not purchase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">product and the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s reputation may suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success depends on the quality and reliability of its products. The Company&#8217;s products incorporate different components including optical components, and other medical device software, any of which may contain errors or exhibit failures, especially when products are first introduced. In addition, new products or enhancements may contain undetected errors or performance problems that, despite testing, are discovered only after commercial shipment. Because the Company&#8217;s products are designed to be used to perform complex surgical procedures, due to the serious and costly consequences of product failure, the Company and its customers have an increased sensitivity to such defects. In the past, the Company has voluntarily recalled certain products. The Company cannot provide&#160;assurance that its products will not experience component aging, errors, or performance problems. If the Company experiences product flaws or performance problems, any or all of the following could occur:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delays in product shipments;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">loss of revenue;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delay in market acceptance;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">diversion of the Company&#8217;s resources;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">damage to the Company&#8217;s reputation;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product recalls;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulatory actions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased service or warranty costs; or</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product liability claims.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with product flaws or performance problems could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations&#160;or cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success and continuing development of the Company&#8217;s products depends, in part, upon maintaining strong relationships with physicians and other healthcare professionals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company fails to maintain the Company&#8217;s working relationships with physicians and other ancillary healthcare and aesthetic professionals, the Company&#8217;s products may not be developed and marketed in line with the needs and expectations of the professionals who use and support the Company&#8217;s products. Physicians assist the Company as researchers, marketing consultants, product consultants, and public speakers, and the Company relies on these professionals to provide the Company with considerable knowledge and experience. If the Company is unable to maintain these strong relationships, the development and marketing of the Company&#8217;s products could suffer, which could have a material adverse effect on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company relies heavily on its sales professionals to market and sell its products worldwide. If the Company is unable to hire, effectively train, manage, improve the productivity of, and retain the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s sales professionals, the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business will be harmed, which would impair its future revenue and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success largely depends on the Company&#8217;s ability to hire, train, manage, and improve the productivity levels of its sales professionals worldwide. Because of the Company&#8217;s focus on&#160;non-core&#160;practitioners in the past, several of its sales professionals do not have established relationships with the core market, consisting of dermatologists and plastic surgeons, or where those relationships exist, they are not appropriately strong.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition for sales professionals who are familiar with, and trained to sell in, the aesthetic equipment market continues to be robust. As a result, the Company occasionally loses its sales people to competitors. The Company&#8217;s industry is characterized by a few established companies that compete vigorously for talented sales professionals. Some of its sales professionals leave the Company for jobs that they perceive to be better opportunities, both within and outside of the aesthetic industry. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability to enforce measures to protect the Company&#8217;s proprietary and confidential information when employees leave the Company varies from jurisdiction to jurisdiction and the Company&#160;must make a&#160;case-by-case&#160;decision regarding legal enforcement action. For instance, covenants&#160;not-to-compete&#160;are not allowed in many states, and if allowed, are difficult to enforce in many jurisdictions. Furthermore, such legal enforcement actions are expensive and the Company&#160;cannot give any assurance that these enforcement actions will be successful.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the Company also continues to hire and train new sales people, including several from the Company&#8217;s competitors. When the Company&#8217;s sales employees and sales management are newly hired or transferred into different roles, and it takes time for them to be fully trained to improve their productivity. In addition, due to the competition for sales professionals in the Company&#8217;s industry, the Company also recruits sales professionals from outside the industry. Sales professionals from outside the industry typically take longer to train and become familiar with the Company&#8217;s products and the procedures in which they are used. As a result of a lack of industry knowledge, these sales professionals may take longer to become productive members of the Company&#8217;s sales force.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Measures the Company implements in an effort to recruit, retain, train and manage the Company&#8217;s sales professionals, strengthen their relationships with core market physicians, and improve their productivity may not be successful and may instead contribute </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to instability in its operations, additional departures from the Company&#8217;s sales organization, or further reduce the Company&#8217;s revenue and harm the Company&#8217;s business. If the Company is not able to improve the productivity and retention of the Company&#8217;s North American and international sales professionals, then the Company&#8217;s total revenue, profitability and stock price may be adversely impacted.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company depends on skilled and experienced personnel to operate its global business effectively. Changes to management or the inability to recruit, hire, train and retain qualified personnel, could harm the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to successfully manage, develop and expand its business, which would impair the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s future revenue and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success largely depends on the skills, experience and efforts of the Company&#8217;s senior management and other key employees. The loss of any of the Company&#8217;s executive officers could weaken its management expertise and harm the Company&#8217;s business, and it may not be able to find adequate replacements on a timely basis, or at all. Except for Change of Control and Severance Agreements for the Company&#8217;s executive officers and a few key employees, the Company does not have employment contracts with any of its officers or other key employees. Any of the Company&#8217;s senior management and other key employees may terminate their employment at any time, with or without notice and their knowledge of the Company&#8217;s business and industry may be difficult to replace. The Company does not have a succession plan in place for each of its senior management and key employees. In addition, the Company does not maintain &#8220;key person&#8221; life insurance policies covering any of the Company&#8217;s employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to dependence on the Company&#8217;s executive officers and key employees, the Company is highly dependent on other sales and scientific personnel. For example, in the first quarter of 2020 the Company experienced turnover of its sales professionals, including several people in key sales leadership positions. Most of these sales professionals went to work for a competitor. Additionally, the Company&#8217;s product development plans depend, in part, on the Company&#8217;s ability to attract and retain engineers with experience in medical devices. Attracting and retaining qualified personnel will be critical to the Company&#8217;s success, and competition for qualified personnel is intense. The Company may not be able to attract and retain personnel on acceptable terms given the competition for such personnel among technology and healthcare companies and universities. The loss of any of these persons or the Company&#8217;s inability to attract, train and retain qualified personnel could harm the Company&#8217;s business and the Company&#8217;s ability to compete and become profitable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To induce valuable employees to remain at the Company, in addition to salary and cash incentives, the Company has provided stock options and restricted stock unit awards that vest over time, and, for the Company&#8217;s executive officers and certain key employees, performance stock unit awards that vest based on achievement of performance-based vesting conditions. The value to employees of such equity awards may be significantly affected by movements in the Company's stock price that are beyond its control, and may at any time be insufficient to counteract more lucrative offers from other companies. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company recently launched AviClear, an energy-based solution for the treatment of Acne and can provide no assurance that the device will be widely adopted by customers or their patients.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company brought AviClear, an energy-based device for Acne, to market in 2022. This launch required, and any future sales expansion for AviClear may require, a considerable investment in resources, including technical, financial, legal, sales, information technology and operation systems. Additionally, market acceptance of AviClear will be affected by a variety of factors, including but not limited to usability, performance, reliability and customer preference.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that demand for this device will not be as strong as anticipated. The Company may be unable to establish and manage a sufficient or effective sales force in a timely or cost-effective manner, and any sales force the Company does establish may not be capable of generating demand for AviClear, therefore hindering the Company&#8217;s ability to generate revenues and achieve or sustain profitability from AviClear.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The aesthetic equipment market is characterized by rapid innovation. To compete effectively, the Company must develop and/or acquire new products, seek regulatory clearance, market them successfully, and identify new markets for the Company&#8217;s technology.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aesthetic li</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ght and energy-based treatment system industry is subject to continuous technological development and product innovation. If the Company does not continue to innovate and develop new products and applications, the Company&#8217;s competitive position will likely deteriorate as other companies successfully design and commercialize new products and applications or enhancements to the Company&#8217;s current products. The Company created products to apply the Company&#8217;s technology to body contouring, hair removal, treatment of veins, tattoo removal and skin revitalization, including the treatment of diffuse redness, fine lines and wrinkles through hemostasis and coagulation, skin texture, pore size and benign pigmented lesions, etc. For example, the Company introduced Secret RF, a fractional RF microneedling device for skin revitalization, in January 2018, enlighten SR in April 2018, truSculpt in July 2018, excel V+ in February 2019, truFlex in June 2019, and the Secret Pro, a device combining the benefits of RF microneedling with the capabilities of a fractional, ablative CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> laser in September of 2020. In 2021, the Company introduced truFlex+, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes. To grow in the future, the Company must continue to develop and/or acquire new and innovative aesthetic products and applications, identify new markets, and successfully launch the newly acquired or developed product offerings.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To successfully expand the Company&#8217;s product offerings, the Company must, among other things:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">develop or otherwise acquire new products that either add to or significantly improve the Company&#8217;s current product offerings;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">obtain regulatory clearance for these new products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">convince the Company&#8217;s existing and prospective customers that the Company&#8217;s product offerings are an attractive revenue-generating addition to their practice;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">sell the Company&#8217;s product offerings to a broad customer base;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">identify new markets and alternative applications for the Company&#8217;s technology;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">protect the Company&#8217;s existing and future products with defensible intellectual property; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">satisfy and maintain all regulatory requirements for commercialization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, product introductions have been a significant component of the Company&#8217;s financial performance. To be successful in the aesthetics industry, the Company believes it needs to continue to innovate. The Company&#8217;s business strategy is based, in part, on its expectation that the Company will continue to increase or enhance its product offerings. The Company needs to continue to devote substantial research and development resources to make new product introductions, which can be costly and time consuming to its organization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also believes that, to increase revenue from sales of new products, the Company needs to continue to develop its clinical support, further expand and nurture relationships with industry thought leaders, and increase market awareness of the benefits of its new products. However, even with a significant investment in research and development, the Company may be unable to continue to develop, acquire or effectively launch and market new products and technologies regularly, or at all. If the Company fails to successfully commercialize new products or enhancements, its business may be harmed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are few barriers to entry that would prevent new entrants or existing competitors from developing products that compete directly with the Company&#8217;s. The Company expects that any competitive advantage the Company may enjoy from current and future innovations may diminish over time as companies successfully respond to the Company&#8217;s, or create their own, innovations. Consequently, the Company believes that it will have to continuously innovate and improve the Company&#8217;s products and technology to compete successfully. If the Company is unable to innovate successfully, its products could become obsolete and its revenue could decline as its customers and prospective customers purchase its competitors&#8217; products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products in any of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s markets could be weakened by several factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to develop an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d market the Company&#8217;s products to the core market specialties of dermatologists and plastic surgeons;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">poor financial performance of market segments that attempt to introduce aesthetic procedures to their businesses;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the inability to differentiate the Company&#8217;s products from those of the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">competitive threat from new innovations and product introductions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">reduced patient demand for elective aesthetic procedures;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">failure to build and maintain relationships with key opinion leaders within the various market segments; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the lack of credit financing, or an increase in the cost of borrowing, for some of the Company&#8217;s potential customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company does not achieve anticipated demand for the Company&#8217;s products, there could be a material adverse effect on its total revenue, profitability, employee retention and stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">petes against companies that offer alternative solutions to its products, have greater resources, or have a larger installed base of customers and broader product offerings than the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s. In addition, increased consolidation in the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s industry may lead to increased competition. If the Company is not able to effectively compete with these companies, it may harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology and aesthetic product markets are highly competitive and dynamic and are characterized by rapid and substantial technology development and product innovations. The Company&#8217;s products compete against conventional&#160;non-energy-based&#160;treatments, such as electrolysis, Botox and collagen injections, chemical peels, microdermabrasion and sclerotherapy. The Company&#8217;s products also compete against laser and other energy- based products offered by other companies. Further, other companies could introduce new products that are in direct competition with the Company&#8217;s products. The Company may also face competition from manufacturers of pharmaceutical and other products that have not yet been developed. Competition with these companies could result in reduced selling prices, reduced profit margins and loss of market share, any of which would harm the Company&#8217;s business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been consolidation in the aesthetic industry leading to companies combining their resources, which increases competition and could result in increased downward pressure on the Company&#8217;s product prices. Consolidations have created newly-combined entities with greater financial resources, deeper sales channels and greater pricing flexibility than the Company. Rumored or actual consolidation of the Company&#8217;s partners and competitors could cause uncertainty and disruption to the Company&#8217;s business and can cause the Company&#8217;s stock price to fluctuate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's&#160;products and its operations are subject to extensive government regulation and oversight in the United States. If the Company&#160;fails to obtain or maintain necessary regulatory clearances or approvals for its&#160;products, or if approvals or clearances for future products are delayed or not issued, it will negatively affect its&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's laser products are medical devices subject to extensive regulation in the United States and elsewhere, including by the FDA and its foreign counterparts. Government regulations specific to medical devices are wide ranging and govern, among other things:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product design, development, manufacture, and release;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">laboratory and clinical testing, labeling, packaging, storage and distribution;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product safety and efficacy;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">pre-marketing clearance or approval;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">service operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">record keeping;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product marketing, promotion and advertising, sales and distribution;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">post-marketing surveillance, including reporting of deaths or serious injuries and recalls and correction and removals;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">post-market approval studies; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product import and export.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA classifies medical devices into one of three classes on the basis of the intended use of the device, the risk associated with the use of the device for that indication, as determined by the FDA, and on the controls deemed by the FDA to be necessary to reasonably ensure their safety and effectiveness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA&#8217;s General Controls for medical devices, which include compliance with the applicable portions of the QSR facility registration and product listing, reporting of adverse medical events, and truthful and&#160;non-misleading&#160;labeling, advertising, and promotional materials. Class&#160;II devices are subject to the FDA&#8217;s General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market surveillance, patient registries and FDA guidance documents.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While most Class&#160;I devices are exempt from the premarket notification requirement, manufacturers of most Class&#160;II devices are required to submit to the FDA a premarket notification under Section&#160;510(k) of the FDCA requesting permission to commercially distribute the device. The FDA&#8217;s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed in Class&#160;III, requiring approval of a PMA application. Some&#160;pre-amendment&#160;devices are unclassified, but are subject to FDA&#8217;s premarket notification and clearance process in order to be commercially distributed. The Company's&#160;currently marketed products are Class&#160;II devices subject to 510(k) clearance, which the Company&#160;has&#160;obtained from the FDA.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before a new medical device, or a new intended use of, claim for, or significant modification to an existing device, can be marketed in the United States, a company must first submit an application for and receive either 510(k) clearance pursuant to a premarket notification submitted under Section&#160;510(k) of the FDCA, or PMA approval from the FDA, unless an exemption applies. The 510(k),&#160;or PMA processes can be expensive, lengthy and unpredictable. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but can last longer. The process of obtaining a PMA approval is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from the time the application is filed with the FDA. In addition, a PMA approval generally requires the performance of one or more clinical trials. Despite the time, effort and cost, a device may not be approved or cleared by the FDA. Any delay or failure to obtain necessary regulatory clearances or approvals could harm its&#160;business. Furthermore, even if the Company&#160;is&#160;granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the device, which may limit the market for the device.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;obtained 510(k) clearances to market its&#160;products. The FDA or other regulators could delay, limit, or deny clearance or approval of a device for many reasons, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified body that the Company's currently marketed devices, or any other future device, and any accessories are substantially equivalent to a legally marketed predicate device or safe or effective for their proposed intended uses;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the disagreement of the FDA with the design or implementation of any clinical trials or the interpretation of data from preclinical studies or clinical trials;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">serious and unexpected adverse device effects experienced by participants in its clinical trials;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the insufficiency of the data from preclinical studies or clinical trials to support clearance or approval, where required;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the failure of its manufacturing process or facilities to meet applicable requirements; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering its clinical data or regulatory filings insufficient for clearance or approval.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulations to which the Company is&#160;subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on the Company's&#160;ability to carry on or expand its&#160;operations, higher than anticipated costs or lower than anticipated sales. The FDA enforces these regulatory requirements through, among other means, periodic unannounced inspections. The Company does&#160;not know whether it&#160;will be found compliant in connection with any future regulatory inspections. Moreover, the FDA and state authorities have broad enforcement powers. Its&#160;failure to comply with applicable regulatory requirements could result in enforcement action by any such agency. If any of these events were to occur, it would negatively affect the Company's&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company fails to comply with applicable regulatory requirements, it could result in enforcement action by the U.S. FDA, federal and state agencies or international regulatory bodies and the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s commercial operations would be harmed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are medical devices that are subject to extensive regulation in the U.S. by the FDA for manufacturing, labeling, sale, promotion, distribution and shipping. The FDA, state authorities and international regulatory bodies have broad enforcement powers. If the Company fails to comply with any U.S. law or any of the applicable regulatory requirements of the FDA, or federal or state agencies, or one of the international regulatory bodies, it could result in enforcement action by the agencies, which may include any of the following sanctions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">repair, replacement, recall or seizure of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">operating restrictions or partial suspension or total shutdown of production;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">refusing the Company&#8217;s requests for 510(k) clearance of new products, new intended uses, or modifications to existing products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">withdrawing 510(k) clearance or pre-market approvals that have already been granted; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">criminal prosecution.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal regulatory reforms and changes occurring at the FDA could adversely affect the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to sell its products profitably and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the clearance or approval, manufacture and marketing of a device. It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, FDA regulations and guidance are often revised or reinterpreted by the agency in ways that may significantly affect the Company&#8217;s business and the Company&#8217;s products. Changes in FDA regulations may lengthen the regulatory approval process for medical devices and require additional clinical data to support regulatory clearance for the sale and marketing of the Company&#8217;s new products. In addition, it may require additional safety monitoring, labeling changes, restrictions on product distribution or use, or other measures after the introduction of the Company&#8217;s products to market. Either of these changes lengthen the duration to market, increase the Company&#8217;s costs of doing business, adversely affect the future permitted uses of approved products, or otherwise adversely affect the market for its products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supports any action that helps ensure patient safety going forward. The Company has a robust, multi-functional process that reviews its promotional claims and materials to ensure they are truthful, not misleading, fair and balanced, and supported by sound scientific evidence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company fails to comply with the FDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s Quality System Regulation and laser performance standards, the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations could be halted, and its business would suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently required to demonstrate and maintain compliance with the FDA&#8217;s Quality System Regulation (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">QSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The QSR is a complex regulatory scheme that covers the methods and documentation of the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of the Company&#8217;s products. Because the Company&#8217;s products involve the use of lasers, the Company&#8217;s products also are covered by a performance standard for lasers set forth in FDA regulations. The laser performance standard imposes specific record-keeping, reporting, product testing and product labeling requirements. These requirements include affixing warning labels to laser products, as well as incorporating certain safety features in the design of laser products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA enforces the QSR and laser performance standards through periodic unannounced inspections. The Company has had multiple quality system inspections by the FDA, as well as audits the Company&#8217;s Notified Body, and other foreign regulatory agencies, with the most recent inspection by the FDA occurring under the Medical Device Single Audit Program in January 2021. There were no significant findings or observations as a result of this audit. Failure to take satisfactory corrective action in response to an adverse QSR inspection or its failure to comply with applicable laser performance standards could result in enforcement actions, including a public warning letter, a shutdown of the Company&#8217;s manufacturing operations, a recall of its products, civil or criminal penalties, or other sanctions, such as those described in the preceding paragraph, which would cause its sales and business to suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the FDA's Bioresearch Monitoring (BIMO) program. As such, the BIMO audits the Company and the Company is also subject to FDA regulations relating to the design and conduct of clinical trials. The Company is subject to unannounced BIMO audits, with the most recent inspection by FDA completed over five years ago in August 2016. There were no significant findings and only two observations as a result of this audit. The Company&#8217;s responses to these observations were accepted by the FDA. Failure to take satisfactory corrective action in response to an adverse BIMO inspection or the Company&#8217;s failure to comply with Good Clinical Practices could result in the Company&#160;no longer being able to sponsor Biomedical Research, the reversal of 510(k) clearances previously granted based on the results of clinical trials conducted to gain clinical data to support those 510(k) clearances, or enforcement&#160;actions, including a public warning letter, civil or criminal penalties, or other sanctions, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such as th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ose described in the preceding paragraph, which would cause the Company&#8217;s sales and business to suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's products may cause or contribu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">te to adverse medical events or be subject to failures or malfunctions that the Company is&#160;required to report to the FDA, and if the Company&#160;fails to do so, the Company&#160;would be subject to sanctions that could harm its&#160;reputation, business, financial condition and results of operations. The discovery of serious safety issues with its&#160;products, or a recall of the Company's&#160;products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is&#160;subject to the FDA&#8217;s medical device reporting regulations and similar foreign regulations, which require the Company&#160;to report to the FDA when the Company&#160;receives or becomes aware of information that reasonably suggests that one or more of its&#160;products may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, it could cause or contribute to a death or serious injury. The timing of its&#160;obligation to report is triggered by the date the Company&#160;becomes aware of the adverse event as well as the nature of the event. The Company&#160;may fail to report adverse events of which it&#160;becomes aware within the prescribed timeframe. The Company&#160;may also fail to recognize that it has&#160;become aware of a reportable adverse event, especially if it is not reported to the Company&#160;as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If the Company&#160;fails to comply with its&#160;reporting obligations, the FDA could take action, including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of its&#160;device clearance or approval, seizure of its&#160;products or delay in clearance or approval of future products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. The Company&#160;may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by the Company&#160;could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the corrective action the Company&#160;takes to redress a product&#8217;s deficiencies or defects, the FDA may require, or the Company&#160;may decide, that it&#160;will need to obtain new clearances or approvals for the device before the Company&#160;may market or distribute the corrected device. Seeking such clearances or approvals may delay its&#160;ability to replace the recalled devices in a timely manner. Moreover, if the Company does not adequately address problems associated with its&#160;devices, the Company&#160;may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. The Company may initiate voluntary withdrawals or corrections for its&#160;products in the future that the Company&#160;determines do not require notification of the FDA. If the FDA disagrees with its determinations, it could require the Company&#160;to report those actions as recalls and the Company may be subject to enforcement action. A future recall announcement could harm its&#160;reputation with customers, potentially lead to product liability claims against the Company&#160;and negatively affect its&#160;sales. Any corrective action, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whether voluntary or involuntary, as well as defending itself&#160;in a lawsuit, will require the dedication of its&#160;time and capital, will distract management from operating its&#160;business and may harm its reputation and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> may be unable to obtain or maintain international regulatory qualifications or approvals for its current or future products and indications, which could harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of the Company&#8217;s products outside the U.S. are subject to foreign regulatory requirements that vary widely from country to country. In addition, exports of medical devices from the U.S. are regulated by the FDA. Complying with international regulatory requirements can be an expensive and time- consuming process and approval is not certain. The time required for obtaining clearance or approvals, if required by other countries, may be longer than that required for FDA clearance or approvals, and requirements for such clearances or approvals may significantly differ from FDA requirements. The Company may be unable to obtain or maintain regulatory qualifications, clearances or approvals in other countries. The Company may also incur significant costs in attempting to obtain and in maintaining foreign regulatory approvals or qualifications. If the Company experience delays in receiving necessary qualifications, clearances or approvals to market its products outside the U.S., or if the Company fails to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive those qualifications, clearances or approvals, the Company may be unable to market its products or enhancements in international markets effectively, or at all, which could have a material adverse effect on the Company&#8217;s business and growth strategy.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">To successfully market and sell the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products internationally, the Company must address many issues that are unique to the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s international business. Furthermore, international expansion is a key component of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s growth strategy, although the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s international operations and foreign transactions expose the Company&#160;to additional operational challenge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s that the Company might not otherwise face.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is focused on international expansion as a key component of its growth strategy and has identified specific areas of opportunity in various international markets. Revenue from customers outside of North America is a material component of the Company&#8217;s business strategy and represented 49% of its total revenue in 2021 compared to 53% of the Company&#8217;s total revenue in 2020. The Company employs a direct sales force in the major markets&#160;throughout Europe as well as Canada, Japan and Australia/New Zealand while using third-party distributors to sell its products in several other country in the Middle East, Asia, and South America in particular. The Company may be unable to increase or maintain its level of international revenue due to supply chain disruptions or loss of distributor relationship.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company continues to have a direct sales and service organization in Australia, New Zealand, Japan, France, Belgium, Spain, Germany, Switzerland and the United Kingdom, a significant portion of its international revenue is generated through its network of distributors. Though the Company continues to evaluate and replace non-performing distributors and has recently brought greater focus to collaboration with its distribution partners, there can be no assurance given that these initiatives will result in improved international revenue or profitability in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To grow the Company&#8217;s business, it is essential to improve productivity in current sales territories and expand into new territories. However, direct sales productivity may not improve and distributors may not accept the Company&#8217;s business or commit the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">necessary resources to market and sell the Company&#8217;s products at the Company&#8217;s expectations. If the Company is not able to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase or maintain international revenue growth, the Company&#8217;s total revenue, profitability and stock price may be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations are dependent upon third-party suppliers, making its vulnerable to supply shortages and price fluctuations, which could harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the components and materials that comprise the Company&#8217;s products are currently manufactured by a limited number of suppliers. In addition, all of the Company&#8217;s skincare products are manufactured by its sole supplier, ZO. A supply interruption or an increase in demand beyond the Company&#8217;s current suppliers&#8217; capabilities could harm the Company&#8217;s ability to manufacture its products until a new source of supply is identified and qualified. The Company&#8217;s reliance on these suppliers subjects the Company to a number of risks that could harm its business, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">interruption of supply resulting from modifications to or discontinuation of a supplier&#8217;s operations;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delays in product shipments resulting from uncorrected defects, reliability issues or a supplier&#8217;s variation in a component;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">lack of long-term supply arrangements for key components with the Company&#8217;s suppliers;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to obtain adequate supply in a timely manner, or on reasonable terms;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to redesign one or more components in the Company&#8217;s systems in the event that a supplier discontinues manufacturing such components and the Company&#8217;s inability to sources it from other suppliers on reasonable terms;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">difficulty locating and qualifying alternative suppliers for the Company&#8217;s components in a timely manner;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">production delays related to the evaluation and testing of products from alternative suppliers and corresponding regulatory qualifications; and delay in supplier deliveries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interruption in the supply of components or materials, or the Company&#8217;s inability to obtain substitute components or materials from alternate sources at acceptable prices in a timely manner, could impair its ability to meet the demand of the Company&#8217;s customers, which would have an adverse effect on the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks related to the reduction or interruption in supply and an inability to develop alternative sources for supply may adversely affect the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations and related product sales.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains manufacturing operations at its facility in Brisbane, California, and purchases many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. Any problem affecting a supplier (whether due to external or internal causes) could have a negative impact on the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In limited cases, specific components and raw materials are purchased from primary or main suppliers (or in some cases, a single supplier) for reasons related to quality assurance, cost-effectiveness ratio and availability. While the Company works closely with its suppliers to ensure supply continuity, the Company cannot guarantee that its efforts will always be successful. Moreover, due to strict standards and regulations governing the manufacture and marketing its products, it may not be able to quickly locate new supply sources in response to a supply reduction or interruption, with negative effects on its ability to manufacture its products effectively and in a timely fashion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company fails to maintain or renew any of its distribution agreements before they expire, its revenues and cash flow may be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company distributes its products primarily through independent distributors in many countries outside of North America. The Company's business may suffer if any of its distribution partners terminates or otherwise fails to renew its distribution agreement with the Company and the Company is otherwise unable to replace such agreement with a distribution agreement containing similar terms. The distributors may sell competitors' products, and if they favor competitors' products for any reason, they may fail or reduce their effort to market and sell the Company's products as effectively or to devote resources necessary to provide effective sales, which would adversely affect its financial performance. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial health of the Company's distributors and its continuing relationships with them are important to the Company's success. Some of these distributors, particularly smaller firms with limited working capital and resources, may not be able to withstand adverse changes in business conditions or mitigate the negative impact of a prolonged economic downturn or recession, including the impact of the COVID-19 pandemic. The failure of the Company's distributors to maintain financial heath and success will impact its ability to generate revenues. In addition, these distributors order the Company&#8217;s products and maintain their inventory based on forecasts of potential demands from end customers, and distributors may not be able to forecast such demand accurately, which may adversely affect the Company&#8217;s ability to generate sales and revenue in a timely manner. In some cases, distributors may delay ordering systems until they receive confirmation of orders from end customers, and this delay may cause disruption and make it more difficult for the Company to fill their orders timely and effectively, which may adversely affect the Company&#8217;s revenue and sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the Company's relationship with distributors may change or terminate due to other factors beyond its control, including but are not limited to, acquisition of distributors by third parties may not be willing to continue the relationship with us; internal restructuring or a refocus of business strategies; and changes in management, all of which may negatively impact its ability to continue to sell to such distributors. Finally, the Company generally does not have long-term agreements with distributors who purchase its products primarily through purchase orders. Without an agreement, the Company is not able to guarantee that such distributors will not discontinue or terminate their relationship with the Company at any time, and any loss of distributor will negatively impact the Company's financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">To successfully market and sell third-party products internationally, the Company must address many issues that are unique to the related distribution arrangements, which could reduce the Company&#8217;s available cash reserves and negatively impact the Company&#8217;s profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into distribution arrangements pursuant to which the Company utilizes its sales force and distributors to sell products manufactured by other companies. The Company also has an exclusive agreement with ZO to distribute certain of their proprietary skincare products in Japan. Each of these agreements requires the Company to purchase annual minimum dollar amounts of their products. Additionally, the Company has entered into distribution arrangements with other companies to promote and sell the Secret RF products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of these distribution agreements presents its own unique risks and challenges. For example, to sell skincare products the Company needs to invest in creating a sales structure that is experienced in the sale of such products and not in capital equipment. The Company needs to commit resources to train the Company&#8217;s sales force, obtain regulatory licenses, and develop new marketing materials to promote the sale of these products. In addition, the minimum commitments and other costs of distributing products manufactured by these companies may exceed the incremental revenue that the Company derives from the sale of their products, thereby negatively impacting the Company&#8217;s profitability and reducing the Company&#8217;s available cash reserves.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company does not make the minimum purchases required in the distribution contracts, or if the third-party manufacturer revokes the Company&#8217;s distribution rights, the Company could lose the distribution rights of the products, which would adversely affect the Company&#8217;s future revenue, results of operations, cash flows and its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company&#8217;s dis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">tribution agreement with ZO requires certain economic requirements to be met by the Company. If the Company does not meet these minimum requirements, the Company could lose the distribution rights to the skincare products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an exclusive agreement with ZO to distribute ZO&#8217;s proprietary skincare products in Japan. There are certain economic requirements in the agreement that were not met for the 2022 fiscal year because of global economic factors, such as the unprecedented decline in the value of the Japanese Yen compared to the U.S. Dollar over the course of 2022. ZO therefore has the option to terminate the distribution agreement notwithstanding certain conditions. If ZO terminates the Company&#8217;s distribution rights, or forces the Company to amend the terms of its distribution agreement, this would adversely affect the Company&#8217;s future revenue, results of operations, cash flows and its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If customers are not trained and/or the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products are used by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">non-licensed</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">practitioners, it could result in product misuse and adverse treatment outc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">omes, which could harm the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s reputation, result in product liability litigation, distract management and result in additional costs, all of which could harm the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company's products&#160;are used by&#160;non-licensed or untrained&#160;practitioners, it could result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation and the Company&#8217;s business. U.S. federal regulations allow the Company&#160;to sell the Company&#8217;s products to or on the order of &#8220;licensed practitioners.&#8221; The definition of &#8220;licensed practitioners&#8221; varies from state to state. As a result, the Company&#8217;s products may be purchased or operated by physicians with&#160;varying levels of training, and in many states, by&#160;non-physicians,&#160;including nurse practitioners, chiropractors and technicians. Outside the U.S., many jurisdictions do not require specific qualifications or training for purchasers or operators of its products. The Company does not supervise the procedures performed with the Company&#8217;s products, nor does the Company require that direct medical supervision occur that is determined by state law. The Company and its distributors generally offer but do not require product training to the purchasers or operators of the Company&#8217;s products. In addition, the Company sometimes sells its systems to companies that rent its systems to third parties and that provide a technician to perform the procedures. The lack of training and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the purchase and use of its products by&#160;non-physicians&#160;may result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation and its business, and, in the event these actions result in product liability litigation, distract management and subject the Company&#160;to liability, including legal expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials m</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ay be necessary to support future product submissions to the FDA. The clinical trial process is lengthy and expensive with uncertain outcomes, and often requires the enrollment of large numbers of patients, and suitable patients may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">be difficult to identify and recruit. Delays or failures in the Company's&#160;clinical trials will prevent it&#160;from commercializing any modified or new products and will adversely affect its&#160;business, operating results and prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;conducted clinical trials in the past and will likely conduct clinical trials in the future. Initiating and completing clinical trials necessary to support any future products, will be time-consuming and expensive and the outcome, uncertain. Moreover, the results of early clinical trials are not necessarily predictive of future results, and any product the Company&#160;advances into clinical trials may not have favorable results in later clinical trials. The results of preclinical studies and clinical trials of its&#160;products conducted to date and ongoing or future studies and trials of its current, planned or future products may not be predictive of the results of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. The Company's&#160;interpretation of data and results from its&#160;clinical trials do not ensure that the Company&#160;will achieve similar results in future clinical trials. In addition, preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in preclinical studies and earlier clinical trials have nonetheless failed to replicate results in later clinical trials. Products in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and earlier clinical trials. Failure can occur at any stage of clinical testing. The Company's&#160;clinical studies may produce negative or inconclusive results, and it&#160;may decide, or regulators may require us, to conduct additional clinical and&#160;non-clinical&#160;testing in addition to those the Company has&#160;planned.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may be required to submit an IDE application to the FDA, which must become effective prior to commencing certain human clinical trials of medical devices, and the FDA may reject the Company's IDE application and notify the Company that it may not begin clinical trials;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators and other comparable foreign regulatory authorities may disagree as to the design or implementation of its clinical trials;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators and/or an IRB, or other reviewing bodies may not authorize the Company or its investigators to commence a clinical trial, or to conduct or continue a clinical trial at a prospective or specific trial site;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may not reach agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">clinical trials may produce negative or inconclusive results, and the Company may decide, or regulators may require the Company to conduct additional clinical trials or abandon product development programs;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the number of subjects or patients required for clinical trials may be larger than the Company anticipates, enrollment in these clinical trials may be insufficient or slower than the Company anticipates, and the number of clinical trials being conducted at any given time may be high and result in fewer available patients for any given clinical trial, or patients may drop out of these clinical trials at a higher rate than the Company anticipates;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's third-party contractors, including those manufacturing products or conducting clinical trials on the Company's behalf, may fail to comply with regulatory requirements or meet their contractual obligations to the Company in a timely manner, or at all;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company might have to suspend or terminate clinical trials for various reasons, including a finding that the subjects are being exposed to unacceptable health risks;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may have to amend clinical trial protocols or conduct additional studies to reflect changes in regulatory requirements or guidance, which it may be required to submit to an IRB and/or regulatory authorities for re-examination;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators, IRBs, or other parties may require or recommend that the Company or its investigators suspend or terminate clinical research for various reasons, including safety signals or noncompliance with regulatory requirements;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the cost of clinical trials may be greater than the Company anticipates;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">clinical sites may not adhere to the clinical protocol or may drop out of a clinical trial;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may be unable to recruit a sufficient number of clinical trial sites;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators, IRBs, or other reviewing bodies may fail to approve or subsequently find fault with its manufacturing processes or facilities of third-party manufacturers with which the Company enters into agreement for clinical and commercial supplies, the supply of devices or other materials necessary to conduct clinical trials may be insufficient, inadequate or not available at an acceptable cost, or the Company may experience interruptions in supply;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">approval policies or regulations of the FDA or applicable foreign regulatory agencies may change in a manner rendering the Company's clinical data insufficient for approval;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's current or future products may have undesirable side effects or other unexpected characteristics; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">impacts of regional or global public health crises including the ongoing COVID-19 pandemic could adversely affect any clinical trials the Company is conducting or plan to conduct, including delays or difficulties in enrolling or onboarding patients, initiating clinical sites, or obtaining the requisite regulatory approvals, interruption of key clinical trial activities, or supply chain disruptions that delay or make it more difficult or costly to obtain the supplies and materials the Company needs for clinical trials.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these occurrences may significantly harm the Company's&#160;business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of its&#160;products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials must be conducted in accordance with the laws and regulations of the FDA and other applicable regulatory authorities&#8217; legal requirements, regulations or guidelines, and are subject to oversight by these governmental agencies and IRBs at the medical institutions where the clinical trials are conducted. Conducting successful clinical studies will require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Patient enrollment in clinical trials and completion of patient participation and&#160;follow-up&#160;depends on many factors, including the size of the patient population, the nature of the trial protocol, the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects, the availability of appropriate clinical trial investigators, support staff, and proximity of patients to clinical sites and able to comply with the eligibility and exclusion criteria for participation in the clinical trial and patient compliance. For example, patients may be discouraged from enrolling in its&#160;clinical trials if the trial protocol requires them to undergo extensive post-treatment procedures or&#160;follow-up&#160;to assess the safety and effectiveness of its&#160;products or if they determine that the treatments received under the trial protocols are not attractive or involve unacceptable risks or discomforts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#160;depends on its&#160;collaborators and on medical institutions and CROs to conduct its clinical trials in compliance with good clinical practice ("GCP") requirements. To the extent its&#160;collaborators or the CROs fail to enroll participants for its&#160;clinical trials, fail to conduct the study to GCP standards or are delayed for a significant time in the execution of trials, including achieving full enrollment, the Company&#160;may be affected by increased costs, program delays or both. In addition, clinical trials that are conducted in countries outside the United States may subject the Company to further delays and expenses as a result of increased shipment costs, additional regulatory requirements and the engagement of&#160;non-U.S.&#160;CROs, as well as expose the Company&#160;to risks associated with clinical investigators who are unknown to the FDA, and different standards of diagnosis, screening and medical care.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development of sufficient and appropriate clinical protocols to demonstrate safety and efficacy are required and the Company&#160;may not adequately develop such protocols to support clearance and approval. Further, the FDA may require the Company&#160;to submit data on a greater number of patients than the Company&#160;originally anticipated and/or for a longer&#160;follow-up&#160;period or change the data collection requirements or data analysis applicable to the Company's&#160;clinical trials. Delays in patient enrollment or failure of patients to continue to participate in a clinical trial may cause an increase in costs and delays in the approval and attempted commercialization of its&#160;products or result in the failure of the clinical trial. In addition, despite considerable time and expense invested in its&#160;clinical trials, the FDA may not consider the Company's&#160;data adequate to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demonstrate safety and efficacy. Such increased costs and delays or failures could adversely affect its business, operating results and prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights may not provide adequate protection for some or all of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, which may permit third parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">to compete against the Company&#160;more effectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on patent, copyright, trade secret and trademark laws and confidentiality agreements to protect the Company&#8217;s technology and products. As of January 19, 2023, the Company had 28 issued and unexpired U.S. patents, 10 pending U.S. patent applications, and four pending international applications under the Patent Cooperation Treaty ("PCT")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or other national or regional patent offices. Some of the Company&#8217;s components, such as the Company&#8217;s laser module, electronic control system and high-voltage electronics, are not, and in the future may not be, protected by patents. Additionally, the Company&#8217;s patent applications may not issue as patents or, if issued, may not issue in a form that will be advantageous to us. Any patents the Company obtains may be challenged, invalidated or legally circumvented by third parties. Consequently, competitors could market products and use manufacturing processes that are substantially similar to, or superior to, the Company&#8217;s. The Company may not be able to prevent the unauthorized disclosure or use of the Company&#8217;s technical knowledge or other trade secrets by consultants, vendors, former employees or current employees, despite the existence generally of confidentiality agreements and other contractual restrictions. Monitoring unauthorized uses and disclosures of the Company&#8217;s intellectual property is difficult, and the Company does not know whether the steps it has taken to protect the Company&#8217;s intellectual property will be effective. Moreover, the laws of many foreign countries will not protect the Company&#8217;s intellectual property rights to the same extent as the laws of the U.S. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The absence of complete intellectual property protection exposes the Company&#160;to a greater risk of direct competition. Competitors c</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ould purchase one of the Company&#8217;s products and attempt to replicate some or all of the competitive advantages the Company derives from the Company&#8217;s development efforts, design around the&#160;Company&#8217;s protected technology, or develop their own competitive technologies that fall outside of the Company&#8217;s intellectual property rights. If the Company&#8217;s intellectual property is not adequately protected against competitors&#8217; products and methods, the Company&#8217;s competitive position and its business could be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The expense and potential unavailability of insurance coverage for the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s customers could adversely affect its ability to sell its products, and therefore adversely affect its financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s customers and prospe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ctive customers have had difficulty procuring or maintaining liability insurance to cover their operation and use of its products. Medical malpractice carriers are withdrawing coverage in certain states or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantially increasing premiums. If this trend continues or worsens, the Company&#8217;s customers may discontinue using the Company&#8217;s products and potential customers may opt against purchasing laser-based products due to the cost or inability to procure insurance coverage. The unavailability of insurance coverage for the Company&#8217;s customers and prospects could adversely affect its ability to sell its products, and that could harm its financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any acquisitions that the Company makes could result in operating difficulties, dilution, and other consequences that may adversely impact the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company from time to time evaluates potential acquisitions of businesses, products and technologies, and anticipates continuing to make these evaluations, the Company has no present understandings, commitments or agreements with respect to any material acquisi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tions or collaborative projects. The Company may not be able to identify appropriate acquisition candidates or strategic partners, or successfully negotiate, finance or integrate any businesses, products or technologies that the Company acquire.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has limited experience as a team with acquiring companies and products. Furthermore, the integration of any acquisition and management of any collaborative project may divert management&#8217;s time and resources from the Company&#8217;s core business and disrupt the Company&#8217;s operations and it may incur significant legal, accounting and banking fees in connection with such a transaction. Acquisitions could diminish the Company&#8217;s available cash balances for other uses, result in the incurrence of debt, contingent liabilities, or amortization expenses, and restructuring charges. Also, the anticipated benefits or value of its acquisitions or investments may not materialize and could result in an impairment of goodwill and/or purchased long-lived assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s failure to address these risks or other problems encountered in connection with the Company&#8217;s past or future acquisitions and investments could cause the Company to fail to realize the anticipated benefits of such acquisitions </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse developments affecting the banking industry, such as actual events or concerns involving liquidity, defaults or non-performance, could adversely affect the Company's operations and liquidity. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the U.S. Department of the Treasury, the Federal Reserve and the FDIC stated that all depositors of SVB would have access to all of their deposits and the Company and other depositors with SVB received such access on March 13, 2023, uncertainty and liquidity concerns in the broader financial services industry remain. Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. The U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments. However, widespread demands for customer withdrawals or other needs of financial institutions for immediate liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions in a timely fashion or at all.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers&#8217; and vendors&#8217; access to cash and cash equivalents in amounts adequate to finance their operations could be significantly impaired by the financial institutions with which they have arrangements directly facing liquidity constraints or failures. Any material decline in available funding could impact the payment of invoices and the Company&#8217;s supply chain. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's cash, cash equivalents and marketable securities could be adversely affected by the failure of SVB or other financial institutions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Defaults, non-performance, bankruptcy, receivership or other adverse developments that affect banking institutions where the Company has deposited its funds or other financial institutions, or concerns or rumors about any events of these kinds or other similar risks, may result in liquidity issues for the Company. On March 10, 2023, California regulators closed Silicon Valley Bank </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(&#8220;SVB&#8221;), and the FDIC was appointed as SVB&#8217;s receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. Approximately $305 million of the Company&#8217;s total cash, cash equivalents, and marketable securities balance of $317 million at December 31, 2022, was at SVB or SVB Asset Management. The Company now maintains these accounts and custodial arrangements with or through First-Citizens Bank &amp; Trust Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Currently, the Company has full access to all funds in deposit accounts or other money management arrangements with First-Citizens Bank &amp; Trust Company and other banks. However, those funds in bank deposit accounts in excess of the standard FDIC insurance limits are uninsured and subject to the risk of bank failure. Future adverse developments with respect to specific financial institutions or the broader financial services industry may also lead to market-wide liquidity shortages. The failure of any bank in which the Company deposits its funds could reduce the amount of cash the Company has available for its operations or delay its ability to access such funds. Any such failure may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. In the event the Company has a commercial relationship with a bank that has failed or is otherwise distressed, the Company may experience delays or other issues in meeting its financial obligations. If other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, the Company&#8217;s ability to access its cash and cash equivalents may be threatened and could have a material adverse effect on the Company&#8217;s business and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company&#8217;s ability to access credit on favorable terms, if necessary, for the funding of the Company&#8217;s operations and capital projects may be limited due to changes in credit markets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to a Loan and Security Agreement (the &#8220;Loan and Security Agreement&#8221;) with First-Citizens Bank &amp; Trust Company (as successor to SVB). The Loan and Security Agreement provides for a four-year secured revolving loan facility in an aggregate principal amount of up to $30.0 million (the &#8220;Revolving Line of Credit&#8221;). The Revolving Line of Credit matures on July 9, 2024. As of December 31, 2022, the Company had not drawn on this credit facility. On March 13, 2023, the Company violated one of the terms of the credit facility by transferring funds from Silicon Valley Bank. The Company received a waiver from First-Citizens Bank &amp; Trust Company for this violation. A future violation of any of the covenants could result in a default under the Loan and Security Agreement that would permit First-Citizens Bank &amp; Trust Company to restrict the Company&#8217;s ability to further access the Revolving Line of Credit for loans and letters of credit and require the immediate repayment of any outstanding loans under the agreement. In addition, these covenants are subject to renegotiation at the beginning of each fiscal year, which further reduces the Company&#8217;s ability to anticipate whether this source of capital will continue to be available in the near term.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in the past, the credit markets and the financial services industry have experienced disruption characterized by the bankruptcy, failure, collapse or sale of various financial institutions, increased volatility in securities prices, diminished liquidity and credit availability and intervention from the U.S. and other governments. Continued concerns about the systemic impact of potential long-term or widespread downturn, energy costs, geopolitical issues, the availability and cost of credit, the global commercial and residential real estate markets and related mortgage markets and reduced consumer confidence have contributed to increased market volatility. The cost and availability of credit has been and may continue to be adversely affected by these conditions. The Company cannot be certain that funding for the Company&#8217;s capital needs will be available from the Company&#8217;s existing financial institutions and the credit markets if needed, and if available, to the extent required and on acceptable terms. The Loan and Security Agreement terminates on July 9, 2024 and if the Company cannot renew or refinance this facility or obtain funding when needed, in each case on acceptable terms, such conditions may have an adverse effect on the Company&#8217;s revenues and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, cyber-security incidents and other disruptions could compromise the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s information and impact the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on networks, information management software and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> other technology, or information systems, including the Internet and third-party hosted services, to support a variety of business processes and activities, including procurement and supply chain, manufacturing, distribution, invoicing, order processing and collection of payments. The Company uses information systems to process financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal and tax requirements. In addition, the Company depends on information systems for digital marketing activities and&#160;electronic communications among the Company&#8217;s locations around the world and between company personnel as well as customers and suppliers. Because information systems are critical to many of the Company&#8217;s operating activities, the Company&#8217;s business processes may be impacted by system shutdowns or service disruptions. These disruptions may be caused by failures during routine operations such as system upgrades or user errors, as well as network or hardware failures, malicious or disruptive software, computer hackers, geopolitical events, natural disasters, failures or impairments of telecommunications networks, or other catastrophic events. These events could result in unauthorized disclosure of material confidential information. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s information systems suffer severe damage, disruption or shutdown and the Company business continuity plans do not effectively resolve the issues in a timely manner, the Company could experience delays in reporting the Company&#8217;s financial results and the Company&#160;may lose revenue and profits as a result of the Company&#8217;s inability to timely manufacture, distribute, invoice and collect payments. Misuse, leakage or falsification of information could result in a violation of data privacy laws and regulations and damage the Company&#8217;s reputation and credibility, and could expose the Company&#160;to liability. The Company may also be required to spend significant financial and other resources to remedy the damage caused by a security breach or to repair or replace networks and information systems. Like most major corporations, the Company&#8217;s information systems are a target of attacks.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A cyber security attack or other incident that bypasses the Company&#8217;s information systems security could cause a security breach which may lead to a material disruption to the Company&#8217;s information systems infrastructure or business and may involve a significant loss of business or patient health information. If a cyber security attack or other unauthorized attempt to access the Company&#8217;s systems or facilities were successful, it could result in the theft, destruction, loss, misappropriation or release of confidential information or intellectual property, and could cause operational or business delays that may materially impact the Company&#8217;s ability to provide various healthcare services. Any successful cyber security attack or other unauthorized attempt to access the Company&#8217;s systems or facilities also could result in negative publicity which could damage the Company&#8217;s reputation or brand with the Company&#8217;s patients, referral sources, payors or other third parties and could subject the Company&#160;to a number of adverse consequences, the vast majority of which are not insurable, including but not limited to disruptions in the Company&#8217;s operations, regulatory and other civil and criminal penalties, fines, investigations and enforcement actions (including, but not </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limited to, those arising from the SEC, Federal Trade Commission, Office of Civil Rights, the Office of Inspector General or state attorneys general), fines, private litigation with those affected by the data breach, loss of customers, disputes with payors and increased operating expense, which either individually or in the aggregate could have a material adverse effect on the Company&#8217;s business, financial position, results of operations and liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that disruptions to the Company's information systems that have materially affected its business, financial condition or results of operations to the Company's may occur and have a material adverse effect on the Company&#160;in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Macroeconomic political and market conditions, and catastrophic events may adversely affect the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business, results of operations, financial condition and the trading price of the stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is influenced by a range of factors that are beyond the Company&#8217;s control, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">general macro-economic and business conditions in the Company&#8217;s key markets of North America, Japan, Asia Pacific, the Middle East, Europe and Aust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ralia;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the lack of credit financing, or an increase in the cost of borrowing, for some of the Company&#8217;s potential customers due to increasing interest rates and lending requirements;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the overall demand for the Company&#8217;s products by the core market specialties of dermatologists and plastic surgeons;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the timing and success of new product introductions by the Company or the Company&#8217;s competitors or any other change in the competitive landscape of the market for non-surgical aesthetic procedures, including consolidation among the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the level of awareness of aesthetic procedures and the market adoption of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in the Company&#8217;s pricing policies or those of the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">governmental budgetary constraints or shifts in government spending priorities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">general political developments, both domestic and in the Company&#8217;s foreign markets, including economic and political uncertainty caused by elections;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">natural disasters and public health events;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">tax law changes;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">currency exchange rate fluctuations; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">any trade restrictions or higher import taxes that may be imposed by foreign countries against products sold internationally by U.S. companies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic developments, like global recessions and financial crises could negatively affect the Company&#8217;s business, operating results, or financial condition which, in turn, could adversely affect the Company&#8217;s stock price. A general weakening of, and related declining corporate confidence in, the global economy or the curtailment in government or corporate spending could cause current or potential customers to reduce their budgets or be unable to fund product or upgrade application purchases, which could cause customers to delay, decrease or cancel purchases of the Company&#8217;s products and services or cause customers not to pay the Company or to delay paying the Company for previously purchased products and services.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, political unrest in regions like the Middle East, terrorist attacks around the globe and the potential for other hostilities in various parts of the world, potential public health crises and natural disasters continue to contribute to a climate of economic and political uncertainty that could adversely affect the Company&#8217;s results of operations and financial condition, including the Company&#8217;s revenue growth and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic declines, negative political developments, including volatile market conditions due to investor concerns regarding inflation and Russia's invasion of Ukraine, adverse market conditions and catastrophic events may cause a decline in the Company&#8217;s revenue, negatively affect the Company&#8217;s operating results, adversely affect the Company&#8217;s cash flow and could result in a decline in the Company&#8217;s stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Certain of the Company&#8217;s product platf</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">orms such as Enlighten and excel HR are only capable of being produced at the single site in Brisbane, and as such the occurrence of a catastrophic disaster or other similar event could cause damage to its facilities and equipment, which might require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is vulnerable to damage from various types of disasters, including fires, earthquakes, terrorist acts, floods, power losses, communications failures, pandemics and simil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ar events. If any such disaster were to occur, the Company may not be able to operate the Company&#8217;s business at the Company&#8217;s facility in Brisbane, California. Before the Company could manufacture products from a replacement facility, the Company&#8217;s manufacturing facilities which require regulatory agency approval, could require </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant delays to obtain regulatory agency&#8217;s approval. The insurance the Company maintains may not be adequate to cover the Company&#8217;s losses resulting from disasters or other business interruptions. Therefore, any such catastrophe could seriously harm the Company&#8217;s business and consolidated results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">From time to time the Company may become subject to income tax audits or similar proceedings, and as a result the Company may incur additional costs and expenses or owe additional taxes, interest and penalties that may negatively impact its operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is sub</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ject to income taxes in the U.S. and certain foreign jurisdictions where it operates through a subsidiary, including Australia, Belgium, Canada, France, Germany, Hong Kong, Japan, Spain, Switzerland, Italy and the United Kingdom. The Company&#8217;s determination of its tax liability is subject to review by applicable domestic and foreign tax authorities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had sales and income tax audits in the past. The final timing and resolution of any future tax examinations are subject to significant&#160;uncertainty and could result in the Company&#8217;s having to pay amounts to the applicable tax authority in order </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to resolve examination of its tax positions. An increase or decrease of tax related to tax examination resolution could result in a change in the Company&#8217;s income tax accrual and could negatively impact its financial position, results of operations or cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may be adversely affected by changes in U.S. tax laws, importation taxes and other changes that may be imposed by the current administration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes in the U.S. and other jurisdictions. Tax rates in these jurisdictions may be subject to significant change due to economic and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/or political conditions. A number of other factors may also impact the Company&#8217;s future effective tax rate including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the jurisdictions in which profits are determined to be earned and taxed;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the resolution of issues arising from tax audits with various tax authorities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in valuation of the Company&#8217;s deferred tax assets and liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increases in expenses not deductible for tax purposes, including write-offs and impairment of goodwill in connection with acquisitions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in availability of tax credits, tax holidays, and tax deductions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in share-based compensation; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws or the interpretation of such tax laws and changes in generally accepted accounting principles.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards and estimates could have a material adverse effect on the Company&#8217;s results of operations and financial position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally accepted accounting principles and the related authoritative guidance for many aspects of the Company&#8217;s business, including revenue recognition, inventories, warranties, leases, income taxes, expected credit losses, fair-value measurements, and stock-based compensation, are complex and involve subjective judgments. Changes in these rules or changes in the underlying estimates, assumptions or judgments by the Company&#8217;s management could have a material adverse effect on the Company&#8217;s results of operations and may retroactively affect previously reported results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has identified a material weakness in its internal control over financial reporting related to information technology general controls ("ITGCs"), inventory controls, and accounting for expense related to equity-based awards, which could, if not remediated, result in material misstatements in the Company's financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act. As disclosed in Item 9A of this Annual Report on Form 10-K, the Company identified material weaknesses in its internal control over financial reporting relating to ITGCs, inventory controls, and controls related to accounting for equity awards. A material weakness is defined as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. As a result of these material weaknesses, the Company concluded that its internal control over financial reporting was not effective based on criteria set forth by the Committee of Sponso</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ring Organization of the Treadway Commission in Internal Control-An Integrated Framework (2013). </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has begun the process of designing and implementing effective internal control measures to improve its internal controls over financial reporting and remediate these material weaknesses. The Company's efforts include implementing additional controls designed to detect potential material misstatements that may arise as a result of control weaknesses over ITGC controls, inventory controls, and review procedures concerning accounting for equity-based awards. If these remedial measures are insufficient to address the material weakness, or if additional material weaknesses or significant deficiencies in the Company's internal control over financial reporting are discovered or occur in the future, the Company's consolidated financial statements may contain material misstatements, and the Company could be required to restate its financial results. In addition, if the Company is unable to successfully remediate the material weakness and is unable to produce accurate and timely financial statements, its stock price may be adversely </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Economic and other risks associated with international sales and operations could adversely affect the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">s business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, 49% of the Company&#8217;s total revenue was from customers outside of North America. The Company expects its sales from international operations and export sales to continue to be a significant portion of the Company&#8217;s revenue. The Company has placed a particular emphasis on increasing its growth and presence in international markets. The Company&#8217;s international operations and sales are subject, in varying degrees, to risks inherent in doing business outside the U.S. These risks include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in trade protection measures, including embargoes, tariffs and other trade barriers, and import and export regulations and licensing requirements;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">instability and uncertainties arising from the global geopolitical environment, such as economic nationalism, populism, protectionism and anti-global sentiment;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws and potential negative consequences from the interpretation, application and enforcement by governmental tax authorities of tax laws and policies;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">unanticipated changes in other laws and regulations or in how such provisions are interpreted or administered;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">reduced protection for intellectual property rights in some countries and practical difficulties of enforcing intellectual property and contract rights abroad;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">possibility of unfavorable circumstances arising from host country laws or regulations, including those related to infrastructure and data transmission, security and privacy;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">currency exchange rate fluctuations and restrictions on currency repatriation;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">difficulties and expenses related to implementing internal control over financial reporting and disclosure controls and procedures;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">disruption of sales from labor and political disturbances;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regional safety and security considerations;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased costs and risks in developing, staffing and simultaneously managing global sales operations as a result of distance as well as language and cultural differences;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased management, travel, infrastructure and legal compliance costs associated with having multiple international operations;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">lengthy payment cycles and difficulty in collecting accounts receivable;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">preference for locally-produced products, as well as protectionist laws and business practices that favor local companies;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">outbreak or escalation of insurrection, armed conflict, terrorism or war; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">supply chain disruption or the loss of distributor relationships.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the geopolitical or economic environments in the countries in which the Company operates could have a material adverse effect on the Company&#8217;s financial condition, results of operations or cash flows. For example, changes in U.S. policy regarding international trade, including import and export regulation and international trade agreements, could also negatively impact the Company&#8217;s business. The U.S. has imposed tariffs on certain goods imported from China and certain other countries, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which has resulted in retaliatory tariffs by China and other countries. Additional tariffs imposed by the U.S. on a broader range of imports, or further retaliatory trade measures taken by China or other countries in response, could adversely impact the Company&#8217;s financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s global operations are required to comply with the U.S. Foreign Corrupt Practices Act of 1977, as amended (&#8220;FCPA&#8221;), Chinese anti- corruption laws, U.K. Bribery Law, and similar anti-bribery laws in other jurisdictions, and with U.S. and foreign export control, trade embargo and customs laws. If the Company fails to comply with any of these laws, the Company could suffer civil and criminal sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Economic Area (&#8220;EEA&#8221;), which is composed of the 27 Member States of the EU plus Norway, Liechtenstein and Iceland, a single regulatory approval process exists, and conformity with the legal requirements is represented by the CE mark. The Company&#8217;s products are regulated in the EU as medical devices per the EU Medical Devices Regulation (&#8220;MDR&#8221;). The Company's current CE marks on systems sold in the EU are set to expire on April 15, 2023, and a new CE marking under the MDR designation is required after April 15, 2023. The Company intends to obtain MDR certification for its principal products sold in the EU ahead of the April 15, 2023, expiration date. From January 1, 2021, the Medicines and Healthcare Products Regulatory Agency (&#8220;MHRA&#8221;) has been responsible for the UK medical device market. New regulations require medical devices to be registered with the MHRA. Manufacturers based outside the UK need to appoint a UK Responsible Person to register devices with the MHRA. By July 1, 2024, in the United Kingdom, all medical devices will require a UKCA (UK Conformity Assessed) mark, but CE marks issued by EU notified bodies will remain valid until this time. However, UKCA marking alone will not be recognized in the EU.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general risks that the Company faces outside the U.S., the Company&#8217;s operations in emerging markets could involve additional uncertainties for us, including risks that governments may impose withholding or other taxes on remittances and other payments to us, or the amount of any such taxes may increase; governments may seek to nationalize the Company&#8217;s assets; or governments may impose or increase investment barriers or other restrictions affecting the Company&#8217;s business. In addition, emerging markets pose other uncertainties, including the difficulty of enforcing agreements, challenges collecting receivables, protection of the Company&#8217;s intellectual property and other assets, pressure on the pricing of the Company&#8217;s products and services, higher business conduct risks, ability to hire and retain qualified talent and risks of political instability. The Company cannot predict the impact such events might have on the Company&#8217;s business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, compliance with laws and regulations applicable to the Company&#8217;s international operations increases the Company&#8217;s cost of doing business in foreign jurisdictions. The Company may be unable to keep current with changes in foreign government requirements and laws as they change from time to time. Failure to comply with these regulations could have adverse effects on the Company&#8217;s business. In many foreign countries it is common for others to engage in business practices that are prohibited by the Company&#8217;s internal policies and procedures or U.S. regulations applicable to us. In addition, although the Company has implemented policies and procedures designed to ensure compliance with these laws and policies, there can be no assurance that all of the Company&#8217;s employees, contractors, distributors and agents will comply with these laws and policies. Violations of laws or key control policies by the Company&#8217;s employees, contractors, distributors or agents could result in delays in revenue recognition, financial reporting misstatements, fines, penalties, or the prohibition of the importation or exportation of the Company&#8217;s offerings and could have a material adverse effect on the Company&#8217;s business operations and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company offers credit terms to some qualified customers and also to leasing companies to finance the purchase of its products. In the event that any of these customers default on the amounts payable to the Company, its earnings may be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers credit terms of 30 to 90 days to qualified customers. In addition, from time to time, it offers certain key international distributors, with whom the Company has had an extended period of relationship and payment history, payment terms that are significantly longer than the regular 30 to 90 day terms. This allows such international distribution partners to have its products in stock and provide its products to customers on a timely basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has an adequate basis to ensure that it collects its accounts receivable, the Company cannot provide any assurance that the financial position of customers to whom it has provided payment terms will not change adversely before the Company receives payment. In the event that there is a default by any of the customers to whom the Company has provided credit terms, the Company may recognize a credit loss provision&#160;write-off&#160;charge in the Company&#8217;s general and administrative expenses. If this&#160;write-off&#160;charge is material, it could negatively affect the Company&#8217;s future results of operations, cash flows and its stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in the event of deterioration of general business conditions or the availability of credit, the financial strength and stability of the Company&#8217;s customers and potential customers may deteriorate over time, which may cause them to cancel or delay their purchase of its products. In addition, the Company may be subject to increased risk of&#160;non-payment&#160;of its accounts receivables. The Company may also be adversely affected by bankruptcies or other business failures of the Company&#8217;s customers and potential customers. A significant delay in the collection of funds or a reduction of funds collected may impact the Company&#8217;s liquidity or result in credit losses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to effe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ctively compete and generate additional revenue from new and existing products depends upon the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to distinguish the Company and its products from the competitors and their products, and to develop and effectively market new and existing products. The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s success is dependent on many factors, including the following:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">speed of new and innovative product development;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">effective strategy and execution of new product launches;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">identification and development of clinical support for new indications of the Company&#8217;s existing products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product performance;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product pricing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">quality of customer support;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">development of successful distribution channels, both domestically and internationally; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">intellectual property protection.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To compete effectively, the Company has to demonstrate that its new and existing products are attractive alternatives to other devices and treatments, by differentiating the Company&#8217;s products on the basis of such factors as innovation, performance, brand name, service, and price. This is difficult to do, especially in a crowded aesthetic market. Some of the Company&#8217;s competitors have newer or different products and more established customer relationships than the Company does, which could inhibit the Company&#8217;s market penetration efforts. For example, the Company has encountered, and expects to continue to encounter, situations where, due to&#160;pre-existing&#160;relationships, potential customers decide to purchase additional products from the Company&#8217;s competitors. Potential customers also may need to recoup the cost of products that they have already purchased from the Company&#8217;s competitors and may decide not to purchase the Company&#8217;s products, or to delay such purchases. If the Company is unable to increase the Company&#8217;s market penetration or compete effectively, its revenue and profitability will be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If there is not sufficient consumer demand for the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> procedures performed with the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, practitioner demand for its products could be inhibited, resulting in unfavorable operating results and reduced growth potential.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued expansion of the global market for laser and other-energy-based aesthetic procedures is a material assumption of the Company&#8217;s business strategy. Most procedures performed using the Company&#8217;s products are elective procedures not reimbursable through government or private health insurance, with the costs borne by the patient. The decision to utilize the Company&#8217;s products may therefore be influenced by a number of factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">consumer disposable income and access to consumer credit, which as a result of an unstable economy, may be significantly impacted;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the cost, safety and effectiveness of alternative treatments, including treatments which are not based upon laser or other energy-based technologies and treatments which use pharmaceutical products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the success of the Company&#8217;s sales and marketing efforts; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the education of the Company&#8217;s customers and patients on the benefits and uses of the Company&#8217;s products, compared to competitors&#8217; products and technologies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, as a result of these factors, there is not sufficient demand for the procedures performed with the Company&#8217;s products, practitioner demand for the Company&#8217;s products could be reduced, which could have a material adverse effect on the Company&#8217;s business, financial condition, revenue and result of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company modifies one of its</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA-cleared</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">devices, it may need to seek a new clearance, which, if not granted, would prevent the Company from selling its modified products or cause it to redesign its products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any modifications to an&#160;FDA-cleared&#160;device that could significantly affect its safety or e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ffectiveness or that would constitute a major change in its intended use would require a new 510(k) clearance or possibly a&#160;pre-market&#160;approval. The Company may not be able to obtain additional 510(k) clearance or premarket approvals for new products or for modifications to, or additional indications for, its existing products in a timely fashion, or at all. Delays in obtaining future clearance would adversely affect its ability to introduce new or enhanced products in a timely manner, which in turn would harm its revenue and future profitability.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made modifications to its devices in the past and may make additional modifications in the future that it believes do not or will not require additional clearance or approvals. If the FDA disagrees, and requires new clearances or approvals for the modifications, the Company may be required to recall and to stop marketing the modified devices, which could harm the Company&#8217;s operating results and require it to redesign its products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company cannot obtain and maintain Medical Device Regulation approvals, the Company will not be able to sell its products in the European Union. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s products are regulated in the European Union (&#8220;EU&#8221;) as medical devices per the Medical Device Regulation (Regulation (EU) 2017/745) (&#8220;MDR&#8221;). The Company's current CE marks on systems sold in the EU are set to expire on April 15, 2023 and a new MDR designation is required after April 15, 2023. The Company intends to obtain MDR certification for its principal products sold in the EU ahead of the April 15, 2023, expiration date. On February 16, 2023, the European Parliament voted to extend the MDR transition periods to avoid a shortage of medical devices in the EU economic region. Under this provision, the Company&#8217;s current certification may be extended until December 31, 2028, subject to meeting certain conditions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, the Company is subject to local rules and regulations implemented by each EU Member State where it conducts business, which can increase the burden of compliance and expose the Company to greater liabilities. If the Company is not successful in meeting the conditions for extension of its current certification in accordance with MDR and local rules and regulations, the Company may be required to remove applicable medical devices from the EU market until they are certified under the MDR, which would adversely impact the Company&#8217;s revenue and results of operations in Europe.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any defects in the design, material or workmanship of its products may not be discovered prior to shipment to customers, which could materially increase its expenses, adversely impact profitability and harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design of the Company&#8217;s products is complex. To manufacture them successfully, the Company must procure quality components and employ individuals with a significant degree of technical expertise. If the&#160;Company&#8217;s designs are defective, or the material components used in its products are subject to wearing out, or if suppliers fail to deliver components to specification, or if its employees fail to properly assemble, test and package its products, the reliability and performance of its products could be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s products contain defects that cannot be repaired easily, inexpensively, or on a timely basis, the Company may experience:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">damage to the Company&#8217;s brand reputation;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased costs due to product repair or replacement;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to attract new customers;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">diversion of resources from the Company&#8217;s manufacturing and research and development departments into the Company&#8217;s service department;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in share-based compensation; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">legal action.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could materially increase expenses, adversely impact profitability and harm the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's products may in the future be subject to product recalls that could harm its&#160;reputation, business and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices can experience performance problems in the field that require review and possible corrective action. The occurrence of component failures, manufacturing errors, software errors, design defects or labeling inadequacies affecting a medical device could lead to a government-mandated or voluntary recall by the device manufacturer, in particular when such deficiencies may endanger health. The FDA requires that certain classifications of recalls be reported to the FDA within 10 working days after the recall is initiated. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. The Company&#160;may initiate voluntary recalls involving its&#160;products in the future that the Company&#160;determines do not require notification of the FDA. If the FDA disagrees with its determinations, they could require the Company&#160;to report those actions as recalls. Product recalls may divert management attention and financial resources, expose the Company to product liability or other claims, harm its&#160;reputation with customers and adversely impact its&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of the Company's&#160;clinical trials may not support its&#160;products claims or may result in the discovery of adverse side effects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot be certain that the results of its&#160;future clinical trials will support its&#160;future product claims or that the FDA will agree with its&#160;conclusions regarding them. Success in&#160;pre-clinical&#160;studies and early clinical trials does not ensure that later clinical trials will be successful, and the Company&#160;cannot be sure that the later trials will replicate the results of prior trials and&#160;pre-clinical&#160;studies. The clinical trial process may fail to demonstrate that its&#160;products are safe and effective for the proposed indicated uses, which could cause the Company&#160;to abandon a product and may delay development of others. Any delay or termination of the Company's&#160;clinical trials will delay the filing of its&#160;product submissions and, ultimately, its&#160;ability to commercialize its&#160;products and generate revenues. It is also possible that patients enrolled in clinical trials will experience adverse side effects that are not currently part of the future product&#8217;s profile.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability suits could be brought against the Company due to a defective design, material or workmanship or misuse of its products and could result in expensive and time-consuming litigation, payment of substantial damages and an increase in its insurance rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s products are defectively designed, manufactured or labeled, contain defective components or are misused, the Company may beco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me subject to substantial and costly litigation by the Company&#8217;s customers or their patients. Misusing the Company&#8217;s products or failing to adhere to operating guidelines could cause significant eye and skin damage, and underlying tissue damage. In addition, if its operating guidelines are found to be inadequate, the Company may be subject to liability. The Company has been involved, and may in the future be involved, in litigation related to the use of its products. Product liability claims could divert management&#8217;s attention from its core business, be expensive to defend and result in sizable damage awards against the Company. The Company may not have sufficient insurance coverage for all future claims. The Company may not be able to obtain insurance in amounts or scope sufficient to provide the Company with adequate coverage against all potential liabilities. Any product liability claims brought against the Company, with or without merit, could increase the Company&#8217;s product liability insurance rates or prevent the Company from securing continuing coverage, could harm its reputation in the industry and could reduce product sales. In addition, the Company historically experienced steep increases in its product liability insurance premiums as a percentage of revenue. If its premiums continue to rise, the Company may no longer be able to afford adequate insurance coverage.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Certain of the Company&#8217;s product platforms such as Enlighten and excel HR are only capable of being produced at the single site in Brisbane, and as such the occurrence of a catastrophic disaster or other similar event could cause damage to its facilities and equipment, which might require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is vulnerable to damage from various types of disasters, including fires, earthquakes, terrorist acts, floods, power losses, communications failures, pandemics and similar events. If any such disaster were to occur, the Company may not be able to operate the Company&#8217;s business at the Company&#8217;s facility in Brisbane, California. Before the Company could manufacture products from a replacement facility, the Company&#8217;s manufacturing facilities which require regulatory agency approval, could require significant delays to obtain regulatory agency&#8217;s approval. The insurance the Company maintains may not be adequate to cover the Company&#8217;s losses resulting from disasters or other business interruptions. Therefore, any such catastrophe could seriously harm the Company&#8217;s business and consolidated results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may be involved in future costly intellectual property litigation, which could impact its future business and financial performance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s competitors or other patent holders may assert that the Company&#8217;s present or future products and the methods the Company employs are covered by their patents. In addition, the Company does not know whether its competitors or other patent holders own or will obtain patents that they may claim prevent, limit or interfere with the Company&#8217;s ability to make, use, sell or import the Company&#8217;s products. For example, Serendia, LLC, filed patent infringement complaints in March 2023 against the Company with the International Trade Commission and in U.S. District Court for the District of Delaware alleging infringement of six Serendia patents by the Secret RF and Secret Pro products, which the Company distributes in the United States on behalf of ILOODA Co. Ltd. If the Company is unable to resolve this matter, it may have to discontinue selling the Secret RF and Secret Pro products and may become involved in litigation or liable for damages as a result of its sales of the Secret RF and Secret Pro products. Although the Company may seek to resolve any potential future claims or actions such as this one, it may not be able to do so on reasonable terms, or at all. If, following a successful third-party action for infringement, the Company cannot obtain a license or redesign the Company&#8217;s products, it may have to stop selling the applicable products and the Company&#8217;s business would suffer as a result. In addition, a court could require the Company to pay substantial damages and prohibit the Company from using technologies essential to the Company&#8217;s products, any of which would have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also become involved in litigation not only as a result of alleged infringement of a third party&#8217;s intellectual property rights but also to protect the Company&#8217;s own intellectual property. For example, the Company has been involved in litigation to protect the trademark rights associated with its company name or the names of its products. Infringement and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intellectual property claims, with or without merit, can be expensive and time-consuming to litigate, and could divert management&#8217;s attention from its core business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s failure to comply with rules relating to bribery, foreign corrupt practices, and privacy and security laws may subject the Company to penalties and adversely impact its reputation and business operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is subject to regulation and oversight worldwide including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the FCPA, which prohibits corporations and individuals from paying, offering to pay or authorizing the payment of anything of value to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the UK Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors; and bribery provisions contained in the German Criminal Code, which, pursuant to draft legislation being prepared by the German government, may make the corruption and corruptibility of physicians in private practice and other healthcare professionals a criminal offense;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Health Insurance Portability and Accountability Act of 1996, as amended by The Health Information Technology for Economic and Clinical Health Act, which governs the conduct of certain electronic healthcare transactions and protects the security and privacy of protected health information; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">analogous state and foreign law equivalents of each of the above laws, such as state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under such laws, it is possible that some of the Company&#8217;s business activities, including the Company&#8217;s&#160;relationships with practitioners and thought leaders worldwide, some of whom recommend, purchase and/or use the Company&#8217;s devices, as well as the Company&#8217;s sales agents and distributors, could be subject to challenge under one or more of such laws. The Company is also exposed to the risk that the Company&#8217;s employees, independent contractors, principal investigators, consultants, vendors, independent sales agents and distributors may engage in fraudulent or other illegal activity. While the Company has policies and procedures in place prohibiting such activity, misconduct by these parties could include, among other infractions or violations, intentional, reckless and/or negligent conduct or unauthorized activity that violates FDA regulations, including those laws that require the reporting of true, complete and accurate information to the FDA, manufacturing standards, laws that require the true, complete and accurate reporting of financial information or data or other commercial or regulatory laws or requirements. It is not always possible to identify and deter misconduct by the Company&#8217;s employees and other third parties, and the precautions the Company takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting the Company from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar laws and regulations applicable to the Company&#160;outside the U.S., all of which are subject to evolving interpretations. Global enforcement of anti- corruption laws, including but not limited to the UK Bribery Act, the Brazil Clean Companies Act, and continued enforcement in the Europe, Middle East and Asia Pacific has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by governmental agencies, and assessment of significant fines and penalties against companies and individuals. The Company&#8217;s operations create the risk of unauthorized payments or offers of payments by one of its employees, consultants, sales agents, or distributors because these parties are not always subject to its control. It is the Company&#8217;s policy to implement safeguards to discourage these practices; however, its existing safeguards and any future improvements may prove to be less than effective, and its employees, consultants, sales agents, or distributors may engage in conduct for which the Company might be held responsible. Any alleged or actual violations of these regulations may subject the Company&#160;to government scrutiny, severe criminal or civil sanctions and other liabilities, and could negatively affect its business, reputation, operating results, and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the United Kingdom&#8217;s Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after June 30, 2023. These reforms may cause LIBOR to cease to exist, new methods of calculating LIBOR to be established or the establishment of an alternative reference rate(s). These consequences cannot be entirely predicted and could have an adverse impact on the market value for or value of LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by the Company. Changes in market interest rates may influence returns on financial investments and could reduce its earnings and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that the policies and procedures will be followed at all times or will effectively detect and prevent violations of the applicable laws by one or more of its employees, consultants, agents or partners and, as a result, the Company may be subject to penalties and material adverse consequences on its business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Risks Related to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Company's Convertible Senior Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing the Company&#8217;s debt, including the notes, may require a significant amount of cash, and the Company may not have sufficient cash flow from its business to pay its indebtedness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $429.1 million aggregate principal amount of the notes outstanding. The Company&#8217;s ability to make scheduled payments of the principal of, to pay interest on or to refinance its indebtedness, including the notes, depends on its future performance, which is subject to economic, financial, competitive, and other factors beyond the Company&#8217;s control. The Company&#8217;s business may not generate cash flow from operations in the future sufficient to service its debt and make necessary capital expenditures. If the Company is unable to generate such cash flow, it may be required to adopt one or more alternatives, such as selling assets, restructuring debt, or obtaining additional debt financing or equity capital on terms that may be onerous or highly dilutive. The Company&#8217;s ability to refinance any future indebtedness will depend on the capital markets and its financial condition at such time. The Company may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on its debt obligations. In addition, any of the Company&#8217;s future debt agreements may contain restrictive covenants that may prohibit the Company from adopting any of these alternatives. The Company&#8217;s failure to comply with these covenants could result in an event of default which, if not cured or waived, could result in the acceleration of its debt.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company&#8217;s indebtedness, combined with its other financial obligations and contractual commitments, could have other important consequences. For example, it could:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">make the Company more vulnerable to adverse changes in general U.S. and worldwide economic, industry, and competitive conditions and adverse changes in government regulation;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limit the Company&#8217;s flexibility in planning for, or reacting to, changes in its business and industry;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">place the Company at a disadvantage compared to its competitors who have less debt;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limit the Company&#8217;s ability to borrow additional amounts to fund acquisitions, for working capital, and for other general corporate purposes; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">make an acquisition of the Company less attractive or more difficult.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could harm the Company&#8217;s business, results of operations, and financial condition. In addition, if the Company incurs additional indebtedness, the risks related to its business and its ability to service or repay its indebtedness would increase.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may not have the ability to raise the funds necessary to settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and its future debt may contain limitations on its&#160;ability to pay cash upon conversion or repurchase of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the notes have the right to require the Company to repurchase all or a portion of their notes of the applicable series upon the occurrence of a fundamental change (as defined in the applicable indenture governing such series of notes) before the applicable maturity date at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion of the notes, unless the Company elects to deliver solely shares of its common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), the Company will be required to settle a portion or all of its conversion obligation in respect of the notes being converted in cash. Moreover, the Company will be required to repay the notes in cash at their maturity unless earlier converted, redeemed or repurchased. However, the Company may not have enough available cash or be able to obtain financing at the time the Company is required to make repurchases of notes surrendered therefor or pay cash with respect to notes being converted or at their maturity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company's ability to repurchase notes or to pay cash upon conversions of notes or at their maturity may be limited by law, regulatory authority or agreements governing its future indebtedness. The Company's failure to repurchase the notes of a series at a time when the repurchase is required by the applicable indenture or to pay cash upon conversions of notes or at their maturity as required by such indenture would constitute a default under such indenture. A default under the indenture governing a series of notes or the fundamental change itself could also lead to a default under agreements governing the Company's existing and future indebtedness. Moreover, the occurrence of a fundamental change under the indenture governing a series of notes could constitute an event of default under any such agreement. If the payment of the related indebtedness were to be accelerated after any applicable notice or grace periods, the Company may not have sufficient funds to repay the indebtedness. Any failure by the Company to repay indebtedness and repurchase the notes or make cash payments upon conversion thereof, in each case, when </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required to do so pursuant to the terms of the applicable indenture, could have a material adverse effect on the Company&#8217;s business, financial condition, and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion features of the notes, if triggered, may adversely affect the Company's financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second, third, and fourth quarters of 2021 and the third and fourth quarters of 2022, a conversion feature related to the sale price of the Company&#8217;s common stock was triggered. No conversion requests were submitted by the holders of any series of notes related to these triggering events. In the event the conditional conversion features of a series of notes are triggered, holders of the applicable series of notes will be entitled to convert their notes at any time during specified periods at their option. If one or more holders elect to convert their notes, unless the Company elects to satisfy the Company's conversion obligation by delivering solely shares of its common stock (other than paying cash in lieu of delivering any fractional share), the Company would be required to settle a portion or all of its conversion obligation in cash, which could adversely affect the company's liquidity. In addition, even if holders of notes do not elect to convert their notes, the Company could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability, which would result in a material reduction of its net working capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transactions relating to the notes may affect the value of the Company&#8217;s common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the notes would dilute the ownership interests of the Company&#8217;s existing stockholders to the extent the Company elects satisfy its conversion obligation by delivering shares of the Company&#8217;s common stock upon any conversion of such notes. The notes may become convertible at the option of their holders under certain circumstances set forth in the applicable indenture. If holders of the notes elect to convert their notes, the Company may settle its conversion obligation by delivering to them a significant number of shares of the Company&#8217;s common stock, which would cause dilution to the existing stockholders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing of the notes, the Company entered into capped call transactions with the applicable option counterparties. The capped call transactions cover, subject to customary adjustments, the number of shares of the Company's common stock initially underlying the applicable series of notes (excluding the 2028 notes issued to Voce Capital Management LLC). The capped call transactions are expected generally to reduce the potential dilution to the Company's common stock upon any conversion of such notes and/or offset any cash payments the Company may be required to make in excess of the principal amount of such converted notes, as the case may be, with such reduction and/or offset subject to a cap. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with establishing their initial hedges of the capped call transactions, the applicable option counterparties or their respective affiliates entered into various derivative transactions with respect to the Company&#8217;s common stock and/or purchased shares of the Company&#8217;s common stock concurrently with or shortly after the pricing of the applicable series of notes. From time to time, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to the Company&#8217;s common stock and/or purchasing or selling the Company&#8217;s common stock or other securities of the Company in secondary market transactions prior to the maturity of the applicable series of notes (and are likely to do so following any conversion, repurchase, or redemption of such notes, to the extent the Company exercises the relevant election under the applicable capped call transactions). This activity could also cause a decrease and/or increased volatility in the market price of the Company&#8217;s common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company is&#160;subject to counterparty risk with respect to the capped call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The counterparties to the capped call transactions that the Company entered into in connection with the pricing of the notes are financial institutions, and the Company will be subject to the risk that one or more of the counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the capped call transactions. The Company's exposure to the credit risk of the counterparties will not be secured by any collateral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global economic conditions have in the past resulted in the actual or perceived failure or financial difficulties of many financial institutions. If a counterparty to one or more capped call transactions becomes subject to insolvency proceedings, the Company will become an unsecured creditor in those proceedings with a claim equal to its exposure at the time under such transaction. the Company's exposure will depend on many factors but, generally, its exposure will increase if the market price or the volatility of the Company's common stock increases. In addition, upon a default or other failure to perform, or a termination of obligations, by a counterparty, the counterparty may fail to deliver the consideration required to be delivered to the Company under the capped call transactions and it may experience more dilution than the Company currently anticipates with respect to its common stock. The Company can provide no assurances as to the financial stability of the counterparties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of the Company's&#160;Common Stock</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions contained in the Company's&#160;amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's&#160;amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions which could have the effect of rendering more difficult, delaying or preventing an acquisition deemed undesirable by the Company's&#160;board of directors. Among other things, the Company's&#160;amended and restated certificate of incorporation and amended and restated bylaws include provisions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">authorizing &#8220;blank check&#8221; preferred stock, which could be issued by the Company's board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to its common stock;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limiting the liability of, and providing indemnification to, its directors and officers;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limiting the ability of its stockholders to call and bring business before special meetings;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">requiring advance notice of stockholder proposals for business to be conducted at meetings of the Company's stockholders and for nominations of candidates for election to its board of directors; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Company's&#160;management.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Delaware corporation, the Company is&#160;also subject to provisions of Delaware law, including Section&#160;203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), which prevents certain stockholders holding more than 15% of its&#160;outstanding capital stock from engaging in certain business combinations without approval of the holders of at least&#160;two-thirds&#160;of the Company's&#160;outstanding common stock not held by such stockholder.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of the Company's&#160;amended and restated certificate of incorporation, amended and restated bylaws or Delaware law that has the effect of delaying, preventing or deterring a change in control could limit the opportunity for its&#160;stockholders to receive a premium for their shares of the Company's&#160;capital stock, and could also affect the price that some investors are willing to pay for its&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's business could be negatively affected by activist shareholders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to actions by activist shareholders could be costly and time-consuming, disrupt the Company's operations and divert the attention of management and its employees. Additionally, perceived uncertainties as to the Company's future direction as a result of shareholder activism or changes to the composition of its board of directors may lead to the perception of a change in the direction of its business or other instability, which may be exploited by its competitors, cause concern to the Company's current or potential customers, and make it more difficult to attract and retain qualified personnel. If customers choose to delay, defer or reduce transactions with the Company or do business with its competitors instead of the Company, then the Company's business, financial condition and operating results would be adversely affected. In addition, the share price of its common stock could experience periods of increased volatility as a result of shareholder activism.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research or reports about the Company, its&#160;business, its&#160;market or its&#160;competitors, or if they adversely change their recommendations regarding the Company's common stock, the market price and trading volume of its&#160;common stock could decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for the Company's common stock will be influenced, to some extent, by the research and reports that securities or industry analysts publish about the Company, its business, its&#160;market or its&#160;competitors. If any of the analysts who cover the Company&#160;adversely change their recommendations regarding its&#160;common stock or provide more favorable recommendations about its&#160;competitors, the market price of the Company's&#160;common stock would likely decline. If any of the analysts who cover the Company&#160;cease coverage of the company or fail to regularly publish reports on it, the Company&#160;could lose visibility in the financial markets, which in turn could cause the market price and trading volume of its&#160;common stock to decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company does&#160;not expect to declare any dividends on its&#160;common stock in the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does&#160;not anticipate declaring any cash dividends to holders of its&#160;common stock in the foreseeable future. Consequently, investors may need to rely on sales of its&#160;common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking cash dividends should not purchase shares of its&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company raises additional capital through the sale of shares of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s common stock, convertible securities or debt in the future, its stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ownership in the Company could be diluted and restrictions could be imposed on the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue shares of its common stock or securities convertible into its common stock to raise additional capital in the future. To the extent the Company issues such securities, its stockholders may experience substantial dilution and the trading price of the Company&#8217;s common stock could decline. If the Company obtains funds through a credit facility or through the issuance of debt or preferred securities, such debt or preferred securities could have rights senior to the existing stockholders&#8217; rights as a common shareholder, which could impair the value of the Company&#8217;s common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">has implemented &#8220;sell-to-cover&#8221; in which shares of its common stock are sold into the market on behalf of RSU and PSU holders upon vesting of RSUs and PSUs to cover tax withholding liabilities and such sales will result in dilution to its stockholders.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under U.S. tax laws, employment tax withholding and remittance obligations for restricted stock units, or RSUs, and performance stock units, or PSUs, arise in connection with their vesting. To fund the tax withholding and remittance obligations arising in connection with the vesting of RSUs, the Company uses the &#8220;sell-to-cover&#8221; method, under which shares with a market value equivalent to the tax withholding obligation are sold by a broker on behalf of the holder of the RSUs or PSUs upon vesting to cover the tax withholding liability and the cash proceeds from such sales will be remitted by the Company to the taxing authorities. The tax withholding due in connection with such RSU or PSU vesting is based on the then-current value of the underlying shares of the Company&#8217;s common stock. Such sales do not result in the expenditure of additional cash by the Company to satisfy the tax withholding obligations for RSUs or PSUs, but do cause dilution to the Company&#8217;s stockholders and, to the extent a large number of shares are sold in connection with any vesting event, such sales volume may cause the Company&#8217;s stock price to fluctuate.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occupies 66,000 square feet for its U.S. corporate office in Brisbane, California, under a lease which extends through January 31, 2028. The original lease expired on December 31, 2017, and the Company entered into a Second Amendment on July 6, 2017 that extended the term of the lease to January 31, 2023 and a Third Amendment on July 9, 2020 that extended the term of the lease to January 31, 2028. The amendment provides for the following: a) the extension of the lease term, with the extended term to begin on February 1, 2023 and continue until January 31, 2028; b) the abatement of the monthly base rent for the four month period beginning September 1, 2020 and ending December 31, 2020; c) the amendment of monthly base rent during the extension term to approximately $0.2 million for January 2021 with annual increases of 3.5% thereafter; and d) the waiver by the Company of its early termination right in the lease. Pursuant to the terms of the Third Amendment to the Lease Agreement, the Company has the option to extend the term of the lease by an additional 60 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has leased office facilities in certain countries as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Square Footage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease termination or Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately&#160;10,760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Four leases, expiring between December 2023 and March 2024.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">France</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 2,239</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in June 2031.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 680</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in December 2023.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Belgium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 151</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in November 2023.</span></td></tr></table></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_28"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. For a description of material pending legal and regulatory proceedings and settlements as of December 31, 2022, please see Note 13 to the Company&#8217;s consolidated financial statements entitled &#8220;Commitments and Contingencies,&#8221; Part II Item 8, included in this Annual Report on Form 10-K.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_31"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_37"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;5.&#160;&#160;&#160;&#160;MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Exchange Listing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s common stock trades on the NASDAQ Global Select Market under the symbol &#8220;CUTR.&#8221; As of April&#160;4, 2023, the closing sale price of its common stock was $23.05 per share.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stockholders</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had five&#160;stockholders of record as of February 22, 2023.&#160;The Company believes the actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners, but whose shares are held in &#8220;street&#8221; name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no repurchases of the Company&#8217;s common stock in 2022 under the Company&#8217;s Stock Repurchase Program.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million aggregate principal amount of convertible notes in a private placement offering on March 5, 2021. The notes bear interest at a rate of 2.25% per year.&#160;In connection with issuance of the notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally expected to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the notes.&#160;The capped calls were purchased for $16.1 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 27, 2022, the Company issued $240.0 million aggregate principal amount of convertible notes (the &#8220;2028 Notes&#8221;). The notes bear interest at a rate of 2.25% per year. A total of $230.0 million of aggregate principal amount of 2028 Notes was issued in a private placement offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and concurrently with this private placement, the Company entered into a purchase agreement with Voce Capital Management LLC (&#8220;Voce&#8221;) pursuant to Section 4(a)(2) of the Securities Act, an entity affiliated with J. Daniel Plants, the Company&#8217;s Executive Chairperson, pursuant to which the Company issued to Voce $10.0 million aggregate principal amount of 2028 Notes on the same terms and conditions. The aggregate proceeds from the offering of 2028 Notes were approximately $232.4 million, net of issuance costs, including initial purchasers&#8217; fees. The notes will mature on June 1, 2028, unless earlier converted, repurchased or redeemed. The initial conversion rate will be 18.9860 shares of the Company's common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $52.67 per share of common stock). In connection with issuance of the notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally expected to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the notes.&#160;The capped calls were purchased for $32.0 million, inclusive of issuance costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2022, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-36">120.0</ix:nonFraction> million aggregate principal amount of convertible notes (the &#8220;2029 Notes&#8221;) in a private placement offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2029 Notes bear interest at a rate of 4.00% per year. Upon conversion, the 2029 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The 2029 Notes are presented as convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-37">115.8</ix:nonFraction> million, net of issuance costs, including initial purchasers&#8217; fees. The notes will mature on June 1, 2029, unless earlier converted, repurchased or redeemed. The initial conversion rate will be 17.1378 shares of the Company's common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $58.35 per share of common stock). In connection with issuance of the 2029 Notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally expected to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the notes.&#160;The capped calls were purchased for $25.1 million, inclusive of issuance costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding the Company&#8217;s intentions with respect to dividends, see the section titled &#8220;Stock-based Compensation Expense&#8221; set forth in Part II Item 7 of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item regarding equity compensation plans is incorporated by reference to the information set forth in Part III Item 12 of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares Cutera, Inc.'s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d the NASDAQ Health Care index. The graph tr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acks the performance of a $100 investment in the Company&#8217;s common stock and in each index (with the reinvestment of all dividends) from December 31, 2017 to December 31, 2022.</span></div><div style="margin-top:10pt;text-align:center"><img src="cutr-20221231_g1.jpg" alt="2333" style="height:466px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*$100 invested on December 31, 2017 in stock or index, including reinvestment of dividends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC rules, the information contained under &#8220;Performance Graph&#8221; shall not be deemed to be &#8220;soliciting material,&#8221; or to be &#8220;filed&#8221; with the SEC or subject to the SEC&#8217;s Regulation 14A or 14C, other than as provided under Item 201(e) of Regulation S-K, or to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically request that the information be treated as soliciting material or specifically incorporate it by reference into a document filed under the Securities Act, or the Securities Exchange Act of 1934, as amended.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6. [RESERVED]</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">following</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">should</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">be</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">read</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">conjunction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">audited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">thereto</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fiscal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">December</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">31,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Form</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">10-K,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">following</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">sections,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">contains</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">meaning</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1995.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Throughout</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">particularly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">7,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">based</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">upon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expectations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">projections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reflect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">beliefs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">based</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">upon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">available</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this Report. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">some</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">you can identify these statements by words such as &#8220;may,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;might,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;could,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;will,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;should,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;expects,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;plans,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;anticipates,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;likely,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;believes,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;estimates,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;intends,&#8221; &#8220;forecasts,&#8221; &#8220;foresees,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;predicts,&#8221; &#8220;potential&#8221; or &#8220;continue,&#8221; and other similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">terms.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking statements are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">subject</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">uncertainties,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">difficult</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">predict.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">actual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">results,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">achievements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">could</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">differ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">materially</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">those</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expressed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">implied</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">include,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">but</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">relating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">grow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">business,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">manage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expenses, generate additional cash,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">achieve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">maintain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">profitability,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">develop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">commercialize existing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">new</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">applications,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">improve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">worldwide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">distribution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">network,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">outlook regarding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">long</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">term prospects. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cautions you</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">place</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">undue reliance on these forward-looking statements,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reflect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">management&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">only</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on Form 10-K. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">undertakes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">no obligation to update forward-looking statements to reflect events or circumstances occurring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">after</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Some</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">important</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">could</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">differ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">materially</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">those</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">uncertainties,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1A&#8212;Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">encourages</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">you</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">read</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">carefully</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">well</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">detailed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">filings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SEC.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_46"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) is organized as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Executive Summary. This section provides a general description and history of the Company&#8217;s business, a brief discussion of the Company&#8217;s product lines and the opportunities, trends, challenges and risks the Company focuses on in the operation of the Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Critical Accounting Policies and Estimates. This section describes the key accounting policies that are affected by critical accounting estimates.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Results of Operations. This section provides the Company&#8217;s analysis and outlook for the significant line items on the Company&#8217;s Consolidated Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Liquidity and Capital Resources. This section provides an analysis of the Company&#8217;s liquidity and cash flows, as well as a discussion of the Company&#8217;s commitments that existed as of December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has omitted discussion of 2020 results where it would be redundant to the discussion previously included in Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K for the year ended December 31, 2021, which has been filed with the SEC.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_49"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company Description</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer safe and effective treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo &#8212; each of which enables medical practitioners to perform safe and effective procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over <ix:nonFraction unitRef="country" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="f-38">37</ix:nonFraction> countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s trademarks include: &#8220;CUTERA&#174;,&#8221; &#8220;AVI360&#174;,&#8221; &#8220;AVICARE&#174;," &#8220;AVICLEAR&#174;," &#8220;AVICOOL&#174;, "ACUTIP 500&#174;," &#8220;COOLGLIDE&#174;,&#8221; &#8220;CUCF&#174;,&#8221; &#8220;CUTERA UNIVERSITY CLINICAL FORUM&#174;,&#8221; &#8220;ENLIGHTEN&#174;,&#8221; &#8220;EXCEL HR&#174;,&#8221; &#8220;EXCEL V&#174;,&#8221; &#8220;EXCEL V+&#8482;,&#8221; &#8220;GENESIS&#174;,&#8221; &#8220;LASER GENESIS&#174;,&#8221; &#8220;LIMELIGHT&#174;,&#8221; "MYQ&#174;," &#8220;PEARL&#174;,&#8221; &#8220;PICO GENESIS&#174;,&#8221; &#8220;PROWAVE 770&#174;,&#8221; &#8220;SOLERA&#174;,&#8221; &#8220;TITAN&#174;,&#8221; &#8220;TRUBODY&#174;,&#8221; &#8220;TRUFLEX&#8482;,&#8221; &#8220;TRUSCULPT&#174;,&#8221; &#8220;TRUSCULPT ID&#174;,&#8221; &#8220;TRUSCULPT FLEX&#174;,&#8221; &#8220;VANTAGE&#174;,&#8221; and &#8220;XEO&#174;.&#8221; The Company&#8217;s logo and other Company trade names, trademarks, and service marks appearing in this document are the Company&#8217;s property. Other trade names, trademarks, and service marks appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, the Company&#8217;s trade names, trademarks and service marks referred to in this Annual Report on Form 10-K appear without the &#174; or TM symbols, but those references are not intended to indicate, in any way, that the Company will not assert, to the fullest extent under applicable law, the Company&#8217;s rights, or the right of the applicable licensor to these trade names, trademarks and service marks</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenue from the sale of products and services. Product revenue includes revenue from the sale of systems, hand pieces and upgrade of systems (collectively &#8220;Systems&#8221; revenue), leasing of AviClear devices for acne treatment ("AviClear" revenue), replacement hand pieces, truSculpt cycle refills, and truFlex cycle refills, as well as single use disposable tips applicable to Secret RF (&#8220;Consumables&#8221; revenue); and the sale of third-party manufactured skincare products (&#8220;Skincare&#8221; revenue). A system consists of a console that incorporates a universal graphic user interface, a laser and (or) an energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. However, depending on the application, the laser or other energy-based module is sometimes contained in the hand piece such as with the Company&#8217;s Pearl and Pearl Fractional applications instead of within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently markets the following key platforms: AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo &#8212; each of which enables medical practitioners to perform safe and effective procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare revenue relates to the distribution of ZO&#8217;s skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service includes prepaid service contracts, and labor, time and material on out-of-warranty products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Business Trends</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the ability to grow revenue will be primarily impacted by the following:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">capturing market share in the Acne space and capitalizing on the momentum in AviClear;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">continuing to expand the Company&#8217;s product offerings, both through internal development and sourcing from other vendors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">ongoing investment in the Company&#8217;s global sales and marketing infrastructure;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">use of clinical results to support new aesthetic products and applications;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">enhanced luminary development and reference selling efforts (to develop a location where Company&#8217;s products can be displayed and used to assist in selling efforts);</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">customer demand for the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">consumer demand for the application of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">marketing to physicians in the core dermatology and plastic surgeon specialties, as well as outside those specialties; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">generating recurring revenue from the Company&#8217;s growing installed base of customers through the sale of system upgrades, services, hand piece refills, truSculpt cycles, skincare products and replacement tips for Secret RF products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of the significant business trends impacting the Company&#8217;s business, please see the section titled &#8220;Results of Operations&#8221; below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of the Company&#8217;s audited consolidated financial statements and related notes requires the Company to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company has based its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. The Company periodically reviews its estimates and makes adjustments when facts and circumstances dictate. To the extent that there are material differences between these estimates and actual results, its financial condition or results of operations will be affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the consolidated financial statements. The Company believes that its critical accounting policies reflect the more significant estimates and assumptions used in the preparation of its audited consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s critical accounting policies are described in Note 1 &#8220;Summary of significant accounting policies&#8221;. The following critical accounting policies reflect the more significant estimates and assumptions used in the preparation of the Company's condensed consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company estimates an excess and obsolete inventory reserve based on expected inventory usage. The Company&#8217;s estimate of inventory consumption is based on historic consumption patterns, expected future sales and production, anticipated manufacturing capacity, and planned product releases. The Company develops an estimate of these factors through analysis of historic and budgeted data, and enquiries of departmental leaders. The Company evaluates the excess and obsolete model and the resulting reserve on a quarterly basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes and Valuation Allowance</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company estimates whether a valuation allowance is necessary for the Company&#8217;s deferred tax assets by evaluating evidence of the existence of sufficient taxable income within the permitted carryback and carryforward periods. The most significant deferred tax assets relate to the Company&#8217;s accumulated net operating losses of $133.0 million at December 31, 2022, and unutilized tax credit balance of $14.9 million at December 31, 2022. The Company considers positive and negative evidence in evaluating the likelihood that these net operating losses and tax credits can be utilized and places greatest reliance on the most objective available evidence, including the Company&#8217;s recent operating loss history or profitability by tax jurisdiction, the timing of the expiration of net operating losses, and credit carryforwards and potential reversal of deferred tax liabilities that would give rise to future taxable income. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected consolidated financial data expressed as a percentage of net revenue.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(Loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected consolidated revenue by major geographic area and product category with changes thereof.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Japan as a percentage of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rest of World as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems - North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems - Rest of World (including Japan)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Systems</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AviClear</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Products</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,683&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Net Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s total revenue increased by $21.1 million, or 9%, for the year ended December&#160;31, 2022, compared to 2021, due to an increase in revenue from system sales of $24.0 million reflecting an increase in systems volume across all geographies. Consumables growth increased by $2.6 million driven by an increased system installed base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These increases were partially offset by a decrease in Skincare revenue of $7.2 million due to devaluation of the Japanese Yen. Foreign currency devaluation in Japan, Europe and Australia adversely impacted total revenue in 2022 by approximately $15.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue by Geography</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s North America revenue increased by $16.8 million, or 15%, for the year ended December&#160;31, 2022, compared to 2021. This increase is due to an increase of $12.2 million is systems revenue, attributable to investments in the Company's sales force, and AviClear revenue of $4.5 million reflecting the commercialization of the AviClear device in 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue in Japan decreased $5.3 million, or 8%, for the year ended December&#160;31, 2022, compared to 2021. This decrease was driven by a $7.2 million decrease in Skincare revenue due to a significant devaluation in the Japanese Yen in 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s Rest of World revenue increased $9.6 million, or 20%, for the year ended December&#160;31, 2022, compared to 2021, driven by continued sales process improvements and development efforts from the sales team resulting in a $9.8 million increase in systems revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Product Type</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue in North America increased by $12.2 million, or 14%, for the year ended December&#160;31, 2022, compared to 2021, due to strong market conditions and investments in the North American sales force. The Rest of the World systems revenue increased by $11.8 million, or 22%, compared to 2021. The increase in Rest of the World revenue was due to increased sales across all international sales regions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear Revenue</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company received FDA clearance related to its AviClear device in March 2022. From April 2022 through November 2022, the Company earned revenue from a limited commercial release and after November 2022 earned revenue from a full commercial release. The AviClear revenue consists of $0.9 million of lease revenue related to the fixed annual license fee and variable lease revenue of $3.5 million related to treatments performed by the lessee.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consumables Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables revenue increased $1.8 million, or 11%, for the year ended December 31, 2022, compared to 2021. The increase in consumables revenue was primarily due to the increased installed base of truSculpt, Secret RF, truSculpt iD and truFlex, each of which have a consumable element.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from Skincare products in Japan decreased $7.2 million, or 14%, for the year ended December&#160;31, 2022, compared to 2021. This decrease was mainly due to significant devaluation of the Japanese Yen in 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Service revenue decreased $2.0 million, or 8%, for the year ended December&#160;31, 2022, compared to 2021. This decrease was due to supply chain constraints on service parts as well as foreign currency devaluation in Japan, Europe, and Australia.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit as a percentage of revenue for the year ended December&#160;31, 2022, was 55.4%, compared to 57.6% in 2021. The decrease in gross profit as a percentage of revenue was driven by foreign currency devaluation contributing to a 2.0 percentage point decrease and the increased manufacturing overhead due to the AviClear launch contributing to a 1.5 percentage point decrease. These decreases were partially offset by an increase in sales volume, which improved the Company's leverage on fixed costs and provided an increase of 1.3 percentage points to the Company's gross profit percentage. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sales and marketing expenses consist primarily of personnel expenses, expenses associated with customer-attended workshops and trade shows, post-marketing studies, advertising, and training. Sales and marketing expenses for the year ended December&#160;31, 2022, increased $30.2 million, or 39%, compared to 2021. This increase was primarily driven by an investment in AviClear sales and marketing resources and an increase in commission expense due to increased sales. This investment in AviClear and increase in commission expense resulted in an increase in labor expenses of $15.1 million. Also contributing to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the increase in sales and marketing expenses was a $6.2 million increase in marketing costs and a $4.2 million increase due to the resumption of travel activities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">R&amp;D expenses consist primarily of personnel expenses, clinical research, regulatory and material costs. R&amp;D expenses increased by $3.6 million, or 17%, for the year ended December&#160;31, 2022, compared to 2021. The increase in expense was due primarily to $1.9 million related to an investment in skin revitalization technology, and a $1.3 million increase&#160;in salaries and benefits.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative (&#8220;G&amp;A&#8221;)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">G&amp;A expenses consist primarily of personnel expenses, legal, accounting, audit and tax consulting fees, as well as other general and administrative expenses. G&amp;A expenses increased by $13.0 million, or 39%, for the year ended December&#160;31, 2022, compared to 2021. The increase in expenses was due primarily to a $9.6 million increase in professional fees, mainly related to the implementation of a new ERP in 2022, a $2.2 million increase in credit loss and other administrative expense, and a $1.5 million increase in labor-related expenses driven by an increase in headcount.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income (Expense), Net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net, consists of the following:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:36.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of debt issuance costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,355)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(710)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(710)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest on Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Loss on extinguishment of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,845)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest and other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,512)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net, changed from a net income of $1.6 million in 2021 to a net expense of $42.5 million in 2022. This change is primarily due to the loss on extinguishment of the 2026 Notes and the increased convertible debt costs in 2022 from the issuance of the 2028 and 2029 Notes. The increased expense was partially offset by interest income of $2.6 million generated from marketable investments. Other expense, net, mainly consists of realized and unrealized foreign exchange losses. The increase in the loss in 2022 reflects the devaluation of the Japanese Yen.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision increased $0.3 million, or 24%, for the year ended December&#160;31, 2022, compared to 2021. This increase reflects higher net earnings from the Company's foreign subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Segment Results of Operations</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:26.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cutera Core</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AviClear</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cutera Core</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AviClear</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,698)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;text-decoration:underline">Cutera Core</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s Cutera Core reportable segment consists of the Company&#8217;s systems, consumables, skincare, and service businesses. The Cutera Core segment develops and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The installed base of systems provides opportunities for the segment to earn revenues through service contracts, consumables and replacement handpieces. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Cutera Core segment&#8217;s revenue increased by $16.7 million for the year ended December 31, 2022, compared to 2021. This increase mainly reflected an increase in system sales of $24.0 million due to volume increases across all geographies. This increase was partially offset by a $7.2 million decrease in Skincare revenue due mainly to a devaluation of the Japanese Yen.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Cutera Core segment recorded a loss from operations of $6.9 million in the year ended December 31, 2022, compared to income from operations of $11.5 million in 2021. This $18.4 million adverse change reflects an increase in operating expenses of $26.0 million, partially offset by an increase in gross margin of $7.6 million due to the increase in revenue. The increase in operating expenses reflects an increase of $13.8 million in professional fees and outside consulting, mainly related to the implementation of a new ERP in 2022, an increase in payroll-related expense of $4.3 million, and an increase of $3.7 million related to the resumption of travel activities and conferences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;text-decoration:underline">AviClear</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s AviClear reportable segment consists of the AviClear business. The Company&#8217;s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. The Company began earning revenue from its AviClear device following FDA approval in 2022. The Company leases the AviClear device to customers in North America and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In the year ended December 31, 2022, the Company earned $0.9 million in lease license fee revenue and $3.5 million in treatment revenue. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The AviClear segment recorded a loss from operations of $31.3 million in the year ended December 31, 2022, compared to a loss from operations of $9.7 million in 2021. This $21.6 million adverse change mainly reflects a $19.5 million increase in sales and marketing expense associated with the commercialization of the AviClear device. An increase in sales-related headcount in the AviClear segment resulted in an increase in payroll expenses of $10.5 million and promotional and travel expenses related to the AviClear commercialization accounted for a further $7.3 million of the increase in sales and marketing expense.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_58"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal source of liquidity is cash generated from the issuance of convertible notes. The Company actively manages its cash usage and investment of liquid cash to ensure the maintenance of sufficient funds to meet its daily needs. The majority of the Company&#8217;s cash is held in U.S. banks and its foreign subsidiaries maintain a limited amount of cash in their local banks to cover their short-term operating expenses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and December 31, 2021, the Company had $345.4 million&#160;and $175.8 million of working capital, respectively. Cash and cash equivalents decreased by $18.2 million to $145.9 million as of December&#160;31, 2022, from $164.2 million as of December 31, 2021, due to the net proceeds from the issuance of the convertible notes, offset by purchases of capped calls and marketable investments, the acquisition of property and equipment and cash used for operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Marketable Investments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s cash, cash equivalents and restricted cash (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,240)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Cash Flow Data</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, the Company&#8217;s cash flows were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66,995)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,934)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(194,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,240)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net cash used in operating activities for the year ended December&#160;31, 2022, was $67.0 million, which reflected net loss, adjusted for non-cash items of $21.0 million, and changes in assets and liabilities of $46.0 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The change in assets and liabilities was driven by increases in accounts receivable and inventory, reflecting an increase in revenue and purchases of inventory parts to mitigate global supply shortages, respectively. These increases were partially offset by an increase in accounts payable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Cash Flows from Investing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net cash used in investing activities for the year ended December&#160;31, 2022, was $194.2 million, due to net purchases of marketable investments of $171.5 million and purchases of property, and equipment of $22.7 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Cash Flows from Financing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash provided by financing activities for the year ended December&#160;31, 2022, was $242.9 million, which was primarily due to the proceeds from the issuance of convertible notes, net of issuance costs, partially offset by the cash used for the purchase of capped calls, and the partial extinguishment of the 2026 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adequacy of Cash Resources to Meet Future Needs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents, including marketable securities, of $317.3 million, as of December&#160;31, 2022. The Company believes that the existing cash resources are sufficient to meet the Company&#8217;s anticipated cash needs for working capital and capital expenditures through at least the next 12 months from the date the financial statements are issued, but there can be no assurances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of 2026 Notes in a private placement offering. The 2026 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year. Upon conversion, the 2026 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">combination thereof, at the Company&#8217;s election. The convertible notes are presented as convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $133.6 million, net of issuance costs, including initial purchasers&#8217; fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company issued $240.0&#160;million aggregate principal amount of 2028 Notes. The 2028 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on June 1 and December 1 of each year. A total of $230.0 million of aggregate principal amount of 2028 Notes was issued in a private placement offering and concurrently with this private placement, the Company entered into a purchase agreement with Voce Capital Management LLC, an entity affiliated with J. Daniel Plants, the Company&#8217;s Executive Chairperson, pursuant to which the Company issued to Voce $10.0&#160;million aggregate principal amount of 2028 Notes on the same terms and conditions. The aggregate proceeds from the offering of 2028 Notes were approximately $232.4&#160;million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company issued $120.0 million aggregate principal amount of 2029 Notes in a private placement offering. The 2029 Notes bear interest at a rate of 4.00% per year payable semiannually in arrears on June 1 and December 1 of each year. Upon conversion, the 2029 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $115.8 million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company entered into the Loan and Security Agreement for the Revolving Line of Credit. See Note 14&#160;&#8211; Debt in the accompanying notes to consolidated financial statements&#160;for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial condition covenants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2021, the Loan and Security Agreement was amended to (i)&#160;permit the Company to issue the 2026 Notes, and (ii) to&#160;permit the related capped call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 24, 2022, the Loan and Security Agreement was amended. The amendment increased the permitted indebtedness by $230,000,000 and provided for the 2026 Notes Exchange and issuance of the capped call transactions related to the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement waived a violation of a covenant and revised the Loan Agreement to permit the issuance of the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement waived a violation of a covenant and revised the Loan Agreement to permit the issuance of the 2029 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had not drawn on the Revolving Line of Credit and the Company is in compliance with all financial covenants of the Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. In addition, under the purchase and assumption agreement, First-Citizens Bank &amp; Trust Company assumed Silicon Valley Bank&#8217;s obligations under the Company&#8217;s credit facility. On March 13, 2023, the Company violated one of the terms of the credit facility agreement by transferring funds from Silicon Valley Bank. The Company received a waiver from First-Citizens Bank &amp; Trust Company for this violation. </span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. Such time periods can vary among different suppliers. The Company believes it has adequate funds to fulfill any such commitments in the future using the sources discussed in this Item 7 &#8211; Management&#8217;s Discussion &amp; Analysis of Financial Condition and Results of Operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of the Company&#8217;s directors and executive officers. The Company&#8217;s exposure under the various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against us. As such, the Company has not accrued any amounts for such obligations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The conditional conversion feature of the convertible notes, if triggered, may adversely affect the Company's financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026 Notes:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ended on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the convertible notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the third and fourth quarter of 2022. As of December&#160;31, 2022, the 2026 Notes are convertible and this condition will remain until March 31, 2023. The 2026 Notes may also become convertible in future periods. Upon any conversion requests of the 2026 Notes, the Company would be required to pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2026 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more holders elect to convert their convertible notes, unless the Company elects to satisfy its conversion obligation by delivering solely shares of its common stock, the Company would be required to settle a portion or all of its conversion obligation through the payment of cash, which could adversely affect the Company&#8217;s liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2028 Notes:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2028 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2028, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ending on September 30, 2022 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2028 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221; per $1,000 principal amount of 2028 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2028, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2028 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the bullets in the paragraph above were not met during the fourth quarter of 2022. As of December&#160;31, 2022, the 2028 Notes are not convertible and this condition will remain until March 31, 2023. The 2028 Notes may become convertible in future periods. Upon any conversion requests of the 2028 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2028 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2028 Notes prior to June 5, 2025. On or after June 5, 2025, the Company may redeem for cash all or any portion of the 2028 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2028 Notes, at least $100.0&#160;million aggregate principal amount of 2028 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, note holders have the option to require the Company to repurchase any portion or all of their 2028 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2028 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2028 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2028 Notes. The 2028 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2028 Notes (including the 2026 Notes). The 2028 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2028 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2029 Notes:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2029 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2029, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2029 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of 2029 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such 2029 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2029, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2029 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the bullets in the paragraph above were not met during the fourth quarter of 2022. As of December&#160;31, 2022, the 2029 Notes are not convertible and this condition will remain until March 31, 2023. The 2029 Notes may become convertible in future periods. Upon any conversion requests of the 2029 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2029 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2029 Notes prior to December 5, 2025. On or after December 5, 2025, the Company may redeem for cash all or any portion of the 2029 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2029 Notes, at least $100.0 million aggregate principal amount of 2029 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, 2029 Note holders have the option to require the Company to repurchase any portion or all of their 2029 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2029 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2029 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2029 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2029 Notes. The 2029 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2029 Notes (including the 2026 Notes and 2028 Notes). The 2029 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2029 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate and Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had not drawn on the Revolving Line of Credit, as amended. Overall interest rate sensitivity is primarily influenced by any amount borrowed on the line of credit and the prevailing interest rate on the line of credit facility. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he effective interest rate on the line of credit facility is based on a floating per annum rate equal to the Prime rate. The Prime rate was 7.50% as of December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and accordingly the Company may incur additional expenses if the Company has an outstanding balance on the line of credit and the Prime rate increases in future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company experienced inflationary pressure on its business, but the impact was mitigated through ongoing cost improvement initiatives. If the Company&#8217;s costs were to become subject to significant inflationary pressures, the Company may not be able to fully offset such higher costs through price increases. The Company&#8217;s inability or failure to do so could harm the Company&#8217;s business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Fluctuations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue in Japanese Yen, Euros, Australian Dollars, Canadian Dollars, British Pounds, and Swiss Francs. Additionally, a portion of the Company&#8217;s operating expenses, and assets and liabilities are denominated in each of these currencies. Therefore, fluctuations in these currencies against the U.S. dollar could materially and adversely affect the Company&#8217;s results of operations upon translation of the Company&#8217;s revenue denominated in these currencies, as well as the re-measurement of the Company&#8217;s international subsidiaries&#8217; financial statements into U.S. dollars. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company experienced an adverse impact on revenues and net loss of devaluations in the currencies of Japan, Europe and Australia. These devaluations adversely impacted total revenue and net loss in 2022 by approximately $15 million and $11 million, respectively. As of December&#160;31, 2022, the effect of a hypothetical 10% unfavorable change in exchange rates on currencies denominated in other than their functional currency would result in a potential reduction of future revenue and increase in the Company's net loss in the consolidated statement of operations of approximately $10 million and $6 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to be exposed to fluctuations in the exchange rate between U.S. Dollars and Japanese Yen, as the Company's skincare revenue is denominated in Japanese Yen. In July 2022, the Company implemented a hedging program to mitigate this exposure to the Japanese Yen fluctuation against the U.S. Dollar.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANIES</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10-K</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Consolidated Financial Statements of the Registrant and its subsidiaries are required to be included in Item 8:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:89.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_76">Reports of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:AuditorName" id="f-39">BDO USA, LLP</ix:nonNumeric>; <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:AuditorLocation" id="f-40">San Francisco, California</ix:nonNumeric>; PCAOB ID#<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="dei:AuditorFirmId" id="f-41">243</ix:nonNumeric>)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_76">73</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_79">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_79">77</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_82">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_82">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_85">Consolidated Statements of Comprehensive Income (Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_85">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_88">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_88">80</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_91">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_91">81</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_94">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_94">82</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_145">Schedule II -Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i62f386bfb76443f0a57b663f9bc3fcbb_145">118</a></span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other required schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the Consolidated Financial Statements or the Notes thereto.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cutera, Inc. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive income (loss), stockholders&#8217; equity (deficit), and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and schedule (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) and our report dated   April&#160;7, 2023 expressed an adverse opinion thereon.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition &#8211; Contracts with International Distributors</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized total net revenue of approximately $252.4 million for the year ended December 31, 2022. As described in Note 1 to the consolidated financial statements, the Company recognizes revenue in a manner that best depicts the transfer of control of promised products or services to the customer, in an amount that reflects the consideration to which the Company expects to be entitled. The Company&#8217;s contracts with customers may include, individually, or in combination, systems, extended service contracts, training, marketing support and accessories. Certain of the Company&#8217;s contracts, which include some with international distributors, can include non-standard payment and other sales terms that can impact management&#8217;s conclusions as to the determination of the transaction price and/or whether control has transferred to the customer. Management applies significant effort and judgment in evaluating the impact of these non-standard payment and sales terms on revenue recognition.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the accounting for revenue recognition in the Company&#8217;s contracts with international distributors as a critical audit matter. The principal considerations for our determination are the judgments related to the identification and, if present, the evaluation of: (i) non-standard payment terms, and (ii) certain other sales terms related to the transfer of control. Auditing these elements involved subjective auditor judgment due to the nature and extent of audit effort required to address these matters. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary procedures we performed to address this critical audit matter included:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Examining certain international distributor contracts, including amendments or modifications, for non-standard payment terms, and where such terms are present, assessing the impact on the determination of the transaction price, based on a consideration of indicators of the international distributor&#8217;s collection and credit memo history.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Examining certain international distributor contracts, including amendments or modifications, for non-standard terms governing transfer of control, and where such terms are present, assessing the transfer of control based on considerations including whether the international distributor has physical possession and legal title to the product, whether the Company has a present right to payment, and other factors relevant to the determination of whether the international distributor has the ability to direct the use of and obtain substantially all of the remaining benefit from the product.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ BDO USA, LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2014.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;7, 2023</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cutera, Inc.&#8217;s (the &#8220;Company&#8217;s&#8221;) internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the &#8220;COSO criteria&#8221;). In our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not express an opinion or any other form of assurance on management&#8217;s statements referring to any corrective actions taken by the Company after the date of management&#8217;s assessment. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity (deficit), and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and schedule (collectively referred to as &#8220;the financial statements&#8221;) and our report dated April&#160;7, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Item 9A, Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. Material weaknesses have been identified and described in Management&#8217;s assessment. These material weaknesses related to Management&#8217;s failure to design and maintain effective controls over financial reporting, specifically related to the following: (1) information technology controls (&#8220;ITGCs&#8221;) including segregation of duties, user access, and reports produced by, certain information technology (&#8220;IT&#8221;) systems that support the Company&#8217;s financial reporting process including those related to implementation of a new Enterprise Resource Planning (&#8220;ERP&#8221;) system; (2) existence, completeness and cut-off for inventory held at third parties, in transit, and held by field representatives and sales personnel, and calculation of adjustments to inventory cost for items considered excessive or obsolete; (3) completeness and accuracy of expense for routine and non-routine equity-based awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2022 financial statements, and this report does not affect our report dated April&#160;7, 2023 on those financial statements. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ BDO USA, LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;7, 2023</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-42">145,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-43">164,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">171,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">2,497</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-47">899</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">45,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">31,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-50">63,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-51">39,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">24,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">14,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-54">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="f-55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">451,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">249,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-58">40,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-59">3,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="f-60">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="f-61">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-62">12,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-63">14,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-64">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-65">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">14,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">10,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-69">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-70">520,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-71">280,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">33,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">7,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">57,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">54,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">11,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">9,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">105,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">73,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">11,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">13,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net of unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-86">12,666</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-87">4,007</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">416,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-90">862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-91">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-92">536,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-93">223,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 13).</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-94"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-95"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-96"><ix:nonFraction unitRef="usdPerShare" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-97">0.001</ix:nonFraction></ix:nonFraction> par value: Authorized: <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-98"><ix:nonFraction unitRef="shares" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-99">50,000,000</ix:nonFraction></ix:nonFraction> shares; Issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-100"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-101">19,668,603</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-102"><ix:nonFraction unitRef="shares" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-103">17,995,344</ix:nonFraction></ix:nonFraction> shares at December&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-104">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-105">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-106">125,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-107">114,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-108">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-110">140,513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-111">58,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-112">15,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-113">56,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity (deficit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-114">520,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-115">280,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-116">228,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-117">205,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-118">125,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-119">23,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-120">25,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-121">22,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-122">252,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-123">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-124">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-125">100,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-126">83,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-127">58,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-128">12,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-129">15,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-130">13,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-131">112,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-132">98,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-133">71,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-134">139,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-135">133,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-136">75,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-137">106,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-138">76,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-139">52,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-140">25,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-141">21,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-142">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-143">45,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-144">32,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">31,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-146">178,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-147">131,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-148">98,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-149">38,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-150">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-151">22,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-152">1,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="f-153">710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:fixed-zero" scale="3" id="f-154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on Convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-155">5,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-156">2,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:fixed-zero" scale="3" id="f-157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on extinguishment of convertible notes  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-158">34,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Gain on extinguishment of PPP loan  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-162">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Interest income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-164">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-165">561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-166">647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other income (expense), net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-167">3,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-168">1,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-169">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total interest and other income (expense), net </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-170">42,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-171">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-172">579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-173">80,702</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-174">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-175">23,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-176">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-177">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-178">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-179">82,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-180">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-181">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-182">4.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-183">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-184">1.43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-185">4.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-186">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-187">1.43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares used in per share calculations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-188">18,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-189">17,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-190">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-191">18,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-192">18,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-193">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">82,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on available-for-sale investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="3" id="f-197">94</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" format="ixt:fixed-zero" scale="3" id="f-198">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="3" id="f-199">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reclassification adjustment for net losses on investments recognized during the year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" format="ixt:fixed-zero" scale="3" id="f-200">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" format="ixt:fixed-zero" scale="3" id="f-201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="3" id="f-202">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized gain (loss) on available-for-sale investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="f-203">94</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="f-204">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="f-205">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-206">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-208">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-209">82,434</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-210">2,062</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-211">23,817</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive <br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b771e0f32854640adb37fcb81cf460b_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-212">14,315,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b771e0f32854640adb37fcb81cf460b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-213">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34b1b427465407d9a74c3746d642f8d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">82,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id024b9170dda414581e1c92eebe3bd2a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-215">36,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf23510a12f84fca9925a26e5d1b065d_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-216">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-217">45,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-218">56,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-219">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-220">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-221">73,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-222">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-223">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with public offering, net of issuance&#160;costs of $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-224">2,303</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-225">2,742,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-226">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-227">26,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-228">26,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-229">490,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-230">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-231">3,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-232">3,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-233">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-234">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae1d9a6f8016476496ef409fccdcff79_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-235">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-236">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in unrealized gain on available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ee0d6962ab14de7be6135cd2e7b9249_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-237">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-238">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f908a491e314b5c86c9269bde35f991_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-239">17,679,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f908a491e314b5c86c9269bde35f991_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-240">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b036d16fce44ae9da1d4c718443132_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25ea7b28b3844cd4a1155d9f70e04574_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">60,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b09c7fe8e9430bb8f6a8a02974f27f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-244">56,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-245">59,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-246">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-247">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-248">71,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-249">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-250">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="f-251">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="f-252">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-253">184,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-254">2,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-255">2,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-256">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-257">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676902d8b941452fb791a00f1146c1bb_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-258">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-259">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9285aaa84b6421b90e1c1305b5a251b_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-260">17,995,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9285aaa84b6421b90e1c1305b5a251b_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-261">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b00ad12fcec4fafb066d792a4d074fa_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">114,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ebb11d45b894f9db048b1331f35f200_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">58,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f897f06eb54a918841c6272f8b6949_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">56,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-266">49,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-267">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-268">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-269">39,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-270">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-271">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call, inclusive of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:PaymentsOfDerivativeIssuanceCostsGross" scale="3" id="f-272">452</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="f-273">57,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="f-274">57,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-275">229,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-276">5,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-277">5,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-278">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-279">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in repayment of convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-280">1,354,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-281">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-282">55,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-283">55,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2bd56525ca43019f62289ecfa3967e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-284">82,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-285">82,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in unrealized loss on available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i691b0e7ec5e74c68a82b35523edcdf7a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-286">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-287">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b6b601d31324e1a930073ea52076b8f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-288">19,668,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6b601d31324e1a930073ea52076b8f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-289">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib52bee5d91bb42b28334013f49e33682_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">125,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51e448c55c1e49beac9e5d5156d2d3c6_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">140,513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b270930e93e45fd9058c41b81f26c8e_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-292">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-293">15,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-294">82,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-295">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-296">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-297">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-298">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-299">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-300">2,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-301">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-302">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-303">3,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-304">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-305">2,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-306">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-307">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on foreign exchange forward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-309">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="f-310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:fixed-zero" scale="3" id="f-311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of capitalized cloud computing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" format="ixt:fixed-zero" scale="3" id="f-312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="3" id="f-313">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="3" id="f-314">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="f-315">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="f-316">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="f-317">220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-318">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-319">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-320">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on sale of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-321">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:fixed-zero" scale="3" id="f-322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:fixed-zero" scale="3" id="f-323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-325">7,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="f-327">2,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="f-328">2,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="f-329">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on extinguishment of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-330">34,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="f-334">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="f-335">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-336">15,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-337">9,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-338">2,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-339">36,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-340">10,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-341">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-342">10,049</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-343">5,766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-344">3,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-345">8,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-346">7,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-347">2,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-348">20,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-349">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-350">6,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-351">3,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-352">21,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-353">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-354">2,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-355">2,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-356">1,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-357">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-358">412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-359">2,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:fixed-zero" scale="3" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="f-362">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-363">66,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-364">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-365">16,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of property and equipment   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-366">22,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-367">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-368">1,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-370">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-371">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-374">5,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-375">158,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:fixed-zero" scale="3" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-377">28,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of marketable investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-378">329,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-380">26,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-381">194,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-382">944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-383">6,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and employee stock purchase plan  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-384">2,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-385">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-386">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of capped call</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-387">56,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-388">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment of issuance costs of capped call</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDerivativeIssuanceCosts" scale="3" id="f-390">352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDerivativeIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDerivativeIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from PPP loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-395">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-396">360,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-397">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="f-398">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of issuance costs of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-399">11,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-400">4,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Extinguishment of convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-402">45,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="f-403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross proceeds from equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-407">28,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance costs on the public&#160;offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-410">2,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-411">5,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-412">2,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-413">3,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-414">520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-415">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-416">537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-417">242,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-418">117,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-419">31,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-420">18,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-421">117,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-422">20,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-423">164,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-424">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-425">26,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-426">146,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-427">164,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-428">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-429">5,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-430">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-431">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid (refunded) for income taxes, net of (refunds) payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-432">2,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-433">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-434">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in repayment of convertible notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-435">55,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under finance lease</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-438">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-439">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-440">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-441">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-442">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-443">11,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:num-dot-decimal" scale="3" id="f-445">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Debt issuance cost accrued  </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="f-447">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Capped call costs accrued</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:AccruedCappedCallCosts" scale="3" id="f-450">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:AccruedCappedCallCosts" format="ixt:fixed-zero" scale="3" id="f-451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="cutr:AccruedCappedCallCosts" format="ixt:fixed-zero" scale="3" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Transfer of inventory to property and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" format="ixt:num-dot-decimal" scale="3" id="f-453">12,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" format="ixt:fixed-zero" scale="3" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Acquisition of property, equipment and software</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-456">4,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:fixed-zero" scale="3" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="f-459" continuedAt="ib8b02e56cdfc40a9aac22eca6d88e2be" escape="true">SUMMARY</ix:nonNumeric></span><ix:continuation id="ib8b02e56cdfc40a9aac22eca6d88e2be" continuedAt="i99fc27ca17d0445ab6c7eae2e9be3695"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNIFICANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POLICIES</span></ix:continuation></div><ix:continuation id="i99fc27ca17d0445ab6c7eae2e9be3695" continuedAt="i42101261296644a5a15e75b9e742e63e"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-460" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear, enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel, truSculpt, Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; each of which enables medical practitioners to perform procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) leasing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices for acne treatment ("AviClear" revenue); (iii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); and (iv) the distribution of third-party manufactured skincare products (&#8220;Skincare&#8221; revenue); are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over <ix:nonFraction unitRef="country" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="f-461">37</ix:nonFraction> countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-462" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:UseOfEstimates" id="f-463" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:RisksAndUncertaintiesPolicyPolicyTextBlock" id="f-464" continuedAt="ia7702645f30c459cbedff88fc71e8e9a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i42101261296644a5a15e75b9e742e63e" continuedAt="i50fa6bbc002d4109b4996820ecad1ebc"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia7702645f30c459cbedff88fc71e8e9a">breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</ix:continuation></span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-465" continuedAt="i093c985e1b364d5cb92b4cb98384ff4e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i50fa6bbc002d4109b4996820ecad1ebc" continuedAt="i193373b3c997452b86ef53aceacf0e57"><ix:continuation id="i093c985e1b364d5cb92b4cb98384ff4e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-466" continuedAt="ib1dba146dd134c9cbbec9b29bdc44804" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately <ix:nonFraction unitRef="number" contextRef="i12f50874bc174d76a3c5aa9d3d3d0590_D20220101-20221231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="f-467">8</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i768f5c2bba054cc9b135fa68bf4eaa0e_D20210101-20211231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="f-468">11</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie5f9e1bcaffa47f6a881fcaf76d33c60_D20200101-20201231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="f-469">15</ix:nonFraction>%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i193373b3c997452b86ef53aceacf0e57" continuedAt="ic3abf27e08974d328badfad5a1d8323c"><ix:continuation id="ib1dba146dd134c9cbbec9b29bdc44804" continuedAt="i5599a074948543ada31452c0199f6d03"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the treatment protocol is initiated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as replacement hand pieces, x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Consumable revenue. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products'&#160;single use disposable tips&#160;must be replaced after every treatment. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:f-470">one</span> to <ix:nonNumeric contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231" name="cutr:ExtendedServiceContractOptionThreeTerm" format="ixt-sec:durwordsen" id="f-471">three years</ix:nonNumeric>. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" format="ixt-sec:durday" id="f-472">180</ix:nonNumeric> days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2022, and December 31, 2021, the accrual for the loyalty program included in accrued liabilities was $<ix:nonFraction unitRef="usd" contextRef="i6422ac28260743888cffc10f5e601c76_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-473">0.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iddd264fa35e046aca3397b855df0cab9_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-474">0.5</ix:nonFraction>, respectively. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ic3abf27e08974d328badfad5a1d8323c" continuedAt="i4ef2b4961f324831a6e97060c3446178"><ix:continuation id="i5599a074948543ada31452c0199f6d03"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract related to the sale of a system, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:f-475">two</span> to <ix:nonNumeric contextRef="i869ee720a299437f94a3f4ee6b7220c6_I20221231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="f-476">three years</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-477">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-478">2.7</ix:nonFraction> million, respectively. Amortization expenses for these assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="f-479">2.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="f-480">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="f-481">2.6</ix:nonFraction> million, respectively, during the years&#160;ended December&#160;31, 2022, 2021 and 2020 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="f-482">3.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="f-483">4.2</ix:nonFraction> million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div></ix:continuation><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-484" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. Credit card receivables, that are collected in a short period of time are also classified as cash and cash equivalents. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-485" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" id="f-486" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns represents the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns and is based on the Company's analysis of current economic trends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of customers, current economic conditions, the age of the accounts receivable balances, historical loss information, current conditions and forecasted information. The Company writes off trade receivables when they are deemed uncollectible.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="f-487" continuedAt="i027b699a1d0a40b88b502ac0626c2e73" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4ef2b4961f324831a6e97060c3446178" continuedAt="i5bbf338c8ce948bc8285fc22ade8160f"><ix:continuation id="i027b699a1d0a40b88b502ac0626c2e73"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with SVB. On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#8217;s receiver. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2022, and 2021, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2022, 2021, and 2020, domestic revenue accounted for <ix:nonFraction unitRef="number" contextRef="icdcec047f47949518eae3be472c59560_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-488">43</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i79f8334ee431491ea8a7102ddfe49fd8_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-489">42</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic1ad808c733c48d59c4363b7215cd797_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-490">41</ix:nonFraction>%, respectively, of total revenue, while international revenue accounted for <ix:nonFraction unitRef="number" contextRef="ie26d7981afe04301908853ba61c5d641_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-491">57</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i693768b6a7e945bdb951b75a87c2e03b_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-492">58</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="idd7ef2fd159c48529daf7452defc65e0_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-493">59</ix:nonFraction>%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately <ix:nonFraction unitRef="number" contextRef="i2743a40780d64a419e4084b9eb8cc1e0_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-494">10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ibcb65f4a3b1046d69abf37f63e36005e_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-495">14</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i84291aab4fff4efe9c464193a3d89fbd_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-496">9</ix:nonFraction>% of the Company's total purchases in the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="f-497" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:DemonstrationUnitsAmortizationPeriod" format="ixt-sec:durwordsen" id="f-498">two years</ix:nonNumeric>. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2022 and 2021, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="f-499">5.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="f-500">3.7</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-501" continuedAt="ide7caf6e833e4c66b136b4d020fcbef2" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-502" continuedAt="i76b23fb598264dd2b220145ddc1798f2" escape="true">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i76b23fb598264dd2b220145ddc1798f2" continuedAt="i9ff38c40667f4d31b9dfa3d66d926d70"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-503">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if730726557904a0e8129172982f3fa0f_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-504">7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a2a89ad78ae47bf9c76026b524514ca_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-505">3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7870599153e64b0fa7a3ebb5df62f415_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-506">3</ix:nonNumeric></span></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i5bbf338c8ce948bc8285fc22ade8160f" continuedAt="i173634f541814645b3a7952ce150fd19"><ix:continuation id="ide7caf6e833e4c66b136b4d020fcbef2" continuedAt="i19ca2297b6e7493a995872213cc4f48a"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2022, 2021 and 2020, was $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-507">2.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-508">1.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-509">1.4</ix:nonFraction> million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19ca2297b6e7493a995872213cc4f48a">The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally <ix:nonNumeric contextRef="i2b739e3ad9964dbf98889c162108b1f8_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-510">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i0cde67dc1f864753bb385d33cbe1b6aa_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-511">ten years</ix:nonNumeric>.</ix:continuation> As of December&#160;31, 2022 and 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="i1b1332d0d5ac433fabf234a1e2f746ea_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-512"><ix:nonFraction unitRef="usd" contextRef="if6506c5c97e94b878215a956808ec764_I20221231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-513">0.4</ix:nonFraction></ix:nonFraction> million in Other current assets and prepaid expenses and $<ix:nonFraction unitRef="usd" contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-514"><ix:nonFraction unitRef="usd" contextRef="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-515">3.5</ix:nonFraction></ix:nonFraction> million in Other long-term assets. As of and during the year ended December&#160;31, 2022 and 2021, there was $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" scale="6" id="f-516"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization" scale="6" id="f-517">0.4</ix:nonFraction></ix:nonFraction> million, and <ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization" format="ixt:fixed-zero" scale="0" id="f-518"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" format="ixt:fixed-zero" scale="0" id="f-519">no</ix:nonFraction></ix:nonFraction> accumulated amortization and amortization expense recorded, respectively. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-520" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, the Company segregated its operations into <ix:nonFraction unitRef="segment" contextRef="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-521">two</ix:nonFraction> reportable business segments: (i) Cutera Core and (ii) AviClear. Goodwill was tested for impairment at the segment level. As of December&#160;31, 2022, there has been <ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-522">no</ix:nonFraction> impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:StandardProductWarrantyPolicy" id="f-523" continuedAt="i7eb95a8736e3452bb314092f530278d4" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:StandardProductWarrantyTermDirectSales" format="ixt-sec:durwordsen" id="f-524">12-month</ix:nonNumeric> warranty for direct sales to customers. For sales to distributors, the Company generally provides a <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:StandardProductWarrantyTermDistributorSales" format="ixt-sec:durwordsen" id="f-525">14-month</ix:nonNumeric> warranty for parts only, with labor being provided to the end customer by the distributor.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7eb95a8736e3452bb314092f530278d4">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.</ix:continuation> </span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-526" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessee</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:LessorLeasesPolicyTextBlock" id="f-527" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the lessee has the ability to perform the patient treatment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 to the consolidated financial statements for more information regarding leasing arrangements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i173634f541814645b3a7952ce150fd19" continuedAt="i6891bab7d11c4b1ebb3b23637fddd05c"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="f-528" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-529" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third-party contractors, regulatory affairs, clinical and development costs.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-530" continuedAt="i09cda02e692541dcb3ed11ef1d7d613e" escape="true">Advertising Costs</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i09cda02e692541dcb3ed11ef1d7d613e">Advertising costs are included as part of sales and marketing expense and are expensed as incurred.</ix:continuation> Advertising expenses for 2022, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-531">4.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-532">2.1</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-533">1.2</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-534" continuedAt="iaff63e861efe425d97c0bb24c0a15549" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period. To estimate the fair value of an award, the Company uses the Black-Scholes option pricing model. The following inputs are used in this model:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the historical volatility of the Company's stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the <ix:nonNumeric contextRef="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231" name="cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount" format="ixt-sec:durday" id="f-535">50</ix:nonNumeric>-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i6891bab7d11c4b1ebb3b23637fddd05c" continuedAt="iff2bc0dba0644edabbaebb22bb381607"><ix:continuation id="iaff63e861efe425d97c0bb24c0a15549"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the <ix:nonNumeric contextRef="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231" name="cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount" format="ixt-sec:durday" id="f-536">50</ix:nonNumeric>-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div></ix:continuation><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-537" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2022 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="iff2bc0dba0644edabbaebb22bb381607"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-538" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-539" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for-sale investments, net of tax.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-540" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Losses resulting from foreign currency transactions are included in net income (loss) are $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-541">3.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-542">1.8</ix:nonFraction>&#160;million in the year ended December&#160;31, 2022 and 2021, respectively, and were insignificant for the year ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-543" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company operates in <ix:nonFraction unitRef="segment" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-544">two</ix:nonFraction> segments. Revenue is attributed to a geographic region based on the location of the end customer. See Note 12 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div></ix:nonNumeric></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_103"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2-<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="f-547" continuedAt="i0f89286a7ccd407d869211a067af6395" escape="true">CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, AND RESTRICTED CASH</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0f89286a7ccd407d869211a067af6395" continuedAt="i3f0420fa912a4e6f886d1409391e237a">The Company determines the appropriate classification of its investments in marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. The Company&#8217;s marketable securities have been classified and accounted for as available-for-sale securities. Investments with remaining maturities of more than one year are viewed by the Company as available to support current operations and are classified as current assets under the caption marketable investments in the accompanying consolidated balance sheets. Investments in available-for-sale debt securities are measured at fair value under the guidance in ASC 320. Credit losses on impaired available-for-sale debt securities are recognized through an allowance for credit losses. Under ASC 326, credit losses recognized on an available-for-sale debt security should not reduce the net carrying amount of the available-for-sale debt security below its fair value. Any changes in fair value unrelated to credit are recognized as an unrealized gain or loss in other comprehensive income.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i3f0420fa912a4e6f886d1409391e237a"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-548" escape="true"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-549" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-550">145,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="f-551">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-552">146,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments - U.S. Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-553">171,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-554">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-555">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-556">171,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="f-557">171,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-558">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-559">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:CashCashEquivalentsAndAvailableForSaleDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-560">318,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-561">164,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-562">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-563">164,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and December&#160;31, 2021, the net unrealized losses were $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:num-dot-decimal" scale="6" id="f-564">0.1</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="0" id="f-565">nil</ix:nonFraction>, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months. The restricted cash balance relates to an outstanding letter of credit for $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="f-566">0.7</ix:nonFraction>&#160;million provided to a supplier.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">All of the marketable investments will mature less than one year from December&#160;31, 2022.</span></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_1532"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="f-567" continuedAt="ia948848fe9e8450ab2da6a213a04f6ec" escape="true">FAIR VALUE OF FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="ia948848fe9e8450ab2da6a213a04f6ec" continuedAt="i168d1859d16143b794f675ac7bb7ab08"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets at fair value, including cash and cash equivalents. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-568" continuedAt="ibcdad5eb5d0543b2b6ec491c4f4d0d4d" escape="true">As of December&#160;31, 2022, financial assets and liabilities measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i168d1859d16143b794f675ac7bb7ab08"><div style="margin-top:10pt;text-align:justify"><ix:continuation id="ibcdad5eb5d0543b2b6ec491c4f4d0d4d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"></td><td style="width:46.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Money market funds </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57b91ff7d8c4faea9f96493ed40332c_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-569">26,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ca02c2f35d427c969131afb737148e_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac9e761079e46d09f596d92d01d71b4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-571">171,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3f7fca92974b8aba97f327669fb368_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Foreign exchange forward</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7081fb323837425eb325cf18993c3f13_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43de6969b39446da9d7aa3def0715785_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeLiabilities" scale="3" id="f-574">558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac9e761079e46d09f596d92d01d71b4_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="f-575">197,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d3f7fca92974b8aba97f327669fb368_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="f-576">558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had no money market funds or marketable investments. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14 - Debt for the carrying amount and estimated fair value of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="id720e09c88e443f2809964bf360c8189_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-577">2.25</ix:nonFraction>% Convertible Senior Notes due 2026 (the &#8220;2026 Notes&#8221;), <ix:nonFraction unitRef="number" contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-578">2.25</ix:nonFraction>% Convertible Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and, <ix:nonFraction unitRef="number" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-579">4.00</ix:nonFraction>% Convertible Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), together with the 2026 Notes and 2028 Notes, (the &#8220;Convertible Notes&#8221;).</span></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_1493"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-580" continuedAt="i762756af4c1041e4ad96370a95b9405e" escape="true">DERIVATIVE INSTRUMENTS </ix:nonNumeric></span></div><ix:continuation id="i762756af4c1041e4ad96370a95b9405e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency exchange forward contracts to manage the impact of currency exchange fluctuations on earnings and cash flow. The Company does not enter into derivative instruments for speculative purposes. The Company is exposed to potential credit loss in the event of nonperformance by counterparties on its outstanding derivative instruments but the Company does not anticipate nonperformance by any of its counterparties. Should a counterparty default, the Company's maximum loss exposure would be the potential asset balance of the instrument.</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="f-581" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow effect of the derivative instruments settlement is recorded in cash flow from operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dollar amounts in thousands:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:23.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Forward</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross notional amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221c5f5bf1c048b58ad83bbe86effde5_I20221231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-582">6,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221c5f5bf1c048b58ad83bbe86effde5_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" id="f-583">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9be7dc17e6d2432fbb9a56dfd5b44ffe_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="f-584">558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-585" continuedAt="i2e1b536989a747a999f4f0b6705cd3f0" escape="true">BALANCE SHEET DETAIL</ix:nonNumeric></span></div><ix:continuation id="i2e1b536989a747a999f4f0b6705cd3f0" continuedAt="i3add47a4e5954989909607abd2baed6e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2022 and 2021, were $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="f-586">3.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="f-587">4.9</ix:nonFraction> million, respectively. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-588" continuedAt="i25417e6fa0724639a50c1e19c66a24bf" escape="true">Inventories, net of these adjustments, consist of the following (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i25417e6fa0724639a50c1e19c66a24bf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-589">36,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-590">24,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-591">2,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-592">2,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-593">25,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-594">13,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-595">63,628</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-596">39,503</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current assets and prepaid expenses</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="f-597" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets and a prepaid expenses, consists of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits with vendors</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DepositsAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-598">13,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DepositsAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-599">4,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-600">7,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-601">7,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-602">2,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-603">2,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-604">24,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-605">14,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net</span></div><ix:continuation id="i9ff38c40667f4d31b9dfa3d66d926d70"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ca417d3e2946ceb0aaf60b4425ef5b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-606">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605a89e30db34ee5b4f659a4a45e8f1d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-607">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a962cbab39448a1a2946df5cccfff51_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b2c4567c63458dbf8d418f20083383_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-609">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5296be68503d4aac9ffe8a6e86065dcc_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-610">19,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a44bf842a0d40fa904345e182ab2a54_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5baea4532648c7a0de553581dd9364_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-612">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i157789288079499a8a2a1e6fa6177625_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-613">1,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd22553f7fc24f4399f493cc7a5b0c69_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-614">5,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib97937e36112460f905b590a698c2662_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-615">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e0968e414b4cce9b5df6a4573b4de2_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-616">17,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70000ea7bfe4aa091134520e36adee3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-618">45,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-619">6,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-620">5,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-621">3,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-622">40,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-623">3,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Materials related to the AviClear acne treatment device were classified as inventories at December 31, 2021. The Company received 510(k) clearance from the U.S. Food and Drug Administration in March 2022 and in April 2022 placed the first devices in service. Beginning in April 2022, the materials used in the construction of the AviClear device have been classified as Assets under construction and the manufactured devices, including devices available for lease and devices placed in service, have been classified as AviClear devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is related to the acquisition of Iridex&#8217;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-624"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-625">1.3</ix:nonFraction></ix:nonFraction> million as of December&#160;31, 2022 and 2021. There were <ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-626"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="f-627"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="f-628"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="f-629">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments or additions to goodwill during the years ended December&#160;31, 2022 or 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i3add47a4e5954989909607abd2baed6e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-630" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-631">18,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-632">21,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-633">9,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-634">9,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:AccruedInventoryInTransitCurrent" format="ixt:num-dot-decimal" scale="3" id="f-635">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="cutr:AccruedInventoryInTransitCurrent" format="ixt:num-dot-decimal" scale="3" id="f-636">4,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:SalesAndMarketingAccrualsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-637">5,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="cutr:SalesAndMarketingAccrualsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-638">4,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-639">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-640">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-641">13,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-642">10,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-643">57,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-644">54,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_109"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212; <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="f-645" continuedAt="ib281f8c473244e8887fa4fab3258f4a9" escape="true">PRODUCT WARRANTY </ix:nonNumeric></span></div><ix:continuation id="ib281f8c473244e8887fa4fab3258f4a9"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="f-646" continuedAt="i02d01c9019cf40dbaf25e315728e2de2" escape="true">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2022 and 2021 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i02d01c9019cf40dbaf25e315728e2de2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="f-647">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="f-648">4,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="f-649">3,710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="f-650">5,135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="f-651">4,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="f-652">5,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="f-653">3,254</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="f-654">3,947</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_112"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:ContractWithCustomerLiabilityTextBlock" id="f-655" continuedAt="i2347f17bb15544659f6f13fd789c2b1b" escape="true">DEFERRED REVENUE</ix:nonNumeric></span></div><ix:continuation id="i2347f17bb15544659f6f13fd789c2b1b" continuedAt="i2e755e4bbcf3448c8ad50ca8fa530e68"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:f-656">one</span> to <ix:nonNumeric contextRef="i627fb423930e40d5904d10ac994e9b22_D20220101-20221231" name="cutr:ExtendedServiceContractTerm" format="ixt-sec:durwordsen" id="f-657">three-year</ix:nonNumeric> terms. The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. Deferred revenue also includes payments for training. Approximately <ix:nonFraction unitRef="number" contextRef="i6174e841cf8942359f88304752a651ea_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-658">88</ix:nonFraction>% of the Company&#8217;s deferred revenue balance of $<ix:nonFraction unitRef="usd" contextRef="i6174e841cf8942359f88304752a651ea_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-659">13.5</ix:nonFraction> million as of December&#160;31, 2022, will be recognized over the next <ix:nonNumeric contextRef="i6174e841cf8942359f88304752a651ea_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-660">12</ix:nonNumeric> months.</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-661" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred revenue balance for the years ended December&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-662">10,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-663">11,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="f-664">21,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="f-665">17,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" format="ixt:num-dot-decimal" scale="3" id="f-666">9,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" format="ixt:num-dot-decimal" scale="3" id="f-667">7,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-668">9,383</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-669">10,545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-670">13,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-671">10,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e755e4bbcf3448c8ad50ca8fa530e68">Costs for extended service contracts were $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="cutr:CostsForExtendedServiceContracts" format="ixt:num-dot-decimal" scale="6" id="f-672">6.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="cutr:CostsForExtendedServiceContracts" format="ixt:num-dot-decimal" scale="6" id="f-673">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-5" name="cutr:CostsForExtendedServiceContracts" format="ixt:num-dot-decimal" scale="6" id="f-674">8.2</ix:nonFraction> million, respectively, for the years&#160;ended December&#160;31, 2022, 2021 and 2020.</ix:continuation></span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_115"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-675" continuedAt="iee2b8e1228654b56b21cd0cef4fd9b66" escape="true">STOCKHOLDERS&#8217; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE</ix:nonNumeric></span></div><ix:continuation id="iee2b8e1228654b56b21cd0cef4fd9b66" continuedAt="ia1847c3eb5d542558136da0a6324b419"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had one class of issued common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-676">0.001</ix:nonFraction>. Authorized capital stock consists of <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="cutr:CapitalStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-677">55,000,000</ix:nonFraction> shares comprised of two classes: (i) <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-678">50,000,000</ix:nonFraction> shares of Common Stock, of which <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-679"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-680">19,668,603</ix:nonFraction></ix:nonFraction> shares are issued and outstanding as of December&#160;31, 2022, and (ii) <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-681">5,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-682">0.001</ix:nonFraction> per share (&#8220;Preferred Stock&#8221;), of which <ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="f-683"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-684">no</ix:nonFraction></ix:nonFraction> shares are issued and outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;21, 2020, the Company issued and sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-685">2,742,750</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="iaae3e0055764457a9c1f55592c65d687_I20200421" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-686">0.001</ix:nonFraction> per share at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaae3e0055764457a9c1f55592c65d687_I20200421" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-687">10.50</ix:nonFraction> per share. The shares include the full exercise of the underwriter&#8217;s option to purchase an additional <ix:nonFraction unitRef="shares" contextRef="i76cbf6cae62846b4918bd5c16022a51e_D20200421-20200421" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-688">357,750</ix:nonFraction> shares of common stock. The Company received net proceeds from the offering of approximately $<ix:nonFraction unitRef="usd" contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-689">26.5</ix:nonFraction> million, after deducting underwriting discounts, commissions and offering expenses of $<ix:nonFraction unitRef="usd" contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-690">2.3</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had the following stock-based employee compensation plans:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2004 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which <ix:nonFraction unitRef="shares" contextRef="i08530b13979643b789fbf75b8ddb226a_I19981231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-691">4,650,000</ix:nonFraction> shares of the Company&#8217;s common stock were reserved for issuance to employees, directors and consultants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2004, the Board of Directors (&#8220;the Board&#8221;) adopted the 2004 Equity Incentive Plan. A total of <ix:nonFraction unitRef="shares" contextRef="iaa3435c591f64b3798ada0cae4b3cb6b_I20041231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-692">1,750,000</ix:nonFraction> shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#8220;fungible share&#8221; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract <ix:nonFraction unitRef="shares" contextRef="i56956846a75c43d6beae2d01dad8e79e_D20120101-20121231" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="f-693">2.12</ix:nonFraction> shares from the shares reserved under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s Annual Meeting of Stockholders in 2019, the Company&#8217;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by <ix:nonFraction unitRef="shares" contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-694">700,000</ix:nonFraction> (in addition to the <ix:nonFraction unitRef="shares" contextRef="i56053101176e4eee83b23bfb85a4c018_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-695">9,701,192</ix:nonFraction> shares provided under the 2004 Equity Incentive Plan); (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#8217;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as <ix:nonFraction unitRef="shares" contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="f-696">2.12</ix:nonFraction> shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as <ix:nonFraction unitRef="shares" contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="f-697">2.12</ix:nonFraction> shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#8220;performance based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum <ix:nonNumeric contextRef="ia2fdd272272b45deb78651a9217686d7_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-698">one-year</ix:nonNumeric> vesting period with respect to awards granted under the 2004 Equity Incentive Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in 2019, the Board also amended the Company&#8217;s Stock Ownership Guidelines to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least <ix:nonFraction unitRef="number" contextRef="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" scale="-2" id="f-699">50</ix:nonFraction>% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), or performance stock units (&#8220;PSUs&#8221;) (net of taxes) for a minimum of one year following vesting and delivery.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#8217;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#8217;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company's stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional <ix:nonFraction unitRef="shares" contextRef="i46004954bc984936a1ba499adac7a1fd_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-700">600,000</ix:nonFraction> shares, available for future grants. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ia1847c3eb5d542558136da0a6324b419" continuedAt="i16f4b710e3e648b288ef4a8555479a07"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional <ix:nonFraction unitRef="shares" contextRef="i7c18e28a9c3b4ac891e9d2b6fea59279_D20210601-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-701">450,000</ix:nonFraction> shares, available for future grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional <ix:nonFraction unitRef="shares" contextRef="ic54be2ac79324b2f8eb1e0feef2c9f6c_D20220601-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-702">600,000</ix:nonFraction> shares, available for future grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-employee directors are granted $<ix:nonFraction unitRef="usd" contextRef="i1a45faa2dad7441e9750fb1049202ddb_I20221231" decimals="-3" name="cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" format="ixt:num-dot-decimal" scale="0" id="f-703">150,000</ix:nonFraction> of RSUs or non-statutory stock options annually on the date of the Company&#8217;s Annual Meeting of stockholders. These grants cliff-vest on the <ix:nonNumeric contextRef="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-704">one-year</ix:nonNumeric> anniversary of the grant date. In the years ended December&#160;31, 2022, 2021 and 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-705">12,496</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i93eb16b5a06840968cbc9875832fe5e7_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-706">41,301</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7c2d12e9c8744b01846c152372849986_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-707">35,735</ix:nonFraction> RSUs, respectively, to its non-employee directors. In the year ended December&#160;31, 2022, the Company issued <ix:nonFraction unitRef="usd" contextRef="id0fc73b5fb954186bdecf4e03ab50a44_I20221231" decimals="INF" name="cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" format="ixt:num-dot-decimal" scale="0" id="f-708">18,135</ix:nonFraction> non-statutory stock options to its non-employee directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2022, 2021&#160;and 2020, the Company&#8217;s Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="ia0f8b1beeb3b46d6896264075a0f642c_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-709">191,993</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i31476d551c22406289d5d7e70159145a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-710">219,686</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i56d977f3237048fd8f92c1754156e659_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-711">405,248</ix:nonFraction> RSUs, respectively, to its executive officers, directors and certain members of the Company&#8217;s management related to annual grants and new hire grants. The new hire RSUs vest quarterly on each of the first <span style="-sec-ix-hidden:f-712">four</span> annual anniversaries of the grant date and the annual grant RSUs vest one quarter on the first annual anniversary and monthly thereafter for <ix:nonNumeric contextRef="i30021351cc7642de9f7e7a753727c538_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-713">36</ix:nonNumeric> months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#8217;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued <ix:nonFraction unitRef="shares" contextRef="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-714">209,981</ix:nonFraction> shares related to this bonus payment to management and recognized $<ix:nonFraction unitRef="usd" contextRef="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-715">2.6</ix:nonFraction>&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2022, 2021&#160;and 2020 the Company&#8217;s Board of Directors granted its executive officers and certain senior management employees <ix:nonFraction unitRef="shares" contextRef="if7a873e55daf4d1096b17ed6d286c540_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-716">169,785</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i2e6c6ee7693f44fbbc190082fa49573c_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-717">178,222</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="ia3b5675f4b3c4a44b1e6ca6d6528fc07_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-718">76,157</ix:nonFraction> PSUs, respectively, related to its annual grants. The 2020 grant vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 and 2022 grants vest one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vests on the second anniversary subject to the recipient&#8217;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted <ix:nonFraction unitRef="shares" contextRef="i675d69b502a848bc9f2401845e49adfc_D20210701-20210731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-719">265,002</ix:nonFraction> PSUs to certain employees. This grant consists of <ix:nonFraction unitRef="tranche" contextRef="i5ce66ed419804b35a387a3a2298ae2b4_D20210701-20210731" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="f-720">four</ix:nonFraction> separate vesting tranches that will vest from April 2023 through June 2025 upon the achievement of operational milestones associated with each tranche and continued service.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board awarded its new CEO, David H. Mowry, <ix:nonFraction unitRef="shares" contextRef="ibe4bf8f916284b378c9dfccf341f2e0e_D20190701-20190731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-721">67,897</ix:nonFraction> PSUs, which vested over <ix:nonNumeric contextRef="i718cf9e3833d4cbe824fb83ef9b96dd7_D20190701-20190731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-722">four years</ix:nonNumeric> from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Board awarded its new CFO, Rohan Seth, <ix:nonFraction unitRef="shares" contextRef="i15d864291f7042989243b040cd710241_D20200801-20200831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-723">60,000</ix:nonFraction> stock options, which vests over <ix:nonNumeric contextRef="ica8f35fa7fcb453b85159c8316392bdc_D20200801-20200831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-724">five years</ix:nonNumeric>, and <ix:nonFraction unitRef="shares" contextRef="i98655c3b6d21446ea2a5d6fface14f08_D20200801-20200831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-725">22,423</ix:nonFraction> PSUs, which vests over <ix:nonNumeric contextRef="ic000f7fad27f41da8a1b11411e5199d4_D20200801-20200831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-726">2.5</ix:nonNumeric> years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for <ix:nonNumeric contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="f-727">six months</ix:nonNumeric>. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"><ix:nonFraction unitRef="shares" contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-728">600,000</ix:nonFraction> shares;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"><ix:nonFraction unitRef="number" contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" scale="-2" id="f-729">2.0</ix:nonFraction>% of the outstanding shares of common stock on such date; or</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">an amount as determined by the Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of the common stock purchased is the lower of <ix:nonFraction unitRef="number" contextRef="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-730">85</ix:nonFraction>% of the fair market value of the common stock at the beginning or end of the <ix:nonNumeric contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="f-731">six-month</ix:nonNumeric> offering period. In the years ended December&#160;31, 2022, 2021, and 2020, under the 2004 ESPP, the Company issued <ix:nonFraction unitRef="shares" contextRef="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="f-732">49,306</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i85b6c70335ab468995fd22f87f7dea79_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="f-733">59,635</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i6cbfe8553003474dbea4fbe1cb946be5_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="f-734">56,751</ix:nonFraction> shares, respectively. At December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i259a5ef49c174b599bbd8e82d8d4cd67_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-735">378,586</ix:nonFraction> shares remained available for future issuance.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i16f4b710e3e648b288ef4a8555479a07" continuedAt="i30359a175bc74af9b10015afaf4df963"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Award Activity</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-736" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-737">761,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-738">295,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-739">25.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-740">3.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-741">3.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-742">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" format="ixt:num-dot-decimal" scale="0" id="f-743">71,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-744">71,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-745">14.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-746">73,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-747">12.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-748">76,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-749">76,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-750">36.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-751">804,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-752">522,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-753">1,085,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-754">217,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-755">22.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-756">3.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-757">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-758">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" format="ixt:num-dot-decimal" scale="0" id="f-759">172,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-760">172,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-761">30.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-762">71,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-763">22.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-764">30,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-765">30,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-766">37.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-767">744,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-768">299,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-769">947,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-770">287,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-771">25.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-772">4.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-773">4.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-774">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" format="ixt:num-dot-decimal" scale="0" id="f-775">296,238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-776">296,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-777">40.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-778">39,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-779">21.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-780">29,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-781">29,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-782">34.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-783">374,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-784">164,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-785">1,070,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-786">513,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-787">34.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-788">6.63</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-789">5.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-790">127,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-791">27.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-792">3.24</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="f-793">2.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest, net of estimated forfeitures, as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-794">483,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-795">34.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-796">6.52</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="f-797">5.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-798">44.22</ix:nonFraction> of the Company&#8217;s stock on December&#160;31, 2022, $<ix:nonFraction unitRef="usdPerShare" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-799">41.32</ix:nonFraction> on December&#160;31, 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-800">24.11</ix:nonFraction> on December&#160;31, 2020 and $<ix:nonFraction unitRef="usdPerShare" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-801">35.81</ix:nonFraction> on December&#160;31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2022, 2021 and 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i30359a175bc74af9b10015afaf4df963" continuedAt="i1381c7e8d3b644009d2f96ae622f30eb"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#8217;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#8217;s common stock. Total intrinsic value of options exercised in 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-802">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-803">1.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-804">0.4</ix:nonFraction> million, respectively. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-805" continuedAt="i13be8129b5744803a720c64ff2b30199" escape="true">The options outstanding and exercisable at December&#160;31, 2022 were in the following exercise price ranges:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i13be8129b5744803a720c64ff2b30199"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-806">10.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-807">14.04</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a5fd5162e3749dda52119ea03e417b8_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-808">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-809">1.26</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a5fd5162e3749dda52119ea03e417b8_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-810">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-811">14.10</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-812">60,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i115c28e37fe341eebe4c63199b303d29_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-813">2.59</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-814">28,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" id="f-815">18.55</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" id="f-816">25.70</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70779460b35645a8ae14d35ecd7316dd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-817">12,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-818">0.91</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70779460b35645a8ae14d35ecd7316dd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-819">12,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-820">29.28</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-821">73,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb2821e1c3f34e6d88ea2da034cb653f_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-822">5.26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-823">31,803</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-824">32.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-825">48,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a6913c1f23c4c2183eb2a516465a2d0_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-826">4.93</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-827">22,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i895e42cc37a4468982700f81c2a36726_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-828">33.45</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i895e42cc37a4468982700f81c2a36726_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-829">150,857</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7dfdf16b051484fbfef1d9db4f028d5_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-830">9.14</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i895e42cc37a4468982700f81c2a36726_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="f-831">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" id="f-832">36.55</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" id="f-833">41.39</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i595dfc44c26342479914423f899ffd41_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-834">91,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-835">6.54</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i595dfc44c26342479914423f899ffd41_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-836">22,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0f809c30032e4095af4562f984e79643_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-837">42.33</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f809c30032e4095af4562f984e79643_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-838">17,335</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a3ed95613494914aa350bfdca948d59_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-839">9.91</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f809c30032e4095af4562f984e79643_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="f-840">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-841">47.40</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-842">4,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib971e664547449019e686dfcda7d726f_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-843">1.96</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-844">4,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="f-845">63.62</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-846">48,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic2c95c2271944120adfe82eb5cc72bed_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-847">9.25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="f-848">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-849">10.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-850">63.62</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-851">513,935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-852">6.63</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-853">127,863</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Awards (RSU and PSU) Activity Table</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-854" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-855">1,104,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-856">22.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-857">37,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-858">667,694</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-859">20.66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-860">684,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-861">17.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="f-862">12,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-863">308,248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-864">23.24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-865">779,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-866">23.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-867">18,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-868">744,949</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-869">40.16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-870">254,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-871">22.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="f-872">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-873">236,856</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-874">27.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida56af569414409888521b3e5deceb5c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-875">1,032,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida56af569414409888521b3e5deceb5c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-876">35.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida56af569414409888521b3e5deceb5c_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-877">42,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-878">374,274</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-879">45.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-880">340,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-881">29.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="f-882">15,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-883">160,131</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-884">41.48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-885">906,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-886">40.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-887">40,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-888">44.22</ix:nonFraction> on December&#160;31, 2022, $<ix:nonFraction unitRef="usdPerShare" contextRef="ida56af569414409888521b3e5deceb5c_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-889">41.32</ix:nonFraction> on December&#160;31, 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-890">24.11</ix:nonFraction> on December&#160;31, 2020, and $<ix:nonFraction unitRef="usdPerShare" contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-891">35.81</ix:nonFraction> on December&#160;31, 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-892">12.2</ix:nonFraction> million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-893">5.8</ix:nonFraction> million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-894">9.9</ix:nonFraction> million.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i1381c7e8d3b644009d2f96ae622f30eb"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-895" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2022, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-896">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-897">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-898">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-899">6,979</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-900">5,305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-901">8,849</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-902">4,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-903">6,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-904">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c559feb1b74bcda18168292816e21d_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-905">816</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a14495444114a1b95d8e60d66bcef2c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-906">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if574d6c9139942fcae8b73ef1132adce_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-907">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-908">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-909">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-910">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-911" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the years ended December&#160;31, 2022, 2021 and 2020 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af1fdd05cd445a0ae8d99f2546c9649_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-912">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb3fa0d043f42818e6ba795391d99b8_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-913">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb210668bb0d40229989bb9910942dc6_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-914">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-915">4,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-916">3,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-917">3,385</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393abfeabcec4e439702c6fb89a55f9b_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-918">2,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950f3f1cbe644accb57140891f583a57_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-919">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a78a9a76abb4ea692915c784e8c9154_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-920">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831c2cc741324fff9890a07923f079f9_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-921">5,332</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1334e42d4dd14b4ba4c5edf93302f4b8_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-922">5,820</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a919cae1df94161b1b26d4d2c036cd7_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-923">3,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-924">14,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-925">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-926">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" id="f-927" continuedAt="iadc71e3566fc4385bcf351b4420047da" escape="true">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:</ix:nonNumeric></span></div><ix:continuation id="iadc71e3566fc4385bcf351b4420047da"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-928">4.03</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-929">3.97</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-930">4.84</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-931">0.49</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-932">0.50</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-933">0.50</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-934">1.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-935">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-936">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-937">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-938">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-939">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-940">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-941">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-942">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-943">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-944">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-945">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-947">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-952">19.76</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-953">15.09</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-954">7.63</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-955">15.77</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-956">9.64</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-957">6.13</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div></ix:continuation></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_121"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-961" continuedAt="i05848d32069c4aa08309f649937291ee" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i05848d32069c4aa08309f649937291ee" continuedAt="i163c661ae61a4c6e8a95c4050d47c580"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-962" continuedAt="ia06d2cd5644146eb871c8680aa927248" escape="true">The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ia06d2cd5644146eb871c8680aa927248"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-963">84,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="f-964">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-965">25,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-966">3,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-967">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-968">2,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-969">80,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-970">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-971">23,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i163c661ae61a4c6e8a95c4050d47c580" continuedAt="i96b89cb5ad4e496eae9d425ff8b2d3c4"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-972" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-973">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-974">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-975">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-976">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-977">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-978">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-979">1,275</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-980">1,512</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-981">747</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-982">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-983">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-984">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="f-985">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="f-986">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="f-987">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-988">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-989">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-990">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-991">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-992">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-993">227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-994">185</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-995">102</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-996">224</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-997">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-998">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-999">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1000" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1001">21,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1002">18,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1003">2,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1004">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="f-1005">4,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="f-1006">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1007">14,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1008">13,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" scale="3" id="f-1009">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" scale="3" id="f-1010">939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1011">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1012">2,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1013">7,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:fixed-zero" scale="3" id="f-1014">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-1015">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-1016">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1017">3,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="cutr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1018">3,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1019">58,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1020">45,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1021">53,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1022">40,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1023">5,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1024">5,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-1025">1,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" scale="3" id="f-1026">990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="f-1027">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="f-1028">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1029">3,066</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1030">3,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="f-1031">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="f-1032">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i96b89cb5ad4e496eae9d425ff8b2d3c4" continuedAt="i5eadd7cfb42e485b9f45e1383d1ef7d3"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1033" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1034">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1035">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1036">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1037">0.16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1038">2.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1039">2.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="f-1040">0.47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="f-1041">9.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="f-1042">0.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-1043">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-1044">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-1045">2.87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1046">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1047">13.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1048">1.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" format="ixt:fixed-zero" scale="-2" id="f-1049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" scale="-2" id="f-1050">44.59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" format="ixt:fixed-zero" scale="-2" id="f-1051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" scale="-2" id="f-1052">8.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" format="ixt:fixed-zero" scale="-2" id="f-1053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" format="ixt:fixed-zero" scale="-2" id="f-1054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" scale="-2" id="f-1055">1.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" scale="-2" id="f-1056">7.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" format="ixt:fixed-zero" scale="-2" id="f-1057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1058">0.76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1059">17.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1060">1.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="f-1061">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="f-1062">17.95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="f-1063">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="f-1064">11.41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="f-1065">72.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="f-1066">25.51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-1067">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="f-1068">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="f-1069">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="f-1070">2.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="f-1071">11.76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="f-1072">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1073">2.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1074">39.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1075">2.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1076">53.1</ix:nonFraction> million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#8217;s net deferred taxes increased by $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1077">12.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1078">2.2</ix:nonFraction> million during the years ended December&#160;31, 2022 and 2021, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $<ix:nonFraction unitRef="usd" contextRef="ie9dea9e779424bb0b81869578a5eb41a_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="f-1079">0.6</ix:nonFraction> million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i7fa86cedc4f743a89628f54d6c8ddd3f_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1080">87.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3a8180f361034cc0a7ddd4675321f231_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1081">45.3</ix:nonFraction> million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized, will generally begin to expire in 2029&#160;through 2039. Approximately $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="cutr:OperatingLossCarryforwardsWithoutExpiration" scale="6" id="f-1082">51.2</ix:nonFraction> million of total federal net operating loss carryforwards were generated after December 31, 2017 and have no expiration. At December&#160;31, 2022, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $<ix:nonFraction unitRef="usd" contextRef="i71b1494dda634811b284b9faa38d0601_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1083">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie45dca5694694e9eaafbe4a6234d3b92_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1084">9.3</ix:nonFraction> million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#8220;ownership change,&#8221; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#8217;s net operating loss and tax credit carryforwards due to prior ownership changes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No deferred tax liabilities have been recorded relating to the earnings of the Company&#8217;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i5eadd7cfb42e485b9f45e1383d1ef7d3"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2009 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#8217;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2017 remain subject to examination by their respective tax authorities.</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1085" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December&#160;31, 2020 to December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1086">2,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1087">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60f899800144726a0adde4f7415072f_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1088">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1089">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1090">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1091">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1092">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-1093">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="f-1094">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1095">3,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1096">2,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1097">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_124"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="f-1098" continuedAt="ic9ebeb87ddc84b908b86830cee3340d1" escape="true">NET INCOME (LOSS) PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ic9ebeb87ddc84b908b86830cee3340d1" continuedAt="ieb2fe47be2e5476bb90ef2db603c091e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company&#8217;s convertible notes were potentially convertible into <ix:nonFraction unitRef="segment" contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231" decimals="0" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="0" id="f-1099">8,354,036</ix:nonFraction> shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the years ended December&#160;31, 2022 and 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2022 and 2020, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1100" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1101">82,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1102">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1103">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1104">18,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1105">17,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1106">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-1108">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="f-1109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-1111">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="f-1112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-1114">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="f-1115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if11b725ce1af4a30b46852703abf3192_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d82e33152c849b3b7b22e9850693bc7_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-1117">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2718ea9e3df24ae9919f09e3a9bd8d2d_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="f-1118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1119">18,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1120">18,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1121">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1122">4.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1123">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1124">1.43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1125">4.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1126">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1127">1.43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ieb2fe47be2e5476bb90ef2db603c091e"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-1128" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d2af5d0d40240728bbaf7100364c888_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1129">10,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica33e5e0a8d149e08222f5657ba8f9bd_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1130">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1222f8a294044704aaca365b5961f91f_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="f-1131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9973a1bb092c40f8b6352bebbf706d79_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1132">8,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i666467d2ee8b4706828ce53f22a78ef9_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1133">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icacb09d5d4564041b646ac2fea6f291f_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="f-1134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0099f611054142b44663a4d35bd018_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1135">514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i435b3ba5e879438ab1c9c925dc8a1ba6_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1136">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c63a15d54b4af684d1b7b298377b14_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1137">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65060ead42404852b4696510b4327f7a_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1138">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3883679f5dd14bd58d3bdc2f35fc8b3f_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1139">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1afd2b598094e77a995de1beb182fc0_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1140">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70b796e7c79344caa2cc64d5b0a40019_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1141">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaaf71e1c04fa42eb8e5bcab09ec61552_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="f-1142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib80255a5d1504da7ac5a65f6a26a95f9_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1143">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64feb72e527a4ddeba367f7807175c19_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1144">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ddee769932a4350a14cc2d6333a6757_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1145">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76980ed1a1534046811d38eed346f857_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1146">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1147">20,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1148">8,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1149">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_127"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1150" continuedAt="ief8afc1286e2460092a36d98acca75eb" escape="true">DEFINED</ix:nonNumeric></span><ix:continuation id="ief8afc1286e2460092a36d98acca75eb" continuedAt="iaa3069de7a1c427aa8213e8aa0f6028b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTRIBUTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN</span></ix:continuation></div><ix:continuation id="iaa3069de7a1c427aa8213e8aa0f6028b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company has an employee savings plan (&#8220;401(k) Plan&#8221;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to <ix:nonFraction unitRef="number" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="0" name="cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" scale="-2" id="f-1151">100</ix:nonFraction>% of their annual compensation, subject to statutory annual limitations. In 2022, 2021 and 2020, the Company made discretionary contributions under the 401(k) Plan of $<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1152">0.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1153">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1154">0.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#8217;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2022, and the related expense for each of the three years then ended was not significant.</span></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_130"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12&#8212;<ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1155" continuedAt="i0e0ce85174c546b7bffb99dcb103218d" escape="true">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTS</ix:nonNumeric></span></div><ix:continuation id="i0e0ce85174c546b7bffb99dcb103218d" continuedAt="i9d517fda34ea4039b298b9d0f8b0285e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the Company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision maker ("CODM") is its Chief Executive Officer ("CEO"), who makes decisions on allocating resources and assessing performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, the Company segregates its operations into <ix:nonFraction unitRef="segment" contextRef="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1156">two</ix:nonFraction> reportable business segments: (i) Cutera Core and (ii) AviClear. This segregation aligns the Company&#8217;s operating business segments with the way the CEO reviews the Company's operations as a result of the commercial release of the Company&#8217;s AviClear acne treatment device in April 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1157" continuedAt="i6af0c278a272475a9c28530958e1a568" escape="true">The Company measures the financial results of its reportable segments using an internal performance measure that excludes General and administrative expenses.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i9d517fda34ea4039b298b9d0f8b0285e" continuedAt="i3ae1eb5dbf6a446babd2b543013bfa7f"><div style="text-align:justify"><ix:continuation id="i6af0c278a272475a9c28530958e1a568"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:46.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3786902aa814d6781382d2a734de748_D20220101-20221231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1158">247,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i846ac160c48140659c8ff08589c1559c_D20210101-20211231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1159">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1160">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1161">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1164">252,399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1165">231,270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="2" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1166">147,683</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3786902aa814d6781382d2a734de748_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1167">20,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i846ac160c48140659c8ff08589c1559c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1168">30,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1169">4,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1170">28,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1171">9,445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-1172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9be98d2423634757af936bba4482f104_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1173">7,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af2f3a0df564393908ceb31eb4f5771_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1174">20,736</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057d976e50f54bb5b4029b6e8eed833d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1175">4,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items not allocated to segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1176">14,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1177">13,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1178">10,109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;ERP implementation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:ERPImplementation" format="ixt:num-dot-decimal" scale="3" id="f-1179">9,211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:ERPImplementation" format="ixt:num-dot-decimal" scale="3" id="f-1180">1,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="cutr:ERPImplementation" format="ixt:num-dot-decimal" scale="3" id="f-1181">1,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1182">5,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1183">3,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1184">3,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Legal fees, severance, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="cutr:LegalFeesSeveranceAndOther" format="ixt:num-dot-decimal" scale="3" id="f-1185">1,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="cutr:LegalFeesSeveranceAndOther" format="ixt:num-dot-decimal" scale="3" id="f-1186">1,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="cutr:LegalFeesSeveranceAndOther" format="ixt:num-dot-decimal" scale="3" id="f-1187">2,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1188">38,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1189">1,830</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1190">22,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Interest and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1191">42,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1192">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-1193">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1194">80,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1195">3,385</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1196">23,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital spending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab29b34be6724c94945ef58bbfbbbe24_I20221231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1197">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231" decimals="-3" name="us-gaap:PartnersCapital" scale="3" id="f-1198">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd1a6a576ea4d019bb8ce898cadf674_I20201231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1199">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51d133a94594ab68d99649b2087f195_I20221231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1200">20,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231" decimals="-3" name="us-gaap:PartnersCapital" scale="3" id="f-1201">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e56fbd57d240fc8787786a963035f1_I20201231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:fixed-zero" scale="3" id="f-1202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1203">22,698</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71acb76f8254ab48b6267e153db44c2_I20211231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1204">1,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3011f822b64b65b4850bdaf7aee0ab_I20201231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1205">1,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia90a17929a2c47458119f913368da54d_I20221231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:fixed-zero" scale="3" id="f-1206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43b61bed02d4fce96d758963f8ca202_I20211231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:fixed-zero" scale="3" id="f-1207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1208">22,698</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1209">1,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231" decimals="-3" name="us-gaap:PartnersCapital" format="ixt:num-dot-decimal" scale="3" id="f-1210">1,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab29b34be6724c94945ef58bbfbbbe24_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1211">154,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1212">76,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51d133a94594ab68d99649b2087f195_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1213">47,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1214">6,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1215">202,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71acb76f8254ab48b6267e153db44c2_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1216">83,202</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia90a17929a2c47458119f913368da54d_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1217">318,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43b61bed02d4fce96d758963f8ca202_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1218">197,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1219">520,988</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1220">280,293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022&#160;and 2021, <ix:nonFraction unitRef="number" contextRef="i0c171c7b5cbf4b489415ee212fd357c0_I20221231" decimals="3" name="cutr:PercentageOfAssets" scale="-2" id="f-1221">99.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i04b0cfbd65e4486580c0b2d539204abc_I20211231" decimals="3" name="cutr:PercentageOfAssets" scale="-2" id="f-1222">99.0</ix:nonFraction>% of long-lived assets were in the United States, respectively.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><ix:continuation id="i3ae1eb5dbf6a446babd2b543013bfa7f"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="f-1223" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32af68888229429c86c1f6d4e66c39d8_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1224">107,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0bee4a202b46a886d4dac9c6a0465c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1225">96,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b100c928a264c0780179352a51b0551_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1226">61,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73bcc961f86c4d37ad3553546f5a6370_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1227">64,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864a42f1b9474cd3bf43681344389c54_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1228">70,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4e54ccf702485ebea23892a41e90d0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1229">43,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79cb131a331f444aaec8d0b8104c73b7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1230">21,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b1f1666e8c420ba4cde97cf41fb662_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1231">12,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105738620d9448cd86de0b72566e2192_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1232">10,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac813d49b5749bdbb352b5de5d1604c_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1233">20,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc14c23d98b5459bbca583cda98d027e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1234">19,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112b7a48420c4a4a815d9a7348d931fb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1235">11,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b2c7662fd449d0afe5418656bb70be_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1236">37,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6629fab6b94f3ab926f0814d6fd0d2_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1237">32,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea513a253ca34fe9a2a2acdd9000fbc5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1238">21,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1239">252,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1240">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1241">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd67954cb584428b5eb9b700919da0a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1242">163,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce4b410a9a94845afb82c481a9282d4_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1243">139,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d978e3d81f43a4920268bc4873fd78_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1244">90,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45100873e384627a7d0d4ae1bee0f3d_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1245">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04aff51169d478787e0b3b3998d9c0a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3183169f49b0407497637750803e56cc_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79831062395d48ff9827b5dd62714018_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1248">18,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570cc80078864aeba21c2158c1c81d44_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1249">16,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i438a7e3fe616461bb35aac62f1dd3281_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1250">9,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfd4323e38a42f380d911aaae444128_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1251">42,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b446bf3d14c44a595ac3dfcbab2b828_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1252">49,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f95e00759c5463c8accbe2d58291bdd_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1253">25,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82a22a9886c4a319a7f2dcb4b5cbdbd_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1254">228,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97f0dbf965b43738ea95b5b2200e359_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1255">205,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806a9486ff1043a2abc3ab0f1747be03_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1256">125,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1257">23,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1258">25,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1259">22,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1260">252,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1261">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1262">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:LesseeLeasesTextBlock" id="f-1263" continuedAt="i86c9725197964851a25dce7400364264" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i86c9725197964851a25dce7400364264" continuedAt="ifec9c79f32f4419bb33d5d6ed1ea5bca"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles leases. The Company&#8217;s leases generally have remaining terms of <span style="-sec-ix-hidden:f-1264">one</span> to <ix:nonNumeric contextRef="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231" name="cutr:LesseeLeasesRemainingTerm" format="ixt-sec:duryear" id="f-1265">10</ix:nonNumeric> years, some of which include options to renew the leases for up to <ix:nonNumeric contextRef="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231" name="cutr:LesseeLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-1266">five years</ix:nonNumeric>. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:LeasesFinancialStatementInformationTableTextBlock" id="f-1267" continuedAt="i7fb5844859774fd381028201893b5c49" escape="true">Below is supplemental balance sheet information related to leases (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ifec9c79f32f4419bb33d5d6ed1ea5bca" continuedAt="if7858770787747589dbfaa1b11210999"><ix:continuation id="i7fb5844859774fd381028201893b5c49"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1268">12,831</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1269">14,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1270"><span style="-sec-ix-hidden:f-1271">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1272">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="f-1273">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1274">14,437</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="cutr:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1275">15,019</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1276">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1277">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1278">11,352</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1279">13,483</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1280">14,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1281">15,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1282"><span style="-sec-ix-hidden:f-1283">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1284">485</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1285">554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1286"><span style="-sec-ix-hidden:f-1287">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-1288">825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-1289">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1290">1,310</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1291">1,284</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the twelve months ended&#160;December&#160;31, 2022 and December&#160;31, 2021 (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1292">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1293">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1294">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1295">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1296">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1297">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1298">3,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1299">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1300">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1301">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1302">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1303">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1304">520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1305">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1306">537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1307">2,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1308">3,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1309">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Maturities of lease liabilities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1310" continuedAt="i5538de156afd4ff29f317e55bac987e1" escape="true">Maturities of operating lease liabilities were as follows as of December&#160;31, 2022 (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="if7858770787747589dbfaa1b11210999" continuedAt="ib5f3e3ebd1f244a0a592c01ad330b905"><div style="margin-top:5pt"><ix:continuation id="i5538de156afd4ff29f317e55bac987e1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1311">3,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1312">2,962</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1313">2,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1314">3,027</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1315">3,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" scale="3" id="f-1316">464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1317">15,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1318">1,773</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1319">14,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vehicle Leases</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-1320" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-1321">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-1322">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-1323">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1324">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-1325">131</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1326">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="f-1327" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1328">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1329">2.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1330">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1331">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor - AviClear</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Lessor revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee. The contractual term of the lease agreement is <ix:nonNumeric contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1332">three years</ix:nonNumeric> with a <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="cutr:LessorDurationOfAutorenewalFeatures" format="ixt-sec:durwordsen" id="f-1333">one-year</ix:nonNumeric> autorenewal feature. Certain lease agreements' terms in excess of one year can be terminated without financial penalty, and these agreements are accounted for as having a lease term of one year. The AviClear lease agreements are accounted for as operating leases. The fixed annual license fee is recognized evenly throughout the period of the lease agreement on a straight-line basis. The treatment revenue is recognized in the period the lessee has the ability to perform the patient treatment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ib5f3e3ebd1f244a0a592c01ad330b905" continuedAt="i837c720610fd40958136e95ba7a6d4fa"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="f-1334" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1335"><span style="-sec-ix-hidden:f-1336">AviClear operating lease license fee revenue</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="f-1337">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:fixed-zero" scale="3" id="f-1338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1339"><span style="-sec-ix-hidden:f-1340">AviClear operating lease revenue</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1341">3,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db954fe033847e2b53b08a387423de3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:fixed-zero" scale="3" id="f-1342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1343"><span style="-sec-ix-hidden:f-1344">Total AviClear revenue</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1345">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:fixed-zero" scale="3" id="f-1346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AviClear device being leased has a useful life of <ix:nonNumeric contextRef="ia982b914a1b146c5a1cab988d0bd6cca_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-1347">seven years</ix:nonNumeric>. The Company expects that a device will be leased for <ix:nonFraction unitRef="lease_term" contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" decimals="INF" name="cutr:NumberOfConsecutiveLeaseTerms" format="ixt-sec:numwordsen" scale="0" id="f-1348">two</ix:nonFraction> consecutive lease terms at the end of which its residual value will be immaterial.</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="f-1349" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the minimum future lease payments as of December&#160;31, 2022, under non-cancelable operating leases, assuming the minimum contractual lease term (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" scale="3" id="f-1350">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" scale="3" id="f-1351">610</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="f-1352">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected a practical expedient applied to operating leases to elect not to separate lease and nonlease components as long as the lease and at least one nonlease component have the same timing and pattern of transfer. As such, updates or upgrades on a when-and-if available basis to the AviClear device are combined with the operating lease revenue. The combined component is being accounted for under ASC 842. Additionally, the Company made an accounting policy election to present AviClear revenue net of sales and other similar taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Capitalized sales commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions related to obtaining AviClear lease agreements are accounted for as initial direct costs and are capitalized and amortized on a straight-line basis over the lease term. Total capitalized costs for the year ended December&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-1353">3.8</ix:nonFraction> million. Amortization expenses for these assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="i4d7a93cebb0445b3adc4fdbd8bcad826_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="f-1354">0.5</ix:nonFraction> million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Sales and marketing expense in the Company&#8217;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="ifc8691977a17471e888e8008855e2dec_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-1355">3.3</ix:nonFraction> million and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Lease installment costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes fulfillment costs incurred before AviClear lease commencement and these costs include freight, installation, and training costs. Total capitalized costs for the year ended December&#160;31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="i1e56eaab24a348b69456952d07cd3e95_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-1356">1.7</ix:nonFraction> million. Amortization expenses for these assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="id9a5220685f0420ab867e7dfb9c2cf00_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="f-1357">0.3</ix:nonFraction> million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Cost of revenue in the Company&#8217;s consolidated statement of operations. Total lease installment costs as of December&#160;31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="i796773bebe7e43e7bcecf719e525f796_I20221231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" scale="6" id="f-1358">1.4</ix:nonFraction> million and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnifications</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i837c720610fd40958136e95ba7a6d4fa"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of the Company&#8217;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#8217;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, intellectual property disputes, commercial disputes, employee disputes, and contractual lawsuits. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred. Certain of the cases below are still in the preliminary stages, and the Company is not able to quantify the extent of its potential liability, if any, other than as described. The outcome of litigation is inherently unpredictable and subject to significant uncertainties. If any of these matters are resolved adversely to the Company, this could have a material adverse effect on its business, financial condition, results of operations, and cash flows. In addition, defending these legal proceedings is likely to be costly, which may have a material adverse effect on the Company's financial condition, results of operations and cash flows, and may divert management's attention from the day-to-day operations of its business. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and&#160;2021, the Company had accrued $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="f-1359">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="f-1360">0.7</ix:nonFraction>&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California. Lutronic employs numerous former Cutera employees. The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act ("RICO"); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting. On March 13, 2020, the court entered a temporary restraining order ("TRO") against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information. The order also prohibits Lutronic, for two years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers. On April 9, 2020, the parties stipulated to the entry of a preliminary injunction providing for the same relief afforded by the TRO. On August 4, 2022, Cutera filed a second amended complaint. In addition to the above referenced claims, Cutera alleges claims for violation of the Lanham Act, unlawful business practices, false advertising and trademark infringement. Discovery is ongoing. No trial date has been scheduled.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Serendia, LLC (&#8220;Serendia&#8221;), filed patent infringement complaints against the Company with the International Trade Commission (&#8220;ITC&#8221;) and in U.S. District Court for the District of Delaware alleging infringement of six Serendia patents by the Secret RF and Secret Pro systems, which the Company distributes in the U.S. on behalf of ILOODA Co. Ltd., a Korean company. If, following a successful third-party action for infringement, the Company cannot obtain a license for its products, the Company may have to stop selling the applicable products.</span></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_136"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="f-1361" continuedAt="iba74471ac0a846ff9d4fa7d5e44f68fa" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="iba74471ac0a846ff9d4fa7d5e44f68fa" continuedAt="ic1e60f8f74ea496397583a5a08a12ccd"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ConvertibleDebtTableTextBlock" id="f-1362" continuedAt="if6b2a5ee06c340c291e1ae236e163c07" escape="true">The following table presents the outstanding principal amount and carrying value of the Company&#8217;s Convertible Notes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="ic1e60f8f74ea496397583a5a08a12ccd" continuedAt="i743e26afe3424755ab3caddc0734c016"><div style="margin-top:10pt;text-align:justify"><ix:continuation id="if6b2a5ee06c340c291e1ae236e163c07"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"><tr><td style="width:1.0%"></td><td style="width:62.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1363">69,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1364">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1365">1,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1366">4,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1367">67,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1368">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1369">240,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1371">6,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:fixed-zero" scale="3" id="f-1372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1373">233,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-1374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1375">120,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1377">4,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:fixed-zero" scale="3" id="f-1378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1379">115,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-1380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible notes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fabcd0c6b145328c06480322497ceb_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1381">416,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1382">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance of convertible notes due in 2026</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1383">138.3</ix:nonFraction> million aggregate principal amount of 2026 Notes in a private placement offering. The 2026 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1384">2.25</ix:nonFraction>% per year payable semiannually in arrears on March 15 and September 15 of each year. Upon conversion, the 2026 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1385">133.6</ix:nonFraction> million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1,000 principal amount of the 2026 Notes is initially convertible into 30.1427 shares of the Company&#8217;s common stock, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ia42551caee064e72b3e0bb899ff817f7_I20220331" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-1386">33.18</ix:nonFraction> per share. The conversion rate for the 2026 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2026 Notes. The 2026 Notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2026 Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance of convertible notes due in 2028</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1387">240.0</ix:nonFraction>&#160;million aggregate principal amount of 2028 Notes. The 2028 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1388">2.25</ix:nonFraction>% per year payable semiannually in arrears on June 1 and December 1 of each year. A total of $<ix:nonFraction unitRef="usd" contextRef="i311a3952ceef49ac9b09d68b91ee185d_I20220531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1389">230.0</ix:nonFraction>&#160;million of aggregate principal amount of 2028 Notes was issued in a private placement offering and concurrently with this private placement, the Company entered into a purchase agreement with Voce, an entity affiliated with J. Daniel Plants, the Company&#8217;s Executive Chairperson, pursuant to which the Company issued to Voce $<ix:nonFraction unitRef="usd" contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531" decimals="-5" name="cutr:DebtInstrumentAdditionalAggregatePrincipalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1390">10.0</ix:nonFraction>&#160;million aggregate principal amount of 2028 Notes on the same terms and conditions. The aggregate proceeds from the offering of 2028 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1391">232.4</ix:nonFraction>&#160;million, net of issuance costs, including initial purchaser fees.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 2028 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1392">2.25</ix:nonFraction>% per year payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2022. Upon conversion, the 2028 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. Each $1,000 principal amount of the 2028 Notes is initially convertible into 18.9860 shares of the Company&#8217;s common stock, which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i69f9433f295c4816bc3f161b64e8c985_I20220531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-1393">52.67</ix:nonFraction> per share. The conversion rate for the 2028 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2028 Notes. The 2028 Notes will mature on March 1, 2028, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2028 Notes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i743e26afe3424755ab3caddc0734c016" continuedAt="i5e2faf6a24fd4121a68986f2e59194d1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuance of convertible notes due in 2029</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1394">120.0</ix:nonFraction> million aggregate principal amount of 2029 Notes in a private placement offering. The 2029 Notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1395">4.00</ix:nonFraction>% per year payable semiannually in arrears on June 1 and December 1 of each year. Upon conversion, the 2029 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1396">115.8</ix:nonFraction> million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1,000 principal amount of the 2029 Notes is initially convertible into 17.1378 shares of the Company&#8217;s common stock, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="idcee2bc0609d4e29aba04556ae20c3bd_I20221231" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="3" id="f-1397">58.35</ix:nonFraction> per share. The conversion rate for the 2029 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2029 Notes. The 2029 Notes will mature on June 1, 2029, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2029 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026 Notes exchange</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into privately-negotiated exchange agreements with certain holders of the Company&#8217;s outstanding 2026 Notes with respect to the exchange of $<ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-5" name="cutr:DebtConversionConvertedInstrumentCashIssued" format="ixt:num-dot-decimal" scale="6" id="f-1398">45.8</ix:nonFraction>&#160;million in cash (excluding $<ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-1399">0.3</ix:nonFraction>&#160;million in cash for the payment of accrued interest) and <ix:nonFraction unitRef="shares" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1400">1,354,348</ix:nonFraction> shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="f-1401">69.1</ix:nonFraction>&#160;million in aggregate principal amount of the Company&#8217;s outstanding 2026 Notes (the &#8220;2026 Notes Exchange&#8221;). Immediately following the closing of the 2026 Notes Exchange, approximately $<ix:nonFraction unitRef="usd" contextRef="i17fbfe26ef264a34b2c3bbbd999e5121_I20220601" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1402">69.1</ix:nonFraction>&#160;million in aggregate principal amount of the 2026 Notes remained outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes Exchange was accounted for as an extinguishment of debt. The Company recorded the difference between the proceeds paid and the carrying amount of the debt as an extinguishment loss, with a corresponding entry to common stock and Additional-paid-in capital for the issuance of the shares at the then-trading price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c543a80fb3441f29a2f3497b9785ec9_I20220524" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-1403">41.31</ix:nonFraction> per share. <ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock" id="f-1404" continuedAt="i6681f34761674aa6aff5faabf9900d4c" escape="true">The table below presents the components of the Loss on debt extinguishment recorded in the Company's consolidated statements of operations for the year ended December 31, 2022 (amounts in thousands, except share and per share amounts):</ix:nonNumeric></span></div><div><span><br/></span></div><div><span><br/></span></div><div><ix:continuation id="i6681f34761674aa6aff5faabf9900d4c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:62.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" id="f-1405">1,354,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing price of Cutera common stock on May 24, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c543a80fb3441f29a2f3497b9785ec9_I20220524" decimals="INF" name="us-gaap:SharePrice" id="f-1406">41.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="3" id="f-1407">55,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used for repurchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="cutr:DebtConversionConvertedInstrumentCashIssued" format="ixt:num-dot-decimal" scale="3" id="f-1408">45,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total shares and cash </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="cutr:DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" format="ixt:num-dot-decimal" scale="3" id="f-1409">101,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Note principal exchanged </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="3" id="f-1410">69,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares and cash exchanged</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="cutr:DebtConversionNetProceeds" format="ixt:num-dot-decimal" scale="3" id="f-1411">32,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes: Unamortized debt issuance costs on May 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id720e09c88e443f2809964bf360c8189_I20220531" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1412">3,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portion of 2026 Note principal exchanged</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="2" name="cutr:DebtConversionPercentageOfDebtConverted" scale="-2" id="f-1413">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted" format="ixt:num-dot-decimal" scale="3" id="f-1414">1,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-1415">34,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion and other features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2026 Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2026 Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="f-1416">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-1417">30</ix:nonFraction> consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1418">130</ix:nonFraction>% of the conversion price for the 2026 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the <ix:nonFraction unitRef="day" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="f-1419">five</ix:nonFraction>-business day period after any <ix:nonFraction unitRef="day" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-1420">five</ix:nonFraction> consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of 2026 Notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1421">98</ix:nonFraction>% </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="i5e2faf6a24fd4121a68986f2e59194d1" continuedAt="i068ded80ac3f432ea431b47eefcff2d7"><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2026 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the third and fourth quarter of 2022. As of December&#160;31, 2022, the 2026 Notes are convertible and this condition will remain until March 31, 2023. The 2026 Notes may also become convertible in future periods. Upon any conversion requests of the 2026 Notes, the Company would be required to pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2026 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2026 Notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the 2026 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="2" name="cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1422">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdTradingDays" scale="0" id="f-1423">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays" scale="0" id="f-1424">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1425">100</ix:nonFraction>% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2026 Notes, at least $<ix:nonFraction unitRef="usd" contextRef="i5360b54f8bd047afbb77191b00d60ec7_I20210331" decimals="-5" name="cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" format="ixt:num-dot-decimal" scale="6" id="f-1426">50.0</ix:nonFraction>&#160;million aggregate principal amount of 2026 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, 2026 Note holders have the option to require the Company to repurchase any portion or all of their 2026 Notes in $<ix:nonFraction unitRef="usd" contextRef="ia1261edff6b94c0eabe87de89ca47291_I20210331" decimals="INF" name="cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount" format="ixt:num-dot-decimal" scale="0" id="f-1427">1,000</ix:nonFraction> principal increments for cash. The price for such repurchase is calculated as <ix:nonFraction unitRef="number" contextRef="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1428">100</ix:nonFraction>% of the principal amounts of 2026 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2026 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2026 Notes. The 2026 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2026 Notes (including the 2028 Notes and 2029 Notes). The 2026 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2026 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2026 Notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i27566a6eb1a14a6da1bcb731ccfcad08_I20221231" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="f-1429"><ix:nonFraction unitRef="usd" contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" scale="6" id="f-1430">103.8</ix:nonFraction></ix:nonFraction> million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2028 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2028 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2028, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ending on September 30, 2022 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="f-1431">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-1432">30</ix:nonFraction> consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531" decimals="2" name="cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1433">130</ix:nonFraction>% of the conversion price for the 2028 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the <ix:nonFraction unitRef="day" contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="f-1434">five</ix:nonFraction>-business day period after any <ix:nonFraction unitRef="day" contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-1435">five</ix:nonFraction> consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221; per $1,000 principal amount of 2028 Notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1436">98</ix:nonFraction>% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such 2028 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i068ded80ac3f432ea431b47eefcff2d7" continuedAt="i19e32e8866f2461f83cdc72e7acecc46"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2028, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2028 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were not met during the fourth quarter of 2022. As of December 31, 2022, the 2028 Notes are not convertible and this condition will remain until March 31, 2023. The 2028 Notes may become convertible in future periods. Upon any conversion requests of the 2028 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2028 Notes have been included as long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2028 Notes prior to June 5, 2025. On or after June 5, 2025, the Company may redeem for cash all or any portion of the 2028 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531" decimals="2" name="cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1437">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdTradingDays" scale="0" id="f-1438">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays" scale="0" id="f-1439">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1440">100</ix:nonFraction>% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2028 Notes, at least $<ix:nonFraction unitRef="usd" contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531" decimals="-5" name="cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" format="ixt:num-dot-decimal" scale="6" id="f-1441">100.0</ix:nonFraction>&#160;million aggregate principal amount of 2028 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, note holders have the option to require the Company to repurchase any portion or all of their 2028 Notes in $<ix:nonFraction unitRef="usd" contextRef="idb3d4792c6144be88746b11a2ee39995_I20220531" decimals="INF" name="cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount" format="ixt:num-dot-decimal" scale="0" id="f-1442">1,000</ix:nonFraction> principal increments for cash. The price for such repurchase is calculated as <ix:nonFraction unitRef="number" contextRef="i4dd175c6046b46988a2632db59313ec8_D20220501-20220531" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1443">100</ix:nonFraction>% of the principal amounts of 2028 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2028 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2028 Notes. The 2028 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2028 Notes (including the 2026 Notes and 2029 Notes). The 2028 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2028 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2028 Notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i003fc45e98c843a98b06a88ed0a0f62d_I20221231" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="f-1444">249.3</ix:nonFraction> million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2029 Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2029 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2029 in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ending March 31, 2023 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="f-1445">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-1446">30</ix:nonFraction> consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1447">130</ix:nonFraction>% of the conversion price for the 2029 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the <ix:nonFraction unitRef="day" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="f-1448">five</ix:nonFraction>-business day period after any <ix:nonFraction unitRef="day" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-1449">five</ix:nonFraction> consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of 2029 Notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1450">98</ix:nonFraction>% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such 2029 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2029, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2029 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i19e32e8866f2461f83cdc72e7acecc46" continuedAt="if75a9f94952046cfa14cafe0a8b246b9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the bullets in the paragraph above were not met during the fourth quarter of 2022. As of December&#160;31, 2022, the 2029 Notes are not convertible and this condition will remain until March 31, 2023. Upon any conversion requests of the 2029 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2029 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2029 Notes prior to December 5, 2025. On or after December 5, 2025, the Company may redeem for cash all or any portion of the 2029 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="2" name="cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-1451">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdTradingDays" scale="0" id="f-1452">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays" scale="0" id="f-1453">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1454">100</ix:nonFraction>% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2029 Notes, at least $$<ix:nonFraction unitRef="usd" contextRef="i723997427a13498fb7414de5cf577325_I20210331" decimals="-5" name="cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" format="ixt:num-dot-decimal" scale="6" id="f-1455">100.0</ix:nonFraction> million aggregate principal amount of 2029 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, 2029 Note holders have the option to require the Company to repurchase any portion or all of their 2029 Notes in $<ix:nonFraction unitRef="usd" contextRef="ia1261edff6b94c0eabe87de89ca47291_I20210331" decimals="INF" name="cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount" format="ixt:num-dot-decimal" scale="0" id="f-1456">1,000</ix:nonFraction> principal increments for cash. The price for such repurchase is calculated as <ix:nonFraction unitRef="number" contextRef="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-1457">100</ix:nonFraction>% of the principal amounts of 2029 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2029 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2029 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2029 Notes. The 2029 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2029 Notes (including the 2026 Notes and 2028 Notes). The 2029 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2029 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2029 Notes was approximately $<ix:nonFraction unitRef="usd" contextRef="ib99c5a3203694570b12bf45da9728932_I20221231" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="f-1458">122.2</ix:nonFraction> million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capped Call Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of each series of the Convertible Notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's common stock upon any conversion or settlement of the applicable series of Convertible Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the applicable series of Convertible Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the applicable capped call transactions, then the Company&#8217;s stock would experience some dilution and/or such capped call transactions would not fully offset the potential cash payments, in each case, to the extent the then-market price per share of its common stock exceeds the applicable cap price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the offering of the 2026 Notes, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $<ix:nonFraction unitRef="usdPerItem" contextRef="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331" decimals="INF" name="us-gaap:DerivativeCapPrice" scale="0" id="f-1459">45.535</ix:nonFraction>, which represented a <ix:nonFraction unitRef="number" contextRef="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331" decimals="2" name="cutr:DerivativeCapPricePremiumOverStockPricePercent" scale="-2" id="f-1460">75</ix:nonFraction>% premium over the last reported sale price of the Company's common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2840cd98ca143cd8b20996a137ad641_I20210304" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-1461">26.02</ix:nonFraction> per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over <ix:nonFraction unitRef="day" contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331" decimals="INF" name="cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays" scale="0" id="f-1462">40</ix:nonFraction> consecutive scheduled trading days ending on March 12, 2026. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331" decimals="-5" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-1463">16.1</ix:nonFraction> million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2028 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2028 Notes sold to the initial purchasers in the offering of 2028 Notes, with a strike price equal to the conversion price of the 2028 Notes and with an initial cap price equal to $<ix:nonFraction unitRef="usdPerItem" contextRef="i560132f058e647e7836489cdaa020a99_I20220531" decimals="INF" name="us-gaap:DerivativeCapPrice" scale="0" id="f-1464">82.62</ix:nonFraction>, which represents a <ix:nonFraction unitRef="number" contextRef="i560132f058e647e7836489cdaa020a99_I20220531" decimals="2" name="cutr:DerivativeCapPricePremiumOverStockPricePercent" scale="-2" id="f-1465">100</ix:nonFraction>% premium over the last reported sale price of the Company's common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5adbe42165d747f9b1a502754f152e1c_I20210304" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-1466">41.31</ix:nonFraction> per share on May 24, 2022, with certain adjustments to the settlement terms that reflect standard anti-</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="if75a9f94952046cfa14cafe0a8b246b9" continuedAt="id2918f488ae04f72ba6fb05f95c50f6a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilution provisions. These capped call transactions expire over <ix:nonFraction unitRef="day" contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531" decimals="INF" name="cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays" scale="0" id="f-1467">40</ix:nonFraction> consecutive scheduled trading days ending on May 30, 2028. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531" decimals="-5" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="6" id="f-1468">32.0</ix:nonFraction> million, inclusive of issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the offering of the 2029 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2029 Notes sold to the initial purchasers in the offering of 2029 Notes, with a strike price equal to the conversion price of the 2029 Notes and with an initial cap price equal to $<ix:nonFraction unitRef="usdPerItem" contextRef="i601beccbd0004b92931f1016a7656cf5_I20220531" decimals="INF" name="us-gaap:DerivativeCapPrice" scale="0" id="f-1469">99.32</ix:nonFraction>, which represents a <ix:nonFraction unitRef="number" contextRef="i601beccbd0004b92931f1016a7656cf5_I20220531" decimals="2" name="cutr:DerivativeCapPricePremiumOverStockPricePercent" scale="-2" id="f-1470">100</ix:nonFraction>% premium over the last reported sale price of the Company's common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0739d3b24f09440ba3de580700fa75f8_I20210304" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-1471">49.66</ix:nonFraction> per share on December 7, 2022, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. These capped call transactions expire over <ix:nonFraction unitRef="day" contextRef="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531" decimals="INF" name="cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays" scale="0" id="f-1472">40</ix:nonFraction> consecutive scheduled trading days ending on May 30, 2029. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531" decimals="-5" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-1473">25.1</ix:nonFraction>&#160;million, inclusive of issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company evaluated the capped call transactions under authoritative accounting guidance and determined that they should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) on January 1, 2021. In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Convertible Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible Notes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company incurred direct costs associated with the issuance of convertible notes of $<ix:nonFraction unitRef="usd" contextRef="id4fabcd0c6b145328c06480322497ceb_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="f-1474">11.8</ix:nonFraction> million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted under &#8220;2026 Notes Exchange&#8221; above, $<ix:nonFraction unitRef="usd" contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231" decimals="-5" name="cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted" format="ixt:num-dot-decimal" scale="6" id="f-1475">1.8</ix:nonFraction> million of unamortized debt issuance costs related to the 2026 Notes was included in the loss on debt extinguishment during the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $<ix:nonFraction unitRef="usd" contextRef="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="f-1476">4.6</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the 2026 Notes, 2028 Notes, and 2029 Notes are <ix:nonFraction unitRef="number" contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1477">2.98</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ibca4ca09a78d4f1db1fbfc595409a42c_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1478">2.82</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i77ed4f6c46564823a197c54da88e53aa_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1479">4.63</ix:nonFraction>%, respectively. Interest expense for the year ended December&#160;31, 2022, including the amortization of debt issuance cost, totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231" decimals="-5" name="cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1480">7.0</ix:nonFraction> million. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231" decimals="-5" name="cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-1481">3.2</ix:nonFraction> million. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company entered into the Loan and Security Agreement with Silicon Valley Bank for a <ix:nonNumeric contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1482"><ix:nonNumeric contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1483">four-year</ix:nonNumeric></ix:nonNumeric> secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1484"><ix:nonFraction unitRef="usd" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1485">30.0</ix:nonFraction></ix:nonFraction>&#160;million. The Revolving Line of Credit matures on July 9, 2024. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as <ix:nonFraction unitRef="number" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="2" name="cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable" scale="-2" id="f-1486"><ix:nonFraction unitRef="number" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="2" name="cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable" scale="-2" id="f-1487">80</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either <ix:nonFraction unitRef="number" contextRef="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1488"><ix:nonFraction unitRef="number" contextRef="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1489">1.75</ix:nonFraction></ix:nonFraction>% above the Prime Rate or five percent (<ix:nonFraction unitRef="number" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1490"><ix:nonFraction unitRef="number" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1491">5.0</ix:nonFraction></ix:nonFraction>%). The Company paid a non-refundable revolving line commitment fee of $<ix:nonFraction unitRef="usd" contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1492"><ix:nonFraction unitRef="usd" contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1493">0.3</ix:nonFraction></ix:nonFraction>&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $<ix:nonFraction unitRef="usd" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="-5" name="cutr:DebtInstrumentAnniversaryFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1494"><ix:nonFraction unitRef="usd" contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709" decimals="-5" name="cutr:DebtInstrumentAnniversaryFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1495">0.3</ix:nonFraction></ix:nonFraction>&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $<ix:nonFraction unitRef="usd" contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" decimals="-5" name="cutr:DebtCovenantQuarterlyMinimumRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1496"><ix:nonFraction unitRef="usd" contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709" decimals="-5" name="cutr:DebtCovenantQuarterlyMinimumRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1497">90.0</ix:nonFraction></ix:nonFraction>&#160;million, determined in accordance with GAAP on a trailing twelve-month basis, but which is only applicable if the Company has an outstanding balance under the loan facility. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the capped call transactions. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:continuation id="id2918f488ae04f72ba6fb05f95c50f6a"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 24, 2022, the Loan and Security Agreement was amended. The amendment increased the permitted indebtedness by $<ix:nonFraction unitRef="usd" contextRef="i51590e3866c44f098a65564cb2ec8b38_I20220524" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-1498">230,000,000</ix:nonFraction> and provided for the 2026 Notes Exchange and issuance of the capped call transactions related to the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement  waived a violation of a covenant and revised the Loan Agreement to permit the issuance of the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement revised the Loan Agreement to permit the issuance of the 2029 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. In addition, under the purchase and assumption agreement, First-Citizens Bank &amp; Trust Company assumed Silicon Valley Bank&#8217;s obligations under the Company&#8217;s credit facility. On March 13, 2023, the Company violated one of the terms of the credit facility agreement by transferring funds from Silicon Valley Bank. The Company received a waiver from First-Citizens Bank &amp; Trust Company for this violation. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib581b45783164777b7e88b6c201257fc_D20200422-20200422" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1499">7.2</ix:nonFraction> million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and SVB as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i11f3386c03a84affa91cabbfd26c26e5_I20200422" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1500">1.00</ix:nonFraction>% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $<ix:nonFraction unitRef="usd" contextRef="id4c7536ce80e4e06b2517e9f76b4751f_D20210601-20210630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1501">7.2</ix:nonFraction>&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.</span></div></ix:continuation><div id="i62f386bfb76443f0a57b663f9bc3fcbb_142"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SubsequentEventsTextBlock" id="f-1505" continuedAt="ia6caabd40c7d430584734fd43e2dc91d" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="ia6caabd40c7d430584734fd43e2dc91d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounts with First-Citizens Bank &amp; Trust Company, which has assumed the deposits of Silicon Valley Bank and continues to perform asset management services. Approximately $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-6" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-1506">305</ix:nonFraction>&#160;million of the Company&#8217;s total cash, cash equivalents, and marketable securities balance of $<ix:nonFraction unitRef="usd" contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231" decimals="-6" name="us-gaap:InvestmentsAndCash" format="ixt:num-dot-decimal" scale="6" id="f-1507">317</ix:nonFraction>&#160;million at December 31, 2022, was at SVB or SVB Asset Management. The Company&#8217;s funds held at SVB or through SVB Asset Management were either (i) US government treasuries or money market mutual funds held in custodial accounts at U.S. Bank National Association ($<ix:nonFraction unitRef="usd" contextRef="i94f427bfbfd74894b34c8a26f7658e98_I20221231" decimals="-6" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-1508">198</ix:nonFraction>&#160;million at December 31, 2022) or (ii) cash sweep investment funds where SVB acts as an agent for the Company ($<ix:nonFraction unitRef="usd" contextRef="i3d6b6a127ff244979a92a75f9e174aed_I20221231" decimals="-6" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-1509">107</ix:nonFraction>&#160;million at December 31, 2022). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed its receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no other events that have occurred that would require adjustments to its disclosures in the consolidated financial statements.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-1510" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUALIFYING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></div><ix:nonNumeric contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="f-1511" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1512">40,485</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1513">18,153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1514">5,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i12c9297e011c43528e40adc29971dc4d_I20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1515">53,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1516">38,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1517">7,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1518">5,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1519">40,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic72b182a81cf43ee99eb4e8a9d3ec1a8_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1520">32,350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1521">7,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1522">2,015</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1523">38,321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7debaf31c58640479aa03b97de9695a1_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-1524">899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1525">1,787</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="f-1526">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488403d682ba4e59b493908691cb1e8c_I20221231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1527">2,497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21545b587824019adbfef02bb41d281_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1528">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dec51418121482fbdb4c18abe975265_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="f-1529">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dec51418121482fbdb4c18abe975265_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="f-1530">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7debaf31c58640479aa03b97de9695a1_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="f-1531">899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d09091e9bde4c10a1ae5c4f5f4d6337_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1532">1,354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1533">2,144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1534">1,900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21545b587824019adbfef02bb41d281_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1535">1,598</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;CHANGES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISAGREEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WITH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTANTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISCLOSURE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_151"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. &#160; &#160; &#160;&#160; CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed in the Company&#8217;s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC Rule 13a-15(b), the Company carried out an evaluation, under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. Based on the foregoing, the Company&#8217;s Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;) concluded that the Company&#8217;s disclosure controls and procedures were not effective at the reasonable assurance level as a result of the material weaknesses disclosed below. Notwithstanding the material weakness, the Company&#8217;s management, including the CEO and CFO, has concluded that the consolidated financial statements, included in the 2022 Annual Report on Form 10-K, fairly present, in all material respects, its financial condition, results of operations and cash-flows for the periods presented in conformity with generally accepted accounting principles.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attached as exhibits to this Annual Report are certifications of the Company&#8217;s CEO and CFO, which are required in accordance with Rule 13a-14 of the Securities Exchange Act of 1934, as amended (Exchange Act). This Controls and Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations Over Internal Controls</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company&#8217;s internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-top:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company&#8217;s assets;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company&#8217;s receipts and expenditures are being made only in accordance with authorizations of the Company&#8217;s management and directors; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, including the Company&#8217;s CEO and CFO, does not expect that the Company&#8217;s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s financial reporting and the preparation of Consolidated Financial Statements for external purposes in accordance with U.S. GAAP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, including Company&#8217;s CEO and CFO, assessed the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022. Management based its assessment on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Management&#8217;s assessment included evaluation of elements such as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and the Company's overall control environment. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this assessment, management identified the following material weaknesses in the Company&#8217;s internal control over financial reporting:</span></div><div style="margin-top:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Information technology general controls (&#8220;ITGCs&#8221;) including, segregation of duties, user access, and reports produced by certain IT systems that support the Company's financial reporting process including those related to the implementation of an ERP system;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Inventory controls related to the completeness, existence, and cut-off of inventories held at third parties, inventories held by sales personnel, and inventories in transit, and controls related to the calculation of adjustments to inventory for items considered excessive and obsolete; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The completeness and accuracy of expense for routine and non-routine equity-based awards.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although these material weaknesses did not result in any material misstatement of the Company's consolidated financial statements for the periods presented, any one of these weaknesses could lead to a material misstatement of account balances or disclosures. Accordingly, management has concluded that these deficiencies constitute material weaknesses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's assessment under the framework in Internal Control-Integrated Framework (2013 framework), the Company's management concluded that its internal control over financial reporting was not effective as of December 22, 2022, due to the existence of the material weaknesses described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has begun the process of designing and implementing effective internal control measures to improve its internal controls over financial reporting and remediate these material weaknesses. The Company's efforts will include:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITGC remediation actions:</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Developing a training program addressing ITGCs and policies, including educating control owners concerning the principles and requirements of each control, with a focus on those related to user access and change-management over IT systems impacting financial reporting; </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Developing enhanced risk assessment procedures and controls related to changes in IT systems; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Implementing an IT management review and testing plan to monitor ITGCs with focus on systems supporting the financial reporting processes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory control remediation actions:</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Evaluating the effectiveness of the current annual inventory count program and controls;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Implementing a global inventory count policy and standard operating procedures to ensure consistent communication of the inventory count process and adherence to these policies at facilities managed by the Company and third-party logistics service providers;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Providing training of standard operating procedures and internal controls to key stakeholders within the supply chain, logistics, and inventory process; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Enhancing existing management review controls related to inventory in transit, inventories held by sales personnel, and key reports used in in the inventory count process.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity-based awards expense calculation remediation actions: </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Enhancing current review controls around the calculation of stock-based compensation expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, has been audited by an independent registered public accounting firm, as stated in their attestation report, which is included in their annual report under &#8220;Item 8. Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation of Previously Reported Material Weakness </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reported in Item 9A of its Annual Report on Form 10-K for the year ended December 31, 2021, a material weakness related to ITGCs in the areas of user access and segregation of duties related to certain IT systems at its Japan subsidiary. During the year ended December&#160;31, 2022, Management implemented measures at its Japan subsidiary designed to ensure that the control deficiencies contributing to the material weakness were remediated. These measures included changing access rights for certain individuals and implementing new controls designed to both review access rights and detect potential inappropriate transactions recorded as a result of user access and segregation of duties conflicts. Management has tested these additional controls and believes they are operating effectively and therefore the Company has remediated this material weakness. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the material weaknesses noted above, and the remediation of the material weaknesses at the Company's Japan subsidiary reported on Form 10-K for the year ended December 31, 2022, there were no changes in the Company&#8217;s internal control over financial reporting during the quarter ended December&#160;31, 2022, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_154"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2023, the Company received a notification letter from the NASDAQ stating that, because the Company has not yet filed its Annual Report on Form 10-K for the year ended December&#160;31, 2022, the Company is not in compliance with NASDAQ Listing Rule 5250(c)(1) (the &#8220;Rule&#8221;), which requires NASDAQ-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NASDAQ has informed the Company that, under NASDAQ rules, the Company has 60 calendar days from receipt of the Notice, or until May 22, 2023, because the 60th calendar day falls on a weekend, to submit a plan to regain compliance with the Rule. If the NASDAQ accepts the Company&#8217;s plan, then NASDAQ may grant an exception of up to 180 calendar days from the due date of the Form 10-K (March 1, 2023, extended until March 16, 2023, pursuant to the Form 12b-25 filing), or until September 12, 2023, to regain compliance.  The Company believes that its filing of the Form 10-K on April&#160;7, 2023, allows the Company to regain compliance with the Rule.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_157"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_160"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information required by Part III is omitted from this report on Form 10-K and is incorporated herein by reference to the Company&#8217;s definitive Proxy Statement for the Company&#8217;s next Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;), which the Company intends to file pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, within 120 days after December&#160;31, 2022.</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_163"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Company&#8217;s Proxy Statement, all of which is incorporated herein by reference: &#8220;Proposal No. 1 &#8211; Election of Class I Directors&#8221;, &#8220;Board and Committee Information&#8221;, &#8220;Executive Officers&#8221; and &#8220;Additional Information &#8211; Stockholder Proposals to be Presented at Next Annual Meeting.&#8221;</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_166"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Executive Compensation.&#8221;</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_169"></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Certain Relationships and Related-Party Transactions.&#8221;</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_175"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, which is incorporated by reference herein by reference: &#8220;Proposal No. 2, Ratification of Independent Registered Public Accounting Firm.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_181"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;EXHIBITS,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The following documents are filed in Part II of the Annual Report on the Original&#160;10-K:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Financial Statements: See "Index to Consolidated Financial Statements" within the Consolidated Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. Financial Statement Schedules:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial Statement Schedules; not applicable or the required information is otherwise included in the Consolidated Financial Statements and accompanying notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The exhibits listed in the accompanying index to exhibits are filed, furnished, or incorporated by reference as part of this Form 10-K. The following is a list of such Exhibits:</span></div><div style="margin-top:10pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001162461/000143774917018538/ex_99509.htm">Amended and Restated Certificate of Incorporation of the Registrant (filed as Exhibit 3.5 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 7, 2017 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cuteraamendedandrestatedby.htm">Amended and Restated Bylaws of the Registrant</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505061000/dex41.htm">Specimen Common Stock certificate of the Registrant (filed as Exhibit 4.1 to the Company&#8217;s Annual Report on Form&#160;10-K filed on March 25, 2005 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177322.htm">Description of the Registrant&#8217;s Securities (filed as Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K filed on March 16, 2020 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022013604/pan_karavitismichaelx821.htm">Employment Offer Letter dated July 19, 2017  by and between Cutera, Inc. and Michael Karavitis  (filed as Exhibit 4.2 to the Company&#8217;s Quarterly </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022013604/pan_karavitismichaelx821.htm">Report on Form&#160;10-Q&#160;filed on May 10, 2022 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022013604/karavitis_coc.htm">Change of Control and Severance Agreement dated February 1, 2018 by and between Cutera, Inc. and Michael Karavitis (filed as Exhibit 4.3 to the Company&#8217;s Quarterly </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022013604/karavitis_coc.htm">Report on Form&#160;10-Q&#160;filed on May 10, 2022 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex41.htm">Indenture, dated as of March 9, 2021, between Cutera, Inc. and U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.1  Form 8-K filed on March 4, 2021 and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex41.htm">Form of 2.25% Convertible Senior Notes due 2026 (filed as Exhibit 4.2 on Form 8-K filed on March 4, 2021 and incorporated herein by reference). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522164029/d311205dex41.htm">Indenture, dated as of May 27, 2022, between Cutera, Inc. and U.S. Bank Trust Company, National Association, as trustee </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505061000/dex41.htm">(filed as Exhibit 4.1  Form 8-K filed on May 31, 2022 and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522164029/d311205dex41.htm">Form of 2.25% Convertible Senior Notes due 2028 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505061000/dex41.htm">(filed as Exhibit 4.2 on Form 8-K filed on May 31, 2022 and incorporated herein by reference</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522164029/d311205dex41.htm">).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex41.htm">Indenture, dated as of December 12, 2022, between Cutera, Inc. and U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.1  Form 8-K filed on December 12, 2022 and incorporated herein by reference).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex41.htm">Form of 4.00% Convertible Senior Notes due 2029 (filed as Exhibit 4.2 on Form 8-K filed on December 12, 2022 and incorporated herein by reference). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919003050/ex_135490.htm">Form of Indemnification Agreement for directors and executive officers (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 21, 2019 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312507056855/dex104.htm">2004 Employee Stock Purchase Plan (filed as Exhibit 10.4 to the Company&#8217;s Annual Report on Form&#160;10-K&#160;filed on March&#160;16, 2007 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312504004524/dex106.htm">Brisbane Technology Park Lease dated August 5, 2003 by and between the Registrant and&#160;Gal-Brisbane,&#160;L.P. for office space located at 3240 Bayshore Boulevard, Brisbane, California (filed as Exhibit 10.6 to the Company&#8217;s registration statement on Form&#160;S-1&#160;filed on January&#160;15, 2004 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505225555/dex1011.htm">Form of Performance Unit Award Agreement (filed as Exhibit 10.11 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on November&#160;14, 2005 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000116246110000009/ex10_19.htm">First Amendment to Brisbane Technology Park Lease dated August&#160;11, 2010 by and between the Company and BMR-Bayshore Boulevard LLC, as&#160;successor-in-interest&#160;to&#160;Gal-Brisbane,&#160;L.P., the original landlord, for office space located at 3240 Bayshore Boulevard (filed as Exhibit 10.19 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on November&#160;1, 2010 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774916036089/ex10-22.htm">Form of Performance Stock Unit Award Agreement (filed as Exhibit 10.22 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;1, 2016 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917013942/ex10-26.htm">Lease Termination Agreement dated July&#160; 6, 2017 by and between the Registrant and SI 28, LLC (filed as Exhibit 10.26 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;7, 2017 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917013942/ex10-27.htm">Second Amendment to Lease dated July&#160; 6, 2017 by and between the Company and BMR-Bayshore Boulevard LP (filed as Exhibit 10.27 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;7, 2017 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149506.htm">Employment Offer Letter dated June&#160; 22, 2019 by and between Cutera, Inc. and David Mowry (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July&#160;10, 2019 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149509.htm">Change of Control and Severance Agreement dated July&#160; 8, 2019 by and between Cutera, Inc. and David Mowry (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July&#160;10, 2019 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920008472/ex_182753.htm">Promissory Note dated April 21, 2020, between Cutera, Inc. and Silicon Valley Bank (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on April 24, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920015031/ex_193496.htm">Loan and Security Agreement, dated as of July 9, 2020, by and among Cutera, Inc., as borrower, and Silicon Valley Bank, as lender (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July 13, 2020 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920015031/ex_193497.htm">Third Amendment to Lease by and between Cutera, Inc. and BMR-Bayshore Boulevard LP, successor-in-interest Gal-Brisbane, L.P. (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July 13, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198097.htm">Employment Offer Letter dated July 29, 2020 by and between Cutera, Inc. and Rohan Seth (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on August 7, 2020 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198098.htm">Change of Control and Severance Agreement dated July 29, 2020 by and between Cutera, Inc. and Rohan Seth (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on August 7, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex41.htm">Indenture, dated as of March 9, 2021, between Cutera, Inc. and U.S. Bank National Association, as trustee (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex102.htm">Form of Capped Call Transaction Confirmation (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex103.htm">Amendment No. 1, dated March 4, 2021, to the Loan and Security Agreement, dated July 9, 2020 by and between Cutera, Inc., and Silicon Valley Bank ((filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference))</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521172458/d188233dex101.htm">Employment Offer Letter dated May 19, 2021 by and between Cutera, Inc. and J. Daniel Plants (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on May&#160;25, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521172458/d188233dex102.htm">Change of Control and Severance Agreement dated May 19, 2021 by and between Cutera, Inc. and J. Daniel Plants  (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on May&#160;25, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921015107/ex_258175.htm">Cutera, Inc. 2019 Equity Incentive Plan (amended and restated as of June 15, 2021) (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on June 21, 2021 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a1zomedicalandcuteraagreem.htm">ZO Medical and Cutera Agreement 5 Aug 2013 (filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a2zoskinhealthamendment21a.htm">ZO Skin Health Amendment 21 Aug 2013 (filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a3zoskinhealthamendment25j.htm">ZO Skin Health Amendment 25 Jan 2021 (filed as Exhibit 10.3 to the Company&#8217;s Quarterly  Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a4zoskinhealthamendment14j.htm">ZO Skin Health Amendment 14 Jun 2021 (filed as Exhibit 10.4 to the Company&#8217;s Quarterly  Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">Amendment, effective January 1, 2022, to Distribution Agreement dated August 5, 2013, between Cutera Inc., and ZO Skin Health, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm"> (filed as Exhibit 10.4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm"> to the Company&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">Annual</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">  Report on Form&#160;10-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">Marc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">h 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828022004539/cutr-20211231xexx1041.htm"> and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cutr-20221231xexx1027thi.htm">Third Amendment, dated May 24, 2022, to the Loan and Security Agreement, dated July 9, 2020 by and between Cutera, Inc., and Silicon Valley Bank.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xex1028four.htm">Fourth Amendment, dated August 10, 2022, to the Loan and Security Agreement, dated July 9, 2020 by and between Cutera, Inc., and Silicon Valley Bank.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">Fifth Amendment, dated December 7, 2022, to the Loan and Security Agreement, dated July 9, 2020 by and between Cutera, Inc., and Silicon Valley Bank</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">filed as Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm"> to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">December 12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312522302737/d411176dex103.htm"> and incorporated herein by reference)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xex211listofs.htm">List of Subsidiaries</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xexx2311.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xexx3131.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xexx3141.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20221231xexx3211.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensatory plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Filed herewith</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_184"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i62f386bfb76443f0a57b663f9bc3fcbb_187"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">Table of C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">o</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">n</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i62f386bfb76443f0a57b663f9bc3fcbb_7">tents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the city of Brisbane, State of California, on the 7th day of April, 2023.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:45.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DAVID H. MOWRY</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David H. Mowry</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Officer</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Power of Attorney</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David H. Mowry, and Rohan Seth, and each of them, as his or her true and lawful&#160;attorneys-in-fact&#160;and agents, with full power of substitution and resubstitution for him or her and in his or her name, place, and stead, in any and all capacities to sign any and all amendments to this Annual Report on Form&#160;10-K,&#160;and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said&#160;attorneys-in-fact&#160;and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said&#160;attorneys-in-fact&#160;and agents, and any of them or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:25.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ DAVID H. MOWRY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David H. Mowry</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ROHAN SETH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rohan Seth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ J. DANIEL PLANTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Chairman of the Board of Directors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J. Daniel Plants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ GREGORY A. BARRETT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory A. Barrett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JOSEPH E. WHITTERS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joseph E. Whitters</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ TIM J. O&#8217;SHEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tim J. O&#8217;Shea</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ SHEILA A. HOPKINS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sheila A. Hopkins</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JANET D. WIDMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Janet L. Widman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JULIANE T. PARK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 7, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juliane T. Park</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>cuteraamendedandrestatedby.htm
<DESCRIPTION>EX-3.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieb5f847906ef486b82b8c2ca2ff09b38_1"></div><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 3.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:100%">AMENDED AND RESTATED BYLAWS OF</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:100%">CUTERA, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(a Delaware corporation)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">As Amended on April 13, 2017)</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div></div><div id="ieb5f847906ef486b82b8c2ca2ff09b38_4"></div><hr style="page-break-after:always"><div style="min-height:145.44pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I - CORPORATE OFFICES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REGISTERED OFFICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OTHER OFFICES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II - MEETINGS OF STOCKHOLDERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PLACE OF MEETINGS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ANNUAL MEETING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SPECIAL MEETING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ADVANCE NOTICE PROCEDURES&#59; NOTICE OF STOCKHOLDERS&#8217; MEETINGS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MANNER OF GIVING NOTICE&#59; AFFIDAVIT OF NOTICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUORUM</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ADJOURNED MEETING&#59; NOTICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDUCT OF BUSINESS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VOTING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RECORD DATE FOR STOCKHOLDER NOTICE&#59; VOTING&#59; GIVING CONSENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PROXIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIST OF STOCKHOLDERS ENTITLED TO VOTE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INSPECTORS OF ELECTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III - DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr></table></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-i-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:145.44pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(continued)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">POWERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NUMBER OF DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RESIGNATION AND VACANCIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PLACE OF MEETINGS&#59; MEETINGS BY TELEPHONE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REGULAR MEETINGS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SPECIAL MEETINGS&#59; NOTICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUORUM</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FEES AND COMPENSATION OF DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REMOVAL OF DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV - COMMITTEES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMMITTEES OF DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMMITTEE MINUTES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MEETINGS AND ACTION OF COMMITTEES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V - OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">APPOINTMENT OF OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr></table></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-ii-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:145.44pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(continued)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SUBORDINATE OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REMOVAL AND RESIGNATION OF OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VACANCIES IN OFFICES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATION OF SHARES OF OTHER CORPORATIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AUTHORITY AND DUTIES OF OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI - RECORDS AND REPORTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MAINTENANCE AND INSPECTION OF RECORDS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INSPECTION BY DIRECTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII - GENERAL MATTERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">STOCK CERTIFICATES&#59; PARTLY PAID SHARES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SPECIAL DESIGNATION ON CERTIFICATES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LOST CERTIFICATES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONSTRUCTION&#59; DEFINITIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr></table></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-iii-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:145.44pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(continued)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DIVIDENDS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FISCAL YEAR</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SEAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TRANSFER OF STOCK</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">STOCK TRANSFER AGREEMENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REGISTERED STOCKHOLDERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WAIVER OF NOTICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII - NOTICE BY ELECTRONIC TRANSMISSION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE BY ELECTRONIC TRANSMISSION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITION OF ELECTRONIC TRANSMISSION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INAPPLICABILITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX - INDEMNIFICATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INDEMNIFICATION OF DIRECTORS AND OFFICERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INDEMNIFICATION OF OTHERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr></table></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-iv-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:145.44pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(continued)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Page</font></div><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PREPAYMENT OF EXPENSES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DETERMINATION&#59; CLAIM</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NON-EXCLUSIVITY OF RIGHTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INSURANCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OTHER INDEMNIFICATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMENDMENT OR REPEAL</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X - AMENDMENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#ieb5f847906ef486b82b8c2ca2ff09b38_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-v-</font></div></div></div><div id="ieb5f847906ef486b82b8c2ca2ff09b38_7"></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BYLAWS OF CUTERA, INC.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE I - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.72pt">CORPORATE OFFICES</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">REGISTERED OFFICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The registered office of Cutera, Inc. shall be fixed in the corporation&#8217;s certificate of incorporation, as the same may be amended from time to time.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">OTHER OFFICES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation&#8217;s Board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may at any time establish other offices at any place or places where the corporation is qualified to do business.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE II - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:1.44pt">MEETINGS OF STOCKHOLDERS</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">PLACE OF MEETINGS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Meetings of stockholders shall be held at any place, within or outside the State of Delaware, designated by the Board.  The Board may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section&#160;211(a)(2) of the Delaware General Corporation Law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  In the absence of any such designation or determination, stockholders&#8217; meetings shall be held at the corporation&#8217;s principal executive office.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">ANNUAL MEETING</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The annual meeting of stockholders shall be held each year.  The Board shall designate the date and time of the annual meeting.   In the absence of such designation the annual meeting of stockholders shall be held on the second Tuesday of May of each year at 10&#58;00 a.m.  However, if such day falls on a legal holiday, then the meeting shall be held at the same time and place on the next succeeding business day.  At the annual meeting, directors shall be elected and any other proper business may be transacted.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">SPECIAL MEETING</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A special meeting of the stockholders may be called at any time by the Board, chairperson of the Board, chief executive officer or president (in the absence of a chief executive officer), but such special meetings may not be called by any other person or persons.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No business may be transacted at such special meeting other than the business specified in such notice to stockholders.  Nothing contained in this paragraph of this Section&#160;2.3 shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the Board may be held.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">ADVANCE NOTICE PROCEDURES&#59; NOTICE OF STOCKHOLDERS&#8217; MEETINGS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting.  To be properly brought before an annual meeting, business must be&#58; (A) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the board of directors, (B) otherwise properly brought before the meeting by or at the direction of the board of directors, or (C) otherwise properly brought before the meeting by a stockholder. For business to be properly brought before an annual meeting by a stockholder, the stockholder must have given timely notice thereof in writing to the secretary of the corporation. To be timely, a stockholder&#8217;s notice must be delivered to or mailed and received at the principal executive offices of the corporation not less than one hundred twenty (120) calendar days before the one year anniversary of the date on which the corporation first mailed its proxy statement to stockholders in connection with the previous year&#8217;s annual meeting of stockholders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in the event that no annual meeting was held in the previous year or the date of the annual meeting has been changed by more than thirty (30) days from the date of the prior year&#8217;s meeting, notice by the stockholder to be timely must be so received not later than the close of business on the later of one hundred twenty (120) calendar days in advance of such annual meeting and ten (10) calendar days following the date on which public announcement of the date of the meeting is first made. A stockholder&#8217;s notice to the secretary shall set forth as to each matter the stockholder proposes to bring before the annual meeting&#58; (a) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (b) the name and address, as they appear on the corporation&#8217;s books, of the stockholder proposing such business, (c) the class and number of shares of the corporation that are beneficially owned by the stockholder, (d) any material interest of the stockholder in such business, and (e) any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;), in his capacity as a proponent to a stockholder proposal. Notwithstanding the foregoing, in order to include information with respect to a stockholder proposal in the proxy statement and form of proxy for a stockholder&#8217;s meeting, stockholders must provide notice as required by the regulations promulgated under the 1934 Act.  Notwithstanding anything in these bylaws to the contrary, no business shall be conducted at any annual meeting except in accordance with the procedures set forth in this paragraph (i). The chairman of the annual meeting shall, if the facts warrant, determine and declare at the meeting that business was not properly brought before the meeting and in accordance with the provisions of this paragraph (i), and, if he should so determine, he shall so declare at the meeting that any such business not properly brought before the meeting shall not be transacted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">Only persons who are nominated in accordance with the procedures set forth in this paragraph (ii) shall be eligible for election as directors. Nominations of persons for election to the board of directors of the corporation may be made at a meeting of stockholders by or at the direction of the board of directors or by any stockholder of the corporation entitled to vote in the election of directors at the meeting who complies with the notice procedures set forth in this paragraph (ii). Such nominations, other than those made by or at the direction of the board of directors, shall be made pursuant to timely notice in writing to the secretary of the corporation in accordance with the provisions of paragraph (i) of this Section 2.4. Such stockholder&#8217;s notice shall set forth (a) as to each person, if any, whom the stockholder proposes to nominate for election or re-election as a director&#58; (A) the name, age, business address and residence address of such person, (B) the principal occupation or employment of such person, (C) the class and number of shares of the corporation that are beneficially owned by such person, (D) a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder, and (E) any other information relating to such person that is required  to be disclosed in solicitations of proxies for elections of directors, or is otherwise required, in each case pursuant to Regulation 14A under the 1934 Act (including </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">without limitation such person&#8217;s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected)&#59; and (b) as to such stockholder giving notice, the information required to be provided pursuant to paragraph (i) of this Section 2.4. At the request of the board of  directors, any person nominated by a stockholder for election as a director shall furnish to the secretary of the corporation that information required to be set forth in the stockholder&#8217;s notice of nomination which pertains to the nominee. No person shall be eligible for election as a director of the corporation unless nominated in accordance with the procedures set forth in this paragraph (ii). The chairman of the meeting shall, if the facts warrant, determine and declare at the meeting that a nomination was not made in accordance with the procedures prescribed by these bylaws, and if he should so determine, he shall so declare at the meeting, and the defective nomination shall be disregarded.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These provisions shall not prevent the consideration and approval or disapproval at an annual meeting of reports of officers, directors and committees of the board of directors, but in connection therewith no new business shall be acted upon at any such meeting unless stated, filed and received as herein provided.  Notwithstanding anything in these bylaws to the contrary, no business brought before a meeting by a stockholder shall be conducted at an annual meeting except in accordance with procedures set forth in this Section 2.4.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All notices of meetings of stockholders shall be sent or otherwise given in accordance with either Section&#160;2.5 or Section 8.1 of these bylaws not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at such meeting.  The notice shall specify the place, if any, date and hour of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">MANNER OF GIVING NOTICE&#59; AFFIDAVIT OF NOTICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice of any meeting of stockholders shall be given&#58; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">if mailed, when deposited in the United States mail, postage prepaid, directed to the stockholder at his or her address as it appears on the corporation&#8217;s records&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">if electronically transmitted as provided in Section 8.1 of these bylaws.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">An affidavit of the secretary or an assistant secretary of the corporation or of the transfer agent or any other agent of the corporation that the notice has been given by mail or by a form of electronic transmission, as applicable, shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">QUORUM</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The holders of a majority of the stock issued and outstanding and entitled to vote, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders.  If, however, such quorum is not present or represented at any meeting of the stockholders, then either (i)&#160;the chairperson of the meeting, or (ii)&#160;the stockholders entitled to vote at the meeting, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present or represented.  At such adjourned meeting at which a quorum is present or represented, any business may be transacted that might have been transacted at the meeting as originally noticed.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">ADJOURNED MEETING&#59; NOTICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">When a meeting is adjourned to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting if the time, place if any thereof, and the means of remote communications if any by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken.  At the adjourned meeting, the corporation may transact any business which might have been transacted at the original meeting.  If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">CONDUCT OF BUSINESS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The chairperson of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of business.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">VOTING</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section&#160;2.11 of these bylaws, subject to Section&#160;217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section 218 (relating to voting trusts and other voting agreements) of the DGCL.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as may be otherwise provided in the certificate of incorporation or these bylaws, each stockholder shall be entitled to one vote for each share of capital stock held by such stockholder.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the rights of the holders of the shares of any series of Preferred Stock or any other class of stock or series thereof having a preference over the Common Stock as dividend or upon liquidation, any action required or permitted to be taken by the stockholders of the corporation must be effected at a duly called annual or special meeting of stockholders of the corporation and may not be effected by any consent in writing by such stockholders.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">RECORD DATE FOR STOCKHOLDER NOTICE&#59; VOTING&#59; GIVING CONSENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board may fix, in advance, a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which shall not be more than 60 nor less than 10 days before the date of such meeting, nor more than 60 days prior to any other such action.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Board does not so fix a record date&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Board may fix a new record date for the adjourned meeting.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">PROXIES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period.  The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212 of the DGCL.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">LIST OF STOCKHOLDERS ENTITLED TO VOTE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The officer who has charge of the stock ledger of the corporation shall prepare and make, at least 10 days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder.  The corporation shall not be required to include electronic mail addresses or other electronic contact information on such list.  Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least 10 days prior to the meeting&#58;  (i)&#160;on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&#160;during ordinary business hours, at the corporation&#8217;s principal executive office.  In the event that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation.  If the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present.  If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting.  Such list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">INSPECTORS OF ELECTION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A written proxy may be in the form of a telegram, cablegram, or other means of electronic transmission which sets forth or is submitted with information from which it can be determined that the telegram, cablegram, or other means of electronic transmission was authorized by the person.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Before any meeting of stockholders, the board of directors shall appoint an inspector or inspectors of election to act at the meeting or its adjournment.  The number of inspectors shall be either one (1) or three (3).  If any person appointed as inspector fails to appear or fails or refuses to act, then the chairperson of the meeting may, and upon the request of any stockholder or a stockholder's proxy shall, appoint a person to fill that vacancy.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Such inspectors shall&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">determine the number of shares outstanding and the voting power of each, the number of shares represented at the meeting, the existence of a quorum, and the authenticity, validity, and effect of proxies&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">receive votes, ballots or consents&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.13pt">hear and determine all challenges and questions in any way arising in connection with the right to vote&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.73pt">count and tabulate all votes or consents&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.78pt">determine when the polls shall close&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.73pt">determine the result&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.68pt">do any other acts that may be proper to conduct the election or vote with fairness to all stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical.  If there are three (3) inspectors of election, the decision, act or certificate of a majority is effective in all respects as the decision, act or certificate of all.  Any report or certificate made by the inspectors of election is prima facie evidence of the facts stated therein.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE III - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:33.16pt">DIRECTORS</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">POWERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the provisions of the DGCL and any limitations in the certificate of incorporation or these bylaws relating to action required to be approved by the stockholders or by the outstanding shares, the business and affairs of the corporation shall be managed and all corporate powers shall be exercised by or under the direction of the Board.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">NUMBER OF DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The authorized number of directors shall be determined from time to time by resolution of the Board, provided the Board shall consist of at least one&#160;member.  No reduction of the authorized number of directors shall have the effect of removing any director before that director&#8217;s term of office expires.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as provided in Section&#160;3.4 of these bylaws, each director, including a director elected to fill a vacancy, shall hold office until the expiration of the term for which elected and until such director&#8217;s successor is elected and qualified or until such director&#8217;s earlier death, resignation or removal.  Directors need not be stockholders unless so required by the certificate of incorporation or these bylaws.  The certificate of incorporation or these bylaws may prescribe other qualifications for directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each director shall be elected by the vote of the majority of the votes cast with respect to the nominee at any meeting for the election of directors at which a quorum is present, provided that, the directors shall be elected by the vote of a plurality of the votes cast on the election of directors at any meeting for which (i) the Secretary receives a notice of a stockholder&#8217;s intention to nominate a person or persons for election to the board of directors in compliance with the advance notice provisions of Section 2.4 of these bylaws and (ii) such nomination has not been withdrawn by such stockholder on or before the fourteenth (14th) day preceding the date the corporation first mails its notice of meeting for such meeting of stockholders. For purposes of this paragraph, a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a director must exceed the number of votes cast &#8220;against&#8221; that director.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">RESIGNATION AND VACANCIES.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any director may resign at any time upon notice given in writing or by electronic transmission to the corporation.  When one or more directors so resigns and the resignation is effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office as provided in this section in the filling of other vacancies.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise provided in the certificate of incorporation or these bylaws, vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having the right to vote as a single class may be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If at any time, by reason of death or resignation or other cause, the corporation should have no directors in office, then any officer or any stockholder or an executor, administrator, trustee or guardian of a stockholder, or other fiduciary entrusted with like responsibility for the person or estate of a stockholder, may call a special meeting of stockholders in accordance with the provisions of the certificate of incorporation or these bylaws, or may apply to the Court of Chancery for a decree summarily ordering an election as provided in Section&#160;211 of the DGCL.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, at the time of filling any vacancy or any newly created directorship, the directors then in office constitute less than a majority of the whole Board (as constituted immediately prior to any such increase), then the Court of Chancery may, upon application of any stockholder or stockholders holding at least 10% of the total number of the shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office as aforesaid, which election shall be governed by the provisions of Section&#160;211 of the DGCL as far as applicable.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">PLACE OF MEETINGS&#59; MEETINGS BY TELEPHONE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board may hold meetings, both regular and special, either within or outside the State of Delaware.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise restricted by the certificate of incorporation or these bylaws, members of the Board, or any committee designated by the Board, may participate in a meeting of the Board, or any committee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">REGULAR MEETINGS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Regular meetings of the Board may be held without notice at such time and at such place as shall from time to time be determined by the Board.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">SPECIAL MEETINGS&#59; NOTICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Special meetings of the Board for any purpose or purposes may be called at any time by the chairperson of the Board, the chief executive officer, the president, the secretary or a majority of the authorized number of directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice of the time and place of special meetings shall be&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">delivered personally by hand, by courier or by telephone&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">sent by United States first-class mail, postage prepaid&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.13pt">sent by facsimile&#59; or </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.73pt">sent by electronic mail, </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">directed to each director at that director&#8217;s address, telephone number, facsimile number or electronic mail address, as the case may be, as shown on the corporation&#8217;s records.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the notice is (i) delivered personally by hand, by courier or by telephone, (ii) sent by facsimile or (iii)&#160;sent by electronic mail, it shall be delivered or sent at least 24 hours before the time of the holding of the meeting.  If the notice is sent by United States mail, it shall be deposited in the United States mail at least four  days before the time of the holding of the meeting.  Any oral notice may be communicated to the director.  The notice need not specify the place of the meeting (if the meeting is to be held at the corporation&#8217;s principal executive office) nor the purpose of the meeting.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">QUORUM</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">At all meetings of the Board, a majority of the authorized number of directors shall constitute a quorum for the transaction of business.  The vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by statute, the certificate of incorporation or these bylaws.  If a quorum is not present at any meeting of the Board, then the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors, if any action taken is approved by at least a majority of the required quorum for that meeting.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise restricted by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of the Board, or of any committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the Board or committee.  Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">FEES AND COMPENSATION OF DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise restricted by the certificate of incorporation or these bylaws, the Board shall have the authority to fix the compensation of directors. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">REMOVAL OF DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any director may be removed from office by the stockholders of the corporation only for cause.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No reduction of the authorized number of directors shall have the effect of removing any director prior to the expiration of such director&#8217;s term of office.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE IV - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:33.78pt">COMMITTEES</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">COMMITTEES OF DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board may, by resolution passed by a majority of the authorized number of directors, designate one or more committees, each committee to consist of one or more of the directors of the corporation.  The Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee.  In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified member.  Any such committee, to the extent provided in the resolution of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers that may require it&#59; but no such committee shall have the power or authority to (i)&#160;approve or adopt, or recommend to the stockholders, any action or matter expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopt, amend or repeal any bylaw of the corporation,</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">COMMITTEE MINUTES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each committee shall keep regular minutes of its meetings and report the same to the Board when required.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">MEETINGS AND ACTION OF COMMITTEES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">Section&#160;3.5 (place of meetings and meetings by telephone)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">Section&#160;3.6 (regular meetings)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.13pt">Section&#160;3.7 (special meetings and notice)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.73pt">Section&#160;3.8 (quorum)&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.78pt">Section 7.12 (waiver of notice)&#59; and </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.73pt">Section&#160;3.9 (action without a meeting)</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with such changes in the context of those bylaws as are necessary to substitute the committee and its members for the Board and its members.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">However</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the time of regular meetings of committees may be determined either by resolution of the Board or by resolution of the committee&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">special meetings of committees may also be called by resolution of the Board&#59; and </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">notice of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee.  The Board may adopt rules for the government of any committee not inconsistent with the provisions of these bylaws.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE V - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:2.06pt">OFFICERS</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The officers of the corporation shall be a president and a secretary.  The corporation may also have, at the discretion of the Board, a chairperson of the Board, a vice chairperson of the Board, a chief executive officer, a chief financial officer or treasurer, one or more vice presidents, one or more assistant vice presidents, one or more assistant treasurers, one or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws.  Any number of offices may be held by the same person.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">APPOINTMENT OF OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board shall appoint the officers of the corporation, except such officers as may be appointed in accordance with the provisions of Sections&#160;5.3 and 5.5 of these bylaws, subject to the rights, if any, of an officer under any contract of employment.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">SUBORDINATE OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board may appoint, or empower the chief executive officer or, in the absence of a chief executive officer, the president, to appoint, such other officers and agents as the business of the corporation may require.  Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time to time determine.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">REMOVAL AND RESIGNATION OF OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by an affirmative vote of the majority of the Board at any regular or special meeting of the Board or, except in the case of an officer chosen by the Board, by any officer upon whom such power of removal may be conferred by the Board.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any officer may resign at any time by giving written notice to the corporation.  Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice.  Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the corporation under any contract to which the officer is a party.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">VACANCIES IN OFFICES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any vacancy occurring in any office of the corporation shall be filled by the Board or as provided in Section 5.2.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">REPRESENTATION OF SHARES OF OTHER CORPORATIONS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The chairperson of the Board, the president, any vice president, the treasurer, the secretary or assistant secretary of this corporation, or any other person authorized by the Board or the president or a vice president, is authorized to vote, represent, and exercise on behalf of this corporation all rights incident to any and all shares of any other corporation or corporations standing in the name of this corporation.  The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by such person having the authority.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">AUTHORITY AND DUTIES OF OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All officers of the corporation shall respectively have such authority and perform such duties in the management of the business of the corporation as may be designated from time to time by the Board or the stockholders and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VI - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:33.78pt">RECORDS AND REPORTS</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">MAINTENANCE AND INSPECTION OF RECORDS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation shall, either at its principal executive office or at such place or places as designated by the Board, keep a record of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of these bylaws as amended to date, accounting books, and other records.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose the corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records and to make copies or extracts therefrom.  A proper purpose shall mean a purpose reasonably related to such person&#8217;s interest as a stockholder.  In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other writing that authorizes the attorney or other agent so to act on behalf of the stockholder.  The demand under oath shall be directed to the corporation at its registered office in Delaware or at its principal executive office.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">INSPECTION BY DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any director shall have the right to examine the corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records for a purpose reasonably related to his or her position as a director.  The Court of Chancery is hereby vested with the exclusive jurisdiction to determine whether a director is entitled to the inspection sought.  The Court may summarily order the corporation to permit the director to inspect any and all books and records, the stock ledger, and the stock list and to make copies or extracts therefrom.  The Court may, in its discretion, prescribe any limitations or conditions with reference to the inspection, or award such other and further relief as the Court may deem just and proper.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VII - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:29.5pt">GENERAL MATTERS</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board, except as otherwise provided in these bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the corporation&#59; such authority may be general or confined to specific instances.  Unless so authorized or ratified by the Board or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">STOCK CERTIFICATES&#59; PARTLY PAID SHARES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The shares of the corporation shall be represented by certificates, provided that the Board may provide by resolution or resolutions that some or all of any or all classes or series of its stock shall be uncertificated shares.  Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the corporation.  Notwithstanding the adoption of such a resolution by the Board, every holder of stock represented by certificates and upon request every holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name of the corporation by the chairperson or vice-chairperson of the Board, or the president or vice-president, and by the treasurer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or an assistant treasurer, or the secretary or an assistant secretary of such corporation representing the number of shares registered in certificate form.  Any or all of the signatures on the certificate may be a facsimile.  In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if he were such officer, transfer agent or registrar at the date of issue.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation may issue the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor.  Upon the face or back of each stock certificate issued to represent any such partly paid shares, upon the books and records of the corporation in the case of uncertificated partly paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon shall be stated.  Upon the declaration of any dividend on fully paid shares, the corporation shall declare a dividend upon partly paid shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">SPECIAL DESIGNATION ON CERTIFICATES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and&#47;or rights shall be set forth in full or summarized on the face or back of the certificate that the corporation shall issue to represent such class or series of stock&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, except as otherwise provided in Section&#160;202 of the DGCL, in lieu of the foregoing requirements there may be set forth on the face or back of the certificate that the corporation shall issue to represent such class or series of stock a statement that the corporation will furnish without charge to each stockholder who so requests the powers, the designations, the preferences, and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and&#47;or rights.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">LOST CERTIFICATES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as provided in this Section&#160;7.5, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered to the corporation and cancelled at the same time.  The corporation may issue a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the corporation may require the owner of the lost, stolen or destroyed certificate, or such owner&#8217;s legal representative, to give the corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">CONSTRUCTION&#59; DEFINITIONS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the context requires otherwise, the general provisions, rules of construction, and definitions in the DGCL shall govern the construction of these bylaws.  Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term &#8220;person&#8221; includes both a corporation and a natural person.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">DIVIDENDS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board, subject to any restrictions contained in either (i)&#160;the DGCL, or (ii)&#160;the certificate of incorporation, may declare and pay dividends upon the shares of its capital stock.  Dividends may be paid in cash, in property, or in shares of the corporation&#8217;s capital stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board may set apart out of any of the funds of the corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the corporation, and meeting contingencies.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">FISCAL YEAR</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The fiscal year of the corporation shall be fixed by resolution of the Board and may be changed by the Board.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">SEAL</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation may adopt a corporate seal, which shall be adopted and which may be altered by the Board.  The corporation may use the corporate seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">TRANSFER OF STOCK</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon surrender to the corporation or the transfer agent of the corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignation or authority to transfer, it shall be the duty of the corporation to issue a new certificate to the person entitled thereto, cancel the old certificate, and record the transaction in its books.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">STOCK TRANSFER AGREEMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock of the corporation to restrict the transfer of shares of stock of </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-14-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">REGISTERED STOCKHOLDERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt"> shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and to vote as such owner&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">shall be entitled to hold liable for calls and assessments the person registered on its books as the owner of shares&#59; and </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.13pt">shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">WAIVER OF NOTICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Whenever notice is required to be given under any provision of the DGCL, the certificate of incorporation or these bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to notice.  Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.  Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the certificate of incorporation or these bylaws.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VIII - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.22pt">NOTICE BY ELECTRONIC TRANSMISSION</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">NOTICE BY ELECTRONIC TRANSMISSION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the manner by which notice otherwise may be given effectively to stockholders pursuant to the DGCL, the certificate of incorporation or these bylaws, any notice to stockholders given by the corporation under any provision of the DGCL, the certificate of incorporation or these bylaws shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given.  Any such consent shall be revocable by the stockholder by written notice to the corporation.  Any such consent shall be deemed revoked if&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.23pt">the corporation is unable to deliver by electronic transmission two consecutive notices given by the corporation in accordance with such consent&#59; and </font></div><div style="margin-top:12pt;text-align:justify;text-indent:86.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.18pt">such inability becomes known to the secretary or an assistant secretary of the corporation or to the transfer agent, or other person responsible for the giving of notice.  </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-15-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">However, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any notice given pursuant to the preceding paragraph shall be deemed given&#58;  </font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">if by a posting on an electronic network together with separate notice to the stockholder of such specific posting, upon the later of (A)&#160;such posting and (B)&#160;the giving of such separate notice&#59; and </font></div><div style="margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">if by any other form of electronic transmission, when directed to the stockholder.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">An affidavit of the secretary or an assistant secretary or of the transfer agent or other agent of the corporation that the notice has been given by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">DEFINITION OF ELECTRONIC TRANSMISSION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">An &#8220;electronic transmission&#8221; means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved, and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">INAPPLICABILITY</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice by a form of electronic transmission shall not apply to Sections 164, 296, 311, 312 or 324 of the DGCL.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE IX - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:33.78pt">INDEMNIFICATION</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">INDEMNIFICATION OF DIRECTORS AND OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation shall indemnify and hold harmless, to the fullest extent permitted by the DGCL as it presently exists or may hereafter be amended, any director or officer of the corporation who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or non-profit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses reasonably incurred by such person in connection with any such Proceeding.  The corporation shall be required to indemnify a person in connection with a Proceeding initiated by such person only if the Proceeding was authorized by the Board.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-16-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">INDEMNIFICATION OF OTHERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation shall have the power to indemnify and hold harmless, to the extent permitted by applicable law as it presently exists or may hereafter be amended, any employee or agent of the corporation who was or is made or is threatened to be made a party or is otherwise involved in any Proceeding by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was an employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or non-profit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses reasonably incurred by such person in connection with any such Proceeding.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">PREPAYMENT OF EXPENSES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation shall pay the expenses incurred by any officer or director of the corporation, and may pay the expenses incurred by any employee or agent of the corporation, in defending any Proceeding in advance of its final disposition&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the payment of expenses incurred by a person in advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the person to repay all amounts advanced if it should be ultimately determined that the person is not entitled to be indemnified under this Article IX or otherwise.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">DETERMINATION&#59; CLAIM</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If a claim for indemnification or payment of expenses under this Article IX is not paid in full within sixty days after a written claim therefor has been received by the corporation the claimant may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim.  In any such action the corporation shall have the burden of proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">NON-EXCLUSIVITY OF RIGHTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The rights conferred on any person by this Article IX shall not be exclusive of any other rights which such person may have or hereafter acquire under any statute, provision of the certificate of incorporation, these bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">INSURANCE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify him or her against such liability under the provisions of the DGCL.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">OTHER INDEMNIFICATION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The corporation&#8217;s obligation, if any, to indemnify any person who was or is serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, enterprise or non-profit entity shall be reduced by any amount such person may collect as indemnification from such other corporation, partnership, joint venture, trust, enterprise or non-profit enterprise.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-17-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">AMENDMENT OR REPEAL</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any repeal or modification of the foregoing provisions of this Article IX shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.&#8221;</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE X - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:2.06pt">AMENDMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These bylaws may be adopted, amended or repealed by the stockholders entitled to vote.  However, the corporation may, in its certificate of incorporation, confer the power to adopt, amend or repeal bylaws upon the directors.  The fact that such power has been so conferred upon the directors shall not divest the stockholders of the power, nor limit their power to adopt, amend or repeal bylaws.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">C&#58;&#92;NRPortbl&#92;palib2&#92;PHO&#92;2660342_2.doc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-18-</font></div></div></div><div id="ieb5f847906ef486b82b8c2ca2ff09b38_10"></div><hr style="page-break-after:always"><div style="min-height:106.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CUTERA, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CERTIFICATE OF AMENDMENT OF BYLAWS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned hereby certifies that he or she is the duly elected, qualified, and acting Secretary or Assistant Secretary of Cutera, Inc., a Delaware corporation and that the foregoing bylaws, comprising 17 pages, were amended and restated on April 13, 2017 by the corporation&#8217;s board of directors.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned has hereunto set his or her hand this 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> day of April, 2017.</font></div><div style="margin-top:24pt;padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Philip Oettinger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Secretary</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>3
<FILENAME>cutr-20221231xexx1027thi.htm
<DESCRIPTION>EX-10.27
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>cutr-20221231xexx1027thi</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- cutr-20221231xexx1027thi001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    THIRD AMENDMENT  TO  LOAN AND SECURITY AGREEMENT    This Third Amendment to Loan and Security Agreement (this &#8220;Amendment&#8221;) is entered into this  24th day of May, 2022, by and between SILICON VALLEY BANK (&#8220;Bank&#8221;) and CUTERA, INC., a  Delaware corporation (&#8220;Borrower&#8221;) whose address is 3240 Bayshore Boulevard, Brisbane, California  94005.  RECITALS  A. Bank and Borrower have entered into that certain Loan and Security Agreement dated as  of July 9, 2020, as amended by that certain First Amendment to Loan and Security Agreement between  Borrower and Bank dated as of March 4, 2021, and as further amended by that certain Second Amendment  to Loan and Security Agreement dated as of May 27, 2021 by and between Bank and Borrower (as may be  further amended, modified, supplemented or restated, the &#8220;Loan Agreement&#8221;).    B. Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.    C. Borrower has requested that Bank amend the Loan Agreement to make certain revisions to  the Loan Agreement as more fully set forth herein.  D. Bank has agreed to so amend certain provisions of the Loan Agreement, but only to the  extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and  warranties set forth below.  AGREEMENT   NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable  consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally  bound, the parties hereto agree as follows:  1. Definitions.  Capitalized terms used but not defined in this Amendment shall have the  meanings given to them in the Loan Agreement.  2. Amendments to Loan Agreement.  2.1 Section 7.9(b) (Permitted Convertible Indebtedness).  Section 7.9(b) is hereby  deleted in its entirety and replaced with the following:  &#8220; (b) Permitted Convertible Indebtedness. Make any payment or prepayment of  principal of, premium, if any, or interest on, or redemption, purchase, retirement, defeasance  (including in-substance or legal defeasance), sinking fund, settlement, conversion, or similar  payment with respect to, any Permitted Convertible Indebtedness, except that Borrower (i)  may repurchase and/or exchange any 2021 Convertible Indebtedness for cash, shares of the  Borrower&#8217;s capital stock or any combination of cash and shares, as applicable, provided that  the aggregate amount of cash used in such repurchases and/or exchanges of the 2021  Convertible Indebtedness shall not exceed the net proceeds the Borrower receives from the  offering of the 2022 Convertible Indebtedness and (ii) may make any required payments of  cash or deliveries in shares of common stock of Borrower or any combination thereof (or  other securities or property following a merger event, reclassification or other change of the  common stock) (and cash in lieu of fractional shares) pursuant to the terms of, and otherwise  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xexx1027thi002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">perform its obligations under, any Permitted Convertible Indebtedness (including, without  limitation, making payments of interest and principal thereon, making payments due upon  required repurchase or redemption thereof and/or making payments and deliveries upon  conversion thereof) (provided that, for the sake of clarity, &#8220;required payments or deliveries&#8221;  shall not include a redemption of the Permitted Convertible Indebtedness by Borrower at  Borrower&#8217;s option, so long as both (i) the aggregate amount of cash payable upon  conversion or payment of any Permitted Convertible Indebtedness (excluding any required  payment of interest with respect to such Permitted Convertible Indebtedness and excluding  any payment of cash in lieu of a fractional share due upon conversion thereof) does not  exceed the aggregate principal amount thereof and (ii) such conversion or payment does not  require any net payment of cash by Borrower pursuant to an exercise or early unwind or  settlement of a corresponding portion of the Permitted Bond Hedge Transactions relating to  such Permitted Convertible Indebtedness).&#8221;    2.2 Section 13 (Definitions).  The definition of &#8220;Permitted Convertible Indebtedness&#8221;  is deleted in its entirety and replaced with the following:   &#8220; &#8220;Permitted Convertible Indebtedness&#8221; means (i) Indebtedness issued under that  certain Indenture, dated as of March 9, 2021, between Borrower and U.S. Bank, National  Association, as trustee (the &#8220;2021 Convertible Indebtedness&#8221;), and (ii) unsecured  Indebtedness of Borrower, issued on or prior to June 30, 2022, in an aggregate principal  amount of not more than Two Hundred Thirty Million Dollars ($230,000,000) (the &#8220;2022  Convertible Indebtedness&#8221;) that (a) as of the date of issuance thereof contains terms,  conditions, covenants, conversion or exchange rights and offer to repurchase rights, in each  case, as are typical and customary for notes of such type (in each case, as determined by  Borrower in good faith) and (b) is convertible or exchangeable into shares of common stock  of Borrower (or other securities or property following a merger event, reclassification or  other change of the common stock of Borrower), cash or a combination thereof, and cash  in lieu of fractional shares of common stock of Borrower; provided, that (i) such Permitted  Convertible Indebtedness shall have a stated final maturity no earlier than one hundred  eighty (180) days after the Revolving Line Maturity Date and shall not be subject to any  conditions that could result in such state final maturity occurring on a date earlier than one  hundred eighty (180) days after the Revolving Line Maturity Date (it being understood that  (x) any conversion of such notes, whether into cash, shares of common stock or any  combination thereof (or other securities or property following a merger event,  reclassification or other change of the common stock of Borrower), (y) a repurchase of  such notes on account of the occurrence of a &#8220;fundamental change&#8221; or (z) any redemption  of such notes at the option of Borrower, in each case, shall not be deemed to constitute a  change in the stated final maturity thereof), (ii) such notes shall not be callable prior to the  third anniversary of the issuance thereof, (iii) such notes shall not be required to be repaid,  prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates or upon  the occurrence of one or more events or at the option of any holder thereof prior to the date  that is one hundred eighty (180) days after the Revolving Line Maturity Date (except, in  each case, upon any conversion of such notes into shares of common stock of Borrower (or  other securities or property following a merger event, reclassification or other change of  the common stock of Borrower), cash or any combination thereof), the occurrence of an  event of default or a &#8220;fundamental change&#8221; or, following Borrower&#8217;s election to redeem  such notes (to the extent permissible under clause (ii) above), and (iv) no Person that is not  a Borrower or Guarantor shall have guarantee or primary obligations with respect to  obligations of Borrower thereunder.&#8221;    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xexx1027thi003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2.3 Section 13 (Definitions). The following new terms and their respective definitions  are inserted to appear alphabetically in Section 13.1 thereof:  &#8220; &#8220;2021 Convertible Indebtedness&#8221; is defined in the definition of &#8220;Permitted  Convertible Indebtedness&#8221;.    &#8220; &#8220;2022 Convertible Indebtedness&#8221; is defined in the definition of &#8220;Permitted  Convertible Indebtedness&#8221;.    3. Limitation of Amendments.  3.1 The amendments set forth in Section 2 above are effective for the purposes set  forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any  amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise  prejudice any right or remedy which Bank may now have or may have in the future under or in connection  with any Loan Document.  3.2 This Amendment shall be construed in connection with and as part of the Loan  Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the  Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full  force and effect.  4. Representations and Warranties.  To induce Bank to enter into this Amendment,  Borrower hereby represents and warrants to Bank as follows:  4.1 Immediately after giving effect to this Amendment (a) the representations and  warranties contained in the Loan Documents are true, accurate and complete in all material respects as of  the date hereof (except to the extent such representations and warranties relate to an earlier date, in which  case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;  4.2 Borrower has the power and authority to execute and deliver this Amendment and  to perform its obligations under the Loan Agreement, as amended by this Amendment;  4.3 The organizational documents of Borrower previously delivered to Bank remain  true, accurate and complete and have not been amended, supplemented or restated and are and continue to  be in full force and effect;  4.4 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly  authorized;   4.5 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will  not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction  with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental  or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational  documents of Borrower;   4.6 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require  any order, consent, approval, license, authorization or validation of, or filing, recording or registration with,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xexx1027thi004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower,  except as already has been obtained or made; and  4.7 This Amendment has been duly executed and delivered by Borrower and is the  binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such  enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other  similar laws of general application and equitable principles relating to or affecting creditors&#8217; rights.  5. Integration.  This Amendment and the Loan Documents represent the entire agreement  about this subject matter and supersede prior negotiations or agreements.  All prior agreements,  understandings, representations, warranties, and negotiations between the parties about the subject matter  of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.  6. Counterparts.  This Amendment may be executed in any number of counterparts and all  of such counterparts taken together shall be deemed to constitute one and the same instrument.  Delivery  of an executed counterpart by electronic transmission shall be equally effective as delivery of an original  executed counterparty.    7. Effectiveness.  This Amendment shall be deemed effective upon (a) the due execution and  delivery to Bank of this Amendment by each party hereto and (b) Borrower&#8217;s payment to Bank of Bank&#8217;s  legal fees and expenses incurred in connection with this Amendment.     [Signature page follows.]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xexx1027thi005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi005.jpg" title="slide5" width="992" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xexx1027thi006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xexx1027thi006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>4
<FILENAME>cutr-20221231xex1028four.htm
<DESCRIPTION>EX-10.28
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>cutr-20221231xex1028four</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- cutr-20221231xex1028four001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    WAIVER AND FOURTH AMENDMENT  TO  LOAN AND SECURITY AGREEMENT    This Waiver and Fourth Amendment to Loan and Security Agreement (this &#8220;Amendment&#8221;) is  entered into this 10th day of August, 2022, by and between SILICON VALLEY BANK (&#8220;Bank&#8221;) and  CUTERA, INC., a Delaware corporation (&#8220;Borrower&#8221;) whose address is 3240 Bayshore Boulevard,  Brisbane, California 94005.  RECITALS  A. Bank and Borrower have entered into that certain Loan and Security Agreement dated as  of July 9, 2020, as amended by that certain First Amendment to Loan and Security Agreement between  Borrower and Bank dated as of March 4, 2021, as further amended by that certain Second Amendment to  Loan and Security Agreement dated as of May 27, 2021 by and between Bank and Borrower, and as further  amended by that certain Third Amendment to Loan and Security Agreement, dated as of May 24, 2022 by  and between Bank and Borrower (as may be further amended, modified, supplemented or restated, the  &#8220;Loan Agreement&#8221;).    B. Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.    C. Borrower has requested that Bank amend the Loan Agreement to (i) waive the Stated  Default (as hereinafter defined) and (ii) make certain revisions to the Loan Agreement as more fully set  forth herein.  D. Bank has agreed to waive the Stated Default (as hereinafter defined) and so amend certain  provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the  conditions and in reliance upon the representations and warranties set forth below.  AGREEMENT   NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable  consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally  bound, the parties hereto agree as follows:  1. Definitions.  Capitalized terms used but not defined in this Amendment shall have the  meanings given to them in the Loan Agreement.  2. Amendments to Loan Agreement.    2.1 Section 13 (Definitions).  The definition of &#8220;Permitted Convertible Indebtedness&#8221;  is deleted in its entirety and replaced with the following:   &#8220; &#8220;Permitted Convertible Indebtedness&#8221; means (i) Indebtedness issued under that  certain Indenture, dated as of March 9, 2021, between Borrower and U.S. Bank, National  Association, as trustee (the &#8220;2021 Convertible Indebtedness&#8221;), and (ii) unsecured  Indebtedness of Borrower, issued on or prior to June 30, 2022, in an aggregate principal  amount of not more than Two Hundred Forty Million Dollars ($240,000,000) (the &#8220;2022  Convertible Indebtedness&#8221;) that (a) as of the date of issuance thereof contains terms,  conditions, covenants, conversion or exchange rights and offer to repurchase rights, in each  case, as are typical and customary for notes of such type (in each case, as determined by  DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xex1028four002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Borrower in good faith) and (b) is convertible or exchangeable into shares of common stock  of Borrower (or other securities or property following a merger event, reclassification or  other change of the common stock of Borrower), cash or a combination thereof, and cash  in lieu of fractional shares of common stock of Borrower; provided, that (i) such Permitted  Convertible Indebtedness shall have a stated final maturity no earlier than one hundred  eighty (180) days after the Revolving Line Maturity Date and shall not be subject to any  conditions that could result in such state final maturity occurring on a date earlier than one  hundred eighty (180) days after the Revolving Line Maturity Date (it being understood that  (x) any conversion of such notes, whether into cash, shares of common stock or any  combination thereof (or other securities or property following a merger event,  reclassification or other change of the common stock of Borrower), (y) a repurchase of  such notes on account of the occurrence of a &#8220;fundamental change&#8221; or (z) any redemption  of such notes at the option of Borrower, in each case, shall not be deemed to constitute a  change in the stated final maturity thereof), (ii) such notes shall not be callable prior to the  third anniversary of the issuance thereof, (iii) such notes shall not be required to be repaid,  prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates or upon  the occurrence of one or more events or at the option of any holder thereof prior to the date  that is one hundred eighty (180) days after the Revolving Line Maturity Date (except, in  each case, upon any conversion of such notes into shares of common stock of Borrower (or  other securities or property following a merger event, reclassification or other change of  the common stock of Borrower), cash or any combination thereof), the occurrence of an  event of default or a &#8220;fundamental change&#8221; or, following Borrower&#8217;s election to redeem  such notes (to the extent permissible under clause (ii) above), and (iv) no Person that is not  a Borrower or Guarantor shall have guarantee or primary obligations with respect to  obligations of Borrower thereunder.&#8221;    3. Limitation of Amendments.  3.1 The amendments set forth in Section 2 above are effective for the purposes set  forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any  amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise  prejudice any right or remedy which Bank may now have or may have in the future under or in connection  with any Loan Document.  3.2 This Amendment shall be construed in connection with and as part of the Loan  Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the  Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full  force and effect.  4. Representations and Warranties.  To induce Bank to enter into this Amendment,  Borrower hereby represents and warrants to Bank as follows:  4.1 Immediately after giving effect to this Amendment (a) the representations and  warranties contained in the Loan Documents are true, accurate and complete in all material respects as of  the date hereof (except to the extent such representations and warranties relate to an earlier date, in which  case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;  4.2 Borrower has the power and authority to execute and deliver this Amendment and  to perform its obligations under the Loan Agreement, as amended by this Amendment;  4.3 The organizational documents of Borrower previously delivered to Bank remain  DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xex1028four003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">true, accurate and complete and have not been amended, supplemented or restated and are and continue to  be in full force and effect;  4.4 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly  authorized;   4.5 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will  not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual restriction  with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental  or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational  documents of Borrower;   4.6 The execution and delivery by Borrower of this Amendment and the performance  by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require  any order, consent, approval, license, authorization or validation of, or filing, recording or registration with,  or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower,  except as already has been obtained or made; and  4.7 This Amendment has been duly executed and delivered by Borrower and is the  binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such  enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other  similar laws of general application and equitable principles relating to or affecting creditors&#8217; rights.  5. Waiver. Bank hereby waives Borrower&#8217;s existing default under the Loan Agreement  arising as a result of Borrower&#8217;s issuance of an additional note in excess of the 2022 Convertible  Indebtedness in violation of Section 7.4 of the Loan Agreement (in effect prior to this Amendment) (the  &#8220;Stated Default&#8221;). Bank&#8217;s waiver of the Stated Default is a one-time waiver that shall apply only to the  Stated Default.  Borrower hereby acknowledges and agrees that except as specifically provided herein,  nothing in this Section or anywhere in this Amendment shall be deemed or otherwise construed as a waiver  by Bank of any of its rights and remedies pursuant to the Loan Documents, applicable law or otherwise.  6. Release by Borrower:  A.            FOR GOOD AND VALUABLE CONSIDERATION, Borrower hereby forever  relieves, releases, and discharges Bank and its present or former employees, officers, directors,  agents, representatives, attorneys, and each of them, from any and all claims, debts, liabilities,  demands, obligations, promises, acts, agreements, costs and expenses, actions and causes of action,  of every type, kind, nature, description or character whatsoever, whether known or unknown,  suspected or unsuspected, absolute or contingent, arising out of or in any manner whatsoever  connected with or related to facts, circumstances, issues, controversies or claims existing or arising  from the beginning of time through and including the date of execution of this Amendment  (collectively &#8220;Released Claims&#8221;).  Without limiting the foregoing, the Released Claims shall  include any and all liabilities or claims arising out of or in any manner whatsoever connected with  or related to the Loan Documents, the recitals hereto, any instruments, agreements or documents  executed in connection with any of the foregoing or the origination, negotiation, administration,  servicing and/or enforcement of any of the foregoing.  B.            In furtherance of this release, Borrower expressly acknowledges and waives any  and all rights under Section 1542 of the California Civil Code, which provides as follows:  DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xex1028four004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">&#8220;A general release does not extend to claims that the creditor or releasing party  does not know or suspect to exist in his or her favor at the time of executing the release and  that, if known by him or her, would have materially affected his or her settlement with the  debtor or released party.&#8221; (Emphasis added.)                               C.            By entering into this release, Borrower recognizes that no facts or representations  are ever absolutely certain and it may hereafter discover facts in addition to or different from those  which it presently knows or believes to be true, but that it is the intention of Borrower hereby to  fully, finally and forever settle and release all matters, disputes and differences, known or unknown,  suspected or unsuspected; accordingly, if Borrower should subsequently discover that any fact that  it relied upon in entering into this release was untrue, or that any understanding of the facts was  incorrect, Borrower shall not be entitled to set aside this release by reason thereof, regardless of  any claim of mistake of fact or law or any other circumstances whatsoever.  Borrower  acknowledges that it is not relying upon and has not relied upon any representation or statement  made by Bank with respect to the facts underlying this release or with regard to any of such party&#8217;s  rights or asserted rights.  D.            This release may be pleaded as a full and complete defense and/or as a cross- complaint or counterclaim against any action, suit, or other proceeding that may be instituted,  prosecuted or attempted in breach of this release.  Borrower acknowledges that the release  contained herein constitutes a material inducement to Bank to enter into this Amendment, and that  Bank would not have done so but for Bank&#8217;s expectation that such release is valid and enforceable  in all events.  E.            Borrower hereby represents and warrants to Bank, and Bank is relying thereon,  as follows:  1           Except as expressly stated in this Amendment, neither Bank nor any agent,  employee or representative of Bank has made any statement or representation to Borrower  regarding any fact relied upon by Borrower in entering into this Amendment.  2            Borrower has made such investigation of the facts pertaining to this  Amendment and all of the matters appertaining thereto, as it deems necessary.  3           The terms of this Amendment are contractual and not a mere recital.   4           This Amendment has been carefully read by Borrower, the contents hereof  are known and understood by Borrower, and this Amendment is signed freely, and without  duress, by Borrower.   5           Borrower represents and warrants that it is the sole and lawful owner of  all right, title and interest in and to every claim and every other matter which it releases  herein, and that it has not heretofore assigned or transferred, or purported to assign or  transfer, to any person, firm or entity any claims or other matters herein released.  Borrower  shall indemnify Bank, defend and hold it harmless from and against all claims based upon  or arising in connection with prior assignments or purported assignments or transfers of  any claims or matters released herein.  7. Integration.  This Amendment and the Loan Documents represent the entire agreement  about this subject matter and supersede prior negotiations or agreements.  All prior agreements,  understandings, representations, warranties, and negotiations between the parties about the subject matter  DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xex1028four005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.  8. Counterparts.  This Amendment may be executed in any number of counterparts and all  of such counterparts taken together shall be deemed to constitute one and the same instrument.  Delivery  of an executed counterpart by electronic transmission shall be equally effective as delivery of an original  executed counterparty.    9. Effectiveness.  This Amendment shall be deemed effective upon (a) the due execution and  delivery to Bank of this Amendment by each party hereto and (b) Borrower&#8217;s payment to Bank of Bank&#8217;s  legal fees and expenses incurred in connection with this Amendment.     [Signature page follows.]  DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cutr-20221231xex1028four006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cutr-20221231xex1028four006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and  delivered as of the date first written above.        BANK BORROWER    SILICON VALLEY BANK      By:    Name: Mark Davis  Title: Vice President    CUTERA, INC.      By:    Name: Rohan Seth  Title: Chief Financial Officer            DocuSign Envelope ID: 80563AF6-70EB-41F8-8401-CC92632B1C7B </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>cutr-20221231xex211listofs.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib98837e494014790abe55278f9e6d2e1_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:125%">Exhibit 21.1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:125%">Subsidiaries of Cutera, Inc. (DE)</font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">&#160;&#160;&#160;&#160;Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">State or Country of Incorporation or Organization</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Australia Party Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Australia</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera SPRL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Belgium</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Canada, Inc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Canada</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;England &#38; Wales</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Importing Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;England &#38; Wales</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera France SarL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;France</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Germany GmbH&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Germany</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera HK Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Hong Kong</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Japan K.K.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Japan</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Spain S.L.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Spain</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cutera Switzerland GmbH&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Switzerland</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>cutr-20221231xexx2311.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i14659f1dc6a5485ea88c21d29f6547b6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div><div style="margin-bottom:0.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cutera, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brisbane, California</font></div><div style="margin-bottom:0.04pt;padding-left:0.45pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237552) and Forms S-8 (Nos. 333-114149, 333-123495, 333-132583, 333-141376, 333-149703, 333-158160, 333-187502, 333-206864, 333-221542, and 333-258283) of Cutera, Inc. of our reports dated  April&#160;7, 2023, relating to the consolidated financial statements, and the effectiveness of Cutera, Inc.&#8217;s internal control over financial reporting, which appear in this Form 10-K. Our report on the effectiveness of internal control over financial reporting expresses an adverse opinion on the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2022.</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BDO USA, LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco, California</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;7, 2023</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>7
<FILENAME>cutr-20221231xexx3131.htm
<DESCRIPTION>EX-31.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6447a1c81d3a4f29b65c3db4f074a88c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.3</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 15 U.S.C. SECTION 7241, AS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David H. Mowry, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this annual report on Form 10-K of Cutera, Inc.&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under the Company&#8217;s supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to the Company by others within those entities, particularly during the period in which this annual report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company&#8217;s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report the Company&#8217;s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on the Company&#8217;s most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 7, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; DAVID H. MOWRY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>8
<FILENAME>cutr-20221231xexx3141.htm
<DESCRIPTION>EX-31.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6f2f986627ee4fdb9f2f7c1859e56462_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.4</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 15 U.S.C. SECTION 7241, AS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Rohan Seth, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this annual report on Form 10-K of Cutera, Inc.&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under the Company&#8217;s supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to the Company by others within those entities, particularly during the period in which this annual report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company&#8217;s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report the Company&#8217;s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on the Company&#8217;s most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 7, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; ROHAN SETH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer (Principal Financial and<br>Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>cutr-20221231xexx3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i62cc3afd7a1a457499622821cb5b5c29_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report on Form 10-K of Cutera, Inc. a Delaware corporation, for the period ended December&#160;31, 2022, as filed with the Securities and Exchange Commission, each of the undersigned officers of Cutera, Inc. certifies pursuant to section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his respective knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">the annual report of Cutera, Inc. on Form 10-K for the period ended December&#160;31, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="padding-left:90pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">the information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of Cutera, Inc. for the periods presented therein.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 7, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; DAVID H. MOWRY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 7, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; ROHAN SETH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer (Principal Financial and<br>Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>cutr-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cutr="http://cutera.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cutera.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://cutera.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://cutera.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://cutera.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>0000007 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsMarketableSecuritiesandRestrictedCash" roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash">
        <link:definition>0000011 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://cutera.com/role/FairValueofFinancialInstruments">
        <link:definition>0000012 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://cutera.com/role/DerivativeInstruments">
        <link:definition>0000013 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetail" roleURI="http://cutera.com/role/BalanceSheetDetail">
        <link:definition>0000014 - Disclosure - Balance Sheet Detail</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranty" roleURI="http://cutera.com/role/ProductWarranty">
        <link:definition>0000015 - Disclosure - Product Warranty</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenue" roleURI="http://cutera.com/role/DeferredRevenue">
        <link:definition>0000016 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpense" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense">
        <link:definition>0000017 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://cutera.com/role/IncomeTaxes">
        <link:definition>0000018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://cutera.com/role/NetIncomeLossPerShare">
        <link:definition>0000019 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlan" roleURI="http://cutera.com/role/DefinedContributionPlan">
        <link:definition>0000020 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProducts" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts">
        <link:definition>0000021 - Disclosure - Segment Information and Revenue by Geography and Products</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://cutera.com/role/CommitmentsandContingencies">
        <link:definition>0000022 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://cutera.com/role/Debt">
        <link:definition>0000023 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://cutera.com/role/SubsequentEvents">
        <link:definition>0000024 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccounts" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts">
        <link:definition>0000025 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000026 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables" roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables">
        <link:definition>0000028 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>0000029 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://cutera.com/role/DerivativeInstrumentsTables">
        <link:definition>0000030 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailTables" roleURI="http://cutera.com/role/BalanceSheetDetailTables">
        <link:definition>0000031 - Disclosure - Balance Sheet Detail (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantyTables" roleURI="http://cutera.com/role/ProductWarrantyTables">
        <link:definition>0000032 - Disclosure - Product Warranty (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueTables" roleURI="http://cutera.com/role/DeferredRevenueTables">
        <link:definition>0000033 - Disclosure - Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables">
        <link:definition>0000034 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://cutera.com/role/IncomeTaxesTables">
        <link:definition>0000035 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://cutera.com/role/NetIncomeLossPerShareTables">
        <link:definition>0000036 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsTables" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables">
        <link:definition>0000037 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://cutera.com/role/CommitmentsandContingenciesTables">
        <link:definition>0000038 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://cutera.com/role/DebtTables">
        <link:definition>0000039 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsTables" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables">
        <link:definition>0000040 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000041 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>0000042 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails">
        <link:definition>0000043 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails" roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails">
        <link:definition>0000044 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsDetails" roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsDetails">
        <link:definition>0000045 - Disclosure - Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsDetails" roleURI="http://cutera.com/role/DerivativeInstrumentsDetails">
        <link:definition>0000046 - Disclosure - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailNarrativeDetails" roleURI="http://cutera.com/role/BalanceSheetDetailNarrativeDetails">
        <link:definition>0000047 - Disclosure - Balance Sheet Detail - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailInventoriesDetails" roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails">
        <link:definition>0000048 - Disclosure - Balance Sheet Detail - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails" roleURI="http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails">
        <link:definition>0000049 - Disclosure - Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailPropertyandEquipmentNetDetails" roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails">
        <link:definition>0000050 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailAccruedLiabilitiesDetails" roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails">
        <link:definition>0000051 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantySummaryofWarrantiesDetails" roleURI="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails">
        <link:definition>0000052 - Disclosure - Product Warranty - Summary of Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails" roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails">
        <link:definition>0000053 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails_1" roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1">
        <link:definition>0000053 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" roleURI="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails">
        <link:definition>0000054 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails">
        <link:definition>0000055 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails">
        <link:definition>0000056 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails">
        <link:definition>0000057 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails">
        <link:definition>0000058 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails">
        <link:definition>0000059 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails">
        <link:definition>0000060 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails">
        <link:definition>0000061 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails">
        <link:definition>0000062 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>0000063 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsDetails" roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails">
        <link:definition>0000064 - Disclosure - Income Taxes - Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveTaxRateDetails" roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails">
        <link:definition>0000065 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000066 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>0000067 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNarrativeDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails">
        <link:definition>0000068 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNetLossPerShareDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails">
        <link:definition>0000069 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
        <link:definition>0000070 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlanNarrativeDetails" roleURI="http://cutera.com/role/DefinedContributionPlanNarrativeDetails">
        <link:definition>0000071 - Disclosure - Defined Contribution Plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails">
        <link:definition>0000072 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails">
        <link:definition>0000073 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails">
        <link:definition>0000074 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>0000075 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFinancialStatementInformationDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails">
        <link:definition>0000076 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>0000077 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>0000077 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails">
        <link:definition>0000078 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1">
        <link:definition>0000078 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseInformationDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails">
        <link:definition>0000079 - Disclosure - Commitments and Contingencies - Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOperatingLeaseIncomeDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails">
        <link:definition>0000080 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails">
        <link:definition>0000081 - Disclosure - Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtOutstandingDebtandCarryingValueDetails" roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails">
        <link:definition>0000082 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://cutera.com/role/DebtNarrativeDetails">
        <link:definition>0000083 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtComponentsoftheLossonDebtExtinguishmentDetails" roleURI="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails">
        <link:definition>0000084 - Disclosure - Debt - Components of the Loss on Debt Extinguishment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://cutera.com/role/SubsequentEventsDetails">
        <link:definition>0000085 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails">
        <link:definition>0000086 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cutr_ExercisePriceRange3Member" abstract="true" name="ExercisePriceRange3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AsiaExcludingJapanMember" abstract="true" name="AsiaExcludingJapanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsNewHireMember" abstract="true" name="RestrictedStockUnitsNewHireMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_NumberOfConsecutiveLeaseTerms" abstract="false" name="NumberOfConsecutiveLeaseTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" abstract="false" name="ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" abstract="false" name="ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtCovenantQuarterlyMinimumRevenue" abstract="false" name="DebtCovenantQuarterlyMinimumRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" abstract="false" name="NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_SystemsMember" abstract="true" name="SystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" abstract="true" name="TheAmendedAndRestated2019EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LargestSupplierMember" abstract="true" name="LargestSupplierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdTradingDays" abstract="false" name="DebtInstrumentRedeemableThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_ExercisePriceRange4Member" abstract="true" name="ExercisePriceRange4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AviClearOperatingLeaseRecurringRevenueMember" abstract="true" name="AviClearOperatingLeaseRecurringRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_PurchaseOfCappedCall" abstract="false" name="PurchaseOfCappedCall" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_CashSweepInvestmentFundsMember" abstract="true" name="CashSweepInvestmentFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" abstract="false" name="DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_PaycheckProtectionProgramCARESActMember" abstract="true" name="PaycheckProtectionProgramCARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2028Member" abstract="true" name="ConvertibleSeniorNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LoyaltyMember" abstract="true" name="LoyaltyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AccruedInventoryInTransitCurrent" abstract="false" name="AccruedInventoryInTransitCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_StockPlanMember" abstract="true" name="StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LesseeLeaseRenewalTerm" abstract="false" name="LesseeLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" abstract="false" name="ShareBasedPaymentAwardPeriodToDetermineGrantAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026Member" abstract="true" name="ConvertibleSeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" abstract="true" name="USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_SkincareMember" abstract="true" name="SkincareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionOneTerm" abstract="false" name="ExtendedServiceContractOptionOneTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_VoceCapitalManagementLLCMember" abstract="true" name="VoceCapitalManagementLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" abstract="false" name="AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_PercentageOfAssets" abstract="false" name="PercentageOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ESPPMember" abstract="true" name="ESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ExercisePriceRange10Member" abstract="true" name="ExercisePriceRange10Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTextBlock" abstract="false" name="ContractWithCustomerLiabilityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_StandardProductWarrantyTermDirectSales" abstract="false" name="StandardProductWarrantyTermDirectSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionThreeTerm" abstract="false" name="ExtendedServiceContractOptionThreeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_LeasedEquipmentMember" abstract="true" name="LeasedEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" abstract="false" name="ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2029Member" abstract="true" name="ConvertibleSeniorNotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AdditionalSharesReservedSharesAvailableForGrant" abstract="false" name="AdditionalSharesReservedSharesAvailableForGrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" abstract="false" name="DebtInstrumentAdditionalAggregatePrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_CapitalStockSharesAuthorized" abstract="false" name="CapitalStockSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" abstract="true" name="RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_PaymentsOfDerivativeIssuanceCostsGross" abstract="false" name="PaymentsOfDerivativeIssuanceCostsGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtConversionNetProceeds" abstract="false" name="DebtConversionNetProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" abstract="false" name="DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" abstract="false" name="DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_StandardProductWarrantyTermDistributorSales" abstract="false" name="StandardProductWarrantyTermDistributorSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ExercisePriceRange1Member" abstract="true" name="ExercisePriceRange1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ERPImplementation" abstract="false" name="ERPImplementation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_AccruedCappedCallCosts" abstract="false" name="AccruedCappedCallCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_CapitalizedCloudComputingSetupCostMember" abstract="true" name="CapitalizedCloudComputingSetupCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LegalFeesSeveranceAndOther" abstract="false" name="LegalFeesSeveranceAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_LesseeLeasesTextBlock" abstract="false" name="LesseeLeasesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_CostsForExtendedServiceContracts" abstract="false" name="CostsForExtendedServiceContracts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExtendedServiceContractTerm" abstract="false" name="ExtendedServiceContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_LessorDurationOfAutorenewalFeatures" abstract="false" name="LessorDurationOfAutorenewalFeatures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" abstract="false" name="DepreciationAndAmortizationExcludingContractAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_StockPurchasePlanMember" abstract="true" name="StockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_CappedCallSecuritiesMember" abstract="true" name="CappedCallSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_CuteraCoreMember" abstract="true" name="CuteraCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" abstract="false" name="ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_UnderwrittenPublicOfferingMember" abstract="true" name="UnderwrittenPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LoanAndSecurityAgreementMember" abstract="true" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" abstract="false" name="InterestExpenseAndAmortizationOfDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_TwoThousandFourEquityIncentivePlanMember" abstract="true" name="TwoThousandFourEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtConversionConvertedInstrumentCashIssued" abstract="false" name="DebtConversionConvertedInstrumentCashIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtInstrumentAnniversaryFeeAmount" abstract="false" name="DebtInstrumentAnniversaryFeeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" abstract="false" name="DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ExercisePriceRange6Member" abstract="true" name="ExercisePriceRange6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_TwoThousandNineteenEquityIncentivePlanMember" abstract="true" name="TwoThousandNineteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AviClearMember" abstract="true" name="AviClearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" abstract="false" name="DebtInstrumentRedeemableThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_OperatingLossCarryforwardsWithoutExpiration" abstract="false" name="OperatingLossCarryforwardsWithoutExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExercisePriceRange2Member" abstract="true" name="ExercisePriceRange2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" abstract="false" name="DebtInstrumentPercentageOfQualifyingAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_SalesAndMarketingAccrualsCurrent" abstract="false" name="SalesAndMarketingAccrualsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" abstract="false" name="EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" abstract="false" name="DerivativeCappedCallTransactionTermConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_UnderwriterMember" abstract="true" name="UnderwriterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" abstract="false" name="ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtConversionPercentageOfDebtConverted" abstract="false" name="DebtConversionPercentageOfDebtConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_DerivativeCapPricePremiumOverStockPricePercent" abstract="false" name="DerivativeCapPricePremiumOverStockPricePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ExercisePriceRange8Member" abstract="true" name="ExercisePriceRange8Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LesseeLeasesRemainingTerm" abstract="false" name="LesseeLeasesRemainingTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_EquipmentAndFurnitureMember" abstract="true" name="EquipmentAndFurnitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange5Member" abstract="true" name="ExercisePriceRange5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LeasesFinancialStatementInformationTableTextBlock" abstract="false" name="LeasesFinancialStatementInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" abstract="true" name="AviClearOperatingLeaseLicenseFeeRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" abstract="false" name="DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_SiliconValleyBankMember" abstract="true" name="SiliconValleyBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AviClearDevicesMember" abstract="true" name="AviClearDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LeaseInstallmentCostsMember" abstract="true" name="LeaseInstallmentCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DemonstrationUnitsAmortizationPeriod" abstract="false" name="DemonstrationUnitsAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" abstract="false" name="ChangeInRightofuseAssetAndLiabilityDueToModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_TotalProductsMember" abstract="true" name="TotalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AviClearDeviceMember" abstract="true" name="AviClearDeviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" abstract="false" name="DebtConversionUnamortizedDebtIssuanceCostsConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExercisePriceRange7Member" abstract="true" name="ExercisePriceRange7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" abstract="false" name="DebtInstrumentRedemptionIncrementalRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExercisePriceRange9Member" abstract="true" name="ExercisePriceRange9Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AviClearRevenueMember" abstract="true" name="AviClearRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsAnnualGrantMember" abstract="true" name="RestrictedStockUnitsAnnualGrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>cutr-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84c66ea6-78ee-4d7f-bb4d-48c6fcff747f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_96c74b95-4926-4c21-994c-03ddb3efe2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84c66ea6-78ee-4d7f-bb4d-48c6fcff747f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_96c74b95-4926-4c21-994c-03ddb3efe2a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_966ffe21-f0de-4bd6-bb0f-3b5de9c62e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84c66ea6-78ee-4d7f-bb4d-48c6fcff747f" xlink:to="loc_us-gaap_CommonStockValue_966ffe21-f0de-4bd6-bb0f-3b5de9c62e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e6144154-07af-473f-9677-d396c75fc799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84c66ea6-78ee-4d7f-bb4d-48c6fcff747f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e6144154-07af-473f-9677-d396c75fc799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aee88f17-0f91-4753-9536-af4aaac71990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84c66ea6-78ee-4d7f-bb4d-48c6fcff747f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aee88f17-0f91-4753-9536-af4aaac71990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_ce9ad092-f69c-46cf-946d-fbeac5eda8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_ce9ad092-f69c-46cf-946d-fbeac5eda8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_9ca3d052-c4dc-4ac4-b2a4-049c879ad890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_9ca3d052-c4dc-4ac4-b2a4-049c879ad890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_50153ae5-5436-468a-a4b6-257993bda334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_50153ae5-5436-468a-a4b6-257993bda334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a8e99fe7-8ced-4cea-a998-a90af5dfa46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:to="loc_us-gaap_LiabilitiesCurrent_a8e99fe7-8ced-4cea-a998-a90af5dfa46a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9ba7c761-8d30-499b-9386-73b4bc0929b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_db1401c7-e764-4e2b-82c3-0832b8496bd1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9ba7c761-8d30-499b-9386-73b4bc0929b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1f6553c3-5840-46d7-a8ab-96a1d7c11873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1f6553c3-5840-46d7-a8ab-96a1d7c11873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dea8b535-0301-4aec-acc9-2767d38f8abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dea8b535-0301-4aec-acc9-2767d38f8abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e075238c-8673-40ac-819f-68aa35c54bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e075238c-8673-40ac-819f-68aa35c54bbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_667697ff-9f16-42d6-9614-660e03613a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_667697ff-9f16-42d6-9614-660e03613a91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_685cb111-6816-4381-9198-a8b3e9483190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_InventoryNet_685cb111-6816-4381-9198-a8b3e9483190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_daed300f-eeea-420f-9438-d1d0929769ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_560831e2-2c43-4ef2-a0b3-5586da73b729" xlink:to="loc_us-gaap_RestrictedCashCurrent_daed300f-eeea-420f-9438-d1d0929769ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_63641ebe-8f5f-418d-a393-4a33bd221ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8f0e412c-f08d-48cf-abeb-bf635795399e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63641ebe-8f5f-418d-a393-4a33bd221ff9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8f0e412c-f08d-48cf-abeb-bf635795399e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_18fd9d1d-d21c-40e8-beb9-c56c90e218ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63641ebe-8f5f-418d-a393-4a33bd221ff9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_18fd9d1d-d21c-40e8-beb9-c56c90e218ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_2966864f-de7f-43b3-a67b-39e8ba56b3cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63641ebe-8f5f-418d-a393-4a33bd221ff9" xlink:to="loc_us-gaap_DeferredRevenueCurrent_2966864f-de7f-43b3-a67b-39e8ba56b3cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5efba99f-327f-43b2-aca2-501b42119080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_63641ebe-8f5f-418d-a393-4a33bd221ff9" xlink:to="loc_us-gaap_AccountsPayableCurrent_5efba99f-327f-43b2-aca2-501b42119080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_23eb384b-ecce-49f2-b80a-0496349bbd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_23eb384b-ecce-49f2-b80a-0496349bbd3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6c379aae-640d-4b75-a4a5-4ac5749a559d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6c379aae-640d-4b75-a4a5-4ac5749a559d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2ad0c108-5ecb-4c83-b9fa-d7e9bdbad8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2ad0c108-5ecb-4c83-b9fa-d7e9bdbad8ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_189964f9-1eab-4da5-9cbf-c5b782661e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_AssetsCurrent_189964f9-1eab-4da5-9cbf-c5b782661e07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8c7dc799-197e-48c2-b57e-e58facf5600c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8c7dc799-197e-48c2-b57e-e58facf5600c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_42207b2d-fe30-481b-b2fd-e1540e6228b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_Goodwill_42207b2d-fe30-481b-b2fd-e1540e6228b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c85a3fb2-94d0-4048-b1f5-8dd9b600eba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_331562d0-2f34-45e1-ad23-09bbfbe2fb61" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c85a3fb2-94d0-4048-b1f5-8dd9b600eba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_51dbbc12-745e-496e-9682-f0ddf244b6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0c997740-20b8-4bcc-8de0-4644d94a2dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_51dbbc12-745e-496e-9682-f0ddf244b6d2" xlink:to="loc_us-gaap_StockholdersEquity_0c997740-20b8-4bcc-8de0-4644d94a2dc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_19dd20d1-4712-45f1-a918-f7eefb4f4776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_51dbbc12-745e-496e-9682-f0ddf244b6d2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_19dd20d1-4712-45f1-a918-f7eefb4f4776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0eb95972-79fb-4a53-8ee0-802b6f194a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_51dbbc12-745e-496e-9682-f0ddf244b6d2" xlink:to="loc_us-gaap_Liabilities_0eb95972-79fb-4a53-8ee0-802b6f194a7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f77d89f2-bb4e-42fc-9893-8da56878b7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_33b2d872-91bb-40ca-9469-383c5f354b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f77d89f2-bb4e-42fc-9893-8da56878b7c8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_33b2d872-91bb-40ca-9469-383c5f354b39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f384d14c-9d14-473c-b73b-cf4808688c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f77d89f2-bb4e-42fc-9893-8da56878b7c8" xlink:to="loc_us-gaap_OperatingIncomeLoss_f384d14c-9d14-473c-b73b-cf4808688c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d45fcdb2-5269-46f3-830f-bb42b8ba057b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0854e54a-069d-4e59-848a-1ef03cbd6f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d45fcdb2-5269-46f3-830f-bb42b8ba057b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0854e54a-069d-4e59-848a-1ef03cbd6f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ab7e9264-9839-4924-a5fa-d18373d5bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d45fcdb2-5269-46f3-830f-bb42b8ba057b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ab7e9264-9839-4924-a5fa-d18373d5bbdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_63713cae-851a-4a61-b8ce-9db0fc8972aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9bac1029-f23d-478b-81f4-a14b10348df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63713cae-851a-4a61-b8ce-9db0fc8972aa" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9bac1029-f23d-478b-81f4-a14b10348df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_438b7141-7580-45f0-9394-ef91815fac16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63713cae-851a-4a61-b8ce-9db0fc8972aa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_438b7141-7580-45f0-9394-ef91815fac16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_e5bcae45-217b-4c5d-81ea-af80a7550e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63713cae-851a-4a61-b8ce-9db0fc8972aa" xlink:to="loc_us-gaap_SellingAndMarketingExpense_e5bcae45-217b-4c5d-81ea-af80a7550e67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d57dcd1c-02e6-4f79-ad99-940df389436a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_eaa36d3d-f69e-4eae-9479-90cb8d4d6657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d57dcd1c-02e6-4f79-ad99-940df389436a" xlink:to="loc_us-gaap_GrossProfit_eaa36d3d-f69e-4eae-9479-90cb8d4d6657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e842a779-f403-466b-a50f-80815bd401bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d57dcd1c-02e6-4f79-ad99-940df389436a" xlink:to="loc_us-gaap_OperatingExpenses_e842a779-f403-466b-a50f-80815bd401bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bfea023b-ce7b-4628-8a91-a6f715346d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bfea023b-ce7b-4628-8a91-a6f715346d86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8fba85bf-c658-416b-9b32-90cb524b4e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:to="loc_us-gaap_InterestExpenseDebt_8fba85bf-c658-416b-9b32-90cb524b4e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_9d4d4790-77df-453b-91c8-b0e9d1f95589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_9d4d4790-77df-453b-91c8-b0e9d1f95589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e3c00692-5ff0-48e0-9c72-915221f33b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e3c00692-5ff0-48e0-9c72-915221f33b90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c2955207-7604-4983-8c4c-f6ba5d599487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_cdb65521-80cf-4aaf-b8de-aa5956c412be" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c2955207-7604-4983-8c4c-f6ba5d599487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e26a22ba-ff86-47db-814f-64075d29bf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4fafbc49-798b-45e1-bbbd-6e93712d3255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e26a22ba-ff86-47db-814f-64075d29bf51" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4fafbc49-798b-45e1-bbbd-6e93712d3255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_045d3f0d-00a7-4b09-86e9-5c3505761088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e26a22ba-ff86-47db-814f-64075d29bf51" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_045d3f0d-00a7-4b09-86e9-5c3505761088" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c07bf7a-4bc7-42ea-9f27-77ede6b39678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f0e7139-67ea-4839-9639-2f7bf1b855d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c07bf7a-4bc7-42ea-9f27-77ede6b39678" xlink:to="loc_us-gaap_NetIncomeLoss_7f0e7139-67ea-4839-9639-2f7bf1b855d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_94aa728c-2d0a-474a-a00d-abcdeb4ee35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c07bf7a-4bc7-42ea-9f27-77ede6b39678" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_94aa728c-2d0a-474a-a00d-abcdeb4ee35d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fb0ee483-19e6-48d8-97d3-2f049d03a637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df2fcad4-60b1-411b-b645-fec8b76a358c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fb0ee483-19e6-48d8-97d3-2f049d03a637" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df2fcad4-60b1-411b-b645-fec8b76a358c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_0b538168-7def-45ff-a1d7-7df0372bea51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fb0ee483-19e6-48d8-97d3-2f049d03a637" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_0b538168-7def-45ff-a1d7-7df0372bea51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1af33d3c-7f59-4d13-9827-35bf7b690bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c737d625-011c-41c9-8d6f-851cd714ddbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1af33d3c-7f59-4d13-9827-35bf7b690bcb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_c737d625-011c-41c9-8d6f-851cd714ddbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5c11f0b2-1f64-4ce6-88ee-db0427f17c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5c11f0b2-1f64-4ce6-88ee-db0427f17c54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_c5581f29-4853-4a05-9dce-cba9443b5f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_c5581f29-4853-4a05-9dce-cba9443b5f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_80e168af-6737-4f03-9922-ed2e109e2684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_80e168af-6737-4f03-9922-ed2e109e2684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e64e871a-6c3a-4801-aceb-5e9aaf26db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e64e871a-6c3a-4801-aceb-5e9aaf26db4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1aaa34d3-1510-4a6f-85dc-b950f8995772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f63d2d3-d9e7-4dba-8336-515f41bd4725" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1aaa34d3-1510-4a6f-85dc-b950f8995772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1af9ccec-f731-411d-b8bc-beea4dc9fd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1af9ccec-f731-411d-b8bc-beea4dc9fd13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_d7d0f48d-c31f-4002-912d-8f608ea0155c" xlink:href="cutr-20221231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_d7d0f48d-c31f-4002-912d-8f608ea0155c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f329476a-b2a4-4221-811f-199d1a2cd951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f329476a-b2a4-4221-811f-199d1a2cd951" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_f8e08cc9-348c-40aa-89e5-c7cc3e4e11a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_f8e08cc9-348c-40aa-89e5-c7cc3e4e11a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_9529fc5f-e0e5-494d-b519-1f6d5925163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_9529fc5f-e0e5-494d-b519-1f6d5925163b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_85b51a7a-68ad-42ed-b16d-ac67acaa5086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_85b51a7a-68ad-42ed-b16d-ac67acaa5086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_0b51bb70-0c9b-4cf7-9442-f0fe31a360da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_0b51bb70-0c9b-4cf7-9442-f0fe31a360da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_a060d3eb-a422-42e8-8b94-289595db0045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_a060d3eb-a422-42e8-8b94-289595db0045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_14769a08-cf9a-42d4-b742-c7413464669f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_ShareBasedCompensation_14769a08-cf9a-42d4-b742-c7413464669f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f7c8bc04-4495-4b08-86f9-619ed99d62a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f7c8bc04-4495-4b08-86f9-619ed99d62a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9f54b1ee-b437-4dba-aaef-8b6b166cc8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9f54b1ee-b437-4dba-aaef-8b6b166cc8fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9c4af903-1da3-43e9-bab1-364506773cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_NetIncomeLoss_9c4af903-1da3-43e9-bab1-364506773cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_6a3f43e4-a2e9-4796-8a30-8196bdf03375" xlink:href="cutr-20221231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_6a3f43e4-a2e9-4796-8a30-8196bdf03375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_72ecbe2a-9d0b-487b-987c-a18e2f4b6b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_72ecbe2a-9d0b-487b-987c-a18e2f4b6b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_b3628c70-dc2b-4bd4-992f-c24633f7401c" xlink:href="cutr-20221231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_b3628c70-dc2b-4bd4-992f-c24633f7401c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1de22fe4-cb1c-4e01-a938-788337dfe78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1de22fe4-cb1c-4e01-a938-788337dfe78b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1127f14f-99a8-42e3-83c0-8797fcf6c3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1127f14f-99a8-42e3-83c0-8797fcf6c3e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_10827b5b-dcb8-4731-9190-0ab3f5fbe212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_10827b5b-dcb8-4731-9190-0ab3f5fbe212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_7fcc90d1-36a5-4810-9474-043104052f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_7fcc90d1-36a5-4810-9474-043104052f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3ab35e58-d04f-463e-94da-4536477f9494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3ab35e58-d04f-463e-94da-4536477f9494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_afb00438-6c72-4ae5-be88-c56c95edb95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_afb00438-6c72-4ae5-be88-c56c95edb95d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_688363bc-0e37-4279-8b78-1a24d7fad0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06297313-8913-4827-89c9-e3142c253313" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_688363bc-0e37-4279-8b78-1a24d7fad0c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_2aa8cddc-a54e-49de-835b-564faa3ade14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_2aa8cddc-a54e-49de-835b-564faa3ade14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_ee44ed97-4421-482c-a355-8c2578f201d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_ee44ed97-4421-482c-a355-8c2578f201d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0ccd3c46-1849-4920-ab7a-fa87b8d7436c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0ccd3c46-1849-4920-ab7a-fa87b8d7436c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ef7fbc5-5dee-408a-94d0-a0504b4082ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1ef7fbc5-5dee-408a-94d0-a0504b4082ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4a2613b8-8cd1-4ed2-b76a-a350d4e894c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4a2613b8-8cd1-4ed2-b76a-a350d4e894c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_9af8cdfe-563a-47f0-8369-0a0bc61080ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_9af8cdfe-563a-47f0-8369-0a0bc61080ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3893234d-ef64-46fe-8f90-da5e7e70e040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3893234d-ef64-46fe-8f90-da5e7e70e040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_28e23f92-fa52-46b1-ae2f-65621e9fb363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_28e23f92-fa52-46b1-ae2f-65621e9fb363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_376061e0-9d79-4665-8496-823a1bfd64fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_376061e0-9d79-4665-8496-823a1bfd64fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_aebad7d7-940e-46c9-9915-0971715e1de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_aebad7d7-940e-46c9-9915-0971715e1de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_bff31e22-e389-41b1-8b1c-b2cb29467b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ba6dc9e-0a3c-4a7b-805e-5cecb1b8f4e4" xlink:to="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_bff31e22-e389-41b1-8b1c-b2cb29467b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5cbddac6-5454-45c2-8790-0dc3960b2ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58b61951-69d2-45a5-9531-a6fa0ceafcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5cbddac6-5454-45c2-8790-0dc3960b2ce9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58b61951-69d2-45a5-9531-a6fa0ceafcdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3645d4f1-b176-495a-b2d8-38690e046a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5cbddac6-5454-45c2-8790-0dc3960b2ce9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3645d4f1-b176-495a-b2d8-38690e046a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c79a067e-8943-413a-89a9-8817fe5e7c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5cbddac6-5454-45c2-8790-0dc3960b2ce9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c79a067e-8943-413a-89a9-8817fe5e7c0b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91130320-aa41-4e76-a923-e650caf2e80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0582f6b-2ebc-4a54-9e5c-effbe344f79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91130320-aa41-4e76-a923-e650caf2e80f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d0582f6b-2ebc-4a54-9e5c-effbe344f79e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_90841332-56ee-4d2f-8d33-a045f3ef1f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91130320-aa41-4e76-a923-e650caf2e80f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_90841332-56ee-4d2f-8d33-a045f3ef1f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_a2807fe5-d80d-4ec9-8021-696dc3fde63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91130320-aa41-4e76-a923-e650caf2e80f" xlink:to="loc_us-gaap_RestrictedCashCurrent_a2807fe5-d80d-4ec9-8021-696dc3fde63d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_9adcad45-fef9-43b6-8dd3-1065b5300181" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_833d2767-5da1-4e0b-b24b-3307fd6faa94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_9adcad45-fef9-43b6-8dd3-1065b5300181" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_833d2767-5da1-4e0b-b24b-3307fd6faa94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d22cc05e-84c7-4910-99de-9920414746b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_9adcad45-fef9-43b6-8dd3-1065b5300181" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d22cc05e-84c7-4910-99de-9920414746b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_7165ebdf-fb70-4ed8-a629-63b8f5674a2b" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f02bb689-9ac2-4f91-b7ef-7475794e79a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_7165ebdf-fb70-4ed8-a629-63b8f5674a2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f02bb689-9ac2-4f91-b7ef-7475794e79a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_34fb29ba-3735-457f-95af-654bafd17cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_7165ebdf-fb70-4ed8-a629-63b8f5674a2b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_34fb29ba-3735-457f-95af-654bafd17cb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_f69fe874-9243-4861-853f-c8d796abf770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_bb8475b5-c8ec-4049-99d3-536ed857bb59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_f69fe874-9243-4861-853f-c8d796abf770" xlink:to="loc_us-gaap_DerivativeLiabilities_bb8475b5-c8ec-4049-99d3-536ed857bb59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c486782-c165-4769-8d04-3ab591955a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_f69fe874-9243-4861-853f-c8d796abf770" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c486782-c165-4769-8d04-3ab591955a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_382af3c3-7110-4830-84d3-806f63666484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_f69fe874-9243-4861-853f-c8d796abf770" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_382af3c3-7110-4830-84d3-806f63666484" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailInventoriesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c4403d1e-5802-4ce0-b780-13c614a761c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_998bd367-6235-432a-ade0-167671ab32f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c4403d1e-5802-4ce0-b780-13c614a761c7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_998bd367-6235-432a-ade0-167671ab32f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0a83eecc-3fda-4fa5-8e14-3637fbad8708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c4403d1e-5802-4ce0-b780-13c614a761c7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0a83eecc-3fda-4fa5-8e14-3637fbad8708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a008ddda-52ac-4552-bd3a-6ee1d70bd78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c4403d1e-5802-4ce0-b780-13c614a761c7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a008ddda-52ac-4552-bd3a-6ee1d70bd78d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cda2e09e-489b-479d-abd2-4b42e2de0fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_7befffd9-dc45-4283-88f0-10382a50d378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cda2e09e-489b-479d-abd2-4b42e2de0fe3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_7befffd9-dc45-4283-88f0-10382a50d378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_c95c937f-eea6-4b2c-a285-673f6a4ecc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cda2e09e-489b-479d-abd2-4b42e2de0fe3" xlink:to="loc_us-gaap_DepositsAssetsCurrent_c95c937f-eea6-4b2c-a285-673f6a4ecc30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_73833c08-5112-46e3-984b-7b3dc6106816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cda2e09e-489b-479d-abd2-4b42e2de0fe3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_73833c08-5112-46e3-984b-7b3dc6106816" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ef5c80fb-5cba-4127-9607-dea306c15e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12410b9a-a8d3-4272-bf17-dd7b4b88bb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ef5c80fb-5cba-4127-9607-dea306c15e45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12410b9a-a8d3-4272-bf17-dd7b4b88bb27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0c6d3ddc-bb9b-4baf-8d1d-6193f9621f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ef5c80fb-5cba-4127-9607-dea306c15e45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0c6d3ddc-bb9b-4baf-8d1d-6193f9621f12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_dce8ad3e-467d-468d-b37f-755fbbca9d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_us-gaap_AccruedSalariesCurrent_dce8ad3e-467d-468d-b37f-755fbbca9d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_6a7906b1-0af9-4c83-9a82-2feded3a0684" xlink:href="cutr-20221231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_6a7906b1-0af9-4c83-9a82-2feded3a0684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_843d5b99-ee40-424e-9d5c-2bfbe4af57e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_843d5b99-ee40-424e-9d5c-2bfbe4af57e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_380a219d-f1a2-406e-9dc3-f1a25b87dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_380a219d-f1a2-406e-9dc3-f1a25b87dcd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_8a4e930c-6362-489f-917a-719aa39aa4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_8a4e930c-6362-489f-917a-719aa39aa4ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent_f7d2d61e-3a96-4116-85c7-acd34c52fd2d" xlink:href="cutr-20221231.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aab30056-c15f-40be-9b16-52e700124497" xlink:to="loc_cutr_SalesAndMarketingAccrualsCurrent_f7d2d61e-3a96-4116-85c7-acd34c52fd2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a9acce0-2733-4ef3-b606-61e3d7f0fb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3d038451-d343-43b9-aa2c-3a98484da417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a9acce0-2733-4ef3-b606-61e3d7f0fb42" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3d038451-d343-43b9-aa2c-3a98484da417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ab8834bd-fc78-460c-991e-e71db6b037a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a9acce0-2733-4ef3-b606-61e3d7f0fb42" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ab8834bd-fc78-460c-991e-e71db6b037a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1cdec5a-cb21-4eb9-b994-5568da54c455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_18a88185-3f37-4137-99c8-2f3853aba3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1cdec5a-cb21-4eb9-b994-5568da54c455" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_18a88185-3f37-4137-99c8-2f3853aba3da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_90dd44cc-f4eb-494b-8536-4fa5201ae586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1cdec5a-cb21-4eb9-b994-5568da54c455" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_90dd44cc-f4eb-494b-8536-4fa5201ae586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_76064d78-63ff-4f1f-a798-488f9706a8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1cdec5a-cb21-4eb9-b994-5568da54c455" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_76064d78-63ff-4f1f-a798-488f9706a8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3136cc58-2664-4b61-96c7-e120251f23c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7c7ec33c-0f71-4422-af02-845c9bfa9c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3136cc58-2664-4b61-96c7-e120251f23c6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7c7ec33c-0f71-4422-af02-845c9bfa9c41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f1e85b26-ea87-4a81-8def-5c49808ad5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3136cc58-2664-4b61-96c7-e120251f23c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f1e85b26-ea87-4a81-8def-5c49808ad5e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c2a45b98-4bed-4519-bb74-97c826f4da58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d85574db-fdcb-44cd-b1d4-280b7332c84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c2a45b98-4bed-4519-bb74-97c826f4da58" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d85574db-fdcb-44cd-b1d4-280b7332c84d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_85fb2eba-adae-4252-b799-f273fa41f07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c2a45b98-4bed-4519-bb74-97c826f4da58" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_85fb2eba-adae-4252-b799-f273fa41f07f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4814ae1b-12b4-490c-b3a4-90f2be9a817c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c2a45b98-4bed-4519-bb74-97c826f4da58" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4814ae1b-12b4-490c-b3a4-90f2be9a817c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_9d404a4b-819f-42dc-89a5-273256954ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c083f232-9036-45a4-b2d4-830cdc9f656d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_9d404a4b-819f-42dc-89a5-273256954ab2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c083f232-9036-45a4-b2d4-830cdc9f656d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_798ee764-d1f3-4068-85da-bfeeed416851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_9d404a4b-819f-42dc-89a5-273256954ab2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_798ee764-d1f3-4068-85da-bfeeed416851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6b307215-0a6b-42c8-b713-53c5dab8e234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6b307215-0a6b-42c8-b713-53c5dab8e234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f5c85145-1b28-457a-91b5-5f1bdace2782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f5c85145-1b28-457a-91b5-5f1bdace2782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_c82a4971-088d-4a60-9034-49a93e3dbac8" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_c82a4971-088d-4a60-9034-49a93e3dbac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_fced3ac6-db87-4ae1-a982-bd869869cf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_fced3ac6-db87-4ae1-a982-bd869869cf6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_f17ebc47-0e1c-4838-bcbb-40653c65b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_f17ebc47-0e1c-4838-bcbb-40653c65b239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_d3f84523-2c0b-4c2e-931c-4f3e198ad4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_d3f84523-2c0b-4c2e-931c-4f3e198ad4ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ea34d948-039e-4ea1-b9d0-cab454d42477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ea34d948-039e-4ea1-b9d0-cab454d42477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_d8541234-2f60-4e59-a1c8-33612f781157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_d8541234-2f60-4e59-a1c8-33612f781157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_0170cd95-7403-4959-9ea1-9ec82cccbb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e765fe95-a1b2-4a72-abc3-83e313a3f6fa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_0170cd95-7403-4959-9ea1-9ec82cccbb13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c285650b-dad2-478e-ac58-b276b7349c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8702257c-e138-4c74-8101-227de90f910e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c285650b-dad2-478e-ac58-b276b7349c4b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8702257c-e138-4c74-8101-227de90f910e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e7f4c19f-2d56-4a09-be36-b38687f39636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c285650b-dad2-478e-ac58-b276b7349c4b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e7f4c19f-2d56-4a09-be36-b38687f39636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_5ecd1ca7-fe35-44c2-be85-93c595e4b305" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c285650b-dad2-478e-ac58-b276b7349c4b" xlink:to="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_5ecd1ca7-fe35-44c2-be85-93c595e4b305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c4e442cd-ac7b-4779-b923-308096485d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c285650b-dad2-478e-ac58-b276b7349c4b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c4e442cd-ac7b-4779-b923-308096485d7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_861dfc75-9297-485b-858c-ad8cf957e58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_861dfc75-9297-485b-858c-ad8cf957e58d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2324c6d8-c0ee-4da4-b3fd-867353ea87bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2324c6d8-c0ee-4da4-b3fd-867353ea87bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0a1e1b67-adbb-446d-b784-6790e517adea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0a1e1b67-adbb-446d-b784-6790e517adea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_7a9c3062-09b9-45a7-836d-b6123b74b3f2" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_7a9c3062-09b9-45a7-836d-b6123b74b3f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_92bf35ae-8705-4f9f-a059-c380f05e33b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_92bf35ae-8705-4f9f-a059-c380f05e33b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_b2469eef-5087-47bd-a65f-45953296f80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_b2469eef-5087-47bd-a65f-45953296f80f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_f51842fc-83c7-42f8-9fdb-9060bf1bc03a" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_f51842fc-83c7-42f8-9fdb-9060bf1bc03a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_a5c03e65-ee5a-4297-8335-08f5efa89b1d" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_a5c03e65-ee5a-4297-8335-08f5efa89b1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_5c24ca39-6197-4cdf-a61c-8dc40f0eb205" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_5c24ca39-6197-4cdf-a61c-8dc40f0eb205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_1fb732fc-28f2-41f5-8a78-ab235af05be6" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_1fb732fc-28f2-41f5-8a78-ab235af05be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_f45918ac-b465-471b-874d-a2018e5b4e77" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_f45918ac-b465-471b-874d-a2018e5b4e77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_cfb8eb6a-26d8-4bd3-bf29-c4d3137a3f48" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_cfb8eb6a-26d8-4bd3-bf29-c4d3137a3f48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_85c2f6d8-8d61-4ef3-a0d4-8986321520e6" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_56768595-aaf9-4076-a51d-5f90aaa3e4fe" xlink:to="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_85c2f6d8-8d61-4ef3-a0d4-8986321520e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf76d86e-c201-4101-affb-3126b9b561db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_acd684c7-5d01-40a7-ab5a-474ce9b24f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf76d86e-c201-4101-affb-3126b9b561db" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_acd684c7-5d01-40a7-ab5a-474ce9b24f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2486510f-47fb-4403-a7d5-09e55a86bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf76d86e-c201-4101-affb-3126b9b561db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2486510f-47fb-4403-a7d5-09e55a86bb97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesFinancialStatementInformationDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_c61a00dd-3b47-42c2-86f3-57a74bdd7f78" xlink:href="cutr-20221231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_13a1aef9-262f-4784-b6d1-e5d5cdcf2517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_c61a00dd-3b47-42c2-86f3-57a74bdd7f78" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_13a1aef9-262f-4784-b6d1-e5d5cdcf2517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_9ffdb0d0-5d74-440f-a6a4-b26951bc0598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_c61a00dd-3b47-42c2-86f3-57a74bdd7f78" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_9ffdb0d0-5d74-440f-a6a4-b26951bc0598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_47f95b47-7b53-4bbc-a6d1-75211d2e64f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_37767a05-9f0a-4b90-8221-4685c76a0f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_47f95b47-7b53-4bbc-a6d1-75211d2e64f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_37767a05-9f0a-4b90-8221-4685c76a0f77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_64836545-f829-422d-bb0b-daa7914c19aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_47f95b47-7b53-4bbc-a6d1-75211d2e64f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_64836545-f829-422d-bb0b-daa7914c19aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_398d7d98-45d2-426f-a363-bb10ce0a5f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_398d7d98-45d2-426f-a363-bb10ce0a5f39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c89da3ad-d530-4715-bd3c-5ed717e98708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c89da3ad-d530-4715-bd3c-5ed717e98708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_577d9693-c8c1-49cf-beaf-148018beed0d" xlink:href="cutr-20221231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_577d9693-c8c1-49cf-beaf-148018beed0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c16e18cc-f52a-4949-ae85-55842acd54a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c16e18cc-f52a-4949-ae85-55842acd54a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6883aec9-e063-4e68-abfd-25032c951a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6883aec9-e063-4e68-abfd-25032c951a97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fb38d8f8-d0af-42b0-bafb-37763fe9c3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0263ea1-a09b-40a4-a14e-a4fbdd2ddc9d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fb38d8f8-d0af-42b0-bafb-37763fe9c3e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac0e5a7f-bd00-444a-8701-7279519c57cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2800a575-6d5f-4d00-a61c-3fcf49be3820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac0e5a7f-bd00-444a-8701-7279519c57cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2800a575-6d5f-4d00-a61c-3fcf49be3820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0c4c5405-9fbe-4ed5-af9a-395917ef312d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac0e5a7f-bd00-444a-8701-7279519c57cd" xlink:to="loc_us-gaap_OperatingLeaseLiability_0c4c5405-9fbe-4ed5-af9a-395917ef312d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53309ce-93b9-4e2f-8412-3ef483549b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_81c77bac-d98e-4b63-a8c2-77aa9d024681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53309ce-93b9-4e2f-8412-3ef483549b59" xlink:to="loc_us-gaap_FinanceLeaseLiability_81c77bac-d98e-4b63-a8c2-77aa9d024681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ad045b45-a8f6-42b4-8e94-c07d72fef319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53309ce-93b9-4e2f-8412-3ef483549b59" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ad045b45-a8f6-42b4-8e94-c07d72fef319" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7f58373-82b1-4dd7-8bb7-da2f599afb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_52ba371b-cd28-414b-bf53-c16ad4f60fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7f58373-82b1-4dd7-8bb7-da2f599afb23" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_52ba371b-cd28-414b-bf53-c16ad4f60fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dad9e0ce-5e9a-4c56-b89d-db667c2a24ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7f58373-82b1-4dd7-8bb7-da2f599afb23" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dad9e0ce-5e9a-4c56-b89d-db667c2a24ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_99142452-f5ff-4c40-bb25-3dcab83766fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7f58373-82b1-4dd7-8bb7-da2f599afb23" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_99142452-f5ff-4c40-bb25-3dcab83766fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_34212d59-a9d8-4ca3-8a13-f6a4a0543b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0a496d69-1f17-4743-9efc-7c93774754c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_34212d59-a9d8-4ca3-8a13-f6a4a0543b57" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0a496d69-1f17-4743-9efc-7c93774754c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_47f490d3-d27a-4e9c-89c1-c4bfd703c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_34212d59-a9d8-4ca3-8a13-f6a4a0543b57" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_47f490d3-d27a-4e9c-89c1-c4bfd703c7ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_284a6557-bb13-44f9-ad4f-4994dc480bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8cae2077-4c9f-4a3b-b365-694bfc295b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_284a6557-bb13-44f9-ad4f-4994dc480bed" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8cae2077-4c9f-4a3b-b365-694bfc295b9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3c14ed71-65d1-4729-8257-e91e59281d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_284a6557-bb13-44f9-ad4f-4994dc480bed" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3c14ed71-65d1-4729-8257-e91e59281d13" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtComponentsoftheLossonDebtExtinguishmentDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionNetProceeds_513807f1-2445-413d-99fa-60d393a163e9" xlink:href="cutr-20221231.xsd#cutr_DebtConversionNetProceeds"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_8bc432e5-6704-4005-adb9-5d21eb89eb79" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_DebtConversionNetProceeds_513807f1-2445-413d-99fa-60d393a163e9" xlink:to="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_8bc432e5-6704-4005-adb9-5d21eb89eb79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a3795b1e-3d87-4a91-96c1-346b594ebe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_DebtConversionNetProceeds_513807f1-2445-413d-99fa-60d393a163e9" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a3795b1e-3d87-4a91-96c1-346b594ebe0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dab2ea16-02b7-4bfd-b2ca-67092c371f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionNetProceeds_be95f240-11f8-46a4-a759-18d25cce8268" xlink:href="cutr-20221231.xsd#cutr_DebtConversionNetProceeds"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dab2ea16-02b7-4bfd-b2ca-67092c371f6c" xlink:to="loc_cutr_DebtConversionNetProceeds_be95f240-11f8-46a4-a759-18d25cce8268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_12d2b506-89ab-47a8-9f17-c74291b55aba" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dab2ea16-02b7-4bfd-b2ca-67092c371f6c" xlink:to="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_12d2b506-89ab-47a8-9f17-c74291b55aba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_b7dd6e1c-5701-473e-8833-97bbb6f60268" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fc12a29f-3822-4e6a-8182-1bb93a83a516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_b7dd6e1c-5701-473e-8833-97bbb6f60268" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fc12a29f-3822-4e6a-8182-1bb93a83a516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued_8fad2ac4-c482-4459-82c9-e627c380342a" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_b7dd6e1c-5701-473e-8833-97bbb6f60268" xlink:to="loc_cutr_DebtConversionConvertedInstrumentCashIssued_8fad2ac4-c482-4459-82c9-e627c380342a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>cutr-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i59e5f55503ad41a8aab2cba6e9256c89_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9dde43b2-84b3-48f8-8a68-f9eebf8936bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9dde43b2-84b3-48f8-8a68-f9eebf8936bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_80f5bbe3-56f1-4bdd-b334-cab2cfdb7d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_80f5bbe3-56f1-4bdd-b334-cab2cfdb7d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3424095a-8e6a-4d7f-9d10-c89659aaedc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_GrossProfit_3424095a-8e6a-4d7f-9d10-c89659aaedc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_78497180-012d-44cf-ba7b-05df9fcc3d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_SellingAndMarketingExpense_78497180-012d-44cf-ba7b-05df9fcc3d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e79fad6c-1561-4159-8786-f332b1871fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e79fad6c-1561-4159-8786-f332b1871fb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_58634b75-87d5-4f4c-8afc-06f4f5df1e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_58634b75-87d5-4f4c-8afc-06f4f5df1e41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_aae4c9f5-108a-458b-9b83-984e6f0c7989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_OperatingExpenses_aae4c9f5-108a-458b-9b83-984e6f0c7989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48074f65-2c14-4a11-be33-93a6cb2eed67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_OperatingIncomeLoss_48074f65-2c14-4a11-be33-93a6cb2eed67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1485be29-aabc-4702-a100-a95a5bbc16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1485be29-aabc-4702-a100-a95a5bbc16a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c12f91dc-e4b0-48cf-8575-6093a4eb6018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_InterestExpenseDebt_c12f91dc-e4b0-48cf-8575-6093a4eb6018" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f85dc88d-29ff-42f0-8104-0bec4b6ca227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f85dc88d-29ff-42f0-8104-0bec4b6ca227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_6f1a629e-aba2-4f3b-8bbc-329a54462eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_6f1a629e-aba2-4f3b-8bbc-329a54462eca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_118fe5ff-a785-4ca7-befb-b2fd698196f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_118fe5ff-a785-4ca7-befb-b2fd698196f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2331a63f-a845-4217-a089-827974709ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2331a63f-a845-4217-a089-827974709ac5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a7d4f55d-5ffa-46d2-b6da-bbd4c4fa5961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a7d4f55d-5ffa-46d2-b6da-bbd4c4fa5961" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_03abb6bc-3178-4216-b5e1-de1ea1dfc64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_03abb6bc-3178-4216-b5e1-de1ea1dfc64e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d3a84838-14cf-4d7c-8ad1-ad57656705da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_NetIncomeLoss_d3a84838-14cf-4d7c-8ad1-ad57656705da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_abd4812d-30f4-41b5-9a10-6fef3a1c61e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:to="loc_us-gaap_EarningsPerShareBasic_abd4812d-30f4-41b5-9a10-6fef3a1c61e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4b4818b1-f4d9-42c6-8e1a-376ec3c10b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4b4818b1-f4d9-42c6-8e1a-376ec3c10b56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a24de09c-8b36-4742-a929-30e83907fca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a24de09c-8b36-4742-a929-30e83907fca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acd634cd-ed92-45d9-b955-3e02a07452d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acd634cd-ed92-45d9-b955-3e02a07452d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:to="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bdfdd1c8-506c-49a6-9857-c854caa78f2a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:to="loc_srt_ProductsAndServicesDomain_bdfdd1c8-506c-49a6-9857-c854caa78f2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:to="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b691509c-a7d0-4d39-8d31-baec54902417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:to="loc_us-gaap_ProductMember_b691509c-a7d0-4d39-8d31-baec54902417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_09d1e34b-6d22-4fdc-bb3d-235453d41ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:to="loc_us-gaap_ServiceMember_09d1e34b-6d22-4fdc-bb3d-235453d41ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_455ce229-9b1b-4dc8-9230-9022f92b80de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_455ce229-9b1b-4dc8-9230-9022f92b80de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3f87abd2-d0c5-4b13-9de6-b223a70f27fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:to="loc_us-gaap_ConvertibleDebtMember_3f87abd2-d0c5-4b13-9de6-b223a70f27fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_fd1a5db7-52b5-499d-aa94-05a440299885" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_fd1a5db7-52b5-499d-aa94-05a440299885" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="i9478ff05f3474abdbd454c9b2684bcde_ConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9d02efe9-f4b9-4b0e-b533-b5dc60a97896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9d02efe9-f4b9-4b0e-b533-b5dc60a97896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0199e370-7daa-4072-8996-77440fb04343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockholdersEquity_0199e370-7daa-4072-8996-77440fb04343" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_646dd9ed-2827-41ec-b7cd-307c1befefd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_646dd9ed-2827-41ec-b7cd-307c1befefd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a3015fa8-614d-4ced-a2e1-86771420eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a3015fa8-614d-4ced-a2e1-86771420eb39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9ac140d-3ff8-4b9b-ba16-751d326c1282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9ac140d-3ff8-4b9b-ba16-751d326c1282" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c80b064e-8758-474e-a807-9fee2cfab04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c80b064e-8758-474e-a807-9fee2cfab04d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4c4e03b8-84dc-45a3-a345-a75a73227e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4c4e03b8-84dc-45a3-a345-a75a73227e1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_cb0f0f9e-f580-44ff-89de-07df63f2264e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_cb0f0f9e-f580-44ff-89de-07df63f2264e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall_dfd19d22-8fd6-4e08-befd-4f619e90b30d" xlink:href="cutr-20221231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_cutr_PurchaseOfCappedCall_dfd19d22-8fd6-4e08-befd-4f619e90b30d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3428570a-a273-40ff-a6f8-b4abd2a19382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3428570a-a273-40ff-a6f8-b4abd2a19382" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_5d86da5b-72c0-4cab-96fa-f7999b85dd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_5d86da5b-72c0-4cab-96fa-f7999b85dd75" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19196df7-1efa-42bf-aacf-f9c5b8b2580d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19196df7-1efa-42bf-aacf-f9c5b8b2580d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_db199555-6c9b-482c-a69b-8fffaf5af63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_NetIncomeLoss_db199555-6c9b-482c-a69b-8fffaf5af63b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77ff4640-9853-4e0c-b40a-cfd26b84c622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77ff4640-9853-4e0c-b40a-cfd26b84c622" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9ad4a962-6533-4790-803a-bcf6e35f01a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_167aae58-c522-446e-89f6-f8fed9c80692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:to="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_39599973-83eb-4678-8a09-82a4c1f48f80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:to="loc_us-gaap_EquityComponentDomain_39599973-83eb-4678-8a09-82a4c1f48f80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:to="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5c5e3f17-bb34-43f2-b100-ed69e6c47c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_CommonStockMember_5c5e3f17-bb34-43f2-b100-ed69e6c47c69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8643f865-c544-4456-a1fc-cde40f3a5a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8643f865-c544-4456-a1fc-cde40f3a5a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bcb38bcb-9956-40a0-9036-0a227bc54749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_RetainedEarningsMember_bcb38bcb-9956-40a0-9036-0a227bc54749" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a248fec6-8c5a-42dd-93c8-2b9c70ff990a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a248fec6-8c5a-42dd-93c8-2b9c70ff990a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i754d5df429e74e43be5b3e0cb3873525_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b50110a2-7cc4-4d96-9f9f-3427ecb59be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_NetIncomeLoss_b50110a2-7cc4-4d96-9f9f-3427ecb59be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a96e698b-95ba-47b2-be6e-6a2220c9e540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ShareBasedCompensation_a96e698b-95ba-47b2-be6e-6a2220c9e540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_95d66962-f8ba-47eb-b146-ace9f11db651" xlink:href="cutr-20221231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_95d66962-f8ba-47eb-b146-ace9f11db651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_f23947f2-d9ad-4728-9fe8-76f154abcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_f23947f2-d9ad-4728-9fe8-76f154abcd17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9d74dc08-c503-4101-b302-06812125d6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9d74dc08-c503-4101-b302-06812125d6db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84eeb691-244c-4f7b-8e45-6fbcdfebc0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84eeb691-244c-4f7b-8e45-6fbcdfebc0eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ea0a04ae-2b68-4367-95c0-7a94e8dbd19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ea0a04ae-2b68-4367-95c0-7a94e8dbd19b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c7232dfd-35ca-4db3-99a8-1c23e70a08b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c7232dfd-35ca-4db3-99a8-1c23e70a08b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7246c076-c817-4fdc-868a-ef54af3fd07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7246c076-c817-4fdc-868a-ef54af3fd07f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6a7400c8-769d-4835-9c83-dc93348ea0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6a7400c8-769d-4835-9c83-dc93348ea0d1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_858e941c-fd08-4acb-a729-cf67da6044fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_858e941c-fd08-4acb-a729-cf67da6044fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2174f3b7-e707-4936-80e5-e0bfcfc93b1c" xlink:href="cutr-20221231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2174f3b7-e707-4936-80e5-e0bfcfc93b1c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7ccef9a2-a3cc-4b5a-9668-facf6f96a64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7ccef9a2-a3cc-4b5a-9668-facf6f96a64c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0c180228-64f2-4d75-9ab1-afbb0773c59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0c180228-64f2-4d75-9ab1-afbb0773c59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1d8bf8f2-1739-4bf1-9a5d-e220b8b68a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1d8bf8f2-1739-4bf1-9a5d-e220b8b68a9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d2e469bb-c640-4098-a63d-cef8c110f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d2e469bb-c640-4098-a63d-cef8c110f9d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3018b382-81a9-4594-8466-52c5b4ede713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3018b382-81a9-4594-8466-52c5b4ede713" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7787a3d3-0493-4df7-b0c1-5bccdedd5de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7787a3d3-0493-4df7-b0c1-5bccdedd5de1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cc062507-e678-40e9-a628-5ce956bbf625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cc062507-e678-40e9-a628-5ce956bbf625" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_eea5d86f-b0ed-48e5-b274-5700ae253b8a" xlink:href="cutr-20221231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_eea5d86f-b0ed-48e5-b274-5700ae253b8a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b6a508ea-28de-4f2d-9923-ded1534ab055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b6a508ea-28de-4f2d-9923-ded1534ab055" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c743339c-e7e9-4d33-ba48-c3854bf55ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c743339c-e7e9-4d33-ba48-c3854bf55ac5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf8bd0cd-04fe-4b0d-b83c-b1077483418a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf8bd0cd-04fe-4b0d-b83c-b1077483418a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76ed289b-a9e9-4658-9bcb-7d1ccfbb1d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76ed289b-a9e9-4658-9bcb-7d1ccfbb1d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d8d8f38f-74f6-4e61-b92a-0dc4b61bf9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d8d8f38f-74f6-4e61-b92a-0dc4b61bf9c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3ac1bc59-126f-4321-b1d3-46a23849fd32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3ac1bc59-126f-4321-b1d3-46a23849fd32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8cafc201-4f63-4c15-896b-c6727ecbfc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8cafc201-4f63-4c15-896b-c6727ecbfc32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0811d76e-a9bf-4266-b968-24b9f03bca0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0811d76e-a9bf-4266-b968-24b9f03bca0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a36a319b-0e32-4dc4-8f8e-748e18f6243a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a36a319b-0e32-4dc4-8f8e-748e18f6243a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50e8e0da-941c-4af7-ac31-6f6b2210fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50e8e0da-941c-4af7-ac31-6f6b2210fc87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2bb1e52e-b7e9-4780-88cf-5fcb65e6f563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2bb1e52e-b7e9-4780-88cf-5fcb65e6f563" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_6ccaffbf-8a3c-4bca-895d-8ed0a3148570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_6ccaffbf-8a3c-4bca-895d-8ed0a3148570" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_38c0a7d0-e650-496f-866b-39c3af1dd1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_38c0a7d0-e650-496f-866b-39c3af1dd1f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bc1413b7-4b86-4745-8928-c617dcc1ab63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bc1413b7-4b86-4745-8928-c617dcc1ab63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_932734b3-4967-4e19-9210-ffccb7f1a3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_932734b3-4967-4e19-9210-ffccb7f1a3a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a926fe94-12de-426b-baa7-c5f06dcb187e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a926fe94-12de-426b-baa7-c5f06dcb187e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b7e7f482-e0cd-45e9-994e-25df67093f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b7e7f482-e0cd-45e9-994e-25df67093f69" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0cb45b5b-b06e-4fc0-b2b5-0da5c48e0785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0cb45b5b-b06e-4fc0-b2b5-0da5c48e0785" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_27ae62e9-6198-4070-8b5f-0f7155add9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_27ae62e9-6198-4070-8b5f-0f7155add9bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_32350624-857d-4f14-8b2b-91ab18fd0d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_32350624-857d-4f14-8b2b-91ab18fd0d3e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5daef03b-4261-4112-bdfb-93eb4f00de03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5daef03b-4261-4112-bdfb-93eb4f00de03" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_93fe92cd-76c7-4a2a-b8ea-2991b5c6a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_93fe92cd-76c7-4a2a-b8ea-2991b5c6a1eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_805bf42e-409f-4f0d-9bf2-beaed98a74eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_805bf42e-409f-4f0d-9bf2-beaed98a74eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fe7e18a0-f5ce-48fb-8446-95e044331bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_bfe9425e-dbde-48b6-8378-df36b4685e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:to="loc_us-gaap_InterestPaidNet_bfe9425e-dbde-48b6-8378-df36b4685e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f1c0555a-4af9-4391-a5a3-bb986e340f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f1c0555a-4af9-4391-a5a3-bb986e340f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_beb231ab-9aca-4b65-a2bb-ac55b394bcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_StockIssued1_beb231ab-9aca-4b65-a2bb-ac55b394bcc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82a1affe-a52b-4223-bdbe-fd18540c5c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82a1affe-a52b-4223-bdbe-fd18540c5c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_21a4d72c-7701-46d0-9338-a6b2400500dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_21a4d72c-7701-46d0-9338-a6b2400500dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction_105473b7-6b82-4a0e-b3fc-c28b50d605cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_NotesReduction_105473b7-6b82-4a0e-b3fc-c28b50d605cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_06ba9fa7-56f6-40a3-884a-02e838f4f1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_06ba9fa7-56f6-40a3-884a-02e838f4f1f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedCappedCallCosts_81696687-c27e-49a2-84b4-9597b2eb0f63" xlink:href="cutr-20221231.xsd#cutr_AccruedCappedCallCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_cutr_AccruedCappedCallCosts_81696687-c27e-49a2-84b4-9597b2eb0f63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_856d107d-af35-49f2-895f-46443e71d617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_856d107d-af35-49f2-895f-46443e71d617" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_013f7bb1-9e63-4b7d-b619-037fdeaceeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_013f7bb1-9e63-4b7d-b619-037fdeaceeaa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_32819eb9-ac50-48d8-bea9-822a1d4cda35" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_32819eb9-ac50-48d8-bea9-822a1d4cda35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9828f5af-c3f2-46c0-88b6-42f8a3a422b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:to="loc_us-gaap_ConvertibleDebtMember_9828f5af-c3f2-46c0-88b6-42f8a3a422b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ifa2c7d760e844ca5a377a37b5921a246_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_58fba4c3-f3d1-4e1a-b1d9-84045d564976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_58fba4c3-f3d1-4e1a-b1d9-84045d564976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_6577a8da-db21-45db-bdf6-6db64ff2e89c" xlink:href="cutr-20221231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_6577a8da-db21-45db-bdf6-6db64ff2e89c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_412dc72b-b90e-4bee-9a3e-5f4aba193227" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_412dc72b-b90e-4bee-9a3e-5f4aba193227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_422a12b6-f146-4ba1-8211-d6339e905e26" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_422a12b6-f146-4ba1-8211-d6339e905e26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_ece3d30a-ab35-4826-a56a-a1ce20df28d4" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_ece3d30a-ab35-4826-a56a-a1ce20df28d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8275d203-9033-47a7-8438-cd9301306c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8275d203-9033-47a7-8438-cd9301306c10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_4e46151c-cc63-4214-b559-4284fe2bd368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_4e46151c-cc63-4214-b559-4284fe2bd368" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_7da299f1-5869-4c95-b380-ebecc1046c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostNet_7da299f1-5869-4c95-b380-ebecc1046c27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_c0f20887-de12-448a-af29-46f0ee54df6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_c0f20887-de12-448a-af29-46f0ee54df6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_446c9e5a-b096-451a-975e-a742f6d468f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_446c9e5a-b096-451a-975e-a742f6d468f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod_7d1627a1-6f59-4eea-8b1a-207bbaef796f" xlink:href="cutr-20221231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_DemonstrationUnitsAmortizationPeriod_7d1627a1-6f59-4eea-8b1a-207bbaef796f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_160b4336-977f-4aa3-9878-bf552237e6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_InventoryFinishedGoods_160b4336-977f-4aa3-9878-bf552237e6ab" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9cff4e08-0d10-4db1-833b-db0b2bbfa122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_Depreciation_9cff4e08-0d10-4db1-833b-db0b2bbfa122" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ffabc34a-5349-4152-ac8a-2dfde371b66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ffabc34a-5349-4152-ac8a-2dfde371b66e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_dda9d696-1552-4e70-ab2d-ee00a9468f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_dda9d696-1552-4e70-ab2d-ee00a9468f8f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_e64278c6-fb15-4de8-81b4-93711da0f72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_e64278c6-fb15-4de8-81b4-93711da0f72d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_ccccfb73-e69a-4c98-88a7-ff451ec06751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_ccccfb73-e69a-4c98-88a7-ff451ec06751" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3359b2db-b943-4326-aabd-502281d5d1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfReportableSegments_3359b2db-b943-4326-aabd-502281d5d1a1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a29d5028-6505-463a-8c8d-43ad5d3a8155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a29d5028-6505-463a-8c8d-43ad5d3a8155" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b99e58f3-06ff-4766-8b1b-0d7821c7536e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b99e58f3-06ff-4766-8b1b-0d7821c7536e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d96397b3-9217-4836-9a55-8a405c1bfa67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfReportingUnits_d96397b3-9217-4836-9a55-8a405c1bfa67" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales_4be7a781-e7c4-429e-8190-1177b4f9a86a" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_StandardProductWarrantyTermDirectSales_4be7a781-e7c4-429e-8190-1177b4f9a86a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales_053aba7c-8328-4aad-83b2-bb1f673f8583" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_StandardProductWarrantyTermDistributorSales_053aba7c-8328-4aad-83b2-bb1f673f8583" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_707b7e7c-9df3-438a-9a15-b2de12cb03ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_AdvertisingExpense_707b7e7c-9df3-438a-9a15-b2de12cb03ea" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_138f8c2a-86d4-4edc-8f34-6fd6d0c2942c" xlink:href="cutr-20221231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_138f8c2a-86d4-4edc-8f34-6fd6d0c2942c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0183dbef-dc12-4037-a4c4-7aaa74625a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0183dbef-dc12-4037-a4c4-7aaa74625a5e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets_ed907c05-4ce1-426f-9187-2a334a41fefe" xlink:href="cutr-20221231.xsd#cutr_PercentageOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_PercentageOfAssets_ed907c05-4ce1-426f-9187-2a334a41fefe" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_8cedc488-f5ac-4fd1-846e-10b35914d7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:to="loc_us-gaap_TransferredOverTimeMember_8cedc488-f5ac-4fd1-846e-10b35914d7ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6746a4ff-a228-4b22-bddc-f2fd33652eb9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:to="loc_srt_ProductsAndServicesDomain_6746a4ff-a228-4b22-bddc-f2fd33652eb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:to="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1fc1dd98-d2bd-4f3a-8aeb-e8c3a285fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_us-gaap_ServiceMember_1fc1dd98-d2bd-4f3a-8aeb-e8c3a285fe06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_2cd6e491-a7ba-4b19-8f77-38a8a47271f3" xlink:href="cutr-20221231.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_cutr_SkincareMember_2cd6e491-a7ba-4b19-8f77-38a8a47271f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_7ce151f5-7043-4361-b67b-08fbf1368cc8" xlink:href="cutr-20221231.xsd#cutr_LoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_cutr_LoyaltyMember_7ce151f5-7043-4361-b67b-08fbf1368cc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_86ea10f8-c793-4314-8bc3-2e6f082dcd6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_86ea10f8-c793-4314-8bc3-2e6f082dcd6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3609886a-d70d-455f-b4b6-2490f78d2d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3609886a-d70d-455f-b4b6-2490f78d2d0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ce0e3e76-930a-40cc-9a24-5885a1d0ce49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ce0e3e76-930a-40cc-9a24-5885a1d0ce49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_33867b21-0b96-4657-acdd-c9a0a2a5bf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_33867b21-0b96-4657-acdd-c9a0a2a5bf8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_a5f2fb97-fc76-409c-b692-018f5b4ba27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_a5f2fb97-fc76-409c-b692-018f5b4ba27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1221eff6-b8f0-4f8b-8b20-935c0e18142c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1221eff6-b8f0-4f8b-8b20-935c0e18142c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_27655982-4095-4480-bf2f-863641e75edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_27655982-4095-4480-bf2f-863641e75edc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_e49f738b-757a-4aa0-98e4-acc4b9d333c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_e49f738b-757a-4aa0-98e4-acc4b9d333c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b94aed2d-63bd-44c3-b3d6-8be7968ea493_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:to="loc_srt_SegmentGeographicalDomain_b94aed2d-63bd-44c3-b3d6-8be7968ea493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:to="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed1cda0a-72c8-4fe2-aa47-1836c64a68dd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:to="loc_country_US_ed1cda0a-72c8-4fe2-aa47-1836c64a68dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_06645a84-1980-4e9e-a5fe-1f3cecafc694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:to="loc_us-gaap_NonUsMember_06645a84-1980-4e9e-a5fe-1f3cecafc694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_2ec49f71-12aa-4e87-bbd9-d4798d12771e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:to="loc_srt_NameOfMajorCustomerDomain_2ec49f71-12aa-4e87-bbd9-d4798d12771e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:to="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LargestSupplierMember_e618ff88-430f-4210-9b79-352bd1fa3dc1" xlink:href="cutr-20221231.xsd#cutr_LargestSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:to="loc_cutr_LargestSupplierMember_e618ff88-430f-4210-9b79-352bd1fa3dc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a70ab5cf-960d-4028-b140-b9a0e2bd4f13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a70ab5cf-960d-4028-b140-b9a0e2bd4f13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_2df86ee1-6fce-4766-97ca-09e3aebe5b33" xlink:href="cutr-20221231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_2df86ee1-6fce-4766-97ca-09e3aebe5b33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseInstallmentCostsMember_59ea879e-9049-4903-b2ff-c6b8622ff116" xlink:href="cutr-20221231.xsd#cutr_LeaseInstallmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:to="loc_cutr_LeaseInstallmentCostsMember_59ea879e-9049-4903-b2ff-c6b8622ff116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_133e6c92-06bd-4c4e-8c58-a709bf51bb41_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:to="loc_srt_RangeMember_133e6c92-06bd-4c4e-8c58-a709bf51bb41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:to="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c3cb916-cf86-435e-a8a4-5faa12163093" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:to="loc_srt_MinimumMember_0c3cb916-cf86-435e-a8a4-5faa12163093" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af063474-9c5c-4bb0-bda3-ca584fc19ff5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:to="loc_srt_MaximumMember_af063474-9c5c-4bb0-bda3-ca584fc19ff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c22fb465-4768-4a5b-b681-83a9f669f2f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:to="loc_us-gaap_ClassOfStockDomain_c22fb465-4768-4a5b-b681-83a9f669f2f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:to="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_a088d2ad-84ae-4dd2-bcef-66e940527e98" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_a088d2ad-84ae-4dd2-bcef-66e940527e98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_146f8cec-7f03-49ff-a837-fc6baa1ccea1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_146f8cec-7f03-49ff-a837-fc6baa1ccea1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b18f0462-8ee1-436a-bbfb-25330474143b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b18f0462-8ee1-436a-bbfb-25330474143b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3be0011e-a7fc-4ec6-a161-ea300e937653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3be0011e-a7fc-4ec6-a161-ea300e937653" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended" id="i0b9f9f8df1b64828bb4eb3660cf38865_SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ca0932e1-87dc-4a91-8861-d26671a41069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ca0932e1-87dc-4a91-8861-d26671a41069" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b5e4f9ae-57b9-4019-909e-af412046df36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b5e4f9ae-57b9-4019-909e-af412046df36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_7d58f5cf-e744-428d-a09e-9caf33e04d21" xlink:href="cutr-20221231.xsd#cutr_LeasedEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_LeasedEquipmentMember_7d58f5cf-e744-428d-a09e-9caf33e04d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDevicesMember_937dc5dc-aa7e-4efa-97f9-d1695e493926" xlink:href="cutr-20221231.xsd#cutr_AviClearDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_AviClearDevicesMember_937dc5dc-aa7e-4efa-97f9-d1695e493926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_61cdd7e4-6024-488b-9803-20795ffc7aa7" xlink:href="cutr-20221231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_EquipmentAndFurnitureMember_61cdd7e4-6024-488b-9803-20795ffc7aa7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_e3a6b7d0-ae8c-4481-8880-7a4f26aaf1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_e3a6b7d0-ae8c-4481-8880-7a4f26aaf1f1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended" id="i3b18e12ec27d431ea038873a95019c89_CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddd98ac3-582c-475b-b9c7-f3e836aa81f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddd98ac3-582c-475b-b9c7-f3e836aa81f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_1473d583-1605-4b1f-9300-ec76a52f2f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_RestrictedCashCurrent_1473d583-1605-4b1f-9300-ec76a52f2f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c24e2fe9-3b19-4a89-bd8e-314fb654be63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c24e2fe9-3b19-4a89-bd8e-314fb654be63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5394db44-07a2-4741-889e-179671250196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5394db44-07a2-4741-889e-179671250196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_650bf5ce-77f2-4b69-91ad-3008834fdf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_650bf5ce-77f2-4b69-91ad-3008834fdf2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_94962a42-5858-4f58-a075-d8d3007f91a4" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_94962a42-5858-4f58-a075-d8d3007f91a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad291b1c-06aa-45ce-8c7a-f5a025854cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad291b1c-06aa-45ce-8c7a-f5a025854cdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7836be59-819c-467e-8da0-fc2db7ba77a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7836be59-819c-467e-8da0-fc2db7ba77a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b23584b-d1f5-49c1-b757-d53793ceba58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b23584b-d1f5-49c1-b757-d53793ceba58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_885f6fac-b97b-4d7e-9644-adb2f28efed1" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_885f6fac-b97b-4d7e-9644-adb2f28efed1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f130ff6-878b-4cc1-bf15-33fcecf8c05d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f130ff6-878b-4cc1-bf15-33fcecf8c05d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0105baeb-67ac-42df-8790-4c6943a58e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0105baeb-67ac-42df-8790-4c6943a58e3a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended" id="i12fd5582660249f4aa2a1d9af7ffc90c_FairValueofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b35143e-28e2-4b4f-a02f-f53438f7daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b35143e-28e2-4b4f-a02f-f53438f7daee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a724cf1d-9647-4c62-a6a8-9817747bee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a724cf1d-9647-4c62-a6a8-9817747bee85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0ea25c38-0c37-4112-a2d4-225bbcaf8e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DerivativeLiabilities_0ea25c38-0c37-4112-a2d4-225bbcaf8e54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2d970595-5e84-4272-a703-5a7c735d782f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2d970595-5e84-4272-a703-5a7c735d782f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9889577a-a7e0-4c74-96ac-8dea9af8af2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9889577a-a7e0-4c74-96ac-8dea9af8af2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a65efb72-e27f-4591-90ab-eccf0a210778_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a65efb72-e27f-4591-90ab-eccf0a210778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_101f9dba-1489-43d2-9acd-16c84853d2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_101f9dba-1489-43d2-9acd-16c84853d2b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_393a70db-e403-4539-b4c6-b9ddc7517c6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_393a70db-e403-4539-b4c6-b9ddc7517c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c0291d76-5d7e-4be2-8ce7-23569a14a847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c0291d76-5d7e-4be2-8ce7-23569a14a847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5f2910d9-f3e9-4295-a9f5-86a88b446cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5f2910d9-f3e9-4295-a9f5-86a88b446cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fae7e3ff-5449-48be-bd27-6628746f58c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fae7e3ff-5449-48be-bd27-6628746f58c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_39df359e-f72e-4df1-b644-32bed30125d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_39df359e-f72e-4df1-b644-32bed30125d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99435c3a-43c6-463f-b95f-01bde40fe744_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99435c3a-43c6-463f-b95f-01bde40fe744_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c622a58e-f123-46fa-bc49-74dac0ea3f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c622a58e-f123-46fa-bc49-74dac0ea3f8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17e8c4a3-1432-4e94-b92e-6502b8208c66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17e8c4a3-1432-4e94-b92e-6502b8208c66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_da5aad0f-06b5-490d-980b-b3e2008be2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:to="loc_us-gaap_ConvertibleDebtMember_da5aad0f-06b5-490d-980b-b3e2008be2de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4a161e9-e15a-4381-a1eb-409917bfea2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4a161e9-e15a-4381-a1eb-409917bfea2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_d900cfa3-ca7e-4d5b-a672-49b2a5c81845" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_d900cfa3-ca7e-4d5b-a672-49b2a5c81845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_867527e4-1e89-4633-9e44-72b5472f17dd" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_867527e4-1e89-4633-9e44-72b5472f17dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DerivativeInstrumentsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DerivativeInstrumentsDetails" xlink:type="extended" id="i7dcce640a3ae49d78623cd81b6f59116_DerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_6001fee2-9e9b-4e18-adfd-46dd13f2aed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_6001fee2-9e9b-4e18-adfd-46dd13f2aed3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64be9cf7-e5f0-48c4-818d-d67bbf2d4b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64be9cf7-e5f0-48c4-818d-d67bbf2d4b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_ac75a88d-13ed-4970-a826-295a5cd3e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_ac75a88d-13ed-4970-a826-295a5cd3e7f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_738fba08-97c9-4d15-8208-e31d2ea85f86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_738fba08-97c9-4d15-8208-e31d2ea85f86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8ee6ca88-39f7-432d-8e0b-ce5fa521915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8ee6ca88-39f7-432d-8e0b-ce5fa521915e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended" id="i37ff7356af454793a3c977166b90cf39_BalanceSheetDetailPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_16459529-6250-40c8-ac02-93e3fa8f8a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_16459529-6250-40c8-ac02-93e3fa8f8a6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_354a3bf5-6e09-4598-b904-dd297a247696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_354a3bf5-6e09-4598-b904-dd297a247696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bb7ba16d-63c6-41a7-8b83-c86e192b37f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bb7ba16d-63c6-41a7-8b83-c86e192b37f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1a67af34-8f91-453f-945a-1651c4423627_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1a67af34-8f91-453f-945a-1651c4423627_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5b29a800-5f41-4bdd-b818-281e744ea372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5b29a800-5f41-4bdd-b818-281e744ea372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_88351e9d-ea83-49e9-98c6-a58885b8fab1" xlink:href="cutr-20221231.xsd#cutr_LeasedEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_cutr_LeasedEquipmentMember_88351e9d-ea83-49e9-98c6-a58885b8fab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_db8b66c7-9a5c-4d60-8b5b-ce679d621554" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_cutr_AviClearMember_db8b66c7-9a5c-4d60-8b5b-ce679d621554" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b54eafcc-3198-42c6-a2ff-d4f8e31c2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b54eafcc-3198-42c6-a2ff-d4f8e31c2de9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b01c9f75-1040-4104-9d93-f22111da3c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b01c9f75-1040-4104-9d93-f22111da3c59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_c6270e89-8806-40cf-9f5b-26deadca4995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_AssetUnderConstructionMember_c6270e89-8806-40cf-9f5b-26deadca4995" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="extended" id="ibea38dedb7d448fb8dcd11d0a73f7081_DeferredRevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:href="cutr-20221231.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_269e2a66-1a8d-457f-82f8-d47c70b3a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_269e2a66-1a8d-457f-82f8-d47c70b3a81a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d81f5a11-6c69-4e09-b19f-db0813988d05_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:to="loc_srt_ProductsAndServicesDomain_d81f5a11-6c69-4e09-b19f-db0813988d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:to="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:to="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:to="loc_srt_RangeMember_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:to="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended" id="if759c42de1de4ba8b76dbeca3b148676_DeferredRevenueNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:href="cutr-20221231.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d81f5a11-6c69-4e09-b19f-db0813988d05_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:to="loc_srt_ProductsAndServicesDomain_d81f5a11-6c69-4e09-b19f-db0813988d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:to="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:to="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:to="loc_srt_RangeMember_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:to="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended" id="i4a75cf6e65f4426a937278afbe8a7f13_StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_eec99c5d-ee67-4a99-b507-ee302be80ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_eec99c5d-ee67-4a99-b507-ee302be80ab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized_453b001d-2dcf-48ae-9173-d86ca26f9434" xlink:href="cutr-20221231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_CapitalStockSharesAuthorized_453b001d-2dcf-48ae-9173-d86ca26f9434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b9ba92d4-91e4-4400-9adb-7171ea8bd0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b9ba92d4-91e4-4400-9adb-7171ea8bd0f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3e7dddcb-a2d1-478b-91f8-10b94ba8be6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesIssued_3e7dddcb-a2d1-478b-91f8-10b94ba8be6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_36bb2ade-d0fd-4887-8578-8ba5dc06198d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_36bb2ade-d0fd-4887-8578-8ba5dc06198d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_09043f4a-d306-42d1-93cc-d9eb62edeaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_09043f4a-d306-42d1-93cc-d9eb62edeaf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0001625e-50a0-4c2a-8439-58efe240aba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0001625e-50a0-4c2a-8439-58efe240aba8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f86f1923-ccd3-444d-9fc1-ee96f0e8322c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f86f1923-ccd3-444d-9fc1-ee96f0e8322c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f1eaf075-bde6-4277-979f-bd3cafcd7fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f1eaf075-bde6-4277-979f-bd3cafcd7fd4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9468bcb1-3e68-43d6-80f2-ab2534503b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9468bcb1-3e68-43d6-80f2-ab2534503b8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a98e4dc0-67b1-4200-be21-32335efad13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a98e4dc0-67b1-4200-be21-32335efad13a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8beb6d22-bb0f-4c0f-9aab-06c9aee83f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8beb6d22-bb0f-4c0f-9aab-06c9aee83f12" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_4752051c-9e06-4897-9875-090644da5c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_4752051c-9e06-4897-9875-090644da5c9d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3651aba6-251a-4618-b3bb-b320092bd252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3651aba6-251a-4618-b3bb-b320092bd252" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_aab61421-5f5f-464d-aac8-2bf1b2e21a28" xlink:href="cutr-20221231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_aab61421-5f5f-464d-aac8-2bf1b2e21a28" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c2e20c5-8c7f-4b8b-b432-51d58f2c1dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c2e20c5-8c7f-4b8b-b432-51d58f2c1dda" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c164d07d-3000-4c17-90d9-5b7edb8730ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c164d07d-3000-4c17-90d9-5b7edb8730ca" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_ab8021a3-f886-4a1e-83df-8944324ce184" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_ab8021a3-f886-4a1e-83df-8944324ce184" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_8fb31687-8157-46c0-b050-dd348b5018f0" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_8fb31687-8157-46c0-b050-dd348b5018f0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_049fd950-cacc-423e-ac33-03dd4dc8edfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_049fd950-cacc-423e-ac33-03dd4dc8edfa" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5977952f-4351-4c82-9d16-a4e5a107943f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5977952f-4351-4c82-9d16-a4e5a107943f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_ec70fd6e-8472-49df-9e7a-d19c0fd2d438" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_ec70fd6e-8472-49df-9e7a-d19c0fd2d438" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_354e58fe-4816-48d1-87ae-4110c5b0a39f" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_354e58fe-4816-48d1-87ae-4110c5b0a39f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4f98c934-bac1-45fe-91fb-952831d96072" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4f98c934-bac1-45fe-91fb-952831d96072" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_0f0ae259-f4d3-4003-86db-c77ea0448fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_0f0ae259-f4d3-4003-86db-c77ea0448fc1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_32a81af2-5180-437e-a26a-d3f7c46208d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_32a81af2-5180-437e-a26a-d3f7c46208d6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_958a3b5d-bfaf-4586-808a-b20abed78bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_958a3b5d-bfaf-4586-808a-b20abed78bea" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1e64eabb-4edc-45e8-839f-fc6a5f8946c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1e64eabb-4edc-45e8-839f-fc6a5f8946c8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2c4d8fae-8718-4613-9a41-ab6933b71722_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2c4d8fae-8718-4613-9a41-ab6933b71722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember_cec31438-068e-4c0f-b7ba-8502737d543d" xlink:href="cutr-20221231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:to="loc_cutr_UnderwrittenPublicOfferingMember_cec31438-068e-4c0f-b7ba-8502737d543d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f8e4472-9f07-49c7-bb97-cc344c164626_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1f8e4472-9f07-49c7-bb97-cc344c164626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember_60782591-f8b9-474b-96c2-6789ec348bfd" xlink:href="cutr-20221231.xsd#cutr_UnderwriterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:to="loc_cutr_UnderwriterMember_60782591-f8b9-474b-96c2-6789ec348bfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bb7db70a-4f3d-46d2-93ea-97f695fbf732_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:to="loc_us-gaap_PlanNameDomain_bb7db70a-4f3d-46d2-93ea-97f695fbf732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:to="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember_d0947ffd-7fac-4e61-92d5-c124e2b967ea" xlink:href="cutr-20221231.xsd#cutr_StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_StockPlanMember_d0947ffd-7fac-4e61-92d5-c124e2b967ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember_3cefefdb-56bd-4a85-a326-26a585bec8ca" xlink:href="cutr-20221231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TwoThousandFourEquityIncentivePlanMember_3cefefdb-56bd-4a85-a326-26a585bec8ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_0f640e40-3c17-4fdf-91f4-4ee14ecad96c" xlink:href="cutr-20221231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_0f640e40-3c17-4fdf-91f4-4ee14ecad96c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_f99aef2b-977a-413e-a4c4-367cb8883bd9" xlink:href="cutr-20221231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_f99aef2b-977a-413e-a4c4-367cb8883bd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember_332622b4-0ab5-4a05-858a-3f5421c0343f" xlink:href="cutr-20221231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_EmployeeStockPurchasePlanMember_332622b4-0ab5-4a05-858a-3f5421c0343f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember_25b8567b-ab4d-48df-b1ee-b58e7a4ef8ff" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:to="loc_cutr_RestrictedStockUnitsAnnualGrantMember_25b8567b-ab4d-48df-b1ee-b58e7a4ef8ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember_106fde14-26bf-49b9-aada-0502b868f9b0" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:to="loc_cutr_RestrictedStockUnitsNewHireMember_106fde14-26bf-49b9-aada-0502b868f9b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0d6a4cb5-36c4-4a2b-bbe5-6647d582a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:to="loc_us-gaap_PerformanceSharesMember_0d6a4cb5-36c4-4a2b-bbe5-6647d582a7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_b92fc55f-a05a-4122-983e-838664131de5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:to="loc_us-gaap_GranteeStatusDomain_b92fc55f-a05a-4122-983e-838664131de5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:to="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_6a1e23fe-e344-4fc5-9777-a64f81714c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_6a1e23fe-e344-4fc5-9777-a64f81714c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a18f257a-d2ac-42f6-8b10-7939c5f8ee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a18f257a-d2ac-42f6-8b10-7939c5f8ee64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0f07ffd5-3726-4c17-9c77-9a4267bb041e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:to="loc_us-gaap_VestingDomain_0f07ffd5-3726-4c17-9c77-9a4267bb041e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:to="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0ada26c0-9f34-448c-b47e-0963293a8720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0ada26c0-9f34-448c-b47e-0963293a8720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_de4f6e01-928b-4630-9bae-74e78c8b5e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_de4f6e01-928b-4630-9bae-74e78c8b5e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_853de6a2-f78f-411b-8352-28e2885acaa0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:to="loc_us-gaap_RelatedPartyDomain_853de6a2-f78f-411b-8352-28e2885acaa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:to="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_297f5d9d-d7ac-4687-9648-4accca3d4122" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:to="loc_srt_DirectorMember_297f5d9d-d7ac-4687-9648-4accca3d4122" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="extended" id="i771126a92ea74f5688414558f3355c0e_StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_613d6274-0296-4e67-a96d-3f789166ca07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_613d6274-0296-4e67-a96d-3f789166ca07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1969e415-956a-4480-b49b-551cfc832d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1969e415-956a-4480-b49b-551cfc832d33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_df3acfbc-cf6c-4d43-ad6e-f8efc1e80874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_df3acfbc-cf6c-4d43-ad6e-f8efc1e80874" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_ae30e4dd-74c2-4949-81d2-6b596bca3a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_ae30e4dd-74c2-4949-81d2-6b596bca3a83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_6ac1f2e6-7522-462f-a195-d51fc492477f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_6ac1f2e6-7522-462f-a195-d51fc492477f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49219d6c-70ba-4ba6-9107-d3c34f0f2e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49219d6c-70ba-4ba6-9107-d3c34f0f2e7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608fc338-e62a-4052-99f2-9dbc46e60055_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_608fc338-e62a-4052-99f2-9dbc46e60055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member_e3095217-592b-43ac-a598-4859e5fc8801" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange1Member_e3095217-592b-43ac-a598-4859e5fc8801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member_d2b55cf0-0d05-4f6e-820e-4c5260b5f5a4" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange2Member_d2b55cf0-0d05-4f6e-820e-4c5260b5f5a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member_944c914c-0a40-42f8-9b27-ddd19dce28e2" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange3Member_944c914c-0a40-42f8-9b27-ddd19dce28e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member_b0edac5e-29b2-4adc-98d4-d0c622a1dcc0" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange4Member_b0edac5e-29b2-4adc-98d4-d0c622a1dcc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member_a51e8e8d-4731-4929-be39-5a8f328cf708" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange5Member_a51e8e8d-4731-4929-be39-5a8f328cf708" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member_7f768c08-e5f0-4bc9-aacc-55a21de74599" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange6Member_7f768c08-e5f0-4bc9-aacc-55a21de74599" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member_5caed721-b4b0-484b-b1b1-bfcdf375d8be" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange7Member_5caed721-b4b0-484b-b1b1-bfcdf375d8be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member_1983125f-ff86-458c-ab72-8041ad3d3f1c" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange8Member_1983125f-ff86-458c-ab72-8041ad3d3f1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member_c97bac68-883a-4ef6-a22e-631dfcced3c5" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange9Member_c97bac68-883a-4ef6-a22e-631dfcced3c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member_74e87ca0-0c46-4af5-90ec-8660ffbb169f" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange10Member_74e87ca0-0c46-4af5-90ec-8660ffbb169f" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="extended" id="ife9cfb5d74d943ad8b07f4f7c3450fc1_StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67871d4f-4d3b-4751-aee4-b3954c47312d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67871d4f-4d3b-4751-aee4-b3954c47312d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdee1e1-7d7b-4670-afbc-86dc96b7291a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdee1e1-7d7b-4670-afbc-86dc96b7291a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7d1b8a67-0a7e-492a-a2e4-10a46c4a98b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7d1b8a67-0a7e-492a-a2e4-10a46c4a98b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19cc98b2-7521-49a6-bafb-3a8ee813d667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19cc98b2-7521-49a6-bafb-3a8ee813d667" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6284345-a72e-463d-8278-74ef58e7bf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00c704f7-6fc6-48c0-8bb1-126a52e60ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00c704f7-6fc6-48c0-8bb1-126a52e60ced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638f8062-0058-4e18-b10a-78c8441db255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638f8062-0058-4e18-b10a-78c8441db255" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d7cbe683-211b-4a54-81a8-db64d4b75039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d7cbe683-211b-4a54-81a8-db64d4b75039" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_84316397-9fdb-4068-b344-6c2d7a0607ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_84316397-9fdb-4068-b344-6c2d7a0607ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c7bb5d0-f283-4482-ae82-644e666ced7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_33dacaaf-a6e0-4ef1-87dd-939456f24b0f" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_33dacaaf-a6e0-4ef1-87dd-939456f24b0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_f17cf7e0-fa6e-44ce-a0d6-c732e083cd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_f17cf7e0-fa6e-44ce-a0d6-c732e083cd23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7234b96d-ffab-4c54-8480-3b00e5a38fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7234b96d-ffab-4c54-8480-3b00e5a38fe2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_45d854a5-946c-434d-a4e4-a6a58ade4adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_SharePrice_45d854a5-946c-434d-a4e4-a6a58ade4adb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:to="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d47f115b-7559-434c-8463-742653c4397e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d47f115b-7559-434c-8463-742653c4397e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_16238483-a941-4d4a-9e81-dab7cbc0ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_16238483-a941-4d4a-9e81-dab7cbc0ca82" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="extended" id="i5d2071ed1e1848bca7501b8b0e6aec82_StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_62996d91-d82c-43ea-bbdb-c7ede3bb9d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_62996d91-d82c-43ea-bbdb-c7ede3bb9d63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:to="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_844fa146-ae60-4fba-8b3c-93216bcc4bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_EmployeeStockOptionMember_844fa146-ae60-4fba-8b3c-93216bcc4bbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_67ff58c4-2ef9-4688-a112-ec2450d3babb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_67ff58c4-2ef9-4688-a112-ec2450d3babb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_aea989b1-dbf3-408a-ad30-bc7d2a8c38f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_PerformanceSharesMember_aea989b1-dbf3-408a-ad30-bc7d2a8c38f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember_0a71972e-4556-452d-8ad5-4c5bdec7892f" xlink:href="cutr-20221231.xsd#cutr_ESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_cutr_ESPPMember_0a71972e-4556-452d-8ad5-4c5bdec7892f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="extended" id="i99ecf6f98b1b44ff82a590eac98a8448_StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_eaaf3c69-eda0-4c98-9f83-a9edeea45f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_eaaf3c69-eda0-4c98-9f83-a9edeea45f6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3438305b-8fd8-46f6-a419-c5e8f8fecc62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3438305b-8fd8-46f6-a419-c5e8f8fecc62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4cf92775-b185-4ea1-8842-8f1d528c5c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_CostOfSalesMember_4cf92775-b185-4ea1-8842-8f1d528c5c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_9ad3378d-0e89-42fb-becb-88cc07af3240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_9ad3378d-0e89-42fb-becb-88cc07af3240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_edc01a8e-4c77-4965-9f7c-1d1ff4bd807b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_edc01a8e-4c77-4965-9f7c-1d1ff4bd807b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f937bb82-8196-42e1-8e02-9734e0539794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f937bb82-8196-42e1-8e02-9734e0539794" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="extended" id="i532b87a3df154455bbddb59f28760524_StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be8ec169-f4d6-42e8-b064-17a3c4b96d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be8ec169-f4d6-42e8-b064-17a3c4b96d31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7d7dc3fe-fd31-4e63-937b-30b078023fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7d7dc3fe-fd31-4e63-937b-30b078023fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f3c0d910-52f3-4103-b9e9-96e8867d2350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f3c0d910-52f3-4103-b9e9-96e8867d2350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f21ff32d-f9b0-40f6-a16f-a571a84d0b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f21ff32d-f9b0-40f6-a16f-a571a84d0b53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bff6d19e-cbc7-43ef-baa7-e139463874e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bff6d19e-cbc7-43ef-baa7-e139463874e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:to="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45103228-0aa3-46e8-ac6b-8f7bc35ed52c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45103228-0aa3-46e8-ac6b-8f7bc35ed52c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_afd6a413-813d-4aef-b693-b5bfb6ffff28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_afd6a413-813d-4aef-b693-b5bfb6ffff28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember_d039677e-d621-44d9-b94b-94f22d3d50cc" xlink:href="cutr-20221231.xsd#cutr_StockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:to="loc_cutr_StockPurchasePlanMember_d039677e-d621-44d9-b94b-94f22d3d50cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i978466efe7d64afab2c8378aa4465191_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ccdc4bbc-eaba-4046-8486-78cbba369b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ccdc4bbc-eaba-4046-8486-78cbba369b9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e4ba885a-b9f2-4b7e-9d07-5ea5a152328d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e4ba885a-b9f2-4b7e-9d07-5ea5a152328d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_920650e5-f6bb-421a-9fdd-cf965584bfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_920650e5-f6bb-421a-9fdd-cf965584bfac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_401c9ed9-a408-4882-a097-996ea7d917c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_OperatingLossCarryforwards_401c9ed9-a408-4882-a097-996ea7d917c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_874b3c88-30ca-4fb0-9e60-f2243117965f" xlink:href="cutr-20221231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_874b3c88-30ca-4fb0-9e60-f2243117965f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_65212ef2-58f6-4d7c-8005-7eb8b031b678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_65212ef2-58f6-4d7c-8005-7eb8b031b678" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_7efe8efc-b30d-47c4-b304-8ad1ef884267" xlink:href="cutr-20221231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_7efe8efc-b30d-47c4-b304-8ad1ef884267" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_29985374-ad4f-4832-a8b4-957b851266c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_29985374-ad4f-4832-a8b4-957b851266c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_832da35f-52b7-4299-bde9-55a30fbc480d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_ForeignCountryMember_832da35f-52b7-4299-bde9-55a30fbc480d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_2512c7ce-c0fa-49e7-827c-9083afab8da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_DomesticCountryMember_2512c7ce-c0fa-49e7-827c-9083afab8da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f25dbb3b-75f6-42f2-b44f-51ecbe21028a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f25dbb3b-75f6-42f2-b44f-51ecbe21028a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8d913739-04f1-43e0-a50f-8e666fc74c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8d913739-04f1-43e0-a50f-8e666fc74c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_19f5a3f3-1841-4469-9b9b-4ee4af2e847c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_19f5a3f3-1841-4469-9b9b-4ee4af2e847c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5e269005-57e9-49ef-aa76-7ff44a77dafe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5e269005-57e9-49ef-aa76-7ff44a77dafe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_ee06bdd2-faa0-44da-965f-e89f7e5c8716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:to="loc_us-gaap_ResearchMember_ee06bdd2-faa0-44da-965f-e89f7e5c8716" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended" id="i43b8ce7e4e424fd68773a1a06d943779_NetIncomeLossPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_03555a2c-20d6-4493-a3d2-00ec84a1fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_03555a2c-20d6-4493-a3d2-00ec84a1fe42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a3a596c-d28c-450c-9738-fae5310b101e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a3a596c-d28c-450c-9738-fae5310b101e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_1e67afed-d423-45be-8eb2-64059d6b6731" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_1e67afed-d423-45be-8eb2-64059d6b6731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7424dbda-8591-447b-a6d1-df4ac201eb92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7424dbda-8591-447b-a6d1-df4ac201eb92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_caa19c91-2749-4876-b021-77c08e2bfebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:to="loc_us-gaap_ConvertibleDebtMember_caa19c91-2749-4876-b021-77c08e2bfebc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended" id="i62dd0e3795c24fec9feb55f0bdf1b5d6_NetIncomeLossPerShareNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc57d014-fb86-4027-9aba-65803f2509cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:to="loc_us-gaap_NetIncomeLoss_fc57d014-fb86-4027-9aba-65803f2509cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8852aac6-ce6b-4061-86ea-593cf2387afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8852aac6-ce6b-4061-86ea-593cf2387afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4414fe4a-f297-479a-be31-3b57588dcbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4414fe4a-f297-479a-be31-3b57588dcbc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_018e8cc3-2b7a-461e-aaf2-37b99c9a874c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_018e8cc3-2b7a-461e-aaf2-37b99c9a874c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_df61f5b3-feb4-4988-b667-a1d385d38302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:to="loc_us-gaap_EarningsPerShareBasic_df61f5b3-feb4-4988-b667-a1d385d38302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7888e434-e9fb-4af6-9e19-1a4a3eb794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7888e434-e9fb-4af6-9e19-1a4a3eb794f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:to="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f76ae6c6-de1d-4c5a-a70a-cd90fc5eb206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f76ae6c6-de1d-4c5a-a70a-cd90fc5eb206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_991dbc09-c794-4cc3-83b2-131d26fb86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_991dbc09-c794-4cc3-83b2-131d26fb86ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3a338975-8ff2-49bd-bb91-be39545cf05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_PerformanceSharesMember_3a338975-8ff2-49bd-bb91-be39545cf05b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_32fe87b1-7581-4f65-b1a1-41f364ad1ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_EmployeeStockMember_32fe87b1-7581-4f65-b1a1-41f364ad1ca9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended" id="id496586ea0cd433b99540693a0678df3_NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d142e24-b12a-4a4b-a484-00ab67e2815c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d142e24-b12a-4a4b-a484-00ab67e2815c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d2bbe4dd-11c4-4295-877f-11395a62bd56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d2bbe4dd-11c4-4295-877f-11395a62bd56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember_1c757b67-3e00-4689-a102-237c7bb02454" xlink:href="cutr-20221231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_cutr_CappedCallSecuritiesMember_1c757b67-3e00-4689-a102-237c7bb02454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_d5d5a6e5-b8a8-4948-bae1-c2bfff6f0007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_d5d5a6e5-b8a8-4948-bae1-c2bfff6f0007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f6ae550a-cde5-4bc2-980b-406152024c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f6ae550a-cde5-4bc2-980b-406152024c05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9ec90eaf-5772-4833-b31c-b5bb0677e994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9ec90eaf-5772-4833-b31c-b5bb0677e994" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_02248b93-3f16-4e9a-8992-349743ab4591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_EmployeeStockMember_02248b93-3f16-4e9a-8992-349743ab4591" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cc248ac1-993a-42a7-992c-14757f294363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_PerformanceSharesMember_cc248ac1-993a-42a7-992c-14757f294363" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails" xlink:type="extended" id="i9cff09a4b5a54fd08fff8ef9bbb44277_SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_70cd9255-a87c-4853-a578-9787cc36cf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_70cd9255-a87c-4853-a578-9787cc36cf83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_19d5fe76-7240-418a-b2b1-743190e09961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_OperatingIncomeLoss_19d5fe76-7240-418a-b2b1-743190e09961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7f5b886f-e890-48f6-bd7f-caa9013a5515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_ShareBasedCompensation_7f5b886f-e890-48f6-bd7f-caa9013a5515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ERPImplementation_43b5d457-7bdd-464b-a958-18b9a2b0d03f" xlink:href="cutr-20221231.xsd#cutr_ERPImplementation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_cutr_ERPImplementation_43b5d457-7bdd-464b-a958-18b9a2b0d03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_763f46cc-88f8-4bd6-9857-c01bf52c1485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_DepreciationAndAmortization_763f46cc-88f8-4bd6-9857-c01bf52c1485" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LegalFeesSeveranceAndOther_574bc613-0b9d-4747-9340-6802f430ef0f" xlink:href="cutr-20221231.xsd#cutr_LegalFeesSeveranceAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_cutr_LegalFeesSeveranceAndOther_574bc613-0b9d-4747-9340-6802f430ef0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_be7434d7-b167-412a-8158-72d09b133fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_be7434d7-b167-412a-8158-72d09b133fc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c45befc0-cdfc-4306-b935-6739d0930abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c45befc0-cdfc-4306-b935-6739d0930abd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnersCapital_9136bd8d-24c5-4676-8fe5-c07c71d6269b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_PartnersCapital_9136bd8d-24c5-4676-8fe5-c07c71d6269b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ffcc4f7b-977d-4f70-bd49-f8d4658cebfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_Assets_ffcc4f7b-977d-4f70-bd49-f8d4658cebfb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:to="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a0bda786-e2b1-4ae1-80c0-2da6e9976b43_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:to="loc_srt_ConsolidationItemsDomain_a0bda786-e2b1-4ae1-80c0-2da6e9976b43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:to="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d3a1846f-db45-450d-8926-ac60ade03c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:to="loc_us-gaap_OperatingSegmentsMember_d3a1846f-db45-450d-8926-ac60ade03c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cd74336b-92c2-4cbb-a0b2-97e5870cd31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cd74336b-92c2-4cbb-a0b2-97e5870cd31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de13b40b-217a-4df0-a1a5-312bd3f5a08a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:to="loc_us-gaap_SegmentDomain_de13b40b-217a-4df0-a1a5-312bd3f5a08a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:to="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CuteraCoreMember_cb4eb7a4-109d-4334-9527-3250945ebc26" xlink:href="cutr-20221231.xsd#cutr_CuteraCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:to="loc_cutr_CuteraCoreMember_cb4eb7a4-109d-4334-9527-3250945ebc26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_0b369b2d-50ae-4bea-b234-b7a48cf36900" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:to="loc_cutr_AviClearMember_0b369b2d-50ae-4bea-b234-b7a48cf36900" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails" xlink:type="extended" id="i4b0d5c4e95d64839ae5cd3515db8ccd4_SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_627d3203-233b-4aa2-8422-61af6f1e9a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_627d3203-233b-4aa2-8422-61af6f1e9a6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:to="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6f537f95-8261-4b91-9d33-53958f56b728_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:to="loc_srt_SegmentGeographicalDomain_6f537f95-8261-4b91-9d33-53958f56b728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:to="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e89567b1-0cfa-47bd-8f19-734a10b1c260" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_country_US_e89567b1-0cfa-47bd-8f19-734a10b1c260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_7ec2c8dd-9104-4a2d-8202-24a562de5f9a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_country_JP_7ec2c8dd-9104-4a2d-8202-24a562de5f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_8ac8f44e-7a9e-48e3-8268-6a6b65ceeb46" xlink:href="cutr-20221231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_cutr_AsiaExcludingJapanMember_8ac8f44e-7a9e-48e3-8268-6a6b65ceeb46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_47847436-06fe-4239-85f1-f345bac61a6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_srt_EuropeMember_47847436-06fe-4239-85f1-f345bac61a6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_6fe59049-5387-47ab-b59c-a11e5944769b" xlink:href="cutr-20221231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_6fe59049-5387-47ab-b59c-a11e5944769b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:to="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fafaf2ef-ba58-41ce-85d7-964fb3006c77_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:to="loc_srt_ProductsAndServicesDomain_fafaf2ef-ba58-41ce-85d7-964fb3006c77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:to="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:href="cutr-20221231.xsd#cutr_TotalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:to="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember_48d377a0-1d63-475e-945b-0a4d35fd84b2" xlink:href="cutr-20221231.xsd#cutr_SystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_SystemsMember_48d377a0-1d63-475e-945b-0a4d35fd84b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_7ffaa4b5-747a-4e14-af1d-3803cffc54c0" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_AviClearMember_7ffaa4b5-747a-4e14-af1d-3803cffc54c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember_03efd98b-edbf-4d9c-915c-6955180f88bb" xlink:href="cutr-20221231.xsd#cutr_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_ConsumablesMember_03efd98b-edbf-4d9c-915c-6955180f88bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_bdf90e4f-027d-4861-83dd-3259f08e2840" xlink:href="cutr-20221231.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_SkincareMember_bdf90e4f-027d-4861-83dd-3259f08e2840" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cd14b6af-2235-43d2-a09c-9e8d93af250d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:to="loc_us-gaap_ServiceMember_cd14b6af-2235-43d2-a09c-9e8d93af250d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="id245a743247e4dd3a1aef792f2bb236c_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm_5aeb050a-da3f-48fc-aa9d-100a03bd9b70" xlink:href="cutr-20221231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LesseeLeasesRemainingTerm_5aeb050a-da3f-48fc-aa9d-100a03bd9b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm_c7b1f10b-edd8-4bdd-80ea-b47078371858" xlink:href="cutr-20221231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LesseeLeaseRenewalTerm_c7b1f10b-edd8-4bdd-80ea-b47078371858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_55d05668-1107-4ae1-9bbd-9ad2ad3b79f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_55d05668-1107-4ae1-9bbd-9ad2ad3b79f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorDurationOfAutorenewalFeatures_45af98f4-eabc-4662-80e6-673f724bdb4e" xlink:href="cutr-20221231.xsd#cutr_LessorDurationOfAutorenewalFeatures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LessorDurationOfAutorenewalFeatures_45af98f4-eabc-4662-80e6-673f724bdb4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a434e953-6d8e-49e7-9f2d-681c64d2b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_LitigationReserve_a434e953-6d8e-49e7-9f2d-681c64d2b55b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_40b15857-e960-41fa-81dc-ecc453fca161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_40b15857-e960-41fa-81dc-ecc453fca161" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfConsecutiveLeaseTerms_502a47a7-72e5-489f-9411-ba512b3651b8" xlink:href="cutr-20221231.xsd#cutr_NumberOfConsecutiveLeaseTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_NumberOfConsecutiveLeaseTerms_502a47a7-72e5-489f-9411-ba512b3651b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_a58df118-c913-45b9-a22c-1fe75f741581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_CapitalizedContractCostNet_a58df118-c913-45b9-a22c-1fe75f741581" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7029fda7-b4f6-4af3-a466-1ec5f19b83d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7029fda7-b4f6-4af3-a466-1ec5f19b83d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:to="loc_srt_RangeMember_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:to="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_588abb85-7ef1-4537-a1f7-fd77d1228e62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:to="loc_srt_MinimumMember_588abb85-7ef1-4537-a1f7-fd77d1228e62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_54523373-fdfb-44ef-8932-9b9a76ba9c97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:to="loc_srt_MaximumMember_54523373-fdfb-44ef-8932-9b9a76ba9c97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7cb76021-cb3c-4fb0-972c-795198d6e269_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7cb76021-cb3c-4fb0-972c-795198d6e269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDeviceMember_951cf41e-42b9-4262-8ad3-ca659a0c939c" xlink:href="cutr-20221231.xsd#cutr_AviClearDeviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_AviClearDeviceMember_951cf41e-42b9-4262-8ad3-ca659a0c939c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_f8a03697-33c5-42ea-ba25-dec7f309e974" xlink:href="cutr-20221231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_f8a03697-33c5-42ea-ba25-dec7f309e974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseInstallmentCostsMember_a6bc5827-17df-4eaa-a631-5cd610680143" xlink:href="cutr-20221231.xsd#cutr_LeaseInstallmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_LeaseInstallmentCostsMember_a6bc5827-17df-4eaa-a631-5cd610680143" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_85810acf-4dd3-4205-b3e7-5f7e2de1240c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_85810acf-4dd3-4205-b3e7-5f7e2de1240c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5d8970d2-027a-4d9c-ad03-d3f0a4e8c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5d8970d2-027a-4d9c-ad03-d3f0a4e8c2d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4c108abb-25f2-41f5-8d11-db7f61e915a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4c108abb-25f2-41f5-8d11-db7f61e915a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_30c06c71-c402-49c7-8686-663733aaf14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_30c06c71-c402-49c7-8686-663733aaf14a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesOperatingLeaseIncomeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="extended" id="id36487ceea114a64a361b121c864d502_CommitmentsandContingenciesOperatingLeaseIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_9938045b-6a46-42b8-8d67-8e76f59ac633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:to="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_9938045b-6a46-42b8-8d67-8e76f59ac633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:to="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c597836f-3c65-4024-934b-cdb01175a980_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:to="loc_srt_ProductsAndServicesDomain_c597836f-3c65-4024-934b-cdb01175a980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:to="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:href="cutr-20221231.xsd#cutr_AviClearRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:to="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_fb309357-741c-490a-8e32-3b30136f9fcb" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseLicenseFeeRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:to="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_fb309357-741c-490a-8e32-3b30136f9fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember_35321441-433f-42ec-8921-a193fb7e3805" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseRecurringRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:to="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember_35321441-433f-42ec-8921-a193fb7e3805" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended" id="ic42fecf023b148428355434b44e26463_DebtOutstandingDebtandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2f24826f-e20d-46a4-8a38-476dd0f23384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2f24826f-e20d-46a4-8a38-476dd0f23384" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_46523bf5-03b4-47c3-b4ba-f40d6a319431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_46523bf5-03b4-47c3-b4ba-f40d6a319431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad948667-382f-47f1-91a3-7ec5c2bd9e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_LongTermDebt_ad948667-382f-47f1-91a3-7ec5c2bd9e1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd5a0a2c-45be-448c-8775-54c1c6248e64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd5a0a2c-45be-448c-8775-54c1c6248e64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_bc813b70-7e5a-4e32-ada1-7cb4dc504fd5" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_bc813b70-7e5a-4e32-ada1-7cb4dc504fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_754d912a-c7d4-4263-b44e-1fe9f84b8207" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_754d912a-c7d4-4263-b44e-1fe9f84b8207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2029Member_76022fbe-d851-4e9a-a547-4d8f31187ce7" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2029Member_76022fbe-d851-4e9a-a547-4d8f31187ce7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03d5e146-ffe8-43e6-817d-3a459d730e3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03d5e146-ffe8-43e6-817d-3a459d730e3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_38ce7aa3-4bb9-4cfe-bf23-1f5e70322aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:to="loc_us-gaap_ConvertibleDebtMember_38ce7aa3-4bb9-4cfe-bf23-1f5e70322aeb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DebtNarrativeDetails" xlink:type="extended" id="idaf38ddb765c41bcb8bf6df3cbc5c74b_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0d2b9049-8f6b-49c4-9b8c-54af836f89d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0d2b9049-8f6b-49c4-9b8c-54af836f89d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34d2da8e-b9ce-47d7-8c66-255a899fc9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34d2da8e-b9ce-47d7-8c66-255a899fc9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc5edd23-e90f-4193-a194-987e8053c210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc5edd23-e90f-4193-a194-987e8053c210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d54e85b0-ca30-48b9-8f1f-7ddba5583bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d54e85b0-ca30-48b9-8f1f-7ddba5583bce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71060c6c-0b28-4f7c-8ad9-42a0038d98a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71060c6c-0b28-4f7c-8ad9-42a0038d98a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_3f071f47-81e3-437c-80c1-9a06687c389f" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAdditionalAggregatePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_3f071f47-81e3-437c-80c1-9a06687c389f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued_1ed88436-e68a-49ab-992b-68e5eef0e6a8" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtConversionConvertedInstrumentCashIssued_1ed88436-e68a-49ab-992b-68e5eef0e6a8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4fd6395e-4e99-4cfc-8e51-67cfb43a93b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4fd6395e-4e99-4cfc-8e51-67cfb43a93b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fb8365bb-4dc9-476d-b1e3-af75e4f60b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fb8365bb-4dc9-476d-b1e3-af75e4f60b42" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a8c0e310-3532-46cc-8f1d-6f8906a6f629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a8c0e310-3532-46cc-8f1d-6f8906a6f629" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3f9bfe5a-5a04-4904-b949-3e3763984c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LongTermDebt_3f9bfe5a-5a04-4904-b949-3e3763984c30" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_ff5a7baf-9919-467e-bc6a-f34c8a850411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_SharePrice_ff5a7baf-9919-467e-bc6a-f34c8a850411" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_992661d1-cd86-42f2-9919-d0d088883c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_992661d1-cd86-42f2-9919-d0d088883c27" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_5bc38552-db85-476e-afc5-5f6c8f467619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_5bc38552-db85-476e-afc5-5f6c8f467619" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4d9d209e-0cbc-43f0-833f-04624c335e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4d9d209e-0cbc-43f0-833f-04624c335e57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_9b4a1dc4-851d-461a-8a01-d2de4cfbc709" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_9b4a1dc4-851d-461a-8a01-d2de4cfbc709" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_f8f052a5-af05-45c7-9ef6-93b83ef8dee7" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_f8f052a5-af05-45c7-9ef6-93b83ef8dee7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_853738e9-d3f0-4a8c-b62d-01288c0abb43" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_853738e9-d3f0-4a8c-b62d-01288c0abb43" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_863e413c-7330-4b99-b559-abe1e0ed4d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_863e413c-7330-4b99-b559-abe1e0ed4d07" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_9ba80dc3-e953-4514-a94d-e89954dad1a6" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_9ba80dc3-e953-4514-a94d-e89954dad1a6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_2322df74-6244-4cb5-b315-858eaaefb473" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_2322df74-6244-4cb5-b315-858eaaefb473" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6280a271-aeca-4da3-9e9a-e93342b27d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6280a271-aeca-4da3-9e9a-e93342b27d31" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f2ab69f9-10d6-4786-8374-5b053cb2b1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f2ab69f9-10d6-4786-8374-5b053cb2b1fd" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_c1490ecd-a016-4097-9645-adaa95177403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCapPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DerivativeCapPrice_c1490ecd-a016-4097-9645-adaa95177403" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_a95f3c87-cf10-4a31-8c0e-d7c74f13bfb0" xlink:href="cutr-20221231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_a95f3c87-cf10-4a31-8c0e-d7c74f13bfb0" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_121ca18b-2c26-4d3c-a9b7-31352b038e2a" xlink:href="cutr-20221231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_121ca18b-2c26-4d3c-a9b7-31352b038e2a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f211c71c-7a8d-493e-9423-23ece9e08b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f211c71c-7a8d-493e-9423-23ece9e08b74" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4abf11c8-6ca3-4947-af69-fd2a8be0bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4abf11c8-6ca3-4947-af69-fd2a8be0bd5a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_388142df-0577-4364-927f-b253fd560c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_388142df-0577-4364-927f-b253fd560c40" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_1ccdd92b-f547-41ee-9523-3eb7b7281759" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_1ccdd92b-f547-41ee-9523-3eb7b7281759" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8e02ea22-4b6f-402d-80d2-f6171841b58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8e02ea22-4b6f-402d-80d2-f6171841b58a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_c23f26b9-1375-42de-b6ab-5f2e1cfbed27" xlink:href="cutr-20221231.xsd#cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_c23f26b9-1375-42de-b6ab-5f2e1cfbed27" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c91681f0-4033-446c-8deb-0bf9f46c9f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentTerm_c91681f0-4033-446c-8deb-0bf9f46c9f5a" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3b1e8b76-1879-4792-b2c0-4177e56781a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3b1e8b76-1879-4792-b2c0-4177e56781a3" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_9a461fed-13ef-4bcb-b64a-42857205bcc5" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_9a461fed-13ef-4bcb-b64a-42857205bcc5" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5de99ce-8e31-4861-ae63-8986bf94373b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5de99ce-8e31-4861-ae63-8986bf94373b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_cefbe276-f009-4086-b65d-259dad646ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_cefbe276-f009-4086-b65d-259dad646ae2" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_ab0c62b1-00aa-407a-88c2-6fcad28c34c6" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_ab0c62b1-00aa-407a-88c2-6fcad28c34c6" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_ec2339f7-7cc4-4ee5-b6ae-3cac15f9ffca" xlink:href="cutr-20221231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_ec2339f7-7cc4-4ee5-b6ae-3cac15f9ffca" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d64dca-fd3c-4439-9b58-ae0a00ef57ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d64dca-fd3c-4439-9b58-ae0a00ef57ae" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6da115b2-e817-45bc-8b9a-9d299450dcea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6da115b2-e817-45bc-8b9a-9d299450dcea" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_99db58f9-5da9-4456-a751-3576d0a7ab80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_99db58f9-5da9-4456-a751-3576d0a7ab80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_14336ca4-353e-4f65-95b1-cd6a42574d1d" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_14336ca4-353e-4f65-95b1-cd6a42574d1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_45d85b0f-f2b2-4117-b146-decbded0a6e9" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_45d85b0f-f2b2-4117-b146-decbded0a6e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2029Member_392c5530-3f13-4daf-b750-c2401a955b13" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2029Member_392c5530-3f13-4daf-b750-c2401a955b13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_b6812f65-a58c-4f86-9e12-b789d1c45af7" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_b6812f65-a58c-4f86-9e12-b789d1c45af7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_3c137d14-fd0f-487e-8532-ac03b9854c4e" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_3c137d14-fd0f-487e-8532-ac03b9854c4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_22ce0bb7-7248-4387-8e9d-0b194db99ffb" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_22ce0bb7-7248-4387-8e9d-0b194db99ffb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_1960f61d-4b63-4384-b4ef-cd8dac9db3a5" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_1960f61d-4b63-4384-b4ef-cd8dac9db3a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_fdc2006d-f906-4c4f-b86d-4590252cdb53" xlink:href="cutr-20221231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_fdc2006d-f906-4c4f-b86d-4590252cdb53" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_9a1020aa-8380-4678-b583-6ebcc51304dd" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_9a1020aa-8380-4678-b583-6ebcc51304dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34bbea3d-c0e6-424b-b873-6f62628d71dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34bbea3d-c0e6-424b-b873-6f62628d71dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f4fd10fc-f5e4-44e5-936c-3c1014973f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:to="loc_us-gaap_ConvertibleDebtMember_f4fd10fc-f5e4-44e5-936c-3c1014973f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:to="loc_us-gaap_ClassOfStockDomain_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:to="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cfff1bf4-69e3-4f93-8db7-29e63cb5657d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:to="loc_us-gaap_CommonStockMember_cfff1bf4-69e3-4f93-8db7-29e63cb5657d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_9190fca4-1d37-48a1-9cb7-5453e57c68ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_9190fca4-1d37-48a1-9cb7-5453e57c68ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_VoceCapitalManagementLLCMember_554bfa1d-b44b-4241-931e-1593495d9318" xlink:href="cutr-20221231.xsd#cutr_VoceCapitalManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:to="loc_cutr_VoceCapitalManagementLLCMember_554bfa1d-b44b-4241-931e-1593495d9318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_967cd654-9525-4f86-b4a8-c4ab9c34042b" xlink:href="cutr-20221231.xsd#cutr_SiliconValleyBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:to="loc_cutr_SiliconValleyBankMember_967cd654-9525-4f86-b4a8-c4ab9c34042b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_20b8308e-0248-4e3b-abe5-90176e0e511e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_20b8308e-0248-4e3b-abe5-90176e0e511e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9c42a329-eb04-4c37-b072-681da86445bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9c42a329-eb04-4c37-b072-681da86445bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eb1f738a-a5e5-4cc1-ac4f-08cf549dd548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eb1f738a-a5e5-4cc1-ac4f-08cf549dd548" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c29fba58-dc6a-4fb2-aee3-523df0c32241_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:to="loc_us-gaap_CreditFacilityDomain_c29fba58-dc6a-4fb2-aee3-523df0c32241_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:to="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_44847acc-af0a-4c44-a538-879fc6cfce38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_44847acc-af0a-4c44-a538-879fc6cfce38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:to="loc_us-gaap_VariableRateDomain_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:to="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_d480a235-8add-479f-aee9-7f7fb329b445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:to="loc_us-gaap_PrimeRateMember_d480a235-8add-479f-aee9-7f7fb329b445" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtComponentsoftheLossonDebtExtinguishmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="extended" id="i9293be7973e74b149ac6f846605b19e8_DebtComponentsoftheLossonDebtExtinguishmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_edc3b320-7333-4f7a-987f-24644d611865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_edc3b320-7333-4f7a-987f-24644d611865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c03c9c58-9e4b-4428-befe-a06e321b30df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_SharePrice_c03c9c58-9e4b-4428-befe-a06e321b30df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_452453a0-77bf-43db-a67b-2bd589c42b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_452453a0-77bf-43db-a67b-2bd589c42b06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued_fdaf52bc-8814-49da-8a85-1b4745293bd6" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionConvertedInstrumentCashIssued_fdaf52bc-8814-49da-8a85-1b4745293bd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_f54c64e3-d2f2-464f-9bbf-f53ed27ffeb0" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_f54c64e3-d2f2-464f-9bbf-f53ed27ffeb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_cf3ad190-1f8c-491b-97a1-7935bffc3012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_cf3ad190-1f8c-491b-97a1-7935bffc3012" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionNetProceeds_5de4e05a-bb17-4d11-b000-00d11767daa1" xlink:href="cutr-20221231.xsd#cutr_DebtConversionNetProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionNetProceeds_5de4e05a-bb17-4d11-b000-00d11767daa1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_01b8ed60-e7e0-49e7-8de6-36dabfc374f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_01b8ed60-e7e0-49e7-8de6-36dabfc374f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionPercentageOfDebtConverted_9b80a7f8-e16b-4e0d-b236-410c0bd38f9e" xlink:href="cutr-20221231.xsd#cutr_DebtConversionPercentageOfDebtConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionPercentageOfDebtConverted_9b80a7f8-e16b-4e0d-b236-410c0bd38f9e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_c5f878ad-ed33-4413-99ba-21bdc0a66753" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_c5f878ad-ed33-4413-99ba-21bdc0a66753" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_54e3024b-a954-47fe-b5b0-e8cd003cfa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_54e3024b-a954-47fe-b5b0-e8cd003cfa4c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7dc05296-3e53-49cb-bbd0-7294d162a136_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7dc05296-3e53-49cb-bbd0-7294d162a136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7936b1c6-d9a0-472e-9abd-e28f5d4a6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:to="loc_us-gaap_ConvertibleDebtMember_7936b1c6-d9a0-472e-9abd-e28f5d4a6a38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_3a4cd964-13d7-4067-afb2-f39911121cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_3a4cd964-13d7-4067-afb2-f39911121cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_de1c0279-13bf-423c-aef9-ed94a42e5d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_de1c0279-13bf-423c-aef9-ed94a42e5d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d61380ba-9971-4e26-8b8a-3968ebe25b2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d61380ba-9971-4e26-8b8a-3968ebe25b2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_f64d249f-d532-41cc-a037-23502673eaf9" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_f64d249f-d532-41cc-a037-23502673eaf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_48861cdb-18b4-42de-aac0-037363504237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:to="loc_us-gaap_ClassOfStockDomain_48861cdb-18b4-42de-aac0-037363504237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:to="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1b59095e-48e8-4310-8005-104d71c5e521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:to="loc_us-gaap_CommonStockMember_1b59095e-48e8-4310-8005-104d71c5e521" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SubsequentEventsDetails" xlink:type="extended" id="ibda8951e98f0411d9d25059d2dda7291_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_c1b34db7-8cdf-4a81-bf4c-42cf94120fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:to="loc_us-gaap_CashFDICInsuredAmount_c1b34db7-8cdf-4a81-bf4c-42cf94120fcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_c1ab6b1d-552c-4de2-a4a7-fc7d7d10cfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:to="loc_us-gaap_InvestmentsAndCash_c1ab6b1d-552c-4de2-a4a7-fc7d7d10cfe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:to="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_051ec02e-812d-42df-bae3-bded057f33c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_051ec02e-812d-42df-bae3-bded057f33c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_dfcce64d-11f7-4469-a95f-deb9fa4afdf2" xlink:href="cutr-20221231.xsd#cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:to="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_dfcce64d-11f7-4469-a95f-deb9fa4afdf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashSweepInvestmentFundsMember_63081787-401d-4d2b-8f5f-c79cb2f22efc" xlink:href="cutr-20221231.xsd#cutr_CashSweepInvestmentFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:to="loc_cutr_CashSweepInvestmentFundsMember_63081787-401d-4d2b-8f5f-c79cb2f22efc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="extended" id="ibb857d82681146fd84e581e8b9b7cf8b_ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_127c3927-fa3d-4dff-8b88-5c76788ae8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_127c3927-fa3d-4dff-8b88-5c76788ae8c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4ef8a733-ea9a-4764-b9f6-80d997709e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4ef8a733-ea9a-4764-b9f6-80d997709e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d0f9544-9fa1-4143-9147-3884f05bb569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d0f9544-9fa1-4143-9147-3884f05bb569" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_82415e84-bfdd-4dda-a171-f6fe5e8f69bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_8a1ca8ac-b666-4c39-9add-83f88ff9b12a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_8a1ca8ac-b666-4c39-9add-83f88ff9b12a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_adf6cce2-dd85-4821-90dd-dd4dc5c6ffcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_adf6cce2-dd85-4821-90dd-dd4dc5c6ffcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_95c00b94-8c26-4af6-a9b7-edec29c5fda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_95c00b94-8c26-4af6-a9b7-edec29c5fda9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>cutr-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_48dbb0ca-af8f-4fe1-950b-9fbc741426c4_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability [Text Block]</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of contract with customer liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:to="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_6318a71f-13da-40cf-9551-5b583b743c7e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_4db35b85-7905-447e-b298-d7cee30bdd5e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_41d9ec44-55bb-48d2-8631-206ba3b8e932_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7d67a62e-8dee-49c0-ab8c-90bc3fbf2a5a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_b01108b1-8bb5-492c-a568-70f4ac4cb0e7_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_ab3583f9-63a5-4c82-a097-4e55be22e750_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_023c7f35-c40c-4bbe-a3fb-2be7edc94f4a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_918e494c-0fd2-4698-9df3-bcf68d6f1dad_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1af6a8c3-0d8e-486f-973a-e92d437b1393_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_bbed0cbb-dceb-4cfe-90da-3f65b6a2f5ad_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_60739871-cc9d-45e7-9136-06f6e7666bc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_da815b00-c920-4168-83c4-df61124e5246_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_655f5f68-f73f-4fae-b66d-b433061b8520_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6098db82-0fb6-44b3-b948-935ed0538b1b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_3274eda3-88c3-4c4e-a433-03b051d7e0cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_bd977192-2d97-413a-8930-b817af406741_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents restricted stock units and performance share units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:to="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6d95fc7-040e-4742-bfc5-b281797ece8e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2e55a58e-bf5c-4b96-a3c9-18c6b696a882_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AccruedCappedCallCosts_e01d4e3e-cca8-479e-98fb-9b67849e7198_terseLabel_en-US" xlink:label="lab_cutr_AccruedCappedCallCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call costs accrued</link:label>
    <link:label id="lab_cutr_AccruedCappedCallCosts_label_en-US" xlink:label="lab_cutr_AccruedCappedCallCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Capped Call Costs</link:label>
    <link:label id="lab_cutr_AccruedCappedCallCosts_documentation_en-US" xlink:label="lab_cutr_AccruedCappedCallCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Capped Call Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedCappedCallCosts" xlink:href="cutr-20221231.xsd#cutr_AccruedCappedCallCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AccruedCappedCallCosts" xlink:to="lab_cutr_AccruedCappedCallCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2029Member_aa850c4d-0fa9-4d1e-8f86-6740f350cb75_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2029</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2029Member_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2029 [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2029Member_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2029Member" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2029Member" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_b493f27e-2296-4a4c-8866-d318331c443f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5b7e3e4f-dbac-48f3-b691-17ee89136989_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b615d60b-6e9c-4f28-9f65-951d7bff3248_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_371e08f5-589f-4067-ba87-02903bca4eaa_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_f48cea17-ead6-4c0c-82e6-1f028ec63390_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d09873e1-23e8-489d-8118-ea3f41951934_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_135fc358-dd1b-4f1d-89d8-3a3625f51eb0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b5e7a03e-10a5-4769-9ca8-18be3750b1b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_ea48d7d7-fcff-4e77-9818-86fffe7137ae_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_42a51d38-59a5-4e44-a77c-076b21d229b8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_0cbc87cd-8c0b-4c07-85a9-c3fe776927c2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EmployeeStockPurchasePlanMember_774c151d-e18e-4a48-9330-a013b5129308_terseLabel_en-US" xlink:label="lab_cutr_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_cutr_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_cutr_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember" xlink:href="cutr-20221231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EmployeeStockPurchasePlanMember" xlink:to="lab_cutr_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_cbc61490-ab4e-4033-a1db-7550bb76cb32_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_97c2a0a4-180b-4547-833d-84bcf70d0640_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6620f530-3b91-4c09-b105-28804effc3b8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_5156f9dc-64e8-410d-a74c-e352a9594f07_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_7891d655-1d07-4f7c-a469-dbbdf2210124_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a2038f3d-e110-4fd6-b3c3-cfc65596374e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SiliconValleyBankMember_ecf1920e-42fd-4242-afce-b2f06230018e_terseLabel_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_label_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_documentation_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to Silicon Valley Bank.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember" xlink:href="cutr-20221231.xsd#cutr_SiliconValleyBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SiliconValleyBankMember" xlink:to="lab_cutr_SiliconValleyBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_0fe0773b-c9f9-4cfa-ac9b-2fec793bebd5_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing amortization expense</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_f581ce4c-4581-4933-9b47-4200e1cd29b2_terseLabel_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</link:label>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_label_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants [Table Text Block]</link:label>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_documentation_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:href="cutr-20221231.xsd#cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:to="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_9da35b62-51d3-4c64-a3b4-2414ec496765_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_95486a81-86fe-4ee3-87c1-5711a96edb6a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_cfffa62f-c7b1-4f85-b112-866100e10a72_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8a7db600-aa1e-49d8-9a87-ce1461c444ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_dc8f32f8-d831-4690-92b9-85e1a957b2a4_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General business credit</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General business credit</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_659e7cad-a4ab-4724-a107-8a49c4f22434_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_e983065f-56c9-4b74-b7dc-c3d3bdbe5cf3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_12ce8654-ca6f-4d96-8792-9c899508826f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_54f6467f-5195-4703-b8dc-bb02658d6f3a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_922b092a-3677-47d4-986e-4bf15da71806_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_e7979477-b667-40e6-a0aa-dfe93b6f0980_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_06f10407-6839-473f-a29c-fc4ed00392cf_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a2a82e66-5f8f-4b49-8cdf-5eb59506f86f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_32478944-6db6-4ce1-99c3-732a498ee7ae_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capitalized costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ESPPMember_897e7c01-999f-4124-9574-3affaf72f326_terseLabel_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_cutr_ESPPMember_label_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP [Member]</link:label>
    <link:label id="lab_cutr_ESPPMember_documentation_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the Company's employee stock purchase plan (ESPP).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember" xlink:href="cutr-20221231.xsd#cutr_ESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ESPPMember" xlink:to="lab_cutr_ESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9bb82e19-1f14-456f-95ca-cd0723979171_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_6d9be068-3a84-4f5e-883f-bb7ec95a01e1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4dc05412-444f-4bf2-87f7-4bd0ce911f39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_913f14ff-17ab-4d9c-a211-b7016c479cac_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_7ed1b4fe-492f-4509-9426-da22ea755670_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued, price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_642cc818-5e4c-4cfd-9fe4-e95f6d3acada_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_16535dd6-b4d8-43a0-934f-a5991d57f594_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_da378939-06f9-4086-a407-6247ddf7c089_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_a8354531-de5e-42b8-ae66-7eea23195c7d_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4da665f2-e348-4226-8b7f-b30f057d6a82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_3d2a9c5d-8384-401d-975d-b2f42e7b6838_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9305f8c8-1fca-4204-8cf6-fbe0ad8dd554_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_7ee6154a-da1a-4523-8eba-adbdfa028495_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920a3f6f-dac5-47c3-88ea-9ab897b25f26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14969ab9-c8e7-42d2-8fd4-86e3f3d12142_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ca6fb129-3c5d-4eb2-a99b-f805b99271fc_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ecd53329-aba1-40fe-90cc-5073034c15d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a1fc736f-2b2a-4336-b4aa-77ecf2dbffd9_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_109fc86b-f0d5-4a7b-97d3-a0325c6b824b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2f02067f-85b6-4f2c-bd6b-9edc168c49d1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e2ac1d4b-8c32-4c7b-90ba-f52ac14c4936_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6f85c392-56fb-4edf-88c0-fb44ca961528_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_a5aa4d32-24c3-4d3e-9480-3404cc9cd085_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_9e8b48d5-1001-44a2-90ee-e2d1c743e9f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_210768e0-01bd-4e4a-93c0-05a7e33ba882_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_1f6fd0dc-8b23-405d-beda-7a0b52d1a214_negatedLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Settlements made during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5869dd54-9de3-4eb4-85a8-0f339a5b49cc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6749f4c3-1e6a-4059-9be3-630c903810f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c27ca6b-1528-4592-8897-3691880d4596_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_d6e517cc-d47b-4e94-b8e4-05b4a4af9c35_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e020ed8a-6017-4dd8-9c4b-c1e045c3dc92_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_f404bd14-3925-4d3e-872e-a1ecde04e70f_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted calculation, grant period (in days)</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_label_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Award, Period To Determine Grant Amount</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_documentation_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Award, Period To Determine Grant Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:href="cutr-20221231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:to="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_fe19db5a-27b6-41bd-ad62-d0c396e423af_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_753d0fe9-c61e-4506-88ed-09553e38ff57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_8adcdac9-9e02-462e-b927-f5b7c39ad8e6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_ce7daf7a-c88a-41c0-b682-8356a466e50c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember_bf603872-4038-49b1-9ba2-0dd753b31502_terseLabel_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear operating lease revenue</link:label>
    <link:label id="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember_label_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Operating Lease Recurring Revenue [Member]</link:label>
    <link:label id="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember_documentation_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Operating Lease Recurring Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseRecurringRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:to="lab_cutr_AviClearOperatingLeaseRecurringRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_2dd6f850-f898-4490-ae40-b28811470ecd_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, aggregate fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, aggregate fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_d29eff9b-ecdf-4f0f-97a9-84c81a096214_terseLabel_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Statement Information</link:label>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_label_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Financial Statement Information [Table Text Block]</link:label>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_documentation_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the financial statement information for leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:href="cutr-20221231.xsd#cutr_LeasesFinancialStatementInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:to="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_57b47fc1-b971-4f79-818c-8b30608b6b94_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Service Contract Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_580d5daf-02fa-4cd5-8b13-00602dd662f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_c1c35980-3e5f-46b8-ac99-89e748dd8de5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonus and payroll-related accruals</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_0cd7ea0e-ce25-4759-a0cb-c35a4948d657_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CuteraCoreMember_c34355da-0685-4087-8f09-1b664b31b05e_terseLabel_en-US" xlink:label="lab_cutr_CuteraCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cutera Core</link:label>
    <link:label id="lab_cutr_CuteraCoreMember_label_en-US" xlink:label="lab_cutr_CuteraCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cutera core [Member]</link:label>
    <link:label id="lab_cutr_CuteraCoreMember_documentation_en-US" xlink:label="lab_cutr_CuteraCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cutera core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CuteraCoreMember" xlink:href="cutr-20221231.xsd#cutr_CuteraCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CuteraCoreMember" xlink:to="lab_cutr_CuteraCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeasedEquipmentMember_fdd1497c-e944-42e7-8995-3d45cfc96bc8_terseLabel_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment leasing</link:label>
    <link:label id="lab_cutr_LeasedEquipmentMember_label_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Equipment [Member]</link:label>
    <link:label id="lab_cutr_LeasedEquipmentMember_documentation_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember" xlink:href="cutr-20221231.xsd#cutr_LeasedEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeasedEquipmentMember" xlink:to="lab_cutr_LeasedEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoyaltyMember_c1cff628-2c55-4465-a790-ea94b1b5b1fe_terseLabel_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty</link:label>
    <link:label id="lab_cutr_LoyaltyMember_label_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty [Member]</link:label>
    <link:label id="lab_cutr_LoyaltyMember_documentation_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to loyalty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember" xlink:href="cutr-20221231.xsd#cutr_LoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoyaltyMember" xlink:to="lab_cutr_LoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_870e6a0a-813c-40f6-89d7-bda61c6ca884_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3e6fd051-f91c-4317-b26b-ee15e951bef3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_497ca47d-4538-4711-b366-a237e7d1d229_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_656d3d94-8243-460c-902a-2c500377a3ed_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_1fe9ea92-bf1a-470a-b818-304ea9177d99_totalLabel_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total leased assets</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Right of Use Asset</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's right to use underlying asset under finance and operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset" xlink:href="cutr-20221231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeaseRightOfUseAsset" xlink:to="lab_cutr_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6a6f4ac4-5b44-4616-b071-914a7f20166c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f8168f5f-b298-49ea-a2d8-50058a98f852_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ee434d16-815a-419c-ba59-416716cbc015_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c52a39db-a58c-4136-aa47-f03f5009b0a2_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7c847e44-4d25-44f2-873c-fd2bba34ed95_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3c12822e-13e3-4a75-a7c9-0b1ed3c3c908_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_3be4df8e-2c25-470c-aa71-03c8357ccb36_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_12ce3ffa-2d3f-4daa-aea7-2711f735b873_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Detail</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_537b3023-d769-466a-b256-413c2231f51e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_8bfd78cb-e587-4e42-9668-b455d6837242_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_26805459-a249-4b85-8c37-ddec79ce4646_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_812fa8eb-ddc9-473a-b076-9fb64f01a0d5_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3cc904a9-e6f4-4ef3-b5eb-116808f98023_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_1e7832d8-f8f4-4b09-bbab-72202bcd229e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_67e56836-5cdc-417e-ab02-a9ffa7290e77_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_9e392de0-c49f-4847-95f2-fa5505cb0c6e_terseLabel_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call</link:label>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_label_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call Securities [Member]</link:label>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_documentation_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember" xlink:href="cutr-20221231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CappedCallSecuritiesMember" xlink:to="lab_cutr_CappedCallSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_44da35e4-a7ca-400b-9bfd-62d9cc323831_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a325c8eb-2f67-4b00-acdf-eab175d3de22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_6f51eb7e-877a-4524-87d0-391e0042a648_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, upper range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_953c02fd-4d01-472f-bb59-8b2147358f60_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_084ca4c9-f83d-4a9c-bc03-6b1840eec2ca_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_5ba5c918-f143-4aeb-ada1-e870c702f21e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_85e4c000-e46d-4137-91c4-d804ab548f07_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible notes, net of unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_35aaeb86-4393-4968-a05d-4ce06230cf46_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_ca738f35-4c88-415c-894a-738e599ee1b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4a2b8c03-2172-4743-b1e6-eac2a277e342_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5b1e604b-641e-432a-bba5-8bddd1b8377a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_f01241b2-5379-4e9c-890b-048699ecda7b_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_4c10dc2f-d010-4873-a8b7-8cace6b2d13e_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing set-up costs</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_defe0c1f-ff88-46d1-b54a-7f93ca0023a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_72be6615-b72e-452d-a663-994e5ce97a32_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2c3f8d70-dd71-4e35-ac49-c76cb4064586_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_71b16e37-1e69-42f9-b847-4321c99ba529_terseLabel_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_label_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_documentation_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:href="cutr-20221231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:to="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_f2a9061a-c4ee-4e31-b47d-4edcadae66c9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_f6949115-dfe2-4bd3-b52a-399267832477_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_ccd5195b-f9e3-4c34-a909-ca9dd20f0acf_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Valuation Allowance Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c6bc931c-e6b3-4a1a-b406-900d3370703d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_641f84a8-c55b-43b3-990a-d0bf5285af3b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_604dec90-07b3-4ccd-bed5-9e48c33acb13_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 174 Costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bf413ceb-041d-4ef2-83ac-9be038d9fc13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c2b053c1-96e6-48ef-8524-13b52bfaca8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_30e4530a-f1de-401e-ae50-7646ae7e1ca6_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_685d54b2-e5fb-4133-bc63-8ee51c44f40f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_bdeb2af6-3860-48c2-a9c7-d107fd3d4395_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term [Abstract]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_25cc9ad8-2532-43a2-a80d-5947b098560f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_fb25262b-18be-485f-bada-a916eea5ccc9_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_0951a7ae-849c-497d-8f2f-a0e79e1e704c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_d8bb9925-6cec-4899-8372-2dabf62287a7_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs, amortization period (in years)</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_1d2c8764-b280-4776-ba08-e904f0e349e9_terseLabel_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement [Member]</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the Loan and Security Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember" xlink:href="cutr-20221231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoanAndSecurityAgreementMember" xlink:to="lab_cutr_LoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c3ea7d79-41bd-4e26-8123-3696dee85874_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_8425dddc-fa1a-4a7e-b5c3-9083600e4d7d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_919775e1-0d09-4357-8081-7f9476424399_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_eb837c4c-cd6a-497d-b43c-9c12fa2be34d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4ccdbd88-a80d-4d8f-9dbe-e55f930832bf_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_da2f9378-5327-47d0-9823-d8f321743e31_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtLineItems_dc75bf34-9105-4c64-a918-4f88396179d0_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems" xlink:to="lab_us-gaap_ExtinguishmentOfDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_598712ad-49d3-4712-9b4a-d58c96844c2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of the Loss on Debt Extinguishment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f7544a3a-4823-494d-8ca4-9088e221aff7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of awards vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_4152c0fe-8384-46f9-b193-5977864ba979_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items not allocated to segments</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_e5bfc547-8e1c-4cbf-8cfd-6ccd9ba277a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_365abdd1-fc2e-4c80-ba7f-df9e93e9a4b2_totalLabel_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares and cash</link:label>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_label_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Value Of Cash And Shares Exchanged</link:label>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_documentation_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Value Of Cash And Shares Exchanged</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:to="lab_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_bd41772e-ff8a-4725-92c0-40aca7fe5fd9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of inventory to property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Transfers and Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_92b5270f-1c5b-4378-bf02-f75dceb4024e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f082d949-3d5d-4d54-8aaa-c322b5053fa6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_a5691771-0066-49db-b502-134e91f55c80_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_92455117-8c00-487b-8539-38950b572138_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_1a841680-43f4-463e-bfb1-263881b71a4f_terseLabel_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty term, distributor sales (in months)</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_label_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Distributor Sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_documentation_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Distributor Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StandardProductWarrantyTermDistributorSales" xlink:to="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6435956d-a5c8-4b49-8ad1-4ccdc3db3c46_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0cd49e10-0966-469a-af67-a373a602e435_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_1cf2dfde-bfa9-4e9e-b990-1d513f9b9715_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_d45afdb8-5757-4124-8377-3ed62cb0475b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, FDIC insured amount</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7919adef-dc06-4da0-995c-b217dc087557_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7c95ecec-ac5e-4222-aae8-756146c7e3ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59dd5bc2-33a5-4037-b901-2c55910bb67f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0b1a5025-f230-4d97-8255-1c2809ed423d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_8185f9e0-863d-400a-a0e4-aaf808b311eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_adebaf91-f641-4365-9976-f6c2b27288ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_385d5457-3c53-45ed-97ed-1b9477ff0649_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_d90e3e35-93ed-4cba-8930-51d417994e3c_negatedLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards granted (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_2c83b1d7-35b5-4d81-b132-a3fa2e01eeb8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_42756e2f-2b75-4247-a6eb-6ca954a0f599_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_46777e8d-9309-4457-830c-0cdb7f8ffd23_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold trading days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Trading Days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_380e181d-cd87-48cb-aa4c-2051886ed722_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, Second Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, Second Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, Second Conversion Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_55e0d5e7-527d-44ef-a8b2-f8ea8a513d65_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_07b6cb1e-9572-43b6-a757-5cb68c058892_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_721e176a-aeb7-4fbb-9b2d-f36513575bbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e8df4a48-dd8b-4388-bcc2-0a140b079a69_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0f1d9bd4-5fa0-4a08-adb3-464b69a404b9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_b81551e7-f2a0-41a5-9596-699cf9d3201b_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on finance lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_bc772141-a026-46b1-978c-253082e77a02_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flow</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_20bd428c-e3c6-4079-8a75-f7dbdadeaee6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_9ea09e93-3038-4b34-bd04-0f3e803d8598_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_3bb1e86c-3be1-4f51-88e1-7825ca08174e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_97e74005-33f3-4fd5-9b8e-0927d75a0294_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_71fe6d9a-27fc-4440-99a0-e657411b6ac2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_b28ff4c3-82a1-4623-aace-33b39721a324_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property, equipment and software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_8890259b-37c1-4c22-9185-907107ef9b09_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_07671304-db03-48e4-8fe0-c91413438833_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_043df30b-73c2-4ee7-9dd0-87bcf62c2540_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_953e4fe4-a990-4867-af18-3d8b52554846_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in debt conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ed4a7d77-ee6e-4098-9111-7255f6459ebb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d3d94cd2-66a4-4ebd-b83c-c1f3b14b083b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_371aacb3-30d1-4a33-a804-1244c1419459_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_08de1dc0-027f-438a-864c-e929177ac1b2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_fc128ba8-25dd-46f3-83f7-10754c53ec81_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_a2b27cf2-46d5-48f6-8fb2-b4db86317089_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_af1169f3-d636-4b23-a32b-3b3afd043790_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6f95225d-33ce-4b84-928a-b1db7c99421b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b2092e67-d2d6-4bec-b81f-ae65cd04dd88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_078eaa18-cb23-4cd9-8ed1-eda30f1ab9d3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4009586e-e6e4-4aea-afa6-7409c02e93af_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e7962df6-6fb8-4606-b3fb-b37333186282_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_f9ce2631-e78e-4f4e-9364-1ee8781c77e8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_258849f9-02ba-458e-801d-e6797107e1f8_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_496c38d6-ee66-4a41-aa33-633ee8eb9288_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_aa23edf9-7cbe-45ba-8e80-1e0c4fa1988c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_93ee0ab8-42c2-4394-98df-87822470722b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities:</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_c64c9bd2-f9ce-41e1-9150-9b7213623f0c_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option one, term (in years)</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_de99f922-2103-4a0c-9926-016830b9bd35_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net of unamortized debt issuance costs of $12,666 and $4,007, respectively</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_33f72443-ddea-4962-8c67-0b7c75f4e870_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_149f450d-7c36-4ea4-8664-5cdfc046f3d2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_621f6053-2842-4257-9b82-b13e7f3e484e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 19,668,603 and 17,995,344 shares at December&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_63d06d20-93b4-4aac-8ff4-8deb8278ef9c_terseLabel_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized capital (in shares)</link:label>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_label_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock Shares Authorized</link:label>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_documentation_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized" xlink:href="cutr-20221231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CapitalStockSharesAuthorized" xlink:to="lab_cutr_CapitalStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e5be35f7-df76-4c85-8d36-5cd5b1bd03ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_c0d9f0d8-2182-4451-8ad6-931228f1804c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f59d05b4-bb08-4aba-822b-216753b89b20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_e915480b-6f54-4fd7-9c09-e32695cc42de_terseLabel_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated economic life of demonstration units (in years)</link:label>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_label_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Units, Amortization Period</link:label>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_documentation_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Units, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod" xlink:href="cutr-20221231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DemonstrationUnitsAmortizationPeriod" xlink:to="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_274365c4-e485-4df9-a72d-c5c27522bd0d_terseLabel_en-US" xlink:label="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_label_en-US" xlink:label="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense And Amortization Of Debt Issuance Costs</link:label>
    <link:label id="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_documentation_en-US" xlink:label="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense And Amortization Of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:href="cutr-20221231.xsd#cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:to="lab_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_9a158faf-bb2f-4b84-b02c-280cceb92569_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ae27d25a-e130-4223-aa50-1509560f78af_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f6e86cb6-a2d5-4645-bb6a-bf2a9782dcc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7295b416-b8dd-4d73-a3ef-231f521bf541_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_c019d70a-b37a-490e-97bf-cc95de1dcb10_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a42c1224-593d-4f30-99c2-61a049a05dc1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_53d7c2f4-b340-4f02-88d0-d78297fa324b_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental repurchase amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:to="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_65c0e1ed-221a-4f71-9fef-d41becb1dc84_terseLabel_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenue</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_label_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Percent Of Total Revenues</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_documentation_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:href="cutr-20221231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:to="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_e0676eae-b310-4a09-8d21-c7b527b684f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_0871431b-88b1-4113-a375-e0ce008c33bb_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_da3f8160-35c3-4648-8583-40dc6a63d5dc_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying accounts receivable (as a percent)</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_label_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents percentage of qualifying accounts receivable for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:to="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_11dc58cc-f670-4fa9-b43c-0b3b01cbc624_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1168dcee-a372-4c31-ba58-8b0cb47211fa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dfec4cea-484d-4bce-8aef-8dae0cb72f7f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud computing arrangement expected contract renewals (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_0ff82b67-8c50-4a9e-aacd-75b2697aae11_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the first conversion trigger of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_ceb3ae47-7faa-4466-be71-3f8a1341a372_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_850287d6-dcdb-4f63-8e7d-1d6a86d830d5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill additions during the year</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ec49f136-e069-465b-8ae8-19af8eded7a7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2cce5643-c4e6-482d-ace4-0f9dbc6a724b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_0a5854e1-9ff2-413f-b71a-b31c405b2661_negatedLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1de55165-26d8-47e0-8ded-1f79264e690c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba3772c7-44a5-4dbc-bf92-537bd2a8616b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_15817662-216e-4c79-8b43-6a7adc8e793a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4563c774-bd3f-4ae9-a6eb-5e3cade065c1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of stock, percent of market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_2c6d2f99-e756-4a56-a050-51dc22f8ada7_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required outstanding amount not subject to redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_label_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:to="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_9db5c6ad-8633-448f-a9d4-80d547512fa3_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5322810e-7e15-429a-b712-0f47f950d023_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a0fec725-b6f0-430b-b5b5-cd97978b4eb7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_b8675407-8de2-46c1-8181-c44d58dcd726_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_ceda5c4a-159d-437b-ba70-46ac7ba52dd3_terseLabel_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use asset</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_label_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use asset</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_documentation_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the change in right-of-use asset and liability due to modification during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:href="cutr-20221231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:to="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5d8342fe-34e0-43d2-97e5-6e122ea36d53_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_50aab489-4922-4b54-8991-bb984bf8e768_terseLabel_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum 401(k) employee contribution percentage</link:label>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_label_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Maximum Percentage Of Employee Voluntary Contribution</link:label>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_documentation_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:href="cutr-20221231.xsd#cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:to="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1c3a4146-d5d0-4e4f-a7c5-a6f833c6b728_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_167a1e89-ff8a-486a-a53e-30899b4142c3_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses, accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5ce78290-2ef9-43c1-ab15-6b9b8c5b8619_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ae888861-e90d-43a0-b496-c6544bcc2ee4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d7b60c5d-b136-4d66-94af-70138aeb7e11_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_27d15462-f5c5-4ecf-afa3-10d2b089b323_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_764a7a84-d174-4f0d-b564-bc6777a3b243_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_0cfcc79a-d8ad-4da5-8d26-464a80e2d5f5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_43a2f447-4e03-4271-beb1-bf61aa21bd4a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LargestSupplierMember_cd61cd47-ad9f-4419-a106-9da5fc50cdb6_terseLabel_en-US" xlink:label="lab_cutr_LargestSupplierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Supplier</link:label>
    <link:label id="lab_cutr_LargestSupplierMember_label_en-US" xlink:label="lab_cutr_LargestSupplierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Supplier [Member]</link:label>
    <link:label id="lab_cutr_LargestSupplierMember_documentation_en-US" xlink:label="lab_cutr_LargestSupplierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Supplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LargestSupplierMember" xlink:href="cutr-20221231.xsd#cutr_LargestSupplierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LargestSupplierMember" xlink:to="lab_cutr_LargestSupplierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_63bfa4a5-028e-497c-9cc2-658b38c2f60e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Operations and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StockPlanMember_c51cca6a-4cb8-4065-b69a-9142f904f7ff_terseLabel_en-US" xlink:label="lab_cutr_StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1998 Stock Plan</link:label>
    <link:label id="lab_cutr_StockPlanMember_label_en-US" xlink:label="lab_cutr_StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1998 Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember" xlink:href="cutr-20221231.xsd#cutr_StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StockPlanMember" xlink:to="lab_cutr_StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c31df381-cb1d-4c6b-81be-fb402583bfb8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_96f7ddc6-dc4e-49cc-9309-8800eff8c34e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_902ac150-3942-440c-8c11-143eea4f5e71_terseLabel_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly minimum revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_label_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Quarterly Minimum Revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_documentation_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents quarterly minimum revenue under debt covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:href="cutr-20221231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:to="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_f8378de6-624e-4f47-a669-061c999915ba_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_492de1ed-803f-406b-a64e-8ef6ef3882f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_ffabb0e3-6a1d-4de3-8014-3da29732b17a_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits with vendors</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent" xlink:to="lab_us-gaap_DepositsAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_d9137e33-fcf1-412b-a546-ac84a2a234e4_terseLabel_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_label_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act [Member]</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_documentation_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:to="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDerivativeIssuanceCosts_589084d7-f7c5-4824-99cd-8e169e98cde8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDerivativeIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Derivative Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDerivativeIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1ee3141b-7e74-48bb-aad8-a2bcc12a1dfd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b34a82a0-0619-4910-afa1-8183c4776bc1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_e9c02dae-041e-405d-b0f5-241ddd487920_totalLabel_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amortized cost</link:label>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_label_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost</link:label>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:to="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2b281e11-f7f8-4cc7-ab22-7495a0415449_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_91448a5c-c4e0-433a-85c0-10850b7719f0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_47c82fd9-972e-488a-88c0-ed35610c605e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information and Revenue by Geography and Products</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross_89a7acbf-9a83-4b51-bbe0-b93cc532052b_terseLabel_en-US" xlink:label="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of capped call, gross</link:label>
    <link:label id="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross_label_en-US" xlink:label="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Derivative Issuance Costs, Gross</link:label>
    <link:label id="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross_documentation_en-US" xlink:label="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Derivative Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:href="cutr-20221231.xsd#cutr_PaymentsOfDerivativeIssuanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:to="lab_cutr_PaymentsOfDerivativeIssuanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_74201262-afc2-4fb1-a44f-bc42db09c6d5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_57a47f77-2fda-431f-808e-b43f7f26fa98_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0440527f-2801-4f1d-9541-edaee3697c63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_35e12747-1e1c-47a5-ae61-5feb505c37d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_b7cc9005-e505-4577-aac6-1a92233b6759_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Marketable Securities, and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_3b9b7634-4f33-4686-accb-0ccbf19199f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b640dbd9-97d0-4e02-b532-e42bb54ef14f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b45d482b-f5f4-440d-a761-8965d234901d_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_84efc217-22a9-4c42-ac3d-0287fa7898bb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_06e0ac1d-0828-452b-954e-d13203a7d06f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_f5101211-8240-4183-9c8d-b9d2de90c213_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_ebbd5f55-c0f9-487e-8c19-1b22ba024368_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_15e1127d-4df8-4d1b-a597-51a075f52aa1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3c9e6855-37db-4ddb-8abb-ebd6d2007a9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCash_9c232954-0983-499a-ac4f-e247e44e7bfd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and cash</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments and Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCash" xlink:to="lab_us-gaap_InvestmentsAndCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_e45268de-f276-445d-a57c-24f093bc9bb5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_be7e1fda-b1aa-43c4-ac1d-5592fe56ec64_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_07bedb79-02eb-47d5-a644-cec13c050491_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_471dcb46-c9a4-426f-b668-08e02e09053f_netLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_0db30f84-8639-46f3-b905-f9560638a11c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ddc9738b-2505-44fc-af5a-225661b32a7a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CashSweepInvestmentFundsMember_47886675-45b7-4b6d-9d5a-49603d7a2ecc_terseLabel_en-US" xlink:label="lab_cutr_CashSweepInvestmentFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Sweep Investment Funds</link:label>
    <link:label id="lab_cutr_CashSweepInvestmentFundsMember_label_en-US" xlink:label="lab_cutr_CashSweepInvestmentFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Sweep Investment Funds [Member]</link:label>
    <link:label id="lab_cutr_CashSweepInvestmentFundsMember_documentation_en-US" xlink:label="lab_cutr_CashSweepInvestmentFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Sweep Investment Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashSweepInvestmentFundsMember" xlink:href="cutr-20221231.xsd#cutr_CashSweepInvestmentFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CashSweepInvestmentFundsMember" xlink:to="lab_cutr_CashSweepInvestmentFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_2f1dab86-04f6-4cf1-a2c7-2e1288cf1338_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_16972d28-59c2-4d6a-8c3b-f3d080bb6099_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1230e682-9c04-4697-9a2d-07fb1ea6968b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_998e5c60-05dd-42d9-9702-ac337e1ab419_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_28df813f-0b8b-4961-9a88-465914dadccd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Leases as a Lessee</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_830503be-8e23-453b-8807-07c0699c91b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_a86233a9-9960-4a14-ad0e-56ebc3272cfc_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsNewHireMember" xlink:to="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4591b423-25d6-4974-989b-10b2b795d842_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b8f01502-798c-49fd-96ad-3c50b038c09d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement Cost by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_5a8affa2-55d7-4013-83c0-201852c8cb77_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_402893a5-9904-4362-8e08-185c44d35342_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_4d8d77ef-5bba-4a39-adcd-d749f09e6b9e_terseLabel_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability To Be Paid After Year Five</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:href="cutr-20221231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:to="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_2d33b905-f922-464c-8bbe-f0adee8a2761_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_72c60997-9c8f-4ae8-ba4b-e926137a77b9_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026 [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to convertible senior notes due 2026.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_119671ea-d61e-4378-b5d7-27ad222675c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b10de0c1-c1db-4668-9cf3-ea563fc1afc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0d5f410a-d324-40c7-bc96-e69434293696_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on foreign exchange forward</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f6cd455a-dd04-450b-9f50-e1068e0e8cd7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_ba48d595-fc18-4d65-b19c-9221e2f70505_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_c2fcea85-164f-4f5f-8129-d398cff4435a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Note principal exchanged</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_51a4864e-331c-4c35-aae7-a5c187fac76b_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_64d8e86b-39f8-4c62-9812-9f7b47425e2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_cbc998f8-d939-4c7b-8209-f9258d78bcd5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of incremental shares and share equivalents:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8a7f946-2565-4f99-a654-64ecb854284f_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0d53343e-f0a1-4e12-954e-41068575650f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_65056d3b-35bd-418f-8595-738cddcaf49d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_1567e7d6-9cf6-4724-89d5-55d32c8eb5cf_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_cc8d9db0-98a2-4caa-ac6e-48022ca6d78a_terseLabel_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for inventory in transit</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_label_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory In Transit, Current</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_documentation_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory In Transit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent" xlink:href="cutr-20221231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AccruedInventoryInTransitCurrent" xlink:to="lab_cutr_AccruedInventoryInTransitCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_VoceCapitalManagementLLCMember_06bc2fc2-eaa7-48ff-84f4-f02d82c087e8_terseLabel_en-US" xlink:label="lab_cutr_VoceCapitalManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voce Capital Management LLC</link:label>
    <link:label id="lab_cutr_VoceCapitalManagementLLCMember_label_en-US" xlink:label="lab_cutr_VoceCapitalManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voce Capital Management LLC [Member]</link:label>
    <link:label id="lab_cutr_VoceCapitalManagementLLCMember_documentation_en-US" xlink:label="lab_cutr_VoceCapitalManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voce Capital Management LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_VoceCapitalManagementLLCMember" xlink:href="cutr-20221231.xsd#cutr_VoceCapitalManagementLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_VoceCapitalManagementLLCMember" xlink:to="lab_cutr_VoceCapitalManagementLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_5902667d-2b8e-4d6e-98c7-8125a81cccd0_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares authorized, percentage</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_7a69d4f7-bc46-46df-bd07-b9cfa6846a25_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b9700acc-96da-494f-ae15-e7416249b53b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LegalFeesSeveranceAndOther_8e051986-17b1-47f7-b8f1-7d8ca3c36f76_negatedTerseLabel_en-US" xlink:label="lab_cutr_LegalFeesSeveranceAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal fees, severance, and other</link:label>
    <link:label id="lab_cutr_LegalFeesSeveranceAndOther_label_en-US" xlink:label="lab_cutr_LegalFeesSeveranceAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees, Severance, and Other</link:label>
    <link:label id="lab_cutr_LegalFeesSeveranceAndOther_documentation_en-US" xlink:label="lab_cutr_LegalFeesSeveranceAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees, Severance, and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LegalFeesSeveranceAndOther" xlink:href="cutr-20221231.xsd#cutr_LegalFeesSeveranceAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LegalFeesSeveranceAndOther" xlink:to="lab_cutr_LegalFeesSeveranceAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_ee681baa-cc43-417e-a5a3-88553fbf2457_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt convertible to common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5a6b35e8-fa72-4133-9f9b-ba7006d4beac_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_68dc49d2-6953-42be-bd50-3113d3b90624_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f5dfd3da-a11a-43b0-a35c-a4746d638b64_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_a66ee384-3e2f-4414-9881-d31962025d8c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_23449737-6e8d-4f71-9d72-ddc23404cbe2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_674b6742-b1e0-40f1-9b50-d6645f076d7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_af587bf2-ef39-4d08-b418-52d7c47a5b1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, lower range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_8727b553-cf48-476c-91ff-ce7e6f0cbd41_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting tranches</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_df937da7-8bf0-4034-a511-3831d65d1a54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028Member_e0d4e7e0-8900-49b9-bebf-e3e9e2f046c7_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028Member_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028 [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028Member_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2028Member" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_16af6d6a-1b95-468d-90fc-20da11c35723_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_224a4f3d-9464-4529-abd2-81fa589f0626_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_21dee51f-40ec-4db6-945d-0b1b98912e81_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e17f5018-5c56-4030-904b-7827cff5fc4c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_371be548-608f-4143-a670-ef857bc58ace_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation adjustment for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_975ea0a4-03f3-40c5-914e-9abbf05d3fcb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer 401(k) discretionary contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_9ed78aef-3469-4d73-9b59-1b8aab5620d1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a380d05a-b3ac-4c2b-b7b1-0275ae4773cd_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PercentageOfAssets_c07bfaf7-ae7d-4bd2-b953-45d75f3d9ebd_terseLabel_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of assets in the United States</link:label>
    <link:label id="lab_cutr_PercentageOfAssets_label_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Assets</link:label>
    <link:label id="lab_cutr_PercentageOfAssets_documentation_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage amount of assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets" xlink:href="cutr-20221231.xsd#cutr_PercentageOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PercentageOfAssets" xlink:to="lab_cutr_PercentageOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_23078690-6145-4433-b13e-51b01cfdc461_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a159c83f-2a3a-4861-91eb-c42ec30113e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearDeviceMember_34809620-b614-4d83-8f5c-859035722ae8_terseLabel_en-US" xlink:label="lab_cutr_AviClearDeviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Device</link:label>
    <link:label id="lab_cutr_AviClearDeviceMember_label_en-US" xlink:label="lab_cutr_AviClearDeviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Device [Member]</link:label>
    <link:label id="lab_cutr_AviClearDeviceMember_documentation_en-US" xlink:label="lab_cutr_AviClearDeviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Device</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDeviceMember" xlink:href="cutr-20221231.xsd#cutr_AviClearDeviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearDeviceMember" xlink:to="lab_cutr_AviClearDeviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4aea0d30-c8c6-4821-af43-3669689cfa1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d6a813f-00ea-426d-aec6-e7e504a794b6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_15a1119f-e49f-4b1d-8d94-314d23718d44_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_0c96cbb9-91e3-4196-ae20-37ccfdd0e8a1_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Available For Grant</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant [Roll Forward]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TotalProductsMember_b44d4f6e-e68d-4ff3-9f93-89cc656f058d_terseLabel_en-US" xlink:label="lab_cutr_TotalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product revenue</link:label>
    <link:label id="lab_cutr_TotalProductsMember_label_en-US" xlink:label="lab_cutr_TotalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Products [Member]</link:label>
    <link:label id="lab_cutr_TotalProductsMember_documentation_en-US" xlink:label="lab_cutr_TotalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TotalProductsMember" xlink:href="cutr-20221231.xsd#cutr_TotalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TotalProductsMember" xlink:to="lab_cutr_TotalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_7f853d50-e88d-4c92-ad0e-8f17a0503cfe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_16907683-6ead-40f2-a982-ac990f4fa075_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_d4d83013-9885-4cd2-8254-445a02724194_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_f25af18d-a9c8-4c3b-8ef9-e1efe3e428c6_terseLabel_en-US" xlink:label="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the world, other than United States, Asia and Europe</link:label>
    <link:label id="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_label_en-US" xlink:label="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World, Excluding United States, Asia and Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:href="cutr-20221231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:to="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0893baf7-6c80-49d6-8809-0a408b5dc158_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f040865-2a5a-4680-b923-4b2beee73862_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_8c846f06-5a66-4919-a167-306d0284f92f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in prior year reserves</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_88b71f24-b79d-4260-8ef6-b0e608ca0fbc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cdf55d2a-52a6-4508-9ff4-2843ee9ac489_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f1ad4760-c12a-4fb8-9ec1-826dffbc9e8b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_1cbbc7c1-67bc-4b59-9bf1-2ad8c5b761db_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_55530e5e-7d2f-4055-9266-68637451e857_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_1f57aabd-60af-4ae8-80a4-dc18b08df234_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net:</link:label>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseAbstract" xlink:to="lab_us-gaap_InterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a36a4f20-7a97-4320-9dfd-14b14c056efe_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Net Income (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_b87ed342-a1b2-440a-8b7c-6721aa6e6045_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f709fc3a-cdb9-4c76-8766-f94cc5623718_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cbfeba30-706f-4123-bf3f-1dc376164454_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c801b719-e0ca-4fa4-9704-a364e5d1094d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_dd1d4d9c-6eb0-4009-9076-f0c1230a39b6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4356e76f-dcb4-44ad-ab44-c866368a4e0e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f2e459ce-6687-4fde-97fe-b476f818df7b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_77b145cb-3925-4c27-be93-982e88b84a86_terseLabel_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets under construction</link:label>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_label_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset under Construction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetUnderConstructionMember" xlink:to="lab_us-gaap_AssetUnderConstructionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1b475baf-d2e5-4ecd-9933-67a9a858d204_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a8014cf6-aeea-4681-b700-0a1a31fc0345_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_9257671d-f5c7-4796-a88f-26f4118e4eb0_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_85e13ddd-e093-4a33-b6a9-1151d1da358e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_336c1c53-bc50-4107-9d81-ac140ba646ad_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_d45f71b1-c5b9-4a01-805b-e37cc787cf3a_terseLabel_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_label_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_documentation_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the underwritten public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember" xlink:href="cutr-20221231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_UnderwrittenPublicOfferingMember" xlink:to="lab_cutr_UnderwrittenPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearDevicesMember_3cee618c-970b-4f33-8148-db8c4f480525_terseLabel_en-US" xlink:label="lab_cutr_AviClearDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear devices</link:label>
    <link:label id="lab_cutr_AviClearDevicesMember_label_en-US" xlink:label="lab_cutr_AviClearDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Devices [Member]</link:label>
    <link:label id="lab_cutr_AviClearDevicesMember_documentation_en-US" xlink:label="lab_cutr_AviClearDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Devices</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDevicesMember" xlink:href="cutr-20221231.xsd#cutr_AviClearDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearDevicesMember" xlink:to="lab_cutr_AviClearDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_27a70345-ed25-484f-b1e8-4a8875fc5999_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConsumablesMember_83ba9558-17aa-41d9-b13c-9e371376cf51_terseLabel_en-US" xlink:label="lab_cutr_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_cutr_ConsumablesMember_label_en-US" xlink:label="lab_cutr_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember" xlink:href="cutr-20221231.xsd#cutr_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConsumablesMember" xlink:to="lab_cutr_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6ccbe518-da67-41e7-b59a-a1be46b3549e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3765e639-abb7-4538-b848-6591ec6edb21_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_6cff509f-17b5-4499-9322-f337e96ac850_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_ae60dbad-8730-4c5a-9e26-b20c25e378e8_terseLabel_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share subtraction (in shares)</link:label>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_label_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stock Awards Counted For Every Share Granted Or Canceled</link:label>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_documentation_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stack awards counted for every share granted or canceled when computed shares available for grant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:href="cutr-20221231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:to="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_f920cc98-18fe-4288-a82b-3912c3dcd286_verboseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of capitalized cloud computing costs</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3a3f56a4-1c5c-4412-bbfb-09bc748134b1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_697a4aa5-8af5-4b8a-b903-968ee6dc9feb_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_label_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Text Block]</link:label>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_documentation_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for operating and finance leases of lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesTextBlock" xlink:href="cutr-20221231.xsd#cutr_LesseeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeasesTextBlock" xlink:to="lab_cutr_LesseeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_87ce6c36-f63b-4abb-a184-d71915f29682_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_a1ac380a-ba92-4176-b752-19805ec2bda5_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8418fed0-70ab-4249-998e-596d1c491677_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fd72cdd8-2864-415a-b2bb-015ee2377cb5_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_af1cde46-04e4-4f54-b71e-abda355d4db5_terseLabel_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved (in shares)</link:label>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_label_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved, shares available for grant</link:label>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_documentation_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:href="cutr-20221231.xsd#cutr_AdditionalSharesReservedSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:to="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_a7759179-bb56-459b-8ac4-6e93f71f3c59_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2e90d394-df12-4594-a46e-9626fae81987_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b09d103d-c463-4037-81b6-e5ad436583ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_662dfa28-dd97-4ea5-8244-76b9c4c4621f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_6b3e91df-680e-48fe-835c-34bef00c118a_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_b34579b7-34e4-421b-b479-aa48d91f8c78_terseLabel_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment and furniture</link:label>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_label_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Furniture [Member]</link:label>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_documentation_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents office equipment and furniture.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember" xlink:href="cutr-20221231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EquipmentAndFurnitureMember" xlink:to="lab_cutr_EquipmentAndFurnitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_538170da-b16c-4430-8ab3-58402e53defd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_13d72510-6ffc-4a02-b989-c653a537ac70_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of operating leases</link:label>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_label_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Leases Remaining Term</link:label>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_documentation_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The remaining term of operating and finance leases for the lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm" xlink:href="cutr-20221231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeasesRemainingTerm" xlink:to="lab_cutr_LesseeLeasesRemainingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f4bcbc9c-dd25-4f70-af78-94fc8bde2660_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_cfb77994-ced9-422a-b155-fce1d69567e9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_c3a46ac5-6270-4fe9-b5b8-82cf99d38e9e_terseLabel_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Four Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the equity incentive plan adopted by the Board of Directors in 2004.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:href="cutr-20221231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:to="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1470ec8a-5f60-4b2b-9203-33241d7717f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_8887cb4e-fcb3-4ca2-8535-ea5302c5e02d_terseLabel_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_label_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_documentation_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_fa3435f5-fd52-4d47-a0d1-65f6688bcb3f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_95f5a9c0-1711-4575-b084-4bdc901adc88_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_6308944d-4e0a-4548-b11d-de82787f7905_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anniversary fee amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Anniversary Fee Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents anniversary fee amount for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:to="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_30758423-d1c2-473f-9851-a69c89e75d2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_96ba86e1-7b23-43d2-991e-c4928208c485_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_c4d17be5-96f5-459b-8d07-97b255508ce1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange9Member_dc62aac1-6c58-4a49-93fd-385722aaf26b_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange9Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 9</link:label>
    <link:label id="lab_cutr_ExercisePriceRange9Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange9Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 9 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange9Member" xlink:to="lab_cutr_ExercisePriceRange9Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_e6bf3f84-3593-428b-8201-a3deedaba8e5_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_9c729850-be08-4269-b434-0013a0c314a7_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Debt Extinguishment Costs, Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Debt Extinguishment Costs, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:to="lab_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PartnersCapital_1e8d3377-b220-4550-9214-3bbd483b59cc_terseLabel_en-US" xlink:label="lab_us-gaap_PartnersCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capital spending</link:label>
    <link:label id="lab_us-gaap_PartnersCapital_label_en-US" xlink:label="lab_us-gaap_PartnersCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partners' Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnersCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnersCapital" xlink:to="lab_us-gaap_PartnersCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_17eb4de4-e09f-498b-907d-827d37b0c5bc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_5f31070c-2bd4-4cdb-a9d4-8a4f5d115232_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of issuance&#160;costs and repayment of convertible notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_6b4c43d3-c4e3-4269-a757-22b534d17444_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_abe79681-d321-40b4-8971-261a55044204_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_37b46e80-a066-4593-bf75-4ece8aa4b6ac_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_6b6c18e6-b710-4b5d-805a-a59091a0c8d3_terseLabel_en-US" xlink:label="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of 2026 Note principal exchanged</link:label>
    <link:label id="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_label_en-US" xlink:label="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Unamortized Debt Issuance Costs, Converted</link:label>
    <link:label id="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_documentation_en-US" xlink:label="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Unamortized Debt Issuance Costs, Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:to="lab_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_65f67d84-ff24-4e42-b29a-0ede6ffb74de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_fffeff1d-0aea-48a5-8906-57ae2c898007_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SkincareMember_9926f6f8-11ef-4d8d-a1ce-22a09fba0fe6_terseLabel_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare</link:label>
    <link:label id="lab_cutr_SkincareMember_label_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember" xlink:href="cutr-20221231.xsd#cutr_SkincareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SkincareMember" xlink:to="lab_cutr_SkincareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5cbcb10b-d5de-49cd-bb73-3e2f3865c64a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_eb2233d1-d613-418c-8994-c867b478fb43_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_50b0e92f-0f17-4079-8cff-d2a0ceb2ee2e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b7960fe6-889a-40fd-9e00-38a6281fbe13_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_1be60a2a-cf02-458f-80a6-c71fb1885e88_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_3c8da9b3-c659-4daa-a4eb-b946ed1c1284_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3cf6f1ec-422b-4332-b78b-1f98e13e7b37_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_2638542f-ca5d-431c-9bcb-b75f68f9a1f6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_64317e5f-8e8a-486c-a748-7a9b2fd26bfa_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_546de565-9353-4c4d-9e52-dab02076a7ab_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_44328ee6-0a2e-4c57-98d5-625958d68b1e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_5d30c651-8769-417e-8b5e-517b40d92942_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_71282a4d-75f3-4b0f-be66-a34afc255994_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_4c5920ae-515c-4921-ac97-e81bbaf6c67c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0771705a-957e-43fe-9ab6-23effa92459b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_e88b3ba9-349b-44af-a7e9-44b16f96e734_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e13d9f2c-11d8-4ae0-ac9f-85ad2056c19e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_0ccfc3c9-7390-45fe-9244-5415ab082d78_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b80f408b-bf2b-4f42-964f-f7d880c8ec87_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_07c140c1-843f-4ece-8afa-7e7bdb4c4cdc_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_930a5fad-b135-483c-8e57-518014753f31_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, First Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, First Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2028, First Conversion Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_51e7d438-2110-4760-b3b4-6c26bf39bb38_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_145dbe1e-009b-4373-860b-8a918a822c2a_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess compensation</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c903312b-2ce2-4270-ae10-4b167f7d9176_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_1252a9d6-5bd0-45c3-a22a-a1b475400f62_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a7ce18f-37a5-4eed-aa0d-3d4435360f71_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0302a926-4db2-4603-9b7d-cf29dc029e9d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f040df60-df82-4481-beed-213a8f5487ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_be3b239a-2a2f-42eb-a8cc-840d216f1c33_terseLabel_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty term, direct sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_label_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Direct Sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_documentation_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Direct Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StandardProductWarrantyTermDirectSales" xlink:to="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5d72f4e3-ee0a-499f-9de7-e1b137598ceb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_cd97ac18-6e7d-48b3-b8a6-19beb4d60921_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of awards officers are required to hold for a minimum of one year</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a43ae26b-4bfb-4a30-bb2b-a4bd5d1fab62_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83781827-7c5e-453a-b65d-e404bb950796_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_6932abd3-ed45-4482-bc03-8371416829b3_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_8ece7758-8a69-43ff-ab7a-539a94b7628c_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Leases as a Lessor</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_86d2ec57-63aa-475a-8c0b-b754c12aea7a_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_72b15b1d-6068-4f0a-9b7f-84d7b80a5608_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_8cbad4db-e20a-41ae-9f17-8a5eed314dec_totalLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_ef2097e9-6533-4fed-a841-559ddfd9cbe5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_d79b494c-945f-4629-aebd-702f53095a77_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration inventories included in finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_905fe999-0304-4f09-8ca5-9e6789562cd1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1032a86f-0f73-4fe7-af25-59f1c6a013a8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of issuance costs and repayment of convertible notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9ab6c896-823c-4974-b216-47406ab810a3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_a12674a7-29a8-4bba-9a50-fb2bc7121db3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9868f643-d252-4e3c-a9d4-04eaa4949f19_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_UnderwriterMember_578bdec8-1604-400e-a024-232c5ee8bb35_terseLabel_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter</link:label>
    <link:label id="lab_cutr_UnderwriterMember_label_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter [Member]</link:label>
    <link:label id="lab_cutr_UnderwriterMember_documentation_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the underwriter.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember" xlink:href="cutr-20221231.xsd#cutr_UnderwriterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_UnderwriterMember" xlink:to="lab_cutr_UnderwriterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_6cd6f2e8-8a04-4444-9442-5694ef045b0b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78d251ca-25b6-45ef-80bc-8f388872cc7f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_266afebd-1186-4722-8a3a-95a076db0ba4_terseLabel_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2019 equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:href="cutr-20221231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:to="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_d5cfc37e-98f6-4d84-aa57-2fe4c3caeb96_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3464b2be-e582-4697-aaad-fee5f1f5f605_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_e959460c-4a5b-440f-9102-26b56215f0ea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_71d0768a-45f0-4282-af93-e33bb7bff1d3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_fc038070-70ef-4f41-bd3e-2bfd0a528107_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_f2f94fdb-715d-4a24-b5b9-8f2a561402f1_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_4ae54661-47c7-4da3-9b27-9d51b26c1948_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_cab273f8-9643-4e29-aced-93ef8008796d_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_9067f7f8-7035-4a88-bbf3-fea5fc9e8368_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_dd91efa8-2190-48c5-9c26-e5789f900c8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_f71c1489-a2a1-430e-bf80-17afa3fc9a9f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ERPImplementation_a6c2549d-9ee6-49d4-805f-0086bac70bbd_negatedTerseLabel_en-US" xlink:label="lab_cutr_ERPImplementation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERP implementation</link:label>
    <link:label id="lab_cutr_ERPImplementation_label_en-US" xlink:label="lab_cutr_ERPImplementation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERP Implementation</link:label>
    <link:label id="lab_cutr_ERPImplementation_documentation_en-US" xlink:label="lab_cutr_ERPImplementation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERP Implementation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ERPImplementation" xlink:href="cutr-20221231.xsd#cutr_ERPImplementation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ERPImplementation" xlink:to="lab_cutr_ERPImplementation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1fd8a5c4-d448-4710-a4f7-6f2c051cae31_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_29030019-d3e4-424a-9492-8c778c859a13_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the second conversion trigger feature of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_bbfedcd9-4278-4322-b265-3a12c0dce5e3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_d8234791-478e-456f-9954-3af6f1e50175_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PurchaseOfCappedCall_7adbdd3b-7315-4526-9dbb-b287e9b90e36_terseLabel_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_cutr_PurchaseOfCappedCall_label_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Capped Call</link:label>
    <link:label id="lab_cutr_PurchaseOfCappedCall_documentation_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Capped Call</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall" xlink:href="cutr-20221231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PurchaseOfCappedCall" xlink:to="lab_cutr_PurchaseOfCappedCall" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_8b5e0fbc-ff09-41bd-9998-6c708ec65c7f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1433217e-8db9-4a01-be0a-53b252bbae52_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_9aa99e10-af33-4077-b9f1-8f0dbb4646b7_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-up</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-up</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_d55fb887-7627-4c03-b257-f37775b3d9dc_terseLabel_en-US" xlink:label="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Treasury Securities And Money Market Funds</link:label>
    <link:label id="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Treasury Securities And Money Market Funds [Member]</link:label>
    <link:label id="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Treasury Securities And Money Market Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:href="cutr-20221231.xsd#cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:to="lab_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2d114b83-2ed2-4534-a54c-8d29a6d6014f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional stock available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_37086979-0530-4051-88dc-cfbfc006e10f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of convertible notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_49213254-5ebc-4bda-b250-e9cac50f9835_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_832b72c5-973e-4087-a829-9960213a89f1_terseLabel_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing accruals</link:label>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_label_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales And Marketing Accruals, Current</link:label>
    <link:label id="lab_cutr_SalesAndMarketingAccrualsCurrent_documentation_en-US" xlink:label="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent" xlink:href="cutr-20221231.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SalesAndMarketingAccrualsCurrent" xlink:to="lab_cutr_SalesAndMarketingAccrualsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9e76bd0e-0c68-4933-a65c-d3284f238357_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9b11ece5-98f0-47ea-91a2-745b793feaec_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_991db374-ecec-45ee-9829-721f409feebe_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option three, term (in years)</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_9ef2ec09-a995-4ab2-90a2-aac709505cfd_terseLabel_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for risks and uncertainties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="cutr-20221231.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_11d3b1b9-68c3-48c7-8bad-f05cba5685e6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d7652a49-ba00-4057-86d1-0fa63bab649f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_29705472-b861-4119-b48e-1376ac3508da_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_42fb3901-c0c3-4d08-a0a4-ab1e8a622631_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5cb2dde8-c819-4585-a5f1-7c8380bd52ab_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_368f106b-7ecd-49b0-bc41-1ee3e47abcb0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_30d53c10-3d74-46e0-a099-9fba8f8bd221_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e46105b2-6bb9-432b-9de4-07c98c3ffa8f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_45af83c8-0309-4732-a936-46929adcbdb8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_925c8321-17fa-4f84-a3ef-54b890cd1d30_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_b8d6b980-3ced-45fb-839c-6aafcdf8d758_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_fbbf3e69-4b94-4c7b-8c3b-748aa387969a_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3f3639d0-2a2f-4564-83a4-073cdf978f23_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under finance lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_64dfc200-8a4e-4e95-bbcf-d5c772817ef6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_4287aaf4-63e3-4c04-8633-1acd99b193c0_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_b03127d1-4ee1-4790-bed6-b1e9413a7c5d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_40073bf0-42b1-4555-82a1-97544781e871_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_e571f55e-ffaf-4dbc-9ed3-205402f6dc2c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of capitalized contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_7fb1de7e-28b0-4393-bbb1-82034a082375_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional principal</link:label>
    <link:label id="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Additional Aggregate Principal Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Additional Aggregate Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAdditionalAggregatePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:to="lab_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4350f3ed-f684-4f39-bad7-871abda3d6c8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_2f80ac2f-b869-4e26-b226-10cf4a9a4fab_terseLabel_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs for extended service contracts</link:label>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_label_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs For Extended Service Contracts</link:label>
    <link:label id="lab_cutr_CostsForExtendedServiceContracts_documentation_en-US" xlink:label="lab_cutr_CostsForExtendedServiceContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred under service contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts" xlink:href="cutr-20221231.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CostsForExtendedServiceContracts" xlink:to="lab_cutr_CostsForExtendedServiceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6f61db86-a273-4469-b707-a336232fa9ca_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_8ec7b7b3-c154-465d-a79e-addb1f8ad57b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_994440e9-4160-4ed1-8898-cdffe2bfc0f0_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf062f7d-b4b9-49d8-be0a-1321a5067708_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fac4ed86-eba3-4b5b-af87-341f88ccd6fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_e205b65d-1d7c-42ea-a10b-f6e04b09ac4c_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped-call transaction term, consecutive trading days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_label_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_documentation_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:href="cutr-20221231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:to="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_781d9aaa-11d6-430c-88c5-49d144561247_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_76c46df6-4267-4f35-8684-d0695d82ef67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_50dee1d5-cfa6-4547-bd0e-af98b8a5e298_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment and furniture</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_009d9cdd-f5f5-4d16-9f04-63190d203ee5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2d0381d7-37ec-44a7-a859-692a0de66781_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_834e03e6-6039-4552-ac87-33b44b5d350e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1db59127-8c50-428c-86e2-8e6b09e37ddd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost accrued</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_beaffa2a-289f-4535-8882-1a9bb61ccd36_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_f862ac82-ef41-430a-a1e6-081ffe9911fa_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_1622aac0-1f28-4d85-b390-c554051512e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_baab002d-3751-4d17-be0d-e9532b226814_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $2,497 and $899, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_4e173178-2629-4897-8807-e7f083aa6287_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_0f43e8b3-2116-4507-8d01-f0a4f15347f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt at fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_22b711a4-5d74-4c6c-812e-0ccd764cbff3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_b2815bd1-4b5d-43b3-8fae-e0ca370f5db6_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_fa4936fc-6857-4a1e-ab6f-95b0d25454c8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_e926b52d-e30a-413a-a75a-1c55eef0d3a7_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_7f5868a1-2121-4db0-bddf-deb6b8893267_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_d8fb1e64-c392-438f-b8b9-0ccd88de2e55_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_329e539e-a1b9-4dff-bb48-fe9c42876ebc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_7868ecfe-223c-4ffb-8c77-3ca7995db7d4_terseLabel_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="cutr-20221231.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0e7ca043-eddf-48f4-b7cb-451ec76ef228_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4f7727e8-96c3-4719-984c-d8c36d709d63_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_63e86fc3-4230-45d0-8c92-6c25435bf051_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_b165cb64-81e1-4b0a-a63c-402298d806b7_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_02ea7798-1c5e-4cf5-93c2-8e4dff8b71c0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentCashIssued_b33b3cea-afd4-4ad9-ae7f-fdb6be318040_terseLabel_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used for repurchase</link:label>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentCashIssued_label_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Cash Issued</link:label>
    <link:label id="lab_cutr_DebtConversionConvertedInstrumentCashIssued_documentation_en-US" xlink:label="lab_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Cash Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:to="lab_cutr_DebtConversionConvertedInstrumentCashIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_8972f1bd-4528-45e7-88b5-9fe2ba03bfd6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_5f0df52e-fd32-4990-ba8f-908a1c72e1b9_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of PPP loan</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Extinguishment Of Loan, Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Extinguishment Of Loan, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8779f629-eb19-4c81-b0b5-699f3860cc85_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2e074fd0-97c0-469c-88c7-bb042e3debe8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_53b59499-0f53-4b6d-a7c0-670b9c56e1d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_4295c2e5-9ae5-4067-95da-cbe384c8f139_negatedLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue recognized from current period sales</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Decrease From Revenue Deferred</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:to="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtConversionNetProceeds_fcdde1da-2f9f-45f6-a72e-9ac7ff190080_totalLabel_en-US" xlink:label="lab_cutr_DebtConversionNetProceeds" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares and cash exchanged</link:label>
    <link:label id="lab_cutr_DebtConversionNetProceeds_label_en-US" xlink:label="lab_cutr_DebtConversionNetProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Net Proceeds</link:label>
    <link:label id="lab_cutr_DebtConversionNetProceeds_documentation_en-US" xlink:label="lab_cutr_DebtConversionNetProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Net Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionNetProceeds" xlink:href="cutr-20221231.xsd#cutr_DebtConversionNetProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtConversionNetProceeds" xlink:to="lab_cutr_DebtConversionNetProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_455033a1-fc01-42ff-af1f-0dfe885c8b2d_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_cc584173-1447-44d6-bff3-cf754aee9a4e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reclassification adjustment for net losses on investments recognized during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d16f1e5c-8756-4557-967f-79401c1f93e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3edf4504-9167-4f65-b182-cf67e67fdc62_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_bf3b8f85-6c06-4cb8-88c6-d8fbe69c9041_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_39390049-6381-4a69-99d2-b36d7dd43557_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_88e46689-2510-4064-a9e2-9383ed775739_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7e9109ae-a5c5-420e-8737-31986f245478_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2d53743f-cd91-4b9f-bf1c-9724e69b2f3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f9347f91-4dec-44aa-ac26-8277a264432d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_65981061-ddb8-4641-833c-a9238a883110_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_8efd39f8-b898-4ec7-9789-864397667edc_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_32513a64-ebcd-45b9-8b6f-167b272d4387_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_38da7063-fde8-46d5-9efd-27249f67ac8c_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_5282b9d0-d74a-49e0-8ac1-e79803750730_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_956ff5e8-9cd6-44ac-9df8-ab44e057abcc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55b73af6-52c5-42f4-a0ad-61118a751292_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_5ce53565-8683-49f5-990f-08031e431759_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_e23dfee9-3c53-4b0f-9387-d64019df4ee3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_104a2c95-f32b-4fc7-abb6-837a6bebf2c0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StockPurchasePlanMember_603599b9-383d-4469-b5b1-c252de5dd282_terseLabel_en-US" xlink:label="lab_cutr_StockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Plan</link:label>
    <link:label id="lab_cutr_StockPurchasePlanMember_label_en-US" xlink:label="lab_cutr_StockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember" xlink:href="cutr-20221231.xsd#cutr_StockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StockPurchasePlanMember" xlink:to="lab_cutr_StockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_fb5c965c-6ef0-4a0f-9f8c-f17eb1cd8d9a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7fd5d1b1-a992-4fe6-848e-1200bd106d87_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_329562ff-4e36-49d1-98af-c9fea46f19ff_negatedLabel_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract acquisition costs</link:label>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_label_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Deferred Contract Acquisition Costs</link:label>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_documentation_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:to="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_a6406a5d-9684-4fed-9555-cd84d7232b59_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0d3c52fe-58d0-44ad-bf62-d082eb70d6ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_056a21c9-34dc-4a43-a248-b8cff8abc734_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5253dc3f-fcc0-4f19-b8d2-7acc57aec945_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_abbe086a-3147-43d3-8178-0898830a5ba8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_588d48ef-6cca-4948-8d97-c75cbe2bb9d8_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_64303b6c-ab54-463a-83ff-1ab75900211a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_406073de-435d-4ea6-b1ab-61d45b855ba9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_d4a06f19-1c6f-4b3b-8581-33a7a9e3e1a2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_18318e13-27ec-431f-9f86-4e003ec534d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1b3aefb0-cd20-4f24-9412-7559ff070771_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_33b25cf3-e753-4ed2-8670-2e3fc28d413b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c81125f5-147c-4e95-9f10-91fdd63aa2a9_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_0f6c1803-718b-42f8-af0c-52547837fbad_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_21049918-4a98-42b4-bb0d-e41b47da7d53_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2b130a1c-e801-4f5b-b79f-fe658af52716_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ff7fb225-7e34-47fb-9be4-f9c7a1c4f887_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_68aa5f6c-5647-402a-845b-4d12bc850647_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_4b55ba9a-6396-4154-b544-1df7c065354e_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AuditInformationAbstract_label_en-US" xlink:label="lab_cutr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_cutr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_cutr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AuditInformationAbstract" xlink:href="cutr-20221231.xsd#cutr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AuditInformationAbstract" xlink:to="lab_cutr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc467c72-1a14-4c48-b759-e669a0e12fd0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_916762d4-1e6a-4523-a7b0-2b1a1fd0a286_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange5Member_76266cde-19e9-4775-9eb7-b60ba415c888_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 5</link:label>
    <link:label id="lab_cutr_ExercisePriceRange5Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange5Member" xlink:to="lab_cutr_ExercisePriceRange5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_a277f2ab-1493-4a4c-b126-b9b137f5c6d2_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_6b053c1a-7a58-465a-9a93-b294a1d0589b_terseLabel_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear operating lease license fee revenue</link:label>
    <link:label id="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_label_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Operating Lease License Fee Revenue [Member]</link:label>
    <link:label id="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_documentation_en-US" xlink:label="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Operating Lease License Fee Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseLicenseFeeRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:to="lab_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_bed730c5-1548-48a7-9718-4ee765b70c63_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCapPrice_c2023305-1f04-438c-8c3a-f4d2d90a488e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cap price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DerivativeCapPrice_label_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCapPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCapPrice" xlink:to="lab_us-gaap_DerivativeCapPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_bef5ccc7-6521-4658-8a74-19b592e89f5a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a28d4171-a5a0-460e-8e02-4fdcd88c6393_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from PPP loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_1540feec-1cb9-4659-a34b-74440940fc70_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_aac506fd-94c0-4441-8f77-63a8287a1344_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a5493505-bf6a-4003-8dae-d4d656f3bddf_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_beda5eaf-966f-4bc5-b9fc-db0cce6d3df2_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_43ab97ef-f475-4681-acb4-58f1d9b61ef7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_3c48b18c-d7b3-48bc-a9e0-21e9966bc5ed_terseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db412f95-c6e3-45ac-96e8-aafae44c0ea2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2beb89bd-6319-4715-98dd-3e85958c71ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SystemsMember_1d22315b-e24a-46cc-9711-ecb2f1124f09_terseLabel_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems</link:label>
    <link:label id="lab_cutr_SystemsMember_label_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:label id="lab_cutr_SystemsMember_documentation_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember" xlink:href="cutr-20221231.xsd#cutr_SystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SystemsMember" xlink:to="lab_cutr_SystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c3454319-a27c-4299-ba4d-ee684c74fed8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_7a1a245b-40c6-4e49-a013-40793401453d_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d37b3654-ef23-4859-b035-4adb307f8a88_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_cc6acaac-8fdd-462e-8329-70ef545e372e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_f6a90296-6b98-4821-b89f-e0ba554ab7ab_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_be759a6b-8091-44a7-8575-13e1c91f1f66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_2d61026c-e306-47cb-a82e-446449aaa4f4_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4a0d3e59-8341-4a7a-bca5-adc001a790ab_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f16ffab5-c2d3-4a86-ac6d-e02abf9fb6da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_47c4cd7c-2f5b-4287-bb62-1097f0078528_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_b353383b-aeec-465c-aace-e7bc98176b32_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation By Share Based Payment Fully Vested Stock Awards Grant Date Fair Value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:to="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e985b14d-6ed5-49c2-8001-67d0e4f3f5b6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_2eaf3d59-5fa4-4fb6-a44c-81a300508fa5_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_fa9d63dd-2e39-42f0-a034-b20cdcc5e436_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_d82e5abf-6b3a-46d2-9f04-0445b37e5741_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accruals for warranties issued during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_92c9f86b-4daf-462b-92a6-af7f3112db4e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_3accc785-9387-491c-b150-8aa01d48d0fb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_13ef53d9-7a5f-4554-b507-473fbede8cf5_terseLabel_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Amended and Restated 2019 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Amended and Restated 2019 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the Amended and Restated 2019 Equity Incentive Plan (the "Restarted Plan").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:href="cutr-20221231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:to="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1f8732f5-4b16-469d-be9e-0f8514a7af41_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f26017d6-58e2-409d-a467-350faf95a81f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_c1086484-2799-4ff5-9c4a-7f6dcf23372c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReduction_62c7c00d-0132-4a46-a6ed-4714198e0718_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_NotesReduction_label_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReduction" xlink:to="lab_us-gaap_NotesReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_fa51adc0-1161-4e88-9eec-1fdfe5991d0a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_32cb62a2-0efa-43d4-9b6d-b90a68a44d8b_terseLabel_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, excluding Japan</link:label>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_label_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, Excluding Japan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember" xlink:href="cutr-20221231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AsiaExcludingJapanMember" xlink:to="lab_cutr_AsiaExcludingJapanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f61cdc57-9644-445b-8c64-ce61a2cf3c76_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5c03c06c-4d44-4f1d-90e0-b201409035b4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_d3461aca-4b33-4ab7-8d5e-9840385779d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_664b61c4-6fd9-4614-853d-3584ee7a652e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_7d77eef6-a7b2-45a4-8a0d-4bb6bd30f50f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_4ae7a701-8a8b-43d9-ac11-3b051e48f7b6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_7c005a9b-17bd-42c0-933b-12692ff72423_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NumberOfConsecutiveLeaseTerms_0c01ed86-6b47-4bd8-852d-bb42b5251939_terseLabel_en-US" xlink:label="lab_cutr_NumberOfConsecutiveLeaseTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of consecutive lease terms</link:label>
    <link:label id="lab_cutr_NumberOfConsecutiveLeaseTerms_label_en-US" xlink:label="lab_cutr_NumberOfConsecutiveLeaseTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Consecutive Lease Terms</link:label>
    <link:label id="lab_cutr_NumberOfConsecutiveLeaseTerms_documentation_en-US" xlink:label="lab_cutr_NumberOfConsecutiveLeaseTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Consecutive Lease Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfConsecutiveLeaseTerms" xlink:href="cutr-20221231.xsd#cutr_NumberOfConsecutiveLeaseTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NumberOfConsecutiveLeaseTerms" xlink:to="lab_cutr_NumberOfConsecutiveLeaseTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_19fcfb47-f4c2-40d4-8733-223f59e9f03d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_71a41156-ac79-45b8-9069-bee3614f4796_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1007d4b0-82e5-4d9f-a93a-7ba318fbee76_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_4375d151-3802-4e06-8cc9-b247defdbe52_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7a2003c4-6b13-46dd-b0ef-4a799db8293c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited(in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_534c8d18-bc95-4d71-a852-fce0e05970b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a763ecf6-5004-41cf-88d4-2083e0534a1c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_e5000214-5a9e-4a21-bfaf-d420c5c318aa_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b20af1ff-bc9c-4e01-9df2-c8fb08545eb0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3a2f5f36-4fdc-415d-9910-1fe59ee41db4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_fd318a5b-665d-47ee-af79-fa18a5592bca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_17c5d95d-729d-47a6-be09-1b60ce90cf48_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:to="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_db81ef34-9439-4199-b823-f13a632ce913_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_c621b4f4-cbb9-4503-aa9d-39a5fadf4b6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid (refunded) for income taxes, net of (refunds) payments</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_705f3c64-1b92-4a54-bed0-71b34784dde2_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue recognized from beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2e9f7328-b404-40ca-a57e-ffc5244fe57d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_422f2846-1806-4ee5-99f5-567a813604f5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_87699905-56b0-4e74-a9ab-a97af31125dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7a7fb387-9ffa-4eff-86d7-d2ce077103ca_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, recognition period (in months)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3b8dab34-4c02-4a08-ab9e-b312df8b7926_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets Measured and Recognized at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_4aa0575d-af2b-48a1-ba5a-db029c732f8b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_0c2a69b1-6e6b-429f-89e4-98b6667c7e0e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a29d52d-9287-4475-bed2-df0abfa544d1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractTerm_7f155930-fa3a-4efe-87df-dbacefd5deba_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractTerm" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractTerm" xlink:to="lab_cutr_ExtendedServiceContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_19c5e534-2a50-449d-8b3f-9c3d56ba3a3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_32a1d07e-12d3-410e-974b-cf5bfb89eae0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_aaa298ac-bcf6-4d0e-9367-fdef190c77c3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_e2a8141e-bcc9-4c67-8fda-de9a5d3dde18_terseLabel_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_label_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_documentation_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_3b692b08-dc79-463e-a2ce-919522c7c2a1_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing accumulated amortization</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_747e9a15-95a1-49d5-b7ef-f21d868be6e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_ce514ea8-40f8-473c-8418-b5df361fcd01_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of convertible notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_36974114-2767-4736-a4b9-a20c5e10d05e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_91883dfc-b13a-4489-b8fc-e483b8b2678a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_3181f532-90c3-43c4-bd66-c2a21e2b06f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_adc14f24-a9ee-4215-af30-9e58986535e9_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_408f74f9-951a-4fd3-94a5-e1a451ee5547_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_b364b503-32f1-4816-8f7d-397ed8feec21_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_b4e54b34-1336-4911-be8b-d616cf03822d_terseLabel_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Cloud Computing Set-up Cost</link:label>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_label_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Cloud Computing Set-up Cost [Member]</link:label>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_documentation_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the capitalized cloud computing set-up cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember" xlink:href="cutr-20221231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CapitalizedCloudComputingSetupCostMember" xlink:to="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9ce12bc8-ac84-400b-8f6b-56bfcb5336d9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_26cfc22e-300c-41f7-aa7e-651226320064_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange10Member_f5949b5f-5d38-4285-83b2-38ad6d289380_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange10Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 10</link:label>
    <link:label id="lab_cutr_ExercisePriceRange10Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange10Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange10Member" xlink:to="lab_cutr_ExercisePriceRange10Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cae6bd8f-429b-4b39-92bb-ed2c372e0247_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0a8e8d7f-cdfa-4f7b-b70b-2be9ee6ad9b2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable investments - U.S. Treasury</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_d5859f82-1118-4e32-963e-a97db8f4383c_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_88432896-d69d-43e0-bb76-224b32edfd46_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_37c03e3a-37c7-44e6-bcf1-31a16b345225_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_7221965f-246c-4948-9054-0cbf206c8b40_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_81d13d42-7408-4f0f-9182-01cbc6e39712_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e7d50302-60b6-441a-850b-68f33ca4e8a7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7fa0cc27-0aea-416c-976a-f53d1408ee71_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13).</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1ae613bb-a4d4-4ee6-9598-74d96a4951c7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6a796d4-0616-4ae2-8ce3-10f4f3dc22cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d3118f57-cf04-40ad-b7db-44af4bf954c7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeaseInstallmentCostsMember_8c80f622-c95e-4ee4-af4c-a54e2ed9ac50_terseLabel_en-US" xlink:label="lab_cutr_LeaseInstallmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease installment cost</link:label>
    <link:label id="lab_cutr_LeaseInstallmentCostsMember_label_en-US" xlink:label="lab_cutr_LeaseInstallmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease installment costs [Member]</link:label>
    <link:label id="lab_cutr_LeaseInstallmentCostsMember_documentation_en-US" xlink:label="lab_cutr_LeaseInstallmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease installment costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseInstallmentCostsMember" xlink:href="cutr-20221231.xsd#cutr_LeaseInstallmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeaseInstallmentCostsMember" xlink:to="lab_cutr_LeaseInstallmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_f4902125-3bd9-49a1-af06-fe2b4a98fbc8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in repayment of convertible notes</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearMember_91116ab5-75c7-42f6-8436-5919dc8cfcc7_terseLabel_en-US" xlink:label="lab_cutr_AviClearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear devices</link:label>
    <link:label id="lab_cutr_AviClearMember_9f171ea7-8fa4-4c3d-ba3f-81c33e06ef47_verboseLabel_en-US" xlink:label="lab_cutr_AviClearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear</link:label>
    <link:label id="lab_cutr_AviClearMember_label_en-US" xlink:label="lab_cutr_AviClearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear [Member]</link:label>
    <link:label id="lab_cutr_AviClearMember_documentation_en-US" xlink:label="lab_cutr_AviClearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearMember" xlink:to="lab_cutr_AviClearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_a3becba9-493a-4116-968c-0a6c7255cf8e_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding letter of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_a9ff4933-4612-47a6-b225-dfa7dd66d9a0_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange8Member_90234d47-49c1-4df9-a663-9643a5275542_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange8Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 8</link:label>
    <link:label id="lab_cutr_ExercisePriceRange8Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange8Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 8 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange8Member" xlink:to="lab_cutr_ExercisePriceRange8Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d2332e59-0d0c-46b5-826c-73db9996961c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_ae707572-4f10-4181-97ef-a3e0805c684c_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_3a77998e-b860-47ec-be7b-282b0649c22f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_57e3f7cf-0f61-4fd0-9eb2-e35216350a94_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_8d386ad2-2977-458e-a29a-cf2c919635d2_verboseLabel_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of increase (decrease) in operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="cutr-20221231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable_3dc2dd23-0b1a-4a6c-aa78-61310704902e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Extinguishment of Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:to="lab_us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_6ce4d740-80c1-431e-a23e-749c7e73fde5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange2Member_217f03f3-565e-40f4-972e-85fe4394bde4_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2</link:label>
    <link:label id="lab_cutr_ExercisePriceRange2Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange2Member" xlink:to="lab_cutr_ExercisePriceRange2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_8e416a05-5cf9-497c-99ff-206e3abe91bd_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Training on use of system term (in days)</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:to="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_1c2581ce-36b4-47c1-a4a1-45e044fe6230_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange7Member_15a9f788-c7b0-4131-957e-2caa3b4161b5_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 7</link:label>
    <link:label id="lab_cutr_ExercisePriceRange7Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 7 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange7Member" xlink:to="lab_cutr_ExercisePriceRange7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d2082504-e6f5-4467-a285-17d14dfe2a29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_de8591da-93b0-4fd3-837c-45fc7f54a68d_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold percentage of stock price trigger</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_0f61d987-988f-4d58-b3ae-118e6ad716b5_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c1d2d696-e108-4202-977b-7a4c0243ef6e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e97c266c-8dd5-48a9-bd1a-49e4f263ae5c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_00f754ab-cfcd-4939-8c76-7dc66c3976b0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b0b8e819-5d88-476a-b350-1bdd554974fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_03dd8b64-4da8-4547-a5f3-0ec34ab29c6a_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_2ec61f28-a9ca-49b7-ba6b-5a7f3d150feb_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Obligations</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_3456aff8-e182-436b-b2ad-500b500da279_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset before valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_807efcde-ab27-4a62-bfde-338238d0ec49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d22cf5aa-a1c0-415d-9427-d01aba3c75dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_3e224368-0265-4bb8-81e3-b685e70b10df_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_72de76eb-ca42-459d-a0eb-e032995c597b_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4453db59-2192-4f40-968e-247f013c6895_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f83e0dee-3261-4b3a-9b7e-bf85da13dca5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange1Member_685e5270-4193-426b-b228-9d52cd4b4221_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1</link:label>
    <link:label id="lab_cutr_ExercisePriceRange1Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange1Member" xlink:to="lab_cutr_ExercisePriceRange1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_1e8e991a-6759-4811-995d-9b989c7d940c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_dd74fc4a-9135-4bbe-8502-a2fe592a4b83_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Payments received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Increase Advance Payments Received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:to="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a4efca9c-38d9-439f-b7dc-853130df3ee1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ad7b74d2-5485-485a-8b1a-aeed35725250_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_8671aa66-1613-4c9c-b7e7-36b7da8cdf30_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued, offering cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_29cd1309-366d-4af5-be02-2c4de65b77be_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs on the public&#160;offering</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_c47e2635-7b7a-4549-8e54-900bcb02d516_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_d88b4830-24ca-43a8-861f-5e6c82676e2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_832ef787-e83b-4efb-a001-0c4b7269ee6c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_7aaf9b5f-d1c3-40f8-89e0-1111e82839ac_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_65fb95e7-9b16-4770-90d0-46158ad54cc3_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7d4b4d2d-b481-4582-9248-9bce6d2df28a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_b1701081-1f95-4d17-95c1-bb81acab4c95_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset after valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_4cff2b83-348a-4370-99f1-5af14cc1a10e_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LessorDurationOfAutorenewalFeatures_0816b0b7-2a25-488e-98e0-6db7bba16e07_terseLabel_en-US" xlink:label="lab_cutr_LessorDurationOfAutorenewalFeatures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Duration of autorenewal features</link:label>
    <link:label id="lab_cutr_LessorDurationOfAutorenewalFeatures_label_en-US" xlink:label="lab_cutr_LessorDurationOfAutorenewalFeatures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Duration Of Autorenewal Features</link:label>
    <link:label id="lab_cutr_LessorDurationOfAutorenewalFeatures_documentation_en-US" xlink:label="lab_cutr_LessorDurationOfAutorenewalFeatures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Duration Of Autorenewal Features</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorDurationOfAutorenewalFeatures" xlink:href="cutr-20221231.xsd#cutr_LessorDurationOfAutorenewalFeatures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LessorDurationOfAutorenewalFeatures" xlink:to="lab_cutr_LessorDurationOfAutorenewalFeatures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9a86c060-93c1-43bd-851b-872bde21f1b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f7e59a2b-df48-4e30-8be9-f186df2b0e24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_664cf897-22bc-482f-a54f-56a365802145_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_abd959dc-8603-4e11-8755-8b02986234a7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for loyalty program</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_2da2e24a-a4de-4527-bb79-7d2e6c7d4bd9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_440f0567-80b0-407f-9e90-a50c6469ac98_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f8666fef-1256-4481-a320-a06145a2c1ce_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_062dd27f-f943-4d7a-905a-5c89a091c2da_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_584fc6c8-f0e4-4df1-8597-78b322933c93_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_48c27333-104c-43f1-81ec-03ee1907301b_terseLabel_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Lease Liability</link:label>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_cc2c1550-8b15-4694-aaf1-1f2076af286c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:to="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_9a89759d-842c-49ff-8470-53906b64bd7f_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of finance leases</link:label>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_label_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Renewal Term</link:label>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_documentation_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The renewal term for leases of lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm" xlink:href="cutr-20221231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeaseRenewalTerm" xlink:to="lab_cutr_LesseeLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6b7bba6a-d46b-458d-830d-b8d6320d2fae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AviClearRevenueMember_4fe1eba0-1c17-4d89-ac90-e5a60a03a727_terseLabel_en-US" xlink:label="lab_cutr_AviClearRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Revenue</link:label>
    <link:label id="lab_cutr_AviClearRevenueMember_label_en-US" xlink:label="lab_cutr_AviClearRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Revenue [Member]</link:label>
    <link:label id="lab_cutr_AviClearRevenueMember_documentation_en-US" xlink:label="lab_cutr_AviClearRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AviClear Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearRevenueMember" xlink:href="cutr-20221231.xsd#cutr_AviClearRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AviClearRevenueMember" xlink:to="lab_cutr_AviClearRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange6Member_9ef2c78d-1b5a-4f58-9bae-77567743fc5e_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 6</link:label>
    <link:label id="lab_cutr_ExercisePriceRange6Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 6 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange6Member" xlink:to="lab_cutr_ExercisePriceRange6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_cc16d55e-1a7b-497c-b5eb-0f750c954f08_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_dc2503e7-9e5d-49bf-9aea-8547659e6bc4_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtConversionPercentageOfDebtConverted_aa974f36-cbcc-4e43-ba70-74fc0360b9a8_terseLabel_en-US" xlink:label="lab_cutr_DebtConversionPercentageOfDebtConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of 2026 Note principal exchanged</link:label>
    <link:label id="lab_cutr_DebtConversionPercentageOfDebtConverted_label_en-US" xlink:label="lab_cutr_DebtConversionPercentageOfDebtConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Percentage Of Debt Converted</link:label>
    <link:label id="lab_cutr_DebtConversionPercentageOfDebtConverted_documentation_en-US" xlink:label="lab_cutr_DebtConversionPercentageOfDebtConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Percentage Of Debt Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionPercentageOfDebtConverted" xlink:href="cutr-20221231.xsd#cutr_DebtConversionPercentageOfDebtConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtConversionPercentageOfDebtConverted" xlink:to="lab_cutr_DebtConversionPercentageOfDebtConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d74e5610-e037-4041-93f8-26332deb99a2_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_83f1241a-0cfc-4145-b4a2-1a407bfc1ee0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_251e74f8-cdc4-498b-a588-2e0717428eb9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_c4183f88-9c66-4d5e-8379-f668224111f8_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_553272e8-5ca8-4e63-9dcf-de7e141638d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from PPP loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_ae64f5c1-5988-4392-995b-a5e2353c6206_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium over stock price (percent)</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_label_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price, Premium Over Stock Price, Percent</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_documentation_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percent premium over the stock price for derivative caps.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:href="cutr-20221231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:to="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_063c0434-8c4f-4911-99d2-9423489b9a62_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_d1905cd5-00a1-4e14-b04a-525b910fb8de_totalLabel_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair market value</link:label>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_label_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-for-sale Debt Securities</link:label>
    <link:label id="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_documentation_en-US" xlink:label="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-for-sale Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:to="lab_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_f98a46a8-a777-4a20-8bdb-de7f6da2335c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_9f5dfc32-99b1-44f2-905d-ea98ac3441fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_d245a324-2057-408e-b576-b779b33b3795_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_8c90d55e-5a52-47b0-bbc7-b63df9236d8d_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption threshold consecutive trading days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redeemable, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:to="lab_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8df2cfa1-83ff-4ecd-8e32-92d04aaf850f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_6da37941-4974-4bf8-9039-f86f048103fc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenditures</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5182316f-7139-4cbe-a167-643ce00d659b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant- Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_155e4a1b-bbb0-488d-af8b-6fee7db6c29c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_80a32978-b2b0-4ca6-ad57-4917da70ce9d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated product liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_01863c5d-44b3-4df1-9567-48ea7a643276_terseLabel_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards without expiration</link:label>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_label_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Without Expiration</link:label>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_documentation_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of operating loss carryforwards that have no expiration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:href="cutr-20221231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:to="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange4Member_23636adf-31a7-4c01-bd3e-6c778484cddf_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 4</link:label>
    <link:label id="lab_cutr_ExercisePriceRange4Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange4Member" xlink:to="lab_cutr_ExercisePriceRange4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_80fc1678-2062-4f7f-b146-2669a961e839_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5e65433a-3412-4a4d-b878-affed527e5eb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_6f420431-b74e-44e9-b4a1-ac8d58dc6701_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_3bd669e4-0bb1-49e3-a399-1f06be8d1a1a_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4aafd5db-1aad-45a8-a711-a4ad6e2f5ebd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_d5e90285-b1ea-4c71-a741-888efc7b7915_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance (as a percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_55ab8a7a-6c9f-4547-a910-03f76104da11_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_8d74ec82-ad92-49a4-b74d-ca1fbc8c6c9a_terseLabel_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for Sales Returns and Credit Losses</link:label>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_label_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for Sales Returns and Doubtful Accounts [Policy Text Block]</link:label>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for allowances for sales returns and doubtful accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:href="cutr-20221231.xsd#cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:to="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bd9e257d-a0ca-4d60-b29a-fc96f417fa48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange3Member_742cac2b-bbc2-4ce0-ae77-8f2bd7cfe070_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 3</link:label>
    <link:label id="lab_cutr_ExercisePriceRange3Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange3Member" xlink:to="lab_cutr_ExercisePriceRange3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_0d8e3c02-ab46-4343-aae5-228e5bb72c3f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_8a44c547-9a13-43dc-9b8a-b6a539408cff_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_361658ab-425f-4462-9639-983d6bfc4c39_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_c0878160-bdf4-45cc-9f63-b14866b41a3f_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>cutr-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3aeb706-a76c-4539-9144-b0de0c8fc48f,g:c7242e89-d91f-40da-b5e5-e503d5a78b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/role/Cover" xlink:type="simple" xlink:href="cutr-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://cutera.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_be5ecc9f-b894-457d-8049-e7d9ad72c318" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentType_be5ecc9f-b894-457d-8049-e7d9ad72c318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_5cf03e08-a5c8-42a3-8d53-41dd2a9c76ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentAnnualReport_5cf03e08-a5c8-42a3-8d53-41dd2a9c76ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b324f000-bc59-43e5-a4dd-6ab7bbf375c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentPeriodEndDate_b324f000-bc59-43e5-a4dd-6ab7bbf375c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b989b5fe-a815-452f-8840-289704f30cd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_CurrentFiscalYearEndDate_b989b5fe-a815-452f-8840-289704f30cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_6501bc2c-5789-4483-805a-07ae2024f6be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentTransitionReport_6501bc2c-5789-4483-805a-07ae2024f6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e3f929d7-ea09-4f28-867a-20fbc0aac31e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityFileNumber_e3f929d7-ea09-4f28-867a-20fbc0aac31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc52bb62-e53b-4525-8a83-023e7fb42087" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityRegistrantName_cc52bb62-e53b-4525-8a83-023e7fb42087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e5217b01-9e11-4572-ac51-1bc96579a6ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e5217b01-9e11-4572-ac51-1bc96579a6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1466e6c3-6b65-453b-9af7-714bce627ad0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityTaxIdentificationNumber_1466e6c3-6b65-453b-9af7-714bce627ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_84e123bf-6b5a-4403-b6e6-983da9148f9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityAddressAddressLine1_84e123bf-6b5a-4403-b6e6-983da9148f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_541814b7-f1df-4569-bebc-d3a02e5c6504" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityAddressCityOrTown_541814b7-f1df-4569-bebc-d3a02e5c6504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ee495ad3-1810-4fe3-b88e-93d7a2305a25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityAddressStateOrProvince_ee495ad3-1810-4fe3-b88e-93d7a2305a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_747b70b2-c258-457f-a1c7-16e4fcbd0b1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityAddressPostalZipCode_747b70b2-c258-457f-a1c7-16e4fcbd0b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3e73a566-2abf-402f-a269-02ca5c7ba0af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_CityAreaCode_3e73a566-2abf-402f-a269-02ca5c7ba0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0f933cff-6052-4388-8424-9381225ebee1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_LocalPhoneNumber_0f933cff-6052-4388-8424-9381225ebee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3797759e-4e2d-4f92-8287-f761c69fc9c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_Security12bTitle_3797759e-4e2d-4f92-8287-f761c69fc9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_de0737f3-addc-4285-ba10-379e232df5f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_TradingSymbol_de0737f3-addc-4285-ba10-379e232df5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ceb78c29-e6df-429f-87da-0ac59797b0b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_SecurityExchangeName_ceb78c29-e6df-429f-87da-0ac59797b0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8c567c84-efa2-4b85-b1db-0e4fe6bd5ece" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8c567c84-efa2-4b85-b1db-0e4fe6bd5ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_64e885ec-960c-4388-ac63-6ab5ef9d62f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityVoluntaryFilers_64e885ec-960c-4388-ac63-6ab5ef9d62f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1e67f877-94f6-4e0d-82e4-2a319e98da38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityCurrentReportingStatus_1e67f877-94f6-4e0d-82e4-2a319e98da38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_56cc04a8-6ad9-4eb0-834d-343fb95533f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityInteractiveDataCurrent_56cc04a8-6ad9-4eb0-834d-343fb95533f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_efceac5f-1a20-4f85-8f88-0420d9e82246" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityFilerCategory_efceac5f-1a20-4f85-8f88-0420d9e82246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_da60d8d5-e3dd-4ac5-ba3c-768f7d566944" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntitySmallBusiness_da60d8d5-e3dd-4ac5-ba3c-768f7d566944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5d4bc838-5dfd-4b09-8ea3-d35fa0912922" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityEmergingGrowthCompany_5d4bc838-5dfd-4b09-8ea3-d35fa0912922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_3134b8aa-8215-4f51-a277-fc9803758f82" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_3134b8aa-8215-4f51-a277-fc9803758f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e74359a3-6cb2-40c4-bd09-020349cf43d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityShellCompany_e74359a3-6cb2-40c4-bd09-020349cf43d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_b24cc79e-9dd3-48f6-98e5-68bdaba75d54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityPublicFloat_b24cc79e-9dd3-48f6-98e5-68bdaba75d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f343e754-244c-4783-a697-ceaef642c076" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f343e754-244c-4783-a697-ceaef642c076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_03c25953-3720-4a5a-a6cb-19211baf6dce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_03c25953-3720-4a5a-a6cb-19211baf6dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_00046f1c-1c19-4202-99e8-6d62c41179df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_EntityCentralIndexKey_00046f1c-1c19-4202-99e8-6d62c41179df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_515c47ea-fa8d-4585-a35b-9b029db7199f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_AmendmentFlag_515c47ea-fa8d-4585-a35b-9b029db7199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_08f95f92-a102-40c5-a884-24adf62a276d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_08f95f92-a102-40c5-a884-24adf62a276d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d1434bc3-8552-4559-ae27-17884dca7f4d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732e4255-464c-4283-a50d-7e8210973b6d" xlink:to="loc_dei_DocumentFiscalYearFocus_d1434bc3-8552-4559-ae27-17884dca7f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/AuditInformation" xlink:type="simple" xlink:href="cutr-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://cutera.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AuditInformationAbstract_6dae61cc-dfb5-438b-9e26-974638f7564c" xlink:href="cutr-20221231.xsd#cutr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_bc8f68cb-4ce6-41f0-b90d-ac112493e981" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_6dae61cc-dfb5-438b-9e26-974638f7564c" xlink:to="loc_dei_AuditorName_bc8f68cb-4ce6-41f0-b90d-ac112493e981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c31c189d-29b7-4d6f-8f8d-d77da4619116" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_6dae61cc-dfb5-438b-9e26-974638f7564c" xlink:to="loc_dei_AuditorLocation_c31c189d-29b7-4d6f-8f8d-d77da4619116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_8e020b4a-3ad9-4c28-a21d-bdd4a1c9571d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_6dae61cc-dfb5-438b-9e26-974638f7564c" xlink:to="loc_dei_AuditorFirmId_8e020b4a-3ad9-4c28-a21d-bdd4a1c9571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dc7b7138-5a1f-4f80-9b49-0da2d5e4e6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc7b7138-5a1f-4f80-9b49-0da2d5e4e6a2" xlink:to="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9c3779b-57e5-432c-a265-87859978334e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9c3779b-57e5-432c-a265-87859978334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_cc824027-215b-490d-a349-f613cc4c9b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_cc824027-215b-490d-a349-f613cc4c9b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd5fc366-9d8e-40fa-adb9-529f3798acdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd5fc366-9d8e-40fa-adb9-529f3798acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_94cd52ab-3b22-4ffe-bdfb-1ecf6f2b62af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_InventoryNet_94cd52ab-3b22-4ffe-bdfb-1ecf6f2b62af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1b5b8623-e2cb-4833-ae65-9b2c994e0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1b5b8623-e2cb-4833-ae65-9b2c994e0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2ce80f29-21c6-4e35-9a3b-38a0601ef904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_RestrictedCashCurrent_2ce80f29-21c6-4e35-9a3b-38a0601ef904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cf167fc5-a3e8-48b9-bcb0-b1e54cb19d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb5ef032-3ae0-4306-9897-d027191c9531" xlink:to="loc_us-gaap_AssetsCurrent_cf167fc5-a3e8-48b9-bcb0-b1e54cb19d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1374510d-5f2b-435f-b286-4c80535d658f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1374510d-5f2b-435f-b286-4c80535d658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_44abb615-eab9-44ef-8d29-dcb065021d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_44abb615-eab9-44ef-8d29-dcb065021d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0613d841-d002-43ab-834b-251658202783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0613d841-d002-43ab-834b-251658202783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fc9edbdf-1bd9-4970-bf81-50ad6128e09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_Goodwill_fc9edbdf-1bd9-4970-bf81-50ad6128e09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_933f47a7-31e2-4f56-8d6b-9315a5b67e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_933f47a7-31e2-4f56-8d6b-9315a5b67e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2e1ae59e-d63a-43f3-8294-4102f957c010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2e1ae59e-d63a-43f3-8294-4102f957c010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1619dd02-010e-4718-aab3-81452549a6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c0cc556-1c2a-4938-9d69-4aec92c53bf8" xlink:to="loc_us-gaap_Assets_1619dd02-010e-4718-aab3-81452549a6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc7b7138-5a1f-4f80-9b49-0da2d5e4e6a2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_afb3bad8-d655-4f3e-a75f-3fbb49afe143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:to="loc_us-gaap_AccountsPayableCurrent_afb3bad8-d655-4f3e-a75f-3fbb49afe143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_97a2c3c1-4028-4733-b4b1-991e37a8f1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_97a2c3c1-4028-4733-b4b1-991e37a8f1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_790f7de7-5274-4c9e-abc4-fc0013c9d98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_790f7de7-5274-4c9e-abc4-fc0013c9d98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_975fbc4c-eeed-458d-8875-946098a89a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:to="loc_us-gaap_DeferredRevenueCurrent_975fbc4c-eeed-458d-8875-946098a89a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ec8442b-23b4-4919-b451-65fe8fa09823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5fb3790e-0eec-4b45-9330-96c5f8a3960e" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ec8442b-23b4-4919-b451-65fe8fa09823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_8f89e863-ca6b-4d33-b142-abe8fedb3c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_8f89e863-ca6b-4d33-b142-abe8fedb3c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_53c69465-a915-4f55-a4af-1d30be3e42b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_53c69465-a915-4f55-a4af-1d30be3e42b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_bc3223a7-f7f2-42fd-87ea-d1b4442aadb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_bc3223a7-f7f2-42fd-87ea-d1b4442aadb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fe5ac539-043c-43c9-9037-d13c3b99d584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fe5ac539-043c-43c9-9037-d13c3b99d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2d6465b3-f0bc-47b3-9f0c-b6c94ced553a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_Liabilities_2d6465b3-f0bc-47b3-9f0c-b6c94ced553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_05f91383-c493-44b6-8e38-c45d723051f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_05f91383-c493-44b6-8e38-c45d723051f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8dbce782-97e7-45e2-ab6d-32ec8d5172f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:to="loc_us-gaap_CommonStockValue_8dbce782-97e7-45e2-ab6d-32ec8d5172f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3c6b0533-f5d0-4552-b2c8-85bf8f03b0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3c6b0533-f5d0-4552-b2c8-85bf8f03b0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_50f40810-b5e2-41d0-9ded-ea4118692077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_50f40810-b5e2-41d0-9ded-ea4118692077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_029afdcf-e579-4ffb-ac7b-bacc2fa92b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_029afdcf-e579-4ffb-ac7b-bacc2fa92b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_64b80c13-ef6e-4ba3-9417-a0d5ac48a13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_156232d9-0775-487d-a20a-2ddf83549cec" xlink:to="loc_us-gaap_StockholdersEquity_64b80c13-ef6e-4ba3-9417-a0d5ac48a13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec67dfe8-7ee9-44c0-88fc-f6e738c33f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed95118a-fd9a-4bbd-a246-9149187f936c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec67dfe8-7ee9-44c0-88fc-f6e738c33f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b26bb4ef-405c-454b-bb9a-e90b1add215a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b26bb4ef-405c-454b-bb9a-e90b1add215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2009b62d-0e44-4dc6-b867-238745b75090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2009b62d-0e44-4dc6-b867-238745b75090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_238c3568-8416-47e6-abac-ec064ae684d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_238c3568-8416-47e6-abac-ec064ae684d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e56a3f89-48b6-42eb-8c0c-0afd9f058ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e56a3f89-48b6-42eb-8c0c-0afd9f058ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5f738a7b-c80c-437f-a665-0d3e462fe65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_CommonStockSharesIssued_5f738a7b-c80c-437f-a665-0d3e462fe65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f0773295-9c1f-4d78-a325-0b4130b86600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bcd897fa-7ac8-4a47-983e-1e2f95a54595" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f0773295-9c1f-4d78-a325-0b4130b86600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_515d624c-e72d-4bc5-9d11-1b3b9ef56186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_515d624c-e72d-4bc5-9d11-1b3b9ef56186" xlink:to="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:to="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bdfdd1c8-506c-49a6-9857-c854caa78f2a" xlink:to="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_b691509c-a7d0-4d39-8d31-baec54902417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:to="loc_us-gaap_ProductMember_b691509c-a7d0-4d39-8d31-baec54902417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_09d1e34b-6d22-4fdc-bb3d-235453d41ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6bafea56-d249-40ff-9319-4705b561feca" xlink:to="loc_us-gaap_ServiceMember_09d1e34b-6d22-4fdc-bb3d-235453d41ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_455ce229-9b1b-4dc8-9230-9022f92b80de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3f87abd2-d0c5-4b13-9de6-b223a70f27fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:to="loc_us-gaap_ConvertibleDebtMember_3f87abd2-d0c5-4b13-9de6-b223a70f27fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_fd1a5db7-52b5-499d-aa94-05a440299885" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_61784ef7-1e61-4d34-b306-f5224d6e691f" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_fd1a5db7-52b5-499d-aa94-05a440299885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e398e90e-0212-44bb-bbfb-1ff549360896" xlink:to="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9dde43b2-84b3-48f8-8a68-f9eebf8936bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_e43ab69b-3b61-4aca-b335-d222ceffb170" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9dde43b2-84b3-48f8-8a68-f9eebf8936bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_80f5bbe3-56f1-4bdd-b334-cab2cfdb7d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6e532a01-14fc-417c-81a5-d8876f869a62" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_80f5bbe3-56f1-4bdd-b334-cab2cfdb7d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3424095a-8e6a-4d7f-9d10-c89659aaedc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_GrossProfit_3424095a-8e6a-4d7f-9d10-c89659aaedc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_78497180-012d-44cf-ba7b-05df9fcc3d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_SellingAndMarketingExpense_78497180-012d-44cf-ba7b-05df9fcc3d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e79fad6c-1561-4159-8786-f332b1871fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e79fad6c-1561-4159-8786-f332b1871fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_58634b75-87d5-4f4c-8afc-06f4f5df1e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_58634b75-87d5-4f4c-8afc-06f4f5df1e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_aae4c9f5-108a-458b-9b83-984e6f0c7989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_OperatingExpenses_aae4c9f5-108a-458b-9b83-984e6f0c7989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48074f65-2c14-4a11-be33-93a6cb2eed67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ffa6f5fc-10be-4326-bba8-6a0efcf81d14" xlink:to="loc_us-gaap_OperatingIncomeLoss_48074f65-2c14-4a11-be33-93a6cb2eed67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1485be29-aabc-4702-a100-a95a5bbc16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1485be29-aabc-4702-a100-a95a5bbc16a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c12f91dc-e4b0-48cf-8575-6093a4eb6018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_InterestExpenseDebt_c12f91dc-e4b0-48cf-8575-6093a4eb6018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f85dc88d-29ff-42f0-8104-0bec4b6ca227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f85dc88d-29ff-42f0-8104-0bec4b6ca227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_6f1a629e-aba2-4f3b-8bbc-329a54462eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_6f1a629e-aba2-4f3b-8bbc-329a54462eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_118fe5ff-a785-4ca7-befb-b2fd698196f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_118fe5ff-a785-4ca7-befb-b2fd698196f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2331a63f-a845-4217-a089-827974709ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_5ed139d0-0688-4659-946a-4dd94e7719b8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2331a63f-a845-4217-a089-827974709ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a7d4f55d-5ffa-46d2-b6da-bbd4c4fa5961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a7d4f55d-5ffa-46d2-b6da-bbd4c4fa5961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_03abb6bc-3178-4216-b5e1-de1ea1dfc64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_03abb6bc-3178-4216-b5e1-de1ea1dfc64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d3a84838-14cf-4d7c-8ad1-ad57656705da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_NetIncomeLoss_d3a84838-14cf-4d7c-8ad1-ad57656705da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_abd4812d-30f4-41b5-9a10-6fef3a1c61e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:to="loc_us-gaap_EarningsPerShareBasic_abd4812d-30f4-41b5-9a10-6fef3a1c61e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4b4818b1-f4d9-42c6-8e1a-376ec3c10b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4a5adb49-1fab-41e3-816c-1265f73e40c2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4b4818b1-f4d9-42c6-8e1a-376ec3c10b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97374d3e-23d2-4785-b04e-7d65eb031876" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a24de09c-8b36-4742-a929-30e83907fca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a24de09c-8b36-4742-a929-30e83907fca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acd634cd-ed92-45d9-b955-3e02a07452d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b98a0307-4154-4863-b515-0a9df71233ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_acd634cd-ed92-45d9-b955-3e02a07452d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eba12d90-1189-471f-90df-38dc33d6d3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9592e46-fc27-423b-b43f-0f0fad33a50f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eba12d90-1189-471f-90df-38dc33d6d3f6" xlink:to="loc_us-gaap_NetIncomeLoss_f9592e46-fc27-423b-b43f-0f0fad33a50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e44404d5-5711-440b-a89d-8658324f264c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eba12d90-1189-471f-90df-38dc33d6d3f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e44404d5-5711-440b-a89d-8658324f264c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_c500f47e-d6c3-43bc-a772-b00422ed9e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e44404d5-5711-440b-a89d-8658324f264c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_c500f47e-d6c3-43bc-a772-b00422ed9e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_c988329b-38f7-43e1-bfa8-c6044409d620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_c500f47e-d6c3-43bc-a772-b00422ed9e8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_c988329b-38f7-43e1-bfa8-c6044409d620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_5a312a5e-4166-4f1d-8db7-9c3c8fb18bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_c500f47e-d6c3-43bc-a772-b00422ed9e8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_5a312a5e-4166-4f1d-8db7-9c3c8fb18bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_63c12cf5-9219-49e9-9cfd-fe037ed2c63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_c500f47e-d6c3-43bc-a772-b00422ed9e8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_63c12cf5-9219-49e9-9cfd-fe037ed2c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_89dddd92-020a-4c1a-8b86-a51240ed6bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e44404d5-5711-440b-a89d-8658324f264c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_89dddd92-020a-4c1a-8b86-a51240ed6bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2a224076-d7aa-4be4-b677-7cb751ac8253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_eba12d90-1189-471f-90df-38dc33d6d3f6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2a224076-d7aa-4be4-b677-7cb751ac8253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_19c77799-fca4-4aa9-bf51-ffac95513fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_19c77799-fca4-4aa9-bf51-ffac95513fca" xlink:to="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39599973-83eb-4678-8a09-82a4c1f48f80" xlink:to="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5c5e3f17-bb34-43f2-b100-ed69e6c47c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_CommonStockMember_5c5e3f17-bb34-43f2-b100-ed69e6c47c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8643f865-c544-4456-a1fc-cde40f3a5a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8643f865-c544-4456-a1fc-cde40f3a5a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bcb38bcb-9956-40a0-9036-0a227bc54749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_RetainedEarningsMember_bcb38bcb-9956-40a0-9036-0a227bc54749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a248fec6-8c5a-42dd-93c8-2b9c70ff990a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e891dd57-f3c6-44bc-a78f-35479331f637" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a248fec6-8c5a-42dd-93c8-2b9c70ff990a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ccbd7795-0be8-46b2-b623-34f56c77b08e" xlink:to="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_843df912-7735-4571-9122-fdf016c906c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9d02efe9-f4b9-4b0e-b533-b5dc60a97896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9d02efe9-f4b9-4b0e-b533-b5dc60a97896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0199e370-7daa-4072-8996-77440fb04343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockholdersEquity_0199e370-7daa-4072-8996-77440fb04343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_646dd9ed-2827-41ec-b7cd-307c1befefd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_646dd9ed-2827-41ec-b7cd-307c1befefd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a3015fa8-614d-4ced-a2e1-86771420eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a3015fa8-614d-4ced-a2e1-86771420eb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9ac140d-3ff8-4b9b-ba16-751d326c1282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9ac140d-3ff8-4b9b-ba16-751d326c1282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c80b064e-8758-474e-a807-9fee2cfab04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c80b064e-8758-474e-a807-9fee2cfab04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4c4e03b8-84dc-45a3-a345-a75a73227e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4c4e03b8-84dc-45a3-a345-a75a73227e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_cb0f0f9e-f580-44ff-89de-07df63f2264e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_cb0f0f9e-f580-44ff-89de-07df63f2264e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall_dfd19d22-8fd6-4e08-befd-4f619e90b30d" xlink:href="cutr-20221231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_cutr_PurchaseOfCappedCall_dfd19d22-8fd6-4e08-befd-4f619e90b30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3428570a-a273-40ff-a6f8-b4abd2a19382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3428570a-a273-40ff-a6f8-b4abd2a19382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_5d86da5b-72c0-4cab-96fa-f7999b85dd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_5d86da5b-72c0-4cab-96fa-f7999b85dd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19196df7-1efa-42bf-aacf-f9c5b8b2580d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19196df7-1efa-42bf-aacf-f9c5b8b2580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_db199555-6c9b-482c-a69b-8fffaf5af63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_NetIncomeLoss_db199555-6c9b-482c-a69b-8fffaf5af63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77ff4640-9853-4e0c-b40a-cfd26b84c622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_77ff4640-9853-4e0c-b40a-cfd26b84c622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9ad4a962-6533-4790-803a-bcf6e35f01a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9ad4a962-6533-4790-803a-bcf6e35f01a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_167aae58-c522-446e-89f6-f8fed9c80692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f1e9cd1-efde-4794-84e4-8ff371c85038" xlink:to="loc_us-gaap_StockholdersEquity_167aae58-c522-446e-89f6-f8fed9c80692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e46b1913-c7d7-4a30-b5b3-fc264871bf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_c64e9dc9-d41e-401b-9a34-0e36aecaa095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e46b1913-c7d7-4a30-b5b3-fc264871bf5a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_c64e9dc9-d41e-401b-9a34-0e36aecaa095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaymentsOfDerivativeIssuanceCostsGross_f7be7850-2444-41a4-a3e4-2daa8ea51622" xlink:href="cutr-20221231.xsd#cutr_PaymentsOfDerivativeIssuanceCostsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e46b1913-c7d7-4a30-b5b3-fc264871bf5a" xlink:to="loc_cutr_PaymentsOfDerivativeIssuanceCostsGross_f7be7850-2444-41a4-a3e4-2daa8ea51622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d757e96a-d5e9-4c67-8b0f-a05958b90a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d757e96a-d5e9-4c67-8b0f-a05958b90a61" xlink:to="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_29dfd17e-4f6e-46ce-beaf-45d2b8f9ab60" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_32819eb9-ac50-48d8-bea9-822a1d4cda35" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_32819eb9-ac50-48d8-bea9-822a1d4cda35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9828f5af-c3f2-46c0-88b6-42f8a3a422b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f315ef8-1b5c-4664-9509-0518eb12b62a" xlink:to="loc_us-gaap_ConvertibleDebtMember_9828f5af-c3f2-46c0-88b6-42f8a3a422b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f1fb3fa-c032-40b9-bf98-9bd8462aedd5" xlink:to="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b50110a2-7cc4-4d96-9f9f-3427ecb59be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_NetIncomeLoss_b50110a2-7cc4-4d96-9f9f-3427ecb59be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a96e698b-95ba-47b2-be6e-6a2220c9e540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ShareBasedCompensation_a96e698b-95ba-47b2-be6e-6a2220c9e540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_95d66962-f8ba-47eb-b146-ace9f11db651" xlink:href="cutr-20221231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_95d66962-f8ba-47eb-b146-ace9f11db651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_f23947f2-d9ad-4728-9fe8-76f154abcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_f23947f2-d9ad-4728-9fe8-76f154abcd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9d74dc08-c503-4101-b302-06812125d6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9d74dc08-c503-4101-b302-06812125d6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84eeb691-244c-4f7b-8e45-6fbcdfebc0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84eeb691-244c-4f7b-8e45-6fbcdfebc0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ea0a04ae-2b68-4367-95c0-7a94e8dbd19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ea0a04ae-2b68-4367-95c0-7a94e8dbd19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c7232dfd-35ca-4db3-99a8-1c23e70a08b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c7232dfd-35ca-4db3-99a8-1c23e70a08b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7246c076-c817-4fdc-868a-ef54af3fd07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7246c076-c817-4fdc-868a-ef54af3fd07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6a7400c8-769d-4835-9c83-dc93348ea0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6a7400c8-769d-4835-9c83-dc93348ea0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_858e941c-fd08-4acb-a729-cf67da6044fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_858e941c-fd08-4acb-a729-cf67da6044fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2174f3b7-e707-4936-80e5-e0bfcfc93b1c" xlink:href="cutr-20221231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2174f3b7-e707-4936-80e5-e0bfcfc93b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7ccef9a2-a3cc-4b5a-9668-facf6f96a64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7ccef9a2-a3cc-4b5a-9668-facf6f96a64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66e6a595-ef38-4fbe-b330-dba1d96636af" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0c180228-64f2-4d75-9ab1-afbb0773c59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0c180228-64f2-4d75-9ab1-afbb0773c59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1d8bf8f2-1739-4bf1-9a5d-e220b8b68a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1d8bf8f2-1739-4bf1-9a5d-e220b8b68a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d2e469bb-c640-4098-a63d-cef8c110f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d2e469bb-c640-4098-a63d-cef8c110f9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3018b382-81a9-4594-8466-52c5b4ede713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_3018b382-81a9-4594-8466-52c5b4ede713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7787a3d3-0493-4df7-b0c1-5bccdedd5de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7787a3d3-0493-4df7-b0c1-5bccdedd5de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cc062507-e678-40e9-a628-5ce956bbf625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cc062507-e678-40e9-a628-5ce956bbf625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_eea5d86f-b0ed-48e5-b274-5700ae253b8a" xlink:href="cutr-20221231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_eea5d86f-b0ed-48e5-b274-5700ae253b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b6a508ea-28de-4f2d-9923-ded1534ab055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b6a508ea-28de-4f2d-9923-ded1534ab055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c743339c-e7e9-4d33-ba48-c3854bf55ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0ce3b6c-7034-4825-9ad6-de2d458ef11a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c743339c-e7e9-4d33-ba48-c3854bf55ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf8bd0cd-04fe-4b0d-b83c-b1077483418a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca46ac36-8c68-4761-874e-957efb840150" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf8bd0cd-04fe-4b0d-b83c-b1077483418a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76ed289b-a9e9-4658-9bcb-7d1ccfbb1d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76ed289b-a9e9-4658-9bcb-7d1ccfbb1d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d8d8f38f-74f6-4e61-b92a-0dc4b61bf9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d8d8f38f-74f6-4e61-b92a-0dc4b61bf9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3ac1bc59-126f-4321-b1d3-46a23849fd32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3ac1bc59-126f-4321-b1d3-46a23849fd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8cafc201-4f63-4c15-896b-c6727ecbfc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8cafc201-4f63-4c15-896b-c6727ecbfc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0811d76e-a9bf-4266-b968-24b9f03bca0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0811d76e-a9bf-4266-b968-24b9f03bca0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a36a319b-0e32-4dc4-8f8e-748e18f6243a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8001d5f-113e-4f6d-8962-122782bf2075" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a36a319b-0e32-4dc4-8f8e-748e18f6243a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50e8e0da-941c-4af7-ac31-6f6b2210fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50e8e0da-941c-4af7-ac31-6f6b2210fc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2bb1e52e-b7e9-4780-88cf-5fcb65e6f563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_2bb1e52e-b7e9-4780-88cf-5fcb65e6f563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_6ccaffbf-8a3c-4bca-895d-8ed0a3148570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDerivativeIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDerivativeIssuanceCosts_6ccaffbf-8a3c-4bca-895d-8ed0a3148570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_38c0a7d0-e650-496f-866b-39c3af1dd1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_38c0a7d0-e650-496f-866b-39c3af1dd1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bc1413b7-4b86-4745-8928-c617dcc1ab63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bc1413b7-4b86-4745-8928-c617dcc1ab63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_932734b3-4967-4e19-9210-ffccb7f1a3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_932734b3-4967-4e19-9210-ffccb7f1a3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a926fe94-12de-426b-baa7-c5f06dcb187e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a926fe94-12de-426b-baa7-c5f06dcb187e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b7e7f482-e0cd-45e9-994e-25df67093f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b7e7f482-e0cd-45e9-994e-25df67093f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0cb45b5b-b06e-4fc0-b2b5-0da5c48e0785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0cb45b5b-b06e-4fc0-b2b5-0da5c48e0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_27ae62e9-6198-4070-8b5f-0f7155add9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_27ae62e9-6198-4070-8b5f-0f7155add9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_32350624-857d-4f14-8b2b-91ab18fd0d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_32350624-857d-4f14-8b2b-91ab18fd0d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5daef03b-4261-4112-bdfb-93eb4f00de03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5e71fe47-f4cf-4638-95ac-45fa8d382fe8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5daef03b-4261-4112-bdfb-93eb4f00de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_93fe92cd-76c7-4a2a-b8ea-2991b5c6a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_93fe92cd-76c7-4a2a-b8ea-2991b5c6a1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_805bf42e-409f-4f0d-9bf2-beaed98a74eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_805bf42e-409f-4f0d-9bf2-beaed98a74eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fe7e18a0-f5ce-48fb-8446-95e044331bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_fe7e18a0-f5ce-48fb-8446-95e044331bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_bfe9425e-dbde-48b6-8378-df36b4685e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:to="loc_us-gaap_InterestPaidNet_bfe9425e-dbde-48b6-8378-df36b4685e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f1c0555a-4af9-4391-a5a3-bb986e340f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c2a9e718-b758-4676-9060-1130e229f017" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f1c0555a-4af9-4391-a5a3-bb986e340f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b55c8b53-e494-4349-8142-0905342606dc" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_beb231ab-9aca-4b65-a2bb-ac55b394bcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_StockIssued1_beb231ab-9aca-4b65-a2bb-ac55b394bcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82a1affe-a52b-4223-bdbe-fd18540c5c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_82a1affe-a52b-4223-bdbe-fd18540c5c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_21a4d72c-7701-46d0-9338-a6b2400500dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_21a4d72c-7701-46d0-9338-a6b2400500dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction_105473b7-6b82-4a0e-b3fc-c28b50d605cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_NotesReduction_105473b7-6b82-4a0e-b3fc-c28b50d605cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_06ba9fa7-56f6-40a3-884a-02e838f4f1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_06ba9fa7-56f6-40a3-884a-02e838f4f1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedCappedCallCosts_81696687-c27e-49a2-84b4-9597b2eb0f63" xlink:href="cutr-20221231.xsd#cutr_AccruedCappedCallCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_cutr_AccruedCappedCallCosts_81696687-c27e-49a2-84b4-9597b2eb0f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_856d107d-af35-49f2-895f-46443e71d617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_856d107d-af35-49f2-895f-46443e71d617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_013f7bb1-9e63-4b7d-b619-037fdeaceeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7ffc37d5-09d9-43d1-92b4-7f914844381b" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_013f7bb1-9e63-4b7d-b619-037fdeaceeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_327b2fc2-3c00-4103-94e2-8c11cb6316d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_2dcf2b68-a69d-48c0-94e2-338d5b5e0f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_327b2fc2-3c00-4103-94e2-8c11cb6316d3" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_2dcf2b68-a69d-48c0-94e2-338d5b5e0f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCash"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_1b4d07d4-7b57-43a9-8a22-c47a4706f65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_f64d749f-194b-435f-843f-4c9658a32202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1b4d07d4-7b57-43a9-8a22-c47a4706f65f" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_f64d749f-194b-435f-843f-4c9658a32202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cutr-20221231.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://cutera.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7291ba6a-bea3-4237-bac7-078281508653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_747381f2-9be0-4c1b-8a50-8b6681a3a814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7291ba6a-bea3-4237-bac7-078281508653" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_747381f2-9be0-4c1b-8a50-8b6681a3a814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="cutr-20221231.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9a7ddc0-3f49-4df3-9a3c-d7c760d88516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_30e427e9-04c1-4b0f-9eaf-9ee338c7804c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9a7ddc0-3f49-4df3-9a3c-d7c760d88516" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_30e427e9-04c1-4b0f-9eaf-9ee338c7804c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetail" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetail"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5aacdd8-461e-415c-abb4-2797a215fdca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b384c722-429e-466d-9a7a-15fac7a4a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5aacdd8-461e-415c-abb4-2797a215fdca" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b384c722-429e-466d-9a7a-15fac7a4a3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarranty" xlink:type="simple" xlink:href="cutr-20221231.xsd#ProductWarranty"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarranty" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_385057a1-ff62-4e7a-979c-1e5f741c9de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_736df6b7-0e06-4e81-9c6f-12287f52fa8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_385057a1-ff62-4e7a-979c-1e5f741c9de3" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_736df6b7-0e06-4e81-9c6f-12287f52fa8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenue" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenue"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b8f04a78-430d-4f6d-b7ee-fadd5f5d651a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock_b032e856-c1f8-4e97-b43b-801aac5d07bc" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b8f04a78-430d-4f6d-b7ee-fadd5f5d651a" xlink:to="loc_cutr_ContractWithCustomerLiabilityTextBlock_b032e856-c1f8-4e97-b43b-801aac5d07bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpense"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1d128a2-4e63-4b90-95e4-0acc6b08b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3b0e836a-da4c-4c93-87a9-df44bd1719cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b1d128a2-4e63-4b90-95e4-0acc6b08b1f8" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3b0e836a-da4c-4c93-87a9-df44bd1719cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d57bbac0-f2c7-49ce-908b-bc4e86ce4298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e61a3e0a-f9c3-4637-846d-5d48fcd03a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d57bbac0-f2c7-49ce-908b-bc4e86ce4298" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e61a3e0a-f9c3-4637-846d-5d48fcd03a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8c438751-3a22-42dd-94a0-271062afdc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fafd3f41-057f-4ba7-9ec8-6a7a67675cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8c438751-3a22-42dd-94a0-271062afdc94" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fafd3f41-057f-4ba7-9ec8-6a7a67675cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="cutr-20221231.xsd#DefinedContributionPlan"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DefinedContributionPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab7acfd1-96a9-4c44-8763-663ba0a3cf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_edfd8011-a2b8-47c0-97ec-c553f9cd7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab7acfd1-96a9-4c44-8763-663ba0a3cf3c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_edfd8011-a2b8-47c0-97ec-c553f9cd7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProducts"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_be6c6bb3-6a85-4d96-899a-b9fcd40d8255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_672e03af-cfbb-441f-b2ee-26635c9d33d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_be6c6bb3-6a85-4d96-899a-b9fcd40d8255" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_672e03af-cfbb-441f-b2ee-26635c9d33d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_40f13084-20b8-4ecc-88b4-36274735b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesTextBlock_4cc73840-2f56-4380-93a5-20a4503f99e3" xlink:href="cutr-20221231.xsd#cutr_LesseeLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_40f13084-20b8-4ecc-88b4-36274735b40e" xlink:to="loc_cutr_LesseeLeasesTextBlock_4cc73840-2f56-4380-93a5-20a4503f99e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/Debt" xlink:type="simple" xlink:href="cutr-20221231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://cutera.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_afa70097-a153-415b-936f-4c7d764a91bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_366f05a7-9e4c-476a-a253-aedc0a056527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_afa70097-a153-415b-936f-4c7d764a91bb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_366f05a7-9e4c-476a-a253-aedc0a056527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SubsequentEvents" xlink:type="simple" xlink:href="cutr-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7b385339-44fa-41e7-bc39-de8e82f55978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_f553f6cd-31c6-43bd-a07e-6b90a77b6c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7b385339-44fa-41e7-bc39-de8e82f55978" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_f553f6cd-31c6-43bd-a07e-6b90a77b6c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="cutr-20221231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_ee333407-87e7-46a4-be8c-7f07b1b163bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2d14505d-89ed-45a4-a9a4-728e46230d10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_ee333407-87e7-46a4-be8c-7f07b1b163bd" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2d14505d-89ed-45a4-a9a4-728e46230d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_e0a08b91-b940-419f-b224-5682b167d326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_e0a08b91-b940-419f-b224-5682b167d326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d1b30a79-52dc-4cdf-b456-14998605e2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d1b30a79-52dc-4cdf-b456-14998605e2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_93c2a4c8-6ce7-4715-8ff0-b390eef85328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_UseOfEstimates_93c2a4c8-6ce7-4715-8ff0-b390eef85328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_bff2776c-8b00-4cd6-b79d-a209d519acbd" xlink:href="cutr-20221231.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_bff2776c-8b00-4cd6-b79d-a209d519acbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d8ef27a1-21e6-4173-bc3f-45a7813d3e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d8ef27a1-21e6-4173-bc3f-45a7813d3e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3f90ca00-35a1-49fd-a6c8-772fd58122ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3f90ca00-35a1-49fd-a6c8-772fd58122ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7012b1a3-954e-48f3-9047-d43a3fc27c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7012b1a3-954e-48f3-9047-d43a3fc27c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b8b1154f-1f9c-443c-9834-91516ba6ab93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b8b1154f-1f9c-443c-9834-91516ba6ab93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_95200d34-073d-4d1b-9335-ac5d17c1dd52" xlink:href="cutr-20221231.xsd#cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_95200d34-073d-4d1b-9335-ac5d17c1dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_16664167-9e2b-49df-809b-f95813829b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_16664167-9e2b-49df-809b-f95813829b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_f20d5212-ba91-4a3c-b8d1-44ab4350f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_f20d5212-ba91-4a3c-b8d1-44ab4350f8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f86c68e3-5a68-40a7-8546-1968cd64222f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f86c68e3-5a68-40a7-8546-1968cd64222f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7d2fa6aa-10dc-4f78-9fd0-0ee82417f304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7d2fa6aa-10dc-4f78-9fd0-0ee82417f304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_07a29e93-4f43-4201-bb56-1ba1106f6b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_07a29e93-4f43-4201-bb56-1ba1106f6b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_e82d7723-9f87-4c22-951c-900a1550d1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_e82d7723-9f87-4c22-951c-900a1550d1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_3ad139f8-d22f-438a-b295-47a2d0707917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_3ad139f8-d22f-438a-b295-47a2d0707917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_f18bf43f-4d81-4534-b377-dfde0b946d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_f18bf43f-4d81-4534-b377-dfde0b946d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1c3207ce-dd0a-407c-9bab-347f513d0065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1c3207ce-dd0a-407c-9bab-347f513d0065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_afbfe8c9-2398-4ac3-a8ac-c6f3194f2e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_afbfe8c9-2398-4ac3-a8ac-c6f3194f2e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7c0f5ea7-c26a-4d28-99a7-1c084129a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7c0f5ea7-c26a-4d28-99a7-1c084129a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_faa81078-3103-4017-a750-b79db3d3a60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_faa81078-3103-4017-a750-b79db3d3a60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_841b03a0-42d3-420e-829d-b0f985cce23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_841b03a0-42d3-420e-829d-b0f985cce23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_71ad536b-4e83-4647-ab78-222d9a213345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_71ad536b-4e83-4647-ab78-222d9a213345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f800f69b-db3e-492c-ba33-88d028179e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f800f69b-db3e-492c-ba33-88d028179e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_72317c6d-d59b-44be-bd9d-950345e68ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09670a41-babf-43f5-9576-a5db7c6b5704" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_72317c6d-d59b-44be-bd9d-950345e68ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b6db6dd5-4704-4381-b390-3dfd1b27f567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ed588886-9b36-4de2-bdd4-34c0223809b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b6db6dd5-4704-4381-b390-3dfd1b27f567" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ed588886-9b36-4de2-bdd4-34c0223809b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_de0ad8fa-1cd8-48d4-9c9e-f91cd94da8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_51673d0d-0029-45a0-ae33-6029b1926197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de0ad8fa-1cd8-48d4-9c9e-f91cd94da8dd" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_51673d0d-0029-45a0-ae33-6029b1926197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_463d3768-4074-4d1f-8752-12adcdbba02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_de0ad8fa-1cd8-48d4-9c9e-f91cd94da8dd" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_463d3768-4074-4d1f-8752-12adcdbba02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_040735cf-f6df-4240-bcd9-607f6fa2941b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_00acbbac-8187-4c5f-a1d5-eb76905b4d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_040735cf-f6df-4240-bcd9-607f6fa2941b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_00acbbac-8187-4c5f-a1d5-eb76905b4d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5658d1f9-bf7e-4316-bc74-99914b90bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_90f98528-8c9a-4786-977a-6ff8521da782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5658d1f9-bf7e-4316-bc74-99914b90bfa6" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_90f98528-8c9a-4786-977a-6ff8521da782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_011e53b3-233c-4856-943e-96644ed24fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e8164e47-7b90-4a9a-a1b1-ec45e65403b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_011e53b3-233c-4856-943e-96644ed24fd3" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e8164e47-7b90-4a9a-a1b1-ec45e65403b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ac3be1fe-1ac3-4b5a-a932-7a4136c8276b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_011e53b3-233c-4856-943e-96644ed24fd3" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ac3be1fe-1ac3-4b5a-a932-7a4136c8276b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0f650777-26a9-449a-8eba-85150b8428c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_011e53b3-233c-4856-943e-96644ed24fd3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0f650777-26a9-449a-8eba-85150b8428c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b7d90c6c-7a3c-46b5-a1ab-0bd7d7b5ef96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_011e53b3-233c-4856-943e-96644ed24fd3" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b7d90c6c-7a3c-46b5-a1ab-0bd7d7b5ef96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarrantyTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#ProductWarrantyTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarrantyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_ef28466b-860b-4ea9-bbfe-4c5c58284f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_340121da-9eab-4f7b-958d-d6106b03ca01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_ef28466b-860b-4ea9-bbfe-4c5c58284f36" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_340121da-9eab-4f7b-958d-d6106b03ca01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3d763a7-75a6-48fe-b5ab-e8bed75ba3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1ecec831-c0f9-4696-8b77-4221e7366722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3d763a7-75a6-48fe-b5ab-e8bed75ba3ad" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1ecec831-c0f9-4696-8b77-4221e7366722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4f136a68-6875-4eef-b413-a22f46053f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4f136a68-6875-4eef-b413-a22f46053f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_f86fa4c1-8d73-4d61-b60b-9e8f7b068fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_f86fa4c1-8d73-4d61-b60b-9e8f7b068fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_d901fb52-1144-4a43-9be6-9dcd5b286643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_d901fb52-1144-4a43-9be6-9dcd5b286643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_76628573-ae9a-4b08-8b5b-35ff91045e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_76628573-ae9a-4b08-8b5b-35ff91045e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4f4b06e7-e96e-4812-ba7c-c394564974f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4f4b06e7-e96e-4812-ba7c-c394564974f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_ce1ee013-acb4-4291-9df3-bab2c85c477a" xlink:href="cutr-20221231.xsd#cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71b547d-56c7-40e0-af47-59c81b3a9437" xlink:to="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_ce1ee013-acb4-4291-9df3-bab2c85c477a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_aaf6f526-17f2-408f-8c22-23fb12e551d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_aaf6f526-17f2-408f-8c22-23fb12e551d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0fa28bbd-684c-41cd-88b5-fb60e016a4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0fa28bbd-684c-41cd-88b5-fb60e016a4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3befa2f3-7c13-4990-92ee-3b9ba7710e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3befa2f3-7c13-4990-92ee-3b9ba7710e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3d899f17-ef8f-42da-a790-66b364c583d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3d899f17-ef8f-42da-a790-66b364c583d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_04bd37bb-fb92-4cbd-aef4-05c0dbc72a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bec38df-4e79-4f0a-8f85-3175c27f8787" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_04bd37bb-fb92-4cbd-aef4-05c0dbc72a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eac27e7a-c9aa-4476-8ce7-3636406d19bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6d9664a3-bebf-439a-85d6-9a55c888d309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eac27e7a-c9aa-4476-8ce7-3636406d19bc" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6d9664a3-bebf-439a-85d6-9a55c888d309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_123b28ec-d824-4f49-81a9-d94e19f41bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eac27e7a-c9aa-4476-8ce7-3636406d19bc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_123b28ec-d824-4f49-81a9-d94e19f41bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9f49c7df-9cb6-4308-8ab1-32ed8f66e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ef74ea5e-cb70-4ca1-9be0-e9db9f6d0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9f49c7df-9cb6-4308-8ab1-32ed8f66e70f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ef74ea5e-cb70-4ca1-9be0-e9db9f6d0fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_5b416b2d-df7c-4c9e-b9e0-9196492f9297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9f49c7df-9cb6-4308-8ab1-32ed8f66e70f" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_5b416b2d-df7c-4c9e-b9e0-9196492f9297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesFinancialStatementInformationTableTextBlock_50b01284-182b-4ba8-a482-f68f34c24400" xlink:href="cutr-20221231.xsd#cutr_LeasesFinancialStatementInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_cutr_LeasesFinancialStatementInformationTableTextBlock_50b01284-182b-4ba8-a482-f68f34c24400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3c8767e0-14ee-4ef3-b5db-af6f6951d346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3c8767e0-14ee-4ef3-b5db-af6f6951d346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_64a3f32b-16c5-4491-b8bd-cdec5b135b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_64a3f32b-16c5-4491-b8bd-cdec5b135b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_f8182a5e-4021-4be5-b48f-fbcb97dd9a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_f8182a5e-4021-4be5-b48f-fbcb97dd9a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_50de4de1-1e78-42e5-8d4f-ef274bf63d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_50de4de1-1e78-42e5-8d4f-ef274bf63d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_77f744ca-2638-47d7-8525-1075c265a29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f273721b-6b5f-4eb4-bbeb-7d64a3179e27" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_77f744ca-2638-47d7-8525-1075c265a29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7ad067d0-1435-4263-8377-f41639948798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_82ddae54-29f8-4c7a-9465-dc9bdb36be04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7ad067d0-1435-4263-8377-f41639948798" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_82ddae54-29f8-4c7a-9465-dc9bdb36be04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_a0e9e395-37f2-4a06-b3fe-f7af5cfc1270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7ad067d0-1435-4263-8377-f41639948798" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock_a0e9e395-37f2-4a06-b3fe-f7af5cfc1270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="cutr-20221231.xsd#ScheduleIIValuationandQualifyingAccountsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_ade8655f-a665-4c08-8ad8-2d07cd387b5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_815fe74f-4cc3-409f-adb1-9a94d34fb6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_ade8655f-a665-4c08-8ad8-2d07cd387b5e" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_815fe74f-4cc3-409f-adb1-9a94d34fb6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7fe486c8-3fe3-4b2f-9507-8d111b46e4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7fe486c8-3fe3-4b2f-9507-8d111b46e4e3" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_e17de5e5-bab7-41d2-b4eb-34aaf975cf0c" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_8cedc488-f5ac-4fd1-846e-10b35914d7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_481791e4-7315-4d1d-b596-dbace09f70d8" xlink:to="loc_us-gaap_TransferredOverTimeMember_8cedc488-f5ac-4fd1-846e-10b35914d7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6746a4ff-a228-4b22-bddc-f2fd33652eb9" xlink:to="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_1fc1dd98-d2bd-4f3a-8aeb-e8c3a285fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_us-gaap_ServiceMember_1fc1dd98-d2bd-4f3a-8aeb-e8c3a285fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_2cd6e491-a7ba-4b19-8f77-38a8a47271f3" xlink:href="cutr-20221231.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_cutr_SkincareMember_2cd6e491-a7ba-4b19-8f77-38a8a47271f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_7ce151f5-7043-4361-b67b-08fbf1368cc8" xlink:href="cutr-20221231.xsd#cutr_LoyaltyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_62d355cd-bb83-4097-ab35-bbffdec12cef" xlink:to="loc_cutr_LoyaltyMember_7ce151f5-7043-4361-b67b-08fbf1368cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86ea10f8-c793-4314-8bc3-2e6f082dcd6b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3609886a-d70d-455f-b4b6-2490f78d2d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_759318dd-3755-4ed3-882a-e3a495b80bcd" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3609886a-d70d-455f-b4b6-2490f78d2d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ce0e3e76-930a-40cc-9a24-5885a1d0ce49" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_33867b21-0b96-4657-acdd-c9a0a2a5bf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_33867b21-0b96-4657-acdd-c9a0a2a5bf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_a5f2fb97-fc76-409c-b692-018f5b4ba27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_93841477-dad6-4362-8adb-a30692bfe903" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_a5f2fb97-fc76-409c-b692-018f5b4ba27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1221eff6-b8f0-4f8b-8b20-935c0e18142c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_27655982-4095-4480-bf2f-863641e75edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_27655982-4095-4480-bf2f-863641e75edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_e49f738b-757a-4aa0-98e4-acc4b9d333c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_af403316-f371-446b-997b-fd8bec5233d3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember_e49f738b-757a-4aa0-98e4-acc4b9d333c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b94aed2d-63bd-44c3-b3d6-8be7968ea493" xlink:to="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed1cda0a-72c8-4fe2-aa47-1836c64a68dd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:to="loc_country_US_ed1cda0a-72c8-4fe2-aa47-1836c64a68dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_06645a84-1980-4e9e-a5fe-1f3cecafc694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9bb58cc7-bf55-4460-90bd-1975c0119520" xlink:to="loc_us-gaap_NonUsMember_06645a84-1980-4e9e-a5fe-1f3cecafc694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_2ec49f71-12aa-4e87-bbd9-d4798d12771e" xlink:to="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LargestSupplierMember_e618ff88-430f-4210-9b79-352bd1fa3dc1" xlink:href="cutr-20221231.xsd#cutr_LargestSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_eb631e18-c901-48e1-8c5a-864e287ad7db" xlink:to="loc_cutr_LargestSupplierMember_e618ff88-430f-4210-9b79-352bd1fa3dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a70ab5cf-960d-4028-b140-b9a0e2bd4f13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_2df86ee1-6fce-4766-97ca-09e3aebe5b33" xlink:href="cutr-20221231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_2df86ee1-6fce-4766-97ca-09e3aebe5b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseInstallmentCostsMember_59ea879e-9049-4903-b2ff-c6b8622ff116" xlink:href="cutr-20221231.xsd#cutr_LeaseInstallmentCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ff672fc-5ddf-4070-8092-3ff6c6d6993c" xlink:to="loc_cutr_LeaseInstallmentCostsMember_59ea879e-9049-4903-b2ff-c6b8622ff116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_133e6c92-06bd-4c4e-8c58-a709bf51bb41" xlink:to="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c3cb916-cf86-435e-a8a4-5faa12163093" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:to="loc_srt_MinimumMember_0c3cb916-cf86-435e-a8a4-5faa12163093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_af063474-9c5c-4bb0-bda3-ca584fc19ff5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a2adc20f-2d1e-4bfe-91a1-c447f3bd569d" xlink:to="loc_srt_MaximumMember_af063474-9c5c-4bb0-bda3-ca584fc19ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c22fb465-4768-4a5b-b681-83a9f669f2f9" xlink:to="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_a088d2ad-84ae-4dd2-bcef-66e940527e98" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_243fa519-b04a-4ee7-b8df-ee0ae4b1fcc8" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_a088d2ad-84ae-4dd2-bcef-66e940527e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_146f8cec-7f03-49ff-a837-fc6baa1ccea1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b18f0462-8ee1-436a-bbfb-25330474143b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b18f0462-8ee1-436a-bbfb-25330474143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3be0011e-a7fc-4ec6-a161-ea300e937653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8c47aad9-2669-4c33-a974-4ccb0848d73f" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3be0011e-a7fc-4ec6-a161-ea300e937653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:href="cutr-20221231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_b34f1def-97c1-4bab-a174-e8709a1a2d1e" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_58fba4c3-f3d1-4e1a-b1d9-84045d564976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_58fba4c3-f3d1-4e1a-b1d9-84045d564976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_6577a8da-db21-45db-bdf6-6db64ff2e89c" xlink:href="cutr-20221231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_6577a8da-db21-45db-bdf6-6db64ff2e89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_412dc72b-b90e-4bee-9a3e-5f4aba193227" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_412dc72b-b90e-4bee-9a3e-5f4aba193227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_422a12b6-f146-4ba1-8211-d6339e905e26" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_422a12b6-f146-4ba1-8211-d6339e905e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_ece3d30a-ab35-4826-a56a-a1ce20df28d4" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_ece3d30a-ab35-4826-a56a-a1ce20df28d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8275d203-9033-47a7-8438-cd9301306c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8275d203-9033-47a7-8438-cd9301306c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_4e46151c-cc63-4214-b559-4284fe2bd368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_4e46151c-cc63-4214-b559-4284fe2bd368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_7da299f1-5869-4c95-b380-ebecc1046c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostNet_7da299f1-5869-4c95-b380-ebecc1046c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_c0f20887-de12-448a-af29-46f0ee54df6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_c0f20887-de12-448a-af29-46f0ee54df6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_446c9e5a-b096-451a-975e-a742f6d468f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_446c9e5a-b096-451a-975e-a742f6d468f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod_7d1627a1-6f59-4eea-8b1a-207bbaef796f" xlink:href="cutr-20221231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_DemonstrationUnitsAmortizationPeriod_7d1627a1-6f59-4eea-8b1a-207bbaef796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_160b4336-977f-4aa3-9878-bf552237e6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_InventoryFinishedGoods_160b4336-977f-4aa3-9878-bf552237e6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9cff4e08-0d10-4db1-833b-db0b2bbfa122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_Depreciation_9cff4e08-0d10-4db1-833b-db0b2bbfa122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ffabc34a-5349-4152-ac8a-2dfde371b66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ffabc34a-5349-4152-ac8a-2dfde371b66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_dda9d696-1552-4e70-ab2d-ee00a9468f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_dda9d696-1552-4e70-ab2d-ee00a9468f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_e64278c6-fb15-4de8-81b4-93711da0f72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_e64278c6-fb15-4de8-81b4-93711da0f72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_ccccfb73-e69a-4c98-88a7-ff451ec06751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_ccccfb73-e69a-4c98-88a7-ff451ec06751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3359b2db-b943-4326-aabd-502281d5d1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfReportableSegments_3359b2db-b943-4326-aabd-502281d5d1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a29d5028-6505-463a-8c8d-43ad5d3a8155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a29d5028-6505-463a-8c8d-43ad5d3a8155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b99e58f3-06ff-4766-8b1b-0d7821c7536e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b99e58f3-06ff-4766-8b1b-0d7821c7536e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d96397b3-9217-4836-9a55-8a405c1bfa67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_NumberOfReportingUnits_d96397b3-9217-4836-9a55-8a405c1bfa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales_4be7a781-e7c4-429e-8190-1177b4f9a86a" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_StandardProductWarrantyTermDirectSales_4be7a781-e7c4-429e-8190-1177b4f9a86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales_053aba7c-8328-4aad-83b2-bb1f673f8583" xlink:href="cutr-20221231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_StandardProductWarrantyTermDistributorSales_053aba7c-8328-4aad-83b2-bb1f673f8583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_707b7e7c-9df3-438a-9a15-b2de12cb03ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_AdvertisingExpense_707b7e7c-9df3-438a-9a15-b2de12cb03ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_138f8c2a-86d4-4edc-8f34-6fd6d0c2942c" xlink:href="cutr-20221231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_138f8c2a-86d4-4edc-8f34-6fd6d0c2942c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0183dbef-dc12-4037-a4c4-7aaa74625a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0183dbef-dc12-4037-a4c4-7aaa74625a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets_ed907c05-4ce1-426f-9187-2a334a41fefe" xlink:href="cutr-20221231.xsd#cutr_PercentageOfAssets"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_73fce8a4-e561-47f5-b866-a8fee139774c" xlink:to="loc_cutr_PercentageOfAssets_ed907c05-4ce1-426f-9187-2a334a41fefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1cabc7e-dac9-49a3-8d1a-0c9179b52cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1cabc7e-dac9-49a3-8d1a-0c9179b52cff" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b5e4f9ae-57b9-4019-909e-af412046df36" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_7d58f5cf-e744-428d-a09e-9caf33e04d21" xlink:href="cutr-20221231.xsd#cutr_LeasedEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_LeasedEquipmentMember_7d58f5cf-e744-428d-a09e-9caf33e04d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDevicesMember_937dc5dc-aa7e-4efa-97f9-d1695e493926" xlink:href="cutr-20221231.xsd#cutr_AviClearDevicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_AviClearDevicesMember_937dc5dc-aa7e-4efa-97f9-d1695e493926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_61cdd7e4-6024-488b-9803-20795ffc7aa7" xlink:href="cutr-20221231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_cutr_EquipmentAndFurnitureMember_61cdd7e4-6024-488b-9803-20795ffc7aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_e3a6b7d0-ae8c-4481-8880-7a4f26aaf1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a1f484e-f94d-4d92-bd65-9c43e83583db" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_e3a6b7d0-ae8c-4481-8880-7a4f26aaf1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3e57cc23-8f02-4f8d-a821-5c43d6dd8ea2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ca0932e1-87dc-4a91-8861-d26671a41069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_65bc89f3-378b-4ac0-ae86-5ef1ed85f489" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_ca0932e1-87dc-4a91-8861-d26671a41069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_dc3001d0-a896-4827-ba89-8205ed87fe6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_dc3001d0-a896-4827-ba89-8205ed87fe6b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f130ff6-878b-4cc1-bf15-33fcecf8c05d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0105baeb-67ac-42df-8790-4c6943a58e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ad03158a-3472-4c5b-bc03-4ecbb3fcba91" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0105baeb-67ac-42df-8790-4c6943a58e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6870590d-2c1d-46be-be8b-2ec2161692ac" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddd98ac3-582c-475b-b9c7-f3e836aa81f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ddd98ac3-582c-475b-b9c7-f3e836aa81f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_1473d583-1605-4b1f-9300-ec76a52f2f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_RestrictedCashCurrent_1473d583-1605-4b1f-9300-ec76a52f2f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c24e2fe9-3b19-4a89-bd8e-314fb654be63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c24e2fe9-3b19-4a89-bd8e-314fb654be63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5394db44-07a2-4741-889e-179671250196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5394db44-07a2-4741-889e-179671250196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_650bf5ce-77f2-4b69-91ad-3008834fdf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_650bf5ce-77f2-4b69-91ad-3008834fdf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_94962a42-5858-4f58-a075-d8d3007f91a4" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_94962a42-5858-4f58-a075-d8d3007f91a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad291b1c-06aa-45ce-8c7a-f5a025854cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad291b1c-06aa-45ce-8c7a-f5a025854cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7836be59-819c-467e-8da0-fc2db7ba77a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7836be59-819c-467e-8da0-fc2db7ba77a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b23584b-d1f5-49c1-b757-d53793ceba58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b23584b-d1f5-49c1-b757-d53793ceba58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_885f6fac-b97b-4d7e-9644-adb2f28efed1" xlink:href="cutr-20221231.xsd#cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b8baa834-494f-410d-8bb1-852d1265d57f" xlink:to="loc_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities_885f6fac-b97b-4d7e-9644-adb2f28efed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_a06884c6-d674-4125-a34b-1bb846dc1948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_a9340af9-e181-48cd-a4e0-3a9553bf287b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a06884c6-d674-4125-a34b-1bb846dc1948" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_a9340af9-e181-48cd-a4e0-3a9553bf287b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_e6b7ae64-f77a-4e06-b73c-0d425ae65e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a06884c6-d674-4125-a34b-1bb846dc1948" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_e6b7ae64-f77a-4e06-b73c-0d425ae65e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9f73d2a0-1ba2-42c2-97c8-0fd0368efe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9f73d2a0-1ba2-42c2-97c8-0fd0368efe2d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a65efb72-e27f-4591-90ab-eccf0a210778" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_101f9dba-1489-43d2-9acd-16c84853d2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5069070d-23c4-40cc-b293-2b1935b7d3c8" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_101f9dba-1489-43d2-9acd-16c84853d2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_393a70db-e403-4539-b4c6-b9ddc7517c6c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c0291d76-5d7e-4be2-8ce7-23569a14a847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c0291d76-5d7e-4be2-8ce7-23569a14a847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5f2910d9-f3e9-4295-a9f5-86a88b446cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e8b830d-439b-44bf-83b6-ee552c0d1a1a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5f2910d9-f3e9-4295-a9f5-86a88b446cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fae7e3ff-5449-48be-bd27-6628746f58c7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_39df359e-f72e-4df1-b644-32bed30125d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdab0739-37ef-453c-b623-62768494603e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_39df359e-f72e-4df1-b644-32bed30125d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99435c3a-43c6-463f-b95f-01bde40fe744" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c622a58e-f123-46fa-bc49-74dac0ea3f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dd197240-641a-476b-8432-78b8e91b9244" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c622a58e-f123-46fa-bc49-74dac0ea3f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17e8c4a3-1432-4e94-b92e-6502b8208c66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_da5aad0f-06b5-490d-980b-b3e2008be2de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_262627ef-552d-443a-9280-d8dca4495ae3" xlink:to="loc_us-gaap_ConvertibleDebtMember_da5aad0f-06b5-490d-980b-b3e2008be2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4a161e9-e15a-4381-a1eb-409917bfea2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_d900cfa3-ca7e-4d5b-a672-49b2a5c81845" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_d900cfa3-ca7e-4d5b-a672-49b2a5c81845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_867527e4-1e89-4633-9e44-72b5472f17dd" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0e5361f6-4e77-4c90-a0d0-013193b3f701" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_867527e4-1e89-4633-9e44-72b5472f17dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5bf6f1ee-37de-4db7-b61f-a31340ecae4e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b35143e-28e2-4b4f-a02f-f53438f7daee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4b35143e-28e2-4b4f-a02f-f53438f7daee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a724cf1d-9647-4c62-a6a8-9817747bee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a724cf1d-9647-4c62-a6a8-9817747bee85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0ea25c38-0c37-4112-a2d4-225bbcaf8e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DerivativeLiabilities_0ea25c38-0c37-4112-a2d4-225bbcaf8e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2d970595-5e84-4272-a703-5a7c735d782f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2d970595-5e84-4272-a703-5a7c735d782f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9889577a-a7e0-4c74-96ac-8dea9af8af2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_965cd00d-d8f4-4125-b4b4-117dae3db5c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9889577a-a7e0-4c74-96ac-8dea9af8af2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DerivativeInstrumentsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88b114c7-c2c5-4bb7-b7c6-541ec4eb137b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88b114c7-c2c5-4bb7-b7c6-541ec4eb137b" xlink:to="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_738fba08-97c9-4d15-8208-e31d2ea85f86" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_8ee6ca88-39f7-432d-8e0b-ce5fa521915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7b87c92d-992d-4d32-953e-d3c504011c65" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_8ee6ca88-39f7-432d-8e0b-ce5fa521915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0270bb7d-b4b6-40c7-aee8-9d985a7d853d" xlink:to="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_6001fee2-9e9b-4e18-adfd-46dd13f2aed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_6001fee2-9e9b-4e18-adfd-46dd13f2aed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64be9cf7-e5f0-48c4-818d-d67bbf2d4b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_64be9cf7-e5f0-48c4-818d-d67bbf2d4b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_ac75a88d-13ed-4970-a826-295a5cd3e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4c585a50-3dbb-4f39-8422-ae5a43fef9a4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_ac75a88d-13ed-4970-a826-295a5cd3e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b245893e-cfed-415e-b42a-c3550476c005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_46322ebe-81e7-49ab-a72d-099f07258190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b245893e-cfed-415e-b42a-c3550476c005" xlink:to="loc_us-gaap_InventoryValuationReserves_46322ebe-81e7-49ab-a72d-099f07258190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_99d726c6-badb-4b93-a200-3289bf79ba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b245893e-cfed-415e-b42a-c3550476c005" xlink:to="loc_us-gaap_Goodwill_99d726c6-badb-4b93-a200-3289bf79ba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_be66b141-b8e0-4f51-a364-66f76151389d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b245893e-cfed-415e-b42a-c3550476c005" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_be66b141-b8e0-4f51-a364-66f76151389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b1b25c68-6d77-4d5c-8a72-3452371c3ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b245893e-cfed-415e-b42a-c3550476c005" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b1b25c68-6d77-4d5c-8a72-3452371c3ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailInventoriesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8cef271-f458-4ce8-8d5e-543a6c65a238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2e685329-3cd8-42cf-aca6-46d1d29beffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8cef271-f458-4ce8-8d5e-543a6c65a238" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2e685329-3cd8-42cf-aca6-46d1d29beffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8c1ffad7-ccab-4dcd-bf6d-58280b749de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8cef271-f458-4ce8-8d5e-543a6c65a238" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8c1ffad7-ccab-4dcd-bf6d-58280b749de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_23ee18b5-f09b-49f8-997c-5f1db44e52f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8cef271-f458-4ce8-8d5e-543a6c65a238" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_23ee18b5-f09b-49f8-997c-5f1db44e52f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0567facf-e5cb-4a45-afce-a0c284d41daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f8cef271-f458-4ce8-8d5e-543a6c65a238" xlink:to="loc_us-gaap_InventoryNet_0567facf-e5cb-4a45-afce-a0c284d41daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05e7e981-03ae-4e0d-bf33-a956d78ee405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_873eed3c-5c9a-4dd8-8dde-39d895365eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05e7e981-03ae-4e0d-bf33-a956d78ee405" xlink:to="loc_us-gaap_DepositsAssetsCurrent_873eed3c-5c9a-4dd8-8dde-39d895365eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_6f5428f4-3648-49a4-bfaa-e2f8cbf9ca6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05e7e981-03ae-4e0d-bf33-a956d78ee405" xlink:to="loc_us-gaap_IncomeTaxesReceivable_6f5428f4-3648-49a4-bfaa-e2f8cbf9ca6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_9fd4d6ab-8c32-4624-9d21-da4517d09f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05e7e981-03ae-4e0d-bf33-a956d78ee405" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_9fd4d6ab-8c32-4624-9d21-da4517d09f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d6a3b98b-ab21-4398-b4db-7099bd09347b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05e7e981-03ae-4e0d-bf33-a956d78ee405" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d6a3b98b-ab21-4398-b4db-7099bd09347b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_128526fa-131a-4bd7-985c-1596b64516a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_128526fa-131a-4bd7-985c-1596b64516a4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1a67af34-8f91-453f-945a-1651c4423627" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5b29a800-5f41-4bdd-b818-281e744ea372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5b29a800-5f41-4bdd-b818-281e744ea372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_88351e9d-ea83-49e9-98c6-a58885b8fab1" xlink:href="cutr-20221231.xsd#cutr_LeasedEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_cutr_LeasedEquipmentMember_88351e9d-ea83-49e9-98c6-a58885b8fab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_db8b66c7-9a5c-4d60-8b5b-ce679d621554" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_cutr_AviClearMember_db8b66c7-9a5c-4d60-8b5b-ce679d621554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b54eafcc-3198-42c6-a2ff-d4f8e31c2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b54eafcc-3198-42c6-a2ff-d4f8e31c2de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b01c9f75-1040-4104-9d93-f22111da3c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b01c9f75-1040-4104-9d93-f22111da3c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_c6270e89-8806-40cf-9f5b-26deadca4995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_baea26cc-bbd3-48e2-a036-50be515cf6bb" xlink:to="loc_us-gaap_AssetUnderConstructionMember_c6270e89-8806-40cf-9f5b-26deadca4995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c30de9e9-eb2d-4594-98f8-915694d78c27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_16459529-6250-40c8-ac02-93e3fa8f8a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_16459529-6250-40c8-ac02-93e3fa8f8a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_354a3bf5-6e09-4598-b904-dd297a247696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_354a3bf5-6e09-4598-b904-dd297a247696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bb7ba16d-63c6-41a7-8b83-c86e192b37f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0a453ecb-a25b-40f9-94cd-5f41d0a19872" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_bb7ba16d-63c6-41a7-8b83-c86e192b37f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#BalanceSheetDetailAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_3932c769-7f7f-43b1-8404-756028d9bb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_us-gaap_AccruedSalariesCurrent_3932c769-7f7f-43b1-8404-756028d9bb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_781160e4-739c-4e47-8cd0-6b4fe1f00598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_781160e4-739c-4e47-8cd0-6b4fe1f00598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_25e41f77-9904-4039-9a3e-aea771552dc8" xlink:href="cutr-20221231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_25e41f77-9904-4039-9a3e-aea771552dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SalesAndMarketingAccrualsCurrent_2e42ed83-88d4-4ac0-b5d7-b94bd5e4e723" xlink:href="cutr-20221231.xsd#cutr_SalesAndMarketingAccrualsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_cutr_SalesAndMarketingAccrualsCurrent_2e42ed83-88d4-4ac0-b5d7-b94bd5e4e723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2afe4697-9114-4322-a3dd-d5f3b0793c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_2afe4697-9114-4322-a3dd-d5f3b0793c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa3ada7a-80b1-44c2-909b-2254976bc651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa3ada7a-80b1-44c2-909b-2254976bc651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_51243fd5-a84b-42a8-baec-294e7b98a022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5e63fe-be7c-4eed-a998-232e760d0ca4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_51243fd5-a84b-42a8-baec-294e7b98a022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#ProductWarrantySummaryofWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_bd3afeb8-a2b0-44c7-8640-e4952f43cb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_bd3afeb8-a2b0-44c7-8640-e4952f43cb9b" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_9463182c-a1f4-4f52-8bbc-85a45f666f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_9463182c-a1f4-4f52-8bbc-85a45f666f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_008ea8f9-18a5-4681-9481-5a6ea590fdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_008ea8f9-18a5-4681-9481-5a6ea590fdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_e97b57b6-0657-4b56-b108-44b7b448466c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_e97b57b6-0657-4b56-b108-44b7b448466c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_f9c86c2b-fed8-43f1-9c58-990fcfb8aadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_766560f2-05fc-4e1f-a996-4fca97525f98" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_f9c86c2b-fed8-43f1-9c58-990fcfb8aadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c94f6597-2ab3-425c-affe-ebc80bfa16a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c94f6597-2ab3-425c-affe-ebc80bfa16a4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_269e2a66-1a8d-457f-82f8-d47c70b3a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_269e2a66-1a8d-457f-82f8-d47c70b3a81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d81f5a11-6c69-4e09-b19f-db0813988d05" xlink:to="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_caf43697-fcf8-42b3-afef-c6192ce34e5c" xlink:to="loc_us-gaap_ServiceMember_4ac229a4-b990-4a22-b94f-4123b0c3499f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4b3d8545-c0b7-41dd-8a5e-4be00b3ffe44" xlink:to="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MinimumMember_8dc20cb1-172d-46cd-bd14-1eae4c32a2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cea03259-0c28-4107-b083-52cb3987c8f3" xlink:to="loc_srt_MaximumMember_81e00822-f304-4f72-9153-100190dcfdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_31ee5cfb-5e19-44ef-89fc-63817992f6c3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:href="cutr-20221231.xsd#cutr_ExtendedServiceContractTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_ExtendedServiceContractTerm_228147cc-8922-48ff-9d4e-115df8c1ffed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_96b20ca9-a185-4d0e-b77a-2cbd9101da8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ee213bb4-ca8d-45ad-baf5-4b96bb22d17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_a5279edf-32bc-41d1-834b-dcf709d04e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:href="cutr-20221231.xsd#cutr_CostsForExtendedServiceContracts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9cd57e3b-4138-44a8-b097-95f2093e911e" xlink:to="loc_cutr_CostsForExtendedServiceContracts_d4963a15-110a-414d-b5b3-fd5cb9ed1dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b9e6426d-280f-4002-b770-d4bf8b12ac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:href="cutr-20221231.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b9e6426d-280f-4002-b770-d4bf8b12ac2d" xlink:to="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_35e504ff-1f04-4ab3-b26d-d74df71dccd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_35e504ff-1f04-4ab3-b26d-d74df71dccd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_db8eabd7-d3cf-4983-8203-94999087f2af" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:to="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_db8eabd7-d3cf-4983-8203-94999087f2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_49f8b77f-9bb0-4b2b-ae72-9ea5d732bf85" xlink:href="cutr-20221231.xsd#cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:to="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_49f8b77f-9bb0-4b2b-ae72-9ea5d732bf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2437c6cd-87e5-42b5-8097-2f2f74f5abd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2437c6cd-87e5-42b5-8097-2f2f74f5abd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3f89edcb-b6ce-41c5-a13b-90b605d46471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_83a7830d-7909-44ad-85ff-faaf3788b05b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3f89edcb-b6ce-41c5-a13b-90b605d46471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a29b35bc-ab86-4d53-8a22-37bf2beb16e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a29b35bc-ab86-4d53-8a22-37bf2beb16e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2c4d8fae-8718-4613-9a41-ab6933b71722" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember_cec31438-068e-4c0f-b7ba-8502737d543d" xlink:href="cutr-20221231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4de0b528-e48b-4b87-afc3-f826aadfe0dd" xlink:to="loc_cutr_UnderwrittenPublicOfferingMember_cec31438-068e-4c0f-b7ba-8502737d543d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1f8e4472-9f07-49c7-bb97-cc344c164626" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember_60782591-f8b9-474b-96c2-6789ec348bfd" xlink:href="cutr-20221231.xsd#cutr_UnderwriterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c722f992-26ac-4c5d-bbd5-96099aecdffd" xlink:to="loc_cutr_UnderwriterMember_60782591-f8b9-474b-96c2-6789ec348bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_bb7db70a-4f3d-46d2-93ea-97f695fbf732" xlink:to="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember_d0947ffd-7fac-4e61-92d5-c124e2b967ea" xlink:href="cutr-20221231.xsd#cutr_StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_StockPlanMember_d0947ffd-7fac-4e61-92d5-c124e2b967ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember_3cefefdb-56bd-4a85-a326-26a585bec8ca" xlink:href="cutr-20221231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TwoThousandFourEquityIncentivePlanMember_3cefefdb-56bd-4a85-a326-26a585bec8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_0f640e40-3c17-4fdf-91f4-4ee14ecad96c" xlink:href="cutr-20221231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_0f640e40-3c17-4fdf-91f4-4ee14ecad96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_f99aef2b-977a-413e-a4c4-367cb8883bd9" xlink:href="cutr-20221231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_f99aef2b-977a-413e-a4c4-367cb8883bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember_332622b4-0ab5-4a05-858a-3f5421c0343f" xlink:href="cutr-20221231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_56878714-06a9-47a8-a88d-0f678525e5c5" xlink:to="loc_cutr_EmployeeStockPurchasePlanMember_332622b4-0ab5-4a05-858a-3f5421c0343f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6cf21f59-20c2-4d9e-b4fb-f0d7eeb9ff54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember_25b8567b-ab4d-48df-b1ee-b58e7a4ef8ff" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:to="loc_cutr_RestrictedStockUnitsAnnualGrantMember_25b8567b-ab4d-48df-b1ee-b58e7a4ef8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember_106fde14-26bf-49b9-aada-0502b868f9b0" xlink:href="cutr-20221231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_f1601569-9830-4575-91f6-fcae3df0a850" xlink:to="loc_cutr_RestrictedStockUnitsNewHireMember_106fde14-26bf-49b9-aada-0502b868f9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0d6a4cb5-36c4-4a2b-bbe5-6647d582a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49ba0b58-b87d-40f5-adec-11dd87b2b464" xlink:to="loc_us-gaap_PerformanceSharesMember_0d6a4cb5-36c4-4a2b-bbe5-6647d582a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_b92fc55f-a05a-4122-983e-838664131de5" xlink:to="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_6a1e23fe-e344-4fc5-9777-a64f81714c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_6a1e23fe-e344-4fc5-9777-a64f81714c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a18f257a-d2ac-42f6-8b10-7939c5f8ee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_bf82764d-cb3b-4358-a118-51e45635eb42" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a18f257a-d2ac-42f6-8b10-7939c5f8ee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_0f07ffd5-3726-4c17-9c77-9a4267bb041e" xlink:to="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0ada26c0-9f34-448c-b47e-0963293a8720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0ada26c0-9f34-448c-b47e-0963293a8720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_de4f6e01-928b-4630-9bae-74e78c8b5e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_1803ca17-25ac-4dee-aa45-85939c18b03c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_de4f6e01-928b-4630-9bae-74e78c8b5e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_853de6a2-f78f-411b-8352-28e2885acaa0" xlink:to="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_297f5d9d-d7ac-4687-9648-4accca3d4122" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9aa51307-ca90-4436-ba55-02fb7e08584b" xlink:to="loc_srt_DirectorMember_297f5d9d-d7ac-4687-9648-4accca3d4122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a637f6c8-8a86-4ed9-a1d5-e34045a087f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_eec99c5d-ee67-4a99-b507-ee302be80ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_eec99c5d-ee67-4a99-b507-ee302be80ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized_453b001d-2dcf-48ae-9173-d86ca26f9434" xlink:href="cutr-20221231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_CapitalStockSharesAuthorized_453b001d-2dcf-48ae-9173-d86ca26f9434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b9ba92d4-91e4-4400-9adb-7171ea8bd0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b9ba92d4-91e4-4400-9adb-7171ea8bd0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3e7dddcb-a2d1-478b-91f8-10b94ba8be6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesIssued_3e7dddcb-a2d1-478b-91f8-10b94ba8be6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_36bb2ade-d0fd-4887-8578-8ba5dc06198d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_36bb2ade-d0fd-4887-8578-8ba5dc06198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_09043f4a-d306-42d1-93cc-d9eb62edeaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_09043f4a-d306-42d1-93cc-d9eb62edeaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0001625e-50a0-4c2a-8439-58efe240aba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0001625e-50a0-4c2a-8439-58efe240aba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f86f1923-ccd3-444d-9fc1-ee96f0e8322c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f86f1923-ccd3-444d-9fc1-ee96f0e8322c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f1eaf075-bde6-4277-979f-bd3cafcd7fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f1eaf075-bde6-4277-979f-bd3cafcd7fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9468bcb1-3e68-43d6-80f2-ab2534503b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9468bcb1-3e68-43d6-80f2-ab2534503b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a98e4dc0-67b1-4200-be21-32335efad13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a98e4dc0-67b1-4200-be21-32335efad13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8beb6d22-bb0f-4c0f-9aab-06c9aee83f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8beb6d22-bb0f-4c0f-9aab-06c9aee83f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_4752051c-9e06-4897-9875-090644da5c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_4752051c-9e06-4897-9875-090644da5c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3651aba6-251a-4618-b3bb-b320092bd252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3651aba6-251a-4618-b3bb-b320092bd252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_aab61421-5f5f-464d-aac8-2bf1b2e21a28" xlink:href="cutr-20221231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_aab61421-5f5f-464d-aac8-2bf1b2e21a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c2e20c5-8c7f-4b8b-b432-51d58f2c1dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c2e20c5-8c7f-4b8b-b432-51d58f2c1dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c164d07d-3000-4c17-90d9-5b7edb8730ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c164d07d-3000-4c17-90d9-5b7edb8730ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_ab8021a3-f886-4a1e-83df-8944324ce184" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_ab8021a3-f886-4a1e-83df-8944324ce184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_8fb31687-8157-46c0-b050-dd348b5018f0" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_8fb31687-8157-46c0-b050-dd348b5018f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_049fd950-cacc-423e-ac33-03dd4dc8edfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_049fd950-cacc-423e-ac33-03dd4dc8edfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5977952f-4351-4c82-9d16-a4e5a107943f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5977952f-4351-4c82-9d16-a4e5a107943f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_ec70fd6e-8472-49df-9e7a-d19c0fd2d438" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_ec70fd6e-8472-49df-9e7a-d19c0fd2d438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_354e58fe-4816-48d1-87ae-4110c5b0a39f" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_354e58fe-4816-48d1-87ae-4110c5b0a39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4f98c934-bac1-45fe-91fb-952831d96072" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4f98c934-bac1-45fe-91fb-952831d96072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_0f0ae259-f4d3-4003-86db-c77ea0448fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_0f0ae259-f4d3-4003-86db-c77ea0448fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_32a81af2-5180-437e-a26a-d3f7c46208d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_32a81af2-5180-437e-a26a-d3f7c46208d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_958a3b5d-bfaf-4586-808a-b20abed78bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_958a3b5d-bfaf-4586-808a-b20abed78bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1e64eabb-4edc-45e8-839f-fc6a5f8946c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_79cdb767-6a5b-4007-a7f3-7a663a327606" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1e64eabb-4edc-45e8-839f-fc6a5f8946c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_26f3a6dc-7fb5-4012-950a-38b0b35ad2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_26f3a6dc-7fb5-4012-950a-38b0b35ad2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant_0dffc424-ec3d-4ed6-b58f-f39049731336" xlink:href="cutr-20221231.xsd#cutr_AdditionalSharesReservedSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant_0dffc424-ec3d-4ed6-b58f-f39049731336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_88dcf162-7502-4d5b-ab36-ff2c7e9ff640" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_88dcf162-7502-4d5b-ab36-ff2c7e9ff640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0b10f335-c3b9-4339-a14b-c98d97af259e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0b10f335-c3b9-4339-a14b-c98d97af259e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_b1bf479d-ce3b-43dd-8d05-304f3ffc7952" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_b1bf479d-ce3b-43dd-8d05-304f3ffc7952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_a8baddd3-4bd5-410b-81bf-102a46f7e667" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_a8baddd3-4bd5-410b-81bf-102a46f7e667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08909aac-7f0d-49d9-b4a9-b4aa1f8098d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_2c85e622-0890-4b91-8ea8-153e0df90271" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_08909aac-7f0d-49d9-b4a9-b4aa1f8098d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c198cc9d-1082-4690-889b-4556f580b8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c198cc9d-1082-4690-889b-4556f580b8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae63fe69-f2e8-477c-822f-705948284696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae63fe69-f2e8-477c-822f-705948284696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_513913a9-6a6f-4bff-bcdc-76a65670031f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_513913a9-6a6f-4bff-bcdc-76a65670031f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_09679c51-38cd-4eec-956c-efa1ba3dca81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_09679c51-38cd-4eec-956c-efa1ba3dca81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_93db4653-0189-42a2-8da4-27cb9f62799d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_58bc1558-68b0-456b-ac45-dbf1eff50897" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_93db4653-0189-42a2-8da4-27cb9f62799d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1eab6fe3-1294-48ec-86ef-872192f227c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1eab6fe3-1294-48ec-86ef-872192f227c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_8536c61a-638b-4f53-a693-4deab5af802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_8536c61a-638b-4f53-a693-4deab5af802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_69021db6-3eb3-4617-8bb4-2fb963e94dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_69021db6-3eb3-4617-8bb4-2fb963e94dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d97e6568-f4f7-4748-b716-6a6a613e0ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d97e6568-f4f7-4748-b716-6a6a613e0ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ff7b58d9-e6d5-4d14-b438-8b8452e0c729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ff7b58d9-e6d5-4d14-b438-8b8452e0c729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8d03d9e5-8fd8-4702-a5d2-4906cb127c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8d03d9e5-8fd8-4702-a5d2-4906cb127c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d89991ec-f68f-4855-a625-5affd2600432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e19678cf-fcba-48bc-812b-c00d2992f3e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d89991ec-f68f-4855-a625-5affd2600432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a2668603-8db3-4a43-af51-3eca1b4c67ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a2668603-8db3-4a43-af51-3eca1b4c67ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_db619c73-48ee-4d94-bb22-ea717b082fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_db619c73-48ee-4d94-bb22-ea717b082fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_81502bca-c5a7-4eb5-aabe-74ee2400e89e" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_81502bca-c5a7-4eb5-aabe-74ee2400e89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_923539bb-61fe-47d5-b660-14ead58c91e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_81502bca-c5a7-4eb5-aabe-74ee2400e89e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_923539bb-61fe-47d5-b660-14ead58c91e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a6159aa8-90a8-47c6-88a0-693aa7f3c122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_81502bca-c5a7-4eb5-aabe-74ee2400e89e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a6159aa8-90a8-47c6-88a0-693aa7f3c122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f7800552-87fd-4302-ac8e-3d7936357a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_81502bca-c5a7-4eb5-aabe-74ee2400e89e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f7800552-87fd-4302-ac8e-3d7936357a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_785748ba-1e08-49d1-afa1-3e80e10786c2" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_785748ba-1e08-49d1-afa1-3e80e10786c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_69378952-513b-445a-a0dd-f5680e4b98f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_785748ba-1e08-49d1-afa1-3e80e10786c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_69378952-513b-445a-a0dd-f5680e4b98f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5c146600-1754-4bcf-bad6-277349303c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_785748ba-1e08-49d1-afa1-3e80e10786c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5c146600-1754-4bcf-bad6-277349303c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b8b7a78c-9b75-4769-96c6-19ce27109e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_785748ba-1e08-49d1-afa1-3e80e10786c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b8b7a78c-9b75-4769-96c6-19ce27109e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_095cff55-c984-4cdc-a2f8-b71488ac9cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb35a5d7-acc8-4b0e-98be-a009dc49fc2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_095cff55-c984-4cdc-a2f8-b71488ac9cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2afc0231-6c75-46af-a125-4d6f1e43d4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2afc0231-6c75-46af-a125-4d6f1e43d4a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_608fc338-e62a-4052-99f2-9dbc46e60055" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member_e3095217-592b-43ac-a598-4859e5fc8801" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange1Member_e3095217-592b-43ac-a598-4859e5fc8801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member_d2b55cf0-0d05-4f6e-820e-4c5260b5f5a4" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange2Member_d2b55cf0-0d05-4f6e-820e-4c5260b5f5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member_944c914c-0a40-42f8-9b27-ddd19dce28e2" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange3Member_944c914c-0a40-42f8-9b27-ddd19dce28e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member_b0edac5e-29b2-4adc-98d4-d0c622a1dcc0" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange4Member_b0edac5e-29b2-4adc-98d4-d0c622a1dcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member_a51e8e8d-4731-4929-be39-5a8f328cf708" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange5Member_a51e8e8d-4731-4929-be39-5a8f328cf708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member_7f768c08-e5f0-4bc9-aacc-55a21de74599" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange6Member_7f768c08-e5f0-4bc9-aacc-55a21de74599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member_5caed721-b4b0-484b-b1b1-bfcdf375d8be" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange7Member_5caed721-b4b0-484b-b1b1-bfcdf375d8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member_1983125f-ff86-458c-ab72-8041ad3d3f1c" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange8Member_1983125f-ff86-458c-ab72-8041ad3d3f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member_c97bac68-883a-4ef6-a22e-631dfcced3c5" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange9Member_c97bac68-883a-4ef6-a22e-631dfcced3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member_74e87ca0-0c46-4af5-90ec-8660ffbb169f" xlink:href="cutr-20221231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9c46f78a-18e2-4c69-80e6-6167e5f9b6b4" xlink:to="loc_cutr_ExercisePriceRange10Member_74e87ca0-0c46-4af5-90ec-8660ffbb169f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a4a167f-7ea9-42c0-a3e6-c27ee5b66c5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_613d6274-0296-4e67-a96d-3f789166ca07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_613d6274-0296-4e67-a96d-3f789166ca07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1969e415-956a-4480-b49b-551cfc832d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1969e415-956a-4480-b49b-551cfc832d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_df3acfbc-cf6c-4d43-ad6e-f8efc1e80874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_df3acfbc-cf6c-4d43-ad6e-f8efc1e80874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_ae30e4dd-74c2-4949-81d2-6b596bca3a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_ae30e4dd-74c2-4949-81d2-6b596bca3a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_6ac1f2e6-7522-462f-a195-d51fc492477f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_6ac1f2e6-7522-462f-a195-d51fc492477f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49219d6c-70ba-4ba6-9107-d3c34f0f2e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6afefa84-02e8-4c18-a0c7-40a760e7019e" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49219d6c-70ba-4ba6-9107-d3c34f0f2e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0b6688d-aba2-4a21-8b55-2a663cb29fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0b6688d-aba2-4a21-8b55-2a663cb29fa7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:to="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d47f115b-7559-434c-8463-742653c4397e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_16238483-a941-4d4a-9e81-dab7cbc0ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e063b7ae-4f78-435f-8042-9cbfac0e1302" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_16238483-a941-4d4a-9e81-dab7cbc0ca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_206905c9-edb8-4f7d-bc3a-66201e373eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67871d4f-4d3b-4751-aee4-b3954c47312d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67871d4f-4d3b-4751-aee4-b3954c47312d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdee1e1-7d7b-4670-afbc-86dc96b7291a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdee1e1-7d7b-4670-afbc-86dc96b7291a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7d1b8a67-0a7e-492a-a2e4-10a46c4a98b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7d1b8a67-0a7e-492a-a2e4-10a46c4a98b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19cc98b2-7521-49a6-bafb-3a8ee813d667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19cc98b2-7521-49a6-bafb-3a8ee813d667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6284345-a72e-463d-8278-74ef58e7bf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e01ead76-c6f9-47f8-882b-1aca60383302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6284345-a72e-463d-8278-74ef58e7bf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00c704f7-6fc6-48c0-8bb1-126a52e60ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00c704f7-6fc6-48c0-8bb1-126a52e60ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638f8062-0058-4e18-b10a-78c8441db255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_638f8062-0058-4e18-b10a-78c8441db255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d7cbe683-211b-4a54-81a8-db64d4b75039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d7cbe683-211b-4a54-81a8-db64d4b75039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_84316397-9fdb-4068-b344-6c2d7a0607ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_84316397-9fdb-4068-b344-6c2d7a0607ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c7bb5d0-f283-4482-ae82-644e666ced7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0718a95-ef41-4d9e-9296-d47e98089252" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0c7bb5d0-f283-4482-ae82-644e666ced7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_33dacaaf-a6e0-4ef1-87dd-939456f24b0f" xlink:href="cutr-20221231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_33dacaaf-a6e0-4ef1-87dd-939456f24b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_f17cf7e0-fa6e-44ce-a0d6-c732e083cd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_f17cf7e0-fa6e-44ce-a0d6-c732e083cd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7234b96d-ffab-4c54-8480-3b00e5a38fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7234b96d-ffab-4c54-8480-3b00e5a38fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_45d854a5-946c-434d-a4e4-a6a58ade4adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b739ae36-3252-4ed2-8518-42c2589c10fa" xlink:to="loc_us-gaap_SharePrice_45d854a5-946c-434d-a4e4-a6a58ade4adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71f3003-117c-494b-ad59-ba5a09be953c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a71f3003-117c-494b-ad59-ba5a09be953c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:to="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_29c4b8ce-d558-4f06-9d7c-3c9f85e8fccf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_844fa146-ae60-4fba-8b3c-93216bcc4bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_EmployeeStockOptionMember_844fa146-ae60-4fba-8b3c-93216bcc4bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_67ff58c4-2ef9-4688-a112-ec2450d3babb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_67ff58c4-2ef9-4688-a112-ec2450d3babb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_aea989b1-dbf3-408a-ad30-bc7d2a8c38f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_us-gaap_PerformanceSharesMember_aea989b1-dbf3-408a-ad30-bc7d2a8c38f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember_0a71972e-4556-452d-8ad5-4c5bdec7892f" xlink:href="cutr-20221231.xsd#cutr_ESPPMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99ef43f0-fbee-4848-9dcd-40bf7ed80687" xlink:to="loc_cutr_ESPPMember_0a71972e-4556-452d-8ad5-4c5bdec7892f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2309dd9c-8dea-4732-af6a-6110ba41ea5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_62996d91-d82c-43ea-bbdb-c7ede3bb9d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_26f2a0f2-6ea4-44a6-a8cd-cd6547f7a302" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_62996d91-d82c-43ea-bbdb-c7ede3bb9d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e75530cf-ab9e-4f48-83c0-b92f3cf072cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e75530cf-ab9e-4f48-83c0-b92f3cf072cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3438305b-8fd8-46f6-a419-c5e8f8fecc62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4cf92775-b185-4ea1-8842-8f1d528c5c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_CostOfSalesMember_4cf92775-b185-4ea1-8842-8f1d528c5c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_9ad3378d-0e89-42fb-becb-88cc07af3240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_9ad3378d-0e89-42fb-becb-88cc07af3240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_edc01a8e-4c77-4965-9f7c-1d1ff4bd807b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_edc01a8e-4c77-4965-9f7c-1d1ff4bd807b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f937bb82-8196-42e1-8e02-9734e0539794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f1f2f95-d8f8-4eb5-a4f2-4ec9e6638846" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f937bb82-8196-42e1-8e02-9734e0539794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d052e660-6907-49b1-bb31-646c19a85d1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_eaaf3c69-eda0-4c98-9f83-a9edeea45f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2639b278-5e73-40f1-a70a-b10db703506e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_eaaf3c69-eda0-4c98-9f83-a9edeea45f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37bbb7e8-930f-4384-861d-5f7c75893fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37bbb7e8-930f-4384-861d-5f7c75893fa4" xlink:to="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:to="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_45103228-0aa3-46e8-ac6b-8f7bc35ed52c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_afd6a413-813d-4aef-b693-b5bfb6ffff28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_afd6a413-813d-4aef-b693-b5bfb6ffff28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember_d039677e-d621-44d9-b94b-94f22d3d50cc" xlink:href="cutr-20221231.xsd#cutr_StockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a717832-1883-43f2-b7db-9c7a2594782b" xlink:to="loc_cutr_StockPurchasePlanMember_d039677e-d621-44d9-b94b-94f22d3d50cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_783729fd-d0d0-4412-a596-ee5c445ae7d4" xlink:to="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be8ec169-f4d6-42e8-b064-17a3c4b96d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_be8ec169-f4d6-42e8-b064-17a3c4b96d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7d7dc3fe-fd31-4e63-937b-30b078023fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7d7dc3fe-fd31-4e63-937b-30b078023fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f3c0d910-52f3-4103-b9e9-96e8867d2350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f3c0d910-52f3-4103-b9e9-96e8867d2350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f21ff32d-f9b0-40f6-a16f-a571a84d0b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f21ff32d-f9b0-40f6-a16f-a571a84d0b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bff6d19e-cbc7-43ef-baa7-e139463874e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd932e15-bd54-45b3-aac2-1cd7f3146420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bff6d19e-cbc7-43ef-baa7-e139463874e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6aa42e26-8455-4d9c-b127-1d3bc04a15d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4f07f845-9bef-41f9-b052-1073198c2645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6aa42e26-8455-4d9c-b127-1d3bc04a15d2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4f07f845-9bef-41f9-b052-1073198c2645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1c8bb5bc-3a12-4b83-a5aa-9182a00098af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6aa42e26-8455-4d9c-b127-1d3bc04a15d2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1c8bb5bc-3a12-4b83-a5aa-9182a00098af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d88c546b-fca9-4855-8900-87ff5ce57521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6aa42e26-8455-4d9c-b127-1d3bc04a15d2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d88c546b-fca9-4855-8900-87ff5ce57521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1bf40c22-4a49-46fd-8cd1-8a46c76f0065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bf40c22-4a49-46fd-8cd1-8a46c76f0065" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8224fd72-a905-4a51-8bef-112e942c8c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8224fd72-a905-4a51-8bef-112e942c8c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_21a9b2c8-0aa2-429f-9fdb-82ddff0f38dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_21a9b2c8-0aa2-429f-9fdb-82ddff0f38dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b1347957-33e6-4c23-9254-7e299611d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b1347957-33e6-4c23-9254-7e299611d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4eb0e193-23de-4416-bfc8-930a9bfff41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6da6e892-c198-4d7e-90fb-f6210f6b687f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4eb0e193-23de-4416-bfc8-930a9bfff41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bf40c22-4a49-46fd-8cd1-8a46c76f0065" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_f04e0708-4b98-435b-b829-93103d954cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_f04e0708-4b98-435b-b829-93103d954cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2f6e94e1-67ed-4252-b0e6-b847cc8b8631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2f6e94e1-67ed-4252-b0e6-b847cc8b8631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f113121b-b8aa-4045-af04-a84a003d9b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f113121b-b8aa-4045-af04-a84a003d9b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d1625513-a49c-457f-9fc9-178f8b6bdcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_06548fa7-c14f-4f96-b023-b5fdc49db9b8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d1625513-a49c-457f-9fc9-178f8b6bdcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4a353e6-c812-4c08-8141-8a59eb5b2a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1bf40c22-4a49-46fd-8cd1-8a46c76f0065" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4a353e6-c812-4c08-8141-8a59eb5b2a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1ac410ec-3344-4042-902a-08e1374cb9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1ac410ec-3344-4042-902a-08e1374cb9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8d6f0b8a-ff46-415f-9a5c-a1a92213df1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8d6f0b8a-ff46-415f-9a5c-a1a92213df1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_721a2917-6ac4-4ab2-95d3-dc164aaa3e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_721a2917-6ac4-4ab2-95d3-dc164aaa3e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac0b45bf-d629-4273-abac-ff17917cbff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac0b45bf-d629-4273-abac-ff17917cbff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_4867475f-0b56-4b51-88f7-402c7f2ad4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_4867475f-0b56-4b51-88f7-402c7f2ad4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8505b714-2f55-4a43-8b00-4caa1d8a0de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8505b714-2f55-4a43-8b00-4caa1d8a0de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_3231dbae-ae88-4e11-a91e-fbb812a6384b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_3231dbae-ae88-4e11-a91e-fbb812a6384b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_31705237-ed2b-470e-906d-3c5e88746c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_31705237-ed2b-470e-906d-3c5e88746c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_2073cb46-f970-4c52-bc7a-1b55eef3cf0b" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_2073cb46-f970-4c52-bc7a-1b55eef3cf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_51c76600-b94b-41c7-9064-5eebd5873e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_51c76600-b94b-41c7-9064-5eebd5873e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f64d200f-dc30-4cfc-b335-28a9a8d58b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f64d200f-dc30-4cfc-b335-28a9a8d58b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f3cbcdbf-ddad-43e5-bda5-b6c671f67c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_f3cbcdbf-ddad-43e5-bda5-b6c671f67c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_13351e9d-55ec-43cc-b77f-11646f71c3af" xlink:href="cutr-20221231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_13351e9d-55ec-43cc-b77f-11646f71c3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_4fe261cb-94a2-453a-a60d-18c9b898fa1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_4fe261cb-94a2-453a-a60d-18c9b898fa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4c2cb44e-54a9-48da-8df6-226c18892c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4c2cb44e-54a9-48da-8df6-226c18892c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_812e870e-1237-4537-8c1a-47938ade10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72052054-f1ca-44d2-85de-0807d7ff3b1f" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_812e870e-1237-4537-8c1a-47938ade10c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b6f49008-ebe7-4c1b-afc3-5de22732badc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b6f49008-ebe7-4c1b-afc3-5de22732badc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_5dcc8cc6-95e2-40fa-a2ad-b23a4be246ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_5dcc8cc6-95e2-40fa-a2ad-b23a4be246ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_20fd9571-816d-402d-a6f2-6abb339b3fab" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_20fd9571-816d-402d-a6f2-6abb339b3fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_9c5752a6-366a-4132-af63-d889c66f3292" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_9c5752a6-366a-4132-af63-d889c66f3292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_db85b590-6bf9-457f-aba8-f74a0dc63f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_db85b590-6bf9-457f-aba8-f74a0dc63f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_cf4c23b5-ceb8-4a55-aaf7-073f9dbbed2c" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent_cf4c23b5-ceb8-4a55-aaf7-073f9dbbed2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_57139d5a-cbba-4a03-86d9-d19b15a1c14f" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent_57139d5a-cbba-4a03-86d9-d19b15a1c14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_01aae2f2-a562-4de1-8d23-bccedebf9fa4" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_01aae2f2-a562-4de1-8d23-bccedebf9fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_771e1c4c-5b50-4fa1-868a-a0ea8f69093c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_771e1c4c-5b50-4fa1-868a-a0ea8f69093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_b7bef471-056b-4846-8ac9-2221c7cc3a88" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_b7bef471-056b-4846-8ac9-2221c7cc3a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_1898e531-0c10-482f-bc5c-a959bde65186" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_1898e531-0c10-482f-bc5c-a959bde65186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_475e247b-9011-4a64-8649-7fea630894fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_475e247b-9011-4a64-8649-7fea630894fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_137d268b-de09-4e27-839c-b3b3cccb87d5" xlink:href="cutr-20221231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_137d268b-de09-4e27-839c-b3b3cccb87d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e167ec8d-fc34-4059-bb6c-9c92f72f14c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab4a8dc1-121a-4e42-8e09-f9177f398f89" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e167ec8d-fc34-4059-bb6c-9c92f72f14c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d70f493c-144c-475c-b9fb-d484d185205d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d70f493c-144c-475c-b9fb-d484d185205d" xlink:to="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_29985374-ad4f-4832-a8b4-957b851266c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_832da35f-52b7-4299-bde9-55a30fbc480d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_ForeignCountryMember_832da35f-52b7-4299-bde9-55a30fbc480d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_2512c7ce-c0fa-49e7-827c-9083afab8da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_DomesticCountryMember_2512c7ce-c0fa-49e7-827c-9083afab8da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f25dbb3b-75f6-42f2-b44f-51ecbe21028a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e145c778-00bb-429f-b84f-2c67188c74a6" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f25dbb3b-75f6-42f2-b44f-51ecbe21028a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f86ad5fe-dcda-41a2-85fa-f75c0f8aeff4" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8d913739-04f1-43e0-a50f-8e666fc74c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8d913739-04f1-43e0-a50f-8e666fc74c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_19f5a3f3-1841-4469-9b9b-4ee4af2e847c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_27225657-d6d3-4209-b4b0-e72d333a35b7" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_19f5a3f3-1841-4469-9b9b-4ee4af2e847c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_5e269005-57e9-49ef-aa76-7ff44a77dafe" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_ee06bdd2-faa0-44da-965f-e89f7e5c8716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_96a41b1a-d85b-45c0-af16-c5076cb9baaf" xlink:to="loc_us-gaap_ResearchMember_ee06bdd2-faa0-44da-965f-e89f7e5c8716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37a9e57f-9262-4de7-8617-0df2c61fb8bf" xlink:to="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ccdc4bbc-eaba-4046-8486-78cbba369b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ccdc4bbc-eaba-4046-8486-78cbba369b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e4ba885a-b9f2-4b7e-9d07-5ea5a152328d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e4ba885a-b9f2-4b7e-9d07-5ea5a152328d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_920650e5-f6bb-421a-9fdd-cf965584bfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_920650e5-f6bb-421a-9fdd-cf965584bfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_401c9ed9-a408-4882-a097-996ea7d917c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_OperatingLossCarryforwards_401c9ed9-a408-4882-a097-996ea7d917c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_874b3c88-30ca-4fb0-9e60-f2243117965f" xlink:href="cutr-20221231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_874b3c88-30ca-4fb0-9e60-f2243117965f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_65212ef2-58f6-4d7c-8005-7eb8b031b678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_65212ef2-58f6-4d7c-8005-7eb8b031b678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_7efe8efc-b30d-47c4-b304-8ad1ef884267" xlink:href="cutr-20221231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3382e9f5-0c71-4875-a6bd-59eea85f8316" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_7efe8efc-b30d-47c4-b304-8ad1ef884267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b69b95e-de20-48f7-b3cb-c920d80e1acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b69b95e-de20-48f7-b3cb-c920d80e1acc" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8ed30761-f023-40d1-bb58-0f4bf74175b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8ed30761-f023-40d1-bb58-0f4bf74175b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_53b4f59a-5bf4-40cf-9815-66b717a2ece5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_53b4f59a-5bf4-40cf-9815-66b717a2ece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7341fc27-ad77-4e9a-8fbf-90c740bc492a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7341fc27-ad77-4e9a-8fbf-90c740bc492a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_addf4cee-994b-48f7-a45f-b2d84318a9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5373b83b-1326-46a4-ac45-19b0a96b03cd" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_addf4cee-994b-48f7-a45f-b2d84318a9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ccaceba2-531b-462f-8be1-6753d04e9f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ccaceba2-531b-462f-8be1-6753d04e9f09" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a3a596c-d28c-450c-9738-fae5310b101e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_1e67afed-d423-45be-8eb2-64059d6b6731" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d50d5d71-784f-41cb-8559-91a20b1c98d8" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_1e67afed-d423-45be-8eb2-64059d6b6731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7424dbda-8591-447b-a6d1-df4ac201eb92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_caa19c91-2749-4876-b021-77c08e2bfebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b50c8c0-4274-47f3-b108-8fd37d0a3860" xlink:to="loc_us-gaap_ConvertibleDebtMember_caa19c91-2749-4876-b021-77c08e2bfebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b287904a-8c63-45cd-8172-d253243085fa" xlink:to="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_03555a2c-20d6-4493-a3d2-00ec84a1fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80cd1fc6-2ef4-4f37-881c-946c354a74e1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_03555a2c-20d6-4493-a3d2-00ec84a1fe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2d8fc808-db8b-4a07-a504-d2a328a78ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2d8fc808-db8b-4a07-a504-d2a328a78ef1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:to="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5b9d39f7-02c0-45c1-a93f-6a0f27c07beb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f76ae6c6-de1d-4c5a-a70a-cd90fc5eb206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f76ae6c6-de1d-4c5a-a70a-cd90fc5eb206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_991dbc09-c794-4cc3-83b2-131d26fb86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_991dbc09-c794-4cc3-83b2-131d26fb86ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3a338975-8ff2-49bd-bb91-be39545cf05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_PerformanceSharesMember_3a338975-8ff2-49bd-bb91-be39545cf05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_32fe87b1-7581-4f65-b1a1-41f364ad1ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dfce05b2-772e-49be-9061-f4df554908d6" xlink:to="loc_us-gaap_EmployeeStockMember_32fe87b1-7581-4f65-b1a1-41f364ad1ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_899a5065-a7f2-4147-b7ee-5401bcaa1b65" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc57d014-fb86-4027-9aba-65803f2509cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c64a7f75-a0f4-4448-914c-5abcb4c6af7a" xlink:to="loc_us-gaap_NetIncomeLoss_fc57d014-fb86-4027-9aba-65803f2509cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8852aac6-ce6b-4061-86ea-593cf2387afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_1ddb4642-bfd9-48f4-9f6b-d9869c60ded1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8852aac6-ce6b-4061-86ea-593cf2387afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4414fe4a-f297-479a-be31-3b57588dcbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4414fe4a-f297-479a-be31-3b57588dcbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_018e8cc3-2b7a-461e-aaf2-37b99c9a874c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_401a5cec-19b1-4273-8b7c-6da003253c9f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_018e8cc3-2b7a-461e-aaf2-37b99c9a874c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_f41593d7-62a2-42e6-89dc-b1e54711bad2" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_df61f5b3-feb4-4988-b667-a1d385d38302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:to="loc_us-gaap_EarningsPerShareBasic_df61f5b3-feb4-4988-b667-a1d385d38302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7888e434-e9fb-4af6-9e19-1a4a3eb794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_219822c4-9774-487f-a9ab-22401e79a980" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7888e434-e9fb-4af6-9e19-1a4a3eb794f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_02091112-8da2-4f33-be95-aa8840eda9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_02091112-8da2-4f33-be95-aa8840eda9b3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d2bbe4dd-11c4-4295-877f-11395a62bd56" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember_1c757b67-3e00-4689-a102-237c7bb02454" xlink:href="cutr-20221231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_cutr_CappedCallSecuritiesMember_1c757b67-3e00-4689-a102-237c7bb02454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_d5d5a6e5-b8a8-4948-bae1-c2bfff6f0007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_d5d5a6e5-b8a8-4948-bae1-c2bfff6f0007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f6ae550a-cde5-4bc2-980b-406152024c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f6ae550a-cde5-4bc2-980b-406152024c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9ec90eaf-5772-4833-b31c-b5bb0677e994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9ec90eaf-5772-4833-b31c-b5bb0677e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_02248b93-3f16-4e9a-8992-349743ab4591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_EmployeeStockMember_02248b93-3f16-4e9a-8992-349743ab4591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cc248ac1-993a-42a7-992c-14757f294363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5ab50e8f-dccf-4f1a-9683-5b1ce4e7f6b7" xlink:to="loc_us-gaap_PerformanceSharesMember_cc248ac1-993a-42a7-992c-14757f294363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d07573a-24b6-4079-8ce0-6d177c90dfb9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d142e24-b12a-4a4b-a484-00ab67e2815c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_917a8516-cb98-4912-8613-6538c3402922" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d142e24-b12a-4a4b-a484-00ab67e2815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DefinedContributionPlanNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DefinedContributionPlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DefinedContributionPlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_903e8d6a-31e3-43d9-8d15-c1d7b8f2eb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_694f5b0a-2b4c-4a21-ba5c-82de44c3b713" xlink:href="cutr-20221231.xsd#cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_903e8d6a-31e3-43d9-8d15-c1d7b8f2eb1a" xlink:to="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_694f5b0a-2b4c-4a21-ba5c-82de44c3b713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_77fcfe4b-a274-4ea6-92b8-7e1b5144c83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_903e8d6a-31e3-43d9-8d15-c1d7b8f2eb1a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_77fcfe4b-a274-4ea6-92b8-7e1b5144c83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a4635fc1-2ea7-4e67-976f-5c741ee6b104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a651c837-39ee-4ef0-9fdc-29e28fcc639f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4635fc1-2ea7-4e67-976f-5c741ee6b104" xlink:to="loc_us-gaap_NumberOfReportableSegments_a651c837-39ee-4ef0-9fdc-29e28fcc639f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cb14a336-0558-4401-9b3c-709014cbd24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cb14a336-0558-4401-9b3c-709014cbd24b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:to="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a0bda786-e2b1-4ae1-80c0-2da6e9976b43" xlink:to="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d3a1846f-db45-450d-8926-ac60ade03c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:to="loc_us-gaap_OperatingSegmentsMember_d3a1846f-db45-450d-8926-ac60ade03c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cd74336b-92c2-4cbb-a0b2-97e5870cd31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8220fbee-b11e-47e1-9828-2833679c1424" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cd74336b-92c2-4cbb-a0b2-97e5870cd31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de13b40b-217a-4df0-a1a5-312bd3f5a08a" xlink:to="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CuteraCoreMember_cb4eb7a4-109d-4334-9527-3250945ebc26" xlink:href="cutr-20221231.xsd#cutr_CuteraCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:to="loc_cutr_CuteraCoreMember_cb4eb7a4-109d-4334-9527-3250945ebc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_0b369b2d-50ae-4bea-b234-b7a48cf36900" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7d74721f-0016-415a-ba30-50d935dddbe4" xlink:to="loc_cutr_AviClearMember_0b369b2d-50ae-4bea-b234-b7a48cf36900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d816555-bbee-4034-8230-7938ac2e6318" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_70cd9255-a87c-4853-a578-9787cc36cf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_70cd9255-a87c-4853-a578-9787cc36cf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_19d5fe76-7240-418a-b2b1-743190e09961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_OperatingIncomeLoss_19d5fe76-7240-418a-b2b1-743190e09961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7f5b886f-e890-48f6-bd7f-caa9013a5515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_ShareBasedCompensation_7f5b886f-e890-48f6-bd7f-caa9013a5515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ERPImplementation_43b5d457-7bdd-464b-a958-18b9a2b0d03f" xlink:href="cutr-20221231.xsd#cutr_ERPImplementation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_cutr_ERPImplementation_43b5d457-7bdd-464b-a958-18b9a2b0d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_763f46cc-88f8-4bd6-9857-c01bf52c1485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_DepreciationAndAmortization_763f46cc-88f8-4bd6-9857-c01bf52c1485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LegalFeesSeveranceAndOther_574bc613-0b9d-4747-9340-6802f430ef0f" xlink:href="cutr-20221231.xsd#cutr_LegalFeesSeveranceAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_cutr_LegalFeesSeveranceAndOther_574bc613-0b9d-4747-9340-6802f430ef0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_be7434d7-b167-412a-8158-72d09b133fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_be7434d7-b167-412a-8158-72d09b133fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c45befc0-cdfc-4306-b935-6739d0930abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c45befc0-cdfc-4306-b935-6739d0930abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PartnersCapital_9136bd8d-24c5-4676-8fe5-c07c71d6269b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_PartnersCapital_9136bd8d-24c5-4676-8fe5-c07c71d6269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ffcc4f7b-977d-4f70-bd49-f8d4658cebfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ca85a67b-7e7e-4035-af1a-c0bdb824d441" xlink:to="loc_us-gaap_Assets_ffcc4f7b-977d-4f70-bd49-f8d4658cebfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_92a195fb-605e-4754-a403-ffb3f650d509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_92a195fb-605e-4754-a403-ffb3f650d509" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:to="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6f537f95-8261-4b91-9d33-53958f56b728" xlink:to="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e89567b1-0cfa-47bd-8f19-734a10b1c260" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_country_US_e89567b1-0cfa-47bd-8f19-734a10b1c260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_7ec2c8dd-9104-4a2d-8202-24a562de5f9a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_country_JP_7ec2c8dd-9104-4a2d-8202-24a562de5f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_8ac8f44e-7a9e-48e3-8268-6a6b65ceeb46" xlink:href="cutr-20221231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_cutr_AsiaExcludingJapanMember_8ac8f44e-7a9e-48e3-8268-6a6b65ceeb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_47847436-06fe-4239-85f1-f345bac61a6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_srt_EuropeMember_47847436-06fe-4239-85f1-f345bac61a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_6fe59049-5387-47ab-b59c-a11e5944769b" xlink:href="cutr-20221231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2cd81136-cc57-4fa9-8ec8-a62244df1006" xlink:to="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_6fe59049-5387-47ab-b59c-a11e5944769b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:to="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_fafaf2ef-ba58-41ce-85d7-964fb3006c77" xlink:to="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:href="cutr-20221231.xsd#cutr_TotalProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:to="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember_48d377a0-1d63-475e-945b-0a4d35fd84b2" xlink:href="cutr-20221231.xsd#cutr_SystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_SystemsMember_48d377a0-1d63-475e-945b-0a4d35fd84b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearMember_7ffaa4b5-747a-4e14-af1d-3803cffc54c0" xlink:href="cutr-20221231.xsd#cutr_AviClearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_AviClearMember_7ffaa4b5-747a-4e14-af1d-3803cffc54c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConsumablesMember_03efd98b-edbf-4d9c-915c-6955180f88bb" xlink:href="cutr-20221231.xsd#cutr_ConsumablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_ConsumablesMember_03efd98b-edbf-4d9c-915c-6955180f88bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_bdf90e4f-027d-4861-83dd-3259f08e2840" xlink:href="cutr-20221231.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_TotalProductsMember_c23acc34-eece-436a-b501-fd7f5c1ec23e" xlink:to="loc_cutr_SkincareMember_bdf90e4f-027d-4861-83dd-3259f08e2840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cd14b6af-2235-43d2-a09c-9e8d93af250d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f252fb20-b63c-4876-86f5-16eaa17be6c1" xlink:to="loc_us-gaap_ServiceMember_cd14b6af-2235-43d2-a09c-9e8d93af250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac37bb47-0548-40bf-98a1-b525d4c858cd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_627d3203-233b-4aa2-8422-61af6f1e9a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f8091391-a063-45b9-a8eb-b58794d5a0ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_627d3203-233b-4aa2-8422-61af6f1e9a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b0b916c8-6707-4950-b0d2-64d79e807544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b0b916c8-6707-4950-b0d2-64d79e807544" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5edac7de-6f31-4d4d-9896-3cc0a9bc44fe" xlink:to="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_588abb85-7ef1-4537-a1f7-fd77d1228e62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:to="loc_srt_MinimumMember_588abb85-7ef1-4537-a1f7-fd77d1228e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_54523373-fdfb-44ef-8932-9b9a76ba9c97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_83ec6427-b83b-419e-a4b2-50070ed10e58" xlink:to="loc_srt_MaximumMember_54523373-fdfb-44ef-8932-9b9a76ba9c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7cb76021-cb3c-4fb0-972c-795198d6e269" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearDeviceMember_951cf41e-42b9-4262-8ad3-ca659a0c939c" xlink:href="cutr-20221231.xsd#cutr_AviClearDeviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_AviClearDeviceMember_951cf41e-42b9-4262-8ad3-ca659a0c939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_f8a03697-33c5-42ea-ba25-dec7f309e974" xlink:href="cutr-20221231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_f8a03697-33c5-42ea-ba25-dec7f309e974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseInstallmentCostsMember_a6bc5827-17df-4eaa-a631-5cd610680143" xlink:href="cutr-20221231.xsd#cutr_LeaseInstallmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_772f7305-9ac9-45f7-943a-416614aa6c71" xlink:to="loc_cutr_LeaseInstallmentCostsMember_a6bc5827-17df-4eaa-a631-5cd610680143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_85810acf-4dd3-4205-b3e7-5f7e2de1240c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5d8970d2-027a-4d9c-ad03-d3f0a4e8c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b0d25df7-b2f0-45f2-95ed-b458bcccebe7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5d8970d2-027a-4d9c-ad03-d3f0a4e8c2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4c108abb-25f2-41f5-8d11-db7f61e915a7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_30c06c71-c402-49c7-8686-663733aaf14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_208ab8eb-25c0-4d66-95d6-dfdbd849baa5" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_30c06c71-c402-49c7-8686-663733aaf14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2d7bb581-8007-4bc1-a3d8-e4a4c6f6d0cc" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm_5aeb050a-da3f-48fc-aa9d-100a03bd9b70" xlink:href="cutr-20221231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LesseeLeasesRemainingTerm_5aeb050a-da3f-48fc-aa9d-100a03bd9b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm_c7b1f10b-edd8-4bdd-80ea-b47078371858" xlink:href="cutr-20221231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LesseeLeaseRenewalTerm_c7b1f10b-edd8-4bdd-80ea-b47078371858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_55d05668-1107-4ae1-9bbd-9ad2ad3b79f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_55d05668-1107-4ae1-9bbd-9ad2ad3b79f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorDurationOfAutorenewalFeatures_45af98f4-eabc-4662-80e6-673f724bdb4e" xlink:href="cutr-20221231.xsd#cutr_LessorDurationOfAutorenewalFeatures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_LessorDurationOfAutorenewalFeatures_45af98f4-eabc-4662-80e6-673f724bdb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_a434e953-6d8e-49e7-9f2d-681c64d2b55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_LitigationReserve_a434e953-6d8e-49e7-9f2d-681c64d2b55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_40b15857-e960-41fa-81dc-ecc453fca161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_40b15857-e960-41fa-81dc-ecc453fca161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfConsecutiveLeaseTerms_502a47a7-72e5-489f-9411-ba512b3651b8" xlink:href="cutr-20221231.xsd#cutr_NumberOfConsecutiveLeaseTerms"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_cutr_NumberOfConsecutiveLeaseTerms_502a47a7-72e5-489f-9411-ba512b3651b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_a58df118-c913-45b9-a22c-1fe75f741581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_CapitalizedContractCostNet_a58df118-c913-45b9-a22c-1fe75f741581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7029fda7-b4f6-4af3-a466-1ec5f19b83d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fab1c57c-e46c-41e2-a49e-910e5888767c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7029fda7-b4f6-4af3-a466-1ec5f19b83d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesFinancialStatementInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f6ea42a0-6110-4d18-8b19-fa7569a72576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ce87013a-c063-4bc9-8ebc-dd8bbbac8ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6ea42a0-6110-4d18-8b19-fa7569a72576" xlink:to="loc_us-gaap_AssetsAbstract_ce87013a-c063-4bc9-8ebc-dd8bbbac8ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6a09fa6-5496-4253-b64e-6583eba482f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ce87013a-c063-4bc9-8ebc-dd8bbbac8ebb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6a09fa6-5496-4253-b64e-6583eba482f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1b09ddfe-93c8-49bf-9717-0eff5fd954ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ce87013a-c063-4bc9-8ebc-dd8bbbac8ebb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1b09ddfe-93c8-49bf-9717-0eff5fd954ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_315c8a81-24f8-4d6c-a839-a256a0525c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_1b09ddfe-93c8-49bf-9717-0eff5fd954ac" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_315c8a81-24f8-4d6c-a839-a256a0525c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_c36d3371-19bd-484a-b113-20da6566d8b7" xlink:href="cutr-20221231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ce87013a-c063-4bc9-8ebc-dd8bbbac8ebb" xlink:to="loc_cutr_LeaseRightOfUseAsset_c36d3371-19bd-484a-b113-20da6566d8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f6ea42a0-6110-4d18-8b19-fa7569a72576" xlink:to="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1fcc1cb0-f151-4cb8-95b3-50fcd7dc1c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1fcc1cb0-f151-4cb8-95b3-50fcd7dc1c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c12c0ec0-7298-47c7-b57f-bd524dafdce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c12c0ec0-7298-47c7-b57f-bd524dafdce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3ff361a5-acec-4cd6-9411-f122e78e0e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_OperatingLeaseLiability_3ff361a5-acec-4cd6-9411-f122e78e0e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_915baf44-f3af-444d-b46b-c390c2fe1f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_915baf44-f3af-444d-b46b-c390c2fe1f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0d3da2f1-f5da-48f9-ad21-c3f65a8c78f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_915baf44-f3af-444d-b46b-c390c2fe1f6f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_0d3da2f1-f5da-48f9-ad21-c3f65a8c78f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1b38aa82-2f6b-4bb3-ac12-e8d437439b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1b38aa82-2f6b-4bb3-ac12-e8d437439b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_a6c9fd44-b4c7-42f3-9d36-c6511d0b4aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1b38aa82-2f6b-4bb3-ac12-e8d437439b7b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_a6c9fd44-b4c7-42f3-9d36-c6511d0b4aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_dd7d388d-b0c6-46f0-8e4e-0fbd2c2cbcef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseLiability_dd7d388d-b0c6-46f0-8e4e-0fbd2c2cbcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_94016074-cd69-459e-b208-aedff6594382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_94016074-cd69-459e-b208-aedff6594382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3904f36e-369a-4f19-8d09-9193ca829f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3904f36e-369a-4f19-8d09-9193ca829f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8f4dfef3-a13e-49ad-b5a4-e3dce3e1c49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_OperatingLeaseExpense_8f4dfef3-a13e-49ad-b5a4-e3dce3e1c49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_1adf588e-3a23-41d8-bc89-accde1f00abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_1adf588e-3a23-41d8-bc89-accde1f00abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_42d1923b-8337-4df4-a4c8-955adc8ec44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_42d1923b-8337-4df4-a4c8-955adc8ec44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f26de653-fe1e-405f-a1aa-4e6dcd83090e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_1f60caf9-47c9-4f55-a321-a3a02eaad275" xlink:to="loc_us-gaap_OperatingLeasePayments_f26de653-fe1e-405f-a1aa-4e6dcd83090e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bb5d965f-980a-4c0f-93d3-956b1636a68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bb5d965f-980a-4c0f-93d3-956b1636a68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ca6e420f-f166-4989-b7aa-0358bd9dec29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ca6e420f-f166-4989-b7aa-0358bd9dec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_055fff2f-6aed-42f2-8dc6-1efd5accde12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_055fff2f-6aed-42f2-8dc6-1efd5accde12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_351dc03f-da47-4672-b3fb-d6f7d586fbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_351dc03f-da47-4672-b3fb-d6f7d586fbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c04e8e33-7060-42a4-9fe4-96b8ec6e6f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c04e8e33-7060-42a4-9fe4-96b8ec6e6f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_608bbc92-a1d3-41b4-94af-86ed4dd8d31e" xlink:href="cutr-20221231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_608bbc92-a1d3-41b4-94af-86ed4dd8d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_79672f24-4926-4f08-9c18-b47b3469d24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_79672f24-4926-4f08-9c18-b47b3469d24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b07e71b4-d6c8-4615-bc67-1b028bcb1b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b07e71b4-d6c8-4615-bc67-1b028bcb1b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ddb2a93-8474-494d-9b92-8e397a4edf84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_31c3d0c3-479c-47f2-85e7-5ef33b3fe247" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ddb2a93-8474-494d-9b92-8e397a4edf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b673ba87-b304-4da9-9d4e-45d05295962c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b673ba87-b304-4da9-9d4e-45d05295962c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5981193b-f181-4b7f-b221-edbb4e8baa82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5981193b-f181-4b7f-b221-edbb4e8baa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_18be9bf8-3938-45e1-9ea0-351bc90fb5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_18be9bf8-3938-45e1-9ea0-351bc90fb5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6bca9aaf-1814-46da-97d8-529b9951efc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6bca9aaf-1814-46da-97d8-529b9951efc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ee6cde81-c4d3-4855-8a4b-c8f86baf0fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ee6cde81-c4d3-4855-8a4b-c8f86baf0fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_24b1ea3d-0f25-47ad-b8a5-9f106046e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89464c41-f414-4a04-8af2-bc6e4db4550f" xlink:to="loc_us-gaap_FinanceLeaseLiability_24b1ea3d-0f25-47ad-b8a5-9f106046e4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_00c7bfeb-c696-4e56-97b0-133055b5018e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c2ba4020-3ba0-4412-baf6-204cd852afba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c7bfeb-c696-4e56-97b0-133055b5018e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c2ba4020-3ba0-4412-baf6-204cd852afba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9fc8945a-aa81-4d89-9ea1-6e9b2877f448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c7bfeb-c696-4e56-97b0-133055b5018e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_9fc8945a-aa81-4d89-9ea1-6e9b2877f448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c1a39357-c782-4da4-9876-df630621d498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c7bfeb-c696-4e56-97b0-133055b5018e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c1a39357-c782-4da4-9876-df630621d498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0bb07e7e-b067-4301-b76b-b96cb01ccbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c7bfeb-c696-4e56-97b0-133055b5018e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0bb07e7e-b067-4301-b76b-b96cb01ccbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesOperatingLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f41716e9-00a4-443a-b83b-70a227171f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f41716e9-00a4-443a-b83b-70a227171f4d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:to="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c597836f-3c65-4024-934b-cdb01175a980" xlink:to="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:href="cutr-20221231.xsd#cutr_AviClearRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3afe9b4-376d-4efe-a327-0b878cc31070" xlink:to="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_fb309357-741c-490a-8e32-3b30136f9fcb" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseLicenseFeeRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:to="loc_cutr_AviClearOperatingLeaseLicenseFeeRevenueMember_fb309357-741c-490a-8e32-3b30136f9fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember_35321441-433f-42ec-8921-a193fb7e3805" xlink:href="cutr-20221231.xsd#cutr_AviClearOperatingLeaseRecurringRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AviClearRevenueMember_81001ccf-50b8-4699-8183-abccb0bebb0c" xlink:to="loc_cutr_AviClearOperatingLeaseRecurringRevenueMember_35321441-433f-42ec-8921-a193fb7e3805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a5cc3855-e490-42d6-9105-9994339ec712" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7b30024-e42e-4e6e-9627-0eec4fb57350" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_9938045b-6a46-42b8-8d67-8e76f59ac633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome_f6f2b46c-6c3d-40b8-a64c-43b02ba25502" xlink:to="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_9938045b-6a46-42b8-8d67-8e76f59ac633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45fca11d-7d76-4e6a-8b8f-318f948ee295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_907bcfd4-95ec-448c-bbf9-d732f0162d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45fca11d-7d76-4e6a-8b8f-318f948ee295" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_907bcfd4-95ec-448c-bbf9-d732f0162d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_91412e98-28ee-4323-9856-e0efd5594e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45fca11d-7d76-4e6a-8b8f-318f948ee295" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_91412e98-28ee-4323-9856-e0efd5594e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_4c37939a-dbfe-4b4c-99ca-d1c13a749f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45fca11d-7d76-4e6a-8b8f-318f948ee295" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_4c37939a-dbfe-4b4c-99ca-d1c13a749f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9f421e21-4ffc-4448-8229-3dd8d863e595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9f421e21-4ffc-4448-8229-3dd8d863e595" xlink:to="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd5a0a2c-45be-448c-8775-54c1c6248e64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_bc813b70-7e5a-4e32-ada1-7cb4dc504fd5" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_bc813b70-7e5a-4e32-ada1-7cb4dc504fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_754d912a-c7d4-4263-b44e-1fe9f84b8207" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_754d912a-c7d4-4263-b44e-1fe9f84b8207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2029Member_76022fbe-d851-4e9a-a547-4d8f31187ce7" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_607ffbb2-da76-4837-ba09-c427770db9ad" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2029Member_76022fbe-d851-4e9a-a547-4d8f31187ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03d5e146-ffe8-43e6-817d-3a459d730e3b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_38ce7aa3-4bb9-4cfe-bf23-1f5e70322aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7951a1a5-9720-4614-b8c9-2649c11c8393" xlink:to="loc_us-gaap_ConvertibleDebtMember_38ce7aa3-4bb9-4cfe-bf23-1f5e70322aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_666168a3-2b41-44fe-81d1-a3622b964e97" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2f24826f-e20d-46a4-8a38-476dd0f23384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2f24826f-e20d-46a4-8a38-476dd0f23384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_46523bf5-03b4-47c3-b4ba-f40d6a319431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_46523bf5-03b4-47c3-b4ba-f40d6a319431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad948667-382f-47f1-91a3-7ec5c2bd9e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9b36259-67dc-4f29-af99-11344a43b54f" xlink:to="loc_us-gaap_LongTermDebt_ad948667-382f-47f1-91a3-7ec5c2bd9e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c427d5ee-8474-4853-a9fd-606c3cac8e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c427d5ee-8474-4853-a9fd-606c3cac8e56" xlink:to="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_99db58f9-5da9-4456-a751-3576d0a7ab80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_14336ca4-353e-4f65-95b1-cd6a42574d1d" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_14336ca4-353e-4f65-95b1-cd6a42574d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028Member_45d85b0f-f2b2-4117-b146-decbded0a6e9" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028Member_45d85b0f-f2b2-4117-b146-decbded0a6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2029Member_392c5530-3f13-4daf-b750-c2401a955b13" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2029Member_392c5530-3f13-4daf-b750-c2401a955b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_b6812f65-a58c-4f86-9e12-b789d1c45af7" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_b6812f65-a58c-4f86-9e12-b789d1c45af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_3c137d14-fd0f-487e-8532-ac03b9854c4e" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_3c137d14-fd0f-487e-8532-ac03b9854c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_22ce0bb7-7248-4387-8e9d-0b194db99ffb" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember_22ce0bb7-7248-4387-8e9d-0b194db99ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_1960f61d-4b63-4384-b4ef-cd8dac9db3a5" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember_1960f61d-4b63-4384-b4ef-cd8dac9db3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_fdc2006d-f906-4c4f-b86d-4590252cdb53" xlink:href="cutr-20221231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_fdc2006d-f906-4c4f-b86d-4590252cdb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_9a1020aa-8380-4678-b583-6ebcc51304dd" xlink:href="cutr-20221231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bf1363a-9ad3-4606-8a40-918b5ee3742a" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_9a1020aa-8380-4678-b583-6ebcc51304dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34bbea3d-c0e6-424b-b873-6f62628d71dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f4fd10fc-f5e4-44e5-936c-3c1014973f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ab01547b-e3ea-4f5a-bf7c-89d9161372c8" xlink:to="loc_us-gaap_ConvertibleDebtMember_f4fd10fc-f5e4-44e5-936c-3c1014973f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f63cc5a-b7e3-4966-a2e6-e7f2b8488429" xlink:to="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cfff1bf4-69e3-4f93-8db7-29e63cb5657d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c6b66a77-b532-4305-848a-f1328d2be459" xlink:to="loc_us-gaap_CommonStockMember_cfff1bf4-69e3-4f93-8db7-29e63cb5657d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9190fca4-1d37-48a1-9cb7-5453e57c68ad" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_VoceCapitalManagementLLCMember_554bfa1d-b44b-4241-931e-1593495d9318" xlink:href="cutr-20221231.xsd#cutr_VoceCapitalManagementLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:to="loc_cutr_VoceCapitalManagementLLCMember_554bfa1d-b44b-4241-931e-1593495d9318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_967cd654-9525-4f86-b4a8-c4ab9c34042b" xlink:href="cutr-20221231.xsd#cutr_SiliconValleyBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_9abe0560-80df-4a17-8c71-19edbf21fc71" xlink:to="loc_cutr_SiliconValleyBankMember_967cd654-9525-4f86-b4a8-c4ab9c34042b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_677a0b17-ecee-4813-9cc3-7c4fb14b0cbb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_20b8308e-0248-4e3b-abe5-90176e0e511e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_680fabcd-5b52-4092-9f65-abce7fd1156e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_20b8308e-0248-4e3b-abe5-90176e0e511e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c42a329-eb04-4c37-b072-681da86445bf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eb1f738a-a5e5-4cc1-ac4f-08cf549dd548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c38fb926-d54e-467c-bd8e-1a98a18ddc3d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eb1f738a-a5e5-4cc1-ac4f-08cf549dd548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c29fba58-dc6a-4fb2-aee3-523df0c32241" xlink:to="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_44847acc-af0a-4c44-a538-879fc6cfce38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_eef097f3-e923-4ae0-a1e4-8aaf7dad0ec7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_44847acc-af0a-4c44-a538-879fc6cfce38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f8cf156a-f85d-4b93-b0fe-8e01583ddfbf" xlink:to="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_d480a235-8add-479f-aee9-7f7fb329b445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b454c4dd-945a-4d69-9088-a6442f5a42e7" xlink:to="loc_us-gaap_PrimeRateMember_d480a235-8add-479f-aee9-7f7fb329b445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8057c2a9-2e48-4ca2-bf76-a212689ec556" xlink:to="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0d2b9049-8f6b-49c4-9b8c-54af836f89d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0d2b9049-8f6b-49c4-9b8c-54af836f89d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34d2da8e-b9ce-47d7-8c66-255a899fc9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_34d2da8e-b9ce-47d7-8c66-255a899fc9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc5edd23-e90f-4193-a194-987e8053c210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc5edd23-e90f-4193-a194-987e8053c210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d54e85b0-ca30-48b9-8f1f-7ddba5583bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_d54e85b0-ca30-48b9-8f1f-7ddba5583bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71060c6c-0b28-4f7c-8ad9-42a0038d98a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_71060c6c-0b28-4f7c-8ad9-42a0038d98a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_3f071f47-81e3-437c-80c1-9a06687c389f" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAdditionalAggregatePrincipalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount_3f071f47-81e3-437c-80c1-9a06687c389f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued_1ed88436-e68a-49ab-992b-68e5eef0e6a8" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtConversionConvertedInstrumentCashIssued_1ed88436-e68a-49ab-992b-68e5eef0e6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4fd6395e-4e99-4cfc-8e51-67cfb43a93b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4fd6395e-4e99-4cfc-8e51-67cfb43a93b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fb8365bb-4dc9-476d-b1e3-af75e4f60b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fb8365bb-4dc9-476d-b1e3-af75e4f60b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a8c0e310-3532-46cc-8f1d-6f8906a6f629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a8c0e310-3532-46cc-8f1d-6f8906a6f629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3f9bfe5a-5a04-4904-b949-3e3763984c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LongTermDebt_3f9bfe5a-5a04-4904-b949-3e3763984c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_ff5a7baf-9919-467e-bc6a-f34c8a850411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_SharePrice_ff5a7baf-9919-467e-bc6a-f34c8a850411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_992661d1-cd86-42f2-9919-d0d088883c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_992661d1-cd86-42f2-9919-d0d088883c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_5bc38552-db85-476e-afc5-5f6c8f467619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_5bc38552-db85-476e-afc5-5f6c8f467619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4d9d209e-0cbc-43f0-833f-04624c335e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4d9d209e-0cbc-43f0-833f-04624c335e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_9b4a1dc4-851d-461a-8a01-d2de4cfbc709" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger_9b4a1dc4-851d-461a-8a01-d2de4cfbc709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_f8f052a5-af05-45c7-9ef6-93b83ef8dee7" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdTradingDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdTradingDays_f8f052a5-af05-45c7-9ef6-93b83ef8dee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_853738e9-d3f0-4a8c-b62d-01288c0abb43" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays_853738e9-d3f0-4a8c-b62d-01288c0abb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_863e413c-7330-4b99-b559-abe1e0ed4d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_863e413c-7330-4b99-b559-abe1e0ed4d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_9ba80dc3-e953-4514-a94d-e89954dad1a6" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_9ba80dc3-e953-4514-a94d-e89954dad1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_2322df74-6244-4cb5-b315-858eaaefb473" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_2322df74-6244-4cb5-b315-858eaaefb473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6280a271-aeca-4da3-9e9a-e93342b27d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_6280a271-aeca-4da3-9e9a-e93342b27d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f2ab69f9-10d6-4786-8374-5b053cb2b1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f2ab69f9-10d6-4786-8374-5b053cb2b1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_c1490ecd-a016-4097-9645-adaa95177403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCapPrice"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DerivativeCapPrice_c1490ecd-a016-4097-9645-adaa95177403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_a95f3c87-cf10-4a31-8c0e-d7c74f13bfb0" xlink:href="cutr-20221231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_a95f3c87-cf10-4a31-8c0e-d7c74f13bfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_121ca18b-2c26-4d3c-a9b7-31352b038e2a" xlink:href="cutr-20221231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_121ca18b-2c26-4d3c-a9b7-31352b038e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f211c71c-7a8d-493e-9423-23ece9e08b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f211c71c-7a8d-493e-9423-23ece9e08b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4abf11c8-6ca3-4947-af69-fd2a8be0bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4abf11c8-6ca3-4947-af69-fd2a8be0bd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_388142df-0577-4364-927f-b253fd560c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_388142df-0577-4364-927f-b253fd560c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_1ccdd92b-f547-41ee-9523-3eb7b7281759" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_1ccdd92b-f547-41ee-9523-3eb7b7281759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8e02ea22-4b6f-402d-80d2-f6171841b58a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_8e02ea22-4b6f-402d-80d2-f6171841b58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_c23f26b9-1375-42de-b6ab-5f2e1cfbed27" xlink:href="cutr-20221231.xsd#cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts_c23f26b9-1375-42de-b6ab-5f2e1cfbed27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c91681f0-4033-446c-8deb-0bf9f46c9f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentTerm_c91681f0-4033-446c-8deb-0bf9f46c9f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3b1e8b76-1879-4792-b2c0-4177e56781a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3b1e8b76-1879-4792-b2c0-4177e56781a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_9a461fed-13ef-4bcb-b64a-42857205bcc5" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_9a461fed-13ef-4bcb-b64a-42857205bcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5de99ce-8e31-4861-ae63-8986bf94373b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f5de99ce-8e31-4861-ae63-8986bf94373b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_cefbe276-f009-4086-b65d-259dad646ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_cefbe276-f009-4086-b65d-259dad646ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_ab0c62b1-00aa-407a-88c2-6fcad28c34c6" xlink:href="cutr-20221231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_ab0c62b1-00aa-407a-88c2-6fcad28c34c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_ec2339f7-7cc4-4ee5-b6ae-3cac15f9ffca" xlink:href="cutr-20221231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_ec2339f7-7cc4-4ee5-b6ae-3cac15f9ffca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d64dca-fd3c-4439-9b58-ae0a00ef57ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d64dca-fd3c-4439-9b58-ae0a00ef57ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6da115b2-e817-45bc-8b9a-9d299450dcea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_953d28dc-f568-4519-8123-798760b26fd2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6da115b2-e817-45bc-8b9a-9d299450dcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#DebtComponentsoftheLossonDebtExtinguishmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe7e7f00-040d-4ac0-8a4d-be71e5a75909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe7e7f00-040d-4ac0-8a4d-be71e5a75909" xlink:to="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7dc05296-3e53-49cb-bbd0-7294d162a136" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7936b1c6-d9a0-472e-9abd-e28f5d4a6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a91614bf-fb88-4363-91d7-6185e9df63f9" xlink:to="loc_us-gaap_ConvertibleDebtMember_7936b1c6-d9a0-472e-9abd-e28f5d4a6a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_de1c0279-13bf-423c-aef9-ed94a42e5d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3a4cd964-13d7-4067-afb2-f39911121cff" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_de1c0279-13bf-423c-aef9-ed94a42e5d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d61380ba-9971-4e26-8b8a-3968ebe25b2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_f64d249f-d532-41cc-a037-23502673eaf9" xlink:href="cutr-20221231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb7bbe11-246c-44c6-a628-9381cf874f28" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_f64d249f-d532-41cc-a037-23502673eaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48861cdb-18b4-42de-aac0-037363504237" xlink:to="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1b59095e-48e8-4310-8005-104d71c5e521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b53dbcb-07cb-4717-9ea9-885cb480c357" xlink:to="loc_us-gaap_CommonStockMember_1b59095e-48e8-4310-8005-104d71c5e521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfExtinguishmentOfDebtTable_285623e5-3a8d-4c51-b347-014a79679c43" xlink:to="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_edc3b320-7333-4f7a-987f-24644d611865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_edc3b320-7333-4f7a-987f-24644d611865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c03c9c58-9e4b-4428-befe-a06e321b30df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_SharePrice_c03c9c58-9e4b-4428-befe-a06e321b30df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_452453a0-77bf-43db-a67b-2bd589c42b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_452453a0-77bf-43db-a67b-2bd589c42b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentCashIssued_fdaf52bc-8814-49da-8a85-1b4745293bd6" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentCashIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionConvertedInstrumentCashIssued_fdaf52bc-8814-49da-8a85-1b4745293bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_f54c64e3-d2f2-464f-9bbf-f53ed27ffeb0" xlink:href="cutr-20221231.xsd#cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged_f54c64e3-d2f2-464f-9bbf-f53ed27ffeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_cf3ad190-1f8c-491b-97a1-7935bffc3012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_cf3ad190-1f8c-491b-97a1-7935bffc3012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionNetProceeds_5de4e05a-bb17-4d11-b000-00d11767daa1" xlink:href="cutr-20221231.xsd#cutr_DebtConversionNetProceeds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionNetProceeds_5de4e05a-bb17-4d11-b000-00d11767daa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_01b8ed60-e7e0-49e7-8de6-36dabfc374f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_01b8ed60-e7e0-49e7-8de6-36dabfc374f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionPercentageOfDebtConverted_9b80a7f8-e16b-4e0d-b236-410c0bd38f9e" xlink:href="cutr-20221231.xsd#cutr_DebtConversionPercentageOfDebtConverted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionPercentageOfDebtConverted_9b80a7f8-e16b-4e0d-b236-410c0bd38f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_c5f878ad-ed33-4413-99ba-21bdc0a66753" xlink:href="cutr-20221231.xsd#cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted_c5f878ad-ed33-4413-99ba-21bdc0a66753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_54e3024b-a954-47fe-b5b0-e8cd003cfa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtLineItems_9e02893d-a855-4ab4-8a68-759f4e364e16" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_54e3024b-a954-47fe-b5b0-e8cd003cfa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3550fa81-269d-4d84-bf05-b31fa6bdcb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3550fa81-269d-4d84-bf05-b31fa6bdcb13" xlink:to="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_051ec02e-812d-42df-bae3-bded057f33c4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_dfcce64d-11f7-4469-a95f-deb9fa4afdf2" xlink:href="cutr-20221231.xsd#cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:to="loc_cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember_dfcce64d-11f7-4469-a95f-deb9fa4afdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CashSweepInvestmentFundsMember_63081787-401d-4d2b-8f5f-c79cb2f22efc" xlink:href="cutr-20221231.xsd#cutr_CashSweepInvestmentFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d5ed966e-1ef5-4942-bbe9-6877d3da6ffa" xlink:to="loc_cutr_CashSweepInvestmentFundsMember_63081787-401d-4d2b-8f5f-c79cb2f22efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_09514d8c-1790-4c4d-bfc3-e05a97083d7c" xlink:to="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_c1b34db7-8cdf-4a81-bf4c-42cf94120fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:to="loc_us-gaap_CashFDICInsuredAmount_c1b34db7-8cdf-4a81-bf4c-42cf94120fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_c1ab6b1d-552c-4de2-a4a7-fc7d7d10cfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e24689b5-f940-4839-8f3b-35340f5b9bc3" xlink:to="loc_us-gaap_InvestmentsAndCash_c1ab6b1d-552c-4de2-a4a7-fc7d7d10cfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="simple" xlink:href="cutr-20221231.xsd#ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_e1ab9e90-b323-450a-be1d-119d9d12b398" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_e1ab9e90-b323-450a-be1d-119d9d12b398" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_8a1ca8ac-b666-4c39-9add-83f88ff9b12a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_adf6cce2-dd85-4821-90dd-dd4dc5c6ffcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_adf6cce2-dd85-4821-90dd-dd4dc5c6ffcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_95c00b94-8c26-4af6-a9b7-edec29c5fda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dac4f6e6-7749-4311-85fb-c2c89ec0de3e" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_95c00b94-8c26-4af6-a9b7-edec29c5fda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bfd48691-2579-438d-8eb9-dc586b75f8e4" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_127c3927-fa3d-4dff-8b88-5c76788ae8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_127c3927-fa3d-4dff-8b88-5c76788ae8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4ef8a733-ea9a-4764-b9f6-80d997709e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4ef8a733-ea9a-4764-b9f6-80d997709e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d0f9544-9fa1-4143-9147-3884f05bb569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5d0f9544-9fa1-4143-9147-3884f05bb569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_82415e84-bfdd-4dda-a171-f6fe5e8f69bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e2245afc-1d89-4f93-8adb-cc6ace4146b4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_82415e84-bfdd-4dda-a171-f6fe5e8f69bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cutr-20221231_g1.jpg
<TEXT>
begin 644 cutr-20221231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R(_X.9/\ @N]\2O\
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MF6ET.\E)FC0=2(+QF)/87T:C[M;_ /P>O?\ *-;X;?\ 9<K+_P!,VK4 ;?\
MP1U_X)J?L^_MV_\ !%7X9_$CXLZ_X\L_B'XJT;6#+\1M$^)&LV^IVMU'JU]!
M!<KMNA$YC2.,;'0HP0!@>M?._P#P:J_\%6OVT/B3^V%XK_X)W_M.?&#6OB1H
M5OX<O]1\/Z[XBU"2^O=+NK*XBB>,74I,LEM*DC861FV,D>S:&8'Q^+]L/_@L
M'^P9_P &[/P/^*7[,/COP@OPD\4V>MZ-JNLZ1X+F3Q!X/DFUB^CC,EW)=RQ2
M+._G!+E((3$[1Q_?,<C?;W_!H[^S)_P3UT;]D2X_:S_9QO\ 5=7^+&LP#0?B
MC/XDNHGNM"G1EE:RMHXT41VDQ6*=7.YI0%#/NB*( ?/_ /P>:6=Q^SOXB^!7
MQ*^ >O:MX*U?QG-XH7Q7<>%=8N+!=5: Z6\4LT<+JCRAKF<F3&]O,.XG Q]Q
M_LI?$&S_ &&?^#=K3/VU/AKX/CU/QQ;_ +.5OXKU#5-4>2ZN=5U5M.^T++=S
M2,998EFE+%"V%3<J[17Q'_P?+_\ (%_9E_Z^O&'_ *#HM?IG_P $W-0^$=C_
M ,$/O@=!\>?L#>#=0^ WA[3?$<6JPF2VGM;NP@MFBE4 YC?SMC9&,,<X&30!
M\*_\&^FG_P#!,_\ X*E_LXW7BK]L6YT?XL?M0W>M:E=?$"Y^(NHM/K=O&;J0
MVLNDAW#6MHEKY S9A!%('4[?D%?<'_!/7]CSXX_L?_MO_'S1/%WQB\>^._AQ
MKOA+P9/\*]3\=:U<ZG+HUM%/KXNM&6[N"S3&"22.0%F+^5<P;RS?,?R'_P""
ME7_!I;^U1^S/XXO?VD/^"5?C:_\ %.B:?>-J.F^$$U1K/Q-H)4EP+.X#*+T1
MX.TAX[C[JA96RQ^F?^#8K_@MO^U/^UE\3_$G_!.7]N>^O=6\:>%_#]Q?^'/%
MNKVAAU0BTFC@N=/U!2 9)XS(K+(ZB0^7*)2S8- 'EO[7'_!5#]I;_@LA_P %
MC?#W_!)']D#XW:]\.O@U;^,+K2?%OB3P;?M::GXB@T^.:;4[C[4GS1P>7;SQ
M01J=DA*O('WJB?I=\8_^"%/[!/BWX"7_ ,,_@A\,G^&GBZ'3'7PM\3O">L7E
MMKVFWZI^XNI;Y9?/N\. 769W#C=T.&'X)?\ !KYHFJ_"S_@OCH7PV^)\+VWB
M.QLO%>D75O=9\Q=1@L[CST.>=P$,V>_!K^KN@#\4?^#:O_@N1^T)\=_C;K'_
M  2]_;^\3RZ[X]T2*]'@SQA?N#>W[V)87>FW;C_7S(B22I,1O9(91(S,%)\
M_P"#E;]B?]H;X0_M3>)OC3^P%X@\9>'_  GX0^%NA>*OB+X<\+^+KZ*/3C=Z
MCJMG_:%M;))MA@0:?%YJQX";_-VA?,9?G/\ X)'>']:^*'_!T=;:U\,T>2RM
M?C/XTUB>ZMA\D6G*-39F8C@(RNL8[$RJ.]?T0Z5I.EZ]_P %9?B-H>N:;;WM
ME>_LS^%(+RSNX5DBGB?7O$JO&Z,"&5E)!!&""0: /EW_ (-X?^"S_A3_ (*O
M?LUW?[-W[2EY87/Q@\'Z+]F\4V-]&FSQ9I1 B&I+&>&8[A'<(!@.RN %F5%]
M:_X)L_LD_!CX5?MI_M3^)_#NE:A/<>&OB[8:9X535=:NKR+0[.X\*:-J4T%I
M'-(RVZM/J=U]P#Y"J?=4 ?BM_P %F/\ @FM\>?\ @@'^W;X:_P""AG[!%]>Z
M7\.M0\2&\\*7D"M(GAK4&#--HMUS^\M98_,$8<_O(3)$V6C+O^P?_!OY^VMH
MO_!1/P;\?/VRM"\)SZ$GC3XNZ9)=Z//('^R7EMX+\.6=U&C#[\8N+>78QP63
M:2%)( !^@U?@'^U?_P %3OVE?^"S'_!8[P__ ,$EOV1/C=KWPZ^"]MXNNM*\
M6>(O!FH-::GXCM]/CFFU*X^U)\T<!2WFB@C4['+(\@?>J)^_-Q')+;R10S&-
MV0A) ,[3C@U_*1_P:X:+J?PN_P""\^B_#?XFV[VOB*RTSQ5I-S;71/F)J$%I
M/YZ'/.X"&;/?@T ?O9\9_P#@A5^P;XN^ >H?#7X&?#-OAGXP@TMU\*?$[PEK
M%Y;:]INH*A\BZEOEE\^[PX!=9G?>"W0X8?$'_!M/_P %ROV@OV@/C-K'_!,/
M]OSQ-+K?C[1(+P^#/&%^P-[J#6187>G7;#_7S1HCRI,1N9(I?,9F"D_M;7\H
MW_!'WP_K7Q/_ .#H>TUSX9I))8VGQ@\::Q/=VX^2'3E34RS,1T5U=(QV)E4=
MZ /6/^#NN?6?V6?V^_ VG_LW>+==\"V'B3X7Q:CK&E>%==N;&SFNQJ-[$9Q!
M%(L:.41%)51G8"><D_KMK'_!*7_@FYXM^#G@70/'VD>,?#VN?$&QM=-T75]
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M_;-'\6)-IT?V35I[*Z:(78BQL4R!(Y&"@*LN[8%"J!^(/_!83]K/]L'XR_\
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M$XL]+L]XD-C9M(!(ZM(JO),X4R&./Y$"?-^B%% 'X6?\'#W_  1]_P""FO\
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MV2#2/BIIMM/:2PS^:CCS,JZD%P1E2.#D\BOK3_@HAHG_  6?_;NT#PW^S/\
M#S]B_P /?#7X;:OXOTJ7XH>(-2^*EA?ZC>Z1#>PS36L,,*J(D*IE\,[2J/+
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M7Q6\5?\ "1^.[GP_&Z:=9NEI!9VFF6/FX=K:UM;>*)9),/*_F2L%\S:ONU%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *QO&/Q#\#?#T:6?'/BRPTG^
MV]9@TG1_MUPL?VR^FSY5M'G[TC[6PHY.#6S7\^7_  =V_MK?M K\9OAMX6^
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M^T?X L=5L=1LI4TK5GM$:]T.Z9<1WEG*1NAE1L-P<. 4<,C,IX?X!>(? ?\
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M^:6;6KJWM&LX9O+?6@MLOD,=R R;I"6#(N(PG[5?_!"?XU_M6?\ !+GX7?\
M!,#Q)^W/X>TO1_AO)IZR>*[+X.S/<ZI;Z?:M;641A;6ML)5'8R,"_F,J%1$
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MTB3>R-&O*9\P#*G\G/\ @G;X]_X.?/A/\$]7'_!/CPJGQ)^&WB'QQJVK6?Q
MN='T^:+Q)>/.8KG4()M5,%W-'+)"2'E0$D'IT !^@7_!I/\ \$^_VL_V)?V4
M/'_C']J7PEJGA+_A9'B&QO?#?@K6XVAO+*"V@D1[N:!OFMWG,J+Y;A9-MJI9
M0"M?I3^U9\+=7^.7[+OQ)^"GAZZ6"_\ &'@'6-$L9W?:(YKNRF@1B>P#2 YK
M\XO^"*O_  5D_P""GWQF_;E\5_\ !-__ (*H_L[6?AOQGH_@-_%.EZO8Z,;*
M80)<00E9UCDD@FBD\_*31;0'B9#O+?)^K= '\O\ _P &?'C5/@7_ ,%<_&/P
M)^)UE)H^N^(?AMJ^APZ;?IY<\>J65]:7,MLRGD.L5M=%EZ@Q'TK^H"OSJ_X*
M'?\ !N[\%OVL/VD[']NW]EGXW:S\!OCGIVI1:D/&'AO3DN[+4+V+&VYN+1GC
M_?$ *TB.JR*6\V.4L<^G^$_@M_P7)U;0XO ?Q+_;F^ ^E6BQ"*X\:^%/@S?S
M:]*!P9$CNM2^P1RL.<FW=%/_ "S8#! /H7]J"]L[W]F?XG6UI=Q2R6W@C5XK
MF..0,8G.GR.$8#[IVNC8/.&!Z$5^&7_!EU_R1']KK_L'^'/_ $FUNOV]_9\_
M9'^%G[._P<U+X.:)=ZUX@C\17=U?>,O$'BO57O=3\27]U&L=S>7DYQND=$1,
M($1$C2.-41%4?F[^Q%_P;5_M$?L)_$OXH^#O@?\ \%+-1T#X,_%"&.VU_0M)
M\'0_\)!>6<7GB"V^WR.1:.B7,T;7-NJR.KL56%RCQ@'S#_P8V_\ (Y?M)_\
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MM] ;18->TCPPVB7"6R2B:UF$;W=V!=03!9%E#!"8TS'PVX ^;/\ @F-^QO\
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MB@T?[%9:<MW=?:KM;>(NS-)-,%9I3MPJA$11O+W?B5_P1E\0?#K_ (*83?\
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MP(!\?>"=*\-Q?\&:D]IH]G;M:GX#:A.Z*@*_:3?S22MC^]Y^]L]=W/6O#O\
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M6O@1J'Q4MX7E%]MTV\N;::==$OKS*A)SIU_*4FP0D5S:RL<M;A:_J?K\K?\
M@H-_P;1M^WS\"_@A\'=1_:L\+^#KWX-^%IM'D\3Z-\()YKK7C*R-)++YFM?*
M&=/.8.TKF>:>3S/WQ4??_P"QC\&OCI^SY^SMX=^#'[07[0EI\4=;\-V$6GP^
M,X?"CZ1/?6L2*D1N8FO+KS;C:OSS!UW\$H&RS 'J=%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-1AA&(;<ROA(+=/X;>!(H@>=F>:]?HHH **** "BBB@ HKPK_@H%^WW\./\
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MZ)IT]_XHM]-CT2[O-$M8BH,T\46IG>I#%_W!E*JC%PF*\A_X)Y?\%T_V8_\
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MT>[U.QT6YU*>VMI)8=.LGB6:Z=5)$49F=(P[$;07=%R1N91DC\]OC%_P<O\
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M /'K+NSC'R]<\?5E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB&WT?X>^"!J?V*W#37$=L+R]N-DA@MQ+(JC",SD.!@([IS?PF_X*P^.?!/\
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MCX0:[K^N?"37K+1M%TGXAZ?<75]<R6,JQPQ1),6D=F( 50220!7PW_P8T?\
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MABAF813!4\Z)HKB%U<HI^8J1E37X]?"OX^_"_P#;4_X)W?MK^.OV0/!OA/\
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MTC1M<2!$,L,L80F*0KS_ /P>P$?\.X_AD,_\UMM?_3/JE?=G_!$30-*\-_\
M!(G]G33M&M$@AD^$NCW3HBX!EGMUGE;ZM)(['W)H Y+]KG_@K._P[_;X\"_\
M$LOV4/AYIGC/XS>,;=K_ %FXU[4Y+71O".FI;R7)N+QH4>2:9H8F=+=-A(:,
MEU\Q SO^"?W_  5AN/VD_P!KWXL?\$YOVC?ASIG@[XT_".=IKN#0=4>[TKQ%
MI>8MM_9M*B2Q86XMRT$@+ 3H0S?.$_'OXH>)5^"7_!WYXH/[0OQ@\1_#S3?%
MOB;^S[?QGHFHQ6D]M;W^AQ1Z<5FGCDC6%G^S0.Q&%&[)7:<?L#\'/^"4_P"Q
M'^S/_P %&;3]LD?%_P ?:[\<O&6D7R>;XG\31W3ZK9Q6L-O/-)!#;H!'%&+9
M/,.U [0J27=0P!]IU_+K_P %:@/^(NW2>/\ FLWPO_\ 2/0J_J*K^77_ (*U
M$?\ $7;I//3XS_"_/_@'H5 '[H_\%F?^"DWQ%_X)4?LL6_[5OA3X#:1X_P!(
M@U^WTS7--OO%LNE7%N;@[8982MI<+*-P(8,4(RI&[D#XM^*?_!RA^VK#_P $
MWO#'_!2SX1_\$Q[.W\!7&JFP\5ZUXJ\>+Y$=P;Z6U1+"*.))[J'*1HUTR(JS
M2-&L<@B9Z]0_X.Z_^4-'B#_L?-!_]*&KXI^)O_*C_P"$?^PG'_ZG%S0!^OO[
M,7_!3_X"_M!?\$S=+_X*A>(5F\)^"9/"-]K?B&VOI1/)I;6,DT%Y "H!G*SV
M\J1D*&E^3"@N%KXK^"G_  6:_;P_X*0_LJ?&7]J7X&_L ^'?^%#^'[/6-#:&
M[\=2KXOU!$L2\UW:6_V<VDYACFCD>W:6/<28HI974U\U_#3PWXV\5_\ !D!K
M&F^ X9Y;J!;Z\O(K<'>;&W\;F>Z/'15@CE=O]E6SQ7MO_!M3X]\&/_P;M?$5
M&UNSM_\ A&KSQG'K\LTZHMJQL%N \A) 4>3*AR>,#VH \:_X,:/^0+^TU_U]
M>#__ $'6J^\O"'_!8'XT?MK_ +1OQE^!/_!,'X+^$O%>E_ FPQXH\;>.M=N;
M>TUW5V:=8M,TZ*VB8[7:UN%%W(VS,>1&RE&?\^O^#)JVUN_^&_[6&G^&+L0Z
MG-;>%4T^4MCRYVAUP1MGMAL'/M7D_P#P:20Z5K'[07QH_9%\>_M'_$#X8^,=
M3MK"_P!)TCPQK-M82ZG-827<5]!,MS;RF2:+SXV"+A@HG8@A25 /V'_8C_X*
MZZM_P4L_X)X:I^U[^Q-\"+#6/'WAZ>:RU[X4^)O%C6+1ZA#"LS6L5[';2A_-
M1XS!(T2(Y?:YB*OM^9_^"?O_  <]:O\ MN6WQEM/%/[,'A7X;:S\)O 5QXBB
MT+Q%\1;J6YUIX9?*DMD1-+#(RRF*(J \ADN(E2-R3CZZ_P""7?\ P3<_8;_X
M)GZK\2OA#^QOXG\0WEW?WFEW/C?3]<US[=_9]QY,S6Z!EB18I6BD+M'DOL:%
MB%5XRWX8?\%K/">E_L ?\%D--_X*H?LK?"]M7^&[?%>*35KF[LXSH^H>,-.D
MBGUBQ@.6W*9/F,Q VWD=X(_FM"5 /Z.?V3?'_P"TQ\4/@]IOCO\ :G^!FA?#
MGQ%JEK%<_P#"):-XLDUB33T= WE7,S6MNJSKD!EC#J"" [8S7IE<A\ /CG\.
M/VFO@EX5_:#^$.N+J7AGQCH5MJVBW:X!:"9 X5P"=DBY*NAY5U93R#77T %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?(_\ P4)_X(A?\$^O
M^"G7Q.\._&']JCX=:M=^(?#FGC3HM0T/7IK%KVQ65Y5M;CR_OQJ\DK*5VN/,
M;#8.!]<44 ?"GQ1_X-OO^"2GQ-^(7@3XBV_[/=SX4N/A]8VUIH]EX(\07.E0
M7,5O,TT1N/)8222B1W8W =9W+9>1B%QUG[>G_!$']B'_ (*0ZUX7U']IJ'Q?
M<V/@G2VT_P (^']#\2&PT_28'$2R"&&./@N((0Q)/$2 8"@5]?T4 ?%G[5G_
M  0>_8K_ &V? WP]^'/[2WBKXE>)-(^%^A-I7A&UF\9F/R(FVAI)"D0,TQ2.
M&,R/EBD*=]Q;V;5?^"?G[-_C+]BV/]@/XN:%J'CGX<Q:%#I$=EXLU W%TMK#
MM^S 7"!) \.R/RY01(OEJ=Q(S7MM% 'YW>'_ /@V-_X)SZ/\ M9_9GUKQC\7
M_$'@_4+A)M%T?Q#\17N;;PQ)]KBN9I-+MO*%O:RS&/RI)_*:9HI94$B^8Q/T
M[^PA_P $X_V5?^";?PYN_A7^R=X7UW1M&U"Z%U?6>I^,-1U&*6YP%:=8;F=X
M8)& 4,T*1[]J[L[1CW2B@".[M+6_M9;&^MHYH)HVCFAE0,DB$8*L#P01P0:^
M,_V8/^"!7_!-_P#8^_:"U#]H;X%_#[Q'IMU?:E%J*>%9?%]W)H-M=PR-+;S+
M8[@DK02,SPB;S1 Y#1A&52/M"B@#XC^)O_! G]B'XM_MC']OGQCXJ^)C_%5-
M=M=7L_%%OXT,;6=Q;!%MA%$(O+6.-(XT6/:5*KA@V3EWQU_X(&?L/?M%_M>K
M^W5\3/$?Q*F^)EOK=GJFE:_9>-6@_LR>T='M!;QK'LC2$HFQ<'[N6W$DG[:H
MH ^=O^"@?_!+7]C[_@IQ\)M+^%/[6W@B[U@Z#(TOA_Q+87OV75=,E=565XIT
M7;B0*N^-D:-BJDIE$*\=_P $\/\ @B9^Q-_P33U5?%/P6@\7>(]>MK.6STG7
MOB!XD.I3Z1:RD&6&SC5(X+4.0-[1Q*[CAF(R*^NJ* "OF7P[_P $N/A?X9_:
MINOVT;+]HCXQ2_$._P!(BTG4=5N?&J/;W6G12>8EF]IY'V<0ARS!%C&UG=EP
MS$GZ:HH *\@^"'[$'P-_9JL?BAIWP!LK_P )0_%CQ;=>)M>CT:>.-;#5+BS@
MMII[)3&1 6^SK-M(<"5W( 4A!Z_10!\W?L;?\$O_ (*?L+>-/$?C3X(?%CXG
M3-XQUV?6_%^G>)_&3:G;:SJ4R%'O)Q/&7\XY4F1&5F*)N+!<5J?M[_\ !.;X
M(?\ !2'X>)\'OVDO%?C!_!_G07%QX9T#6DLK:YN(79XYI&6(RLP+=-^SY5.W
M(S7OM% 'Q]^R)_P1'_9 _8:^'7CKX1_LY>*_B-I/ACXBZ+=Z?XET&[\7?:[1
MVGMVMVNHXYHF6.X6-L"0#G:H8.% $GPB_P""+G[,_P"RUI:Z-^P]\6_BQ\#[
M66*,:K9> _&HNK35)40)]IGM-9AOK83E5 ::.*-VP,G@5]>T4 >&_LI_\$]/
MV>/V1O&'BCXM>"X-<\1_$/QPR'QE\3?'&L-J>NZNJ!1'$\[ +#"@1 L$"11
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M^)_A_P"''>26\U3PGX@DBUF\FESY]Q-J$HDG>>4D%I]WF_*H5E"@#Q[XC?\
M!"[]C3XM?L<^&/V"OB%XH^(>I?#'PAK<FJZ)H<_BE/-CN&WE=UP(/.=4:6X9
M06)S<R9+#8$^S** /"_V"/\ @GQ\$_\ @G#\*)O@;^SMXF\82>$6NVN;#0?$
M_B%M0ATR1V9Y?LV]0T2R,Q9D!VELL &9BWNE%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !4=W=VFGVDM_?W4<$$$;2333.%2- ,EF)
MX  !))Z5)7R%_P %X_@%^TI^TY_P2F^+7P7_ &3OM<_C'5=+M7BTK3YO+N-6
MLX;R&:[LHVR"6EMTE0)_RUSY720T =EIO_!7#_@FIJGQ.E^$MO\ MH^ DU-(
M+22"[N-<2+3;PW,ES%#';W[XM;B1GM+A?+CE9@4QCD5WW[4O[9?[+G[%'PM_
MX71^U/\ &W1/!GAIYU@MM0U2=F-W,REEB@BC#2W#E06V1JS;5+8P":_$+_@D
MK_P4[_9!_;@\:^//V#_^"G'@W1/AUJGC'X&^#OA+9:-JUJUO8ZC>:'<:\I8>
M:@73+P?VE:F*-R-L\#>6RMY<=?L'XX_X)=_L>_&V3P?-^TY\+=.^)R^!O MM
MX8\-Z9XSLH[O3;!$ $]Y#:."B75P$@5Y3N*K;1"/9\Y< Z7]CC_@H%^QM_P4
M"\'7WCO]CSX^Z-XWL-+G2'54L5F@NK%W!*>?:W"1SPA]K;2Z -L;:3M.,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%H?V5OV@_B9X#_X)G_\ !/K]CSQ%X+\+^']$U+6?%VM^,-0@GN)+6*$AKDM
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M?^"B'_XFMVB@#PS_ ()]222?!+5!(Y8)XWUA$R<[5%P0%'H   !VKW.O"_\
M@GO_ ,D3U;_L>]9_]*37NE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%
M_P#!/?\ Y(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\
MD3U;_L>]9_\ 2DU[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4452TOQ)X=UN]O=-T77[*\N--
MG$.HV]K=)(]K*5#!)%4DHVT@X;!P0:3:3L)M)V9=HHHIC"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_^">_
M_)$]6_['O6?_ $I->Z5X7_P3W_Y(GJW_ &/>L_\ I2:]TH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]?$U/&FE1VRGQXFGZ?*(4 8L\=Y;,[-/:\\7 *LAW,1$<,?VE5510B*  ,
M< 4DT,5Q$UO<1*\;J5='7(8'@@@]14SX1IUH^UK8BI*NM54O;E?]V*T2[K\4
M1/@6E7A[:OBZL\2M8U7*W(_[L5HEW7W-'SA_P3V_X*:? S]O_P &;O#%RFA^
M,["V#Z_X,O;@&>'H#- W'VB#)QO !7(#JI(S](U^8O\ P4)_X(R^+? _C,_M
MC?\ !-.YNO#GBK2;DZA=^#M%F\@F09+3:<1@(Q&=UJ?D<$JF.(V]"_X)E?\
M!:#PO^TE>VW[//[5$5OX2^*%O+]CAN+B/[-::Y.IVE K8^S76X$&$X#-]S!/
MEKM@,ZQ.%Q*P&;)1J/X9KX*GH^DNZ_*Z1T99Q#B\%BXY9G:4*KTA47P5?1])
M=XZ:[6ND??%%%%?5'VH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'A?_!/?_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/
M5O\ L>]9_P#2DU[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%))(D2-+*X55!+,QP /4T +17R1^UA_P6I_8?\ V7/M.A6OCH^.
MO$D&5_L+P:Z7*QN.,3761!'@\, S.N#\G:OC:[_;5_X+'?\ !4NZET+]DOX9
MW/PZ\$7,AC?6],E:U01YP?,U68*SLO<6JH_JIKYW&\3Y;A:OL:3=6K_)37,_
MFUHO/6_D?*YCQAE&"K?5Z+=>M_)37,_FUHO.[NNQ^C_[3W[>W[)W['VGO/\
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MA?\ P3W_ .2)ZM_V/>L_^E)KW2@ HHHH **** "BBB@ HHHH **** "BBB@
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M!_>GV:Z-=F%%%%=IZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVE;"/Q1X0^&7A&[T#X.:'J0\VU\-0":]A34[.,Y6WU"3[&DWVM,3(SE5<*%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_ACG_@I=;77ASQ3I-P-/M/&6M0^23(,!8M1!X1B"-MT/D<$,^.96_3NOF_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\D3U;_L>]9_\
M2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***^1/V]?\ @LC^S'^Q4EYX+TF^3QOX]A#(/"^BW:^792?]/EP
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M2RD,>@^)_P +?AY\:? FH_#+XJ^$+'7=!U: PZAIFH0[XY5Z@^JL#@JZD,K
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >$_MU?\ !/?X"_M[_#W_ (1?XH:5
M]BURQB8>'O%UA$OVS37/.,G'FPD_>A8[3U!5L./SA^#G[3/[9W_!#/XN0?L[
M_M3Z!>>+/A)?W+G1KVS8R1I%N^:?3I7P%(SNDLY"N"<C9O\ ,?\ 92N/^.WP
M#^$G[2WPUO\ X2?&OP5::[H6HK^]MKE<-$X!VRQ.,-%(N3M=2&&3SR:^=S7(
MOK-98S!R]EB([2Z2_NS75>>Z\[6/E<[X;>,Q"Q^7S]CBH[26TE_+-=5Y[KSM
M8E^"GQO^%7[17PXT_P"+/P8\:6>O:#J<>ZVO;-_NL/O1R*<-'(N<,C ,IX(%
M=77XT?%+X _MJ_\ !"/XO3_'/]G36[OQC\'M4NT75K6[4M#Y9;"P:A&@Q#*,
M[8[M  20#C>8F_2K]B#]OGX"_MY?#@>,_A-K7V?5;.-!X@\+7TBB]TN4]F4?
MZR(G.V5?E;I\K!E5Y5GOUJL\'BX^RQ$=XO:7G!]5^*\]PR3B18VN\!CH>QQ4
M=X/:2_F@_M)_>O.USVVBBBOH3ZH**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN(_:1_:+^#O[)/P-\2?M'?'[QE#H'A#PGIYO-9U29&?RTW*B(B*"T
MDCR.D:(H+.[JH!)% ';T5\&:K_P6V\1^%-2\3>-?&G_!//XH6_PX\,?#?PYX
MXU77].U#2KS6--T75YM42&^N]+CN=R0JFF/*XAEFFB1F,D2;#7T%^U+_ ,%#
MOV;OV0OV;X_VIOBM>>)+GPQ<:$NKV:^&_"5[J-S+:M&D@D=(8RMLF)$S)<-%
M&I8!G!- 'N-%?,__  2G_P""EG@O_@JQ^S7J/[3_ ,//ACJGA31(/&=]H>FV
M.M7L<UU<1VZ0.+B01#9$S>=CRU:0+M^^V>/GO_@J=_P<4?#;_@FA^TS'^S#9
M?LJ>+OB=JL'AVUU/7+[PUJ"10Z9)<-(8[60&)R93$B3'H-LR=<G !^CE%?'7
M_!/[_@KWX3_;+_8N\;_MW_%KX%ZS\&_ O@B[O5N[GQ9J GDN+:SMDGN;I42)
M&\M=_EJ &+NKJHR,'S32_P#@X%\%Z)\)/A3^V!\</V;KOP7\ OC1XSG\-^#?
MB!<^+$N=2L)UDN$AN=5TQ;94L[:46L[AXKJY94C+,@XR ?HA12*RNH=&!!&0
M0>M+0 4444 >%_\ !/?_ )(GJW_8]ZS_ .E)KW2O"_\ @GO_ ,D3U;_L>]9_
M]*37NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445X-^VG_P4>_9?_86T!I_B
MWXQ%UK\T'F:;X/T<K-J-UG[K%,@0QG_GI(54X.W<1M.&)Q6'P=%U:\U&*W;T
M.;%XS"X##NOB9J$%NV[+^O+J>[3SP6L#W5U,D<4:%I))& 55 R22>@ [U^?O
M[=7_  7G^#WP6O9_A-^R1IMO\1_&KR_9DU& M)I%G.3M"AHSNO7S@!(B$.?]
M9D%:^;]3^(/_  5!_P""Y>O3>'?A_I1^'?P<^TF.[D$TD6GN@/*SS@"34I1_
MSR0"(,%W+']^OOC]A7_@E!^R[^PQ90:]X;T/_A)O&HBQ<^--=@5KA&(PPMH^
M5M4ZCY<N0<,[BOE7F>;9\^3+(^RH]:LEJ_\ !']7^#/BWG&><3/DRB/L:'6O
M-:M?].X/?U?X,^+/@;_P26_;1_X*'^/+?]I'_@IQ\4-;T?3)OWECX9=E34GA
M)W>4D&/*TR(\?+M,A(.44G?7Z>_ G]GGX+?LS> K?X:? OX=Z=X<T>#!,%C%
M\\[XQYDTC9>:0CJ[LS''7BNSHKV,KR+ Y5><$Y5)?%.6LG\^GHCWLFX;RW);
MU*:<ZLOBJ3?-.7JWMZ*WG<****]D]\**** "BBB@ HHKBOB=^T3\&_A!&Z^.
M?'5G;W*C(TZ!O.N6]/W2989]6P/>N+,,RR_*<,\3C:T:5-;RG)12^;:1U83!
M8S,*ZHX6G*I-[**;?W([6H=0U'3])LY-1U6^AMK>%=TL]Q*$1!ZECP!]:^4?
M%G_!0GQ_X_U1O"?[-_PGNKFXDR([J\MVN)\?WA!%E4QZLS#U%4=/_8]_:D^/
M]['KO[1/Q.DTZV+;UL))A<2)_NPQD0Q9'<'([K7Y?6\6*&:57A^%<#5S":TY
MXKV="+_O59I+[E9]&?<TO#^K@*:K9]BH82#UY6^>JUY4XW?XW75'L?B?]NK]
MFKPOJYT:3QRU\Z9\R?3+.2>%3Z;U&UOJI(]Z;9_MZ?LLW1 D^(\D!/03:-=_
MS$1%)X,_80_9N\)Z5]@O?!KZS,P'FWNK73M(WT"%57\ #ZDU9O/V&OV6;W)?
MX61H>QAU6[3'X"7%$?\ B.DU[5?4(WUY)>W?+Y<T=WW>U]M!R_XA7%^S?UMV
M^TO9*_G9[+\;%VS_ &Q_V9;X P_%W3ES_P ]HIH__0T%:EG^TO\ L^7V/)^-
M'AI<_P#/;6(H_P#T-A7$WG_!/;]F6Y)\GPUJ-O\ ]<=7E./^^RU95Y_P35_9
M\N<^1JOB:WS_ ,\=2B./^^X6JOKWC;1^/!X*I_AJ58_^E(GZKX85?AQ&)A_B
MA3?_ *2>P6?QA^$>HX_L_P"*7AR?/3R=<MVS^3UJV?BCPSJ'_'AXBL9\]/)N
MT;^1KYVO/^"8/PD?/]G_ ! \1Q>GG&WD_E&M95Y_P2V\-/G^S_C!?1>GG:0C
M_P I%H_UD\7J/QY%2J?X<5"/_I2#^Q?#NI\.:SA_BH2?_I+/JP$$9!R#T-%?
M(I_X)B>(]-.[0?CWM/4?\25XN?\ @,Y]J/\ A@C]HW3/^0#^T7MQ]W_3;R'_
M -!)H_UX\1:7\?AF:_PXFC/\D@_U6X-J?PL[B_\ %1J1_-GUU17R+_PR?^WC
MI/S:7^T=YJCHG_"6ZA_Z"T>*/^%/?\%(M(XLOBE]JQT/]N(^?^_J"C_B)7$%
M+^/P[BU_A4)_DT'^I.45/X6<X=_XG*/YH^NJ*^1?L'_!4O2.8+S[4HZ_O-(?
M/_??/Y4?\+"_X*::1Q>^"/M6.O\ Q++1\_\ ?IAZ4?\ $6Z-/^/DN80]<-I]
MZFP_XA[4G_"S/!R]*^OXQ/KJBOD7_AI/_@H/I'_'[\ _M6.O_%*W;Y_[]2>]
M'_#;W[6VE_\ (?\ V;MN/O?\2*_A_P#0F;T-'_$:.%(?QZ.)I_XL/47Y)A_Q
M#3B"?\*K1G_AK0_6Q]=45\B_\/(OB7I?_(?_ &?MN.O^ES0_^A1'VJ>T_P""
MINGL<:A\$YX_7R=?#_S@6JCXX^&5^6IC7!]I4JR_]QV$_"WCBUX8927E4IO_
M -O/K.BOF"S_ ."H7PY?'V_X9ZW%Z^3<0O\ S*UJV?\ P4T^ \Y"W7A?Q3 >
MY-C;LOZ3Y_2O0H^+_AK7^',J?SYH_P#I44<=3PZXVI?%@I_+E?Y-GT517A-G
M_P %%?V;KD S7^LV^>TVE$X_[X9JU;/]O3]EFZ($GQ'D@)Z";1KO^8B(KU*/
MB/P!7^'-,/\ .K!?FT<%3@OBZE\6 K?*G)_DF>PT5YG9_MC_ +,M\ 8?B[IR
MY_Y[131_^AH*U+/]I?\ 9\OL>3\:/#2Y_P">VL11_P#H;"O5H\6\*XC^%CZ,
MO2K3?Y2."IP]G]'^)A*J]:<U^AW%%<Y9_&'X1ZCC^S_BEX<GST\G7+=L_D]:
MMGXH\,ZA_P >'B*QGST\F[1OY&O4HYCE^(_A5HR]))_DSAJ8/&4?XE.2]4T7
MJ* 01D'(/0T5V',%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% %;6=&T?Q'I%UH'B#2K:^L+VW>"\LKR!989XG!5D=&!#*02""""#7
MY5_MO_\ !)?XU?L;?$<_MM?\$O\ 5]4L6TN1[K4O!VFN9+FQ3K)]F0Y^U6S
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M\6WL_P!LG\-&_DGM%F/S;KRX8^9>R9QE01'D$$RJ:^X/V9OV2/V??V0? R^
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MI"/_ "D6OJRBO+K>#'AC7^++8_*52/\ Z3-'=3\2N.*7PXV7SC!_G%GR*?\
M@F)XCTT[M!^/>T]1_P 25XN?^ SGVJ"?]F#]MKX*R?VS\)OBP^LHHR]G%J#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%%>J< 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M18BEUA6BJD7\W[W_ ),?(VB_M_\ QA^&6H)X=_:&^#<R2#@W,$#V<S =6V2
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?_!/?_DB>K?\
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M<<;\1YS3]C5K<E+94Z:Y()=K1W7^)L****^]/D@HHHH **** "BBB@ HHHH
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MYU'_ 'I-_==V7R"BBBO8/-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?AOL;P3\.-)L94^[=+:!Y_\ OZ^7/YUUE%?8Y'P%P;PY9Y=@:<)+:7+S3_\
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M"JW[++ &^L_&UKQR'\%7<F/^_*O^GX9J]!_P5+_8NE^6?QQXG@;G(F^&>OX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK]DO_@HY\+E^)_[+_P 3(-3\A$_MOP]>@0:KHTC#B.ZMB2R<@@2*6C?:=CL
M37A<2<$YAD5&.-HS6(PD_AK4]8^DEO"71I]=$VTS6CB857RO279GN=%%%?&'
M0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEU9^=C&M0IUU[V_1]4?DE_P2S_X.>/AM\:-=@_9C_P""D^B6_P *OB;9W/\
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M?%C]ESXGVVLP1*@UC1;C$.I:/*P_U5W;$EHFR& 89C?:2CN.:]KK\PQ>$Q6
MQ,L/B8.$XNSC)--/S3.V,HR5T[H****YQA1110 4444 %%%% !1110 4444
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MWF06&O6\6M64;CE50@P3QCI\S22$=<'I7[$T5GE'&W%>166"QDXQ7V6^:/\
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MX/[+\,\Y_P!TQM7"3?V:T.>%^RG#9><A\^,I_%%27EI^9^Z-%?@C_P -5?\
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MX@SOB"O[;,<1*K+IS/1>D?ACZ)(Z:=*G25H*P4445XYH%%%% !1110 4444
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MM/C3_P %?_VS]2TJ-G\U/#4.J+K&IP*W+11JC"PTX'MY/FJ#G,8K]//V(_\
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MP#HOAC0;!-ECHOA_2XK.UMU]$BB547\!6W117Y_.<ZDW*;NWNWNSKV"BBBI
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\D3U;_L>]9_\
M2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH **** "BBB@ HHHH ****
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M^PS]CU[PA\#8?&7BNUVL/&'Q"*:G=K(.CPQ,@M[9@<X:*)7&<%C7VF  , 8
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MAOP9H%WXJ\8>(;'2=+L(&FOM2U*[2"WMHQU>21R%11W)(%?F;^WC_P '57[
M7[,'VSP=^SBEU\:/%<&Z-3X>G^S:)!(./GOW5O.'0@V\<JMR-ZFOD3PU_P $
M=_\ @NE_P65U^T^)/_!3[]HR_P#AQX*DG6XM/"^J@&>).H^SZ+;-'!;-C*E[
MADG& 662OTR_8._X(.?\$X?V ?L?B+X>?!F+Q5XPM-K#QQX[V:C?I(/XX%91
M!:$'.&AC1\'!9J^M_L;@+A;7-<2\;77_ "ZH.U-/M*J]U_@LUV,/:8JO\"Y5
MW>_W'Y?_ -B_\'(W_!>GYM8GF^"7P<U7_EDXGT#3+FU;_8&Z_P!35EZ;MUNS
M#K'FOM;]@[_@UF_X)[?LJ?8O%_QYL[GXT>+;?:[3>*K80Z-#(.\>G(S+(.O%
MP\X/4!:_3.BO.S/Q&SO$89X/+8QP>'_DHKE;_P 4_BD^[ND^J*AA*:?-/WGY
ME30M!T/POHUKX=\,Z-::=I]E"L-G86-NL,,$:C"HB( JJ!P   *MT45\ VY.
M[.L****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !65XS\#>"?B/X>G\(_$/P=I6O:3=#%SI
M>M:?'=6\P]&CE5E;\16K151E*$E*+LT&Y\)?M+_\&W/_  20_:4^T:@W[.(\
M!:K<9_XFOPUU%M*\O/\ =M</9C_OQ7PW\1/^#2_]I[]GWQ++\2?^":W_  45
MO]$U1.;2VUV2[T6\0*<A?[0TUFWGT_<(,]^>/W1HK[7*_$7C+*H>SABY3ALX
MU+5(M=K3NTO1HYIX3#S=W&S\M#\"-2^%_P#P>);%_9+N?'.M/INH'"^/;;6]
M#!AMUX9CJR8NXNH;!(N#M^4$9!];_9(_X-&/ D_B ?%O_@I;^TMK7Q'\1WLP
MN=4T'PS?3PVL\Q^\+C4)_P#2[H'^\@MV_P!HU^SE%>AB?$_/WAW2R^E1PG-\
M;H4U"4GW<M6O^W;/S)6"I7O-N7J[GG7[-_[(O[,?[('@X> OV9/@9X;\%:85
M43QZ%IB12W17HT\W,MP_^W(S-[UZ+117Y[7KU\56=6M-RD]VVVWZMZLZDE%6
M04445D,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ=FFFFGV:>J9VIJ2N@HKXI_;Q_X+^_\ !-S]@G[;X:\6?%]/&OC*UW(?!7@
MQZA=1RCC9<3!A;VI!QN6202 '(1NE?FOKO\ P5@_X+U?\%I]9N? 7_!-OX!7
MWPO\ SS-;W/B?1Y?+>-,X;S]<N51(W4?-LM%CF&"!OK[+)O#[B'-L/\ 6ZL8
MX?#]:M9\D+>5]9>5E;S.>IBZ5-\JU?9:G["_MG_\%-?V'?\ @G_H;:I^U'^T
M!HN@WS0>99^&X)#=ZM>#^'RK.$-*5)P/,95C!/S,!S7Y/_&__@YG_;O_ &Z?
M'5Q^S[_P1M_8\UI+J?Y%\3ZGHZZKJT<9.!/]G3=9V"@]7G>9,=2M>D_L8?\
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MEKW>X4445\D;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!X7_P $]_\ DB>K?]CWK/\ Z4FO=*\+_P"">_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH \+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(G
MJW_8]ZS_ .E)KW2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_\ @GO_
M ,D3U;_L>]9_]*37NE>%_P#!/?\ Y(GJW_8]ZS_Z4FO=* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW
M_8]ZS_Z4FO=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P ,R?LV_P#1O?@?_P ).S_^-T >6?\ #VK_ ()T_P#1TFB?^ =W_P#&:/\
MA[5_P3I_Z.DT3_P#N_\ XS7J?_#,G[-O_1O?@?\ \).S_P#C='_#,G[-O_1O
M?@?_ ,).S_\ C= 'EG_#VK_@G3_T=)HG_@'=_P#QFC_A[5_P3I_Z.DT3_P
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M_1TFB?\ @'=__&:/^'M7_!.G_HZ31/\ P#N__C->I_\ #,G[-O\ T;WX'_\
M"3L__C='_#,G[-O_ $;WX'_\).S_ /C= 'EG_#VK_@G3_P!'2:)_X!W?_P 9
MH_X>U?\ !.G_ *.DT3_P#N__ (S7J?\ PS)^S;_T;WX'_P#"3L__ (W1_P ,
MR?LV_P#1O?@?_P ).S_^-T >6?\ #VK_ ()T_P#1TFB?^ =W_P#&:/\ A[5_
MP3I_Z.DT3_P#N_\ XS7J?_#,G[-O_1O?@?\ \).S_P#C='_#,G[-O_1O?@?_
M ,).S_\ C= 'EG_#VK_@G3_T=)HG_@'=_P#QFC_A[5_P3I_Z.DT3_P  [O\
M^,UZG_PS)^S;_P!&]^!__"3L_P#XW1_PS)^S;_T;WX'_ /"3L_\ XW0!Y9_P
M]J_X)T_]'2:)_P" =W_\9H_X>U?\$Z?^CI-$_P# .[_^,UZG_P ,R?LV_P#1
MO?@?_P ).S_^-T?\,R?LV_\ 1O?@?_PD[/\ ^-T >6?\/:O^"=/_ $=)HG_@
M'=__ !FC_A[5_P $Z?\ HZ31/_ .[_\ C->I_P##,G[-O_1O?@?_ ,).S_\
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M^S;_ -&]^!__  D[/_XW1_PS)^S;_P!&]^!__"3L_P#XW0!Y9_P]J_X)T_\
M1TFB?^ =W_\ &:/^'M7_  3I_P"CI-$_\ [O_P",UZG_ ,,R?LV_]&]^!_\
MPD[/_P"-T?\ #,G[-O\ T;WX'_\ "3L__C= 'EG_  ]J_P""=/\ T=)HG_@'
M=_\ QFC_ (>U?\$Z?^CI-$_\ [O_ .,UZG_PS)^S;_T;WX'_ /"3L_\ XW1_
MPS)^S;_T;WX'_P#"3L__ (W0!Y9_P]J_X)T_]'2:)_X!W?\ \9IK_P#!6_\
MX)SQLJM^U'HV6.!BPO#^>(>/QKU7_AF3]FW_ *-[\#_^$G9__&Z\5_:@^ 7P
M)TCXQ?!FQTKX*^$K6"^\:RQ7T-OX;M42XC^SL=C@1@.N><'(H U_^'M7_!.G
M_HZ31/\ P#N__C-'_#VK_@G3_P!'2:)_X!W?_P 9KU/_ (9D_9M_Z-[\#_\
MA)V?_P ;H_X9D_9M_P"C>_ __A)V?_QN@#RS_A[5_P $Z?\ HZ31/_ .[_\
MC-'_  ]J_P""=/\ T=)HG_@'=_\ QFO4_P#AF3]FW_HWOP/_ .$G9_\ QNC_
M (9D_9M_Z-[\#_\ A)V?_P ;H \L_P"'M7_!.G_HZ31/_ .[_P#C-'_#VK_@
MG3_T=)HG_@'=_P#QFO4_^&9/V;?^C>_ _P#X2=G_ /&Z/^&9/V;?^C>_ _\
MX2=G_P#&Z /+/^'M7_!.G_HZ31/_  #N_P#XS1_P]J_X)T_]'2:)_P" =W_\
M9KU/_AF3]FW_ *-[\#_^$G9__&Z/^&9/V;?^C>_ _P#X2=G_ /&Z /+/^'M7
M_!.G_HZ31/\ P#N__C-'_#VK_@G3_P!'2:)_X!W?_P 9KU/_ (9D_9M_Z-[\
M#_\ A)V?_P ;H_X9D_9M_P"C>_ __A)V?_QN@#RS_A[5_P $Z?\ HZ31/_ .
M[_\ C-'_  ]J_P""=/\ T=)HG_@'=_\ QFO4_P#AF3]FW_HWOP/_ .$G9_\
MQNC_ (9D_9M_Z-[\#_\ A)V?_P ;H \L_P"'M7_!.G_HZ31/_ .[_P#C-'_#
MVK_@G3_T=)HG_@'=_P#QFO4_^&9/V;?^C>_ _P#X2=G_ /&Z/^&9/V;?^C>_
M _\ X2=G_P#&Z /+/^'M7_!.G_HZ31/_  #N_P#XS1_P]J_X)T_]'2:)_P"
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M_P ,R?LV_P#1O?@?_P ).S_^-T >6?\ #VK_ ()T_P#1TFB?^ =W_P#&:/\
MA[5_P3I_Z.DT3_P#N_\ XS7J?_#,G[-O_1O?@?\ \).S_P#C='_#,G[-O_1O
M?@?_ ,).S_\ C= 'EG_#VK_@G3_T=)HG_@'=_P#QFC_A[5_P3I_Z.DT3_P
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MG_@'=_\ QFC_ (>U?\$Z?^CI-$_\ [O_ .,UZG_PS)^S;_T;WX'_ /"3L_\
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M /"3L_\ XW1_PS)^S;_T;WX'_P#"3L__ (W0!Y9_P]J_X)T_]'2:)_X!W?\
M\9H_X>U?\$Z?^CI-$_\  .[_ /C->I_\,R?LV_\ 1O?@?_PD[/\ ^-T?\,R?
MLV_]&]^!_P#PD[/_ .-T >6?\/:O^"=/_1TFB?\ @'=__&:/^'M7_!.G_HZ3
M1/\ P#N__C->I_\ #,G[-O\ T;WX'_\ "3L__C='_#,G[-O_ $;WX'_\).S_
M /C= 'EG_#VK_@G3_P!'2:)_X!W?_P 9H_X>U?\ !.G_ *.DT3_P#N__ (S7
MJ?\ PS)^S;_T;WX'_P#"3L__ (W1_P ,R?LV_P#1O?@?_P ).S_^-T >6?\
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MI^+?'OQ3\2)H7PY\"Z-<102ZI=M)#$7EGF(CMH$>X@5I#N.95PK?,5Y[3O\
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M7\5^"]5&E^/O 6OLAO=$NCO"Y9/EEA<QRA) %),3@JI4BOJ.@ HHHH ****
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M?M(? WQ*NK^%/&&DQZAHU\$*,T;9#(Z'E)$<-&Z'E71E/(H [>BBB@ HHHH
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MZ_#Z\T;1='\):/\ #CX*O?O&3=Z2A-[J=XBJQVI)>E=A(#%00:^SZ "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***^+_^"S_QF_X*D?!GX8^"]3_X)<?"C_A*
M]?O=>N(O%-O_ &%%?>19B$&-MLCJ%S)QD9KT,JRZIFV84\)"<8.>G-.7+%:-
MZRZ;?>1.:IP<FK^A]H45^$?_  W5_P '=_\ T9S_ .8]M/\ X_1_PW5_P=W_
M /1G/_F/;3_X_7W7_$,<Q_Z#\)_X/7^1S?78?RR^X_=RBOPC_P"&ZO\ @[O_
M .C.?_,>VG_Q^C_ANK_@[O\ ^C.?_,>VG_Q^C_B&.8_]!^$_\'K_ "#Z[#^6
M7W'[N45^$?\ PW5_P=W_ /1G/_F/;3_X_1_PW5_P=W_]&<_^8]M/_C]'_$,<
MQ_Z#\)_X/7^0?78?RR^X_=RBOPC_ .&ZO^#N_P#Z,Y_\Q[:?_'Z/^&ZO^#N_
M_HSG_P Q[:?_ !^C_B&.8_\ 0?A/_!Z_R#Z[#^67W'[N45^$?_#=7_!W?_T9
MS_YCVT_^/U]H?\$8/V@_^"TWQF^)WC33/^"H_P $/^$4T"RT&WE\+7'_  C4
M-CY]X9B)%W1R,6Q'S@XKS\UX"QN4Y?4Q<\9AIJ&O+"LI2=VEI&VN_P!Q<,5&
MI-146O5'O'_!6_\ X*$:'_P3$_82\8_M7WNCP:IJ^GQQ:?X1T:Y<K'?ZM<MY
M=NCX(/EK\TT@!!,<+A2#BO@[_@AQ^P;8?\%0_P!G>+_@J%_P5HU2]^-OBGX@
MZW?MX+\->,[EYM!\/:9;7,EK_H^F BV1I)X9B,H55%C*@,SL_LW_  =3_LH_
M$O\ :J_X))Z\/A3I%SJ>I?#SQ58^,;C2K*,O-=6=M%<V]SM4?>\N&[DG(_NP
M-C)P"S_@U+_:'\#_ !H_X(Y^!?A_H.L6\FN?#;4]4T'Q+8)(/,MW>_GO+=RO
M4*]O<Q8;H660 Y4@?"G2>KW'_!,<_!;]N?X*?'K]EGQCXHT3X;>'M4UE/&WP
ME7Q7=2^';22?0[^"TU6SL9Y3':R+)(+=T@4*PN5<(NV5F[7X'?\ !7+]AO\
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M#7XD^ OC'\/]&^*WPM\6V.O>'/$6FPZAHFLZ;.)(+RVE4/'*C#J"I'N.AP:
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MC_6S"_\ 0-6_\%O_ ##_ %XP?_0)B/\ P4_\S]9**_)O_AJ__@XR_P"C:_\
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M-+N,K2L9,A44?I]_P5P_9H\:_MA?\$U?C-^SE\-HS+XB\2>";A=!M@X4W5Y
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MO6]K/9>,M&\,ZA?PQQW$@BB,\=O \MOF5A"1(JE93Y;8;BOP\_X)MZ?IZ_\
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MM[/JE[/(XX4QP7B)@D9E9(_O,!0!_1)+%'/&T,T:NCJ5=&&0P/4$=Z_G-_;
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M9STK]K?XT?$J>/X;ZREI)I_B_0-"O-7LWBNE5K:4M912E8Y0Z;)" K%E .2
M?Y\?CMXR^!GBO_@@Q\?+7_@GUH8\#?L[Z3\<=-MK#3/&^M/JGBKQ=K;RZ>[W
M!!=8M+LX[98"D")-+*8G9Y$V.'^M?V\I7E_X,R_ #.Y8CP1X)4$GL-3M !^
M&* /T'TG_@N__P $P/$7QB^%?P&\+_M$_P!I^)_C%;V,W@_3[/0;PE$O?^//
M[7NB'V-IB5V1R[7PZ,RJC*Q['X[?\%5_V._V?_'WB_X:^(O$^O:[JGPXT*/6
M_B<O@SPK>:O'X.TYQE;G49+9&6#*!I/*!:81HTGE[ 6KQO\ X(-_LI?LXQ?\
M$H?V:/'.I_!#PGJ7B#2?"O\ ;VC^(=3\/6UQ?Z?J%X[O/<07$B&2&0@B/<C
M[$1,[5 'YK?\$%='^)?[2_[3O[=?[&?Q(_:0C\#>-/B+KE__ ,)EIFH>&8+^
M_P!:@:YU6SU'RVFD0QM;M=@$ -_Q\@XPIH _H ^&GQ+\ ?&7X?:-\5_A7XNL
M-?\ #?B'3HK_ $36=,G$L%Y;2*&21&'4$'ZCH<$5N5\Y_P#!*O\ 9%^'W["'
M[&NC?LG_  L^.5]\0="\':WJUK::[J$<:O%*;Z:2XM/W1*?N;AYHR ?E8,IP
M5('T90 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 $ C!&0>HKY*U;_@B7
M^P19_&34?V@/@GX4\6_"'Q=K39UW5?@UX^U+PTFIC=O*SVUG,MNP+$L0(QDL
M2<GFOK6B@#S#]G[]CWX$_LTWVI>)/AYH.IWOB36XHXM=\9^+?$5[K>N:E&A)
M2*:_OY99S"I+%(0XB0L=B+DUY)\9O^"*_P#P3G^/G[6,G[:?Q)^!DL_CJ]M4
MM]=GL?$5]:6>N1K&L06^M8)5BNE,:(CHZE)54+*LB\5]544 ?/7[&7_!*O\
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M -E>:>V_X3_]EK2OB1J,.RV67=>65JS7/VDV-VA8-#!(6CDD<B-HR OZ1_\
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M$%[)%C!#7L4ZW1)'!;S=S9.2:Z:B@#Y8_9%_X(K_ /!-O]@WQY>_$O\ 9&^
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M)ZGH7A&SE=[#0K_Q9J>K0V>]F=U@_M"YG:!"[,Q2,JI9F;&237I]% 'YF?\
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M@O6/@/=2?"G2[];Z/PM!XVUFV%U<J05EN9X+M)KH@JI42NZKL0*%"*!].T4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cutr-20221231xex1028four001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
MSC.!VSQGUK/USQ4NBWE[;FS,WV72)M4W"3;N$9QLZ<9]?TKG/"GA_5+?5-%:
M^LM4B&EVKQ%[FZMS"I*A=L2QC<RG&?FVXP.IK0\5Z#J6I:GJLUI;>9'/X<NK
M&,[U&Z9V!5>3W]>GO0!8A\6ZE;OI\FLZ$EG97\D<,=S!>"<(\GW XV*0"2!D
M9Y(KI[>[MKL2FVGCF$4C12;&!V.O53Z$>E<5+;Z]XAL=)T>XT"?3+2WGMIKJ
MXN;B%MPA97"HL;L22RJ,G&!FNRLY)9!/YMFUMMF95#,I\Q1T?Y2< ^AY]: .
M;L?&S7>I6:/IOE:??7D]E;7'V@-(9(M^[?'CY5/EO@Y)Z9 S3M+\9/J%SIKR
MZ8;?3=69UT^Z\\,TA"LXWI@;-RJS#D].<&N<TKPKJ,.IZ<SZ-)!JT-[)+J&M
MF9"MW"V[<!AB[;@5PI4!<>PS<TK1-;:U\,Z)<Z:T$6@,6>\>1#%<;(7BCV!6
M+<[PQR%Q@B@#4T/QG-K$+WTFG6]OI:1/.UQ]N5Y%C&2&:,+D9 SUJ;3/%=[>
M@S3Z%-';-:M=1&"8328 !"2( -DC Y"@MGD9S7,CPC<ZJ+"SA\-0^'C;V=S;
MW=Q"8O+F$D+1A(]C%F7<P?+@$;1W-3:)X>U2SN].GT_P]#I%WI^G307$TCQF
M.]F*J$!,;%G7<"Y9@#STR30!T^C^(KN\U@Z5J6E?8+MK47D:K<"8>7NVD-\H
MVL"1QR.N"<&F^'?%T'B'4M1LTMG@^S,6@D9\BYBWO'YB\<#?&P[\8/>N:GT_
MQ#+J%_J^B^'Y=)O9]/D@N%DGB_TFY=E"2#:Y!$?SMN."0< 5:MO!>H>&]3\/
M7FEZC>ZC'8C[!+;SB! EJXY(*HI)5E1N22<'')Y -+0/$VO:_:VE]%X>M8M/
MN&_UK:EEU0,06V>5R>"<9_&I-+\67&JWT!@TDG3+B1TBN5N T@5<XD>+'RQL
M5(#9)Y&0,U3\$>";/1M'TZXO=-6'6(@YD?S2Q#%F]"5Z&L/0_!EWIQT33H=$
M^Q76F73O/K:/%^_AVN  02[%@R JRX&WV&0#O]7O-2LX4?3=-BOF)/F"2Z$(
M0>N2IS7.V'C>]U+3=.D@T,"]U*646D#7>(WAC&3,9-F0IR,?*2=R]C4^L:#J
MP\(W^F6VJ7^IW%ZR0F6Y:)&BB=E60@HJ#A"Y[G/2I=:TZYL=6T+5=-TY[J'3
MHYK9[2W9%<12*F"F\JIP8U&,C@GTH J-XWN[@Z7;Z=HRS7UY)<PRP3W8B$$D
M!"NI8*V[GH>XP>]6-0\2:UI>G6\MWH-L+RZO8[2"!-0W*V\'YB_EC'3I@URM
MYX3U%Y-(O;[P[+J2M>7]W=64-Q$K0F=@8URSJ&( &<$\@U9U70)+WPY:VEEX
M*N[>"#58;J:QDN8"TZ $,01*1Z#!(H ZW1=?NK_5;W2M2TT6-]:Q1SE8[@31
MO&Y8*0V!@Y1N"!VZTGB[Q5;>$](^V2P/<S,=L5O&<,^.6.>R@<D_0=2*YW0?
M"]ZFJ:E+8V5YX5T^YMHT,23Q2RO.KY\P#,B+\OR^IST& :C\4^!M<O-.U"6R
MUV:^N9;-;5([JWB+LH;<0'&U5R>20!G:OH* .FU_Q5!H5[I]F;6XN9[RYAA_
M=H0D2R2!-[OC Y/ ZGZ9(KW7B/5V\1WVD:5HEO=_8HH9)99K[R?]9NP /+;^
MX>]2^(=+U"]TG2H$(NKB#4+.::0 1[ECE5G?!/' )P/PK/?P;:ZIXVUG4=7T
MY9K:6WM4M9#(1DJ)-XPISW7K^% $FJ^,KS2Y)XCHT<DUCIZZAJ"_; HBC)88
MC)7]XWR-UVCISS70W6J06NAS:NZR&WBMFN2%7YB@7=P/7':N(\3^&9;O6+UY
M_#TNLV\EC'!IC1SHGV)QNW9WNI7)V-O7)^7'89U;OPYXADT"<1>)KTZF^G>0
M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY\.:;/JT7E:C);1M<QXQMD*C<,=N>U<?\6_$VK^'O#BRZ&I:Y@DCNKEP?]7
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MF:UT:[\^X<S1J6!>-L*"V2<(>N.U>DJ2R@E2I(S@]10 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[P1C[L+&1QA?3('_ ([0![%1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGI\$-W(GEO,J_.RYS@GKC(J"X\(Z#<RW$DFF0@W1S<*A*+.?615(#_\  @:
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M4W\:7<U[X>M]/TA)AKE@]Y \MSY>S:J-M?Y3@?O!R,_2@#L*8LT33/"LB&5
M"R!AE0<X)';.#^5<C9>.C<Z1;O)IZQZM-J4FEK9B;*>>C,&._;G8%4MG;GMC
M-5/"B3)\3O&7VBU@MY3;V!;R&W+)Q-\W0')[Y].] '=E@O4@?6D#J3@,"?K7
M(?%6&*7X8Z^9(T?9:LR[AG:01@CWJ+1+?19[S2\>'38SVMK]K2]>V6+D (0&
M'7(<Y_#\ #MJ*XR3QXT.A6?B233U_L"YF6/SQ,?-CC=]B2LFW&TDC(!R 0>>
M14UQXRG@@\6L=-C,GAY0Y7[2<3KY(EZ[/E.#C&#SWH ZVFNZQHSNP5%&2S'
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M989$DC;HR,"#^(KDK'4M3U/QUXET>\M[232[6WM@J&0DX<2G)4KABV ",@
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M)XC1_+$USY9@=2 P;Y3D GJ/0\5%;?%N.+P9KVM:GIHBNM'O6L7MX9MRS29
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MPGJ&C6CPQR7D1B,DQ.$![X .?TK2L;:1=)AM;Q(BZPB*01L2IXP<$@'FKE%
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MD3F-I9(R@W  D<\]"*AM/'&E:I)<#2X;[4;:W8I+=6EL7A##J W\>/\ 8#4
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M''4]ZZ'Q+J$^GZ)*;)&>_G(@M47!)E;@$ D [1ECDCA33]#T&S\/6;VE@9A
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M !.<Y!P!TI-0^''AW4[+2K.YAN3;Z4 +-$N77RB,<Y!R3P.30!<T 7T(E;Q
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M)8 BW;SV5ESC^(8)Z#\J .HKB_!\K:EXF\:W%R-SKJ"V05NT4<2[1]"7<_\
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M:[KN@ZA91V^HZ/-LD>!RT4JY(##(R.G0^M<#KZ)J7[1!MK?5FL97TIH4NH)
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M],BO+-:U72A#<1VK0:>MEXJ@>:TY,JE9D4S.3]Q"!\H  QCDYQ73V5QIL?Q
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M:UI<1C-CL2-K4[-L@E 0';D8Y/)QWKU!F"J68@*!DD]!0!Q>A^(/$FN0:Y)
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MPXXB+$E@I_NDDD#MD]L 7\9HHH 3 '04CHD@PZJPSG!&:=10 $ ]11@>E%%
M!3418UVHH5?0# IU% ";5P1@8/48H95=2K %3U!'6EHH 0*H   P.@Q2T44
M5KZV>\LY+99VA$@VNZ?>VGKM/8^_:I+6U@LK2&UMHEB@A01QQH,!5 P /PJ6
MB@ (!!!&0:,#.<<T44 )@>@I&1'7:ZJR^A&13J* $9%=2K*&4]01D4A16385
M!7&-I'&*=10   # & *0@'J ?K2T4 )M!!&!@]1CK2*BH,*H48QP,4ZB@!JQ
MHIRJ*.O0>O6G  =!110 U41 0J@ G)P.IH6-$4JJ*H)R0!BG44 (B*BA44*H
M[ 8%+C/6BB@!IC1B"R*2IR,CI3J** &E$+ARHW 8#8YI2 >HI:* #&.E%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #719$9'4,C#!5AD$54L]'TS3Y&DLM.M+9V&&:&!4)'N0*NT
M4 9G_".Z'Y;Q_P!C:?L<@NOV5,,?4\<U+:Z+I5E.)[33+.WF"[1)% J,!Z9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#%&NGMI4A4@X(+E0HP>.30!T-%-1TDC62-E9& *LIR"#W!IU !1110 4444
M%%%% !16?K6MV'A_3FO]2E>*V5E0NL3/@L0!G:#C)(&3QS6A0 4444 %%%%
M!1110 44@()(!''!]J6@ HHHH **S[;6["[UJ[TB&5S>VD:231M&RA5;.T@D
M8.=IZ9J6]U*WL);2.?S=UW,((MD3.-Q!/) ^48!Y/% %NBBDR,XR,GG% "T4
M44 %%9U_KFGZ;>6%K=2LLNH2^3;8C9E=L$XW 8' )Y/:M&@ HH) &2< 4=:
M"BBB@ HHI 0>A![4 +1574M0@TK3I[^Z\SR($WOY<;2-CV502?PJRK!E##."
M,C(Q0 M%%9?_  D6E_V]_8GGR?VEY?F^1Y$F=F<;\[<;<\9SB@#4HHHH ***
M* "BBB@ HHK/U76[#1?LGVZ5X_M=PEK#MC9@TCG"@D @9)ZG% &A139)$BC:
M21U1$!9F8X  ZDFL:#Q;HMQ-;1I<R*;M@MLTEM+&LY/(V,R@/QSP3QSTH VZ
M*** "BBB@ HJHFI6\FJS::OF_:(8EF;,3!-K$@8;&"?E/&:M @C((/TH 6BB
MB@ HJMI^H6FJ64=Y8SI/;29V2(<@X)!_4$59H **** "BBB@ HHHH ***3(S
MC(SUQ0 M%%9]GK=A?ZM?Z9;RNUW8",W"-&R[=^=N"0 <[3R,T :%%%("& ((
M(/((H 6BBL^QUNPU'4M0T^VE=KG3V1;E&C9-A8$KU SD#.1Q0!H4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM.8PK*A)!VHB@'YCTJQK7A^#6[G39YKJYA;3KD74(A* %P"HW;E.1AB,<=:
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MGQ:OJR:;:W:7EK:"2,K;NK;@%8IN*Y[$F@#I=;L;?5-!U#3[N4Q6US;20RR
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M 2:;87.G6LD6A0WL+W=I;(3;^8/,$8 4,5ZX]Z?J^L6.A:<]]J%PD,"D*"[
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MOE&1U8Y%<'8&VO/ /@^)ITE>#Q.(!Y<A!1#<2@*,'(&T# ST H ]LW+@G<,
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M&W>&+Q6\9:50P5#<R@@D]C@9]>*Z76DB\'^+(=<TFQAFM==MA8;(4&W[4 3
M>.BN,J<<<*: /2*Q_%7B"/PQX;O=7DA><P)E(4^](W91_7T )[59T72H-$T>
MUTZW V01A2P4#>W=B!W)R?QK%U$W6L>)U@LA:2P:4FZ9;@G:9Y5( X[K&6X/
M_/4>E '0V%];ZGIUM?VKA[>YB66)AW5AD'\C4X8$D @D=1Z5YY\/IIM)@USP
M5=7$<-UH[L]JX.0+:4;T(SR=I)!_"L3PQ966NKX.(FT\SV"R/>3K=1NU[E2
M0 V\EFQ(=X!&#WH ]>W#.,C/I0&!) ()'7':O(;#2((O#7C76--M=^LZ=J6I
MK8RH27@^7!"#/7!/'T]JOV"Z/<^5KOA?689M2.ESK#:6,:*9?DROG*,G*O@
MGG<<=Z /3PP)(!&1U'I1N7(&1D].:\N\*1>'M:;PYJMKK43:BL+1RVMNB+--
MN3]XMP/O, 022W?G/(S@VNEZ>OPUT'44B5;V/Q (H[I7(D1&OG4JKYR 5)R
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MF&P99IS[NTA S@#IP!@8P,;DNF//XDM]3DD4PVUL\4,6.0[L"S'\$4#ZMZT
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MV1RH_E@=: .>U+QIXIOOAM)XBMK&PL;:XM8FCD%PSRJ7D"-\NT <-D'/OC/
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MV&E6MK/<R7,\4:K)/(Q+2-CEN?4Y^E6Z "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S=:T'3O$%O#
M#J,+N()EGA>.5XGCD&<,K(0P/)Z'O6E45Q<P6D#3W,T<,2_>DD8*H^I- & _
M@+PW)::A:M8/Y&H2++<HMS*!(RXP>&X/RJ3CJ0"<UH'P[IIUA-6,<_VY+<VR
MR_:I?]63DKC=CJ <XSD9JRNJZ<UC]M6_M3:9QYXF7R\YQ][..M/M]0LKN:>&
MVN[>:6W;;,D<@9HSZ, >#]: ,&;X?^&I]&CTI[!_LL4[7$/^DR[XI&))9'W;
ME))).#WJRW@_1'LK&T:UE\FQG%S!BYE#"4?QLP;+-R>6)ZU0UKQ4;7Q+H.G:
M?>6$R7EZUM=Q [Y8P(W8$8;Y>4QR*ZF42&)Q"R+(0=K.I8 ^X!&?S% &1)X2
MT2:;5)9K,S'545+U99G=90HPOREL# Z8 Q4-AX*T33KVTO88KI[FSC:&"2>]
MFE*(<97YF/' XZ56\%>*X]?\-Z5<:A=64>JWL)E-K&X5B Q&50DMCBM^;4]/
MM[R.SFOK:.ZE_P!7"\JAW^BDY- &/I'@?P]H6HO?:=8F&0LSJGG.T4;-]XI&
M3M4G)Y '!(Z5"WP\\-,LD8LYU@DN!=?9TNYEA64-NWJ@;:IR,\ 5=MO%VAW6
MH:C9IJ5J'T]E2=FF4 ,1DCD]L@'W..M:"ZKIS2PQ+?VIDG :)!,N9!ZJ,\_A
M0 Z\L+74-/FL+R%9K6:,Q21OR&4C!!JC:Z#9:2/M-I#-<7,,!B@-Q<O(RKUV
M*SD[02!D]\#.<"KK:GIZ0S3-?6RQ0MLE<RJ%C;T8YX/UI4U&RDL?MR7ENUF1
MN^T+*ICQZ[LXQ0!BZ!9WEYJ<_B'5M*CT[4)K=+5+?S5E>.-2S'<Z\'+-T'91
MW)%;&IZ99ZSIEQIVH0">TN$,<L9)&Y3[CD?44B:MILMFMY'J%H]JS;%F692A
M;.,!LXSGBGVNH65\TRVEW;W#0MLE$4@<QMZ-@\'V- &=%X5TB"_M;Y(KC[5:
MPM!%*UW,Q",<L#EOF)(!).3P*J_\('X>%M! MI.BP7+W<3I>3*\<KYWL'#[A
MNR<C.#FK7B[5;O0O"FI:M9K"TUE;O/LF4E7"C)'!&/K6%J/BW5M!T'2]=U".
MRNK&[:!9X[='BDA\W !7+,'P2..* -8>!_#HTV^T]=/*VM].+F9%GD'[P,&#
M*0V4.0#\N.:VX[6&*T%JJ9A";-KDMD>Y.2<]\]:BNM4T^QE2*[OK6WDDQL26
M94+9.. 3SS2W.IV%FSK=7UM R1F5A+*JE4! +')X&2!GW% &5H?@S0O#D[3:
M99O$3D(K3R2)$"<D(K,0@/\ L@4S2_ OAW1M2DO]/L6@E9F<()Y#'&S<,R1E
MMJDY/( ZU'X@\07-C=^&VTZ6UFLM4U!+:1L%R49'<,C!L?P>AZUOPWMI<RRQ
M07,,LD1Q(B2!BA]"!TH H6'AK2=-T^\L;:V?[+>O(]Q')/)('+YWGYF.,Y.<
M52C\">'HOL!CM)U:Q0QP.+N;=L. 49MV73"@;6R,#&,5NW-U;V<)FNIXH(@0
M"\KA5!/3DU&NIV#6D=TM];&VE8+',)5V.2<  YP3GB@#'C\#>'H=-M-/BLI$
MM;.Y^UV\:W4H\N4'(8$-G@DX'0>E6'\)Z/))JLC03%M60)>G[5+^]4+M ^]Q
M\O'&.*T;34+*_P#-^QW=O<>4^R3R9 ^QO0X/!]JYR\\5'_A-]"TC3[RPN;2]
M%P+E8SODC:--PY#8 )[$=J .DL+&WTVP@L;562W@01QJSLY50, 98DG\35*?
MPYIEQK\&N2PS'48$,<<HN9 %4]1M#;<'OQ6E,)3$PA=$DQ\K.I8 ^X!&?SKS
M_3/&7B&]^&X\9-#ICHD4L\MD$>,[(V8-MD+$9PA(ROM0!V-UH.GWNL6FK3Q2
MM>VBLD$BSR*$#8W#:&"G.!G(["J#>"- :QELS:SFWEO/MSK]LF^:?=NWYWYS
MNY],U?M==L+C0;+6)9TM;6[@CF1KEPF ZA@#DXS@U9.H60@AG-Y;B&<JL4AE
M7;(3T"G."3VQ0!5AT#3K?7)=9CCE%_+$L+RFXD(9!G VEMO&3V[FLNZ^'WAN
M[-\);.80WT@FN;>.[E2&23(._P M6"AB0,D"M?\ MW1_($_]JV/DLK.)/M";
M2JG#'.<8!X)[5)/JVFVIB%QJ%K"9@#$))E7>#TVY//X4 .NM/M[S3I+"82FW
MDC\M@LSJQ7IC<"&_'--72K1-(&EJLGV,1>2%\Y]VS&,;\[NGO3WU&QBN3;27
MENEP%+F)I5#!<9SC.<8[TQ=7TU[87*ZA:- 7V>:)E*[O3.<9]J ,F'P-X?M]
M.L+"*UN%M=/G%Q:Q_;9\12#."/G[9/'3DU9;PMI#7.IW!AG\W5$$=XPNI1YB
M@8 QN^7 )'&.M7Y-3T^&^2RDOK9+N3[D#2J)&^BYR:3^U=.^TK;?;[7SVD,0
MB\Y=Q<#)7&<YQSCTH Q+OX?^&[VVTZ&6RE7^SH_*M9([J5)(X^FS>&W%<=B:
MOGPQI!O=.O!;,DVFQM%:>7-(BQ*P 8!0V#D 9R#TK2NKF&RM)KJYD6."%&DD
M=NBJ!DD_@*SM.U@3Z-%JU^\-E;7*K)$LS!"B-]W>2<;B""1VSCG&2 5)/ _A
MZ73+O3Y+)WM[JY-Y(&N)&83DY\Q6+95L]U(I%\#Z"#>L\-U*]];BUNI)+V9G
MEC&>&8OD]3SUP<=*V!J5BUB+X7ML;,\BX$J^6><?>SCKQ4EM=VU[")K6XBGB
M)P'B<,N?J* ,Q?"ND+/I<X@G\S2D*69^U2_NE(VD?>^;CCG/%5IO OAVYT^_
ML9[!I;>_N/M5PLEQ(Q,W'S@ELJW Y7'2MN>]M+5U2XNH86<,RK)(%)"C)(SZ
M 9-5AKND-#;S#5;$Q7+;('%PF)6Z84Y^8^PH SO^$(T$Z*=)>UF>T,JS/NNY
M2[NI!4L^[<V"!C)P,"KG_"-Z6=5FU-H)'NYK;[)([SR,&BY^4J6VXY)Z=S5J
MXU33[.XCM[F^M8)I,;(Y9E5FR<# )R>:>M_9M>-9K=P&Z49: 2#>![KG- $&
MCZ-8Z!IT>GZ=$\=M'PBO*\A Q@#+$G    S@ 563POHR76I3BR#-J8/VM'=F
MCER I.PG:"0 "0!G S6G;W5O=HSVT\4RJQ1C&X8!AU!QWKF[KQ)-I_CUM+O;
MBR@TD:4U[YLGR,CB54PSEL8Y/8=: -/3?#>FZ5)#);QS,UO$88#/.\ODQG&5
M3>3@<#IZ =A3]=\/:9XEL/L.JPR3VVX.8UG>,$@@@G8PS@@&K;7]FED+UKN!
M;0J&$YD 0@]#NZ8IUK=VU];I<6EQ%<0/RLD3AU;Z$<&@#-A\,:9#>V]WF^FE
MMF+Q?:-0N)E5B"N=KN5S@GG'>F1^$M&AN))([9UCDN/M3VXF?R3-G._R\[<Y
M /3&1GKS47BSQ-!X;LK5FEMUN+NZAMHA,X 7>X4N1D$JH))_F,YJ31=2F9+Q
M=2U72KGRG\R*6T?:?((!#2*20#G/(.",&@"O?> _#FI2ZA)=6+M_:!5KE%N9
M51W&,/L#!0_ ^8 'WJW'X6TF*^N+V.&=;BXMUMI7%U+\T:YP/O8&,GD<\FKK
MZMIL<4<KZA:+'*K-&YF4!PH))!SR  2?I64?%VE7E_=Z7IFI6<M_%;+.OSAT
M.X,5'!&[A<X!Z$'O0!J:3I-EH>F0:;I\316D"[8HVD9]H] 6)./QK%C^'WAF
M%852PD"6]R;J!/M4NV*0YSL&["J=QRHP#W%.\'>)X]>\.Z1/>75HNJ7EHMP]
MM&X#8/4A"2<5MOJ>GQWRV+WULMX_W;<RJ)&[\+G- &3)X*T&;3]2L)+69K74
MIC/=QF[F_>N<9)^?(S@<# X%277A'1[S4X=2DAN%O(XO(,T5U+&TD?\ =D*L
M-X_WLUHMJNG+<BV:_M1.9/*$1F7<7QG;C.<XYQ5EY$BC:21U1%!+,QP !W)H
M I:+HMAX>TJ'3-,A:&TA&(XS(SX_%B35!O!VCM'<Q!;N."ZD>6X@CO)5CE9R
M2V5#8Y).0,9[UIV^J:?=P2SVU_:S0Q?ZR2.965.,\D'CBFIK.ERS>5'J5F\O
ME"?8LZD^61D/C/W<<YZ4 9NL^#-!UUK-KRR*R62[+>2VE>!XUZ;0R$';CMTI
M=3\&:#J]I8VUS9%5L/\ CU>"5X9(>,':Z$,,CKSS6I!J=A<V)OK>]MI;0 DS
MQRJT8QU^8''%,35],EL6OH]1M'M$)#3K.IC!'8MG% %*\\)Z->Z99Z?);/'!
M92":V,$[Q21.,_,'4ALG<<G/.3FJK^ O#DEG?VC6,GD:A(LMTBW4J^8RXP3A
MNORCZD9.:V[?4+*[GG@MKNWFFMSMFCCD#-&?1@#D?C7.:[XJ-EX@T&PT^\L)
MA>7_ -ENX<[Y8QL=LC#?+RF.0>M &S>^'].U"XT^>ZCFDET]_,MF^TR HV,9
M.&^8X)'.>IJI>Z5#I$^I:_I&D/>ZO<!2]NMT8UG887.&.Q6V_P 6,D#&>:U'
MU/3X[Y;%[ZV6\?[MN95$C=^%SFL?QGXC7P]X<U&ZM[RQCU&WM7GAAN6SYFT$
MX"A@3G&.* +/A[3'LTO;ZZM8K>_U*?[3<1QD-L^4(J[AU(51D],EJMZAH]GJ
MDUI+=+,SVDOFP[)Y(PKX(R0K '@GKGJ:ETZ=[K3+2XDQOEA1VQTR5!-32RQP
M1-++(L<:#+.YP /4F@#.UWP[I?B2VAMM5@DFBAE$R*D\D6''1LHP.1VKCM;\
M.3W7BJYN;OP[J5[ 8HH;6[TS5?(<(H)(E#2H6.YFY^;C'?.>X36=+DE>)-2L
MVD2(3,@G4E8R,[R,\+@]>E/AU*QN+'[=!>VTMG@G[0DJM'@=3N!Q0!AZ5X1M
MHUTV[U$W4U_I[2FU>2^ED:%'/W"V1OXP"6!Z8Z"I=4\$>']9UA=5O+)C>;!&
M\D4SQ^:@Z+(%(#CV.?3I6U:7UI?PF:SNH+F($J7AD#KD=1D=ZYJZ\5$^.=$T
MBPO+"YL[R.Y-P(SODC:-01R&P =W0CM0!<UCP5H.NW]O?7MFWVN!/*2:"=X6
M,?\ <)0C*^QJV/#>E+JL.II;O'=P6WV6)HYY$5(N/D"!MH' [=A6;J'B7_A'
M_"VKZQJ-[87?V5YS MLVP-C)2(DD_/@8./RJ&QU#7;C4;&8ZUH$NEW)4@(K"
M9VVMOC3YR#@[2#UZY% %S_A"- _LG^R_LL_V+[1]J\K[9-_K=V_=G?G[WS=<
M9YIMSX%\.W>N'6);%OMCA?-*SR*DVW[OF(&VOC_:!]ZV9-3T^&]CLI;ZVCNY
M/N0-*H=OHN<FLKQ=X@30/#VHW,-Y8Q:A!:27$$-TW^L*J3C;N!.<8XH G;PO
MI+WFI79AF\_4XUBNV%U*/,0 @# ; P">F.IJ(>#]#6/2HQ:2!=*4I9_Z1)F-
M" "A.[+*0 -K9''2M'2+J2^T6PNY<>9/;QROM&!EE!./SJVS*BEF(50,DDX
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ML<>G2NBO=2L--17OKVVM5<X5IY50$^V30!:HI 0P!!!!Y!%+0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7)>/M1L]-M-'EO8H]AU2(1W,[,(;5P&(EDP1D#& "0,D9(KK:,9ZT >
M&:G<V+^!O'UO-<+-)_;B31F5-A.[[/A@,#&<,1CJ 3SR:Z#7"L'C?5X/#AMX
M[V7PG(+9+8J"THD)3 '5L'(_PKU.B@#R%-;T"]3X;FPG@\RTNQ%+$/\ 66Q^
MSNK(XZJ=P'7KC/->O4@50<A1G.>E+0!XCH^F:=>_#?PU::?#;CQ1!?PL/+4"
MX@99LR-)CYE C!SGC[H]*T#<:5>SZ_X9\37^H0ZC)JLD\-E%&H>Z4R;H'B;8
M6.%"K][C;S@5ZZ% )( R>I]:-H+!L#(Z&@#@M!2QN/&OCG1[P*SW<T),##EX
M3;(I;_=SD9Z9XZURZG6-.TG3M1DMIGE\$W1LIB$RUY QV-M^D)C?W)]J]FI,
M#GCKUH \V\1RR^&YO"^H:G-/:6!FN)-1N8$5Q!<2J"K-E6^4$N@.. 16?J$F
MFZ-INGZUI5UJ$GA]M<:[O[Q$5QEXF7SE79M\L2%2<+C(R.0#7K) (((!!Z@T
M8&,8X]* /'O$L7AN3PCJ6I:;=O>17VJV4KW4VT1R2"5 YC 51]P?,5&/?(-=
M/I+:?;_%[4[>Q-M'')HUL3'#M 9EDD[#N%*_@17=      #L*6@#E?B3-%#\
M-_$/FR(GF6,J)N.-S%2 !ZD^E<!XB72V\%Z#=^'M1DO_ !+:_9GL;-;MKQ6D
M^4,&B9F50 6^; VXZBO::* /(/'>I6LB>-]/*I9W_P#9<1E4AI)+W$;,#&#P
ML:9() SG))7&3IVTNC7_ ,4=+N)3:2J_AQG+R!?F;S4P3GJ=NX@^G/2O3,#T
MHH \*AN0_P /_!MKIVHVMM>)K]PL#N0PAYN0C%<_=&Y/;D5Z3X"UJRU'29+(
M1):ZM9RM%J-J7W.)@<,^3RX8\AN<Y]17644 <AXXU*RTZ\\.F\6*+??GRKZX
M9A#:N(G^9@" Q()4 G&3GM7G<T^GR>$M1M[B5)'B\8A@9T",$:X1B<$#&5R2
M !Q7N>,T4 >0>(_,BUGQW:^&_+2[ET*V,<5K@,Q#2!MH7^((>W/(]JT&USP]
MJGC7P#<Z/<6SPI%=1!8L9A!A4+&P'W3GC::]/I J@\*!]!0 V::*WA:::1(X
MD&6=V  'N37A6@P>&KSX(1PWNK2)?K'.Z6L=\[,91*YC7[/N*MGY?E*X.<^]
M>\44 >7Z7J.J6GB3PG?^+(TLXIM$> ,ZA(X;PLI(;LC-&N ..<@>E8>H6EI!
M:*]QY TF?QE#+8"3&WR25\UDS_RS+;NG'?H:]K90PPP!![&EH \WU;2_#R?%
M#PY8_8M-6"2PO-T B0*[,T9&5Z'/SD9Z\TVTET^RU'QOI'B'R(!<,&MDE 59
MK/R0B)&.X4AA@=&/J:]*I"H)!(!(Z>U 'EJVFK^'O#?@GQ%=VT]QJEA$EC?0
MJ,R/#, H4^K*_E?CFK?A/3-0T_7+GPI>Q;[*RN%U9)E7$;"7)$8'8"<2,/\
M<%>D=:,<YH \@M;C2M0_M+PUXDO]0CUA-6EN([&-%5YSYI>&2)MF[&W:,[N
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MD<<\K[5>DUSP[JOCSP/<Z3<VLEO]EO(OW6/W:F--L; ?=(Y^4]*]-"A0 H
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M(/F;"]F'M6G)J^D:W\0=(DM;F"\M9=!NHMZC?&[%XCMST)X.1V[UZ8%"C"@
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MGTFS-[?F':!%'@' W$;FVG.!V[]JI7/Q3TFST[0-0GT_44MM<E$=LP6-RN2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 9D_A_3)[Z6],#Q74P42
MRV\SPM* ,#?L8;L#@9S5VTM+>QMDMK6%(8$^ZB+@#G)_7FIJ* "BBB@ HHHH
M **** "BBB@".>"*YA:&9 \3<,AZ,/0^H]JD P,"BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ(7=@JJ,DDX %1P7,%S")K>>.6(_QQN&7\Q0!+14$%Y:W2,]O<PS(IPS1N&
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MQQ[5;DGT;4K&^UWP;K-S?:TFBS110VPB41IMRHD1$4A@WW0><]!C->I16\,
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MFN#:W$1<D;B!;D!<]<9XQ39H[ ^ _B59I';F]BO;^3RE4;T3"E3CJ!Z?I7L
MM;<$$01 CH=@XIXCC!<A%R_WCC[WU]: /+KO6M&@\3Z4;W4X;/0;G2/+L[I5
MB-L9]Y\U2SJR@E=GIT(]J982:7X>\0>$K-[R=O#*VET+"YOV&TW!<;26P!CR
M]P3..&XKU"2UMY85AD@B>)<81D!48Z<4Z:"&XC\N:*.2/KM=01^1H XCX92V
M!'BJ&PD@,2Z]<.J0L,!65,$ =CSCM5>YCT__ (6IKT4BVVR7P[&TZL%PY\V3
M)8=^-O7MBO04C2,$(BJ"22%&,GUIC6\#,6:&,L>I*C)H \<T*#3;/P_\+KZ!
M+:*\ENECDG7 D=3!(&4MU(R%&.W KM/BLD1^'U[)*BE8I[9RS#.T">/)]N,Y
M]JZ[[+;\?Z/%QT^0<5*Z*Z%'4,K#!!&010!YY(FB:I\6+6-ELKJS_P"$>=HT
M.UHS_I Y Z$8R1^=<KH.KV^GZ#X*EU"_:UT13?VYN5"-'#,)B(=Y96"C8' .
M.,^E>TFV@+;C#&3C&=@Z=*1K6W:%H6MXC$WWD*#:?J* ,'P38Z58Z/<+HEY/
M=V$MW+-'+(RF,EL%A%M 'E[LXP,9S7/V6K:=9_&;Q%]JO[6#.FVJCS9E7)!?
M(Y/7D?G7H:JJ(%10JJ,  8 %1&TMF))MXB3R24% '!^,/$%K>KH]Q:W$=SH=
MMK4,>ISQL&B VDKN(X*JYC)/0''H:RO$LEI8:SXPO4A>XT&31HOM\5K)L5[E
MI"H^9>A\O&XC^'!.>*]4$,0B,8C01G@J%&#^%-CMX(8/(BAC2'!'EJH"X^E
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MU0Y,;@ E3[X(J<00A5411@*=R@*.#ZCWIR1I&6*(JESN8@8W'U/Y4 .HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9XSO$?G -C& W[L'CC/8CBNG\&W^H37GB'3-0O7OCINH>3%<2(BNT;1HX#!
M%R"Q&0!0!U54[;5+*\O[VQ@N$>YLBBW$8ZQEEW+GZBG:E?Q:7IES?3 F.",N
M57DM@< >I)X ]37E]G)+X7\;Z+JT]M=0+K:FQU9Y8BJ&Z=C)$P/?YBR#T7%
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M2SWME?VFX0WEC/Y4JJWWESR"I]"*!X1L5O\ 2;Q+F\672Q)Y&90VXR?ZQG+
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M;TLT4$9DFD2.,=6=@ /Q-(\\4<)F>5%B SO9@%QZYH YRP\#:=IS:(;>[O\
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M\P,-N/7- '-P^ ]*M],T>QBN+Y%TB1GM)5FVR(&!5E+ #((8CU]ZZCH*B-Q
M$D<S1A(SAVW#"GW]*<LT30^<LB&+&[>&&W'KF@#!?P7H\LFL^<D\MOJY+75J
M\I\HL552P7LQ"KSVQQBK&G^'+>RN;:YFN[N^GM(C#;27;*QB0XSC:HR3M +'
M)XZ\G.HMS \ G2:-H3TD# K^=(;JW"RL9X@L1Q(2XPGU]* %NK:*\M)K6= \
M,R-'(I_B4C!'Y&N9M?#'VKP4?".J//\ 9H81:>?$0#/ .$YP<': &'7(.."#
M73R3PQ0^=)*B1 9WLP"X^M+YL>U&\Q=KXVG/#9Z8]: ,#4M$?5KW1[64R-8Z
M7.EV\DF-TTJ*1&HP!P"=Q..JJ!GG'15GZEKFG:3HUSJUU=1K9VZEGD# CCL/
M4D\ >M7D=9$#(P93T(.: *#Z'82>(8]<:'-_';-:K)_L%MW3USGGW/K5#_A"
M]%'A&;PNENR:9*&RB/A@6<OD'U#=/H*VVN8%G6!IHQ,PRL98;B/8=:'N8(Y5
MB>:-9&&51F )^@H Y^+P58Q:A)J!O]3DO)+/[%)-)<[BZ9)!((QD;CVQSG&>
M:NVGANPM/"P\.?O)M.%N;7;,06\LC;MR .U;%1"Y@9U031EWSM4.,MCKCZ4
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M$211*,*B*%4?0"@#B?$>K6FE_$;1_P"WI8H='EL)EMY;@@0K=;USN)X#>7D
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MJ:.=;>2T1=H-R8XMK*N3P<^N,UV,$C2V\4CQ-$[H&:-B,H2.AQQD4 24444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445Q7C?QY/X/U71+)=)CO!JT_V>)S=F/8V5'S
M#8W'SCIZ4 =K17(0>.DM_&47A;7+#^S]0N8_,M)$F\Z"X'/ ;:I#<'@J.GN,
M]?0 4444 %%%% !117*P^*-5N_%FK:#;:19E].BBE,TM^RB02 D<"(X/RG-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?<(V@#=@8/6L[0/#^H>']7\$VMS!<3#3=*N8+J>.-G2.1S&0NX#D?*P_ >M
M'9VOBG2+W3+74+6X>6&ZE:&%5A?S&D7=N79C<"-K9!'&#6AI]_;ZG9K=6K.8
MBSI\\;(P96*L"K $8*D<BO-+/1?M.ARVNI:?K-LS:]=W4%W9QNDUKO9VCE7
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MSOI4<-Q;W&F60!FMQ*ZNL@53AF)3Y@#QGOC- '6?\)OX=^RV-S_:'[J^F:"
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M\6G4FA$)#M;F=F#*IQG@@XZUZ!::_P#:/$,FCRZ;?6TBVPN$FF0>7(/EW*K
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M/$9E7RFQL!P26Q@<GH3FL_Q;XCC\*^';C59()9_+*HB1H6^9B%7=CH,D9/\
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M&U&<#:"=R]^,C.,T[4_%6CZ.9_MMRR);E!<2+$[I 6QMWL 0N<CKT!!/!S7
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M:(EH/(8^<PMO+(!QC[W'Z].:I06U]HVIV-[?>'=2U/3[W2+2U=;:,F6UFA#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8K:"YDUK3D@N#B&5KI LI]%.<'\*)O$NA6]TUK-K.GQW"KN:%[E X'J03G%
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M'T^9CCN0*ZV.-8HUC0851@#.>*I:OHFF:_9?8]6L8+RWW!A',N0&'0CT/N*
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M-[0Z-9?9WN/M31^2,&7.=_UY/YU;CT;3H=3;4H[2-;UHQ$TP'S%!T7Z#TZ4
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MKP%7<1S(?NL%Z=0-N!@9KLXO#.BP/8/#IMO&VGJ5M"BX\D'KMQTSW]>]/L]
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M1+'R;-BUNGDC$9/WL?7 SZ]ZD_X130!8FR72+1;?SS<!$C"XE)SO!'(;W'-
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M>PWB-#%*8)/E(=90<>64(W!\D#;C/(XK,U7Q+I-SX?NYX/$*Z9Y4RP/<&/\
M>0R;@=AC<9#$<8(S@YKGO$1EN=/L-?TKP_?"SM]5%W=6\$3075TAB:-I0@P^
MX;A@'!(7TQ5+Q%:VE_X$U^[T70M5674)+7+303O<7+)(ISL;+ *HZG&>?09
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M";<+G$F 3@'&,X&<=<<UQFARS#QQI>IM9:N]L^@R0-))I[Q+'()(V\L)M&P
M XXYQP6-4=,M+N#P)\/;9M,U!+BSU:.2YC^Q2[H5 E#,PV\#YEY]Z .J^(?B
MI=&\):Q)INHM;ZE:19$D</F+&YP0K$J54D$8!P>1ZBNQB):%&)R2H)KQ_4/[
M0MO GC/PU=Z7J,NK3W-S- \5I)(ETDC[E=74%>!Q@G(P!7KEG)YME!($=-R
M[9%*L..X/(- &.FM:?;ZQK<D_B")X;**(SVK!0MG][DL!DEL=">-OO4MCXMT
M'4KV&SL]2AEN)H?/B10?G3 )()&"0",CJ.XKD[V.X_X2/Q^XL;YDN=)@B@=;
M20K,ZQR@JA"X8Y=>GK4-E!<1W/PR_P")??*+.U=+D_8Y (";;9A_E^7YN.:
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MO0=^^.,@'9T@(;."#@XXKGSXECO[FTL-,M5N[BZL1?%)I/+2.%N%W$!CEB2
M #T/3'.5\*1CP41Y/D8U"\_=<?)^_?Y>...E ';4A(! )&3T'K7.>/=9OO#_
M ()U35-.CC>Y@BRID; 3/&[H<D9SCO6!JDEW!\3M"NDTR.349=)NU:*.8;3A
MXL9<@<8]N_0T >AT5R=IX[M+G0+*_E@6UNKJZDLA;3SJJI-&7#AI.FT>6QSC
MGCC)Q5[PWXE3Q VH0FW\FXL9A%)LD\V)P1E7C? W*1[ @@@B@#>HKD+[QG?Q
MZSK&EZ;X;N;ZYTR.*5L7"1B17#'C.>?EX'4^V*6#QRFI:39ZCI6G236UQ8O>
MM-<R>3%&%8*8R^UAYF[(QT^4G- '426L,MS%/(NZ2')CR3A21@D#IG!(SUP3
MZFIJXU_'WFQ>''T_1KFZ.O0/-;CS43:5CW[6R?P)Z?7I2:/XDUZ_\97^GW>E
M16T-MI]O.;<7(:1'D\PD9"[2<J%Z@<9SS@ '9*P894@CU!I:X?0/%6D6OA#2
M9K+3X=.2_N)XK:SEG"(C+)(7+/T ^5CP#RP S4L/Q#M&LW:>WCM[A=1&G?O+
M@?9RY4LKB;;RA"G!QG/&!0!V=(""2 1D=1Z54TVZN;NU:2ZM/LLJR,A3?O!
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M%QHW]HZ<UK::PPCM)A,'*R,NY$E7 VE@#C!89&,UKZOJ4NF6T3P64UY--/'
MD<8.%+'&YR =J#J3@XH T**Y%?'UG'HFMZA=6Q5M(NA:2QP2B59'.S9L; X)
M=1R!@YSTJ2;Q?<VNN7FD7&C2-<VUC]O+07"LC1<C@MM.=RD8QZ&@#JJ*XRQ\
M>/<:+;:O>:.]E8WD5N;.66Z3$LDO\!_N@==Q[<X[4^'X@6:_VHE[ D4MB\*J
M\$XEAN/-(5-DA"C.XX.0-O7IS0!V%%<YHGBM-5UR\TB2WC2>"%9UFMI_/AE0
MG'#X&&!ZJ1W!YJ37?$4^DS3I#IIF2WLVO)9YI?)BP#@('VD%SSP<<=^: -^B
MN73QI;W9TB.QAC:XU2Q^W6\5U.(=R87Y <'<_P W3V)S706\\UQIT5Q]G,<\
MD(?R)&P58C.TG'&#QTH FWJ'"%AO(R%SSBLD^'HCXM'B+[9<_:!:?8_(^3R_
M+W;O[N[.1US7!Z/=VKZ?J/B'Q%IT4US9Z[.MI-%,3,9O-\J.)>%^7D+R<$<D
M"NTB\0;_ !"/#NK6"6]Q<VS3P%9?-BG0'#KDJIW#(R,=#UH WMZXSN&,XSGO
MG&/SIU>,V%O%_P *O\$MY:[HO$400XY4&\<'%>AW?BB42:L-,T[[>FDD+=D3
M;&+[0Y2,8.Y@I'4J,D#/7 !T=8^G>'HK#5KK49+^_O)IF<QBZFWK;JQ!*1@
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MQQ3W4)2-Y,[0V01G'..*S_[&UVX\7Z1KEQ'IRK:V,UO-''<.3ND9#\N4Y V
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MR-B15QEE!8.,>F>U:?B&PFUK5/%6J:0CS6D_A>6R)B4XN;@[R@7^\57C(_O
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MR:?!8&RNH)I/"T42W$-HTDMTX5@8"=I"!3U! .6ZC'(!Z<VMZ6E];6+7]O\
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M<6\J30RJ'22-@RLIZ$$=14E9'ABPL],\.6=IIUC+8V<:MY-O,S,Z*6)&=Q+
MG.<'D9QVK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1&F1\[X'3@<CGFHX_'7VW4K.RTS1KNZ>]TW^T8&=TB!7<J[6R<J06YSW' -
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8]._HH Y1=%U76-6T*_UN*U@?2?,D(MY3()IF39D94;5 +'USCTYL>,-%O\
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MZH\*Y#DJ_E%"H? !P3][D@'IV.B:)?IK_B6_OHH$L]9,+QHDI,B!85C(8;0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&5.*WZ\^TCQ[X3T;P?HLMA!=PZ/<7(TZPVP$EB.-Q'7&<^Y()Q7H- !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M H"*#D*,_2G44 -,:$,"BD-]X$=?K3@,# Z444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;(C(QR,C&0>#P:3PUX@CL_!7AB%UEN[^XTF&81*ZAF41IN8L[ =6 Y.23['
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M=6YR#G!&0<\XK<L-+U>#QM;ZK/IQ%O'H:V3&.9&_>B3?@9(.,<9]?;FNSHH
M\HT[PIXET;2O#M[!I-O>7NFK=6UUITTZ 3132^8&C?E0P(7K[BNBU31)];TF
MUMM7\-02V\LK2O;6DZK+9M@!&23*9;@Y(QUQR!SVM% 'G3^$[^\T#2]-\06-
MUJK6XG:.]BND2\M#O'DXD++EMG#$$C*CJ.:[#PW:ZE9>&]/MM8N?M.HQPA9Y
MLYW-[GN<8R>_6M6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6XB@0D!F*H C.!CY3DY/;IG(ALO$>O7-QH>B:C:0Z;K5Y#-/>$8D6..-@H*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%<7<)XT6PU$16EI+<+J.^ &]9/M%L6) SC]V0-@P.NUO7) .THH&<<]:*
M"BBB@ HHHH **J:HMX^DWB:<Z)?- XMWD^ZLFT[2?;.*Y^S7Q0U[HANK&".T
M:W=+Z-;YV:!^<$'&9,C YZ$D^AH ZNBOG:/Q%>1_\+'6X\3:G%>:;?&+1X_[
M0D+9$D@"*A8[P=J@Y!P*]1T+QC>P:#X=L]<LYYO$VHVS2FSB14?:@)+ON("9
M ''J< >@!W%%<1=?%/P_;:5H6I[+R6SUF7R8)(XU/EN#M(<;L@@YZ ].,\4V
M]^*&G:9I,&HZAHNN6L4VH'3T26U59-X&0VTMDJ><$9Z&@#N:*X.3XI6$4^MV
MKZ)K O=&C\^YMO+CW"+;N,F[?MP!@XSGG@'G%'Q)XLT[4XO!&HP:CK5E;:E?
MQ-!]C" 2DD#RI@6!QD\XW#KUXH ]*HK@-)\>:AJ?Q!U_14T6[:UTN)$"QO#N
M+G<2S%G'##:% S[XSQ7\'_$T:MX1U7Q/K5K+9:=;SR,DN49 @*A8QAMQ?)[J
M 2>#VH ]'HKEH_'VDI_:2ZC'<:=+I]HE[-%<!2QA8<,-I.3GY2.N>.XKA]6\
M87VI^/O ,]BFK:;8:HSN\,TP"7,6%*$JKD="3@X/(]J /8:*XOXH^,I? _@J
M;4K5%:]FE6VMMXRJNP)W$=\!6/U I^A>%9F\.6\U]K>KRZQ<0+)+>"]D&R1A
MGY8\^6%!/ VXXYH [&BN3'B5= ?1_#5PMQJFOO8B25("N6"+AI&+D#YF!QW)
MJK>?%/P_:>%=-\1JE[<Z??W MD,$2EXY.?E=2P.?E/3/3W% ';45R%E\0K*\
MN=>LQI>IQWVBQB6>T9(_,D0C<"F'P>.<$@\COQ5C1/'%AX@T;2]4T^SO7@U*
MX:WB4B,.A7<27&_@ (QXR>G'(H Z>BN2/Q$T<7>T)<&R_M$:6;X!?*%SC.WK
MNQGC=C&?;FJ5Y\4M,M=4U?3(]'UJ[OM+=%F@M;99&8,?O+M8_*.,YQU% '=4
M5P.B^.M0UCXA:]HBZ/="TTV.-!M:+<'.XEVRXX(V@ 9]\9X\]U?Q).GP5CU7
M1/$.ORRKK/E_:KR4QSX.24^1CE>G4]<].E 'T!17)1>,[/4=9U#PU<6E_INI
MI:&XC2<JIEC(^\C(QP1Z9!'X''*_#7QLUK\,-,O]<O+N_OKV_:SMU9_,EGD9
M\*H+'I[D@ 4 >KT5D:#XBM/$"7HMUDBGL;E[6Z@EQNCD7Z$@@]00>:\\O;Z_
M7]HBQT==2OQILMB;A[47<@C+[7YV[NG XZ<4 >M45Y_??%K2;(ZX#I.KR_V'
M,D5\4BCVIN8J&!W\C(Z=>>G!QL:CXXTVVN-&LK:"ZO[S68O.M+>VVJQBV[BY
M+,H48]\T =117D7P^\9_V?HWC/5O$&HWK6.G:HZ1BZD:22-,X6, DG.<#&>M
M;OBCQ<EWX4\56< O=,UG3=/^T[&<)(H9=R.K(Q[\$9X/!]P#T"BO-?!OQ CA
MT;PEIVN0Z@MSJULJV^H7&UDN)0!D$[BP))&"P&<U<\.>/;O6?&WB73I]-FM]
M/THQQ&5GBQ"0)"[R'=GYMH "[L8YQ0!WU%<II?Q TG5;S385BN8(M529]/GF
M50EP(C\^,'*\<C<!D?E7GWQ'^(4FJ^#(=4\-MJUG;KJBV\>HQ2^5'. &W !7
MW8.."R]C0![917(ZO\0;'2?$\GAXZ9J=UJ"VAO$6WC0J\8SG!+C'0]<=/<9+
M7XC:)=^$M/\ $,0N#%J$ZVMM;;!YTDY8J(P,XSD'G.,<YH ZZBN.N?B3HMG8
MSS7*S17$&HKIDELY166=NF6+;0I&6W9Q@'OQ4]]X[L=-BLQ=V=U!=7EX;.&V
ME,:L7 SG<6V[<$8.><C'6@#JJ*YF:WN?$4VBZK:S:GIIM+F3SK=I0BNJMM99
M4&0^=I"X.!N)ST!N>'-(NM(BOX[B_O+N.:[>:#[7-YKQH0/EW8Z;@Q [ @4
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MJV[(P0<8R21@XP+?7GL?B!XEN[NWU.*VL](@G>UD?S"/FD+,BABN" .A'0T
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M)]AJI;:K87M[=V=K>0S7-H5%Q'&X8Q%LX#8Z'@\4 8'Q$\&IXZ\)3:1YPAN
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M:#K'B%-&\0WLEU8W4L.M36V^=?)2%%D5#(27QM5!G;P3C[Q)JU#XOU&;3O&
M"6LT^B)YD,C021),AA\P!D)R.XR#@\&I+GX?22VU_!!KDT*3ZJ-6@'D*PAFW
MAR&&?G7<.!Q^-3CP5<[_ !'(^MO(^NVZQ3;K9<1L(_++  C^'H,\=]U %5?$
MVNW&H>&;&TCTZ,:OI;W3221N?*=5C)PH897]Y]W(Z=16SX.UN[UW1II=02%;
MRUO)[.8P B-VBD*;E!)(!P#@DU5M?"-Q;:CH%Y_::,='LGLT7[-CS58*"Q^?
M@X1?U_"_X9T!_#UK>PO>"Y^U7DUX2(MFUI&+,/O'(R>* ,"_!_X79IA3;O\
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M:ZY8,[+J)B5_,WXWJ\?"E3@8'&,"I;OPE=WJ:0T^LM+<V%\+^2:2W!\Z0*4
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MR?9B0B@L=P^?KEV_2@#+^'>L3ZOX<T6#39K7[#I^G6T%X9$+2--Y2':N&&T
M'DD')Z9ZUWE<=I'@:30]0TR\L=46-[:QCL;I1;?+>I& L;.-W#J!PP]?3BM?
MPS#J\%C<IJ]\]\YN7-O-) L+F(@8#*.F#NQWQC- '*>+-!U"^\92ZSH,WE:Y
MI>GV\ENK'"7"M)/OA?V8*,'L0.E:'A_Q+:>*=;T[4;2-HYETZZBN+:3B2"59
M(-T;>A!_H:Z*+3+F/Q%<:H;N,Q36\<!@$)! 1G8'=NZY<YX["J'_  ANFIXF
MO]=@WP7&H6;6MR(N ^2,2#T; QGOQZ<@&/IOB[5I?$&BZ;>"Q+ZE!<&5((V8
M6DL8!V>8&*R8R0<8(([9Q6-:^(]?T[X8:[KTT]E?7%O>7("SV[!2%G9#G#\C
M&,#C &,GK6[IG@*ZT^;P[(_B"64:$CPP*+5$#Q,H7:>OS8 RW?T!YI9O $DG
MA?6?#ZZRZV>HSR2KNMU)A$DAD8 Y&XY/!/;M0!HR:W>W_B:]T+2I+:"2QM8Y
MYYKB)I 7D+;%"AEXPI).>X%8">/=6N],T*>ULK..ZNM6?2;V&8L1'*@?)0CM
M\F>0>M=!+X9N$\0KKUAJ$=O?R6HM;L/;EXIU4Y5MN\%6!)P=QX.*JR>!T6UT
M>"TOO*_L[4&U%WDAWM<3-OW%L$8!,C=/;TH J6_B?7EA\16<\>FRZAI-W#%]
MH&8(/*D5&,C!G.-BLQ(W<XP*S-9\17.L>$/B#IUSY4@TZR81SQPO%YB20%QE
M&)((.><X(P16MJ/@&;4+K5[D:R89K^\MKU"EMD120;0F06^=<*,@XYY]J6?P
M)<7"^)/-UV1SKULD%QFV7"$)L++@C^'H.W?=0!T^C?\ (#T__KVC_P#015VJ
MVGVSV6G6UK)*)6AC6,N$VAL#&<9./SJS0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %9/B7Q%8^%="N-7U L+>':"$&6))
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M.,,.3_>W'MC'JVG_ /(-M?\ KBG\A0 E_?VVF6$U[=R>7!"NYFQGZ #N2<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK5DNMFHJ4: K(3))(5&",G<"F/7BO0M+LCIVE6MB9?-^SQ+$)"NTL%& 2/7
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M,Z$Y4'AL U8NM#\2^*_"^I:3XD?3K(W%JT"_8&>0-(<$2'<!@ C[HSU.3TH
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MUOJ-I!# OGL&#1A_O#9@ [^Q/2L:S\)^(K'0?"=@!IUS'I2M'>V<EPXAN/E
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M-)9%MQR;14\[RB>N.=G^Z,5U=EX)_P"$>FT"ZT;9+)I=D^GRI,VS[1$V&SD
MX8.N[&,?,?:H5\"3QV<=ZDL)UM=9;6"V2(R[?*T6<9V^7\N<=1G':@!=.6)/
M'NO>%MF-,DL8+Z&)#M%NY+(VS'W<E588Q@Y(Y-:W@G6I]9T*07C;[VPNYK"Y
M?&-[Q.5W?B-I^IHTW26L=;UCQ-JCPQ3744<857W+!!&">6(&2268\8' YQDP
M^ =+GT[0[JYNHVBGU2_N-1:)A@QB5\JI'8[0N1V.: "TU!M:\=ZM9-S::)'
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M>2Q("@@<!<#IVK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC(X;(*X]\]NB6_UOQ))XA71]32PN-,O/L=M&\:LCLJ(S-+E2V&+$#;C &>M
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MQ1(/X548 _(5/2$@8R0,]* ,'Q+I+^(1::4Z$6(N([F[<]&6-MZQCU)95SZ
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M^\&:;K-W?W\D^HVW]JV@MKVWCE\M95"E06&,A@&(X.#W!%=/D8SGCUI<@]*
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MQ%9?#O3+#^R?+U#56&DR,UF'N>(U92ICX'*X)'KVSBNN5L\<9'49Z49&<9%
M'+2> ]/DT.]TAK[4#;7EX;Z8[X]QE,@D.#LX&\ X]O2G7/@33[C7)M5COM3M
M9;I56]BMKCRX[O:, R #KCC*E:W8]2M)=4GTV.96NK>))98Q_ KE@N?KM-6L
M@DC(R.M '-:GX'T_4-;75X+W4M,NS$L,S:?<>4)XU^ZKC!Z= 1@CUKHH((K6
MWCMX4"11*$11V & *DZ4FY0,Y&#WS0!BMX7M?[<OM7BNKR"XOH5BG2.0;&V@
MJK;2#\P#$>GMD9JG!X'L+>PT.RCO;X0Z+*);0%DR"%*C<=G(PQ'XUTY('4T
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M&02ASSD#&-HXY^M %_0[*YT[1+.SO+F2YN(8PKRR/O9OJV!N/;..<9K0HHH
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M3UK9\>1QR_#_ ,0[QD#3IW!ST(C8@_GBK=]X=TV]T>;2A9VL5I,<O&MNI'U
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M(QDC#+R,CFN=\)_VYHEM_P (M>>'[B=K>[D>#4CL-L\32EQ(QW;@XW'Y0,Y
MY')&3K>EZTNC>/M%@T2\N)=5N7NK6>/;Y3H\<:XR3G<"A&,>G;F@#T&]\1V%
MC).LGGR?9XUEG,,+.(E;.TMCUP?H.3@<U2LO%L-WXJUC1VMYX8]-CB+SR1D*
M2P=F);H%PHP3C//;%<SXDTG4+N[GU+2;75=,\01V\:V\D0#P7@QGRIU!*8!+
M#)Q@'@G&*EU#0-7OM:\:6/V62--<TZ&."]4CRD98G1@W.[[Q QCH: .JMO%6
ME7-Y9VPDFC:^0O9O-"R)< #)V$CDXYP<$CD9%4)OB%X>A@N9WFNO(M;HVMS+
M]CEVP., [SM^498#)K(-AJ/B*Q\(VD^FW-C=:3>0W5ZTJX1/*C92J-T?<Q&-
MN>,YQTK*O](U6X\"^.["/2[LW6I:G--:1^7@RH^S:P[#[IZXQ^- '<0>+M'G
MU"YLC-+#+;VYNB;B!XE>$'#2(S !E![CU':EL?%FEW]RMO$UPLKVGVV)7MW!
MF@R!O08R>HXZ\CBN=U^'5I?%T6I:7IDDY30;J"/SX\1F=RC(CY[':<]O>J6B
M6VJ1^,-&UB?1M66(:1+;7,EP4)24M&Q^0-A5^4@!0,]AWH W5^)7AM]/?4$F
MO7LD@-PUPMC,4"!]A.=O4'&1U'?O6^=7M1<V-O\ O?,O49X0(F/R@ DDX^7J
M.OK7/> =)EB^'%GHVKV,D+B*6&XMYEZJS-QQP00W;UJ'X?Z9?VL,XU*99UTU
MGTNPESDO!&Y^<_[1PJ'WBH T/'^OW'AOP;?ZA:!_M2H$B=8BX1F(7<>,#&<\
M\9I+*XMM(O)&%]JUT;]?,@TZ=7DDB"<.R[OF"G*_>.,XQUQ4?Q(L[O4? FHV
M-A:375W/Y8CBB7).)%8\G@< ]:KWT%[9_$*S\2QVMS<:9<:8;"98XR9+=Q)Y
MBN4^\0>0< ]!VH TI?'&@0Z9::BUX_V:ZN1:1L()"5FSMV.,91@<\-CI6II6
MJ6^L:>M[;).D3,R[9X6B<%25.58 CD5YS=>'-2M[1;E+"X=[WQ9'J[6\:@M#
M K+DMSC<0N[&<_-CJ#7J0.0#Z^M '+R?$+P]$D\C3W7E6UU]DN)/L<H6"3('
M[P[?D&6 R<?I6K?^(+'3YY8'\^::"(3S1V\+2M%&<X9@!WP<#J<' .*\]U#2
M-5G\#^.;&/2[LW6HZK)/:1^7@RHWEX8=A]QNN#^8KH+*.^T3QQKFI2V-W<Z?
MK,-O+!)#$6:*2--AC9>JYX()XZY(H NWOC>RAU+P];V<<MY;ZQYDB7$$;.OE
MK&S<8ZMG;QV&<XJ]?^+-)TV0_:I95@6=;:2Y$3&&.0D *S@8') ST!."0:XK
M3?#&K>'(/ [?8);K^SY[QKJ*W9283.KE1R0,*6VD].,TZQTNZLKW5-"U/P:N
MJK<WTUS::@\<4ENR22&0><6.05)/ !)QQVH [E_$-BEV;<>>X6X6U:5(F:-9
M3C"EAT^\.>F3C.>*OW=U;V-I-=W4R0V\*&221SA54#))-<#=Z/?Q^*3J6AQ:
MA87LFHH+VV8%K*\@# -,<_*K[!P00V1T.<UT7CS1+OQ%X(U32[!U6[FC4Q;C
M@,RL&"D^AVX_&@"U;>)=.N-12P/VB"ZEA,\,4\#1F:,=2F1R1D9'49Y%<UH-
M]<^+=5U.;[;JEC)IVK-'"L:,D301A,QNK#:2Q+$Y^89XP!5F:WN_$OB/PQJ;
M:?=6(TKSI[G[0FTJ[Q[/*7^]R221D87KS4W@>WNK67Q$+NSN+?[3K$]U 94P
M'B8(%8>G0\'GVH Z"^U:VL;B*V=99;B5'D2&&,NQ1<!FP.P+*/Q&,U5MO$^F
M7=[9VD4DWGWMG]MMU:%UWQ87)R1P?F7@\\UC^,M(BU6^L"T>J6T\$<K6^JZ;
MN,ENY*_(5&=RMZ$$?+SBLJ*#Q%9:QX2UG5-,FO+F/39[2]%DJ9CE<QE21D
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MO#'.R$*SH\A8>O1QUI?&5I?2:EX9O[.QFO$L-2,L\<&W>$:*1,@,0,989YH
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MRB">65E(  5CA 2>3C.?;D6TO7\6^#KH6-R(+/3KB&YD,9 B=UB"@_BC=.*
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M]X[5R2.!@G@"LCPE%-<2:=#J'@@:=J6GIMFOI8HC&#MVDPL"6);Z  9R3QG
ML=%UZQ\$^%2_AZ:YGT"9TN]/D*9N$971FCY()7((SC/- '<R>/- AL)+R>YE
MB2*[%E,CV[AH9B0 KC'R]1R>#V-(GCS1&N+>W/V]+BX,HAADL)E=_+^]@%<D
M\C@<\US>MZ?+?^&A-IGA273WGU.TG-NL"+/(L4JLSR!20. 0 3GCWP-S6K>Z
MG^('A:^AM+A[2UBNQ/,(SB,R*@3/?DJ?IWQ0 \?$3P]]B%X9KM8!-Y$[&SE
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M2".E6+.SM]/LXK2UC$<$2[47).!]3R3[GDU/10 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cutr-20221231xex1028four002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&EUSQ#8Z#IU]=7#
MB1[2V-R]NC#S"F< X/0$\9/%<5/H>M:EX*7PZ/#<-K<6FD268NYY(R&DV*H$
M)4DA7*Y)8+QCOTORP>(]3UK4-5@T-;,MI2VT,.HR1N)7$I9D8(S84J2 ?Q([
M$ V+/7]8^T+'J>A1V\4L#S0W-M>>?$-H!VR-L782#P>0<'FK+>*]&M;:R?4M
M4L+.:Z@6=8WNE(VD=0W&5SP&Z&N/L?#MW_:8ET;PS=>';;[/.M[ ]U'Y-RS1
MD(J1H[*"&(._"\ CO65=)<^'/#NOVES8PW<DV@VT=P#<Q VC);E"L@9LE<@E
M2@;))'O0!Z3<^*O#]G.D%SK5A#*^W:CW"@G< 5[]"".?<4>)M;?P]H4FH1VH
MNI!+#"D)D\L,TDBQC+8.,%L].U<>?#&I3^&_%D:V(,^IZ5!!:AF4&1UMMNWD
M_+ASWQ6]XYTF[U?P3+86UFUY.9;9VMU=5,BI-&S@%B!]U6ZD4 7;35=7C,\V
MN:79:;8PQ-(]RNH>:%QR<@QK@8R<Y[5-;^*- NA<&#6;&06[*LQ6=2$+-M7/
M/<\#WKCI-#:70->L=,\$7FEW-YID\"2RW4#*[,A"I\LK8R<<XQZFM:_\*-J6
MKK#-;B/3I-!DT^1T*C8Y="H SG@ D'H,4 =)=ZOIMAY_VN_MH/(C6:7S90OE
MH20&.>@)! ]2*SYO%5@8],FT^6&^AOKX67F0R@B-BK,2>O(V]..M<;+X5\27
M_A\:CJ,;#76U&WN9X+::/<T4"[%5&;*9SNE ;C+8..UBU\-:K->PWYM+^-I-
M8AN)&OKF%IO+2!T\QECPH.6 P"Q( SB@#M;;Q#HUYJ,FG6VJV<UY'NW0),I<
M;?O<9[=_3O3=/\2:)JUQ]GT[5K*ZFV>8$AF5R5XY&#R.1^=<;I>B:PMAX7T:
M;2&M?[#F$D^H&6,QS!8W3,>&+DR%LG<!C)SGBLKPWI6I^(_!?A*UM]-?3(K/
M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>[<K(P!P02>HZ&BXTC7KKQ1X9U6XBM6%B+DW0CEP$\U0JJF1EMN.2<9ZX[
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M"=O3DX +'_"3Q)H\.H3V<\8NK@6]G#E2]P6.$*\X 8?-SC"\G%<I\0-6>_\
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M&1OD8@;E_B& 2.G3!-6O#OB?]]HNB76FW5L;K3A+:7$A0K.(U3>, DJ?F!Y
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MPMJEO#!>[0)DADWIN[E20#CZU<H **** "BBB@ HHHH **** "BBB@ HHHH
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M?+C3!D9"V[!'8]NGM6Y>^([_ $7Q=J5K=3+<:?9: =2VK$%D9U<@Y(ZDA>P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'--OM-2_6\O[R[2:[>6#[7(KO&A ^7*C 7.<#L,?0.G\/0S^*;77S>72W%M
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MY;!@H  PRYQG@DT 4;R.VG\5WOAC5KVRA@33(#9"^1G#@[Q+)&2XPX;'/)
MQC!KN/#<7D>'+"$:A)J(CA"+>2C#3@<!CZY&.>_7O4$?A+17TBPT^_TZSOTL
MD"PFY@5PG^Z&SM'MZ "ML *H50 !P .U 'CQFFO_ (2W7B++)XLMKR0F9?\
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MD>QH XMM%@TCXCZ"VCM.JZC;7/\ :B"=W$D:H-DC9)PV\@!NO-<U!%YOP_\
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MSAG*@[1P3SV&>E8GB?Q0EOJ/AVPM9;@V^JS,9+BUADD+0B)W'ELBG))"_=Y
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MRXU#P/H5Y=RM-<SV$,DLC=68H"2?QK<KG_ L%S:^!-"M;NUEMKBWL8H9(I0
MRLJ 'C\*Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'(=P.<MP.!G!/M7/Z_K4'BKP1X:UO[(D4C:[:*%+!_+9;GRVVM@9!*GGC(H
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M/.!WS6/9^,-0NK6Z T&;[7;WJ6I(+"!D;GSPY4'8!G/'!&/>@#JA;P_:3<[
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M:.WDC;<IYP7YX)XXZ =2Y=$U"\UVVUS4ELQ>65I);VT$$C,FZ0KO<L5!&=H
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MC*]GJPOUDVN@9%G,VT]>23CV]Z[#1=>TWQ!:R7&FW'FK%*T,J,C(\4B]596
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M]_'EOK\36QMX=/DL_*9V#DLZON^Z0/N 8]\^U=%37?RXV<ACM!.%&2?H* .
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MZ;SHWD^T+'F)-I'RLW9CG@=\&K= '/\ C#1+SQ!I,%G9O!&T=Y!<LTQ(&(Y
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M;;1IUT?48FRKJ "Z$ #$N[82W\0 Z=ZT_P#R1OP*+/\ UYN]-\G;U\S<,_\
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M9TCC7:@<KP6^\>#W [5-9>%["QELW5[F86.[[(D\I<0%AM)7//0D<DX!P,4
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M3].DA:>WT^6.:U$[ES$R?<()YX]Z .+T"QFL?C%F[Q]MN/#GVBZ(.1YKW1)
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M^%;66>GVB[_]*)*Y?P7<RVOAN^2SOFM=-N/%,\=A'$FY[FWSGRH?[N2#\W
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M7H\X_O %V #^[\OR\8XIDG@G2&NK&Z1KR"ZL[<6J3P7+QN\(Z1N0?F'UY]Z
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M=QC%=CJWA^PUJ>RGO%E$UE(9()(9FC925*L,J0<$'!%59O!^DS7-]+LFCCU
M@WMO'*5BN#C&67U(X.,;AUS0!H:+?MJN@Z?J,D7E/=6T<[1_W"RAL?AFN"M=
M=U-=9\,RQZG/>P:CJ%Q;W%P%"V\Z;9&41H>1MV ;AC.#RV:]*"JJA5 "@8
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M+M&?-).,YR1TXKB(M%\-GXNW&F?V=IGD#0X\6GDILW^>Y/R8QNP0>F<&N?\
M$3:9_97Q7A4VN-\+1H-OW_(09 ]=V?QS0![%#?6=Q<2V\%W!+/#CS(TD#,F>
MF0.1^--&I6#7+6ZWML9U^]$)5W#ZC.:X2#^R[;XH:&M@]K#Y^ASJQ@*C?\\1
M7..I^\1^-<SX=N= U>T\)Z1=:WHY?2;V23,TP\^YSO55,;#Y68L"P))R.Y/
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MSZ++%$S\;Y//C.T>IQS].:X=6TI/A\M\K6@NT\4[UGRN\#[:3D'KC82?H2:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(-,T3P(S:2[W.BSSBZMQ/$"%DCD0,&W;2 6&><^U>GHBQHJ(H55& H& !2T
M</XBT&:Y\<:;+9RI''J=NUOJT/\ SU@B8.&_,^62>TM:WCS1I]?\":UI=J,W
M$]LWE+_><?,!^) 'XU>TOPYI.C7=[=V%FL-Q>R&6>3<S%V)R>I.!DDX&!6I0
M!G:7J"WWAZSOX(VE$MND@C7 ;) RO) !!XYQTKE_#V@ZY;?"(:!AM-UE+*6"
M-VD5@CG=M8,A/'(YZBNLGDL-%LKN^F:.UMD#3SN3A5[LV.WJ<=35J*1)HDEC
M8/&ZAE8="#T- '%6GA@2^)=(U6WTA])^SV;VM\I=,7$90*D>$8[MIY#'' Q]
M,^/P?J<G@NQ\$36[?8[>\3S+XNFR2U27S5P,[MY 52,8!R<XQGTBB@#C]9LW
MU/XF^&3$,II,%U=7#=E\Q1%&/J3O/_ #1X@T_5K3QOI/B33K%]1@CM9;&ZM8
MI$215=E82)O(4\J 1D<5U<-M#;M*T485I6WR-U+'W/TX]@,5+0!YC;Z;XMLX
M=1:'2)UBN_$37D\,-U$LTEJR 85MP"MN49Y!QT-:WA3PY<PV_BG3=6TA+?3]
M2OI)D43*ZO%)$BE>.01M.<XYZ9ZUTT^OZ5;:C%I\U_"EU+)Y2(QZR8R$STW8
MP=N<X/2EUK0M-\0V2V>J6WGP+(LH7S&3#+T.5(/>@#DO"VEZC'X+U![Q(M8N
MFA>QMD<@+<VT1=(PQ/'SY8D]PPJWX.T"]T+5KR.V%];>'W@0P6-],LK039.X
M1D,Q"8QP3UZ5V$,,=O!'##&L<4:A$1!@*HX  ["GT >;^,M&\2ZV?$]@-+:\
MM;FR5-+<7*)$C;#O#J2"9"WW201C'*\FM.\L=8N/$W@^_P#[(E$-A%<"[Q-$
M?*,D851RPR<CG&1Z$UV%S<P6=M)<7,T<,$:[GDD8*JCU)/2FV5Y;ZC907EI,
MLUM.@DBD7HZGD$4 >?ZAX5UN^C\;:;';)$FJ7$=Y9WCR*8V94CPC*"6'S1X.
M1C![]*N6D&K7^C7_ )O@RVTBZ-E+#MCDA9YI&7 ",IP$ZDEB#TXKNZ* ,7PC
M:W5AX.T:QO;=K>ZM;*&WEC9E;#(@4X*D@C(KE;S0]<6'Q]90Z4TR:RKO9S+/
M&%<M;K'MP6!!##G.!CH3TKT2B@#@+C0=5O-3\);].GB@L]-N+6\D\V+,+21(
M@X#Y/*GIGM3/!VF:S80V&D:EX3L()-/"QG5U:)EF1!A611\X=@!G.,<G/:O0
MJ* ./^(6F:EJ^F:9;Z9827;PZG;W4@62- $C?<WWF&34<&D:IX;\627VC6#W
M&BZMF6^LED16M;C_ )ZH&8 ANC 'J,C/2NTHH \VT70]8TB\NM&G\*V-[;M=
MRS6VL2-$0L<CE_WBGYRZ[B..#QR!S6SKWAF\N_%]CJ-B46TNX#9:LI/WX5/F
M(0.Y)#(?:3VKL*IOJMA'JL>EM>0B_E0R);[OG*CJV/3F@#G&T[4]'^(%_K5O
M92W]AJEI%%*L+H)()8BVWAV4%2&/0\'MCFL0^$M6L=$T*&&R:XG7Q#_:UVD4
MJ!8$9W8J"S#) 91QU(->E44 <?X@\,WM[XML-2L"BVUU UCJRL?OP [UX[G(
M9/I)[5-J6GZA)\1M'U2&PDDL;6QN(99EDC&&<H5&"P)^X>W<5O1:K83ZG/IL
M-Y#)>P())8%;+1J> 2.U7* /+X_#NOKX#L],.CS?;(M=%ZT?GP_ZK[49LYWX
MSM.,>M+K%O?7/B7Q*-/T/4+RPOXHK2^;3[NW7S&$>&#"4@JP5POR]N^>GI]8
M,_@W0KC4IM0-K+%<3MNF-O=2PK*?5U1@K'Z@T 6=(O(I_#L$]E87$4:1F)+-
M@JR(4)0IRVW(*D=<<=:Y/P.OB#PMX"L=(N?"M]-?6JR#$=S;>6Q+LP^8RY ^
M8=OSKM([S3K2]@T>.6&*X\@R16R\'RE(4D#T!(%7: ./%AJZ_$.RU::P>6WC
MT5[6::-XP#,TB/@*6!Q\I&<=Q]:Y^S\.Z_!X'\+::^CS?:]/UE+NXC$T/RQ+
M,[D@[\'AAQ]:]0HH \X@T76-*U_5[4^%;+5[/4+Q[NVU"5XAY'F<LDJM\Q"G
M)&W.1^G7>)[:ZN/"6HV5E:M<W,]J\,<:%4R64@?>( 'XULT4 <1?^$;N\\=V
MVLVY^SZ=>VZKJULY&Z5X6#0]"03G@]MJX[U1ATOQ3:W/CR[T_3C;W>I,DFFR
M321,&*Q!.0&.#D<9&.F:]%I"0H))  Y)- 'GFF:'JY\8-J+:+-:6MUHAM))+
MF\2659MY;+D,Q8G/!!(P.W2JMKHGB&T\*># ^B2-=Z!<H)[5+B(O*@B>,NAW
M;?X@0"P/7I7H>G:I8ZO;M<:?=Q74*R-$9(FW+N7@C/M5N@#RO5O#WB2_T;QS
M NBL)M8N(9;11<Q'("1@Y)88QL.??ID<UU'C"QU+58O#SV6G32M;:M;WDZ>9
M&ICC3.[.6P3ST!-=95/4]5L-%L7O=2O(;6V3 ,DK;1D]![GVH P=#T[4M/\
M&WB6::Q/V'4989X;H2KCY850J5SNW97TQCOVJCX/T&73?$&K0^<DFDZ=<2)I
ML8_Y9&8+)*O_  $D!?0,PKKM2TZUU?3KC3[Z+S;6X0QRIN*[E/;(((_"C3M-
ML](L(K&P@6"VB&$1<GODDD\DD\DGDT <QX^TW4]3'A_^S=.EN_L6L6]]-LDC
M3$<>[(&]AEN1@?K47B?1]5\;K:Z1/8-IVBK<)/>O<2HTLX0[A&BHS  D#+$C
MIP#7;44 >8>+-$\4:U;>(K1](>\9KF&3391=1I"(5:-BH0MD295\LPY!QNP
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M \&G3PB"[_L\6[1LX8*_E[>HR,9KD;31O$']B>!+:;1)8Y-%N(_M0^T0G"I
MT98?/SDMD 9..N#Q7I5% 'G%UIGBJVN/%5UING2JU]J5M/&!/$KS6ZI&DH0[
MOD<A3@G'7/!JM+X5UJY@\=V\.C_98M9LHQ9^9<HQ+K$5*L02=Q/4DD<]3UKU
M"B@"CHSW+Z1:F\LVM)Q&JM [J[+@8Y*DC\B:O444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7'>$+R;6=5\5ZDS@31:E)
MIMON&X1QPJ!TR.KL['D9S["NQKE]&TN70=;URWC^6WU6Y-_;2E=RK,R 2(W3
MNH8=,ACZ&@"AX?\ $NO:EX@N=!ODL(+_ $Z9FO2D3;)+<@>4T67SELG).0N"
M",XS8O+Q]+^*>EV\?^HUJQF65!T\V#:RO]=K,ON /04]O!;B]TC4;?4O)U.Q
M,GGW0@R;P/\ >60;NA/..Q VXQBIQIC:IXZAUIU(M=,M)+:V)&/,ED8>8P]@
MJJN>Y)]* .C<LL;%%W, 2%SC)],UP^E^+M5F\0:/IMW]AD;4;2>206\;;;::
M/:2@DW%9 -Q!QT([9Q7:7ELM[97%J[.J31M&S(<, 1C(/8\UR&G> [JQN/#\
MS>()96T2&2W@7[*BJ\3*JA3WSA!DYY[8/- &7:^-?$C:'IFMW$>E_99=7_LZ
MX@CBDWLIN&A#JQ;"D8'!!SSR.@UQXIU"QUGQ%IVJ_95>RMEO+#R86!N(FR.A
M<Y8. I QR1ZTQ? 4J^&K?11JPV0ZC_: E^S<EO.,VW&[IN/Y?G27$>E^+_&.
MG201W+2Z#/+]JF:!XD+#&(LL '^<*XP2!Y?N,@'76/VO[!!]O,)O/+'G>2I"
M;\<[023C\:P[O6-0O=?U'1=':UBGL+2.>22YC+AGDW[$ #+@?(23GN,5TE<O
MJ_A*YNO$B:]H^M2Z5?- +:YVP+,D\8)*Y5NC DX:@".'Q!JUWK-GH!BM;'5/
M[-%]>E@9DB);8$0!ESE@QSG@ =<Y&,WCS66T^V$=I8C4(O$"Z+>H^_RV)/WX
MSG(!!!YSC/?'/03^$MFL6&L:=J#P:E;6[6LDL\?G+<Q,=Q$@!7G=\P((P2>,
M<56N/ R26EK%#?\ ES1ZL-7GF:'<9YP<],C:O08ZX Y[D K0Z[XGDD\4Z6@T
MVXU724BFM76!UCG$B,P0KO)!RI&=W<'%6;'Q:]_I&EZI#) UJ^GO?WQ$+915
M'W5^;Y6W;ASG[C>E:>FZ!)8>)]7UEKQ9/[26%6A$6W9Y8(7!W'/#'/'Y5'HO
MA+3]%@U6"+=+!J,\DKQOT1'R3&OHN6<X_P!LT 96G>(/$E]=:1/'IR2Z=J$1
M>8B!D-IE-R-O+_O%SP< 'N/2J&E^*O%EYX6N/$+6FG30P+=)]EMH9&E=XYBB
MLOS<C"G*]3C@\X&MX>\'W^@K%:'Q)=7>E6O%G9S0H#&/X0[CYG"]AQT'H*GT
MCPM<Z/X8ET>WU9A(9WGBN5@ 9&:4RD$;B",DCZ''- &3-XQN+CP5KNNZ7?Z5
MJ<-G:F6$B%UP55BZ2H6R#P/3K6E'XAO-0URWT2Q:W@N!IB7]Q-+$9%7>=JJJ
MAE[AB3G@ #OD177@9+RW\0^9=Q17>N6ZVUS+;VVQ BAAD)N.7.\_,2>W''-A
MO"<L6JZ?J]EJ"P:G;6?V&5V@WQ7$(.0&3<""#R"&[GJ* ,!?'FM3V^FQQ6EB
MEZ==?1+Y'W[!(JLV^,@Y"D*#@YZX[9KH?"^LZE?:IKNE:J;62YTNXC036L;1
MI(CQJZ_*S,01DCK5>3P,GEZ=Y%]LDM=4;5II&AW&XG8,#G!&%PY&!T '/'.E
MI.@2:9K^LZHUX)?[4>-VB$6WRRB!!@Y.> ,^_P"5 #O%6O+X:\/7&I&(2R*R
M111DX#2.X103V&6&?;-9TNN:KIGBW3M#U!K29-5@F-K<0P,GES1*&974N<J5
M.000>"/>M?Q#H5IXET*ZTB^WB"X4#?&<,C @JRGU! /X54MO#]PVIV6I:K?I
M>WEC \5LR6_E*I? 9V&XY8A0."!C.!S0!A?#R"YN;?6WU"2UN437;PJ/LY#+
M(LI&X$L<#C@8R/4UT?BC5Y]"\/SZC;V[S&)H]X6,R%(RX#OM7EMJDM@>E1^&
MO#\OAZ&^B>]%T+N\EO"?)V%7D;<P'S'C/2K^J6ES>6@CM+TVDZR)(LNS>/E8
M$J1D9!'!Y'!H Y"X\9WB>'8M8T^_TK4K:75+>UCEAC;#0R-&IR-^5D#,W7T'
M JUJ7C*?1=9\217L<,ECI6F1W\?E*5D8L7&PDD@_<&#@=:+KX?V]SIVK1"[%
MO>:C>0WIGMX J12Q;2A6,DYY3+9/))Y'&)!X&%UJ.J7>K:I+>KJ>GK8W,(A6
M-2HW<KC)'WS@=O4T 332^(_+D%XEA-IT^GR/*\(9&@EV\*,L=ZD$\X'3WQ7,
M>#=:U?2]%\!6LWV)],U2T6V"*C>=&RP%U;?NP0=I!&T8SU-=)I7A/4['3FLK
MSQ+/J$<4#06@EMU7RE*[<OM.9&"\9)'4\9J.V\$R6UIX8MEU,%= 8&(FWYE
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M*A8/UZ*"!V/K4]EX7G$VE2:KJ0O_ .R0?LO[CRR6*[-\AW'<P4D<!1R3CI@
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M6"2-$3RSN7<1AE?<%*@G()]* .GT2:_N=&M;C4EC2[E02/'&A0)GD*02>0,
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MY8Y,_P!FXF!'F<?+G_@0'U.*O7^LZ=IC%;R[CB81F5@<DK&.KMCHH_O'B@"
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M.R$4CQ':Y1&W;6(P<';G'>NVHH YSQ]87^I^!-8L],0R7DD'R1@_ZP @E/\
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MQ'=3Z9&\;W$31[$N@BG/4D'';)&0:[?PE#I/DWU_H]C=V]O>S^:\MT90]P^
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MZ2=,NU,K\#,9WI\OS?ZOH=O7K0!TNM:U#HT-MO0RW%W<):VT*G!DD;.!GL
M23Z ]3Q5"V\2S3:KJ&BRV*0ZO:P+<I"9\Q3Q,<!U?;G (((*C!]>M)XN\/W.
MMP:;<:?-%'J&F7J7EN)B1'(0"&1B 2 58C(!QQ3+?1;Z3Q)=^)+F&W2]:P6Q
MM[99B5"AR[%GV]2Q X!P%[YX ,7X;:?%JGAS1?$>H647]J^0[+>I*?,F\PDO
MO  SST!W8[8J>;5]1U77/&&C7=G;'3K*SC5?WI)^>.1MQ&WDGY1C/&T=:V/
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M)+;>%X [9KIM9U>TT'1[K5+YF6VMD+OM&2>P '<DX ]S5ZL7Q;X?7Q3X5O\
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MX0FZ>UDTE)E5;P2-YK6PE$@0IMQOXVYW8QS[5H2>'-7.L^+KM5LC%K%I%!;
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M!4"+@H5.<GD$4 =+17-ZYK4\7B?1/#]M*;=]16>62X"@LJ1*#A0P(R2PY(.
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MY@Y7"X"GRR<?>&??% '>45YG;^/WM]&U.\FO+@ZC860:YTK4+=8989BRJ&&
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M 9T#''MDUJ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7-R^#+)KC5&@O+RVMM5):^M(641RL1M9AE2REAP2I&>O!YKI*0
ML 0"1D]!ZT 8EUX7M;G6M*U-+JYMVTN-X[:"'RQ&%=0K @J3T4=^,5HZE8+J
M>GR6C3S6^_:1+ P#H00P()!&<@=JR]*U^XOO%6OZ1<6T,,>F"W,<BR%C()58
MY.0,=!QS]:WBRJ,L0!TY- '.7?@K3M1M]7CU":XN9=5MTMKB<[4?8F=NW:H
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M86US<3P^;),#<%2P9V+M]U1QN8G\:K3^$[=M6OM1M+Z\L9=0C5+Q+<IMFVC
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MQZ@]B#@@^HJ[N&<9&?3-+0!RL7@2S;1+S2]1U35=3CN;<VOFWDX9XHSCA2%
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MX\,3Q74:=J5IJUH;JRF6:#S)(@Z\@LCE&QZC*FLO2-?N+_Q/K^DW%M#"FF-
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M>V,ADM;RS<)+$2,,!D$$$<$$<UN%@N,D#)QS2T <[=>#K"[TVUMI;F]-U:W
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M <  < 5HT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"XU&//*O;LN& ]'#(C>H!K<\<Z+=>(?!&KZ38R!+JYMRD9)P">NTGL#C'XT
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M,>)Y+V)4GE(YVX!)VCU/4GCI0!VNG^,]"U/5VTJVO&^UB(S*LD+QK*@ZLC,
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M/4&KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDR>*_&RW$4,<HOX=RP?</^CI@CTR.<=B>IZUW#EQ&QC56?!VAC@$^YP<?E0
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MS0R+N22-@RL/4$<$5RNH:Y/K']MZ=IMI!(MA;+]I^UY&^1TWB(#L0N"2<X)
MP>:F^&__ "37PY_V#X?_ $$4 =117&77C.[_ +$U77]/LH;C3-,GECD0N1+,
MD1Q*Z'H,8; /WMO49I!XNUC4/$4VF:+IEE/$MG;7T<\UTR!X96(Z!.&PIP.1
M[]J .TJ$W=L+M;0W$0N60R"'>-Y4<%MO7'(Y]ZH^(M;A\/:+-J,T9E*E8XXE
M.#)([!47/;+$<]NM<=<3W%A\5[6]U5+1$BT"ZE>6WS]U9(BP(/)VXX/?/04
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MX"G'+8R,\CMUH [JBN(O?&>J);7SV.D&[N=-98KBVACFD\Z78K2)&ZH0-N[
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M,!0.@ ["G52T;4DUC0]/U2-#&EY;1W"H3DJ'4,!^M7: "BBB@ HHHH ****
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MG@GBLNT\#:A:Z#X5TS[?;-_8-TMP9/*8>>%5U QGY>'///2NY!R <$9[&EH
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M8GE6<\%U)'-$F,;1(#N(P .36_965OIUG%:6L?EP1#"KDD_4D\DD\DGDDYH
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M FMI,$KD@@@Y!!'(((!!'(K'U708[?0-8:UCN;W4;JQ>V6263S)'&U@J DX
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M!>5F#L %!P3@8  X]*@N_#&G7>IS:CB>"ZN(A#</;S-'YZ#H'P><9.#U&>M
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M4M/N9[>T"EFA58C-M7D'[ISQ@X(-=AX4G\/:QK]UKVBZE<ZE/-:I#<7! 6,
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MW 94C..N.Q!-*?QWI=O<68>.?['=W?V.*\!0QF4DJ,C=O"D@@-MQ^!!H Z?
MSG STS2T5SLOC"SB3Q 6LKW=H2A[I $RRF/S,I\^#\O/)!H Z*DVC.<#-<O/
MXZM([ZULK?2]3N[J[L/M\$<$2'>F5&,E@ ?F'7 XZYP"[3_'6E:GI-I>VT=T
M9KJY:S2Q9 LXG7)=&!. 5"DDDXP.O2@#IZ0@'J ?K7+7?CS3['3M9N;FSO8Y
M]&"M>6FU#*JL,JX^;:RD="#V.<&K=AXKM[[Q!_8[V%]:3O;&ZMWN$4+/&"%)
M7#$@@L.& //2@#?P!T%(0#U /UK*U+74L-1@T^*RNKR\FADG6. *,(A4$EF(
M&<L !G//IS66/'VF26^@SV]I?W$>N*QM/*B!.0A<JV6X/RD>GJ0.: .I(##!
M (]Z4 #I7(R?$&Q@\/WVKS:7J2+I]V;2]@VQF2W?Y>6^?:5^93D$\'/K6^=4
M3^V(--%O.TDMNUP9%VE(U! PWS9R2>, YP?0T 7B <9 ..>:6LG4->BLKU[&
M"TN+Z\2W^TO!;[<I'D@$EF R2" .IP?3-5H/%ME>Q:=]AM[JYN+^V-U%;! D
MBQ# +/O("\L!UY)XSR: *-EX4U>UM&TR7Q"ESI9W@B6Q4W!5B209=VTGD\E,
MUU44200I%&H6-%"JH[ < 5R\GQ TJ/3+>^^S7S"34!ILL*Q R6]P6V[77/8G
M^'.>V<BGIXV@,&MF32-3BN='19;FT*QF4QLI977#E6!"MQG/&,9H ZBL31]%
MO;.\FO=5U9M3NB&CA<P+"(8BV[: O4G"Y)Z[5Z4^#Q%;7-OI-Q#!.T6IQ>=&
MP*8BCVAMS_-P,$#(SR1ZUGQ>.],DO]-MS#<)%JF197!V%)2!N P&+*6'(W 9
M]CQ0!U%4=/TR/3&G2V;;;2R-*(,<1NQRVWT!))QZD_2N;A^(VGRVTUV=*U6.
MR@>:*:YDB0)')&^S83OZDD 'ISR1SBYK>N6P\.:VVJ:9J,5M:VQ:X6-E#O$R
MG+1LK]@#SD'B@#IJ3 SG')K#37K6%;"PLK:YNKF:S%S';HR[TA  #.SL!U('
M4DG/H2*+_$#2ETVQO5M[Z1;J_P#[.:-(09(+C)!21<Y!!!Z9]LY% '5X&<XY
MJBVF1RZO'J,[>9) C);KC BW8W'W8XQGL.!U.:>A^(X=;N]1LC97=E>:>Z+/
M!=!-P#KN1@49@01[]C3KSQ#'!?W-C:65UJ%U:PK-/';;,QJV=H.YE!8[6P!Z
M=LC(!L4@51T 'X5P/B7Q:+_1_#5SHT=Q<V&K:E#$[Q%$+I\Y:([F!#$I@@\8
M!!/:M^,:=X-\/W%TQNH[0RB7R9I0YB:1E41J2<*NX@8SM&3SB@#H,5BZ)HM[
M832W6JZLVJ7K+Y:3&!81''DG:%7N3C)[X'I5?4O%T6CZ7>ZA?Z7J$45G)&DJ
M@1L2'P R_/@KE@.N>O%6+CQ/86>NW.E72RP-;V!U![APOE>2&VDY!SD'U Z4
M ;.!D' R.]+7/P>(H-1OK?3)M/U&U%_;-/;S. H=!C(W(Q9&PP.#@\^O%<K\
M/O%HM?"'A6SU"UU!_P"T 8$U"0 QM-EV"DEMY)"GG;C/>@#TK%%8_B'Q';>&
M[>TGN[>ZE2YNH[53;H'*N[!02,YQSVR?:JEIXRL)3K*WUO=:8^D(LUTMV$XB
M92RN"C,""%;C.<C&* .B(!Z@'OS2USZ>*X!J-G8W6GWMI-?Q-)9^<$Q.5&XH
M"&.U\<X;'UX.,[P[XW;4/#*ZMJ5C+;-+>2V\$8:,^:PF=%13NZ@)R6VC@GIS
M0!V-%<M%X]TMUU%)HYX+NPN(;>:V<H6+3$"(JP8J0V>N1C!SBMS3K]K\7(>S
MN+62WF\IDFV_,=JMN4J2"N&'Y&@"[2 !1@  >U<A_P )'I.F7_BZ^%GJ1GTU
M(I+\$[@RB,LIC4O@#8,G[N?<U:L_&EO>:E:V/]EZC"][:-=63S(BK<A0I95^
M;(8;A]X*/?% '345QOA[QP;_ ,*VNKZC8S02W=T]O;0H48S.97543#=0%Y+;
M1P3TK:TSQ#;ZAJMYI3P3VFHVBK));S[<M&WW74J2&7((ZY!&"!0!KX&<X&>F
M:6L34?$L%C>7EI%9W-Y/9VZW-PEOLW*C;L8#,"Q^1NG\R!7,2:O+HOQ'\2R)
M::EJ"+IMK-]G@??LYEW$;V"KP!P#D]@: /02 <9 ..1FEKGE\76=S%IC:?:W
M5Z^HV9O8$B55/E *26+$ 'YU&,YR?QJHWQ TTV6AW5O9:A<IK0;[((HESN"%
MMC988/RD>GJ0.: .LHKE+KQY9VFG37DFFWX^RP+/>0$1K); KNVLI<98+\Q"
MYXQZ@59D\86+"5K"WN-06*SCO7^S;,B*0$H0&8$Y"DX'\^* .BKF(_#NM6M_
M>O:>((_L5W<-.\-S8B61"V,A7W@8   W*V  .<5N:IJ5IH^F7&HWTOEVUNF]
MVQDX] !U)/ '<FLV+Q/#_;,.DW=A=V=[<0M/:I-Y>)POWE4JQ&X9&02.N: -
M2PL8=-L8;.W!$42[1G&3ZDXXY/-6:\^\+J_BK4M3O=1M]0@N+#6I1;SK.JA$
MC*J("%<Y!&=PQM.2<YKH]4\4V^FM?K%97E\=.B$UX+55)B4@D##,-S;1G:,G
M&/49 -ZBL23Q-;O.+>PM+J_N!:I=O% %4I&^=F[>RX9L-@=>#G%4?^$^TJ2V
MT:XMH+VYCU>1XK<Q1#*R*&)1P2"&&TCZCTYH Z@@$8(!^M+7&R?$2VBL=3N7
MT+6 ^E2%=0AV1;K=0H;>3YFUAM.?E)/M5^?QC;)K*Z5:Z=?WMU)8_;H?(1 L
ML98#AF8 'G^+ X]< @'1T5Q]M\1-/NK/3+Y--U-;"_N%M?M+Q(JPS,Y0(XW;
MOO#!*@J#WJ[?^,;.RAU"Z6TO+FRTV0QWES JE82 "_!8,VT$;MH..>I!  .C
MQ17-7/C.UCUC^R[/3K^_N6LA?0_9E0I-$3@%69@/SQ^)(SJ:#K5KXBT.TU:R
M$@M[E-RK(NUEP2""/4$$?A0!H;0#T'7-+6#8^*(M26&6ST^[FMKCS1!<*8]C
ME,\??RI.TXR![XK,\/>-_M_A&WUK4[*:W>YN6@@B4HQF=IF1$3#<D8 );:."
M>G- '8UB1:+>MX@?4+_5VNK6-S)96?D*BV[%=I)8<N<%L9Z;CUXQ$OC#3HKG
M4;745FTZXT^W^US)<[>8.?WBE20PR"/4'C'2HYM?COY9M)GT_4K*:>Q>YBD?
M"AD'!PZ,2K#(X.#S0!TE%</X!UPMX0\-67DW5[=2Z?'+/*A5A",#!D+,#EN<
M=2<'TKJ-4U>WTD6RRK)+/=3""W@B +RO@G R0. "220 !0!H45S9\6QRVVLQ
M0V5RNJ:6FZ:RDV!\,N5<'=M92 3D'/!&,\5F^ ;,:AHNC^(KE;Z+4)M/03O)
M."EV756,A56(/.<$X(!QC&* .U(!!!&0>U+TKRW3[[3H?%OC2WUO6]1AMK2>
M'[.IU*X41(80S;=K^IS6KX+\47*>!;?4=:FFN?/O6M]/<A?/NHV?;#D<#>1U
MSC@9..30!U]UID=Q?VVH(WE7EN&19 ,[HVQN1AW!P#[$ ^N;N!G.!GIFN<D\
M96=N^J075E>07FFVWVN6U94+R0\_O$(;:PX(ZY!'TJBWQ%LX]/M]0FT768[.
MY>V2&=H%VR>?]TC#9.#UXSTQG(H [*D(!QD XY%<];^+!<RI:IH^HIJ+))*;
M*01I(D:MMWDE]N&/W>>?H"1 OCS3)+33;J.VO7BOKW^SS\B VUQDC9*"P*G(
M(XSV]1D Z@@'J ?K6%?>'I[SQ?INN"\B6*R@E@^S-;EBXDVY.[=Q]P8X]:9'
MXOM'EUZ)K*]CDT10URCB/+@KO4IA^<CIG'IUINJ>,;72XKEGLKJ5[.!;B[BC
M:+? I!.#EP&; )PI/ZC(!T=5A91?VC]N8LTPC,29QA%)!8#ZE5)SGH*YN?X@
M6 NXK:QTW4]2DGT]=1@^R0JWFPD@97+#GGH<=,=<"KOB[7)=&T>W^RX6^U"[
MAL;4L,A))6QN([[1N;'M0!T%%8\^I6VCS6>DPQSW=Y.CO'"K NRKC<[,Q QE
MAR3R6XK+F^(.E0Z<EVUK?9&H+IL\ B4R6\Y8+AP&Z<@Y4MD'C- '6452TK4'
MU.Q%S)87=B^]D,%VJAQ@D9^4D8.,@YZ5=H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7NA6]_;2RW7]G&X#:?;7<PEEMX]HRI8$\;MV!DX&.:Z>B@#S_4- UBXF\?\
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M"J>.1SQ47BCPK?:LYDAT]XM8MK9%T[6+&=8#')CE9!NSY>[G&&X)&,]?0:*
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MQ6\30%?](:XV*VXL<*"<XQD =376?VYJ6E^,]-T/4FM[F#5()7MIX8C&R21
M%U8%FRI4Y!Z\8YZU#'X"MY/#>K:'?WKW%OJ-U)>&1(_+>*5W\S*G)Z-R./KF
MM*V\/SG4K74]3OTO;VS@>"V<0>6J;\;G*[CECM4<$#&< 9H \ZMA_P 6HT/_
M +&5/_3@U=N=<U75]0UZUT1[2(Z0RPK]HB9_/F*!R#AAM7D+GDYR>V#63P"\
M?ABTT,:L?+MM0%^LIMQN+"4R[2-V,;C^7'O6@?"TUMK>H:GI>I?8WU-$6\C,
M'F*SJ-HD3D;'QQSN!P,B@#'T[QQ>ZG)X4OXX[>#2==BDC;S(V:2&Y5253=N
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M^&5#E7&>.#^A-5'\,2W4UU>WM\DNHS636*3);[$BC8Y;";B=Q.,DM_".!SD
MC\&:AKVL:/9:MJKV'V>^L8)XHK:-U='9<MN))!!R".!CISC)DO=;N9O%T?AN
MP>*&86)OIIY8R^%+[%55R.20Q))X Z<Y&AX?THZ%H%AI)N/M"V<"0)(4VDJH
M 7(R><"JFI^'#=>(;37[&[^R:E;PM;,S1^9'-"QW;'7(/#<@@C!]: .*U#Q3
MK>J6VF6ZSP65Y;>)DTJ^"1%HYBN75E^8$(0%.W.>V>.;<YUB/XA^)GTR>SBN
MH]'M':6XA9U)!F. @88SZ[CCT-;=UX&@FTV&&&^EAO4U0:LUV(U8O<9.25/&
MW!V@=@!UQS87PO.FN:GJBZGNDO[..T97@!VA-V&R&&3\[9[?2@#*LO&EYK-K
MHD5G (KN_P!+&HS%8?-$8.U0JKN7/S$\D\ =.<BM_P )-XQ-SX<T^>QL+"^U
M)KJ*83(SA3$A99%VO]TC!VGGMGO5K_A7DEO8:&--UVXL=2T> VL-['"K>;"<
M921&R&Z _7FM%_"4SZIHFH-JTDL^F/+(SRP@FX>1=KEL$ #'   Q@=: -^Q%
MVMA;B_>%[L1KY[0J0A?')4'D#/K7,:1K>O:]I^E:YIL=D^G7EP?,MI 5>.VR
MP$@?/+\ E<8Y([9/7UR&B^")="G-O::[=_V&LYGATPQIB-BV[;YF-VP-SMX]
MR1G(!RFGZSK'A[1?$&KV;61LK?Q/<+/!+&S22J]R$.U@P"$;LCALX[5O>*_%
MVK:!_:=ROV/R[*6W\JV"-*\T3E0[NRG]URS!=PYV]\U8E\ O-X=U31VU;$>H
MZ@=0DD%O\R.9!(5'S8QN4=>V?K3-2^'KZC%KMO\ V[<0VVL2I<2Q) AVS*$&
M03D[?D7Y<\8ZT 2WNL>(IO&6I:#I\NFPQPZ='>0S30.Y!9W7:0'&?N=<C&>A
MJOIWC:\U33O!K+#%;2Z^CM+,5+)$R1EBJC/5B.,GH#UK8B\-7,/B.YUH:GOG
MGL4LBLEN.BEF#<$<Y8YZ#Z5QNLZ.OAW3?#GAV75KJVLK%)&34&TX7$+,,!4D
M0A@&PS$,<#CU/ !J67C75S9NMU%:O<2ZS)I-JT$#;7\O>6EP7^8$(< $<@C-
M=#X<OM=N;K4K?6+'RX8)$^R7801_:$89(*;F(93P3G!R"*YVU\.77B70GL;O
M5Y&AM9HKG2]2M['[')#*N[.$/#*!CG !W,.V:ZS1-+O-.AD;4=6FU.\DP'G>
M)8@%&<!47@=2<\DYZXP  5-2UN?_ (2NR\.6+11W$UI)>2S2H7"1JRH JY&2
M6;UX"GKFN,\5>(-2U3X<>-+&X,$%_I)>VN7CC;9/&5!5D&[*%E89!+8P>N:[
M;5_#@U#6=/UJTNC::G8J\:2&/>DD3_>1UR,C(!&"""*HZAX)BOO#>L:4;UDF
MUB0RWMUY0+,2 ,*,X4 *JCK@#N>: -_3[9XH4DN3;R710*TT4/EY4<@8)8\9
M/?N:N5%;)+%;1QS2+)(HPSJFT'\,G'YU+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYS[4 $OAW2)[IKJ6PB>X:'[.TK EC%_<)Z[?;I31X:T58[.,:; $LCFU4+Q
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M90!(V<$#Z$'/ICFGV/B/1M1L[J[M-2MY+>T)6XDWX$6!D[L]!CG/I0!J 8
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MVVHP10V9Q<F8^683C.'#8*Y'3(YH AM?"'AZQTF;2K71[.*PG.Z:!8P%D/\
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MCM5F^O8--L)[VZ<I! A=V"EB /8<FLO2?%>FZIX<LM9,GDQ72(51@2V]E#!
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MXQDCT^B@#RU9IX- ^(#)HLM^\NI230VD]J^VXC*1+N (&\##' Z[:(8[B_\
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M1=*M+NQT]+>]U&34)U9B;B2-49@6) (4 <# X'.* ':EJEEI%H;J_N%ABW!
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M&N:IKGA:VBU5K.#5M&DNIUB@C8K(%B.4+ X/SGKD>U 'H#,J#+,%&0,DXY/
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MI)*%90=N><GDY//6NHBU'4/$/B+Q'IEIJ4NG#2O*AA,4:,6D>/?O?<IRO(
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M];73+!&W)8VRGS?.R(E'[S^_T^][]:633K&4S&2SMW,V#*6B4^9CINXYQ[T
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M&?*<6:E67^ZV0.1SQ7K<]M!<JJW$,<JJP=1(@8!AT(SWJ Z3II,A.GVA,O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA0#D9XYS6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPO()-571]-:^?2W$<D0BE9IWV*[(A12%(5AUZGC ')9%XKUW4/$5UI6GZ);
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M?4VMV6WU6>V3RBWRA-J@ 'MCGW)- '42W=M!/##+<11RS$K$CN TA R0H[\
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M)/FQJ6/;(&<#W///%6;QY-%X9A\6"SB;0'F"MASYR0F3RQ-C&#S@[?0]<\4
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M81FUO;HWEQ'VDE+!]Q_%1^52:OX<T[6KRQN[M9UN;)F,$T$[PNH8 ,N5(."
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MW?8\CR[R9,]PNU0!TR3D'C'(V^H:CXBF\#RZE=W"72:K>6<LD#>6LQBCF7S
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M@K!=Q7DJ7 !^\#(&W$'W-6SX5TK[;I=VD<T<NF*ZVNR9@$###Y&?F+=RV2:
M.22+6)M>\3Z1)XEU/R=/TZTDAE7RUD#E),G(3N5!/'/KCBH-,U?63!X"UF?5
M[B9]9*0W=L500D- SY"@9#!E!SGN>W%=L?#.G_VCJ-^#<+<ZC$L-RPG8!D4$
M* ,X& 3TQUJO'X-TB*UTBV1;D0Z0X>R7[0_[H@%1WYX)'.>#0!7\3ZO/;:_X
M;T6*5H(]5N)5FG3A@D<1?8#V+' SUQG'/(Y/Q'K>MZ/9^-]-M]3N0--LH;ZR
MNOE:2,/N!B9B#D94D'[V#UXKT/6-$L=<MXH;Z-F,,JSPR1N4>*1>C*PY!_\
MU54N?"6E7NEW]A=)--'J&/M<C3,))L# !8<@ #H,#\S0!9T73[FRBF>YU2ZO
MFN&$O[\*!%\HRJ!0,+GG!S7+^'[K4?$^A6'B.+6WLI3?.T\+ -$(%D9# 5R
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MQ#<QR%&<Q_ZN4%2"KC )]\]15^'3(M*6YNK6&6[OIE57DFER\F/N@L>BC).
M.Y."3R 8'PWGD;3M=LB3Y&GZY>6MO[1A]P'T!<C\*K17^H>(U\6R0ZC<6,^E
M74EK9K$0 A2-6WNI&'W,3P<C &,')KIO#FB+H.D+:>8)9Y))+BYF QYDTC%G
M;Z9)Q[ 5%=>%-+NM0N[W;/#)>QB.\$$S1K<*!@;P#UQQD8..,XH XG1+ZY\1
M^-/"6K7,MS!)=^'Y+EX8Y"$#;X<X'HV<^I&.>*SH)M0TGPOJVMV6IW,+6OBB
M91;(%\J17O C!P1DY#'N,8&/4^EW7AG2[J_T^]:!XI[",Q0&"5HP(SC*$*0&
M7Y5X/'%4F\#:*^DW&ELET;.XNOMDJ?:7RTN_?NSG/W@#CID4 8<]UXA\33>(
M8]&OHK.ZTZ]^S6Q:Y*+'M5&R\8C8.&R>IZ=,$$D0:QK'CN_TUO$-W;6L>G6E
MVJV?E[0[.^X*Q7E#M[\G(Y[5MWW@30M0UHZM-%<)=2(J7!AN9(UN548 E52
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MD@D<#TY&!@YK2J*UMH;*UBMK>,1PQ*$1!T %2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'-<06
MRJT\T<0=@BEV"Y8G  SW)[5)7"_%..T.AZ3+>)'Y4>M69=W'W5,HW<]ACK0!
MUT&JZ==033V]_:RQ0$K+)',K+&1U#$'C\:(]5TZ5)GCU"U=8%5I6692(P1D%
MN> 1R,UYAKVFZ9'J_BZ]TN.T326\-/%=>2%$+766,?3@N%].1N7U%2WPLM'\
M#^$M:LH5BL4DM9-5N;*%7?8(6 =_E.X)(P)R"0>>M '?ZAJBW&@S7>CZMIB,
M" EU.XD@4AAN!*L.V1UZXJ^;^S$TL)NX!+$N^1/,&Y%]2.P]Z\H\36^@7?@+
MQ5JVD7,VH)>26TLMTX7RFE5U7,8"J-P7&X@<Y'.<UTNHW]GI'Q?@N-0G2VBN
M=#,$#R<>;()\E%_O-@CY1R<T =B=1LA9?;3>6_V3_GOYJ[.N/O9QUXKE--\3
M7^JIXK2*_P!*C&G3+%9WA!\C#1*X9SNYP6P2".E<-X<U6'3]&\ 7=[((]$@N
M+Y+F5QB."X+,(3)_=X+8)X&<U)JESI5SH'Q4\F2VDBDD66$K@J[&W3#+V)+9
MP1US0!Z[/J-G86L4NH7UK K ?O))!&C'';)I]UJ-E8VPN;N\M[> ])99513W
MZDXKSLZ_IFE>,6;Q#/&FEZCHL$5A<R<PG!;S8PPXW-N4^X4>U1WU_I_AGQ#H
MAN9;O1O#CZ2;:RF= RQ/OSL?S%8KN0(><'Y<'I0!Z?'(DT2RQ.KQN RLIR&!
MZ$&JR:II\EZ;)+ZV:[7.8%F4N,=?ESFLSP=8Z?IOAFVMM)^TG3P7:W-Q]XJ6
M)R!@84DDCCH17F=MK6FSR^$+FV=+2&'79U>Q4,\EL7$^1*QRV]F.=O'7 #8S
M0!ZZ^L:7'(L;ZE9J[2^0JM.H)DX.P#/WN1QUY%2I?V<MV]I'=P/<IR\*R NO
MU7.17BVIQZ0/ /Q%EB6S$ZZS+Y#+MW#_ %17;^(;&.X-=IXK:?0]?T_Q=HUN
M+S[9'_9MS'%@B7>?]'?(]),*3Z/[4 =Q;W5O>1>;;3Q3QY*[XG##(ZC(JJVK
M6#EH8-2LOM!5]BF93ROWC@') [^E+I>GQZ5H\%CN#K%'B1V&/,8\LQ]R22?K
M7GO@VRT";P[XFNFMM.D:#4]1Q*R(3'&SMC![*5Z8X- '?6-\(M#M+G4]0L7=
MHU\RYA8)#(Q[J23P>W-9'BKQ++IND6=]H]Q93K)?6T$A/[P%)9%3*E6&#SU.
M:X6QU2STGPI\--6GOX(H[6%HWCG8K$28"I)< A77H 1SN(XY-0WJ:%'X&N9K
M74]+NSJ'B2&YG%K*K+$&N%;R\\$A5R>0.I.,4 >LOKNDQV5W>'4K0VUGG[1*
MLRE8B.H;!X/M2Z-K%GKVDVVI6,JR0SQJXPP)3*AMK8Z$9&17 RK9KXR\:6>G
MB ";08<0P8^=P)AP!U(!7\Q74?#^\M;SP#H;6LJ2+'8P1.4Z!UC4,/J#P?0C
M% &W+J=A#>)9RWUM'=28V0O*H=L],+G)I+C5=.M)#'<W]K"Z[<K+,JD;C@<$
M]SP*\L>6*?P#XPT352/^$A-Y=.D#'$TTK-NMGC'4C_5A2.FW':M+3=/T^[^*
M,UIJ\-C=WG]@6HG615</.LCES@]6Z'UQB@#T>>Y@M8Q)<3QPH6"AI'"@D\ 9
M/<U6;6=+2S-XVI6:VJN4,QG4(&'4;LXR,=*Y3XKBS/A&'[7Y(_XF-IM,A ('
MGINQ_P !SG';-4/$%UIOA;QEI=Q-*-)T&YLY4CNK6"/REN6=6._*,!O4#YN^
M.O6@#OSJ%DJ0NUY;A9P3"3*N)!C.5YYX&>.U0?V]HYMHKD:M8^1,_EQR_:$V
MN_\ =!S@GVKS233_  ]8ZEX$M[+Y[!M0NFB:\QEXVBD.0"!A"YX&,<C'454O
MH=&.A_%,*ED2LDAA "\$VZ?=]RX[=QZT >N7FIV&G!#?7MM:^8<)Y\JIN/MD
M\]:6]O[6Q@\RYO+>U5N$>=PJYQ[D9KRLZSIJ:U?6GB759K2PU;2[5;.8(CQ7
M,?EE9(PQ1OF#EC@$'YJT+"]LO#?CFP@U662TTLZ'%!I4VH-M (8^8C,>!(5$
M>0><*!0!T?A#Q6-6\.V]YJ]W8PW<US<0HJ.(U<),R#:&8D\ =SUKI5NK=[I[
M59XC<(H9H@XWJ/4CJ!7E&@:2-7^%(.D*@U/2=2N;RP 7&V1+B1E3'8,IVX]&
MKNO",YU>Q?Q'+ \+ZJ$>*.0?-' HQ&I^N6?_ +:&@#7?5-/CFEA>^MEEA7=*
MAF4%!ZL,\#D=:!J=B\,4D=_:E9FV0OYJE7;T'/)]A7(>+(KG2/%VF:W86GV@
MZC"^D7$>W(+,"\+-_LA@P)[!JJ^!K"[LKA_#M\KM:^&9Y!;W$@ $RR+F%O3*
MQO(I^JT ;7A+Q2=4L7&KW5C%?F_N;6*)&\OS1%(4&U68DG ]ZVK>:X?6[V)[
MRSDMTCC,=O&/WT1.[)?GH<#' Z&O'W?3!\/KV]5K7[6OBGS$F!7>!]M!!!ZX
MV$GZ$FMZ\,DOBCXAPZ')'_:,^C6Y@$##<\NR;IC^+E>?<4 >BKJ-K>//;6%_
M:27D:G*!Q(8STRR@YQGZ5B>"O%2^(/#6DW.H7-G'JE["TQMHW"D@,1E4))QQ
M67X7UOPEK8T>\L47[?IUD8G'S)]@3:-ZR= .5  /U'&37&:(VFVW@3X<7*-:
MQW7]LQB20%0^")0VX]<<J#GV]J /5_%>IW6B>%=3U6S$+365M)<!)E)5PBDD
M<$8SCK7/:AXOU?0O#.F>(M0BL;JPN?(^T10(\4D0EP 5RS!\%AQQ6E\19HH?
MASXB\V1$WZ?.B;CC<Q0@ >I/I7G>O)I+^ =!NM"U*2]\26JVKV-DEVUX&EPH
M8&%F90 "W.!MQU% 'L%SJFGV4R0W=];02R8V)+,JLV3@8!//-+<ZG861<75]
M;0&-/,<2RJNU,XW')X&2!GWKRCQSJ5M+#XWL&6.RU'^S(3,GS227F(RP,8/"
MQID@D#KDDKC)UK631=0^*=K<2FSF5_#@<M*%^9O-')SU.W)SZ>U '2ZQK]U:
M>(?#%O926LMAJL\D<C[2S$"%I%*,#C!VCL:W[>]M+MI%MKJ&9HCMD$<@8H?0
MXZ&O#K.XEF\)> K72=2M;;45O+Y('D(81'9.J9&>!RH'U'7I7J'@76]-U;0Q
M%:0K:7EL[17MF7W/%,#\Y8]6RV3OYW9SG.: -VYU73K+S?M=_:P>4H:3S9E7
M8"< G)X!-"ZII[745JM_:FYF3S(H1,N]T_O 9R1[BN(6/1W^+VLBZ6R9?[&@
M,@E"XW>9+N)SWVD9]C7)Z.VFV_P_^'%RK6T=T-7@$DN5#@8D5@3UQC:#GMCV
MH ]C&J:>;[["+ZV-WS^X$R^9P,GY<YZ4L6I6$YF$-[;2&#/FA)5/EXZ[L'C\
M:\@N-:TZ;^Q9H'2S2W\5EIK$!GE@8O*&>9CD@N3D*,##8&[''3Z[:WVA^,7?
M2H7\CQ3&+25XQ_Q[W2 XF_[];R?4QB@#O8;F"XMUN(9HY(6&1(C J1ZY'%5X
MM7TR>XBMX=1M))IE+Q1I.I9U'4@ Y(X/(]*?]FLK/2Q:F.*.QAA$>Q\;%C Q
M@YXQ@5XUHATRU\"?#BYC-K%=#6(A)("H?&)0P8]<<J#GV]J /99M3L+>[CM)
MKZVCN9,;(7E4.V>F%)R:1]4T^.6:)[ZU62%=TJ&904'JPSP.1UKR]IH9?!OC
MC1=8*_VX]W=/' W^MG9N;9XQU;H@7'3;CM6IJEKJFAZIX>U4V_VN]U"P&C:@
MN-RM,4W1NW^R'#@GT:@#O5U/3WCAD6^MF29MD3"52)&]%.>3["L;Q9K5]HK:
M(UG]G,=YJD%G.)4).QSR5((P>.X/6L#P)87EK<MX=O4D>W\,SR);SN/]<)!F
M%A[K&[J1[BK7Q+>U^S>&XKMXA&^O6FY9",,H)W9SVYY^M '6V^IZ?=6TMS;W
MUM-!$2))8YE94(Z@D' Q34UC2Y;62ZCU*S>WC;:\JSJ44^A.< \UY9J]]I.F
MZKX_22UAN+/.FEK>-RB*>A=MG.U3M+8[#!ZUK^&I+'5_'7C"SN+N+4(=1L;,
MEDCVQSILE5RF,Y7D#.3VY- 'H']H612!Q>6^VX.(3YJXD/HO//X4B:G827S6
M,=];/=H,M LJF0#W7.:XCP;#JDMHVDW:,)O#7F64,T@^6:3;B*0?2$K_ -_#
M6-X0N=$UFU\.6-[?:@?$6CR+OT\HJ20S ;96<A 2ARQ)+'=GNQH ]8DDCAB:
M65U2-!EF8X 'J35>#4["ZMGN;>^MI;>,D/+'*K*N.N2#@5R_Q%DGM]/T:[VL
MVG6VKV\NHA1D" $_,P[JK;&/TSVKG_$26MWKOBG4[.6WETF3PTT=W(K!HI+G
M+>5ST+A<^X!7U% 'I-MJ%E>NZ6EY;SM&%9Q%*K%0PRI.#QD<CUJ.YUC3+/S?
MM6HVD'E%1)YLZKL+9VYR>,X./7%8W@.RTV'P?I%U8V]LLD]A;B::%%W2%4'W
MF')();KW)KE'BT=_%OQ&\]+(_P"@6^=X7KY4@?KWSMS^% 'I"ZC8O??8EO;=
MKO9YGD"53)M_O;<YQ[TV/5-/FO&LXKZU>Z3.Z%9E+KCKE<YXKRO39--MK+X5
MW$36R7! $KJ5#G-JP8,>O+8!SWQ573-:TVXOO UU:R):V\6I7*&Q0,[VI>.7
MY)7.6,C,>G&<\ XS0!Z]%JNG3P2SQ7]K)#%_K)$F4JGU.<"H-9OY;;PY?:CI
M\D#R16SSPLX+QMA2PZ$9!QV-<7=Z;<Z9XOOO#UK;L=)\3G[4SJ/E@9<"Z!]-
MZ;<'^\QKK_%#QP>$-89V6.-;*89)P!\A H C\-:_#K&C:6\UW:G4[BPANIK>
M-QN7>BL3LSD#)K0CU33Y;UK*.^MGNESN@692XQURN<\5Y?I+:;:W?PKDMVM8
MY7LY%E9"H9LVO(8^[@#GO[U1L=:TVXN?!=S;.EI!#K%PC6*AG>U+I-E97.6\
MQF.=O'7 !QF@#UZ+5=.FBEEBO[62.'_6NDRD)_O'/'XTD^KZ9:K"UQJ-I"L^
M/),DZJ),]-N3SU'2N(N+"YTWQSJ&B6\#'3/$R"Z=U'RPNF%N ?3>FS!_O&L_
M5[[2[?Q;XFT7Q3J%Q86FI1PBS B4I<P>4%:-"48[@^_@$'+9'- 'J9( R3Q6
M5I=^5TJVDU+4M.FGED:,36S;8I&WD!5RQR<8!&>H-3:=!!;:!:V[K(MO%:HA
M6[(+! H&')ZG'7\:\>L3I4OP\\"1S-:,J^(2I5RO">;-D'_9P5SVY% 'M%G?
MV>H1-+97<%S&K%&>&0. PZC([^U9\OB72X_$2Z!]M@&HM 9O+9Q\O("@C/4Y
MR!UP#[5SWA)[./XB>-;:T:%4WV;B*(@#/E88@#W !I;JYMK+XRP-=.L0N-#\
MN$L/]8XGR0/4@')]!STH O>$?%)U730=6NK&+4'O;FVBB1O+\P12,@VJS$G@
M>]=!/J=A:W,5M<7UM#<2D".*2559\^@)R:\9#Z6OP^:]5[472^*?,68%=X'V
MW.0>N-A)^A)K4N+O1[O4/$WASQ3J%[!->7QF@MHXU)O(2%,)B;86)&T# /!'
MUH ]8FGBMH6FGE2*)!EG=@J@>Y-<;X;\6W/B%M-U*/4=(33[SS%>R=\7$?)$
M>T[CN8X&00.O%=?OCM[(/<.$CC0%VF8< #^(]/QKQW3;FUB^$W@6\>6)8+'5
M[:2[ER,0*'D!9S_"!D<GUH ]7OM?TG3K&]O;G4+=(+(9N&\P$Q^Q'J>PZFET
M[7=-U."VDM[VW9[B,2)$)E+XQD\ ]N]>;7EY;:I<?%(63B?[1I,30[ 3YH%L
MXRO]X<C!'7(]:M2ZQID6H_#O5WO((]-C@N('NV;;$KM F%+'C)*D?4$=10!Z
M*NJ:>\(F6_M3$9!$'$R[2YX"YSUY''6F-K6E)9?;6U.S%H6*^>9U\O(ZC=G&
M>#^5>-WEQI=SHFI?:&AQ_P )NKXF&UA&98]QP<$# .?H:ZK7[K3O"OC33I;F
M7^R-!N+&6.&YMH(_)2X:0,X;*,%WKCGC.V@#T6.:.6%9HY$>)EW*ZL"I'J#Z
M56_M;3?LXN/[0M/(+^7YGG+MW?W<YQGVK-\&V.G:=X:M[?23<G3PSM UQU96
M8G(&!A222..F.U>8:SJ-E:^"/'.E33(M_P#V\\_V7&9!&UQ$ROMZ[2/XNG;K
M0![#<ZOIEGYOVK4;2#R=OF>;.J[-V=N<GC.#CUQ4EU?6MG;^?<W4$$1X$DL@
M5<GIR37FKKHESXS\>22BQD5M*MF#/M()*2[CSWY7/U%4O#FMP:=?^"+O6+I(
M]);PXL%O<S.!%'>?)O#,>%8HN!GW'<T =OX1\23:OI6J7FI3V:I9ZC<6RS0_
M)&8XVP&R6/7KU[UN)JVFRV8O(]0M7M2VT3K,I0G.,;LXSFO'K74H=/TF6^AD
MECT>S\7W4MXUK&&,,+;Q')M*D; Q4]#C (Y%6O%,?AJ;P7K6IZ=>O>1WVHV4
MKW4I41O()D#F/"J,A!\Q4?CD&@#UVVO+:]C:2UN(9T5RC-$X8!AU!([CTJ-M
M3L$OELFOK9;MND!E42'C/W<YZ46%E865N5TZVMX()6\TBW155R?XN."3QS7D
MN\WGPHU+0[I@/%L5]*?)SB=KLSEXY$[D$%2&'&T'G H ]9EU73H9_(EO[6.;
M>L?EM,H;<V=JXSU.#@=\5%K$]Q!:PM;7EG:NUQ&I>[&592PW*.1\Q' ]ZXGP
M]8Z3=_$[Q6EU!8W%U&EA(N45L2*C%F4=B&"DD<@XJ]\4&M8]#TN2<Q*Z:Q9L
MC/@$ 3*6(S[9S[4 =7<ZOIEGYOVK4;2#RMOF>;.J[-V=N<GC.#CUQ5P$, 00
M0>017ETT6BS>,_B TZV+_P#$LMSE]IYV2[C]>5S]175^!YGN/AKH302J\W]F
M0J&)SAQ&!@_0]: -U=2L'OC8K>VQNP"3 )5\P#_=SFA]3L([U;)[ZV6[;[L!
ME4.>_"YS7G7@C4] U31M TN^@=_$NE2DRVK!Q-#<#(DE?'8Y9B3P<CJ<"LLO
M]K^%>L:'>$?\)7'?3'R<XG>Z,Y>*1!U(P4PPXV@\X% 'J]SJ^FV7F_:M1M(/
M*V^9YLRKLW9VYR>,X./7%/FU"RMRHGN[>+>A==\@7*@9)&3T YS7FP@TMO&W
MC)=0%C)*NCVWF%PN"^V42'GORN?J*SM#;3+N\^%OVEK6:0:3.DGF%6.X11!0
MV>X(. >X- 'K4>H64UB+Z*\MWLRNX7"RJ8\>N[.,46^HV5W:&[MKRWFMESF:
M.5608Z_,#CBO'HM0CT[1[BZ@E==(L/%]R]W]D57\B []C[<$; [*W0],CI5_
M5I=*ATNX\1:)/>:GILNKV=UJ\RJ#'+&F0Y554 [<1EL#!QSR#0!Z#J?BS1-+
MT"[UJ74;:2SM@=SQ2J^Y@.$&#]X]A4POVN=6LC9ZEI[V4D,C-$&W2RL" &0A
ML;1\V>#7!>,)M!UKP'XPU7P^GVI[JUC-S=P[BDI3@ 9XRJYS@<9&?;0N-0TN
M\^*GAB[LKBV=9]-NP)$(^<$Q[>>X.&QZ\XH [<ZG8+?"Q-];"[/2 RKYAXS]
MW.>E,N=8TRS\W[5J-I!Y142>;.J["V=N<GC.#CUQ7DP9[[X1W.B3,!XOAO6_
M<YQ<?;/M&Y9%[X((;<.-N>< UH30Z0_BCXB_:EL7<:;;Y+!?O>5('(SWSMS^
M% 'JP((!!R#T-%<_X%F%QX \/2"02'^S;<,P.?F$:@@^^<YKH* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *PO%&@3^(;6QAAO8[7[+>PWF7@,NXQL&"_>7 )'-;M96NZ_;>'K>VG
MNX+AXI[B.V#Q*I".[!5W9(P"2!F@#31=B!<*,?W1@4[K6)'XGM)-6U733;W,
M<^F0K/,9 @5D8$J5.[D':>>,8YQ5+^V=/N?%&D*\&J1:A-833P0L2D93Y"P=
M=VTORN.N,]J +.N>'KC7'-I-?QKHTBQB6R%M\[,D@?(DW# . "-IXZ8-;Q )
M!(!(Z>U>6:YXIO=<^'%SJYM[W37@U2.)&CFQE!=B(J=C$M\H(((QD\9KNM*\
M2VNJ:O>:6+6\M;RU1)3'=1A#)&Q(5UP3QE2.<$=Q0!LE5*[2H*],8XH  Z#%
M9FI:Y!IU_:6 M[BZO;I))(H( N2J8W$EF51C<HZ]ZRE\?:1);Z+-#%?3+K ?
M[*([<D[D5B5;T/RD=_RYH Z@J&QD X.1FAE### $>A%<H_Q TV+0;O5Y;+4(
MXK*[^R7<31+YEO)D?>&[&WYEY!(P:WCJ:#5X--\B8RRP-.7&TJB@@?,<YR21
MC@YY]#0!>I,#T'K7$^.Y;B'7/"*07EW;I=ZHMO.L%P\8DCV,V" 1W YZUV<L
ML5K;/+-((X8D+.[MPJ@9))/M0!)6(VBWUQXA-]>:LTVG1LLEMIXMU412!=NY
MGZOU) /0D>@J*'Q?827.FQ36]W;1:G_QXW$Z*(YSC<%&&)4E>0&"D_7BF1^-
M--DNK6,0W0M[J]>PANRB^4\Z;@5^]N'*, 2N..O2@#HZ*Y&\^(FEV::I(UCJ
MDD>E3>5>NEMQ$,!MYR1E<,.G/?&*ZL[)X>&)1UX9&(R#Z$<T 8FM:)J-[JEK
MJ6F:N+.>")X3%/;">%U8J22NY2&^4<ANE6]*TIK&2>YN9TN+VX5%EECA$2D+
MG: H)P!N8\DGGKT XOP)I\^O>%KJXNM9UA;P7US#'<+?2$HJ2,JX5B5. !U!
MS5KPGXVF;3+ZTU]Q-JNG:HVE;H$ -X_\#*O0$C)/0#:3P.@!WM%84/BW3"=4
M2\,MA-I:"6[BN@ R1D$AP5)#*<'H3R,=>*C/B^VCNY[6?3]0@N([(WRQR1IF
M6$'#%2&(!'&58@\]* .@VJ6#8&X=#CFEK!B\7:?,= *1W.S7(_,M'V#'^K,F
M&YR#M'H:S9?B-I,5G<WK66I_8[2\-G=3_9P%@<,%RV3G&3C@$CN!Q0!V%(RA
MAA@"/0BL"#QAI[ZG>6%U#=V$EK:F]+W<019( <&1>20 >H8 C/2A/%UG_:T.
MFW%G?6MS<V[W%JLL:_Z0JXW!0K$[@"#M8 \]* .@HKDM/^(6E:D-(EBM-1CM
M=5D,5M=2P!8S)AB$)SG)"G& 1VSG(JSX:\2W.NZIKEM+ILUM%I]Z;9'=D(.$
M0\X8G)+$\#&,<YXH Z,J&QD X.1D=*"H;&0#@Y&:6B@#'US2M1U3[-%9:R^G
M6HW+=1QP*[3HPQA6/W".>1GK6K#%'!#'#$@2.-0J*HP% X %/HH ,48HHH *
M*** $"@9P ,\G'>EHHH **** $P/04M%% !1110 4444 )@>@K%LM%ODUN;4
M-2U9KY%=S90?9UC6V5L9&1R[ # 8]B?6MNB@ HHHH 0JI8,0-PZ''2EQ110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\^
M\;^.?$/A&:&^3P[%<:(;E;9Y#<?OW).,J@& ,CCDD\=,UZ#7DGQ(FTKQEX>F
MO/#WB"?^V]&NPL%M;S,K-.K[=OE'!+<G# ?B10!ZQ+*(8'E*.P12VU%RQP,X
M [FO.K;XA:_:>/M/\/>(O#2:?!J@8V<L5R)6& 3A\<9]<=,CJ*Z.#Q?I]KK5
MMX;U.X*:R-/%W.=F(@ /F.[H.A/I7!Z7X_\ "/B3XDV]^;N2YOHW^P:3:I ^
M$#-B29F(QEAGOPH]3@ 'L-%%% !1110!6U"6Y@TZYELX5GNDB8PQ,VT.^. 3
MV&<<URA\1>(QXR3PV;72O/;3C?\ F^9)MP) FWIGJ<YKM*X)[B$?'F%/-3?_
M ,(XZ[=PSG[0IQ]< T :%OXEU2/Q78:3JEM9VL4VFS7<S*[$H\;HIPQP-OS$
MYQZ=*WK^XNC!:2Z=-9;9+B,2/<,=K1$\["O5SQM[5R6LP6%[\7=(MKU()D_L
M>Y)BEPP)\V+&5/7H3SZ9[5Q]HUB/ _A;YH,6OBX1P'(_=I]JDX4]AMQ^&* /
M9GN[:.X6W>XA69AD1EP&(Z=.M35YCJ4\^F^(KF\MWL]8TJ?6;=;JS<;;NRN<
MQHK1D?>7A6VGG;GMFO36940N[!549))P * .;\3>,+?PWJFBV<T3.E_<B&64
M=($/RJS>F7*#G_:]*Z.21(EW2.J+D#+' YZ5Y[=Z+<>/-"URZAO[ 66JCR;=
MG@:1DCB)$;!PX ^?=(..-_/2L+4_$5IXJ^$VDWM[) =0M]2LX+K+#=',LZ*Y
M![9 +<=C0!ZR;^S6.60W< 2$[96,@PA]&/8_6GRW,$$!GFGCCA SYCN N/J>
M*\]ATC0/^%KZI9M8Z?\ 96T6"5[<QIY9<22C<5Z9"D#.,X/O7,>'-9@LM%\"
MRZOJ36NCOI]Q ET=C1QW =0H<NK*O[L, 3CN,X)H ]J\^'9&_FQ[9/N'<,-W
MX]:(;B&XB\V":.6/D;T8,..O(KR6ZTCP[;-X,M[&<WFGR:W+Y4MR4(>-XI"R
MQX !BW<8Q@^X(JIJ<\>EVOC2WL$5-*AUZS:]AMAPELR1>=A5Z X(..V: /0[
M?Q+)<^/O[$A:SEL#IK78FB?<^\2*A4D' ')_2N@2\M9)$C2YA9W7>JAP2R^H
M'<5YQ)=>'KSXI2/;SZ=-;W/AJ1',;HR28E4@''!^7MZ>U<_IUCI'_"%?#*X,
M-J+B:^AAFEXWR(890R,>I4X4$'CH* /:(;F"XB,L,T<L8)!='# $=>138KVU
MG@:>&YADA7.Z1) 5&.N2.*\?U>:'2-1\9Q6*B'3+;4]-FO8;-%.R HOFL$P1
MC@;AC! .>]6O$-OX8N_"/C+5M*U8ZH;G3,SL#$8%D53Y9^10!+^N,9QQ0!ZN
MMW;,\B+<1%HU#. XRH/()]!571]:L->L!>Z=<)- 7=0RD'.UBN?H=I(]17#6
MUKI=G\0_"ZV<5K']MT6Y6?8%_?C,1&_^]_$<G/>K_P )9+(^!+6&W,/VF%Y5
MN43&Y&\Z3 ?'0X['M0!VL]U;VP4W$\40<[5\QPN3Z#-8#^(YXO'@T:7[*NFM
MI3WXN"QW9$B)R<X"X8G\JR/&BW2ZVMWI=YI[WMOI\GGZ7J0_=75N6RVUOX6!
M7!/(Y7-9>GG2]:\?:";FRC2"3PKYBV=UAC'F6,A6!ZD#/4=LT >DR7=M#;?:
M9+B)(" ?-9P%P>G/2L+Q?X@N="\/QZGIZVTX:Y@B)D)*E))%3(QU/S9ZUY]X
M;U73+7PWX,@GEMXY!>:@MK<W,N+>W"/(N&&0&;8P"@D=R#Q@UDO;4?"&[MQ=
M1'[/XA";<A=@^WA@,?P\<X["@#TR#7+Q_']UH$D4 M8].2\CD7.\EI&3![?P
M_K1XVUR\\.>%[C5;**"62%XP5FSC#2*G;O\ -FLN":)OC1=HLJ%O[ AX##/^
MOD/]1^=/^*@S\-]5SG:# 6(., 3(2?; [T =;%<03O(D4T<C1G:X1@2I]#Z&
MDCNK>::2&*XB>6/[Z*X+)]1VKS/6-)CM?%,ESX(@@BG.A7GVHV( 1G*C[-G;
MP7+;B#U(!J7PC)X7UJ^\.ZAI^L7$NJ6=N\9LXQ$K1*4PZSJJ!MH8<9/WL8SF
M@#TVH8+JWNE9K>>*8*=K&-PV#Z'%<S\2)KFV\#7L]O'+(D;PM<I$,LUN)%\T
M#_@&[/MFN=\276DZEX:\1:KX)E6ZU272UCDEL)"56-6SMP#@2;"^.-PQVXH
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M/=(YQL4R ,=W;CO7-Z[9:3H&M^++BQL2-!.@HNH6NGGRD,YD(7E>%/EY)P.
M<D<\@'J\%Y:W2.]O<PRHAPS1N&"GWQTJEJ7B+2=*M/M-U?0A#)'&H60$LTA
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MBAEB$V)5VLJD9^8=B*R-.\9:=J5U8PI#=Q#4+9[NRDDC&VXC7&2N"2#AE.&
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MQCIOVS3HGCN([?4G,=E>,@\F=\$@ @Y&0"02 &[$T ;4UI;7)4SV\4I4Y&]
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MFQ(^.FY0<5GZ#KMIXATTWMHLT865X9(ITVR12(Q5E8=B"*QHO$>CZ?/XJO\
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MVWBW3KG6O!>LZ=:(/M5W8RQ1(Y ^=D( )Z#FMNB@#SC4],US[5H&O)X:2_\
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MO,;RVDCD0;9&C"-'(&8$#*C!&1CWXJIHGA74O#^M^%(EMI+FTTO2)K2>Z1T
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MM5U7PFZ6?A>/3YYKVUE%G$\(D"12J[,[!@N< @ $_K@:T=GJ*?$F[U@Z;/\
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MAW4KS2I[ Z3YMQ,CR1L7E:/8(T*L<C))R<# 'J<=G3)98X(7FF=8XHU+.['
M4#DDGTH \^T[PWK#_!B^\.36)M]3>VNHTBDE0AF=W9?F5B.=PZU;^Q:S=^)_
M".HR:+/!#8VMS'<AIHB8BZHJYP_/*'IG@CZ#M+6Z@O;2&ZM9DFMYD$D<B'*N
MI&00>XQ4M '+>"-.O].@UM;^R>V-SJ]S=PAG1MT<CY4_*QP?8UBW>B:S*OQ$
M":5,?[9A"6/[V+]X?LPB_O\ R_,,\XX_*N[N+^TM)[:"XN8HI;IS' CL 9&
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MMUDGT^*-O+DM)9?/D=!((PR$!/E*C<<\MTP.6CQ-X@O/$EII%KI]G9O<Z/\
MVA_IA=G@?>JE&5<9P6(P",]<CH1_!>JVVM'5-'\1BPFN8(H;^,V8ECG,:[5=
M06^1MO'4CI6C'X9N(?%<&MQ:B"(=-.GK%-"79@6#;V?<,G*CMZT <M+XJUO6
M='\&7MO+;6+ZAJC6MW$(FD4M'YHX.X'9F+..O(YX.=M/%T\WBJXT,3V-O>6]
MS&@L[F-DDN82%+2Q,6P>K84 _=YJ"W\ 7-MH&CZ?%K*"XTK46OX;@VF58L9"
MR,F__IJW((Z"KNI>#Y]8DB34=0AN((+Y+RW<VN+B':P;:LF[ !(P3MZ$CTP
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MUGPAX/GO;^"XM-/MH+B&&&':?-6+:N]MQSLW'@ <@'MBM_P]X>FT&YU0B_\
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M<=>V.>\&[:,D%L<D#C-<SIG@\6VE:]INH7:7EMK%S//*J0F(H)AAE!W-GV-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **CAG
MBN(A+!*DL;9PZ,&!P<'D5)0 4444 %%%% !115-M6TY'*-J%J&!P09ER#^=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*HQAAAE.0 O?MUZTGC#P'<^+;&2PNKRUFMWAC1)+BW)FMY03NE1E('S @;<
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M@,<S,\<BQ"0AP1C!!/3.,51T#Q=J<'AVXO\ 5O)N;B?6);&W2%7^_P"<R 8
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M]AMB8WN0J=3(&4HJ$@GGG@<]*XN'5]:N/!?AN5M7NXKEO$?V"65'#-)$+B1
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M6\@0%P8N00,@_,>>H[8KGKK4]0D\$>')YC/J=W9^*#!'O<>9.(I)E0%CQN(
M&30![%17-^#+N'5]&&LI?3W$MVS-+'([!;9\X:((3\NTC'K^!%87C.^NA+XA
M^PZE=M/8:1YZPV\AA2S?$C"1V!^<MM&$P1A><!LT >@T5YMKFLZM#8V.J745
M_<:3+I,;W,NESE)[*9@29C&"-Z8QZ@;#QUKOK9H=1TF%XIVE@N(%99HV*%U9
M<A@1R,@Y]: ,RU\41WM];QVFG7L]E/-+;K?1(K1*\98-NP=RKE6 8C!(]P3L
MW4_V6UEG\IY?+0MLCQN;'89(&?QKR70KZ70?AGI,EK/<1MJ6MFQEF:5F$$;W
M<@9E#$A3@$9QU.:ZAY[S2?'K:-%<7%QIE[I,MT8YY6E:"2-@N0S$G:P8<$]1
MQB@#0B\<64NE>'M16SN_(UR:.& X7]VS@D;_ )N.%/3/2NGKR.P_Y)W\+_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 0 5)(& 3C &,U6L/!.A:=>65W!!<-/8HT=L\UY-*8T;&5&YC\O XZ"NAHH
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M:-:O;6,31Q/,\S!I&?+NQ9CEB>YZ5=HH **** "BBB@ HHHH **** "BBB@
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MVYN+VYAMH1UDFD"*/Q/% $]%4YM7TVW6W:;4;2-;C'D%YE ESTVY//7M5R@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU]* *9UN:+Q=JUG_ &19?;;72HKH7*RX:=2S@(S;,J 5;'WNM4M)\<:G>?\
M"+W-WI5M#8:\NU&2X+21R>69!E=N-IVD=<]#[5IS^';]_%>IZS'<6VR[TY;%
M(F5LKM9F#$]^7/'MUK/M?!>HVVF>$;/[9:M_PC\@=FV-^_ C:/ '\/#$]^:
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M1/8V#6L:ZG=0RW#!!)-''&C!0PV+EMQ9<<#C)] 72:-K5S:1)J%SIVH^;O\
MMMK- 5MY 0H54!+%0NW.3NSD],C&+%\/M0TBST:;P_JT5OJ6F+-$/M$3202P
MROO,1&=P53C:<YXH F_X3G5Q9:*\GAUH+F_U!M/DBN)'BVN%9@Z[DR48+G/!
M&>AK/U_QEKL?A/Q.JV]K::KI-S%;2/%*SH4E"$.A(!W8D[]",^U;VH>&M6U
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MEUS4H]4\/7,.ISWD-]K$UI/< !;::,B4JD:$Y^38HW@#)!Y;-17W_'I\7/\
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MH:I(L\<ZQX*^0[!1M0$ ,N0,]ZSM:US4K6Y:\L]3GN=GB""T9XP%MXXF=$:
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MIUQJ%[*(K6WC,DKG^%0,GZUSVJZI-/X\TWPV)I+>VEL9KR5XVVM*5955 W4
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M%%IJ5CJ!D%E>VUR8CB00RJ^P^AP>* *+>&-,_M'3;V..2&3386@M%B<JD2,
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M178C2\^VQ1K>2A(9<DDH V%R2<X]:Z!]1L8XHI9+RW2.8%HF:50' &XD'//
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M-++>VD%Q';S74,<\O^KC>0!G^@/)J)-6TV2&69-0M6BA_P!8XF4JGU.>/QH
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MBB]4KM/4#9DC';-=SX?NK6+XH^++=I$$UREG+ O>1!$067U7/!/3./6NYHH
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MUE9R<-(#C!_^M6P+%]>TG5M-U/2C8V%TKPI"[(TC!P2\AV,P&68X&<_+GOP
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M0&N?U#1?$-^?'<G]BO'_ &WIT,%HGVB(G>(G4AOFP,%QGDC@X)K6U_3-6O=
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MW90+<21V]OG<C9Y4D@'[I_IDU93Q5IUQ::7/9B:[?5(O.M(80 [IM!+'<0%
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MAGN(Q):[MN')!(DR74_*>YZ8Q0!W%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !679^'-)L-9N]7MK)$U"\_UTY9F+=.F3A>@SC&<#-:E% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4V1%EC:-L[6&#M8@_F.13J* (1:6XMDMA!%Y" !8
M]@VKCI@=.,5-110 4444 %%%% $45M##-++%&$>8AI"O 8@8R1TSC SUX'H*
M=-$D\+12 E'&& )&1^%/HH :B)%&L<:*B* JJHP !T %.HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%U'PGHNJ
MZB-0N;61;S:$,]O<20.RCH&,;*6 ]\UHVVG6=I##%!;1(D))CPN2I/4YZY.3
MD]3FK-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML'&!0!-14+W5O%+'%)/$DDO^K1G +_0=Z5[F!)!&\\:N2%VEP#D]!CWP?RH
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M;L=+ETV *F'%P@(F9,>K*H'NE>F[5+!MHW $ XY /_ZA0JJ@PJ@#). .YY-
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M;]BG:/\ =W'EYW[3UZ GD#('&:Q7\:6FJ>&O$EQJ$>J:9964\UJT]NC"5 @
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M=(6A:)I"X=\G?O7., ') Y YKM/%D-Q<^$=7M;6WDN+BXLYH8HX\99F0@=2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7SY\6I/%(T:X?5?#\,4$NJQ^5?"]5RR*7$48C RHP23SU)/?CZ#J&Y
MM+:\C$=U;Q3Q@[@LJ!AGUP: .?/CC2+*]CTO6+F.QU9=/^W7-L<NL*A<N-X&
M#C!^H&:X[6[6XG^)/A+Q3X;UN2_AU"0V\T <21K;8W.R8^ZH YS_ !;>_%>G
MO8V<MR;F2U@><QF(RM&"Q0]5SUQ[=*CL=(TW2]_]GZ?:6F_[WV>%8]WUP!F@
M"Y1110 4444 %<*[+_POB%=PS_PC3\9_Z>5KNJJG3; W?VLV5L;G.?.\I=^?
M][&: ..UNPL]3^+&DVM]!'<0-HUR6AD&4?\ >Q<,O1A['CCVKD=-U*/3O#/A
MFWO;E+?0EU>_M9995#Q1[9)! KYXV^F> 0I["O8)-.LIKD7,MG;O.!CS6B4M
MCTSC-,&DZ:+22T&GVGV:7_60^2NQ_JN,&@##\%Z?INGP:DFDZD;ZTENVE_=[
M?(A=@"R1;> .A(' )/O6?(8K_P"*E[IFM0136ITJ-]/BG4-&_P ["8@'@M]P
M'O@#M79V]M!9VZ6]M!'!"@PD<2!54>P' J.\TZQU%$2^L[>Z5#N43Q*X4^HR
M.* /'X++[3IOA&"_)GM5\2W%M9O(Y)DLPLP0$]2IP![C':M_58-'\/>,+*PD
MCLGTE=&DABTV6>-!"QER7 E8 AQE>#D;?2O09]-L;GRO/LK>7RN(_,B5MGTR
M.*YO6_#>IWVO/?1IHVH6DD*1BUU2V+>1M))*,,_>SR".PYXH Y73[+3M$L/!
M^CWUS9W-\T-S-]HEF#6;,%4.S9_UK $*O(_B.161IXM+[P)X)BDF25X?$OV?
MY)""J>;/A1@Y P%P,] *]2TGPQI^G68BDLK%F\\W(6*V5(HI" ,QISMX4=\D
MY/>K[:1ICJ%;3K1E#F0 P*0&/);IU/K0!YI<6%C90?%/3+6"*"QALHYX[>(!
M4C=K5B6"C@$E0?J*M:FUI/H/A[3+&RL[OQ%J6FP1027$2RK:0!07G(/0#=Q_
M>; YQ7H1TG36:5FT^T+3?ZTF%<OW^;CG\:8^AZ3($#Z79,$7:NZW0[1Z#C@<
MF@#@6LO#.B:AH/ANU>!C:6UR1)?.#;Y^02.ZG_62Y/0$8!?D=*YW2SIMYX1^
M',M^;2=(=4EMY7GVL$7;/M1B>@X7 /H*]C&DZ:%@4:?:!8&+PCR5Q&WJO'!]
MQ3CIE@;<6YL;8P!_,$?E+M#YSNQC&<\YH \PU:2ZL;[XFS: -MV-/LI(O(ZC
M,<FYEQWVY(QWK3N;:Q&N>";WPTD2K>;TG$  $UF8BQ,F/O8;;@GHS>]=]'8V
M<-S)<Q6D"3R??E6,!F^IZFF6VE:=9-*UK86L#2_ZPQ0JN_ZX'- 'C<&FZ?;^
M [;58H8UOK;Q/L@N<Y>)?MQ4JI[*5)R!P<\U9\57^FO%K5Y:300W-KX@ME>6
MZD#7/F+)"K>7T,<87..N<MT!KUC^Q=*\KRO[,LO+W;MGD+C/KC'6G/I&F2-,
MSZ=:,TP592T"DN%Q@-QSC QGTH Y>UECE^,=T\;JZMX>@92IR"//DY'YBG?$
MF_:PT736D8IILNJVT6I/T"VQ8[MQ[*2%!]B1WKJA86:W9NUM(!<D8\X1C?C_
M 'NM2S0Q7$+PS1I+$XVNCJ&5AZ$'K0!Y+KDL6F^+O%3^&/LZ7S^&5DB6U*Y,
M@>3E0/X@N#Q[5HSQ6JR> ]3\+K$MQ<RA)#%@>=:F%FD,F/O88+R>C'U->@VF
MEZ?8$&SL+6V(3RP8853"Y)V\#IDDX]Z6UTRPLII)K2QMK>64YD>*)49^_) Y
MH \X\'3^'M;T30[C4;A1XFM[QC<(KA;IKG++(KK]XI@DD= H'85A:I-IUM\.
MO%UI));1S0^))3%"2 T8^TQD%1V&W/3M7LD>FV,5])?1V5LEW(-KSK$HD8>A
M;&33)-(TR6>:>33K1Y9PHED:!2T@4@C<<<X(!&?04 <(=(TC5_B-XHBN[6WN
MK:32;64H^&1B3+\V.F<8P>W:L+1[6VA\-_#+6411J<]Y#!+=DYEDC,,@*%CR
M5X QT&*]:;2]/:625K"U,D@VNYA7+#T)QS3?[&TO9&G]FV>R,[D7R%PI]1QQ
M0!Y=HATK7K6VDU36EM/$EEJK-+#&B+>>>)6 3)^9D92!CIMXX XIZOI&FOX;
M^)ETUM&T]E?O);2'DP.(8F#)_=;/<<GI7L']F6 U#^T!8VWVTKM^T^4OF8]-
MV,XIAT?2RLBG3;,B4YD'D+\Y]3QS0!PPCTP?%M+F[2U667P_%*DKJNYI?.(W
M*3U;&!GKTJ+P8)])\0:587MK97JW&G2_V=K=E\IN(08V;SUZ[ON'=D@DGN37
MH0T^R#PN+.W#0*5B;RAF-3U"\< ^U)::9I]@[-9V-M;LXPQAB5"?K@4 <Q\1
M[R6RT;3')(TY]5MDU)NPMBWS;O\ 9+;0?8D=ZJPZ;!#\3KJTM+>#^Q[C1Q+?
MVP0>3YOF8C8KTW%0WU"^U=S)''-$T4J*\;@JRL,AAZ$56@TO3[6U:UM[&VAM
MG^]#'"JHWU &* .3^$EM:P_#31IH((4DFAS*\: %R&8?,1UQ[U5\:HLWQ*\!
MQ&Y>W):__>1L%8?N1TSGZ5W5K9VME&8[2VA@0G)6*,*/R%17.DZ=>R^;=:?:
MSR8QNEA5CCZD4 >;0_:=)^*VJ6^D7#:S<76CO++/<,));-U)\N/<, (QQ\F,
MY.:K1+'<_#SPEK&EX_X2+[;;(TPXFEF+[;A)#U(QYA8'LN>U>KVUG:V49CM;
M:&!"<E8D"C\A3(M,L(;U[R*QMH[J3[\Z1*';ZMC)H X'PUX<T74?%?BV2[LH
M9WM-6#0[R2(B;=,D#/&<G/KCVKF-/L;;3/@QI>OVEN1<R+#!J%VC$R?8_M \
MT9STP,'T&:]ECTS3XC,8[&V0S#$I6)1O'^UQS^-/@L;2U@:"WM8(86SF..,*
MISUX'% '$7.EV@^(VGV^F6]N=-O]*G_M.WB4>2\8*"%BHXR2S 'J0#V%<<T,
M^FZ1;*+%)+CP)?,UQ*T7S36I;Y0O8YA<N?0H#WKV:RTZQTZ-H[&SM[5&.66"
M)4!/N *E:W@=9E:&,K-_K05&'XQ\WKP,<]J /-_$,T>F:1I>K7(2TL=6U=9]
M3E,((6)HW$(E']T$1;L\9SZUE>)]+T6W\%^(9],U1;R":^LIB+<H(+>0S(K>
M64X5BO+#/<'O7KLT$-Q \$\22PN-K1NH96'H0>M5AH^EBR2R&FV8M4.4@$"[
M%/LN,"@!-*T;3M$@E@TVTCMHI96F=4SAG.,M]3@5YP_A[0-7\5?$*#5XHFAA
M%O*"[D>1FWR9 ,\'.3N^OJ:]31%C1410J*,*JC  ]!7+:=X59/%NN:OJ5KI]
MQ%?O"\ (\QX3&@3^)>^ >#Q[]: .'T'1H];UWPO:^)K;[1/<>%I#<QSDYD(D
MBV[^Y('//.1GJ*FF71M7N?$NE:]K$6F7]K?_ +@%46X2%=I@:!F^;H!@+W)X
MRW/JK6%F]VMVUI URO28Q@N/^!8S39M,L+B]BO)K*VDNH>(YWB4NGT8C(H X
M36XV\*^-[76;6S$HUVU.GR QC_C\ W0LV.@?YE;MP#VJ2_TFST7QQX M+9$7
MREO(MP 4OB#))QW))/U)KOWCCD*ET5BC;EW#.T^H]^:AEL;.XN([B:U@DGC^
MY(\8++]">10!Y*V-1^%FM:A<KM\5VE]/F91_I$5T)CY2*>HRI10!P0<5J;[2
MT\6^,XM3-K"]UH]I(T;[0)7VS!B ?O?-@?E7HC:98-?"^:QMC> 8%P8E\P?\
M"QFEGTZQNKF.YN+*WEGC4JDLD2LR@]0"1D T >2V"7-SX0\.7NF?V9JS6GA^
M,7>D7IQYD1 W-&_.U\J5.1CIG'%;ZW-M?^+OA_-#$\=O<:1=ND4WW@C1PD!A
MZXZUVTFBZ5,L2RZ99NL2[8PT"D(/0<<"I9;"TEN$N7M+=KB,?NY7B!9?3!ZB
M@#SBTTM-,US4? 2V2G3M1N5U&!Q'\JVI.Z9#]'4(.X$J^E>BZBT]MH]V]C$&
MN(K=S!&!P6"G:,?7%9VA:;JT4SW^OW5I<Z@T8A3[)$T<4<8)/ 8DY8XR?]E1
MCC)W* /%Q<Z'<^$/ &J":U;43J]H;NX=E$QE.?.WGK]_KGV]JM9TG7FUVTUO
M6DL-9M=6D9-J(+M0LF8#"6^8@IM "]<D=Z]0&BZ4MP]PNF60G=Q(T@@7<SCH
MQ.,D\GGWJ233+"6^COI+*V>\C&$N&B4R*/0-C(H XI8XI_'GC>*8*R'2;/<I
M^DU826"I\)O"'BB"V6:\T&WM[L_*"SP!<2I_WR2P]"HKU%M+T]Y996L;4R2C
M$CF%<N/0G'-216=K!;&VAMH8[<@@Q(@"D'KQTH \\\27"6?AE?$)006NIZI;
MRWTPAR5L\[4+CKMP$+ _WV%8_BO3=#C\$>,KS2M5BO4N+:*62*UV?9X9 <*R
M[. [#KZX!/:O7WACDA,+QHT3+M*,H*D>F/2JJ:-I<5E]BCTVS2T#;O(6!1'G
MUVXQF@#@O$=MI'AK7-!CQ!8:-J,T[W<\JAXGNMB")I-QQD@/R>_/7FL^Y&FZ
M%!HMI;ZF;OPS=:\_VN0E?L\99"R0J1\OE>9CCH""/45ZC-I]E<67V*:SMY+3
M 'D/$I3 [;2,4-IUD]A]@:SMVL]NS[.8E,>WTVXQB@#BO"0TVW^)OC*"P-LB
MO'8OY<) &=DFX@#W(S[GWIWC^WTY_$/@Z;4(;5H?[2>.1[A5*[3!(<$GMD#C
MU%=G:Z=8V.?L=G;V^5"GR8E3('0<#H*?<6MO=HJ7,$4R*P=5D0, PZ$9[B@#
MS!!9ZMH?CXZP(QJ-G=3F*1N)((5C!MFC/51@9&.ISW)KT'PV]_)X7TE]4!&H
M-9Q&Y##!\S8-V??.:M3:987-W'=SV-M+<Q_<FDB5G7OPQ&15J@#S32;6.\^)
M7C]3JMS8X-D"UO*J'_4<GD'I7/Z%?V=IX(OM.NT^T:;%XB2UM+U)/+2_8R!M
M\[G(9<CYVY!' KUMM!T=W+OI-BSDY+&V0DG\JLS6-I<6AM)K6"2V( ,+Q@I@
M=!M/% 'BNLR6C>&/B?9"XLI%B>*>*.UPL:DPQ[F1<G'S<$]S]<5V=K866D_%
MNS6PBC@%WH<TEQL/^N99H]KN?XFY;YCSR>:[)])TV17#Z?:,) H<&%3N"C"Y
MXYP.GI2'2-,9P[:=:%E78"8%R%Z8Z=/:@#R7X9W4!MO#=GXAMH6BDLR=#F8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cutr-20221231xex1028four003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/ER W(SC(K5U'PO>^(+_ %/4[F*.RFGT672[:)I-Y!D)+.Y'&,[0 ,\9/?%
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MIVSV5[:%[N,Q@&)V0-&8,#D D@[R<C!K'\!PZW??#Z*6'7'6\FO)F,UQ DF
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M3KD742P[,,X4K\VY3D88CC'6LZ?P/9W%GX@M7U&_\O77+76#'E<J$(3Y./E
M'.:ZBB@"O;6QMK"*U6>1O+C$8E;;NX&,\#&?PKGHO E@GA*]\-R7M]-97;O(
M7D9!)&[/YA92J@??YY!KJ:* .;L_"(M==76I-9U*YU#[']C:24QX9=V[.T(
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MINV2-08IQNX;YN1\IPRY%96JZ1XCCOM"\1Z?I]G)?67GQW&EI,$4PR[>%D(
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M7CB5;!FCU:TBALSYL?S,L+1G(S\HRV?I[\4 ;\GB2TF:SM[&*>]GO;7[7''
M0I$)Q\[%B-H)8 <Y)^A(X[P?XJBT;PI!+?0:E-]MUVXLXL_O9(V:9@JOEB>
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MS@@9]IX8UV#P3X9TM]-)NM.UA+R=1-'CRUF>3@[N3A@,>H-%UX<\2VFB^,=
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M:EL_'5C>W>CHEC?I::PO^AWLD:K'(VPOLQNW@X!Y*X..":JKI6J1>*_%-_\
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M=7C<C)(R",@$]..M;1U?6X-4U[PUK<MI=YTA[^UNK:$P_)RC(REFY!Q@YZ4
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M'#2(N1(IR3N=3MP!C(84 =C15/2A?#2K7^TVC:^,:F?REVJ'(Y &3P#Q5R@
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M6]031I)S<'2?D,0<G<0&QN"9YV@@'OD9%:F@^'_[#N=4F%X\_P#:-VUW(K(
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M</,1;C[PZ-[L.V>!Z'H0#I**1%"(J#.%&!DTM !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGKW_ "KJ*"0 23@#J30!QL7@:>RNM(O].U@VVH6%@NG22-;!X[F!?NADW##
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MS6XXX]3LX[I(G#HDF2%8=& ]1ZTVU\/:197HO;?3K=;L+L$Y3=(%] QY ]J
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M;WPQH]X]_.^F6DEU?0^1/)(G,JXQAB.3QCWX'- &E/<1164MRTP2%8S(91R
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MBC8QD4 >6:Q:9T[XEZDES=PW-C>>?;-!</&$D6WB(;"D;CP.N?U.>HFN9_\
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MVN;^RCN)K8[H'?.8CZKZ'W%1MX:T9EOE:PC(O_\ C[!)_?\ &/GYYXXY[<4
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MX!E4D<=^E<AX?TF\L/%5SX:,7_$CT^?^U+5\\!9=VR''HL@E8?[J5U?B@_\
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MO,V[2!M&2<$\=.^* -_4?$]YHQL)&\01W=MJUS!;QE[=%>VSN,K@@ $87 #
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MQGMYH@=EKH3B=ATS),-BGZ[&/X4OB*\,'C7386M+B%)+*95U&VM6FD+%E_<
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MW$#.'"R)@\,.H(8'.!UKE+FYN]+^*NMRZ5HSZA<R:1;.T22I$"?,ER2S=\
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M@'6@#C=,\(WNB>)-(N++[+)ING:,=-7S)F65VW(V[ 0C'R>O>M+P3HM_X?\
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M)Y/2M.@#EO[&U75-=TG6=4@LX9]*AF\J&"=G62:10I)8H-J@ XX)^;VYQX/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6WGC62&5"CHPR&4C!!_"@#AI_$&LZ78>%M9FO%NX-7N+>WNK;RE"Q&=<JT1
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M+6_C2[TYXAI["!=H+P"0*P.<@DX)_E3HOAO906=G81ZQJPT^QO$O+.U\R,K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"L-.L0\#BSMP\"E86$2YC!ZA>. ?:FVFEZ?I[L]E86MLS##&&%4)'O@5;HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$;-\S$*H^4'&20,F@#0HHK/76K!]>?1%F/\ :"6_VEHC&P_=Y"[MV,'DXX-
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M979688&V3"C..*O:EX&L]1L]/ U#4+?4-/D::#4HY0;C>PPY8D$$,.",8P
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M2O#9&.<]SVW[K5;[7;[Q/865Y]CATF(0@B-7,LK1[R6W#[@!48&#UYZ5-+X
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M.1C:MO!(CTB\L+O7M6O_ +1;-:">YD1GBB888+\N,GC+$$\"K,]Q'X2T#3[
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MRY) V@GH.,]ZQKKP5#>Z7;V=SJVI22Q7<=ZUTS1F666,@IG*;0!@<  ?K73
M$* 3D@=3WH \XF\9:L/A]#X\AF5K;S!+)IQC7:;<R[,!OO>8!@YSC.1BKJP7
M+?&B8B_E"#1(Y-FQ,;3._P G3IQUZ^]:5OX%L+:S?34NKDZ,US]I&G':8U;?
MOV@[=VS?\VW/MTXJ^/#L:^+'\1?;KK[0]J+0P_)Y?EABP'W<YR3SGO0!C?$5
MKM+'0EM+V6U636K.*01A?G!E&,Y!Z$ X[]^*R[B#5#\1?$"Z?J2VUQ'HMJQN
M'@61F(:;'R\*,GKQ],=NR\0:#!XBT^*UFGGMVAN([F&: KOCDC;<I&X$'D="
M#52/PI%%K%[J:ZG?&XO+1+23=Y9 1<X(^3[V68\^O2@# T[Q;JVH/X G+P1P
MZY%(;R)8N2RV[/\ *Q/ W#IC\:FTKQ3<W'BU=(U&[ET_4!<SYL+F +'<VX#^
M6T$F/F.-A/S?WN!5^S\"VEDGAY(M1ORN@[A:AC'\P9"A#_)S\I(XQ5I/"D)N
M;&2ZOKJ[CL+EKJVCF"?NW8,,;@H)4!S@?3.<"@#8O[V'3=/N+VX)$-O&TCX&
M3@#/ [FO+=-NCX=\>:3JLR7D8\1(;75//M98D2[)+PX9U .,M$,=@*](UG2!
MK-O# UY<6R1SQS$0[/WA1@RAMRGC(' QFJWBCPS;>*]&_LR[N;FWC\Q)?,MB
MHD#(0P()4XY':@#+U#4-;E^(2Z#::A#;6<NDO=!OLP=T<2HF<DX/#'MCV-<]
M;>*O$O\ PBNDZ]/?VS8U1=/N;=+8 3K]H,!?.<JW<8X^M=FOAI1XBAUQM3O'
MO(K(V7S"/:R%@Q) 3[V0#QQQTK/'@"S'AV+1!JFH?9H[W[<K_NM_F>;YO79C
M&_GI[4 9\^O>)=6BU*Z\/0.\MCJ$EK';OY(@E6)]KAV9MX)PQ!& /EX/6H-0
MUKQ-+J'C."UU.VMH]&@BN+?%H&)S$TFULGID8)_+'?8;P%:KK5W?VVJZG:P7
MS^9>V,$JB&X?&"Q&W*EOXMI&:LR>#[=[K7[C^T+U6UN)8;A1Y>$55*#9\G'R
MDCG- &=I_B:\\0ZKIFF03?86ET:+5+F6)59LR$!47<"  =Q)(/8<<URVAZIK
M&C>%=/%G=6XFNO%4UG<L\&0X>X<$@9XY'3WZCK78CP);0S:3=66JW]I?:;:"
MQ6ZC\LM-;C&$D!0J<8R#CKS4<7P]LXK&WM%U74MD&J'54),9/G;BV#\GW<D\
M?K0!F_VCXH?4O%.DKK< ;2X(KJ&Z^QKO/F([;"N=N 4/.,X/7O3].\6:IXBC
MT^VM%F@N9=%M]1F>U6)B'EW  "5@-H*'.,DY'(QSO_\ "*0_VIK.H#4;P2ZM
M D$P'E[45 P7;\G!PS=<]:S&^'-G'#I)L=8U2QO-,M19Q7D#H))(!TC<%-K
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MD C!8#<""#D9%6KV^MM.M6N;N41Q A<D$DL3@* .222  .230!3L_#>AZ?\
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MHH **** "N9\:S7T-IIK6=A+=1_;X_M+P0"::WCPV9(U(/S9P,@$@,<5TU%
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MWC/1KS3KNZ;4[JXN;*2*%GCG69 !&6 PA4C:=Q Q@]*]#>6.-T1Y$5I#A%+
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M[=2M%^QM.A=IB;;RP,Y)R6[?PCKCI6HUO=-K?P^E%C>>79P3+<M]G?$): (
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M[70]"K#U!R*NTR**."%(HD6.-%"HBC 4#H *?0 4444 %%%% !1110 4444
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MKO7S T;1X'!Z!LY.,^@IUWX,U6ZT3Q?I_G62MKUPTL;[VQ"&14P1MYX3/XT
M;5YXEE_MR;2--LTN+J'3Q?N9I3&I5F*JHPIY)4Y/0<=<U)H'B:+6?",7B.X@
M%G:R0FXPTF_;&!DDG ]#Q[5QNNM<77B\V]O>Z%#=V.FQV\\5]/+ S;R6;:Z%
M6=,!>", ].2:ZW0X_P"VO"$FGWUI9PV[QO9[=/<M \6W;F(D [<''3MQD<T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"K=:;87S(UY96UPT?W#-$KE?ID<5:    & .U%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6;KN@Z=XDTI].U2#SK=F#C
M#%61AR&5AR"/45I44 8%OX1TZVTPV/G7\RM*DLLT]T\LLI4Y4,[$DJ,?=Z=>
M.3F?_A&=-_MR\U?9(;B]A$%RA<^7,@& &3H< GGKSCI6Q10!SNA>"M'\.N39
M?:VC4%88;BZ>6.W4]5C5B0H/YU'I'@C1/#ETUW8)>+&A:2*U-S))# 3G<8XL
MD G)Z#/) ZUTU% ' ^!/"Y7PO;6^L07L;PWDMR;*=OW>_P YGC;'?@J<9QD9
MQFNJMO#]A9Z[>:Q LRW5YM,X\YO+9E4*&V9V[MH SBM2B@#&U'PQINIZQ;ZK
M.+A+N&)H-\%P\?F1DY*/M(W+GG%5=/\ !6F:1;6T&FSW]JMO&T*;+EF^1CDJ
M0V1V&...V,FNCHH J6FF65CI46EVUNJ6440A2'J F,8YZ\5A67P_T*P?3'A%
M\3IC,;3?>RL(E88* %ONXXQWQSFNHHH YJ;P-H]QI^HV,C79M]1NA>72^>1O
MERIW9'(Y5>!@<"K6O>%-,\1VUK'J G\ZT?S+>ZAF,4T38P2KK@C/>MNB@#G9
M?!6CRQ:<I^V)-82/)#<I=R"8LXP^Z3.YMPQG)["H6^'WA]M+FT\07"Q279O4
M87+[X9LD[XVSE#DGIZG.:ZBB@#EWT6#PNU]KFFV.I:KJ4Z112Q_:RSRJIP#\
M[!<@,3^>,5>\-:2-,M+NXDM8[:[U&Z>\N8T(.UFZ D<$A0H)'!.3WK:HH S-
M3T*SU>\L+JY:82V$OG6_ER%0KX(R1WX)'/K6;=>!=&O%OQ.+HM?7,=W*XG96
M69,;'0C[I  ''I72T4 <XO@?1TFOID-Z)KX1>?)]LD+,T9!1LD_>!4<]>*U-
M/TBWT^YN;I6DEN[K8)IY2"[A00HX   R>@[D]35^B@#'O/#=E=ZNVJK+=6UX
M\(MY9+><IYD8)(4CIP2<$8(SUJMJG@G0]5TZPLWMY+9=/.;.6TE:&2W.,':Z
MG(SW]?K70T4 <Y?^!]$U'1K?3+B*X*VTOGPW(N'%PDO>3S<[BQ[DG^E.?P;I
M4EA9VCM>,MI=+>)*]RS2/.O21W))8CWX[8P!70T4 9EGH-I8ZU?ZM$TQN[X(
MMP6DRK! 0N!T& 3T]>:COO#ME>ZM'JJO/;:@D1@-Q;2;&>,G.QNQ&>1D9'8B
MM>B@#$N/">DSV%A9I%);KI\GFVDD$K*\3X(+9[D[FSNSG)SFEG\*Z5=:1J&F
MW,+S1:CS=R/(?,E.  2W7C QC &!@"MJB@#G)?!&C37B74GVTS"U^R2M]LES
M/'DG$GS?/RQZ^N.G%+;^"])M$T9(3=@:/G['FX9MF5VG.>OR_+@\ =,5T5%
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M:*** "BDW L5R-P&2,\BEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'AI=1U.&"-Y)YPIBD+<+-(NW!48 "@ \YZ\5 GA[5SK_ (6OW%B(M)LY;>X
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M-'+YB2J55@ZM@9'S$=.H-<G9>&->LY=>+0Z+<0:G=Q3_ &5RWEM&(T1XVRA
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M[OS<NH[<GZXH:;8S:!KOB76=7N-/M]/U&>&2-VN"-FV-8@'W* ,X'<]<56\
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M((SQD5<TK6=/UN"2;3[E9EBD,4JX*M&XZJRD J?8@&N,N#?#XX7'V!+=Y/\
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M60X6-  7!&/F)/&>GOGKO#']M+HRQ>('@DU".1D:2$CYUSE2P  #;2,@<>E
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MFO)"GF^6,X484*H&YC@+U)/6J=OX+L+4:$(KN] T-2EF"Z' *["&^7GY>/\
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M\D<9 =U4G.,G&<=: .>7P3I)TW5].N3/=6NK3M<W*3./]8<?,I4 J?E4C'3
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M;BV+1M'M$08L% *$=23GK[TD'@K1(K358)K=[LZL,7TUS(7DG&, %NP Z 8
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M^4-\K *V[*\Y  ]L<8K=6Y@=U1)HV=EW!0P)(]?I0+F SF 31F8=8PPW#\*
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M3::; \CP6L2PQF0@ML48 ) &<  5<IL<D<J;XW5UR1E3D<4Z@ HHHH ****
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M2 .I/<GN:>]K;RRK+)!$\B]'9 2/QH \3O\ 3]*A^'/C:XBM[99=/UN=;.0
M9M@)8V C/\ R3PN.M6O'FIZ;/9>-/L\UO!>02VOF>>^^>5E$;*T0R-B <Y&<
MG<>.I]>_LZR"E?L=OM)R1Y2X)_+W-*;&T.[-K!\R>6W[L<K_ '3[>U '#>)W
MC\/>(]/\;:9:K>0WD7]GW:VX!,N_F!P1U^?"9]''I78:%I:Z/H]O9@(9 "\S
MHN!)*QW.V/=B352;2=3N]?$UWJ$#:-"R2P626^'\Q1QO?/*AOF  '(7TYW*
M/&;G2-$O_#OQ DO;>"358M5NOL;=;B.4JAA\O^(%GQC'WO>K=Q/9R:[JFC>-
M]66P>XTRV6)[CR@DJ>5B78[J0&$FX\'/0]N/5#9VK72W36T)N%&!,4&\#TSU
MI9[2VN6C:XMXI3&VY#(@;:?49Z&@"KH4*6V@V$$4MS+'';HJ277^M90!@OP/
MFQUXKR;5?LL_PF\=-(8G$>O73*6P=K>>N"/0\_K7M/6JPT^R"%!9V^TD$KY2
MX)'X>YH XF_L-+O?C+;)<V]K.)= D9TD4,),3Q[=P/WL#.,^GM7'6UGIEO\
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MPFMV6EW_ ,6K*#5X+:>V?0YML5T 4=A,AQ@\,0,G';&>U85EX7FN/ 5W/IL
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M$L02<D\# QS6='!X@G\/>#M+E\-7R76B:A;"Z*M%Y;)%&R;T8N,@C![>GID
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MCIWKM]/O;B\>\6?3Y[007#11M*5/GJ ,2+@]#GOSQ0!=HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT(]: +=%5--DOI-.@?4XH(;TK^]C@<NBMZ D G\JM@@C(.: "BD!!&0<BEH
M**P/$6OW&BWNB0Q6T4T>HZ@EG([2$-'N5F!"XY^Z>X_&M[(SC(SZ4 +17.ZK
MKM\-9N-&T:V@GU""R%ZRW#E48,Q54!'0G:W)X&!P<\;MO(\D$;2QB*8H#)&&
M#;&(Y&>^/6@"6BBN?M/$4LOBW6='NH(8+?3[6&X6?S2=ROOR6R %QL]_K0!T
M%%5["^@U/3K:_M7WV]S$LT38QE6 (/Y&K% !111D'O0 45@>)=?GT.;1DAMH
MIDO]1BLI&:0J8P^?F QST/<?C6]D9 R,GM0 M%&1ZT4 %%<MXB\8+IGA>\UG
M2XX;Y;6Y6VDW2%0&\Q8VQ@'."W3CH>:ZG(/X4 %%)D$D9&1UI3G!QU[9H **
MYOPUXEN]?U'6K:73H;5-,O&M&=;DR&1@ <@;!@8([UTA( R3@4 %%&1C.>*3
M(QG/'K0 M%&0>_2B@ HKG]>\6V>@:UHFFW*,6U2X,/F#[L7!VEO]YMJCZGTK
MH* "B@$$9!R*3(/0B@!:* 01D'(-("",@C'K0 M%)D<\CCK1D8SGCUH 6BC(
MQG/%07=Y;V%E/>74R16\"&261C@*H&230!/14<$R7-O%/'G9(@=<]<$9%24
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MRRK@'.#VKTRZT;2KZ;SKO3;.XEQC?+ KM^9%36]C9V<!@MK6"")NL<4853^
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M>,#%22:?92SO/)9V[S/'Y3R-$I9D_NDXR1[4 >0:):6UYX>^%8N!O$DDJ/\
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M;SSG,TL4*HTA_P!H@9/XU;(!!!&0>H- '!> ;F!-<\;AYHU(UQR06 X\M/\
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M[1;029QE-IP&8<L,^A[UZO%IMA!8?8(;*VCL]I7[.D2B/!ZC:!C%1IHNE1V
ML$TRR6S!W"W6!1&#Z[<8S0!Q%SX>T<?%:UM/L4)M[W1II+N$\K<LLL>UI!_R
MT/S-RV?TKF=*U&*PT[P[87US%;Z%_:6IVI>Y0/"CI*1 CY.,8WXSP"!Z#'K_
M /9.FB9)O[/M/-1=BOY*[E7I@'' ]J8=$TDV4EF=+LOLLIS)!]G38Y]2N,&@
M#S+5-'TNTT72(+'4FO;1O%5N8VC;;'#O8%HXBIX0'L#P<CJ*CUC3+&SM_BEI
MEK:0QV<6F07*6R(-B2F&4EPO0$[5.?49KU-](TR2VAMWTZT:"#_4Q&!2L?\
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M>5<$@.&.>A& !SR17/RZ<T&N^#9K/0)K&SM[FZGE@BAW"W62)E4OMR Q8@D
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M.8;^VN]1U'PMXIBTFZM5TV6>*6QD0><L$J;-VQ<\@JK;1D[3Z\5';+?:-?\
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MGSC;P-H7&<$DG -<_=>(%L;;P1>V?B&]N]*NKJ2.:>9!NND$4C L @8G<H
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MC;CQA2WRC/)SGC%9)^']^?#\^F)K,<,D&I/J6F7$=O\ -#(9&D_> MAQ\Y7
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MQG),5Q"T+XZX8$'^=6:* .'LM&O-1^&$OA"66.WU""R.FRNZD@*%V+(!W#*
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MVHZMI=_:1QZO%&M];W$3.%D1=H>,@CMP0?3-=?10!PND>"-2TQ?""OJ%I,-
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MDEMPX?8D[Q@L"""=A&<$ U OA72!J%M?2PSW-S:G,#W=U+/Y1]5#L0#[@9H
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MQC_N L3A>>@QGJ:H)X#\/10:=%':W"#3BWV5UO)@\88 %=^_=MP -N<8 XH
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MDEF; ]3U-<]IEM?ZOK\>LZQHJ:=)81RV]JC3),[[V&Y\KP!A% '7YFSVKIJ
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M6SH-W-9>(]*MK6\M=:T>ZO+AX 1B\TV0B1GWX.&3)923@Y9>O&0#TXD*I9B
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M;Z#)87MO?)"+AA(J%/+.0&W*Q[@K]1^-1:O?:?#XN\/6EU#>F\F:<VDD3D1
MB(EPX##=\HXR#R>U '0;5+!B!N'0XI:XV3XCZ?';7-TVEZJ+2SOC8W<YB0+
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MKI.KVVMZ':ZO8!Y+>ZA$T2D ,01G')P#VZ_C0!?Q2$ @@@8/:O*M:\37NO\
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M<;I'BE/#+^+I[VWU2\LK;6V$DZMYHMHS'$ 278$J"3PN2!V H ]-I%4*H50
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MK')<1R0B:)(P TBD9&-Q R1ZD4 6L4FU=V[ W8QG'-<M!X]T^XL-#OH[*_\
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MD,*!$7.< >_>IJIZ5?MJ>G17;V-U9,Y8&WNU"R)@D<@$CG&1ST(JY0 4444
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MKC3Y#:3Z1':1GS(]QD5W8C&[@?.!GV-=-9ZE9Z@]TEI<),UK,;><*?\ 5R
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MN78'J/E&,UUTLB0Q/+(P6-%+,QZ #J:AL;VVU*Q@O;.99K:=!)%(O1E/((H
M\WE\*:[_ ,(UXWTR'2+>'^UY3)9I#<+M&Z)%P>!@ J<G\@>M=%XFT'4]4T[1
M;W2MMKK6G3HT;2D':CC9*IP<$;23[E17744 <1XE\/:C:WN@ZGH&GV^HC2X9
M+233[B0)YL+A.5=N P,:GGKS3-8TK6]1LM"D71X89;?6(;Z6U@E3$,2 @@L<
M!G.<\#';/&3W5%  .E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<7\2O,&D:,851I1KMCL#G
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M=-T._>UGCU:"8VMQ% R>5-$H9E92YRI4Y'(/!'O6OXAT*S\2Z%=:1?;Q!<*
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MS+GP<+V^\13W-\3'KEDME-&D6TQJJNH*G)Y^=NH]*V=&T^;2])MK*>\:[>%
MGFM&$R  !P.G H X+1/%&J:7X3O=0O[F&]NI];EL+8&(I^\:X,2ECN/R <X
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MQ90R1!%^[(&((W>NT@D>YSVH S+?Q'>ZI80WNES6<D']E"]D:2%N7<9C P_
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M)$A-XS# )./D"GD!<#&!0!L4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC*N2".G4#GK46C:_J,_QC&E^'M6GU;PVMKNOS++YR6\F&P$D/).0G&3]X^G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+EC&VTMD@8!]*Y?0=EA\8KZVTN[;5;2YT\2WMU,_G/:.K82,2]E(YV'ZU/\
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MAC$<2*B#HJC 'X4^L&X\8:1;74D3R2F.*[2QEN%C)CCG;&U&/K\R\] 2 2*
M-6XTZQO)4EN;*WGDC^X\L2L5^A(XJ6:WAN$"3PQRJ#D*ZAAG\:YR^\>Z'83:
MG%(;UWTPK]L$5E*WDJ5W;C\OW<<YZ8Z9K3NM=LHC;11-)<3W<1E@BMEW.T8
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M@D:2*WBC=OO,B $_4UP<.IW'B77]?@-QK-B-,NH5M3:(ZX C5V#K]UBQ8C#
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M))R22>22222>230!PFI^'[>_L]-5]!N]&P9YX+C2<+-82'9C<(^&+C.[ 8<
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MTMK=6053+&'*,LB*^ 2"N",CK7:6MU;WMK%=6LT<]O*H:.6-@RN#T((ZBI:
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MTD/EDKDXW#D@'!XK1UW3KC4_"%TVF>$GT^:ZO+206XBB2>013*[/)M.T *"
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MB@>WEC4KM=79<*0<Y[<U6U.QU/2_%JZM<^&!K5C?6$-O-%:+&[VDL9<@*)"
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MW_+]P<8/>LB#P!J5GI>FV=MKT6-+U%KRT$MEN0JQD)610XW$>8<,"N,#C/-
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M0V7^C^48OO;DSGYP/D.[N2?2@";7K^[TZQCELX87+3HDLL[A8[>,GYI6R1D
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M=/:F[B,8F0;BO?IW'&".X)%8D?A'5CK<^K3ZU;-/<:6-/DCCL=L8PS$,HWY
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M&>)M?D\1_"3Q%-<0QK+:7IM&* A7,<Z . W*Y&#@]*Z!P!\9X" ,GP_)D_\
M;PE5IOA]>S>&=>T8ZXA75;]KSS6L\F+<ZNPP'&>5'/&!VK;'A^[/C6'Q"]]"
M0FGFR:W%N1NRX<L&W\<CI@\4 :&N:O;Z!H5]JUT&,%G"TS*O5L#.![GI5.RN
MO$!U6"*^L;5[">V,CS0-@V\F1^[(8Y<$$_, .G3FKVLZ5;:YHM[I5X&-O=PM
M#)M." PQD>XZUD>'M"U[3(8XM4\0)J"6L?EVVVU\HGC :4[CO(''&!U/)P0
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M)#XDC^TP7FGWEH858M;!D>&4GF-T9B00.YQGG@=ZVE>&?$=GISV-[XJ-S'#
M\-E(EH(Y$)4JKR'<=Y4'IQDC)YQAR^%KFUU/4=?2[M;?5I]/-KYUK9G:SYW"
M5TW$NP(&!Z9&3G@ ZVBL_0O[1_L.S_M9U>_\L><ZILW'U*@D*2,$@=#FM"@
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MO,B\Q')C+YW,,ID9).#@Y%;/PZMDM_AYX?*O*WF:=;N?,D9\$QKP,G@>PXH
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M!4TNOZ-!=&UFU:QCN!(D)B:X0-O;.U<9SN.#@=3BM&@#G=*\#>'=$OY+W3K
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M&&))X'89).!T&23@"K]%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M$:A=G2?BK!>ZHXATNXTDV]M<R'$<<XEW.A8\*67;C/7;CM7;T4 >.ZE;/IWP
MM\0J^8[2[U[S]-A((/V<W43?*O7;\KN/8YKV".1)HUDB=71AD,IR#^-.HH \
MY\1:E;Z+\0+A]?GO+;2M0TZ*&VN8D+1AU:3?$V%."V]3[XHU?28M#\(Z#K>B
M65TH\/2^=%!)N:9[1R5E3!YR4(8 \C:!VKT:B@#SGQ.+K1+'P_J]ZET+:/4'
MNM5:U7>\)DC=5; !RJ%@O3H!6/XBA\/3>%+F_P!,\^>WU#6+.:6>X#8G82IY
MC(K <!1R0,'!]#7KU% '%^-=,2RT>V\1Z/;1+=Z+,;]5A4+YT1'[]./[R9.?
M516]X=MY8],-U<QE+N^D-U.K=5+8VH?=4")_P&H]6T.YU;4(&?5IXM,5-MQI
MZ1)MN#G(W.1N [$#J..YK:H XWXC-Y-CH-TX;R+;7+2:9PI(C0,06..W(JGX
MG6^TGQ'8>(M#@:1]6B&F7"%<8=@3;S,#@_*V0V>=K>U=]6+'H=RWB!]2O-6G
MNK=&WVEDT2*ENQ7:6W ;F."V,GC<?K0!R6MV>D:/X]\$VUT(%M8+*\B5[@#&
M5$.TL3QGW/<^IK DM9M$@N=9M8+E?#:^)C=E+1,E8#"4:95 .4$IW# Z $=C
M7I5_H$M[XLTO7!>I&-/BFB6#R<[Q)MW9;=P?D&./7K6Y0!PFEZWX4T2SU;Q/
M!<WAL;V6'S[Z2.1EEDQM&U=N>!MRP&#ZY!KNE8.H92"I&01WJ&\M([ZU>VF+
M>3(-LBJ<;U/52?0^U3@   # '0"@#R#Q'<74'C_Q#J%L$N[*T@LI+ZP[W<2>
M;O53W9-RMMZ'H>N*W]6U/3M2\=>!;^UGB>%Q=G?T*AH<*&SRN3Q@]^.M>@44
M >*7JV0^'?C-HEA\]_$3O&54;V'VA&4KW(P&(([9KIX]6MM.\?\ B:/6GVQ:
ME:VYTR5D+)/"L9#1H0""=[,=HY.[.*]$HH \^^'OB+3=.\$>$-+O)I(;R]MO
M+@1X7 9DZC.,#J,9ZYXKT!MH4[L;<<YZ8J">SBN9H))=S"%MZ)GY=W9CZD<X
M[=^H&+% 'BCBR3X<:F\2PK/_ ,)/YJ%0 ^T7H8,.^-F3GTSVJ;QKJ-O=6'C*
MV@BDM9TN;:1HHH6D>\"^41.6P0$ &!MQRN2><5[+10!P]O=Q)\7)Y6$JI?:)
M;BW8Q-\Y$LA8=.,!@3GIFN+TS4+>/P7X&TPB8WNG:[$EY"L+EH"#+D-@<'G.
M.XYKVRB@#R_1;"*_LOB"NFQ6YU1[^Y:RD"C<K&W5493V&XL,CWJ7PG>^']<N
MM#N$&IG6-)@9'MY8W06.8]KJ_P H!'  '.>"!P<>ET$9!&<>] &=H>NZ=XCT
MN/4M+G,UJY*ABC(00<$$, 17,>-+UM*\6^%-3O0XT2"2X6YEVDI#*\86)WQT
M'+C/;=78VEI%90F.+)W,7=F.6=B<DG_/L.*GH \9O+EY#XQN]+@N9[:/7+*]
MF6VB.Z:!4B+E,C#'(W>^,]*V9!X5US3=8U>SOM4>.[A@@NM34.OED2+Y9 90
M"4)R>#@<'K7IM% 'D%_>Z\VCZ@UTD&L1:9J-C<7%_IT>/[0ME;<ZE 2"Z84D
M#C!%6O&U_P"']=\">)=4T>#SI+NWACDO/*=?.=7^1%# ;F49S@<9'X>JT4 <
M!XWCTNWM_"\MG':QQMKUI-OA50"HR"^1V P"?3%8VS06U7XCVFHQ6S2S2(L<
M3(#))FV3 C'4MN[+SDCVKUBL/1= ETG6=9U![U)_[4G6=HQ#L\LJ@0 '<<C"
MC\: .-TF&YT+Q+X)BUCS!,OA^2S=]I?,V83LR,\X!_(FL@F8^'M:FL8VFM;7
MQC]LO((5W&2U61&)"C[RY /'4*:]EHH \XU7[-J?BV\UK3IX9M-7P_-#>3QL
M&BD<MF),]"P^8^H!'J*RM)^QV]E\*C&(8Y(D(FV@ H3:LK;O3+X!SWKURB@
MKQT+)=?"K4_#%V#_ ,)4EW*! >)I)VN"\<R=RO*G>.  ><"O8J* //\ P[:V
M,WQ+\5"ZCMIYQ%8E79 <NB-N*Y[AMN<=#BN[NEE>TF6!@LQC81L>S8X/YU+1
M0!YIX)U31[_1M T>^T^8^(='(66"6%PUM* 5>5FQMPP).2>2P[U@79M#\/?%
M$J"(W+>)FE1E WL/M:,K#N1MW$'TS7M5% 'C?CK48+NQ\;VD$3VUQBWD*10M
M(]Z J$3%L$", 8&W'*Y)YQ71VRZ7JGQ<NW>&">.71( @EB'S,)78C##[V-IQ
MUQ@UZ#10!XQ<:I;7 T66*&:S%KXJ+SZ?';NQ@R\H+R,026<G( (&&P <9K7T
MO4=,$FN^&/$EC-/J<VK2W,-NT+G[8A<-"ZL!C  49) 4+S@"O4** /+;U+R6
M?XEZ78I,-3N@LMM&J,#(GV9%^4XQR05Z]:6"_P##'B*WDU6U:_EOK339X95N
M4:-;163F-\J%)W  +STR.E>HT4 <I\.;6SB\!Z%+!!"D_P#9\$<SJ@#[@HRK
M'KD,6X/<FK?C71I=<\*7EM:\7\06YLW[K/&0Z$?B /H37044 >51OK-WK=EK
MD%K-!#XNM19S0@8:TVKNCD)]?+\X\^JBMJ9;"+XP6BR+ L5OH#HFX#;&WG*0
M!GH=F>/3/:N[HH \;\,:G:V.B^#X)8_(<3:@B7YC9S;?O6Q&JCC>ZD;=P(P.
M <U'I\RP> /#C2+.J:?XH+W+20LOE+]HFY88&/O+G'3/:O:** /+]9NYK+Q%
M?7^BWL=V)[VU-[H-Y'AY7VQ;98#PP(4(2"",H<XQ4L,\%H_CO2?$( N+ZXDF
MMUD&3=6[PJD:Q_WRNTKM&2"?>O2Z* /'K&>;PQ>V-KXSN;ZWAN]#M;9+F-2Z
M"1-_F0N0K?,=X^N/I6UJ^E1Z!X:\.Z[HEC=A=!D^6V?+3/9R';(F#SG:58 ]
M-N*]'HH \Y\3BYT"'PWJE\+D6<5W+-JLMHI=H9)48!\ $E5+%<XX!%9'B"#P
M^_A1[S3!--:W^N6EQ)-<AL3MYB>8ZJP'R[1R0,'!]*]=HH QFUC1-*U:QT96
MC@N=1WRV\<4)"2$<L=P&W)Z\GFMFJ\UG%<7,$\NYC 2T:Y^4,01N]S@D?C5B
M@#R2_P! U?R]<\-:;"T::7=_VYID^WY<MEXX5]/WHE''88[U<\62M?\ PBU;
M5KB!H;C5_)F6!^65-Z;$QZ[%W$=B6KT^B@#S+78S-XXU&WT-XDN)_"<T-L82
M #+OS& 1QG!R/;GI4GA*[\/Z_?Z'/"-3;6-+A:-K>9'C%CF/:ZO\H4C(  R>
MQ'0X])HH \4MY[8_#?PUIMRN);7Q%"MU#+&1L NW9MV1C 7D^@(SUK0UY)YM
M6^(,.D1^;/)9V#K##C,X0MYJKZG9\I'N!7K=% 'F!O/#.OV6JZYI\U]=72Z/
M-;337*LBQ*1D1,"H!?=T SC!]1GJ? %M91>"-#EMH(4E;3K=)G1 &+*@R&/7
M(8MP>Y-=-10!Q/Q1;_BG+&-9A%*VJV;*V 2H6926QW ')^E<]-JL;?#GQ;H.
MJ+$NNVMI.L[CD7SM&=DR$_>+ KQU4X& ,5ZO10!YB?(3Q/X*&FO!%*VCW409
M, *S)%L#8_V@W'J#6;$K:G\+]&T& -%XILKRW4V[?ZZ"=)@9)6'4*5WMNZ$-
MUYKV"B@#S?7- N9O%6K^'X86&F>*+43RS!05MY(L)*<>K*8L'^]SVJ329;[4
M? NJ:CK\'E7<%A+IQ$O1FB#+(X_WY!^.Q:]$HH \GTO[';CX5&,0QO' ZS;0
M 5+6A4AO3+X'/?WKU=LE3M(#8X)I:* /&T2:_P#A(OAILIXN@NU7R&_URW(N
M-WG#OM()??TP3S73Z!;Z=<_$[Q@9(;:60&R:(L@/S+&=Q7/<-C..AQ7>T4 %
M>)VVH6\'@?0-)<2_;]/\2H;N!86+0C[6[9; [J01Z]NAKVRB@#R34$L)!\56
MV0%Y;=5B)49<_9%&%]?G&./XO>JNKO?7NN:*^CW437,?AK+QN^T7&)86: OG
M*,RJW/7CTS7LM% 'F&K:QHGB!_ =W:QQ);_VB"UO+&%-NHAD&UE_A ;:/3IC
MM67J@G;_ (3+^SHVG@AUVSO+BV@&3-;JL1EV@?>Y4YQUP17L=% '#!;?7?B1
MI^J:3+%<V*Z5-#?S1D-'(&93%&3T+??..H'7&>>4DL-9TW172&WE)\#WK2VS
M;<F[@.&" ^UN[*1W.WTKV2B@#S;QA:QIX:T)M0B07%UKUI=7*2 ':&E!8'V1
M,*3Z**L66JZ=HOC_ ,9W\\JQVD=C92.8U+9V"4-@+U(!4''J*]!IDL9EB9!(
M\988W)C(^F: (K&]M]2L+>^M)!);7$:RQ. 1N4C(.#R*L5%;6\5I:Q6T"!(8
MD"(H[ # %2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,1 C\KR68#J4)R0/O'TYH V+/X@Z7=&]MS'(+^TNHK0VT;I)YKRC,>Q@=I!
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M:K:SJ0)(HY-DC,XY#'#%<# XR#5:\\0^)-1759O#EEY[Z?>FUC@<1A)RA7S
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M&6!*D;B,CG![=:G\-:_+KW]K":S6V?3]0DLBJR^8'V*IW9P.N[I6Y0!Q^E^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:Y:71["0W6/M!>V0^=CIOX^;'O0!QNJV5KHFN>&+*,2KIFLWSMJ+RS.ZS3"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ K#U/5W_P"$AL- M'V7-S$]S-(
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M<,[6!VW2^4X,1QG!!'7'.!7! 74_AKX=QC2]322PO+;[2KV4@:();NC,PVY
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* .8NO!>KW/AOQ=I?FV2OKMW)<1OYCD1!U1<'Y>2 F>/7VKN(!,MI&)%03!
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M*6WCN=/+KK<NIO!(SF&>-V9O+?Y<_*6!'!!*CBO0 Z%V0,I=0"R@\C/3-.H
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M>7#3RN!T!9CG R< <<GU-0ZYX8L?$%S93WLMTKV,GG6_D3&/8^,;N.IP<<T
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MAVX/4-X7L6U#5+WS;E9]4A6"Z(DX9%!"@#'& S#(YYJC=?#_ $2ZL-+M=U[
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MMC;('!4\XX/UI8IX9BXBE238VU]K [3Z'T->*W<6G#PEJ]L!;K!:^,U2!%(
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MTV34O%-DS6\%ZN@[6:[;<9U(E*I F1SG[S<\[>.,T >GR311?ZR5$X+?,P'
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M^S^+XFGCFDW7 99@CR,2?W<>. ,8VXYYQ5^[U+3KBV^(UIKTENNHD2?9DN2
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M[BUU2_MH//@PI"-* Z\D%7(#+Z@YY!% ':&UMVN%N#!$9U&U9"@W >@/6I"
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MB65JTOF1%@,IC[W7/''XX%2:EXQTW2HY;BXCN?L,$RP7%XJ Q0.2!AN=W!8
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M  Q4]% $1M;<L[&"(ER&<[!\Q'0GUQ22V=M/())K>&1PI4,Z D ]1D]C4U%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHD3IO0[\D'(." ><<UZ;10!Q6N^&M1UKX?7=G#MAU:YF6^VR'CS1*)%C8CL
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M9!8C') Z\UC7_A[7KGP-XVTV/1Y_M>J:E-/:(98OG1]F"3OP/NG@\]*]1HH
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M3;)2T9"\-SPAY'&2.:[RB@#SS3/#%Q/\,=1T;686TV;S[JXCE>1#Y),S2QR
MJ3C;E2?H:Z3P=!?+X>@O=5"C5+\"ZNPHP S* %QVVJ%7\#5O5_#FE:[/9RZG
M:?:&M&+P@NP4$XSE00&' X.16I0!QZV&IZ)X_P!4U>*RFO\ 3]6MH%;R&3?!
M+%N !#,/E8-U!X/7'6L.7PIJVG^$=%L;>P>ZNDUU-3N8X9$"PIYYE90689P"
M!QU(->F44 12*T]JZX*LZ$8;L2.^*\SL-$\0Q>&?!&GS:'.DNBW\;W.)X3\B
M1R(6'S\@EQ@=>O XSZC10!YCJ_A;7-2NO%\MOIZH]Q?65]8"Y=#'<F!(P48!
MB0"4(Y ZBNH\+I<32O=S^%(- /E^6RYB:61L@G!CXV#'?DYZ#'/344 <GXGL
MM1N?%/A:[M-/FN;>PNI9KB1'C&Q6A=!PS DY8=.U95OHVLZ59>+=&&FO>1:M
M<7%S97*R($_?K@I)DY7:V>0#D=.>*]!HH X31/#NH:)XRTD+:33:=9>'TTPW
MF],&174_=W;L84]JH6NB:KIFLZMITWA*RU6VO;V6ZM=3D,16,2MN*RJWS_*2
M>@.1@<5Z510!YAK5O>2^)O$J6&BZE=V%_#%9WKZ=/;_O&$9# B0@JVQPOR]O
M?I?TVWN;?Q19^(],TNZ?2KC3!ILMG\JS6;PR-MR&;!'WE.">0#R*Z*?P;HD^
MI3:@(+F"XG;?,;6\F@65NF75'"L?<BMN&&*V@2&"-8XHU"HB# 4#L!0!YM=>
M%-6@T#$%@\UU>>)EUB:!)(QY$?G*Q4DL 3M49P3\Q/;FM)M,U;_A(/&ET-*G
M,.HV,$-HPDB_>.D<BD8W\<N.N.]=U10!Y7]FU;3$\&I;:+=2ZOIFDF&ZCMKB
M#S(UVQIM8.VUD9E)!!SE..]=!X9O'T[1H;#3O#NI),E^$O(KR6)9$$I+O.64
ME6&6SA>>P Q6WJOA;2=9OH[ZZ@F6\C3RUN+:YDMY-F<[2T;*2,DG!XYK0L;"
MVTVW\BUCV)G<26+,Q]68DEC[DDT 6:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKK\^G7GCK5]&\1WUI9VTNGQ?8?MJ(49#O$I1GX#AL9QSPOI5'7]%6'3M%O\
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MQV\TXZ59UJ:]M?$7Q DTG<+Z+0;8P"+[RL!-]T>H[?A0!Z:&5B0&!(X.#TK
MUKQ!/I?B#0=/BMX9(=2N7@DD,AW1D1LXPN.^WKG\*X62327TV3Q'X2UB*;5$
MTBX$-I8QH"XV9!F49.4;&,\[CCO2>9X=-W\-M0T^6SWR3L&F#KYCYMWW;SU+
M;^N>=Q/<T >M;EW!<C<><9YH+*I + 9.!D]:\?O[>WU<>(M&EOM/?49-=$D-
M_+=1JT$89"4(+!\JH:/ &#GKR:MZBNC7_B'Q/H'B#4K335CCA6Q^T*BE+;R5
MPT+OT*N'/'0X]* /52RJ0"P!/3)I:\H\11SV$=UJ@6#7]-M["WCU&UO!Y=[
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MCWT+W(^RSE59I(W"A% 088Y)' YZ]Z -&+1M+@C6.'3;.-%C,85(% "$Y*X
MZ9[4]--L([-[-+*V6U?.^%8E"-GKE<8-9L/BW2)$U'S9I+:73F1;J&>,K)&7
M^Y\O\6[/&W.3P.:HZIX[T_3M,UJ<6]TUYI5N)Y;-HBK[2"5;TVG!R<\8.>>*
M -_^RM.,JR_8+7S%38K^2N0N,8!QTQQBD_LC3!9R6?\ 9UI]EDY>'R%V/]5Q
M@UA_VW97FJ^&UN+K4;2]NED>&V6-TBG(C)829&" .0,YS@U;N_%^D67F232R
MBTAG^S37@B)ABESC:S=N2 3T!X)!H T&T?3&MX;=M.LS#!_JHS NV/\ W1C
M_"I9;"SGN(KB:T@DFB!$<CQ@L@/4 GD5BW_C72-/O[VQ?[;+=V42S30P6<CL
M$;.&&%Y'RGD<>^>*VK"^MM3T^WO[.42VUS&LL4@_B5AD'\J (ETC3$,)73K0
M& 8A(@7]V/1>./PIR:5IT<,T,=A:K%/Q*BPJ%D_WACG\:Y];Z_3XJG36O9'L
M&T8W*VY50J2><JY! R>/4GO6-XV\0R6OB&"QNM3UG0--5%']IVUHKP22N?NO
M(RL%  7''5CD\4 =W%IUE;V/V&&SMX[3!7R$B41X/4;0,8IUG8VFGVXM[*U@
MMH%.1'#&$4?@.*S=4O9[#3H+*RE\_49H]L,DN&P% W3/CJ!P>V25'&:P_#']
MK^)?ASH$KZO<6TUS;+)=7<04S-QT4L" 2>IQT''7( .KO--L=1""^LK:Z$9R
M@GB5]I]1D<4MQIUC>",7-G;SB/[@EB5MOTR.*YOP5-JR7FOZ5J-])J-OIMXL
M-K>RJ!)(K1JY1MH )7<!G%;E]K5K8W26A6:>[:,S"WMXR[[ <%B.PR<<]3TS
M0!H*JHH50%4#  & !5+^QM*"QK_9EGB-BR#R%^4DY)''!S7,>*O&<,?@A-7T
M2:29;N:*".:.)CY>Z58WR"/E8 L #SN%;>EVATRWO;M;K4[FWF/G1VMT6DDA
MP.57=\_)YP2<=L4 73H^ED2@Z;9D3',F8%^<^_'-))HNE2M&TFF6;F)0L9:!
M3L Y '' K@-0\93ZQX8\+Z];R7>G17.LVZ2Q@%1)"SM\I/\ %P!G'!.:[&R\
M6Z3>PZC)YD\!T]U6YCN8'BD3<,K\I&3NSQ@<].M &S-#%<0M#/$DL3C#(ZAE
M(]P:BCL;2&T-K%:P);,"#"L8"$'KQTJEI_B&QU#5+C3%\Z"_MXUE>WN(RC&-
MC@..Q7((XZ'@XK&U_7+R;QEI?A+39S:R7,#WMY<JH+QP*=H"9!&YFXR1P,]^
M@!T,>D:9#8FQBTZTCLR<FW6!1'GUVXQ1/I&F75I':7&G6DUM&<I#) K(A]@1
M@51.DWUKJ6GS6>J71LTE8W=O<2>8)%,; $,WS ABIP#CVIEAXOTC4KNRM[>2
M7%^LCV4K1$)<!/O;3[=><9'(R* -:6PLYY())K2"1[<YA9XP3&?]DGI^%0OH
MFE2PQPR:99/%$28T:W4JA/)P,<9[UPUIK"V_ASQM)K>L:G':VNKS0+=P%FF@
MC\N(@)M4[0"3VP,UJ>)]>>W\1>'M%5;[[+?&9KA[=7#NJ1$J%9<'[Q!.T@\>
MA- '476EZ??6R6UY8VUQ A!2*:%75<=, C J&]T6TO[NPGFBB/V)_,B_=C<K
M=L-U4< X&,X'88.1!KFG^&M,FM;S4;_4(].;9=WTD9D\G)W 2,HY(5ER0"0,
M%L9S4NH^.-$TR^>RD>ZFN5MUNMEM:22[HBV Z[5.X>XR!B@#<NK.UOHQ'=VT
M-Q&#G;+&'&?H:BMM)TVRD\RUT^T@DQC=%"JG\P*PKGXA>'[5+UY)+PQV,_D7
M;BREQ < Y?Y?E7YAR>O.,XJV=1T__A-?LIU"]6\33FE-J0PMC%O7][DC!;)Q
MD'@9H U+K3-/O9HYKNQMKB6+_5O+$KLGT)'%*^GV4EVMV]G;M<K]V9HP7'T;
M&:R].\7:5JEW9V]N\P-]"T]F\D15;B-<;F0^V0<'!P<]*J>./$=SH&G6,&GB
M,ZEJE[%86ID&5C9SR[#N% )QZXH WX=/LK>YDN8;.WCGD^_*D8#-]2!DTBZ9
MIZ7S7RV-LMXW6X$*B0]OO8S6/>:#J,>F/_9VN7_]HA0?-F=664CJ"N-JYZ94
M#&::NM:;;^(-<;[9J4L]E;0O<VAC<QQ+\Y#1KM^8G!R5SG H Z)HT:19&12Z
M9VL1RN>N#0D<<081HJ!F+':,9)ZGZUEVWB/3[O3M,O[<S26^I$"V*Q-ELJ6!
M(Z@;5)Y]*XSQ+K"GX<^)]0T/6M4\ZVOG#2RDH\,F] T2[E!5!G 'ZT =[%I&
MF0R7$D6G6D;W/^O9(%!E_P!XX^;\:FM;.VLHO*M+>&"/.=D2!!GUP*6ZN8K.
MTFNIVVQ0QM(Y]% R?T%<CX1EO_%V@P^(=0O;JW%Z6DM;2VD\M;>+<0F2.78@
M9);(YX H ZF\TRPU'R_MUC;77E-NC\^)7V'U&1P:>;*T,TDQM83+*FR1_+&Y
MU]">X]JR+6\FT*SCM=8O9+Z\GN94MBL8\R=<EE&U0 -J\$\#Y<\5+#XJTB;3
M;R^-R8H[*0PW*2QLLD4G V%,9R<C&,[LC&<T 9FO>$A?WNAFQL].CLK"[:YF
M@==HES&R8VA2.C9R?2NA.E:<;,69L+4VH.X0F%=@/KMQBN1M-<FE^*=S;RW%
M[;V4>B?:'MKH;$C;S0-X[?=[Y..1QR*W[7Q3IMUJMOIV9X;BZB::U\^%D%PB
MXW%">N 0<'!P<XQ0!HSZ=8W-E]BGL[>6TP!Y$D2LF!T^4C%,ETC39[>&WET^
MTDAA&(HWA4J@_P!D8P/PJY7.3>-]%M]/U6]E:Y6#2IO(O#]F?,38!Z8R1@@Y
M'&#0!KSZ1IETD27&G6DJQ+MC62!6"#T&1P*?)I]E--%-+9V[RQ#$;M$I9/H<
M<5DZ]JR?V7=VL$MS!=R:?+=121I]P*.I;! .2.#^'3C*\'>,+.ZT?PYI]W-=
MOJ-YIL<BS2POMN'6-6D"R$89AR3@^M &OHVFZNMZ^H:]=V=Q=JC0VXM(6C2.
M,MD_>8DLV$SV^4>Y.W)''-$\4J*\;@JR,,A@>H([USFC:[I$>D7]_'J=[<6R
MZA+$[7BMO64OM\I%*AL!B%5<9[5B^-_%"7'@CQ.NEWEW8:KI4*O*@'ERQ[N5
M.?0C/(/:@#M;?3;&U:-K>RMH6C3RT,<2J53.=HP.!GG%-ATG3;8W!@T^TB-R
M<SE(57S?][ ^;\:HZ=XGT[4=7DTF)KA;N. 7 $T#QB6/.W>A8#<N<#(]13]9
M\3:7H-S9V^H2S)+>,RP*D#OO95+$ J#S@<#J>, T 6?[%TKRDB_LRR\M&+(G
MD+A2>I QP>!1_8NE>7)'_9EELD.YU\A<,?4C'-8:_$3PZ='NM3DGN(8;.=;>
MYCEM9%D@D8@ .I&5SD<GCWJ]#XLTV>-3&EX)7N'MXK>2U>.65E&XE58 [<'.
M[@>] &A<:1IMW'#'<Z=:3)#_ *I9(581_P"Z"./PJR\4<L+0R1H\3+M9&&01
MZ$>E8$_C?0[?1I]5EFG%M;3_ &:Y'D.7MY,@;77&5Y(YZ<@YP:T+[5[6UD-M
M/]I5VMGN"T4+.41< GY0>>1@=3VS@T :!CC,HE*+Y@4J'QR <9&?3@?E4*6%
MG'=M=I:0+<O]Z98P';ZMUK$TG7-,M_#6C207MY?I>1JMFTP+W%S\N<G@<X!)
M)P!WQ6/X0\0EI/%5QJ%Y=O!;ZOY$*W*G>F8XP(U0#KO8@ #G/&<T =C::986
M$DTEG8VUL\QW2M#$J%SZL0.3]:CAT32;>8S0:9912F3S=Z6Z*V_INR!UY//O
M5"/Q?I+_ &Y)'F@N+%XXY[>:(K(&D($>!_%N) !&1FM'3]2BU$W"I%/%);2>
M5*DT>TJVT-QV(PPY&10!R">"]1>:>+4+?PWJ4<LLC_;KNPWW!#,3AE/!(!P.
M0, <=JZI-"TP6]C%+907!L45+>2XC5W3:  0Q'!XZBJ6H^,-(TN>[CN)9=MD
MT:WDJ1EDMS)C9O(]<@\9P""<58OO$5E837$3K/*;5%>X,,1<0AL[=V/7!Z9P
M.3@<T 6Y=+T^XNENIK"UDN%P1*\*EQCIR1FK,D:31/%*BO&X*LC#(8'J".]1
M7ER+.SEN&CDD$:YVQJ68_0"N#\*:Q]LT71_%&HZGJ<=Q=Q^7+:$,8;J60Y41
MH<_=P<%,< [N 30!VR:1ID:*B:=:*JQF)5$"@!"<E>G3/..E T;2PL2C3;,"
M(YC'D+\A]1QQ6'JWB"#4/#/B-+"YN+34=.M9#+&5V30-Y993@CH<9!&0><&L
M:/4=0-S\-7_M"YVWT1%TF_B<_9&?+]R=W/)H [2;1=*N+E[F?3+.6XD4*\KP
M*S,!T!)&2.!^57@   !@#H*PKSQ=I%AYTD\LHM;>86]Q=K$3##)D#:S=L$@$
M] >"14S^)=/35KO2\7#7EK;"Z>-8&.8B<!E./FY!'&>E &DUM R2HT,96;F5
M2HP_ 'S>O  Y]*;<V5I>^7]JM89_*8/'YL8;8WJ,]#[UFVGBG3+[3=-U"W>9
M[;4GV6S^4WS<%LD?PC"L<GTJ33O$%GJ<\$=NEQMN+<W-O(\1"2Q J-RG_@:\
M'!P<XH LOI.FR1&)]/M&C,AE*M"I!<]6QCJ?6K)AB81@QH?+.4RH^4XQD>G!
M(_&JNDZI;ZUIL=_:K,L,A8*)HFC;Y6*G*L 1R#5V@"M>Z=8ZE$L5_9V]U&K;
M@D\2N ?7!'6FW.EZ?>B,75A:SB,83S85;:/09'%6Z* $50JA5 "@8 '054CT
MC38=OE:=:)MD,J[85&'(P6''4CO5RB@"A_8FD^4T7]EV7ELVYD^SI@GU(QUJ
MA'I6JSZ[YM_<V1TFTD\RQMK>%E<-LV_O"3@@9;  ZD'L*WJ* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KB?$T.L77B.2U33+JXTR;3&2*2U=8
M\W!8Y65BP8(!@@#@Y.03C';44 >9:)IFK0M\.OM&D7<(TJTEAO"P4^43 (U)
MP3U8'IR!UQ52;0]>%M>7UMI=P\MIXK.KI:MA6NK<J%^3)QNY) .#Q]*]8HH
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MOQL1DDD\UD>'8-?\&_#72K*/3]4U'4I$57A'E,;(8 (&2H('8$G)/)Q7HU%
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M<G&3C ZU5\2:-J%IXUTOQ?I=JUZUO;O8WMI&P$CP,=P9-Q )5N<$\CI7:44
M9,.J7=^O^AZ=<1 *27O4\H9QPH'4G..<8QGD]*X'2K'7YM9\':E>Z%J"7%F]
MQ'?EWC$<;/$5'EH'PL8/< $C'WC7JE% 'EM]H^K3^#/']C'I=T;G4]0FELTV
M@>:CI&H.<X'*-UQ6_JT-Y/XQ\(7T6GW36UFER;F0)_JM\0501U/([9Q79T4
M>>6^FZKI5GXPT6739[P:K<W-S8SQ@&.03KC8YS\FT\$G QTSTJ7P[H-]HGC/
M38G@GEM+3PY#IQO-OR-*CY(]<8[XQVKOJ* /+]0TC59_#?Q"M(],NC-JMT[V
M2[1^^4Q1H#UXY4]<5K&VU0^.X-2M].F\M?#SVJO,N$%P9%=4;G/\/)Z>]=U1
M0!Y=H]CKDGB#P=J5UH>HI+;07$-^\LD82.1T0?(@?"Q@J<;0,C'!-=-X]\.W
MFNZ=I]UI?EG4])OHK^VCD;:LI0\QD]L@GGUQ75T4 8EKKMW?Q*D6BW]M='AE
MNXPJ1'N2P.& _P!DG/MU&=IEG=Q_$K7KV2SF6SN;.VBBG9?E=HS)N'K_ !CK
MUKK** .+\(>';_1M2OK.Y4?V5I\\G]DX.?W<V'88_P!@DH#Z%JYZ^T;5Y_ /
MC2PCTJZ-WJ&KRSVL6T RQLZ$-G.!PIZX/YUZK10!6N((M2TV:WF5Q#<Q-&ZD
M8;:PP1['FN.\&G5/"6B0^&]4TN\G^PEH[:]M(Q)'<19)4G!RC '!#8''4UW5
M% '%ZY9ZN?$OASQ(MD\L-D;B&YLXB&DCCE50' SAB"HW!<\'C.,G!UOPMK-[
M<:WXBT^T<S2ZG87L%A(P1KA+4#.<\*6). >?E&<$XKU*B@#S74].U7Q3XCU&
M6+2;ZQM;_P -RZ>L]T$3RY6<D;@&)Q]!^G-7_"JW%Q+9&^\#IINHV$;":[>.
M';NV%3Y#*=QW?0#&1D\5W=!&01ZT 97A[67UW2A>2Z?<6$HD:.2VN,;D93@\
MC@USFL>%;J]\8W*HG_$CUJS5=4PV#OA.% _WU8*?9#[5VD,,5O$L4,:QQKT5
M1@"I* .$T+1]9LO VHQ:LC3ZF+5]/A$?+211!DB/U8DMG_:&>E4K+3-2A3X<
M!]-N@=*A*7WR?ZD_9C%SSS\WIGCFO2** /*SH6OGPW>S6FG2?;K3Q-)J\%K,
M0GVJ+S2P .< E2>O0BM3Q2^K>*?A_KL5MX>O+2:[MQ#!!<!!/*^>20K$*H[9
M.3SP.,^@44 <>;>[E^)FFZFMC<"R71Y;9YF3 61I(V"GOT4\]*@\;SFV\4^"
MI1%)+MU&7*1KEL?9Y,D#OCK@<\<9-=O67J6@VNJZCI]]/).LVGR&6W\M\!6(
M*DD8YX)'- ' >)/#NI7UIXMU*TTZX>35Y[!;>V"@.Z6[J6D8$C;D;L X.%'K
MBNCU^SOX_%_A_P 26MM-=6EM%-;74"#]Y&LH4B0*>N"H! YQT!KL** .+T_P
MJ-2N/&%QJ,#Q6GB!DC6W? 81I"(]Y'\+$Y..HP,X/ D\,6.L6OA>XFUV,R:K
MY'V3$?S%XX@40_5B6?\ X&/2NPHH \JTK2==T2R\"ZFVDW5P-*LI;&_LX]IE
MBWA1YBC.&P5&<'H:9=:'K]Y!X@NX-#E\P:[#JEO:W31@7<:1HK1\,<$X/7C.
M*]8HH X"2RM=8T*_ED\"26D%R(89H&CCCNI@) 2P*-P$^\,G)(X XSJ^"[+5
M=/74K:\O+R[TY9E_L^:_7%P4VC<'X!(#< L >#VQ7544 >6>--.\0ZS;>*]/
M_L:\F\P1'3FMW1(9$ 4L7^8%Y,@C# XPN,<FKGB;2M0O]0N=5TBSU32_$"PQ
MK;2QD-!=C&?*N%R4PI+ DXQG@G&*]'HH K7;NFG3,8VDD\L_)$,ECCH*\VL-
M"UNT\(>![A=/G-YX?E!N[$X#LA1HV*<X9@&R!GGGOQ7J5% ' :AHUYJ%_P"*
M==AL[A%O-&&GVUNR;9)WPY+%3TY=5&<=">!@EB:=J(;X=DZ=<_\ $L0B]^4?
MN3]F,7///S'MGCFO0J* /,HM$U>V\&>(_"$NG33SWDUT+.Z !BE2=BP=V_A*
MECD'GCC.:U];\-ZG!=^'+K19";JVB.F74Q.#]F=,&3W*,BL!ZFNVHH X?PKX
M9O=!OM4M'B5M)LI)3I"$YRDP#NIS_=;*@^C-5?PCHU]I.NVO]F1ZC::)+:NU
MUIM_\R6<V5VK QR<'YL@$KQZX%>@44 4M)OI]1TV*ZN=/GL)7+ VTY4NF&(&
M=I(Y S^-7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cutr-20221231xex1028four004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;^SM2RRR-@.P9N=V[<IR?IT(- '9:C\3K+3?#FKZK+82M+H]Z+.]MDD!*L2
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MHFEC;=,^U5"L&/0'TJ'QWX-O/%_P]CT>&2*WU"#RI8MYRGF(,8) Z$$\X]*
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M $>\[LD*<=,]/2NCNM$\16GBVP\2VJ6E].U@;"_MC*8@%,AD5HV(.=I)'/)
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M2F-=RAMVT-@' R0/3IO#6HKJWAZ"]AU.'44E,ACNHUP&7>VW*C&& P"..0:
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MV:V4Y^4J3G)'J/F /H[>M:M% &7X?T"Q\-:2NFZ<A2W61W 8Y/S,3CZ#.![
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MO:[:UM[*V2VM8(H((QA(HD"JH] !P*JVVAZ397;7=KIEG!<,2QEC@56)/4Y
MZGOZT <)J,<GAKQ9J6E6T.8?%$0^Q-MW"&X'R2K_ +NUO-QT^5\5WR6D-AI
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MX-4EU2+2K*/4)01)=+ HD;/7+8R:ELM+T_3/-^P6-K:>:V^3R(5CWMZG Y-
M'(>-H;\ZJMY9VEGK$-M9-]JTFX?9)L9C^]A;H'^4C\."*Q(]1T_Q!K*Z9>75
MM;Z?<:':SZ:FIP[BR,&WNIWJ!(/DR1D\<8YSZ1>:-IFH3+->Z?:W$JIL#RPJ
MS!>ZY(Z>W2F:CH.D:ND*:EI=E>) <Q+<0+($^F1Q0!Y[;:;IT7C?PB+JYCU,
M+H]THO[E%W7&QXMC$GK@$D'/.<]ZR9+33[3X7?$);>"WBF6^U&,!%"L$63@<
M=AD?F*]>N-,L+J6VEN+&VFDM6W6[R1*QA/JA(^4_2H)- T:;[5YNDV#_ &M@
MUSNMD/G$="_'S$>] '&:Q=PW7C>'1-5N+&*RETA)+1+^(O'+)O82;?G4;PH3
M'4@9QC)J@FE0)KW@33WU6YU6W,-_"UP\K 7"(HVY ." #C/\0]0:]"OO#^C:
MG:0VE]I-C<VT!S%%-;HZQ_[H(P/PJ5](TR6YM[B33K1Y[8;8)6@4M$/13C*C
MZ4 >/:AIMM;?#WQI<P^:LNBZM.NFMYS?Z(%:-@(^?EY8_@<=*W=2:U\0>(O%
M6CZQJME836[1_9'N$_>00&)2)87+J%(?>20.N,\8%=[_ ,(YH9MY[<Z-IWDS
MOYDT?V5-LC>K#&"?<T77AW1+V:VFNM(L)Y+4 6[R6Z,8@.@4D<?A0!Q,6D6F
MJ_$866H2SWUO)X;@DD$SNHF;S67>R9X) !QTS[BL#28[;4=(^&%QJBQ7)\ZX
MA>6Y 8E%BE 4D]OE7\A7K;Z1IDEZ]Z^G6C7;IY;3M I=E_NEL9(]JB_X1[1?
ML45E_8^G_98I/-C@^S)L1_[P7& ??K0!4\7:&/$?A.^TZ)ML\D1:VD!QLE R
MA!^O7V)'>O/(/$C?VOHWC*+3O]$O+7^RIX0A!^V;=RX'^^/)SZ\'H*]@JN+&
MT$*PBVA$2R>:J;!@/NW;@/7=SGUH X;4]+31O$'@"UC<[DNIDE*L0LC?9Y"S
M%<XY;FN;GL]/M?!/Q0\F"VBN!>WB+M4*WE^5$<#OC)S]37K=SIFGWMQ#<75C
M;3SP',,DL2LT9]5)&1^%0S:#HUQ)<R3Z382O= "X9[9&,V.F\D?-CWH XVPL
MH-)^).B"SWH+_1IFNLR,WG,C1;6;)Y(W$9]#CI5GXAV=G<:EX/>ZMX9!_;:1
MEI5!^4Q2Y7GL2%X]A75IHNE1W,-RFF6:SP+LAE6!0T:^BG&0/85+?:=9:G;B
MWU"SM[N$,'$<\2R+N'0X(QD4 >8:EI=AJ6K?$=Y4\Q+>PMI(-DA"HPMF*N,'
M&1@8/;MUI;;45UG4].TS7;RR6*Y\/6MQ;#4(BZ32,&\YE.]1O^YSR0.1CG/H
M[:#H[/<NVDV)>Z&VX8VZ9F'H_'S?C4=UX:T*^L[>SNM&T^>UMSF&&2V1DB_W
M5(P/PH C\*VXM/#%C;+J<NIK$A1;R4?-,H) /N,8P>XP>];%(B+&BHBA548"
M@8 'I2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJQ'S;1[G&/QH Q?&&L:YI?PMN/$,-\]IJA6&;:B(R1!Y$'EX93G 8C/4GGT
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MO<RR&=H7G\J&%Y7$:X#.0H) !(&?>AO$.E_8K&[CN?.BOP&M1"C2-,"N[*J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MION9/#0G+;R-T@FCQW]^G3FNS;PWHKB]#:;;D7W_ !] I_K_ /?_ +WXT_\
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MC[U5_P"$6T(:?:Z>-)M!9VC^9!"(P%C?.=P'9L\YZT .AT>UTOP_-IUJ]RL
M20J6N9&D7<2W#D[AR>.>*\SL&.D?"W0_$1O[Q;B^2SM[^\GN)'6.%I!N;;N
M7@[2PP<$\YYKUV6"*>!H)4#Q.NUE/0CTJI!HFEV^DMI46GVZZ<RE#:^6/+*G
MJ-O3'M0!YWX@\[PG:WU];Z^OV&]DLQ<6]I&RI:0M*J23(V]MFY21QCGD<BK_
M (M*>%O#WB+5?#]_/]HDL8Y!:QOOC@7=M,ZCG#%6)SG!V9YP:Z[3_"^A:5IL
M^G6.D6<%E<9\Z%8AMDR,'<._''-/TKP[HVAV4MGI>F6MI;RDF2.*, /GCYO7
MCCF@#F+N+^R?&?A1]#ED-KJ0FBNXQ*72:)8MZRG)/S X^;J=V">:Q-.T_5=;
MTW2%$ET=3BUB4ZCJ$%R\:36PDDW 2(P)4C8JJ.A'0 9KT*ST'3M*1O[,LX+:
M7RS'&P3(C'4*!GA<X.T8%<%9?#IY8UAU#PSH<%\!^\UFUNG$K/WE5!&N'SSC
M< #ZCB@#/U>S,FF_$BX:]U#S-,F,UF?MLO[EQ;HX(^;U['(';&373">>3XD>
M'&:XFQ<Z+/)+'YK;"P,6&"YP#\QY KI6\-:*Z7B-IENRWIS= IQ.?]O^]^-/
M_P"$>TC[1#/_ &?!YT$1AB?;\R1GJH/8>U '#Z186VM>)HKFQGN8?#VBR"$7
M!N7)U&Z!"\G/S(IX]&8]P*K:$)O$FE6&NR>(8K'4K?43]J"Q.9=PD*FV<>9C
M:00 NWT(&>:[RW\+:#:+"EOI-K$D#!XE2,!48'(('0$'FA/"V@QZZ=;32+-=
M4.<W0B&_)X)SZX[]: ..M+J[TOQ=9C5[8W-M=ZE.+'6+28G<S>8!!.G4;1E1
MC(R@Z<UH?$>SM[J3PH9DW?\ $^MTSN(X8/GI]!73V^@:5:W7VF"QB242-*"!
MPLC9W.!T#')R0,G)J;4M+L-8M?LNHV<-W!N#^7,@8;@<@\]Z /.KS2K74/%7
MCI'><10Z59M$(9W3D1S;6RI!.,<9XJ.&^_MK2-)6XN9;N_/A:.[GCFF\N&+>
MH_?Y')ER"!CH >5SSZ#_ ,([HXEN91IUN)+J,13L$P94' 5O4 <8J'_A$_#Q
M>T<Z-9%K-/+MR80?*3^Z/0>W:@#SVS6/5[GX6WNHNT]Q-8S>=*\AW,1;!LDY
MZYY/KWKJ?B>9$\$RS07$\$J7=J%>&5D.&GC4@X.",,>#D5MCPMH LK2R&CV7
MV:S?S+>+R5VQ-Z@=C5S4=+L=7MOLVHVD5U!N#>7*NY<CD''L: /-/$-U>^$M
M:\6+H<ER2/#R7RI+,\VV;S9$,@WD\A1D]CMK6NE_LS6?!EYH4\KIJ,OD7*^:
MSBZA,)?S7R>67:#NZ\XSS78IHNFIJ#:@ME#]L:+R6G*Y<Q_W2>X]J;I^@:3I
M3A[&P@MV"E5V+]Q2<E5'\()QP,#B@#F?BM;0S^!Y7E4EDNK7:=Q&,W$8/3VK
M/\5I:_:]8LK225Y+#1&D,4LY2*TR7(E4\L921^ 7J,X/=ZEI.GZQ;"VU*SAN
MH P;RYEW+D=#BJUSX:T2]NX[NZTJTGN(HC"DLL0=@G]W)[<F@#BM'U8:SK?A
MW2M9G,L%SX;BNT21R!<7#8WD_P!Y@N"!VW$^]17VD:?'XA\ 6S7UQJ44,U[!
M]KN9B7=5AD."PQG!&,]]HZUVEUX.\-WNEVVFW.B6,ME:G,$+0C;'Z[?3/?U[
MU;NM"TF^MK6VNM-M)H+1@UO&\2E8B!@;1T''% '#175UI?BZV.JVQNK*[U65
M;'5[.8DAF+J+>=/1>5!&1E1T.36WXUU":VU+PS8L[Q:?J&I""[D5BNX;&*1D
MCH&< 'UQCO6[#H&E6]V;J&QB24RM/D#@2-G<X'0,<G+8SR:L7^GV>J6;VE];
M17-N^-T<JA@<'(/U!YS0!YCXE^UZ8WCK3;*XN8]-AT1;^(1S.OV6<B0;4(.0
M&";MO3VYKO/#.D6^FZ<MQ%+<R2WD44DS3W#R98(!D G"Y]!@59.@:2VGSV+6
M$+VUP<S1N-WF\8^<GEN !SGI5VVMH;.VCMK>-8X8UVHB]%'H/:@#S'3+22.P
M\9ZW%<7]QJ.CZC?FP1[N1U!$"X4J3AAD]#GH*MZ5I\5_'HVN6OB5?*N;21)8
MK82*]Z6CS\[>:2'0@G< ".1Q7=V&D:=I;SO8V<5NUPYDF,:X\QSU9O4^]9]O
MX6T71FOKS1]$LX+ZY1@S0QJA?/;/89YH \UTZTN;?P7X&\2VFH:A)K$UU:02
MF2Z=UN(Y&VO&4)VX R<XSP23GFM?2K)PGC/5TGO[B^TC4[MK"-[N1E#"W0A2
MI;Y@2>AST&*Z/P-X330/#6E6U]90+J-E%Y9='WJ&Q@NG8$@\G )YS706.D:=
MIDMQ+96<5N]P_F3-&N#(W]YO4^] '#:!;)=KX?\ $5KXGA59K=EF2*)F-X6C
MR?,S(?F0@MG&1@C@<5CIJVK>'+&[AO+%AK<>B7,ECJ5K,9;?4=JHQE93R)!A
M3SG.X\X(%>C:?X4\/Z5?7-[8:/96US<@B66*$*S ]1QT!]JGL="TO3&4V=E%
M#LC\I HXC0XRJ@_=7@<# X% '(Z1ID%U>Z5J]GXD1K6\M'C>"V$@-X"FX.S>
M:2'4C.[KR03S7-Z"LMOX8^'>MB]O7O[O4$MIY)+EV$D3I+E2I.WJH/3.1GK7
MI6G>$O#^D2W4NG:/9VDET"LS0Q!2X/;CH/8<4]?"^AI;6MLNEVRP6DGFVT83
M"PO_ 'D'\)]QZT >=VB:;I.C>/KB2YNK'_B<O );63][AU@ "Y.,LS8W'IG.
M13KM'\_X@:5.D<-LNBQ3K913L\<<ACFR1TY.U2<#G'?K7H<_AG0[F2^DGTFS
MD>_4)=,T*DS 8P&]>@_(>E%KX9T*RE,MMI%E%(8/LY985!,?)VGCH<G/K0!P
MR1)967PU-I--&LL\2S(D[['S:LWS+G!Y /3BE$K:[HGCB[OKF:#4M,O+F.VD
M64HUHD2!HF7!X!^\3_%DYR*[:+PMH,,-I%%I-I''9OOME6, 1-_>7T/O4MSX
M?TB\OFO+C3X)+APJR.5_U@7[H<=&QVSG% '!:9%<>(/&.DIK,EVIO/"R7%W:
MI<R1H93(@/R@C;UY Q[U4T>37+OP3X;N;58]9>V^V+/IMU<%'NHDF\M75SP7
M0!0-W][UQ7IDFC:=+J1U)[.(WIB\G[1CY]G]W/7'M56/PKH4,4$<.F00K;ES
M#Y(*&/?C?M*X(W8&<=: &>$+ZUU'PGIMU9?:1;M%M471)E7:2I#D]2"",]\5
MMU%;V\-I;QV]M$D,,:A4CC4*J@=@!TJ6@ HHHH **** "BBB@ HHHH ****
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M8+AP%V/'LD+9+#*D%,=NX-;MAXMT'4["XO;/48Y8;>01385@R.2 %*$;LDD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[<JV0=OWL9YYX]Q):^,-6NM<O]-7P^B+ILT"WLSWR@11R1ARX^7YBH/3VZT
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MM(S'!-;QN)I\*54R9X7'4XSD@<]<YR_#]K[4)[N^BL[&2\TV:RU Z<[8O6D
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MRLM?TJ6SRME)8W$=UNX1G5PZ[>I!7H<9]17/VW@/7].T/1S8ZG8KK6D7=Q-
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MPVL K;L@DY  Z\8XQ0!Q]@NM?\(SXTG\/W3P:C;Z]=S1JL:/YVW83'AE/49
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M $B@@$Y!SP3QTYH Q+:^U'7M?\0Z3;:K/9?V0L$$<B1QEI)7CWF1P5((Y P
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MB0V\43M&ACD9ADR'<Q.TG&5Z5VFBZ'#HEN\:75Y>2R$>9<WLYEE?'0$GL.<
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M<RW5G!<;8FD)!+@8R"<<X.#Z5K)X;MH]?36ENKO[6EI]C7=(&'EYW<Y!).X
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M[T0^3"2KEO+,7*X8^8T8Y[..>];T'@K2[=)+:-[D::]S]J.G%QY DW;\@8W
M;ANV[MN>U:5[HEAJ&JZ=J5S#ONM.9VMV_NEUVM]>WX@4 <WX:UN^\3Z?IDT&
MHSPM'8%K\>7&3]H)*!3\O!5DEX&.B^M8.B>(/$3:+X(UN[UE[@ZM=+:75J8(
MUC9760[AA=P8%!T./:O0-/T&QTJ+4$L%:W-_</=3.F,^8^,D9&.U9</@;3;?
M2]'TZ.ZO5MM(G%Q:#>I*N,@9.WD ,W7U^E #O$FM7%IKOA[1+:4V[:M/*KW
M4$HD<9<A<@C<QP.0>,]ZYG6?$6NZ3;^-=-34':;2K!-0L;UHD+A65OD<;=IP
M4.#C.#STS7<:UH-GKL-NMUYD<MK,L]M<0MMDAD'1E/3H2""""#R*IW/A&PO-
M-U.SN9KF1M44)>7!91+*H&T+D+A0!D84#J3U)- $V@6NI)9O/J&KR7K72I(B
MF%$$&5&0N!R,\_-D_6N+?Q-KB> KC4_[2<WEOKILQ(88OGB^UB+:PVX^Z>H
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MC!+<E\8_VJS?";Z%K=GX>^VZS<IXET^[#362")+G[0"1*'&S>8SEBQST[Y%
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M!]%\;ZCH]I;;;/Q7")%>-.(94PL_3IF,AQG^(>] 'H,EW;1*C27$2+(<(6<
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MP,9(B_W"0,C:W9LX]ZD_X3/36GU"W2&^-S96WVOR6MF1IHLD;H]V-PR,9XH
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MUIM,]M.FUU#?=;T*GGD$CC'6@"XEE:I;"W2VA6 =(A& H_#I3C;0&W-N8(S
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MF, QF3G''S#CJ<\ UGS^.+5M6\/6MA;SW5MK$,EQ'<)&2/+5,\#KG++GC@4
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M=Q;QR@%6;'0@\'\>/6N-TRRU2+QG_:QT/5%M9M$^SO)=3(\OFB0L0P#G&>@
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M]FUZ?2YH[6\==*_M!6LE8#>K;6B!+,'.2/F!]1BNCU_2O[=\/ZAI1N)+;[9
M\/G1_>3<,9]_I7.VW@W58]6AU.77X_M":4^FD060C4 D%67YSM((!/7/;;0
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M(SG!!P2.WY5PU_;C4_'W@B[NUN89[K3KN66-+F5-C;(3@ ,-O).<=>^:]%H
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M('=CZ5K3R-%;R2*A=D0L$'5B!TH DJCJ&J0V%K>RA6N);2#SY((BN_;\V.I
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MMRZ^:-B#S'EW;E1">%&<EA@<<8%AJ&JW_A/P'-+J]\D]SJTEI<21SG,L:^>
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MS"UVB"1X!("ZJ>C%>H'O0!C:?X(\.:7IMUI]EI<<5M=*%F7>[%E'1=Q)( [
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M;^WUO3X[!7MM51-LL8W "";'!;'(/!X.1S5KQZXMKWPI>R*_V>WUE6F=4+;
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M7-'N]7^SQP:S=:?;J6%S';HA-PA&-NY@2O?E>>?IC4BB2&)(HD"1HH5548
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M&1]\NUQE4+$=0!WZ$5#XAB-S;_%6WM(S(TL,#QI&N=Y$ #E0.N",''>O7J*
M*FF7L&H:=!=6S,T,B HQ0KD>N" :MT44 %%%% !1110 4444 %%%% !1110
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M/''&\>1E1R=^<>W7GCH= TF_L?%?B;4+F%$MM2FAD@*R;FPD2QG<.V2N1UH
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M<6LV>0R\?+Z=>G4U;OM9N+CQG%X9LYA;,-/:_FGV!FV[PBJH/'7<22#T [Y
M!K6NC:99:C=:A:V%M#>79!N)TC >3'J>IJ]7FDGC7Q UM;VT9L4OX/$2Z+=.
MT+%)5(W+(HW?+E2,CGO@BN^TN+4+?38X]3NX;N\7=OFBB\I6Y.WY<G'&!UH
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MMJ%)B4@D#YF&6(4G:,G'U&5;Q-;2306]A;7-]<S6BW@AB"HR1-]TMO*@$G(
MZ\'T-8<UCXDT+QMJNI:5IL&J6&L+"TBO="!K:6--F3D'*%0.F3QT]9AI.L:3
MXU.O1P?VC#>Z?':WD<+*CI+&25=0Y *'<PQG(XZT 3GQ_I)L-*O(8+V:/4KH
MVD8CB&Z*8;LHZDY!&UAWZ>G-0O\ $&".#56;0=8^T:4V;VV"1%XDV[P^?,VL
M"O("L3P>*R/^$0U2S@T=HK433?\ "0R:S>K'*H6(/YGR+N(W$!U^N#[5<ET3
M5VOO'4HT]RFL6Z1V9\V/YBL'EG/S<<G/T]^* -&X\=V27\=C9Z;J>H7$U@NH
M0K;1*1+$Q !!9ACKWQ^9 .'KOB*U\1Z-X3UC3)KJ*.37[:&2)F:-E.\AXY$!
MP2".AS[56T5;_2/'FCVLFFRRW%OX4C@FBBDCW*RR@9!+!2,CUSR.*L2^$-5M
MM'TU(;59KIO$?]M7:1R*%B4R%RBEB,D @>Y!Z4 =#K/CC3=%2\FEAGFMK&18
M[N:$H1"3@GY2P9L!E)V@XSZ@@1VOBV6?QGJ.EM9.FGV=E#<_:_,CVX?>=Y^;
M(7"X& 3U) K)BTCQ#HWB/5H[70]/U33M3N3=PW4\ZHUH[ !E=2"64$9&W^O%
MF[\-:E/XIUG,2-IVKZ1'8O="0*T+*) ?D[Y#@C'% &E;>-].N-7T[3W@N(3J
M:,]E-)L*R[1N(P&+*=O(# ?GQ6QJNJVNC:=)>W;,(U*J%499W8A551W)) 'U
MKEO"-IXDMH[/3]7T+3K7["@C?489E?[2%& 40#*D\$EO? YXT/'.AW^N:%"-
M+:/[?97D%];I*V$E:)MVPGMGG\<4 8D>KF#XJWD]^EY86L'A]KB5+F8-& )1
MEU"LRC@8.,'C\3NV_C.SFUF#2GL[J&ZNK=[BT5S&?/"#+*,.=K $'#8_G7.:
MIX=UWQ5KE]/=::-,M;W0)--9I+E)'BE9]P.$R"/QZ>G2MCPP/$7[E-8\/6%A
M):H1)<V\R2&Z8#'R* -@/7YC[8YR #"T'4(=1M;GQ'K4>H6]Q9:M.D,R3J X
M\TQ);[5<Y'W1@@#/.>IK>G^(6FVBZNMS9WD=QI=L+N:!?+=GA.?G0JY4@8(/
M((K#C\):Y<>!K_3OL\=KJ::L^IV@G=7B<^?YJJVTGJ.#_6KM_8^(-<\&ZU:R
M^'+32[JZL9+6*WBN(Y&=W&-Q< !5'IR3D\# R ;-IXTLY]5CL9[*^L_.M&O+
M>:X10DT:XWXPQ8$;APP%36GBJUN;5;V6VN+:P>R:^6[E*&,Q+@DY5B0<,#@C
MI6+<Z3K+^(/#M_#IQVV&F7%O+YDD>!(ZQA1C=R,H<_45E1> ;F9-2M+"WGT/
M3-2TR:"ZL6G66!;E\;7B56.T#YL_=R,<=< '5V?C&QN=>M=(EM[BUN+R%IK4
MRE")0N"P^5B58 @X('%:6KZQ#H\5LTD4TTES<);0Q0J"6=LXY)  P"22>U8/
MA9/$3-;QZSH&GZ>]LFV6Z@F63[2V,910 4!ZG)SVP<Y%SQ=;ZU<6M@-(C,T:
MWB->VZ3B%YH,'*JYZ<[21D9 (SS0!6N/'VG6NAWVJ365\%L+W[#=0JBL\<NY
M5'1L%3O7D$]>E6;?QC8M?ZE9WUM=::]A;"\=KQ5 > [AY@VL>,J<@X(]*XV?
MPEX@'AGQ-I<.CVT?V_5XKVV6"Y78$#0L1R!C B(^I'&.:T?$_A/4_$NNZQM@
M:VM;_0181SNZ';,)&D&Y02=O(!(]_K0 NHZM-??$'P3(MIJ-I!<?:G ED 25
M?(8C**QPPSGY@#S[$#?EU>WL;O5M9O)&%I;&.RA51DN^1G:.Y9W5,>J5@-;>
M*]0U7PKJ%UH$<,NDF?[4/MD9$A:$H"F,\$G/.#Z^M:&O>%;[4? UO86LL2ZM
M;317RLY(CDN%D\QL^S,6^F10!I'Q;;0W]QI]W8WEM>Q6INT@<(QGB!PQ0JQ!
M(/4$@\^G-+X;\4Q>)HH[BVTS48+66VCN(KBYC54D#?PC#$Y'?CW&1@UEW^D:
MCK>MVVMSZ;+:-8Z?<016SRQL\LLP4'E6*[0%ZD@DGH,<ZO@JPO-*\%Z1IM_!
MY-U:6J02+O# E0!D$'H: %UCQ1!I-U<6PLKN[EMK,WTX@5<)$"1U9@"3M; '
MI],H?%=G*;5;&WN+V6YLA?I'#L#&$XP<.PR3GH/QQQG&\4:1K^J:S?0+9Q7N
MDW&FF&V62X$:07!W;F=,'>2"N#@XQVR367-X3OK_ ,-Z-8ZEH4BWNGZ9'%;7
MMA>(D]K<*NT_/N7Y3A3QD>Q[ 'HUM.+JTAN%5E65%<*PP1D9P?>N?L?&MC?7
MNF0+:7D46J-,ME/(JA93&"6XW;ER%)&0,@=JU]+AOH-#LX+^X2?4([9$GF ^
M5Y0H#-CT)R:\^L/#WBE]3\,:EJ.EP2:AI]U,;ZZ>\#-,'C= Z\<(-P(7MTV]
MZ /1-3U*UTC3IK^\<I!$ 6(&223@ #N22 !W)%8\WB^&U?4H[S2]1@FL+3[:
MZ%$;S(N<E65BI(P<@D'ZT_QKH=UXA\*W5A83)#>[HY[=Y/N^9&ZNH;V)7'XU
M1F?Q/K?AG5(;_18K":6QEMX[9+I)6EE=<;MW 51]23D\# R 2VGCFTN;.*Z;
M3-2@BN/(%F98E'VMI02JQ_-U&#G. !SG'-2OXUTVV_M.._BN+.ZTY$DFMYMN
MYD<X1D(8J5)XSD8/7%8]YX;U>?PIX4:W@5-5T&2WE:UDD&V;9'Y;H&&0"03@
MGVSBI+_0;W4]:U'7YM'20RZ=%IJ:;=.A,T?F[Y2Y!*C@X7D],]Z -NX\3PV4
M$[WMC=6S1RPPHLAC_>M*VU-K!L8R<9)&.:T-.OVOQ<![.XM9()?*9)MOS':K
M94J2",,/UKA[+PE=6.FZMIPTN:]\/W,D @T>_N%D:%.?-V-N( ^Z5&[JIZ9S
M5[0_!9_LF]TO59=0.E"[$NGV\E\XG@C" ;6DC;)7<6PNXX&,\] #MZ*JZ;IU
MOI.GQ6-H)1!%G;YLK2MR2>68DGD]S5J@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHKGKS5[RY\3RZ!ILD$$T-D+N6::,R?>9E10H([JQ)SZ#OD '0T
M5R,7B#69=2TC0+F&TL]9N;*2\O&7,L<2HRIA!D9+,P/)X /6L>]\<ZU:Z7J2
M>39?VGI>K06%QE&$<T<KH$=1NRA*OT.[!'>@#T:BN)75?%3^*]1\.BZTD2K9
M1WT%U]EDPBLSH4*>9\QRGWMP^A[9UAXU\0:S'X2%G%IL,FMVEQ)*94=A%)$!
MD@!AE23G;UXZT =WJ>K:?HUI]JU*[BM8-P3?(V,L3@ >I]JN5Y-XAU[4M5^'
MGBC3M:BMUU/2K^WMY7M@1'*IFB=' ))&0>F371^,/$^K:"FKSP&S2.QLENK>
M)HVFDN2-Q?<%(,:# &XC&3UXQ0!UDVI6<&HVVGRW")=W2N\,1ZN$QN(^F15J
MN5N/$%\/%WA^PC2V%IJ=E/.2R$R(R*A SG&#O';M7/)XS\2KH2ZW-_9?V:#6
M3I\\"0ONE3[1Y.Y6+_*1D'!#9]1TH ]+HKC='N=5F^)_B.WFOHGLK:WM-D/D
MD;582D '=P<\DD'/MBMKQ3KT?ACPQ?ZS+&91:Q[ECSC>Q(51GMEB.: -BBN3
MNM<U?1O$>C:=J#VEQ!JXDB26&%D\B=4W@$%CN0@'T(QUYXB\$ZQXC\0V<.IW
M[Z8ED7N87BAB<2%XYF16!+$ 84Y'MG/.  =C16-XEUMM$L+9HD1[F\NX;* 2
M?=#R-M#-CG &3COC'&<UDZOK^M>%]-UB^U2*TNK6'R182Q9C,LDC!-CKDX 8
MCD=CTR* .OHKDY];U;2O%>EZ+?26L\>K13"WN(H&0PS1KN(9=YRI7..01C'.
M<UEV7C75KGPIX2U=X[(2ZMJ*6=T@B; 5F<93YN#\G?/6@#T"BO.-1\6^)X++
MQ==P-I03P_<'"O!(3/&(ED*_?^4X8_-S]!5L:MJ)^),S/?(NF0Z&E[Y!@)*J
MTAW8.X?-\@YQ[8[T =Y17$Z;XB\2ZC)HE]!IJRZ;J*!YU\K:;5'7<CAR_P X
M&0#\HSU&.E9L'C/Q%%H>HZ]>C2VLK"\N+)H(XW5Y76411$,6(4%B,\'C)]@
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MMCJ5GJ0N/L=PDWV:=K>;;_!(OWE/N,U:/3BO.;GQGKEMX2US4TCT\W6G:V;
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M4T[P^^G^)]6UG[8'&HK$KP>5@((P0N#GT8Y_I6Y10 R66.&)Y975(U&69C@
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M1N';P\\VKM+)HTAD5FMU'FDQF/! (P-I/X\Y[4V3P/#+#XDM)-0G-CKK/))
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M[:O)!NB-ZR;3+M8CGDY(QC.3G&:V:C@@BMH(X((DBAC4(D:*%55'   Z"I*
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MM&LIQ9/:2>7?JB.KA"5YD3<&7W[=QZG8WB7]E%=1QSQ+(H;9/$T;K[%6 (-
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M/B);BXL73<ZR.2NP*-G! "X!/4 YR0#LK'QCX?U*\M+2SU2&6:\C,ENH#8D
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MC<?56Y'XBKE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJP0O*X<J@+$(A8_@!R?PK!C\:Z-+I6D:DCSFVU>=+>T;R&^9V; W<87H>N*
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M!. 3]<?TKA_#FA>*?#VBZA8I;Z-++=7D]RDK7<A5/-8M@KY7S8SZC/M7=44
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M@\F"9Y&1HRYZE%!!W]<#Z=ZK^(/#>MZGK]Y/!+82V-SIIM(A=,^ZSD.X,Z*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M03(W=.^,D8KM=/9UT.U9$WN+9"JYQN.T<9H NT5QJ?$"%]%TO4SILT<5_?\
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M-#+ 4EW, D2QD,,#&=N>":Z:B@#FO&6D7^LV^DI81PLUKJ=O>2>;)L^2-MQ
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M-X?TO2[BTACU,W$;O- 7*%(BX8889'M[=:TM"\/C0[K5)UO)9_[1NC=R*Z*
MCD!3MQVPHZYHU3P^-3U[2-5^V2PR:6TCQ1JJE7+J4;=GGH>V* .=EUOQ1<C5
M;#356XU+24CB9XX8Q%<W!B60[@\@*H=P''(Y.3TH?5_%NH>*6T.":PTR0Z/#
M?MYEN9F@D9V5D.'PV"OWN!CL>M:>H^"S<>(Y=;TW6]0TFXND2.]2UV,MP%&%
M)#J=K <;AVK(6SF7XLNFGW$EK#%H,-JKM"9$9EED)7)ZL%(/7OSF@"E9>-/$
MFIVOAJ-/L%K>7M_<Z=?!H6=5DB63YT^8<93.W\,BK[ZUXJN%U73]/V7.IZ0L
M<321P1K%<SF,2?,'D!5"&4<=\G/:M7_A"+6(Z)]EO)X1I,\ERGRJQFE<,':0
MD<YWL>,<GZ4:CX+-QXCEUO3=;U#2;BZ1([U+78RW 484D.IVL!QN':@#)UKQ
MAJ&FWD-MJ;C0GN+*)[::>(2VS73;M\4DHX7;A0.1G).3P*M:GKVO7][KEKX>
MMRT^ELL48*1LDTIC63#EG4A2'"_+[G)Z5I:EX234+2[T\W\J:9>6RVTMJR*X
M55&W<C'D,1CDYZ XSS56Z\#)_;C:II.M:AI#SQ1PW<=ML99U0;5/SJ=K!>-P
MYQ0!4.K^)[WQ<FB)+9Z=YNC)?,'@\YX)2^UER'P^#GG@?6L2WU_6O$+?#V\-
MZEJ][-="XCBBRC21PRC=R<XX.!GC/? KM(_#"6_B1=9M[R2-TT\:?' 5#(L8
M.X')Y)S[UFVOP_@L],T2T@U:]231[B2:VN%6/>1(&#J05*G(=N<<<4 4=9\5
M:MI=]O\ /MW"ZQ!9&VAC,B""1E7,DG\,OS;MN>!C@]:FT>35Y?'WC!/[25DM
MEMEA22#*H&C9@."#@%CGG)]:DN/AU#-%>0)K>HQ6T^HC4TB41D13[PY()4DC
M(Z$D#/>M:'PP+;7]0U>VU*ZCDOX8TFB(1D+(I17Z9S@],XS0!R\7C#6O^$%\
M,>*)I;=;:YEB&JXA_P!7'(VW>O/ !*YSG@Y[5LZMXDO; S2P[98[C48M-LEV
M#[Y_UC9+#."&4#(Y4\\U=T_PA9V7@C_A%)99+JQ^SM;;I  ^Q@?3C(SU^E)?
M^#=.U#PC#X>EDN$A@6,Q7,;XF21#D2AO[^>2>^30 OA^X\1-JFHV^KVC"P38
MUE=/Y:R/D?.CJC$<'H>,@U =7OM8\3ZSHNG726?]E0P%Y6B$A>64,R@@G[@
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M:K$8UVRI(%#;O<A1TQ570?!!T!D@AUW49]+MR6M-/G*&. ]OFQN8+V!.!QW
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MRB@G R:JZ=J-GJ^GPW]A<)<6LPW1RIT89Q_,4 6J*** "BBB@ HHHH ****
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M%I-<:^MC<A8&VR;)G ."P903&"5SGG&?76L?#^K:PVEZG/K+17.F32I:W"6
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M]\($8-"0 8VCZ$<#J<@\YK4O_"+WUKI>=7N!?V%X+S[8T:,9'VLK K@*!M;
M Z8'6@"A#XNN)O%DVARW-I9WD5T$2SN8&1KFWP,R1.6PQ/)P < $8[UU]VTJ
M6DSP%!*J$IY@)7..^*YZZ\)/J,UL-0U 7-M:WXOX-UN!-&P;<%$F?NY_V<XX
MSCIT%[+'#8SR2NJ(L;$LQP!Q0!YS9^-_$ZZ)X:\1WT&F-I6J2PV]Q! CB6(R
MG:L@8M@C=CY<=.Y[:=QXJU^\ANKW0=.%Y':W[VWV0PG,Z1R>7(1*7 4Y#$<'
M@#UXH^ -"DU7X?\ A=+^\62UL?+N!;+#M<2H2561L\A2<XV@\+DGG.Q'X(N+
M36;Z?3_$%W::5J$[7%WIRQ(P:1OOE)#\R!N^/4X(XP 16&L>*=6\1ZS86\FD
MP6^F7J0L\D$C,\;1!^ ''S L/8^W?-\*ZUKP\ :7J$][9RM=7LBSW-PFTPH9
M9=QQO^=BP555<8W#@XKJ]&\/R:3K.LZ@UX)O[4F69X_*V^6RH$&#D\;5'XUA
MP?#R2TT_3;:UUZX0Z9?/=61:!&5 V_<C+_%Q(PW9XXQCG(!0NO'&K+\/O$>K
MQQ6;WFD7LMJ/.MW5)54KABA;<IPXX)ZBMG4-8U]_'4GA[3Y-.AA;3/MB3SPN
M[(WF;,%0P##\1U[XP:\WP],V@>(-(;6[AH=9N3<2.\"%HRVW=C&,DE1[#TK7
M'AZY_P"$L'B ZA&9Q8?8?*^SG;C=OW?>SG=V]./>@#G;3QKJEYH/@_4FM[-6
MU74197:;&.TCS 6C.>.8SUSUHU+Q1XGCF\8K9MI2)H"),AE@D8S*8?-*'#C!
M[;OTJ[:^ I+71]"TU=6W)H]^;Z)S;<R,2YVM\W3]XW3V].;4W@Z2:3Q.QU(
M:_$(I1]G_P!2!'Y7R_-S\OKWY]J &CQ/=W^M:3IEHL5I]OTIM1\^9#("<H!&
MHR,D;\GGH/?(M>"-:U#Q%X6MM6U&*"*6X+[4@5@H56*YY)SG;D'T(KC_ !%;
M"TU32M*N]9DL(M/TY8H;F?2A<V]RQ.TX!!"NJHN><G?P ,Y[7PH^HMI3KJ%P
MMRJ2;;:<6AMC)%M7!,9/RX.X#ID ''- &5/=:J?BW#9K?1+8+H[S^0T)/69%
M;D,/F.!@] .W4U0G\<:DO@E?&T,=L^DB4LUGY;>;]G\WR]P?=C?CYL;<=O>N
MEN_#IG\6VGB"&_D@DBM6M)8@BL)8RX?&3]WD=1V/;K67!X"B@TF;0%ORWAZ2
MX\X630_.BE_,,0DS_JRW;;G!(S0!UQ)>(F-@"R_*Q&1[''%>/7EUJE]\%-6N
MM1O([J1M1(4^44.5O\<G<1C@8  P..:]CKBI?A^S^&+_ ,/IK,HLKJ[-P@:!
M2809O.*@Y&?F[GMQCO0!:L=8UL>,K[P_>O8.QT];ZUEAA=1'EV0HX+'=@@'(
MVYYX%8=K\0+E/!_AO6-1$%A;ZDLGVJ\2V>2&V8'"*0#E0W]XG''OD=1_PCUS
M_P )8WB 7\?GM8"Q\K[.=H 8ON^]G.X]/3CWJGI'A"[T31-,TNTU='ALHI8&
M2XM=Z3HY!^=0PY&#@@]SQ0!O:/<37>D6MQ<36TTLD89I;4YB?_:3D\'J.35V
MLSP]H=OX<T*UTFU8M#;AL$C'+,6.!V&2<#L.*TZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(\3>([+PIH-QJ]_N\B':"
MJ#+,20.!^.?H#6O7):U#/KVNO916-O>V%C Z7"33F,&:5,8X5LE8F/\ W]%
M'5QR)-$DL;AXW4,K*<@@]"*=7G?@>ZN?^$*U;PQJ4KIJ6@;[.1HY2K&+;NA<
M,,$ I@ \?=K#T^VD_L/X<:@+_4!=ZBT=M=R"\D_>QM;NQ4C.!RHY !SSG/-
M'L%%>17>IS>'+CQ%ID%]+;Z7%KEC"TLTKR"VBFB1G^8MN"EN#\PQN."*M>*=
M+GT7PGXOF@\0.RR6*W,-I:>9$+5@"-ZMYC$!_P"[P#@^] 'J=8NO^(#H4^DH
M;-IUU"^CLMX<*(B^<$]ST-<C<M-X=\:)+8274[7'A^YN989IWD$TT;1E#@G
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M97=FR 0=I# 8SSCD5N:EX<T75]+CTS4-+M;BRBQY<#QC;'@8&T?PX''%:E%
M&2/#.B".QC73+94L.;153:(#ZKCH?>K%SHNF7FHPZA<V%O->0H8XYGC!95/4
M ^E7J* ,2U\'>&[%[9[71+&)[5S) RP@&-CU(]*>WA307M+BU;2[=K>YF\^:
M(C*R29SO8=VS@Y/H/2MBB@#-;0-+>\>\:S1KIX?L[3$G>T?]PG.=OM4<?AC1
M(DLDCTV!$L26M548$!/4I_=_"M:B@#EO$/A5)]&O8='L=/\ /O9HY+R*Z!"7
M:JP+*S '!(&-V"1_*CX:\&P:=JL.HQ>'[#0FB#!DLKMI3,"I&UAM50HSGN<@
M=,<]O10!2U'1]-U<0#4;&"Z$$GFQ><@;8W3(S59O#&B/%>1-IL#1WS;KI2#B
M<^KC^+\:UJ* ,74O"'A[6([5-2T>TNUM!B#SHPQ0>@)[>W2K9T336U*'4391
M?;($\N*8##(G]T>@]NE7Z* ,>[\*:!?ZS%K%WH]G-J,6"EP\0+@CH<]R.V>E
M6CHVFG5CJIL;<WYC\HW!C&\ISQG\3^=7J* ,VP\/Z3I<HDL;"&!E#!-@XC#'
M+!!T4$]0,9J+0?#]IH"WHM(HH1>7+7+QQ+M16( X'X9)[D]A@#7HH QKSPGX
M?U"ZNKJ[T:RGGND$<\CQ F0 8&?PXSUJ1O#6BO(7.G0#*HC*HVJZK]U64<,!
MV!! K5HH BNK6&]M9;:YC$D$JE71NC ]0?:L]_#6BR6ME:R:7:O!8L&M8WC!
M$)QCY<]!CC%:M% $5S:P7MK+:W4,<\$JE)(I%#*ZGJ"#U%95AX1\/Z7<0W%G
MI%I%/ A2*01Y9%/8$\BMJB@#'TOPIH&B7\]]IFD6=I=3Y$DL,04D$Y(]AGL*
M2R\)^'].U6?5++1[.WOI\^9/'$%8YZ\CIGOCK6S10!CGPKH1L)+$Z7;FTDE\
MYX"/D:3.=Q'0G/.?6GW'AK1KNXDN+G3H9II8/L\CR#<7B_N'/5>^/7FM6B@"
MI9:79Z>TC6T 1Y  [EBS,!]T%B2<#)P.@R:9)HVG2ZG_ &D]JAOO*,/V@$AP
MA_ASZ=\>O-7J* ,:3PEX?FT9M'DTBT?3B_F?9FCR@;.=P'8Y)Y'J:D/AG0SH
M7]AG2K0Z7C'V7RAY?7.<>N><]<\UJT4 9</AO1+?1&T6+2[1=,<$-:^4-C9Y
M.1W/OUJ*U\)Z!9:0=*MM)M8K%I!*843 +@@ACWR"!@]1@>E;-% &6_AW29(!
M$]DC 3"X#EB7\T+M#[\[MP7C.<XXIMQX7T.[MH+>YTNUFB@E,T8D3=ASU;)Y
M).3DGKWK6HH Q?\ A$/#O;1[-?\ 2/M7RQA?WW]_C^+T/;-0:Q8ZOJVH+IK6
M]B- =4:>5Y&,SE6R8PF,8. ,YZ$]\5T-% %2]TRRU%[5[RUBG:UF$\!=<^7(
M 0&'OR:MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME !1110 4454U+5+#1[)KS4KR&UME(!DF<*,GH/<^U %NBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BD9@JEF(  R2>U5=/U.QU:V-SI]
MW%=0!VC\R)@R[E.",CT- %NBBB@ HHZ54T_5+#58I9=/NX;J.*4PN\+AE#C&
M5R.XR* +=%%% !1110 4444 %%%% !1110 4444 %%%07EY;:?93WEY,D-M
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MOF;Q=/H1N+.SNH[F)8;6[B96NX"%+21R;@I/+X4 _=YZTR;P#--X8U71&U=
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M&[D%I&3#*&&?N]B,9[]*R-/\;Z]<Z1X7UN>#3DLM5O([&>V17,BNQ9?,5RV
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M?>P !;&,GUH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+SC9<FT:!X6683C_ )9[",[N_P!.>E &Y17-3>.]"M=.OKRYEG@%A.MO=Q/
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MXE^QRA('R!\Y*_*,L!D_RKI;FY@LK66ZN94A@A0R22.<*J@9))]* ):*P/\
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M-:WKLP5QU==W*YST!Q[5OT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLD!5BK-N+!]YP<GIB@#"U>YU._UWP#?WL=I'%<WS2K%&&WPEK>0A2Q.'X/)
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M??G?ZGIZ=\\UBZ;\.[_18=$GT[6X5U+2XI;8RR69,5Q!(^\HZ!\@AN00WX4
M6?AL)A!XG%RL2S#7[K?Y6=N<)R,]CUI;_P 6ZM8S^*+5H+/[5I5NEW9H0_\
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M1GK110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV?=N8C QDG&!Z5T%% %&?1[*YU&PU":-VN; .+=_-;Y=Z[6R,X;('?-7J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***B-S )O),\8E_N;QN_*@"6BBB@ HHHH **** "BBHI;
MF" @331QD]-[@9_.@"6BF1S13+NBD21?56!%/H **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 AS@XP3VS7F&B6,NA>-[0>*O#VE/J6H2RFTUVSRQ:7#,8WWC*G9
MD#'&!@5Z9.LK6\JP.L<Q0B-V7<%;'!(R,C/;-8EII.J7<MA<>(+BREEL7,L2
M6<3*K2[2F\[B3]UFPOJ<Y/& #?HHHH **** "BBB@ K@/BS'&VB:(\EN)]NN
M6?R;02WS\@9]>E=_7->,O#M[XDM-/@M+FWM_LE]#>EI5+;C&<A<#'7US0!RM
M[/ GQ8\-BUL)-"8QSB>6:,1+?@K\L*[25=@?FY(QVS6W=>-KE= O_$=G817&
MCV,\D<@\PB:6.-MDDB\8X(8A3U ZC.*L:AX5OM?US1[[6+VV%MI4_P!JAMK6
M%@7F ^5F=FZ#T ^IJHG@B\M]'UCP];WL(T34I97RRGSK=)3F2->S Y;!.,;N
M0V* )9/%FL7?B2?2='TJSN42TM[V.>6[9 \4C$=-APV%.!R/?L8;3QMJD@U:
M^N]*M+?2='N[F"]F%V6<+$FX,B[!NR>,''45J6'ARXL/&5QJ\<EN+*2PBL4M
MP#N18RQ4YZ?Q$8_6JVG>#W72O$FF:I-%-;:W=3SMY(*M&)5"E>>I&.#^E  _
MBR]L9="EU*QABL]:D6")XI2S6\SKNC1\CY@V",C&#V/6LV]^(-]I_AW5]1N=
M.M4GTG419W5N;AN$)7$JG;D@JX?&.@/I6C:^%=0FMM"LM8O+>XM]%F2:*2)"
MKW#QJ5C+@\+C.3@G) Z#@V+GP9:7GBJ\U:>0O;7EF()[0CY7D =/,/OY;LGT
M- #]3\4'2QJ%R\,<UE:0PXDB8EI)Y6PL8&/=#GT<<5G2^,-6M9-5270VD2TT
M]KZ&Y"30PN5SNB9GCX?N,9R/2I(O D?_  KMO"UQJ$SRNBYO@/G\Q"#&_OMV
M(/HHI\>B>*;S0K^RUK5[">>:TDM(C;6[1I\XP9) 6.YO0# Z^O !?\,:KJ^L
MV4=]?Z?;6EK<6T,]L8IS([;URP8;0%QQC!/6L_4O$NN)XMN/#^EZ19SRQV4=
MZDLUV4#(TA0@X0X/RG'4>XZ5NZ#83:5X?T_3KB2.22TMXX"\8(#[5"YP>F<=
M*H)H5XOCV7Q 9X/L\FGK8^3@[QM=G#9Z=6(Q^M &5=>.+O8UYINCSW]E'>FU
M=(8)FE95D,;R*0A4@,#QGD#.0>*J77CGQ"MIK]W:>'K2:'0[MXKD&](:2-$5
MR8_DY;#$X.!T R>ES3_"FOZ/J5Y;:=K=NF@7=R]R89+<FXMR[;G2)PP !))!
M(.,_C63H5G?ZM-X]TVUN+:.WN]6E@DE;)DBW0QJQ Z,<<#)&"._2@#3?QGJU
M_K,6GZ%I-I<K<:5%JEO+<79C#1NP&& 0X./K]12WOCB\2.:\TW1Y[^TM[PVL
MD<$$SRR!7\MW0A"IVL#QGD+G(Z5>L/"TNF^+;?4K:2%=/M]*32X[<@[PJ-N#
M;NGMC'OFJ=EX4U_2=5OH=,UNWCT*^N7NGADMRT]NSG+K$X8  DD@D'&>E %J
M#Q:][XBO-*M!:>?9W202VDLI2X,1"DS*,<K\W3T&<]JIR>.+N007FGZ//>Z>
M]Z;9A#!,TNP.4,P(380""<9Z<Y!X$VJ>$+C6M2M9[UK,M9WZW=K?1J5N8HU?
M=Y.>X/()SC!^Z2,U'I/A37]$O)[&RUNW'AV6X>X6%[<FYA#L6:-'#8"DD\D$
MC/'/- %74/'.M6T/B:>#1;-HM E_?[[Q@98Q&LAV_)][#=\ >I[6XM=U:Y^(
MZV,0A.E_V.EXL>6#G?)@D\8+?+@#W//-,NO!NH7%GXPM_M=JO_"0D[6VM^X!
MB$7/][A<]N:M0^&-2@\1V>KQ7]NA32UTZXC,3,3M8L&0Y&,DGJ#B@!_A3Q6_
MBA8;FW^QO:20,\RQ2DRVDH*XAD4CK@MSQ]WIWK5US4KK3HK8VULD@EF$<L\K
M[8[9-I)D?VXQCU(Y%8VF>$IX?$UIKUX;.._AM7M[B:S4H;XMM^:0'IC:<#YN
M3UXQ5WQ/H5_J\^DW-A>00R:?=?:##<QEXIOE*_, 0<KG(/8B@#"?XA7(\*7&
MKQ:;!/):ZK_9LJI<$*_[U8Q(AV\@[@<''UJX?&LVEW^NVWB"S@METVQ34%>U
MF,H>)BXVG*K\V4QZ'-4)? 6K/HNJZ<=4M'^VZPNIA_L[+M(D60J1N.<E /8>
MM7M7\$R:]K&L7%]/$MIJ>E+IS1QY+Q[69@X)X/+=,=A0!F:D^H7'Q#\!W5_9
MVL)E-VP\IRSQYMF.QB0,]>HQSGCO74^+M:N_#OARYU>ULTNQ:@/-&SE2(\_,
MPP#G:.<>@-8EOX6\22ZEX<N]2U;3I&T5I!NCMGW7"M&8\ME\!L'/' /KTKL[
MBWBN[:6VG0/#*AC=#T92,$?E0!S(\7;/&,NB3BT2W_LW^T(;H2D[U!PP(Q@8
MX/4\&FW/B35[>RM99M/M;0R6374DUQ,1$LG&V < ER"?ICH:SX?AM$FCZ':2
MZA)+<Z;<[Y+DCYIX2GEF$_[)C"*?]W/6M75_#FI7GBJ'5[/4+>.'["]F\-Q
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M/,]HK^6JSF/.QC@!L="?K7D=]J6IZU\+;74]5CMY[@:Y'Y31D[LB^*[1N^Z
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M%HLJS1/"C*UQ(J%$=P>%P&)(!.3CD 8,USX-M;OQ7=ZO/(6MKNS$$]ICY9)
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M>:B!6,>=IP,9&:GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#4/B+'I1UF_@L9=#^T-% ZJ0_FJN0V,@X[]?<"@#N))8XMOF.J[F"KDXR3T
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M,[B<Y.<@8 LZ9:ZCK'C3Q+;7'B#4TM=.O;<PPPNJ JT*LR,0OW<MVP>^2<$
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M&Q>VBN4O;=H)6"1RB52KL3@ '."2>,4 94O@S0YDU5'MI?+U4L;R-;F15D+
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M#R-IMO-$&5E16N9'6%6ZB,%B$S_LXHC\$:#%IFGZ=';SK::?<"YM8Q=R_NY
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT0+CIMQ7?>$O#[>&/#5EI$EQ'<M:Q^4)UB\LLH/&1D^OK6T44N'*@L.AQR*
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ML]]B@42R,JQ[]K$M][&.Y'/)QS5D>.89+J>SBT+69+Z&SCO'M?)17"/GCYG
M##:003U&!FL72O#^MVA\ ++IKXT6VDAO2)H_E+0^6"OS?,,C/T]^*VHM/U&#
MXA:KJ_V"1[.;38;>)UDCRSHSL>"V0#O&,^AH +/Q_IMZ=&DBL]06QU=ECMKU
MXE6(R%2PC(W;@>",[=N1UK<U35[?2A;+*KR3W4HAMX(@"\KX)P,D#@ DDD
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M!C8H06.[@_(>/<4 =-'XFNW\=7VA?V7.;>ULXY_-5HSN+EAG&[./DP!USG(
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M:$+&&C?84)W'YN,CC&.^00,SPI;^(K:.UM-5\-Z?:O8Q[)+Z"9'-UM7 \M<
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MC]:N^&%\09A&K^&K#3Y;5");BWEC<W38Q^[  V ]?F(QT[Y !1\!ZVME\/\
M2/M4D]U=W-Q=1Q*TFZ24K-*3EG(Z*O))_4@'6M_'6F7-FTB07?VE=0&FM9[5
M\Q9SSM)#;<8^;=NQCOGBN3M?"GB.P\,^'IXM+@N-2T>ZNGET^XF39<Q3.Y(5
M^0& *D9[@_CN:A;>)I])LY;32(;,-?(UYIMK<HDC6X4@CS1@;BV"0".!C/7(
M!K0^,]/EL9YVAN(I8-0_LU[:0('^T$C"@[MN"&!SG&#Z\58;Q+!%%^_L[J&Y
M:Y-K';2; \CA-^5.[;MVY.21T]>*Y"Q\+ZA#8:_I^H>&;2ZTW4-6^U?98[A.
M86C0?)]W#*R YR.>GK5=_"'B.SL+2YM%.HG2]2DFLM.U.=7=K1XPC1-)R-P.
MXJ23@8R>U '5VWCG2KBRNYF2XBN+2[6RDLV53*9V(V(N"5;=D8(.,9)(P<9F
MB7EQ<?%?6HI8KVW1=+MV\BYEWJ&,DF60!F4 @#ICD&H-9T37M6T:PU"UTBST
M_4-/U*&_ATT3+^]5 P97D4;0Q#G'4# YY.+5E;Z^?&NH^(&T/R8I=(C@BAEN
MX][2H\C;#MR!G<!G)&.?4  [:O/O&=TMI\0O",4^I7=I87BW@NDCO988WV1J
M4R%8="?UKN;&6YGT^WEO+86UR\:M+ ) XC<CE=PX.#QFN5\2:=JMQX\\,ZM9
MZ9)<VFEK=>>5EC4MYJ*J[0S#.".<X_&@"CX7UIKCQ[K-GIFI37WARVLT>26X
MF,GD76[E$=OF*[.3DD ^E;B>-=/(TV>2WNXK#4Y1%9WSJOE2,WW.C;E#8^4D
M#/MD5BS>$]0U[QO=ZY=P#2K232I-.\M9%::<OGYGVY4!0>!DG(%0P>&]:O\
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MFK;7NH)I]S;)&Y<EI6B,BN6PHW#.TJ>/XJ /2*J2W]C_ &BNE23Q_:YH6E6
MGYFC! )QZ9(%<%J'C'Q/;Z9XJU")=*$>@7A0HT,A-Q&$1RN=XVMAC\W/T'4]
M"VN7K>/;32%2V%I<Z5+=I(4)D5U>-<$YQM^;./UH DTX^%/"!BT6P-II_G3!
M%B7.&E89"EC_ !D8P"<D8Q6IJNBV&MP10ZA"TL<4BRHHE=,.IRK?*1R#R/2N
M!\/1Z\^E>,)[5M-O;R#6;EX8;BT8AYD";<'S.!P .X.#DUTFC>)9]>BT"6PD
MMVCO+5KJ\S$V4 PNT?-\K;R1SG[K>E &Y?ZMIFCQ1G4=1M;-&.Q&NIU3<?0%
MCR:+/6-+U&5XK'4K.ZD09=()U<J/4@'BN1^+!9?#.G,B;V76+,JN<9/FCC-9
MWB&\FD^)OA";4K%M(@CDECANV=9#<R.N!!E,[0>OS=>U 'IE%<)J?B_5=-U6
M".5;+9)K,>GFVC1I&6&0A5D:16VHYR&VD#CCWJ#4O%/B>.3QA]D_LI$\/A9D
M\V&1C,GD^:4.'&#CC=^E ';?VK8?VO\ V2+N$ZAY1G^SALN(P0-Q'89(JY7F
M6K>);6P\?Z'J\XV?:] =84)X,DDT.Q2QP ,GJ<"O0M.74%LHQJ<MM)=XRYMH
MV1 ?0!F)/U_04 68XTBC6.-%1%& JC  ^E51JM@VKMI*W<+:@L7GM;ALNJ9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N9NO";ZC=VKZA?I<0V>H&_MLV^)8VW%@@DW?=!..F2!C-=-10!Q4_@&6X\.
MZUH[ZL FJW[7TD@MN8V9U<JHW=,J.O;/7LFK?#^756\0*=<FA@UR)!<Q) IV
MR*@0%222%P!\OZUVU% '.CPU<?\ "2:?K3:GYDMI9O:;7@'[P.59F)!&#E1C
M Z>O6I_#&@/X=L+BT:[%R);J6YW>5L(,CEV'4\9)Q6W4-Y+-#93RVUO]IG2-
MFC@WA/,8#A=QX&3QD]* ,*;PQ-)XAU/5TU!5:^L5LO+,&1&JEB&SNY.7;]*I
MV_@F6WL_#%LNJ*5T!@8B;?F7$9C&[YN/E8]._P"5=5;22RVL,D\/DS,@9XMP
M;8Q'*Y'!P>,U"]Q=KJT5NMB6LVA9WN_-4;'! ";.IR"3GH,>] '&W'PWE;1=
M2T*TUZ6WT6\G^T1VWV97:W8R"0JKD_=R"<$9&>OK?NO!EZOB&;5](\1W6FR7
MB(E_&L$<JSE!M#@,,(^.,@$=.*ZZB@#GH_#,EOXI36H+X 1Z<-/2"2(OA VX
M,6W9)S^GOS67'X"EB\,:=HBZL-EC?B^24VW+,)3*%(W=-Q/X8^M=K52VN+N6
M]O(I[$P01.H@F\U6\\%02=HY7!R.>N,T <S<>!I;G2O$M@^JJ$UZ4RS,+;F+
M**A"_-Z*.OO6@GAN=?$UCK;:@C26MBUEY0M\!U8JQ;.[@Y0?K70T4 <K9VL/
M@73M8U'4=0:>UN;U[V4QVC%HWD*@@!2Q*].V?4T[P9HMMIZ:GJ5O!+ NJ7;W
M$<4H*F./)VC:>5!8O)MP"/,(/-=110!S_BSPW)XHL;:T6^%HD%U'=;A#O+-&
M=RCJ.,]:AN_"<FL:MIE]K>I&Z339OM%O;0PB*/S1T=N6)([<@5TU% '#2_#R
M9X9+=/$%PEN-6&JP)]G1C')YGF$,QY89SCIC/.:NR^#)I1XG#:H,:_&(Y2;?
MF("+RLCYN3M_7GIQ7644 <;+X!CO+BV:_NXKJWATIM+>!K;"R1DJ=Q._ALHI
MXZ4]-$\1:98:'96WB&:Y-I<()G>U7-Q " RR,2<$+G!')..O)KJ9KN"WFMX9
M9522X<QPJ>KL%+$#_@*L?PJ*UN+N6\O(I[$P01.H@F\U6\\%02=HY7!R,'KC
M- %+Q/X>M_%&B2:;<2RP$NDL4\1^>&1"&5Q[@BLE/!=Q=:S_ &EK.LF^9]-?
M39H4M5B26-SDYY)!..Q_+I7744 <KX<\)ZAH7DP3^)+O4+"T7;9V\T**8QC
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MV&OPZG<WJ3*FF?V9)!]GPLD9(8G.XX)(^F/SKIJA^UP&]-F)5-P(Q*8^X0G
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M&1D\X K1K,TV_P!2N+V[MK_23:+$$:*=)Q+',&SD#@$,,<@CN,$UIT %%%%
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M$$=R"??@5N:[%JFH:EXPLH_M4]YY$ T>2UD(^S.8^A8']VV_YB3C*D=1@5V
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M@?4T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K'O?#\=_K<&HSW]^8H57%@)0+=G5MRNRXR6!P>
MN.!QQ6Q10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNJZG'9KI4$Z107;Q!)"THRI4@C[HX!P>^:Z*]\$^'-1N+V>[TJ&62^ ^T9+
M2$<!L X#<?>'/O5F/PSI,-W-=16K1SS0"W=TF=<QCHO#< 9.,>IH X7PWX@O
M==?P7I>HW<PCO-&>]FD60HUU*NU0I92#P"S$ \\9K:^'$"VJ>*8%DD=4U^Y
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M-?E <A<9QC))QCKS0!P=E)JOB;3;C5X-:73[RRU2996,\A6%(Y67R7A!"$%
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ME,T\,KLX>0G)?DDAB><CG-6]&T+3/#]E]CTNT6W@+;B 2Q8],EB22< #D]J
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MH"3^IY/XU:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.,D?WO6@#L*SSKFF"\%H;V'SV=HU3/WF4$LH[$@ D@<C%:%>:6/VO3_%5O\
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M!#.6B;RL*"0< X!],5SD+QP^%/"8O[6:)8_%TK2)/ PPK-<L#R.1@@Y&1^5
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MAHW8*50H02F%;<, ]#74Z2;.]^*>L72HDT$^EV@@FV;DDPSL0K8P>J'CV]*
M.JDU[2HM02PDU"W6ZD?RTC+@%GQG8.V['.WK1<:]I5I>I9W&H6\5P[B-49P/
MG(R%ST#$=!U->;Z&NGSPKX:\0Z;J\NMVFH/,D69Q#*WFLZ7"NOR!?FR23USP
M3P2V73Y7U;POXETW5[C4)-2FGMXHS.(;M6E,D;JZ?*H&0"21C;0!W]UXN\.V
M7G_:=;L(O(<1R[IU^1CV//!_E5B#Q!H]UJK:7!J=K+?*F\P)*"^WN<?B/SK@
M[E8VOOB@QA)-S;1I$?+/[[%J$(7CYOFXXSS3 A^T?#=;93%)%93H[B,@0LUM
MM&_CY?G&.>XH ] 37])?4!8+J%N;IMVV/>,MM^\!ZD=P.G>JP\7^'&F@B77+
M!I)Y3#$%G4[WSC:.>N>/KQ7">$#I5]9Z%I.IZ7JX\0:,R;X9C.(X'0;3-OSY
M94C) SSG&*S[F-3\.?$R1V[_ &B7Q(T\:+"V]U^UHP<#&2-@)SZ T >DVWBS
M2[GQ+?Z&EPHN;*.-Y"QP"6WDJ,]=H3)/O[&KUEK&GZC,T-I=QRR*@D**>=AZ
M-C^Z<'!Z''%<5,\,/C/QDM[:7<UKJ.D6[1^1$Y$T:1S"0*P& ?F Z]2,4WP[
MJ%YH5Y>K=7[:WH=GIOGPZ@+8_:80&_U$FT?.V.>@88.1S0!Z+1573=0M]6TV
MWO[1F:WN$$B%E*G!]0>0?:K5 !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9&OZ]'H$-G--;R31W
M-W%:9C(RC2,%4D'MD\XH UZ*YJ]\8P6-UKUO)I]U(^C6B7DOEE#YD;!S\N6'
M("-D'\,TS3O&B7VJZ793:5=VB:K:M<6<\K(5DVJK,N 25X8$9 SS0!U%%>9^
M-=<_MKP_I=[96DS:>^LVJ0W8E #XG52VS/W#@@$\GC@ YK>USX@:;HGVZ1D\
M^'3Y!'=E)D#J2 3L0G+[0PST[@9(( !UU%<K+XU+:[<:38Z'?WLL,<$Y>)HP
MK12D@."6Z#'0X/M@$U9TKQ1_;,4%S96#S6=PLAAG253RG\+C^!CV'/O@\4 =
M#17$^'/&E]J'A2SU2]TN5KB]O7MH(X2&7)FD49(^ZJJO+$<XZ<U-<?$"UM=
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M3#:'?Y:^Y'F-^@[4[P[9^+/L,.CZ];Z<EK;0F![VVF+/=KM*C"%1L/0DY/3
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ML^<5VD/\O ';G&,UUE% 'G.D>%=?TO3_  7++;6DL^A1S03P17'+JZ! RL5
MR,9P<?6I=3\#:C??:M9BD@CUM]6M]4BA9SY0$*>6L3-C/*[LD#@MW R?0:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cutr-20221231xex1028four005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% %#5=$TO7+=8-4T^VO(T;<BSQAMI]1G
MH?I4FG:78:1;?9].LX+6'.XI"@4$^IQU/O5NB@ HHHH **** "BBB@ HHHH
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M :=%8\GBSP[$)2^NZ:ODRK!)FZ3Y)#D!3SP3@\>Q]*S].\>Z%J?BV^\/VU[
MT]HJ L90/,D.[<B#^(J%R<>OM0!U%%9]AKVDZI,8K#4K6ZD"E]L,H8[<XW<=
ML\9Z5H4 %%4=4_M0Q0II36L<K2@227,;2*D>"2=H923D =>]<CI>N>+=5O?$
M5I;SZ,9=(N1 BFRE'VCY _7SOEZX[T =Y17'V'BY;?Q'XCLM>U+3[6VLKF"&
MU>1A"&\R(/@EF.6Y_3H*W;NY===TZWCU.SA1UD,EG( 9;CCY2G(("X)/!S[4
M :=%4XM7TV>\-I#?VLER-P\E)E+_ "_>XSGCOZ5<H **Y3PWXQ&N>)=:TF2#
MR1:E9;)C_P O%N<H9!ZC>K<^A6MN\UW2-/:9;W5+*W:%!)*)IU0HI. 3D\#)
M H T**SDU_1Y+NVM4U:Q:XND\RWB6X0M*G7<HSEA[BI)=8TR"^CL9M1M8[N1
M@J0/,H=B1D +G.<4 7:*S+GQ'H=D9!=:SI\!CD$3^9<HNUST4Y/!]JL7^HV>
MGPA[J]MK7?D(T[A03C/<C/K0!;HKDO!WBH:IX9MK[6+^R2YN+NX@C*L(UEV2
MNB[ 2<\*.YK6_P"$K\.BR-[_ &]IGV42^29_M<>S?_=W9QGVH UZ*IWNK:=I
ML*S7U_;6L3#*O-*J CU!)ID^MZ5:[?M&IV<6Z(S+YDZKF,=7Y/W??I0!?HK!
MU+QCH6F:=87\FHVTEO?W$<%O)'*I60LX4D-G&%R23VQ6T+B%K<7 FC,!7>)
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M>0UV6J6MU>:9/;V5^]A<NN([E(UD,9SUVMP?QINDZ:-+LO):XDN9W<R3W$@
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MTDTGX6K.B;HI)Q()4QM_<R 9R.FXK@],XKVFB@#Q^^CL&T#XIA4MS)+-(8L
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M8<#=&H!9B6(P!N4>N3TZXQ[#2]:T'7=?FAL%OK76&6ZCV3*/(GV!'5]V"4.
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ME6$V\L*E0=I_@(.>,D>A[Z/P^TK4=#\$:=IFJ01PW5NK*RI)O&"Q(Y QW]Z
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M9SW%M*MM(F_RX_E8!E<'=P23TYX)I9_#%]-XK@UFQL)-*U$7X-U=P7"B"\M
MQXDC#9+E,#[O!YSZ02^&]>'A/QGHJV$;MJ=U=RVDJW"_.)SD9!^[C)SG\,T
M;+^)[F'Q?I6AVVEW$EI/IKW7F"1"QPT:C[S X 8Y[DD8!J7_ (3K3QH/]L&S
MOA;K??8)%VIOCD\WRLD;\8W=P3]*JG2=7C\6^']7ALD>*+3)+&Y1YE5H2S1M
MNXSN'R$<>U<_=>&/$P\.:GH4&EPR*=:^WPW+72JLL9N5FQCJ"!D'/IQF@#J(
M?%DW_"8ZWIEU9/!I^F6L,[W3.FU0PD+.WS9"X0   G@YQ4UIXTL+G7+'2I+>
MXMYM0B>6S>0H5E"@%A\K$JP!SA@./?BLG4O#&J:AXA\2*T,2V&NZ3':-<B;F
M!U653\N,M_K 1TZ&K/A2+Q(OV6VUG0M.LC:)LEO8)ED^U$+M!10H*9ZG)[8Q
MSP =%JVKVVCV\4MP'9IID@@BC +RR,>%7) SU/)  !)X%9,OC6RM5U=+NRO(
M;O2K?[5/:E4+O#@GS$(;:R\$=<@C!'2D\9Z)?:K!I5YIFQKW2K^.]2&1MJS
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M;/;K7(-X8UM3XT$&BV\$.MZ9'!;QQW*DK((Y$(;@<Y<$G/T+4 =/IWC*UO\
M5['3WT^_M3J%LUS9S7"*$F50I8##%@0&'W@,]O?F_&/B$:IIFB76GPWXLY-<
MM(X[R.0+%*/. ;*ALE#@@$K@_B";KZ#JD^J>$)'L72#3K">VNV$J91I(T0;?
MFYP5)^A'TK&B\.>*X?!ND^&6TJ"5])U"VD2\%TJQSPQ2A@0OWE; P01],]*
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MB1@2P+< EN.M5;GP'?Z^WB/4]8N((-3U2P.GVL<#%TM(1\P!8@%B6P3P/04
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MEVL:Y1\XQAR2000?0C!K,N=)UB7Q/X4OVL(O+L!=&[\B10D7FJ JJ#@MM[G
MSUQSBF>-=&?4=:T2?3[I;>^DDDL+C'62TD0M*..A7:&4]CCUH ZG2=235]+M
M]0C@FABN$$B+-MW%3T/RDCD<]>]7::B+'&J(H5% "J!@ #M3J "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/\)6K-#%J&M6LMU/,L>5C2,#(12>I+ #.< 'K5;5_&NN:9HOBN$?9&U309H
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M]O'(7"1ONED#%58.ZX7"CIR<GD8Y .EO;^VT^)9+F0J';8BJI9G;DX50"6.
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MYMM<1K+$^"-RD9!P>:Y)-;U\:[XDT^.YLY;;3+2.>&>2U+,SNK-L<JZCC;G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J
M>H:MIVDQJ^H7UO:J^=IFD"[L#)QGK@<GT%7*\Q\3P7^G?&'2->N[*[NM _LV
M2T=[>!YA YW$EE4$@$;1G'\J /2H)XKF!)X)4EAD4,DD;!E8'H01U%25Y=\
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M#<Q*YC9XG#!6'53CH1Z5:KS/4/$T^B^)[OPMH5G:PW<.G/J=S);:<[BYN6P
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M'?I/&;22(3+,3A2A&0V3VQS7G[ ?;_BG_P!<8_\ TC%=;X._Y$?0/^P;;_\
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MFPBDB2#R,AEDQNRV[KP,<?G4NIZ!)J'B;1]96\6+^S!,%A,.[S/,4*V3N&.
M,<?G6Y10!Q5QX!EN/#^LZ2VK )JFH_;WD%MRC%U<J!NZ91>O;/X7=;\)3>(+
M>]LM0U".73[MXW:)K;+PLH4$Q/N^7.W/(.,FNHHH SM<TZ?5M&N=/M[S[(UP
MAC:81[R%(P<<C!([U6\0^'D\0^%+K0II(XDN81$SK#D+C'*KG@@@$<G&!UK4
MM;J"]MH[FVE66"091UZ,/45EZ5X@_M/Q!K6DFS>!M+:$%V<'S?,4L" .G H
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MH^SH64DN2K,?O']XV&_,&N@\6>(/^$6\-7FLFS>[6U4,T2.%)&<9R?K[UM4
M<N?",QG\32_VDO\ Q/D"./L_^IQ'Y8Q\W/R^O?GVK9T33FTC0['36F$WV2!(
M%DV;=P50H)&3S@5?HH Y#3_ WV32+31+C4?M.C6=P)XH#!MD<J_F*LC[L,H;
M!X5<X&>,Y1?!-U:ZW?7.F^(;JRTS49C/>6"PHVZ1OOE)#S'N[X_ CC'7.ZQH
MSNP5%&69C@ >IIMO<175M%<0.'AE0.C#^)2,@_E0!G>(] M/$WA^ZT>\+I#<
M*!OC.&1@0RL/<$ _A6*G@N]NM6L;_6==-^UM:36;QK:+$L\<FW=NY/)V\X_#
M'?KZ* .2\/>#KW1%BLY_$5U?Z1; K:V4L**47& KR#EP >!QV]!3?#_@J\T!
MX[2/Q%=S:);OOM=/>%,Q\Y53+]YE!Y XZ $D<5U]% '%3> I9_#.L:*VK )J
M=\U[)*+;E&:02%0-W3('7MFKNI>#DUC7)K_4+M)(;C2WTR:W6$J&C<AF8-N)
M!R./0?G5[1O$']KZMK6GFS>W?2YTA8NX;S-R!P1CIP1WJY>ZG':7=K9JOFW=
MT6\J(''RKC<Y/91D<^I ZF@# TKP=>6]@^G:SX@N=8T\0-;Q02PI&0C*4.]E
MY<[21DXZDXS@BI!X!OH[71+.;Q)-+:Z+=I/: VJ"38J,BH[9(; ;&<#CJ#U&
M]H'B#^W+C5X39O;-IMZ;1@[ABY"*V[CI]_IS5Q]3C@U>+3KA3&]PI:V<G*R[
M1EE]F YQW'(Z' !2\4>'(O$VEQVK74UG<03I<VMU#C?!*N=K '@]2".X)JF_
MAC4;OPWJ6FZCKSWEWJ$#6TETULJ*D94C"1J0 ?F)R2>3Z  :^N:I_8FB7FJ-
M;O/':0O/(B, Q102<9XS@5AR>.H;/1K#6=1TN\M-*O!$PNMT;K"),;#( V0#
MD#(!QGF@"34/"=S?Z/HE@=31#I5Q!<+(+;/FM#]T$;N >^/PQ4=_X/O7\1RZ
MWH_B"?2KB[C2._C2W25)]@PK /G:P'&>>,<>O644 <A<>";B'71JVAZ]<Z9+
M-;QV]XIA6<7"H,*QW]' )&[GZ=<WIO"W_%0:7JUKJ$T#V5JUHZLHD,\3,K<D
M]&R@R>^3]:Z&B@#$\.Z ^@G5"]X+G[??27K?NMFQGQE1R<C@8JOI'@O3-)\.
MZAH8#S65Z\WF(Y^[')D",>BJIP/S[UT=% ',>&_"^HZ)Y,-YXDNM3L[1=EI#
M+"B%!C:-[CF0@' S@=\$XQ9\0^'I=8O-*O[2_-C?:;,\D,AA$JD.A1U*DCJ#
MUSQ6]4=Q(T-M+*D3S,B%A&F-SD#H,\9- 'EWBWP\?#VA2C^V))I=2\0VM[NE
MC0&-O,3<V!U "@GH..@KK[GPA:ZR^H7&M3)>O?67V',,?EI'"26.T;F.XL0<
MY_A7&,<Z>@:N=<T:&_:SGLG=G22WGQOC='*,#C@\J:TZ .:L_"UP'TIM3U,7
M_P#9()M";?82^PH'D^8[F"DCC:,DG'3&>? 4I\-/HO\ :R[&U'^T/-^S<[O.
M\[;C?TW?I^==K10!A>+M!?Q)X4O-,61$N759(9",*LJ,'0GVW*,^V:J7FD3>
M(KW1=;M[V?3+W3Q*CPO"),>8JAT(/&X8&&&1WY!KJ** .+7P[<^'_!NHZ%8W
MLM]<W[W M?,C5?*,S,2S;1T4N23WP !D@'I-,TBWTO0+31X<FWMK9;93W*JN
MW/UK0HH XJW\!7%OH^@:;_;;21Z+=)<0%[498(K*JG##C#')ZDXZ5+>^ H=3
M?Q%]MOW*:TT,G[F/RWMWB $;(V3R-H/3K^5=A4-S=06<0EN)5C0ND89N[,P5
M1]22!^- &5H.C:GIV9-7UZ;5K@)Y<;M D*HO?Y5ZL<#))[<8YS5OO"T[>*AX
MATK5&L+J6 6UW&T ECG122IQD;6&3@\_2NEJ&UNH+VW6XMI5EA8D*Z]#@D''
MX@T <=!\/I+/P_I.GVVMRB[TJ^>\MKJ2W5AER^Y60$9!\QN^>E$_PYCNX-92
MZUF[>74;J*\CG1%1[:>-5"NI'?Y>G3!Q[UV]8'B#Q/\ V#?Z7:'3YKEM2G^S
MPM$Z@!\%L-N(P, \T 3Z%I.HZ>C/JVM2ZK=$!!*8%A55'HB\9/<YYP.F*S-2
M\(7DOB677-%U^?29[J-(KV-8$F2<)PK8;[K@'&>>.WK>M/$\$OB'^P;RSN+'
M4'A,\*R[62= <$HRDC([@X/MBMV@#F]0\(PZI;75I?7 N;22R^R01S1EC"3]
MZ0MN^9R=ISP1M&,<YHWG@F^N['1W'B.XBUO20RV^IK I9T8 ,LB$X?( STY&
M:[*L6S\0?:_%>I:$;-XFLH(I_.9P1()"P& .GW#UH S-3\%3:GI]BS:Y=)K=
ME<?:H=3$:Y$A7:1Y?W=A7 V^W))SE^H>$+G4M'@AN-;E?5(+R*]COF@7:LD?
MW0(Q@;,9&,]R<YKJJ* .//@0W!\2&]UB><Z]:I;SXA5 A5"@9?S.!],YZU8F
M\*7=R/#[3ZOYDND3>>'-L!YK;"F,!A@;6/J<]^U7]5UU[34H]*L+1;S4Y+:2
M[6!I?*7RT*J<M@X)9P ,>N2,4S4O$+Z5X1DU^YTVX00V_P!HGM"RB6, 98=<
M$CZT 9Q\$F*/6;*SU)H-*UB1Y;FV,.YT:08D\I]PVAO0AL$DC%6H/"S6?B.?
M5K2[CB5]/CL([?[/E8T0L5.=W/+'\,5#-XUBL;/3[[4],N[.POFC1+HLCI&9
M,;/,VME0<@9P0.Y%=30!C^%]"_X1KPU9:*+DW"6D?EI+LV$KVR,GFN=L/AW/
M8PZ)"/$-P\>C7+RVH^S)G8RLI5CW;#GYOTSS7=5BZYX@_L6_T>V:S>9=2O!:
M"4. (V*LV2.IX4T 8MQX"DN?#VOZ0^K )K-XUW)(+;F,L5)51NZ?(.OO^$\O
M@ZZ37-0U/3]9-I_:D*IJ$/V8.DCJNT2)EOD;''\0/I71ZG=S6.F7%U;V<M[+
M$A9+>$@/(?09XINDZBFKZ19ZBD4D*W,*RB.489<C.#0!6\-:+_PCOARPTC[4
M]TMG"L*RN@4D 8' K5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO'>J2V":%:B9X+;4=5BM+
MF9&*E8R&;;N'*[BH7/H376U4U+3+'6+"6QU&UBNK648>*5=RGN/Q]Z /,-9E
M;POXA\<W>E;XY(M&M)5P2_E9>4,R@] !EL=,YKJ=%TPV_B&UU2UU^*6RO+,K
M]CA#NEQC!$V6D;!&<%N^1DYQ6U9>%M"TZ=Y[72K5)I(O)>0IN9DY^4DY)'/X
MTW2?">@:"+D:3I5M9?:1B4P+M+#TSU ]A0!YOH[RP_#;X?20W$\1;68(G$<K
M*KHTLF58 X8<#K6_J-S/X9\<WL'F330Z_: :>DLKND=VIVM& 3\JL'5SC^ZW
MI74KX4T)+&ULETV%;6TE\ZWA&0L4G7<HSP<\Y'J?6M*:SMKF:WFFA222V<R0
MLPR8V*E21^#$?C0!P4T#77BNX\(R:CY<5MI4+6@N'D9YB2XDE#!U)<$)R<X[
M8R:IS:;/<:_X0TB\\07U_%/87L5U<03R0BY\O8%; ;@\GY@<GU(-=UK7A?0_
M$?D_VQI=M>F YC,J9*^N#UQ[=*E?0M+>]M+PV47VBS39;.!CR5QC"XZ#  P.
MM '%:C*_@7Q4'#W=WI^KV8MK6.>X>39>1CY4!8G'F@]?[R^]=QI.G?V;HUM8
M//+.\40629W8L[8^9LDYY.3[5F-9:OJ?B!3J5K91Z58S^?:-'(7DF?854L"H
M"[=S'@GG'IST- 'C5C<_V!X+N'LY);>.X\4265U,LS9AMC=E6(Y^4XPNX<_-
MG.:[&%9](^)]OI]@\ITV]TR2>XMV<LD4B.H5UR?EW!L$#KC/45T"^&]%1;]1
MI5IMU!BUVIB!$Q/7<.^>OUYJ?3](L-+W&TMPC,H5G+%F*CHNYB3@9.!T&: .
M1^+"LWA:Q57*,=7LP& !P?-'/-9OBN.[T?QYX/O[^\.KP37IM(+1T6-H)'&#
M.NS&[ Z[AQVQFN^U71--UN*.+4[..ZBC8.J29*AAT./4>M1VOA[1[*]6]@TZ
MW6[52JSE-TBJ>H#'D#Z4 >=WU^YN].U/3[RXE27Q2EJUW+.59U,A1X5C''E
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MV]K#I4$=O;S>?#$F0L4G]]0#PW7D<\U9/A[26GO9S9)YM\H2Z?)S,HX ;GD
M<?3B@#S_ $C4;OQ-=:7I.HWZ(T_ARTNXEE+@SR.&\V0%77+#">N,DC&34IL;
MD:_X)TRZ\07NHK);7T-S<13/"+GRPH4D!NHR1N!R?7FNPO?!?AO4;"TLKS1K
M2>VL^+9'3/E#T4]0.!QTXJZ^@Z6]U9W1LHA-9)Y=JRC;Y*XP0N.@( &!V% '
MF=KJ]U8:9;Z.UY<+82>+9M+:=YF+I;@LRQ^83NY("YSG&1FKL]C%8>*/'T=I
M)/ /[#@E0QSNK1L!,1L(.5&0#@>I]:[AO"NA/I]W8/I=N]I>2&6XB==RR.3D
MN<_Q9YSUXID/A#P];^?Y6DVRM/#Y$K[?F>/^Z6ZD<\^O>@#A+2S<3_#N4:AJ
M(?5;,Q7Q%Y)^^3[+O QG"\KU7!Y/.>:KC5;C14OM*%_)#IB^*5L3-<2N_D0M
M ) A<L&"F3 ^]T8C->DKX;T=38$6,8_L\8M.3^X&,?)SQQQQVXZ4UO"^AO;W
MUO)IEO)#?MNND==PF;^\P/4\#GKP* .!\5Z;>:%X/\4M%X@E8$VUQ;VULTD?
MV/<X5@&WDE7P3M/ YXYK3ELEL_B!J.E)<7<EE>Z ]Q/%-<R.&E$NW<,GY20<
M8&![5T\/@_P]!HC:-%I%JFFN^][<+\KMZM_>Z#KZ#TJVNB:<FI+J0M5-ZL7D
M"<L2WE_W<D].^/7F@# ^%\$4/PWT$Q[MTEE$[Y<MSM]SQTZ"L,Z#:Z[XW\<1
MW=Y>6R1K9LDEM=/#Y;>0<.=I&2/?(]J[[2]'T[1+4VNF64-I 6+F.% HR:@N
M_#FCWUZ]Y<6$3W$B!)7Y'FJ.BN!PX]FR* //+74-2L_#?@WQOJEQ<E$B2'54
M:5@C12?*D[)G&5.TDXZ,?2N]\,Q.=-?4)3*)-0E:ZV2.Q\M&/R* ?NX7;D#N
M34&N66K:K=#24M;$:#/$HNIGD/FXW?-&L>W!#* ,Y&,D]AGH>E 'FMPMQXJU
M'Q59/K<>F7FG702!SO$EI$(T995Q(HP3N))'/()P !1\87LDFF>*+BTU"XN;
MW3M.@=IS(;=+.387!B4<EWR&.<<8&3TKO]1\)^']7U2'4M0TBTN;V'&R:2,%
MACD9]<=LTM[X5T'4KV>\O=)M)[BXB\F622,$NF,8/X'&>M '-1W2>(O&.IZ'
MJEU+&L>E6\MG''*8RV_?YLPQU92$ /\ #CCJ:J75A#>>-/!]E)J-U>P#2;Q&
MNO-*/< &$;BRX//7((SZD'GK+_P;X;U.&SBO=%LIH[,;;=6B'[M?0>WMTJY)
MHFFRW\%\]HGVJW0QPRC(,:GJJXZ#VH P?AS-,_ANYMY9Y9EL]2N[6)IG+L(T
MF8*"QY.!@<^E8IT5/$'C;QEI]YJFIQ6T,5H\*Q7TB"%VC<[QANQYV_=]NF.[
MT[2;#2(I(K"V2W260RNJ9PSGJWU/<]ZYFT\+/<>-_$.I:G8!K*_CMXX6$W+*
MBE75U!Y5LC@Y!QR* .:T/4KK7]%T*/4KB>YU-M"DN);>24PQ!"X5;EF')<A>
M, ]2<KUJ/3Y;K7+3X9B\U*_)O[:=+LQW3H9@+9C\V#][_:Z\]:])N_#FC7]W
M;75WIEK-/:ILA=XP=B_W1[>U06_A+0+7[%]GTJWA^Q$M;>6-OE$]2N.A/0GN
M.* .2T;P_I]O\2=;LMUT8X])LT#O=R%VR95R6W9)P!].U,\.R74LJ>";V>Z>
M^TJ^:6YN6F??-:K\\3ELY)<NBD9Y"O7;WVD6K7;ZQ;Z=:3:S%;M';S2C:>A*
MJ6 ) R>O;)JOH-C?K)<:KK$-M%J=VL<;QVS%UBC3.U-Q +<L[9Q_%CG&2 9/
MQ5_Y)?K_ /U[_P#LPK)U&2Z\.>-M1_LV:ZF,GARXO3#-.\HDN(W 1@&) /S$
M87 ]J[S4M,LM8L7LM0MDN;63&^*3E6QZCO42:)IJ:C'J(M5^V11>2DQ8EA'_
M '<D].^/6@#C/#]BVH'P]KT'B13#<P%)XHO,)OBT>2&/F':ZD$Y !&".!7/Z
M=)-IGPJ3Q2=2U%[[>]K+/-=22+' U[M=MN>JKD[NO)YZ8])T[PAX>TB]N;W3
MM(M+6YN 5DEA3:Q!Z@$?=S[8JU9Z%I5AIDFFVMA!'8R;@]OMS&0WWAM/'.3G
MUS0!P>O:']GT7Q+.-:CGLKO09Y%T^'?L+HI(G5C(V,Y ('#<'G%/T^95U3P9
MH#M(FF7>E/<,OFMB>=4CPA.<X"EFV].G'%=CI7A30-#M+FUTS2;6V@N1B=$C
M&)!@C#9ZCD\=.32_\(OH8TVWT]=,@2UMG$D"(NTQ./XE8<J?<'- &/X+EO(M
M7\3Z3)-+/8:??*EG)*Y=E5XED:/<>2%+8&>F<=JYSQY>,8/&$]C=W+W6F6<+
M%VG,2V+[2Z^4%Y9VR"<X&,#)Z5Z79V5M86X@M85BCR6(4=23DDGN2>23R:SK
MWPIH&I7D]Y>Z1:3W%Q%Y,TCQ@ETQC!_ XSUQ0!R]Q:_VM\2[>TN;N]-I/H#3
M2P17<B(S^<@SA2-OOC&<<UB>']:N[G3O ND7]Y.UK?3WT<\KR'=-Y#.L4;-U
M.>,C^+;CG)!]'A\.:/;W4=U!8113Q0?9XY(\J4B_N#!X'?'KSUJ%_"/A^325
MTI]*MS8K)YR0[?E1\YW+_=.23D8ZGUH P?!%K%9>+O&UO 6\M;Z J&<L1FW0
MXR>PS@#L.*?9222_&75EFSB#1H%MP?[K2.6(_$ ?@*Z33= TG1YYY]/T^WMI
MKC'FR1H SX  R>IZ5%>Z06UVUUNTVB[AB:VE5N!-"Q#;<]B& (/U'?( /.Y-
M&@OX/B%?27]]9SV6HRS6\MO=/$(G6VB8.0I ;H/O9XZ8R:TO$UYJ$W@WP1J-
MRI356U+3I'7&#YCC;(,=LAF!%=I+X;T::^DO9-/A,\I5I3@@2E?NEU'#$8&"
M0<8IM]I']J:Q8W%UM^RZ?(9X8P<EYBI4,?0*&; [DYXP,@%?QO\ \B#XC_[!
MES_Z*:O./$UG>V_P9T;4KC4Q=:=:6ME//ID\:HETH"8CWJ PP2".N<<UZY?V
M%KJ=G)9WL*S6\HVR1MG:X]".X]JSHO"7A^$V^W2+4BW(,"NFX1$="H.0"/:@
M#GK&Z_X2?QKKFFZFMQ#!;6-I):6WF-&0)58O)\I'S!L+G^';QC)SS.ERZEKC
M^!X=4U&_(N)-1M9GBN7C^U11*X1SM(Y('WAR>N>:]1OM#TW4KF.YN[1'N(U*
M),"5<*>J[E()4]QTI)- TJ6XLIVL8O-L1MM"HV^0,8P@'W>...W% '$VWA^&
M?XA7^C2:AJQL;32[*6*/^T)<AP\@W$[L]$&1T/4C.",U[^ZU+X9ZYXF:[N+?
M7[&ZN75EE8&W>*4A(=N<;2@4%2.=V3R<UZ7'H^GQ:M)JJ6J+?R($><$[F4=%
M/M[5"WAW2'OY+TV$7GRNLDA&0LCK]UF7HS# P2,C H XG6)KC2_$>;PW8A\1
MZ7Y,4"W#CR;Y<$*AS\FX-U'=,U%X?U'4+CP\8)/.DU7PO;W*70\QSY]RH98L
M\_.&52Y![E:])GM+>YDMY)X4D>WD\V%F&2C[2N1[X8C\:(+2WMI;B6&%(Y+B
M023,HP7;:%R??"J/PH X#P[9OJ4?ASQ!!XD39<0E+B./S"UZ73)5OWAPZD$Y
M !7!' J;X;:8MSHT6KW-[J%Q=K<7MN/.NY'79]H< %2<$C;U///7ICI=/\(^
M'M)U"XO]/TBTM;NX!$DL*;6(/7&.F?;%7=,TBPT:W:WTZU2VA9BY2/IN/)./
M4T 8/BVVU&.WTQ-$MK:Y%O(TDFE-+Y NH@NW"L. 5+ @'C\A5SP9J%MJ7ABW
MGM5O(T$DJ-%>$F6)Q(P9&))SM.1G/0"M.^TJRU)H7NH-\D#%HI Q5HR1@E6!
M!'''%36EI;V-LEM:PI%"F=J(,#DY)^I)))[DT >6S:2=4C\>O-K&J0OIMV\E
MFZ7\BBW86Z.#][D9['( SC&33;W4KK5_#]U<3SW#ZK;^&8KFYC:8P1V<K1N_
MF+MY,K$=,8 7J,X/3:+X3SKOB.[U?3D,6HWBSQ R[@\815"R*#@\J3@Y'-;]
M[X9T34K_ .W7NEVMQ=>483))&"2G]T^HY/TH XJZU"71!X5\9WEY</836<5K
MJ@:5C&AD12D^S.T$-\I..CT:S:7=O9^$YI+J_MKC4==1KF-;IQM259'\HC.,
M* J^VW(QFNAN-#O'E@T&UTW3K;PO&L3,5<^8=K;C&(]N,$@9.>A/<\;E_I%A
MJCV[WMLLS6T@EA+$_NW'1AZ'WH \WETI#<>/]/\ MNI"TTZ&.YLXQ?2_N9&M
MRY8-NW'YE!P21G/%3:?J-SXCU+2](U"^C3S_  [:WD:R[QY\C[O-<;77+#"8
MZXR2,5W;>'=):6^E-DA>_4+=MDYG & &YY&./IQTJM?>#/#FIV%I8WNCVL]M
M9C%NCKGRAZ*>H' XZ<"@#C5L+E?$'@O2[OQ#>ZDDEK?Q7-Q%-)"+GR]@4D!C
MR,D%@<GUYK(N81<>%8;2XEGFBT_QHMI;F2=V9(A<@!=V<G . 3R*]5;0=*:Z
ML[G[#$LUDGEVK*-ODKC!5<=!@ 8'I4!\*Z$UA<V+:9 UK=2^?-$PR'DSG><_
MQ9 .>M %^6U@DTU[7#- 8C'C><E<8QNSG]:\G\/79TWX?> ;2*26&UU6[BAO
M95E8'&URJ Y^4,R@<8SR.]>O111P0I#$BQQ(H5$48"@= !Z5EQ^%M!BTN;3(
M])M$L9GWR0"(!2V<YQZ@\CT[4 8FC_:=.^).JZ/;R2OI+:=#>"-W+"WF9W0J
MN>@8+NQTR#CK53XB1R2Z[X*2*9H7.L<2*H)7]T_8\5V=CIMIIRNMK"$,A#2.
M269R!@%F.2>..35?4M TK6)H)=1LH[F2 [H3)D^6?5?0^] '"W/VC1?C+HS:
ME=?VJ=0LIX[=V4(]@J#>QVK\I5NFXC/&,]JJ:3>R?V[X*NK2\N9+34I;L/=3
MSGS;U/*=PSH/E4 @;><@8X7I7HUEH.E:=<R75II]O%<R+L>8(#(R^A8\D>V:
MIP>"_#-LT+0:'8H89O/C(B'R/SR/3J>.G- 'FUZD\/@[Q3JZZCJ1O=+\02+9
MNU[(1&HFC7;C=AA@D?-GBKOB;5)=*^(>MNZRIIDMC8PZA=P']Y:PLTPWJ/K@
M%ARH.<'''H#>%-">RN;)M-A:UNI?.GB.2LLF<[F&>3G!R?0>E2-X;TAYKF9[
M%&ENH?(G=B298\8VL2>1@G@^M %ZSA@@LXH[9BT 4;&,A?(]=Q))^N:\K?4+
MS4/A;JGBG[7<0>(;2YN) 5D;]R\<Q58-F<;=H52I'.[/4YKU*PT^TTNSCL[&
M!8+:,82)?NJ/0#L/:JA\.Z0;^2]^P1>?)(LLA&0KN.CLOW2PP,,1D8H Y0V,
M5Q\8+":XCD29]!>9T$S@*XFBXX/3VZ&MCXC?\DV\2?\ 8.F_] -;#Z+ITFKK
MJK6JF_5/+6XR=P3.=N<_=SSCI4NHZ;9ZM9/9W\"W%M)P\3YVL/0CN/:@#RKQ
MI;7NG_#;1=7NM1^WZ?9?8YI=+EC5!=?="J&4!L@D''(..:N>.+YI;;Q;<V5S
M=&[TZPA<EYS"M@^TNOEA>6=L@G.!T&3TKNX?"F@P26\B:5:EK8@P%TW>41T*
MYSM/THO?"N@ZE>SWE[I-I/<3Q>3+))&"73&,'\#C/6@#EIK;^UOB39VES>7I
MM+CP^TTL$5W(B,XEC&<*1MZ\XQG'/>N9:_U-_ 7@FXA#:AJ$&NS1P+/*093&
M+E45G.>R@9->IP^'-'M[J*Y@L(HIXH/L\;QY4I%_<&#P.^/7GK4,?A+08HK:
M*/384CMI3/ BD@12'JRC/!Y/(]30!2\&R:=J_AXWT4LUS)=LXO4NB=T<N?GB
M,9)"!3QM';USDUO&,>J1W6FRZ79Q:C!;QS&?2?/\EYD^0"2,]-R= #_?XYQ7
M0V6C:=IUW=7=G:1P3W;E[ATR/-;U;U/O2WVD6.HSPSW,&Z> ,L4JNR.@;&X!
ME(.#M&?I0!4\)WUKJ/A/3+JR>Y>W:!0ANL^;Q\I#YZMD')]:V:BMK:"SMH[:
MVB2&")0J1QKA5 Z "I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *YCQ_JNH:)X1N-1TVX6&XBE@&
M6C#Y5Y40CGCHQKIZX_XH*\G@&]ABBDEE>:WVQQ(79L3QL< #/ !/X4 =!J6N
M:9I SJ%[%;@+O8N?NKG&YO[JY[GBGW6KZ?9+$T]T@\U#)&%RQ9  2P R2H!&
M3T&17 :I<VMCXTUE-?M-5FTO6+>'['-9+.\;J(]CPL(NY))&1_$:;J-S:>$/
M$NA7<-M<VL::*UI]FDAFN$CC#H47=&KD,".<Y! QGH: .Y3Q-H<UJES;ZK:7
M$4DGE(UO*)=[@;BH"Y)..<#MS6+XL\1RP^%[+5]!U"%HI;ZVB,J*) Z/,J,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5@:AX:GN-;?5M/UR^TZXEB2&9(UCDCD5"Q
M7Y9%.TC<W(QUK?HH J6%@EA"ZB66>61_,EFE(WR-@#)P .@ P !@"K=%% !1
M110 4444 %%%% !1110 4444 %8NI^'_ .TO$&D:O]L>)],,C1Q! 5<R+L;<
M>O3IC'XUM44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
?!1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>cutr-20221231xex1028four006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xex1028four006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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M(OW8@\_R@I<$)O&6RV=W!/X4 6]"\43ZGJ(L+[3DLYI+-+Z$QW(F5HF./F(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "J5UI&F7UU#=7>G6EQ<0_ZJ6:!7=._RDC(_"KM% !1110 4
M444 %%%% !3(88K:!(((DBBC4*D:*%50.@ '04^B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1Q%%PA^A#?7KWH XOQ]-/X-^*OAOQ&]Q/_8E])]GNX6E;RHY,8W[<X'#!O\
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MLXYS@XP<S5?"GBC4'NS+;Z?=3IK,5[;7<MRP9K=)5980-A\L #!P<$\X).:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX"87$<P0X;8Y&UL>QK%BU75(_%&K>%[F]=RNGIJ%G>K&@D5"Q1D< ;20R\$
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MZA*%&B)($V(1M\]ODZ=..O7WK-F\5^(H_"U[>1W=K]JM_$9TT$V^%:+SUC
MSQP>O)H ]-HR,XSSZ5P.MZWJ_A:2V37-4N#ITJRLVK6M@I6!RP\M)5^;" 9^
M88R>XI+:6_N_B;H^=9:6!O#[7!$ 0Q2$RPABO'1N#GKC&,4 =_17,^-]3U#0
M]*M]7M+CR[6UNHC?IY:L3;LP5V&1P5SGZ9K&7Q5?1^(_$FE/>-(4@1](;RD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1/#*@XYV. <<CG'<>M$OBK2(]3N--CGEN;RV4-/%:6\DYB!Z;MBG:3Z'D^E
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MQ%?3-_:"_L)[1I9(EF0HSQXW $8.,@C]*XVW^%&@0>'QH!NM3DT?SO.:R:X
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M8-:?A7PG9^#]-_L[3KN]DLP2R17,@<1D\G:< @'TZ4 ;U%%% !1110 4444
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M>%I;[4WTF.02+$TRDC!R &VYQGG%6M:^'FB^(-*TRQU![MFTPJ;6Z20)-'@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI;KM>5]I2X Z,"I.&]1^(]NMHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0$8/H>* -6BH;:\MKP2FVGCE$4ABDV-G:XZJ?0CTJ:@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HZSJUOH>D7.I76[
MRH%SM499B> H]R2 /K7.P:'KVOPB[UO6;W31)\T=AIL@B\H=@\F"S'UZ"I?&
MPWR>&X2?W<FM0;Q_> #L ?Q _*NKK5/DBFMV9M<TFGLCE/\ A!8O^AC\2_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +5%<KHOBV]U/Q0^DW6@SZ?&UD;R"2XE7S&3>$PR#[A.<XR3ZXKJJ "BBB@
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M% $/A[0DT#3W@^UW-[<32&:XNKE]SRR'&3CHHX "C@ 5K444 %%%% !1110
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MH6T[5K9.(XY9F26->R[R,, /49KMZ*N,VM.A,HIZG)_VKXU_Z%BQ_P#!B/\
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M_ON7_"MNB@#$W>*/^>>C_P#?<O\ A6E8F^-O_P 3 6XFW'_CW+%<?CSFK-%
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M9;.WD,<&O6J*%H#.<>[\6J6QINGM@,1B4\X(  R>^21]#G'&;&[Q1_SST?\
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M #ST?_ON7_"MNB@!%W;1NQNQSCIFEHHH **** "BBB@ HHHH **** "BBB@
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MXG\#:E')%)/++?Z/=\PS2HQ60HW5')4^Q/?'% 'HEG<I>V-O=1@A)XUD4-U
M89&?SITEQ##)#')(JO,Y2-2>7;:6P/P4G\*\[M?$#^*M6TO3[<&RL[K0H[^"
MV^TR0$EV*L T>"=@"X'3YLXZ8K2Z5<+XC\ VVJZM+J-W&]]!+=PS21;]D;8^
MZP^8?=)ZG!SZ4 =SH?B"/7+G58$M)K=].NS:R"4J2S;%;(VDC&&'>MBO'=4A
MFBTKXCZK;:A>VMU8:BT]N;>=HU#K!$<L%QO!Z8;(]J]>MY#+;12'JR!C^(H
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M:IZC .,' SQS@5?HH RK'PWI6FR026ULRFW#" /,[K%NZ[%8D+GIQBM6BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ JE<:59W6H6]_*DAN;<$1,)G4+GKP#CG SQ5VB@"O
M/8VMS<VMS- CSVKL\$A',992IP?<$BL63P+X9EDF>32(6,UP+IOF;'FYSO S
MA23UQC/?-=%10!C'PKHQ_M'_ $1L:DH6\ GD F &W!^;IMXX[<=*<OAG25FT
MV86S^9IJE+,^?(?)!&"!\WIQSVXZ5KT4 8.G^"_#FE:Q)JMCI4,%[(S,74G
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M8+8SS7!AC5#-.VYY,#&YC@9)ZF@">BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cutr-20221231xexx1027thi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV;17>P/&>7)"/G+-C@]D7H<BN5^&WAGQ!X'U;7;!M-D;P]<3M/8XN(VDC/0
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M!&;/6+8&2SF<C=&_]QBI/!P.AX.#VK!^(WA#7_$.@^%['3+ 2RZ=)'-.6F1
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKD-8
M\>0Z/XTTWPO)IMQ+=ZBNZWE1U$>.<[L\C[I[&@#KZ*9)*D,+2RNL<:*6=F.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSNX?!NA:O<ZBO]C0V=\DL$BJJQ,9P=Y;N,*W7I^-5[J8V_[2&C:I?;EL=2L
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MP+X7MHI8X-#LXHY?]8J)M#_4#K5U/#>CQ)9)'811I8_\>JIE1#U^Z!TZG\Z
M/'],TK6/AQX^LO"J[[GPQJU\D]C*YR8'5MQ7/K@8([\'U%=#^T#Q\,6_Z_8O
M_9J]-N+2WN_*^T0I(89!+&6&=CCHP]#R?SJIJ^@Z5KT"P:M8PWD*-N6.8;E!
M]<=,^] $FC_\@2P_Z]H__015VH;6UALK:.VMTV0QC:B DA1V SVJ:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=P0>*O7.O:W8-?\ VK0X_+M[!KR.>.Y)B9E^]$Q*9#8Y! ((]* .EI"0H))
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M#AE/'?/!XZ"'1OB;>W^O>&+*]T6&VMO$%JT]O)'=&1XRJD_,-H&#CC![CZ4
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MQ+Q2# ..0,CT[5J:KX>\0:QING"\N[!KV#4H+Z01ATA58F#"-.I.<<L?7IC
M&T?$=B/#*>(%$SV#PB=2B;F*'D':.3GCCKSTS6I#)YT*2;'3< =KC##ZCUH
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MSEY+6UNG2(L>I"_P9_V<5?U'PQHVJ^'WT*\L8Y-.88\G)&#G.01SNSSG.<T
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M_ENVYAP%.W=UP.^*Y58=3_X5M;Z0I?\ X2W_ (2O>T6?WXEVDF0CKCH=W3%
M'T/-K>DV\L\4VIV4<ENF^9'N%!C7CE@3P.1R?44TZ[I 8J=5L0PB\XC[0F1'
MC._K]W'.>F*\KN-.TK6_VBM0L]3B@NK<Z*%,,F"KOE.".Y )..V >U-UC2='
MN?V@=&TF>WMGT^+0A +5@#'P9-J%>AP,$#V!H ]7FUS2+>T@NI]5L8K:X&Z&
M9[A%208SE23@\<\4Z;5],MI88I]1M(I)P#"KSJID!Z%03S^%>6WUI!X>^+P^
MV)%::#'X<D@T\.=L2X(WH,\;L;B>Y!%<RGA_6O\ A06C:P\<J:KH=U_:%D'4
M[UAW]/7&,-]%% 'NJZ[H[B<KJMB1;_ZXBX3]WSCYN>.>.:DN-6TZTDACN=0M
M87GQY2R3*IDR<#:">>2.GK7DUAX?UC3OBN$>'_0_$UB+S4DSE8I(W#.@]1R$
M^DAJEJYMY/B?XQT3Q/J;Z=:ZQ:P)9S-&&$D2C[D9/0[CT'4@]Z /9IM7TVWN
M7MI]0M(IT0R-$\RJRJ!DL03D#'.:PIM<UF?5+M=+_L>XTQM-:YLKOSV($HQC
MS2. C9)!4YPC5Y]J^GZ?>?'/PKINHD7<":$(I4N\$RMB7 D7H6/!QZU[#86%
MII=A#8V,"6]K NR.)!@*/04 85KXAOK:ST6XUNVAMUU$I;OY><0SMG;UYV/C
M S@@E0<YXZ:N*^*B23>"&@M\_:Y;ZS2WQU\S[0F,?@#7:T 4SJ^FA)'.H6@2
M-MKMYRX4^AYX/!J'4]42#39WL[JU-U]G>:!9&W!P 3G ()'':N&U[1)6\5:Q
MX>B@/V#Q9:B5I0F5MY8\+,WL2A0@_P!X"K/A^[N]1\)7NJZW']GN;"QETUFE
MX'F1Y6:0'T9E4?\  * .D\*^(8];\/Z1/<W%J-2N[&*ZEMXW 8;E!)"Y)"Y-
M:IU&Q%Z+(WEN+LC(@,J^8>_W<YKR713IEI9_"J> VL5PZE)74J&.;5@0QZ_>
MP.>^!3 [7WPCN-(E8+XO@OF_<YQ<"]^T;ED'?D$'<.-N>PH ]=EU&Q@NDM9K
MVWCN'QMB>50[9X& 3DYHEU&Q@NX[2:]MX[F7_5PO*H=_HI.37G&KW5QIGB*]
MN;*[L]4MI-3M1J&CSC%Q%./*"20$')Z(VTC'RGGK5![C2+^X\0^&_$VHWUOJ
M,FJR30V<:()+E-X:!H6V%B=H5>&XV]A0!Z_55]2L(KQ;.2]MDNG^[ TJAS]%
MSFK(Z"O&/$VL:<]OK2PRQ64EKXDMI+BW<EIF998E,[$GY(R -N !P.><4 >I
MZ_J\6DZ7<2B[LX+L0N\"W+@!V SC&03Z<>M5]"UY;OP9I&LZG<6UJ]Y9PS2,
MS!(P[H&(&3TR>F:XM]8L(]:\=6>O3117%Y IL5N?E%Q:^3A5CS][#E\J.<L:
MH>&-:M=.O_!$^JW,<.DGPTD%K<3,!$EV-F]2QX5MBX&?<=Z .X\)>)I-7TZ]
MN-2GLD:'5)[&)XCL20(^U<98Y)^O>MM]8TN.R2]?4K-;1SA9VG4(Q] V<'H?
MRKQ=9-%DTBVB9K3RD\=/M5L +$96Z>BD8SVQ75:W<Z7X7\<00WTXT;0KG3#'
M:2PP1BW$QE=I4.Y&"E@4/;.* /0KC4;*UBCEN+RWACD^X\DJJ&[\$GFFSZKI
MUJL37%_:PK*NZ,R3*H<>HR>1S7FLEE!H]EI"^&=9CMIK2PG^SVNMX,5[:M)D
M@DX*_=4@@?=*Y&.E74KZ3^S!JNG-:6\C:%;B_P##>I=)K?#E5C?[P<;G7IR2
MN0#0!Z_5".:Y.NW$+75FUJL",D"@^>KY.6;G&TC&..H-6K:5I[6&9HFB:1 Q
MC?[R$C.#[BO/9Y--C^)'BQ))5CC?0(C<>00).#+O(_V@N/TH [ZVU&QO79+6
M]MYW3[RQ2JQ'UP:DN7FCMI&MXA+,%.Q"VT,>V3V'OS]#7!^"[J]A\0KI=S<6
M&KP1Z:'M-8LQM8PAU"QS*"1N[@CKAO>NYO[^TTNQFO;Z=+>UA7=)*YPJCU-
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M:%-4O/LC-/&S&,[2VX889Z8QQ]:N>#K#3]-\+VEKI37+:>F\V[7)^8H6)!'
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M<VWSLCJ78D[3M#<GCGM4&F:MJ=Q\3)1=S2Q:?)HIN8+-L@1CS@H9A_?(&3Z
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M5F8*H9NI Y-.P!T%%% "!5&, #'3 HP/04M% #61'QN56VG(R,X-.P/2BB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 457L;ZUU*T2ZLITGMW+!9$.02"5/Z@BK%
M!1110 4444 %%%8C>+-'74;G3Q-</=VH#3Q1V<SF,'H3A#@'L>] &W1573M3
ML=7LUO-/NHKFW8D"2)MPR.H]B/2K5 !137<1HSG.%&3@$G\AR:I:-K%CK^EQ
M:EITIEM96=4<H4)*L5/# $<J>M %^BBB@ HHK/UK6[#P_IYOM1E>*W#*A=8V
M?!8@#.T'&20,GCF@#0HILCB*-G8,0HR=JEC^ ')K A\<>'9[(WR7["R#%&NG
MMI4A4@X(+E0HP>.30!T-%-1TDC62-E9& *LIR"#W!IU !1110 4444 %%%%
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M4 +1167_ ,)%I?\ ;W]B>?)_:7E^;Y'D29V9QOSMQMSQG.* -2BBB@ HHHH
M**** "BBL_5=;L-%^R?;I7C^UW"6L.V-F#2.<*"0"!DGJ<4 :%%-DD2*-I)'
M5$0%F9C@ #J2:QH/%NBW$UM&ES(INV"VS26TL:SD\C8S* _'/!/'/2@#;HHH
MH **** "BJB:E;R:K-IJ^;]HAB69LQ,$VL2!AL8)^4\9JT"",@@_2@!:***
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M@ @[@#R3C'& 3D3P1"VAWVEWFM:O??;(#;/<W,R-*L1&"J_+M&>YQD\9/ P
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M-1XP89H@ C)\G8 #!R/QH Y7Q#KVKW7@_P ?V;7MU$=+5/(G:-(YFCDB5RK
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MGWL@'/MTQ0!#X%UB\UWP=97^H,CW9:6*5T7:',<K1[L=L[<X]ZR%_P"2[/\
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MH]O+Y @:W25D;YL^8),+G/3/&,5OZ3X=DMM7&NWM]/)JD]E%;72#8(24R?E
M7(^9F/7O52V\!6%EK%Q>6NHZG#9W,YN)M,2<"V>0G).W&0">2H.#W&.* ,Q]
M=\2ZS;7M]H$;F2TU&2V2WD\@6\B12;'#L3Y@8@,01@#Y1@\DLO-5\1W&K>,K
M2WU>.UCTF"&>U*6JL1NB9]IW9R,CGOZ8[ZQ\!6"ZW=ZA;ZCJ=M!>R>=>:?#.
M!;W#]V9<9&[O@C/>K;>$K8WVN78O[Y9-9B6*X ,>$55*C9\G'!(YS0!SMCXC
MUS[;X-OKJ]BDM-?@)FLTMPJPG[.90R-]XG(P<G!SP!4FD:WXGURTT+7+"-S9
MWLBO=03^0(8X'SRC ^877C@\'G@<"MF/P7:1)X?5=0O\:$,6F3'R-GE_/\G/
MRDCC'YU#I/@*QT6]+V>HZF-/$IGCTQIP;:)R=V57&< \A<XSSB@#EY_$WB>#
MPYK&MMJL!&E:V]I]G6T4+/$)TCPQY(X;C'.>I/;=TD7DGQ8\1*^I7+00V=FR
M0$)L ;SOE^[D 'GKD]R>*M2^ ;&;0]2TA]2U$V^HWAO9VW1;O,+AS@^7P-P!
MQCM6G'X;MXO$KZZEW=BXEMT@GC#*(Y@F[:S#;G(W'H0/:@"OXFUN;3[O1=+M
M'$5SJUWY F*@^4BHSNP!X+87 SQDYYQ@\I!)J&D^*?'\T6I6QNH[2Q:*ZOP$
M1!MDY?8 #CGH.>*[3Q%X;L_$EI!%<2SV\UM.MQ;7-LP62&1>C*2".Y!!!!S6
M/<_#NQOEU8WVJ:G<2ZK%#'<2-)&IS$<QNH5  0>>F/:@#)FU[5I9/%NFK?WB
MQVNDI>VEU+ D4ZEA)GC:.,H,94,,GVIVC:M?6ND>$M$AN+N::^TH7331K#YB
M(B1 (N_"]7SDAC@'UR-Z'P39IJ-W?W&HZC=S7ED+*Y\Z5=LJ#=AB%48.'(XP
M.^,\U6G^'EA-I&EV0U358[G2C_H6H),JSQ+M"[00NTKM !&WG'/.30!2CUWQ
M':R:-H6JF.#4]2OYX4NE"%OLT:&3>5&5$A&%QR <G!Z5)X0AG@\?^-H[BY:Y
M<26>)7558CR3C(4 9'3@"M&]\$6-]IMI!)?:@+VTN/M4.I"4&X$N,%B2-IR.
M"N-N !C@5;T;PQ%H^KZCJ@U"]N[K4!&+@W#)@E%VJ0%4 ''IQ[4 5/$=_J$.
MJQ6MK?BWC:SED6*VC62Y>4%0IPRE1$ 3ECCD@9KGO^$VU$>%O#6MZ@+JWTZ]
MLC)?WMA;B7[/+A=I92&Q&?G)(!YQT[]7J/A6VU'7XM9%[>VURML;25;>156:
M$MNVMD$CG/*D'GK572_!<6BV%C:6&L:E''9P-;KO:-]Z$@X8%,<8&, =\YR<
M@&SHMP;O0["X:[AO&DMXV:YA^Y*VT99?8GFKU4M(TJTT/2+73+%"EM;1B.,$
MY.!Z^]7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***XWXAWDEI;:'YAVZ7+J\$6HL?NB(YP'_V"
M^P'/'8\&@#L0P*[@01ZBN:T'Q!J>OC3]2MK*W.B7J2,)/-(FA )"$CHV['08
MVY[]:RK7388/B5JUA;6\/]B3Z3'->6VP&%;GS"%.WH"44D^NT$U+\);6UA^&
MFBS000QR36X,KQH 7(8C+$=3]: -3QEXDN/"VDQ7\-C'>![B*W*/.8B"[!0<
M[6SR:Z!"YC7S JOCY@IR ?KQ7!?$N[MM0TA-(M)XYM1CU*P9[9#EU#3#:2/0
MX-273V-G\7Y&NVMX8;CP^=YE*JLA$_.<\'C'X4 ;OB/7KC1+S0XHK:*6+4=0
M2R=VD(:/<K-D#'/W#W'XUO5XSHLT,G@/X=B.1#L\1;2 ?NG-QQ[=JV]4M&\,
M>+[^SL+1?(\5PB.!EC!$-T/E?(_NF-C)@]T;UH ]+KD+OQL\.F:CK4%@LVCZ
M=<O!/()2)6"-MD=%VX(4YX)&0I/IGI[&RM]-L8+*TB6*W@01QHO0 # KS3Q/
MX=O]*TC5?#>B:BDP\17#M#8O;[I(/-(\Y_,#8$0!)Y4\D ')% 'J,<B31)+&
MP9'4,K#H0>AJEJUY=V5F&L+$WMW(X2*(R>6N<$Y9\':H /.#V !)IMA<Z=:R
M1:%#>PO=VELA-OY@\P1@!0Q7KCWI^KZQ8Z%ISWVH7"0P*0H+L!N8\!1GN: ,
M'1O&4DS:W;:_IZZ7>:-&L]R$F\Z)H65F$BM@$C"MP1D8J2Q\6R23:*;^Q6TM
M]:4FS82[F5MN]4D&  S)D\$\@CT)P-1@LM?\*^*XM.U&ROM>U2R=Y(K.=9=B
MJNV.+*]N<9/5F8CC@-U%EURV^&\-@=S?:H;]MO\ !%%"=Q/IRRK]3B@#6U#Q
MEJVDWEI<7WA[R]#NKI+9;H70,T9=MJ.\6WA22.-Q(SR,\5?O/$\_]IZI8Z78
MI=OI4"2W>^;9EF!98TX.6VC/. ,KZG&=J?B'PYJ^I10W6MZ<ECIMP)71KE-T
M\Z'Y5"YR0K<].6  Z'-71Y%T+Q/X^DOV$:L8M01WXWP^3MR/8,C#_P#70!V>
ME:G:ZSI-IJ=D^^VNHEEC8C!VD9Y]#5RN+^'1BT+P3X;T+4;F*#59;0RI:2.!
M*1DL0%// //I@UH>/;NRL_!.I2Z@;@6I5(W^SR>6QW.J@;C]T$D GTS0!T:L
MK#*D$>QH#!NA!^AKR6%K0^(/&FF_VMI^G1W6F6V'LL"*%SYBEL9^; V[CQD#
MH*Z7P7+<P:]JNF:GI%G9:I%;V[R3Z>?]'N8\R!'"XRC9# @^@["@#M68*,L0
M .YI<C&<UQWB^YT[_A(_#]E=^7]HD^T20B[<"U 5 &9U/WV ;Y1D=6.17!V!
MMKSP#X/B:=)7@\3B >7(040W$H"C!R!M P,] * /;-RX)W# .,YH+!1EB /4
MUY8/#FB/XB\>Z<VG6WV&&SMKB.UVXBCE:*7=(J= WRK\V,_G5#2M3M[Q_#MC
MXCOK:.TNO#5L]L]^BO%++R)N7.-^/+]\?6@#V/('4T@((R""/45Y4NB:8NN?
M#^P%U+JEIY5_$L]PV3<1*GR@XX9,' [%?4&LY;M-(T2:P!$&@Q^,WM+I0<1P
MVQ^;8>RQERH(Z8)'0T >D6.OSW7C34M#>WA6&UM(;F.9)"QD#LXY&!C&SW^M
M;P8'."#C@X[5Y!K<T.E>)/&[^'O)CN3H5O($M" V0TF\J!_$$YX]C4FH/IL.
MDW_B/PAK,,^H_P!CRA+;3HT4% ,B215Y#(>A/.>/6@#O=5U^?3_%>@:2EO#)
M!J;S(\QD.^,QQ-)@+C'.!SG\*M>)=4GT3PSJ6JV]O'<265M)<>5)(4#!%+'D
M ]A_^JN )\.KXJ^'-[I3V8647 \U&4,ZFV;&\]2=Q[\Y)[DUVGCK_DGWB3_L
M%W/_ **:@#6TV[-]IEI=,%5YH$E90?N[E!JU7ED.@V%IK'@>]T6%5O;R(K?E
M&+"XM?()9I<D[@&V $]R!Z4_3],73]8OOA^;,&PGNUU.!_+ROV,MN="?42*(
M^>=L@]* /4,X&:Y;5_&"VVF:3J.EQPWEI?:G%8-*9"-H:7RRZX!W<@XY'8\U
MTSPQ2P-!)$CPLNQHV4%2O3!'I7B>FPZ=_P *J\+Q0+ DSZ[:+<^20C_\?; ;
MBO(. <=QB@#VX$'H0>U-::)(GE>1%C0$LY8 *!U)/:O*-0&D^'K[XAVWERVN
ME?8;*1X;!A$0\GF(Q7LI;Y<G'N:=;?8CXL\3Z?G2S#<Z#$_V2S ,1<&7C'\;
M!0.<#C' H ]/T^^M]4TZVO[1]]O<Q++$V,;E89!_(U8+!<9(&>!FN4^&HL5^
M'FA"R%N";& S^2%_UGEKG=C^+USS6)?76BWWC7Q1HWBR:WAB:T@^PFZ=4 @9
M#YC1%N P?.2.>%]. #T8L%&6(';F@D#J0/K7EMY/I=QXGET37+^*WL)-'M_[
M.;5$5O,3YQ(=SD8D^YGOP/2F/H.E7?BCP;IMQ-+J=G)I-[$9;EOFN8U\O86Q
MC<,$D'Z&@#TNWU*TN[Z[LX)EDFM"HG"G.PL,@'WQ@_B*M!@V=I!QQU[UY/;Q
M^'_#^H_$7S($M4MHXP@M JW"1&T7=Y9Z@]3GUY-3>'6L$^(D-HDFFI;77AT
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M4P0"RT_Q<D<$;*-EO&9H"RKGA5^9N.F":]FM!;+:1+9B(6P7$8AQL ]L<8H
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M$=Z+CPPWV@.^]96'D\.,X;DG@]_I74?##">#C;H?W5M?WD$2YSL19W"J/8#
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M!=K?(KVTLMXKHS8#_N/NGU!]._2N2NA_PC$6NP63-!X3BUZTC<@%XH(V0&<
M?\\Q*4!'3[P]10!ZYJ.IV>E:9<:C>3I':6\9DDD)X ']:M!@R@CH1FO(/%&D
MZ(G@CQG<Z9J,&H1SVL<[PVR(;:"0<!T"Y"N1R<<\ ]Q6UXC@TG0;[P_XKT^T
MMGL(6?3[Q;2)6#13<*0%X)$F!_P,B@#T:DW ,%R,GH*\M\):9)!?S^"M0L(0
MEG>#5CMCS&87&]$!/4K+E<]UC(JI =+UY=2BUC6H[#7K+5Y#A407BE9281$3
M\S*4V* !@@D4 >NE@" 2 3T'K06 ZD#ZFO)+DZ5KMWXFL-?UF+3M3MM28Q$H
MHNDB!4P- QYY & HZD\9;F:[T33-0\0_$1+ZU2<1Z=:RA9>0LAAE._'0-D9S
MU'..M 'JU%8G@V>2Z\#>'YYI#)++IMN[NQR68QJ22?K6W0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !3)H8KB%X9XTEB<;71U#*P]"#UI]<A\3M0O=(^'VJ:GIMY+:WEJJ-')'CC+
MJ#D$$'@F@#I8-,L+:T:T@L;:*V;[T,<2JA^J@8I]K96MC'Y=I;0V\><[8HP@
M_(5PFK:[/I6L>'HM$UUM6EO;U(+G3V>.8F @[YLJ-R;.#G..>E=3J/BC3=-:
M[$S3R+9*&NWAA:1;<$9R^!Z<D#) Y/% &@VG6+7ZW[6=N;U5V+<&)?,"^@;&
M<<GBBXT^RO)H)KFSMYY;=MT+RQ*S1GU4D<'Z5CZEXUT32Y[>&6:>:6YMVN;=
M;:W>7SHU )*%00W!!P.W/3FHXO'FB3ZC]@A-\]R)(8W06,P,9E&4+Y7Y1TY/
M'- &P=&TLQ11'3;,QPG,:>0N$/J!CC\*S[+3=7EUN2]UBZLI8+>23^SX;:)E
M*JW :0L3EPN5XP/F;UX&\7Z0DD)>:06TUQ]ECNS$?(:7)7;OZ=01GH3QG--F
M\8Z1 FL-(UR/['P;T?9GS&"-P.,?,,<Y&>* -^H8K2VMY9)8;>*.24YD=$ +
MGW(ZU337;*1[)091]L@:XB8QD*(U )9CT4?,O7U%4T\7Z2U[;VK-<QO=1--:
ME[=\7**,MY?&6('..I'(!% %[^Q[4Z]_;!CC^U" P*ZQ@-M)!.YNK?=&.PY]
M:L7=A9W\:QWEI!<HIR%FC#@'UP:R=!\8:3XDD1=,:YE1X//29K:1(V4-M(#D
M8)SVZ_D:75/%VDZ1+>1W,DK?88TEO&BB+BW1\[6?'K@GC)P,]* -.TTVPT\N
M;*RMK8OC=Y,2INQTS@<TZ"PL[:666"T@BDF.97CC"ES_ +1 YZ]ZR;[Q?I-C
MJK:8YNI;T6WVI88+620O'D#*X'S<GMTP<XJ6'Q5I-SI%AJ=M.TT.H';:HB$R
M2MSE0O7(VMG/3!SC% $Z>']%C=731]/5U.59;9 0?4<5:N+"SNY(I+FT@F>(
MYC:6,,4/J">G05RG@G5+G4M=\6)-<W<L-O?I'#'<C:T0\I2R@8&!N)Z=>O/6
MJNMZC/;_ !0L-,EUN>RTVXTR6X=/-1%,JN ,%AQP3QGM0!UMWH]K>ZM8ZA-'
M&9;(LT+>6-X)!4_-UQ@G@=\'M5R>"&Y@>">))8G&UXY%#*P]"#UKB?#?B>;^
MU_$\5WJ:W^@Z4J21:HRK@?*6DC+( K[<=0,CH<FM^T\5:;=W$MN/M,<\=JMX
M(I+=MSPDX#J "3R,8ZCN* +ZZ1IJJ573[0*8A#@0KCRP<A.GW<]NE26EA9V$
M;1V5I!;(QR5AC" GZ"L'3_'F@ZG-IJ6TUP8]2R+6=[:18I& )V;R,;L G'MC
MKQ69X:UY[(^)#JEY=W0BUY[2V!4R/@QQE455'09)X' R3W- '97-C:7IB-U:
MP3F)]\?FQAMC>HST/O4+:/I;J%?3;-E$AE ,"D;SU;IU/<U8>XBBM6N9F$,2
M(7=I#M"*!DD^F*XB^\127?C[PA%9SW\-G>"Y=HY(S'%<((25;D9.#@X/L<=Z
M .P.DZ:TDLAT^T+S#$K&%<N/1CCG\:9-HFDW%I':3:7926T;;DA>W0HI]0I&
M :H6?C#1[^[LX()92+[S?L<IB;R[CR\[]A]L$\XR!D9JKH?C6UU6UU2ZGM[B
MT@LKQ[4&6%LL58)CW<L<!1SR!C- &_)IUC-/%/+9V[RQ#$<C1*60>QQQ3%TC
M34@G@33[189_]=&(5"R?[PQS^-4(?%FDR/J,<\SVDNG1B6ZCND,;1QD$A^>J
MG!Y&?3K6"=<GNOBAH]I%+J$-K-IUQ*]M/&8T;!CV.!CD\MP>1W H ZZTTK3M
M/(-E86MMA!&/)A5/E!)"\#IDGCWHL]+T_3C*;&QMK4RMND\B%4WGU.!R:BU'
M6K33+BUMI?,DNKLN(((EW/)M&6([8 [GU'J*JV_BG2[S3K&]LY)+A;YF6WC2
M,AW*9WC:<8V[6SG'3'I0!;M]#TBTE$MMI=E#(',@>.W13N/4Y Z^]7B 001D
M'J#5>POH=2LDNK?S!&Y8 2(48%6*D%3R#D'K67/XNTBV.^6:06HN/LK7GE$P
M++NV[2_0?-\N>@/&<\4 :-KI=CIRR_V=8VEH\G),4*H&/J=N,UGZ#INJPR27
M^O7-I<:E)&L(^QQ,D4<8). &).23DGV48XK$UG5I-0\>1^&2^I6]JVG23&2T
M#QOYID1%;>O\*@M_LY/.<4_QK#KUEX-M8]%U:?\ MF-XH8[AE7_2&Z'>N,?-
MCMTS0!VE46T;2W0H^FV;*9#*08%(+GJW3J?6L>P\7PZEX$M_$5M%NEGB4);Y
MP3<$[!%_W\^7]:P_ ?B2XC\%_P!I>(]3ENKN749+-6V??<2E$1$4=\?XG H
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MDTGE^82$C2-=SN<<G&5 '<GJ*R-.\-Z]I?B'7=5M[_36&K31RF*2W<^7L38
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M'D [AL8>F<5HZGX9UG5M.TU;O5+9[VWU*'4)7$++%^[((C1=Q*@XZDDYR>^
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M[D^F3V' J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMEJ-S%-!XIDB,H8;I5:[1&W''<$],5TU_81R_&736,UR"VCSR86=U (EB&
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M@L#G/OQCK0!Z)XBU^#PUI7]H7-O/-")8XCY(4E2[!%)R1QEA6M7CVJ7.I?\
M"!>)])U"\FOAI>MVUM;W<V"[QF:!P&/=ANP372W]QJOB+Q#XDT>QNOLLVG)"
MELZWCPF-GCWB4JJGS!N.,,<?)C')- '>45Y[#_:U_P".+32KW7;@PR^'A//]
MA<)&TPE52Z$#(!ZYZ^AQ6+9:CK*^#?#NNR:Y?RW:ZQ'8NK.!'+#]I:$AU ^8
ME1G<><T >N45YP+K7O$EIJU]INHPV-WI^J30+))>.(X4ADP5DA"[6#(,DDY^
M;((  J+46U2[U7Q[%_;VI0QZ;;0SVBPR!/+<PL_8=,CIW[YXH ])::-)4B9U
M$DF=BD\MCKBGUYI:&35_&_@O4+J>X\ZZT"2XD$<S(N_]R3A0<#)8Y]>,]!3]
M'NM>\2:5I_B*TU&&T<7K-<B2\<QF(2,K0&';M!Q@ YW9&<\T =IXBUR'PWH-
MWK%S!//!:H9)$@"EL>O) _6M*-Q)&C@8# $9KR7Q%>2^)_AGXSU2>[N8Y+:>
MYMHH(Y2J11Q-MVL@X8L 22P)^;C&!7HVJZC)I'A&]U**+S9+2Q>=(_[Q5"P'
MZ4 :U%><3:AJ.GZ/X.UVUU&YNI=3N;6"]C>0M'.LZ\LJ=$*GD;0. 0<U<\%0
M:AJ.H:G?7NNZE,-/UF\MH[<NHC>,84!P%YQU&,8Q]<@'=T5Q?BUK^3QCX6T^
MVU:\L[:^-U'.MNRKN"PE@02.OOVZ]>:SE76=7O->T&QU29;K2%AMK:YEOFCE
M#&%7$TBJF)-S$YW<$+P!R2 >BU%&T".UM$8U:-0QC7 V@DX./<AOR-><Z]K.
MJZ9B[U>2ZETI[*!3JFCS$I93[<N\D0(+(V5(.#@8X&:?:^5:^,?'VH?VI+:B
M"TMI4N9)6DCAW0R'<4SAE!Y"_EUH ](ID4T<Z;XG5UR5RIR,@X(_,$5Y]HMS
M?OXP@TJ6YU#[#>:"UPWVBX;S'D61%\T<DQ$ASP",<< BL?PKJ%QI_@;P18PS
M2#^V)'29Y;ITSM21@BO@E"Q Z#)Y'!.: /7*R;;7X+KQ+>Z$+>X2XM((YV=P
MNQU<L!MP2?X3U KCKZ\UWPX+;2KS5%:/5=:AMH'69I9K2"0,2AD8 DDH55CR
M-QYR!5W0[-;+XM:]&DT\B-I5HR^=*TA7YY> S$DC()Y)Z^E '=5C:[XEM-!T
MX7LL4UQ#]I2V8V^T['=P@W9(XRPSU-;#+N4J21D8R#@UXM]D\KX37KI/<,[>
M(0FZ69I,8U  '#$\^I[]Z /:J*\SU76]2\)ZKXMCAOKJ]CM]&CU"$7;>9Y4I
M:1"1@#"_*"5'''&*W]*LM7AUZROUU.)M*N;<K)!)>O<F>3&Y9(RR@+P#D+\I
M';B@#I)+Z&/4(;$DF>5&D"C'"KC)/XD#UY] <9&K>,=-T;PPWB*>.XDTQ=I,
ML*JQVLP56QG."2,=^>@J_>Z%I>H:I8:G=V<<M[8%C;3'(,>X8/3K^-<'\3]!
MTOP]\&/$-II-G':6\CQS-&F<%VFCR>>G0<=* .\TC4[;Q#HMOJ,5O(+2[C62
M-9U7+H1D' )Z^]:-<IX*NX-/^%FA7ERX2"#289)&/91&":\_U7Q+K.H7/Q)N
MSJ%Y9MX>6)-.CAF9%0@L2S*#A]VT?>!X.* /:Z*\EO\ Q)J6K6OAF6349(Y-
M1T9[B33+-WAF:4QY\[S%8;47&>3ZX#'IS5_XN\02_ #1-;&KW<>J'4/(:ZCD
M*NZ!I!AL=> .OI0![_17F?A6_P!1M?C/XF\/RZI>WEA%90W$:74OF%'(3)7^
MZ#O/ P/;BNU\27\MCI#+:B0WERPM[<1+N8,V<L!WVJ&?'^S0!-I&N:?KL5S)
MI\XF6VN9+64C^&1#AA_(_0UHUXAX%G'@7XNZEX9,5S;Z1K:_:;!;D$%7&3CG
M_@:^IVK5KQ%>^*6U?QM ]SJB7L*6_P#8,-BTFTJS')VIPS' SNZ<]!0![+17
MC_B"?Q#8>*_A[HZZQ?6D]_ Z:AMG+Y<*"W7()!9L$@]LYQ4E[<ZMH_CGP_X'
M;5M2O[=[*>Z:>2[,4]S(S2;5,@P<(!D 'GC/3% 'KE%>/W>N^*M.U+P-X8UR
MY#W-VT_VZ6TN3&;DH"(U\P8*G[N[&"3]:J>*+OQ?H6C^%;2_UF:"^DUP6C36
MUP69[=B"HDR,,P! Y!Z=\F@#VNBO"+J\UB.^^)6G)XBU@6VCVZW5G_I;;T<H
M6^_][;_LYQ[5I-XSUBYM/AK82SRD:S$7O)8YO)>X9% 5=XP5RQ!.,$\"@#V6
MBO%?&MYXN\.?#_3Q>:M+!J*ZXMO'/;7)9VMF5F59#_$PXZYZ#U-6K*^U*+QI
M\0_#[ZOJ,]E;:<L\!FN&+Q.8@Q*MU7ECP,"@#T35/%>G:7I::ELN;NT:Y-L\
MEG"91$065F?'15*D$TU?%EF;W5;5[._C;3"AG:2W*JT;9_>)_?4;6SCG@\&N
M0^"NF6\WPKTN:9IY?.>1FCDF9HP5F?&%S@>I]3UKT=+6&.::98QYDV!(QY)
MZ#GL,GCIR?4T 21R)+&DD;J\;@,K*<A@>A!IU<9\+)Y9? T,,A+):7-Q:Q,>
M\:2LJ_D !^%=G0 4444 %%%% !1110 4444 %%%% !1110 4444 ! /44444
M %%%% !1110 WRT\SS-B[\;=V.<>F:=110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%4-9T:PU_3)=-U*)YK2;B2-97CW#T)4@X]JOT4 8VH>%]+U1;$7*7)>Q8M;S
M1W<J2ID88>8K!B"."">:J?\ "!^'!:26BV4B027GVYHX[J5!YV=P8;6&,'&
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M;V43W%O'=RI"\@8-OV*P4,2!D@5;LO#D-EXIN]:BWHUQ;I Z^>[^;MQAB&.
M0!@8Z[F)/-;E% &==Z%I][K%GJL\4C7MD'6WD6=U"!L;OE#!3G SD=JH/X)T
M"73+_37M9VM-0G-Q=1F\F_>2$@DD[\C) X''%=!10!BW'A72;B]>\:.=+B2$
M03217,B&:,= Y##=C)Y///6C4/">C:D;!I;5H9-/&VTEM97@>%<8*JR$';@8
MQTK:HH YS_A!?#W]F7&G?8YOLMQ=?:Y8Q=S#=+NW;LAL]0#^ J^_AW39-<AU
MEHYC?PQ>3'+]IDP$)!*[=VT@D G(YQ6I10!AGPAH36^J6\ED98=5??>QS322
M+*V ,X9C@\#D8Q@>E,T_P7H.FZ5=:;%9&6UND\N=;F9YBZ<@+ER2%&3@#@9K
M?HH YVR\$:'I]U974,5T\]BCQVSS7LTGEHV 5&YC\N !CI5CPOH$7AO1_P"S
MX-PB\UY$C,K2"(,?NAFY/KSW)Z=*VJ* ,>/PSI<=R)A%,VVY:\6)[AVC69B2
M7"DX!RQ..@)R!FJ5WX!\.7K7WVBSE9+Z87$\0NI1&90P;>$#85B5&6 !//J:
MZ6B@#AK+PU<3>/?$-W>6=]!875M;003I>;1($5PX(5]W<8)&>O([OUCP[--X
MV\,/9Z;/'I6FVMQ"9K:98A"7$80 !@Q "$$ $?6NVHH Q;GPGHMYHS:3/:NU
MF\WGNHGD5I)-V[<S!@S'< >3V'I4&K>"- UK48-0O;20W<,?E":*XDC9T_NN
M58;Q]<UT-% &4/#FEKK"ZJD$D=XEM]D5XYY%58>NP*&V@9 /2J:^"- 728=+
M%K.+*"X^U1Q?;)OEEW;]V=^?O<]<9KH:* .=F\"^'9]=;67L2+QRK2E9G5)B
MO0N@;:Y'N#5E_"ND27&JSM!-YFJH([TBZE'FJ!@#&[Y>"1QC@ULT4 8@\(Z*
M#I9%K(#I:&*T/VB3*(0 4)W?.ORCALCBH(/ WAZVUV368; QW<DOG.JS.(FE
M_OF/.S=WSCKSUYKHJ* .:O? 7AW4)]0EFM)@-1'^F1174L<4Y_O,BL%+>^,]
M^M=!#;0P6J6J*?)1-@5V+<=,$G)/XU+10!B:?X3T?3&@^RV\BQVSL]M"T[O'
M S9!*(20O!(&.@) QFK.DZ#I^A_:O[/BDC^U3M<3;YY)-TC?>;YF."?:M*B@
M#-OM!T[4=4L=2NHI6N[$L;9UGD0(6&&X5@#D<<@\51U?P3H&MZM'JE[9,;Q4
M\LRQ3R1&1/[K[&&X>QS7044 8UUX7TJ\DN&EAEV7,:Q3PI.ZQ2HHP%* [<8X
MZ<C@Y%)=>$M#O;^[O+BQWRWEO]FN!YKA)8\%0"@.TD!B <9 /!K:HH P+#P7
MH6FWUI>V]K-]JM(3!%++=2R,(S@[3N8[@,# .<8XQ43> O#3Z"^B-IV[3VD\
MU8FFD)C8$D%&+93!)P%( R?4UTE% & ?!>@/H#Z++9&6SD<2/YLSM(7&,/YA
M._<,#!SD8QTJ%_!&C*E[(L%S/<W=I]CFDGOYBTL?/#,6)_B//4=JZ6B@"AHF
MFC1]$L].$C2"VB$89B3T[9))P.@R2<5F2>!?#TMO<V[6<ODW-S]KDC6[F5?-
MW;]P ;Y?F^; P,\UT5% &3_PC6E'5+C4GMGDNKBV%K,TLSNKQ<_(5+%2.3V[
MGUJOH'@S0O#,CR:5:/$2I50\\D@C4G)5 S$*,XX&.@]*WJ* "LW7= TWQ+IC
MZ;JT#SV<A!>(3/&&P01G:1GD UI44 <U_P (%X?.G0:<T%ZUC!M\NV;4KDQ@
M*<J-IDP0,#@\<5-J7@K0=6N[JYN[-B]XB)=B.9T6Y5#E1(JD!L>_;CIQ6_10
M!@:EX)\.:OJ=GJ-]I44MS9Q>1 VYE58^?E*@A2.3P0>IJFWPU\)MX?CT$Z6W
M]F1SFX6W^U3 !^><[\]SQG'-=710!BVGA31K'Q%<:_;VTBZI<1B*:=KB1MZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9)6;4MK@1AFD7='\OO\ 2O9:X3X@^"M3\7:CH-Q97%I FDW7VG]\6)E.5.W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK)M/$NCWUY#:VUZKRSAV@^1@LP0X8QL1M?'?:34MKKNFWMVEM;W!>21&>/\
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M#+=RH9(T7)$@')VMC:Q&>0#D4X>)-(.H16/VU1/,S)%N1@DK+]Y5<C:S#!R
M21@^E &K17/_ /"<>&=ZH-8MR6N/LV5R5$F<8) P.3C)X)XI]MXIL[GQ;>>'
MDCG\^UACD=S"^TE]W&<8QA>O0YP.0: -VBL+6/%-GHVNZ5I,T<[3:@TF"D+L
M%5$+$Y .3D 8]\U8O/$FD6$SQ75ZL?ENL<LA5C'$[8PKN!M0G(X8CJ/44 :M
M%0W=W;V%I+=W<R0V\2EY)'. H'<UC1^-_#<LL$:ZO!NN(?/A+9 D3 ;@D8)P
M0=O7VH WZ*Q[?Q5HEUI<NHPZA&UK%-]G=BK!EER $*D;MQ)&%QDY&.M8?C/Q
M.1X U[4M U%H;W3E(8^5AXG&#M9)%R."#R.X- ':45275;0Z@=.\TF[6)970
M(Q"J<X)., '![]J@M?$>DWM^EC!> W$D9EB5D91,@ZM&2 ''(Y4F@#4HJK>Z
MC:Z>L9N9"ID;;&BH7>0XSA54$L< G@= :K0^(=*N-,CU""\26VE<QH8U+,SC
M(*!0-Q88/RXSP>.* -.BL0^,/#ZV"7KZK D#W'V4&0E2)LXV%2,JP)&00,=Z
MH6_Q T2^UZRTNPEEN3<I*YFC@DVJ494(^[UR?H,<]10!U5%9*^)='>^CLUO5
M,LDS6Z'8VQY5SN0/C:6&#P#G@^E4D\0Z58W6NW=UXBCDM;1XQ+$RJ%LCM^[N
M RQ;&<')% '1T5DV'B;1M3U)]/LK^.:[2/S3& 1E,XW D88 G!QG!ZT_5/$.
MD:+-!#J-_#;RW&[RD<\OM!)P![ T :=%8C^+]"33HM0^WAK22$7 ECB=PL1Z
M.V =B\'EL#@^AJS%K^ESZK'ID5VKWDD'VE(U4G=%Q\X.,%>0,YQDXH TJ*YZ
M^URPGN]-CBUPV;M?F'R?*YNF4,&B^89 SU(Z;<9K0DUW38KP6K7!\WS1!D1.
M4$AP0A<#:&Y'&<T :-%8>G:K9-=:W.=>2Z@MIAYJ,%5+(!!E=P SW8DDXS5F
MU\0:7=W$MO'=!)XHO/:.9&B;R_[X#@$K_M#B@#3HK M?&WAN]FLXK;5H)&O'
M,=N5SM=@2-N<8!^4X!Y/;-7O[=TW[:MI]H)E>4P*1$Y0R $E ^-NX '(SG@^
ME &C16)XD\2VOAJWLI+F.:1KN[BM8UCC9N7< DX!Q@$GWQ@5->>(]*L%+7-R
MR!8A/)B)V,49Z-( #L'!Y;'0^AH U:*9%+'/"DT,BR12*&1T.0P/((/<4^@
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M-:44<R:W\/91I]^([33YX[AA92XA)A10K?+\I)4C!]*]&I-R[MNX;L9QGG%
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MHCQ-E,;2BL <'.0<#I6CX0\+'PU<:JT*1VEC=RI)!I\,K21VY"_.5R!C<3T
MP,#\ !;OQ3>IXDO="L=#>ZNK>T2[1GN5C2169EQG!QRI[?@!S5&Q^()O;;0-
M0_L::+2]9E2WCN'F7?',P. 4'5<J1NR/IBKZ:-JD7CV^UU4LVM9M.CM(T,[!
M]R.[9(V$ '?CJ>E8-IX+UVV\(>%=()TYI]&U".ZF?[0X614+'"_N\Y.[OZ4
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M<7,BWF\26LI4*S*%&'!V@X)'/<=:N_V'JD?CP:XAM9;5-*^P@23,LKOOW[B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M21$9)0@E(.#L)X?!XXS26_BOP_=WT=E;:S937,K.J1QS*Q8H,OC'H,Y^A]*
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MH=)(V#*RGD$$=14E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^[7>SIYL+Q"5HF=2JNF-RG'49[BL[0M$_L:V<2W]UJ%W+CS;NZ(+N ,*.
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MG&)'Q%<,P!5DD8 %<9)..-IX)ZS>'_%,6N:AJ6GF!8[FP*;FAE$T,JN,JR.
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M8I L9R,GGE^G'XU/I5UXGU#Q?K&FR:W;);Z3/:%MMB,SH\>YUY;Y<^N3V_$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD^E-N4;6OCOIVK:=*KZ=I&F.E]=HW[O<WF8CW="?F#8[5ZB1D8/2D5510J@
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MZ);?$&_A22&WLY?"LOG"S*ABHDSE0.K!"Q%-TNZG1=5TS5;C3-8LX]%+P:Q
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MOX 7[R\<8R.F:Z#4W:7Q[XICT1XTU.?PRGD!,*YFW2XXZ[N5Z\CBO3L#THH
M\K$MGK&A^ 5T5HUU*SN[<2Q+Q);Q+&1<K(.JCC:<]3M]16#<KH\?P[\57,(L
MEGC\2N89%V[E NT*[3U V[B,=LU[B%4,6"@$]2!UI: $1UD171@RL,A@<@CU
MKBM?NVT[XEZ!=:BXCTAK.XABED.(XKIBI!8G@$H&49]2!UKMJ1E5U*L 0>H(
MH \9UZ)+3X?>/Y4DC72;J_W:<"1M8GR_,,?JI?=C'H:]CMY89H$DMWC>%AE6
MC(*D>Q%2=** .+^);QPZ+I%U.52WMM;L99I&^[&@F7+$]A[UGM+HVH?%VX:Y
M:SF@'AV(J)MI4?OI">#T^4@_0^AKT3K10!XCX?UJ/2O#O@._U"_FMM'2RN+5
M[N)5=;>X++LW[E8+\JLH..,GH":],\%V>EV>BR_V-+<2V$]S)/'++T<L06*
M 83=G& !U(X(KH64,I5@"#U!%+0!A>-9(8O ^NM,Z(OV"< N0!DQM@?7-<7%
M?QVI^'%_++'_ &&EH8YY@1Y<5RT"B,N>@/WU!/0M[UZC2$!@0P!!Z@T >+>+
M+>W70O'UVK0_V/<7MD]F<C8TX*>>T9]SC)'<-Z&NB\23Z9X7\2Z#?AETS0)H
M[A7N[*&/RTN7\O8[_*PY164-C//7&:]'    & .@%#*&4JP!!Z@B@#RG4UT3
M0_#6CZCINH2+IL>OB\C>\)6&<L&+8(7")DLRG;C<.."#5"^^Q76@>)=:T:\L
M-0:[U2WNK^VTYQ*\=HK('4X )W!"S#&#R.>2?2]>T6^U.>PN=.U7[#<63NRB
M2 312;EVG<F5.0,X(88R?6I=+TB:UN7O;^YAN;YH_*\R"W$"*F<X"Y8\GU8]
M.,4 <S*UGJGQ(TW4])N+>>P&E3KJ<T;!HFC)4PJQZ9R7(SV![5Q6F'29O _P
M^CF:T8+KTB,K%>$W7&0?]GE>.G(KW!55!A5"CK@#%+0!X_J:V+6WQ2LK>[CM
M(!Y$F(%W 'R4W?*O8L-K?4YK;\-W^A^(_B -<BU/1I+Q-,6UCM+6X$KY#%FD
MY ( !VC Z$YQTKL=?TF76M*:T@OI+*7S$E29$#\HP8!E/#*2.1W%5K'1+_[9
M;W>LW]I>36S%X/LUE]G 8J5+'+N2<,1P0.>AXP ;M>6^'=/L+Q/'CZ7!92:M
M#J5RUBZ*I>)S H1D/\/S%AD>]>I44 >5^&+K0O$"Z%)9:A>OK^EVSQ)9M&L9
MLV,>UQ* @.W(QR>3C%3>"-3\/ZKH_A[3;R%W\2Z5(?-M6#+-!/@K+*_L<LQ)
MX.1U.!7IH5020H!/4@=: JABP !/4XZT >+7CV?_  @'CQ;8PF.'Q(LI6+!"
M1B6W); Z#"MS[&M7Q9K6DWE_X@M[>2&":?P^0D[9=KZ,B4A(%^[M!R2P!)#=
M@,UZK28&<XYH \OL]2M)]:^%[BZC8M83C);DDVZ+W]2"/<BG>';N:S\1:1:6
MUW:ZUHUU/</;,1MO-.<J[.),'#)DE23@Y(Z\9]/Z4@50Q8* QZG')H 6O%_$
M^KZ>]MKB0R1V,EKXBMI)[=LM,[++"#<,3G9&0!MP .!SSBO:*3 ]!S0!Y;(F
MAW/C'Q]),EDP.EVS#S O4QR[C@]^5SWY%5/#FN0:?J'@BZUBZCCTI_#:06]S
M,X$27GR;PS'A7*+CGW'<UZ]2,JL,, 1UP10!P_PPEM7T[7X[0IY::[>E508
M4R?+@>F*TOB+%J,WP^UJ/24D>\:W^5(_O,F1O QW*;A73@ =!BB@#S^>:QUS
MQAX.U#P[+#(D44_VHP$82U,?"2 =/GV@*>A!]#7(07FGGX4Z#8330B6#7H8[
MJ)R 4Q>,2K9Z$+R1V!!Z&O;E55SM4#)R<#J:6@#R75E*ZW\0;/P^(Q<R:/:M
M'!:D NP$H8*!_%MP/7D>U2->>$O$5C=:Q9ZE/>W,&D302)*B1I;Q%<A)0$4
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M#G(XZ8K;HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JCJFJV^DP123AW>>58((HP"\LC=%7) [$
M\D  $G@5>KE_&VD:IJ%MIE]HJQ2:AI5\MY';ROL6==K(R;OX25<X- $Z^,;!
M+?49+NWN[26PG2WD@EC!9W?'EA"I*MNW #!^N*</%ELE_=:?=65Y;7UO;?:Q
M;NJ,TT0."R%6(.#P1D$?3FL?7M*\1>*?#JS/9P:=J%I>6][9V;SB0%XFW8D=
M1@;NF!D# .>2!+=Z3J&L>((]>FTZ6U-GILUM#;/+&9)99<9Y5BH4!<#)Y)/
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M3'*Y=E:/&YF!9L8X/'(J3Q-H37WC329K.X1/ML+VNJ18SYUJA#_^A83/I,:
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M'=NSC)R0 <$@FK6D>(=&M[#5[R"._C"ZL]M+%<,7DDNF*+MC!8X!)  X Y/
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MTT'08-*MKV9;ZT::T@DD4RF)-N2S._)^=>,D\^@..EO-_P!BG$<;2.8V"HI
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M%=H(/8M[T =7I6HIJVE6VH1P30QW""1$F #;3R"<$CD<]>]7*155$"*H55&
M , "EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M% !1110 4444 9NL>'])\0);IJUA#>);R^;$LHR%;&,X[\'H>*T@,# Z444
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MX+9)RH;R(P,R. >"P'0'C)JY=^'9DMHCINJZC%<QRQNS2W;RB95<%D8.2 &
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M#[->F1=B.D17:RYW?> [8P3SV-[0%U.9/-O/!5MI-U!"RR21M"S3.1C$14\
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M9P723S*Z *9 @7@L"?NG.!Z4 6[3QAI5WHBZHIG16N39_9Y(\3?: ^SRMO\
M>S[X[YQS574?&]M8Z=K<GV&Z_M#2;8W,UC)M5S'@D.#N*E.#D@G&",9XKEQX
M7U\Z?)=1Z>Z7=GXHEUB&UDEC_P!)A9F^4$,0K;6.,XY%:6M>&]0\17VO:K':
M/:O<^'I=)MH9V4-([EF+-M)  )4#)[MVQD Z_0[^74]%L[R>W>"6:)797 ')
M .1@GCTJ+4-9MX+LZ:D-S=7C0&9H;7 =(\XW$EE R<@<Y.#CH<+X;^UCP[81
MWMD]G/% D;0R.K,"J@')4D=0>A/&.G0<_-9ZQHOQ$O-8M],FU+3M4M(87\B2
M-9+>2(MC(=E!0ACR#U[4 5_A_K[?\(#H[W+WE_?7;W/E(S;II0LSY)+D8 &T
M98C&0.I I/$WC<2> KO4]$6Y\X7*V4ORA7M9/-6-U8$\,-QQC/.#TYKGM/\
M#/B+2]'\.7TGAV._FTYKV&ZTV66(EXIY?,$D9)VY&%X.">170>(M)U34? ,]
MI8^'8[6ZN;N&9;*W>)3&J2QL2[9"EB$/3/4#G&: +&FIING^-UC^U>($O;JS
MDN$L;J=Y+>) 5#$#)RQ.TX!;&3TS5F'XB:--';S+!J(MIKPV1N&MBL<4N_8
MY/3+<>V1G%+=V6HS?$;2M6339_L4.G3P22%X_E=V1@,;LG[AZ>HKFCX>UX^
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MPU"S+*()[12AZ?,KJ6)5@>W'!'%4M3\17Z^(=2TFQ%K ]CI@OO,ND9A,26
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/Y 0"%R?F.3DYYX]*XOQ7+%=>-KA+G68]*\BWCA@34-*6ZBGW99FB+8 ZJI
M.25Z<"O3Z* ..MM%U77%T'4=0OXDGTNZDFC*V31_:%*L@)0ME,JQX]<'VK6U
M+PQ::EXDTO6Y'=)[!738O296P0&]0K*&'N*VZ* .4U3PC>R^)7UW1->ETFXN
M8DAO$%NLR3JN=IPWW6 )&>?IZV8_#$L'B>VUF+4,FWT]K$1S1;RX9E<NS;AE
MMRCMZUT5% &+X5T!_#6B+IK78NE6:659/*V']X[.1C)[L?PK,N? EM>R>(X;
MJ]DDT[7"'FM1& 8Y BKN#]?X%(&.".]=;10!SUIX;N3?:9=ZOJ*W\NF(XMBM
MOY669=ID?YFW-MR.,#YCQTQ/XET ^(+2S2.\-I/9WD5Y#+Y8<!T)P"I(R"">
M];5% '-IX8N8_$&H:N-35I+RRCLRKVWW0FXALAADY<YX Z=*R5^'=Q::=H2Z
M9K\EEJ>CP&UBO%M@RRPG&4DC)P>@/4<\UW5% ',7/A2YN9]$N)=7:6XTVY:Z
M>26 $SR,A0\ @*NUB  .,#KWAF\&330^*8SJ: >(%VR8MO\ 4CRA%Q\_/RCO
MW_*NMHH IZ?9RV&CVUEYR2200K$)?+P#M& 2N?;IFN5MO ,UMH.AZ6NKJ5TG
M4/MR2&UYD;<[;2-_3,C=/;\>VHH P]+T"33O$FLZNUXLO]IF(M"(=OE^6NT8
M.XYXZ\=?2DU'P[)=^*+#7;;4&MIK:WDMI$\H.)8V96QR?E.4'/IZ=:W:* .)
M_P"$!F_X1K^QO[73;_:7]H^;]EYW>=YVW&_IN_3\ZG?P9?0:_>:AI/B*XTZV
MU%A)?6B6Z.'D "EXV;_5L0!G@_RKKZ* (7B=;0PVSK&P7:C.I<+]1D$_G7)Z
M%X0UKPYX9@T+3_$<*P0*RQS/I^Z1=S%LY\S;U)[5V5% ',IX3DL-=?5M'U 6
MTT]K';723PF9)A&,(_#*0X!(SD@CMWJK'X#6PN=&GTG5);5].CFB<O$LOGB9
M@TC<X"N6&<@8YQC'%=A10!Q%E\/YK'3M%LDUII(])U![Z(R6PRQ8O\IPPX_>
M-S].G2MO2- DTO7=:U-[Q9O[4ECE:,0[?+*($&#N.>%'XUN44 98TNX/B7^U
M9+Q'A6W-O%;^3@Q@D,Q#;NI*KGCHH_&A/X8F;QS%XGM]06%EM/LDUL(-PFCW
M;OF;<.0>AQQ[UT=% 'CNFW%Q-=W%_8:]!'K$EQ+.--O="\RZ1BQQ&S@JW"X7
M=T [X%>A:/X>FL=8UG4[JZCF.KF)YK<0X$92,1X#;CD8'/'Y=*Z"B@#D/#W@
MR^\/O'9IXCNI]#MWW6U@\*AHQG*H9?O,H/0<= ,XXI-(\$WFBWCP6GB&Y70#
M.TZ:88%RA+;B@EZA-W\./;/)SV%% '&S^!99]$\2:8VJJ$UVY>XD<6W,6]54
MA?GYX0=?>K=[X1.I:Q9WM[>1R106$UA+ +<@2I*%#\[^/NC'XUT]% '*>'?"
M>J:&D-M/XEN+^PM%*V5O+;JI08(7S'!S)M!X''Z#%6+P%-#X:TS1EU=2MAJ(
MOTE-KR["4RA2-_3<Q_#'UKM:* .<B\,75IK.NZC9:N\!U5%;9Y"MY,RQB,."
M>HP =OJ.N.*W+**>"QMX;FX-S/'&JR3E GFL!@MM' R><"IZ* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_'D/BQ],N+
MCP[K-MI4=G;M.S/;B5YV )V9;A% '7!))[ <]A7G_P 2]7U5((=&T_PWJFJV
MMT,W[6:E08O^>0?!P6Z''1<]SD &Q\.]=U#Q+X#TK5]4B6.\N(V+[5VAL,5#
M8[9 !_&NHKA;?Q5KUKX<TFXB\$749N+P6OV"-L-9P#Y0[?+TX)'  !'/KW5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%<7=K]LM$GCV&XA_OI_@<''.,5D'XM^%!;&Y,UX+=+O['+,;1PD,GH[8P/\
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M@%/+1@QR3@C)'0U<N/"NL:K\0_'$ZV<]O9:QHWV.UNI!A3)Y:+@]P,@]1VH
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MFJ[HH421C<-K;0!CD=,YJ4^$[^P\3MK.C:JD1NK:*VOHKR$S>=Y8PD@(92'
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M0N+N&X@U=XV,"P%#'LC$>-VX[L@>@K.\.^%=8\.I%82>(Q/H%F=UO"UOMF5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/-10P#*&.1GKGOTY%8FLZ=-K'A^XU70O#-[:W"75I<RPWB>7<7RPR;BA!).
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MI0*I=CACQS]!S6A??$'1XM'TW4[!Y;ZWO[Z*SC:&!VV,SA6W#&58#.%(R3@
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MFE)=I<^;AYTW.!&S;,J 5;^]UH T_P#A$]'_ .>-Q_X&3?\ Q='_  B>C_\
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MKLVT<G=R2"0%[U>F\57EAK5UHU[8P&\%BU]:/',1'.J'#H25)5AQV((.>.E
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MGANH$GMY4EA<922-@RL/4$=:\\U+6M5U;Q#X$GBT_P"RI=&XF-G>L\;K(L#
MAQMXVY.#W]!5EO$Z:'8W:^'O#YGT^PO7@DM;2&4R2-YF)6C"H5^5BW!/.#TX
MH [ZBN-\0^-;K0/M=Q-I\26EO<0PHLTVR:Z5R@9XUQT4OWZ[3TJRWBUYO$UW
MHMHEH;JTN(8WMIIBDTD3A"TR#&"JACQWVGD<9 .IHKC=6\:76D7JBYL(8K=M
M2CL4CDGQ/*CLJ^>JXQM#-C'?!Y'2JVH^-]9MF\4?9M$M)%\/XDF,EZ1YL?E"
M4[<)][:>AX'J: .[HKFSXFGU"[:ST6UBFN$L([Z3[0Y15$F?+3@'YCM;)Z#
MZYJ"3Q;=,;.S73&MM4FLA=S6]P'<6X)VA3Y:L22P;GC@$^U '5T5E>&]7FUW
M0;;4+G3KC3IY 1):W"E6C8$@]0"0<9!P,@BM6@ HHHH **** "BBB@ HHHH
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M$XYSO/'M530M.U_P[_PC>B)<6=QI]K:F"["Q-O.U3LD#=%&0HV\YR?3CLZ*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[K^YN-#A,2V&\(4=F7,F'V[G"G !W$<D<D<5+C4=4'B_Q38IJ<ZPV^DPW-L
MD?[AV,N2,KS]P?>S5GPII=Y:W[W*R^($L6A*-!K-X)V9\J591N8J  P.2,[A
MQQFM67PQ8S:G?ZB9+D7%_;BUG*RX!C&< #MC<>1SR: .,T75-:C;P!?7.LW-
MT-;@V7<$B((S_HQD#+A<AMR\G)SD]!P-Z]\3:EJ6G:C;:-HNJVNHQPEH)+ZV
M$,;L& VJ[$C<<_+D8J_%X.TR&/1HT>Z":-_QXCSC^[^7;S_>^4D<YXK6U'3X
M=4L)+.X,@C<J28G*,""&!##D'(% 'FVI>*YG\$^)[W3;_5+'4M.CB9K*^0":
MS?)]00Z-U!YZ'GH!TUQJ%ZGQ(@TX73FQFT6:X: @;?,62-0PXST8]\5I2>%=
M,N;74H;U9+LZE"(+J69OG>-00JY4 #&XD8 Y.>M0V/@S2['4[;4A)?3WMO;M
M;+-<7;NS(2"0W/(X'!X[XSS0!YWX>DUG0OA[X-URSUBXDA>2UM9M-:-/)>*1
M]GR\;@X)!SD_3'%=)9:[>IXLBTO6Y]0T^ZFNYQ;2J%>TOH2'\M4;!".H*G!P
M25YSG%=%IO@_2M+2TAA^T/:V3^9:6TTQ>.W;GE0>3C)QDG';%2P^%["&>!VD
MN9H[>X:Z@AFEW)%*V[+#O_&V 20,\ 4 <+X6FN;/P'9R#6KF-[K69H65_P!Y
M+,/M,N8X^,AWQRQ/ !.1U#;[Q#KL/@;Q?-'J%S;W6E:J(+9Y!&\BQ'R3L<X(
M./,;D'/3FNN?X?Z$UL8%6\C5;W[="8[N0&"4EB3'S\H)=L@=<_3!+X T*6SU
M.T*W@@U*59KI?M<AWLNWG))()*J2>IQR: ,#6->U7PEK^N!K^?4H(] ?4TBN
M%4!)D?;A=H&$((R.>G6M*]N-2T/1F\21ZV;VVCTJ6>6UF4$7,HC\Q&C(QM&
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M?$FE?\([I^OW\#PRW<\-_?6C\X"%H%=MJ["?XB /NCD9K9O? >BWVF:99/\
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MY(VE!N8KC#9)(SD<'J "I/9/+\9T/VVZ0'0VDPC* !YZC;TZ?K[UECQ!K(\
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MEHYX%P!M5QSC  Y]* ,"YG\5Z>?"MAJ&N1_:Y]2DM+J2T".)(_*D="VY!AP
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M=ZOTU%V(JEBQ QN;J?<TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIL)(4CH2.XKSK0-2TN?QWHK_ &VQELY_#DD"I",PJ%DC(BW'.\JN<YZ<DA:
M/4$U.PEFBACOK9Y906C195+. <$@9YQ@_E2QZC8S1RR17MNZ1<R,LJD)]3GB
MO%]&&DVO@#P#>1?9([G^W8U:8%0^WS) 03UQM(&/3%=5J&GW.D>+[[1;*W;^
MS?%8\TO&,"WE7"W!/IOBY!_O"@#T+S//MO,M98SO7*28WJ??@C(_&O-X?B/K
M%OX'B\8:AI]B^FBY,-S#;LZRQ*)3%O4G(;D [>.O6O2?W-K;CE(H8UQV55 _
MD*\N^&F@Z1XD\ V0OI9+R&"^GE-IYY\K>)W*ED'7L<'@]<4 >F3ZC8VTL,5Q
M>6\,DW$222!6?Z GFB74+*"7RI;RWCDW*NQY5!RV=HQGJ<''KBO,-0N]'FUS
MQ7X?\6ZG<V37MPKV\0C3_2;<QH$$1*%BP8-PISGH,DU<T#2]#N_B5XCM[JUM
M;B2.ST]PETJ.X=0Y9CV+@A<GUH ]!.J:>LD<9OK4/)(8D4S+EG'50,\GVIR7
MUM<FXCM;NWDE@^60+(&\MO1@#Q7BMW%HR_#'Q3/&MFLL7B&3R9%VAD'VM2NT
MCD#;DC';-=7.FBVOQ.NK>(6,5K+X:8RQKL5'Q+D9'0_*3^% '3KXFM-+M-'A
MUK4K!K_4#L5K9\1.P4LS+DY"#'4GJ0.]7-.\1Z5JNI7UA97D,T]DXCE"N#\V
M 2!ZXR,^AXKR_2KFR@\)_"V\NI84MH9C'+,Y&U";>0!6/8YXQZU8OIG1/B39
MZ>I.IO/'/';1KB5X/(BWE1C."H8?7CK0!ZI:ZA97S2+:7EO<&(XD$4H?8?0X
M/%<]JGBEK?Q=H&E6-Q8SPWL\L-TH;=+$5B=QT;CE<<BN2N;K2]<T[4]<\'ZK
M>:AKBZ++ @A5$\I,9575$7#@_=!YSG' IJZSX<O=7^&TVF7-IB!Y8BJL-\ -
MLPV..JG< ,'J10!Z%XE\0VOA?0YM4NE>0(52.&/[\LC'"HON2?ZU2O+GQ7::
M+/?K!ID]TD)D&GHK@YQG:)<_,?\ @ S[=:S/BEI5[J/ABTNK"W>YFTO48-0-
MO&,M*D9.Y0.YP2<>U;MIXMT&_LX[FRU.WN?,'R0Q.#*Q_N[/O;O8CCO0!HSZ
MC96KQ)<W=O \O$:RR!2_T!/-.GOK2U)%Q=00D(9")) N%'5N>PR.?>O/;>YL
MO[4\=:?XG,4<ERP>-;@@>;9F(*@3/7:P?@=&/J:R?#EDB^+/"<'B)+=]1'AI
M_M"W(4ON$D>T/GJP7/7T- 'JK:G8*D+M?6P2<9B8RKB0>J\\_A4GVJW\YX?/
MB\V-=SIO&Y1ZD=A7E.CZ9_:WPD9M*\J2_P!'U*YO-/5,':\5P[J@]F7Y<>C"
MM+7KRXOO DOBF*WN%BO+BTN)HD0-*M@DBDK@@@C&]R",8<@\4 =_#JFGW-M)
M<P7UM+!%D22I,K*F.N2#@50U#Q9H>FS6T,^IVOG7$X@1%F4D,1GGG@ <Y/MZ
MBO/-?/A?5/"OB[6],U1]3DN-(:.:9M@A#J#Y0("J/-Y..X'7&15W6[70],L?
M!.IP0V-O;2:I;M<W2JJJ_P#H\BAG?OR0,D]30!UNM:KJ>GV/B"]MKG394LK$
M7-M"0S.I",S>9ANC;1MQCOUJ[H6LPZKIEDS7-L;^2TBGF@C<;D+*#G;G('/>
MN"N#:R:_\38;,1F6?18"(XQAG;R9\_+USRN>_(J.PT[2KI_ %SX>CM/[3A*/
M>36NW(M_((E\TKZOM'S<Y)]Z .S\*Z]=ZK;ZT^I&VC.GZG/:!H@579&%PQR3
MSR<UNVE[:W\/G6=S#<19*[X9 ZY';(KR!]2$&AZY>13.]C;>,7FOS; 2,EOQ
M\^W!R VUNA^Z:[CP@NA76JZMJ^B:E/J/VT1&YN,KY+.H( 7:JC?CK^&: )M:
MU_4=/\:Z!HD"VIM]5%P6DD1B\7E(&.,-@YSCMCWK>?4]/C=4>^ME=I?)"M,H
M)DX.SK][D<=>:XKQ3>6T?Q:\#))<1*RI?[@S@$;HEVY],]O6N,U*'1U\!?$2
M>)+(3Q:S+Y#KMW)_JBNWTY!Z>AH ]FU*_AL;8E[NUMYG!$)N' 5F],9&?H*Q
M_"WB4:IX'TO7M6FM;1KJ$22,6\N-22> 6/\ 6N>AUC3X?B'XD@UZXMTBO+*W
M&F-<,/+GM]A\Q4)X/SDY Y/'7%<GX7UNVTO2/!5SJ>HR66D-I,MLMVBHT<5S
MO!*N65@I*# /'0]B: /2]8\17%AXE\-VL$EHVFZFTXFE;)("0M(&5LXQP.QJ
M]J?BC1]*T8:K/?V[6C,(XWCD5A(Y. JG."<_ESZ5Y[-IN@6,_@B.%FE\/_VA
M=LLM]CRFWQ.5QD !"Y^48P>V015#7-.M[+1O&5Y811QZ VJ:=+!Y8 A#K)'Y
M[IVVYP"1QE6]* /7IM5TZWABFGO[6**;B-WF55?Z$GG\*=>WMM8V_F7%U;VP
M;A'G<*N[MU(KS74]8T8>+M8M->U5K+2M4L(5L)@D9AN(=K"1%9D;G<2< \A@
M>>*ETR]L/#_CBSM-5GDMM,_L.*'29M28+G#'S%+-@"0KY>0<' % '4^#O$DF
MM^&;?4-3DM(;F:XGA C.U6\N5U&T$DGA<]:W8+ZTNK8W-O=036XSF6.0,HQU
MY''%>)Z,-&FT7P/ XM"(_$%Y&8WV_+&6N"%(/\)RG'3D5<O[J+3Y/%OV$XTZ
MT\06=Q>16:JQ2#RX_,<)@@@, 3P?NG- 'KT&I6-S:O=07MM+;IG?+'*K(N.N
M2#@8H34["2U>ZCOK9[>,X>595*+]3G ZBO.;B+PQJ>GZUJNF^);D?;6LQ/J:
MB,P13+*ODD@*JD@[=P/\/7&14?VJ[O\ 3[^SU2^L=+U6#5H#%J]HN^UNI_*#
M(75CUVJ%89X.W% 'I]O=6]W%YMM/%-'G&^-PP_,5*2 "2< 5PWAKQ7;6>GRC
MQ +'3KR;5FLA);,Q@O)RJG?&>P/0YZ,#DYK0^(K7<?@B]EM(YI/+>&2=(5#.
MT"RJ90 <@_(&X/49H W8]7TV:"2>+4+1X8FVR2+,I5#Z$YP#4D=_9RR1QQW<
M#O*NZ-5D!+CU SR.#^5<)IM[X,O;S4O$<>L/J%N^F^1?RR!! (@<JKJJ+F3E
M@ <G&1Z5G^$F;PYJEUX<NV6/4);(R:"\\RN5MB25M\]-R-UZ[ACDA10!Z6FH
M64EXUFEW;M=(,M") 7 ]2N<TBZA9/>M9)>6[7:C+0"52X'J5SFO.?!VI>']7
MT+P]9LA;Q1I:L#;,66:"XVE99)!QP2226X)(ZG%4O"4^AZW9>'K+4-1OCXCT
MJ<&73]B++'.,B5GP@8H<LS$M@@]2: /46U33UFCA:^MA+(YC1#,NYF'50,\D
M>E5;;Q%I=WKUWHL%Y$][:(C2QAQD%MWR_4!<D=@17D;Z5H=YX#\7V\5O:G6$
MUJ\CL5C $Z2B<^4L?<#/8<=?>NT\.R16GQ0\16MY)$M]<6=B\:D8:7:D@=E]
M1GJ?<4 =3JOB+2]&O+"TOKN*&>^D,<*NX&<*6+'/0 #KZD#O65H?B=[C5=>M
M-6N+&!;&_6TMF!\OS T:.!\S'+?-V_*J'CJ6UM/$O@V\O6CBMH]1E6267 5=
MUO(%!)]3T]ZY#6%TF[T?XISRBUEG60^4[[2RD6\>-N>0=P[=Q[4 >O7.HV-E
M)&EU>6\#R<(LLJJ6^F3S5-_$6EQ^(DT)KN+[>T)F,6\94;@ #[G/ ]C7F/BC
M6-.O+'Q3;)+##>2>'HBTDC&22^'E2,HA7. JDG<P!Y)Z8S6QH^H6+?$71KF2
M>(B\\-QI!(W_ "VD$PR%/\1QSQVYZ4 =1XZU^[\+>$+[6[.."9[158Q3 X<%
M@O4'CKGO575_$FI^&KK2#JD5I<V6HWD=EYEL&C>&23.T[6+;ER.<$$>AJE\8
MIHH_A7KBR2*K21HJ G!8^8O ]:Y[QA_9J7GAZ^\+ZDVJ:Y%>QB"S-ZU\C(W#
ML5=F\O _Y:#!'K0!ZE/J%E:SQP7%Y;PS2G$<<DH5G^@)YI;G4+*S)%U=P080
MN?-D"X7(&>3TR0,^XKSA)[-H/B#I?B-HUO)KB62-)L;I;8Q*(/+S][!! "]&
M]S5/2M-MKGQKX:L?$L%I<:@_A<I=QW(5F>7?%PX/WFQNZ^A- 'J1U&Q$RPF]
MMQ*S[ GFKN+8SC&>N.<41ZA9374EK%>6\EQ'R\*RJ77ZC.17F>F:7I]SJ_Q!
M72K2P?4[:=7T[:B$PR_9E"LG]T[\\CO]*9%);:IX4\!IH[*NL6EY;*\:G$T(
M48N1(.H& V[/4X[D4 >F?VOIOE&7^T;3RPVTOYRX!],YZU,MW;-,L*W$1E9-
MZH'&XKZ@>GO7F6M>'[B?6?$7@^UAV6NO*NJ6\^S*6\BX$I^I=(B/^NA/:G75
MYJVN_#74_$)L9TU%[:*W:!$'F&.)Q]H"C_:/FC'<*M 'H]OJ5A=K*UM>VTRP
MG$ABE5@GUP>*=;WUI=NR6UU!,RJKL(Y Q"L,J3CL1T]:\W\[PGKMOJNMZ?JT
MFI2'1I()RZQK#'']Y%D4(H#YZ \\&NB^'%AID/@C1+VRMK9;B;3;=9YXE&]R
M$&0S#DX)/!Z4 ;)U;S_$+:1:!6DMXEGNY&Y$:L2$4?[3;6/L![BJ[W^IVVG:
MC>%[&]-K<2,L-J"&,( .PDD_O0.?0\#C.1C^%$>/X@>.4G'[QKBTD4GO&8<+
M^&58?@:B^',MDEOXJ2!X!!'KUT=L9&U5^7L.W!H [*QO;?4K"WOK242VUQ&L
ML3CHRL,@_D:L5QGPGBFB^%VA+.&#&%F4-UV,[%/_ !TK79T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/:!X<FTG5-8O+
MBY@N/[1N_M2A8"IA.Q4P"6.>%'I70UR5Y\0;"T35W&F:K,FD2;+UHX%Q&NT,
M7Y894 @\<^V* .L*J6W%03C&<5BZCHM]J.K0LVJB/1E5#+IZVZYE=6W F3.0
MO"@KCD#W-0V_C&QGUF#3GM;V 74#W%I<S1!8[A$P6V\[@0&!^91D=*9IWC.Q
MU*ZT^".TO8QJ5L]S8R2*@6X1,$XPQ*G#*<,!P: .C*@]0#]:-B_W1S[5SUGX
MQLKW0;K5H[.]5+6Y:UDMW5!-YH<(5V[L9W$#!//XBKVO:[;^'=!N=8O8;AH+
M:/S)$A4,X'TSC]: -%HHW4*R*R@Y (SS3BH)R0,_2L"'Q;;RC!T[48I'F\JV
MCFB5#<_)OW)EL;0N<EB,8QUP*H'XC:.D*-);WZS'4/[-D@$(=XI\9"G:2#D<
M@J3GM0!UVQ<$;1@]1BEKC6^)&EQ:?K%S<V&IVTVD;6O+2:)%F1&^ZX&[#*?8
MY]JVYO$-M!X@_L5K>Y-T;-KQ"J JZ*RJ0.<[LL."!0!K;5((P,'KQUH*@]0#
M]:Y/3OB%IFI:<NHI8ZG%8/")(KF6WPDC&01B)<$Y<L0 /UZUD^//$(O/!?BF
MSCBU'3=1T^S6?E_+)5ONLKQL01P01GZB@#T(JI.2!Z=*-B_W1^5<_8^++.;5
M9-*GM;VTFCLS>(]Q$%6:$$!F7!)X)'# 'GI2:9XQL=2O;"V%M=V_]H6C7EG)
M.JA9HEVY(PQ(.&4X8#@_A0!T) /4 _6D>-)%VNBLOHPR*PK3Q=8W=M'>&"XA
MT^6T>]CO9-GE-$FW)X8D'# X(!QGN"*+7Q99SZY;:1/:W5I<W<+3VOGA,3*N
M-P&UB0P!!(8 XH W7BCD&)$5P#GYAFL"Y\.S7'C:#7FN8#!%9/9FU: DL&=7
M+;MV,Y4=JNZEKD.G7]G8"VN+J\NUD>*& +DJ@&XDL0!]Y1U[_6LE?'^DRVVB
MSPV]_*NL%UMA'!DAT#%E;G@_*1W_ "YH ZED5T*,H*D8((X-(8T,?EE%V8QM
MQQCTQ7/6GC73;C2;V_EANK5K.Z^QS6LZ#SA.2H5 %)#%MZXP2#FLC3;ZXN/B
M]=PR0W]K&-$20V]S*&3<9B-ZA691P .,=* .YV+LV;1MQC&.*6N9L-;BMH(;
MB437%UK5S)+:6\6"SQA?E(W$!1Y:JQR0,MZD9CN?B!I-GI5[?7$%ZC6%REK=
MVWE RP.Y 7< <;3N4@@D'/% '4%$*%"JE3U4C@U7O+&*]L7LW)2%UVL$P/E]
M!QQ]1R.V*BTK4SJEO+*;"]LO+E:+9=Q;&;'\0&3E3G@UE-XVTU+K3T>*Y6TU
M&?[-:7I"&*60YVCAMPW8."5 /KR,@'1(BQQJB*%10 JCH!0(T  "* !@8'2N
M:A\;V4U]=Z>MA?B_M;F.V>T98Q(Q<%@RC?@IM!.[/0'T-6-5\66>E_;S]EN[
MM-.17O6MD5O(!&><L"3M^8A<D#'J,@&[L7^Z/RK&TK1K^WU*:_U75?[0E&]+
M4+;K"L$3,"5P"=Q^51N/]T<=<\L->.F?$'7[B.'4]1MCI=K<I;P$OM!,I9E#
ML%7@#C()[ FNB'C&PGBL&L+>ZOGOK(W\4<"J#Y(V\G>R@'+ 8SG- '1$9&#2
M!0.@ ^E<RWCO2O(T.:&&]N$UM"UH88,YPA?#<\' Q_/ YIUOXWTR71+[4YXK
MJT^PW/V.XMIT'FK-E0J *2"6WK@@XYZT =&T:,RLR*67[I(Y'TI=JYS@9^E<
MZ?&>GPZE?6%Y;W=G-8VXN9S,BE5B(.&RK'.<$8'.1CTJ:S\4VMSKXT6:VN;.
M^>W^TPI/L(EC!P2I1FY!(R#@T ;>Q?[H_*EV+_='Y5DZGXAAT[4$L$M+J[O&
MMWNO*MPN1&A ))9E'5@ ,YK/;QWI930V@@OKA=:B:2S\F#.<(7P>>#@8]N^!
MDT =-M7&-HQG/2C SG R>]<F_P 0-.BT"?5Y;#44BM;PV5W$8TWVTF0/G^?&
M/F7D$CD5OG4T_MF/3!!,96@,[2#;L1<X ;G.2>G'.#Z&@"XD:1YV(JY.3@8R
M?6D6*-&)6-022<@=SWK#U_P\=;9FN-9U&QMHXOD%C<F J_.79A][ Q@'@8/!
MSQR%CKNMW&@>!M)O[F47NM32?:+E<QR/;Q*S@Y'*LZB/)'/)Z&@#TZF+#$DC
M2+$BR-]Y@H!/U-<58S7MQXF\1^$UU"YA@@6WN;>X$A::.*0'S$#MD]5."<D!
M^.@IWANROM'\=ZII4.I7U]HZV44Y%[.TS6\[.PV*[<X*KNP3QD>M ':-&CLK
M,BLRG*DC)'TI2JDY(&?I7)>&Y[L^._%]I/>W%Q! UH84E;(C#1%B% P ,T_Q
M_P"(;O0-%M(].*IJ.J7T.G6TCKN$3R'[Y'? !_'% '5  = !]*      !P *
MYV]\*EM'F@L=5U.'4#&0EV][(Q+XZLI)7!] !C/&.*DO_%EI8_VBZ6EY=PZ;
MQ>RVRJRP':&((+ L0I#$*#@'UXH W%BC1-B(JKUP!@4[:N,8&/3%<Y/XUT]-
M2MK"TM;V_FN[(WUL;6(,LT>5'#$@9^8=<#WZ5$OCW37TC2M32TOC;:E="S0[
M$!AFWE-D@+#;\RD9Y''N,@'4;0#G SZTB1I&6*(JECEL#&3[UE7GB&UL;FZA
MFBG'D"(;P%*R/(=J1KSG<3V( &02<'-95U\0=,L8-8:\M+Z&?28UFN+;8C.8
MVZ.I5BI'![\=\4 =6%49PHY]J1$2- B*JJ.@48 KB[[QY<)J>E6EIX?U/R[R
M]\CS9T2,2+Y329CW.,YQWQC!SS@5!KU_97%MXZCM&U.WU.STQ9)G,[HBGRI#
M&8L-Q]TYQC/'6@#O"JDY*@GZ4FQ?[H_*N+\.>,[1HM"T:\M=2MYKRS06UU<0
M[8KEUC!8*V<YZGD#/;/%0^#M673M(U<W<]Q<-_PD%W:6Z/(9)'(D(5 6/8#N
M<  DG H [HQHQ4LBDKRI(Z?2D:*-H_+:-2G3:1Q^596B^([36[O4+*.*:WO=
M/D5+FWG"[DW#<K94E2".00:YV66=/C,+3[7>FS&A-=FU6XD\LRB?;NV9QG;Q
MCI0!W#HCH4=593P5(R#2[5V[=HVXQC'&*Y&T^(NF7<.GW*V&II9WUV;);F2!
M52.;>R!6^;/++U (Y&2#Q4/C;Q C>%?$UO817\LEC:2++<V;A!;R^7N W;@Q
M(RK';G //I0!V;1H^W>BMM.1D9P:&C1\;T5L'(R,X/K7,V/B&.RT'3H1;W-_
M=IIL-S+% 4WJA7 8EV49)5L#.3@US][XGM[KQ?X4UK2VO[VQO].NW6VMRS>:
M5\L#Y"0H898$G'N: /1@B  !5P.@Q2A5'0#GVKAKSXBQRZ387>E:;=R2SZM%
MIES!,J1R6TA<;D968?,5Z8..<DBMC5/&-GI-O=SRV=Y+'8JK7QB$9^S94,0P
MWC<0I!(7=P: -]8HTC\M454_N@8'Y4"&)8_+$:"/^Z%&/RK#O/$5G<K+:64-
MWJ#&T6YD^PL%,<3@[#N+*06 ) !SQ]*Y?P5XOCL?!WA.SO8M1O;_ %*TD>)T
M3S#(R9)!8GKTZ^O) R: .\O--M[V&*"48@C=7\M0 &VG(!XZ9],9Z=,BK=<[
M8^,M/OM,^UK!=1S?;'L39RJHF$ZYRGWMN< MG=C SFHX/'&F3"ZC:*XBO;:[
MCLI+.38)/-DY0 AMI##D'=V/?B@#I%BC12J(JJ3G &!FEVKG.!D>U8C>)H$:
M&&2QNX[N:Y:VCM7\L.[*F\D'=MQMYSFM+3KX:C9+<B":#+.ABF #J58J0<$C
MJ#T- %@1HKLX10S?>8#D_6D\M0S.JJ)&&-V.3Z9KSFTOUUS4?$E[KG]I:=;Z
M/?AHKE+E4%K'%%&Y0A7.=V6+<$$'&>!CJH_%=K_:-G8W5E>V<M]$TEIYZ+B?
M:-Q4;6.&QSM;!_(T )X7\.2Z!%?+<7$%T]S?3WBND!0IYK%BO+'(!-;^!G.!
MGIFN=\/^,K7Q)+&++3=36!Q+_I,T 6)6C?84)S]X]1[>X(%O4O$4&GSW%O':
MW5[<6UO]IGBM0I,<9S@G<P&3M; &2<'B@#7(!Z@'OS1L7^Z/RKG)?&NGB**2
MUMKR\\S3_P"TML,:J5@[$[V7D\_+UX-2CQ;8S1V[6,%S?-/8KJ"QP!0WD-]U
ML,RY)]!D\?2@#=V)G.U<XQT[4NT<<#CI[5P%QK$MI\3O/@AU*\BGT!9TLH6+
M?,9NH5F"*=H&3D?B3SV&AZS:>(-%M-5L2_V:Y3>@==K#G!!'8@@@_2@"^0#U
M /UH  Z #Z51U35H-*6V\U7>6ZG%O!$A4&1R"V 6( X5CR>WK@5Q_B[5WD/A
M>^2/4;0C7EMIK?<0S@+)E2B,5<$J".O:@#O6C1G5V12R_=)'(^E+M&<X&?6N
M9C\<Z<;'4I[BTOK6;3[B.VGM)8U\WS)-OE@;6*D-O7!SCUQ2W'C>PM+'6[BY
MM+Z*31=IN[?8K.%9=ZL-K%2"/?MSB@#I0H!R  ?I2+&BNSJBAV^\P')^M<];
M^,+>X(5=-U))9'"VT<L2QFY79O+H68#:!U)(P<#J0*;9^-],OX(_L\5P;M[V
M2P-FP195G12S*<MMX49R&(/&,T =)@9SCGUH  & ,56TZ^&HV2W(MYK?+NAB
MG #J58J<X)'53T/2L6?QMIMO;+?/#=?V4;C[,=1"KY*OOV9/S;MN_P"7=MQG
MOCF@#HEBC0$*BJ"<D 8R:4  8 Q7!ZI<3ZW\0Y_#EU::@-/72ED4P3K&5=Y6
M7SLAP> @QW'/'/.KXAUVY\,1Z!96]I<WYO+N.S,S2(6X4DYW$9=@IYX'4Y'
M(!LRZ7&VKQZI"WE7(C\F4XR)8\Y"L/8DD'MD^II^I:>-1L9+,R&*&8;)M@PS
M(>J@]L],]<9Q@\CA(?$+:#XQ\:3S6VJWMO!%:3F"(^;]G3RF9R-S!0.^U3SV
M!Q75S^*+18HFLH+C4'EM5O!';; PA;[K'>RCG!P,Y.#Z&@#9BBC@A2&)%2.-
M0J(HP% X  ]*?5#1=8LO$&C6NK:=+YMI=)OC8C!]"".Q!!!^E7Z "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSVYT'69;+
MX@1+ILF[6@PLOWL?S9MUBY^;CD9Y[>_%>A5E2^)M @N);>77--CFB_UD;W<8
M9/J,Y% '+W6D:[)JGA*YM=/*/IMA<0S/))&5CE>)%3(#98!ER<=JHZ3H?B0Z
M_P"%-5OM'VW-G%<0ZE<2WJ.[NZJ-XQGY,@X4=,XPHYKT>">&Y@2>WE26)QE9
M(V#*P]01UI[ ,I4C((P10!Q*Z#(OQ+N'MIT_LN>*+4;RVQ_R\KNCC;TPP&[_
M 'H0:U?'>G7FL>"-7TS3X#/=7=NT,:;U49/<EB!BK^B>'])\-V1L]'L8K2 L
M7*IDY/J2<DUIT <3XJTC5[R+0-7T[38;N[TQF,VF73H!-&Z;6 ;E0PP"#TK)
M\3?;HK+PQ<S:)#8ROXBMF2P@="V DGWF&%+'GOCISUKTRL[5-#T_66M6OH7D
M-I,)X-LSILD'1OE(Y&3^= '%^(_!^I>)(_%5\EN+6XO],CL+2"5UW-L9G+.5
M) R6"CG@#)ZU=MX/$%UXZL=?N-":VMH]*EM9(C=1M(KM(C8X.#]PXY],D=*[
MBB@#S6U\):Z?A+IFCK"EKKFES17,,<LBM'))%+O )4G@CCZU>\10^)_%/@36
M+*70A8W-S;>1#:FZCD9G)Y8L"%"C''))R>!791:E8SZA<:?#>027EN%::W60
M%XPW(++U&:M4 <5?Z;KDWC&UU6RL3$(]%GM5EFDC(CG=D9,@,20"G.,UE:3H
M?B,>(?#.K7>C;)[:TN(-0GFO4DD>1Q'\YQG*Y5MH'3.,**]*HH \L7P'J%U!
M=6UA;3Z#::EIT\6HV33K);?:&4;&A56;;\VXGID8&,UT?A6+7&D@75O#&GZ7
M+;)MENH9(W^T-C&8PHRH/4[N1TP<Y'855OM1L],BCEO;F.!))4A1I#@,['"K
M]2: ,'Q';ZW/K^E_9K/[=HWERK=6ZSK%^\.W8SY^\@&[*C/7.#@5RV@^&?$&
MGVO@VWN-)"C1[ZZDG,=Q&PV.)0I'(_YZ#CT'KQ7J--=UC1G=@J*"69C@ >IH
M \RO_"GB"Y76KFVLQ'=+K\&L64<TR!;A8T1=A()VD[3U]OPNW-AXCU/Q9/JB
MZ-)8P76CKIY:2YB,D+-,2S85B#M5BPP><#OQ7<:=J5EJUDE[I]S%<VLA8)-$
MVY6VDJ<'OR"*M4 <EX@T2]C\1>'=<TFV%PFEB6WFLE94+0R*!E"Q"Y4JIP2,
MCO6#K_A/5[^S\2WUM8,;W6;NQ:.U,L8,<5NR'+G=MW':_ )_A]\>ET4 ,'[V
M'YE9-Z\J2,KGMQQFO/O"&BZ]HL5IH5YX=T]HK!PL>M"2,^;$IRI\O&\28P.>
M ><]CWUU=6]E:R7-U/'!;Q+NDED8*JCU)/2BTNH+ZS@N[659;>>-9(I%Z.I&
M01]0: .&U31]=DURV\76&GL-6AF^RM8M)$!+8Y.0S;L;L_.#G@X7&,DRP6OB
M?0/%6KSV&CIJ&G:S)'=*SW21-:2^6J,) <[E^4'*YQCO7=44 <7%I>KQ>,-<
MU"2Q>6&YTN"VCE1XQYDB>86^4MD [QC/O6/H^A^)[+3O#VEW>EBXTZVTO[-/
M;FZ142Y! #R8)WQ[>@&<'G;G%>F44 >9:'X<\06=AX"@N=**MHKR_:MEQ&VU
M3$T8/49Y;.!GCWXJ/5=(OH=%\5PW>F9DU?6(I=/C>Y1&D8^4HVD$[7'ELPSQ
MP,\9KU&J.JZ/I^N61L]3M([F#<'"N/NL.C CD$>HYH \]NM*U#78M7T_4-'O
M]/U?5[,0P7]W<03(?*^=4(BQM&223MYR>>@KI?"ZZQ-*CZIX7L=&>%"LDD,L
M<AF?I\FT?*O4\G/08ZFMG2]!TW1MQLK<J[#:9))7E?'IN<DX]LXK2H Y+Q#9
MZY=^);=8[$7VB-9NC1?:!&J7!;AY >73;P  V#DXZ5@:#X=\064/@&.ZTHI_
M8JS)=E+B-MH:(QJ>O/)S@9X]^*],HH XW0?#TTEKXML=:L&CM-7U&:9 TB-O
MB>-$_A)P?E)_*I?A[8WL'AY+O4KI;NZF"Q)< 8WV\>5B/_ AF3ZR&M7Q)I>A
M:GI>?$,5N]C:N+@M</M1&4$;B<CU/7CFM&RGMKJPM[BS9'M98E>%H_NE",J1
M[8Q0!S?BF;7YKJ*RL?#S:CIA7=<G[9'#YI[1X;G;Z^O3IG,&H:9K&L#0M=ET
MV.TU/2KQI5L5G5RT#*8W7?PNXJ=PZ#@ GO746>HV>H&Y%G<QS&VF:WFV'/ER
M+C*GW&15J@#BET[6K"_\0^);32Q/JFH^3!:63S(OE1QJ0&=LXY9F; )XVC/7
M%SPQ)KB3M;WWA[[!"P:::[EO4FDGE.!R$'?UZ * !C&.IJK>ZC9Z:L#7ES'
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MN-5W!6)'*<^QK1DTW5_$%WX;N-3TQ[)](E-U<?O8V\V41E L>UC\I+$Y;;P
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MDJ2K=&&3AOTJ=/"\D7B;3]834686=H]H8Y8MS2AV5F9GW#YB5!X&.O% %O\
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M-:&'+IYAS(D<F[Y5;G@J2,G!]-+7/"MCKC:29"T/]FW EC\OC<FTJT1_V&!
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M;F:UU#4KF-KR>X(>\C*RGYHQ\H12HV]Q@<+0!ZO5>^N39V%Q<K"TQBC+^6A
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MN;>W=$<@N6W!=QQG=D!CS0!ZW534K]--L9+IH99BN L4*[GD8G 51TR21U(
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M@@90I?>V @8X!8]%!/0G&:AU'Q3H&D320ZAK%E;2QQB5TDF 94) #$=@210
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MN74)@R&3//5N$!_I7376MZ99VL5U/>PK#*GF1N&W;TQG<,9R,$'/3F@"\!@
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M!P:GD_L\:GXB\/>)]+U>Z;4+Y[BT6#[08;V)MI104.U2NT EL 8'->K4@(8
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MI0;^/E^;CG'->C[EP3D8'7GI2T <;\3H_.\)1PB%IBU_:'RUC+DJLZ,QP >
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M '#^$[A+KX@>+KJ&"X%O<K9M%,]LZ))MB(."P [C_P#54EY(;'XMV]W/#/\
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M&NK-)J>EM+XG>ZL[^.U=/)8P#;(=RX*':ZD'^]SC.:]<HH YOP3<:I<:-/\
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M[^%8$'=R.WO6:G@G4=-;P]<Z?+:7%W8WUS=W?GLT:2-<*X<K@,?E+\#N!U%
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MP-S#:>V.<\USGA_1M3U/PAIEUIWV:6]TSQ%=W9BF<QI,!+,C , Q7[^1P>E
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M;,8HQNAFXC<*%PVPA]_'\!Z5VE]=_P!E:-<WDI><6ENTK9P&?:I)Z#&3CL*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M [GW$Y?"J., <]<T 7[JPLAHLEDUM";-(=HA9 4"@<#!XXP*\IT4P6'@3X>
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M2NQL\465[<'SE'[^&X64^2B'J!M\M0!P0<=Z]=AABMX4A@B2*) %1$4*JCT
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M< 5N4BJJ*%50JJ,  8 %+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M899TC)57=HRH]3PAZ4 3VGC_ ,/WQL#!/<F*^G-O!.UI(L?F[BH0L5PK$J<
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M/3Y@>N..:@UFSU[4+#5M-;1;YX9M"2&R-N5C#2^6X<3'<&)#$!5Y7!)P<YH
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M[Z? MS<1R6S[UB;.'  )(^4].F#G%-L?&FC:C?6UI!)<^9=6YN;9GMI%2=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BN+=+JW>"7=Y
M;C#!6(R/3(I\<:11K'&BHB *JJ,  = !3J* (/L< O3>*FV=D",RG&]1T#>N
M,G'ID^IJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J 6D(O3>%-TY38'8YVKU('H"0"<
M=<#/05/10!EZQH-KK<EB]S+.IL;A;J 1,!B500&/'. 3P>.>E:E%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!&T$33K.T:F5
M55CR5!ZX]*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>cutr-20221231xexx1027thi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZUN"_P!JD(P&P5'EKW[GITQR 6_#'B>3Q-;PW<>CWEK93VR7$-Q.R;9-W50
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M&S\#7S?#V_T#4-1#WT\7V>*[ SLCC.(,^N  Q]V:M'3&\875A+%K5CIUO)'
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M=U6:*8R"[EVD*2I4;%SR>2?H* )SXQAATB75KJS>/3UL_MB7$<JR*ZY'RY'
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M[2XB$2J(99$+(T9 SM!4@ABW&.: -_4/%&D:7<^1=W#JPECA=UA=TB=_N!V
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MIR,#&6Z #IUKF!XH\3Q^'9==EU*V9;/7#8R6RVH FB^TB'DY)4X.1CTYSG@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTM?!7_"*S3W=Q8*<QR2.HEC.[>&5E48(;D'%=/&7,:&10KD#<H.0#W&>].H
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MS6>H@TC6/#V@OJPOM"O-4NS)QM@1Q&K16P.3E S,0I)Y&.V*]*O-(TW4-/\
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M1\.:$;66U.BZ=]GE?S)(OLJ;'?\ O$8P3[U=>UMY(8X7@C:.-E9$*#"E2"I
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M<7]H]Q)&EQ/&?,=S*R^6JA020WR@ 9.*S?!&CZEI*36NIHQM]',EEISG+-+
M2'#^_P OEI]4;UKE[+3=:L?#7AV^72KV4Z3K=U=75B(B)6BD>7:Z*?O$"0'
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MK0:C>O=6=Q&NZWD23!V2Y(";3QR.@Z=,@'H][?6^GVC7-U)LB4JN<$DEB%4
M#DDD@ #DDU0;Q-I4=M-/+-+$L-PEJR202*YE?:50*5RQ.Y<8!SFH/%5E;77A
M66SNK&XNK=FA1XK/<)$'F+\Z8YRGW^.?EKCBOB?3])GA,=YK%E%JMOY%Y-9
MWJV^W+N$91N=&PH8KGJ<<"@#6\:^)O-^'VNW^A:C/;7FGL(Y"(MDD;Y7*LKK
MD9# Y'J"#75'6;!=0N+$S,)K>,2S$Q-Y<:D$@L^-HX!."<UY9J>E:H_AWQ]9
M0Z+JI?4;B&2T\U3(THV1#KDDGY6SZ8P<' K6_LW67T/Q+X0\FZE2]MY9=.U2
M2%E\SS03Y4[8X<$XW'J,9P1B@#MK/Q+I=]J:Z=%-(MV\7GQQS0/%YL?0LA8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>..O;G@]* )]5\)V&JVAM6EN+>!KE+LI;LH'FJV\-R#CY@"0.">3U.=Q054
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M>)9]!6.<7D%LMTS,F$*,Q48/?D'MVJW_ &?9?;/MGV.W^U=//\I=_P#WUC-
M''R^!KN'3],-E>6_]HVVL/JT[RHWERR2;PX !R  _'^Z,]:DN_!,^JZAXI_M
M&:#[%KEG!;9B)WQF(. V",<E\XSQCO7:T4 <G#X=U6^?0SKDMI)_8S^<C0,V
M;F4(45V!'R !B< MSCG YRV\$ZNWA&?1O/L?-EU;^T?,WOM ^T";;C;UR-N?
MQ]J] HH K7UE%J>F7-C=+^ZNH6AE53_"RD$ _0FN3M/"&I2:+HVA:K<VLUAI
M,\4J3Q[O,N%A_P!4K*1A>BY(+9V]!GCM:* .<T;1-0L/%>OZK.ULT&J-"R)&
M[;H_+CV<Y&#GKVQ[U)XMT.ZUW3;2.RFABNK.^@O8O.!*,8G#;3CG!]JU[Z[C
ML+&>[E61HX4+L(UW,0!G@=ZBTC4X-:T:RU2U#BWO($GC$@PP5@",CUYH Q8M
M#U6/QG<:\[V<BR:9'9; S(2RNS[NAP"7(QDX ZFN?L/ GB#1--T";2=1L$U;
M2K=[.03J[074#,&P<892" 1C->CU!<7<5O',QR[0IYC1QC<^.<<=><'\C0!%
MID-[#9+_ &C<1SW;DM(T2%8P3_"@)) 'N<GKWK#FT#49/B+;^(U>U^RQ6#6)
MB+MO(9P^_P"[CL!C]:V-#UBV\0:)9ZM9B06UW&)(Q(,-@^HR:T* .:\6>']0
MU673-2T6]AM-6TR5G@-PA:*177:Z.!S@C'(Y&*IZMX>\0ZQI=@MW=V#7T.HP
M7T@0.D*B)@PC0<DYQRQ]>G0#J+J_AM9H(7):>X8K%$@RS8Y)]@!U)XZ=R :K
MZW'%]O::SO88;*0+),\.$92H8NG.649P2.A!]* *%]HM_<^--*UN,VP@LK::
M!HV=MS&38<CY<<;!]<]JP9_!&KS^#]:T7S[%9=1U1[]9=[E4#3"7:1MY(VXS
M[Y[8KOD=)(UDC8,C %64Y!![BE9E12S,%51DDG  H Y-_#%_<^(->OIY;:.#
M5=.2RVQLS-&5#_-R #_K#Z=*IP^$=<BL/"9^VZ?]MT$E!^[?RWC,)ASUR6Q\
MW8=O>NDNO$%G::]IFD.LS3ZBLC0.J9CPB[FRV?3'3/6M6@#B;#PQXDT;4[ZV
MTW5K(:%>W+W1$L+&YMFD.Z18R#MP2203TST/>*X\'ZU;2^)K;2KRQ.FZ\))7
M2Y#[[>9X]C%=O#*< \XQ[]^[HH SM!L)]+\/Z?I]S+'+-:VZ0L\:E5;:H&0"
M3Z5AQ>&]2T+Q%J.J:!):26NIN)KNPNV:,";&#(CJ&QN'4%3R.HKK:* .6\0>
M&;[Q'I 6XO8[;4(+B*[LS$I:*"6,Y7.<%\Y()XXQ@#',5]X9U#5[NYU.]^QQ
MWW]F2Z?;11R,T:>9]]RQ4$]%P,< 'DYXZZB@#B[;PIJD#^#"9+,CP_$8Y<.W
M[[,/DY7Y>./FY^GO6B?"J_\ "=?\)"EP5ADMU6:V XDF3*QR'Z([K_WSZ5T=
M% '&#PWXDTKQ#J4^A:I8)I>J3?:)XKN%GDMY2H5FBP0#G .&XS^M_3M"OK+Q
MIJ6L/) ]K=VL%NJ[V,@\K=ACQ@YWG\N]=)33(@D6,NHD8%@N>2!C)Q^(_,4
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MMOJ$D#W,4:HQ@4A. !QGGM6A110 4444 %%%% !1110 4444 %%%% !1110
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M:8"P"O=*%9HT(&3N$B8R>"&':N\L-*M--@FB@0GSY#+.\AW-*Y&"S$]> !Z
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M:C'/Y+!4=H3LWA<8RPSGZ\8KI8]&NKKXEZS>NFH6MI-806\5Q"VQ9"I<NO\
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M(W>,2<C<5+A22<$CGBN@\%ZU;ZQ;:@8;B_\ ,AN=LEGJ"%9[,[%_=MGDC(+
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MY&X8;<23NR,#GH!QBJTW@+0;G3+[3[B&::"]NC>R%YFW+.?^6B-U4\#IQ^M
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M>%M+U.UTZWECEA&G.KVCVTS1/#A=N RD'&WC%5!X$T%;*^M!!<>5>7(NY/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8 OV.+Q7;7+.JX"H#;EG^F,G/IS0![!)>0NMS%;W5O\ :(D)8,X/EG'!8 Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA-8\7ZKI.H
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M8RR+)=^62K!@%(W#@AL^U>M5Q3^ I9/#=[HQU8;+K43J#2BVY5S,)MH&[IN
M_#\Z[1=P4;B"V.2!@9H \[NO&FMVGA/Q'JD<&G&ZTS6#9*OEN$=-\:9/S9W?
M/G/MTK=TS6M77QO=Z!JGV*1#8)?026T;(4!D*%&W,=W0'<,=^*I7'@*6XT+6
MM*;5@$U74/M\D@MN8VW(VT?-TRB]??\ #8CT"9?&/_"0R7J,QL19- L. 5#[
M]P.X\[C^7YT 9OQ2_P"28>(/^O4_S%3WFNW5CXUTO3'2V^PW&GW%PTFP^:IC
MV9 .<8.[T[5H^*-#_P"$E\-WNC&Y^S)=IY;RA-Q"YYP,CFJT_AN6Y\2:;K$U
M[&QLK62V,(@^602;=QSNX^Z,?CUH Q]/\3^(M4&BZA9Z<LNG:EAI4^SE6M8W
M7*2;R^'QQN  SGCI5>+QMJ[^#M-UAH[+SYM8&GSH(GVE#<F'<OSY!P,\YYK1
M\/\ @J[\/R1VD?B*[FT.!]]MI[Q)F/G(4R_>90>@XZ $D<54?X=S&P;3DU^:
M/3TU(:C;1+;)NB;S?-*EB?F&[..!C/.: .Z) !)X KS^?QSJ*>"D\:Q16KZ1
MYNY[3RV\[[/YGE[P^[&_HV-N,<9[UWX&% )+<=3WKC[?P%';Z/+X?%_N\//<
M><+-H?G1=_F&(2;O]7N[;<X)&: *D:7UQ\8+V)[FU>V.BPDQ-;,<Q--)E?OX
MSQR<8/'%=9JTUSIN@W4NF6L$EQ! 3!#(XBCR!P">BJ/Y"J47A^:/QG/XA^W*
M?-M$LS;^3P$5BP.[=URQ[8]JL>)=#C\2>';W1Y+B2W6Z3;YL8!*D$$'!ZC(&
M1W&10!D>'_$UUJ'BJ^T:>6WN88K*&[ANH('B#!V92,,2&&5R&!Q@]Z/B:URG
MPWU]K:9(B+.3>60L60J00,$8//7GZ5/IOA>ZM/%!UZZUJ6ZGDLDM)H_LZ(C[
M69@1CD#YCQZ]\<5?\3:*?$7AR]T?[3]F2\C,3R>7O(4]<#(YH YF]U#7M.UG
MP[IMD-'>ZU2UF0W4EJZE!$@91PY)7+=,_EFHO$7B_7_#EA?7-T--,MC';OY$
M4;R&X#;1*_#9B7<6"EA_#WSBMZ?PU<W&LZ#J4FHQ^9I*2($6WP)?,4*V?FXX
M QCOZ]*S-8^'SZK_ ,)#$NN3P6FME))8A CE)%55!#'G;A1\O'UH O76M:MJ
M&J:WIVA?9%N-*BC_ ./I&833.A=4X9=JXV\\_>]N<ZVO=?G^)B6D]S;P1KH<
M=RUIY1=8W>0JZA@PR<H/FQT[=S;N?!EZ-?;6=+\17-A=74*0ZABWCD%SLX5P
M",(X!(S@C';UN?\ "+&'Q-;:S::C+"8K!;&2)T$GFHK%U)8\@Y)R>^>QYH P
MM+\;7USI&E1O#9IJFIZK<V,>Q&$2+$\FYRN<GY4Z9&2W:C5O&6L:,/$UA+'9
M2ZAI6GC4K6;RV6.>'Y@0R[LA@RD<-@]>.E6XOA\L>BVUI_:;"[L]0?4;.[2$
M Q2.[,P*Y.Y3N8$<<>_-6M0\&G5+36OM=\IO]6M!92W"086.$!OE1"QQR[')
M8\GT % %:S\1:Y'XFTRPOX["6#5-/ENH$MT9'B>/82K,S$,"'ZX&*ATCQ=J<
MWB/1M-OOL4G]HVL\DJVT;8MI8]I*"7<5DQN*G'0CMG%7[KP?)>WVF7,VI8%E
M8S66V.':76555FSN.T_*,>G/6JNF^!+FPN?#T\FOS3'1(7MX5%JB!XF55VGW
MP@R>_;!YH ?\._\ CR\0?]C!?_\ HTU-XJ\5GP_JEC;7%Q!I]G=1OC4+J!I(
M1*"H6-B& 3().2><5H>&] ?P_#?QM>"Y^V7LMZ3Y6S:TC;F'4Y&>G]:?JVCW
M6HS2>7>PBUFMS!-:W-MYT;\D[L;EYYQZ?I@ Y747U.X^(/AAX'LTOY=%N2\C
M R1*Q:$D@ @L,]!N'UJSIGBS5[_P_87,JV%O,;^>ROK@Y*(8V=08XRVYF=E4
M!021GOBK]CX+73-2T2YM+\B+2-/:PBBEBW%T;;EF;<.?D7H,=:HV_P /Y[0V
M$MOKCQW-E?7-Y&_V8%3Y^?,4J6_VC@]O>@"@GCK6YM#TRY@@L3<SZ\VD3>9'
M(BD!V4.%)RAPO(.<9K3.O>(!=S:*6LVU:UM5N)YX+.22)C(\@C4)O!7B/+$D
M]>*CC^'LT,$4*:Y(Z1:R=73S;92?,+,VTX(R"6.?PQCOH:WX2NK[7X-=TC6Y
MM)U%8/LT[+ LT<\62P#(W&02<'WH UM O+_4-"L[K5+ V%_)'^_MBP;RV!P<
M$=CC(]C6%?ZU?ZO<>)-/TM[6*/2H1%(\\3.996CWE1AAM4*0,\\D^G/3V-K]
MBLX[<S23LH^:64@L[$Y+''')).  !V %<Y<^#IUU_4M3TO5WLDU6)4OK<P"5
M795VAT)(V-CCN#Z4 87@C6KVUL/!&BJ+<VE[H1F+%&WHT:Q@<[L$'?Z=NM6[
M#QO?W-M!;R10'4+C5;NQ1H8690D!;+[-V22%'&[OGM@V;;P'-86_AT66N2QW
M6BP/:K,]NKB6)PH*E<C!&Q<')]\U"?AN%TOR8==NXK^+4I=2L[U8TW022$EE
M*]'4AB"#U]NE &[X:O\ 6KR.]CUJQ$#P7!2"=4V+<18R&V%B5/4$$]JCU+6K
MVR\;:)I""W:TU&"Y=BR'>C1!2,'=C!W=,=JOZ-IUU86S?;]2DU&\D(,D[QK&
M,#H%1>% _$Y)YJEKWAV;5=5TK5+/438WNG&4(QA$JND@ =2I(Y^48.>,=#0!
MS,OC?74THSQP:?).GB3^QB"KHK)YH0,/F.&YZ\@>AI+[QYJ_A:^UJR\16]E<
M26UBE_92V2M&LJM((@CABV"'91GT.<51\4:!_P (WHEM -7>62]\407PDFC4
M&+=,&9L#J%ZD]/I75WW@JSUY=3DUJ<7<NH6BV>^!/*6*(,7&P$MSO.[))Z+Q
MQ0 VYUW5](\3:3I6H&SN(M625(9H86C\F=$WX8%CN4C..A!'OQ@Z?XU\1S:+
MH.M74>F?9;[5/[/G@BC??AIGB#JQ; P5'RD'/)R,X'46WARZ:\T^\U34DOKG
M38W2T?[/Y?S,NTR.-QW-MXXVCEN.1C+B\!2P^&]-T9=6!2PU 7Z2FVY9A*90
MI&[IN8_ACZT ==>W<5A8W%Y-D16\32O@<[5&3_*N=TS5O$%[#HVK-%8'2KZ
MW%RBY62U1DWH0VXB3T/ ]172S01W-M)!.H>.1"CJ>C C!%<OX<\'7>@I#92>
M(+J]TBUR+2REA0%%_A5W'+A<\#CMZ"@#+F\<:E#X.M/&?E6K:1+*C2V@C;SD
MMWDV!P^[!89#$;<=1GC)-2\4>)DN?&$=G_92)H")/&989&,RF'S2A <8/;=^
MG/&A:^ TMM''A\Z@9/#Z7 FCM&A_>*HD\P1&3=RFX=-N<<9J:;P?+-/XGD_M
M)0-?B6*0?9_]2!'Y8V_-R=OKW_*@"$^*-037/#)D2UCT?6X#M8QL9(Y_+#JA
M;=C##=CCJN.]-/BC47N[2RC$)EOQ<7,$D=LS[;:-E56*[_F+;U8'( ':KNH>
M#X=4\'V>@75TX-H(/*NH5V.C1$;67G@X&.O<T>(?"7]K2:9=Z9J,FD:CIFY;
M6XAC5U$; !HV0\,I '';% &+<^*O%=IIVCFYTVSMKR[UC^S7$RL%D0ABLR ,
M2H(7[I)/6C4_%NL:)=QZ5J]YI5E?RVF^VNI+>06EU.6<>6&+CRR%"9R3DM[8
M.M>^$KJ^MM*6;67DN;&_34'GD@!,TB@J!M! 5<'&!Z#G.29]>\-3Z['?VLM_
M%_9]];B"6WEMO,V$;OGC.X;6^;N#@J#]0"C>^+)M)\3Z]#?10'3].TA=1#Q(
M?-8;G!4DG!^X<<=ZBE\4:OIL?AR_OTLY+'69HK9XX8V5[:25<QG<6(=<_*>!
MZCTJZ/!=NVKWES/<>=9W6F)I;VK1_P#+%=V/GW9S\QR<4ECX/DAM=(LK_4S>
MV.D2++9HT&V0LBE8_,;<0VT'C 7) )H YZY\:^);?0]:U@II7D:/JS6<L0BD
MW3QAT0X.[Y&PV<X;/H,<^E'IQ7%W'@*2X\.ZWH[ZL FK7S7LD@MN8V9E8JHW
M=,J.OO\ AV2!Q&HD96?'S%1@$^PR<?G0!X]K-UJU[\-O'<FHWL-R(M4D@4+"
M4(V2Q*,'<0%P!QC/?)KK+OQ=J6@:YJMMK2VDUK;Z.^JQ?949&4(VUHR68[CT
MPV%^E.O?A^UUI6OZ8FLR1V>KW;73(;=6,3,RLV#D9Y48ST!/7@B_?>$%U77I
M=1O[I)89]+?3)K982H>-SN8@[B0<_I^= %>TU?Q/+J]K"UC%+8W5N[//]G:(
M6LH&5!RY\Q6Y' !R/?C'TGQIXAF\*:?XAOXM-\C41%;P6\$<F];B28("26P4
MQD[1SQC/-;F@>%M5T:*."X\37.HV]JA2RCGMT7R^-H,C+@R$ XY(_/!$4/@*
MW'@"/PG<W\LD<&#!=Q+Y<L;*^]&')^8-0!2O?%^N:%'J4FI::LMN/)2PN1$8
M!)+(X3RW4LQ&"0VX=L]ZT9-<U73O%MEH-\]I*-4MIGL[J*!E\N6( LKH7.5P
MP(((Z$>],E\$SZKH-UIOB/7;G5))D5(YTA2 P[6#!E5?XMP4Y.>@X SG0M_#
M]PVIVNJ:G?QWE]9V[P6KI;^4B;]N]RNXY8[5'! QG &: .;\ Z:=8\)7T.KF
MUNX)=1OOE-N0RN9Y%9MQ8^IQ@ C/4UM?#K5[G6_ NG7=ZYDNU#V\TAZNT;M'
MN/N=N?QIVCZ7-X.\/W-NLYU&1YY9H(UAV,\LC,^WJ1C<3SQ@<D\9JWX1T'_A
M&?"MAI+2"26!"9I!T>1B6<CVW,<4 59-:OM3\0ZMH^E/:PG2X8C-)<1-)OED
M4LJ@!A@!0"3S][CISROP^UR=?#'A+P[8F&.ZGTR2\EFE0NL<:/M "@C)+-Z\
M 'K74W'A2=/%5QKNE:J]C)>Q)%?0F 2K-LX1QDC:X!(SR/:L[3/A[_8]GH1L
MM7<:CH\;PQW,D *2Q/RT;H",C."/FR#WH BB\=W:?:=,NK:+^V8-573=T4;&
M-]T9E64)G/* _+NZ\9[TZX\4^(=*T[5KC4=+8P6EQ (;V.V;#P.1YCF$,6S'
MSG!YX/K5N_\  -MJ&EW,;WTT.ISWRZB-0A4*T=PH"J54Y^4*-NTD\9YR<U<M
M] UB.S!G\1RW&I>:CFY:V58]JY^3RE(&#N.3G)SU&!@ M>&M6.M:=)>I?V-_
M;-*1;W%F"%9-J_>!8X8$L"/8<"L[6M:UJW\9:9H>G_8%BOK2>;S9XW9HVC*<
MX##</GZ<?6M'0/#T.A/J,T;(9M0N?M,PBC\N,-M5?E3)QPN3R222?:F7N@2W
M?BO3]<6\6,V4$L"PF'<&$FW<2=P_N#'XT <]8>.+Z;1K"*XBM1K%UJ\ND[D5
MO)#1LX:3;G.-J9VYZD#-5?%'BG6]/M?%.C-/;Q:A9Z0VI6=[#"0'B^96!4L=
MKAA@')'(..,5IK\/T_LIK9]2;[5'JCZM:W4<(4P3LQ8C!)#+\Q&/0_C5Z[\'
MQZI%J[ZI=B6\U.P_L]YH8O+6*'YN$4EN<N2<DYX]* -;0A<C0[+[5+'+*84.
MZ.,H,8&."S<^^:T*I:193Z=I=O:7-X;N6) AF,83.!@?*.GZU=H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO,@VI>)X
M->N(=<73+W3-4EC$OF2?Z-'$_P NZ,,%9609.1SN/H, 'IM%>9^,9;C1?$Z7
M2:K?II%_$D&J[9Y"-/#. DR?-^[W$%..GWNQ!V)YTU#Q]+X:N;FXBM(M(2>V
MCCN'1I69V5GW Y8J%7&2>I- ':45YS'+<7'B*S\*2ZR]Y'%I/F)/-,\3W4@E
M='.Z,@EE"KW[D\]:9!/J4&IZ!X6U#6TOB]I=$W3,\7VN6.15"$JV2RJ6SSR1
MD\B@#TFL;0?$":[-JL2VDMLVG7K6;B5E)8A%;=\I(Q\X[UQUI)?V/B/0?".I
M:W)>V\AO)6F5V1Y2FTI SYW-M#DGG)P,]\Z?P]MDM+[QA;H\CJFN/@R.7;'D
MQ<$GDXZ<T ='K&N0:3IFI7@C:Z?3[<W$T$)7>%P3W('12:M:;>C4M*L[Y4*+
M<P),$)R5#*#C]:\TFLH(KCXJR*TVY;<X!G<CYK/)R"<'DG&>G;%2Z?\ :-%U
M7P5):75[-_:&D3?:()+AGCD,<$;IM0G:I!R/E ZT >H45YMX:74-;TSPUXGC
M\0)&TA0W@$DCK<EQAX2A;:I#'C ^7'I72>*YU^VZ)9"ZN!-<W3;+.!MGVH+&
MQ(=\@JB\,<9S@#!SB@#I:*\KM=2UK_A!=0$=U,[VGB)[1PMPSRFV%R%,4;G#
M,V#M'\1' YQ6DUIK=O)XOU'3KF[M[460_LI;V9TC2;RV,C;)#\JYVX+#&<]J
M /0J*\_TBPO]0U[1KF!]8M]-&F$WZ7$\T>Z<[=G#'YF^_DCCISTKG-.N;O3O
MAO8>)9M9U)[B:Y^Q7$UQ=NT<4#7FUG(SP0H(W]1NZ\# !['17!7>GZUHUMX@
MN;#7(0UQICRVMK)*SK!*H/[T/(QV@Y'!XR,^M06<5X=5L=42XU:QTFWT=I;\
MW<DJA9Q@JQ5C\[ ;RW4' Z\4 >B5%!<PW4;/!(LB*[1DJ> RL58?@01^%>;:
M)<7:>)_"T2W5Z]EJ>E7#2R3W3%[O:(BLK)DB-CN)&TY ;'&,5E:!=_V+X%T"
M*&Y>WAU+7)[2XEDN)-JJ);@J =WR;F502,9SS0!['17.>&M,O-)U#58+C51=
M02/'-!:$NYM 001O<DE6*D@=N:Y632I];\0>.;277=6MH[)X'M/)O700,UN'
MW<'D;B3M/'MTP >FU4MKJYFO;R&:QD@AA91#.SJ1."H)( .1@\<^E>7Z(VH^
M*]6\/Q:IJ>IVXO\ PP;FX2VNGAW2"2,!P ?E)!SQCTZ$@W;J:\AM_B="FI7^
M+"%'M7-RY>$_9!)\K9R/F.<"@#TZBO,H9;S1];\*7-O>W]U)J.D7#W,,]R\B
M3/'%&Z84G:IR2/E ZUH^%E36M!\->)#KUVMS.@:Z"S%DN9'4AHBA.%VMG&!\
MNT^YH ['3[JYNHYFN;&2S9)WC17=6\Q <*XVG@,.<'D5;KR"2[U'_A&#LU?4
M$E3QC]C687+%_*^TA-I))W #L<BKFHO-X4\0^(; :_J4.D2Z&;TSSRM<R6<_
MF>6"FXD_-DD#/4=J /4)G:.%W2)I64$A$(!;V&2!^9K,\,Z[%XF\.66LPPO#
M'=IO6-R"RC)'./I7->'IKVU^(MYILGGPVCZ/#<BVFNVG*OYKKN.<A6( R%)'
M&<FK7PI_Y)=H'_7O_P"S-0!V-%>5V6HW)U7PE?6>H7=S::AJ-S$]W-.P^UH4
ME8?N<E50%0%/!^7H,U0U+[8G@SQOJ:ZOJ@N])U>?[$XO9,1!?*(&,X8<D8;(
MQTQDT >QT5YIK=Y>^%O%-W-I]S>W)D\/7=Z\%Q.\JO/$R;6"DX7[Q&% &.U.
MFGNK+3/!.M:=?W=Q-J-U;6]X'G9UN8YD)=BI. 5QN! &,$=.* /2:*\DO]1O
MH?AUXNG74KU9[+7Y(K>7[4^^-!/&H0-G.-I(QTYK3OK.74?%OC2UEU/4TM[?
M3[:>&.&]DC$<A64[EVD$<J#CH>X.!@ ]#DN88IXH'D599L^6A/+8&3CZ43W,
M-LJ-/(L8=UC4L>K,< ?4DUY?I&=7\2?#_4;Z:=[JYT"66:03NFY@(3G@@<DD
MGU[YK=^(MI%<W/A(R&4'^W84RDSIP4DS]TCG@<]1VZT ;^F>($U/7]9TD6DL
M,FEF$,\C*1)YBE@1@GC [\\]!6S7E6H:>MQKGQ%D6\O8&M;*VEA:WNGC(=;=
MBK%E(+8QT)(/<&KEIJMYXAU72=)NKH)]H\/V]\JF:2(S2/D2,"A!)7"\=MQ/
MT /2:*\OEL-1_M?P;HU[XDOKSSHK^WN[BUG>'S_+7"YP?O+D@MUR#S3H;:^U
MX>(=+@UV2RNM'N%MH)Y;F3S;>-(T*RL P#[OF)+9SD@\ 4 >G5FZMK$6EM9P
M[/-NKZ?[/;1;MN]]K,<GL JDD\_C7*:7-+XH\1^)--U"]N4^P16T=L;:9X,"
M2+>9@%(Y+$XSG 4#USSEI+<^([3X;:AJ\DYO;BZGBE>.=X_,"Q3!7 4@ L #
MD8)SCIQ0!ZCI%_<:C8">ZTZ>PG#LCP3$$@J<9!'!4]0>XJ_7/^,;F.S\,R!K
MZYL_,EAA22VYE=FD4"-22,%ON[LC&<YXKS_6KW4[72?B-;+=W5I]@M[:>U2&
M]=S SQDL%<X(!P"1TSF@#V"L;6_$":+?:1;26DLHU*[%HLJLH6-BK-SSGHIZ
M"N.U&[N_"_BJ6>TNKV[$GAVZO9(+BX>19)HBA5@I.%)W$84 >U5+F".XT_X<
M:P;VXNKF[U*WDFE>=F61G@D8G;G:,'(  & 2* /3+^_M],L9;R[DV0QC).,D
MDG  '<DD  =20*A-[>?:K&+^S)?*N%<S2^:F+; !4,,Y)/3Y<@$=<<US7CV2
M3^T_!]L<BVFUR(R^A*H[(#_P( _\!%2Z[-/#\2/"<<=U<)#<1W@FA65A&^V-
M2I*YP2,GF@#9?6)[:SO;N]TR>""UG92=ZN7A _UP"GI_L_>P#QT!U(Y$FB26
M)U>-U#*RG(8'H0:Y'P))-/'XFAN;B>Y2'7+F&/SY#(5C"IA<GL,]*B^%<\TO
MPRTPRN?W7G0QNW/[M)75/P"J/RH [6BO+=,OKZWD;2M=2_@U1]+N#!>V]Z\E
MMJ. K&52#E)!@'&!@,>V!4NGZE>26?POG?4+II;V,+<YN&_?C[*S'>,X8[@#
MD]Z /3:QM!\0)KD^K0BTEMFTZ\-HXE926(16W#:2,?,.]<MX=D/B;0+;7KC6
MKNSU"#4Y/M CF.U=LS(+8QYVX*[1C&22#U-<]JL$L6B_$;5;>^O;:ZL-3:>W
M-O<-&JNL,)R0I ?/3#9&.PYH ]CHKF/'&M7.C> KW5+9S',B1YD49,2NZJS@
M>JAB?PK-\0;_  QI>KZ[H^IW,[_V0\D%E),T\;,G/G@L2> PSC@\4 =S17GE
MX\^F3>#+_2[Z[N%U2X2UNT>X>07$<D+.9<$D!EV[LKCKCIQ7/Q/>P>#X=;_M
M?4WO;7Q$;>,O>2%3$;SRRC+G# J<?-D^A H ]CHK@-2OKCPQXZNDDGNKBVUR
MSQI\4MP[(EVAP8E!.%#AU/&,;339([B?Q2WA%]0EV6VDQ2PM-=2K).S,ZR2[
ME8%B-J=3QGB@#T&BO+DTV_N?$N@:)J'B74+M9-)NTNKBTN'A$SQR(H; /##/
M)'4@YX)%6+B\O=%\1QKJRWL^ESZC%'9ZM:W;,(CE4$$\>>A8$%N02V3S0!WU
MG=7-Q<7D<]C);)#+LAD9U83KM!W  Y R2,'TJW7E%_KVHZ+I7C:6*]N2(=:@
MMEFDE+FUAD6$.5SG  =L>A.:V]4CN=)\;Z7I]A=7AL-5L+O[5$UR[^4T04K*
MK$DJ27VD@\Y'>@#O**\CT*6]@T?X=:R=4U&:[U"=;:Z\ZZ=TEC:&1L%"=N05
M!SC/J378>,=3GM=3\-:<))(+34M0\BYFC8H<"-F5 PY&Y@!QS@$=Z .LHKR7
MQ9<ZEI"^-M,L[^]6R@TB/4+>1;A]]K*Q=2BOG=M;9NVYP.<5Z)H>DIIMO)(+
MR]N7NMLLAN9VDVMM .T'[H/7 X],4 :U%>.W-M?3>#_&&L)X@U>*]T;4[QK)
MA>/M01$$(5SAP0-N&S[=\S>*]6OGT+Q'JEI>7?VZQ@M7?$[0QV$NU&,:*#^\
M8[LMD 8;&3C% 'KE%<)XAU!O"7C"SUZZNKM]%OH'M9XC,[1P7 &^-E3.!O"L
MG ZX]:IW=C?6NO\ @JRN-2U&-[UKMKZ-+V0AF,+/M!)Z*25!'( &,'F@#T>B
MO';V*Z@\&^-YX]7U82:%J$PTYOMTF8@J1R $YS(,L1A]W'XUNS27_BO7/$6D
M+J7V*XLXH!;%)I(VB#Q!_. 1@&^<D<Y^Z!W.0#T6HIKF&!X4ED5&F?RXP3]Y
ML$X'O@$_A7GT-M<:GX[L].O-:O;BVF\.+-,;6Y>&.>3S57S%"G*9Z_*1^6<X
M.F"36+/X;SZC=74\YOKRW:8W#J[*B3J"2"/FPHRW4T >R5C0>($G\6W?A\VD
ML<EO:)=><S+M=69E& "3U4]<5F^.]6FTRPTB&*9X(M1U6WLI[A&VM'$Y)8AO
MX2=NW/;=GK7)Z[-+X5\6>++_ $H2R3P^&HYXEED:78PEE&1N)X&-V.G7UH ]
M7HKSZ]EN-(O/!U_I-Y=W2ZE,MM=127#2K<QM"S^9AB0&7;G(QP<=.*J>&SJ/
MB'1_#_B9->2VF-RK7@\R1Q+N;:]N8RVU>2 .., ]S0!Z917G/A[4+VT\3:=I
M^NQW8NKGSFL]1@NFEM-17:7Y7/R.%Y QC .#BM+Q:L\GC3PC;1WU[;P74MS'
M.EO.T8D40,PR >N>_4=B#@T =I39)$AB>61U2- 69F.  .I->31:Q?:7:SZ2
M+V[-F?%ZZ7Y\D[/)%;LBOL\PG<,L=N<Y ;KG%+XW2XLI?%>BQS7,NE2^&Y-0
M\N2=V\B=6*C:2<A6 SMSC*GCK0!ZO%*DT*2QMN1U#*?4'I3ZS= @CMM!L8XV
MD*^0A_>2LYR5!ZL2?PK2H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "L.Z\&^';S75UNXTBVDU%2I\\@Y)7[I(Z,1@8)!Q@
M>E;E8X\6>'VOTL5UBR:Z>?[.L2S L9<9V<=\$?G0!--H&F7%OJ$$UMYD6HG-
MVC.Q$O '//H ,#L .E4[_P %^'=3M;*VO=+BFCL1BVW,VZ(?W0V<X]LXXJY!
MK^DW.H+80W\+W3JS)&&_U@7[Q4]&QWQG%,F\3:+;72V\VI0)(TP@7+<-*3CR
MP>A?/\.<^U $.K>$/#^N6MI;:CI5O-#9X%NH!3RAC&%*X(' X'' IVI>$] U
M?2[?3+[2K>6SML>1$%V^5C@;2N"OX5*WB31DLKJ\?4K=;:TD,5S(6P(7&"5?
M^Z>1U]:B?4K<>)C"==ME6.Q:633B$W*-R_OBV<J #C!XYS0 ESX2T&[TRTTZ
M73(?LMFP>V5,H86]592"#ZD'GO5C2] TK17N'TZQBMWN7WS,HY=L8R2:@L_%
MOA[4)3'::S93,L#7)V3 XB4X+Y] >]6K#6M.U.>:"SNXY9H,&6+D.@/0E3S@
M]CT- %>Z\+Z)>W=Y=SZ?$T][$(;F0$@RH!C!P?3CZ<=*<GAO28Y]/F6U/F:<
MA2T8RN?)4C!"\]",#Z #I5N]U&TTY(VNYUC\UMD:\EI&P3A5'+' )P.P-5#X
MFT-;.TNVU:S6WNY/*MW,H D?.-H]2#P1V[T 06/@WP[IFLRZO9:1;07\I+-*
M@/WCU('0$\Y( )R:MZKH6F:XMN-2LX[C[/)YL);(*-C&01@]/SJO'XM\/RV%
MU?IJ]HUI:OLN)A(-L1[;CVSG@]#5TZK8@V8-R@-YQ;?]->,\?AS]* .6\1>#
M+8:0;;1-"TZ:">]6YO[.1O*^T 9/RN =K!MI[#@CC-9L?@FY32M1.DZ1;Z3+
M<VCVQL[B^DGCG#%<[QRJX4, 0"<MSP,'O-2U2PT>T-WJ-Y#:VX(7S)G"C)Z
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M+>_MWLMT.H/YEVAE<B9O5N>>@_(4:]XHT_P]/IT%XY$E_<""( ' X)+$XX
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MQ12M"[PN&"N.JY]>1^=7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1NR-RX)(P<^QR=%L=3UC3/'.D6J6RP7VLWENUR\AS$'55<[-O) .1R,GKCN
M=:?$YO+NYM=$M%U"2VMX[B8M-Y2XD!9%4X.6*C.#@ $9/-9L7Q"@OFT'^S-+
MN;M=9CF:$ETCV/$/G1@3P0>#VX.,]*=8^&+_ ,-^)+R_T5+>YLKZU@AE@N)C
M&T<D*;$8$*V5*X!'7(SSTJGIO@B_T>_\*M;/:RP:5]KDNW>1D:22XY8HNTC
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ML"^A3K)<,)WQ(%C=/E^3K\^><=* .MUG6HM'6T0H9;F]N%MK:$'&]R">3V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,,??:!FKU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG]T8 '.!DXR<#)X%)J_AB#6-:TO59;Z\AGTQW>W6$Q[,LNULAD).1QUK<HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJWC*?7-7N)-,TBY1(PT*GRT,8<D^6FX]>OH*ZGP[;16NDCR-*72XY':5;4*
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M>6PSDCY>&&?:H]!TZ>T#>&]7\(SWMS#>/)!J+HKVLB&0NLK,6X8 _=QG(]^
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M6+=;DP:QIL!$D?[P;?,B0'_6+M8J1C*D'!KMO#)U0^&=._MI(TU+R5\]8P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L'QCH5QXE\-SZ3;W$=NTSQ,99$+@!)%?H".NW'7O6]10!R'B7PC
M=>*(+JSOI+)[:8H]O*8SYUBX"[FC;N21D=,9YR.*W/$&B6_B+P[?:-=,ZPW<
M)B9U^\OHP]P<&M.B@#BH/"WB*;5/#M[J>L6$K:,91F.T<&X5X]F6R^ V.>.
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MI)NP%))Y()&3CGFNSHH XR/PIKNFZYJ,FC:Y!;Z3J<YN;B":V+RPR-]\PMN
M&[&?F! /8U#<>"=4@?Q';:5J=M'INNK(\L5S"SO#,Z;&9&##(;@\]/>NYHH
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M+;3SVS".4+][#$8/('UQ0!N:;\0['4_&FJ:#!!=;+"- THM)6W2'<2,!>%
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MFNKJQ6%TF:,MD,@(R3CC(Z;O8T >^Z7J]CK-O)-83^:L4K0RJ5*M'(IPRLI
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M8?V \'GBTD*^8=S!<XZX(X]>.M<?;>&O$EO\(_#+QZ1J)N]%UDWEQ8")TF9
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MKZ1:WRQO'YT:N5>-D() )^\ 2.>O>KU9/AB=I_#6G%K:XMV2WC0QW$1C<$*
M<J>1SD<^GI@UK4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !117+S>*;Z:.\NM)T<ZA:6=[]CE"3;9I&5@LC(NW!"DGJ1G:
MW3C(!U%%<?K/CA[%M2.GZ>+X:;((IHA(PEE;:K,(P$() 8=2,G(XZTC^+]6N
M/$-QI.F: EPT5M;W8>:[\G,<K$'(*$AAM/'L>1T(!V--=TCC:21E5%!+,QP
M!W)KAM!\3Z_/IVMW=QID=Y+!J\EE#%;3-\NV18^<IPBC+%N3U.!4Y\8)?Z/X
MKCETZUO#H\9$T4=P'ANHVBWD!BOIE2"#R* .R1UD171@R,,JRG((]13JXN'Q
M7=13>'=+TW0X,:GIAN;=?M/EQP[%0[" APHW@9 /3I6SX6U]_$6D/=36HM;F
M&YFM;B$2;U62-RC8; R.,]!UH VMPSC(S2UY]J%G;GXX:9*+6%Y?[$GD!*@$
MN)5 .<=>2,^]/M?B#J$VFZ=JDVA1Q:?<ZD=.F;[9NDC<S&(,J[,,N0,Y(//
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M(-G9(Z[,!#@9.[Y<C\,^S\9:_:^'/$VM76F6MXNF:C/&8HKME*QQ$*VW,9R
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M%Y%)+7"1=DV_*2!R:Z'_ (32:W@T/4+[35ATO6)8XH95GW20M*,Q>8NT !N
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M/(]Q3MP)QD9KC/A.,?#/21Y8CP9_D'\/[^3BJ?AFRM8_B]XUD2VB5TAL"K!
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M &QR <@'ZUYV? _B$Q01'4M.=K;6QJ:W$D3F6<;F($ASU4-M '8 9&*]%HH
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M)D7]TS=1@C8<\@\]:@L/$&I7UAK5MIQU"V\006L1_LK4V4,C[B&>.0C:P?.
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M+QRABX=7ZA@3U_#I3W\%:-)HNH:6R3^5J4AEO95F99;ACUW,,'!Z8&!CC&*
M.?\ "FEVUUX_UCQF[1PG4T6UT^'(#R0H%W2D=?F* C_9 SUK*\-_\G'>,?\
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M:;K!ADCN],B\FS\J0JD28(VA1QC!(J7PUX4TOPG:W%KI*2QPW$QGD624OER
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MVZUGA^ZL!7H#T^8?-N.#Q7>WG@S2+^Z>6Y6=XI+B.ZDMC,?):2,*$.SMC:O
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MDB4=E&T$LQY]  .>HK#MO'WF>#X]4GTXPZF]]_98L3)D&[\SR]H?'W<Y.<=
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MHNBWUW':+Y<[&Y@,AVHTBE0O)QD DC/4UVU<!=>-/"6LZQ!Y^O:>;;3[C=#
MLRM)<7 RJD*.2JDG:/XFP1P 6[&VUK3;S5;S2[>\BDOK,*;B!3\T889&1]*
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MG3CX'^'5Q=RVYAM=5:">68C;$-DX",3T_AX/M0![1)>6L4L44ES"DDO^K1G
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M":8WP\LT/V;RXO%VV/! V*;PYVGL-OIVK3UB-M/U;X@VGAJ.."X.C6LD<%F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[#[?+))$\RP)LW!0BD%B6R.HP!FLR]^*VH6&F^&[C5=..C+J#S17EQ=6DCI
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M\"7]A<^&YI=>64:'%);QHEDJ"2)E5<'YCAOE&6[^@/-;/A3P]+X8TMM.-_\
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M8<(H"@J22Q/<8"GKFN*\5^(]0UGX<>((G$%I?:;?)8WJJK,LG[V/#(<C"LK
MX.>X]Z[75?#DEUXCLO$&GWBVFHVT+VSF2+S(YH6.=C ,IX8 @@]?6LW4O IO
MO#.I:5'J*PW&IW8O+NZ-ONW.&5@%7<, !%49)X'<\T =/9V8@9[B9+8WTP G
MGAA\OS N=N<DG@'N3U/K6)-K5S%\0AI!L[=X3I,EVDJY,S%9$79GH <_RKHH
MA((U$K*TF/F95V@_09./SK"NO#EQ<>+QKR:@L8&GO8B$0$D!F#;M^[J"H[4
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M<$[P%..@[$]*CLO SP:-9Z#<ZF+G1+*X2:&%H,2E4??'&[[L%0P'102 !ZY
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M=0@BUA].>S6ZM;#&22&$CIN;S&!48'U'.> #K:*S]#&HKHEF-6D$E^(QYSA
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M:3971MKF_ABE#(C!FX1G^X&/12W8'&>U/N];TVQG\FYNXXY 5!!SA2QPH)Z
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M-MP>,C@^M%MH6G6>J76I00%+RZQY\OFN?-P,+N!.#@$X].U5GU=KKQ0=$M&
M-K MS>2XR5#$B.,>[;6)/8#W!$%OX@TVS35KV]\2V4]G#=>6#E$6U.U?W18'
MYFSD^O..U #]+\%^'-%OI[S3-)@M;B<,&>+(QNZ[1G"9_P!G%:&E:/8:):&U
MTZ#R("Q?RP[$!B<DC).,DD_6F6.O:3J=[<V=CJ-O<7-MCSHXY 2F>,_3((JW
M=7=O90&:YF2*,$#<QZD\ #U)/ '>@"J^AZ9)K(U=[*(Z@(O*\\CG9SQZ'J?S
M-0V'AK1]+ECDL[(1>46:%-[%(2WWO+0G:F<G[H'4T^+Q#I$VGO?QZC;FVCD\
MEWW?=DR!L(ZALD#;UY'%2VVLZ;=V<]W#>PF"W9EG=FV^2R\L'SC:0.<'% ":
MEHNGZN]L]] 96M91- ?,9?+<=&&".1SS[U5UOPGH/B22WEU?38;J6WSY4C$J
MR@]1D$''MTK.\2>)XU\(Z_>:'J$(O]-M'G(9-S(0A9<H<<''!(P?>K^A^)--
MU0164>I6\^I);)+/"CC<,@9.![G!QT/% &/JGAN6[\<Z'=1:>ZZ7864UOO@F
M$1C9RFW;M8,  I!QZ]ZWKGPUH]WHQTB>PC>Q+;_+R0=^[=OW YW;N=V<YYS6
MA<W4%E;M<7,R0PIC<[M@#)P/UXJE'X@TB6SN+M=0@$%L_ESLS;3$W'RL#R#R
M, \G(]: *1\%>'"ETG]E0XNXUBN"&;,J+T#'.2/7U[YJUJ'AO1]6T=-)U"Q2
MYLH]NR.5F8J1T(;.X$>N<U+!KFF7%M<W$=[%Y=JVVX+':83C.'!Y4X(//K2Q
M:WILT-Q,MY&J6Q G+_(8B1D!@<$$Y'!]10!5/A/0SIEOIHT]%L[>4311*[*!
M(#D.2#DMGG)R<TMQX6T6[EO9;FQ69[Z(0W/F.S>:@Z @GMV].U6]/U:PU43?
M8;J.9H'V2H.&C;&<,IY!QZU=H Y]?!'AI6+?V1 7-O\ 9F<Y+-'GH23D]3SU
M[9J_%H6FQ1W*?9A*+F,13FX=IC(@SA"7))7EN.G)]:2#Q!I-U?)9P7\+SR%Q
M&H;_ %A3[X4]&*]\9QWIZ:WILE\MDEW&;AW:-%Y^=E!+*#T)&#D#ICF@"MH7
MA70_#*RC1].BM/-QO*DDD#H,DD@<GCI5E=%T]=:;6! ?[0:+R3-YC9*9SMQG
M&,\XQUYJW//%;023SRI%#&I9Y'8*J@=22>@KDK/Q-+??$S^R;:^273O[):Y,
M/E;6602HH))YP5)QT'/>@"?7O"J'P_JEMHMC;//J$JR7<-U*^RY&X;P2<[69
M00&QQQZ#&9H/@R&'4(KJ/07T-4#"58]4DE,ZE2NS:#M"Y(;/7*C [CJ$\2Z+
M).\*:E TB1&;:&Y9!U9?[P'JN:K:)XNTK6] CUF*=8[:0X&\X/+$*,>IXX'/
M.* )$\):'':V-JEEM@L)/-M(Q*^(6]5^;CJ?S/K2R^%-#FFO9GTZ+S+YE>X9
M25+LI4@\'@Y53D8^Z/2G?\)3H/V-+LZM:+ \WV<,TH7][G&S!YW9/3K4,7C3
MPS.%,6O:>^[?@+.I)V?>./04 1:QX.TO5=$O-,:U1UNV5I9)Y'=]R_=8L3N8
MK@8!.*V+O3K6_P!-DTZ[0S6LD?E2(SD;UQ@@D')R.OK68OC/PTT-K,-<L?+N
MGV0MYH^9L[<>W/'/>I!J5NOB*]1]>M3%;VJM+8$(#;G<<R,^<@$8&#Z9H >G
MAK28[FRN4MF$UE$8;9_.?,2'JHYZ<#\AZ58TS1[#1HYH["#R4FE::0;V;<[<
MLW)/)/7UJI:^+/#]]>6UI:ZQ9S7%TI>"-)03( ,\>O'/TYJQ/K^DVM\EG/?P
M1SO((E5FP/,(R$ST#$=%ZF@"FW@WPZ^O_P!NMI-O_:6X.9\'EAT8C."P]2,T
MRX\$>&KJ6ZEGT>W=[J43S$Y^:0$'>!G@Y R1C/?-5_&WB6+1/#6KR6NHPP:E
M:VCS1ADW[6VDH&'0;B,#/7MFMO2YY;K1+*>1P9I;9'9B/XBH).![T 9]YX,\
M.7^JQ:G=:1;27D2JBR;2,A?NA@.& XQD'&*L-X<TI[F_N3;-YVH(([IQ,X,J
MC@ \] "0/0$CO7-^$_'%I+:BTU[6[-=4DU"YMX8V*QLZI,R)A??;@>I]:ZNW
MUG3KN^N[*WO(I;JTQ]HA0Y:+/3<.V>WK0!+86%MIEC#96<?E6T"A(H]Q(11T
M SV'I5FH+.]MM1M4NK.9)H'^Y(AR&^E3T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7F>F7D-I<Z_X9U_1;J\NKK59;JU0
MVC217D;N'C._!5=N%!W$;=H]*],HH \?\:3S7EEXPLTTZ\MIUNK=UAMK)V%V
MBF(^>\FT@\*0 I&-G.2:TO$+W<.M:AJOA^>X^V2/;BXT:]MF,6HKM3:T>0"C
MA3@D=-GS 5Z=10!Y7/\ 88M:\2:#XGTO5[D:E>&>T%L)VAO(F5 J90[0R[<'
M=@  <XKO+'6[(ZT_AY4GCO;:V64JR,4*< [9",/C<N?K]:V*@%I$+QKL@M,4
MV!F.=J\$@#MD@$^N!Z# !R_BV]^R>(?#P:TE6-VG!U&&U:=[8[  B@!L%\D9
M(/"D8YR.0T:T63P?86EQ<ZKHU_:ZO>/;WWV<_N)#)*09 PVLC*Q![9(&:]>H
MH Y_P7<:E<^'$?58(8[I9YE+PQE$G D;$H4\C?\ >_'/>O/_ !A<37=CXKM$
MTZ\MIX]0MY!;VUD["Z16A/GO)M.>%( 4C&WD$U[!10!PVF^3=?%;5;A[9_+E
MTFV2-Y8& +!W9ER1U&4)'7\JP- 2QF@B\->(-)U>;6[._:5$)N!!(WFLZW"N
M#L"\Y.><Y&"3@^L44 8GC&WFO/!&O6UO&TL\NG7"1QH,EF,;  #U)KE]5C>\
M^'>DZ_IT4J:CH,4=Y")HVB+A$ FC(8 X9-Z_4"O0ZQM5T ZMJ-O-+J=['9QK
MB6QC*B*XY!&_C/;D C(XZ9R <7XM@\CPCHUWJ,!\Z\U^SN[N(IO(W2CY"!][
M:@5/?;5JZM([GQAK^O62$V!T'[)+*B';<3EF(VX^^57 R,_> [$#JO$>@#Q#
M!91-=O;BTO(KQ2B!BSQMN4'/;/6M@9P,G)[F@#R>QNKG0=-^'VL7=G=R:99Z
M6UG>B.!W>TE:.,!V0#=U1E)QQGWK5OKVSM]1T*>QT.:PLKNYNI1J$=@S2QLR
MCD1[24:4DC+*>%Z<\>B44 >-1+,GPN6R:TOEN(?$(9HY+=]^T7OF$].0%Y)'
M%>O7,A%C++'%YY$998P?]9QP/QJ>B@#R'1;LR:UX%O?LE]##!#=136ZV$D<-
MBS1J!$,KG ((+$D<9R.E0V<1B^''A^+[+,EQ%XD6XDC\A@ZJ+MFWD8R!L(.?
M3%>R44 >2W=W+8Z/\1-&U*UNVO[][NYLV6V>1;F%X0L>UE!'RA0I';%>C^'&
M+>&=+S'+&PM(E*2QLC*0H!!5@"*TZ* /,_"MY#%8+X5US1;JXUFTU&291):.
MT4I,S2+<"7&T ;LY)SD$ $X%96O/+;>'_B/HS6=X]_>W;W-O'';.PDC>*(!@
MP&WJK#KG(QUXKV&B@#S#Q(;E+R]U30KFXBU$VL23:5>6K-#J:;>$4$!ED^9E
M..1QD '-/U"UU*XU[QY86T%Q#?:KID LG$;;&80R*P\S&T88@=>I%>F44 >;
M,#XBLO \6GV\UO?Z;>0RW2/$R-:1QQ,LJ-D<9.% _BSD9 S6-J,!E^'WQ$A2
MUF:>ZU6=X$$#;I@?+VLHQEAD-@CT->Q44 >;^(Y0GC&*ZM-->_A7PW=Q"!(F
MV3,2C+"2!@%@IP.M5- O,^-M!U!DOC;-H4L!<V#Q0PN'B;RU&WY54 \L3TQD
MFO4Z* .!^'VC6E_\*K72K^R*"6":WN(I(BC@,[9!!&1P0?R-3^ X=5G#-K0W
M3:.KZ5#+G/G[6^:;_@2K$/4%6]:ZC6-/GU/37M;?4KG3I692+BVV[UP0<?,"
M.>G2I=.L(=,L8[2$NR)DEY#EG8DEF8]R223[F@#F/BD'D^'FIPQ12RS2^6$C
MB0NS$2*3@ 9/ )J&_N7L/B78:U<;VT6YTE[2.X52R03>:'.[^Z&4 9/=0*[>
MB@#Q^[TN:UTQ9)+:8V=YXRCOX(#"Q*6^\;G*XRJDAFY X8>M>O1JBIB-553E
MOE&!SSFG44 >.:E"9/ /Q"CCM9FN+K6)'@18&WS+F+:RC&6&58@CT-=197?]
ME>/O$-QJJR?8-5M[:2QN/*9T940J\7 /S;B6"]3N.*[NB@#R32-,O_#EO\/6
MO[6[\NUFO0ZI"TC0+*CF)&"@D<$+['BGVZ6+RZQX7\2:3J]S>S:E-<6\<9G\
MB[1Y3)&X=#L3;P"3C&VO6** /-+E;RQ\4/<:)<RS1W.JHM]HEY 6!.]0;B%\
M94  /GE>#WXKI/B'I^H:KX!UBRTM2]Y)"-D8/,@# LG_  )0R_C73T4 <)<2
M)XE\6^$]4TM)46Q%Q+=L\3(88WCV^4^0,,6Q\O4;2:L> '_>^)U9)$,FN7$T
M8DC9=\9" ,N1RIP>179T4 <7XSMO-U;3I[35KC1]4@@F-O>>5YENRDINBE!&
M/FPI'(/RG'2L:"^N[77O!FLZQIDMDKZ3/:RQV]O(ZPRDQ%4VJ"5R%. ?IU%>
MFT4 >-6$M_INFZ7K$FF7[V>G>(KZ:]MQ;.76.4RJLH7'SA=^?ESUK9\62:?J
M?A5[K3-)E2&\U>SF=C:.CW6V5"\A0KNVA5ZD<X/;!/IE% '&:80?BQK,J(XA
METNU59-A".ZO(2 V,$@,OYT[QQOAU;PG?&">2WM=4+3-#"TI0-#(H)"@G&2!
MT[UV-% ' >(]/U"R\70SZ4C+#XDA&GWN#@PNH++-]1$)1]0M)<2Z=IGQ@A%P
ML<,*>'1'$Q3Y4Q.1C/;CCWZ5T]AH!M=9N=2N-3O;UY&?R(K@KLM58@E4  ]
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M1E ">['<Q..!D#G&:YV/X=ZD=*T3S]11]5LY3!<7(_Y:613RFC'N4"M_OY-
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MC"KC*L=JALGCG!-5[WPEKESX<\:Z<L-J)=<NWFMF,YPJLB)\_P O!^3/&>M
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M*7$8;!R>ASS5Z?P=IOF:5-8-+IL^E1F&UDMMO$1 !C8,"&4X'7G(R#FNAHH
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MO+=7\HEN)G"@N0H4<*    .U6K2_M;]KD6TJR_9YC!*5Y < $C\,@'WR*LT
M8NH^&X+W6[;6H+FXLM2@B:#SX-I\R(G.QPP((SR.X-5+CP3836EA EW>0?8[
M_P#M'S(V3=-<$DEW+(<Y+-P,#GT QT;E@C% &?'R@G )]SVK&\(Z])XF\-P:
MK+;+;/++-&85DWA?+E>/[V!G[N>G>@#:)VJ2<G ]*\Z\*>'FU6P\0VNI-J4%
ME=:U<S/9S0>4L\32;EP60-M8 9 /Y9.?1J* ,>U\.P6GB:\UU+NZ,]W"D$D+
M;/*"IG;@!<\;CW[U07P-IZ17MFES=+I5[.;B?3@4\HL2&8 [=P5B,E0<=>@)
M%.B\1:AJ%_,NDZ;%=6=IJ/V"Z9Y]DBX"[Y%!&"%+8QG)P<=LN\1>);K1-7T;
M3X-.BN3JDS01N]R8PC!2W(V-Q@'I0!BV6GW=S\2_$\J3:G8036MI%'-';8CE
M*B3=M9T(RN1@@]SU[:-]\/\ 2YTTLZ?<WVD7&F1&"WN+&4*_E'JC;@0P)YY'
M7FK=IXG)\4?\([J5B;2_>W-S T<OFQ3(#AL-@$,#U! _&NAH YYO"%JU]HUX
MM_?K+I32/$=Z-YK2 AVD+*2203T(Z\8IU[HUO8:U=^*8WU!YQ:".:SM<,+@1
M[F4!<9+?,0 & .>:WZ* .7\-:?#<:QJ?B@Z9/83ZDL4:QW*;)=B+C<ZY.UB>
M,>B+FNCN83<VLL EDA,BE?,CQN7/<9!'YBI:* .73P)IJ>&+#0OM5ZT>G2)+
M97)9!-;NA^5E(4 XR1R#D'FKA\,6\D6I&>\N9;O4+<6TUV=@D$0!PJ@+M ^9
MCTZD^V-RB@#FH_!=I$/#P74;_&@KMM,F/YAL\OY_DY^7CC'YTC>"+#&I6\=U
M=Q:;J4IFN[!&7RG9OOX)7<H;'S $=\8R:U=4U5-(,$UR@%E)(L4DX/\ JF8A
M5+#^Z20,]B1VR1HT 96K^'M/UHZ<;R+/]GW*W, 7C#*" #_LX/([TMAH%AIF
MK:KJ5JA2YU-T>X/;*KM&!V]?J:U** .3D\ 6,N@WVCMJ6I?9[V^-]*VZ+?YA
MD$AP?+P!N .,5)K&@R6UUJ/B*SDOKW5/[,:SCM1)&BR 98 $*"&W$G.:ZBL+
M7]?FT74=$MTM$FBU*]%HTAE*F(E&;(7'/"GN* .1\-V-[!+81:3JWBK$+1+-
M;:K8+%"(@0'!9HU).W(&UF.<=LFNV\0Z!;>(]+%C<S3P;9HYXIK=@KQ2(P96
M&01P1W!K5HH PM)\+P:1K5]JR7]]<7-\D:W'GR*59D& V HP<=AQZ 5-JWA^
M'5]3TN_EN[J&3396FA6$IM+%2IW;E)/!(X(ZUKT4 <S+X)M)H/$$+ZCJ&S7<
M_:^8N,H$.SY./E '.?SJ"[\ VD]Y97MKJ^JV%];6RVCW-K*BM<1+T60;2IQV
M( -=;10!@IX4M(M=L-6BN[Q)+*V:VCBW*R,C$%MQ*EB25!)W9S]37'W=O=2^
M*=6FEN?%VE7,MSB%+&U$]O*BJ%5PYC=5R!D@E<9Y'4GTZB@#C7\%2:G)I^K7
M6K:CI^NQVP@N+FQD2,SIG.V1=I4D9Z@=<XXQ6I_PBEHNM:9JD=W>))IT+P11
M!E965\;RY92S$E02=V<_4UO5A^+]=F\,^%;_ %F"T2Z:T3>8GE,8(SCK@^O3
M]: -J6-)HGBE0/&ZE65AD$'J#7,:!X&M/#LR"WU35)[* DVMC<3AX;?.?NC
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MBQ ZGJ:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\N3YZ_ZZ"=)3Y4:GJ!MV*%Z$-WS6L-'MM9^(VHVNL0F59=!MI)[<RL4\PR2
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M=CDLQC7))]:WJAM;2VL;=+>TMXK>!.%CB0(J_0#@5-0 4444 %%%% !1110
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M72KJ.[9H-6<1V4GD2;96() SM^4X!^]CI6C?7]KIMHUU=RB*)2%R022Q(
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MN6TII6O988V=8MT+J!D#D!F X[#- '<62CP_H3-J>K2W,4.YS=70 <(3E5;
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M(=(OKF>.9(TXEVPR$ KMW[@RXV^O&,UBZ-#KGAE?">KRZ%J%S;Q:(-+O+:!
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MUQ/8022R-U=B@))_&MVN?\#07-IX$T.TO+66VN;>RBADBE #!E4 ]"?2N@H
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M^4))(]5LBG3.?/3@$],]*67Q?JMG)XEMKW3[-;O2+%=0B$4[,DL1#G:25!#
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M.@7B3V\1TRY-S(A5CYA*,F >PPQ.>:NW6OVMGXBT_1)(I_M-_'+)"X3]WB,
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M+Q+5K*XAG!V3PEMPY'*LK<YP<Y(K,N/ T[6EL(+R 77]MKK-W(\9VR2 YV*
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MCV>1<J,&(IDD*I]3DCG/-=!8V.O'5K2X.K1G2;NV9)E-X97DD*[DDA_=J%.
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M^S_9MWFMM\K.[;MZ=><XS4L.D6,&LW6K16ZK>W44<4THZLJ9V_\ H1_(>@H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXHI\1+!PT*[0=LG)^;.3VX(KSVRO+2WU3X:74TJ"!M'F@$G4&0QP83C^([2
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M':KFW=53/KG@#UXZUW/Q(EN(/"B744,L]K;WMM/?0QJ2SVRR*T@QW&!R/3-
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M.F*MR2)#$TDKJD: LS,<!0.I)KQ"R_LFW^'.@W,?V..X3Q.C>8NT,JB\;OU
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M;I 95\P\9^[G/2H]&T_^R])M[1F#RJ"TT@&/,E8EG?\ %BQ_&O*-[7GPFO\
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MP*6WDY^[P #W)%>;>&=8TV/3_!5K(\=M</H31I>RAF!YC#01I]UI"0#R"<#
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MNW*=I'7 YZU6\:7-]X$M+;Q'8:A=S:=#<1QW]C=3-,KQ.P7<C/EE8$CO@^E
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M2WFFP7$UO)!(Z E)-N?K\I(_6K= !1110 4444 %%%% !1110 4444 %%%%
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MJ]N]QIUU%<PI(T1DB.5W*<$9]JN4 >6:MX=\27^C>.(%T8B;6+B&6U5;F,Y
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M#S1;X6CY61&?Y2.6!&?2O4J* .'GTG53XD\)7JZ/'%!9&Z:Y2U>,)!YJ;54
MD%B.Y ]2/2J_B;PWJ&H:[<ZEI-C<V&LQ21+:ZG;W"+%/%A=RSINRP!WC&TG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7'>#[R;6=4\5ZDS 31:G)IL&X;A''"H &,CJ[.QYYS78US&CZ
M7-H.MZY;Q?+;:K<F_MI2NY4F9 )%;\5##IG<1VH S_#_ (EU_4O$-UH%^NGP
MW^FS,UZR1-LDMV \IH@9,Y;)R3D+C!'(S/>WCZ7\5-*MX_\ 4ZS8SK*@Z>9
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MDBR700E6# *1NST;..U>M5Q<G@&27PW?Z,VK?N[S43J#RBV^97,HE*@;L8W
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ML!AL!@.AZ<=*=:^ XK;2/[ ^WM)X?%P)TLVB^=0'\P1>9GF/=VVYQQFM33-
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MW:6]_:2VEW!'/;S(4DBD7<KJ>H(JA#X:T6WFMIH--MXI;6,Q0.B[3&AZA<=
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M^,@D=,;AD]!F@"W=Z!I5]<-<7%C$\K1"%VY&^,$D(P'WEY/RG(Y-:( 4
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MEYH.EZA/%/=6<<DT2&-)3D.$/52PY*GN#P:2^U_2M,E:.\OHH2@4R%LXB#<
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MYL3(H5/+7:NW'/3KG- '!:-87OA&Z\"MJ\-RRV^DW%G,\,#S>5*QC94.P$]
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MN+=)8R2C#(RI!_(\BI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYT^QNV5#;&P+R(LJ.KK(Q8 _>0?*!P">3D8EGT'7_%'AK4-*\3RV%L+FU:W
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M@Y.,Y([#JOA/2?%>D6EGI&IW6FR:=IZB**Y@W^?<1J,(K*1A,#&2"<XQWS0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+*H<;57=%D]03QCGFNFTP^)(_$:BY,LNCRVYW&[\A98YP>-GE=4(SP>01UH
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M@*!D=L8]3DUU!=595+ ,W0$\FL'3O$%Q=>+]<T:X@AAATZ*WDCE60DR"7?\
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MY)P.3Z>YSI:;)?/8!]32VCN0S[A;.60*&.WD@'.W&??-6@ZE-X8%<9W \8H
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M /-=4TO3M4\1?$?[?;17'DZ=;.@E&X1MY$A# = P['J.W6H/M^GW]IHL%[+
M]^WA5)GEU!PT.QPH.Q#C=(67DY&!CKG%>GMI6G.\KM86I>;_ %K&%<OW^;CG
M\:%TO3U:!EL;4&#/DD0K^[SUV\<9]J /)]'CL=:/PM-T8[MI+"XBGW/NW[;=
M?D?U]P?4YZTN(K+P3XBMK>YM[6RLO%1C2V=Q'$\7FQ,8,]$5BQ'.%YYP,UZL
MNDZ:AA*Z?: PC$6(5_=C.?EXXY]*R-?\-/>6,4>CKI]HZW"SRPS6H:&Z !^2
M0+@XR0P/JHX- '#ZC$B6GC3Q+HC6VZ6UA$4%G-')+$J\3/\ NV(4LOH<_)GK
M70>&(/#ESXDAU?0]:AN9)K'RWMK%8TC,8(*M*JCA@3@9P>H['&KH7A@6.HC4
MKFRTBUNEB:(+IEMY8(8J3N8\M]T8& !SU[;MGIUCIXD%E9V]L)&W.(8E3<?4
MX')H Y/Q5'$/B%X&E*J)3<W2;NY'V=^/SKA-3TO38_ WCS4%MXA=6.O2M:S?
MQ6[!H2"A_@/TQGH:]HFL;2YFCFGM8)98_N.\89E^A/2HO[&TORWC_LVSV.=S
M+Y"X8^I&.30!'KL,=SX>U&*2)94>VD^1EW _*<<5Y;90Z7<>#_AE;P"V*27E
MN+E82!N?[(^X/M[] <_C7L*1I%&L<:*B*,*JC  ] *J?V/IFV-?[.M-L9)0>
M0N%).21QQS0!Y/?31^'T\66MFHM=%MM>LC=1P1Y2&!XXS(=@XVEL9'0C(KM?
M"5EHL6N:G>Z+K$=ZMW'&T\5IY?V>-AD*P"<!R.OJ ,]JZ=-.L8FE:.RMT,P(
ME*Q*-X/7=QS^-+9V-II\'D65K!;0Y)\N&,(N?7 H \]\=1SP:CJVJ116.KV,
M%@BZEIEP=DT,0WL)8'Y )!;@CDIP<U!/<:+9>._%>HWL*PDZ)!<IL15N/NS%
MS'WWX'4>G->CSZ987-PMQ/8VTLZXVR21*S#'3!(S4C6EL]P+A[>)IPA02% 6
M"GJ,]<>U 'E?AR;35\<:!%#)IJVMWX?DB-O"X?<-T6Q9&Z2/@M_".IK*T>]T
M_2O ?ADM);6UB=5ECU:18U;8-\XB\X?W=^W[W P*]E@TRPM3$;>QMHO)W>5Y
M<2KLW?>Q@<9[XZTO]GV7D30?8[?RIR6FC\I=LA/4L,<D^] 'EFL?V;H>C7$^
ME:L;O1;S6K0ZJ8"OV:WB8_O I3@!L)O&>C>];>E_V1!\9KM=.:S03Z%$Q6W9
M0'83-V'?;M_#%=S%86<-E]BBM(([3:5\A(P$P>HVXQBFVNF:?8$&SL;:W*IL
M'DQ*F%R3C@=,DG'O0!Q_Q!LK&XUGP<;JVMY7?64B)EC5BR>5*=O/49QQZU4C
ML[-/&_CFW$,2PMI-H6C  7[LW;\J[VYT^RO'1[JTMYV3[K2QABOTR.*8=+T\
MR22&PM2\@VNQA7+#T)QS0!Y3H-A96-E\+=1MH8X[VY AFN!]^5#:N2K-U(!
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M.0 "Q&._O7L444<,2Q1(L<:C"J@P /84U+6WCGDG2")9I0!)(J ,^.F3U.*
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M8*X'L:I^)])NM,U[1M6L=!&L:9:V;V$]C&$,D2$H4>,.0#C9@C/0T :I\?\
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M&21V"HN>V6(Y[#FN/N9[G3_BM:WNK"U5(M NIGEMU(^59(BP(/)QC@YYST%
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M5KT<&BZC<-=36TEMNFA=^9/*?< -QYY!QG@5U=A=I?Z?;7D:LJ7$2RJK=0&
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M6+07^IR0S1[+!G$;(B(0%WG=D*0/3KFNQ@-RUC$9UC6Z,0+@<J'QS^&:GHH
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MP2<<#UK3HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.=ZQD[0<G/ X/(YJQ8Z%IVFZC?:A:Q2)<WS!KEVGD<2$# .&8@8  X'3B@#
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M7O[R[!D:7S;R4.R@G.W.!\H[>E>?Z7JE_P#V]X0DBU*\O+34Y;J.>ZED*I>
M1NZLD.2(U!48(VG';!KTT(HC"<E0,?,<Y'OGK7.6O@#PS9FS,&G,OV*4S6P-
MQ*PA)!!"@MPIR?D^[[4 9GPVM$@@\0.LMPY77+V(>;.[C:LF!]XGGWZFJ=G9
MH/'GCV7S;DE+2V95:X<K\T4N1MSC'H.@[8KLM/T'3=*O;R[LK<Q37DIFG/F,
M59S]Y@I.%)P,X S@9J*X\,:1=:I<:E);.+NXA$$TB3R)O0 @9"L!D!B V,@$
MC- 'GOAAKS2]/^&T\.I7C1ZA +:>V>3]R4^S,ZX3H""HYZGN:T+&YUWQ+IAU
MJSU**RGMM2E$K27LGEI%'*RF%X-NWE .<[LG.>U=;'X/T2*+2XH[:98]*.;)
M?M4N(3C''S<\$CG/'%1?\(/X=&OOK:Z<%OI)!+(5E<1O(.CM&#L+#KDC.>>M
M $'CC6+C2;'2H[>1H1J&J6]C+.O6*-V.X@]B0-H/;=FL'6[O4]%\0:OI5E?W
MGV*;0)K^-GE,LEK-&=N5=\G:P(X.>1QBN[U/2[+6=/EL-1MTN+64 /&WL<@@
MCD$$ @CD&LC5- BM_#VKIIUM/=7]U9/;JTLYDD?Y6"KOD;@ L3C..2>IH X^
M!]9TZ+P+K2ZYJ%X=7:WM+VUGDW1NLD);>JX^5EVYSU/<]:SE%QI7PJ\9W^GZ
MA?6]U;ZE?".47+,P"SD#[Q/..IZGUKN_"7AN'3M"T1KRTGCU"RM$BV3W!E$+
M[ K[!N91G!&1V..!Q5B;P3X?GMM2MI+%C!J4AENHQ<2A9&)RQ #?+D\D# ..
M<T 9WVV76O'VHZ#<7%S;VMEIT,T203-$TKR,P9]RD$A=H &<9)SGC'+VVLZ]
M?6OAN&?5KN.4:_<:7-/%M7[5'&)0'(QC/R#VR"<5Z'=>&],N[FVNI(YENK:,
MPQW$5Q(DOEGJI=6!8=\$GGGK39?"VC3)IR-:,JZ=)YEJL<TB"-^?F^5AD\GD
MYSD^M &1X,FNH]8\4:3->W-W!I]\BV[W,ADD57A1RI8\D L<9JO;3W'B?Q!X
MKL)+Z[LCICQ6]J+>9HS'NB#^:0#\V6/1LC"].3GIK#0]/TR_O;VTBD2XOG#W
M#M,[^8P& <,2!P ..PJ&\\-:7?:C)?R0RI=2Q>3+)!/)$94'17V$;L9.,],T
M >=O>7'BC1/AQJVI-/'=W6H!9?)F>,-B*;YP%( )QG([''2N^\67 L/"MTRZ
ME)IYPD:7*H97!+*H51G)9L[0<]3GM4]YX:TF_.GF:U8#3F#6BQ3/$L) P"%1
M@.!Q].*L:MH]AKNERZ;J5N)[24#>A8@\$$$$$$$$ Y!S0!Y]/J.K6Z_$"U2Z
MO;1;'2XKRS1[GSI(',4I/SMNZE%) ) YP:LZ?)?VOB/P@KZM?W,>LZ;-]KCF
MF)4LD<;*R 8VGYB,CD]R3S72?\(-X>+7;&RD9[RW%K<N;J4M-&,C#'=DG#$;
MNN"1G%6#X8TJ*;3KJ.VF:XTN)H[+-U+\BD8*\M@Y  YST% '(Z9?7\<U[X+N
M]0O)-6345:.Z:9O,>R8^8),YXPJM&<<;L>M:WQ4&/AGJX!_AB )Y_P"6J5?T
M&TO[[5)/$&LZ3%IM\ULMI%;B99G2,,68EU&#DD<=MON16IK&C6&OZ;)IVI0M
M-:2$%XUE=-V#D9*D'J : .)U+5-0\+>*=;6&]O+^)/#TFIB"YDWCSXW(^4?P
M@CJ!@<43WU_INF^#-;M-1NKN34[JUM[V.24O'.DZ9+A3PA4_,-H QD'BNQ'A
M[3!K U8PRM>BW^R^8]Q(P,6<[2I;!&>>1UJ+3_"NCZ6\!M+9U2V9FMXGF=XX
M"V03&C$JO!(X' ) P#0!P-SK=QH%MXZN[9_*EDUZ"W$Y (A$D<"%^>. 21GC
M.*O:I&?#_P 1Q>VTES<M#X:O)EBN)WERR21G@L21G X'%==_PB6AF'5(7LO-
MBU1MUZDLSR+*V ,X9B < <C&,#TJ.P\&:)IU];WL,%P]S;0F"*6>[EE*QG'R
M_.Q^7@<=!0!@:'%K6H#0-<BUA([2Z@_TL&]>871=,@HC(%C96YPO'4$<4_X;
MP7U_HMKK=_K6I74V^Z@,,LH,147#@$KCE@%X.>AQTQ6SI/@;P[H=Y+=:;IYM
MY'W8"S2%(RWWC&I;"$^J@5I:-HFGZ!8_8M-A>&WWLX1IGDPS$DD;B2,DD_4T
M <MI]FA^,6M2F6YRNF6L@7[0^W)>48VYQCCITSD]37*>'6O-,\'>#-2MM2O%
M,VL_8Y+<28A:*2>56!3H3WR>0:]1G\/:9<:T-7DMV%^(?(\U)G3*9) (! )!
M)()&1GC%4D\$Z!'IMGIR6DRVEE<?:;>,7<W[N7)8,#OSU)/XF@#EOM.N>);?
M6KK3]2BL+O3M3E@25[V18X$A?&)(0NU@R#)+'/S9!& *LV<6H:AXY\31RZUJ
M@M],EL[B"V@E"JQ,9=D(QRI/&.^?IC?N/ _AVZUXZU+IP^W.5,C+*ZI*5^Z7
M0':Y'N#5^ST+3[#5KW5+>*1;R]V_:',\C!]HPOREB!@<# H XOP[-KFNZ9X<
M\2PZI#"D[(]\&O9)(YU?Y6B$14*C!B "#D$8).<UGOKNIW?PLF\;P7US%JT,
MTDX@\UO)"I.4\AHONXVC&<;L\YKM=/\  _AW2M8DU2RTX0W+N9,"5_+5SU98
MR=BL?4"IU\)Z*ES-,MJRB><7,L F<0O*"#O,>=A;(!Z=0#UYH YS[$DWQEAE
M=[I&;0O.*"X< -YZ_+@'&W_9Z'TJWXVEOTUCPM;V>IW5G'>:@UO,("HW+Y,C
M=P><J,=O:M\Z!IS:\-<,4O\ :(A\@2BXD \O.[;MW;<9YQBL/QII%[J^J>&O
ML]C<7%O9ZA]HN)(9UB*+Y;J""75LY8'B@#C==O==T'2O'>F0:YJ,L6FPVUU9
M7<DNZ:/S<[HR^,D?+D=P#UKI?$5M?:!-H+0:[J<WVW7X%G6:4%2C*=R# &$R
MN=O3DUT5SX3T:\TN[TZYM7EM[UQ)=;IY-\S# &YPVXC  QG& !4U_P"'M-U2
M*QCO(II5L95GMS]ID!61>C$ALL1SR<]: .1CO;WQ%9>,;G^T;JRN]*O)K:S$
M,I181%&K*S)T?<22=P(QP,8JA97FK>*]=T**XU;4=.BU/PV;R:*SD$>R7?$-
MR<<?>SSGCCH37<77A71[R^N;R6V=9;M!'="*=XUN% P!(JD!^..1TXZ<5,?#
M^F'6X=8\AUOH8?(C=9G55CX.W8#MQD#MV% '-_%&W#>!"#+/F.[LP&65E+9G
MC4[MI&>">O?GJ!4@N'O_ ![<^&I+F[ALK+3([B-4N7229G=@7+@[B%"@=<9)
MSGC'3:MI-CKFF3:=J, GM9L;TW%<X((((((((!R#VJI/X8TJXEM)C#*EQ:(8
MX9XKB1)0AZJ7#!F!/)W$\\]>: ,[P%J6H:CH=Y%J4K3S6&H7-@+D@ SI$Y4.
M<<9[''<5Y]>V:0?#+QXZRW#,-:GB'FSO(,">/'#$\^_6O8K*RMM.LX[2TA6*
M",':B^YR23W))))/))S6-<^"/#UW'J$<UBYCU&7SKI%N9561\@DX# #) )QC
M) SG% '-ZEJ>H^%_%.MK!?7=]$GAV74Q#=2;P)XW(&T<;01U48%7M$@U>:_T
M/6(]6C_L^ZMR+F-[UYQ=EDW(R*5"QL""2%XQD8XKHQX=TS^V!JIAD>]%O]E\
MQ[B1@8LYVE2V",\\CK5/1/!/A_PY=O<Z58>0[;MH\UW2//)V*Q(3/^R!0!4U
M_4Y7\:Z!X>\Z2WMKV*XN)6C<HTOEA=L88<C[Q8X(/RCL37*Z:W]EQ>*K==5N
MH#)XFBA1ES)/.&2']RK$@AF&5WDY Y)XS7H.M>'=,\0);C4(&=[:3S8)8I6B
MDB;U5T(8?@:SV\!>&WMKF!K&0K<W"74K&ZEWF9<;9 ^[<&X'(()[T >?>(Y[
MVX\)^.K"[GNECT^^M3;QM=N[1K((F*%\Y8?,3@D@9[X!KJ[V:[O?%MWX8MYI
M4CMM-BGAW:C+#*S.\@9]ZAF?;M48)P,\@\8V3X'\.-'J4;:<&74D5+O=-(?-
M"@ $DMPW )8<DC))-)J7@;P]JR60O+)VDL@5@F6YE250>H,BL&;/.<DYR: +
MWAQ+^+P_:0ZI>PWU_$ICGN81A9&4D$X]>.??-:E16UM!9VL5M;1+%!$H2-$&
M H'0"I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.CEQM#*HO'Y/?&PC_@)]*N^);[2H]4\:Z#>ZS86ZZN8<RW[.C0DQ*"5&TAU
MP1R/FR/>@#V!)$EC#Q.KJPX93D&N7\,:]JNKZ_XALKPV8@TNZ%NAAA96DR@;
M))<@=0,8K?TP6BZ5:_898I+3RE,4D9!5UQPP(XYZ\5P'A'Q!HUCXL\:F\U6R
MMQ+J2O&9IU0.!$H)7)YY!'% '<ZI/-#-IZP7]G:^9<JLBW(R9DP<I'R/G)QZ
M]#Q3KC7-(LRXN=4LH#&ZQOYMPB[6/13D\$XX%<3XLU?3M5D\':A \9B_X2!!
M%,V 7C5)59AGG;NP,]#P>XK)U"'2GO/BH7CM&?[(@C)"YS]EP=OOOP..^.]
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M]\[<^^* /5000"#D'H:*PO!4HG\"Z XD#G^SK<,<Y^81J"#[YSFMV@ HHHH
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M0 &YSDD\8!S@^E %\@'J**R-0UZ.SO7L;>TGOKR.W^TR0P;04CR0"2Q R2"
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MD-!S^\4J3N&00>^>,<BF3:\M])/I-QIVHV4D]B]S%(V%!4<$;T8E'&1P<=:
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MC(YJ[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6\0O(6&<?)E).,]QS@5U.GZ1<W/C2?Q-=6[6A_L]+"&W=U9\>89&9MI*CDJ
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M/'R K)@9[]<5Z;10!P.O>#;OQA=:I>W$;::\^CG3;=)'5F#,_F%VV$C *H
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MPP!*GL1P:T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4MQ#"6)2:?S0&!_O%5Y /3<3V& #N:Q/%7B!O#6D+J LS=+Y\4+*) FWS'5
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M56:Y8K"AZN0I8X^@!KS::\36+*Q2>>2ZOAX82[FCGEV0PAP/W_ R9<@@8Q@
M\C/-6P6'5=0^&%]J#^?<3:7.9YI'.YB((VR3GKDDT >GVL]Y+=WD=Q9""")U
M6WE$P?SU*@EMH'RX.1@^F:MUY)K&K7VBV_C^6VNKD)%J5G&93*SM;PR)%YA4
MDDK@,V,=,Y'2NAO+3^S?B%HEII32)I^IV5T+Z"*5@H$80I*,'Y6R^W<.3D4
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MI<C@GD#'3-;'B&2W\+V @LM6D6PNM;A2\,K%HK&.12?+!4KM0L$R-PP'[ T
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MEN99M#T^22Z<23LUNI,C @Y/')R ?>GP>)M(N-2&G+>;+UD$@MYHWC<K@G<
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M1B>,-L/MGI3VT+2GN+.<Z=;>;9+LM7$8!@7&,)_=&..*L7][#INGSWMP)##
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M>17H=% 'G<6FK8^*O!8LM#NK*PM8+[,:0.ZVPEVE [ $*QP<C/!R*QY+&_\
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MALMGD]N:LZ-X2N-,\1W&MP6EAI[SV9BN+2SG?R;F8L")"-@"XP1D D[CGIR
M<Q)>65W8?#G5]'T-+</>2BWLXF4%%,,OR[C@ 9&3_6KWB7Q#_P )!X"\:Z7J
M>D_8=3TNS9I;=Y!,N&0M'(C@#(.#V!!%6]/\%:SI_AOPI;+)827V@W+2E/-<
M1SJ5=?O;,J</G[IZ5;U3P??ZEI?BB0O:KJFNVRVH7S&\J"-5*J-VW+'YF8G
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M?$UYKI?28II])2S2$,[JDBR.XR2HW+\W)P#SC'&2 :/_  EJV^E76J7D-O\
M8(XX7@N;2Z$T=PTC% H8JH!#;1Z?,*71O%?]I>(;C1I;6)9$MQ<QW%K/Y\+K
MNVE2VU=K@X^7'0YKGI/ALT]OKB6A@T1-0C@:*VLY&DBCNHI/,$V"J@<A!@ 9
M SU/'4:!'XG)\SQ'+IJLB;%CT_>5D/&78N!CIPH]3R>, %*_OSJ/Q!L_#I_X
M];>P;4;E>TK%Q'&I]@=[8]0M1VNJ6;ZSXPCCT)5NK-8?M3!US>@Q$KGL %XY
M/>G7MBVG_$JRUYO^/6\T]M-E;M'()!)&3[-EU^NT=Q1;:!JMOKOBN_(LS'JR
M1+;KYS94I'L^?Y.,]>,XH R;W58+/X7:9XMTBQ6Q%E;0W,5K&<@0$KOA)XR-
MI/\ P( ]J[/4M3^PZ)/J4-K<7OEP^:D%LFZ27C@*/4UQFI:!?P?"BS\&.T+Z
MC<01:>K0L67:"H>3D @! 2>.N!U(KI_$FD7NH^$KO2M(NQ973PB.&8D@+@C@
MD<@$ C(Y&: .?UGQ FKZ;XK\/WUE;K<6FE-<-Y4_GQD,K@ Y52K*R],>AJ#P
MUXLNM-T[PGIVHZ++;V&H6D%M:W_GJ^Z7R@0KH.5W '!R?<#M-%X/UB75M0N)
MCI5G:WVBC3C!:AV\A@9,;<A01\^<\=,8[U:L?"^I7%GX<LM7%G';Z&T<B_9Y
M6D-Q)'&8T)RJ[!R6(YYP.W( ZX\>)!H9\1"P\SP^LYB>Z6;]X$$GEF7R]O*;
MO]K..<=JOP>)F?Q1J.BW-K';_9;1;R*=I\K/$21N V\ $8//&1UK @\#:E#X
M0N?!AFM6T629A%=>8PF2W:3>8RFW!89*AMW<''&#L^(_"?\ ;6IZ->6\XMS9
MN\-R,?Z^U=?GB_$JGTYH AE\:,D<<(M+2/439K>26US>^4$5R=B[BA)<[6XQ
M@8Y/3-#7/$R?\(19>.K.">V:W:*2:&9=KM"T@26-A[9)'NH-7=9T+Q!!XL'B
M#PW/8%I[9;6\M+\NJ.$9F1U902&&YAC&,&H_&>F7FK^#X_#<LRSW^J2QQRNB
M[55!('E<#LJJ"!D]U&230!V8.1D=*Y_7O$5SI$LRPZ;YL4%FUW)<3S&&'@X$
M8?:P+GG@XXQZU+:WFK'Q9>64L=DVDI KP20EO-C?C*R9^7G)(QT"\]169KOA
MW6=0\2O>6TUC)8R:>UJL=UO)M9"6S*B@88D$ \J>.O:@!&\</--X=CL-(EN/
M[=LVNK=FF5 F$5]K=?[XR?K@'I2V?CE+C1UGFL&BU)M2?2A9"4,#<*Q! ?'W
M< L6QT!X)X-'2?"6N6,_@U[A].=="LI+6;RY7!?<B("N4YQLSSCKCMDU'\":
MV;2:>&XL(M3@U^36;/YW>)@^08I/E!'!(R,T 6O#(F'Q5\5&XLX;65K*R+"&
M3>LG,OS9VJ<]N1VK3EOSJOQ$_L4\V>FV*WDJ=I)G<B,'U"JK''JP/511HNC:
MU#XRU'7=1%A%'>VD$'D6\KR%&C+G[Q5<@[^N!].Y:UBVE_$QM5;BTU6P6U9^
MRSQL2H/IN5CCW7'<4 01Z\EM?>,9[#P\IO\ 3FB>Y"S />?NMRG(!Y"8 '\J
MUK+Q -5M]%DMK:*6+5+<W#?OLB./:I)^[\W+*N..3]:AT31;^P\5>(]3N?LW
MV?4Y(7B6.1F=?+C$?S J!SC/!IGA'PJ?#/V^,W E@>=OL2 <6]N6+B/\&=_P
M"^E $?AS4&@\4Z]X:<DQ6/DW-IDY*PRJ<I]%=6QZ @=J=?>*;^+Q1<:!8:(;
MJZCLEO$=[I8T=2Y7!."1RI['MQCD1^'K!KCQEXA\1$?Z/<B&SM3_ 'TB!W./
M8NQ ]=N>A%3G1M33Q_/KZ+:-:MIBV2(TS!]RR,^3\A 'S8ZGIGVH AT_QO!J
MVGZ%)8VA:\UF)Y8K>63:(U0?O"[ '@' & <DCWQH:!XB769]2LIK8VNHZ;.(
M;JW+[P,C<C*V!E64Y!(!Z\5RNC^!=8T:Q\,7$4UD^J:*LT$D?FN(KF&4Y(W;
M<JP."."./?CJ-"T.2PU36-7NS']MU66-I$B8LD:1H$102 2>"2<#EO:@#C=6
MM='_ .%RW*ZG8K/;-X?65D6V:7]YY[#?A02&QQGKVJ;P=K6I>'_#-E8:UO6]
MN[BX>PBU.?RGCM4(V^:Q!((W 8P3\P]#C?70=4'Q+D\1D6?V)M-%@$\UO,XE
M+[\;,=\8S^-.\5:%J]YJ6E:WH%S:Q:GIWF)Y5WN\F>*3;N5BO(.54@CN* ,[
M_A8C'2[.Z71)WEFU4:5)$LPVK(3PR,0-Z$<AL >N*N'QA?)=Q:9/I$%OK+6K
M77V&6_ \P!V4+&P4AV(7..,;AGVCU?0?$6KV6CM/+IS7EKJD6H3*'=(E5./+
M0[23GKN..<\8X#_%_ABX\3":UGL=.NK0VP%O)-*T<UK<9;,B,J$XP4[C[OO0
M!>?Q%<7&H7>GZ7IZ75W901S7*2S^4$:0$K&#M.6P">0 ,CGGC+B^(4=\OAY]
M,TN>Z36_.6/=*L9ADC5BR,#W!4@_B1GH7:=X9UCP_KUQJ5A<6^H"_L[>&]%Y
M*T3&:%-BR@A6SN'4>O.>U5K+P/>Z5<^%?LDMK+%I,MS/=/([(TLDZL&*@*0
M"Y(R>@ ]Z -_PSX@?7[6],]E]CN[&\DL[B$2^8H=0#E6P,@A@>@KF;[5=2U>
M?QWI5_:6AL+"U$: 2EB-T+2!L%.2<C/(Q@8SU._X6T6_T>ZUV2]^S%=0U%[V
M+R9&8J&55VG*CGY,\>M4+CPSK"ZOXJGM9+%K;6[=%02NZO&ZP^5@X4C;T;/)
MXQCG( *7@_Q+<6NG>#M&NM+,5OJ&EQK:W7GABSQP*Q#(!\H*@D')Z<@5I6WC
M6236-'L;O2VM/[6:9;=)9L3Q^6&8&2(J-H8*<8)[54M_"FLQ-X*RUB/[!@:*
M<B9R9"8/)RGR?\"Y^GO5#3?!?B6VE\.RW-QI+SZ5=RRSW ,C/=B1'0R,2!\^
M&'R\CC[P'% &[X-UO5M:FUPZC!;1I:ZG-:Q^5,6V[ HVX*C(ZG.>I/ HN=7L
M;7Q[/!-I/^EP:,]S]O4@NT(D&8P.O7GKU%3^&=#U'1+_ %L3R6LEE>W\M["4
M+>8#)MRK C Q@]"<Y[8YAO=#U>3QO+KEI):)%_9#V,1>1MZR%]X<KMQ@$ 8S
M_A0!;\/>(9-?BM[J*VMS8W%OYT=S;W7G -D?NV^4;6YZ<]#Z5%JOB:ZL?$]K
MH5KI#74]U:RW$4AN%C3*%00>"0/F'./P-4M!\)2:9XIDUM;:STWS[0Q75M8R
MLT5Q*6!$A4JH4@!AT).XYZ<W;[1=1G\=:;K</V4VEI9S6[*\K!V,A0Y "D8&
MSU[T 5;#QS%?:3I\PL6CU*^O);!+)I00LT9;S,N!]T!&.<>G&369XE\=7]AH
M'B>&&RBMM;TFW6;:\Q>-HG!VRHVT%L'/RD#D=:BM_ NL6]G9W"362:II^L7&
MHV^)',4B3,Q>)CM!7Y6QN /3I5S6O!-WK]MXCN+F2WM]0U6P2QA5&9XX43<P
MRV 22S<\< #K0!V5F]Q):1M=1QQS$?,L<A=1^) S^53U6T\7@L(1J @%UM_>
M"W)* ^@) )^N!]*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !117G&M>(=6L;LW-MJ3W"IKT%FRP1)]GCA=T0Q,6&YI.2
M25)P>..E 'H]8MSXJTNTUS^Q9#=-J'DFX$,5G+)F/.W<"JD8SQ6U7GVH_;/^
M%WVGV$0&7_A'9,^>2%Q]H7T[YQ0!V.E:YIVM+.;"X\QK=_+GC9&CDB;T9& 9
M3]16A7D%MK]QX6UWX@:AJL"/XA2TBO%2#)MGA1=D6/XLY/S9_"NGO=2U;0]1
M\+RG4Y;ZVU>86=RCQI\KM&766/:HP 5.0<C'OS0!W%%>::7=^)+WPWK>LR>)
M9P^GRZC#'$MK#M?RF8(S?+U&WMP1VZDK:ZOKEM9>%3<ZY+/+XD^SJ6,$:BU
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M'E%$4;A2-N",L>HS[U>\3ZOJ<(OS9ZI(LEOH_P!JCM[2-"\<N&/FREQM"?*
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M+BY88 *\;$49RQ.!G:,\X-.U\2>(=0\+>#+H:HT%SJ.J/8W;B",[U4S#=C&
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MXT*>&".TCTU;U9]YW',A3!S@#H?6E\3:]=:)+H@M[>&6*_U**RD9W(*!\\J
M.>A[_G0!)9^$='M#J3O ]U-J:>7>374AD>9,8VDGHN#C P*33O"EEIQL@+B[
MN$L%*V27$@<6P(V_+QDD+P"Q8@9'<UHPO?G5;I)A:BR"1FW*.QE).=^\$8 X
M&,>]65EC=F5)%9D.& .2/K0!B6?A.RLM%U'2HKF[-O?O+),6=2VZ0DR8.WC.
M3],\8HF\(Z;<>'K'1I6N&AL#&UI-YF)8&CX1E8#J!QSU'7-;8EC:4Q"1#(HR
M4##('TK,_MA=1LM4&B2VTUY9N\ \YB(O."AL,5R<#< <=P1VH FT_1X-/N;B
M[\R6XO+D*LUS,1O=5SM7Y0  ,G@ <DGJ:SV\%:$^DW&EM9C[)<7WV^1,]9?,
M$F?ID 8].*VDEV6J27+Q(VT%V#?(#WP3VS4I=0H8L #C!SZ]* ,7Q'X6T[Q-
M':_;&N8+BTD,EM=6DIBFA8C!VL/4=1TJ"?P;I\]GI]NUS??Z%=+>)*9M\DDX
MX#NS EC@D8Z8XQ@#'0+(CABKJP4D$@YP1UI(Y8Y5#1NKJ>ZG(H ?61J/AVTU
M#5;;55EGM-1MXVB2YMV 8QMR48,"K+D9P1P>1BM1Y8X@#(ZIDX&XXR?2LKQ#
MKBZ';6>%5I[V\BLX0Q^4,YQN/L "<=\8XSF@"M<^#M,N+"RLP]S#':7@OE:-
MQN><,6\QR02QW$GT.:Z$#  SGW-9>GRZVUC=?VA!9"ZCE98&A=O+FCX*L0<E
M"<D$<].IKEM/\>:M>> 5\8'0[4V0BDGE@CO3YJQHS!B,Q@,0%)QD?6@#J]:T
M'3]?M8[?4(2_E2"6&1'*20R#HZ,.5(]15.3PK;W=U83ZE?WVH&PF%Q;).R*J
M2 $!OD52Q )ZDUIV6I6M]I5MJ44@%K<0I/&[_+\K $9STX(JSO4*&W#:<8.>
M#GI0!S&H^ =)U.;5FFFODAU4#[7;Q7!6)V"A=^W'WL #TX!QGFGW/@72;F[E
MN&EOT,]F+*X1+MP)XP"%W\Y)&X\Y[X.171>?$$W^:FWGYMPQQUI6EC0H&D12
MYPH+8W?3UH P-.\&:?I=_I]Y;W-\9;"T^Q0^9,''E9!*G(YY4?3 Q@56N_A[
MHUX-11YM02&_N5O)(8[IE19@RMO4=B2HSG(],5U)=0<%@#Z9H\Q,9WKCIG-
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M#CC.2.M;9 8$$ @\$'O2T4 <[8^#-,T^.WMXGN6L+:?[1;6+N###)DD%>-V
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MEIX6O[36=4TG6(KXS:'*DUO;+$( @!9&D55&UP>%S@\'T./2K>QL[,8MK2"
M;0G[J,+\HZ#CMR:9%I>GP02016%K'#*VZ2-(5"N?4C')H Y7P9!H'A[P3I&L
M/]DLWO-/LTN+IV"^:VP!0S'J<L0/R[5VFQ>?E')R>.IJ#[#9_9A;_98/(#!A
M%Y8V@@Y!QTSGFK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>cutr-20221231xexx1027thi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM?,LKB.253$Y"$'[FT\G/)(Q]8O#GB72-+UGX@:C<S:F@T^='O%N9Q+&I^<
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M4"NPC\S!4'<OR@X)'./QJM_86K+KGC"[%O$8M6M88;7]]SN2-D.[C@$MGC/
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M^E6:Q_"VG7VD>&;*PU*[:[NX5*M*[ER1N)4%C]XA2!GOC-;% !1110 4444
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M 8--LH+2-CEEA0+N/J<=3]:NT44 %%%% !1110 4444 %%%% !1110 4444
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M&2-JC&<#_P"M44GA*PFUK4]1DEN'34X%@O+,LODRA5* D8W9VL1UQ[9%;]%
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M8L!C;G.2><ULT4 4M-T]]/2Y5[ZZN_.N'G!N7#&,,?N+@#"CL*NT44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:S((HIE5 (9"<;9,L,=&Y&1\IK&U+PAKLWQ \5ZQ#8A[/4M#?3[8^<@8R%4
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MB!R#@8Y].:WM&\7):Z!X4T]UN-1UK4=*CN!&'!9E6(,TCLQ[GCU)/U(XZY\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<Y/X4\K7[C6]'U"73KRZ55NT$:R0W&WA69#T8#C(
M(]\UT=% &!J?A6VUO1KFPU2YGG>XV,;A2$>)D.Y#& ,+M/(Z^^:?!X?D%^NI
M7M^;K48K9K:"8PA5B5B"Q"CJS%5R<XX& .<[E% ''V_@-+;1- TM-4F,.B72
MW-NQB7<[*& #^WSMTQVK8O/#=C?>)M.UZ0,+NQBDB3:<!P^/O>N""1[G-;%%
M '+:EX,>X\1R:WI>N7VD7-S&L5ZMLL;K<*O"DAU(# <!AVJU!X82U\40ZU%>
M2#RK$6"VY4%?+#;LEC\Q;/?/^-;]% ',GP<BMX@$.IW,<&M;FEAVH5C=D",Z
MG&<[5& 3@>AI#X."0>'S!J4L=WH<1AMIC&K!T*!"'7O\JCD$<UT]% '+:CX(
MMM1T*_TYKV9)=1N4N;N["J9)'0J5 XP -B@#'0>I)I-1\&2W.O\ ]MZ=KM[I
M5[-$D-Z;9$9+E5Z$JX8!AD@'L*ZJB@"&"V6ULX[: D+&@1"Y+'@=23R3Z^M<
M@?AY&WAS6-$;5[@P:M>/>3R>4F]79@S!>P&5'4'O7:T4 <[=^$XM0UY]3O;H
MS++ISZ;-;^6 DD3G+=\@D^_3\ZS;?X?R0PZ-;2>(M0EMM'N1-9HT<6Y5564(
MS;?FP&QGT_.NTHH Y&T\"C3]5N9+/6]0ATFZG:YFTI=AB:1CEL,1N52>2H(S
MD]N*G?P<OG:PL.IW$5EK$AEO( B[BQ0(VQ^JAE4 ]3Z$&NGHH P'\*6P\0V>
MK6MS-:_9[/["UM&JF.2$,&53D$C!';MQ5'0O W]@3K#;ZYJ$FC0R&6WTR388
MXFSD#?C>5!Y"YQTSFNMHH X63X:Q_P!CW>B6^N7UOHTURMS%:(D9\AA*)"JL
M5)V[AD#M[]#IGP>3<^()SJ<I;6X$@FS$OR!4* KC'.TG.>,]ATKIZ* .-N/
M.8M'EL-;O-/U/2K46<=["B$RP@ ;)$8%6Z ].O-:G_"/3Q+ +?59CMADBG%U
M&LJW)<@EW''S9SC&  <8Q@5O44 <FO@>*WT?^QK34)4TQK!;"2WFB60%07RZ
MYQASO/.".!QQ736=K%86-O9P B&"-8HP3DA5&!S]!4U% %)[*X?6H;X:A.MN
MD+1M9@+Y;L2"')QG(QCKWJ[110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<7<
M>)==AL-1E_X1_57EMM1\G9#"C&2#<=KP@GY^ N2>A8^F*[2B@ '(Z8HHHH *
M*** "BBB@"IJDUU;:3>3V,'VB[C@=X(<_P"L<*2J_B<"N?M/$&JS7FBHVB:L
MMO>6TCR-+#&K12+G"S<X3('&.I8>AKJZ;(XCC9V#$*"2%4L>/0#DT >6W.O>
M._#OQ&\/V&JW>GWVG:Y(Z"UMH-IMMH!;#'YCM# Y/4 \"J^M?$75_P#BM=0T
MV9([?PS/;P1VYC5EN6,A67S"1N'0@;2,=\T:?XIU;4/'BW\_@77O.DD%G97%
MU;-'#9VY8;G/'WC]YCZ +V)./K7A/5K&'XBZ1!87-Q+X@NK>XT]HHF9)-TI9
MP6 PNW)SN(XYH [#Q=J_BV\\)#Q)X7O[*PL(M/6_*SQ"22<%-Y7)!"@+[9)S
MT%6['4_%OBSP!H]_I,MGI6H7MOYL]Q-$9 GIL0_WNN3G ]<U@^++N]T30-%\
M&P^'-:U>PAM(8M0EL+9RLJ(H B#X_B(^;';COQIZOXPUFV\!6EQ8^%=6AO[T
MM%'9VUHSR6<08KN88P&V@%0>Y'4 T 6OA5XGUGQ/X:NI==2,WEG>R6C31+M6
M;:!\V!QU)'''%0^*?&>H?\)UIG@CP^T,6H72&:ZO94WBVB )^5>A8A3UXY'K
MQ>^'-X\^A-:1^&KW0;*S*Q00WJD2RGDLYR!G)(Y[G-<WXH\/:GH7Q=TWQU96
M5Q?Z<\7V>_BMD,DL7RE-X0<L,;3QD_*?44 =JUEXAL;_ $WR-7:_LVFVWHNH
M(Q($VM@HT:J!\VW((/7J*D_X3+P_]O\ L?\ :*>9]I^Q[]C>5Y^,^5YF-F__
M &<YJ>TUV+4KB.*QM;UXVR9)Y;9X4C&./]8 6).!@9QWQ7AW_"(>(/\ A7(\
M&"RN_P"VO^$A\TS>2_E^5M_U_F8V[?QSGC&: /8]1\>^&=)O[RPO=3$5W9Q^
M;/#Y,A94X.X +R,$'C/'/0&GW'CGPW;6VF7$NIKY.J8^Q.L3L)B2!@84\Y(X
M/->>:MINHM\4/&MZNEZ@]K<^')+6"9;21DEEV)\BD+@G@]/2FP>#;W6?V>K+
M2Y+.YMM:TY7N;>.6)HY4E21V  (!^920/J* /5+CQ!I=H;_[3=B!;!%>Y>5&
M5(U(R/F(P<^Q-51XOT/[%?W;7C)%IX5KL202*\*L,AF0KN (YSC'7TKAO&GA
MWQ#K7P<D40M+KURT-]>01#EV&W* >JJ%X[E/4U'=V5OK'@SQ+K%AHNO)JNH:
M4;:9;R*3S'?&%C5",M@_Q 8]^N #K6^)7A/R[AH=56X:"R-^Z01.[>3QSTZ\
MC@\X.3QS7-WGQ#EU;P7I&K:?JD&A3W5\BNUY9RO&T99OW8;806( Y'H>1VMZ
M%H4Q^!XTR/37AU-M%FMO)EA,<GF,C97Y@#RQ^E<+JNFZM=?!?PEI46AZL;VQ
MU&-IX?L,FY0OF;CC&<#<O/0YXS@X .U;QY<:5\6-;T;5;QO[&M-.6ZC5+8R.
MK'83]Q2Q !8^PZ]*=X^\<7%AH'AW6?#.HQ26NHZE%;,X1722-@V>HR""N.V.
M<U1:&ZTWXR^(-=N--OGTR?2%MXIH[5W$DF(VV  $YP"/KQUKD+CP=KVE?"CP
MGILNFWL]\NMK?3000/*;>+#?>V@XZ@X]2?2@#VS4O%>B:3=26U[?K%)$J/-A
M&985<[5,C $(">A8BM65&EA94E:)F'$B $CW&01^E>-7&C30?$7Q79Z]I6M7
MFC^(5A>"6QB=D?:,"-R/NXSCDC&WG .:]?@6/3]+A39(L<$2KL&Z5@  ,< E
MC_.@#S?X6^.M0UOP=JWB'Q/J ,5E<O$QC@ 5$5$8L0JY_B.>V*Z[3O'WAC5=
M1L["RU:.6YO(S);J(W E Z[6(P2,'(SFO*_ &D:MI_P7\8Z5>:1J4%_<?:&A
MMY+.0-('A5%VC;S\PQQ2Z7I&JQ:C\*V;2-21=.AF6\)LY ("QP-_R\=#_/I0
M!W'Q \?6ND>']:71]3VZQIRH6V0&2-&)&$=BI0$C/&0>*V=+\5VL?A;P_>:M
M<_Z=J5E',(XHF=Y6\H.Y5$!.!R3@8%>37.E:QIGAOXB^'Y]'U.YO]1OC<VDL
M%J\B7$;.#D.!C( R1G/.,&K]SI^KZ1K/@/7)M-U=].M]$33KQ+.!S/;2!2"2
M@&<9('3D+],@'4>,_'4VF:GX+NM'U*)])U>\$<[A%=7BRG*G&0<$C^F:Z-O'
MOAXZ+JFJ17<DL6EY%W$L#K-$1V,; ,,XZD =>>#7 >(/#!T\_#]=#T;45TS3
M=2>[EC9'ED@B\Q&+,.2,\G;U[8SD4-X8U;5=0^)FLVUG.EOJMD;6QBD0QM<,
ML>"P5L'&1@$]=U '<:!X\TW5/"EEK=XS6GVED01-%)EI'/RHG&9#_NY[UHR>
M+M!AT*76I=2BCL(9#%)(X8%) <%"F-P;/&W&?:O(;W3M<7P-\/[^#2-68:#.
M!?VJ0,D^. 61",G !YQ_%]<7O&7A=I_"5OJGAS2=5>(:XFJ7=M<*_GW'&'D$
M;?,.2!C [G&.2 ='HGC>]U#XM:KHHNI)-'@TS[6D4EJ4EC?*9!4J'Z,>",\C
MK6[;?$OP?=O9K;ZW$XO)O(A81R;3)_=+;<*?3.,UR>C&ZN/CCJFOC2]3CTN;
M1Q%'<2V4B!F&QL8(R#A3P0#Q[C/!67A[7(?A;X<L&T+55O+?Q&+F:'[%+N2(
M+]\C;TY'^10![YJ?BK1='N7M[Z^6*2.,2R@(SB)"=H9RH(12>[8'7TI+[Q7H
MNG7<EM<7A\V*)9I?+A>01(Q(4N5!"@X.,D9KS+4=(GMOB?XECUO3-9N]$\0V
M\(BFL(G=3M4+Y;[?N]^N,8!Z'-0^,?#-_9:M'JOA2'4[76;6"VLS:-"\]O?P
M[57:SXVY4<-N."%SP>: /4Y_%6C6VI2:?)=M]HBDBBE"0NRQO(0$5G"E5)R,
M D=16-?P^,/L_B 6FL*&\V-]-?\ L]24Y.Z':3\RXV#S#CJQZ"N,\1:'JMK\
M0?[=\-)?Q:A/>P0:A8R6[O:W<>%/FA\;0%'7/(()&#U]EH K7$XMM-DFNYTM
M]D69)1]U#CDC/]:R],UJQAT+3'DU674C/;[X[E;<L]PH S)L1>!R,G&!D>M:
M>I-MTN[.UW_<M\J(68\= !R:\QT_2IF\(^$HS)K.B:S9:<R17L5G(RQ,-@:*
M:,J<AL @'&=O!]0#U*TNH+ZS@N[:026\\:R1N.C*1D'\C7&^,O%@M8M-72=2
M>.9]7M[20I!NCE!E"R1[RI7<!G(!R,'T-;WAYM3N?"%B=1@CLM2>U DCC7:L
M;XP,+V['';I7FL3WR?#W0M N-%U0:KI6IVOVI%LI'4JDX9I5<#:P(YX.>30!
MZ?J'B32-*E*7MX(0K*DCE&,<3-C:'<#:F<C[Q'4>M8.L^();KQHGABWO+NP#
M6#SFY@MB[>:71$^\A&T98D],X&1SG ,2V^KZ_HNO>'M9U&+4;QKFT>W\UK>X
MC<+A'PP5"I&#NQP!6ZD<L/Q7MI?L=T+9-#-MYRV\AB$GG*P3?C'0$]: +&C>
M(;#3- N;O5O%<6IK%=F"6[:%8E27"CRU51SR??KUXK8L/$NCZI<W=O9W\4DM
MHH>8<KM4YPP) !7@_,,CWKS;4+.]F\#>,;9=+U%IKKQ#Y\,7V*7=+&9HFW ;
M>1A&.?:M'Q7I>H:UXIUN+3K:Z4W?A@VL,S0.D;2^8S>67( !*GN>] '=67B'
M2M0OS8V]UFZ\KSEC>-D+QYQO3<!N7W7(KFO$/BL#6/#,.D:D_EW>J+;S*L&8
MYX]KEMKE<'#*H^4]ZSK54\4V,SVF@:Q8:[%83P"XU(S*+61XRNU&=B&RV/N\
M8&3@X!STN[B[T+P)9#0]5AN])U&V2]B-C)B$1PR(6#8VLN<'()X(H ]#\2WL
M%AX=O9[C5O[)01D?;=H8Q'U (()]L5%=>*]#TVX^Q7>IQ_:TMQ.T84LY3@;M
MJCJ<] ,^W%4OB-!/=?#S7+6VMYKBXGM6CCBAB:1F8]  H)K.M_,_X6;:7QLK
MT6R^'S"9C:2!1)YJMLSM^]@'C\* .PT_4+35=/@O["X2XM9U#QRH>&%<9K7C
M;[;X:\7/H\MU:7FC)*$F:V.&9(U<_?7'5L8/) R..:O?#.">U\"V=M<VUQ;3
M1RW&Z*>%HV ,SL.& XP0:YN_M[V+1?B3IITS4'N+Z6::V,=J[K,KV\:+M8#!
M.X$8'3'.* .TT/Q/IFJ/!I\=^DNHBU2:2/!&X8 9@<8;!.#C.#5F#Q)I%QJ,
M-A'> W$ZLT 9&59@OWO+8C:^.^TFN,U"SN[W7O#*6MM>0@:)=VS3FUD58)'2
M,(&.WY>5/7TIO@\07L>BV&H>&=7AUC255'DNS+]G@95VEXW+%2& X"YZ^@S0
M!Z%>WUMIUL;B[F6*($+D]R3@  <DDD  <DFN4T#Q(]YXT\503Z@[:;806LB)
M<1"'[.6$A?.55OX0?F[8IWCV.^BD\/:K;6D]Y:Z;J2SW=O;H7<H49-X4<MM+
M9P.?RKE]6M=1UW4/&TFDZ?? WMC8/:/-;R0+.8F9G3+ $$C"\X//I0!Z'!XD
MTJYGN+>*XD^T6\8FD@:"19-AX#!"H9ESW (KAK3Q%<ZWX;M_$4WBVXT*%Y76
M>)K)6CVF5EC6,LOWL* 2-V<G@<8VO#EUINIZD-8B\/ZS:74%LT4T^I)-YD8)
M!\I Y)?D$_*"./4URXM+X_ 1=,_LS4?MXD4&U-G+YG_'UO\ N[<XVC.: /0[
M_P 7:#IEW/:7>I1)<P1B62%59W53WPH)/0\#T)J*ZUK3[JYT%[;7UA2]D\R"
M*)5<7J%"=O() _BR,=*R4WCXJWNH&SO/LIT**%9_LDFTN)9'*@[>N&7C^M<Q
MH=G?0>'?AQ!+IFH)+8WCFZ5K.4&%?+E7+?+P,LOYT =E#XST[4X?$$2W,^GI
MIKO UY+ RA"$4E_F7'!?@'KC.,&M.WUBRM='TR2;4'NS<P(895B+27/R EQ&
M@SR/F.!QGM7'PQ75K;?$.QDTZ^,EW-/<6[);.R2H]NB+M8##$L",#)&.:BTJ
M&_TG5/!^KW-G>-IZZ"--G46[E[2;]VVYDQN .S;G'&!GB@#LW\6:!%IUOJ$F
MJVZVMQ,((Y"V,R$[=N.H(/!!Z=\5/I7B#2M;DNHM.O%GDM6"S(%*E,C(."!P
M1T/0]J\WU'1KV/3]1NTL+QH-1\46U]#;I;.S+$CQ[Y&0#*YVLW(!QCUKJM*2
M4?%'7KDVMTEO/86J1S/;NL;LADW ,1@D!E_.@#I+[5+/3FC2XD;S)<F.*.-I
M)' ZD(H+$#(R<<9%<]XI\9VVG>"I-:TJ=;GS62."6.-I%#-(J$G X*[CP<<C
M'7BH=36[TOXFVFM307$VE3Z6UB9(8FD^SRB3?EE4$A6'&<=5&:YG5-&O[?P)
MXD\NQO';5=>6]M;6*W=W6+SXB6*@97(1GP<=?7B@#OM,BU"WM[^Z&HW&I0S#
MS+."Y@$,D9 .5)PN03TRHQ[UE6/B+69X_#QGT/5HTO3*EV6@17MY 0%+C/RQ
MGYR",GA?7GKHW$L:NH8!AD;E*G\CR*<3@9H \Q.O^(Q9^-;V/6T!T"YD%O%/
M;1F.1$C$FUR #DYQD$5U=AXQL)/#6G:MJ&^U:ZLDO)(5C>0PHPR6;:"0O7YC
M@<5S?A70K/4M?\7'5]%E>*XU3SX/MMFZI*@10"-PPPW _P Z76-^C^.=0EU+
M2=7O=)U.TAC@ETT2N(V0,&B=(R.#NR"1CD^] '4WWC/PYIH3[5J]LF^W-TFT
ME]T7'SC:#D<BHYO'7AF!+EWU>$BV"M-L5G*!AD$A0>,<D]N^*Y^WT\67CKPN
MMOH]S:V5MI=S"%6%Y([<NT91&< J#@-GG'OTICPSC7?B)(;"]*75G"D#"TD(
MG*P,I"';\W) XH ZRW\5:'=:I'IT&I0R74L9DB5<[9% R=K8VL0.2 <BL6;Q
MAI^B^'KW53JDVL1?VBUO&8X.(G9PHBRJ_=7(&X]>F2<"L2TM[F.+X8@Z??*;
M&';=_P"AR?N#]E,?S_+\OS\<_7I5&XL+^7P%XG2/3;\RGQ(;U(C:N'DA^U1O
MN12,M\H)X]* .Z_X3"P/BJUT%(KHRSVC7.\VT@"C>BJ.5[[CDG@8YZU<7Q)I
M#:C#8"\ GG9DAW(P25E^\J.1M8C!R 2>#Z5SEV;E_B1I^I)97ZVMWHLMI',+
M9CY<AF1AOX^3Y03\V.F.O%8WA"!)+/1M"U?PWJ_]L:1)&#).93:H8^!.CEMA
MRN< #.3C&,F@#9^('BP:9X;O'TK4GAOX+B*+?'!O3<74-&6*E0VUB<9!Z5W%
M>,W U*#X7:GX5N](U.76H+TN3'9R2)<JUV)?-5P"IR#TSG(Z5[)&XDC5P& 8
M @,""/J#TH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4UW6-2SL%4=23@4ZO/O"9C\7^)/$VIZK$ES
M'IVI/IEE;S*&2!8@-SA3QN8GD]<#'2@#T $'H0>]+7+WL>E^"OMVL00[1>FW
MMDLXOE5IB[*@4=%W&09QQP3ZU(OB:Y@\0G0K_3XXKV6U:ZLVBN"\<X4X9,E5
M*L,@]",'/M0!TE%<+I?Q N[^V\.7\^ABWT[6YOLZ2_:P\D<I#%<IMP5.PC.0
M?;UT+;Q?/(WB.&YTV."[T9E A%R6^T!EW1L#L& W0<'D$4 =517(ZKXTFL3?
MPV]A!<7FGQ*]S;_:2I+E=_EQX0[FVD=0H.0/7$,OC?49]6BT[2?#KW4T^EIJ
M40GN1 =K,%*,"IVL,G\?S !V;,J(7=@JJ,DDX %,$\)\O$J'S1F/YA\_&>/7
MCFN%LO$6K75EXUEU33;.ZM-.N)H1;K<'YD6&-C'@I@@@L23W.,8YK/OYP^O_
M  [U/2M(A$\VGW!AM5=8U13 A5"^.%7/H?8=J /3))$AC,DCJB#JS' 'XTZO
M*O%NOCQ'\/M<@U#3!8ZKI5_:Q3V[.)0C&:,JZ/@9#*W!P#UKK-;\8'3[G4+:
MQM8;NXT^)9)HI)S&SEEW!$PK9;;@\X'S+[X .IHJGIUY'J^D6UX()(X[J%9/
M)G3:RAAG:RGH><$5YCX:U6+P?X1\8ZU;:7'.;;Q!=H8T81'9YBJ #@\#(XH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&+B-6!!4C@D@8YQCKSTJ+POX?\4Z#%;Z-/JEA-H=D0+>98W%TT2GY8V_@&.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<UXN\1:KH%
MA)<:5X>EU9H8C-/^_6%(T&<X)!+-P?E /3W&>EKFO$RZ?XDMK[PFFO&PU&6W
M+ND$BB41D$<@]5/?&#CN,T 7/"?B*'Q9X7L-<@@D@CNT+>5)R5(8J1GN,@X/
M<5LUYEX!\4IX=^'.B#Q9>I \]PUE9/Y9/FH&(0_*.F!PQP,8/>O3: "BBB@
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M^3IUR/6@#VCPOK@\2>&=/UD6_P!G%Y")?*+[MF>V<#/Y5J>;'M+>8FT'!.>
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M?">DKJ4":+<W]_-:QVBJQ0S^9\X3 .U=S=^ 3C/%>DT %%%% !1110 4444
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MV=-@;^]MQC/O6A10!3_LC3/*M8O[.M/+M&#VR>0N(6'=!CY3]*N444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%<YJ?CWPMHVM1Z/J&M6\%_(0!$V3M)Z
M!B!A>HZD=: .CHHK,M?$.CWVKSZ3::C;W%] GF30Q/N,8SCYB. <GIUH TZ*
M** "BBB@ HJ&\NX+"RGO+J01V\$;2RN03M4#)/'L*Q/^$VT'[6+3S[K[28O.
M$/V"?>8\XW[=F=N>,]* .AHK'L_%.D:AJ-M86MRTD]S:F[A'DN%:($ MN( Z
ML..M;% !1110 4444 %%%% !116?9ZW87^K7^EV\KM=V C-PC1LNW?NVX) !
MSM/3- &A1110 4444 %%("& (((/0BEH **** "BDR,XR,]<4M !16-:^*-)
MO-4AT^&>1I;A'>!S"XCF"'#;'QM;'L?<<5LT %%(2!U(';FJ%GK=A?ZM?Z9;
MRNUW8>7]H1HF7;OR5P2 #D*>1F@#0HHJI_:5O_:YTO\ >_:1!]H_U3;-F[;]
M_&W.>V<]Z +=%%% !16'/XPT*V$KRWCK#$YC>X%O(80X."OF!=F<\8SUXZUN
M4 %%%(2 0"1STH 6BJEEJ5OJ#W:P>;FUG-O)OB9/G !.,@;AR.1Q5N@ HHJK
MJ&HVFDV,M[?3I!;1@;G;W. /4DD@ #DDT 6J*R=#\2Z/XDBFDTF]6X\A]DR;
M61XV]&5@&'XBM:@ HK/UK6K'P]I,^IZE(\5I ,R.L;/@?1035\$,H(Z'F@!:
M*** "BBB@ HHHH **** "BBL;4_%&DZ1,T=W/(/+:-)G2%W6$N<)O*@A<GU]
M1ZT ;-%8T7BC29M5M].CGD,URTB0/Y+^7*T>=ZJ^-I(P>_8^E;- !12$A022
M !R2:JSZE;V^HVEA)YOGW8<Q;8F9?D )RP&%ZC&2,]J +=%%% !1161K'B73
M-#$AO99/W40FF$4+RF*/.-[!0<+D'GV/H: ->BFQNLL:R(P9& 92.X-.H **
M"<#)K.EURP@UNUT>25A>W4;RPIY;;65<;CNQMXR.,YYH T:*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BD!# $$$'D$4M !1110 4444 %%%% !1110
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MZ2ET@0274K +M"*RLNT9)9C@#Y>1FM'1])72+0Q&[NKR9VW2W-TX:20XQS@
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MSNK6UG7:%FNB=B L 3P#EL$X&.6P*AT;PV=(O'N9-;U?46,?EJM].KJ@R"2
MJJ,\#DU8\0Z#;>)-(?3KJ6>%2Z2I+ P5XW1@RLI((R"!U!H \X\4:U?7WA7X
MA:7=23RV]E9026\ES"L<I6522&"@<97(R >>:W;S7-=\+>)M/34[Z+4=+U&V
MN7\N.V$;6SPQ&3Y2"2RE01\V3G'-:4GP_P!-N7U=KR^U*Z_M:V2WO!),H#[
M0'&U1AN3P/E]JT[7PY#'=Q7=]=W&I7$,+01/=!,(C8W85%49; !)';''- '*
MR^)]9L_"OA_Q8]TL\&H2VWVNQ$:[(XYR /+8#=N4LO4D'G@=K0U[5-/UWQ'H
M]]>-+<+#%<:0?+12Z2'RP.%Y(E(4D]B#BM.P\$V%A;6MDMU=S:99SBXM;&5E
M,<3 EE&=NXJI.0"QQQUP,:5]X?L-0US3=8GC)N].$@@8'C#@ Y'?H"/0\T <
MW=:IKMYJ&K:-ID]R;S2[>%1/''!B69T+@R!R,)T&% /WN>E=9I4M[-I-I)J4
M,<-\T2_:(XFW(LF/F /IG-8NK^"K74]>76K?4]2TN^:(0SO83!!<(#P'!4@X
MR<$8(KH;:WBM+6*WA4K%$H1022<#W/)^M ' ^-?$VL:)#KUY9WR,=.2&2"U@
MB#J%."_V@LORDY.T*P.,'!J[->>([_Q]J>BVFL0V=I;6MM=(?L8D;YG<,IR>
M<A.O;M5C5?A[IVK2:UYFH:E#;ZR%-U;0RJ$+JH4.,J2#A1QG!QR#6E8>&8;#
MQ!-K(U"^FN9K9+:19F0JRH20>%!SEF/7OZ8H YRTUWQ+KEG:ZSH\;F%KUU>W
ME\@0&W61D;YL^8),+G/3/&,5WLD@BB>1L[54L<>U<M:^ K"QU>XN[74=3AL[
MB<W,NF+./LS2$Y)VXR 3R5!P>XQQ75T <'H^L^)]:M]!UNRC=K*^97N[>;R!
M%' XX,;*?,+KQPW7G@<"F^%;*[?Q?XU!U:ZR+V%2VR+)/V>/!^YU'3T]JT]'
M\!6.AWNZSU'4_P"SUE,T6EO.#;1.3G*KC. >0"2 ><5H:=X:CTS4=5OH-1O6
MFU.02S;_ "R%8*%!4;.,  <YZ4 <)X/U6[T?X=>&8XYYYYM5O&MH_ECS#\TS
ML5S@%CLP-Q/)[]#L3:YXDTB=;'4<"/4-3@L].NYQ%YJHZLS[UC^3<-A"GH=P
MR."*T1\/=*/A"#PV]W?O;6T@FM9S(JSV\@8L'1U48(+'J#UI]QX#L+[0I-.U
M'4-2O9GD247\TX^T1NARC(P "[<G&!W.<Y- &'X]C\06'@/Q1Y^L;X%5&M)8
MU59S&V%D23"A<9)P5 ..IK:OM0U33O&OAO2?M_G6=[%=F<O"HD9HU4J<@ #[
MW0 =.]6'\&6EUX=O](U'4-0O_MT8CGNKB4>;@?=VX4*,'D<=2<YS4S>%HI-5
MTC4IM3U":YTM)%C9VC(D\P .7^3O@=, 8XQ0!A6FN:O%=>(M"O+XOJT-S&NG
M2>4@W0S#]V^T#YMI#[_9#C%+=ZOXAU.;7+707G%UI4RVT)*P&.:01HY,VXA@
M"7Q\@&,9YZ#II_#]A<>);37Y(S]NM;=[=&!XVL0>?<?,!_OMZUEW_@>TN_$,
MVLVVIZIIL]RJI>)93A$N0HP-P()! XRI!QWH Z*T>:6R@DN(UCG:-6D16W!6
M(Y /<9[UP=JTMA\2O%M_-?7+PVFFVL[Q!(_F0>>VS[N<#!QCGU)KOXHD@A2*
M)0D:*%51T ' %9%OX:MX/$5_K7VNZDEOHDAF@D\LQ%$W;0!MSQN;OSGF@#EI
M?$^LV?A30/%CW2S07\MO]JL1&NR..<@#RV W;E++U)!YX':[X<O/$>L:[J_G
MZQ"EGIFK26Q@2S7,T?E(0N[.5P6!SR>N>V-"P\$V%A;6MBMU=RZ99SBXMK&5
ME,<3 EE&=NXJI.0"QQQUP*OZ+X>AT.ZU*>&[NICJ%R;J99BA D("DKM48X4#
M'/2@#,^)4EQ#\.=>FM;J6VECM'8/%C.,<CD'&>F1SZ$5BZI:WO\ PFW@N"'4
M&$YL+[_29(E9E!6'HH 7/89'US7;:QI5MKFC7FE7F_[-=PM#)L.& (QD'UK+
MC\(PIJ6E:A)JNHS7.F120Q-(T9WA\!MWR=?E7ICI]: .<L/&&J_V-:VMRYN-
M1EUR?2/M,4:*S+&9#O"L0@8JF,=,G.#T/3>'&U\76I0ZRI:U216L9I3&)G0C
MYA(L?R@AAP1U!JC+\/=*GT6[TR:[OW6>_;44G\Q5EM[@MNWQLJC!R3U!ZULZ
M)HHT:!U>_O=0N),>9<WD@:1@.@X   R> .Y/4T 8_B[4]8L=8\.6>EW<$":C
M=O;RF2#>0/*=@>O;;T[^M<OJ7BGQ-HFG^++*YU%+B]T4VL]M>BW1?.BF;&UT
MQ@$889&,\5O>.;>XNM>\)"W2^ @U%I99[6V:3R5\IU!)VLH&2!SZUJ77@W3K
M_2]7L[R2XG?5L?:KDL%D.T )MP  %P,#'N<DG(!5N]5U./Q]/I$%TJVS:*UX
MBO$&\N42A,\8)&.Q/6N5_P"$A\7)\,[7Q:=:MGDN8;7_ $8V2@*SS*A;=GN&
MZ8(&.*["#P9'%JXU:76M4GO_ +$UDTTCQ_,A;=G:$V@YQT Z<Y)-8/B_PY_8
M_P *#X=TP:E>B*2W2 )$990BSHQ_U:=@"<D=J $U+Q/KO@W7[N+6+N+5;"72
MKC4(/+MQ"T4D."T?!.5(88)R15NXUW6-(C\+:E/>"\MM8N(;6Z@\I56)IERK
MQ$#. 1@ABV0?6M^+PY9W-Q+>W\DVH2SVAM,W2*NV%N67:JKC=QG(SP.F,5!I
MW@^TL(].@>]O+NUTQM]E!<,A6$A2J\A06VJ2!N)QGU - &)I?BRY?Q'_ &;J
MUW<6&H1RSL^GW%NHCN8%#[&MY OS8&PGYL_>X&*71]9\3ZS!H&M6<;M97Q62
M\@F\@11PN,@QLI\S<O'#=>>!TK<A\)VZ7%A)<WMW>)I\KS6L<^PB-F5EZA02
M &( )_/ Q4T;P%8Z%>;K34=3_L]93-#ICS@VT+DYRHQG /(!) /.,XH S_"_
MBBZU'7H]-U2[GLM61)#<Z7=0*@;GY7@<+\Z#G^(G'/;GJ/$-QJ-IX?O;C2K<
MW%]'&6BB&,L>^ >"<9P.YQ5.Q\*6]I<Z9//?7=Z^F(Z69N=F8PR[2254%CMX
MY_4\UJ:G8#4["2T-Q/;[BK"6 @.A5@P()!'4#J#0!P\7CI/["O[^RU&6\D6Y
MMK1;:\MUAN+.660(1*F$'&<CH#@C/>D\0S>*K;0?%!EN;F&P32I+BUNI3 MS
M',JG<F(\J5(Q\V 1SST-=!=>"=+U&WU:/4C+>/JD<<5S*^U&VQY*;=H !!).
M>N?8 !+/P9;PZ3>Z??ZIJFJ+=VSVK2WLX9TB88*J0 !GN<9.!D\"@#0\-120
M^&M-62XDG8VT9W.%! VCCY0!Q6K5'2--&D:7!8K=7%T(5""6X8%R ,#.T =
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MQI8WRQ^9?(D)!]1GK^5 'LNY< [A@\ YJJSWXU=(Q%;_ -G&!BTAD/F^;N&
M%QC;C/.>M>27NA:2OA_XE1+90B+399);&,#Y;5_LR/NC'1#NYR,5T=@L=Q\3
MM*DE"R/=>%V,V[GS,RQ=1WH [C3M2M-6M/M=E,LL'F21!U/!*.4;'J,J>:M!
M@PRI!'J*\3TR[L-'^'6F-&;:VMSKLD6KND2DI!]HG">:!SL#;!SQCCI6CK?V
M#0]"UF]T76/M-A=WMD=2%EM$%M$7"RE-G"LR_>P<X(/&10!WHU^<^/!X?-O#
M]F;3FO5N%D)8D2*FTKC ^\>Y_"M_I7GEDFBVWQEMSIGV*)9_#[\6Y4*Y\]-N
M ."=OZ#VJY\58X6\(122L4$>HV9\P.5V SH"<]N": .V!!S@@XX- 8'H0:\R
MN/#]EI'CG5;;28!#IMSH$DNH0(3Y?F[\1N?1R _/?:361#:Z?H?PP\+ZW'$L
M*W:V$6K7>"^;?:?OC/*ARH(]..G% 'L@8,,J01ZBH;M[@6-PUBL4ETL;>2LC
M$(7QP&(R0,XS7EFLC3]$T/7-2T35_M=E<7%G)J4=@%\F"'S )"@3HS)G=CG'
M/'!K4UNT\+2^'/%=WHD\$IGT9WF2SE!@78C&-L+P'/8]2%]J /0+=Y3:PM<B
M-)V1=ZHV5#8Y"D]1FI2RJ,D@#U)KR_4+>\DTO1[RPCT[5/LVA1FZTB]^7S(6
M S)$_(5_E(.1CI[5$^J:5J>NV=GJT\-EI5YH-O+IT>I1J5(.[S!EB ),&//?
M H [C4=>N+'QAHFC"UB:WU*.X8SF0[E,2@XVXQSN'.?PK>KS2UMK>R\2?#RT
M@OYK^".VU!(KFX(+2H$3:<]QC&#W&#43:8NC>(M5\&PV8%AXC<7=LZQ_+&G
MND)[8 ROH9!0!ZA2!E+%01D=1GI3 L5K;!40)%$F B+PJ@= !7CVB7^F#7O
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MUAND3INP!U'!^E 'I5(64$ D GH,]:Y+X73//\--">21I"("@9CDX5F4#/L
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MR ?2JEMHNF"]^&L@MHP]_9/%=N"0URGV0,%<]77('!R.W3B@#UH$$9!!'J*
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MTRPMDD2"QMHDE4+(L<2J' &T X'(P,?2BSTVQTZV-M965M;0$DF*&)44D]>
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MBJVGZA:ZKI]O?V,ZSVMP@DBD7HRGH:LT %%%% !1110 4444 %%%% !1110
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M9S@_>'3-68M&U:U\'^)O"4NG33W%[-=?8KH#,4J3DL'=OX2I8Y!YXXS7IE%
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M73I[J34I[N2QN% ,4JW .-[?P%23G..!QFKNCZ1>:-XVM6>WN9K*T\.PZ?\
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MACB>=3)&BDX*'[A.1D$C!([9QVKFM*\4^(-9@O[@:)IXL[.>[M9@]XVYGB)
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M[+<PSEY4+#]W(K@8!'4J!53Q!X;U6[UJPU[0]2@LM5MH6MY5N(C+#/$Q#%6
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MM1TG3]+L7@L'M6>>2[8;X9026 V?> &<=..O-7/&>J?V3IUC*^FVU]%+J%M
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MSO)$GE^<.,=>=G]WOGBG7OB_6QJ?B2ST_2K&3^QX(KA9);I@)4='?H$X8A<
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M0!';P1VUM%;Q B.) B DD@ 8')Y-2444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$C7(&YV &3P!0 ^BBB@ HHHH **8\L<;HCR(K2':@9@"QQG ]> :?0 4444
M%%%% !1110 4444 %%17%S;VD)FN9XX8AU>1PJC\34BL'4,I!4C((/!% "T4
MQY8XB@DD1"[;4#,!N/H/4T^@ HHHSB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\4^->E:-8#3M4E
MBU*'49+^-GUB,.XM8\GCK@8XVJ,'C/7.?:ZXG4/#GB7Q!I>JZ%KMUI<VF7DO
M[NY@5EFCBW!@NPC:6P,!MW'7!H Z\,MY8A[><A)H\QS)C.".&&>.^:\E7P3;
M:+\:]%?PP;F():R7&L,T[R!E;(7>6))9VSQ_LYQQ7=G2?$-KXEBGL-3MDT"&
MP\B+3GCY\X<*Q;&<=._;IWKFM#\'^/K'7!<WWBJQDLIKL7-Y%!:A9)L$';O(
MW8P N,_=&.E 'I=%%% !1110!6U"Q@U/3KFPNEW6]S&T4J^JL,$?D:\[;PUH
M(^-$-D-$TW[)_P (Z\GD?94V;OM"C=MQC..,UZ;7,-H&HGXD)XD#6OV5=-.G
M^5O;?@R"3?\ =QVQC]: .>N-.70?B9H]OH6G0/(NB7,<<;R>4@42Q;0S!2=H
M!P, GI[FK<OB^'5/#_A[4;O0893=:S'9/%+*&^R3K*T?F*=OS8*D@\'I6W=Z
M)?2^.K/7HC;&WM[&6T,;.P=B[*V[[I'&P#\:P(O!&L1:!ING>=8F2TUO^U2^
M]\,OFM+L^[P?FQGVSB@#:C\6-=Z_>Z596]M+-974<$\+W.R<(P0F54V\J _K
MS@\]JZ>N,UGPA=:YJ<%S=)8I/:WR7%IJ43,MS#$K!C%C;A@0&7EL8;H2.>QD
M+B)C$JM)@[0S8!/;)P<?E0!YK\1=3NDNO[3T^\5?^$7DBNY;8. ;EF'[Q,?[
M,+$_]M*ZCQ!XK72?#MEK5E:B_MKJ6W1=LNSY965589!S]X<<?6I-)\/B'2)(
M]6M+"ZOI7DDGD"[EE9V)ZLN0.<8YP *YFV\#Z_#X$MO#,EW82+:7L4]O,7?Y
M8DE$@C/R\D8VY].W'(!K+XIUU]=U#0ET&T_M""W2[A)OSY3Q,67YF\O*ME2,
M!2/<=:2R\?0:GI>CSVELB76IVKW0BGD(6%4(5LLJDGYF ''/)XQ5Q-%U*/QO
M=:^/LABFTZ.S6+S6W!E=GW$[>A+X_#/M7.6'@3Q!HNEZ!+I.HV":OI,,MJXF
M5V@NH'8,0V,,I! (QGI0!?3Q]>R6VC,/#TJ3ZA>R6+Q2S;/+D56;<I*C>A"Y
M#<<'IGBIX?'30V&K'4].6#4-/OH[#[-!/YBSR2!#%M<JO7>,Y'&":EO_  ]K
M>H7&@75Q=6<MQ87QO)\;D0YC9-D8P2  V<D\D>_&9J7@+4-3_P"$@<WEO;3W
MM_!J-C*FY_)EA554,"!D'9SCU]J (U>^@^+T]Q-IUJMR/#KN/(F)$V)UX9B@
M((Z=#QCZ">U^(&HSV'AW4F\/H++7&$,6V]!D25D9E!4H!M.TC.<^W8VHM \1
MS>*5UZ]ETI9!I;V+00F0@L7#;@Q' R/0^G/6JMMX,U6W\.>$M+\ZR9]"NHYW
M?>P$P1'4 ?+QG?G\/>@"W%XZ>W&K6^JZ?';ZA87<%J(H;@R1RM, 8R'* @8)
MS\O&T]>E0W7CV\LK#7YI=%WOI5N+I'CE80W$>"2 [(,,,<C![5#JG@74=3O_
M !!=K?06DU[<6MW8S1Y=K>6W4!2P( (..?3/>KE_H?BC7?"6JZ=J]YI@O+RV
M:UC6U6184##!<ELLS>W &/>@">T\5:C+X@M]*NM(AMS?6+W=D_VO=N*;<I(
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MQX<U#3K*]:RN;F!HX[A<YC)'7CG\J ,2W\;,NJ:CI][91>?9:9_:+"SN/..
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M:7,EH$<21>4[H6W(,2 !>V.^#0!WM_9Z?=1!]0MK::.'+[KB-6">IYZ?6K0
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M(B% SJI<[5!.-QQG _ '\JX+3;W5K/Q1X52?5[B[AUG3IGN(950(CHD;*R8
M(^\0<DYJ?QC;R3^-_!:+>W4"/=7(*Q. ,BWD.[!!Y[9/8GUH Z33=>M-5U/5
M-/@2=9]-D2.?S4V@EEW#;W(QC\ZU*\IU)+Z/5/B7?V.JW-C+8QPW,?D*GSNE
MH& ;<#E>.@QU-;*ZSJOB+51I=M,MLRZ/;7N4N/)9I)=^6'R-E5VCC@9;G/&
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MU56%XQU6%8;QFNY"945=O.3UP3SUYZXJY_PC%B=0TR^,ER;C38FAMF,O"HP
M8$=#D*.3Z5LJRN@=&#*PR"#D$5RVN>(=4L/&&C:'9P6<BZG'.ZRS%@8_*4$Y
M ZYW>U #KCX?Z#=:;=6$\5P\=Q>&_+F=A)'<$Y,B,.5/TX]JF?P5I4NC+IDK
MWLL0G2X>66Z=Y99%(*LSDEC@J,#..!4">*KFP\46F@:[8QVTE^K&QN[>4O%.
MRC+(<@%&QSCD'U[5T9N[9;H6QN(A<,-PB+C>1ZXZT 9C>&-.DU2[U&;SI9[R
MU%G/OD.UXAGY<#@?>/(YY-0VGA&QT^"QCLKK4(#91M#"XN6<A&V@J=^01A%
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MD@[FR,]ZW_M=M]J^R_:(OM&-WE;QOQZXZTDMY:P;O.N88]N-V]P,9Z9SZ]J
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MPVX"'+<_>''% %Z3PAIDAUDLUS_Q.4"7H$QQ(H78 /[OR_+QCBJ]_P" M%U
M:<S->P7.GQ>1;W5K=/#,(O[A=2"1]?ZFN@CNHF2'?-"'E'RA9 0Q[X/>N/G\
M7:K#:>-9!;69ET#YH!\VV1?)$OS>_..,4 =C:6D%C:16MM'LAB7:BY)X]R>2
M?<\FIJJ:7=/?:197<@423P)*P7H"R@G'YU;H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA_C!(D?
MPJUW>ZKNB0+DXR?,7@5W%,DBCE $D:.!TW#- &.OBG0UBM(XM4LYYIV2*&*&
M=7=V; & #GW/H 37G+NE[\,_$UKJ&!XGAO[ABN<3_:?,S;E._(\L*1V&!Q7K
MBVUNC!D@B5AT(0 B@VT#7"W!AC,RC D*#<!Z9ZT >.>-=0MI-,\96<TEO!JT
M6G6PNO.;?)<N(]X,*Y^5%))+ 'G/3&3O10Z'J_Q762:.QNXIO#J2MO"NLA\X
MC<0>&X[^E>C-!"[L[Q1LS+L)*@DKZ?3VI#;0%MQAC+8QG8.G2@#DOA3*LOPT
MT?9('5%DC!#9P%D< ?@ *H^*;VTMOBUX,,]S#$$M[[<9) N,HF,Y]<5WT<4<
M2[8T5 3G"C%,>V@D8L\,;,>I9 30!Y_XBDC\7^.?#%GH[BY@TB[-]?7D1W10
M[1A8]XX+,?X1R!R:P"WV[X3ZK;W.!XM@U"4L <7 O?/)B*]^5* $<;>.E>QJ
MJHH50 !T %1FV@-P+@PQ^>!M$FP;L>F>M 'F*7^B2ZMXMT+QO-#'=W,L1B65
MBIGM_+38L..20X<X7G<3WJ^UWI^F?$W4Q?/':K=Z#;B*.X8;I2)) 5']]N0,
M#)Z5Z ]O#)*DKPQM)']QV4$K]#VH>"&21)'B1G3.QF4$KGK@]J /%_#J:7>V
M'PI$PM9B8[F&0,5)($#_ "'VSC@^M+?Z?HP\(_$S;;V>;6\F-M@+^Y)AC;Y/
M[N7STQR/:O9OLUOA!Y$6$ "_(/E [#TI/LMO@C[/%@]?D'- 'E=WJ&CW>OZW
MIOBK6#8V]_86_P!CDE\H)/ 8@'".Z-\PD+' .<D$=*N6FEZ.WQ,TNTN(EN$7
MPQ@B_53+)MEC"F4$<MM]1_*O2'M;>3R]]O$WE',>4!V'U'I3FMX7<NT,98\%
MBHS0!XMILFGIX*\!3W+VWV6WU^:%I)2NR./-R%4D\ 8VXS[5NWMQ+I^ORWMH
M]EK&D7&L6XN+-QMN[*XRB*T9_B7A3M(!V^V:]+%M $V"&,+D-MVC&1WH^RV_
MV@7'D1><!@2;!N'X]: *UCK.FZG=WMI97D4]Q8R"*YC1LF)O0_D?R/I7)^.]
M2CTOQ#X:GU*[DL]&+SI-<A5*13E5\HON5@!CS #CC/:NNMM-@M;Z[O5&;BYV
MAVP!\JYVCCTW-R>>?H!9EBCGB:*:-)(VX97&0?J#0!YK-H?ABY\%7NFZ?>RW
MJ:CJ#R:;*73 NFPVZW*J $5@2<# P_7I5&75IV^&WB2V6,GQ+93@:U'"1YDP
M#KYDBXP2C19V^@X[5ZOY$(" 1)B/[@VCY?IZ4JPQ(Y=8T5SU8* 30!YUJMWH
M>K:)K>K>"Y5N=6;16A$E@YPD8Y5"HX63EMHQNX-9X7PCXAL9=3TK59+ZY31I
MX6M46$+'"4)"S(J#&& V@]^G&:]4AMX;="D$,<2D[B$4*"?7BJ6I:8+C2-0M
M+-(();N)T+[,#+ C<<=>M 'E^G:1ICZ1\-;[1(K<:P7MOM$L&#)) (#YXD(Y
M*C 7GH< 8SBNF^&[6,;^)+6+R%NX];O"\:@!U0R?+D=0#V_2ND\-:*-"T&QL
M'6![BVMH[=YXH]OFA%"@GOT'J:U5C169E10S'+$#D_6@#D?&>HV%EK/AI+PP
MPS27,K6]U=2%;>!A$P)<9 9B&(4$CDDYXYXW066[\-16NGZY:V>IVGB.\-F)
MXP87?,V(W3(VAD+$8Y'!%>OR11R@"2-7"D,-PS@CO3)+6WEC:.2WB=&)+*R
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M+7793;RJ%W0D/$1L/\/.>E>XJRN@92&4C((.0:B^R6V"/L\6#SC8*E50JA5
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M3D%CT7'0@9;%:VBZ387,OCV?3;.TDU>TU&=[!E52T,IMDVE/[I+$].I'M7J
MMX 21#&"7WD[1RWK]?>A((HF)CB1">I50,T >9^$)?#&MW/AN]L]8N9-7L8&
MC-D@B5XLIB19E"!MH(ZL>6QC)-=3\1G5/AMXC+L%!T^8#)QR4( KHX[>&*22
M2.&-))#EV50"WU/>G/&DB[9$5U]&&10!YI##96'CKPL=*2UAN+O1+D.8\ S-
M^Z9=Q_BYR<GWK/\ ";^'M<L?#J7NKW7_  D.G3?OK#$2SB;!6;S!LWF,Y8L2
M>1WS7K MH%8,(8P5Z$(.*!;0"9YA!&)7&'<(-S#T)[T >/Z1IEH/A5K>I:-9
M0R:K!/?1QRVZ@S)$9VW(A'(R@X ]>.M7KC_A&-9TO5M7T#6)[^\.@7,#0P")
M52(H2HE1$4A@>%!YZX& :]4CACB!$<:)GKM4#-)#;PV^[R88X][;FV*!N/J<
M=Z /++'2M+>;X?WGA^*V&IX1KR6VQE[;R#YIE(Z_/L W=S5Q-+DTOQ-J'@R*
MS_XE&MRC48V5/DCBR/M,9]B0@'IYWM7HT5M!;ES##'&7.YRB ;CZG'6LC0](
MU*UGDO-:U*/4+XIY2/%;^2D<><X"Y/).,G/.U?3D VBJ>64*KLQ@@CC%>/Z+
M:>'+3X:>(M7FTV.Y:VN-1B+6I"RK$TK#8KCE%VD=. "3CGGV(@$$$9![5&L$
M**RI$BJWW@% !^M 'E^EW5E<_$&]@CO-/NDN_#B*B68!B<K(^%7D[RH[_H.E
M95O-I,GPN\ R1O:&:WU735D==N4?>N\$]FP.1UQUKV5((8MOEQ(FU=J[5 P/
M0>U(;:W*A3!&5!) V#&3UH XB)-/?XUWBE;9I!H4+8PI._SY,GZX(_,5R,5[
M!IOAJ[FCD,6D6_C&X^W-;(K"*#<VUBN"-H?RST/2O9?L\&_?Y,>_^]M&:5;>
M%%95AC"L,, HP?K0!Y+KITFTT#6=6T'4[C4M/O+^R?6)(2C0"$,!+L\M0,E
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M;D8(!SC&,UB:CX5U<V5[=P:=))=:AX@M]2:V66,&&&)DZDL 6(0G@GDX[9H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA,@WD>NWK22:A90F02W=NAB&Z0-(!L'J>>* +%%5Y;ZTAM5NI;J".W;&V5Y
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MUC:= 0=N_=@?7"YQZ$>M %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"T.RO]4^$W@N72-7AMM;L9[N:S@N2/+N-LC!HSNXW;3P#V)Z=1ZS\-M2&K^
M-+OAIR:?YHD)MX_N*?,;)4=E)R0.P(%="VFV+PF%K*W:(]4,2E3T[8]A^565
M540(BA548  P * .%^+UYIUCX"FEU,WOE&XB"+:2B-F<-E0S$$!>.>#T]<5P
MOAC4(IO&'Q*5[NTD2YTY9@(/EBD_='+(">1\W7OG/>O<I8HYXS'-&DB'JKJ"
M#^!IK6MNS.S01%G4*Y*#Y@.@/J* /FC0X;.UT'X3WD*0Q7<NLRK-,H =E^T
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MH+<$00QQ ]0BA<_E4CHLB,CJ&5A@J1D$4 <"]W8M\2]+A?[*VAS:3*-.*[3
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MH9%V2!#D!U/((R,9&<'@X-</:^'==?X;Z;;1Z?+%JFE:O_:0LY65?/47#R!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &5K7AW3O$ MAJ*3.ENY=42=XU;(P0P4C<".QX_6
MM0 *    . !2T4 %%%% &78:#::=K&H:I"\YN=0*&X+R95BHVK@=L#CBM2BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKE/'OCFT\#:/'=2PFYNI
MY%C@MPVW=DC+$X. ,]?4@=Z .KHH/ KD=%\<KK/CK5?# TNXM9-.@6622=UR
MQ.W "J2,88'.?P% '74444 %%%% !137+B-C&JL^/E#' )]S@X_*N?\ !WB6
M?Q3I,U_-81V:QW$MN$6X,N3&Q4G.U<<B@#HJ*3(YY''7VI<T %%)D8SD8H)
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M!&,*<<#'I0!Y9X3_ +)URS\.:E-K<</B"VN!]IBBC5;N2;E98Y>=Q4\D\<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6?JVN:?HB6SZA*\2W,ZV\16%W!D8X53M!QD\<XK0K&\
M5Z)_PD/A?4-+#;)9HLPR?W)5^9&_!@I_"@"6'Q%ID^HZC81S2FYTY!)=(;>0
M;%()!R5PV0#C&<XJK<>,=%MH1*\\Q7[(+UPMM(S1P<_O'4+E1P>HSP?0UQZZ
M#XBO=2TG6IX#%<:W;FSUJ#=Q;PX#+CT("NO^]+5WQ;#JMWJVL6":1>26L^D&
M.TELD"^=+A\K+)D$!<C"YP<MP20* .BU'QKH&ER0QW-XV^>V-U$L4$DGF1
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ML,!8\#DLQ/'T/7I6!#X^O+S2?"E]9Z1$W]NR&(I)<E?)<([8^[RN4//7'8T
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M9P8G\Q!SW![C/ K&\%ZI=Z?\./"4<$,*PS61,U[<OMBMPH^4$9!)8G ^A^A
M/1:*\YNO&>K:KX<\*:GIT4%M_:>K+:7$;NQY5W! 8#[I,1R<9P<8ZUI:GXTO
MX%U%M+TI[]M-E$,T,4,S-.X"EQ&RH5&-V!GJ0>!P2 =I15:2>:33&GMD"S-%
MOC2X!7!(R PZCW%</X7\7ZC/X7\,B\6"?5M<W& [R% "L[NW'  & H]0,CJ
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MY8X/7 H ].HJKIE\FIZ59ZA&I6.Z@295/4!E# ?K5J@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M+Q9H4WB'1DM;:Y2WN(;F&ZB>1"Z[HY X# $'!QCK6[10!S$.@:I%XNN->>ZM
M)&FTY++RPC+\RLS[^IX)<C'H!R:Q+?P!JVFZ'X=73-7MX=8T-)(8YGA+0W$3
MXW(Z9R.B]#QCWX]"HH HZ5;WUO9_\3*[2YO)&WR-$A2-3@#:BDDA1CN22<GO
M7*W/@S5H+CQ'%I6I6B:=KPDDFAN869H9G38S(0PR&P.O3'?I7<44 <#'X%UB
M$HBZS:/&VBII4ADM&)C"@C?$-_R[@1G.>5!]A:MO!VJ6R^$Y5U2U^TZ';/:2
M$VS;98V1$RHW9##RQR3@Y/':NODG2-_+SNE*,ZQ C<P&,X!]R!^(JAX=UVW\
M2Z)#JMK%-%#*\BA)@ X*.R'(!(ZJ>] '/Z-X4U[0[J6PL]<@_P"$=>X>=(6M
MS]IA#,6:))-V N2>2"0#Q@\UO>)])FUWPQJ6DP2QPO>V[P>8X)"!A@G Z]:U
MJ* .3D\*WESK6B7MQ-;-#I]C-9RQ!6S*) @)![?<''/4\U#X;\->(]!AATN7
M7;>ZT:SXM5^SE+AE'W(W?=C:.!PN2!Z<5V5% '&67@:3_A7]YX5U&\1EG>5T
MN;=2I0O*90<$]58COSBIK?PWK>J:->:9XKU:VO8)K9[4"SMS"7##!D<ECE_0
M  #GKQCK:* .2M?"VH3PZ';:S>6]S#HLJS1/$A5[AT0I&S@G"X#$D#.3CH.#
M<\.Z%>Z1JFMW5S/;RQZG=_:@L:D&([%3;SUX4<\?2MYY8XVC5W56D;:@)QN.
M"<#WP"?PI] '+>(-.:W\6:'XE0$Q6BS6MWC^&*0##_175<^@8GH*KW'AG7;3
MQ/>ZMX=UFTM[;5-C7EO=VQE"NJA1)'AAR5 X/''>NQH    & * .5UOPD^OV
MMS9ZA<+-;+:B*R+$^9#,/^6S'N^0N",8P?[QJG>^%/$%P-$U2+6;1?$.EH\+
M7#P,8;N-P P= <@_*#P>OUX[:B@#C]7\*:QJ$.F:A!K4<7B'3YGF2X,!,#!U
M"O%Y>[(0@#N3D9ZFLCQG#JEMI?ALZCJ%M-J4OB&T;<L92!#\V%52Q.WU).22
M?8#T>L3Q'JNGZ2-/;4+!KI;N\BLXV6-6$;R,%!;<>!D]L]* ,K5/!DFO1Z]/
M?W,45[J>GC3HC$"R6\0W,.N"Q+,2>G  [9/2:7!>6^FP0W\T,URB!7>&,HG'
MH"2?U_PJX!@8'2B@#A9_A_/=:;KNG2ZFB6]]J#:E:21P'S+>8LK@DEL, R],
M#()YK:M]#N[K7K'6M8DMFN;"WDAMX[8-M#2;=[DMSDA0 .W/)SQT%% &!XGT
M&ZUIM)GLKJ&WN=-OENT,T1='&QD*D @]'SU[5E3>#]2F7Q>K7MKGQ!$(PVQO
MW.(1%D_WN!GMSQ7:44 <1-X1URTO=,U71-5M+?4;>P33[N.X@:2"XC0Y5L!@
MRL"2>O?'UZZP@FMK*.*YN3<SC)DE*[=S$Y.!V'/ YP,#)J:66.",R2NJ(O5F
M. *?0!Q>D>%->T2\GL;+7(!X=EN'G6%K<FXA#L6:-'#8"DD\D$@'CGFGZ[X0
MOM;66\-[!!K,-TDVFWBHQ%JB_P &W/S;@6W?WMW/  '8T4 <Q+X:OKCQ9%K4
MEW;!)=-%A>P>4QW@.7RAW#&=Q'.>*J^&O#/B+08X-+FUV"YT2SXME^SE;ED'
MW(W?=MVC@<+D@8X'%=C4%[>V^G6%Q?7<HBMK>-I99#T55&2?R% '$R^!=3E\
M*:CHWVZT#WFJG4?.\ML)F<3;,9YY&,YZ'I6YI^@7MCXPU365NX#:ZE'#YUOY
M1+J\:%1M;.-O.>F>*MZ7KC:E>RVSZ7?VFV%)XY9XU\N5&Z8921N'=3@UK4 8
MVNZ7<ZHT40CL;JP,<D=S97B$K*6V[6!P<%<-V/WNW6L"/P-?:;:>%_[+U&$W
M6AB6,&[C9TDCE&&& V1MXV\]!@UW%% 'GK_#S4OL5RT>MQ1ZDNLOJ]E<+;'$
M;L,%'&[YE(R"!C&>]:.L>&==U[PQ-87^J69O9YH)&>*!EAB6*17"HI8DDE>2
M3W]@*V].U^WU+6]6TJ."XBGTPQ"4RA0K^8I92N"<C [XZUK4 <]!H=XOCF7Q
M#)-!Y4FG)9&!0=PVNS[MWU8C&*76M"O-1\2Z#JD$\$<>ER2NT<BDF7S$*$ C
MI@'/>K6MZ_;Z$VG"X@GD%]>1V:-$%(1W. 6R1QUZ9Z5K4 <A?>&=<MO%5UK7
MAW5K2V74$C6^M[RV:52R#:LB;64AMN!C.#BLTK>6_P 7HX+2>&>:/PXJO]J8
MAI/WY^;*C@YYZ8Y[5WPEC:9H0ZF5%#,F>0#D X]\'\C44EO!&[W2V:27"@D%
M47>QQT!..?J: .1B\#7-I<:'-;7D#26-_/J%T\D9!N)9@X? !^4?.<=>@JQJ
M7AK6X?%4^N>'=5M;4WL217MO>V[2QN4R%D7:RD, <8S@UTUC?6^I6B75K)OB
M8D<C!5@<%2#R""""#R"*L4 <AX@\)7>NV$^F7<MG>V<UJL2O>1DRP3_-F=2.
MYR/E&W&W@@<5!_PB.NZ5KLM_X>UR".&]BBCO8K^W:;+QH$$J$,OS%0,@\$C-
M=M10!S4?AZ^@\8QZVEU%+''I8T\)+GS'(??O9AQR1C&/?VK'L_ FI6>@>'[.
M+4K47FC7\ETDK0,T<BOYF05W @CS#W[>]=5XAUR#PWH-WJ]S!/-!:H9)%@ +
M8'?D@?K6C&XEB20 @,H89]Z . O? 6M7,&J6ZZU:&.ZU2/4HY);5FEW*Z,(W
M(< J-F!@=,=*W+?P_J-EXLU+6;>^MFCU"VACFADA(;S(@X4A@W"G?DC!/%2Z
MGXOL=,L3>FWN;BU%VEIYT*J5,C.(^Y&0&."1WSUP:W)Y## \BQ/*5&=B8W-]
M,D4 <+IW@&]TO2O#/V>_@.J:!YD<<IC(BN(I.'1AG*]L$9P1T.<5/K'@:YU7
M2M=7[7;QZEK4L#S2["4B2$KL11G+?=/)QRQ.!P*["RO+?4+.*[M91+!*-RL/
M\.H/8@\@U/0!RUYX=U6X\47&MP7MM;R2:0VGQ@(S&-RV\29XSANWIWIVC>%O
ML'B>ZUYX[2VN+FU6":*R4JDS!MWFL#_%V'4@9Y.>.GHH YS5M!U*Z\5Z?K5C
M?V\:V]O);O!<PF15WD'S$PPP_P N,GL:Q-,\":IIVE^%[)M2M)AH=T\X;R67
MS5*NH7J<'#DY^G%;\WBN"/Q%-H4>G7\]_% +DK&L>#$6*A@2X[@C'7VK2TW4
MEU))R+:XMG@E\J2.X4!@=JMQ@D$88<@T <=J'P_O-1?69CJ,,%S=:E!J=E+'
M&6^SS1*JKN!/S A>>G6M33O#^M+XQ'B'4KZP9FTY;)X+:!P.'+Y#,WJ?3V[9
M/544 9'BC0QXC\.7FF>;Y,LJAH9L9,4JD,C_ (, :S8/!5M;>)].UB*X<"VL
MS;RQG_EX<'*2-ZD;Y3]6![5U-,26.1I%1U8QMM< YVG .#[X(/XT <)KG@35
MM47Q+!%J]JMMK#QRJTMLSRQ% N(]VX#9E<@8XW'US6U8Z#J,'C.YUVXNK:1)
M[&*T:-(V4Y1F;<.3P2Y&.PQR:Z2J6J:I;:19BYN2V&E2&-%&6DD=@J*/<D@>
MGKQ0!S=IX0U"+P_XETR34DBDUBXN+B.XMU8- 91TY/./7C/M4>G^$M:M-;L]
M5DU#3=\&E-IS6\-JR)C<K*5^8XY'/MP!WKHM-U>34(;MGTN^M9K:4Q-#<(H,
MF "&1MVUE(/7/J#BLBQ\>6&H:2VK0:;JS:>C.K3K;;MI4D-\JDL<$'H.U &=
M:>!]1M= \*Z6+VU8Z#=+<&38P\\*KJ!C^'ASSSTJ9_!FHC2?%>F1:C;?9M;D
MN)(]T+;H3,H5LG=\V.<  =>375Z;J5EK&G0:AIUS'<VDZ[HY8SD,/\\8[4NH
MZA;:5IMSJ%[*(K6VC:65S_"H&30!R5UX2UN"^TO5]%U2TMM3MK%;"Z2XA:2"
MXB4Y4X!#*022.>^/K?U#P]?ZA9+9WTECJMK) R7,-[$0K2%B0Z8SM R0!UQC
MYLC)T]-UE]0OKBUETN_LVA1)%DN$7RY5;.-K*2,C'(ZBM2@#-T/2VT/P[8Z4
MMPURUG;K")9>"Y48R>N/UKGK+P/)_P (%>^%M1O$9;B2:1;BW4J4+RF4'!/5
M6/KSBMWQ+K]OX8T"ZUBZ@GFM[9=SK  6QG&>2*TS+&)EA+J)74NJ9Y(& 3CV
MW#\Q0!SNCZ;XHBMW76]8LKR2.(Q0?9[=H@Y/\<OS')]E  R>O&,?3? ^L:7;
M>&$M]5LV?189+=EFMV>.0. !(%##:X (Z]">F:Z?6M?M]#FTV.XM[B3^T+M+
M.-XPI5';.-V2#C@] >E:U ' V_@+4K;PSI>F)JULUQIFK'4+>5K8[6!>1MK@
M-DG]X>1CH/K5I?"WB'3=>OKK1=<M8;'4W6:[AN+4NT<NT*TD6& !8 <-D ^O
M2NTHH 8L06 1;F("[<L<D\8Y/<UP=CX U"QT;0(DU2W;4/#\K&QF$!5'B8%6
M20;B<LIY(Z8''KW]% &+I.AO::SJ.M7;QM?WZQQLL0.R*.,':H)Y/+,2>.HX
MXK.UCPQJ5_XFDU.UU*"."?3FL9(IX#(T66)+QD, "<@'/]T=<8KJZ* .(TKP
M;JEA-X3>6_M)AH-K);,%B9?-#HJ9')Q@(#[DGI6QX6T*ZT)-56YGAF^VZA-?
M+Y:D;/,.2ISUQCKW]*WZ* ./N_#.NVOBJ\UCP]J]K;1:D(_MMO>6S2J'1=HD
MCPRX;: ,'CBJ^J>"=4O+S6##K$1M]3TM;!VNH#)+%A67*,&  ;=EN.HKN*0G
M )QGV% '(Z=X6U.TU_1M2GO;246&F-I\BI$R^9DH=PY.,; ,<YYZ4[_A%]0%
M_P"++@75MC7(T2-=K?N=L7EY/][CGMZ>];&@:];^(;6ZGMX)X1;7<MI(DX 8
M/&=K="1C/O6K0!PTO@O5[>P\.3Z5JMO;:SHMI]C\R2$O!<P[5!5UR".45N#P
M?SJY=>&M8O+_ $&^N-2MI;G3KI[J;]TRHY:,Q[$&3L4 ]R23R>M=;10!#=VL
M5[93VDXW0SQM&XSU5A@_H:X.'P-X@31]%T=]:L7M-&OH;BUF:U8RO''G:C@.
M!D @<=?;OUFA:_;Z^E^T$$\)LKQ[.59P =Z $D8)X^:K<=Z[ZK/9&SN42*))
M!<LH\IRQ(VJ<YR,<\=Q0!Q,O@/6FB:%=9LRB:TNK1226C-(Y#[MLAWC( ^48
MQP!TQ6A=^")+[4?$HN;Z-M-UZ"-)HUB(E1UC\L%6SC' ;IUKL:* .5T?3/%5
ME9LFL:]9W7V:%EMI(K5D+MMP))OF.[']U<#OZ5J^')-4DT&V;6C&U_\ ,)'C
MC,8<!B%;:>5RNTX/3/;I6K10!Q=[X.U"[/C$"\M57Q#"L*Y1B8 (O*R?[W'/
M;FK2^&K_ /MWPYJ#W-MMTFTEMG0*V9=ZH"P/;&P''/6NJJC-J01[#R+:>[BO
M'VB: !DC7:6#L<_=.,9&>HH =JVFV^LZ/>:9=+N@NX7AD'LPQ^=<O!X!1'\.
M7$]^\MWIF[[9-C!O-V&(;V$B1L!Z+BNTHH YUM"OE\<3^((YK<QOIRV*P,&!
M&UV<,3]6QC'XUB6?@;4;3P_X7TO[=:N=#O1=&3RV'G !P%QGY?\ 6'GGH*[*
M]O7LWM%2SN;D7$XB9H5!$(()WODC"C&.,]15N@#C8O"FMZ9KVIRZ-K-O;Z5J
MLYN;B&:W+RPRD .T3!@!NP#\P(![&G2>$[]KSQ9,MU;;=<MT@C!5B8=L9CR3
M_%D'/;ICWKL** ,_0K"72M T_3IY$DDM+>. N@(#;%"YP>F<=*T*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *YGQAJ\NG/H=G',;>/4]22TEG4X*J59L ]BQ4+GJ,G'.*Z:L_6
MM#T[Q%IDFG:K;+<6KD$J2001R"".01ZB@#F]6BN-#L+^%O$TZQW-Y;_98BAE
MGC5V"F%&+;F,A5@K'[N3SQD9=M?^(7_X3+3K%Y/M%E<6ILX+JZRX61$9XO-.
M<%AN .3M+<'BNG;P3H3Z(=)DMII+<RK.9'N9&F\Q<;7\TMOR,#!SQTZ4#P1H
M*O>2+:SK)>>49Y!=R[F:,@HV[=D,"JG=U..2: .1_P"$P*:;)%:OJ%G=RZM;
M65S::G(PDL1(O02'=\K;3AN?O9';'6>'['6-/U?44OKZ.2QF"26MJ;EYY8#T
M?YW4$J3@C.<<U9N/">BWEA?V5[:?:XK_ &_:C.[.TFT87YLY&,<8QCKUJ70_
M#NF^';9X=/CE&_&^2:9Y7;'0%G).!DX'09/K0!S?V0-\:I6,]S@:&DH03MMS
MY[#&W.,<#CIGFN5T%[[2_!OA?4[74[M/,UYK1[8,!"T4EW*K KCD\YR>1VKT
M^[\/:;>ZS#J\T,GVZ&(PK*DSIE,[L$*0&P>1D'!Y%4D\$:"FEVNFK;3BTM;G
M[7#']KE^27=NW9W9^\2?3)H YI[G7O$T>NS:9J$5C=Z=J4EO%(]XZI"L1'#Q
M!"K!ER<L<_-QC%6=0UBX\*^,)I-0N;BXTW5;)GLHO-)6.YCY:%/]\$%<]P0*
MV[KP+X>O-=;6)K)OMDFWSBD[HD^WIYB A7Q[@U'<VU_KOB&""_T5(--TRZ%U
M!=23)(;APA"%5'*8+$DG^Z.N3@ U])MIM.T6VAO;II[B.(&>>1R<OC+')[9S
MCVK@=)U74?[?\(F/4KN[MM4%TL]U(VV.[Q&75XXB3Y:@@8Z9'8CFO3&570HP
M#*PP0>A%<U:_#_PW9&Q,%G,/L$C26NZ[F;R=P(*KEN%P3\O3VH XZWU'5[+P
MKXB\32ZYJ%Q/I-Y?P00.R^2RJY12ZA>=O7C XZ=<]7I5EK-OX@M;TZE$VE7-
MN5>W>]>Y,LGWEDC+(-O&<@?+CMQ6MI_AK2M,L[VSM[=C;7LCR7$4TKRK(S_?
M)#D]<G/K5?0/!NB>&79]+MI(R5**)+B241J3DJ@<G:,@<#&<#TH Q/&%H+GQ
M[X*#3W**\]TI$4[(.+=R#@'KVSUQQ571;74=6U3Q*]UX@U7R],U62.&*.545
ME\A#M;"\@%L@#&"/<UV.K:#IVMO:/?PN[VDIE@=)7C9&(*GE2#@@D$=".M)I
MF@:=H]S>SV4<J27LOG7&^=W#O@#.&) . !QZ"@#A-.UO5)O#7PYOI+^=KC4+
MF.*[;?Q,IAD8[ATZJ.:FM+K7_$FG2ZS8:C!93VNI3*YEO'\N.**5E,4D(3;R
M@!R3G)SD#@=#;_#[PY;"T6.TGV6=Q]HM5-W*1 W/"#=\J_,?E'!XST%2GP-X
M>_M^36A8LMW+()90DSK%)(.CM&#M9N^2.O/6@"?Q==FS\-W$BZB=/=GCC6=(
M_,?+.HVJO=FR5'H3GM7$W6JZO;V?Q#MX[N]LQIMA%=V:R3B:6!FAD8C>=W4H
M#C)QDX->A:SHUAK^F2:=J4'G6TA5BH<H05(((92""" <@UEMX%\/M]N+6L[&
M_MQ;W;-=RDS( 1\QW9)P2-W7!QF@#G8;[4='\2>'I)-3O;V+4M)N)[F"9P5W
MQ)&RE !\I^8CW[Y/-9%[+-K7@WP;XAN;Z>2ZO=:L)I464^4-TP^0)]T!>!D#
M/').37HB^%]*2]TZ\$4YGTV)H;5C<R'8A !&-V#D =<]!6</AWX;5?+6TN$M
MQ<B[2W2\F6*.4'=N1 V%.>> * )O'.MS>'_"=S?P2")_,AA\X@$0B214+\\?
M*&)YXR!6+XNN;[P7HVKZQ9:Q-+$UK&L-I<DS&&0R*C3AF). )%)7&,@>M=I?
M:?::GI\UA>P)/:SH8Y(I.0RGL:RM,\&:%I6G7%A#:-+;W$?DRK=3//F/H$RY
M)"C/0<4 9%])>Z'XU\/65I?7<]EJZ7$-PD\IE*.D>]94+9VG@@C[O(XKF;5M
M:E^&&K>)'\3:M]MM8-06-0Z;#LE?:2-OWALQD8X.!7HEAX;TW36C:%9W>&$P
M0O-</(T,9QE4+$E>@Y'/ YX%0Q>#]%@\/W.A1V\PTVY+F6$W4IW;R2WS%L@$
MDY /<T <Q--J&ER^'[4ZM=W3:](#*;JY\I4*0%O+C94)3<<'N>, Y.::]WK>
MB:IINA:GJJ&VU35&6.1)V>:"#RF=83(0"2SK@-][!/.<$=9J7A31M7T*'1K^
MU:>RAVF(/*^^,K]UE?.X$>N:@E\$>'[C0#HL]DTMH9!,6DF=I?,'1_,)W[AT
MSGIQTXH Y7QOI<]GX:F@FUJZNH_[9LY((S(P>"-YD&QFW9<9W$%NG'H#7>WK
M+I^B7+_:_LZP6[M]IG)?RP%)WMGKCJ?I5 ^#]$?0)-%DMI)+.5UDD+W$AE=P
M00YDW;]P*K@YXP!TK3?3K272WTV6+S+22(PO'(Q;>A&""2<G()R2<G- '!:+
MJ6I0^*M+M1>7;6MYH<MP\E](2)I4:/$VPD^6#O)V@C@\@8JSX0U>Z.O0Z5KB
MZE9:TEDQEAGE,MO>D,F9H7S@8Y^4 8#].*VK7P'X>M);26.UG:2TA:"%Y+N5
MRL;8^0EF.5&!@'@=L5?L/#NG:;/!-"DSR6\)@@:>=Y3%&<95=Q.,[5YZ\"@#
M)UK4YI?'6C>'3++!:7-K/=2-$Y1I63:%0,,$ ;BQP0>!VSGD=>N;ZX\&?$/1
MKVZN)XM(#?9K@N0SH\(<1N1][;NQSU&,UZ1JNAV&L-;27<3>=:R>9;SQ2-')
M$Q&#M92#R.".A[U!/X7TFZT6ZTF:WD:SNV+7(\]PTQ/4NX.XYX')Z #H* +6
MCVZVND6L:R2N/+4YED+GD#N:XGPYJUVVOVND>(#J-KJDT4Q619VDM-17KOB8
M'"$#G: , ]^*[ZUM8[.UCMH=_EQJ%7>Y<X'N22:S=/\ #&F:;):/!',WV-&2
MU$T[R" $8.W<3CCCV' P* .$L-;U67P+X*U"34;EKNYUF.VN)"_,L9FD4JPZ
M'A1^5:]E/>>*+37+N/7)M,N].U:6WC93F.".%AD/'D!]Z@DENF[CH*U1\/O#
MBA%%I/Y<=U]LBC^UR[(9<ELQC=A/F).%QS4TW@C0)]=?66LF%W(5:8).ZQS%
M?NEXP=KD>X- '':C;7$OB+XBW%OJ5Y926MI;3QM:N$)=;=RI)QDCCIT.><UW
M&F:M+)X)L]9N%\V9M.2ZD51C<WEAB!]30_A32)+C59VAG\S54$=X1=2CS5 V
M@8W?+P2.,<&M'3]/MM,TZWL+5&6VMXQ%&C.7*J!@#+$DX'K0!Y?>M-JWA;P+
MK]Q?SRW5[K%C/,HE/E9=L[ G1=O0$<\<DY-6];UB_MYWO['4[JY\OQ#!:M*K
M>7!'&TB1M;^7DAR,G+X')X.1BNE3X=^&XU2-+6X2WCN1=Q6ZWDPBAE!R&1 V
M%Y.>,4^?P!X;N&NC)938NKD7<B+=2JHF#!O,50V%8D#)7!- ')7=Y+X?UWXD
M:S;RW$D]C;V\L223,R F%CRN<%03G';M73:59ZS#K]G?#4XFTJYMRLD#WKW!
MGDQN62,LBA> <A?EQVXK6_X1?1_[3N-0-F#/<P""<&1C'(@4J R9VDA21DC.
M"1571/!^B>%O,FTFRF#["J(UP\FQ2<E(P[80$@=,=L]* ,SPG-)'X\\<:>I/
MV6*ZMKA!V#RP O\ JH/XUT^L7 M-%OKDW:68BMY'^TR+N6'"D[R.X'7'?%<_
M+X-CO-!UBVO426[UBX^T7)$SHJL-H10RX8JBHH[;L'IGCH7TRWN-&.EW@-U;
MO;_9Y?-.3*NW:=WN10!P^A7NI'QE9::;S4!:7FA-<%[B3<\DJR1KYRJV[R\A
MS\O3IE1BLC1-2UE?#?@;79M;OI[F_P!12TN8Y''E21OYH.5QU&T$'K^' [FT
M\#Z#8W-K<P6]R+BU@:WBE>\F9Q&<?+DMD@8& >F.,4L?@G08M-T[3X[:=;73
MIQ<6D8NY?W4@S@YW9.,G@\<F@#A?$5Y-XG^&OC34Y[NYC>VGNK:*".4JD<<1
MV[63HQ89)+9/S<8P*[WQ%>SZ=X!U2^M21<6^F2RQ$=F6(D'\Q4%[X"\/7\^H
M2S6LRC41_ID45U+'%.>FYD5@I;WQGOUK=6QMET_[ 8]UMY?E%'8ME,8P23D\
M>M 'G.O6ZP_!7088&VC_ (E>UP,\F6+YO<Y.:U].&I:)\2!I!U:]U'3K[3GN
MRMVP=H)4D5<J0!A6#?=Z9'%:=CX9A/AA?#.JP_:K&V"1P2;RI:-#F/D$,KKA
M1D=P"#S@:5MI5MI?GW5M#-<7;H$:268O(X7.U=SG@#)..G)/4T <[X&FD76O
M&-ADFWMM89XO13(BNP'_  (D_P# C6;>C4[[Q/XTL_[=U&"WLK&VGMT@D5/+
M=DE/! SC*CZ]\UU_A[11HUG<>8RO=WES)=W3KT:1SR![ !5'LHI&\,:4]]J-
MZ8IQ<:E$L-TPN9!YB*" ,;L# )Z8ZF@#DM#\07OB'4O#6EWUQ+''<^'4U2=X
M7,33S,47&Y<$ 99L CJ.PK:\$:CJ%TNMZ??S/<G2]3DM(;EP-TD>U67<1U8!
ML$]\>M7AX/T9;738(H)8O[,7992QW$@DA4C!4/G)4C P21P/2M.PT^UTRV^S
MVD7EQEF=LL69F8Y9F8\DD]2>: .'E2]?XWW8L;BWA?\ X1^+<9X&E!'GOT =
M<?G5_7K37CX(O$@U)CK]H7NE-J3&)5$C,J;<D@,@V@9.#WXK7F\):3/K<NLL
MMXNH2Q"%IHKZ9"8P<A<*X &><5>TW2+32A/]E$Q:XD\R5YIWF=FP!]YR3C '
M'04 <9J7BPR^&-1\6:3/(;2VT^,0!G)3S7 9F9>0=BNGX[@>E6)++7K2:YO(
M]86'3Y].DQ&+UKES,!N66,N@"\9R!QW %=1::%I=EHS:1!91+I[B0-;E<H0Y
M)8$'L2Q_.LW2O N@:-:W%O96TZ13Q&$AKJ5RD9ZHA+$H/9<=!Z4 <CHM[JL0
M^'M_+K-]<-K$'E7D4K@QL#;&0$#'#!E'S=3DYK9^&UJ(8?$#^=<R$:W>1#S9
MF?A7P#R>OOUK;C\'Z+%'I,:03A-)_P"/(?:I?W/&W^]SP<<YXXJWIV@:;I-[
M>W=E T4M[*9IOWKLI=OO,%)PI.!G &<<T 8*WDNO>.==T.:ZN;6WTVUMVA6W
ME,3.\H<M)D<G;A0!TZY!KD;R\O?$'@GPU<ZK/,;N'Q'#9O-$YC$P2Y*>9@<9
M.WKV.<8KTF^\/:=?ZE'J4B2Q7T<1A%Q;S/$[1DYV,5(R,\\]#R,5'>>%-&O;
M"QL9;5EM;&1);>.&9XPCJ<JWRD9(//.>>: -:&,0PI$&=@@ #.Q9C]2>IKB?
MA*0/ $1)P!>7?_H]Z[5HE:#RBS[=NW(<AOSZY]ZY^U\":!9Z<VG0P78L6+,U
ML;^<QMN.6RI?!!).0>#F@#SGPIJMS86<\.GLL6E:SXLN8;.0RF)3#L9@$< [
M0SH%! ]<8/(U_&.FZM:_#WQ?#J>HB:!8A/9PI=/))"A&"CN0"Z[@2,Y[^E=[
MJ?AG1M7T,:+>:?"VG*%"0(-@CV_=*[<%2.V,55_X0K0CX?GT1[>>2RN#F</=
M2EY?]Y]VXC@<9QQ0!G:DC1ZKIVDP:C?2DV<LILHIV61N5 E>;<"J+DC'.2W0
MXXP=$U_5;W3OAS>3WTS2ZA))%>8;"S!89"-PZ9RH.:[2Y\)Z/>7EG>3PSM<6
MD1ACE%S(&:,G)1R&^=<CHV15<>!?#Z:-::5%:S0VUG/]HMC%=2K)$_/*N&W#
M@D8SC% '#^)KRZN/ OQ)MI[F6:*TN_*@$C;O+0QQ-M!/.,L:Z*2T$GQI1S/<
M@#0_-""=@N1.HQC.,' R.]:S>!/#KV6I6;6<OV?4G#W:"YE'FD #)PWL,^O?
M-7I?#FF3:K9ZG)#*U[:1>3'+Y[Y*9!VMS\XR ?FSSS0!@?$5&D3PNB2M$S:_
M; .H!*_*_(SQGZUDG4;S3&\:Z9)X@NH8;*6T^RW=POGRQF95RB]V)/"CL6KN
M-6T*PULVAOXY'-I.MQ!LF>/;(.C?*1DC)Z^M4;OP5H-^=4-U:22G5/+^U[KB
M3YRF-A'S?*5P,%<4 <U:7NNMJ?C+2[*:6WEAL[:73XKZX\TPR2+(,%R6QDJO
M&6 /Y5J^#-934-0U*UFBU2QOX(XO/TS4)#(83\_SQR$G>C=,@_P]LU?7P/H"
MRW4OV6=I;N!;>>1KN4M(JYP2Q;)89/S?>QQFM*QT>TL+F6ZB$CW,J+&\TTK2
M.47.U<D]!N)^I)ZT <\+R77?'>M:'-<W-K;:=9V[PK;RF)I'EWEI-PY.W:H
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MJ"ZE CDY^8?-[GCIR>.:ED\'Z++'JT;P3E-6_P"/T?:I?WW&W^]QP,<8XXH
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M HHHH *1F5%+,P51U). *6O&_C5K-S=^%REE<B/3XM1BMIMIYN9 26'^XA4
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M[L%O)&TAMH;GD9((XQFM)?$$[^+;SP^ME'YD-BEY%,9SB0,[(%(V_+RIYYH
MW:8LL;NZ)(K.APZ@Y*_7TKS\>-M6U=?!-WIME;PP:U)*TL,MPV?EBD(3<$/'
M&<XSD 8'6L^WU>Z\+:IX_O\ 3](AN+6TO8[BX7SQ#A!;QLVP!3N;J<' ]\T
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M>,S '@$A1@<DCISCEM&UV?PGHGCC5?[)A9[?7CYEK#/M4;DA7*MMYY8'H.M
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M3B\AMENF+1X0H6*C![\@_E1JNO6FCWNFVMRDYDU&X%M"4CRH<@GYCT'"G\J
M,N/1=?T_Q! =+U"UB\.6VG?9H-,>,Y$JC"$O@G& .<]NG>N<T/PA\0+'7!<W
M_BC3WLI[L7-[';VVV2;!!V[RN<8 7&>%&*] AOQ-J5U9?9;I#;JC><\6(I-V
M>$;^(C'/ID5;H ***J7VH)8V%U=+#-=&V4EX+5/,E8@9VA>[8(X]Z +=%-C?
MS(U?:R[@#AA@CZTZ@!LA<1L8U5GQ\H9L GW.#C\JX;0?#/B70_",VA12Z27E
M>=A=,TC;/-=F/[O:,XW?WA7=T4 <'8?#Z3PXGAR;0[I)+G1X)+:1;HE5NHI#
MN;) )0A_F'!]*75_ ]]J&BZXD<UJNIZS>07,[LS>7$L138@XRW$>,X'+$^U=
MW10!S>L:+J.H>)?#FJQ?9433'E>:-I&RYDC*$*=O;.<GK[5'_8&I:9XNU/6]
M)>UECU6*(75O<NR;)8UVJZLJMD;>"N!TSFNHK+LM>M+[7M1T>))Q<Z>D3S%X
M]JD2;MNT]_NGVH P9O @3P#!X?LKSR[RUE6Z@O2GW;D2>87QV!8MQSP<58LO
M!<.G^+HM7MIV6V6S2)[<]9)D#*DI/<['=3ZY!KJJ* .+B\.>)M)U[4GT34]/
M72-3N#=2I=1,TUM*P <QX.&SC.&X!_'.CHVAWVG>+-=U29X&MM1$ C578R)Y
M2%/FR,'.<^WO6W=7L-I!/*Y9O(C\QTC&Y]O./E'/.#^1J'1M5M]=T:SU6T#B
MWNXEFC$@PVTC(R* ,SQ3HE[K,^B/:-;J-/U%+U_.=AO"JR[1@'KNZ^U8NI^#
MM:O7\6/;WMK;/K+6SPD,YVB(*I1^!\KA2#CH"1S7=U4U348-(TVXU"Y$AM[>
M-I)3&NXJH&2<#DX [4 <I;>&?$-KK6IZI#<Z3$]Y96\"PI$^R-HBV%]TPV,X
MS["KWAGPHNA:UJFHQ06UA#?)&#8V;EH1(N[=)RJ@%MP& !]W/.>-O2=4M]:T
MRWU&T646UPBR1-(A4NA&0V#S@@]ZNT <W-H>HQ^.GU^SFM3!-IZ6DL,P8-E'
M9P5(XP=^#GIC.#TK"M?!.L6WA3PYI'G6+2Z3J2WKR>8X615=FV@;>"=^/P]^
M/0:* .)L_#7B71]6U"#2]4L!H=_=/=$31N;BV:0YD$>#M())(+=">A[W/B7Q
M\,_$?_7C)_*NJK,\076E6.AW5[K:0MI]NGF2^=&'7 ]CU/I]: ,1?#MQKUQH
M]WK MA!8VTBQQV[LWFO+'L+$D#: I; &>6Z\<T[3P5J)\,V/A;4+BUFTFRGB
M9;A2WG30Q.'2-DQA3PH+!CP.@SQVMLD"6T:VJQK!M'EB, +M[8QQBI: .;U#
MPHE]XQM-;,P6!;8PW=L1D7!5@T.?]TES^54M)\!PV7@S4O#EU=/-#>":!9/X
MHH#D1(,_W5(_'-=C10!R&E:7XQCT]K/6-1TRY6&!HH7@1T>X.TJ&E)R%X.2%
M!R<<C&#J^$M)N=!\*:;I%V\+RV4"P;XB2KA1@'D#'TK:HH X#Q'X*UO6)_$R
M17UB;;6+9(H7N$=I;;:N#&N. A8;L^I/!K5M="U>'QB-=F>QD']E+8F-'=<N
M'+[N0<#)Q^OM7544 ><:9X#UO1;;P]=6-W8-J>DI/;R)(7\FY@E?<1D#*,#C
M'!Z5T?A30M2T:YUN:_GM9/[1OVO%6!6^3*(I!)Z_<':NDIJR(Y8(ZL5.UL'.
M#Z&@#S_Q#X(US6#XGABO[ P:NL?DRW".98 H7]T,<!,KNR.Y/!SFM>;0=;3Q
MA#KMI<Z?F;3ULKM9$<;"KEP\8'7[Q&"1VYKJZ* //=-\#:SINA>$K=+ZP>]T
M*9V)9'\MT='0^Y(W9[9QVJS=>$-6N+/QG!YMD#X@&(VWM^Z_<B+YAMYX&>/I
M[UW-% ''6OAG5-*U^'6K!K.26:PBL[ZUEE94<Q_<D1PI.1DC!7H:K1>![RRN
M-"EM9K61[/4;C4KQY"R>=),'#!0 < ;^,G^$?6NZHH YZ;1+V3Q_:Z\K6_V2
M&PDLRA9MY+NK[NF.-@&,]ZQ].T^Q\)>"F\/^*]3TU=/D\ZWA+-Y9F1B[$'<>
M6PV,#T[YKN:BGM;>Y,9G@BE,3AX_,0-L8=",]#[T 8/@;1Y]&\*6<-Y++->2
M(LD\DPPY.T*H;W5%1?\ @-+>:%?-XZL]?M)[80K8M97$<JL6VF17RF.,\8YZ
M9SSTKHJR]/UZTU/5]4TR!)UN--:-9_,CV@EP67;GKP.M '*V_@2^A\)S^#6N
M+9]">8^7/N83I 9-YBVXP3U4/NZ'..*Z?Q+H,?B/PU>:.9FMQ.@$<J#F-U(9
M& ]F4''M6O67=:]:6?B#3]%E2?[5?I(\+"/Y,(,MEO7D<>] &9IEMXS2SE;5
M+S2);N.$QVXMTD6.1SC]Y+GGC'W5&.3STQ6L/"M_HWBB+5-.FA%O=6X35HII
M&)N)@<B9<+@,,D=@00,# K<U?7K31)M.BNDG+7]TEI"8X\@.V<;CT X/Y5J4
M <3X<\->)?#VS1TU2QD\/02EK=S&_P!K6/=N$1.=N.V[KCL.,+H_ACQ%H5Y=
MZ?9:E9?\(_/=/<H7C?[3 ';<\:\[<9)PQY&>AKM::\B1@%W502%!)QDG@"@#
MS_5_!&N7=GXKTRSO-/2PUR4W*R2AS+&[(BLI XV_(#GKVQW&O)X9U"7Q9'JS
MW%H]O-I8TZ\C*,"0'+93GON(Y/'7GI6OIVO6FIZOJFF0).MQIK1K/YD>T$NN
MY=N>O'?WJS-?B'4[:Q^RW3F='?STBS%'MQP[=B<\#O@T <QX7T#Q3HD5MI%W
MJMA/HUEA;>5(G%U)&OW$?G: . 2,Y QQG-:'BG1=2U:;29]/GML65UYTMK=A
MO*G&T@9QW4G<.,9 ]*Z*B@#SN3P-KC:)J>GF]T^0W>M+J:OM=, 2K(5(YZE<
M>W7)J[K7@FY\0:OK<MY+!%9ZGI26'[MV:2-E9G#\J >6Z9[>]=3I^L6.J7%_
M;V=PLLEA/]GN /X'VAL?DWY@CM5Z@#AX?#OBFYU;PU>ZG=Z5NT8RB1X1(QN
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MCEMG60OY-S#(<D$@91@0".#3[OP/KEWH'B>P>[T[S=:OENU(#A8L>7D$]_\
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MP3860@?.",9!QTZUVM% &-X3TFYT+PIIFDW<T4TUG;I 7B4A3M&!U^E;-%%
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M ;2.JG(] *O^!HM2G\/Z?J^H:Q<WKW^GVTAAD1 D;%,DK@ \Y&<D\C\ _3?
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M*+<@# W#L<<97!QQF@#C9?%&IZSX>74X;V:&X;0%OA9V:@&WF(8^;(S<%#M
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M6XEC0B JI/(="(\. H QN![]:ZFZ\,Q6=_J^OZ6DLNLW=L4,<EP5BF*J1&K
M< #@9'(]:Y30/#MY"MA!8Q^+M,FMO+5EO-05[5%7&Y0N]@P(!  'I]WJ !EI
MK&N6GAGQ#XEN=;NKIM(NM0@BM7BC$<JHQ5"^U0<@@'@C@=.N=B:;Q'HC2:VU
M[!=:2FG32RP2W/F/+*J%T:+$:@9 .0#C'('%=#IOAG3=,L+^QC22:UOY9);B
M*X?>':3._KV;/(Z55T+P3I'A[<MH;R6+88XH;JZ>:.!#U5%8D*#^= &3I"^)
MKN;1-575(/[.N[?-X&N _F%T!1X5\L!2#VR01UR>:YRUU?Q$?!>@:ZWB"Y>[
MEU@64B-%'Y4D;73Q'<H4$G&,8( P.*[;1? NC^'[@R:>UZB+N\B"2Z>2*V+9
MR8T8E5/)YQW([FA? VD)HMKI"M=BRM;H7<2>><K*'+@YZGYB3@\<T <OJ?B/
M5?"U_P"*+5M3FO8K>WLIK>6\"9@:>4Q,<JH&T<-C'&*U+R'Q1I@UBX.JI'8'
M2Y)85,PFGCN4YW+NB V$8R#G!Z8S6Y<>$=)O+[4+J\CDN6U&W6UNDE?*21KG
M QVQDG(P>:KZ=X'TK3=-N;&*;4)8[B$VY:XNWE:.(]8T+$[%^GMZ# !SFDZC
MK46H>!9I]:N;E-<L6%U#(B!%86XD5DPN0V0<DDYS^%:/PSAE32=4DDO+F<_V
MM>1_OG#?=F89SC.>*V8_".G1/HK+)=9T9"EE^]^XI780?[WR\<YX]ZHZCX'L
M7TC5+.P>\@?4)S<'9>R(L<A;<67!^4%N2!U_D ;NN7+6>@ZA<I=PV;Q6\CK<
MSC,<1"G#,.X!YQ7&Z5JVKIXKETU+FY>&30?MD9U *-TX<+YF!RBMGE3C&.@K
MM+[2K;5-&FTK4%-Q;3PF&8,<%P1@G(Z'Z5C0^!-&BN4N6:_FG6S>R,DUY(Y>
M)OX6R><=O3KUYH S/!VO3WNL'3=3DU*SUB&TW76GWR@J[;E!FB=1ADSD<' R
M.!6EX@N;AM>L[""_G >UFD-E9@"9V!4+(7/"HN3U(R2.O2M*QT"ULKV.\,MQ
M<W,4!MH9;B3>T<9()4''.2JY)R3@<U'J/AC3M3UBVU6;[1'>01-!O@N'CWQD
MY*-M(RN1G% '$6/B'7=3T+X?W1U62&7596AO#'%'B3$4AW<KP<J#Z9['I3+J
MYUZ+2_'$:^)+\'P^S36<NR+>_P#HZRA9#L^9021@ <$YSQCK;3P)HUC;:5;V
MQNTBTN5IK0&X9MC$$'KG(P2,=.>E3OX/TV1-91Y+HKK(Q>CS?]8-NSC^[\HQ
MQCB@#G4U?6_%%Y?V%A<K:36VGVTJ%)_+(EF0OO(V-N4' QTX.<Y& 3^(KCQ9
MHND7FN&$W&CS27GV!4*><CQJ6C9DR,Y/4''. #S6Q>> -%O)[*XWW]O=6< M
MDN+6[>&1X1T1V4@L/U]ZT!X9T]-6M-2B\Z&>TMC:P"-\(D1QE=O0_=')]* .
M*T?Q3JES8>'-'N+YS<W^IWEG+?;5#M%;F3VP'8*JYQZD<X-5I-1N/"VM>/+B
M*Y:63[1ID*37!!\H2@)DG'(4,2"0>@SFNP?P#HCZ2NG$70CCNS>PRK.PEAF)
M+%T<<@DD^W-/3P-H?_$U^T1W%W_:L:17GVFY=Q*%&!P3@$=B.1VQ0!S^NZGX
MD\&6&MZQ/<V]QIZ6(>WMYIS+*ESO"[L[%S'\ZDC/!'&,U)?V$MG\2O!C2:C<
MWF^"]#&8J06$:988 QG/0<<# '.=W3O!&C:?IMS8.+N^@N(C XO[EYR(O[B[
MC\J_3'0>@IECX%TFQN],NA/J,TNF!UM#/>R,(U8 %<9Y&!C!_'/& "A\1DDD
MB\,)%*89&U^V"R!0Q4[7YP>#^-4$C\21Z[K_ (6@\074S_V='?Z??3)'YL$C
M,Z^6^%"LI*YZ=,UV>LZ)9Z[:Q07@D'D3+<0R12%'BD7[K CN,GVJI/;#P[87
MNHV.GW>JW\I0RA9%\Z?!"CEB% 4$G P.O&2: ,;PQKT_B<:,T-Q/$]K;,^J1
M'&1,#Y?E/Q_?24\8^X.QIOCV&676/" 2\N8%?5Q&RQ. #^YD.<$')&!C/O6Y
MX:TG^SX+V\EM$M;S4[IKNXB4@[2<  D<$A5&<<;BQ'6K&M:#8Z]%:I>B8&UN
M%N89(96C=' (R&4@]&(_&@#S^^BODUWXC75CJMS92V=M;3HT*H2[I;%ANW*<
MCCD#&?6MJVUO4[GQ3X.W7CBVU32IKFXM@JA/,5(B"#C=_&>,XK:/A#33)J[[
M[H'5XUBO!YOWT"[ !_=PN1Q_/FG0>$].M[S2KI'N3+I4!MK7=+D+&0 5([Y"
MJ,GG@4 <[H6OWI\46VE:Y+?66IR23,B. UI?QX8J87 X*KM.W@XSG)YKK]<U
M%M)T:YNXXO.G50L$/_/65B%1/Q8@?C56S\+V-G-9OYES.MB6:TCGDWB L"I*
M\9/!(&2< \8JUJ6D0:I-9R32SJ;2431".3:-X! )'?J>#Q0!YWI2/X/^(.G,
M]G=VUCKUN+.ZEN-@$M\F660[6/S."X^M;MP=5U'XAZIHJZY>6MD-+AN8Q L8
M:-VDD4[25/'R@\Y/N!70>(/#=AXFM8+?4?/\N"9;B/R93&1(OW6R.<BD3PY:
MQZS-JZW%U]NFMEM7D\SK&I) QC ())S[T <%I6NZ]+X>\$>(+C6)Y9M2O8;.
MZMO+1871PX+8"YW94'.>N> .*T;*_P#$WB+3H]<TN^MK?R[^021SW&(A!'*R
M-&R>6<-M7.[=G/.0.!T$?@?28=)TO3(VNUM-+G%Q:()CF-QG!SU.,G@Y'--C
M\!Z)#KLVJPK=Q-/-]HFMH[IUMY9>N]H@=I;//IGF@#D-4U+Q NE^.KV/Q#>1
MMH=T7M%6.+! A1]K_)RO)&!CJ<D]NCM=6N?$7BW4-)%W-906%C;S8@(5I)9@
MQW9(/"A0 .A).<\5HR^#-+FMM8MI'NC%K#;[U?._UAP%./[O  XQP*)_!NF3
M:C:Z@LEY!>V\ MO/M[AHWEB'1'(^\/U]Z . \,76J6GA'P#;6>J2VZ7E]<6U
MP$C0[Q^_;/(.#E>.WJ#5ZYN=>BTWQS$OB2_!\/EI[.79%O;_ $=9@LAV?,H.
M1@ <$YSQCK+3P)HUC;:7;VQNTCTR9KBU!N&;;(V<GG/]YN.G)XJ=_"&FR+K2
MM)=$:R-M\/-_U@V[./[OR_+QCB@#G8]8UKQ1>7MA87"VDUMIUK,A2?RR)9D+
M;R-C;E! &.G!SG(P>?XBG\5Z'I%[KAA:XTB9[S[ J%/.C>-2T;,F1G)Z@XYP
M >:V+SP!HMY-8W&^_M[JS@%LES:W;PRO".D;LI!8?K[UH?\ ",Z>NK6>I1>=
M#/9VQM8!&^$2(XRNWH?NCD^E 'G<UYJ6K>&?"QO-3NFGB\3FQ>9"JF94EE56
M8 8+ (O;&><5Z=;V%S#JLMT^I7$MN\"1+:NJ[492<OD#.3GGZ?ED_P#"#:-_
M9*Z;_I?DI>_;XV%PP>.?<6+JPY&23^9JQ:Z!]E\5RZM%/<+$]H+9H7N&='(*
M[6"GA=H!&>IW'\0#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBO(?C5K5]+X6,>GS&+3TU"*VN)%ZSODDH#_ '5*C/JW'\)% 'KU%-D5GC95
M<HQ! 8 $J?7FO%I+?1] ^/>C6]C?:E9230R"\:[:9EOI""%4,_7).<CY<@ <
MT >UT444 %%%% !15;4+*/4M.N;&8L(KB)HGVG!VL,'![<&O/6\/:./C'%IH
MTVV^Q'P^\Q@V#9YGVA5W8_O8XSUH ]*R 0,C)Z"EKS>XL1H'Q+T>'2; W,BZ
M)<QQH9 N0)8MH9SV XSR?K6W:>/+2[T/3KUH4MKJ^FEMUM[F=46.2(L)-SXQ
MM!0\@'.1QS0!UM%8?AGQ(GB*"\/V<P3V=PUO*H?S$8CD,C@#<I!X.!WXIUWK
MLG]M2Z/IMJEW?0VXN9A)-Y2(K$A1N"M\S%6P,=!R1QD VJ*XL_$2&6PT>YL]
M*NIVU&\>Q,1=$:"=0V4;GKE#STQSFKT7BB]EO8=+_L;RM8:Q-]-:2W2[8DW[
M%7>H(8D@XXQ@<D4 =-17):9XVDUK2=+O[#1IPFH"5T:YD"11(@Y:1U#;<G@#
M')!J!?B%%+H&AZM!I-Q,FJWOV$1I*F8Y-S*>2?F&4;!X'3)% '9DA022 !R2
M:4$$9'(KC+CQ6EWHOBJWU70G\S2(3]KLA.KK-"\1?(;@<KG([8[U<_MYM/\
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MBONZ'G'W#CU]NM5[+Q]]L'A^Z_LB:+3-;98H+EYEW+*4+A2@[?*PSGJ.F.:
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M19736DWF1-&1(H4D88 _Q#F@#%70=6C\4^(M45;)H-1LH;>!3.X8-&'Y;Y,
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MI=YY)GL[2*W=H6+*Q10N02 ><9Z5K444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q?Q+%Q_86G>
M1>W%MNU:S1O)*_,#,HYR#TZXZ<<YZ5VE9FO:':>(=,-A>-,B>8DJ20OM='1@
MRLI]00* .7N'\0W7CRZT"V\1RVUM%ID%VLGV6)WWF5U.?E P0G/'?C%9M_XF
MURW\#>,+^/4G^UZ3JLL%M*88\^6ICPK#;@_>/.,^]=G:^&K:T\0'6EN[Q[IK
M5;1A)(&5HU)8 \9SEB<YSSZ<5FZA\/=)U$:M%+=:BEKJL@FN;6*XVQ>9\N7
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M+3Q'K$6KZ"?[2-Y#?ZI-9W#11(+7;B0JL;$!RR[%R<E2=PR:[^SM(;"TBM8
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M#$B,TDLJ%]S;@?E V@ 8R=W/3$LW@73KC2=8TR2[OC;:O<&YNQO3+.<9P=O
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MQHLC3H"P*%%'RE0<@YQ@'UK,N-;UG2['PIJ[Z@UY%JUQ;VUW;F) BF=<AXR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/3Y[&6&,07#9F C7+YZ_0GUZ^F#R-"B@   &!P!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ&%#,5*X.UOR[5H7W@32M0T::PGENA-+=_;S?1R!)UN.TBL!@$#"@8P ,8H
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M9&<9&?2C(]17DWA,:5KMGX<U.37(HM=@F N888U6[EF((FCEYW,N<D\<  C
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M_O.-QY.2<U9\.VGAW5M0TG5=.UJVD>6SDBDM+-%0SQLN3YX!+?*1U/.XX[T
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M5VP6\:QKZG ZGW/4GU-7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+^+$"O.=5M=0\%ZKX;\275O:16UK_P 2W4YXKII&ECF;/F.#&N,2G<>3RQH
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M]J@TOPUH>B2/)I>D6-D[DEFMX%0G/T%+9^(--O[J*WMII'>:-I8F,$BI(BD
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M=W>J:A)=RI?W%NFZ.- J1N5'W5'/%=%?:Q9:=*D,\DAGD1G6&&%Y9"JXRVU
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MO.'8!6"C(/+#!P?0UE>$?$8?P+X>O-6NI)KZ^M5?Y8S)),V,L0B DX[X&!0
M_7O#=SK'C/0=2>WLY=/T^*X259I#O+2!,%1M(XV>HZUOOI&FR:8VF/86S6#
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MXVXQDGMGWSS0!Z(JJB!$4*JC  & !2U0T2:2XT#3IYG+RR6L3NQZDE02:OT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5RGC^SNKO1].DM;66Y^R:K:74J0KN?RXY0S$+U8@=AS75
MT4 <A9Z8=5\?7.O_ &62.P.E#3R+B%HVN&,F\Y1@&VJ,#) SN..E4_ ^DWUE
MJ%WI]XPDL=!D>STV3=N+I(%D&[W1"B _[U=?JFGKJNF3V+7-U;"9<>=:2F.5
M.<Y5AT/%+ING0:58QVEOYA1<DO*Y=W8G+,S'DDDDDT <E\3[6:_T;2[>"PN+
MS;JMM/+'#;M*!$CY<D 'C';O6?J.D&]\:>'KSPKI$^FFWN-^I7GV5K2.2WQS
M$RL%,A)Z<''7(KTBB@#RU-,U*'P/XF\(W6G74^H74]T+280LT5P)F+)(9,;5
MP6Y#$$;>_%;6BV%S8_$:8RP74D*:';6@O&@;9))&[EANQC."#7<44 >>Z-I5
M[?:#X[TY8;BRN-2OKQK:6:%HPRR1JJ."1TR#[U"+.]U_0O!^F'3;RRO]*O;6
M:[\Z!D2$0*0VUR-KAN -I.0WL:](HH \[U;PA>ZCXAUW1U5H] UR!;N>93CR
M[A1L*CW8B%_^ ,.]-;1O$>L_#+4#>0A/$5S#&IB9L;O((PF>.'*NWMYM>C44
M >>020:QIU_?Q>$]6LKY-.F@:2^B<RY8?ZJ/))<$\Y QP/7CI?!44EOX'T.V
MF@E@F@L8898I8RC*ZH P(/N#6]10!Y]:07NC7/C+3K[3KR[35+F2[LY88&D2
M=9(E3RBP!"%2H'S$#!STJO:Z/?:)J'P[LYX+JX_LJUGCNYXH7=(RT(4#<!TS
MP/ISBO2:* .5^)-K<WWP\UJSL[::YN;B#RXHH8R[,Q(["JTJ74?Q-T[4UT^\
MDL[C1VM1*D)Q')YRMA\XV?+D\^F.O%=F3@9/2D!#*&4@@C(([T ><^$=/U#3
M=;TY-,74H]#F@D>YT[4K=A_9SX!"Q2, 2"QQM!(P,UK^(+>]LO'>A:^MO/=:
M=%;SV=PL$9D> N599 B@D@E-IP..*Z\,K$@$$J<'!Z&EH \JU/P_J+_VMK,%
MC<M;W7B"QODM5C/F>3#L$DGE]<L0QVXW8 XK<N+&74/%6I^(X;2YCM5T1K!0
M]NZ27$C.7XC(#84 #)')8XZ5W-% 'E\%E?)X6^'%NVG7PFT^Z@:[3[,^80L#
MHQ;C@;F%4]76,W_BS1WL=;.E:E>(UPUIIK708[(_,*2(?ES@#!4D8)[X'KE<
MVG@^UM+JXFM=5U:UMIY7GEM8KO$19B6<C(++DDD[6'6@#D/$LUYKL'B*&RTF
M^DM+W1E.G36=N5%V3&_$LG#94G C)'4\$G%:=K'?0^+?"^I/I5_Y!T:2S?$7
M,,A:(CS.?E&%)Y^G7BN[M4@CM(4M0@MU0"()]W;CC'MBI: /*)]&UB\\->)U
ML[&Y%ROB3^TX;>6)H_M42-&V%+  YV''N!ZUMZG;RZYXGLM=M;2]AMK'2[J.
M;S;62.25Y0H2,(P#-C#$X!&<5WE% 'ENG6-]#H?PVA?3KY9=.E7[6OV5\P@0
M.AW<<?,P_G5O1M/U"P\364NC+J4.GW-U,VH:7?6[&&U)#DRPR,/ERQ'RJ3G>
M>!@X]'HH Y#QW#<B3PYJ,%G<W46GZLD]PEM$9)%C,<B%@HY."PSCFN0URSU2
M_P!(^(JQZ+J0;4WMS:*8"3+B*-> ,^ASZ=#@\5Z]10!Y]KUC>ZKXS=K&"ZB6
MX\-W-G'=-;NJ1S2,I0$XX/!/MCUK*2;4;O0_ ]B?#VJPW>D:A;K>1FU(2,1P
MNA97^ZRDX(()'KCC/JU% 'ENFV,L$E]X:UKPMJ-_*U_-/;77S-9S(\ID5W;=
MM4J6Y&,\<9-='X,AFAUOQ8\UI<PK<ZIY\+RP,@DC\J-<@D<\JU=>3@9/2FQR
M)+&LD;JZ,,JRG((]C0!R7BV&[3Q3X2U.&QN;JWL[FX$XMTWLGF0,BDCTW$#/
M0=ZY?4K"_G\*?$6VCTR^:?4;UWM$^ROF93%&H*\=,JWY5ZO3!+&TK1"13(H!
M9 >0#T)'X'\J /-[P7&G>++VYU#0-7U/2M7M8!$]E&[&%T4JT<J @@'.<GCD
M^^.\TJ"/3M$MH4LULXX8@!;1#<(A_=&.N.G'X5?HH \Y\!:A)H/A^\M]0TG6
M(YVU"YG1%TZ9MR/(64@A<<@]R*MQ/J5EX\A\0WVGW?V#4=)2 K#"TKVDJNSA
M'5 2,AN2!C</I7=TV.1)HQ)$ZNC=&4Y!_&@#R^UT[5=#2UD.EW)M-0UR\O9&
MM[<2W%C%(#Y848)3=_$1RH8C@\BC;:?J4.FVEL^BZHAA\8F].^%I#Y'F.V_<
M-V0 1DY.<\$\UZZLL;NZ)(K/&0'4')4D9Y].*?0!R.@0SI\0_%EQ):W,=O<K
M:>3,\+*DFQ&5L$C!P2*L:G%+K/BBTL3]OMK:Q0W(N(X2%>8_*H#LI4[5+D^[
M+CD&NDDECB ,CJ@9@HW'&2> /K2++&\CHDBL\9 =0<E<C(SZ<4 <%I-E>>&/
MB;J$,4.HW6E:Q D\MRT!98KI<KR54##+C)]0,USL$UK#;R:=>V6NQZ-;:U)?
MHT6EO,H"3,X_?H2"FX;ONY .,G&:]B(R,&N9L?!-EIT0M8=2U4Z:HVK8/=;H
M57^[TW[?;=C''2@#/\/V\\_BGQI*L-S!%J$D#6MR\+*LBBW5"RL1SA@?YBLC
MP?;,UKH^BZKX3U!-4T@HANKC<UJIC&WS8W+8)(' 49R<<#)KTT    8 [44
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M7,,+%5$?S(F[:5!+[3SQA2#U%=$SJN-S 9Z9/6DCD26-9(W5T895E.01Z@T
M>?WNGWGAOXE:;J]HFIZC;:C;-::FP@,GEA2#%(=B@<'(]<&JMU9WDEG\3$73
M[TMJ*,+0?97_ 'Y-JL?R\<_."/UZ<UZ6K*ZAE(92,@@Y!I: /-[ZPO;W4?!:
M0VMY$(=-NH)IC;.!;O) B+N../F!_*F^$(C+!I&F:IX2U&'5=)"H]S<AFMHR
MB[?,B<L0Q8#@*._H,UZ510!Y)=6%_)\/?$5HFEWYNKCQ US#%]DDW/&;I) X
M&.FT$_IUK4#:AI.N>,(+G2]1NHM947%C<V]LTBM^Y">4^!^[((XW8'->CT4
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M=H?(NX&AD!Z@,,?F,UYK%HWB_P"RZ'KK1LNN6K'294R<&V(,9F8=SY@67_=
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M=:>!M:L_#>AV*WM@]UI&JM>QL4<)(C&7(/<'$O;CC'O5W4/!5SK.J^(FU"6
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M,G>6)<\DC"G)'0<]JCTOP=K5BG@Q9I["3^P(Y(Y=C.OF!HO*&W(/('.3C/3
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MT3QOJ,?B&[230[YC:((HL,JQQOL?Y.5^8C QU.2>, 'J;E($DEV'IN;8N6;
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M8J64G(SR.2>>M 'H5C=QZAI]M>PAA%<1+*@88.U@",^_-6*RO"__ "*6C?\
M7C!_Z+6M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "FRQI-$\4JAXW4JRD9!!ZBG4C,%4LQ  &23
MVH Q;?PGHUM;:+;QVBB/1FW663DH=A4D^N0Q/UP:GN-!M+G7[36I'G^UVD;Q
M18?"A6QN&.^<#\JOQ7,$\/G0S1R1<_.C K^8I8YX9BPBEC<J 2%8'&1D?F*
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M8L2ZF,)^ 'S^_2@"Y_PC%BVJ6FHR27$EQ:6[6L>]P5,;8W*PQ@YP.OI5/1?
MFC^'[@R:>]\D:[C!;O=.\-L6SDQHQ*J>3S@]3ZFNB$\+0>>LJ&';N\P,-N/7
M/3%+#-%<1++#*DD;='1@P/XB@#/T'0K3P[IHT^Q:;[,KLZK*^\J68LV">>22
M?QKF?&>GW-YXAL)GT[69+*"VD5+K1KORIDD=EW*R[E)3"+R,\^E=S44=S!+-
M)#'/&\L?WT5P2OU':@#E-.\*"_TA[;5I-4D@%PES9?;KD/=6SJ.'$BDX.>@R
M>,YZD#H=/TBWTZ:XN%:2:ZN=OG7$S9=PHPHX   R<  #DGJ35H7,#2B(31F0
MY 0,,\=>/;(HBN8)GD2*>.1XSAU1P2I]_2@"IIVB:?I1OC9VZQ_;KAKFX'4/
M(P 8_CC^=9.C>!-&T"Z,VGM>I&I9H+9[IW@MV;.3'&3M4\GMQD^M="EU;R7#
MVZ3Q-,@RT8<%E^HZB@W5NKJC3Q!F?8%+C);KCZ^U &+;^#]-MO#=WH$;W7]G
MW7F>:AERV)"2X#=1DL?SXQ3QX5L1=Z7=">[\[2X6@M6\P?*C !@1CYL@ 9/I
M5[S;U=:9&>S&G_9MP&X^?YF[DD=-F,>^:L+=VSL%2XB9CT <$F@#GQX&TE=$
MBT<27@LHKK[6B>=R)=_F9SC/W_FQZU9N/"6EWFH7M[>++<O?6HL[A)7RCQ#)
M"[0..23D<\UKQW5O+-)#'/$\L?WT5P67ZCM62=>75M%OKGP]=V,D\$C1))=.
M?)W*V&)*\[>#S[>E %;3/ ^EZ587%G#<:C*DT)MPUQ=O*T,1ZI'N)V#ITYX'
MH,2Q>#]-A71522Z T48LAYOW!MV8/'S?+\O/:MN:Y@M4#W$T<2DX!=PH)].:
M>TB)MW.J[CA<G&3Z"@#FKCP%H=Q!>Q,MVJW=W]M.RY<>5/N#;X^?D.X9XIX\
M#Z0IU4AKW=JL @O&:Z=C(H7;GDGDKQGKCIBM^.X@EA,T<T;Q#.75@0,=>:RO
M$&MMI_A+4]9TPVUT]G;23J"^4;8I8C*_2@#1T^QBTW3K>QA9VAMXQ''O.2%
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MV[2"X4$?-]T8;/&<XXJ[IGB*VU66V%O;7(AN[<W-M<.J^7+&"O(()(SO4@,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9'#%$7,<:(7;
M<Y48W'U/J:?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<A\0?'5OX'T>*X\G[
M3>7$BQPP9P.2,LQ[ ?J<"@#KZ**YG1O%3^)M0NET2W1]+M)C!+J$K';+(/O+
M$H^\!_>) ],T =-1110 4444 %%5M0FN+?3KF:TMQ<7*1,T4);:)' X4G!QD
M]ZY8^)O$(\8)X;.F:7]I;3S?^;]KDV;1($V_ZO.<G- '945REKXFU/\ X2NP
MTC4;&VM$GTZ:[E*RERCQNBD D ;?F)SWXZ5U'FQB+S=Z^7C=OSQCUS0 ^BFI
M(DJ!XW5T89#*<@TCS11NB/(BNYPBLP!;Z>M #Z*;YL8)&]<CJ,]*1YHHHC+)
M*B1CJ[, /SH ?136DC2,R,ZK&!DL3@8]<TBRQL%*R*0XRI!Z_2@!]%4=5UBQ
MT;2KK4KZX2.VMD+R-D=NP]ST [FEEEO3J=F+<VAL'63SR[GS=W&S8!P1][.?
M:@"[13/.B\[R?,3S<;MFX;L>N*1YXHL^9*B8QG<P&,]/SH DHHJ-9XGE:)94
M:1/O(&!(^HH DHJ,SQ!@IE0,6V@%ADGKCZU7U2]-CI\TT9A,RHQB2638'8#.
M,\G\J +E%9'A;5I=>\*Z5JT\:1RWEK'.Z)G:I8 X&:I^,?$<WAS2!=VB6TTP
MG@C>.60@A))5CW #D_>]J .CHICS11NB22(K.<(&8 L?;UK"77;L^/W\/O!"
M+4:;]M24,2Y/F!,$= .OK0!T%%4=-FO#I\;:JUFMV6<-]E<F/ 8@8+<YQC/O
MFKNY=VW<-W7&>: %HJ..>*96:.5'"G#%6!P?0T"X@/2:,XQT8=^10!)12;EW
M;=PW=<9YKGG\07$7CTZ%-%;I9?V8U\)RYW9$BI@YX Y/K0!T5%-\V,!3O7#<
MCGK2[E+%0PW#J,\T +17+ZIXCU*T\:V'AZULK207EM)<+/+,R[=A (("G/4=
MZFT7Q-)?>(M2T"_LEM=1L8TF_=2^;'+$_1E; (.1@@C\Z .BHIB3122/&DB,
MZ?>4,"5^H[4>=%OV>8F_D;=PSQU_F* 'T4Q)HI"0DB-@!CM8'@]#2)/#+'YD
M<L;IG&Y6!'YT 244SS8\@;UR>G/6@RQJC.TBA5^\2>!]: 'T4P31M&L@D0HV
M,,&&#GIS2HZ2+N1E9>F5.10 ZBF>=%YWD^8GFXW;-PW8]<5SVJZ]>?V\^@Z.
M+3^T$L3>[KK)0_/L5/E(()(;GG&!P<\ '245F7.LPZ7IUE/JYCM9[F2&#RE?
M=^^D(78IXW8)Z^@)K/M/$4\GC/5='N8[:*TM+2"YCF#G+>8SCYLX ^[^O6@#
MHZ*IW3WRWUB+;[)]E=V%SYK,),;25\L#@G/7/;-6!/$93$)4,@ZIN&1^% $E
M%%<YH_B^UU?Q7K&A)&R2:>$:.1NDZY*NR^RNI0^XH Z.BF/+''G?(JX4L=QQ
MP.I^E)Y\68QYJ9D&4&X?,/;UH DHIC31)*L32(LC_=0L 6^@I'GBCSYDJ+C&
M=S 8ST_.@"2BHYID@B:1W1 .[MM&>W-8?A+7Y]>T>:\O8H()8[V>UVQ,2O[N
M0H.3USB@#H**B-S (VD,\>Q6VLV\8!]"?6G2S10)OFD2-,XW.P _6@!]%-9T
M7&YE&>F3U[U2U'6M/TNP2]NKF-8))$BC8,#O=V"J!ZDDT 7Z*0$$ @@@]Q3(
MYXIF=8Y4<H<,%8':?0^E $E%1B>(NJ"5"S9VC<,G'7'TK(\6ZY)X?\,ZCJ5L
MMO+<VUN\Z0S2;0X0$GIR>!0!MT57M+GS]-@NI=J;X5D;G &1D_A7-ZIXR"6&
MAW^D+;W5GJ6IQ632NQX1W*[E Z]#C)]* .LHIJ21R@F-U< E25.<$=J2.:*8
M,8I$<*=K;6!P?2@!]%-9T09=U7ZG%"RQM$)5=3&1D,#QCUS0 ZBHUGA>(2I*
MC1GHX8$'\:R-?\01:1!8B(QO-?7L=E"2<JKL3EFQV 5CCC)&,CK0!MT5F:7=
M:@MLXUS[%%/Y[)"]O(0DR?PMAN5)_NY/3K6B\L<0S(ZH,$Y8XZ=: '45&]Q#
M&I9YHU4 $DL  #T-+YL?F^5YB^9C=LSSCUQZ4 /HJ,3PM,T*RH95&2@8;@/I
M0T\2L%:5 2VS!8?>ZX^M $E%,DFBAV^;(B;CM7<P&3Z42S10*&ED2-2< NP
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MG/E-$I3/KC&* /,$ET?PU=^$K9M0DN/"9DNUCNKME,(F.#%R %V#]Z$/3N.
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MB_X<CGO&M@--NCN2;RV^\F.??!_*L&-[_3O$_C>T\,7#ZJ9-'-R;]F\V:&[
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MK+!BN+>6U0=F5QM'X&O(],&FR?"_P1!&;<2'6[-+I8R%;=YCC#8YSCUYKVX
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MNS5=4PV#OA.% _WU8*?9#[54L/"FN7GPYU;2M3E1=5FM'TZ"4GAHHMR1%O\
M>)+$^CCTH Z9/%NEF^-E+]J@G-N;J));9P9HAU9!C)(R,K][GI1H/B[2O$C+
M_9AN9(W@%PDSVSI&ZDXX<C!(/4=1^!Q@Z"TEWY=Q=>!1I5_:0N)KAH(B2Q7!
M6 H2Q!/4\#''-:GP\L[O3O .CV%];26UW:VXBEBD R&'TX(^E &G?Z_9V%S)
M;%9[B>*(3RQ6T1D:.,Y 8@>N#@=3@X!P:Y_Q3XNBCT;0[C2999[;5KZWA%Q;
M(S9A9OF"D=&(!&.HR<8(IT-M?Z#X_P!<U&2SN;O3M7AMVCDMUWF&2)2AC9>H
M# Y!Z=<D5@_\(SJ>D>$/"NG+933SVVMQZA<QP886\9E=V&<X.T.!@9S@XH [
MK2;/^R=.N'>]U"Z@D<SQK=;I)84(!\L<%VP<X!R><5S=MXQL=-T?PPE@^I:K
M;ZI.T4=Y<(SR%0'8EN 2WRX QTY/3GMVE"PF7:Y 7=M"G<?;'K7ENE:+K-CX
M0\"[](NGN-(OV:[MEV>8JLDJAAE@",NO?O[&@#OCXCL1<F%5N'5;A;5I4B)1
M)6QA">WWAST!.,YXJ]?W]KIEC+>WDPBMXAEW.3WP  .222  .23BN#N='U%?
M$XU31;?4-.OY=03[;;M\]E>0!@&E.>%<(.",-D=#G-;WCW1[_6?#!CTM1)>6
MUS!=Q0LVT3&*0/L)/ SCC/?% %B;7[6^%_I<<MS9:DEJTZQR1[)/+Y =,@@C
M/''0]<5S_@GQW83:!X:L=3NKLZA?6L:K<SP2>7/-MR5$I&UG]L]>.O%6[G3K
MGQ%XKT[68[.XLX;'3[F)A<IL>224* F/1=I)/3)&,\XR--T+4=0\'^$_#UQI
MUQ:W&DW-M-=RS* L?D'/R,"0Q8@ ;<X!)..A +5CJI@T_P =G6-6U%;.TOY(
MEN8LM+;Q^1&<IM4[<%B<XP.M=5_;=E:QZ?;*\]U<7-OYL,2KNEDC4#+MT ZC
MDXR3@<UQDVEZF^@?$6V73;KS=4FF-DNS_7!H%C!'/'S*>N.*74Y;O3M9\-WM
MEI.HSWUMI3Q7"VL:2LB$H CQLZ<;E8A@W53U&< '46WC;1+ZSM+FSFGG%Y,8
M+9!;2(TSJ"6"AP,X"MD]!@C.:IZIX\L;70K34[&"XNEN-0CL"HB8&)S*(W#C
MJ".1CN<8XYKGK%I[?3-%L='T;6/L-M>S+J:2QI'>H[J7# [@ K-(<LA&!P".
M:J1Z#K<7A"ZM_P"Q;H2VWB8:@D/F(S2P_:1)\AW<D+ZD9H [FWU.PG\8O M[
MJ"7BZ<)6LI49(5C+\28( WY^7(/0$5)#XNTF:>R022I%?MLL[AXBL5PV,X5N
MG(!(SC<.F:Y[4-*U#6/&M])]DN;2VO?#C6 N& (BF9V;!P3R V<CC/&:J1:1
MJFK^$_#/A^ZTV>TO-+NK5KJ9@/+5;?\ C1^C;]H  Y&[G&* -^?XA>'[=+N1
MY+ORK.Y^S74@LY=L#?+RYV_*OS#D]><9Q6G?>(K&PFN(W$\IMD5[@PQ%Q$&S
MMW8]<9XS@<G YK@M1T?5KCPAX_LH]+NC<:I?R2V:; /-5DC4'.<#E#UQ5OQ)
MI-]>7]QJ>B6VIZ=KR11+;31C,%ZN!^[G4_+A26&6Q@=">E '>ZGJ-OI&F7.H
MW9<6UM&TLK(A8J@&2<#DX JI_P ))IHO=.M/,E\W48&N+7$+$2(JAFY X(!'
M!YYH\26%QJGA+5]/@"FYNK&:!!G +M&5'/IDUQMC'J]SK?@BZ?P_J$$&FVD\
M%TTNP%&,4:YQNY&5..Y["@#H+?X@^'[K[(T4MT8;JY-HD[6DBQK+N*!&8KA2
M6& #STZ9%1^,O$45IX?UZ&SGNUO+.S=Y)K2,M]F8H2FXXX/0X&2 <G YKE4T
M?5Q\/[;3SI-W]L37Q=M#L&1%]K,N[.<?</3.<\5:EL]:TR'QOI1T>\O4UEI[
MNQNH I4^9"$\M\D%2I4 >HZ>E '3Z7X@BMO#.D-<_:KN\DTZ*XD2&,RR%=@R
MY^IS[DYQFFS>/_#T<6GR1W,]PNH0/<6GV>UDD,RH,MMPO+#NO4=P*Y./3=4T
M>_T?4[SPI-JMI+HUO87%LBQ23VDT6X@@,VTJV\]#VY]*UO[+N8/%7@^6WT(6
M5E9Q7HFBM8U$5KYVW8IV\9X.[;D9R>G- '2:OXB@TOPE<>(!;W$T$5J;D1+&
M5<KMW<@\KQUSTYKE]3\1W']M^"+XSWEO;7C3BYM5C8"4BW9A\F-S?-C YSQ7
M4>+;"XU3P;K>GVB;[FYL)H8DSC<[(0!D^YKF&@U*ZU/P'<MI%["FGF7[4'52
M8@;<Q@G!/5CVR<<G% '2V/BO2K_2Y=0BDF2.&X-K)%+"RRK-D#RRA&=V2./<
M5/I6OV.KW5[:0&6.\LF5;FWF0H\>X94X[@CH1D5Y[=Z#K4UIKEQ;Z2TTL7B1
M=5AM+@!5O(!&J%03P"?F(!]!79>%TAG>XOXO"XT,2JJ'SH8XYY2,_>V$_*.V
M3GKP.X!G:U=WT?Q0\/:=%J%S%8WEK<RSP(PVNT87;SC(^]V-==>WMMIUE->7
MDR0VT*%Y)'/"@=ZXWQ#%?K\2M U2#2KVZL[*UN8YY(4!VM(%V@9(S]WM1XL@
MUCQAX:U33;#3;BR:-(I86O-J?:)5D#[!AC@83!)QRP]#0!T,'B;3I=0:PE::
MTNO(-RL=U$8R\0ZLN>#CN.H[@5%8>+M*U&XMX86G#75LUW:EX& N(AC+)QS]
MY>.#R.*PM3M=3\1:WHVLV>F36LVE6MV_EWJA-\TD818NO(SDEAQP,$]LK2+/
M63XC\*:K<Z)J:F"RN(+YYFCQ'(PC^ZBMA4^5L!0,\<4 =/:_$#0+W["T,MT8
M;VX-M%.UI(L?F[BH1F(PK$J< \].F1745Y3;Z/J\?@#0[!M*NQ=VVOK=RQ;!
ME8A=-*6SG!^4C@'/:O1M:O;JQT:YN;&SEO+M8SY$"#EWQ\H.<8&>M '*S^*[
MZV^(]G;R[1X?O#)IL4G_ $^( ^<^A^:,#^\AKK-0U:UTZ6U@F9FN+MS';P1C
M+R$ L<#T !))P!7$^)?!"2^ FBTZ34Y=4M@MU9EIY"3=*=X;83M!9LYXXW&C
MQ!?7UQ)X3U8:)J UFW:662W@6-Y(@8]L@*,ZAT)91N##''<XH W&^(/AU+4W
M#SW21K=K9.6LI@$F+;=A)7&0>O/'XBKD/BJPN+5)88+]I9#)MMC:.LQ$9PQV
M, 0,D<GKD#KQ7!S0&[T1;33M&UD:@->M]5OHKNW6-V#2[VD&&*[<(0 "3\O?
MK6YXIL[RU\7V.OKH#ZYIKV1M+BVB1&F@;?O615<@'.2",CM0!T5MXJTJ^TRS
MOK&9[N.\W?9XX8R9'V_>&TX(VG@YQ@\=2*J+X]\/O#92+<SG[9.]M&HMI"PE
M0'=&PV_*XP?E/)[ US6JZ/=V-SH6MVGA&":Q@2XBN=&MXXO,A25D82*N=A?*
M#< ?XL GK4]UIL[W?ABYL?#1TZ"/5GO9X(845HD,+)OE"'!<DC(!)QCTH V'
M^(>A)9WERPOP+*0I>1_89=]L  =TB[?E7!!R>HSCH<:M]XBL+&,L/.N2(!<L
MMK$9"L1SASCL<''<X. <&N/NM-U&2/XCJNFW1.JQ;;+Y/]<?LPBX]/F'?''-
M4X]/U#1]5M+^[\*3:U8WFE6MK+$D<;S6DT08$%7(&UMW4'''Y@'7MXYT'S;*
M*&XGN7OK8W5J+>VDD\Z,8^[A>3R..H[XJG?^/["+1])U&P@N;J+4;]+(8A8&
M)M^UPZ]0PPP ZD^U4XM,N;7QIX<N(M%%G8VNGW,4B6L8\JW:1D94 7K]TY(&
M,_6L6/1=83PW;D:3=--:^*CJ30 *'> S.P9<G!.&'&: /4XW$D:N P# '##!
M'U':LW4=>L]-NX[-Q--=R1/.L$$9=_+3 9L>@+ >I)XS45IKLMQXBFTB?2KJ
MV*6ZSQW$A4QR_=W*,$\J6 ]^<=*RO$ U5_%=E&FFW5SI+V<BF2S=4?SRPPLC
ME@PCVC/!Y/7/2@#6C\3:9<VFGW-G))=KJ$1GMEA0EGC &YL'& -RYSSD@=:T
M+&]AU&P@O;??Y,Z"1-Z%6P>F0>0?8UYCI?AR>7P5X8T[5M+U?3KVPMY52_LF
M_?6D@*@<(3E7!/!!^[R!UKO_  PNKIX8L%ULH=3$6)BH"Y.3@D#@'&,XXSG%
M $%IXPTB^O+.WAEE*WSRQVDQB(CG:/.\*WMM;KC.#C-4YOB'X?@@NKAY+SR+
M2Z-K<R_8Y=L#C )<[?E&6 R:Y.SLO$5S?^%;^^T&_%[97\QO@)(UA0-'(H\I
M ^ @W#YL G_:-.O]'U:X\#>.["/2[HW6IZE-+9QE #*CA K9S@?=/7!_.@#N
M;3Q7I5WJL^FK)-#/% ;D&X@:))(@<%T9@ R@D<^X/2DA\6:7+J$%D3<Q37,+
M3VOF6[C[0BC+&/C)(!!V]<'.*YGQ/HU_K_B11;VUQ%;W'A^[L#<NF%BEEV;0
MW?\ A.<5+X5665['[?X&33=0T^,B>]>&(KG85/D,I+$M] ,9&3QD U;+Q_H%
M^=.-O+<F'4)3!;SM:R+$9,L A8C 8[3@'FJ7C[Q*EKX2\0KI]Q>)=V5NVZXM
M$)$$NW*JS8X/*YQT!!.,USUEH^K0^ _"=A)I5V+NQUN.YN8M@)CB69W+9S@_
M*PX!)_*EN]/UVQ\/>-_#QT6\O)-3EN[FQNH-ICD689"L2P*LIXQCGC% ';GQ
M%:Z=I<!N/M-Q,EFEQ.L$1E9$Q]]L>I#>YP< X-2GQ+IDUO9M9S/=M?0&>V6U
M3>S1@#+X[ 9'7') Z\5Q<ECJ&E>($U"]\)3:Q8ZAI]O \2+#)-:31A@5(9MN
MU@V<ANU6XM/U+P[XSLM6BT$MIEQI8LFM=-5?]"D$C.!MR 5(;!([C/ H T_A
MMJ-QJGA:6YN;JXN6^WW2))<9W[%E8*"#C& !Q@8K(LO&4'A_7/%B:S=ZC<6U
MK?H$98'F6VB,*,2VQ<(N6/7'?K@UM?#VSO['0KR'4+":SD;4;J9%E*DLCRLP
M/RD]CWK.6TU&PU3QG"VDW%Q_:\BO9LH4Q2@P+&0S9^3!!SNQQTSTH Z:'Q-I
M=QK<.D0RN]S/:_;(BL;>7)#Q\ZOC:1R.ASS5RPU&#4DF>W$FV&9X&+H5RZ':
MV,]0"",CCBN'UGPY>Z!X/\,RZ9+%+K6@&"WA9R0MP'VPO&?9L@CT*BNXTNP3
M2]+MK)'+^4@5I#U=NK,?<G)/N: .%USQA/JOA'QJ;%;[3Y](\Z.&=4*$E(D;
M)/8DL>.#C!XKH]%\5:??7$&E[[G[;]C6X4RP.JSH,!F1B,/@D=/7C-<G?:3K
M":'\0M+72+J234YYIK.5"I2420QHJCG.<J<Y  QUZ5K"UO6\:>%[T6%T+:UT
MR>"XD,?$;OY>U3W_ (&Z9% &CHVO:4FERW%O?W]ZDNHRVZ"Y4^:9MQS$BD A
M5P0 >@!YXK<T_4(=2@>6%94"2-$RRQE&5E.",'^?0]N*\]L]">?PU>V.KZ+J
M!CGU^YN@T!*36Z.[O'.A4YR#M&!SR>#TKJ_!EOK%KH\\&KW,UR4NI!:SW"A9
MI+?C89 /XNO7!QC.#0!'XXU#5;70)+;0,'6;E7^S9&=H12['\AM'^TZU<T;Q
M+9ZMX0M?$0+"VEMA.X1&<I@?,N%!)(((X':J,5@^M^)+Z\OH=0M$M5%M9E97
MA#H<-(X*-_$V!@]HP>]87AS3]0\.R^*="33;Y]'>1[C3)B-V2Z?/'R<\/G!/
M7)YH W8?B#H$QT\B6Z$6H1[[69K239*=N[8IQR^/X1SGCKQ5RR\6Z3?6=W<*
M\\1M)Q;30S0.DJR'&U=A&26W+C'7-<=::5JD7A_X=VSZ9=";2IHVO5V?ZD+
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MFCIJ=O/=2/D!F PRJ/T!_'C!W/"6NOXE\*V&KRP+!).A\R-6R%96*M@^F5-
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M#\IQU]<]JK7'C7498FOM)TR2^M([UK5K>.UF,DB)(8WD60#9P0QV\Y Z@G
M.VCCCAB2*)%2- %55& H'0 5$][:QWL5D]S$MU*C/'"7 =U7&2!U(&1^=<CK
M/C2]M$\4365M;LGAY4:6*<D-<9C$AVD?<&TX!PV2#TJQ%KUW)XNT.QNM,LT:
M]T^:Y$RN7DCVE,H,J, [AGZ>U '6T5Q6@^+[OQ'!(]C-IRRI#+Y]I(K">QE!
M&U9$+98=<D!>G'6LG2O%NOV?P_\ "^IRQ6M_<:K=6\#L[M&1YK=>X)SGT ]#
MTH ]+HKB=3\1^)-'LIVU"VTJ"6"SDN!(KM(ERZLV(HUR'!V*"6P0-W3BH9O$
M&K:AXG\&FSE@@L=4L)KQH'4L<A$."01G DXXZC)SQ@ [6WO;6[DG2VN8IGMY
M/*F6-PQC? .UL=#@CCWJ>N&B\9_V?IOB>^NM-MHI=/U06:1V[?\ 'Q(RQ!"S
M$#DEP"<< =\5HR>(-2TWQ19:'J$-I*^I6\LEE/#NC7S(P"T;@[CC!R&'H>*
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M<Y=8Y-WRJQS_  DC/&#S4H\(W=G=:XNEZE'!8ZT[33Q20%VAE9=KO&=P'S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>cutr-20221231xexx1027thi004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K.UC6+?1K>!YE>26YG2VMX4QNED;HHSP.
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M:%V#R3W1*+\HW$?,S*  <=^*AT_PC?Z!KWAV;3A!<6=AI+:9.TLA1Q\T;>8
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M9@Q9Y""S,P& HV@#J>2<#@4 :7AGQ+)XEMHKM-'O+2SGMHKB"XG9-LF\9*@
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MN)&0JS"/S"I .1\N<$CG'I@U%>Z#J.KZO/K<]HEO.FE2V-M;&8,2\ARS,PX
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MH4>XDE!."Z[=JQ 8&?ER>,U!!XHU:ZF\ S"2".'7(6>[B6+)+?9FE&UB>!N
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MTK4HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD?\ Q,;>X417-L&&Y9DW98[-R@;3R%Y Z=[(S)$[K&TC $A%(!;V&2!^= '
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M ,NTG)QSC'K70>"]$O="MK^UEEN?[/-QNT^WNYA++;Q;5RI8$\;MV!DX&.:
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MA53P!H<FF+?;[D7%G:SR66F'_GG;*Y)&>Y#$I](EH ZO4M1MM)T^:^NWV01
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MD>L+*I,L*GY1Y>-P?  ))P.3ST(!NGQC:>9:O'97LMC=7GV*.]B16C,F2N<
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MTR1H$BF\PQ@,-^<%AU4$#(R0>*K^.M?6?PAXH@L(+Z8V-K+'+=6L@00R^7N
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'4M8T_2/LWV^Z2
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MZ6]_:W5M 8<*#L:-E+-T+ @YZ4 =+'XBTF6VTRY2\5H=48+9N$;]Z2I8=N.
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M6XD V[CM;YL9SVZ5HV.J7=J_A?08YH3>7]DTK77D8,4$:)\JC/+$L.3QP>*
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M!O,WQAP<#IP1ZT 59O"/FW6C71U2Y:?3)GN/,D56:>1U*L7X QM) "@ <8X
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M <1X/NKC5+&RTRZ5VO\ PX9(KWYB/,G3*1Y/\0=<R'WVU3\,1OK^D^'/$?\
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MI-I)%,4,BO&#N*$E3^&3CZF@#RS7@TO@CXAV-R4\JROHV@@29G2#*1$JN<<
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M30+^]N+R[T>SFN;F/RYI'B!,BXQ@^O''TXZ58CT+2HKV"\BT^WCN8(_*AD1
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M<B)@>H !R1\N 1Z"NC^S?V[XD\*7]G:W,46D1S27$TUL\)4-%L$0# $DDY(
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M)!,G(Y.2N<4 = GB"[\0:WK5O9:I>::NEW$2Q;-/:195"*\GF*4SD[BH (/
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M]X%("<H0I.5;KD=,<]KX6.GGPII\&DS2O9V\"VT33(5D'EC9AE8 A@5Y! H
MD/B71UOHK-KU1++*T,;%&$;R+G*!\;2PP?E!SP?2J]MXS\.7>H)8V^K6\ER\
MDD:HN?O1C+C.,# SW['T-<KX*N)[?1],\,:MX<NWU32YL&>:U)MQM8_OTE(Q
MDJ3C'S9)'J:9IVDW^H^#_'NG6]M<6MY?W]\UL9X'A\U9% 0@L!D'IF@#MK/Q
M%I5_?BQM[K-R8O.2-XV3S(\XWIN #K[KD<US?B7Q8%U/PW%I&I.%NM72VF"P
M9CGCPVX+(5P<%0/E/K6?8;/$UKN@\/ZO8:[!93PBXU$S*MI(\94B-G8ALMC[
MO89.. <R.ZN;CPSX&TXZ'JL-[H^I6B7L1L9,1".-T9PV-K*>N5)X- '6W?BS
M3]%T[Q)J[:K+J<-C)\UM%%G[,P0?NP5'.3R2>F>36V->L%LK:XD>13<Y\J+R
M)#(Y R<1[=QQ].G->?:GIU_?:3\3;>#3[PR7K;K4-;NOG@0(IV9 W<J1Q6K)
M/=1>,M!\1M97S:3)IDMBX-L_F6TC,CAVCQN ;9MSCC S@4 =+)XMT"*PMKZ3
M5;=;:YF%O$[-C,F=NTCJ"#P0<8[XIL/C#0KBS%W!?&:#:[%HX9&**C%6+ +E
M0"",G X-<!J.C7D<=S>K87CVU_XKMK^.W2U=V6%"@>5D RN2K'! .,>M;WC.
MSFEU<WVEW.IZ=J\%CF&XAM7GM[I2S'R)$VD9R,CH?GXZ4 =!='5YO$FDW%A?
M*=(>-_M5L;8?,"I*R"3.0=VP;<<@D]JT-5UC3]#L6O=3NX[:W4A2[^I. /<T
MNDM<OH]BUY;I;W1MXS-"GW8WVC<H]@<BN<^)UO-=_#[4K6VM9[J:4Q!88(6E
M9L2J3PH/8&@"Q-XHT;4KFP2Q\1I PU'[.8XT#?:7"DF+YAT^8'</3K6C?>)]
M&TUYQ>7R1+;LJ3R%6*0LV-H=P-JDY'!(ZCU%8?C19+FZ\)26UI=S)%K$5Q(8
MK:1O+C$<BEFP/EY9>M<EJYM1=^+="N(]7CTS4K]9)Y(=+EN>=D9D*2)D#.T
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MW)_>4YX/L: +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;+;PAMBDDEF+,Q)R22>2223FIZ* "BBB@ HHHH **** "BBB@ HHHH ****
M.>G\* ZO=:C9:UJNGO=LKW$5O)&T<C!0H.)$;:=J@?+CI6U9VD5C;+;PAMBD
MDEF+,Q)R22>2223FIZ* "BBB@ HHHH **** "BBB@ HHHH *YN#P>MI=3M9Z
M[K%M:SS/-)9I,ACW.Q9L,R%U!))^5AUXQ7244 1P016UO'!"@2*-0B*.@ &
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M9)%C2&$J"<]3EB   "3SVKG(_'%Q-=ZQ:0^&[^6?2-GVE$FAS\R;QM^;YN*
M.PHK$TKQ"-3\0ZSI/V-X6TT0'S&<'S1*K," .G"_KVK0GN+N/4K2"*Q,MK*K
MF:Y\U5$) &T;3RV[)Z=,<T 6Z*** "BL8^)M/'B]?#)<_;VM#=@=MH;&W_>[
MX].:V: "BBB@ HHHH **Q=&\0?VOJNM6!LWMWTNX2!B[AO,W('!XZ<,.];5
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M114-K=07L'G6TJRQ;F3<O0E6*G]010!-1110 4444 %%%% !1110 445"UU
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M">\MQB*<@AU'7&X8..3Q[F@#E_!'B6[TWPS]G\::G;I>0ZG+ID%U*X7[7L(
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MG.T?/CMGK^-4M3\(>'M:FMIM3TBUNY;8!8GF3<P7T)/4>QR*V0 H    X %
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MRLT@!,N<>7@\[LGIUK@M2M[73+72M=TK2-6&B+JLUU>)&T_VA_-B*?:-I/F
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MNH6^K:;;W]J6,%Q&)$WJ58 ]B#R#[5:H **** "BBB@ HHHH **** "BBB@
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M1T^YF:=,Q-YOE!@H^\-Q&<=,\9YH ZC3=+>S=I[J^GO[MEV&>=44A<YVJJ*
M!GVR>,DX&- D#J0.U4]8NY]/T:]O+:%)IH(7D2-WV*Q S@G!Q^5><:EJ%YJ7
MA[X=ZU?VBO?RZC:N/)8%I ]N['J %R>V<# YH ]4HKDX/',*6NKMJEDUC=:7
M<QVTL'G*X=I0IBVOP,-O'7&.<U9T3Q9'JVNW>CO#$MQ;PK.LMM.)X94)QPX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2%Y*D="!GU%;6J:I::+IEQJ-](T=K;H9)76-GVJ.IPH)JQ;SQW5M%<1$F.5
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MV6QU;IQ7>@Y /KZBEH Y&X\,76M:K>ZIJ(AM9IM)DTR&**0R[!(27=B0O?:
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MEQ7$8L;VTNI'C,63OCV8.[/3Y^@QTJ]H7A\:*C&75-0U.=E"">_E#NJC^$8
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M '3L2"?NC*=/?K731>%HH=<GU==2OS=36:V;%FC(V*20>4^]EF/X],<53MO
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M7K5PTZ@A7-RV2< $Y/)R?RKH;CQ9JV@7'BBTO;I;]K!K(VLK0K&5-RVS# $
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>E^!_&NKQ:JT]W9:A?>6US"K#]T< X&.<*!Z#TKLI?"<-S-%]KO[JYMH;_\
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MT\WNG;(U#90XECSCYF&4*CT;G-1MJNMR:D/#XFG^WV^G1W5S<6T<!)DD9U
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MR%'EQ<#T Z8[8Q0!W-%<'J%S8:A\1-1T/Q \:VITN*2PBF8!&W,XE=<\;QA
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M 0D\_=!W+G(!4>G"&:VU.+P:(K2\TW&N7-K<V;7!_=OMF+H"I *AN 1VP.*
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M7OB;S_RXV_\ Z3/52>W_ +,\$>"_%\49<Z19VQO$'/F6K1*KG'<IG>/3!]:
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MMUH"X0=ANZ].<\#.* /4M/NC?:;:W9389X4E*@YQN ./UJS6=H'_ "+FE_\
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M+8P',5L]LACC_P!U<8'X4R+Q-I<LUU")IDN+6(3RP26TB2",_P 80KN9>,9
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M2K$6UVQ>XA%NFR9CU+#&&/N:P+KXE^&X=,N;RVN+B\\B":;9#:RG(B.'&=N
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M(5 *?W<8Z>W2M"B@#..@:.=-73O[*LA9(P=;<0*(U8<@A<8!]Z=)HFE3:?\
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M!7(R>F<\UTE% " !5    X ':J&IZ%I&M&$ZII=G>F$[H_M,"R;#[9'%:%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ\.>?AMX;_[!T/\ Z *Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBH+R]MM/M7N;N9884P"S>
MI. !ZDD@ #DDT 3T5QFC>(Y+SQ[X@M)+]VTVSLK>98YX?)^SLQDWYW*&Z*I^
M;M6];:[IVJ7,VGVEZR7BQ>;L:)D?8>!(H=?F7/< B@#5HK@?#?B&:_\ !'AB
M\U;Q!]EO[VZ4%O*3-V?,8>5MQ@ \<@#&.M=;:ZYIU[>7MI;SF2XL<?:8Q&VZ
M/(R 1CN.1CKVH T:*R9?$VD0V,5ZUTQ@EB\]"D+N?*_OE0I(7_:(Q4-YXR\.
M6"0O<ZQ:JL\!N8BK;M\0 .X8SD<CZT ;E5KZPM-2@6"\@2:)9$E"/TW*P93^
M! /X53TWQ)I.L3SP:?=B>6!$DE58VRJN,J>1_$.1ZCI5RRU"VU"Q2]M9#);N
M"R/M(W#U (S0!%J6C:;K MQJ5C!="WE$T/G(&V..A%7JYW1?&6F:S87]\&>V
MMK2>2)GN(VC&$;;D[@.20>.O3(S6G8ZUI^I7$]M;3DW, !E@DC:.1 >A*L <
M'L<8H OT5R/Q!U;4M%T:RNM,NS;R27]O;/\ NU<%)'"G[P/(SQ45_K6IZ#XT
MT'2&O%U*WU4RH\<D:K/!L7=Y@*  IV.1^/:@#LZ*R3XET=;Y;,WJ^:UQ]E4[
M&V&;&?+WXV[_ /9SFJUYXW\-6#W27&KP*UJX2<#+>62,\X!P.F3T&1G% &_6
M+-X0\/7&I-J,VD6DE\_WKEDS(>,?>Z].*SIM6O(_B7:6"WI;3)M(FNC"$4C>
MLD8#!@,GACQGO70Z?J-KJMFEY92&2WD&4D*,H8>HR!D>] %"/PGH$5E=6<>D
M6BVUVP:YB$8"S$?WO[WXT3^$] NM.M].GTFUELK8[H+=TRD9]57H*EO_ !'I
M.F22)>7BQ^3M\Y]C,D.[IYC $)G_ &B*QO$_B;[#KVAZ-%-/"NH/*9IX("[*
MBQ,PV?*P)+;>QP,],YH U=6\*Z#KWV?^U=)M;PVW$33IN*CTSUQ[4[5O#&AZ
M[:06NJ:5:74%O_J4DC&(^WR^@P!P*A>]E\+>$YKW7+^74391O)+<);;7D4$D
M91>,@8!/ XSP*YZ]\72_VUX/NUO7M=,U%)VNX)(L E8-ZX+*&^\>W7B@#J+K
MPSH5]:VEK=:192V]F0;:)X%*PX_NC'%/AT#28-8DU>+3X$U&1=KW*IB1EXX)
M[C@<>PK+U+Q+I%[X2GU*T\1)I]L7\H7RQ@M$X8 KL<?>[8(SS6K?:[INFR.E
MU<%3&@>3;$[B-22 6*@A0<'&<9P: +4-G;6]Q<3PP(DUPP:9U7!D( 4$GO@
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MBN5DDSG>P[MG!R?0>E2R>'M)EN7N'L8VE?9YA.<2;,!=XSAL8&,YQBJ[^,-
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M:VT8PD4*!5'X"K-0VEW!?V<-W:R"6WG021N.C*1D&IJ "BBB@ HHHH ****
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MT-=K:VT-G:0VMN@2&%%CC0=%4# 'Y"LRV\/10:[/JTM]?W4DA)B@N)MT5MD
M'RUP,9 [YZG&,G.Q0!Y&VGZO_P (Q?6T&F7S7&F^)VU*6W,#*+J 7)D C)X?
M(PP S]W'4C/506[:Q\1K/7K..>.SMM,DMYI987B,K.ZLJ88 G;AB>."0.M=E
M10!POQ4MY+WPW96L5C=7I.I6TDD4%J\W[M7!<L%!XQGKUK,U/28YO&/AZ[\'
MZ/<Z?<1W0.I72V+VD+6G\2.&50['C  )'M7IM% 'D.HO?W9MW?1=2@EL_$\=
MQ+:VM@XA6(2G]]N"_O6888D$XST'4Z%Y;W,C?$XC3+_-]:JEM_H<A\\_9=F$
M.WYOGXXSZ].:]-# D@$$C@@'I2T >/ZKI.KZKJ.A"PAOK>6#P]L9I[*3R7E#
MQ-Y$N5X5@C CC^A]+\.ZPVMZ+;WDFG7FG3,H$MK=P-$T3=Q\P&1Z$5JT4 ><
M6\=UID/C;1]2L+NXDU*ZN+FS:.W>1+F.6,*J!@" 5QM(8C P>G-)'IM]I&J?
M#FSN8+NY?3;::*[GAMY)$C8VX098 CEN!7I%% &-XMM9[[P9KEI;1M+<3Z?/
M''&O5F:-@ /J37'Q/-=ZM\/)QIFI+%:13+.TEC*OE$V^P;LK\OS<<XZ9Z8->
MDT4 >0ZG:7LO@3QW;1Z7J337>MM+;1"QEW2H6A.Y1MY'RMS[5J^+(+PZK?ZI
MH#ZC;ZL+>-3:R6;RVFJ)C(C8%<*PR5)R"H//'3TFB@"":Y^RV+7,T<AV)N:.
M%&D;/HJJ,L?H*X*[\*S>)/ FH->7^I6\^J(UY+:FV4&*;@HNTQ^9\FU%X.3M
MXKT,LH8*6 8]!GK2T >7W.I:EK_ACP5<7VCZI'J$&K6TE]$^GR@Q[%</(1M^
MZ20<^_L:NF*8>(_B#*;"]V75E D#BSD(F*PNK!#M^;D@<9KT.B@#R#2C=Z"^
MB76JZ1KDNGW.@6=DQLXYQ);3PAMR21IAL'?U(/(K:334L?%/@A++1+NSL+2&
M^S&L#R+;"0+L#L 0I/.1G@Y%>BT4 >/FVU6WMI-1CTO4)+>R\7S:A/;?9762
M6W;<!(BD O@MNP/2M.>:2^U_QE>6^G:DUM>Z'%';N;"5?-<"4%0"N<_,O&,_
MA7IM(S!5+,0% R2>U 'FEO;W"M\,MVG7P^PPD7.;*3]P?LI3Y_E^7Y\#GZUF
M7MKJD=QK.HV^DZG-#;>)EOW@BAEADN+?[.(F:(_*6())P#SMKU^D5E=0RL&4
M]"#F@#RSQ':VNI^!/$5YHV@:LL^HBV1FG@F>XNF1Q_ V6VJO<XSSZ"MRXBFN
M/B>9XK.[^SR>'WMQ,;:18_,,H8(6*X!QDX-=Q10!RGPW,T?@'2+.XM+JVGM+
M9()4N86B(=1@@!@"1[C@]C6=&1IGC;Q?)?Z==S0ZC#;?9Q':O(MR%B*L@(!&
M<G&"1USTYKO** /,9_#FH^&OAQX=O442:WX<59O+#_ZQ&XE@![Y4X'NJXKO=
M#L9-/TF&*X(-T^Z:Y8=#*Y+/CVR2![ 5!>^'HM0UNWU&>^OS'"J@6*S8MG96
MW*[)C)8''?' XXK8H \PGC6R\1>(M)U[0M9U"VU6Y^T6LEGYKP3HT:*8WVL%
M4@IC+8&.^!53Q;#?3VGBO1XM$O86.EQ):BQM6=;S$1SOFQSL/RA203Z-G ]:
MHH \VAU&YT/Q9/?:AHVIW.EZQIMM%$\5F\K0O'O!B= "5W;\\COSWQ=DMWB\
M>^%98]'GM;6VTVZC*0VK&*V+^7L0LHV@X4C ../I7=LRHI9F"J.I)P!2T <A
M\.XIX-'U*.>UN;=CJUY*BW$#Q$H\K,I 8#((.:R[2\L[7XC>-TN[::=9;:R&
MR.V:7S!Y3Y3Y0>3Z'K^!KT.L>P\/1:?XAU/64O+F2;41&)HI-FQ?+!"[<*".
M">I- 'G^BZ=J?A^U\/Z'?:;=@KHSHUW9VYED,K29^S-* ?+4#!SD D#YACF/
MP[!=I!\,UGTG4D.GI.ESOL9,0DP% 6^7Y1NX!./7IS7KE% ''6J3V?Q6U*22
MSNC!>Z;;)#.D+&+*-+N!?&U2 PX)&<\9JCX=T>\L/%EWH)13H>G3G4K,@_=,
MVX+%CT1O.8?5*[BYB%[93VZSR1>8C1^; ^'C)&,J>S#^=4]%TB#1+3[,EU<W
M4TAWRW%W+OFF( 7+'CH HX % &+\3H+B[^'.LVMK;7%S<30A(XK>)I'8[AV4
M$UDZ[97>I^-Y5L;>[B2Y\,W-G'<FVD2-)7=2@+%< X!.#TQ7H=(2%!)( '))
M[4 ><^%);34&T@7OAK68-7TF,B5[P3&.V(3:QC8DJ^[& %SD'VJAI^E:K+\%
M/L5IIUTFIV]RUP;26)[>24+=F7:,@'YD P1ZBO5LY&12*RN,JP(SC(- 'G+1
M6?B/1==O=+T#5X=0ET:XL_.U)95E)925A42$[OFR21P#CGDU':/>6^I^#M<D
ML+_^S;?37L+A'M7$EM(RQG>8\;MI*%2<=L]#FO2Z* .3\(Z;/!K7B?5#')#9
MZG>I+;12(4)"Q*K2;3R-S ]>2 #WKE_'(O[[_A,M-CTB^5Y;!/LK6=FQ%_B,
MDF24#DH25"9!]FS@>J44 <%9M+)\2+#4&T^_2V'A\Q&5[.0!7,JMM)V\-M!.
M.O;KQ7,Z+#J>CZ;X,U.?2]1-EIMWJ"7L M)/-A\YW\N7R\;BH!Z@' :O8Z*
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M[4BN$VQNB;BI8XSVR<8'/7H:WB#PMJ/B*SFM+RXC_P!&@1M.N(YF1Q=CGSW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%(2 0"1ST]Z6@ HHHH **** "BBB@ HHHH **** "BBB@ H
MI-R[MN1NQG&>:6@ HI-RXSD8Z9S2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!Q=W96E]\6H5N[6&X6/1#(@FC#A&$XPP
MST/O7/:KJ5CH7B[5$\<Z=*;&^G4Z;K.TM'!'L4"+<.86#!CD8R23VS74$X^+
MJ_\ 8"/_ */%3SVVO-#J5G<Z?INIV=S))Y"SW#+B-OX) 4.1UZ=N,<4 4I)M
M.TR3P3IL]J=39B(K/4?,!5'6!OGSG+%E!]N>M2ZKX[ATZSUN_BL)+FRT6807
MCK(%?=A2VQ2,,%#KG)'?&<<T+3P1J.EV7@NRM9K>XBT*5I;B261D+[D=2$&T
M\ OQD] !6//;WNJ:KXBN["QT74=*EO=EQ'+J4EMN:$*I$B!&4X93R<;@!D$8
MH ZF7QA>'7)-&M?#MS+?+8)>JKW$2*59BN"P) Y!'?GMCFI++QC_ &KI.C7N
MFZ=+(-4A>8&9C'%;A!\PD<!L')P..>?2JVF6>JWOBQ/%?V6VBMKK1HK=8'N#
MYBN':3G"8Q\V,Y[9QVK(TCP?XETO2_#%F_\ 9EU!IJ31W5K).XB=F;*2CY/F
M*\_*1WX/< %JZ\=7E]I'A?4='L4$6KZB+6033 ,A7?N48!!!,3#=Z=N>-=O%
MS1_\))&^GXFT*))95$V5E5HS)\IQUP.XZ_G7/V?@OQ!9^&-"L@VFR7>D:PU\
MH\UU2:-FE)R=I*M^]Z8/W>O/%O4O#/B ZGXH:R&GR6^O621M++*ZM#(L31X"
M!3N!R.=PQSUZ$ M3>.IVN[&ST_P_=7ES?:7_ &E @GC0,/D^3)/'W^IQS]:-
M5^(5KID5W.+9)HK&58;J-;E1.&XW>7'SOV[N>1T.,XJ+1O#6M6/B#0+VX6P,
M.GZ,=-F\N=RQ;*'<H*#C]WW(Z^U%OHGBO1-=U1-(ETR72-2N6N]]TSB6TD?&
M_"@8<9&0,CD]: .GU;54TO0;O5A!)<QV]NUP8XR S*J[CC<0.E<[9>/6EU+1
MH+[0[JQL]9C!LKMY496DV;]C*.5R,X)Z^@[:_BX;? VN@L6QIMP,GJ?W35SN
MD:+?Z]H?@Y[Q+>WMM,AANU:.0NTL@AV1X&T8 WEC[@#WH T[3QIY^JZ19W.F
M2VJZN9A:^:^)5\L$_O(R 5R%)&"??%07OCZ*VL)]3BTV6XTZ'4?[.:1)5$AD
MW^7N"G V[SMR6![XQ6/IG@_Q/!=>&[F[&E/=:9=3/=W(FD:2[#QLGF$E!\PW
M#Y<D=L@5F6@OIX;[6K33M$U'19-2EOT!U22!2RO\K-'L*AOE!Y/+<D ] #K=
M8\>VVEI?.ELD_P#9Y47<)ND68,55BL:<[RH89Y [ DYKITN?M%@MU:*)?,B$
MD2L=F[(R,G''Y5QUMI?BK3=<OKS1!I[Z9K#I=R17[.DMG,456("@[P0H^7(Y
M&,CK7:JLD5L%#>;*J8W.=N\@=3@<9^E 'E_AJ[M6T&R\3:YIRRZJ=4GBLYXI
MCYTTTD\D0C/3Y0,#!) "YP,5V*:ZE[J]YX:U2R6"\^R?:402>;%/"3M)5L Y
M!X(('4=17.P>!M8/@>STN66RAU33=3.IV<B2,\32><\@5\J"!ARIP#Z^U;T>
MBW]WXD/B&\@MX;F'3VL[:V2<N,LP9F9]HQ]U0, \9/?  .$TR)&\!?"V8J#*
M-3MU#]\%)21^8'Y5W=[XO,-OJUY9:<][9:1(T=Y(DH5]R*&D$:D?/M!YR5Y!
M S6':>#=<MO"O@[2R-/:;1+V.XG;[0^UU177"_)U._OCI5R'PQK.ECQ+86!M
M)K#6IY;F*6:5E>VDE7$@*A3N7/S#!'H<=: -./Q:EQKEAI]M;+)!J-@U]979
MEVI,!MRF,9#88'Z<^U1:/XQ_MK1++4+>P ENKUK/[,TXW1LI8,20,<!&;'IW
MYQ4&J^"F?P_H%AI%V;6YT9XE@N3]X1;?*D_$H2?J!4VA^#UT3Q5J-];R*FF3
M*CVUHHXBF*A)&_%8TQ]6H LZ7XH.L70%G:)+:?:YK225)\R0-'O!,D>/E!*8
M'.?F7IFJWQ&L;2Z\ Z[-<6L,TMOI]P\+R1AFC;RSRI/0\#D>E4(O"%Y)XJL-
M<:VL["_AG<W=W9S-_IL!#!4=-H!;E"2<XV\$]K/BI]3;X6^)#J\=K'=_8+L;
M;5F9-FUMO+ '.W&?>@#IM-_Y!=I_UQ3_ -!%6JJZ;_R"[3_K@G_H(JU0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %.ZTK3KVXCN+O3[6XFCX2
M26%79><\$C(YJY110 5E3>&- N=1_M&?1-.EO<[OM#VJ&3/KN(SFM6B@ HHH
MH **** "BBB@"&[L[:_M9+6\@CN+>0;7BE4,K#T(/6BUM+>QM8[:T@C@@C&U
M(HU"JH] !T%344 %92^&- 34O[231-.6^W;OM(M4$F[UW8SGWK5HH **** "
MBBB@ HHHH **** "JE]I>GZFJ+?V-M=JF=HGA60+GKC(XJW10 BJ%4*H 4#
M Z"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>cutr-20221231xexx1027thi005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 ^ # 2(  A$! Q$!_\0
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M3_"C_A'=$QC^Q]/Q_P!>R?X4 87]NW7_ #\+^E URZ/2X'Z5N_\ ".Z)_P!
M?3__  &3_"@>'M%!R-'T\'_KV3_"@##.MW8_Y;C]*0:W>'_EN/TK?.@Z.?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **0 @GDG/KVI: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* ,+P=JEUK/AJ*]O&#3M/<(2%VC"3.B\?116[3(HHX4V1(J("3M48')R?UI]
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4449YZ4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 448Q10 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M117 ?&"^O=*\#27^G7MQ:7<<\:I)#,R<,V"" <'CUH [^BO._$7BC5_"NF:+
M<Z?;+J%DUN;B\6;S'G\L;-S*Q;K\_1AQBN@T#7+C6]5G>&YM9M*-K#<6[1P,
MKGS"XPS%R.-A[#KVQR =)17E_C'4]2\+?$;0KN34+MM"U*3R9;?S3MBDZ9Z]
M/F!Q_LFJFD^);K2OBQ?:5>:E=W.CW"R_9&GD)$;H,L <Y(&UU[\@>YH ];HK
MS+5O$^N>%/ NFZS&T5U)>W W17F]V19260!MP^ZH P0<^M3>+?%_BGPK8_;I
MK?2G@:\BM(P4D#/N0$OC?T#;ACKQ0!Z/17G/B'Q?XL\,6JW5WIEA=QI.PD2W
M#J6@558R*23T!.01QM)SBM&'Q1J.J274^D76FRV"V*WL$CP.2P)<;&PXP08S
MDX[^U ':T5P7A#Q=K_B"'3+VXM].^RW<!FFBMPXF@'S;2<G!!*$?6E\,>.+_
M ,3P_;;.UL7MC<B)[87!%Q;)NVEY 1@^N!C [GF@#O**X7P_XWO?$*2W=C:6
M<MN+L0-;"X(N8$W!2[KC'J<<8'<U'\5+[7=%\/1ZSHFH3V_V:0"XBCC1Q(AX
MR=RG!!QR/7Z4 =]17D7BKQA?:5J_AC4[37+O^PM35&N8_+B_=JV-K;BF1D;C
MC/\  :Z+5?$UWHT/B/7HIFO=/TXQPK:R.J+O !=E8(3_ !J,$GE6H [NBN"U
M'Q]?Z=IGAR].DPN-<EBA1/M# Q-(,C)V<CI4]_XUU*T\67.@+IED9(;$7HGE
MO61"I;8%_P!6<'- ';45Q%_XWU"RU#PY9MI$(EUM3M66Y9#"X4,RL/+/KC-$
M?Q!9]*\0SG34^V:#(4NH%N"48 $Y5]G/ /! QWH [>BN2\/^,9]9-K)<:;%:
MVMS8F]$RW7F>6,@!7!1=I.6/4CY&]*I+\1FNM!N_$5AH=Q<Z):LP:<2JLLBJ
M<,\<?=1[LIX/% '=45Q%U\0&&LZ)8Z;IT5Y'K,32VEP;HQKA5R0PV''Z_A70
M>']8GUBUFEN+(6KQR;!LE\U)%*JP='P-RD,.WK0!KT5@:YXLT_0=3TVPN2WF
MWTC*,*2$4*S;C@>H Q[Y[5D:#XPCCU'5['7=5M%EAU+[+:%ML9D4HA QWY;&
M?<4 =M15"ZUO3+&8175]!"_RY#N!C<<+GTR>!GK5FYNK>SMGN;F:.&!!EI)&
M"JH]230!-1639^)M$O[U;.TU6SFN602+$DREF7&<@=^,&EM_$FBW=TUK!JEK
M).JLVP2C)"_>(]0.^.E &K17,ZEX]\/6%A+<IJ=I=,@R(H)U9F^8+QSV)J_:
MZK;WNKJMMJUG-$UN7%JA#29##Y\AON\@8QU/6@#7HJA:ZUI=[<26]IJ-I//&
M,O'%,K,HSC) /K18ZWI>IS/#8ZC:7,B#+)#,KD#U(!H OT5RFI^(;G2_'5AI
M]Q<VL6E3V4T\C.FUD9"O)<MC'S>G;K6Z=9TT:='J!U"U%G( 4N/.7RV!]&S@
MT 7J*HMK6EI;PW#:C:"&<9BD,R[9/]TYY_"HD\1:+(MJRZM8D76/LY%PA\W)
MP-O//(/3TH TZ*Q;;Q5I%WXAN=$BO86O;=4+)YBY8L&)4#.20%R>.,BM&WU&
MQNY'CMKRWF=/O+'(&*_4 \4 6:*YOQ=K6H:(=(>R$#1W6H0VDPD1F;#L!E<$
M 8&>N:VDU&Q>WDG2\MVAB)6202@JA'4$YP* +5%5$U73I(!.E_:M"QVB19E*
MD^F<U+]KM]X3SXMQ7>%WC)7U^E $U%06U[:WBLUK<PSA3AC$X;!_"EN;RVLH
MO-NKB*"/.-\KA1GTR: )J*JSZE8VJ1O<7MO"DGW&DE50_P!,GFI/M=L&=?/B
MW(-SC>,J/4^@H FHJ*6ZMX$5Y9XXU8X#.P )]*22[MX51I)XD#G"EG W?2@"
M:BJ]W<BWMVD!BW=%$C[%)[#.#C\C61X-U^3Q+X6M=7FA6%YVDS&I)"[79<9/
MT_\ K4 ;]%<CX@\;0V&A:S>Z6L-W<:4VR6.1RH)PI.W .[&\#MSD9XKITG$D
M1"LC2A1N4'H2,\^E $]%5+6XD%A%+?M;QS$ 2>6^8PW3 ) SS5L$'I0 45S?
MB;Q?;>&M0T:UFC,AU&Z$#,#_ *E3QO/MN*#\:Z/(H 6BDR/6C(]: %HI-P]:
M1FPIQR>P]: '45A>%_$#>(;&[N'MEMS;WDMKM$F_)C.TG.!WS6YN'K0 M%)N
M'K1N'K0 M%59M1M;>^MK.24+<7.XQ)@Y;:,M^61^=+?:A;:;;?:+J41Q[TCR
M1G+,P51^)('XT 6:*0,"*1F(0LHW$#@>M #J*P_"_B(>)-,EO/LK6QCN9;=H
MV;<08V*GGZBMO(H 6BBL2+Q'')XPG\.FW=98K1;OS2PPREMHP.O7- &W1378
MJA(4L0. .]8WACQ$GB739;U+62V$=S+;E'8,<HVTG(XZB@#;HHI"0* %HHSF
MDR/6@!:*,T9H **AFNH+8QB:9(S*XCCW-C<QZ >IX-39% !161XC\06_AK2'
MU.Y@FE@1E5O*VY7<0H)R1QDBM8'(S0 M%)D>M+0 45DZIKL6E:AIMI+;SO\
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M=2>7!!&TDCXSM4#)-9VD>([;5[VZLUMKRVN;=4=H[J'9N1AE64Y((_4'@@4
M5KT7MQK>D2?V7.ULL<@G;='^[+@  C?SCG.,]NM<YIO@>Z\+R>*5TR-[BPO[
M8+8VZR#,+'S-R ,0,9<'.>E=;JOB73](>Q6X:5_MMRMK"T49=?,)Q@L.!SGK
MZ'TK7!R* /+_  )H>L>';*RMT\-R6=W+$(M0N3)"8SL\QE8!7)9B6 R1]:;_
M ,(MJ]UXBT35H-#.CZM%*&U.[M[F/R9X\#<H4'+%CZJ.^2>*]3JGJFI6^CZ;
M/J%V9!;P(7D,<;.0HZG"@F@#S:?PMK-[KVA:K#HATG689U.HWMO/'Y$T6/GR
MH.6+9/&.YY/!KTC5].BU?1[O3ILB.YA:)B!R,C&1[CK4FGWL.I:=;7UN28+B
M)98RRX.UAD9!Z<&K&Y0P7(W$9 H \CT_X<7\7PGO]-OT\W5W3=%&S;@@B8F.
M-3GH?F_[^&MS5?#^I0_"9]%M[>:ZU6XA7S-A )E9@SL22 .<]_2O0:J:CJ5K
MI5H;J[E$<8(4<$EF)PJJ!R220 !UH \FU/PF\=CX-.F^&98KFPN;>;4&AMHU
M<A/O9((R<@GC.<@U;UC0[K4_B1=:K<Z/J<FEFR2.)XT&X3QR*ZD+N!V_*>O'
M-=]H?BC3?$%Q<V]D;CS;4XF2:W>,QMDC:=P'S<9QZ$'O6W0!Y3XELM8\2:[X
M4N[C1[VW2W^T&\,*G=;!P F&!SG !.W."*K6.CZU8> ?$WA>YT21[@K(EK=0
MQ?\ '\&S@L1_%TR6]1W!KUXD _6EH \O\)^'KNWT8Z-)9:A#_:&FK;WLMUG;
M"RHR_(<G))<8   "D]3S7L=/UW2/AEJ'@^31KFXU+9-;PR1(##,LK,?,WY
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M<=L9-=Y8V<6GV,%I NV*% B#V JMJF@Z1K:QC5=,L[T1$F,7,"R;2>N,@XH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "DQS2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 444#- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,**_ED.AQD/\F3]T<@@\?6IIO#UF^OKKD2^3?BU>U,J*N61BIR<CD@J,?4T
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M0 4444 %%%% !112 D]1B@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "C%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.]_9K9W4%Q)!)"K[P-IX(; R""".!UH UZ*** "BBB@ HHHH **** "BBB@
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M_9U)XX!Z@]P0>E;,UG:W#QO/;Q2O&<HSH&*GU&>E2-%&[*S(I*'*DCH<8X_
MF@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 45#/=06WE^=*D?F.(TW'&YCT ]ZFH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3J<].YH T:**3(H 6BDR*,CUH 6BC-&10 449HS0 449HR* "BC(HH ****
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M)O\ H.:I_P!]Q_\ Q%:]% &4NC3+_P QK4C]6C_^(J1=,G5L_P!K7Q^OE_\
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M04AN85D\LRH'QG;N&<=.E $M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P?Q.N88K/0D>>-&_M
MJT=E9P,('Y8Y[#U[5WE(5!ZB@#A/'DUB;WPG,\EJ7_M:)T=W4$1[6)8'^[G;
M^.VN;+Z98P_$J )9QWH\WR(AM#A#:J!@=0I/'IGCJ:]>V+CH*;Y,8=G"+O;
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ML5L+D3S"SO)&1A*L)R),(<;<G!YSGH*W_$VF6FF?#+7;>"S@@C^Q7$K0Q@E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JE?V<UX8A%
M=O JNK/L'+ ,"1[9QC\35VB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI#0 M%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !0:*0T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @()(]*6BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@T4AH 6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ H-%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 44@(.<$''6EH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $"JI
M)  ).3[TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4A[4M(>U "T444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>U+2'M0 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !2'M]:6D/:@!:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-
M+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %!HH- !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4A[4M(>U "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %(>U+2'M0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !2'M2TAH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IJ
M($! )Y)/)S3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0]
MJ6@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !2'M2TA[4 +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1W]J** #K12    # %+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !2&EI#VH 6BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#VI:0]OK
M0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !2'M2T&@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *0]J6D/:@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "D/:EI#VH 6BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ I#VI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,\XI:;L7?O
MP-V,9H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 444C-M4L>U "T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44U
MFVXXSS3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "FR M&P'4BG44 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% "!<$\DY]:6B@T %)D^E+CC%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !129&<9&?2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $P-V>]+110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 G?%!HHH 6BBB@!*6BB@!,\XHSS110 4M%% !FBBB@!,T9HHH 6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#110 E+110 4444 %%%%
M'(^*O%%]H=_'!;16[HT8<^8I)SD^A'I6&/B)JFX VMGR?[K?_%444 >DJ25!
M]12T44 %%%% #)7\N)WQG:I.*\ZM_BA/-=Q0'2XQOD5,^<>,G'I110!Z1111
M0 4444 %%%% !2444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% &-=:]]FNY(/LV[8<9\S&?TJQIVJ?VA(Z^3Y>T9^]G/Z444 :-%%% "
M4M%% "'(%9G]L?>_<=/]O_ZU%% &E&^^-6QC< <4ZBB@ HHHH **** "FLVW
MM110 ZDSSBBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>cutr-20221231xexx1027thi006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20221231xexx1027thi006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :S,"N%R">3GI3J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BFLI8<''X9IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !30I#ELG![=J=10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 @(89!R*6D50HPHP/04M !1110 4444 %%%% !1110 444@
MSD\\4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4A8 X/4TM,:)&=79067@$CD4 /HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!KH'&& (IU%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 YH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BFLP1<L<"G4 %%%% !1110 444=: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **"<=:*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C&
M.E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 8SUHHHH  ,=**** "BBB@ H  & *** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M " >M%%% "8YSS2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% ^M% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6+#=\N.G/'( ' K3\$62IH&EZE>Z5:6]W:VT/]DR1X!N'>%@=S8&2<\@],4
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M1U6RCMKB&339A#(9E WDC.5]L5A^-M5N;?4_#FC17$EK!JEX8YYXW*N$5<[
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MS&&53"9R?84 :U%>2^&-6U<^)]*A?4M0GM-6T^9VN;IP!(ZX(EBC_P"6:\X
M/;M46B:AKZZ/X.UV?Q!>W+:AJ M)[>3;Y91C)S@#)(V=2: /1O$?B2U\,V,=
MW=PW$D<DR0CR4R0S' SD@ 9]ZV:\4UBZN?$G@Z77[G4;D$ZPD(L1)B&)%G"!
M2N.6X!S[U[4&!Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(3@9KS3XB>+
M4DT26#1[R^BGBO8H)+BWA;RMV\!D,F,=^QZC% 'IE&17/:GXST72[F6&[FE
MA=$GF2%FBA9L8#N!M7J.I[U@1ZE/'X[\4QW6HW']GPZ;#*H7GR00Q)0 =>_>
M@#T"BN0TKQ9I-CIF@6AN[^]_M&-4M+J2W8F<XZLP& <<\XX&:OMXRTE3>@FX
MS9W M9 (&):4]$0 ?,>_'8T =!17*R_$/P]!IDU_-/<1107(M9E>W</%(>@9
M<9 ]Z>/'NB-9QW,7VR59%=PD=I(SA4.&8J!D+D=30!J:IX=T?6G1M3TZWNS'
MG9YR!MOTS3(/#.BV]U;W4.G6Z3VZ[(9%091>>!Z#FJ=SXPT@Z;:3P3S7 OXB
M]N+2%I9"H'+!0"1CW'7BLWX<:A>7W@H7<\TMW</<W&&F.&($K  ^G Z8% '7
MI;0QSO,D:K(X =@.6QTSZTV[LK>_@,%U$LL1(8HXR,@@C\B ?PK#3QOHLFK_
M -F)+,9OM+6@D\EO*,RC)CWXQNQVI]EXRTJ_U2.PM_M3/(\D<<IMW$3LF=P5
M\8.,'\J -J6TMYIH9I8E>2$EHV89*$C!Q^%4M2\.Z/K$T<VI:?;W4D7^K:5
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M9VP"3[$#B@#<E\%>'IKN2[DTV,W4HVO-N8.P]"V<XX%$O@OP]+]CW:;&/L0
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M[A/+%W"%"L!SUZD?A78>![!;<WUW%X970H;C8%CDQYTA&<E\$X R,?C77T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH  0>E%&,44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 9Q100#UHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***16#9QV.#Q0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !112%@" 3R>@H 6BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@>XHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HQ110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[J5UJ6E:G?G2XFGL)(GO))%D8;")$+'*GEA^% 'H=%>,^'?$%SX,\7ZYX?\
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MFH74V"[3S,R)_LH#T ]\GU-=#0 4444 %%%% !1110 4444 (3@=*4<C-%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAH;*2P2W,C31MA@Q8@J#G'S8S[5UE% 'G?A[P,WA+QQJ^JZ;#G3;VU/E6ZL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-$TW5-8PVTO:6CB,'W=@!4B:MXWOYRL7AVPTZ C*R7EYYC?]\QCK^/% '99
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M=]YH&F6&GZ9C,$NJL[//[A4/ ^M4],M7^)?B(Z_J,1;PY8.4TVU=<+<L.LK
M]1Z?_KKT34;^ST;39KZ[E6&V@3<S$\ #L!ZT 87A;Q!J=[J-]HNNVD,&JV21
MRNUNQ:*2-\[67/(Y!&#Z5U5<CX+MKVX;4/$&I6WV:[U6576$CYHH47;&K>^,
ML?\ >KKJ "HY)XXF19'52YVJ"<;CUP/R-25SWC#PK!XMTI+*6XGMI8I!-!/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !111S0 4444 %%%% !129'K2@YH **** "BBB@
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MD9&*0+@8HW#W_*C</?\ *@ VBC:*-P]_RHW#W_*@!:3;SFC</?\ *C</?\J
M% Q2$9&*-P]_RHW#W_*@#-F\.:)<2&2?2+"60G)9[9"3]>*N6]E;6D7E6T$4
M$8Z)&@4?D*FW#W_*C</?\J %Z"BDW#W_ "HW#W_*@!LD:2J ZA@"#@C/-.
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M_1=!TG2XFXW7ER964>N$[UWR *H4# %+F@#A!X/\4:@0=4\;WL8Q_J].MTA
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M4H/@+0BH7_B98'IJMSG\_,KIJ* .8_X0'0=FW&IX_P"PK=9_/S*3_A7^@_\
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M^-K8!XZ=Z]"\/07]MX?L8=4E66_2!%N'7H7P,_7GO0!IT444 %%%% !1110
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MK::A;VMP5"7<84*1Z9X)Y]JZ;1FN].M;[4;;P@MBLK1*EE%Y:W$IR0SNP.W
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MK8^'](TP,+/3[>+<=S$(,L>,DGJ3P*\X^)D&G:GX@T/0]*@3_A(#>1S^;!&
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M> 7 W-U^;I7J%KX+\.6FIW.I1:1;&\N9&DDF==Y+,221NSC))Z5N*BJH55
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MW^TIG5B#Y>W")D?WF/3T1J+'Q1IFF7'BV[;2FM6T^>-+AD<NURY4!,#H"05
M'O6CX,\&IX1M+J%)VG::9MC,3\D()\N,?0$].Y-8DG@35M0_X2VVO)K6"VUJ
M9)H)K>1FDB:,C82"H'\(/!H UAXSO=.M-2N?$6B/IT=G#',C1S"590[%0H(
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MO,0R.A9@!QSDG&>U8MOX0\26GA[P]+!;6+ZII#3H]I/+NBGCD//S8X/ (^E
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M10 4444 %%%% !01D444  &**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!"#N!R<>E+110 4444
M%%%% !1110 4444 %%%% !1110 4444 %-W'>%P>1G/84ZB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHI,'.<\>E "T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%-$BEV0$97J*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %)SNZ<>M+10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 8&<T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !110
M3B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHINWYRP)Y&,9X_*G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 44$X[9HH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBFLZJ0"0">@]: '4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !4,T;.\960IM;)  .X>GM_]:IJ* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M :7PZK@\YYQ3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:T:.
MRLR@E3D$]J=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 44'I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 449&<9YHH **** "BBB@ HHHH **** "BBB@ HS110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 $X&:8LJ,[(#EEZCTI_6DP* %
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1LX.!D^E"DE 6
M&&QR/2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@! H!) Y/4^
MM+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !4<AD#ILV[>=^>O3M4E%  .E%%% !110: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHY"X*;5!YYR>@H
MDHH'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
M%4*N!2T44 %%%% !3$WY;> .>,'/%/HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I">1P:6B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** $S\Q&#]:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **.:* "BBB@ HHHH
M**** "BBB@ HHHH *,@]#1350)PHP,YQ0 ZBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **.M% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %)GD#'XTM% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4&BB@!%4*, 8%+110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1GG%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 9[4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !WHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #-%
M&** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH 0D @>M+110 4444 %%%% !1110 4444 %%%% !1110 4444 &<44U
MD#8R3P<\4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HJ"ZO(+-$:>18Q)(L:%CC+,< ?4FIZ "BBB@ HHHH **** "BBB@
M HHHH **** "BBC% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&>: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!&56QN4'!R,BEHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HI" >M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1100#UH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,@T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 48HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *0C<,&EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** #-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 444A('6@ (R,4M%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444ASD8QCO0 M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% "'.1BEHHH **** "BBB@ HHHH **** "BBB@ HHHH *3G
M/M2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !29YQ2T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111TH **0,&&00?I2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$9I:* &J@084 #K@
M"G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %,:5$D5&=0SG"@GD\9XI](45F5BH)7
MD$CI0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !113<-YA)QM[>M #J*** "BBB@ HH/(IJ*54 L6/J
M: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M .:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "FR.L:;FSCV&:=28!H 6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MYHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **;O7>%YR>G%.H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $?=L.W&['&
M:%Z<XSWQ2T4 %%%% !1110 4444 %%%% !1110 444F10 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )BEHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "HRK>:K;L*,Y7'6I** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD
M8$J0IP?6E'3F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $SS2T44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 $X&:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "D+ $ ]Z6D(!(R.E "T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 (,@X[=J6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BDW#=MR,XSBEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "FY._&WCUIU% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #=B[R^!N(QG'.*=110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-G''6@9P,]:6B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***#TH **122H+#![BEH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BFC=N.<;<<>M.H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHI" 2#SQ[T +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1349B/F !]C3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** #.:*:J!22!R3DTZ@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "F*I#,2>OO3Z* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKN$&6
MX%.HH !THHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFA2"3D\G\J
M'4444 %%%% !1110 4444 %%%% !1110 4444 %%-12N<L3DD\]J=0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "  # I:** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999563216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 04, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUTERA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0492262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3240 Bayshore Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">657-5500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock ($0.001 par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CUTR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,788,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Part III incorporates by reference certain information from the registrant&#8217;s definitive proxy statement for the 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998261536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999667856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 145,924<span></span>
</td>
<td class="nump">$ 164,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable investments</a></td>
<td class="nump">171,390<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $2,497 and $899, respectively</a></td>
<td class="nump">45,562<span></span>
</td>
<td class="nump">31,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">63,628<span></span>
</td>
<td class="nump">39,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets and prepaid expenses</a></td>
<td class="nump">24,036<span></span>
</td>
<td class="nump">14,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">451,240<span></span>
</td>
<td class="nump">249,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">40,368<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">12,831<span></span>
</td>
<td class="nump">14,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">14,620<span></span>
</td>
<td class="nump">10,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">520,988<span></span>
</td>
<td class="nump">280,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">33,736<span></span>
</td>
<td class="nump">7,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">57,452<span></span>
</td>
<td class="nump">54,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">11,841<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">105,839<span></span>
</td>
<td class="nump">73,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">1,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">11,352<span></span>
</td>
<td class="nump">13,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes, net of unamortized debt issuance costs of $12,666 and $4,007, respectively</a></td>
<td class="nump">416,459<span></span>
</td>
<td class="nump">134,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">536,169<span></span>
</td>
<td class="nump">223,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13).</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 19,668,603 and 17,995,344 shares at December&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">125,406<span></span>
</td>
<td class="nump">114,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(140,513)<span></span>
</td>
<td class="num">(58,173)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">(15,181)<span></span>
</td>
<td class="nump">56,569<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 520,988<span></span>
</td>
<td class="nump">$ 280,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998348736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss, current</a></td>
<td class="nump">$ 2,497<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt issuance costs</a></td>
<td class="nump">$ 12,666<span></span>
</td>
<td class="nump">$ 4,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">19,668,603<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">19,668,603<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699994518048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 252,399,000<span></span>
</td>
<td class="nump">$ 231,270,000<span></span>
</td>
<td class="nump">$ 147,683,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">112,570,000<span></span>
</td>
<td class="nump">98,165,000<span></span>
</td>
<td class="nump">71,911,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">139,829,000<span></span>
</td>
<td class="nump">133,105,000<span></span>
</td>
<td class="nump">75,772,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">106,947,000<span></span>
</td>
<td class="nump">76,762,000<span></span>
</td>
<td class="nump">52,766,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">25,155,000<span></span>
</td>
<td class="nump">21,568,000<span></span>
</td>
<td class="nump">14,322,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">45,917,000<span></span>
</td>
<td class="nump">32,945,000<span></span>
</td>
<td class="nump">31,512,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">178,019,000<span></span>
</td>
<td class="nump">131,275,000<span></span>
</td>
<td class="nump">98,600,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(38,190,000)<span></span>
</td>
<td class="nump">1,830,000<span></span>
</td>
<td class="num">(22,828,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs</a></td>
<td class="num">(1,355,000)<span></span>
</td>
<td class="num">(710,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="num">(5,658,000)<span></span>
</td>
<td class="num">(2,514,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="num">(561,000)<span></span>
</td>
<td class="num">(647,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(3,676,000)<span></span>
</td>
<td class="num">(1,845,000)<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total interest and other income (expense), net</a></td>
<td class="num">(42,512,000)<span></span>
</td>
<td class="nump">1,555,000<span></span>
</td>
<td class="num">(579,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(80,702,000)<span></span>
</td>
<td class="nump">3,385,000<span></span>
</td>
<td class="num">(23,407,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,638,000<span></span>
</td>
<td class="nump">1,323,000<span></span>
</td>
<td class="nump">470,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82,340,000)<span></span>
</td>
<td class="nump">$ 2,062,000<span></span>
</td>
<td class="num">$ (23,877,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="num">$ (4.39)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="num">$ (4.39)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">18,747<span></span>
</td>
<td class="nump">17,891<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">18,747<span></span>
</td>
<td class="nump">18,362<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="num">$ (34,423,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember', window );">PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,185,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">228,796,000<span></span>
</td>
<td class="nump">205,703,000<span></span>
</td>
<td class="nump">125,113,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">100,254,000<span></span>
</td>
<td class="nump">83,048,000<span></span>
</td>
<td class="nump">58,325,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">23,603,000<span></span>
</td>
<td class="nump">25,567,000<span></span>
</td>
<td class="nump">22,570,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">$ 12,316,000<span></span>
</td>
<td class="nump">$ 15,117,000<span></span>
</td>
<td class="nump">$ 13,586,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002219536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82,340)<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Available-for-sale investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Net change in unrealized gain (loss) on available-for-sale investments</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Less: Reclassification adjustment for net losses on investments recognized during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Total change in unrealized gain (loss) on available-for-sale investments</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (82,434)<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,817)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993932128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,315,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 45,942<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 82,346<span></span>
</td>
<td class="num">$ (36,358)<span></span>
</td>
<td class="num">$ (60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">73,227<span></span>
</td>
<td class="nump">73,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance costs and repayment of convertible notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance&#160;costs and repayment of convertible notes</a></td>
<td class="nump">26,495<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">26,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(3,428)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(3,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">10,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(23,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">56,880<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">117,097<span></span>
</td>
<td class="num">(60,235)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">71,798<span></span>
</td>
<td class="nump">71,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_PurchaseOfCappedCall', window );">Purchase of capped call</a></td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(2,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">13,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">2,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 56,569<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">114,724<span></span>
</td>
<td class="num">(58,173)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">39,960<span></span>
</td>
<td class="nump">39,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance costs and repayment of convertible notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,354,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance&#160;costs and repayment of convertible notes</a></td>
<td class="nump">55,949<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">55,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_PurchaseOfCappedCall', window );">Purchase of capped call</a></td>
<td class="num">(57,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(5,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(82,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="num">$ (94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">19,668,603<span></span>
</td>
<td class="nump">19,668,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="num">$ (15,181)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 125,406<span></span>
</td>
<td class="num">$ (140,513)<span></span>
</td>
<td class="num">$ (94)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_PurchaseOfCappedCall">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of Capped Call</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_PurchaseOfCappedCall</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997500944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_PaymentsOfDerivativeIssuanceCostsGross', window );">Payment of issuance costs of capped call, gross</a></td>
<td class="nump">$ 452<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_PaymentsOfDerivativeIssuanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of Derivative Issuance Costs, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_PaymentsOfDerivativeIssuanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993553968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82,340)<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">14,400<span></span>
</td>
<td class="nump">13,172<span></span>
</td>
<td class="nump">10,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts', window );">Depreciation and amortization</a></td>
<td class="nump">2,621<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Amortization of contract acquisition costs</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">2,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized loss on foreign exchange forward</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment', window );">Impairment of capitalized cloud computing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Change in deferred tax assets</a></td>
<td class="nump">188<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale of property and equipment</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification', window );">Change in right-of-use asset</a></td>
<td class="nump">2,653<span></span>
</td>
<td class="nump">2,292<span></span>
</td>
<td class="nump">2,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivables</a></td>
<td class="num">(15,900)<span></span>
</td>
<td class="num">(9,574)<span></span>
</td>
<td class="num">(2,550)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(36,305)<span></span>
</td>
<td class="num">(10,936)<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Other current assets and prepaid expenses</a></td>
<td class="num">(10,049)<span></span>
</td>
<td class="num">(5,766)<span></span>
</td>
<td class="num">(3,164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(8,091)<span></span>
</td>
<td class="num">(7,128)<span></span>
</td>
<td class="num">(2,067)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">20,979<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
<td class="num">(6,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">3,282<span></span>
</td>
<td class="nump">21,608<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(2,597)<span></span>
</td>
<td class="num">(2,151)<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">2,673<span></span>
</td>
<td class="num">(412)<span></span>
</td>
<td class="num">(2,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(66,995)<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
<td class="num">(16,934)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of property and equipment</a></td>
<td class="num">(22,698)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable investments</a></td>
<td class="nump">158,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable investments</a></td>
<td class="num">(329,484)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,060)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(194,182)<span></span>
</td>
<td class="num">(944)<span></span>
</td>
<td class="nump">6,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">2,765<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="num">(56,680)<span></span>
</td>
<td class="num">(16,134)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDerivativeIssuanceCosts', window );">Payment of issuance costs of capped call</a></td>
<td class="num">(352)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="nump">360,000<span></span>
</td>
<td class="nump">138,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of issuance costs of convertible notes</a></td>
<td class="num">(11,202)<span></span>
</td>
<td class="num">(4,717)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment of convertible notes</a></td>
<td class="num">(45,776)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs on the public&#160;offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,256)<span></span>
</td>
<td class="num">(2,176)<span></span>
</td>
<td class="num">(3,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments on finance lease obligation</a></td>
<td class="num">(520)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
<td class="num">(537)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">242,937<span></span>
</td>
<td class="nump">117,526<span></span>
</td>
<td class="nump">31,276<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(18,240)<span></span>
</td>
<td class="nump">117,817<span></span>
</td>
<td class="nump">20,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">164,864<span></span>
</td>
<td class="nump">47,047<span></span>
</td>
<td class="nump">26,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at end of year</a></td>
<td class="nump">146,624<span></span>
</td>
<td class="nump">164,864<span></span>
</td>
<td class="nump">47,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">5,486<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid (refunded) for income taxes, net of (refunds) payments</a></td>
<td class="nump">2,004<span></span>
</td>
<td class="nump">891<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock in repayment of convertible notes</a></td>
<td class="nump">55,947<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Assets acquired under finance lease</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Assets acquired under operating lease</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">11,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReduction', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Debt issuance cost accrued</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_AccruedCappedCallCosts', window );">Capped call costs accrued</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges', window );">Transfer of inventory to property and equipment</a></td>
<td class="nump">12,180<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Acquisition of property, equipment and software</a></td>
<td class="nump">4,131<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember', window );">PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,185)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">$ 34,423<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AccruedCappedCallCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Capped Call Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AccruedCappedCallCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the change in right-of-use asset and liability due to modification during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInRightofuseAssetAndLiabilityDueToModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDerivativeIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of a derivative security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDerivativeIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTransfersAndChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cutr_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700087955488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">SUMMARY<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNIFICANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POLICIES</span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear, enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel, truSculpt, Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; each of which enables medical practitioners to perform procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) leasing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices for acne treatment ("AviClear" revenue); (iii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); and (iv) the distribution of third-party manufactured skincare products (&#8220;Skincare&#8221; revenue); are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 37 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 8%, 11% and 15%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the treatment protocol is initiated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as replacement hand pieces, x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Consumable revenue. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products'&#160;single use disposable tips&#160;must be replaced after every treatment. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:f-470">one</span> to three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2022, and December 31, 2021, the accrual for the loyalty program included in accrued liabilities was $0.3 million, and $0.5, respectively. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract related to the sale of a system, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:f-475">two</span> to three years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2022 and December&#160;31, 2021 were $2.0 million and $2.7 million, respectively. Amortization expenses for these assets were&#160;$2.4 million, $1.9 million and $2.6 million, respectively, during the years&#160;ended December&#160;31, 2022, 2021 and 2020 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022 and December&#160;31, 2021 were $3.8 million and $4.2 million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. Credit card receivables, that are collected in a short period of time are also classified as cash and cash equivalents. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns represents the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns and is based on the Company's analysis of current economic trends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of customers, current economic conditions, the age of the accounts receivable balances, historical loss information, current conditions and forecasted information. The Company writes off trade receivables when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with SVB. On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#8217;s receiver. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2022, and 2021, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2022, 2021, and 2020, domestic revenue accounted for 43%, 42% and 41%, respectively, of total revenue, while international revenue accounted for 57%, 58% and 59%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately 10%, 14% and 9% of the Company's total purchases in the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2022 and 2021, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $5.7 million and $3.7 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2022, 2021 and 2020, was $2.2 million, $1.3 million, and $1.4 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2022 and 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4 million in Other current assets and prepaid expenses and $3.5 million in Other long-term assets. As of and during the year ended December&#160;31, 2022 and 2021, there was $0.4 million, and no accumulated amortization and amortization expense recorded, respectively. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, the Company segregated its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. Goodwill was tested for impairment at the segment level. As of December&#160;31, 2022, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessee</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the lessee has the ability to perform the patient treatment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 to the consolidated financial statements for more information regarding leasing arrangements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third-party contractors, regulatory affairs, clinical and development costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2022, 2021 and 2020 were $4.9 million, $2.1 million&#160;and $1.2 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period. To estimate the fair value of an award, the Company uses the Black-Scholes option pricing model. The following inputs are used in this model:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the historical volatility of the Company's stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2022 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for-sale investments, net of tax.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Losses resulting from foreign currency transactions are included in net income (loss) are $3.6&#160;million and $1.8&#160;million in the year ended December&#160;31, 2022 and 2021, respectively, and were insignificant for the year ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company operates in two segments. Revenue is attributed to a geographic region based on the location of the end customer. See Note 12 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003440768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents, Marketable Securities, and Restricted Cash</a></td>
<td class="text">CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, AND RESTRICTED CASHThe Company determines the appropriate classification of its investments in marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. The Company&#8217;s marketable securities have been classified and accounted for as available-for-sale securities. Investments with remaining maturities of more than one year are viewed by the Company as available to support current operations and are classified as current assets under the caption marketable investments in the accompanying consolidated balance sheets. Investments in available-for-sale debt securities are measured at fair value under the guidance in ASC 320. Credit losses on impaired available-for-sale debt securities are recognized through an allowance for credit losses. Under ASC 326, credit losses recognized on an available-for-sale debt security should not reduce the net carrying amount of the available-for-sale debt security below its fair value. Any changes in fair value unrelated to credit are recognized as an unrealized gain or loss in other comprehensive income.<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments - U.S. Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and December&#160;31, 2021, the net unrealized losses were $0.1&#160;million and nil, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months. The restricted cash balance relates to an outstanding letter of credit for $0.7&#160;million provided to a supplier.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">All of the marketable investments will mature less than one year from December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993480800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">FAIR VALUE OF FINANCIAL INSTRUMENTS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets at fair value, including cash and cash equivalents. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, financial assets and liabilities measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:46.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.992%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Money market funds </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Foreign exchange forward</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had no money market funds or marketable investments. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14 - Debt for the carrying amount and estimated fair value of the Company&#8217;s 2.25% Convertible Senior Notes due 2026 (the &#8220;2026 Notes&#8221;), 2.25% Convertible Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and, 4.00% Convertible Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), together with the 2026 Notes and 2028 Notes, (the &#8220;Convertible Notes&#8221;).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003537392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">DERIVATIVE INSTRUMENTS <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency exchange forward contracts to manage the impact of currency exchange fluctuations on earnings and cash flow. The Company does not enter into derivative instruments for speculative purposes. The Company is exposed to potential credit loss in the event of nonperformance by counterparties on its outstanding derivative instruments but the Company does not anticipate nonperformance by any of its counterparties. Should a counterparty default, the Company's maximum loss exposure would be the potential asset balance of the instrument.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow effect of the derivative instruments settlement is recorded in cash flow from operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dollar amounts in thousands:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:23.621%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.836%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.385%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Forward</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross notional amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003416720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Detail</a></td>
<td class="text">BALANCE SHEET DETAIL<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2022 and 2021, were $3.6 million and $4.9 million, respectively. Inventories, net of these adjustments, consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,628&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,503&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current assets and prepaid expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets and a prepaid expenses, consists of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits with vendors</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,036&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,545&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Materials related to the AviClear acne treatment device were classified as inventories at December 31, 2021. The Company received 510(k) clearance from the U.S. Food and Drug Administration in March 2022 and in April 2022 placed the first devices in service. Beginning in April 2022, the materials used in the construction of the AviClear device have been classified as Assets under construction and the manufactured devices, including devices available for lease and devices placed in service, have been classified as AviClear devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is related to the acquisition of Iridex&#8217;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $1.3 million as of December&#160;31, 2022 and 2021. There were no impairments or additions to goodwill during the years ended December&#160;31, 2022 or 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003551888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranty</a></td>
<td class="text">PRODUCT WARRANTY <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003508432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTextBlock', window );">Deferred Revenue</a></td>
<td class="text">DEFERRED REVENUE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:f-656">one</span> to three-year terms. The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. Deferred revenue also includes payments for training. Approximately 88% of the Company&#8217;s deferred revenue balance of $13.5 million as of December&#160;31, 2022, will be recognized over the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred revenue balance for the years ended December&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,383)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Costs for extended service contracts were $6.3 million, $8.3 million and $8.2 million, respectively, for the years&#160;ended December&#160;31, 2022, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of contract with customer liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003475120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had one class of issued common stock with a par value of $0.001. Authorized capital stock consists of 55,000,000 shares comprised of two classes: (i) 50,000,000 shares of Common Stock, of which 19,668,603 shares are issued and outstanding as of December&#160;31, 2022, and (ii) 5,000,000 shares of preferred stock, par value $0.001 per share (&#8220;Preferred Stock&#8221;), of which no shares are issued and outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;21, 2020, the Company issued and sold an aggregate of 2,742,750 shares of the Company&#8217;s common stock, par value $0.001 per share at a price to the public of $10.50 per share. The shares include the full exercise of the underwriter&#8217;s option to purchase an additional 357,750 shares of common stock. The Company received net proceeds from the offering of approximately $26.5 million, after deducting underwriting discounts, commissions and offering expenses of $2.3 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had the following stock-based employee compensation plans:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2004 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which 4,650,000 shares of the Company&#8217;s common stock were reserved for issuance to employees, directors and consultants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2004, the Board of Directors (&#8220;the Board&#8221;) adopted the 2004 Equity Incentive Plan. A total of 1,750,000 shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#8220;fungible share&#8221; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract 2.12 shares from the shares reserved under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s Annual Meeting of Stockholders in 2019, the Company&#8217;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by 700,000 (in addition to the 9,701,192 shares provided under the 2004 Equity Incentive Plan); (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#8217;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#8220;performance based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum one-year vesting period with respect to awards granted under the 2004 Equity Incentive Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in 2019, the Board also amended the Company&#8217;s Stock Ownership Guidelines to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least 50% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), or performance stock units (&#8220;PSUs&#8221;) (net of taxes) for a minimum of one year following vesting and delivery.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#8217;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#8217;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company's stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 600,000 shares, available for future grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 450,000 shares, available for future grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 600,000 shares, available for future grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-employee directors are granted $150,000 of RSUs or non-statutory stock options annually on the date of the Company&#8217;s Annual Meeting of stockholders. These grants cliff-vest on the one-year anniversary of the grant date. In the years ended December&#160;31, 2022, 2021 and 2020, the Company issued 12,496, 41,301 and 35,735 RSUs, respectively, to its non-employee directors. In the year ended December&#160;31, 2022, the Company issued 18,135 non-statutory stock options to its non-employee directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2022, 2021&#160;and 2020, the Company&#8217;s Board of Directors granted 191,993, 219,686 and 405,248 RSUs, respectively, to its executive officers, directors and certain members of the Company&#8217;s management related to annual grants and new hire grants. The new hire RSUs vest quarterly on each of the first <span style="-sec-ix-hidden:f-712">four</span> annual anniversaries of the grant date and the annual grant RSUs vest one quarter on the first annual anniversary and monthly thereafter for 36 months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#8217;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued 209,981 shares related to this bonus payment to management and recognized $2.6&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2022, 2021&#160;and 2020 the Company&#8217;s Board of Directors granted its executive officers and certain senior management employees 169,785, 178,222, and 76,157 PSUs, respectively, related to its annual grants. The 2020 grant vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 and 2022 grants vest one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vests on the second anniversary subject to the recipient&#8217;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted 265,002 PSUs to certain employees. This grant consists of four separate vesting tranches that will vest from April 2023 through June 2025 upon the achievement of operational milestones associated with each tranche and continued service.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board awarded its new CEO, David H. Mowry, 67,897 PSUs, which vested over four years from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Board awarded its new CFO, Rohan Seth, 60,000 stock options, which vests over five years, and 22,423 PSUs, which vests over 2.5 years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for six months. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">600,000 shares;</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">2.0% of the outstanding shares of common stock on such date; or</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">an amount as determined by the Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of the common stock purchased is the lower of 85% of the fair market value of the common stock at the beginning or end of the six-month offering period. In the years ended December&#160;31, 2022, 2021, and 2020, under the 2004 ESPP, the Company issued 49,306, 59,635, and 56,751 shares, respectively. At December&#160;31, 2022, 378,586 shares remained available for future issuance.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Award Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296,238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,863&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest, net of estimated forfeitures, as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $44.22 of the Company&#8217;s stock on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020 and $35.81 on December&#160;31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#8217;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#8217;s common stock. Total intrinsic value of options exercised in 2022, 2021 and 2020 was $1.1 million, $1.3 million, and $0.4 million, respectively. The options outstanding and exercisable at December&#160;31, 2022 were in the following exercise price ranges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.363%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.79</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.04</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.70</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33.45</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,857&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42.33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.91</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47.40</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63.62</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10.79</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$63.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">513,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Awards (RSU and PSU) Activity Table</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,949&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,856)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,274&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,131)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $44.22 on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, and $35.81 on December&#160;31, 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $12.2 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.8 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $9.9 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2022, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the years ended December&#160;31, 2022, 2021 and 2020 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.76&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.63&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.77&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.64&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002107472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,066)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.04)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company recorded a valuation allowance of $53.1 million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#8217;s net deferred taxes increased by $12.6 million and $2.2 million during the years ended December&#160;31, 2022 and 2021, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $0.6 million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company had approximately $87.7 million and $45.3 million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized, will generally begin to expire in 2029&#160;through 2039. Approximately $51.2 million of total federal net operating loss carryforwards were generated after December 31, 2017 and have no expiration. At December&#160;31, 2022, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $7.5 million and $9.3 million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#8220;ownership change,&#8221; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#8217;s net operating loss and tax credit carryforwards due to prior ownership changes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No deferred tax liabilities have been recorded relating to the earnings of the Company&#8217;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2009 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#8217;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2017 remain subject to examination by their respective tax authorities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December&#160;31, 2020 to December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002107472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company&#8217;s convertible notes were potentially convertible into 8,354,036 shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the years ended December&#160;31, 2022 and 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2022 and 2020, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,935&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003431808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text">DEFINED<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTRIBUTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company has an employee savings plan (&#8220;401(k) Plan&#8221;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to 100% of their annual compensation, subject to statutory annual limitations. In 2022, 2021 and 2020, the Company made discretionary contributions under the 401(k) Plan of $0.5 million, $0.3 million and $0.2 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#8217;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2022, and the related expense for each of the three years then ended was not significant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003537392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information and Revenue by Geography and Products</a></td>
<td class="text">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the Company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision maker ("CODM") is its Chief Executive Officer ("CEO"), who makes decisions on allocating resources and assessing performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, the Company segregates its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. This segregation aligns the Company&#8217;s operating business segments with the way the CEO reviews the Company's operations as a result of the commercial release of the Company&#8217;s AviClear acne treatment device in April 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the financial results of its reportable segments using an internal performance measure that excludes General and administrative expenses.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:46.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252,399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">231,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">147,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,012)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items not allocated to segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;ERP implementation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,821)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Legal fees, severance, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Interest and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(80,702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital spending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">202,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">520,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022&#160;and 2021, 99.8% and 99.0% of long-lived assets were in the United States, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003601648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LesseeLeasesTextBlock', window );">Leases</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles leases. The Company&#8217;s leases generally have remaining terms of <span style="-sec-ix-hidden:f-1264">one</span> to 10 years, some of which include options to renew the leases for up to five years. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is supplemental balance sheet information related to leases (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1270"><span style="-sec-ix-hidden:f-1271">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,437&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,019&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1282"><span style="-sec-ix-hidden:f-1283">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1286"><span style="-sec-ix-hidden:f-1287">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,310&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the twelve months ended&#160;December&#160;31, 2022 and December&#160;31, 2021 (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Maturities of lease liabilities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows as of December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,962&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,773)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vehicle Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(131)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor - AviClear</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Lessor revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee. The contractual term of the lease agreement is three years with a one-year autorenewal feature. Certain lease agreements' terms in excess of one year can be terminated without financial penalty, and these agreements are accounted for as having a lease term of one year. The AviClear lease agreements are accounted for as operating leases. The fixed annual license fee is recognized evenly throughout the period of the lease agreement on a straight-line basis. The treatment revenue is recognized in the period the lessee has the ability to perform the patient treatment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1335"><span style="-sec-ix-hidden:f-1336">AviClear operating lease license fee revenue</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1339"><span style="-sec-ix-hidden:f-1340">AviClear operating lease revenue</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1343"><span style="-sec-ix-hidden:f-1344">Total AviClear revenue</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AviClear device being leased has a useful life of seven years. The Company expects that a device will be leased for two consecutive lease terms at the end of which its residual value will be immaterial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the minimum future lease payments as of December&#160;31, 2022, under non-cancelable operating leases, assuming the minimum contractual lease term (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected a practical expedient applied to operating leases to elect not to separate lease and nonlease components as long as the lease and at least one nonlease component have the same timing and pattern of transfer. As such, updates or upgrades on a when-and-if available basis to the AviClear device are combined with the operating lease revenue. The combined component is being accounted for under ASC 842. Additionally, the Company made an accounting policy election to present AviClear revenue net of sales and other similar taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Capitalized sales commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions related to obtaining AviClear lease agreements are accounted for as initial direct costs and are capitalized and amortized on a straight-line basis over the lease term. Total capitalized costs for the year ended December&#160;31, 2022 were $3.8 million. Amortization expenses for these assets were&#160;$0.5 million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Sales and marketing expense in the Company&#8217;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022, were $3.3 million and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Lease installment costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes fulfillment costs incurred before AviClear lease commencement and these costs include freight, installation, and training costs. Total capitalized costs for the year ended December&#160;31, 2022, were $1.7 million. Amortization expenses for these assets were&#160;$0.3 million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Cost of revenue in the Company&#8217;s consolidated statement of operations. Total lease installment costs as of December&#160;31, 2022, were $1.4 million and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of the Company&#8217;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#8217;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, intellectual property disputes, commercial disputes, employee disputes, and contractual lawsuits. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred. Certain of the cases below are still in the preliminary stages, and the Company is not able to quantify the extent of its potential liability, if any, other than as described. The outcome of litigation is inherently unpredictable and subject to significant uncertainties. If any of these matters are resolved adversely to the Company, this could have a material adverse effect on its business, financial condition, results of operations, and cash flows. In addition, defending these legal proceedings is likely to be costly, which may have a material adverse effect on the Company's financial condition, results of operations and cash flows, and may divert management's attention from the day-to-day operations of its business. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and&#160;2021, the Company had accrued $0.5 million and $0.7&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California. Lutronic employs numerous former Cutera employees. The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act ("RICO"); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting. On March 13, 2020, the court entered a temporary restraining order ("TRO") against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information. The order also prohibits Lutronic, for two years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers. On April 9, 2020, the parties stipulated to the entry of a preliminary injunction providing for the same relief afforded by the TRO. On August 4, 2022, Cutera filed a second amended complaint. In addition to the above referenced claims, Cutera alleges claims for violation of the Lanham Act, unlawful business practices, false advertising and trademark infringement. Discovery is ongoing. No trial date has been scheduled.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Serendia, LLC (&#8220;Serendia&#8221;), filed patent infringement complaints against the Company with the International Trade Commission (&#8220;ITC&#8221;) and in U.S. District Court for the District of Delaware alleging infringement of six Serendia patents by the Secret RF and Secret Pro systems, which the Company distributes in the U.S. on behalf of ILOODA Co. Ltd., a Korean company. If, following a successful third-party action for infringement, the Company cannot obtain a license for its products, the Company may have to stop selling the applicable products.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating and finance leases of lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003591888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DEBT<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the outstanding principal amount and carrying value of the Company&#8217;s Convertible Notes (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"><tr><td style="width:1.0%"/><td style="width:62.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible notes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance of convertible notes due in 2026</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of 2026 Notes in a private placement offering. The 2026 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year. Upon conversion, the 2026 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $133.6 million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1,000 principal amount of the 2026 Notes is initially convertible into 30.1427 shares of the Company&#8217;s common stock, which is equivalent to a conversion price of approximately $33.18 per share. The conversion rate for the 2026 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2026 Notes. The 2026 Notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2026 Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance of convertible notes due in 2028</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company issued $240.0&#160;million aggregate principal amount of 2028 Notes. The 2028 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on June 1 and December 1 of each year. A total of $230.0&#160;million of aggregate principal amount of 2028 Notes was issued in a private placement offering and concurrently with this private placement, the Company entered into a purchase agreement with Voce, an entity affiliated with J. Daniel Plants, the Company&#8217;s Executive Chairperson, pursuant to which the Company issued to Voce $10.0&#160;million aggregate principal amount of 2028 Notes on the same terms and conditions. The aggregate proceeds from the offering of 2028 Notes were approximately $232.4&#160;million, net of issuance costs, including initial purchaser fees.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 2028 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2022. Upon conversion, the 2028 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. Each $1,000 principal amount of the 2028 Notes is initially convertible into 18.9860 shares of the Company&#8217;s common stock, which is equivalent to an initial conversion price of approximately $52.67 per share. The conversion rate for the 2028 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2028 Notes. The 2028 Notes will mature on March 1, 2028, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2028 Notes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuance of convertible notes due in 2029</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company issued $120.0 million aggregate principal amount of 2029 Notes in a private placement offering. The 2029 Notes bear interest at a rate of 4.00% per year payable semiannually in arrears on June 1 and December 1 of each year. Upon conversion, the 2029 Notes will be convertible into either cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $115.8 million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1,000 principal amount of the 2029 Notes is initially convertible into 17.1378 shares of the Company&#8217;s common stock, which is equivalent to a conversion price of approximately $58.35 per share. The conversion rate for the 2029 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2029 Notes. The 2029 Notes will mature on June 1, 2029, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2029 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026 Notes exchange</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into privately-negotiated exchange agreements with certain holders of the Company&#8217;s outstanding 2026 Notes with respect to the exchange of $45.8&#160;million in cash (excluding $0.3&#160;million in cash for the payment of accrued interest) and 1,354,348 shares of common stock for $69.1&#160;million in aggregate principal amount of the Company&#8217;s outstanding 2026 Notes (the &#8220;2026 Notes Exchange&#8221;). Immediately following the closing of the 2026 Notes Exchange, approximately $69.1&#160;million in aggregate principal amount of the 2026 Notes remained outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes Exchange was accounted for as an extinguishment of debt. The Company recorded the difference between the proceeds paid and the carrying amount of the debt as an extinguishment loss, with a corresponding entry to common stock and Additional-paid-in capital for the issuance of the shares at the then-trading price of $41.31 per share. The table below presents the components of the Loss on debt extinguishment recorded in the Company's consolidated statements of operations for the year ended December 31, 2022 (amounts in thousands, except share and per share amounts):</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing price of Cutera common stock on May 24, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used for repurchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total shares and cash </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Note principal exchanged </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares and cash exchanged</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes: Unamortized debt issuance costs on May 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portion of 2026 Note principal exchanged</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion and other features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2026 Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2026 Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2026 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of 2026 Notes for each trading day of the measurement period was less than 98% </span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2026 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the third and fourth quarter of 2022. As of December&#160;31, 2022, the 2026 Notes are convertible and this condition will remain until March 31, 2023. The 2026 Notes may also become convertible in future periods. Upon any conversion requests of the 2026 Notes, the Company would be required to pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2026 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2026 Notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the 2026 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2026 Notes, at least $50.0&#160;million aggregate principal amount of 2026 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, 2026 Note holders have the option to require the Company to repurchase any portion or all of their 2026 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2026 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2026 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2026 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2026 Notes. The 2026 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2026 Notes (including the 2028 Notes and 2029 Notes). The 2026 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2026 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2026 Notes was approximately $103.8 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2028 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2028 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2028, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ending on September 30, 2022 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2028 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221; per $1,000 principal amount of 2028 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such 2028 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2028, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2028 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were not met during the fourth quarter of 2022. As of December 31, 2022, the 2028 Notes are not convertible and this condition will remain until March 31, 2023. The 2028 Notes may become convertible in future periods. Upon any conversion requests of the 2028 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2028 Notes have been included as long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2028 Notes prior to June 5, 2025. On or after June 5, 2025, the Company may redeem for cash all or any portion of the 2028 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2028 Notes, at least $100.0&#160;million aggregate principal amount of 2028 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, note holders have the option to require the Company to repurchase any portion or all of their 2028 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2028 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2028 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2028 Notes. The 2028 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2028 Notes (including the 2026 Notes and 2029 Notes). The 2028 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2028 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2028 Notes was approximately $249.3 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2029 Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2029 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2029 in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During any fiscal quarter commencing after the fiscal quarter ending March 31, 2023 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2029 Notes on each applicable trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of 2029 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company calls such 2029 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 1, 2029, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2029 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the bullets in the paragraph above were not met during the fourth quarter of 2022. As of December&#160;31, 2022, the 2029 Notes are not convertible and this condition will remain until March 31, 2023. Upon any conversion requests of the 2029 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2029 Notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the 2029 Notes prior to December 5, 2025. On or after December 5, 2025, the Company may redeem for cash all or any portion of the 2029 Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2029 Notes, at least $$100.0 million aggregate principal amount of 2029 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a specified corporate event occurs, 2029 Note holders have the option to require the Company to repurchase any portion or all of their 2029 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2029 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2029 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2029 Notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the 2029 Notes. The 2029 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2029 Notes (including the 2026 Notes and 2028 Notes). The 2029 Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2029 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the 2029 Notes was approximately $122.2 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capped Call Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of each series of the Convertible Notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's common stock upon any conversion or settlement of the applicable series of Convertible Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the applicable series of Convertible Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the applicable capped call transactions, then the Company&#8217;s stock would experience some dilution and/or such capped call transactions would not fully offset the potential cash payments, in each case, to the extent the then-market price per share of its common stock exceeds the applicable cap price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the offering of the 2026 Notes, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $45.535, which represented a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ending on March 12, 2026. The capped calls were purchased for $16.1 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2028 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2028 Notes sold to the initial purchasers in the offering of 2028 Notes, with a strike price equal to the conversion price of the 2028 Notes and with an initial cap price equal to $82.62, which represents a 100% premium over the last reported sale price of the Company's common stock of $41.31 per share on May 24, 2022, with certain adjustments to the settlement terms that reflect standard anti-</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilution provisions. These capped call transactions expire over 40 consecutive scheduled trading days ending on May 30, 2028. The capped calls were purchased for $32.0 million, inclusive of issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the offering of the 2029 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2029 Notes sold to the initial purchasers in the offering of 2029 Notes, with a strike price equal to the conversion price of the 2029 Notes and with an initial cap price equal to $99.32, which represents a 100% premium over the last reported sale price of the Company's common stock of $49.66 per share on December 7, 2022, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. These capped call transactions expire over 40 consecutive scheduled trading days ending on May 30, 2029. The capped calls were purchased for $25.1&#160;million, inclusive of issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company evaluated the capped call transactions under authoritative accounting guidance and determined that they should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) on January 1, 2021. In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Convertible Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible Notes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company incurred direct costs associated with the issuance of convertible notes of $11.8 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted under &#8220;2026 Notes Exchange&#8221; above, $1.8 million of unamortized debt issuance costs related to the 2026 Notes was included in the loss on debt extinguishment during the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $4.6 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the 2026 Notes, 2028 Notes, and 2029 Notes are 2.98%, 2.82%, and 4.63%, respectively. Interest expense for the year ended December&#160;31, 2022, including the amortization of debt issuance cost, totaled approximately $7.0 million. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $3.2 million. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company entered into the Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $30.0&#160;million. The Revolving Line of Credit matures on July 9, 2024. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $0.3&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis, but which is only applicable if the Company has an outstanding balance under the loan facility. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the capped call transactions. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 24, 2022, the Loan and Security Agreement was amended. The amendment increased the permitted indebtedness by $230,000,000 and provided for the 2026 Notes Exchange and issuance of the capped call transactions related to the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement  waived a violation of a covenant and revised the Loan Agreement to permit the issuance of the 2028 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement revised the Loan Agreement to permit the issuance of the 2029 Notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. In addition, under the purchase and assumption agreement, First-Citizens Bank &amp; Trust Company assumed Silicon Valley Bank&#8217;s obligations under the Company&#8217;s credit facility. On March 13, 2023, the Company violated one of the terms of the credit facility agreement by transferring funds from Silicon Valley Bank. The Company received a waiver from First-Citizens Bank &amp; Trust Company for this violation. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $7.2 million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and SVB as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $7.2&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003473120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounts with First-Citizens Bank &amp; Trust Company, which has assumed the deposits of Silicon Valley Bank and continues to perform asset management services. Approximately $305&#160;million of the Company&#8217;s total cash, cash equivalents, and marketable securities balance of $317&#160;million at December 31, 2022, was at SVB or SVB Asset Management. The Company&#8217;s funds held at SVB or through SVB Asset Management were either (i) US government treasuries or money market mutual funds held in custodial accounts at U.S. Bank National Association ($198&#160;million at December 31, 2022) or (ii) cash sweep investment funds where SVB acts as an agent for the Company ($107&#160;million at December 31, 2022). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed its receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no other events that have occurred that would require adjustments to its disclosures in the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003505008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUALIFYING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2022, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997509488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Description of Operations and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear, enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel, truSculpt, Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; each of which enables medical practitioners to perform procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) leasing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices for acne treatment ("AviClear" revenue); (iii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); and (iv) the distribution of third-party manufactured skincare products (&#8220;Skincare&#8221; revenue); are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 37 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity </span></div>breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 8%, 11% and 15%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AviClear</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the treatment protocol is initiated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truFlex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as replacement hand pieces, x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Consumable revenue. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products'&#160;single use disposable tips&#160;must be replaced after every treatment. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:f-470">one</span> to three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2022, and December 31, 2021, the accrual for the loyalty program included in accrued liabilities was $0.3 million, and $0.5, respectively. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract related to the sale of a system, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:f-475">two</span> to three years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2022 and December&#160;31, 2021 were $2.0 million and $2.7 million, respectively. Amortization expenses for these assets were&#160;$2.4 million, $1.9 million and $2.6 million, respectively, during the years&#160;ended December&#160;31, 2022, 2021 and 2020 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022 and December&#160;31, 2021 were $3.8 million and $4.2 million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. Credit card receivables, that are collected in a short period of time are also classified as cash and cash equivalents. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock', window );">Allowances for Sales Returns and Credit Losses</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns represents the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns and is based on the Company's analysis of current economic trends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of customers, current economic conditions, the age of the accounts receivable balances, historical loss information, current conditions and forecasted information. The Company writes off trade receivables when they are deemed uncollectible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with SVB. On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#8217;s receiver. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp; Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2022, and 2021, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2022, 2021, and 2020, domestic revenue accounted for 43%, 42% and 41%, respectively, of total revenue, while international revenue accounted for 57%, 58% and 59%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately 10%, 14% and 9% of the Company's total purchases in the years ended December&#160;31, 2022, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2022 and 2021, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $5.7 million and $3.7 million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2022, 2021 and 2020, was $2.2 million, $1.3 million, and $1.4 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div>The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the fourth quarter of 2022, the Company segregated its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. Goodwill was tested for impairment at the segment level. As of December&#160;31, 2022, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Obligations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.</span></div>After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Accounting for Leases as a Lessee</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessee</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Accounting for Leases as a Lessor</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the lessee has the ability to perform the patient treatment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 to the consolidated financial statements for more information regarding leasing arrangements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenditures</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third-party contractors, regulatory affairs, clinical and development costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising CostsAdvertising costs are included as part of sales and marketing expense and are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period. To estimate the fair value of an award, the Company uses the Black-Scholes option pricing model. The following inputs are used in this model:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the historical volatility of the Company's stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2022 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Computation of Net Income (Loss) per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for-sale investments, net of tax.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Losses resulting from foreign currency transactions are included in net income (loss) are $3.6&#160;million and $1.8&#160;million in the year ended December&#160;31, 2022 and 2021, respectively, and were insignificant for the year ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company operates in two segments. Revenue is attributed to a geographic region based on the location of the end customer. See Note 12 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for allowances for sales returns and doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003440480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003622256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments - U.S. Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments - U.S. Treasury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Market<br/>Value</span></td></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</span></td><td colspan="15" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003620176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Assets Measured and Recognized at Fair Value on a Recurring Basis</a></td>
<td class="text">As of December&#160;31, 2022, financial assets and liabilities measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"><tr><td style="width:1.0%"/><td style="width:46.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.992%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Money market funds </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Foreign exchange forward</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003717504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flow effect of the derivative instruments settlement is recorded in cash flow from operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dollar amounts in thousands:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:23.621%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.836%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.729%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.385%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Exchange Forward</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross notional amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700093979888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">Inventories, net of these adjustments, consist of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,628&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,503&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other current assets and prepaid expenses</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets and a prepaid expenses, consists of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits with vendors</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,036&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,545&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, net</a></td>
<td class="text">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003669280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranty Accrual</a></td>
<td class="text">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2022 and 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,254&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003659840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Deferred Service Contract Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred revenue balance for the years ended December&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,383)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002137680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Payment Arrangement</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(296,238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,863&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest, net of estimated forfeitures, as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $44.22 of the Company&#8217;s stock on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020 and $35.81 on December&#160;31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2022, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Payment Arrangement Exercise Price Range</a></td>
<td class="text">The options outstanding and exercisable at December&#160;31, 2022 were in the following exercise price ranges:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.363%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.79</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.04</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.70</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33.45</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,857&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42.33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.91</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47.40</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63.62</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10.79</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$63.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">513,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,863</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,949&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,856)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,274&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340,836)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,131)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $44.22 on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, and $35.81 on December&#160;31, 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $12.2 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.8 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $9.9 million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Share-based Payment Arrangement Cost by Plan</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2022, 2021 and 2020 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the years ended December&#160;31, 2022, 2021 and 2020 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock', window );">Schedule of Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</a></td>
<td class="text">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.76&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.63&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.77&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.64&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998260000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax</a></td>
<td class="text">The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 Costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,066)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.04)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December&#160;31, 2020 to December&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997067664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,935&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699996834992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information</a></td>
<td class="text">The Company measures the financial results of its reportable segments using an internal performance measure that excludes General and administrative expenses.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"/><td style="width:46.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252,399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">231,270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">147,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,012)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,796)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Items not allocated to segments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;ERP implementation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,821)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Legal fees, severance, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Interest and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(80,702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital spending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total capital spending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cutera Core</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;AviClear</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">202,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">520,988</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280,293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of Revenue by Geography</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AviClear</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997143344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LeasesFinancialStatementInformationTableTextBlock', window );">Schedule of Financial Statement Information</a></td>
<td class="text">Below is supplemental balance sheet information related to leases (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1270"><span style="-sec-ix-hidden:f-1271">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,437&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,019&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1282"><span style="-sec-ix-hidden:f-1283">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1286"><span style="-sec-ix-hidden:f-1287">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,310&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the twelve months ended&#160;December&#160;31, 2022 and December&#160;31, 2021 (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Liability</a></td>
<td class="text">Maturities of operating lease liabilities were as follows as of December&#160;31, 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,962&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,027&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,773)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Finance Lease Liability</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(131)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Schedule of Operating Lease Income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1335"><span style="-sec-ix-hidden:f-1336">AviClear operating lease license fee revenue</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1339"><span style="-sec-ix-hidden:f-1340">AviClear operating lease revenue</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-1343"><span style="-sec-ix-hidden:f-1344">Total AviClear revenue</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Schedule of Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the minimum future lease payments as of December&#160;31, 2022, under non-cancelable operating leases, assuming the minimum contractual lease term (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeasesFinancialStatementInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the financial statement information for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeasesFinancialStatementInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997642736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Convertible Notes</a></td>
<td class="text">The following table presents the outstanding principal amount and carrying value of the Company&#8217;s Convertible Notes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"><tr><td style="width:1.0%"/><td style="width:62.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes due in 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible notes, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock', window );">Schedule of Components of the Loss on Debt Extinguishment</a></td>
<td class="text">The table below presents the components of the Loss on debt extinguishment recorded in the Company's consolidated statements of operations for the year ended December 31, 2022 (amounts in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing price of Cutera common stock on May 24, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used for repurchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total shares and cash </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Note principal exchanged </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares and cash exchanged</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes: Unamortized debt issuance costs on May 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portion of 2026 Note principal exchanged</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7516071&amp;loc=d3e13374-112631<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003664880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of Valuation Allowance</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699991667248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>country </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment </div>
<div>country </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity operates | country</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod', window );">Training on use of system term (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Accrual for loyalty program</a></td>
<td class="nump">$ 13,498,000<span></span>
</td>
<td class="nump">$ 13,498,000<span></span>
</td>
<td class="nump">$ 10,825,000<span></span>
</td>
<td class="nump">$ 11,237,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DemonstrationUnitsAmortizationPeriod', window );">Estimated economic life of demonstration units (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Demonstration inventories included in finished goods</a></td>
<td class="nump">5,700,000<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization', window );">Capitalized computing amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization', window );">Capitalized computing accumulated amortization</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_StandardProductWarrantyTermDirectSales', window );">Warranty term, direct sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_StandardProductWarrantyTermDistributorSales', window );">Warranty term, distributor sales (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Other current assets and prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Capitalized computing set-up costs</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Capitalized computing set-up costs</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount', window );">Shares granted calculation, grant period (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">50 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized costs, amortization period (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized costs, amortization period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember', window );">Lease installment cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember', window );">Lease installment cost | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_PercentageOfAssets', window );">Percentage of assets in the United States</a></td>
<td class="nump">99.80%<span></span>
</td>
<td class="nump">99.80%<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Revenue from Contract with Customer, Product and Service Benchmark | Largest Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing | Capitalized Cloud Computing Set-up Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing | Lease installment cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionThreeTerm', window );">Extended service contract, option three, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember', window );">Loyalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Accrual for loyalty program</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues', window );">Total net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Training Provided With Sale Of System, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DemonstrationUnitsAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Demonstration Units, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DemonstrationUnitsAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionOneTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option One, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionOneTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionThreeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Three, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionThreeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization, Consolidation And Presentation Of Financial Statements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_PercentageOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage amount of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_PercentageOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Award, Period To Determine Grant Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StandardProductWarrantyTermDirectSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Term, Direct Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StandardProductWarrantyTermDirectSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StandardProductWarrantyTermDistributorSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Term, Distributor Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StandardProductWarrantyTermDistributorSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cutr_LargestSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cutr_LargestSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_LoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993799872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember', window );">Equipment leasing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearDevicesMember', window );">AviClear devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember', window );">Office equipment and furniture</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699994430016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 145,924<span></span>
</td>
<td class="nump">$ 164,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Current restricted cash</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows</a></td>
<td class="nump">146,624<span></span>
</td>
<td class="nump">$ 164,864<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost', window );">Total amortized cost</a></td>
<td class="nump">171,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities', window );">Total fair market value</a></td>
<td class="nump">318,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable investments - U.S. Treasury</a></td>
<td class="nump">171,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair market value</a></td>
<td class="nump">$ 171,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-for-sale Debt Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002111888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Net unrealized loss</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letter of credit</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993525312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Convertible Senior Notes Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair market value</a></td>
<td class="nump">$ 171,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Total</a></td>
<td class="nump">197,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Foreign exchange forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">26,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair market value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Total</a></td>
<td class="num">(558)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Foreign exchange forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities:</a></td>
<td class="num">(558)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999652480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Details) - Foreign exchange forward<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">$ 6,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value</a></td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized loss</a></td>
<td class="num">$ (558)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002228432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Valuation adjustment for excess and obsolete inventory</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,339,000<span></span>
</td>
<td class="nump">1,339,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill additions during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998259840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 36,323<span></span>
</td>
<td class="nump">$ 24,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">2,117<span></span>
</td>
<td class="nump">2,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">25,188<span></span>
</td>
<td class="nump">13,344<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 63,628<span></span>
</td>
<td class="nump">$ 39,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993432048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Deposits with vendors</a></td>
<td class="nump">$ 13,917<span></span>
</td>
<td class="nump">$ 4,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Foreign tax receivable</a></td>
<td class="nump">7,147<span></span>
</td>
<td class="nump">7,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepayments</a></td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">2,544<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 24,036<span></span>
</td>
<td class="nump">$ 14,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999740352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">$ 45,615<span></span>
</td>
<td class="nump">$ 6,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: Accumulated depreciation</a></td>
<td class="num">(5,247)<span></span>
</td>
<td class="num">(3,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">40,368<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">793<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember', window );">Equipment leasing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearMember', window );">AviClear devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">19,904<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office equipment and furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">5,106<span></span>
</td>
<td class="nump">3,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember', window );">Assets under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">$ 17,876<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_AviClearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993801504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Bonus and payroll-related accruals</a></td>
<td class="nump">$ 18,951<span></span>
</td>
<td class="nump">$ 21,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Accrued sales tax</a></td>
<td class="nump">9,066<span></span>
</td>
<td class="nump">9,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_AccruedInventoryInTransitCurrent', window );">Liability for inventory in transit</a></td>
<td class="nump">7,028<span></span>
</td>
<td class="nump">4,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_SalesAndMarketingAccrualsCurrent', window );">Sales and marketing accruals</a></td>
<td class="nump">5,347<span></span>
</td>
<td class="nump">4,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty</a></td>
<td class="nump">3,254<span></span>
</td>
<td class="nump">3,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">13,806<span></span>
</td>
<td class="nump">10,321<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 57,452<span></span>
</td>
<td class="nump">$ 54,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AccruedInventoryInTransitCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory In Transit, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AccruedInventoryInTransitCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_SalesAndMarketingAccrualsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_SalesAndMarketingAccrualsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126907644&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003936032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty - Summary of Warranties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at beginning of year</a></td>
<td class="nump">$ 3,947<span></span>
</td>
<td class="nump">$ 4,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Add: Accruals for warranties issued during the period</a></td>
<td class="nump">3,710<span></span>
</td>
<td class="nump">5,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Less: Settlements made during the period</a></td>
<td class="num">(4,403)<span></span>
</td>
<td class="num">(5,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at end of year</a></td>
<td class="nump">$ 3,254<span></span>
</td>
<td class="nump">$ 3,947<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997173152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_CostsForExtendedServiceContracts', window );">Costs for extended service contracts</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ExtendedServiceContractTerm', window );">Extended service contract term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ExtendedServiceContractTerm', window );">Extended service contract term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Deferred revenue balance (as a percent)</a></td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue balance, amount</a></td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue balance, recognition period (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CostsForExtendedServiceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred under service contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CostsForExtendedServiceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700001925424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of year</a></td>
<td class="nump">$ 10,825<span></span>
</td>
<td class="nump">$ 11,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived', window );">Add: Payments received</a></td>
<td class="nump">21,984<span></span>
</td>
<td class="nump">17,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred', window );">Less: Revenue recognized from current period sales</a></td>
<td class="num">(9,928)<span></span>
</td>
<td class="num">(7,006)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Less: Revenue recognized from beginning balance</a></td>
<td class="num">(9,383)<span></span>
</td>
<td class="num">(10,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of year</a></td>
<td class="nump">$ 13,498<span></span>
</td>
<td class="nump">$ 10,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699987447328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 12, 2004 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>tranche </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2004 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 1998 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_CapitalStockSharesAuthorized', window );">Authorized capital (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,668,603<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,668,603<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,798,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear', window );">Percentage of awards officers are required to hold for a minimum of one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember', window );">Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,274<span></span>
</td>
<td class="nump">744,949<span></span>
</td>
<td class="nump">667,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Share-based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,496<span></span>
</td>
<td class="nump">41,301<span></span>
</td>
<td class="nump">35,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,993<span></span>
</td>
<td class="nump">219,686<span></span>
</td>
<td class="nump">405,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember', window );">Restricted Stock Units, Annual Grant | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember', window );">Restricted Stock Units, New Hire | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember', window );">Restricted Stock Units, New Hire | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,897<span></span>
</td>
<td class="nump">169,785<span></span>
</td>
<td class="nump">178,222<span></span>
</td>
<td class="nump">76,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_StockPlanMember', window );">1998 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,650,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember', window );">2004 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled', window );">Share subtraction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,701,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled', window );">Share subtraction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember', window );">The Amended and Restated 2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember', window );">2004 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage', window );">Additional shares authorized, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of stock, percent of market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">ESPP stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,306<span></span>
</td>
<td class="nump">59,635<span></span>
</td>
<td class="nump">56,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock issued, price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering | $</a></td>
<td class="nump">$ 26,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost | $</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | Underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">357,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CapitalStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CapitalStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of stack awards counted for every share granted or canceled when computed shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cutr_UnderwriterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cutr_UnderwriterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699991551776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward', window );"><strong>Shares Available For Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance (in shares)</a></td>
<td class="nump">947,347<span></span>
</td>
<td class="nump">1,085,170<span></span>
</td>
<td class="nump">761,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_AdditionalSharesReservedSharesAvailableForGrant', window );">Additional shares reserved (in shares)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted', window );">Options granted (in shares)</a></td>
<td class="num">(296,238)<span></span>
</td>
<td class="num">(172,139)<span></span>
</td>
<td class="num">(71,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (expired or forfeited) (in shares)</a></td>
<td class="nump">29,518<span></span>
</td>
<td class="nump">30,173<span></span>
</td>
<td class="nump">76,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross', window );">Stock awards granted (in shares)</a></td>
<td class="num">(374,274)<span></span>
</td>
<td class="num">(744,949)<span></span>
</td>
<td class="num">(804,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod', window );">Stock awards canceled (expired or forfeited) (in shares)</a></td>
<td class="nump">164,572<span></span>
</td>
<td class="nump">299,092<span></span>
</td>
<td class="nump">522,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance (in shares)</a></td>
<td class="nump">1,070,925<span></span>
</td>
<td class="nump">947,347<span></span>
</td>
<td class="nump">1,085,170<span></span>
</td>
<td class="nump">761,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance (in shares)</a></td>
<td class="nump">287,175<span></span>
</td>
<td class="nump">217,007<span></span>
</td>
<td class="nump">295,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(39,960)<span></span>
</td>
<td class="num">(71,798)<span></span>
</td>
<td class="num">(73,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">296,238<span></span>
</td>
<td class="nump">172,139<span></span>
</td>
<td class="nump">71,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (expired or forfeited) (in shares)</a></td>
<td class="num">(29,518)<span></span>
</td>
<td class="num">(30,173)<span></span>
</td>
<td class="num">(76,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance (in shares)</a></td>
<td class="nump">513,935<span></span>
</td>
<td class="nump">287,175<span></span>
</td>
<td class="nump">217,007<span></span>
</td>
<td class="nump">295,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">127,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">483,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in dollars per share)</a></td>
<td class="nump">$ 25.89<span></span>
</td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="nump">$ 25.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">40.95<span></span>
</td>
<td class="nump">30.71<span></span>
</td>
<td class="nump">14.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">21.28<span></span>
</td>
<td class="nump">22.02<span></span>
</td>
<td class="nump">12.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options cancelled (expired or forfeited) (in dollars per share)</a></td>
<td class="nump">34.91<span></span>
</td>
<td class="nump">37.14<span></span>
</td>
<td class="nump">36.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in dollars per share)</a></td>
<td class="nump">34.41<span></span>
</td>
<td class="nump">$ 25.89<span></span>
</td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="nump">$ 25.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">27.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 34.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract', window );"><strong>Weighted-Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">6 years 7 months 17 days<span></span>
</td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">3 years 9 months<span></span>
</td>
<td class="text">3 years 2 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">3 years 2 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest</a></td>
<td class="text">6 years 6 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Balance</a></td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 4,460<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">$ 5,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AdditionalSharesReservedSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AdditionalSharesReservedSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998205040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 63.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">513,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">6 years 7 months 17 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">127,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member', window );">Exercise Price Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">5,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">1 year 3 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">5,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member', window );">Exercise Price Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">2 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">28,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member', window );">Exercise Price Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 25.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">12,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">10 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">12,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member', window );">Exercise Price Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">73,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">5 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">31,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member', window );">Exercise Price Range 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 32.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">48,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">4 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">22,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member', window );">Exercise Price Range 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 33.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">150,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">9 years 1 month 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member', window );">Exercise Price Range 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 36.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 41.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">91,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">6 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">22,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member', window );">Exercise Price Range 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 42.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">17,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">9 years 10 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member', window );">Exercise Price Range 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 47.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">4,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">4,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member', window );">Exercise Price Range 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 63.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">48,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">9 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993588784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">209,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,904<span></span>
</td>
<td class="nump">779,757<span></span>
</td>
<td class="nump">1,104,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,274<span></span>
</td>
<td class="nump">744,949<span></span>
</td>
<td class="nump">667,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(340,836)<span></span>
</td>
<td class="num">(254,946)<span></span>
</td>
<td class="num">(684,491)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited(in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(160,131)<span></span>
</td>
<td class="num">(236,856)<span></span>
</td>
<td class="num">(308,248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906,211<span></span>
</td>
<td class="nump">1,032,904<span></span>
</td>
<td class="nump">779,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.00<span></span>
</td>
<td class="nump">$ 23.96<span></span>
</td>
<td class="nump">$ 22.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.36<span></span>
</td>
<td class="nump">40.16<span></span>
</td>
<td class="nump">20.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.04<span></span>
</td>
<td class="nump">22.94<span></span>
</td>
<td class="nump">17.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.48<span></span>
</td>
<td class="nump">27.33<span></span>
</td>
<td class="nump">23.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.39<span></span>
</td>
<td class="nump">$ 35.00<span></span>
</td>
<td class="nump">$ 23.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue', window );">Vested, aggregate fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,443<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 12,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,073<span></span>
</td>
<td class="nump">42,680<span></span>
</td>
<td class="nump">18,800<span></span>
</td>
<td class="nump">$ 37,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Grant date fair value of awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997176784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="nump">$ 13,172<span></span>
</td>
<td class="nump">$ 10,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,979<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
<td class="nump">8,849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,430<span></span>
</td>
<td class="nump">6,591<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_ESPPMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_ESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_ESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700001822128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="nump">$ 13,172<span></span>
</td>
<td class="nump">$ 10,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,998<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,405<span></span>
</td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,332<span></span>
</td>
<td class="nump">$ 5,820<span></span>
</td>
<td class="nump">$ 3,390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700001844048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">4 years 10 days<span></span>
</td>
<td class="text">3 years 11 months 19 days<span></span>
</td>
<td class="text">4 years 10 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">1.99%<span></span>
</td>
<td class="nump">0.48%<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (as a percent)</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 19.76<span></span>
</td>
<td class="nump">$ 15.09<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember', window );">Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 months 26 days<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">3.79%<span></span>
</td>
<td class="nump">0.14%<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility (as a percent)</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 15.77<span></span>
</td>
<td class="nump">$ 9.64<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700093979360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (84,189)<span></span>
</td>
<td class="num">$ (356)<span></span>
</td>
<td class="num">$ (25,793)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">3,487<span></span>
</td>
<td class="nump">3,741<span></span>
</td>
<td class="nump">2,386<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (80,702)<span></span>
</td>
<td class="nump">$ 3,385<span></span>
</td>
<td class="num">$ (23,407)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998214160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">126<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total Current</a></td>
<td class="nump">1,453<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">182<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total Deferred</a></td>
<td class="nump">185<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision</a></td>
<td class="nump">$ 1,638<span></span>
</td>
<td class="nump">$ 1,323<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002267760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 21,443<span></span>
</td>
<td class="nump">$ 18,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2,594<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accruals and reserves</a></td>
<td class="nump">4,592<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Credits</a></td>
<td class="nump">14,908<span></span>
</td>
<td class="nump">13,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves', window );">Accrued warranty</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">2,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Section 174 Costs</a></td>
<td class="nump">7,578<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,541<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">3,384<span></span>
</td>
<td class="nump">3,784<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax asset before valuation allowance</a></td>
<td class="nump">58,675<span></span>
</td>
<td class="nump">45,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(53,118)<span></span>
</td>
<td class="num">(40,485)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset after valuation allowance</a></td>
<td class="nump">5,557<span></span>
</td>
<td class="nump">5,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts', window );">Deferred contract acquisition costs</a></td>
<td class="num">(1,763)<span></span>
</td>
<td class="num">(990)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(138)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(3,066)<span></span>
</td>
<td class="num">(3,480)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993613808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax rate</a></td>
<td class="num">(0.16%)<span></span>
</td>
<td class="num">(2.55%)<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent', window );">Meals and entertainment</a></td>
<td class="num">(0.47%)<span></span>
</td>
<td class="nump">9.28%<span></span>
</td>
<td class="num">(0.65%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="num">(0.07%)<span></span>
</td>
<td class="nump">1.11%<span></span>
</td>
<td class="num">(2.87%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">0.89%<span></span>
</td>
<td class="num">(13.08%)<span></span>
</td>
<td class="num">(1.07%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent', window );">Extinguishment of PPP loan</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(44.59%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent', window );">Debt extinguishment costs</a></td>
<td class="num">(8.48%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent', window );">Excess compensation</a></td>
<td class="num">(1.34%)<span></span>
</td>
<td class="nump">7.88%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(0.76%)<span></span>
</td>
<td class="nump">17.03%<span></span>
</td>
<td class="num">(1.05%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent', window );">General business credit</a></td>
<td class="nump">0.78%<span></span>
</td>
<td class="num">(17.95%)<span></span>
</td>
<td class="nump">2.74%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent', window );">Valuation allowance</a></td>
<td class="num">(11.41%)<span></span>
</td>
<td class="nump">72.82%<span></span>
</td>
<td class="num">(25.51%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Change in prior year reserves</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.08%)<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent', window );">Deferred true-up</a></td>
<td class="num">(2.02%)<span></span>
</td>
<td class="num">(11.76%)<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(2.04%)<span></span>
</td>
<td class="nump">39.11%<span></span>
</td>
<td class="num">(2.01%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Extinguishment Of Loan, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Debt Extinguishment Costs, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002100800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 53,118<span></span>
</td>
<td class="nump">$ 40,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="nump">12,600<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">$ 778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_OperatingLossCarryforwardsWithoutExpiration', window );">Operating loss carryforwards without expiration</a></td>
<td class="nump">51,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">87,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Internal Revenue Service (IRS) | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">45,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | California Franchise Tax Board | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_OperatingLossCarryforwardsWithoutExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating loss carryforwards that have no expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_OperatingLossCarryforwardsWithoutExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700001770576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 2,746<span></span>
</td>
<td class="nump">$ 1,864<span></span>
</td>
<td class="nump">$ 1,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 3,725<span></span>
</td>
<td class="nump">$ 2,746<span></span>
</td>
<td class="nump">$ 1,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003610016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt convertible to common shares (in shares)</a></td>
<td class="nump">8,354,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699991252912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82,340)<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</a></td>
<td class="nump">18,747<span></span>
</td>
<td class="nump">17,891<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">18,747<span></span>
</td>
<td class="nump">18,362<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share, basic (USD per share)</a></td>
<td class="num">$ (4.39)<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share, diluted (USD per share)</a></td>
<td class="num">$ (4.39)<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998227760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">20,935<span></span>
</td>
<td class="nump">8,652<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember', window );">Capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">10,780<span></span>
</td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">8,697<span></span>
</td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">514<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993579824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution', window );">Maximum 401(k) employee contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer 401(k) discretionary contribution</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700003702512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699994359248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 252,399,000<span></span>
</td>
<td class="nump">$ 231,270,000<span></span>
</td>
<td class="nump">$ 147,683,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(38,190,000)<span></span>
</td>
<td class="nump">1,830,000<span></span>
</td>
<td class="num">(22,828,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="num">(14,400,000)<span></span>
</td>
<td class="num">(13,172,000)<span></span>
</td>
<td class="num">(10,109,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_ERPImplementation', window );">ERP implementation</a></td>
<td class="num">(9,211,000)<span></span>
</td>
<td class="num">(1,498,000)<span></span>
</td>
<td class="num">(1,139,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(5,821,000)<span></span>
</td>
<td class="num">(3,188,000)<span></span>
</td>
<td class="num">(3,987,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LegalFeesSeveranceAndOther', window );">Legal fees, severance, and other</a></td>
<td class="num">(1,608,000)<span></span>
</td>
<td class="num">(1,048,000)<span></span>
</td>
<td class="num">(2,797,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total interest and other income (expense), net</a></td>
<td class="num">(42,512,000)<span></span>
</td>
<td class="nump">1,555,000<span></span>
</td>
<td class="num">(579,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(80,702,000)<span></span>
</td>
<td class="nump">3,385,000<span></span>
</td>
<td class="num">(23,407,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapital', window );">Total capital spending</a></td>
<td class="nump">22,698,000<span></span>
</td>
<td class="nump">1,015,000<span></span>
</td>
<td class="nump">1,279,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">520,988,000<span></span>
</td>
<td class="nump">280,293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(7,150,000)<span></span>
</td>
<td class="nump">20,736,000<span></span>
</td>
<td class="num">(4,796,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapital', window );">Total capital spending</a></td>
<td class="nump">22,698,000<span></span>
</td>
<td class="nump">1,015,000<span></span>
</td>
<td class="nump">1,279,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">202,384,000<span></span>
</td>
<td class="nump">83,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Cutera Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">247,943,000<span></span>
</td>
<td class="nump">231,270,000<span></span>
</td>
<td class="nump">147,683,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">20,862,000<span></span>
</td>
<td class="nump">30,181,000<span></span>
</td>
<td class="num">(4,796,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapital', window );">Total capital spending</a></td>
<td class="nump">1,780,000<span></span>
</td>
<td class="nump">438,000<span></span>
</td>
<td class="nump">1,279,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">154,978,000<span></span>
</td>
<td class="nump">76,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | AviClear devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">4,456,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(28,012,000)<span></span>
</td>
<td class="num">(9,445,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapital', window );">Total capital spending</a></td>
<td class="nump">20,918,000<span></span>
</td>
<td class="nump">577,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">47,406,000<span></span>
</td>
<td class="nump">6,342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Items not allocated to segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapital', window );">Total capital spending</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 318,604,000<span></span>
</td>
<td class="nump">$ 197,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ERPImplementation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ERP Implementation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ERPImplementation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LegalFeesSeveranceAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal Fees, Severance, and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LegalFeesSeveranceAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of ownership interest of different classes of partners in limited partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cutr_CuteraCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cutr_CuteraCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cutr_AviClearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cutr_AviClearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699993719504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 252,399,000<span></span>
</td>
<td class="nump">$ 231,270,000<span></span>
</td>
<td class="nump">$ 147,683,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_TotalProductsMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">228,796,000<span></span>
</td>
<td class="nump">205,703,000<span></span>
</td>
<td class="nump">125,113,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SystemsMember', window );">Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">163,637,000<span></span>
</td>
<td class="nump">139,633,000<span></span>
</td>
<td class="nump">90,765,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_AviClearMember', window );">AviClear</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">4,456,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">18,203,000<span></span>
</td>
<td class="nump">16,401,000<span></span>
</td>
<td class="nump">9,287,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SkincareMember', window );">Skincare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">42,500,000<span></span>
</td>
<td class="nump">49,669,000<span></span>
</td>
<td class="nump">25,061,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">23,603,000<span></span>
</td>
<td class="nump">25,567,000<span></span>
</td>
<td class="nump">22,570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">107,453,000<span></span>
</td>
<td class="nump">96,629,000<span></span>
</td>
<td class="nump">61,238,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">64,920,000<span></span>
</td>
<td class="nump">70,235,000<span></span>
</td>
<td class="nump">43,265,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember', window );">Asia, excluding Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">21,873,000<span></span>
</td>
<td class="nump">12,649,000<span></span>
</td>
<td class="nump">10,707,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">20,882,000<span></span>
</td>
<td class="nump">19,444,000<span></span>
</td>
<td class="nump">11,185,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember', window );">Rest of the world, other than United States, Asia and Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 37,271,000<span></span>
</td>
<td class="nump">$ 32,313,000<span></span>
</td>
<td class="nump">$ 21,288,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_TotalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_TotalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_AviClearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_AviClearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997219664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lease_term</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LessorDurationOfAutorenewalFeatures', window );">Duration of autorenewal features</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated product liability</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_NumberOfConsecutiveLeaseTerms', window );">Number of consecutive lease terms | lease_term</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_AviClearDeviceMember', window );">AviClear Device</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember', window );">Lease installment cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember', window );">Lease installment cost | Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember', window );">Lease installment cost | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LesseeLeasesRemainingTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Capitalized Cloud Computing Set-up Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LesseeLeasesRemainingTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LesseeLeaseRenewalTerm', window );">Remaining lease terms of finance leases</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Capitalized Cloud Computing Set-up Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The renewal term for leases of lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeasesRemainingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining term of operating and finance leases for the lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeasesRemainingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LessorDurationOfAutorenewalFeatures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Duration Of Autorenewal Features</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LessorDurationOfAutorenewalFeatures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_NumberOfConsecutiveLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Consecutive Lease Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_NumberOfConsecutiveLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_AviClearDeviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_AviClearDeviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_LeaseInstallmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999617840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Financial Statement Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 12,831<span></span>
</td>
<td class="nump">$ 14,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease</a></td>
<td class="nump">$ 1,606<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LeaseRightOfUseAsset', window );">Total leased assets</a></td>
<td class="nump">$ 14,437<span></span>
</td>
<td class="nump">$ 15,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">11,352<span></span>
</td>
<td class="nump">13,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">14,162<span></span>
</td>
<td class="nump">15,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, non-current</a></td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 1,310<span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease cost</a></td>
<td class="nump">3,560<span></span>
</td>
<td class="nump">3,542<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flow</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flow</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow</a></td>
<td class="nump">$ 2,526<span></span>
</td>
<td class="nump">$ 3,092<span></span>
</td>
<td class="nump">$ 2,139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance and operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699991523072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 3,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">3,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">3,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive', window );">Thereafter</a></td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">15,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,773)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">$ 14,162<span></span>
</td>
<td class="nump">$ 15,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999833680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(131)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 1,310<span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700001951312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">6.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699998041296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Operating Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_AviClearRevenueMember', window );">AviClear Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease income</a></td>
<td class="nump">$ 4,456<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList', window );">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Total net revenue<span></span>
</td>
<td class="text">Total net revenue<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseLicenseFeeRevenueMember', window );">AviClear operating lease license fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease income</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList', window );">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Total net revenue<span></span>
</td>
<td class="text">Total net revenue<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseRecurringRevenueMember', window );">AviClear operating lease revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease income</a></td>
<td class="nump">$ 3,534<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList', window );">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Total net revenue<span></span>
</td>
<td class="text">Total net revenue<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of comprehensive income that includes operating lease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_AviClearRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_AviClearRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseLicenseFeeRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseLicenseFeeRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseRecurringRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_AviClearOperatingLeaseRecurringRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997490784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2024</a></td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total lease payments</a></td>
<td class="nump">$ 1,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699997193072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Outstanding Debt and Carrying Value (Details) - Convertible Debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 416,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">69,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(1,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,007)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">67,572<span></span>
</td>
<td class="nump">$ 69,100<span></span>
</td>
<td class="nump">134,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(6,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">233,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member', window );">Convertible Senior Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(4,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 115,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699982764608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>$ / item </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / item</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 24, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,680,000<span></span>
</td>
<td class="nump">$ 16,134,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,355,000<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416,459,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416,459,000<span></span>
</td>
<td class="nump">134,243,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,423,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0301427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCapPrice', window );">Cap price (in USD per share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCapPricePremiumOverStockPricePercent', window );">Premium over stock price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays', window );">Capped-call transaction term, consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from convertible notes, net of unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionConvertedInstrumentCashIssued', window );">Cash used for repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,776,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Payment of accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued in debt conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,354,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,572,000<span></span>
</td>
<td class="nump">134,243,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger', window );">Redemption threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdTradingDays', window );">Redemption threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays', window );">Redemption threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption', window );">Required outstanding amount not subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted', window );">Portion of 2026 Note principal exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount', window );">Incremental repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.018986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCapPrice', window );">Cap price (in USD per share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCapPricePremiumOverStockPricePercent', window );">Premium over stock price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays', window );">Capped-call transaction term, consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from convertible notes, net of unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount', window );">Additional principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233,092,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger', window );">Redemption threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdTradingDays', window );">Redemption threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays', window );">Redemption threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption', window );">Required outstanding amount not subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028 | Convertible Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028 | Convertible Debt | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount', window );">Incremental repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes Due 2028 | Convertible Debt | Voce Capital Management LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member', window );">Convertible Senior Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0171378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCapPrice', window );">Cap price (in USD per share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCapPricePremiumOverStockPricePercent', window );">Premium over stock price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays', window );">Capped-call transaction term, consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member', window );">Convertible Senior Notes Due 2029 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member', window );">Convertible Senior Notes Due 2029 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from convertible notes, net of unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,795,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption', window );">Required outstanding amount not subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member', window );">Convertible Senior Notes Due 2029 | Convertible Debt | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember', window );">Convertible Senior Notes Due 2026, First Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember', window );">Convertible Senior Notes Due 2026, Second Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember', window );">Convertible Senior Notes Due 2028, First Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger', window );">Redemption threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember', window );">Convertible Senior Notes Due 2028, Second Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Silicon Valley Bank | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable', window );">Qualifying accounts receivable (as a percent)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee amount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtInstrumentAnniversaryFeeAmount', window );">Anniversary fee amount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtCovenantQuarterlyMinimumRevenue', window );">Quarterly minimum revenue</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Silicon Valley Bank | Revolving Credit Facility | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember', window );">PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionConvertedInstrumentCashIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Converted Instrument, Cash Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionConvertedInstrumentCashIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Unamortized Debt Issuance Costs, Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtCovenantQuarterlyMinimumRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents quarterly minimum revenue under debt covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtCovenantQuarterlyMinimumRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentAdditionalAggregatePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Additional Aggregate Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentAdditionalAggregatePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentAnniversaryFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents anniversary fee amount for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentAnniversaryFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of qualifying accounts receivable for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedeemableThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redeemable, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedeemableThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption, Incremental Repurchase Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCapPricePremiumOverStockPricePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percent premium over the stock price for derivative caps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCapPricePremiumOverStockPricePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Capped Call Transaction Term, Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense And Amortization Of Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCapPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCapPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cutr_VoceCapitalManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cutr_VoceCapitalManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699999587264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Components of the Loss on Debt Extinguishment (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Mar. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,423)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued in debt conversion (in shares)</a></td>
<td class="nump">1,354,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Value of shares issued</a></td>
<td class="nump">$ 55,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionConvertedInstrumentCashIssued', window );">Cash used for repurchase</a></td>
<td class="nump">45,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged', window );">Total shares and cash</a></td>
<td class="nump">101,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">2026 Note principal exchanged</a></td>
<td class="num">(69,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionNetProceeds', window );">Value of shares and cash exchanged</a></td>
<td class="nump">32,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="nump">$ 3,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionPercentageOfDebtConverted', window );">Portion of 2026 Note principal exchanged</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted', window );">Portion of 2026 Note principal exchanged</a></td>
<td class="nump">$ 1,824<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">$ 34,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionConvertedInstrumentCashIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Converted Instrument, Cash Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionConvertedInstrumentCashIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Converted Instrument, Value Of Cash And Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Net Proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionPercentageOfDebtConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Percentage Of Debt Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionPercentageOfDebtConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Unamortized Debt Issuance Costs, Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140700002005904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Investments and cash</a></td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember', window );">US Government Treasury Securities And Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=cutr_CashSweepInvestmentFundsMember', window );">Cash Sweep Investment Funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cutr_CashSweepInvestmentFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cutr_CashSweepInvestmentFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140699994348496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax assets valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 40,485<span></span>
</td>
<td class="nump">$ 38,321<span></span>
</td>
<td class="nump">$ 32,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">18,153<span></span>
</td>
<td class="nump">7,503<span></span>
</td>
<td class="nump">7,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">5,520<span></span>
</td>
<td class="nump">5,339<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">53,118<span></span>
</td>
<td class="nump">40,485<span></span>
</td>
<td class="nump">38,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember', window );">Allowance for credit losses, accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">899<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">970<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">$ 2,497<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 1,598<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>cutr-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:cutr="http://cutera.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cutr-20221231.xsd" xlink:type="simple"/>
    <context id="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4254762331b5400eafbadf6adc174e06_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0eb77ba8cb414b3998c3a159344980fd_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="i22c2b0a369614a47bb4d25533345f31f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id98fc580362c485a9aa22ac1e8f9841d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b771e0f32854640adb37fcb81cf460b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia34b1b427465407d9a74c3746d642f8d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id024b9170dda414581e1c92eebe3bd2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icf23510a12f84fca9925a26e5d1b065d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib60f899800144726a0adde4f7415072f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idba8742059574d5d885b961563cd6219_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae1d9a6f8016476496ef409fccdcff79_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ee0d6962ab14de7be6135cd2e7b9249_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f908a491e314b5c86c9269bde35f991_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3b036d16fce44ae9da1d4c718443132_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25ea7b28b3844cd4a1155d9f70e04574_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8b09c7fe8e9430bb8f6a8a02974f27f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i866a04e8824b4dbf9ff659afa11d7000_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i676902d8b941452fb791a00f1146c1bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9285aaa84b6421b90e1c1305b5a251b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b00ad12fcec4fafb066d792a4d074fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ebb11d45b894f9db048b1331f35f200_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24f897f06eb54a918841c6272f8b6949_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c3134540cd9425da9486334219fdde0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0e2bd56525ca43019f62289ecfa3967e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i691b0e7ec5e74c68a82b35523edcdf7a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b6b601d31324e1a930073ea52076b8f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib52bee5d91bb42b28334013f49e33682_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51e448c55c1e49beac9e5d5156d2d3c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b270930e93e45fd9058c41b81f26c8e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12f50874bc174d76a3c5aa9d3d3d0590_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i768f5c2bba054cc9b135fa68bf4eaa0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5f9e1bcaffa47f6a881fcaf76d33c60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6422ac28260743888cffc10f5e601c76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iddd264fa35e046aca3397b855df0cab9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07b7b9884af54beba53177415e5ee110_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i869ee720a299437f94a3f4ee6b7220c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabc624c81f7f4b68aa9384952bc72b52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdcec047f47949518eae3be472c59560_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79f8334ee431491ea8a7102ddfe49fd8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1ad808c733c48d59c4363b7215cd797_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie26d7981afe04301908853ba61c5d641_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i693768b6a7e945bdb951b75a87c2e03b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd7ef2fd159c48529daf7452defc65e0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2743a40780d64a419e4084b9eb8cc1e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibcb65f4a3b1046d69abf37f63e36005e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84291aab4fff4efe9c464193a3d89fbd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cutr:LargestSupplierMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerProductAndServiceBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if730726557904a0e8129172982f3fa0f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a2a89ad78ae47bf9c76026b524514ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7870599153e64b0fa7a3ebb5df62f415_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b739e3ad9964dbf98889c162108b1f8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0cde67dc1f864753bb385d33cbe1b6aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b1332d0d5ac433fabf234a1e2f746ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6506c5c97e94b878215a956808ec764_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ac7a7e554464f1d8c996aff630afeb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic57b91ff7d8c4faea9f96493ed40332c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7ca02c2f35d427c969131afb737148e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ac9e761079e46d09f596d92d01d71b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d3f7fca92974b8aba97f327669fb368_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7081fb323837425eb325cf18993c3f13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43de6969b39446da9d7aa3def0715785_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id720e09c88e443f2809964bf360c8189_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i8340bed1b672419cbaface1d8b4809cb_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i221c5f5bf1c048b58ad83bbe86effde5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9be7dc17e6d2432fbb9a56dfd5b44ffe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i46ca417d3e2946ceb0aaf60b4425ef5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i605a89e30db34ee5b4f659a4a45e8f1d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a962cbab39448a1a2946df5cccfff51_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4b2c4567c63458dbf8d418f20083383_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5296be68503d4aac9ffe8a6e86065dcc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a44bf842a0d40fa904345e182ab2a54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc5baea4532648c7a0de553581dd9364_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i157789288079499a8a2a1e6fa6177625_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd22553f7fc24f4399f493cc7a5b0c69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib97937e36112460f905b590a698c2662_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12e0968e414b4cce9b5df6a4573b4de2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id70000ea7bfe4aa091134520e36adee3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d329e32bed04599a6821d1b1a10a95b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i627fb423930e40d5904d10ac994e9b22_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6174e841cf8942359f88304752a651ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="iaae3e0055764457a9c1f55592c65d687_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i76cbf6cae62846b4918bd5c16022a51e_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:UnderwriterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="i08530b13979643b789fbf75b8ddb226a_I19981231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-12-31</instant>
        </period>
    </context>
    <context id="iaa3435c591f64b3798ada0cae4b3cb6b_I20041231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2004-12-31</instant>
        </period>
    </context>
    <context id="i56956846a75c43d6beae2d01dad8e79e_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56053101176e4eee83b23bfb85a4c018_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia2fdd272272b45deb78651a9217686d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i46004954bc984936a1ba499adac7a1fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c18e28a9c3b4ac891e9d2b6fea59279_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic54be2ac79324b2f8eb1e0feef2c9f6c_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1a45faa2dad7441e9750fb1049202ddb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i93eb16b5a06840968cbc9875832fe5e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c2d12e9c8744b01846c152372849986_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id0fc73b5fb954186bdecf4e03ab50a44_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0f8b1beeb3b46d6896264075a0f642c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i31476d551c22406289d5d7e70159145a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i56d977f3237048fd8f92c1754156e659_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0697b2b0d3684173ba373c05bd2a350c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAnnualGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30021351cc7642de9f7e7a753727c538_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="if7a873e55daf4d1096b17ed6d286c540_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e6c6ee7693f44fbbc190082fa49573c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3b5675f4b3c4a44b1e6ca6d6528fc07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i675d69b502a848bc9f2401845e49adfc_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i5ce66ed419804b35a387a3a2298ae2b4_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ibe4bf8f916284b378c9dfccf341f2e0e_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i718cf9e3833d4cbe824fb83ef9b96dd7_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i15d864291f7042989243b040cd710241_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ica8f35fa7fcb453b85159c8316392bdc_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i98655c3b6d21446ea2a5d6fface14f08_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ic000f7fad27f41da8a1b11411e5199d4_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-01-12</startDate>
            <endDate>2004-01-12</endDate>
        </period>
    </context>
    <context id="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i85b6c70335ab468995fd22f87f7dea79_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6cbfe8553003474dbea4fbe1cb946be5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i259a5ef49c174b599bbd8e82d8d4cd67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8a5fd5162e3749dda52119ea03e417b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53f46393f84249579bf1f0ecda83cecf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i115c28e37fe341eebe4c63199b303d29_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70779460b35645a8ae14d35ecd7316dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieff965b22673420b9ac95034349a3a3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb2821e1c3f34e6d88ea2da034cb653f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa282846e30940929a3b644c6b61c15d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a6913c1f23c4c2183eb2a516465a2d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i895e42cc37a4468982700f81c2a36726_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7dfdf16b051484fbfef1d9db4f028d5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i595dfc44c26342479914423f899ffd41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f809c30032e4095af4562f984e79643_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a3ed95613494914aa350bfdca948d59_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibd90507e569a4a009155cc0c1d41eb33_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib971e664547449019e686dfcda7d726f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4eaa18236bf541fd9be0327591bddadb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2c95c2271944120adfe82eb5cc72bed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf9eb37cd2f843bcb2780db55cc261c7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida56af569414409888521b3e5deceb5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38c559feb1b74bcda18168292816e21d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a14495444114a1b95d8e60d66bcef2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if574d6c9139942fcae8b73ef1132adce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2af1fdd05cd445a0ae8d99f2546c9649_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iedb3fa0d043f42818e6ba795391d99b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb210668bb0d40229989bb9910942dc6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i393abfeabcec4e439702c6fb89a55f9b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i950f3f1cbe644accb57140891f583a57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2a78a9a76abb4ea692915c784e8c9154_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i831c2cc741324fff9890a07923f079f9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1334e42d4dd14b4ba4c5edf93302f4b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a919cae1df94161b1b26d4d2c036cd7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38375ff36c734db9af8789f600457e7c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4d3740b151434c4f9e44cbd4fadbf958_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i11097d39ff414e72bbef9a4dcb529f5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie9dea9e779424bb0b81869578a5eb41a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fa86cedc4f743a89628f54d6c8ddd3f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a8180f361034cc0a7ddd4675321f231_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71b1494dda634811b284b9faa38d0601_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie45dca5694694e9eaafbe4a6234d3b92_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if11b725ce1af4a30b46852703abf3192_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d82e33152c849b3b7b22e9850693bc7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2718ea9e3df24ae9919f09e3a9bd8d2d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d2af5d0d40240728bbaf7100364c888_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica33e5e0a8d149e08222f5657ba8f9bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1222f8a294044704aaca365b5961f91f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9973a1bb092c40f8b6352bebbf706d79_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i666467d2ee8b4706828ce53f22a78ef9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icacb09d5d4564041b646ac2fea6f291f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c0099f611054142b44663a4d35bd018_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i435b3ba5e879438ab1c9c925dc8a1ba6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27c63a15d54b4af684d1b7b298377b14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65060ead42404852b4696510b4327f7a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3883679f5dd14bd58d3bdc2f35fc8b3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1afd2b598094e77a995de1beb182fc0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70b796e7c79344caa2cc64d5b0a40019_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaaf71e1c04fa42eb8e5bcab09ec61552_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib80255a5d1504da7ac5a65f6a26a95f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64feb72e527a4ddeba367f7807175c19_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ddee769932a4350a14cc2d6333a6757_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76980ed1a1534046811d38eed346f857_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3786902aa814d6781382d2a734de748_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i846ac160c48140659c8ff08589c1559c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9be98d2423634757af936bba4482f104_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7af2f3a0df564393908ceb31eb4f5771_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i057d976e50f54bb5b4029b6e8eed833d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab29b34be6724c94945ef58bbfbbbe24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iabd1a6a576ea4d019bb8ce898cadf674_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:CuteraCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id51d133a94594ab68d99649b2087f195_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8e56fbd57d240fc8787786a963035f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie71acb76f8254ab48b6267e153db44c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb3011f822b64b65b4850bdaf7aee0ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia90a17929a2c47458119f913368da54d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic43b61bed02d4fce96d758963f8ca202_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c171c7b5cbf4b489415ee212fd357c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04b0cfbd65e4486580c0b2d539204abc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32af68888229429c86c1f6d4e66c39d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc0bee4a202b46a886d4dac9c6a0465c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b100c928a264c0780179352a51b0551_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73bcc961f86c4d37ad3553546f5a6370_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i864a42f1b9474cd3bf43681344389c54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b4e54ccf702485ebea23892a41e90d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79cb131a331f444aaec8d0b8104c73b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie5b1f1666e8c420ba4cde97cf41fb662_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i105738620d9448cd86de0b72566e2192_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ac813d49b5749bdbb352b5de5d1604c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icc14c23d98b5459bbca583cda98d027e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i112b7a48420c4a4a815d9a7348d931fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79b2c7662fd449d0afe5418656bb70be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc6629fab6b94f3ab926f0814d6fd0d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea513a253ca34fe9a2a2acdd9000fbc5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6dd67954cb584428b5eb9b700919da0a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ce4b410a9a94845afb82c481a9282d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53d978e3d81f43a4920268bc4873fd78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib45100873e384627a7d0d4ae1bee0f3d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie04aff51169d478787e0b3b3998d9c0a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3183169f49b0407497637750803e56cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79831062395d48ff9827b5dd62714018_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i570cc80078864aeba21c2158c1c81d44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i438a7e3fe616461bb35aac62f1dd3281_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1cfd4323e38a42f380d911aaae444128_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b446bf3d14c44a595ac3dfcbab2b828_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f95e00759c5463c8accbe2d58291bdd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id82a22a9886c4a319a7f2dcb4b5cbdbd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie97f0dbf965b43738ea95b5b2200e359_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i806a9486ff1043a2abc3ab0f1747be03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:TotalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebd28db3d2e64dce9fe6cfe6eac074bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseLicenseFeeRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseLicenseFeeRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4db954fe033847e2b53b08a387423de3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseRecurringRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearOperatingLeaseRecurringRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:AviClearRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia982b914a1b146c5a1cab988d0bd6cca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:AviClearDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4d7a93cebb0445b3adc4fdbd8bcad826_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifc8691977a17471e888e8008855e2dec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e56eaab24a348b69456952d07cd3e95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9a5220685f0420ab867e7dfb9c2cf00_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i796773bebe7e43e7bcecf719e525f796_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:LeaseInstallmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e1b769004c940138fbdcc25ec85a289_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a0cca728a634df5a5f6d19439a8e76f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7719fc175b6482682d41fed2b2280cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc01ef124dcd4432926e7fafc9179e82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bc2557870e243c2a5677cb7decf7012_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4fabcd0c6b145328c06480322497ceb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f3d4babfce840a2b159fd70abd4be03_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia42551caee064e72b3e0bb899ff817f7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i311a3952ceef49ac9b09d68b91ee185d_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:VoceCapitalManagementLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i69f9433f295c4816bc3f161b64e8c985_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="idcee2bc0609d4e29aba04556ae20c3bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i17fbfe26ef264a34b2c3bbbd999e5121_I20220601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-01</instant>
        </period>
    </context>
    <context id="i4c543a80fb3441f29a2f3497b9785ec9_I20220524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5360b54f8bd047afbb77191b00d60ec7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia1261edff6b94c0eabe87de89ca47291_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i27566a6eb1a14a6da1bcb731ccfcad08_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028FirstConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028SecondConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="idb3d4792c6144be88746b11a2ee39995_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i4dd175c6046b46988a2632db59313ec8_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i003fc45e98c843a98b06a88ed0a0f62d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i723997427a13498fb7414de5cf577325_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib99c5a3203694570b12bf45da9728932_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib2840cd98ca143cd8b20996a137ad641_I20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i560132f058e647e7836489cdaa020a99_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i5adbe42165d747f9b1a502754f152e1c_I20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i601beccbd0004b92931f1016a7656cf5_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i0739d3b24f09440ba3de580700fa75f8_I20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ibca4ca09a78d4f1db1fbfc595409a42c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77ed4f6c46564823a197c54da88e53aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="iae49b5f0167c4c098a4473073d17fb51_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i51590e3866c44f098a65564cb2ec8b38_I20220524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="ib581b45783164777b7e88b6c201257fc_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="i11f3386c03a84affa91cabbfd26c26e5_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="id4c7536ce80e4e06b2517e9f76b4751f_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i907329613e904271948adfa043a3fa61_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i94f427bfbfd74894b34c8a26f7658e98_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cutr:USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d6b6a127ff244979a92a75f9e174aed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cutr:CashSweepInvestmentFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i12c9297e011c43528e40adc29971dc4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic72b182a81cf43ee99eb4e8a9d3ec1a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7debaf31c58640479aa03b97de9695a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i488403d682ba4e59b493908691cb1e8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib21545b587824019adbfef02bb41d281_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9dec51418121482fbdb4c18abe975265_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d09091e9bde4c10a1ae5c4f5f4d6337_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="country">
        <measure>cutr:country</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>cutr:segment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>cutr:reporting_unit</measure>
    </unit>
    <unit id="tranche">
        <measure>cutr:tranche</measure>
    </unit>
    <unit id="lease_term">
        <measure>cutr:lease_term</measure>
    </unit>
    <unit id="day">
        <measure>cutr:day</measure>
    </unit>
    <unit id="usdPerItem">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>cutr:item</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-32">0001162461</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-33">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-35">2022</dei:DocumentFiscalYearFocus>
    <cutr:ExtendedServiceContractOptionOneTerm
      contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"
      id="f-470">P1Y</cutr:ExtendedServiceContractOptionOneTerm>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i07b7b9884af54beba53177415e5ee110_I20221231"
      id="f-475">P2Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:NumberOfReportingUnits
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-545"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="0"
      id="f-546"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <cutr:ExtendedServiceContractTerm
      contextRef="i3d329e32bed04599a6821d1b1a10a95b_D20220101-20221231"
      id="f-656">P1Y</cutr:ExtendedServiceContractTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0697b2b0d3684173ba373c05bd2a350c_D20220101-20221231"
      id="f-712">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i38375ff36c734db9af8789f600457e7c_D20220101-20221231"
      decimals="2"
      id="f-958"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i4d3740b151434c4f9e44cbd4fadbf958_D20220101-20221231"
      decimals="2"
      id="f-959"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i11097d39ff414e72bbef9a4dcb529f5c_D20220101-20221231"
      decimals="2"
      id="f-960"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <cutr:LesseeLeasesRemainingTerm
      contextRef="iebd28db3d2e64dce9fe6cfe6eac074bd_D20220101-20221231"
      id="f-1264">P1Y</cutr:LesseeLeasesRemainingTerm>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      id="f-1270">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1271">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      id="f-1282">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1283">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1286">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      id="f-1287">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231"
      id="f-1335">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231"
      id="f-1336">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="i4db954fe033847e2b53b08a387423de3_D20210101-20211231"
      id="f-1339">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231"
      id="f-1340">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231"
      id="f-1343">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList
      contextRef="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231"
      id="f-1344">http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerIncludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331"
      decimals="7"
      id="f-1502"
      unitRef="number">0.0301427</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531"
      decimals="6"
      id="f-1503"
      unitRef="number">0.018986</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i907329613e904271948adfa043a3fa61_D20221201-20221231"
      decimals="7"
      id="f-1504"
      unitRef="number">0.0171378</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-4">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-6">000-50644</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-7">CUTERA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-9">77-0492262</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-10">3240 Bayshore Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-11">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-13">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-14">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-15">657-5500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-16">Common Stock ($0.001 par value)</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-17">Common Stock ($0.001 par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-18">CUTR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-20">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-24">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-25">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i4254762331b5400eafbadf6adc174e06_I20220630"
      decimals="-6"
      id="f-29"
      unitRef="usd">670000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0eb77ba8cb414b3998c3a159344980fd_I20230404"
      decimals="INF"
      id="f-30"
      unitRef="shares">19788358</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-31">Part III incorporates by reference certain information from the registrant&#x2019;s definitive proxy statement for the 2023 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2022.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="INF"
      id="f-36"
      unitRef="usd">120000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231"
      decimals="-5"
      id="f-37"
      unitRef="usd">115800000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-38"
      unitRef="country">37</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <dei:AuditorName
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-39">BDO USA, LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-40">San Francisco, California</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-41">243</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-42"
      unitRef="usd">145924000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-43"
      unitRef="usd">164164000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-44"
      unitRef="usd">171390000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-45"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-46"
      unitRef="usd">2497000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-47"
      unitRef="usd">899000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-48"
      unitRef="usd">45562000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-49"
      unitRef="usd">31449000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-50"
      unitRef="usd">63628000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-51"
      unitRef="usd">39503000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-52"
      unitRef="usd">24036000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-53"
      unitRef="usd">14545000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-54"
      unitRef="usd">700000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-55"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-56"
      unitRef="usd">451240000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-57"
      unitRef="usd">249661000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-58"
      unitRef="usd">40368000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-59"
      unitRef="usd">3019000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-60"
      unitRef="usd">590000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-61"
      unitRef="usd">778000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-62"
      unitRef="usd">12831000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-63"
      unitRef="usd">14627000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-64"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-65"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-66"
      unitRef="usd">14620000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-67"
      unitRef="usd">10169000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-68"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-69"
      unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-70"
      unitRef="usd">520988000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-71"
      unitRef="usd">280293000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-72"
      unitRef="usd">33736000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-73"
      unitRef="usd">7891000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-74"
      unitRef="usd">57452000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-75"
      unitRef="usd">54100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-76"
      unitRef="usd">2810000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-77"
      unitRef="usd">2419000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-78"
      unitRef="usd">11841000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-79"
      unitRef="usd">9490000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-80"
      unitRef="usd">105839000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-81"
      unitRef="usd">73900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-82"
      unitRef="usd">1657000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-83"
      unitRef="usd">1335000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-84"
      unitRef="usd">11352000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-85"
      unitRef="usd">13483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-86"
      unitRef="usd">12666000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-87"
      unitRef="usd">4007000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-88"
      unitRef="usd">416459000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-89"
      unitRef="usd">134243000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-90"
      unitRef="usd">862000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-91"
      unitRef="usd">763000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-92"
      unitRef="usd">536169000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-93"
      unitRef="usd">223724000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      id="f-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-97"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-98"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-99"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-100"
      unitRef="shares">19668603</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-101"
      unitRef="shares">19668603</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-102"
      unitRef="shares">17995344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-103"
      unitRef="shares">17995344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-104"
      unitRef="usd">20000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-105"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-106"
      unitRef="usd">125406000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-107"
      unitRef="usd">114724000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-108"
      unitRef="usd">-94000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-109"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-110"
      unitRef="usd">-140513000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-111"
      unitRef="usd">-58173000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-112"
      unitRef="usd">-15181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-113"
      unitRef="usd">56569000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-114"
      unitRef="usd">520988000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-115"
      unitRef="usd">280293000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231"
      decimals="-3"
      id="f-116"
      unitRef="usd">228796000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231"
      decimals="-3"
      id="f-117"
      unitRef="usd">205703000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231"
      decimals="-3"
      id="f-118"
      unitRef="usd">125113000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"
      decimals="-3"
      id="f-119"
      unitRef="usd">23603000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231"
      decimals="-3"
      id="f-120"
      unitRef="usd">25567000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231"
      decimals="-3"
      id="f-121"
      unitRef="usd">22570000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-122"
      unitRef="usd">252399000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-123"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-124"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icaf9576e07534f2b830c7b319dc69115_D20220101-20221231"
      decimals="-3"
      id="f-125"
      unitRef="usd">100254000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1f8994cd6fcd40929d3aef8f40e903b3_D20210101-20211231"
      decimals="-3"
      id="f-126"
      unitRef="usd">83048000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6aeb9b77a7fb4b7387a74bbf5457abb3_D20200101-20201231"
      decimals="-3"
      id="f-127"
      unitRef="usd">58325000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"
      decimals="-3"
      id="f-128"
      unitRef="usd">12316000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231"
      decimals="-3"
      id="f-129"
      unitRef="usd">15117000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231"
      decimals="-3"
      id="f-130"
      unitRef="usd">13586000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-131"
      unitRef="usd">112570000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-132"
      unitRef="usd">98165000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-133"
      unitRef="usd">71911000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-134"
      unitRef="usd">139829000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-135"
      unitRef="usd">133105000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-136"
      unitRef="usd">75772000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-137"
      unitRef="usd">106947000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-138"
      unitRef="usd">76762000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-139"
      unitRef="usd">52766000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-140"
      unitRef="usd">25155000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-141"
      unitRef="usd">21568000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-142"
      unitRef="usd">14322000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-143"
      unitRef="usd">45917000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-144"
      unitRef="usd">32945000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-145"
      unitRef="usd">31512000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-146"
      unitRef="usd">178019000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-147"
      unitRef="usd">131275000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-148"
      unitRef="usd">98600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-149"
      unitRef="usd">-38190000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-150"
      unitRef="usd">1830000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-151"
      unitRef="usd">-22828000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-152"
      unitRef="usd">1355000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-153"
      unitRef="usd">710000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-154"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebt
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-155"
      unitRef="usd">5658000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-156"
      unitRef="usd">2514000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-157"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231"
      decimals="-3"
      id="f-158"
      unitRef="usd">-34423000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231"
      decimals="-3"
      id="f-159"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231"
      decimals="-3"
      id="f-160"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231"
      decimals="-3"
      id="f-161"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231"
      decimals="-3"
      id="f-162"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231"
      decimals="-3"
      id="f-163"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-164"
      unitRef="usd">2600000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-165"
      unitRef="usd">-561000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-166"
      unitRef="usd">-647000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-167"
      unitRef="usd">-3676000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-168"
      unitRef="usd">-1845000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-169"
      unitRef="usd">68000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-170"
      unitRef="usd">-42512000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-171"
      unitRef="usd">1555000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-172"
      unitRef="usd">-579000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-173"
      unitRef="usd">-80702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-174"
      unitRef="usd">3385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-175"
      unitRef="usd">-23407000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-176"
      unitRef="usd">1638000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-177"
      unitRef="usd">1323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-178"
      unitRef="usd">470000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-179"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-180"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-181"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-182"
      unitRef="usdPerShare">-4.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-183"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-184"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-185"
      unitRef="usdPerShare">-4.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-186"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-187"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-188"
      unitRef="shares">18747000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-189"
      unitRef="shares">17891000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-190"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-191"
      unitRef="shares">18747000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-192"
      unitRef="shares">18362000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-193"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-194"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-195"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-196"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-197"
      unitRef="usd">-94000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-198"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-199"
      unitRef="usd">-3000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-200"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-201"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-202"
      unitRef="usd">-63000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-203"
      unitRef="usd">-94000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-204"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-205"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-206"
      unitRef="usd">-94000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-207"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-208"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-209"
      unitRef="usd">-82434000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-210"
      unitRef="usd">2062000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-211"
      unitRef="usd">-23817000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5b771e0f32854640adb37fcb81cf460b_I20191231"
      decimals="INF"
      id="f-212"
      unitRef="shares">14315586</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5b771e0f32854640adb37fcb81cf460b_I20191231"
      decimals="-3"
      id="f-213"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia34b1b427465407d9a74c3746d642f8d_I20191231"
      decimals="-3"
      id="f-214"
      unitRef="usd">82346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id024b9170dda414581e1c92eebe3bd2a_I20191231"
      decimals="-3"
      id="f-215"
      unitRef="usd">-36358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icf23510a12f84fca9925a26e5d1b065d_I20191231"
      decimals="-3"
      id="f-216"
      unitRef="usd">-60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="-3"
      id="f-217"
      unitRef="usd">45942000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="INF"
      id="f-218"
      unitRef="shares">56751</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"
      decimals="-3"
      id="f-219"
      unitRef="usd">632000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-220"
      unitRef="usd">632000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="INF"
      id="f-221"
      unitRef="shares">73227</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"
      decimals="-3"
      id="f-222"
      unitRef="usd">947000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-223"
      unitRef="usd">947000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-224"
      unitRef="usd">2303000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="INF"
      id="f-225"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="-3"
      id="f-226"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"
      decimals="-3"
      id="f-227"
      unitRef="usd">26492000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-228"
      unitRef="usd">26495000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="INF"
      id="f-229"
      unitRef="shares">490918</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="idba8742059574d5d885b961563cd6219_D20200101-20201231"
      decimals="-3"
      id="f-230"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"
      decimals="-3"
      id="f-231"
      unitRef="usd">-3429000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-232"
      unitRef="usd">-3428000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibb38b0a4a2bc4357950438c955790817_D20200101-20201231"
      decimals="-3"
      id="f-233"
      unitRef="usd">10109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-234"
      unitRef="usd">10109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="iae1d9a6f8016476496ef409fccdcff79_D20200101-20201231"
      decimals="-3"
      id="f-235"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-236"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1ee0d6962ab14de7be6135cd2e7b9249_D20200101-20201231"
      decimals="-3"
      id="f-237"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-238"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2f908a491e314b5c86c9269bde35f991_I20201231"
      decimals="INF"
      id="f-239"
      unitRef="shares">17679232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2f908a491e314b5c86c9269bde35f991_I20201231"
      decimals="-3"
      id="f-240"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia3b036d16fce44ae9da1d4c718443132_I20201231"
      decimals="-3"
      id="f-241"
      unitRef="usd">117097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25ea7b28b3844cd4a1155d9f70e04574_I20201231"
      decimals="-3"
      id="f-242"
      unitRef="usd">-60235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic8b09c7fe8e9430bb8f6a8a02974f27f_I20201231"
      decimals="-3"
      id="f-243"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-244"
      unitRef="usd">56880000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231"
      decimals="INF"
      id="f-245"
      unitRef="shares">59635</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"
      decimals="-3"
      id="f-246"
      unitRef="usd">1184000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-247"
      unitRef="usd">1184000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231"
      decimals="INF"
      id="f-248"
      unitRef="shares">71798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"
      decimals="-3"
      id="f-249"
      unitRef="usd">1581000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-250"
      unitRef="usd">1581000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cutr:PurchaseOfCappedCall
      contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"
      decimals="-3"
      id="f-251"
      unitRef="usd">-16134000</cutr:PurchaseOfCappedCall>
    <cutr:PurchaseOfCappedCall
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-252"
      unitRef="usd">-16134000</cutr:PurchaseOfCappedCall>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ib41c46ed80fe4bc2b9fa5359360a022b_D20210101-20211231"
      decimals="INF"
      id="f-253"
      unitRef="shares">184679</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"
      decimals="-3"
      id="f-254"
      unitRef="usd">-2176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-255"
      unitRef="usd">-2176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2c335ee9dad44ce09809b4c2eabfa616_D20210101-20211231"
      decimals="-3"
      id="f-256"
      unitRef="usd">13172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-257"
      unitRef="usd">13172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i676902d8b941452fb791a00f1146c1bb_D20210101-20211231"
      decimals="-3"
      id="f-258"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-259"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id9285aaa84b6421b90e1c1305b5a251b_I20211231"
      decimals="INF"
      id="f-260"
      unitRef="shares">17995344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id9285aaa84b6421b90e1c1305b5a251b_I20211231"
      decimals="-3"
      id="f-261"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7b00ad12fcec4fafb066d792a4d074fa_I20211231"
      decimals="-3"
      id="f-262"
      unitRef="usd">114724000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ebb11d45b894f9db048b1331f35f200_I20211231"
      decimals="-3"
      id="f-263"
      unitRef="usd">-58173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24f897f06eb54a918841c6272f8b6949_I20211231"
      decimals="-3"
      id="f-264"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-265"
      unitRef="usd">56569000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"
      decimals="INF"
      id="f-266"
      unitRef="shares">49306</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-267"
      unitRef="usd">1873000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-268"
      unitRef="usd">1873000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"
      decimals="INF"
      id="f-269"
      unitRef="shares">39960</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-270"
      unitRef="usd">850000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-271"
      unitRef="usd">850000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cutr:PaymentsOfDerivativeIssuanceCostsGross
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-272"
      unitRef="usd">452000</cutr:PaymentsOfDerivativeIssuanceCostsGross>
    <cutr:PurchaseOfCappedCall
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-273"
      unitRef="usd">-57132000</cutr:PurchaseOfCappedCall>
    <cutr:PurchaseOfCappedCall
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-274"
      unitRef="usd">-57132000</cutr:PurchaseOfCappedCall>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"
      decimals="INF"
      id="f-275"
      unitRef="shares">229645</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-276"
      unitRef="usd">-5256000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-277"
      unitRef="usd">-5256000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-278"
      unitRef="usd">14400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-279"
      unitRef="usd">14400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"
      decimals="INF"
      id="f-280"
      unitRef="shares">1354348</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0c3134540cd9425da9486334219fdde0_D20220101-20221231"
      decimals="-3"
      id="f-281"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i29d44ec054514f298f1f9198d169e9ef_D20220101-20221231"
      decimals="-3"
      id="f-282"
      unitRef="usd">55947000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-283"
      unitRef="usd">55949000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="i0e2bd56525ca43019f62289ecfa3967e_D20220101-20221231"
      decimals="-3"
      id="f-284"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-285"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i691b0e7ec5e74c68a82b35523edcdf7a_D20220101-20221231"
      decimals="-3"
      id="f-286"
      unitRef="usd">-94000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-287"
      unitRef="usd">-94000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8b6b601d31324e1a930073ea52076b8f_I20221231"
      decimals="INF"
      id="f-288"
      unitRef="shares">19668603</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8b6b601d31324e1a930073ea52076b8f_I20221231"
      decimals="-3"
      id="f-289"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib52bee5d91bb42b28334013f49e33682_I20221231"
      decimals="-3"
      id="f-290"
      unitRef="usd">125406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51e448c55c1e49beac9e5d5156d2d3c6_I20221231"
      decimals="-3"
      id="f-291"
      unitRef="usd">-140513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b270930e93e45fd9058c41b81f26c8e_I20221231"
      decimals="-3"
      id="f-292"
      unitRef="usd">-94000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-293"
      unitRef="usd">-15181000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-294"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-295"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-296"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-297"
      unitRef="usd">14400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-298"
      unitRef="usd">13172000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-299"
      unitRef="usd">10109000</us-gaap:ShareBasedCompensation>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-300"
      unitRef="usd">2621000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-301"
      unitRef="usd">1344000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-302"
      unitRef="usd">1394000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-303"
      unitRef="usd">3200000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-304"
      unitRef="usd">1857000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-305"
      unitRef="usd">2593000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-306"
      unitRef="usd">1355000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-307"
      unitRef="usd">710000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-308"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-309"
      unitRef="usd">-558000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-310"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-311"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-312"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-313"
      unitRef="usd">182000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-314"
      unitRef="usd">805000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-315"
      unitRef="usd">-188000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-316"
      unitRef="usd">135000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-317"
      unitRef="usd">220000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-318"
      unitRef="usd">1787000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-319"
      unitRef="usd">87000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-320"
      unitRef="usd">2144000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-321"
      unitRef="usd">-168000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-322"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-323"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib48cb6ff37a645ed894630613444dae8_D20220101-20221231"
      decimals="-3"
      id="f-324"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1cf685e9ebc04cf696ec707adb43d86a_D20210101-20211231"
      decimals="-3"
      id="f-325"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i66c989ac208c472aa01d9fa9807bb0d3_D20200101-20201231"
      decimals="-3"
      id="f-326"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-327"
      unitRef="usd">2653000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-328"
      unitRef="usd">2292000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-329"
      unitRef="usd">2522000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231"
      decimals="-3"
      id="f-330"
      unitRef="usd">-34423000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231"
      decimals="-3"
      id="f-331"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idd7807a800dc433b8f7a6ea7e1c27f53_D20200101-20201231"
      decimals="-3"
      id="f-332"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-333"
      unitRef="usd">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-334"
      unitRef="usd">1000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-335"
      unitRef="usd">513000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-336"
      unitRef="usd">15900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-337"
      unitRef="usd">9574000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-338"
      unitRef="usd">2550000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-339"
      unitRef="usd">36305000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-340"
      unitRef="usd">10936000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-341"
      unitRef="usd">-5413000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-342"
      unitRef="usd">10049000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-343"
      unitRef="usd">5766000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-344"
      unitRef="usd">3164000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-345"
      unitRef="usd">8091000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-346"
      unitRef="usd">7128000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-347"
      unitRef="usd">2067000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-348"
      unitRef="usd">20979000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-349"
      unitRef="usd">1207000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-350"
      unitRef="usd">-6034000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-351"
      unitRef="usd">3282000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-352"
      unitRef="usd">21608000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-353"
      unitRef="usd">161000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-354"
      unitRef="usd">-2597000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-355"
      unitRef="usd">-2151000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-356"
      unitRef="usd">-1598000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-357"
      unitRef="usd">2673000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-358"
      unitRef="usd">-412000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-359"
      unitRef="usd">-2985000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-360"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-361"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-362"
      unitRef="usd">-93000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-363"
      unitRef="usd">-66995000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-364"
      unitRef="usd">1235000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-365"
      unitRef="usd">-16934000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-366"
      unitRef="usd">22698000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-367"
      unitRef="usd">1015000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-368"
      unitRef="usd">1279000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-369"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-370"
      unitRef="usd">71000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-371"
      unitRef="usd">30000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-372"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-373"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-374"
      unitRef="usd">5648000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-375"
      unitRef="usd">158000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-376"
      unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-377"
      unitRef="usd">28050000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-378"
      unitRef="usd">329484000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-379"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-380"
      unitRef="usd">26060000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-381"
      unitRef="usd">-194182000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-382"
      unitRef="usd">-944000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-383"
      unitRef="usd">6389000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-384"
      unitRef="usd">2723000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-385"
      unitRef="usd">2765000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-386"
      unitRef="usd">1579000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-387"
      unitRef="usd">56680000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-388"
      unitRef="usd">16134000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-389"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDerivativeIssuanceCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-390"
      unitRef="usd">352000</us-gaap:PaymentsOfDerivativeIssuanceCosts>
    <us-gaap:PaymentsOfDerivativeIssuanceCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-391"
      unitRef="usd">0</us-gaap:PaymentsOfDerivativeIssuanceCosts>
    <us-gaap:PaymentsOfDerivativeIssuanceCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-392"
      unitRef="usd">0</us-gaap:PaymentsOfDerivativeIssuanceCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-393"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-394"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-395"
      unitRef="usd">7167000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-396"
      unitRef="usd">360000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-397"
      unitRef="usd">138250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-398"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-399"
      unitRef="usd">11202000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-400"
      unitRef="usd">4717000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-401"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-402"
      unitRef="usd">45776000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-403"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-404"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-405"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-406"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-407"
      unitRef="usd">28798000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-408"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-409"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-410"
      unitRef="usd">2303000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-411"
      unitRef="usd">5256000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-412"
      unitRef="usd">2176000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-413"
      unitRef="usd">3428000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-414"
      unitRef="usd">520000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-415"
      unitRef="usd">462000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-416"
      unitRef="usd">537000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-417"
      unitRef="usd">242937000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-418"
      unitRef="usd">117526000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-419"
      unitRef="usd">31276000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-420"
      unitRef="usd">-18240000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-421"
      unitRef="usd">117817000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-422"
      unitRef="usd">20731000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-423"
      unitRef="usd">164864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-424"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="-3"
      id="f-425"
      unitRef="usd">26316000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-426"
      unitRef="usd">146624000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-427"
      unitRef="usd">164864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-428"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-429"
      unitRef="usd">5486000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-430"
      unitRef="usd">1663000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-431"
      unitRef="usd">63000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-432"
      unitRef="usd">2004000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-433"
      unitRef="usd">891000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-434"
      unitRef="usd">-1000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssued1
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-435"
      unitRef="usd">55947000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-436"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-437"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-438"
      unitRef="usd">689000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-439"
      unitRef="usd">828000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-440"
      unitRef="usd">43000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-441"
      unitRef="usd">908000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-442"
      unitRef="usd">123000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-443"
      unitRef="usd">11735000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NotesReduction
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-444"
      unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:NotesReduction
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-445"
      unitRef="usd">7185000</us-gaap:NotesReduction>
    <us-gaap:NotesReduction
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-446"
      unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-447"
      unitRef="usd">635000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-448"
      unitRef="usd">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-449"
      unitRef="usd">0</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <cutr:AccruedCappedCallCosts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-450"
      unitRef="usd">100000</cutr:AccruedCappedCallCosts>
    <cutr:AccruedCappedCallCosts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-451"
      unitRef="usd">0</cutr:AccruedCappedCallCosts>
    <cutr:AccruedCappedCallCosts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-452"
      unitRef="usd">0</cutr:AccruedCappedCallCosts>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-453"
      unitRef="usd">12180000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-454"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-455"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-456"
      unitRef="usd">4131000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-457"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-458"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-459">SUMMARY&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SIGNIFICANT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCOUNTING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;POLICIES&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear, enlighten,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;excel, truSculpt, Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; each of which enables medical practitioners to perform procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) leasing of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; devices for acne treatment ("AviClear" revenue); (iii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); and (iv) the distribution of third-party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFlex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services the Company&#x2019;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 37 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#x2019;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &#x201c;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#x201d;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted by the Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#x2019;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 8%, 11% and 15%,&#160;respectively, of the Company&#x2019;s total revenue for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#x2019;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#x2019;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#x2019;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#x2019;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Systems&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl Fractional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; applications, rather than within the console.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the treatment protocol is initiated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consumables and other accessories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its customers' purchases of replacement cycles for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFlex,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as replacement hand pieces, x&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;eo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hand pieces, and single use disposable tips applicable to&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as Consumable revenue. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products'&#160;single use disposable tips&#160;must be replaced after every treatment. The Company&#x2019;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skincare products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Extended service contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of &lt;span style="-sec-ix-hidden:f-470"&gt;one&lt;/span&gt; to three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Training&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#x2019;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines standalone selling price ("SSP") for each performance obligation as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loyalty Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#x2019;s advanced training event for a product, or a ticket for the Company&#x2019;s annual forum. A customer&#x2019;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2022, and December 31, 2021, the accrual for the loyalty program included in accrued liabilities was $0.3 million, and $0.5, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract related to the sale of a system, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally &lt;span style="-sec-ix-hidden:f-475"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total capitalized costs for the year ended December&#160;31, 2022 and December&#160;31, 2021 were $2.0 million and $2.7 million, respectively. Amortization expenses for these assets were&#160;$2.4 million, $1.9 million and $2.6 million, respectively, during the years&#160;ended December&#160;31, 2022, 2021 and 2020 and were&#160;included in sales and marketing expense in the Company&#x2019;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022 and December&#160;31, 2021 were $3.8 million and $4.2 million, respectively, and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. Credit card receivables, that are collected in a short period of time are also classified as cash and cash equivalents. The majority of the Company&#x2019;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Sales Returns and Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for sales returns represents the Company&#x2019;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns and is based on the Company's analysis of current economic trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses on trade receivables is based on the credit quality of customers, current economic conditions, the age of the accounts receivable balances, historical loss information, current conditions and forecasted information. The Company writes off trade receivables when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#x2019;s operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to risks related to changes in the value of the Company&#x2019;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with SVB. On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#x2019;s receiver. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp;amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp;amp; Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2022, and 2021, no customer represented more than 10% of the Company&#x2019;s net accounts receivable. During the years ended December&#160;31, 2022, 2021, and 2020, domestic revenue accounted for 43%, 42% and 41%, respectively, of total revenue, while international revenue accounted for 57%, 58% and 59%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplier concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately 10%, 14% and 9% of the Company's total purchases in the years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#x2019;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#x2019;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2022 and 2021, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $5.7 million and $3.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for 2022, 2021 and 2020, was $2.2 million, $1.3 million, and $1.4 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Cloud Computing Set-up Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain set-up costs for the Company&#x2019;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2022 and 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4 million in Other current assets and prepaid expenses and $3.5 million in Other long-term assets. As of and during the year ended December&#160;31, 2022 and 2021, there was $0.4 million, and no accumulated amortization and amortization expense recorded, respectively. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#x2019;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the fourth quarter of 2022, the Company segregated its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. Goodwill was tested for impairment at the segment level. As of December&#160;31, 2022, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#x2019;s future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#x2019;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the lessee has the ability to perform the patient treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 13 to the consolidated financial statements for more information regarding leasing arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#x201c;hand pieces&#x201d;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenditures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third-party contractors, regulatory affairs, clinical and development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2022, 2021 and 2020 were $4.9 million, $2.1 million&#160;and $1.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#x2019;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period. To estimate the fair value of an award, the Company uses the Black-Scholes option pricing model. The following inputs are used in this model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For the underlying stock price volatility of the Company&#x2019;s stock,&#160;the Company estimates volatility solely based on the historical volatility of the Company's stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forfeitures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options ("options") on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock units (&#x201c;RSUs&#x201d;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Performance Stock Units (&#x201c;PSUs&#x201d;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#x2019;s common shares on the grant date. The quantity of the PSUs granted is calculated by &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8 - "Stockholders&#x2019; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#x2019;s stock plans and share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#x2019;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#x2019;s deferred tax assets to the net amount that the Company believes is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#x2019;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#x2019;s uncertain tax positions in the Company&#x2019;s provision (benefit) for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#x2019;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#x2019;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#x2019;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign subsidiaries at December&#160;31, 2022 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#x201c;GILTI&#x201d;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#x201c;NOLs&#x201d;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Computation of Net Income (Loss) per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes all changes in stockholders&#x2019; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for-sale investments, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Dollar is the functional currency of the Company&#x2019;s subsidiaries and the Company&#x2019;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Losses resulting from foreign currency transactions are included in net income (loss) are $3.6&#160;million and $1.8&#160;million in the year ended December&#160;31, 2022 and 2021, respectively, and were insignificant for the year ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company operates in two segments. Revenue is attributed to a geographic region based on the location of the end customer. See Note 12 &#x2013; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-460">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear, enlighten,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;excel, truSculpt, Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; each of which enables medical practitioners to perform procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) leasing of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; devices for acne treatment ("AviClear" revenue); (iii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); and (iv) the distribution of third-party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFlex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets, sells and services the Company&#x2019;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 37 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-461"
      unitRef="country">37</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-462">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-463">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#x2019;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <cutr:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-464">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity &lt;/span&gt;&lt;/div&gt;breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</cutr:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-465">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &#x201c;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#x201d;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption of the amendments in this update did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted by the Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-466">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#x2019;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 8%, 11% and 15%,&#160;respectively, of the Company&#x2019;s total revenue for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#x2019;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#x2019;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#x2019;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#x2019;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Systems&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl Fractional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; applications, rather than within the console.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is not established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AviClear&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the treatment protocol is initiated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consumables and other accessories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its customers' purchases of replacement cycles for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truFlex,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as replacement hand pieces, x&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;eo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hand pieces, and single use disposable tips applicable to&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as Consumable revenue. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products'&#160;single use disposable tips&#160;must be replaced after every treatment. The Company&#x2019;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skincare products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Extended service contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of &lt;span style="-sec-ix-hidden:f-470"&gt;one&lt;/span&gt; to three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Training&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#x2019;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines standalone selling price ("SSP") for each performance obligation as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Extended warranty/Service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loyalty Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates a customer loyalty program for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#x2019;s advanced training event for a product, or a ticket for the Company&#x2019;s annual forum. A customer&#x2019;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2022, and December 31, 2021, the accrual for the loyalty program included in accrued liabilities was $0.3 million, and $0.5, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract related to the sale of a system, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally &lt;span style="-sec-ix-hidden:f-475"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total capitalized costs for the year ended December&#160;31, 2022 and December&#160;31, 2021 were $2.0 million and $2.7 million, respectively. Amortization expenses for these assets were&#160;$2.4 million, $1.9 million and $2.6 million, respectively, during the years&#160;ended December&#160;31, 2022, 2021 and 2020 and were&#160;included in sales and marketing expense in the Company&#x2019;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022 and December&#160;31, 2021 were $3.8 million and $4.2 million, respectively, and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="i12f50874bc174d76a3c5aa9d3d3d0590_D20220101-20221231"
      decimals="2"
      id="f-467"
      unitRef="number">0.08</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="i768f5c2bba054cc9b135fa68bf4eaa0e_D20210101-20211231"
      decimals="2"
      id="f-468"
      unitRef="number">0.11</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="ie5f9e1bcaffa47f6a881fcaf76d33c60_D20200101-20201231"
      decimals="2"
      id="f-469"
      unitRef="number">0.15</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:ExtendedServiceContractOptionThreeTerm
      contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"
      id="f-471">P3Y</cutr:ExtendedServiceContractOptionThreeTerm>
    <cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-472">P180D</cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6422ac28260743888cffc10f5e601c76_I20221231"
      decimals="-5"
      id="f-473"
      unitRef="usd">300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iddd264fa35e046aca3397b855df0cab9_I20211231"
      decimals="-5"
      id="f-474"
      unitRef="usd">500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i869ee720a299437f94a3f4ee6b7220c6_I20221231"
      id="f-476">P3Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-477"
      unitRef="usd">2000000.0</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-478"
      unitRef="usd">2700000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231"
      decimals="-5"
      id="f-479"
      unitRef="usd">2400000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231"
      decimals="-5"
      id="f-480"
      unitRef="usd">1900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231"
      decimals="-5"
      id="f-481"
      unitRef="usd">2600000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostNet
      contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231"
      decimals="-5"
      id="f-482"
      unitRef="usd">3800000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231"
      decimals="-5"
      id="f-483"
      unitRef="usd">4200000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-484">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. Credit card receivables, that are collected in a short period of time are also classified as cash and cash equivalents. The majority of the Company&#x2019;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-485">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-486">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Sales Returns and Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for sales returns represents the Company&#x2019;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns and is based on the Company's analysis of current economic trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses on trade receivables is based on the credit quality of customers, current economic conditions, the age of the accounts receivable balances, historical loss information, current conditions and forecasted information. The Company writes off trade receivables when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;</cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-487">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#x2019;s operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to risks related to changes in the value of the Company&#x2019;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with SVB. On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB&#x2019;s receiver. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp;amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp;amp; Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2022, and 2021, no customer represented more than 10% of the Company&#x2019;s net accounts receivable. During the years ended December&#160;31, 2022, 2021, and 2020, domestic revenue accounted for 43%, 42% and 41%, respectively, of total revenue, while international revenue accounted for 57%, 58% and 59%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplier concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately 10%, 14% and 9% of the Company's total purchases in the years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icdcec047f47949518eae3be472c59560_D20220101-20221231"
      decimals="2"
      id="f-488"
      unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i79f8334ee431491ea8a7102ddfe49fd8_D20210101-20211231"
      decimals="2"
      id="f-489"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic1ad808c733c48d59c4363b7215cd797_D20200101-20201231"
      decimals="2"
      id="f-490"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie26d7981afe04301908853ba61c5d641_D20220101-20221231"
      decimals="2"
      id="f-491"
      unitRef="number">0.57</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i693768b6a7e945bdb951b75a87c2e03b_D20210101-20211231"
      decimals="2"
      id="f-492"
      unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idd7ef2fd159c48529daf7452defc65e0_D20200101-20201231"
      decimals="2"
      id="f-493"
      unitRef="number">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2743a40780d64a419e4084b9eb8cc1e0_D20220101-20221231"
      decimals="2"
      id="f-494"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibcb65f4a3b1046d69abf37f63e36005e_D20210101-20211231"
      decimals="2"
      id="f-495"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i84291aab4fff4efe9c464193a3d89fbd_D20200101-20201231"
      decimals="2"
      id="f-496"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-497">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#x2019;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#x2019;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2022 and 2021, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $5.7 million and $3.7 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <cutr:DemonstrationUnitsAmortizationPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-498">P2Y</cutr:DemonstrationUnitsAmortizationPeriod>
    <us-gaap:InventoryFinishedGoods
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-499"
      unitRef="usd">5700000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-500"
      unitRef="usd">3700000</us-gaap:InventoryFinishedGoods>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-501">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for 2022, 2021 and 2020, was $2.2 million, $1.3 million, and $1.4 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Cloud Computing Set-up Cost&lt;/span&gt;&lt;/div&gt;The Company capitalizes certain set-up costs for the Company&#x2019;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-502">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231"
      id="f-503">P4Y6M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if730726557904a0e8129172982f3fa0f_D20220101-20221231"
      id="f-504">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3a2a89ad78ae47bf9c76026b524514ca_D20220101-20221231"
      id="f-505">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7870599153e64b0fa7a3ebb5df62f415_D20220101-20221231"
      id="f-506">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-507"
      unitRef="usd">2200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-508"
      unitRef="usd">1300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-5"
      id="f-509"
      unitRef="usd">1400000</us-gaap:Depreciation>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2b739e3ad9964dbf98889c162108b1f8_D20220101-20221231"
      id="f-510">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0cde67dc1f864753bb385d33cbe1b6aa_D20220101-20221231"
      id="f-511">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="i1b1332d0d5ac433fabf234a1e2f746ea_I20211231"
      decimals="-5"
      id="f-512"
      unitRef="usd">400000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="if6506c5c97e94b878215a956808ec764_I20221231"
      decimals="-5"
      id="f-513"
      unitRef="usd">400000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231"
      decimals="-5"
      id="f-514"
      unitRef="usd">3500000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="i7ba3d6ca0d334b41a9273ff28dcbcdc8_I20211231"
      decimals="-5"
      id="f-515"
      unitRef="usd">3500000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-516"
      unitRef="usd">400000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-517"
      unitRef="usd">400000</us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-518"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-519"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-520">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#x2019;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the fourth quarter of 2022, the Company segregated its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. Goodwill was tested for impairment at the segment level. As of December&#160;31, 2022, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231"
      decimals="INF"
      id="f-521"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-522"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-523">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.&lt;/span&gt;&lt;/div&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.</us-gaap:StandardProductWarrantyPolicy>
    <cutr:StandardProductWarrantyTermDirectSales
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-524">P12M</cutr:StandardProductWarrantyTermDirectSales>
    <cutr:StandardProductWarrantyTermDistributorSales
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-525">P14M</cutr:StandardProductWarrantyTermDistributorSales>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-526">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#x2019;s future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#x2019;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-527">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The Company classifies its lease income as product revenue and classifies the AviClear contracts as operating leases. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. The treatment fee is recognized in the period the lessee has the ability to perform the patient treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 13 to the consolidated financial statements for more information regarding leasing arrangements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-528">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#x201c;hand pieces&#x201d;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-529">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenditures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third-party contractors, regulatory affairs, clinical and development costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-530">Advertising CostsAdvertising costs are included as part of sales and marketing expense and are expensed as incurred.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-531"
      unitRef="usd">4900000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-532"
      unitRef="usd">2100000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-5"
      id="f-533"
      unitRef="usd">1200000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-534">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#x2019;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period. To estimate the fair value of an award, the Company uses the Black-Scholes option pricing model. The following inputs are used in this model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For the underlying stock price volatility of the Company&#x2019;s stock,&#160;the Company estimates volatility solely based on the historical volatility of the Company's stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forfeitures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options ("options") on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock units (&#x201c;RSUs&#x201d;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Performance Stock Units (&#x201c;PSUs&#x201d;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#x2019;s common shares on the grant date. The quantity of the PSUs granted is calculated by &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8 - "Stockholders&#x2019; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#x2019;s stock plans and share-based compensation expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount
      contextRef="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231"
      id="f-535">P50D</cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount>
    <cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount
      contextRef="i9ca2e3223fc649d98cf35a5fb752dc72_D20220101-20221231"
      id="f-536">P50D</cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-537">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#x2019;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#x2019;s deferred tax assets to the net amount that the Company believes is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#x2019;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#x2019;s uncertain tax positions in the Company&#x2019;s provision (benefit) for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#x2019;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#x2019;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#x2019;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign subsidiaries at December&#160;31, 2022 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#x201c;GILTI&#x201d;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#x201c;NOLs&#x201d;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-538">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Computation of Net Income (Loss) per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-539">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes all changes in stockholders&#x2019; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for-sale investments, net of tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-540">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Dollar is the functional currency of the Company&#x2019;s subsidiaries and the Company&#x2019;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Losses resulting from foreign currency transactions are included in net income (loss) are $3.6&#160;million and $1.8&#160;million in the year ended December&#160;31, 2022 and 2021, respectively, and were insignificant for the year ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-541"
      unitRef="usd">3600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-542"
      unitRef="usd">1800000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-543">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company operates in two segments. Revenue is attributed to a geographic region based on the location of the end customer. See Note 12 &#x2013; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-544"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-547">CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, AND RESTRICTED CASHThe Company determines the appropriate classification of its investments in marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. The Company&#x2019;s marketable securities have been classified and accounted for as available-for-sale securities. Investments with remaining maturities of more than one year are viewed by the Company as available to support current operations and are classified as current assets under the caption marketable investments in the accompanying consolidated balance sheets. Investments in available-for-sale debt securities are measured at fair value under the guidance in ASC 320. Credit losses on impaired available-for-sale debt securities are recognized through an allowance for credit losses. Under ASC 326, credit losses recognized on an available-for-sale debt security should not reduce the net carrying amount of the available-for-sale debt security below its fair value. Any changes in fair value unrelated to credit are recognized as an unrealized gain or loss in other comprehensive income.&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable investments - U.S. Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and December&#160;31, 2021, the net unrealized losses were $0.1&#160;million and nil, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months. The restricted cash balance relates to an outstanding letter of credit for $0.7&#160;million provided to a supplier.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;All of the marketable investments will mature less than one year from December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-548">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable investments - U.S. Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-549">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's cash and&#160;cash equivalents and marketable investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable investments - U.S. Treasury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-550"
      unitRef="usd">145924000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-551"
      unitRef="usd">700000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-552"
      unitRef="usd">146624000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231"
      decimals="-3"
      id="f-553"
      unitRef="usd">171484000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231"
      decimals="-3"
      id="f-554"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231"
      decimals="-3"
      id="f-555"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ac7a7e554464f1d8c996aff630afeb1_I20221231"
      decimals="-3"
      id="f-556"
      unitRef="usd">171390000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cutr:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-557"
      unitRef="usd">171484000</cutr:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-558"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-559"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <cutr:CashCashEquivalentsAndAvailableForSaleDebtSecurities
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-560"
      unitRef="usd">318014000</cutr:CashCashEquivalentsAndAvailableForSaleDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-561"
      unitRef="usd">164164000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-562"
      unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-563"
      unitRef="usd">164864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-564"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-565"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-566"
      unitRef="usd">700000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-567">FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets at fair value, including cash and cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy contains the following three levels of inputs that may be used to measure fair value, in accordance with ASC 820:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1 inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considering counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, financial assets and liabilities measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Foreign exchange forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the Company had no money market funds or marketable investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 14 - Debt for the carrying amount and estimated fair value of the Company&#x2019;s 2.25% Convertible Senior Notes due 2026 (the &#x201c;2026 Notes&#x201d;), 2.25% Convertible Senior Notes due 2028 (the &#x201c;2028 Notes&#x201d;) and, 4.00% Convertible Senior Notes due 2029 (the &#x201c;2029 Notes&#x201d;), together with the 2026 Notes and 2028 Notes, (the &#x201c;Convertible Notes&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-568">As of December&#160;31, 2022, financial assets and liabilities measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.239%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Foreign exchange forward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic57b91ff7d8c4faea9f96493ed40332c_I20221231"
      decimals="-3"
      id="f-569"
      unitRef="usd">26408000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie7ca02c2f35d427c969131afb737148e_I20221231"
      decimals="-3"
      id="f-570"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8ac9e761079e46d09f596d92d01d71b4_I20221231"
      decimals="-3"
      id="f-571"
      unitRef="usd">171390000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d3f7fca92974b8aba97f327669fb368_I20221231"
      decimals="-3"
      id="f-572"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7081fb323837425eb325cf18993c3f13_I20221231"
      decimals="-3"
      id="f-573"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i43de6969b39446da9d7aa3def0715785_I20221231"
      decimals="-3"
      id="f-574"
      unitRef="usd">-558000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i8ac9e761079e46d09f596d92d01d71b4_I20221231"
      decimals="-3"
      id="f-575"
      unitRef="usd">197798000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i1d3f7fca92974b8aba97f327669fb368_I20221231"
      decimals="-3"
      id="f-576"
      unitRef="usd">-558000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id720e09c88e443f2809964bf360c8189_I20220531"
      decimals="INF"
      id="f-577"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531"
      decimals="INF"
      id="f-578"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="INF"
      id="f-579"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-580">DERIVATIVE INSTRUMENTS &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses foreign currency exchange forward contracts to manage the impact of currency exchange fluctuations on earnings and cash flow. The Company does not enter into derivative instruments for speculative purposes. The Company is exposed to potential credit loss in the event of nonperformance by counterparties on its outstanding derivative instruments but the Company does not anticipate nonperformance by any of its counterparties. Should a counterparty default, the Company's maximum loss exposure would be the potential asset balance of the instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flow effect of the derivative instruments settlement is recorded in cash flow from operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dollar amounts in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Forward&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-581">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flow effect of the derivative instruments settlement is recorded in cash flow from operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dollar amounts in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Forward&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i221c5f5bf1c048b58ad83bbe86effde5_I20221231"
      decimals="-3"
      id="f-582"
      unitRef="usd">6128000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i221c5f5bf1c048b58ad83bbe86effde5_I20221231"
      decimals="-3"
      id="f-583"
      unitRef="usd">558000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9be7dc17e6d2432fbb9a56dfd5b44ffe_D20220101-20221231"
      decimals="-3"
      id="f-584"
      unitRef="usd">-558000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-585">BALANCE SHEET DETAIL&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2022 and 2021, were $3.6 million and $4.9 million, respectively. Inventories, net of these adjustments, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current assets and prepaid expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets and a prepaid expenses, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits with vendors&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Materials related to the AviClear acne treatment device were classified as inventories at December 31, 2021. The Company received 510(k) clearance from the U.S. Food and Drug Administration in March 2022 and in April 2022 placed the first devices in service. Beginning in April 2022, the materials used in the construction of the AviClear device have been classified as Assets under construction and the manufactured devices, including devices available for lease and devices placed in service, have been classified as AviClear devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is related to the acquisition of Iridex&#x2019;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $1.3 million as of December&#160;31, 2022 and 2021. There were no impairments or additions to goodwill during the years ended December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus and payroll-related accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-586"
      unitRef="usd">3600000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-587"
      unitRef="usd">4900000</us-gaap:InventoryValuationReserves>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-588">Inventories, net of these adjustments, consist of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-589"
      unitRef="usd">36323000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-590"
      unitRef="usd">24035000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-591"
      unitRef="usd">2117000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-592"
      unitRef="usd">2124000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-593"
      unitRef="usd">25188000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-594"
      unitRef="usd">13344000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-595"
      unitRef="usd">63628000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-596"
      unitRef="usd">39503000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-597">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets and a prepaid expenses, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.375%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits with vendors&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:DepositsAssetsCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-598"
      unitRef="usd">13917000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-599"
      unitRef="usd">4389000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-600"
      unitRef="usd">7147000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-601"
      unitRef="usd">7612000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-602"
      unitRef="usd">2972000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-603"
      unitRef="usd">2544000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-604"
      unitRef="usd">24036000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-605"
      unitRef="usd">14545000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i46ca417d3e2946ceb0aaf60b4425ef5b_I20221231"
      decimals="-3"
      id="f-606"
      unitRef="usd">793000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i605a89e30db34ee5b4f659a4a45e8f1d_I20211231"
      decimals="-3"
      id="f-607"
      unitRef="usd">826000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i4a962cbab39448a1a2946df5cccfff51_I20221231"
      decimals="-3"
      id="f-608"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ia4b2c4567c63458dbf8d418f20083383_I20211231"
      decimals="-3"
      id="f-609"
      unitRef="usd">107000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i5296be68503d4aac9ffe8a6e86065dcc_I20221231"
      decimals="-3"
      id="f-610"
      unitRef="usd">19904000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i6a44bf842a0d40fa904345e182ab2a54_I20211231"
      decimals="-3"
      id="f-611"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="icc5baea4532648c7a0de553581dd9364_I20221231"
      decimals="-3"
      id="f-612"
      unitRef="usd">1936000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i157789288079499a8a2a1e6fa6177625_I20211231"
      decimals="-3"
      id="f-613"
      unitRef="usd">1527000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ibd22553f7fc24f4399f493cc7a5b0c69_I20221231"
      decimals="-3"
      id="f-614"
      unitRef="usd">5106000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ib97937e36112460f905b590a698c2662_I20211231"
      decimals="-3"
      id="f-615"
      unitRef="usd">3983000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i12e0968e414b4cce9b5df6a4573b4de2_I20221231"
      decimals="-3"
      id="f-616"
      unitRef="usd">17876000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id70000ea7bfe4aa091134520e36adee3_I20211231"
      decimals="-3"
      id="f-617"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-618"
      unitRef="usd">45615000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-619"
      unitRef="usd">6443000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-620"
      unitRef="usd">5247000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-621"
      unitRef="usd">3424000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-622"
      unitRef="usd">40368000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-623"
      unitRef="usd">3019000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-624"
      unitRef="usd">1300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-625"
      unitRef="usd">1300000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-626"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-627"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-628"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-629"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-630">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus and payroll-related accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-631"
      unitRef="usd">18951000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-632"
      unitRef="usd">21649000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-633"
      unitRef="usd">9066000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-634"
      unitRef="usd">9110000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-635"
      unitRef="usd">7028000</cutr:AccruedInventoryInTransitCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-636"
      unitRef="usd">4265000</cutr:AccruedInventoryInTransitCurrent>
    <cutr:SalesAndMarketingAccrualsCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-637"
      unitRef="usd">5347000</cutr:SalesAndMarketingAccrualsCurrent>
    <cutr:SalesAndMarketingAccrualsCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-638"
      unitRef="usd">4808000</cutr:SalesAndMarketingAccrualsCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-639"
      unitRef="usd">3254000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-640"
      unitRef="usd">3947000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-641"
      unitRef="usd">13806000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-642"
      unitRef="usd">10321000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-643"
      unitRef="usd">57452000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-644"
      unitRef="usd">54100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-645">PRODUCT WARRANTY &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-646">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2022 and 2021 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-647"
      unitRef="usd">3947000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-648"
      unitRef="usd">4124000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-649"
      unitRef="usd">3710000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-650"
      unitRef="usd">5135000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-651"
      unitRef="usd">4403000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-652"
      unitRef="usd">5312000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-653"
      unitRef="usd">3254000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-654"
      unitRef="usd">3947000</us-gaap:StandardProductWarrantyAccrual>
    <cutr:ContractWithCustomerLiabilityTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-655">DEFERRED REVENUE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#x2019;s extended service contracts typically have &lt;span style="-sec-ix-hidden:f-656"&gt;one&lt;/span&gt; to three-year terms. The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and variable lease income related to treatments performed by the lessee. The fixed annual license fee is recognized evenly over the period of the lease contract on a straight-line basis. Deferred revenue also includes payments for training. Approximately 88% of the Company&#x2019;s deferred revenue balance of $13.5 million as of December&#160;31, 2022, will be recognized over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in the deferred revenue balance for the years ended December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Costs for extended service contracts were $6.3 million, $8.3 million and $8.2 million, respectively, for the years&#160;ended December&#160;31, 2022, 2021 and 2020.</cutr:ContractWithCustomerLiabilityTextBlock>
    <cutr:ExtendedServiceContractTerm
      contextRef="i627fb423930e40d5904d10ac994e9b22_D20220101-20221231"
      id="f-657">P3Y</cutr:ExtendedServiceContractTerm>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i6174e841cf8942359f88304752a651ea_I20221231"
      decimals="2"
      id="f-658"
      unitRef="number">0.88</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6174e841cf8942359f88304752a651ea_I20221231"
      decimals="-5"
      id="f-659"
      unitRef="usd">13500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6174e841cf8942359f88304752a651ea_I20221231"
      id="f-660">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-661">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in the deferred revenue balance for the years ended December&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-662"
      unitRef="usd">10825000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-663"
      unitRef="usd">11237000</us-gaap:ContractWithCustomerLiability>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-664"
      unitRef="usd">21984000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-665"
      unitRef="usd">17139000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-666"
      unitRef="usd">9928000</cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred>
    <cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-667"
      unitRef="usd">7006000</cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-668"
      unitRef="usd">9383000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-669"
      unitRef="usd">10545000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-670"
      unitRef="usd">13498000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-671"
      unitRef="usd">10825000</us-gaap:ContractWithCustomerLiability>
    <cutr:CostsForExtendedServiceContracts
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-672"
      unitRef="usd">6300000</cutr:CostsForExtendedServiceContracts>
    <cutr:CostsForExtendedServiceContracts
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-673"
      unitRef="usd">8300000</cutr:CostsForExtendedServiceContracts>
    <cutr:CostsForExtendedServiceContracts
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-5"
      id="f-674"
      unitRef="usd">8200000</cutr:CostsForExtendedServiceContracts>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-675">STOCKHOLDERS&#x2019; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had one class of issued common stock with a par value of $0.001. Authorized capital stock consists of 55,000,000 shares comprised of two classes: (i) 50,000,000 shares of Common Stock, of which 19,668,603 shares are issued and outstanding as of December&#160;31, 2022, and (ii) 5,000,000 shares of preferred stock, par value $0.001 per share (&#x201c;Preferred Stock&#x201d;), of which no shares are issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Issuances of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;21, 2020, the Company issued and sold an aggregate of 2,742,750 shares of the Company&#x2019;s common stock, par value $0.001 per share at a price to the public of $10.50 per share. The shares include the full exercise of the underwriter&#x2019;s option to purchase an additional 357,750 shares of common stock. The Company received net proceeds from the offering of approximately $26.5 million, after deducting underwriting discounts, commissions and offering expenses of $2.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had the following stock-based employee compensation plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2004 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which 4,650,000 shares of the Company&#x2019;s common stock were reserved for issuance to employees, directors and consultants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2004, the Board of Directors (&#x201c;the Board&#x201d;) adopted the 2004 Equity Incentive Plan. A total of 1,750,000 shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#x201c;fungible share&#x201d; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract 2.12 shares from the shares reserved under the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the Company&#x2019;s Annual Meeting of Stockholders in 2019, the Company&#x2019;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by 700,000 (in addition to the 9,701,192 shares provided under the 2004 Equity Incentive Plan); (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#x2019;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#x201c;performance based compensation&#x201d; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum one-year vesting period with respect to awards granted under the 2004 Equity Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in 2019, the Board also amended the Company&#x2019;s Stock Ownership Guidelines to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least 50% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), or performance stock units (&#x201c;PSUs&#x201d;) (net of taxes) for a minimum of one year following vesting and delivery.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#x2019;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#x2019;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company's stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 600,000 shares, available for future grants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 450,000 shares, available for future grants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan and approved an additional 600,000 shares, available for future grants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s non-employee directors are granted $150,000 of RSUs or non-statutory stock options annually on the date of the Company&#x2019;s Annual Meeting of stockholders. These grants cliff-vest on the one-year anniversary of the grant date. In the years ended December&#160;31, 2022, 2021 and 2020, the Company issued 12,496, 41,301 and 35,735 RSUs, respectively, to its non-employee directors. In the year ended December&#160;31, 2022, the Company issued 18,135 non-statutory stock options to its non-employee directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2022, 2021&#160;and 2020, the Company&#x2019;s Board of Directors granted 191,993, 219,686 and 405,248 RSUs, respectively, to its executive officers, directors and certain members of the Company&#x2019;s management related to annual grants and new hire grants. The new hire RSUs vest quarterly on each of the first &lt;span style="-sec-ix-hidden:f-712"&gt;four&lt;/span&gt; annual anniversaries of the grant date and the annual grant RSUs vest one quarter on the first annual anniversary and monthly thereafter for 36 months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#x2019;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued 209,981 shares related to this bonus payment to management and recognized $2.6&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2022, 2021&#160;and 2020 the Company&#x2019;s Board of Directors granted its executive officers and certain senior management employees 169,785, 178,222, and 76,157 PSUs, respectively, related to its annual grants. The 2020 grant vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 and 2022 grants vest one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vests on the second anniversary subject to the recipient&#x2019;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted 265,002 PSUs to certain employees. This grant consists of four separate vesting tranches that will vest from April 2023 through June 2025 upon the achievement of operational milestones associated with each tranche and continued service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board awarded its new CEO, David H. Mowry, 67,897 PSUs, which vested over four years from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Board awarded its new CFO, Rohan Seth, 60,000 stock options, which vests over five years, and 22,423 PSUs, which vests over 2.5 years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for six months. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;600,000 shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;2.0% of the outstanding shares of common stock on such date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;an amount as determined by the Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price of the common stock purchased is the lower of 85% of the fair market value of the common stock at the beginning or end of the six-month offering period. In the years ended December&#160;31, 2022, 2021, and 2020, under the 2004 ESPP, the Company issued 49,306, 59,635, and 56,751 shares, respectively. At December&#160;31, 2022, 378,586 shares remained available for future issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Option and Award Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions ) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and expected to vest, net of estimated forfeitures, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of $44.22 of the Company&#x2019;s stock on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020 and $35.81 on December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Approved by the board of directors and stockholders in 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#x2019;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#x2019;s common stock. Total intrinsic value of options exercised in 2022, 2021 and 2020 was $1.1 million, $1.3 million, and $0.4 million, respectively. The options outstanding and exercisable at December&#160;31, 2022 were in the following exercise price ranges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prices&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$32.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$33.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$41.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$42.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$63.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$63.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;513,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127,863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Awards (RSU and PSU) Activity Table&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information with respect to RSUs and PSUs activity is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-&lt;br/&gt;Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the value of the Company&#x2019;s stock on the date that the restricted stock units and performance stock units vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of the Company&#x2019;s stock of $44.22 on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, and $35.81 on December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $12.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $9.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the years ended December&#160;31, 2022, 2021 and 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized during the years ended December&#160;31, 2022, 2021 and 2020 was recorded in the Consolidated Statement of Operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation Assumptions and Fair Value of Stock Options and ESPP Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Purchase Plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company has not paid dividends since its inception.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-676"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cutr:CapitalStockSharesAuthorized
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-677"
      unitRef="shares">55000000</cutr:CapitalStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-678"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-679"
      unitRef="shares">19668603</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-680"
      unitRef="shares">19668603</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-681"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-682"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-683"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-684"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421"
      decimals="INF"
      id="f-685"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iaae3e0055764457a9c1f55592c65d687_I20200421"
      decimals="INF"
      id="f-686"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="iaae3e0055764457a9c1f55592c65d687_I20200421"
      decimals="INF"
      id="f-687"
      unitRef="usdPerShare">10.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i76cbf6cae62846b4918bd5c16022a51e_D20200421-20200421"
      decimals="INF"
      id="f-688"
      unitRef="shares">357750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421"
      decimals="-5"
      id="f-689"
      unitRef="usd">26500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="iaf23fb3202e24ceeb361c6cb064050ef_D20200421-20200421"
      decimals="-5"
      id="f-690"
      unitRef="usd">2300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i08530b13979643b789fbf75b8ddb226a_I19981231"
      decimals="INF"
      id="f-691"
      unitRef="shares">4650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iaa3435c591f64b3798ada0cae4b3cb6b_I20041231"
      decimals="INF"
      id="f-692"
      unitRef="shares">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i56956846a75c43d6beae2d01dad8e79e_D20120101-20121231"
      decimals="INF"
      id="f-693"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231"
      decimals="INF"
      id="f-694"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i56053101176e4eee83b23bfb85a4c018_I20191231"
      decimals="INF"
      id="f-695"
      unitRef="shares">9701192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231"
      decimals="INF"
      id="f-696"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i5a458861cfc24a59bdc453f431486f37_D20190101-20191231"
      decimals="INF"
      id="f-697"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia2fdd272272b45deb78651a9217686d7_D20190101-20191231"
      id="f-698">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear
      contextRef="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231"
      decimals="INF"
      id="f-699"
      unitRef="number">0.50</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i46004954bc984936a1ba499adac7a1fd_D20200101-20201231"
      decimals="INF"
      id="f-700"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i7c18e28a9c3b4ac891e9d2b6fea59279_D20210601-20210630"
      decimals="INF"
      id="f-701"
      unitRef="shares">450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ic54be2ac79324b2f8eb1e0feef2c9f6c_D20220601-20220630"
      decimals="INF"
      id="f-702"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue
      contextRef="i1a45faa2dad7441e9750fb1049202ddb_I20221231"
      decimals="-3"
      id="f-703"
      unitRef="usd">150000</cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231"
      id="f-704">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i64ed0b5d2ebb4602bc58af45041ee0bb_D20220101-20221231"
      decimals="INF"
      id="f-705"
      unitRef="shares">12496</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i93eb16b5a06840968cbc9875832fe5e7_D20210101-20211231"
      decimals="INF"
      id="f-706"
      unitRef="shares">41301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7c2d12e9c8744b01846c152372849986_D20200101-20201231"
      decimals="INF"
      id="f-707"
      unitRef="shares">35735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue
      contextRef="id0fc73b5fb954186bdecf4e03ab50a44_I20221231"
      decimals="INF"
      id="f-708"
      unitRef="usd">18135</cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia0f8b1beeb3b46d6896264075a0f642c_D20220101-20221231"
      decimals="INF"
      id="f-709"
      unitRef="shares">191993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i31476d551c22406289d5d7e70159145a_D20210101-20211231"
      decimals="INF"
      id="f-710"
      unitRef="shares">219686</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i56d977f3237048fd8f92c1754156e659_D20200101-20201231"
      decimals="INF"
      id="f-711"
      unitRef="shares">405248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i30021351cc7642de9f7e7a753727c538_D20220101-20221231"
      id="f-713">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401"
      decimals="INF"
      id="f-714"
      unitRef="shares">209981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401"
      decimals="-5"
      id="f-715"
      unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if7a873e55daf4d1096b17ed6d286c540_D20220101-20221231"
      decimals="INF"
      id="f-716"
      unitRef="shares">169785</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2e6c6ee7693f44fbbc190082fa49573c_D20210101-20211231"
      decimals="INF"
      id="f-717"
      unitRef="shares">178222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia3b5675f4b3c4a44b1e6ca6d6528fc07_D20200101-20201231"
      decimals="INF"
      id="f-718"
      unitRef="shares">76157</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i675d69b502a848bc9f2401845e49adfc_D20210701-20210731"
      decimals="INF"
      id="f-719"
      unitRef="shares">265002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i5ce66ed419804b35a387a3a2298ae2b4_D20210701-20210731"
      decimals="INF"
      id="f-720"
      unitRef="tranche">4</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibe4bf8f916284b378c9dfccf341f2e0e_D20190701-20190731"
      decimals="INF"
      id="f-721"
      unitRef="shares">67897</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i718cf9e3833d4cbe824fb83ef9b96dd7_D20190701-20190731"
      id="f-722">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i15d864291f7042989243b040cd710241_D20200801-20200831"
      decimals="INF"
      id="f-723"
      unitRef="shares">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ica8f35fa7fcb453b85159c8316392bdc_D20200801-20200831"
      id="f-724">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i98655c3b6d21446ea2a5d6fface14f08_D20200801-20200831"
      decimals="INF"
      id="f-725"
      unitRef="shares">22423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic000f7fad27f41da8a1b11411e5199d4_D20200801-20200831"
      id="f-726">P2Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112"
      id="f-727">P6M</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112"
      decimals="INF"
      id="f-728"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage
      contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112"
      decimals="INF"
      id="f-729"
      unitRef="number">0.020</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231"
      decimals="2"
      id="f-730"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="id0a0ff0b3f3c4b4a8dc476bab3e69439_D20040112-20040112"
      id="f-731">P6M</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ibb2e3995e0c443c3b14bfa02c945aedc_D20220101-20221231"
      decimals="INF"
      id="f-732"
      unitRef="shares">49306</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i85b6c70335ab468995fd22f87f7dea79_D20210101-20211231"
      decimals="INF"
      id="f-733"
      unitRef="shares">59635</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i6cbfe8553003474dbea4fbe1cb946be5_D20200101-20201231"
      decimals="INF"
      id="f-734"
      unitRef="shares">56751</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i259a5ef49c174b599bbd8e82d8d4cd67_I20221231"
      decimals="INF"
      id="f-735"
      unitRef="shares">378586</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-736">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions ) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(296,238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and expected to vest, net of estimated forfeitures, as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of $44.22 of the Company&#x2019;s stock on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020 and $35.81 on December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Approved by the board of directors and stockholders in 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="INF"
      id="f-737"
      unitRef="shares">761705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="INF"
      id="f-738"
      unitRef="shares">295699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="2"
      id="f-739"
      unitRef="usdPerShare">25.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib7f5c0f00256480ab23266c26ff54361_D20190101-20191231"
      id="f-740">P3Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="-4"
      id="f-741"
      unitRef="usd">3040000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-742"
      unitRef="shares">600000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-743"
      unitRef="shares">71088</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-744"
      unitRef="shares">71088</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-745"
      unitRef="usdPerShare">14.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-746"
      unitRef="shares">73227</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-747"
      unitRef="usdPerShare">12.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-748"
      unitRef="shares">76553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-749"
      unitRef="shares">76553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-750"
      unitRef="usdPerShare">36.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-751"
      unitRef="shares">804949</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-752"
      unitRef="shares">522949</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="INF"
      id="f-753"
      unitRef="shares">1085170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="INF"
      id="f-754"
      unitRef="shares">217007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="2"
      id="f-755"
      unitRef="usdPerShare">22.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      id="f-756">P3Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-4"
      id="f-757"
      unitRef="usd">1470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-758"
      unitRef="shares">450000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-759"
      unitRef="shares">172139</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-760"
      unitRef="shares">172139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-761"
      unitRef="usdPerShare">30.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-762"
      unitRef="shares">71798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-763"
      unitRef="usdPerShare">22.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-764"
      unitRef="shares">30173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-765"
      unitRef="shares">30173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-766"
      unitRef="usdPerShare">37.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-767"
      unitRef="shares">744949</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-768"
      unitRef="shares">299092</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-769"
      unitRef="shares">947347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-770"
      unitRef="shares">287175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="2"
      id="f-771"
      unitRef="usdPerShare">25.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      id="f-772">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-4"
      id="f-773"
      unitRef="usd">4460000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-774"
      unitRef="shares">600000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-775"
      unitRef="shares">296238</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-776"
      unitRef="shares">296238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-777"
      unitRef="usdPerShare">40.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-778"
      unitRef="shares">39960</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-779"
      unitRef="usdPerShare">21.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-780"
      unitRef="shares">29518</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-781"
      unitRef="shares">29518</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-782"
      unitRef="usdPerShare">34.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-783"
      unitRef="shares">374274</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-784"
      unitRef="shares">164572</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-785"
      unitRef="shares">1070925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-786"
      unitRef="shares">513935</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="2"
      id="f-787"
      unitRef="usdPerShare">34.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-788">P6Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-4"
      id="f-789"
      unitRef="usd">5990000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-790"
      unitRef="shares">127863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="2"
      id="f-791"
      unitRef="usdPerShare">27.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-792">P3Y2M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-4"
      id="f-793"
      unitRef="usd">2150000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-794"
      unitRef="shares">483844</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="2"
      id="f-795"
      unitRef="usdPerShare">34.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-796">P6Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-4"
      id="f-797"
      unitRef="usd">5690000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharePrice
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-798"
      unitRef="usdPerShare">44.22</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="INF"
      id="f-799"
      unitRef="usdPerShare">41.32</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="INF"
      id="f-800"
      unitRef="usdPerShare">24.11</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="INF"
      id="f-801"
      unitRef="usdPerShare">35.81</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-802"
      unitRef="usd">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-803"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-5"
      id="f-804"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-805">The options outstanding and exercisable at December&#160;31, 2022 were in the following exercise price ranges:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prices&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$32.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$33.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$41.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$42.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$63.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$63.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;513,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127,863&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231"
      decimals="INF"
      id="f-806"
      unitRef="usdPerShare">10.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231"
      decimals="INF"
      id="f-807"
      unitRef="usdPerShare">14.04</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i8a5fd5162e3749dda52119ea03e417b8_I20221231"
      decimals="INF"
      id="f-808"
      unitRef="shares">5709</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ib4f638fc9db348c09ec422d655f356d0_D20220101-20221231"
      id="f-809">P1Y3M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i8a5fd5162e3749dda52119ea03e417b8_I20221231"
      decimals="INF"
      id="f-810"
      unitRef="shares">5709</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231"
      decimals="INF"
      id="f-811"
      unitRef="usdPerShare">14.10</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231"
      decimals="INF"
      id="f-812"
      unitRef="shares">60000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i115c28e37fe341eebe4c63199b303d29_D20220101-20221231"
      id="f-813">P2Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i53f46393f84249579bf1f0ecda83cecf_I20221231"
      decimals="INF"
      id="f-814"
      unitRef="shares">28000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231"
      decimals="INF"
      id="f-815"
      unitRef="usdPerShare">18.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231"
      decimals="INF"
      id="f-816"
      unitRef="usdPerShare">25.70</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i70779460b35645a8ae14d35ecd7316dd_I20221231"
      decimals="INF"
      id="f-817"
      unitRef="shares">12775</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i3e04a35577d8455ab61360574445bbbc_D20220101-20221231"
      id="f-818">P0Y10M28D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i70779460b35645a8ae14d35ecd7316dd_I20221231"
      decimals="INF"
      id="f-819"
      unitRef="shares">12775</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231"
      decimals="INF"
      id="f-820"
      unitRef="usdPerShare">29.28</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231"
      decimals="INF"
      id="f-821"
      unitRef="shares">73667</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="idb2821e1c3f34e6d88ea2da034cb653f_D20220101-20221231"
      id="f-822">P5Y3M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ieff965b22673420b9ac95034349a3a3e_I20221231"
      decimals="INF"
      id="f-823"
      unitRef="shares">31803</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231"
      decimals="INF"
      id="f-824"
      unitRef="usdPerShare">32.87</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231"
      decimals="INF"
      id="f-825"
      unitRef="shares">48806</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i5a6913c1f23c4c2183eb2a516465a2d0_D20220101-20221231"
      id="f-826">P4Y11M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="iaa282846e30940929a3b644c6b61c15d_I20221231"
      decimals="INF"
      id="f-827"
      unitRef="shares">22291</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i895e42cc37a4468982700f81c2a36726_I20221231"
      decimals="INF"
      id="f-828"
      unitRef="usdPerShare">33.45</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i895e42cc37a4468982700f81c2a36726_I20221231"
      decimals="INF"
      id="f-829"
      unitRef="shares">150857</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="if7dfdf16b051484fbfef1d9db4f028d5_D20220101-20221231"
      id="f-830">P9Y1M20D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i895e42cc37a4468982700f81c2a36726_I20221231"
      decimals="INF"
      id="f-831"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231"
      decimals="INF"
      id="f-832"
      unitRef="usdPerShare">36.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231"
      decimals="INF"
      id="f-833"
      unitRef="usdPerShare">41.39</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i595dfc44c26342479914423f899ffd41_I20221231"
      decimals="INF"
      id="f-834"
      unitRef="shares">91719</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ie88f57b11fe74f67b7e48a4475cc998a_D20220101-20221231"
      id="f-835">P6Y6M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i595dfc44c26342479914423f899ffd41_I20221231"
      decimals="INF"
      id="f-836"
      unitRef="shares">22540</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i0f809c30032e4095af4562f984e79643_I20221231"
      decimals="INF"
      id="f-837"
      unitRef="usdPerShare">42.33</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i0f809c30032e4095af4562f984e79643_I20221231"
      decimals="INF"
      id="f-838"
      unitRef="shares">17335</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i6a3ed95613494914aa350bfdca948d59_D20220101-20221231"
      id="f-839">P9Y10M28D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i0f809c30032e4095af4562f984e79643_I20221231"
      decimals="INF"
      id="f-840"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231"
      decimals="INF"
      id="f-841"
      unitRef="usdPerShare">47.40</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231"
      decimals="INF"
      id="f-842"
      unitRef="shares">4745</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ib971e664547449019e686dfcda7d726f_D20220101-20221231"
      id="f-843">P1Y11M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ibd90507e569a4a009155cc0c1d41eb33_I20221231"
      decimals="INF"
      id="f-844"
      unitRef="shares">4745</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231"
      decimals="INF"
      id="f-845"
      unitRef="usdPerShare">63.62</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231"
      decimals="INF"
      id="f-846"
      unitRef="shares">48322</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ic2c95c2271944120adfe82eb5cc72bed_D20220101-20221231"
      id="f-847">P9Y3M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i4eaa18236bf541fd9be0327591bddadb_I20221231"
      decimals="INF"
      id="f-848"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-849"
      unitRef="usdPerShare">10.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-850"
      unitRef="usdPerShare">63.62</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-851"
      unitRef="shares">513935</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-852">P6Y7M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="INF"
      id="f-853"
      unitRef="shares">127863</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-854">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information with respect to RSUs and PSUs activity is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-&lt;br/&gt;Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the value of the Company&#x2019;s stock on the date that the restricted stock units and performance stock units vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of the Company&#x2019;s stock of $44.22 on December&#160;31, 2022, $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, and $35.81 on December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $12.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $9.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231"
      decimals="INF"
      id="f-855"
      unitRef="shares">1104802</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231"
      decimals="2"
      id="f-856"
      unitRef="usdPerShare">22.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231"
      decimals="-3"
      id="f-857"
      unitRef="usd">37442000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="INF"
      id="f-858"
      unitRef="shares">667694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="2"
      id="f-859"
      unitRef="usdPerShare">20.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="INF"
      id="f-860"
      unitRef="shares">684491</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="2"
      id="f-861"
      unitRef="usdPerShare">17.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="-3"
      id="f-862"
      unitRef="usd">12036000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="INF"
      id="f-863"
      unitRef="shares">308248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="2"
      id="f-864"
      unitRef="usdPerShare">23.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231"
      decimals="INF"
      id="f-865"
      unitRef="shares">779757</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231"
      decimals="2"
      id="f-866"
      unitRef="usdPerShare">23.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231"
      decimals="-3"
      id="f-867"
      unitRef="usd">18800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="INF"
      id="f-868"
      unitRef="shares">744949</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="2"
      id="f-869"
      unitRef="usdPerShare">40.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="INF"
      id="f-870"
      unitRef="shares">254946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="2"
      id="f-871"
      unitRef="usdPerShare">22.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="-3"
      id="f-872"
      unitRef="usd">8287000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="INF"
      id="f-873"
      unitRef="shares">236856</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="2"
      id="f-874"
      unitRef="usdPerShare">27.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ida56af569414409888521b3e5deceb5c_I20211231"
      decimals="INF"
      id="f-875"
      unitRef="shares">1032904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ida56af569414409888521b3e5deceb5c_I20211231"
      decimals="2"
      id="f-876"
      unitRef="usdPerShare">35.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="ida56af569414409888521b3e5deceb5c_I20211231"
      decimals="-3"
      id="f-877"
      unitRef="usd">42680000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="INF"
      id="f-878"
      unitRef="shares">374274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="2"
      id="f-879"
      unitRef="usdPerShare">45.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="INF"
      id="f-880"
      unitRef="shares">340836</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="2"
      id="f-881"
      unitRef="usdPerShare">29.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="-3"
      id="f-882"
      unitRef="usd">15443000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="INF"
      id="f-883"
      unitRef="shares">160131</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="2"
      id="f-884"
      unitRef="usdPerShare">41.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231"
      decimals="INF"
      id="f-885"
      unitRef="shares">906211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231"
      decimals="2"
      id="f-886"
      unitRef="usdPerShare">40.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231"
      decimals="-3"
      id="f-887"
      unitRef="usd">40073000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharePrice
      contextRef="i40b9c39f2f6340b89ff1afcf31f5b575_I20221231"
      decimals="INF"
      id="f-888"
      unitRef="usdPerShare">44.22</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ida56af569414409888521b3e5deceb5c_I20211231"
      decimals="INF"
      id="f-889"
      unitRef="usdPerShare">41.32</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ib9f63feee35d437d87d7b2c8c1eb58ea_I20201231"
      decimals="INF"
      id="f-890"
      unitRef="usdPerShare">24.11</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="icf9eb37cd2f843bcb2780db55cc261c7_I20191231"
      decimals="INF"
      id="f-891"
      unitRef="usdPerShare">35.81</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="-5"
      id="f-892"
      unitRef="usd">12200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="-5"
      id="f-893"
      unitRef="usd">5800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="-5"
      id="f-894"
      unitRef="usd">9900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-895">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the years ended December&#160;31, 2022, 2021 and 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="-3"
      id="f-896"
      unitRef="usd">2175000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="-3"
      id="f-897"
      unitRef="usd">782000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="-3"
      id="f-898"
      unitRef="usd">370000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="-3"
      id="f-899"
      unitRef="usd">6979000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="-3"
      id="f-900"
      unitRef="usd">5305000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="-3"
      id="f-901"
      unitRef="usd">8849000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231"
      decimals="-3"
      id="f-902"
      unitRef="usd">4430000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231"
      decimals="-3"
      id="f-903"
      unitRef="usd">6591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231"
      decimals="-3"
      id="f-904"
      unitRef="usd">666000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i38c559feb1b74bcda18168292816e21d_D20220101-20221231"
      decimals="-3"
      id="f-905"
      unitRef="usd">816000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6a14495444114a1b95d8e60d66bcef2c_D20210101-20211231"
      decimals="-3"
      id="f-906"
      unitRef="usd">494000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if574d6c9139942fcae8b73ef1132adce_D20200101-20201231"
      decimals="-3"
      id="f-907"
      unitRef="usd">224000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-908"
      unitRef="usd">14400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-909"
      unitRef="usd">13172000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-910"
      unitRef="usd">10109000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-911">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized during the years ended December&#160;31, 2022, 2021 and 2020 was recorded in the Consolidated Statement of Operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2af1fdd05cd445a0ae8d99f2546c9649_D20220101-20221231"
      decimals="-3"
      id="f-912"
      unitRef="usd">1665000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iedb3fa0d043f42818e6ba795391d99b8_D20210101-20211231"
      decimals="-3"
      id="f-913"
      unitRef="usd">1408000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifb210668bb0d40229989bb9910942dc6_D20200101-20201231"
      decimals="-3"
      id="f-914"
      unitRef="usd">1665000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ied0d8c6d38e847f1b34b8e9fb647751a_D20220101-20221231"
      decimals="-3"
      id="f-915"
      unitRef="usd">4998000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie39cdb855de243d395bde3deb44004d9_D20210101-20211231"
      decimals="-3"
      id="f-916"
      unitRef="usd">3160000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c3ab544380346e298c21f60a885b0ab_D20200101-20201231"
      decimals="-3"
      id="f-917"
      unitRef="usd">3385000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i393abfeabcec4e439702c6fb89a55f9b_D20220101-20221231"
      decimals="-3"
      id="f-918"
      unitRef="usd">2405000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i950f3f1cbe644accb57140891f583a57_D20210101-20211231"
      decimals="-3"
      id="f-919"
      unitRef="usd">2784000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2a78a9a76abb4ea692915c784e8c9154_D20200101-20201231"
      decimals="-3"
      id="f-920"
      unitRef="usd">1669000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i831c2cc741324fff9890a07923f079f9_D20220101-20221231"
      decimals="-3"
      id="f-921"
      unitRef="usd">5332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1334e42d4dd14b4ba4c5edf93302f4b8_D20210101-20211231"
      decimals="-3"
      id="f-922"
      unitRef="usd">5820000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9a919cae1df94161b1b26d4d2c036cd7_D20200101-20201231"
      decimals="-3"
      id="f-923"
      unitRef="usd">3390000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-924"
      unitRef="usd">14400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-925"
      unitRef="usd">13172000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-926"
      unitRef="usd">10109000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-927">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Purchase Plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company has not paid dividends since its inception.&lt;/span&gt;&lt;/div&gt;</cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      id="f-928">P4Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      id="f-929">P3Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      id="f-930">P4Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"
      id="f-931">P0Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"
      id="f-932">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"
      id="f-933">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="4"
      id="f-934"
      unitRef="number">0.0199</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="4"
      id="f-935"
      unitRef="number">0.0048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="4"
      id="f-936"
      unitRef="number">0.0015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"
      decimals="4"
      id="f-937"
      unitRef="number">0.0379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"
      decimals="4"
      id="f-938"
      unitRef="number">0.0014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"
      decimals="4"
      id="f-939"
      unitRef="number">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="2"
      id="f-940"
      unitRef="number">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="2"
      id="f-941"
      unitRef="number">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="2"
      id="f-942"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"
      decimals="2"
      id="f-943"
      unitRef="number">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"
      decimals="2"
      id="f-944"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"
      decimals="2"
      id="f-945"
      unitRef="number">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="0"
      id="f-946"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="0"
      id="f-947"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="0"
      id="f-948"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"
      decimals="0"
      id="f-949"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"
      decimals="0"
      id="f-950"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"
      decimals="0"
      id="f-951"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="2"
      id="f-952"
      unitRef="usdPerShare">19.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="2"
      id="f-953"
      unitRef="usdPerShare">15.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="2"
      id="f-954"
      unitRef="usdPerShare">7.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie091d3280b26407fb20e3b253f89d97c_D20220101-20221231"
      decimals="2"
      id="f-955"
      unitRef="usdPerShare">15.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1e4ac291a065422fb213ccf1084f712f_D20210101-20211231"
      decimals="2"
      id="f-956"
      unitRef="usdPerShare">9.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i60bc355381dd46a0aa462026a19c5767_D20200101-20201231"
      decimals="2"
      id="f-957"
      unitRef="usdPerShare">6.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-961">INCOME TAXES&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. The Company&#x2019;s income (loss) before provision for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between the U.S. federal statutory income tax rates to the Company&#x2019;s effective tax rate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt extinguishment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General business credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in prior year reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company recorded a valuation allowance of $53.1 million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#x2019;s net deferred taxes increased by $12.6 million and $2.2 million during the years ended December&#160;31, 2022 and 2021, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $0.6 million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the Company had approximately $87.7 million and $45.3 million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized, will generally begin to expire in 2029&#160;through 2039. Approximately $51.2 million of total federal net operating loss carryforwards were generated after December 31, 2017 and have no expiration. At December&#160;31, 2022, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $7.5 million and $9.3 million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#x201c;ownership change,&#x201d; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#x2019;s net operating loss and tax credit carryforwards due to prior ownership changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No deferred tax liabilities have been recorded relating to the earnings of the Company&#x2019;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2009 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#x2019;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2017 remain subject to examination by their respective tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits, excluding related interest and penalties, in December&#160;31, 2020 to December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-962">The Company&#x2019;s income (loss) before provision for income taxes consisted of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-963"
      unitRef="usd">-84189000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-964"
      unitRef="usd">-356000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-965"
      unitRef="usd">-25793000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-966"
      unitRef="usd">3487000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-967"
      unitRef="usd">3741000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-968"
      unitRef="usd">2386000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-969"
      unitRef="usd">-80702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-970"
      unitRef="usd">3385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-971"
      unitRef="usd">-23407000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-972">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-973"
      unitRef="usd">52000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-974"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-975"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-976"
      unitRef="usd">126000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-977"
      unitRef="usd">-87000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-978"
      unitRef="usd">-53000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-979"
      unitRef="usd">1275000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-980"
      unitRef="usd">1512000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-981"
      unitRef="usd">747000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-982"
      unitRef="usd">1453000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-983"
      unitRef="usd">1425000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-984"
      unitRef="usd">694000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-985"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-986"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-987"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-988"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-989"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-990"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-991"
      unitRef="usd">182000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-992"
      unitRef="usd">-105000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-993"
      unitRef="usd">-227000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-994"
      unitRef="usd">185000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-995"
      unitRef="usd">-102000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-996"
      unitRef="usd">-224000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-997"
      unitRef="usd">1638000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-998"
      unitRef="usd">1323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-999"
      unitRef="usd">470000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1000">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1001"
      unitRef="usd">21443000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1002"
      unitRef="usd">18274000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1003"
      unitRef="usd">2594000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1004"
      unitRef="usd">3160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1005"
      unitRef="usd">4592000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1006"
      unitRef="usd">2863000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1007"
      unitRef="usd">14908000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1008"
      unitRef="usd">13634000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1009"
      unitRef="usd">778000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1010"
      unitRef="usd">939000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1011"
      unitRef="usd">1857000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1012"
      unitRef="usd">2226000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1013"
      unitRef="usd">7578000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1014"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1015"
      unitRef="usd">1541000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1016"
      unitRef="usd">977000</us-gaap:DeferredTaxAssetsOther>
    <cutr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1017"
      unitRef="usd">3384000</cutr:DeferredTaxAssetsOperatingLeaseLiability>
    <cutr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1018"
      unitRef="usd">3784000</cutr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1019"
      unitRef="usd">58675000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1020"
      unitRef="usd">45857000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1021"
      unitRef="usd">53118000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1022"
      unitRef="usd">40485000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1023"
      unitRef="usd">5557000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1024"
      unitRef="usd">5372000</us-gaap:DeferredTaxAssetsNet>
    <cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1025"
      unitRef="usd">1763000</cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts>
    <cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1026"
      unitRef="usd">990000</cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1027"
      unitRef="usd">138000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1028"
      unitRef="usd">124000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1029"
      unitRef="usd">3066000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1030"
      unitRef="usd">3480000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1031"
      unitRef="usd">590000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1032"
      unitRef="usd">778000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1033">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between the U.S. federal statutory income tax rates to the Company&#x2019;s effective tax rate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt extinguishment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General business credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in prior year reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-1034"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="INF"
      id="f-1035"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="INF"
      id="f-1036"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1037"
      unitRef="number">-0.0016</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1038"
      unitRef="number">-0.0255</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1039"
      unitRef="number">0.0277</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1040"
      unitRef="number">-0.0047</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1041"
      unitRef="number">0.0928</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1042"
      unitRef="number">-0.0065</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1043"
      unitRef="number">-0.0007</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1044"
      unitRef="number">0.0111</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1045"
      unitRef="number">-0.0287</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1046"
      unitRef="number">0.0089</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1047"
      unitRef="number">-0.1308</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1048"
      unitRef="number">-0.0107</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1049"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1050"
      unitRef="number">-0.4459</cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1051"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent>
    <cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1052"
      unitRef="number">-0.0848</cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent>
    <cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1053"
      unitRef="number">0</cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent>
    <cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1054"
      unitRef="number">0</cutr:EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1055"
      unitRef="number">-0.0134</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1056"
      unitRef="number">0.0788</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1057"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1058"
      unitRef="number">-0.0076</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1059"
      unitRef="number">0.1703</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1060"
      unitRef="number">-0.0105</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1061"
      unitRef="number">0.0078</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1062"
      unitRef="number">-0.1795</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1063"
      unitRef="number">0.0274</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1064"
      unitRef="number">-0.1141</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1065"
      unitRef="number">0.7282</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1066"
      unitRef="number">-0.2551</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1067"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1068"
      unitRef="number">-0.0008</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1069"
      unitRef="number">0.0055</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1070"
      unitRef="number">-0.0202</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1071"
      unitRef="number">-0.1176</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1072"
      unitRef="number">0.0208</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="4"
      id="f-1073"
      unitRef="number">-0.0204</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="4"
      id="f-1074"
      unitRef="number">0.3911</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="4"
      id="f-1075"
      unitRef="number">-0.0201</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-1076"
      unitRef="usd">53100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-1077"
      unitRef="usd">12600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-1078"
      unitRef="usd">2200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ie9dea9e779424bb0b81869578a5eb41a_I20221231"
      decimals="-5"
      id="f-1079"
      unitRef="usd">600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7fa86cedc4f743a89628f54d6c8ddd3f_I20221231"
      decimals="-5"
      id="f-1080"
      unitRef="usd">87700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3a8180f361034cc0a7ddd4675321f231_I20221231"
      decimals="-5"
      id="f-1081"
      unitRef="usd">45300000</us-gaap:OperatingLossCarryforwards>
    <cutr:OperatingLossCarryforwardsWithoutExpiration
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-1082"
      unitRef="usd">51200000</cutr:OperatingLossCarryforwardsWithoutExpiration>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i71b1494dda634811b284b9faa38d0601_I20221231"
      decimals="-5"
      id="f-1083"
      unitRef="usd">7500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ie45dca5694694e9eaafbe4a6234d3b92_I20221231"
      decimals="-5"
      id="f-1084"
      unitRef="usd">9300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1085">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits, excluding related interest and penalties, in December&#160;31, 2020 to December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1086"
      unitRef="usd">2746000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-1087"
      unitRef="usd">1864000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib60f899800144726a0adde4f7415072f_I20191231"
      decimals="-3"
      id="f-1088"
      unitRef="usd">1426000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1089"
      unitRef="usd">36000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1090"
      unitRef="usd">37000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1091"
      unitRef="usd">32000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1092"
      unitRef="usd">1015000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1093"
      unitRef="usd">919000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1094"
      unitRef="usd">470000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1095"
      unitRef="usd">3725000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1096"
      unitRef="usd">2746000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-1097"
      unitRef="usd">1864000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1098">NET INCOME (LOSS) PER SHARE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the Company&#x2019;s convertible notes were potentially convertible into 8,354,036 shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the years ended December&#160;31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the years ended December&#160;31, 2022 and 2020, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231"
      decimals="0"
      id="f-1099"
      unitRef="segment">8354036</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1100">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1101"
      unitRef="usd">-82340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1102"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1103"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1104"
      unitRef="shares">18747000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1105"
      unitRef="shares">17891000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1106"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231"
      decimals="-3"
      id="f-1107"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6fc7f475453d44a7a88ffdf3b838faf5_D20210101-20211231"
      decimals="-3"
      id="f-1108"
      unitRef="shares">68000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2406b4a263fa436c85b113428ea90e85_D20200101-20201231"
      decimals="-3"
      id="f-1109"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i89bb0f4421c8450bae1eff33752b3fe3_D20220101-20221231"
      decimals="-3"
      id="f-1110"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1264abf5db9241ae92cf03ef3c75e2ba_D20210101-20211231"
      decimals="-3"
      id="f-1111"
      unitRef="shares">294000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if884fb195001403da3afcf50b8a7fa29_D20200101-20201231"
      decimals="-3"
      id="f-1112"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic4d039818a2e496a918fc3ce32855a31_D20220101-20221231"
      decimals="-3"
      id="f-1113"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idd8b99dd6b9f4186a642299017c87c42_D20210101-20211231"
      decimals="-3"
      id="f-1114"
      unitRef="shares">104000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id3357f0e4d7c48489cb7e2338cb9f8e1_D20200101-20201231"
      decimals="-3"
      id="f-1115"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if11b725ce1af4a30b46852703abf3192_D20220101-20221231"
      decimals="-3"
      id="f-1116"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9d82e33152c849b3b7b22e9850693bc7_D20210101-20211231"
      decimals="-3"
      id="f-1117"
      unitRef="shares">5000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2718ea9e3df24ae9919f09e3a9bd8d2d_D20200101-20201231"
      decimals="-3"
      id="f-1118"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1119"
      unitRef="shares">18747000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1120"
      unitRef="shares">18362000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1121"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-1122"
      unitRef="usdPerShare">-4.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-1123"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-1124"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-1125"
      unitRef="usdPerShare">-4.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-1126"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-1127"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1128">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6d2af5d0d40240728bbaf7100364c888_D20220101-20221231"
      decimals="-3"
      id="f-1129"
      unitRef="shares">10780000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ica33e5e0a8d149e08222f5657ba8f9bd_D20210101-20211231"
      decimals="-3"
      id="f-1130"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1222f8a294044704aaca365b5961f91f_D20200101-20201231"
      decimals="-3"
      id="f-1131"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9973a1bb092c40f8b6352bebbf706d79_D20220101-20221231"
      decimals="-3"
      id="f-1132"
      unitRef="shares">8697000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i666467d2ee8b4706828ce53f22a78ef9_D20210101-20211231"
      decimals="-3"
      id="f-1133"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icacb09d5d4564041b646ac2fea6f291f_D20200101-20201231"
      decimals="-3"
      id="f-1134"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7c0099f611054142b44663a4d35bd018_D20220101-20221231"
      decimals="-3"
      id="f-1135"
      unitRef="shares">514000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i435b3ba5e879438ab1c9c925dc8a1ba6_D20210101-20211231"
      decimals="-3"
      id="f-1136"
      unitRef="shares">166000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27c63a15d54b4af684d1b7b298377b14_D20200101-20201231"
      decimals="-3"
      id="f-1137"
      unitRef="shares">244000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i65060ead42404852b4696510b4327f7a_D20220101-20221231"
      decimals="-3"
      id="f-1138"
      unitRef="shares">460000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3883679f5dd14bd58d3bdc2f35fc8b3f_D20210101-20211231"
      decimals="-3"
      id="f-1139"
      unitRef="shares">32000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id1afd2b598094e77a995de1beb182fc0_D20200101-20201231"
      decimals="-3"
      id="f-1140"
      unitRef="shares">724000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70b796e7c79344caa2cc64d5b0a40019_D20220101-20221231"
      decimals="-3"
      id="f-1141"
      unitRef="shares">38000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaaf71e1c04fa42eb8e5bcab09ec61552_D20210101-20211231"
      decimals="-3"
      id="f-1142"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib80255a5d1504da7ac5a65f6a26a95f9_D20200101-20201231"
      decimals="-3"
      id="f-1143"
      unitRef="shares">87000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i64feb72e527a4ddeba367f7807175c19_D20220101-20221231"
      decimals="-3"
      id="f-1144"
      unitRef="shares">446000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8ddee769932a4350a14cc2d6333a6757_D20210101-20211231"
      decimals="-3"
      id="f-1145"
      unitRef="shares">120000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76980ed1a1534046811d38eed346f857_D20200101-20201231"
      decimals="-3"
      id="f-1146"
      unitRef="shares">68000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1147"
      unitRef="shares">20935000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1148"
      unitRef="shares">8652000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1149"
      unitRef="shares">1123000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1150">DEFINED&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONTRIBUTION&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PLAN&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the U.S., the Company has an employee savings plan (&#x201c;401(k) Plan&#x201d;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to 100% of their annual compensation, subject to statutory annual limitations. In 2022, 2021 and 2020, the Company made discretionary contributions under the 401(k) Plan of $0.5 million, $0.3 million and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#x2019;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2022, and the related expense for each of the three years then ended was not significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="0"
      id="f-1151"
      unitRef="number">1</cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-5"
      id="f-1152"
      unitRef="usd">500000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-5"
      id="f-1153"
      unitRef="usd">300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-5"
      id="f-1154"
      unitRef="usd">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1155">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment reporting is based on the &#x201c;management approach,&#x201d; following the method that management organizes the Company&#x2019;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#x2019;s chief operating decision maker ("CODM") is its Chief Executive Officer ("CEO"), who makes decisions on allocating resources and assessing performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the fourth quarter of 2022, the Company segregates its operations into two reportable business segments: (i) Cutera Core and (ii) AviClear. This segregation aligns the Company&#x2019;s operating business segments with the way the CEO reviews the Company's operations as a result of the commercial release of the Company&#x2019;s AviClear acne treatment device in April 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the financial results of its reportable segments using an internal performance measure that excludes General and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;231,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;147,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;ERP implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Legal fees, severance, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,830&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Interest and other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(80,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;202,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;520,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022&#160;and 2021, 99.8% and 99.0% of long-lived assets were in the United States, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the world, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231"
      decimals="INF"
      id="f-1156"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1157">The Company measures the financial results of its reportable segments using an internal performance measure that excludes General and administrative expenses.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;231,270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;147,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Segment income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;ERP implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Legal fees, severance, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,830&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Interest and other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(80,702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total capital spending&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Cutera Core&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;202,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;520,988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280,293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia3786902aa814d6781382d2a734de748_D20220101-20221231"
      decimals="2"
      id="f-1158"
      unitRef="usd">247943000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i846ac160c48140659c8ff08589c1559c_D20210101-20211231"
      decimals="2"
      id="f-1159"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231"
      decimals="2"
      id="f-1160"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231"
      decimals="2"
      id="f-1161"
      unitRef="usd">4456000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231"
      decimals="2"
      id="f-1162"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231"
      decimals="2"
      id="f-1163"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="2"
      id="f-1164"
      unitRef="usd">252399000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="2"
      id="f-1165"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="2"
      id="f-1166"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia3786902aa814d6781382d2a734de748_D20220101-20221231"
      decimals="-3"
      id="f-1167"
      unitRef="usd">20862000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i846ac160c48140659c8ff08589c1559c_D20210101-20211231"
      decimals="-3"
      id="f-1168"
      unitRef="usd">30181000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if696d53d3e774d6780e594d3eb7a560b_D20200101-20201231"
      decimals="-3"
      id="f-1169"
      unitRef="usd">-4796000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib905f9f58ad14343878166fa1b14890e_D20220101-20221231"
      decimals="-3"
      id="f-1170"
      unitRef="usd">-28012000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9dcae24b0a4743b4bab6ea7e7657dcb6_D20210101-20211231"
      decimals="-3"
      id="f-1171"
      unitRef="usd">-9445000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id244e79f67204e70a5ef86eb68b681c7_D20200101-20201231"
      decimals="-3"
      id="f-1172"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9be98d2423634757af936bba4482f104_D20220101-20221231"
      decimals="-3"
      id="f-1173"
      unitRef="usd">-7150000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7af2f3a0df564393908ceb31eb4f5771_D20210101-20211231"
      decimals="-3"
      id="f-1174"
      unitRef="usd">20736000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i057d976e50f54bb5b4029b6e8eed833d_D20200101-20201231"
      decimals="-3"
      id="f-1175"
      unitRef="usd">-4796000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1176"
      unitRef="usd">14400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1177"
      unitRef="usd">13172000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1178"
      unitRef="usd">10109000</us-gaap:ShareBasedCompensation>
    <cutr:ERPImplementation
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1179"
      unitRef="usd">9211000</cutr:ERPImplementation>
    <cutr:ERPImplementation
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1180"
      unitRef="usd">1498000</cutr:ERPImplementation>
    <cutr:ERPImplementation
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1181"
      unitRef="usd">1139000</cutr:ERPImplementation>
    <us-gaap:DepreciationAndAmortization
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1182"
      unitRef="usd">5821000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1183"
      unitRef="usd">3188000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1184"
      unitRef="usd">3987000</us-gaap:DepreciationAndAmortization>
    <cutr:LegalFeesSeveranceAndOther
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1185"
      unitRef="usd">1608000</cutr:LegalFeesSeveranceAndOther>
    <cutr:LegalFeesSeveranceAndOther
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1186"
      unitRef="usd">1048000</cutr:LegalFeesSeveranceAndOther>
    <cutr:LegalFeesSeveranceAndOther
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1187"
      unitRef="usd">2797000</cutr:LegalFeesSeveranceAndOther>
    <us-gaap:OperatingIncomeLoss
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1188"
      unitRef="usd">-38190000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1189"
      unitRef="usd">1830000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1190"
      unitRef="usd">-22828000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1191"
      unitRef="usd">-42512000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1192"
      unitRef="usd">1555000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1193"
      unitRef="usd">-579000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1194"
      unitRef="usd">-80702000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1195"
      unitRef="usd">3385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1196"
      unitRef="usd">-23407000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:PartnersCapital
      contextRef="iab29b34be6724c94945ef58bbfbbbe24_I20221231"
      decimals="-3"
      id="f-1197"
      unitRef="usd">1780000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231"
      decimals="-3"
      id="f-1198"
      unitRef="usd">438000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="iabd1a6a576ea4d019bb8ce898cadf674_I20201231"
      decimals="-3"
      id="f-1199"
      unitRef="usd">1279000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="id51d133a94594ab68d99649b2087f195_I20221231"
      decimals="-3"
      id="f-1200"
      unitRef="usd">20918000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231"
      decimals="-3"
      id="f-1201"
      unitRef="usd">577000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="id8e56fbd57d240fc8787786a963035f1_I20201231"
      decimals="-3"
      id="f-1202"
      unitRef="usd">0</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231"
      decimals="-3"
      id="f-1203"
      unitRef="usd">22698000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="ie71acb76f8254ab48b6267e153db44c2_I20211231"
      decimals="-3"
      id="f-1204"
      unitRef="usd">1015000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="idb3011f822b64b65b4850bdaf7aee0ab_I20201231"
      decimals="-3"
      id="f-1205"
      unitRef="usd">1279000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="ia90a17929a2c47458119f913368da54d_I20221231"
      decimals="-3"
      id="f-1206"
      unitRef="usd">0</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="ic43b61bed02d4fce96d758963f8ca202_I20211231"
      decimals="-3"
      id="f-1207"
      unitRef="usd">0</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1208"
      unitRef="usd">22698000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1209"
      unitRef="usd">1015000</us-gaap:PartnersCapital>
    <us-gaap:PartnersCapital
      contextRef="i866a04e8824b4dbf9ff659afa11d7000_I20201231"
      decimals="-3"
      id="f-1210"
      unitRef="usd">1279000</us-gaap:PartnersCapital>
    <us-gaap:Assets
      contextRef="iab29b34be6724c94945ef58bbfbbbe24_I20221231"
      decimals="-3"
      id="f-1211"
      unitRef="usd">154978000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5a90bf6157c14f9ab26b4c4c273a7a63_I20211231"
      decimals="-3"
      id="f-1212"
      unitRef="usd">76860000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id51d133a94594ab68d99649b2087f195_I20221231"
      decimals="-3"
      id="f-1213"
      unitRef="usd">47406000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i641f0aef1ca94d02a2e1df383f1df9b2_I20211231"
      decimals="-3"
      id="f-1214"
      unitRef="usd">6342000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ica79ba80e1a4499d9ceddbe07c866fa3_I20221231"
      decimals="-3"
      id="f-1215"
      unitRef="usd">202384000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie71acb76f8254ab48b6267e153db44c2_I20211231"
      decimals="-3"
      id="f-1216"
      unitRef="usd">83202000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia90a17929a2c47458119f913368da54d_I20221231"
      decimals="-3"
      id="f-1217"
      unitRef="usd">318604000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic43b61bed02d4fce96d758963f8ca202_I20211231"
      decimals="-3"
      id="f-1218"
      unitRef="usd">197091000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1219"
      unitRef="usd">520988000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1220"
      unitRef="usd">280293000</us-gaap:Assets>
    <cutr:PercentageOfAssets
      contextRef="i0c171c7b5cbf4b489415ee212fd357c0_I20221231"
      decimals="3"
      id="f-1221"
      unitRef="number">0.998</cutr:PercentageOfAssets>
    <cutr:PercentageOfAssets
      contextRef="i04b0cfbd65e4486580c0b2d539204abc_I20211231"
      decimals="3"
      id="f-1222"
      unitRef="number">0.990</cutr:PercentageOfAssets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1223">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the world, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AviClear&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32af68888229429c86c1f6d4e66c39d8_D20220101-20221231"
      decimals="-3"
      id="f-1224"
      unitRef="usd">107453000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc0bee4a202b46a886d4dac9c6a0465c_D20210101-20211231"
      decimals="-3"
      id="f-1225"
      unitRef="usd">96629000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9b100c928a264c0780179352a51b0551_D20200101-20201231"
      decimals="-3"
      id="f-1226"
      unitRef="usd">61238000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73bcc961f86c4d37ad3553546f5a6370_D20220101-20221231"
      decimals="-3"
      id="f-1227"
      unitRef="usd">64920000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i864a42f1b9474cd3bf43681344389c54_D20210101-20211231"
      decimals="-3"
      id="f-1228"
      unitRef="usd">70235000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0b4e54ccf702485ebea23892a41e90d0_D20200101-20201231"
      decimals="-3"
      id="f-1229"
      unitRef="usd">43265000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i79cb131a331f444aaec8d0b8104c73b7_D20220101-20221231"
      decimals="-3"
      id="f-1230"
      unitRef="usd">21873000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie5b1f1666e8c420ba4cde97cf41fb662_D20210101-20211231"
      decimals="-3"
      id="f-1231"
      unitRef="usd">12649000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i105738620d9448cd86de0b72566e2192_D20200101-20201231"
      decimals="-3"
      id="f-1232"
      unitRef="usd">10707000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2ac813d49b5749bdbb352b5de5d1604c_D20220101-20221231"
      decimals="-3"
      id="f-1233"
      unitRef="usd">20882000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icc14c23d98b5459bbca583cda98d027e_D20210101-20211231"
      decimals="-3"
      id="f-1234"
      unitRef="usd">19444000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i112b7a48420c4a4a815d9a7348d931fb_D20200101-20201231"
      decimals="-3"
      id="f-1235"
      unitRef="usd">11185000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i79b2c7662fd449d0afe5418656bb70be_D20220101-20221231"
      decimals="-3"
      id="f-1236"
      unitRef="usd">37271000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc6629fab6b94f3ab926f0814d6fd0d2_D20210101-20211231"
      decimals="-3"
      id="f-1237"
      unitRef="usd">32313000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iea513a253ca34fe9a2a2acdd9000fbc5_D20200101-20201231"
      decimals="-3"
      id="f-1238"
      unitRef="usd">21288000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1239"
      unitRef="usd">252399000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1240"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1241"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6dd67954cb584428b5eb9b700919da0a_D20220101-20221231"
      decimals="-3"
      id="f-1242"
      unitRef="usd">163637000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2ce4b410a9a94845afb82c481a9282d4_D20210101-20211231"
      decimals="-3"
      id="f-1243"
      unitRef="usd">139633000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i53d978e3d81f43a4920268bc4873fd78_D20200101-20201231"
      decimals="-3"
      id="f-1244"
      unitRef="usd">90765000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib45100873e384627a7d0d4ae1bee0f3d_D20220101-20221231"
      decimals="-3"
      id="f-1245"
      unitRef="usd">4456000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie04aff51169d478787e0b3b3998d9c0a_D20210101-20211231"
      decimals="-3"
      id="f-1246"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3183169f49b0407497637750803e56cc_D20200101-20201231"
      decimals="-3"
      id="f-1247"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i79831062395d48ff9827b5dd62714018_D20220101-20221231"
      decimals="-3"
      id="f-1248"
      unitRef="usd">18203000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i570cc80078864aeba21c2158c1c81d44_D20210101-20211231"
      decimals="-3"
      id="f-1249"
      unitRef="usd">16401000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i438a7e3fe616461bb35aac62f1dd3281_D20200101-20201231"
      decimals="-3"
      id="f-1250"
      unitRef="usd">9287000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1cfd4323e38a42f380d911aaae444128_D20220101-20221231"
      decimals="-3"
      id="f-1251"
      unitRef="usd">42500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0b446bf3d14c44a595ac3dfcbab2b828_D20210101-20211231"
      decimals="-3"
      id="f-1252"
      unitRef="usd">49669000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1f95e00759c5463c8accbe2d58291bdd_D20200101-20201231"
      decimals="-3"
      id="f-1253"
      unitRef="usd">25061000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id82a22a9886c4a319a7f2dcb4b5cbdbd_D20220101-20221231"
      decimals="-3"
      id="f-1254"
      unitRef="usd">228796000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie97f0dbf965b43738ea95b5b2200e359_D20210101-20211231"
      decimals="-3"
      id="f-1255"
      unitRef="usd">205703000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i806a9486ff1043a2abc3ab0f1747be03_D20200101-20201231"
      decimals="-3"
      id="f-1256"
      unitRef="usd">125113000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6a6ea20d4d754ea5bd6f969093c305e2_D20220101-20221231"
      decimals="-3"
      id="f-1257"
      unitRef="usd">23603000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i80e299bc8462483cb6d96e99c7a547d1_D20210101-20211231"
      decimals="-3"
      id="f-1258"
      unitRef="usd">25567000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2acfe64493a844d9a85fe1b68f924137_D20200101-20201231"
      decimals="-3"
      id="f-1259"
      unitRef="usd">22570000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1260"
      unitRef="usd">252399000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1261"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1262"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <cutr:LesseeLeasesTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1263">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;LEASES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#x2019;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles leases. The Company&#x2019;s leases generally have remaining terms of &lt;span style="-sec-ix-hidden:f-1264"&gt;one&lt;/span&gt; to 10 years, some of which include options to renew the leases for up to five years. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#x2019;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is supplemental balance sheet information related to leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1270"&gt;&lt;span style="-sec-ix-hidden:f-1271"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1282"&gt;&lt;span style="-sec-ix-hidden:f-1283"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1286"&gt;&lt;span style="-sec-ix-hidden:f-1287"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the twelve months ended&#160;December&#160;31, 2022 and December&#160;31, 2021 (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 were as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Maturities of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows as of December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Vehicle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate, as of December&#160;31, 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor - AviClear&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Lessor revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases the AviClear device to customers and receives a fixed annual license fee over the term of the arrangement and revenue related to treatments performed by the lessee. The contractual term of the lease agreement is three years with a one-year autorenewal feature. Certain lease agreements' terms in excess of one year can be terminated without financial penalty, and these agreements are accounted for as having a lease term of one year. The AviClear lease agreements are accounted for as operating leases. The fixed annual license fee is recognized evenly throughout the period of the lease agreement on a straight-line basis. The treatment revenue is recognized in the period the lessee has the ability to perform the patient treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1335"&gt;&lt;span style="-sec-ix-hidden:f-1336"&gt;AviClear operating lease license fee revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1339"&gt;&lt;span style="-sec-ix-hidden:f-1340"&gt;AviClear operating lease revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1343"&gt;&lt;span style="-sec-ix-hidden:f-1344"&gt;Total AviClear revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The AviClear device being leased has a useful life of seven years. The Company expects that a device will be leased for two consecutive lease terms at the end of which its residual value will be immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the minimum future lease payments as of December&#160;31, 2022, under non-cancelable operating leases, assuming the minimum contractual lease term (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected a practical expedient applied to operating leases to elect not to separate lease and nonlease components as long as the lease and at least one nonlease component have the same timing and pattern of transfer. As such, updates or upgrades on a when-and-if available basis to the AviClear device are combined with the operating lease revenue. The combined component is being accounted for under ASC 842. Additionally, the Company made an accounting policy election to present AviClear revenue net of sales and other similar taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Capitalized sales commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions related to obtaining AviClear lease agreements are accounted for as initial direct costs and are capitalized and amortized on a straight-line basis over the lease term. Total capitalized costs for the year ended December&#160;31, 2022 were $3.8 million. Amortization expenses for these assets were&#160;$0.5 million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Sales and marketing expense in the Company&#x2019;s consolidated statement of operations. Total capitalized costs as of December&#160;31, 2022, were $3.3 million and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Lease installment costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes fulfillment costs incurred before AviClear lease commencement and these costs include freight, installation, and training costs. Total capitalized costs for the year ended December&#160;31, 2022, were $1.7 million. Amortization expenses for these assets were&#160;$0.3 million during the year&#160;ended December&#160;31, 2022, and were&#160;included in Cost of revenue in the Company&#x2019;s consolidated statement of operations. Total lease installment costs as of December&#160;31, 2022, were $1.4 million and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#x2019;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of the Company&#x2019;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#x2019;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named from time to time as a party to other legal proceedings, product liability, intellectual property disputes, commercial disputes, employee disputes, and contractual lawsuits. A liability and related charge are recorded to earnings in the Company&#x2019;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred. Certain of the cases below are still in the preliminary stages, and the Company is not able to quantify the extent of its potential liability, if any, other than as described. The outcome of litigation is inherently unpredictable and subject to significant uncertainties. If any of these matters are resolved adversely to the Company, this could have a material adverse effect on its business, financial condition, results of operations, and cash flows. In addition, defending these legal proceedings is likely to be costly, which may have a material adverse effect on the Company's financial condition, results of operations and cash flows, and may divert management's attention from the day-to-day operations of its business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and&#160;2021, the Company had accrued $0.5 million and $0.7&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California. Lutronic employs numerous former Cutera employees. The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act ("RICO"); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting. On March 13, 2020, the court entered a temporary restraining order ("TRO") against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information. The order also prohibits Lutronic, for two years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers. On April 9, 2020, the parties stipulated to the entry of a preliminary injunction providing for the same relief afforded by the TRO. On August 4, 2022, Cutera filed a second amended complaint. In addition to the above referenced claims, Cutera alleges claims for violation of the Lanham Act, unlawful business practices, false advertising and trademark infringement. Discovery is ongoing. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, Serendia, LLC (&#x201c;Serendia&#x201d;), filed patent infringement complaints against the Company with the International Trade Commission (&#x201c;ITC&#x201d;) and in U.S. District Court for the District of Delaware alleging infringement of six Serendia patents by the Secret RF and Secret Pro systems, which the Company distributes in the U.S. on behalf of ILOODA Co. Ltd., a Korean company. If, following a successful third-party action for infringement, the Company cannot obtain a license for its products, the Company may have to stop selling the applicable products.&lt;/span&gt;&lt;/div&gt;</cutr:LesseeLeasesTextBlock>
    <cutr:LesseeLeasesRemainingTerm
      contextRef="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231"
      id="f-1265">P10Y</cutr:LesseeLeasesRemainingTerm>
    <cutr:LesseeLeaseRenewalTerm
      contextRef="i2acddaa200d148dd957498ed169a6cf0_D20220101-20221231"
      id="f-1266">P5Y</cutr:LesseeLeaseRenewalTerm>
    <cutr:LeasesFinancialStatementInformationTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1267">Below is supplemental balance sheet information related to leases (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1270"&gt;&lt;span style="-sec-ix-hidden:f-1271"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1282"&gt;&lt;span style="-sec-ix-hidden:f-1283"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1286"&gt;&lt;span style="-sec-ix-hidden:f-1287"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the twelve months ended&#160;December&#160;31, 2022 and December&#160;31, 2021 (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 were as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cutr:LeasesFinancialStatementInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1268"
      unitRef="usd">12831000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1269"
      unitRef="usd">14627000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1272"
      unitRef="usd">1606000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1273"
      unitRef="usd">392000</us-gaap:FinanceLeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1274"
      unitRef="usd">14437000</cutr:LeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1275"
      unitRef="usd">15019000</cutr:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1276"
      unitRef="usd">2810000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1277"
      unitRef="usd">2419000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1278"
      unitRef="usd">11352000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1279"
      unitRef="usd">13483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1280"
      unitRef="usd">14162000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1281"
      unitRef="usd">15902000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1284"
      unitRef="usd">485000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1285"
      unitRef="usd">554000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1288"
      unitRef="usd">825000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1289"
      unitRef="usd">730000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1290"
      unitRef="usd">1310000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-3"
      id="f-1291"
      unitRef="usd">1284000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1292"
      unitRef="usd">643000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1293"
      unitRef="usd">484000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1294"
      unitRef="usd">431000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1295"
      unitRef="usd">76000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1296"
      unitRef="usd">59000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1297"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1298"
      unitRef="usd">3560000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1299"
      unitRef="usd">3542000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1300"
      unitRef="usd">3275000</us-gaap:OperatingLeaseExpense>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1301"
      unitRef="usd">78000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1302"
      unitRef="usd">56000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1303"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1304"
      unitRef="usd">520000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1305"
      unitRef="usd">462000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1306"
      unitRef="usd">537000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="-3"
      id="f-1307"
      unitRef="usd">2526000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ibfeabd40b8a643ea9d4b371b4cbd8dcc_D20210101-20211231"
      decimals="-3"
      id="f-1308"
      unitRef="usd">3092000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i5a0103df55c74734b79edb071c9e7ff3_D20200101-20201231"
      decimals="-3"
      id="f-1309"
      unitRef="usd">2139000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1310">Maturities of operating lease liabilities were as follows as of December&#160;31, 2022 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1311"
      unitRef="usd">3420000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1312"
      unitRef="usd">2962000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1313"
      unitRef="usd">2932000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1314"
      unitRef="usd">3027000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1315"
      unitRef="usd">3130000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1316"
      unitRef="usd">464000</cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1317"
      unitRef="usd">15935000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1318"
      unitRef="usd">1773000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1319"
      unitRef="usd">14162000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1320">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1321"
      unitRef="usd">542000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1322"
      unitRef="usd">604000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1323"
      unitRef="usd">295000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1324"
      unitRef="usd">1441000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1325"
      unitRef="usd">131000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1326"
      unitRef="usd">1310000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1327">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate, as of December&#160;31, 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1328">P5Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1329">P2Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="3"
      id="f-1330"
      unitRef="number">0.047</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="3"
      id="f-1331"
      unitRef="number">0.062</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      id="f-1332">P3Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <cutr:LessorDurationOfAutorenewalFeatures
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1333">P1Y</cutr:LessorDurationOfAutorenewalFeatures>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1334">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1335"&gt;&lt;span style="-sec-ix-hidden:f-1336"&gt;AviClear operating lease license fee revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1339"&gt;&lt;span style="-sec-ix-hidden:f-1340"&gt;AviClear operating lease revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-1343"&gt;&lt;span style="-sec-ix-hidden:f-1344"&gt;Total AviClear revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ic0d7a5375fc84542a91dea74df7c28b8_D20220101-20221231"
      decimals="-3"
      id="f-1337"
      unitRef="usd">922000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="iac1f888ba1dc42248dd31987664bbb4c_D20210101-20211231"
      decimals="-3"
      id="f-1338"
      unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i245361d231e04e79b09b398ae6a26dd1_D20220101-20221231"
      decimals="-3"
      id="f-1341"
      unitRef="usd">3534000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i4db954fe033847e2b53b08a387423de3_D20210101-20211231"
      decimals="-3"
      id="f-1342"
      unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231"
      decimals="-3"
      id="f-1345"
      unitRef="usd">4456000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i69dad4bf7a524446a238dd3880a0df9f_D20210101-20211231"
      decimals="-3"
      id="f-1346"
      unitRef="usd">0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia982b914a1b146c5a1cab988d0bd6cca_D20220101-20221231"
      id="f-1347">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <cutr:NumberOfConsecutiveLeaseTerms
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      decimals="INF"
      id="f-1348"
      unitRef="lease_term">2</cutr:NumberOfConsecutiveLeaseTerms>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1349">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the minimum future lease payments as of December&#160;31, 2022, under non-cancelable operating leases, assuming the minimum contractual lease term (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1350"
      unitRef="usd">610000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1351"
      unitRef="usd">610000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-3"
      id="f-1352"
      unitRef="usd">1220000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:CapitalizedContractCostNet
      contextRef="iabc624c81f7f4b68aa9384952bc72b52_I20221231"
      decimals="-5"
      id="f-1353"
      unitRef="usd">3800000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i4d7a93cebb0445b3adc4fdbd8bcad826_D20220101-20221231"
      decimals="-5"
      id="f-1354"
      unitRef="usd">500000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostNet
      contextRef="ifc8691977a17471e888e8008855e2dec_I20221231"
      decimals="-5"
      id="f-1355"
      unitRef="usd">3300000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i1e56eaab24a348b69456952d07cd3e95_I20221231"
      decimals="-5"
      id="f-1356"
      unitRef="usd">1700000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="id9a5220685f0420ab867e7dfb9c2cf00_D20220101-20221231"
      decimals="-5"
      id="f-1357"
      unitRef="usd">300000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i796773bebe7e43e7bcecf719e525f796_I20221231"
      decimals="-5"
      id="f-1358"
      unitRef="usd">1400000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:LitigationReserve
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-5"
      id="f-1359"
      unitRef="usd">500000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="id98fc580362c485a9aa22ac1e8f9841d_I20211231"
      decimals="-5"
      id="f-1360"
      unitRef="usd">700000</us-gaap:LitigationReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1361">DEBT&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible notes, net of unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the outstanding principal amount and carrying value of the Company&#x2019;s Convertible Notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Convertible notes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Issuance of convertible notes due in 2026&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company issued $138.3 million aggregate principal amount of 2026 Notes in a private placement offering. The 2026 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year. Upon conversion, the 2026 Notes will be convertible into either cash, shares of the Company&#x2019;s common stock or a combination thereof, at the Company&#x2019;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $133.6 million, net of issuance costs, including initial purchasers fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each $1,000 principal amount of the 2026 Notes is initially convertible into 30.1427 shares of the Company&#x2019;s common stock, which is equivalent to a conversion price of approximately $33.18 per share. The conversion rate for the 2026 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2026 Notes. The 2026 Notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2026 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Issuance of convertible notes due in 2028&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company issued $240.0&#160;million aggregate principal amount of 2028 Notes. The 2028 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on June 1 and December 1 of each year. A total of $230.0&#160;million of aggregate principal amount of 2028 Notes was issued in a private placement offering and concurrently with this private placement, the Company entered into a purchase agreement with Voce, an entity affiliated with J. Daniel Plants, the Company&#x2019;s Executive Chairperson, pursuant to which the Company issued to Voce $10.0&#160;million aggregate principal amount of 2028 Notes on the same terms and conditions. The aggregate proceeds from the offering of 2028 Notes were approximately $232.4&#160;million, net of issuance costs, including initial purchaser fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The 2028 Notes bear interest at a rate of 2.25% per year payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2022. Upon conversion, the 2028 Notes will be convertible into either cash, shares of the Company&#x2019;s common stock or a combination thereof, at the Company&#x2019;s election. Each $1,000 principal amount of the 2028 Notes is initially convertible into 18.9860 shares of the Company&#x2019;s common stock, which is equivalent to an initial conversion price of approximately $52.67 per share. The conversion rate for the 2028 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2028 Notes. The 2028 Notes will mature on March 1, 2028, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2028 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Issuance of convertible notes due in 2029&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company issued $120.0 million aggregate principal amount of 2029 Notes in a private placement offering. The 2029 Notes bear interest at a rate of 4.00% per year payable semiannually in arrears on June 1 and December 1 of each year. Upon conversion, the 2029 Notes will be convertible into either cash, shares of the Company&#x2019;s common stock or a combination thereof, at the Company&#x2019;s election. The Convertible notes are presented as Convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;The aggregate proceeds from the offering were approximately $115.8 million, net of issuance costs, including initial purchasers fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each $1,000 principal amount of the 2029 Notes is initially convertible into 17.1378 shares of the Company&#x2019;s common stock, which is equivalent to a conversion price of approximately $58.35 per share. The conversion rate for the 2029 Notes is subject to adjustment for certain events as set forth in the indenture governing the 2029 Notes. The 2029 Notes will mature on June 1, 2029, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2029 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2026 Notes exchange&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company entered into privately-negotiated exchange agreements with certain holders of the Company&#x2019;s outstanding 2026 Notes with respect to the exchange of $45.8&#160;million in cash (excluding $0.3&#160;million in cash for the payment of accrued interest) and 1,354,348 shares of common stock for $69.1&#160;million in aggregate principal amount of the Company&#x2019;s outstanding 2026 Notes (the &#x201c;2026 Notes Exchange&#x201d;). Immediately following the closing of the 2026 Notes Exchange, approximately $69.1&#160;million in aggregate principal amount of the 2026 Notes remained outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2026 Notes Exchange was accounted for as an extinguishment of debt. The Company recorded the difference between the proceeds paid and the carrying amount of the debt as an extinguishment loss, with a corresponding entry to common stock and Additional-paid-in capital for the issuance of the shares at the then-trading price of $41.31 per share. The table below presents the components of the Loss on debt extinguishment recorded in the Company's consolidated statements of operations for the year ended December 31, 2022 (amounts in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued for repurchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closing price of Cutera common stock on May 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash used for repurchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total shares and cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Note principal exchanged &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares and cash exchanged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes: Unamortized debt issuance costs on May 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Portion of 2026 Note principal exchanged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Conversion and other features&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2026 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their 2026 Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During any fiscal quarter (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2026 Notes on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During the five-business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the &#x201c;trading price&#x201d;&#160;per $1,000 principal amount of 2026 Notes for each trading day of the measurement period was less than 98% &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Upon the occurrence of specified corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2026 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The circumstances described in the first bullet of the paragraph above were met during the third and fourth quarter of 2022. As of December&#160;31, 2022, the 2026 Notes are convertible and this condition will remain until March 31, 2023. The 2026 Notes may also become convertible in future periods. Upon any conversion requests of the 2026 Notes, the Company would be required to pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2026 Notes have been included as Long-term debt on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the 2026 Notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the 2026 Notes, at the Company&#x2019;s option, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2026 Notes, at least $50.0&#160;million aggregate principal amount of 2026 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a specified corporate event occurs, 2026 Note holders have the option to require the Company to repurchase any portion or all of their 2026 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2026 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2026 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2026 Notes are general senior unsecured obligations that rank senior to any of the Company&#x2019;s indebtedness that is explicitly subordinated to the 2026 Notes. The 2026 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2026 Notes (including the 2028 Notes and 2029 Notes). The 2026 Notes will be junior to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2026 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the 2026 Notes was approximately $103.8 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2028 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their 2028 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2028, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During any fiscal quarter commencing after the fiscal quarter ending on September 30, 2022 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2028 Notes on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During the five-business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the &#x201c;trading price&#x201d; per $1,000 principal amount of 2028 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The Company calls such 2028 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Upon the occurrence of specified corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after March 1, 2028, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2028 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The circumstances described in the first bullet of the paragraph above were not met during the fourth quarter of 2022. As of December 31, 2022, the 2028 Notes are not convertible and this condition will remain until March 31, 2023. The 2028 Notes may become convertible in future periods. Upon any conversion requests of the 2028 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2028 Notes have been included as long-term debt on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the 2028 Notes prior to June 5, 2025. On or after June 5, 2025, the Company may redeem for cash all or any portion of the 2028 Notes, at the Company&#x2019;s option, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2028 Notes, at least $100.0&#160;million aggregate principal amount of 2028 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a specified corporate event occurs, note holders have the option to require the Company to repurchase any portion or all of their 2028 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2028 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2028 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2028 Notes are general senior unsecured obligations that rank senior to any of the Company&#x2019;s indebtedness that is explicitly subordinated to the 2028 Notes. The 2028 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2028 Notes (including the 2026 Notes and 2029 Notes). The 2028 Notes will be junior to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2028 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the 2028 Notes was approximately $249.3 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2029 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their 2029 Notes at their option prior to the close of business on the business day immediately preceding March 1, 2029 in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During any fiscal quarter commencing after the fiscal quarter ending March 31, 2023 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the 2029 Notes on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;During the five-business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the &#x201c;trading price&#x201d;&#160;per $1,000 principal amount of 2029 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;The Company calls such 2029 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Upon the occurrence of specified corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after March 1, 2029, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2029 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The circumstances described in the bullets in the paragraph above were not met during the fourth quarter of 2022. As of December&#160;31, 2022, the 2029 Notes are not convertible and this condition will remain until March 31, 2023. Upon any conversion requests of the 2029 Notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election with respect to such conversion requests. To the extent there are any conversion requests during the twelve months ending December 31, 2023, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2022, the 2029 Notes have been included as Long-term debt on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the 2029 Notes prior to December 5, 2025. On or after December 5, 2025, the Company may redeem for cash all or any portion of the 2029 Notes, at the Company&#x2019;s option, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2029 Notes, at least $$100.0 million aggregate principal amount of 2029 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a specified corporate event occurs, 2029 Note holders have the option to require the Company to repurchase any portion or all of their 2029 Notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of 2029 Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the 2029 Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2029 Notes are general senior unsecured obligations that rank senior to any of the Company&#x2019;s indebtedness that is explicitly subordinated to the 2029 Notes. The 2029 Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the 2029 Notes (including the 2026 Notes and 2028 Notes). The 2029 Notes will be junior to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The 2029 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the 2029 Notes was approximately $122.2 million as of December&#160;31, 2022, which the Company determined through consideration of market prices. The fair value measurement is classified as Level 2, as defined in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Capped Call Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of each series of the Convertible Notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's common stock upon any conversion or settlement of the applicable series of Convertible Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the applicable series of Convertible Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#x2019;s common stock exceeds the cap price of the applicable capped call transactions, then the Company&#x2019;s stock would experience some dilution and/or such capped call transactions would not fully offset the potential cash payments, in each case, to the extent the then-market price per share of its common stock exceeds the applicable cap price. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In connection with the offering of the 2026 Notes, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $45.535, which represented a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ending on March 12, 2026. The capped calls were purchased for $16.1 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the offering of the 2028 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2028 Notes sold to the initial purchasers in the offering of 2028 Notes, with a strike price equal to the conversion price of the 2028 Notes and with an initial cap price equal to $82.62, which represents a 100% premium over the last reported sale price of the Company's common stock of $41.31 per share on May 24, 2022, with certain adjustments to the settlement terms that reflect standard anti-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dilution provisions. These capped call transactions expire over 40 consecutive scheduled trading days ending on May 30, 2028. The capped calls were purchased for $32.0 million, inclusive of issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In connection with the offering of the 2029 Notes, the Company purchased from the option counterparties capped call options that in the aggregate related to the total number of shares of the Company's common stock underlying the 2029 Notes sold to the initial purchasers in the offering of 2029 Notes, with a strike price equal to the conversion price of the 2029 Notes and with an initial cap price equal to $99.32, which represents a 100% premium over the last reported sale price of the Company's common stock of $49.66 per share on December 7, 2022, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. These capped call transactions expire over 40 consecutive scheduled trading days ending on May 30, 2029. The capped calls were purchased for $25.1&#160;million, inclusive of issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company evaluated the capped call transactions under authoritative accounting guidance and determined that they should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#x2019; equity with no recurring fair value measurement recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company early adopted ASU 2020-6, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) on January 1, 2021. In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Convertible Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"&gt;Debt Issuance Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the Convertible Notes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the Company incurred direct costs associated with the issuance of convertible notes of $11.8 million. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted under &#x201c;2026 Notes Exchange&#x201d; above, $1.8 million of unamortized debt issuance costs related to the 2026 Notes was included in the loss on debt extinguishment during the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $4.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective interest rate on the 2026 Notes, 2028 Notes, and 2029 Notes are 2.98%, 2.82%, and 4.63%, respectively. Interest expense for the year ended December&#160;31, 2022, including the amortization of debt issuance cost, totaled approximately $7.0 million. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $3.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan and Security Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 9, 2020, the Company entered into the Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#x201c;SVB Revolving Line of Credit&#x201d;) in an aggregate principal amount of up to $30.0&#160;million. The Revolving Line of Credit matures on July 9, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#x2019;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#x2019;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $0.3&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#x2019;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis, but which is only applicable if the Company has an outstanding balance under the loan facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;4, 2021, the Loan and Security Agreement dated July&#160;9, 2020 was amended to (i)&#160;permit the Company to issue the convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the capped call transactions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 24, 2022, the Loan and Security Agreement was amended. The amendment increased the permitted indebtedness by $230,000,000 and provided for the 2026 Notes Exchange and issuance of the capped call transactions related to the 2028 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 10, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement  waived a violation of a covenant and revised the Loan Agreement to permit the issuance of the 2028 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 7, 2022, the Loan and Security Agreement was amended. The amendment to the Loan and Security Agreement revised the Loan Agreement to permit the issuance of the 2029 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, and the FDIC was appointed receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp;amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp;amp; Trust Company. In addition, under the purchase and assumption agreement, First-Citizens Bank &amp;amp; Trust Company assumed Silicon Valley Bank&#x2019;s obligations under the Company&#x2019;s credit facility. On March 13, 2023, the Company violated one of the terms of the credit facility agreement by transferring funds from Silicon Valley Bank. The Company received a waiver from First-Citizens Bank &amp;amp; Trust Company for this violation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Paycheck Protection Program (PPP) Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;22, 2020, the Company received loan proceeds of $7.2 million pursuant to the Paycheck Protection Program (the &#x201c;PPP&#x201d;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and SVB as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $7.2&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1362">The following table presents the outstanding principal amount and carrying value of the Company&#x2019;s Convertible Notes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notes due in 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Convertible notes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231"
      decimals="-3"
      id="f-1363"
      unitRef="usd">69125000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231"
      decimals="-3"
      id="f-1364"
      unitRef="usd">138250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231"
      decimals="-3"
      id="f-1365"
      unitRef="usd">1553000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231"
      decimals="-3"
      id="f-1366"
      unitRef="usd">4007000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231"
      decimals="-3"
      id="f-1367"
      unitRef="usd">67572000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7a0cca728a634df5a5f6d19439a8e76f_I20211231"
      decimals="-3"
      id="f-1368"
      unitRef="usd">134243000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231"
      decimals="-3"
      id="f-1369"
      unitRef="usd">240000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231"
      decimals="-3"
      id="f-1370"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231"
      decimals="-3"
      id="f-1371"
      unitRef="usd">6908000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231"
      decimals="-3"
      id="f-1372"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ia7719fc175b6482682d41fed2b2280cf_I20221231"
      decimals="-3"
      id="f-1373"
      unitRef="usd">233092000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifc01ef124dcd4432926e7fafc9179e82_I20211231"
      decimals="-3"
      id="f-1374"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="-3"
      id="f-1375"
      unitRef="usd">120000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231"
      decimals="-3"
      id="f-1376"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="-3"
      id="f-1377"
      unitRef="usd">4205000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231"
      decimals="-3"
      id="f-1378"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="-3"
      id="f-1379"
      unitRef="usd">115795000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5bc2557870e243c2a5677cb7decf7012_I20211231"
      decimals="-3"
      id="f-1380"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id4fabcd0c6b145328c06480322497ceb_I20221231"
      decimals="-3"
      id="f-1381"
      unitRef="usd">416459000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231"
      decimals="-3"
      id="f-1382"
      unitRef="usd">134243000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331"
      decimals="INF"
      id="f-1383"
      unitRef="usd">138300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331"
      decimals="INF"
      id="f-1384"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="-5"
      id="f-1385"
      unitRef="usd">133600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia42551caee064e72b3e0bb899ff817f7_I20220331"
      decimals="2"
      id="f-1386"
      unitRef="usdPerShare">33.18</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531"
      decimals="INF"
      id="f-1387"
      unitRef="usd">240000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f3d4babfce840a2b159fd70abd4be03_I20220331"
      decimals="INF"
      id="f-1388"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i311a3952ceef49ac9b09d68b91ee185d_I20220531"
      decimals="INF"
      id="f-1389"
      unitRef="usd">230000000</us-gaap:DebtInstrumentFaceAmount>
    <cutr:DebtInstrumentAdditionalAggregatePrincipalAmount
      contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531"
      decimals="-5"
      id="f-1390"
      unitRef="usd">10000000</cutr:DebtInstrumentAdditionalAggregatePrincipalAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"
      decimals="-5"
      id="f-1391"
      unitRef="usd">232400000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531"
      decimals="INF"
      id="f-1392"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i69f9433f295c4816bc3f161b64e8c985_I20220531"
      decimals="2"
      id="f-1393"
      unitRef="usdPerShare">52.67</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="INF"
      id="f-1394"
      unitRef="usd">120000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i22c2b0a369614a47bb4d25533345f31f_I20221231"
      decimals="INF"
      id="f-1395"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i5b1034aac577429c85e82e69d338c3b0_D20221201-20221231"
      decimals="-5"
      id="f-1396"
      unitRef="usd">115800000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="idcee2bc0609d4e29aba04556ae20c3bd_I20221231"
      decimals="2"
      id="f-1397"
      unitRef="usdPerShare">58350</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <cutr:DebtConversionConvertedInstrumentCashIssued
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-5"
      id="f-1398"
      unitRef="usd">45800000</cutr:DebtConversionConvertedInstrumentCashIssued>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-5"
      id="f-1399"
      unitRef="usd">300000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="0"
      id="f-1400"
      unitRef="shares">1354348</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-5"
      id="f-1401"
      unitRef="usd">69100000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:LongTermDebt
      contextRef="i17fbfe26ef264a34b2c3bbbd999e5121_I20220601"
      decimals="-5"
      id="f-1402"
      unitRef="usd">69100000</us-gaap:LongTermDebt>
    <us-gaap:SharePrice
      contextRef="i4c543a80fb3441f29a2f3497b9785ec9_I20220524"
      decimals="INF"
      id="f-1403"
      unitRef="usdPerShare">41.31</us-gaap:SharePrice>
    <us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1404">The table below presents the components of the Loss on debt extinguishment recorded in the Company's consolidated statements of operations for the year ended December 31, 2022 (amounts in thousands, except share and per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.237%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued for repurchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Closing price of Cutera common stock on May 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash used for repurchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total shares and cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Note principal exchanged &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares and cash exchanged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Notes: Unamortized debt issuance costs on May 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Portion of 2026 Note principal exchanged&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfExtinguishmentOfDebtTextBlock>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="0"
      id="f-1405"
      unitRef="shares">1354348</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SharePrice
      contextRef="i4c543a80fb3441f29a2f3497b9785ec9_I20220524"
      decimals="INF"
      id="f-1406"
      unitRef="usdPerShare">41.31</us-gaap:SharePrice>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1407"
      unitRef="usd">55948000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <cutr:DebtConversionConvertedInstrumentCashIssued
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1408"
      unitRef="usd">45776000</cutr:DebtConversionConvertedInstrumentCashIssued>
    <cutr:DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1409"
      unitRef="usd">101724000</cutr:DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1410"
      unitRef="usd">69125000</us-gaap:ExtinguishmentOfDebtAmount>
    <cutr:DebtConversionNetProceeds
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1411"
      unitRef="usd">32599000</cutr:DebtConversionNetProceeds>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id720e09c88e443f2809964bf360c8189_I20220531"
      decimals="-3"
      id="f-1412"
      unitRef="usd">3648000</us-gaap:DeferredFinanceCostsNet>
    <cutr:DebtConversionPercentageOfDebtConverted
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="2"
      id="f-1413"
      unitRef="number">0.50</cutr:DebtConversionPercentageOfDebtConverted>
    <cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1414"
      unitRef="usd">1824000</cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531"
      decimals="-3"
      id="f-1415"
      unitRef="usd">34423000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="INF"
      id="f-1416"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="INF"
      id="f-1417"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="2"
      id="f-1418"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="INF"
      id="f-1419"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="INF"
      id="f-1420"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="2"
      id="f-1421"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="2"
      id="f-1422"
      unitRef="number">1.30</cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdTradingDays
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1423"
      unitRef="day">20</cutr:DebtInstrumentRedeemableThresholdTradingDays>
    <cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1424"
      unitRef="day">30</cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1425"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption
      contextRef="i5360b54f8bd047afbb77191b00d60ec7_I20210331"
      decimals="-5"
      id="f-1426"
      unitRef="usd">50000000</cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption>
    <cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount
      contextRef="ia1261edff6b94c0eabe87de89ca47291_I20210331"
      decimals="INF"
      id="f-1427"
      unitRef="usd">1000</cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331"
      decimals="INF"
      id="f-1428"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i27566a6eb1a14a6da1bcb731ccfcad08_I20221231"
      decimals="-5"
      id="f-1429"
      unitRef="usd">103800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0e1b769004c940138fbdcc25ec85a289_I20221231"
      decimals="-5"
      id="f-1430"
      unitRef="usd">103800000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531"
      decimals="INF"
      id="f-1431"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531"
      decimals="INF"
      id="f-1432"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger
      contextRef="i687803cc4a6c4204a168057f0ef568d5_D20220501-20220531"
      decimals="2"
      id="f-1433"
      unitRef="number">1.30</cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531"
      decimals="INF"
      id="f-1434"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531"
      decimals="INF"
      id="f-1435"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i63b15d81e53d4840992ef67247f4dcf6_D20220501-20220531"
      decimals="2"
      id="f-1436"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger
      contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"
      decimals="2"
      id="f-1437"
      unitRef="number">1.30</cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdTradingDays
      contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"
      decimals="INF"
      id="f-1438"
      unitRef="day">20</cutr:DebtInstrumentRedeemableThresholdTradingDays>
    <cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays
      contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"
      decimals="INF"
      id="f-1439"
      unitRef="day">30</cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6e35e4b82e84474d86460de3d49fbcf4_D20220501-20220531"
      decimals="INF"
      id="f-1440"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption
      contextRef="i8340bed1b672419cbaface1d8b4809cb_I20220531"
      decimals="-5"
      id="f-1441"
      unitRef="usd">100000000</cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption>
    <cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount
      contextRef="idb3d4792c6144be88746b11a2ee39995_I20220531"
      decimals="INF"
      id="f-1442"
      unitRef="usd">1000</cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i4dd175c6046b46988a2632db59313ec8_D20220501-20220531"
      decimals="INF"
      id="f-1443"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i003fc45e98c843a98b06a88ed0a0f62d_I20221231"
      decimals="-5"
      id="f-1444"
      unitRef="usd">249300000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="INF"
      id="f-1445"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="INF"
      id="f-1446"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i0211537b220e4b369bf6ea7d0d4b1083_D20210301-20210331"
      decimals="2"
      id="f-1447"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="INF"
      id="f-1448"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="INF"
      id="f-1449"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic1ad1a68e1924c1cb44b4fed229818ee_D20210301-20210331"
      decimals="2"
      id="f-1450"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="2"
      id="f-1451"
      unitRef="number">1.30</cutr:DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger>
    <cutr:DebtInstrumentRedeemableThresholdTradingDays
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1452"
      unitRef="day">20</cutr:DebtInstrumentRedeemableThresholdTradingDays>
    <cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1453"
      unitRef="day">30</cutr:DebtInstrumentRedeemableThresholdConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i8ad31ab1e2864ae1802626c099b7200d_D20210301-20210331"
      decimals="INF"
      id="f-1454"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption
      contextRef="i723997427a13498fb7414de5cf577325_I20210331"
      decimals="-5"
      id="f-1455"
      unitRef="usd">100000000</cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption>
    <cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount
      contextRef="ia1261edff6b94c0eabe87de89ca47291_I20210331"
      decimals="INF"
      id="f-1456"
      unitRef="usd">1000</cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6059a3095059465a8d3b02003bfcf8af_D20210301-20210331"
      decimals="INF"
      id="f-1457"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ib99c5a3203694570b12bf45da9728932_I20221231"
      decimals="-5"
      id="f-1458"
      unitRef="usd">122200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeCapPrice
      contextRef="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331"
      decimals="INF"
      id="f-1459"
      unitRef="usdPerItem">45.535</us-gaap:DerivativeCapPrice>
    <cutr:DerivativeCapPricePremiumOverStockPricePercent
      contextRef="i1a84a6fdf1f449e5bc26890c7f1d9a31_I20210331"
      decimals="2"
      id="f-1460"
      unitRef="number">0.75</cutr:DerivativeCapPricePremiumOverStockPricePercent>
    <us-gaap:SharePrice
      contextRef="ib2840cd98ca143cd8b20996a137ad641_I20210304"
      decimals="INF"
      id="f-1461"
      unitRef="usdPerShare">26.02</us-gaap:SharePrice>
    <cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays
      contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331"
      decimals="INF"
      id="f-1462"
      unitRef="day">40</cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="iba6f8db32e7c482b97b185b61a64245d_D20210301-20210331"
      decimals="-5"
      id="f-1463"
      unitRef="usd">16100000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:DerivativeCapPrice
      contextRef="i560132f058e647e7836489cdaa020a99_I20220531"
      decimals="INF"
      id="f-1464"
      unitRef="usdPerItem">82.62</us-gaap:DerivativeCapPrice>
    <cutr:DerivativeCapPricePremiumOverStockPricePercent
      contextRef="i560132f058e647e7836489cdaa020a99_I20220531"
      decimals="2"
      id="f-1465"
      unitRef="number">1</cutr:DerivativeCapPricePremiumOverStockPricePercent>
    <us-gaap:SharePrice
      contextRef="i5adbe42165d747f9b1a502754f152e1c_I20210304"
      decimals="INF"
      id="f-1466"
      unitRef="usdPerShare">41.31</us-gaap:SharePrice>
    <cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays
      contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531"
      decimals="INF"
      id="f-1467"
      unitRef="day">40</cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i70e92a4cfb8445b69742ef18c7c3ea4e_D20220501-20220531"
      decimals="-5"
      id="f-1468"
      unitRef="usd">32000000.0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:DerivativeCapPrice
      contextRef="i601beccbd0004b92931f1016a7656cf5_I20220531"
      decimals="INF"
      id="f-1469"
      unitRef="usdPerItem">99.32</us-gaap:DerivativeCapPrice>
    <cutr:DerivativeCapPricePremiumOverStockPricePercent
      contextRef="i601beccbd0004b92931f1016a7656cf5_I20220531"
      decimals="2"
      id="f-1470"
      unitRef="number">1</cutr:DerivativeCapPricePremiumOverStockPricePercent>
    <us-gaap:SharePrice
      contextRef="i0739d3b24f09440ba3de580700fa75f8_I20210304"
      decimals="INF"
      id="f-1471"
      unitRef="usdPerShare">49.66</us-gaap:SharePrice>
    <cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays
      contextRef="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531"
      decimals="INF"
      id="f-1472"
      unitRef="day">40</cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="ia1597808c8a542cd84a28777b0ffe666_D20220501-20220531"
      decimals="-5"
      id="f-1473"
      unitRef="usd">25100000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id4fabcd0c6b145328c06480322497ceb_I20221231"
      decimals="-5"
      id="f-1474"
      unitRef="usd">11800000</us-gaap:DeferredFinanceCostsNet>
    <cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted
      contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231"
      decimals="-5"
      id="f-1475"
      unitRef="usd">1800000</cutr:DebtConversionUnamortizedDebtIssuanceCostsConverted>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i9b4680e0181e43aeaccd2a4d0af076c9_I20211231"
      decimals="-5"
      id="f-1476"
      unitRef="usd">4600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231"
      decimals="4"
      id="f-1477"
      unitRef="number">0.0298</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ibca4ca09a78d4f1db1fbfc595409a42c_D20220101-20221231"
      decimals="4"
      id="f-1478"
      unitRef="number">0.0282</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i77ed4f6c46564823a197c54da88e53aa_D20220101-20221231"
      decimals="4"
      id="f-1479"
      unitRef="number">0.0463</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts
      contextRef="ibc17ad3b59664df49df18e44e735b529_D20220101-20221231"
      decimals="-5"
      id="f-1480"
      unitRef="usd">7000000</cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts>
    <cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts
      contextRef="i398059a02fc14dcbaf17eb4a4c643116_D20210101-20211231"
      decimals="-5"
      id="f-1481"
      unitRef="usd">3200000</cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentTerm
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      id="f-1482">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      id="f-1483">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="INF"
      id="f-1484"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="INF"
      id="f-1485"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="2"
      id="f-1486"
      unitRef="number">0.80</cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable>
    <cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="2"
      id="f-1487"
      unitRef="number">0.80</cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709"
      decimals="4"
      id="f-1488"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib329923cc251490aaa6a0d138e44e584_D20200709-20200709"
      decimals="INF"
      id="f-1489"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="INF"
      id="f-1490"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="INF"
      id="f-1491"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      decimals="-5"
      id="f-1492"
      unitRef="usd">300000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      decimals="-5"
      id="f-1493"
      unitRef="usd">300000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <cutr:DebtInstrumentAnniversaryFeeAmount
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="-5"
      id="f-1494"
      unitRef="usd">300000</cutr:DebtInstrumentAnniversaryFeeAmount>
    <cutr:DebtInstrumentAnniversaryFeeAmount
      contextRef="iae49b5f0167c4c098a4473073d17fb51_I20200709"
      decimals="-5"
      id="f-1495"
      unitRef="usd">300000</cutr:DebtInstrumentAnniversaryFeeAmount>
    <cutr:DebtCovenantQuarterlyMinimumRevenue
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      decimals="-5"
      id="f-1496"
      unitRef="usd">90000000</cutr:DebtCovenantQuarterlyMinimumRevenue>
    <cutr:DebtCovenantQuarterlyMinimumRevenue
      contextRef="i91404ecb3ed84886bed8c4364ec3ccee_D20200709-20200709"
      decimals="-5"
      id="f-1497"
      unitRef="usd">90000000</cutr:DebtCovenantQuarterlyMinimumRevenue>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i51590e3866c44f098a65564cb2ec8b38_I20220524"
      decimals="-3"
      id="f-1498"
      unitRef="usd">230000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib581b45783164777b7e88b6c201257fc_D20200422-20200422"
      decimals="-5"
      id="f-1499"
      unitRef="usd">7200000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i11f3386c03a84affa91cabbfd26c26e5_I20200422"
      decimals="INF"
      id="f-1500"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id4c7536ce80e4e06b2517e9f76b4751f_D20210601-20210630"
      decimals="-5"
      id="f-1501"
      unitRef="usd">7200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1505">SUBSEQUENT EVENTS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accounts with First-Citizens Bank &amp;amp; Trust Company, which has assumed the deposits of Silicon Valley Bank and continues to perform asset management services. Approximately $305&#160;million of the Company&#x2019;s total cash, cash equivalents, and marketable securities balance of $317&#160;million at December 31, 2022, was at SVB or SVB Asset Management. The Company&#x2019;s funds held at SVB or through SVB Asset Management were either (i) US government treasuries or money market mutual funds held in custodial accounts at U.S. Bank National Association ($198&#160;million at December 31, 2022) or (ii) cash sweep investment funds where SVB acts as an agent for the Company ($107&#160;million at December 31, 2022). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed its receiver. On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank &amp;amp; Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank &amp;amp; Trust Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no other events that have occurred that would require adjustments to its disclosures in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-6"
      id="f-1506"
      unitRef="usd">305000000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:InvestmentsAndCash
      contextRef="ieec1fb784aae4900ae4e0cde895dc9e0_I20221231"
      decimals="-6"
      id="f-1507"
      unitRef="usd">317000000</us-gaap:InvestmentsAndCash>
    <us-gaap:CashFDICInsuredAmount
      contextRef="i94f427bfbfd74894b34c8a26f7658e98_I20221231"
      decimals="-6"
      id="f-1508"
      unitRef="usd">198000000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashFDICInsuredAmount
      contextRef="i3d6b6a127ff244979a92a75f9e174aed_I20221231"
      decimals="-6"
      id="f-1509"
      unitRef="usd">107000000</us-gaap:CashFDICInsuredAmount>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1510">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II CUTERA, INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;AND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;QUALIFYING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;For&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2022, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231"
      id="f-1511">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231"
      decimals="-3"
      id="f-1512"
      unitRef="usd">40485000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231"
      decimals="-3"
      id="f-1513"
      unitRef="usd">18153000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i721d0b37bff544ccbac700969a1f1398_D20220101-20221231"
      decimals="-3"
      id="f-1514"
      unitRef="usd">5520000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i12c9297e011c43528e40adc29971dc4d_I20221231"
      decimals="-3"
      id="f-1515"
      unitRef="usd">53118000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231"
      decimals="-3"
      id="f-1516"
      unitRef="usd">38321000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231"
      decimals="-3"
      id="f-1517"
      unitRef="usd">7503000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifdb5ebbc0f2840ca8792db1bd24e7049_D20210101-20211231"
      decimals="-3"
      id="f-1518"
      unitRef="usd">5339000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idbaf66959ab14c7789e42bdaa2cd69f7_I20211231"
      decimals="-3"
      id="f-1519"
      unitRef="usd">40485000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic72b182a81cf43ee99eb4e8a9d3ec1a8_I20191231"
      decimals="-3"
      id="f-1520"
      unitRef="usd">32350000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231"
      decimals="-3"
      id="f-1521"
      unitRef="usd">7986000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5d736fd469ae4575a07108608dbeb007_D20200101-20201231"
      decimals="-3"
      id="f-1522"
      unitRef="usd">2015000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i83af4225c54e407a9cf601bc3e1a2d3e_I20201231"
      decimals="-3"
      id="f-1523"
      unitRef="usd">38321000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7debaf31c58640479aa03b97de9695a1_I20211231"
      decimals="-3"
      id="f-1524"
      unitRef="usd">899000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231"
      decimals="-3"
      id="f-1525"
      unitRef="usd">1787000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i09714f8d0c714f48918c0d9b35bbcde7_D20220101-20221231"
      decimals="-3"
      id="f-1526"
      unitRef="usd">189000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i488403d682ba4e59b493908691cb1e8c_I20221231"
      decimals="-3"
      id="f-1527"
      unitRef="usd">2497000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib21545b587824019adbfef02bb41d281_I20201231"
      decimals="-3"
      id="f-1528"
      unitRef="usd">1598000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i9dec51418121482fbdb4c18abe975265_D20210101-20211231"
      decimals="-3"
      id="f-1529"
      unitRef="usd">271000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i9dec51418121482fbdb4c18abe975265_D20210101-20211231"
      decimals="-3"
      id="f-1530"
      unitRef="usd">970000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7debaf31c58640479aa03b97de9695a1_I20211231"
      decimals="-3"
      id="f-1531"
      unitRef="usd">899000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i5d09091e9bde4c10a1ae5c4f5f4d6337_I20191231"
      decimals="-3"
      id="f-1532"
      unitRef="usd">1354000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231"
      decimals="-3"
      id="f-1533"
      unitRef="usd">2144000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i8e0e50296e8e4887b3ec53a5a6ef186e_D20200101-20201231"
      decimals="-3"
      id="f-1534"
      unitRef="usd">1900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib21545b587824019adbfef02bb41d281_I20201231"
      decimals="-3"
      id="f-1535"
      unitRef="usd">1598000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>116
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MCH^QJBD?2V(E/KT#GUX]/J,DR4B$GNB:"ZD#9=:1(M/A]8U534%9$BN!ZA]
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MA>]WC>9X3V\4AJ">7NS?H"^P'?HST8\YLZ2'NPZZ(V_IB@N*[J*74#^+K48
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M_O"#N2W9-(K&T*)TQ7D0VI2ZF^:FMX*T#F;_*(0^&_: KELG?P%02P,$%
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M6.)W!2AK@.\74IKGB6U=[9=*]@]02P,$%     @ _8B'5H[O$C6_!P  >2X
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M.@@@HT:@:C&4FCQ6>BR#[%SF%<>*<7SHB&9**)ZK$Q_KX$#UW*P4JA,?E,Y
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MG(0FFD ZB;V$FS9L':.N5HXUHF _HG1=,\@.<H*34_E)0Y=-0,[P<AQ]4BL
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M?=-5S3K[:.NJJ(Q[\:B#_?"M1X6L_8K7/CNP]NE9]KMMNHW+?FE*4Z8+/ )
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M>'8)9-(TI)170)39:[A_$M*G3S Y=/K3C$\ #Z,#A$2!I =B%V0B.6"?R0T
MF@H^2 ?:+^OYUG)2"^1^>&5&L4'XBV,$>+ZM+3G:TYJNM6XGP/*1 @;S\A_@
M>7M'!41LO^U9\X,)$BP%W# ]K_9"XW%I584*S(2=:..:9%6UC=8^'G2;DLS4
MA: I"@PF^\+=)+=<#6.C4>"+"I8M2G1^O E7DKFFH:MMCJ*M,-45F;\@A:[R
MJJ95*>R"(411&M[[VIBZ/.[L\18E-PJLTBP[]1#0#= IL)]W'N]>LJ-HN8(C
M0_.?399XZ:B-E45$9*O4SRP0>,P"S"3AX.T>MAG[';I@'B)3@.(AQ5X:M-E
M;<4;J:L5Z!.PV9*KF6<?K:TEN"X(IZ,ZT/&8AT##!!4ZVLMP\:"""D>7AK$U
M?Z9!V,U+2L5TP")_S9L>Q3\G64_PH_P0I9/5-@=)AP\)CVF7H46WLB1CA&(6
M>;!BR($"X6^;^WG'*>A@\,-U$T#CFR1N\A1P#/@^)@H8$ W**(:!S0*$ K72
MN@<H0%?,L]_L-29T!EDY?V,E"S[\;D B(],>;;I[P"-66\!0GL0]R'UU+*@V
MH.4S3OBX#1#6,5G^FB$TL@S::W7EV/BZS86FVQCADSU'?U'\_!^@=<4 +$ H
MDLD4I#U<ID5;2G,%!3;6P:P,T;:X40B8S6[G.3*41WQ''WO>(K]M\,HU>KS'
M=K4*H9-\C>%FB0<%I%QO#)UT3Q=2&B _,O8ES@^ 4K[DHE^#4$>^>2HV!)@%
MP1P CA(5_Y14O#<=T*7_&[EQ6H>+<G]Z=O+P6?8ZAIK>M*"?,,AYG%V2J>XS
MR/JA3\S;K,3P1J<W$=-CABM4:%]?F6&40>L(CAF)O(G\6$5[XBX%*C)GANC&
M9=@,W<"2*"/+T@RC:N0?XBGYNJB:!K4)>NU,.$Z5,/2-76)\@2BG:G9]YT(\
M03(6V3O\_^S\P!GO/$&(UDZ?80)ZDOJ2ZVR2&!U%AU>&#)?N&B.W#-PI/<C_
M/N,7IR.*P9'1:E:'B%!*MR@!VA"68R"\:@3;/(;#*,%.+(][_I.(6@+3;?\)
MZP6M=ZU55 :<#4O1R(0>3.$>OC).%A)'#TC,>?L7)"9ZF<J@V\6]Z[T<UAN,
M7EX=W/)^^FV<Z)O4=SLK42XV(B:B$B1\@K'+ANXMXN>GX],S+WVPB :#09_S
MF^A1_/CXY.'Q@F)6J[VW:Y4[@SA/WIOY1&8G=1.@$S@0(M@/TMB+&8K0@5!N
M"M(7ZG:583C-8WSU#!;2?S#SP-FH?7"%Z8Z6QN]9HW-L@RXKOP$7\YK<? Z\
M2;XC;QJ,LT2R]5$R<M)[R<C(PZE5+4X/!UU83=/&)#OQ4J<M+:(;;V"@<<,B
M-K6X3J<H4+_WKZ"XH.[0USA,;V<GQ^!2OT;+AC8&,J$_B.TO;2-A ]KL ]WT
M!R$8(<?'/YYP[OXUG.F*TL9,3+^9<HVX\LM>^F("O*!?B"C"43]<PT<<(?>J
M]?3)0U)]3BA=&R&>S N"CU0\&V=*VZ&%2-3N681CV(3"(CT7&" ;_9F+R3"P
MHDWM1ILE6O5+\,&"S&&,(\>33%-KKTQ.]6QB/%+Z =Z6+?&B?6G&!ORP&%"_
M!0*^JZD]@@I"XAOZQHQ*+Z0=(##>'VD#>+>T\BI2&>7L,58&VIP($=!;]9AP
M'RZURZORF!(DE"9@]O!N.KHWA"@W>:4BF0I-+4&*!(*Q0#"24HD!PU Z=^O9
M4/?UG 1%'8+F":"_ZVI)J6#YE@MLE%;Z:7?#>U@.;NJ:"@VJ4& V>4U$:J/C
M$?C;'%6N@"&Y):!)=(7!033>[Q''*XHZ3(I4=8\G!=6,^MJAO..W!CY%#*L8
MSDR&@Y ELALZB4K,CL3=PI!_S@6?*3SO3>?5SP,,<#TD@!8,4(CYO1U%X08A
MO_= =O\.2_G@H/A[_C3Z9%@K:*[1OJIK\DYH!Y9T'%Y'&M[#8N%$LS2OGNQ,
MH4L+.,>WV,EGNYOS %K*X^ZN!PMEL 1%)OY7A+UVIS])UA@38V!6$Q#^,S*Z
MZ&,,X?0[=@O)@/7Y[];6DA[%0'T98]U(9:'2Q:JJ1>8\MHF93D6)NQ !"'D\
MR@F3M::OB='G1.00#PM]@^7!^AXY-,"$6=T$H.FB*YWV5/EGD@(._NTHSF J
MTE=4:T+Q&90%'9*Z!=N S 3X-.*5).^AI8.4\6@521JQ%?<9B!],!=Q0P@[(
M\NGWL^ST]'NBLM,GWU.R,%BRLT.%J)WM*+\D@(JQSG%5C+&7T<#TI?;,JK0/
M6^R:938@$[THDKI2BG!04G\M5"P)'LYMA.+7R7SQ/'O#,(%<7?9-B9<\6C -
MRX1X IXF)@:FUZ<:4%&1!Z^H6JDH ,;3FJ([0#_3>ZCW<+$\7"Y(XR;DP(."
M]MF02*[(W%A"@=H)/B6]S.8QW++MVT+K9.S'J5 DA]"GA K\KAP%J:8I(N3;
M;&1T!91FHN&Z*"P\,NL8F>-8)QZ.098=@O$]NL]IW!XD)\2A+]^BHLP6,6RW
MRZK)M>,6:]T/7/0S!H?WH1NTJ^Z:JBOAM T@Y8$735S6B540TVL]#&75.66]
MJ-0D>Z#JE]$(;8$!R.&1-'I\% LY.F; B9K94&2IZBHHE$U"@C*'K!O<F)'N
MCU?MV'#ZYP!$PZ*.^/UV:ZCN3:*C(+6K-KF3$3 ^5AS+@+ 4B6,<^ ++VY6^
M*81\T.L@MR3NV$%,4IE$= )'AZ>K-VM*M!N,(A;&\]/RH+B8BSL#*]R"LT&U
MK+K(6% <-4Y0 5/UUPB=?Y1JG@ZKL0DEM1BT =Q"KQ.4&$GX#OJC Y&)#M9(
MR98A7?8Q%Q-)\9@4M[G#PCA%S-2)WK!'(V@F61F5S/2J PU2<S4UDX^JYDQ+
MG8(+!>1 S2W3B_MX7,V5SP<+J"2!HNF8ZWXX#I-V4:06 COL&#U'1(.5=X.H
MX9B&%UTKL*R9C#92'N3C69'L?8>,6(,Q<1'[EN2,T7"N,78(6'^?=Q+__*B5
MX,+?O]!9^/\V&IB^C: <MP_HTNO1E[YCA2[@IN)RMM#P<N$I6H).7",D]K )
MTLV7V2/B^J9"5Q>PQJ7<!<:16P[XK'(J9<_J'#\"$F.9G?2(@>/6UU)%@U:Q
M%U!>C5 &$Q,V5[;N,))-A>I@XE=%VI:"U('U3[9-FH+(<?3F5=H<1%=Q)VB(
M;3&\V%JF>$#88,9.1RY<,R6@/Z*[Q[UZ]*\W+;,&)JD2@ "G00KB:I7.[@WD
M-<EX-VAK4B4I7-"O93[=WM(XL)HJ]AJJ5GK(L$@MU14[,) V6!4GTH5\"LQ&
M'P>_C3S8M.$JMNAYR3C:9]W::V+9RDEWEAF>XC[-691H,L*;H+TVU@JP85$M
MGCBOG;'=1T0MH02L#$^Y2]J^&'X@#+]]J"'&S(I/;R>1I4"SK=EQ53INR=U2
M!^2<)"E'1E/EB(/66&DE%N,*7%J&6#*'W128+,H]DDAO<(M 3;@$Q7JLD>VC
M-9R6Y$(I=-3;25?6)_<"6F->QK.O *OW\>K9%D7?NKB(-]G1 MY4NUVLY0S&
M,=KM_O'P89#::I&9%#A1RHV?;X)P'4CL>?9W7%-2DIYE*HDQA&PO\7I>7OER
M/MIVQX7!^9X;*;UTC4>=1AS' $C<=!P$X(37:$6Q-UE9BP*5IZ<I:.*^?>O'
MX%)U^X<[!.A "N"]^,H;_%PMD4JC;K_#?'.]C[<3D(0N9>>T9K&^SF!DPWNQ
M=WZ2E?G>:1CFV:5(\;2<4'>U).8H):5#63DZ40(16;#S:![\R\V'4(W-A<A2
M=?R-QD1BS/M..NXB2);-@\N=M#ZH5Y+#*^/;J;I;QA/O>O#P*6WA9D @ 2/1
M^>%C4#6XMP_%V 53&:3M,3;/:V-/]3*/MA&E&3)-^FFLT[0X)(+D*R@ ;B92
M;:@'R/(6Y ::^$M0FM)7$GMPJ9F6HRN3#9>)(7.P>?<F,]:_%5HXTT?( __G
M^W,!BHB35#&JUO7T'1_L^,MM &PQ#;8,3:JEE!^B(M_'>[HMF/&-#>#B&9(H
M4(KO8,OW8M0^K*^>VQ&_H?>X:K@34(R*T??TAU"-6.OYH?5;B:_4)!+\$ #
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M--Z SG--O=&^^ #=/Q3C?P%02P,$%     @ _8B'5FT V(I!!@  / X  !D
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M60EB6FCY3@C_-8&SXV #G^LCZ%LA0F8$C\PUSPE<8)!0= T,R%)/"8"*'E;
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M&D\-\'Y>54UW0P/TG\R_^3]02P,$%     @ _8B'5I;NW[BP#   S2$  !D
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M9 M5,$" 6-NU;8NP<Z&N*3H5.57SKH[<,X=WZJJ]7N$"O4=<[/LF#0>H2TG
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M_WC 7IAJPR_L%Y4QU9I_KA2 K*8!>+ZL*M-=T +]7W"<_P]02P,$%     @
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M3$#G:TD3J_E@ =TK].I?4$L#!!0    ( /V(AU:+$2OP"P0  )P(   9
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;)56:V_;-A3]*X3:%2V0VK*<M$%B
M&XB3%/.PID$>VX=A'VCIVN)"D0I)V?&_W[F4[3AIDF& ;9'4O8?GOCU86G?G
M2Z(@'BIM_# I0ZB/NEV?EU1)W[$U&;R965?)@*V;=WWM2!91J=+=+$V_="NI
M3#(:Q+-+-QK8)FAEZ-()WU25=*LQ:;L<)KUD<W"EYF7@@^YH4,LY75.XK2\=
M=MTM2J$J,EY9(QS-ALE)[VB\S_)1X ]%2[^S%FS)U-H[WDR*89(R(=*4!T:0
M>"SHE+1F(-"X7V,FVRM9<7>]0?\6;8<M4^GIU.H_51'*87*8B()FLM'ARBY_
MI;4]!XR76^WCKUBVLGW<F#<^V&JMC'VE3/N4#VL_["@<IJ\H9&N%+/)N+XHL
MSV20HX&S2^%8&FB\B*9&;9!3AH-R'1S>*NB%T1G-<%*(4VN"4],FNNI22S/H
M!L"S4#=?0XU;J.P5J%XFO@.E].+<%%0\!>B"UY9<MB$WSMY$/*.\(_J]/9&E
M6?8&7G]K;#_B]5_!NZ*@'"&E@AB3@>7!B[].ICXX),??+UG<XNV_C,<%<^1K
MF=,P045X<@M*1A_>];ZDQV^PW=^RW7\+_?^%YC^@SK]-+L[/Q.F/BYNKR?CV
M9O+C0ES^?G(A)D:$DL1MY[JS%U>GMJJE68E2>B&-H*K6=D4DO%PH,_>B!@'Q
M\<.[PRQ+C_?3WL>[3Y%4/.D=?P*(#.*^D5K-% $#'RX3<@ZV>*E1^D(Z)\V\
MC42#9''B>EVE:T0[BV0F)I S4HLK6I!IF%U!'7&NU5Q--6W9>93$"M\[$@NK
M&Q/XDGS';UX$&Q%W&(NFYM->FOZROD\YF&Q ';H5VIZ7K+N'CC7]!_Q8V@<9
MFF#9AE92JTJ%*.<[[$U.U9BP/4@4O$B?.K:2!8E"^=P1:_W,M'7(<[)@^#[M
M'* ':!U)8=??[.)5.,@>7R,?:XHM3Z\Z AULEP0'J_?UV(O?)+;(7#;1JT*!
MS1['ZPF];0ZXQ_J):< Y,B5"EL M4ZW0AHKH!%D4JG4=QH;PMJ)-1)\3L#AT
M+(7V:1Y9('.>>JV@VGJNUQG<X]$D0RF4\0WR**<8+FG62LH5GVOIPDH$AP9*
M? H6RB!\<[M 0K$%GRMI,'4*S(7<(F,\1\$KR,.Z",_7.[IOUB9[-D';G&,N
MEPCVS;-JF35:KR(_H.)" +L&2W8!,[?PT+S-%*X*H*&_436%_9L>MQ<#V5ZL
M98 R/7 >4@0AF9<;/X;2(2 KDL[S'B&(URX!;&P0'MY$_>72A,Y+K:B[,S$J
M<O,X%]D%\$0[/+:GV]%[TDZ<1_%V;G^7;HY("$TSJ*:=KP>)<.TL;#?!UG'^
M3&W -(O+$G\?R+$ WL^L#9L-7[#]0S+Z%U!+ P04    " #]B(=6%J$#DXL'
M  !2$0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6RM6&MOXS86_2N$
M.^TZ@!KK_<@+R,--4VP>B#-=#!;[@9%H6X@DNB05)_WU>RXE.4XFDRF* D%$
M4;SGO@])'ZRE>M!+(0Q[JJM&'XZ6QJSV)A.=+T7-]:Y<B09?YE+5W.!5+29Z
MI00OK%!=37S7C2<U+YO1T8&=NU%'![(U5=F(&\5T6]=</9^(2JX/1]YHF+@M
M%TM#$Y.C@Q5?B)DPGU<W"F^3#4I1UJ+1I6R8$O/#T;&W=Q+2>KO@]U*L]=:8
MD2?W4C[0RT5Q.'+)(%&)W! "Q^-1G(JJ(B"8\4>/.=JH),'M\8#^B_4=OMQS
M+4YE]9^R,,O#43IBA9CSMC*W<OVKZ/V)""^7E;;_V;I;&V%QWFHCZUX8%M1E
MTSWY4Q^'+8'4_8: WPOXUNY.D;7RC!M^=*#DFBE:#30:6%>M-(PK&TK*S"A\
M+2%GCF9B@1 ;=M%T";:1:@IV*QY%TPIV_\S.A5PHOEH^VP\W2A9M;O3!Q$ ]
M@4SR7M5)I\K_ABK/9Y>R,4O-IDTABM< $]B],=X?C#_Q/T0\$_DN"SR'^:[O
M?X 7;((16+S@.\&X%2NI3-DLV'^/[[51*)W_O>=OAQ:^CT;MM*=7/!>'(_2+
M%NI1C(Y^^L&+W?T/; TWMH8?H?^SB?M0U?N.S*;GE].K.W9Q]<OU[>7QW<7U
M%3N^.F.WT]^G5Y^G[.0+.Y]>G]\>W_SZQ7ZXN;T^^WQZ-V.#Y6H3Y5+;SBH8
M?#!+P7[Z(?5]=[_F#7C!KN6KE9(\7SKVD[?/YK("GY P"=3"+&6!(3=L2PI<
MQ9OR3Z'MHE-9KWCS3 A>LJ][_?R^$DQW)FG *K9>EOD24RNNN!%L7C:\R4M>
ML7(KU#"YYH5@_)&7E<4PTK%Q%H^\:B%80,&BK;BJGI$,QYJ0+TLQ9V!4()/M
MA<A+2V\U?Q *"AB'6WGW$:&6K<IA/<'2-ZV%UO0) -:4)A>[[.X=W[ZC:#PZ
MO3Z['.V0&R7</K7+IT\B;XDDV?5\7N;=NNGU:,=!3*05U1LD3<GZIK7?,/5$
M+,JFL2GO,CV'C%FR/UJN#/3)N6UE9SM?E!Q$$A'M;.V=(@O*QDAFUG([E?<M
MU$+W)J=[;%SNL-,6^!R82E@#QR4FCQ_+TTIP13$L]4:1;:6J7#3OU\U+5+_2
M!?*&-R2TYL^=\/0:UCW29K(-]J]7?G#\40"QDU (;*7(NA;*EIW"%H;N&+Z\
M-6=P AM<@RK$SFQL\1?0F@L*]/%*E94-[*MB0==PW:J^.U[*O#-$DSZ*]WMM
MTMK4\H8R(%0#H:TT#[A=.XJGO&H+*#D7#1RNNO(HL)65Q*RVW,03SA@HF%WV
MA1RQVP,#N8OZ'D4Q$#S]\^B?R\9G:'^N=%=&LM4 U3OL2A"K=/RWG?!/S \3
M)PL#&@'.3UR,/,S%:? 2P- )H]B2C^?O;YYWTL#J9@L:()'O!%GV+MQ%@]P)
M-JZDADES)>OM5+\QRW72V,<@<!TO]3 8ATZ2Q2^ER<9^ZKB>O\/&F1.&T<[&
MKH%&RP_UC1/'B]P=TI0$\0;^PHA:LT::H841</32)L$S(_.'GSM2!CREI^N+
ML8<HN0 <>X'C)627!]O=;(=-;V]86:\JR[W]ZLSQ/8_6.&&6VJ<78.F9P$:"
M8MOL6KRFK>#/7BIRX")60T.:VF>6)COLWVC.BLV%T XL?82/J+:.="5*6!%\
M['9JW)">/KR%X"DB(:NRL&Y^)UY!ZG@9_/.<-$"A@8Q2'U 75.A"FRUM U!?
MO6!)*I)QZ#L1Y<MSHBB"+TGVH0'W8DZUT$\:_H1601FDR)<+%)2&$Z013?D!
M(D_>\%5)):FAMJ ^?%U3GI.D5(]AD-HW/\E>J@EED'DIBY+D37WWF6?Y6W $
M(,Y2X+A>U*-!$2B!]L:WO?(:\RNL3P/:IQYOL*];3YN&>=LB7A0Z64(B28QF
M<;?:-4$\8A8[0>B_\:)' E<@>"%+ P?#+;L#+T6EA,S+$L?-O-?Z/[&(PI22
M3A]Y\#-PA*7#KRF)JH%HR6%9MIO^:-\Q<G^DY95L%C]7(+AB@%X+FVI+N)^;
MDJIA9FAG<XAU5\)>4:KGCJ:WCCB6?>W9BYJ3#U<H4J)>SGN+S7F/CC&DXYGB
M)-ZG4Z?CT]X#E/HK+MW[JU0\G#?K\NF5#7NO':1,NDA81!R<Q4[L$WO&2#_*
M]#>._8C%2#0 $T0\B%"^CA]'"'S)G7X3H5!T2Q'P- F8AVH*,P"C5Q(V;14:
MV7)JZB.UH$MD&(R#]KFEUNTW4%P3J\+IFQA[5/,V%:33QJ5'#!(4J<<"%),7
MD&X?M=&7^'9C_[7]X4W 5MVQG!$'+Z1"W&;/VK(S1.+ B8.$1D&&D8T=G*6X
M?+QI$>&T-96-9JAUWT6P8K2+Q\#(:<)F#R <CF(DMG)=%@(^SF"WX\9#.PR6
M#6[YV(FP>2# $>)-T8\<#P&9X4) )PWP4XQIS$9Q0IT>P>^_':;WKDB3K7LN
M3D<+>YO'85>VC>FNO)O9S0\&Q]T]^65Y]VO#)5<XBFI6B3E$W=TD&C'5W>"[
M%R-7]M9\+PWNX':X%#CQ*UJ [W,IS?!""C8_HQS]'U!+ P04    " #]B(=6
M,]F-6>$2  "F-0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6R]6VES
MVTB2_2L5&N^T%4$=/"1+OB+4LCVK75]AN6=B8V,_%($B66T08*, R=Q?O^]E
M58$ >+2[9V*_B 2(RLH[7V9!+Q^+\IM;&%.I[\LL=Z^.%E6U>GYVYI*%66IW
M6JQ,CE]F1;G4%2[+^9E;E4:GLFB9G8W.SR_/EMKF1Z]?RKW/Y>N715UE-C>?
M2^7JY5*7ZY]-5CR^.AH>Q1M?['Q1\<;9ZY<K/3?WIOIE];G$U5E#);5+DSM;
MY*HTLU='-\/G/T_XO#SP=VL>7>N[HB33HOC&B[OTU=$Y&3*922I2T/AX,+<F
MRT@(;/P6:!XU6W)A^WND_DYDARQ3[<QMD?W#IM7BU='5D4K-3-=9]:5X_'<3
MY+D@O:3(G/Q5C_[9\?F12FI7%<NP&!PL;>X_]?>@A]:"JWT+1F'!2/CV&PF7
M;W2E7[\LBT=5\FE0XQ<155:#.9O3*/=5B5\MUE6O;XOETE;0<N64SE-U6^25
MS><F3ZQQ+\\J;,$'SY) [F=/;K2'W'"D/H#"PJFW>6K2+H$S\-8P.(H,_CPZ
M2/&-24[5>#A0H_/1Z "]<2/P6.B-]]![;V!#I_[[9NJJ$C[Q/[N$]"0FNTDP
M3IZ[E4[,JR,$@C/E@SEZ_=>_#"_/7QQ@<-(P.#E$/3"XBZO#ZVX_??AP]_7#
MVX]?[]7-QS?J]M/'KW<?__;VX^W=VWOU_NW-/3^,<\:HKPL#2R]7.E\K"\.K
ME2ZKM:H*E9BR0B@K1'VIZ0GB%3.;ZSPQ*O/*0RY0#V9AD\RX@2IF,XO?1"/R
M-)RV1$"KF4YL9BLXTFE[Q[_^Y6HT?/;"P8TK4UJ=M38+&R0%HMY5(-VA/E#:
MJ4=$,#^W=]G%:HN2KA%,Q=2"Z?#K;K;"2L0 N,JRM5KH!X,$Q!1''L'TT@EK
M>5>3J>%/,(M3%MMQ;W$Q^8+%5+005[I2%DRNF)A.U:>N^!#.F1".F=731KJ2
M7"3%/+?_:U+2J!9!3NRP1 PGAH&L4NAUFVJ;5&G$<7-/(GY_T%EM*)A?L-)K
MGQ?RHE)KU(>5MNE>;KLD2R9#^E/-)W)5(QN4V5K\B<^+<!2(&355]0H)FNN*
M TSK]%?D0SQ-]\-F#7^XU$E2UOBIR_D 6L9:>%AJH3D:PO&N?XH6R%D3<(?L
M6%C1EJ)!&G>GF/"88F/G/ZR]@:R(_F)<91D#3NZ"G5+L!W:=2>H2XDR+$MF#
M3)3R7()KXZ"L5!RQD(4@49=>1=B]\8FN=P=%BVU JK4W- \1'C34#)H^?*@R
MU.AO1GPWM?13: D,XCN4I;,UHLJK;8G+N7>\7^MTSB_8V8!,U5(Q'2$EQ[,Z
M#V9:%)DHO2P>3"A 70]_7)A<&5WF]':LPNYU8MHJ;&)6_.VDF)W4T51X.M.5
MW[/1B:B$3V CO2S*2O:I%F51SQ<;Q^T2TL[O+$J@BLUW0"+\#+[+5@S2*4Z5
MX!PF55>O5EDTZ%1GDI4\T+*Y1U,>V#1LAL3SU#(6BMI!9G?\7/T75.#+J4(Q
M-,LI=HT%D7^&ZL:'X&T&ABW2I:?\94L4MQ6\V^(Z]40-1X.K\9!?)H/+T3/U
MKIU3U>>2L8%R09N8WVJ[HI #E4.RX>#R_%*-KT>($\HM*](6Y<E@,G[&+Q>#
M\^'U#\CVOI4!>@(>RG '?H,?UP@CN.<A D\4E# \E\\).#U(,"_RDQ\@ZG4$
M#XK/KNB"D&0X'(PO1FHX'DRNQD%UAYF#(H>7(Z_(Z_/17D7V5+;1:]>F;>)[
M?]DH[B:FVPY/DZL+_+VXF!PBT5$5@J=469'/3Q@\'7)7HPOU;'P>E+&?6VA@
M,!8[#0>CJXEZ'^HA$KU*D1>9)Q&B%6 #JOC2@U.SQ^/HT?V[PS\1D/ASWN.9
M'*D;GW.\+6(:>:(N)V-1WX1_QWW;R,J['!I"TI;BU\$X6//LDGJ_)J7QEM_(
M\O[-S=[CP<7EN?^<C.1S].Q"W6JWD(HE^R%5ULS/2.=93;&MK]9+T*I]T=H4
MOK9Q_D4&>#3,U\2=&9+KG\F08I"-$A**-V.B?M=7Y155>>E5Z7\\O.!B1.U-
M)!8OD-IV;=+7/G/*Q>A2M'U^/9+KX?A:?>A4\FUU=G\_A)7Z&M.R8ELY?4W>
MB*7YVUBXFT Z7$S X/6EZ/*"7\?R]9+LHSR,^&<,"<Y97DNC9_!5J&32+@(;
M0,2,-;Z05N0YZW]=B4<%_WXZ'#Q[-CY&E=D)JW9FP;_[7D2%WNYFM[!=\/6H
MG:!F6X7J"T!GE_6RSVV[UXGE3-!L*V])3J-79'H*-GHMR ''[:J; 2C*OCR?
M!%5?7^S1X6 R&>Y7X7CXHPJ4W/D/F5V8] 2-CO14FV9G VTD-E/K$F&9('*P
MSZT&??]['M+RUTCG3:3SA6#TQ_9_ND:8N^-^-#EU<=I+MDZ-3L?;5#O,;Y.9
MG#Y3_]8G='DZPDTJ&GYPHFX>[&W&;!/N #B;O.ZV@6$EG:UY/#4/[&+98,M,
MQY0N0-K$"#S6\)KO@G/SFN;&T\S/,]."F:*% /%U6>H\P&Y/R#/21KV(Q##9
M@:A$G.PHU@&Q<@[@.X38IG+?]A:A[YF7QF]C*1,NE-A!/=IJ ;;1!)_PAK37
MJ.KF$61FAID*]&_#.*%'R_T4NFC+,IB F=A/"RG$DIIZ>6$-BL/-BKIJM2>H
M7SJKUKX'J3RJ;\A[@)^(M4/#"&=$'R\-:-NI6MMZ;30FZ[.\FV9_=.&)[+6E
M=>T&AS;+UK'_H'S24)K2%ND^*W"2J3BZ$N3.(1!;.QLV;FS>.$1WQU"XPQ8;
M3X!NO,?ZY""CH. T?@%DE-X^T@]R2GA+B9?,YT>[V"D0\^EM1ZT"DD 0=  %
M^D V61O&/:O4N,25E%1T8$5F4_$)5^$C3 ":'=BB_2%X<.#'X<89MFOMQJ:1
MX2?J>L1:+DWIZ,7^Q7$!(-=XTCSN\WRS:$,5+9, DN;!'8EE:AKRJ=A2L^&>
MU?2^F61_1WH^=+N# 4+!I*+!-%)))/AHLXPQ&$C2VZO'0@Q@DIHM?2N*7!Q&
M =9QKT>4RX6R,A5R-F40^"H4J=IEG/WU_<AZSXG%>%8SC_2KW]ZRXPMSKQSW
M0Y1E"XX:@6G<JIT&VU7G8,F^' 9\Q"_>@M*( #9])C'T79EZ"PVG5CCO*)XG
M$TP3</WXJ(F/*KU:9=8G\JWQ*.[)8IDMX<*9E9::%I(%K  =-)/!%3)<4!LQ
MBPJAOGD8UN-%):EP>Z4?@'*)TPC:RB[C7!AI 4K*)5>A'KF901:]X>PC6< :
MJ]1/F$I\G9<Z]=,F+8.=$ZP_X9B4DR>QDZ2Q.*[I.SB3+QB:VCQ4@YWCPA T
ML:Z%QS>"@+Z/E&X>]VYS<W^KKB8C")#ZB1>'OUW0N(0,'&>&Y:2T0CY*@C'9
MU3%Q!N2U%<NA^W<Z"\/J0AI@!X5F>*S2WUE ;O7*PI$D7_M'!:<Z)\GM?NM.
MJ^07TRK@IC]8QG;-29L9;=)B2.XUD[-]Q6CW:,S'1YN:WT>2RR+4_GV=H2#*
M)^/3*P1LELG<?%<WW5#;S+/\RO/3B[BRW98>VM-C"UG>+E3WC?G\B)2D8C\=
MBE9_/+F[;G7+UG[]'$;9T,FXD2R:K,UO?\H2U/(CK';&EJ<!Q-L<$F292. 9
M;&>U#?LP19W-;.=)\,79#R@;V&D+;76.,3; KEE+F=2L%& _B(R(^@(.+(/[
MRXI_SN.B>H=H"_ZLRXW_12YW6_@CK!XV^F?<+-MCR]]QMN'IY/_)V3[79;(@
MC^TCZJ^=9&S#L5KKT#+'5M 16I&U6D4*28N"U Y"$YG/6S9B+*<Y!UE,9LNB
M8%^3IP((;%ZC]/MGUV+G;V;=JJE[3A!MA-%>;F*77;S8]BDC6_?2)B&3L\@P
M9Z<G<C;F 7L\OO!73OJD!PU)D9'A7*F=H0#3E(UL\-B,Z&6^\,IIV"C*5'I0
M*:LY0)IA5!H>3"1&RK$</YJY\(8ZRA.G0=.&MAG7Q&Z=,NE+<RR''HH-*&"R
M,&F=&>_E_CR/#UN6R-]J6X82Y<^JBH[/_(3;M>/AJD,=-9!^!264$2^D)@,F
MA2K@O/."RN$AH>]@Q*L$ I?$$E#*':)OF3=C<8<;0B7GTT@815TZ$SNPOG4C
M&[W#/$Y?Z.@TWJ;:"JH.Y[]P+UC+FFKM8SG@!!U.UQZEI_=3<CF/[#*)XI[9
M>0SB=Q#/?-?+%;79YH/@7WCQ$Z%BBTR+.8D%HX'5P0]CPI?_(@PGS/<(]?TA
M?+@=HXV18,! L3;[CM*1(0L)+(^PN 4UP) Z(!WCHLZ_Y<5C'K LNT+M@,BF
M63PV%1<5(,LH>R@X7 [=0I)INPRJ7^HU&PX/W.;,%E5;72VTVE<B=XW'RKP7
MA^!, ES1M4?GO9G^^Q6YYNAE5A9+@F<9 \FG[KQZX<&@A!R;X01.#HIPAM@9
M-VEE(+.^C)"S]@_[ [G4.HX">5##0EHF'M+%F]%8K5LQSS6-CWYTM65>NVEE
M,3]@\B@3Z:.<F^:HMDQ]ON(Q+;G]H4R_F>*T>GCJU0N?='0II\ ")0LGKM'*
M5Y!\VB2KUL0A#)"VG :;>T=E67(NCK5*<V+8H IS$@]M@.]G)1*1K=2D^19*
MT[NT3G0'H1Y:R<@NJ06F^U@KZHJL-W+6@ ]H@>_XMDC#[.9P7MY:43X0Y)V'
M(*UH C+218-S#Y"6V+[+5)#K.@\;%U72Z&$0=/IX$IIV_VI 6!T6]89',P1%
M5#'E";;VJ^0]HJEA0[@1 #&82_2(<P=)F_=^HD5;=D*^<'::!7DH8,?&!PSK
M!6HN/7&.:-LR<3<:!=\WTS#L8IK&\W<==7MZ(AC0FW1F_, _XMS-!#1H.)$&
M?BHO"3"&P"X<*8[E$&1LKEG2L>$\1FC52R?,3-0(6/ZM9LF8^9IKOE<![S'3
MK@I>B9Y;B6-&<PQ"LO'F@4I0FDL[C=$!-Y7Q')6&OM G.>YL\X4 #.B]SE=\
M&R2I&MNX>OHKFT<.).S<IW9P4^>A8/@7P>YFWA]F 1@M9800W_UPS..$!JCE
M"(UUM$J0GC:6#%!GJ9]*M+PI+%(&*"B102FUL*G6&V,V[[0(**FS_@0QY,5X
M?B>  >3CFM3,3'@#1T382ME456:_!?ZGOH'A+,$/QEB3?I_Y+O;Y<>9[O,>7
M=%@=L$75>E_G)\[MQ$>PG:].1%)Z?5(5)_AH$PT^%;5YNN^037;C[+1?4-.F
MF'9:<3Z.&TV+)4)Q( EFJ;'6<",BAU50?JO&R2RJ7R5;Q:SSEEYA? @A"*V1
MP98,/GM9J7TPT<" > Z^,V6=JD^Y^@^=UPS?H(_S@;I%I2UYO)/)K"\PU8"1
M]W55%KE-U U2U\)4-FEJZ"^YI>CWE4S1WEC?'T"0NJR:%O:M=C*":WX&O[=H
M=O%[;O7IAKZO_A"]AM:H1SD1*B-_/23'%B=CT&XSVD'^9L[:X@$767HZ/(8I
MG5X1E$"='MO)>!!USYFD#.W@@RVRYE?)KO[U39.2.-7T0CT='7>?H\!?=/+-
M5 :<W^6SK.:X( VO+I=EO:K4IW*N\]"C.W4#E3P]^G)W^^GH&!3'Q_Z<5!HE
MF7.C++<1D#@<5^+AR:Z'(5AT4(7:F!=+Z 3ABUR'N,*JBV/DO)E&4T,EPJ(D
M]T)8?'IYK+1-X_A4LUSB0CSG@T9KQE> @M_X8D131SBOT7JA\2SI7](MAF&'
M]'(0\NL7R'C(7F!]8:=68 U<4$*> 4T2+(O.R'D;;P2O@'PS !8I(P)$5^Q?
MP," 2]I&;4.@4$6$+9VYHMG8-5P-FB,%.9(8M)D1=-U^1R[Z.KI7!)OOY3AV
M%4F$$R9%OJ&'U4V72&L-FFZ%-D-)(H*-)["B]AM(E*GKMM:)R(D\49M7=><E
M0BC"MYBZ4ZMM_BNJG+#*MQF]@2/3,C/GPP;+9C./F,,Q+"SFF:CG;(4G<=;2
MRQF.?L;TXZ=&36QVZE+D44\+>5TY.&T:HK,ANB-HMV+LO<X7>LG8X9D*8I$G
M28UBPW$%T<D,YC6^>%761;\6O^!PE%;DW,OX(T,Y]9<NG2/B?%Z([W_D4;5T
M*DP";+VF!I _#@M2D=)'!T]=!NJ>DJ56#]3[][?J*7N,T?F+>%<NAR^.!T%]
M*RV@J,W)1H-N5U.X.5^0MZYR[0\#U%=Q]]MF]-YL???U-NX:.G?UR^G]Z;Z4
MW4[5;Y!N'F4D3[-(8+89I:?;[XW$01@7_>?>A]Z7=[)MN/I< H"M415H=(\X
MVL*ELON4_5]3:,AL062]T!E?N5=W[S]]>G.#-2@@57H*$*'^LT#-RU42&^>[
MV:!U;J<9M:R7]!2 M#(]\8VM3IH0;DO6A0>AE_''%RR2\7BU\$.#4-M=_S0F
MX"@BSJI8(4ZR+$Y9Y?PL$7 :5Y_N^N^,L];_SB IS.4_A 1BYI7_-YKF;O-/
M2#?^?V\VC_O_8(*/SCF.S,P,2P%J+H[\"[;Q CS*?^),BPH92+XN#'RJY /X
M?58 LH<+;M#\:];K_P-02P,$%     @ _8B'5MH'2[-&&@  GX(  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C,N>&UL[5UY<]M&EO\J*(V<E:H@B@1)B?!5
M)<O.Q*G,VA4[V=K:VC^:0)/L,0@P."1K/_V^H[O1.$A1MI0H<:IF8I'HX[W7
M[_QUL_'\.LL_%2LI2^_S.DF+%P>KLMP\/3TMHI5<BV*0;60*3Q99OA8E?,R7
MI\4FER*F3NOD-!@.ST[70J4'+Y_3=^_SE\^SJDQ4*M_G7E&MUR*_>263[/K%
MP>C ?/&S6JY*_.+TY?.-6,H/LOQE\SZ'3Z=VE%BM95JH+/5RN7AQ<#%Z^FJ"
M[:G!KTI>%\[?'G(RS[)/^.%M_.)@B 3)1$8ECB#@GRMY*9,$!P(R?M-C'M@I
ML:/[MQG]>^(=>)F+0EYFR7^IN%R].)@=>+%<B"HI?\ZN?Y":GRF.%V5)0?_U
MKKEM<'[@15519FO=&2A8JY3_%9^U')P.L^&6#H'N$!#=/!%1^5J4XN7S/+OV
M<FP-H^$?Q"KU!N)4BHORH<SAJ8)^Y<O7<EX^/RUA)/Q\&NE>K[A7L*77*/#^
ME:7EJO#>I+&,FP.< @F6CL#0\2K8.>)K&0V\\<CW@F$0[!AO;/D:TWCC'7QY
MKU41)5E1Y=+[GXMY4>:@ __;QRV/->D?"^WB:;$1D7QQ (I?R/Q*'KS\[A^C
ML^&S'91.+*637:-O78%;>KUY]=&[S-(KF9=JGD@OS4I9^%X*=IPMO"H5ZPR>
M_)^,04=!%*HH*I%&THNRHBR\CROI+;($3%*E2Z\4. +QEL+#$AZ"_1:E2&-\
MO,E5&JF-2#P8M$I+#[[W(I'G-_CT2B25Q#FQVV6VWHCTYKM_S(+1^;.B0>%_
M(H7>D4JA9585,$AQ_-3[;RERUB(/=$"NYS*W>H#_&>E^,4P"7>&;,^_=+N(.
MO;/0'P53^&,TGOG!=.C]<HLTCD;^=#H^]HXF_G!X?NQ=&MY^)=Y@Q'-_>A[0
MB!,_F(P[-,UNHRF8#&'L(?Q%L@F>W4[4F1\.9\>V?8>H8#SVAV'@#-FF*KR-
MJE%P9ZJ _^%T!U6CT=0_#Z?.D%NT]-";C,[\R31TQ/K63 ;J%+6[-53@;>K]
M2^31BE3$=W6/* ;J#V'U!V/PF4E"[G^YS.52E+(K!YB,QF3QP0P"VUQ1VP3,
M'F(0-EI(Z+@<D.TX[>>HP"HM)9@/F ;\S\NQ*XXZ"*9/O UH] TVVH@;,K1"
MKI5(TTHDR0U-ET,XS0LO,SR-IF1B'^2F9(. +V X*> 9CC3P?ME 8Y80AD<6
M@$/4-7 -E#6$"#1FGE30,@?K+5:^5ZP$$+W-=J-LO899( 1%G[PL![[@F[E*
M!853'$9F"Q\Y[NMMXB[+JZ,#P+3U.+!8HOAR9^9[3 XR6V2)B@6..!<)-:'0
MR$2X*I!%4L:%M\BS-?L[O;S>-;#EB0VT^*P@Z$M8(M"D\>#,:)(EJTT%:%52
MD:6I5)4*]&M3P6I"R@!KNY"R&'AO< 4/1V1S?6K86D55F*& BLY2CH>#T20X
MO\,J^M[U2@$%,*[\K0(-3U"S82CAZ!(2QA;8D@((830C;:896:9./])Z2!-[
MN"BJ^;]!'6BJ^-^0U9!)8=L(6(+4T9-7%'I #PI)3\J5IWA9%02'M,0@OLQ@
MKI0B5F.*CDV2^@/=V,FQ*HHJ9SXH5"(+D('($X7&P)*5L0]I9BS!WN$OH"V7
M9@%C,M,HRO*85OP:K(AH *M?%]V5&^SMR6;LR6XHWO7[,0@=@^'^?FS6DLGL
M(?S4CU4JO1%Y*1NU1RT?=0'+70)U\.UA,'9Y0-W:DPWO6A1&$K=X9DY+LC2J
M@,ZT!)KU,H$"=GHU12U)+#';E;!V"U3FDB>AH7X%KP$.+\7VJKSQQ&*A$D7N
MAI[_./!>BU3)Q'L/S@=]0I]%OODLHPIK$>]R)50.8B_0J\"DJ#)D)&RF/<H
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M\T^F_OGYF?>1:G2SE@3L0X=#;S0<^>?!I#8$QYZ,3XN](\;:CSMDV)'JMN/
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M6'\%2NN>2]1_'XN7O?1M):ZP6)"I#LZ,;OV4I<L3Q LXG=L3L3+,H+YAXL
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MHDK1L[]T^0WIBJ"?W*1Y0:.2PP:=C\+!U%39N"([::L38,?,V#*W:,U#@#>
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MC927N?XN[E-=1O$N)[0)TFM35;)8/ZAE3QQ>3UCO(Z06CP9FE,?4)75KO'Y
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MMG@$HWX0,::R@+J(X-)0)UARS&WRY6?7]C/RPE"L;,+/W1;=5@-*E(B65S@
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M]E9DCFJU1=A:!Y"?EIVRMQ4[(WI0S-M.&]>% -CDO16;*$N)ENE;(<, [$G
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M+DO]FND4Q\X?\1'VR1Y37 +GK3T0T_7#]2=OLP:2LG>_#M"$9_FM2_EZ3%D
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M?^2HB_#/&CQY":>T%+N.GRC\$^0.Y?M\<;R> WKXCO ]C81[YW+(L.LYQ$W
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MWXP& >CN'>DF5NU\[]XH2R^!'];T]*)V!K1?*65/$Q>@?\P7_P!02P,$%
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ME(8F)K<L:$1%90U(OY+2;#<V0#?T3O\#4$L#!!0    ( /V(AU9",X2$- ,
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M<IGQ%$?K'?@\-<;M-SY _;\P^0=02P,$%     @ _8B'5KTIK(<H!0  [ P
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MNUQ+@9I,"_!^J93M;\C \)_-Y3]02P,$%     @ _8B'5@G)A=R<!   >PL
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M;??WT+UXLPHW]AOC<?\/W25^N+2E"?@^-\9O7LC ]A?N]#]02P,$%     @
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M2O'<-%= D1_= ;\O.%?U@YZ@.1Z<_@=02P,$%     @ _8B'5L]&JS\P!
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MM>:2?EDHC0/MSX70NXD)T/T$1_\ 4$L#!!0    ( /V(AU8K@O=?60T  *6
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M!8P+H.\+K7$[<1NT?ZGT-U!+ P04    " #]B(=62KT8(^<$   #)@  &0
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M(F82;9LOHKCN#T;9O<+&F?X5%XK\Y,$"B)R0*Q'Q:"1X0*XC;=3"%MAH<L+
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M?LNO=;S\R!R4YZHJ#!8MK\R69?)+E?DN#0\*U5C'-;?5Z+1:G?9K-4KYE=5
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MRKK.#LO*C5+4/L#=+Y6RVXT7Z(=S_@=02P,$%     @ _8B'5OEQXCKD @
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M&6LP6(_:H.;DCDNL&F>"3-$(V-76D)\W,V,U]N6OKGK4 GK= MRW>FU*EL'
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M=8YTJJ)RVEY4O3#) -8Z=FH;6,ZO[SB!'!:\="]Z _Z8>?W,>&QGM)7J7J\
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M#GO.X;..SF\(AV?'-ATD:71"Z+!*PN#T^/A';YK]GOA(U9()33@LT"^X&J"
MZM[HKF-DTSYS<VGPT6R;*_RL 64-<'XAI3ET[,O9?R@5OP!02P,$%     @
M_8B'5AQ37:GR @  ^P<  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL
MK55M;]HP$/XKIZR:6FEMR NP,8C$RZ9-6B54UO7#M \F/HA5QV:V ^V_GYU
M2B&@?MB7Q';NGGN>R_FNOY'J46>(!IYR+O3 RXQ9]7Q?IQGF1-_(%0K[92%5
M3HS=JJ6O5PH)+9UR[H>M5L?/"1->TB_/IBKIR\)P)G"J0!=Y3M3S"+G<#+S
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M&X"=\1>%G3RZ1L:5.>??S,W'=.0%QB+((%&&@NB?+4PARPR3MN.?DM2KUC3
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M51WG?LG+,M_L7]YE:36TKA>H_OXFS\NG/]0;^)87O^_?SH?_!U!+ P04
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M+B&[YHORM&S^1X\=UIB@:%M6^;H+YD^P3K+V+WWJA#@((/8+ :0+(&* ]4*
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MIJ(\-^U<=W#0&-[K&&= ;.+U8QQ".&N)3QSTA/?</*O&)Z<1@='02/KR2OD
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M=T9Z2X"6Z2/;%_76E,A0[^Z_ *BTI5.&;3739,FMD4"!Z2)Q(1E*<-(!/I(
M92-\K"N-H>"=48?V6QD_J-/]WFEE"[6R15K98EULPXIW3A\JW>6HBYWG_]2D
MDXO=L#D#/R;V-&?L["PC&(UL$A@R1M/(6SANV%ENJ/;<_072F7IK-=PM&T1]
M,^T8X_E;AC,-.!)=@D.FX;JB[)JR&,K>^7.H-NB]M=*9JFNU[BW;4*7 &'D!
M*0X9XLHSDN&@9_BB&="5Q5#USDU#I;'KUDQ3A-?JKUNV83.&AKC8"64XY!F6
M)0HOPUD&&EF#MW"\L+.\<)KG/5-ZK?ZW9?.' X@5B,H'/YP (@F59 *(=3W_
M\$5@YWV1VOLV8\P%2-9K@M?5JFE5K9H.KZV:U'13Y6[9^CI"Q[:%!AQ*8#[R
MQ3\;9&3(%">)6%<&0\$[ XS4!OCV)'16,)(5-%LJU-;J@]'8M=JFZ8W4EL"0
MZYNBW&,8]'W3%.6&XZ[BV78WZ ]U[*PM4EO;>DT"TF&+K?X$38X)22DXU U;
M*JI6L]NR]?,+ E&%4()R1EI%$A1$:"SI6YA<U)E<I#:Y_^T-C)ITLNK66>]@
M9##)2Q@)3/861@*3O8:9]S:O;#%9U]N,*%B6^X(U>S1.5T];F6[K#3S"]3MX
M%34;DCJ:9G_4IX2L^= !<KSBE*;A\29#FBU'S0DK=_46F>>2L7);'VYPDF)2
M ?COJ[)D+R?5#4X;OQ;_ E!+ P04    " #]B(=6R\+/$B8$  "_&0  &0
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M*OY!;_P+PC@B&_$?=X!\WQEH+^#25:@3%NB$A9I@#17\2@7_E4N)KU-$G;!
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MR0Y<)ZCW2\;D+M 'M/\5XK]02P,$%     @ _8B'5J/' Y%G P  < T  !D
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M*LB5D:#Z;POW4%5&2?OXKQ7UNC4-\?AZK_[9!J^#>:82[GGUHRS4:NY-/53
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M,P&_SX30+R]F@?K_"</_ 5!+ P04    " #]B(=6 E#?]"T#  !X"0  &0
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MF)P+B#M ["+32G%QR*FAV4S)+5'6&MELPP73H5$^$S;MMT;A+$.<R3Z*0E9
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M>X(#PO("^?Z64G$ZR3^@WHM;_ =02P,$%     @ _8B'5C*J_(BU @  W <
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M_Q*\.R\YMWBEY0]14CUG'QF4N.&=I+7>W>#@Y]SS%5K:\(3=D!LS*#I+NAG
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MS9.3.B9;,A;;85)[1TJ/<:1/M0C;.7J>;UOG.0"T%J8+<BBB]Y_4[3]/:0C
M7IZY.8<VE"!H;'0#Q<9&#FGJ_25U^\L36H&]@4=Q3*#R:2/], 3TQ-:SA $]
MK#=X[)B]P.$NP.Q=.2_T,'"1 <B >< =@CNB;UQ:K'=?[(G=P*8>H4IJQ(M"
MIER+#&F)E&.GQ<UX\C.U,=F2L=@.L]F;/D:?ZSFETTV>G-0QV9*QV Z3NO?L
M=RR_R6Q[:*W+)R&).YQOE=L[4?;_G"BSGZ$R8NPEL$\!0$D<FK(+E*%1K>AT
M[ZV-4M2+]NT7A5*YKG3W#L/N[.X-FS?M>R5?G7]+SI/N/9F>IGMMYR.O%WFE
M4"'N#"5^'1J5=?<F3'>@Y:I]-^16:BW+]N-2\$S4#<!\?R>EWAXT/[!['VGV
M'U!+ P04    " #]B(=6[1'0H/$%   A+   &0   'AL+W=O<FMS:&5E=',O
M<VAE970W-"YX;6RU6FMOVS84_2N$-PPMD-4BJ9>SQ$!B=EN'%0CB=?LP[ -C
M,;906?0D.FG^_:A'3+.B.1N]_I+H<>\Q[Q&/>4S=JV=9?:Y70BCT95V4]?5H
MI=3F<CRN%RNQYO4[N1&EOO,HJS57^K1:CNM-)7C6)JV+,0F">+SF>3F:7K77
M[JKIE=RJ(B_%787J[7K-JY=;4<CGZQ$>O5ZXSY<KU5P83Z\V?"GF0GW:W%7Z
M;+Q#R?*U*.M<EJ@2C]>C&WS):-(DM!%_YN*YWCM&32D/4GYN3CYDUZ.@&9$H
MQ$(U$%S_>Q(S410-DA['OSWH:/>93>+^\2OZSVWQNI@'7HN9+/[*,[6Z'J4C
ME(E'OBW4O7S^5?0%10W>0A9U^Q<]]['!""VVM9+K/EF/8)V7W7_^I2=B+P''
M!Q)(GT"^3@@/)- ^@1Z;$/8)8<M,5TK+ ^.*3Z\J^8RJ)EJC-0<MF6VV+C\O
MF^<^5Y6^F^L\-9V+I7Z*"GTHNSG4/HLR0_?B291;@1Y>T"]"+BN^6;VT-^XJ
MF6T7JD8_HKF>A-FV$$@^NN/?,*%X7M1O=?"G.4-OOG][-59ZU,UGCQ?]"&^[
M$9(#(\0$?92E6M7H?9F)S 88ZW)W-9/7FF^)%Y&)Q3M$\04B 2&. <V.3\>.
M='9\>N"IANZ>(&WQZ"&\O.;+9266W</;>Q9__ZY#T0<EUO4_+MX[W-"-VWSA
M7-8;OA#7(_V-4HOJ28RF/WR'X^ G%V>08 P(S.(SW/$9^M"G?TC%"U3JK]RJ
MX]%%70<1M1#-5^O3E$2$3B9!H!_ITSXOCDB*21(,(MDP$H=)G-+]2*NB:%=1
M=$1%FTZXOJJ\,*=."$@P!@1FT1?OZ(O/)+ 8DD](, 8$9O&9[/A,OEU@'42\
M+QN2)I-X*#!'9! E 1T*;!B)283Q88&ENXI2;T7SE[J9 ZXZO(FG3@%(, 8$
M9A$VV1$V.9.D)I!\0H(Q(#"+3QP8&Q=\NZAZ#$L!,8UI,E25*Y1.8NJ0E2-T
M$B1Q=%!6>,^<8F]5-T_YK!"\<A;C33UU*H"B,2@TFS9B:"-GDE</#$4J)!J#
M0K-)-38;>UWGD0JC RV$8>18M1R! UWY0NPBC+?%?G,[DZ7^A<\?"N%<K?S9
M)S]^2#0&A68S9SPTCLZE*5!;#8K&H-!L4HVSQEZC>:2FXN%2E!*'P9NY(N,P
MP(XU:Q@YT?[R\))ES"WVN]OYY[Q<\,I=B3?UY)D B<:@T&S:C(/&Z;GD!6JQ
M0=$8%)I-JG'9V&LZCY379+ADD<:\#>7EB)S$\7#3@SDB-62,#^J+&*-+_$9W
MKEG*%\Y*_)FGS@10- :%9K-FC#3!9Y(7 ;79H&@,"LTFU=ALXG6<Q\FKQ["D
M0&/7ZN6*C*)X^..,N2))9.\IVC49ETO\+O=3F2N1H;GBRFT1_?DGSP?0;6,H
M-)L[8ZY)>"Z1@?IN4#0&A6:3:GPW.6;S^O]$%@V-7Y"$D4MEPU"]AA''(N:(
MC#&AZ6&5&=]+_+[W-[[AI;,0T"UC4#0&A69S9HPU2<ZE+E#;#8K&H-!L4HWM
M)OZ=Z^/4E0Z%$$Z(PR$Z(I. T,@AKF%D2(EGTY 8UTO\KO>FSOD%$E\6Q3;+
MRR4Z+#;0S610- :%9K]2-BZ;!N=ZJ0QJPD'1&!2:3:HQX=2_FWV4V'H,R]OA
M-'&L9(Y(3+0PAV)S109)<'B[@QH/3/T>^/VVDAMW(:!;R:!H# K-)FVO8^-L
M+1NP/1NP31OG<-_4N&\*T+?18]AOB].4.-0UC,23, P=ZG)$8IP>7LJH,;_4
M;W[O1:V:Z:%6HNF?*[(+)/5QI2_P$EF_U2Y0L^ZU+5H>38)N18.B,2@TFVIC
MR>FYNCPHJ&<'16-0:#:IQK-3@%:/'F._\8DF)!GNVL]<D81BQSMI1R3!)'7\
M=AOO]4ZN1;5L>U!KM)#;4G4MA;NKNS[7F[:[\ZOKM_B2==VJ!J9KGOW(JV5>
MUJ@0CQHR>)?H855=/VIWHN2F[=!\D$K)=7NX$CP351.@[S]*J5Y/F@_8=05/
M_P-02P,$%     @ _8B'5BQO\LKW!@  ISH  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S4N>&ULM9M=;]LV%(;_"N$50P>TMD7)SL<2 XG9806:KFC6[6(8
M!D:F;:*2Z(E4DA;[\2,E130=F;&2HYO$EL6'.J]XQ/-*U-F=R+_*-6,*W:=)
M)L\':Z4VIZ.1C-<LI7(H-BS3ORQ%GE*EO^:KD=SDC"[*1FDRPN/Q=)12G@UF
M9^6V3_GL3!0JX1G[E"-9I"G-OUVR1-R=#X+!PX;/?+569L-H=K:A*W;-U)?-
MIUQ_&S64!4]9)KG(4,Z6YX.+X)1$$].@W.,/SN[DUF=D0KD1XJOY\GYQ/AB;
M(V()BY5!4/WOELU9DAB2/HY_:^B@Z=,TW/[\0/^E#%X'<T,EFXOD3[Y0Z_/!
M\0 MV)(6B?HL[GYE=4#E <8BD>5?=%?M.YT.4%Q()=*ZL3Z"E&?5?WI?"['5
M( SW-,!U [S3 .,]#<*Z07AH@ZAN$)7*5*&4.A"JZ.PL%W<H-WMKFOE0BEFV
MUN'SS)SW:Y7K7[ENIV9SD:9<Z1.I)*+9 LU%IGBV8EG,F41OT4>:Y]2<&O2:
M,$5Y(G]"KQ#/T!5/$GWBY-E(Z<,PL%%<=WE9=8GW=!E@=*5[64OT+ENPA0L8
MZ>-O@L /05QB+Y&P>(C"X W"8XS1EVN"7K_Z"25,CX=_%,O3EF.<'TX,'H@M
M&'(X9MR.<0(.F[,6EMQP#_<#DY*Q-^B#"?$-(DS&.=^4B?37![TO>J]8*O]N
M.S<5.&H'FZO,J=S0F)T/]&5$LOR6#68__A!,QS^WB0@)(T P1]"H$33RT6>E
MD,B,%?1:#^YOC.:R[7Q?^C%AU;)-*F_#KE(!P1RI)HU4$V^,I# 7!#W2Q!+1
M0HF<9>R.)FC)J"IT=VVJ^8E!J5J;:-YV744#@CFB31O1IMX0WTG%]23%%FB3
MBT41*Y1P>L,3KKZUZ57!@NJB;:;NV]EX.#D;W6Z+T[K3D;L3\1[6,X,^:H(^
M\@;]L4AO6&[&2:PG"A87Y3R2-*DFT7_^B_1EQ9]N18AW1/ >0=<1 @1SQ#IN
MQ#KVBO6[4#J)8KKA^C__KD=*+*1JS:8*-/&H4NT1A-N[/!H:WN-Y9K0G3;0G
MWFA_4VL],A*1K=Z6%UVJY[/V8+V<KO,5)(P P1S]@K&MV\9]E0 U&4A34!J!
MHKFJ;E7# 506UB0GR<+A\4XFMNT5#7?RE?B/ZKE18QLU]D9]31-6E?_:^WUE
MQ@"T1NRE=!XWD#0"17,5M/5XT%M!'H!6Y* T D5S5;5%>> OIR]2D2O^O2DW
MW;S,5$YU(;4_0:/'!1(>1KL)VK)7,#S93=!6UK39RPW0EM*!O_*]N.5S70'E
M>L#<\IBU1@%9 \]!:02*YJIG:^I@VEO2 =7%M:J0- )%<U6U17O@K]KGB2A,
M>J6;PDP$R-P RE;,W")"['[#8K6=?;7[DT_8YB?Z/-KOF_TM.VO;1XD?V!H_
M\!?Y\ZT+6*7SO-'YFJFWQ49OD$K[HL,+9'^7G8<R)(U T5RYK<D(3GJ[0(#Z
M#E :@:*Y]UJM\\#>&KQ+C5R3G&DS'(8[4["_OZ[J0-%<=:R#P'X'<7B*'UAU
M^_OK.A)!:02*YFIM?0O&?>4W!O4RH#0"17-5M5X&>ZOZ%U;=-=PQO(_O7?H/
MH;-@?=@4;&T*/N3A <^D5BDIZR2C3JLXD$\!YJ T D5S1;16"$]ZRV50BP1*
M(U T5U5KD;#_N4.7N7KZ.'&#W9O&<W]_G=7IP^I@:W6PWW:T)VZGZMO?0^>Q
M!VIVH&BNNM;LX./>,AK4TX#2"!3-5=5Z&NQ_<M(EHT_:,GKW!IB_O\[J].%-
M0NM-0K\WV9O1!Q;;?GSGY1&@Q@:*YDIKC4T8]+;F!-3"@-((%,U5U5J8T/_H
MY67%=@W?60.PZZ_]A]!9L#[<2;BU\LGO3JYXQM.B=;6 OV7G80:[N*D/BQ):
MBQ)&O24OJ&<!I1$HFJNJ]2RA__'-9V96UIH[.]N+6G06BPTSBZ0>?FC/W><N
MBO(W["QA'P8EM 8E]!N4.IWU#'W@C;-6*4&?YH#2"!3-U==:G/"HM\0'M3:@
M- )%<U6UUB9\XCE.'\_(GNC3L[;4W[*SMGT8G- :G-!O<*[H_=X)'O2A#"B-
M0-'<Y<O6^$2]+0>+0#T/*(U T5Q5K>>)_ ]S7C3!/\$.QI[%XJ 6!XKFBF@M
M3N2W.'M%7/*,9C'S2>@G3SP*@GH>*)JKH/4\T1.>I[HDOJQ(\O?1.<U!W1$4
MS=5WZ^6/WMQ1!.J.0&D$BN:J:MU1Y'<PO11)3_3IO:B"^B8H6B7N:.L-OI3E
MJ_)-2*G5*3)5O0?7;&W>MKPHWS'<V7X9G)+JG4F+J5[AO*+YBF=27VV7&CD>
M'ND \NJMR.J+$IOR/<$;H91(RX]K1A<L-SOHWY="J(<OIH/FW=39_U!+ P04
M    " #]B(=6CRZ#P 4%   !&0  &0   'AL+W=O<FMS:&5E=',O<VAE970W
M-BYX;6RU65UOXC@4_2M6=K2:D=H2.Q^$+D5JR8QVI)F=JIWN/JSVP0T&HDEB
MQC:E_?=K)Y" ;5R*F!>(P[TG]UQ?7Y^8X8JR'WQ.B #/95'Q*V\NQ.*RU^/9
MG)287] %J>0O4\I*+.20S7I\P0B>U$YET4.^'_=*G%?>:%C?NV6C(5V*(J_(
M+0-\69:8O=R0@JZN/.AM;MSEL[E0-WJCX0+/R#T1#XM;)D>]%F62EZ3B.:T
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MEJBR\-HMU%LYX@6.86+(UXX#6X,1??Q@!]:7MGS_R>Q56K=)ZW:Y1W+3W+:
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M\TT"RG8P[0LI\;EBK[WZ*R?^!U!+ P04    " #]B(=6#,WN$3P"  "P!0
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MT'Z!F]\J98\=?\W[1SK_"U!+ P04    " #]B(=6"(."-'H#  "?#P  &0
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M09H O#\60B\&Y@%%3][_#5!+ P04    " #]B(=6+HP:<T4"   Y!0  &0
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M$Z CAZ@6H5J,:@+5)*HI5-.45@^BLH'<_\LKR.81.J<26D)&-1?5/%3S42U
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MMIO;1FBW&]4"5 M1+4*U&-4$JDE44ZBF*:V>1&6W>V3N=M]EZ6JQ7UF;YR*
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MZ, 1JL6H)E!-HII"-4UI]8 I*]03<X7Z"W?F&AM/[ZWRK-U[Z^YP),K2Z_:
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M#I#OWS"Y^M4OR@/L']"?_PM02P,$%     @ _8B'5K!M_O&D @  9P@  !D
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ME#%;"&/F%!-9*&.V$,8L*":R4,;=%X*8)5V-@BR4<_>%(.8+BHDLE#-;*!J
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MJJ_K"[_ONGUOY/+A9W@//R%\_0]02P,$%     @ _8B'5E(UQJ.* @  N3(
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MA'HG KT-]38"O0WU-@*]#?4V KT-]38"O0WU-@*];?*QDD!O0[V-0&]#O8U
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MM.=?\24QEK[X_>P\[<8V;\R.U_MS=(=E'CY;'I??\>\S?JG_SCX$I \)Z:.
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M4$L! A0#%     @ _8B'5B7TLG+O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ _8B'5IE<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #]B(=6FI-CL;H'  !%+P  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ _8B'5N*+M"0Z @  N04
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M965T-BYX;6Q02P$"% ,4    " #]B(=6.IJ$CI,)  "84   &
M    @(%T*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M_8B'5F7*^ZIS @  ? 4  !@              ("!/3(  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /V(AU9XV4T=+0P  'Y"   8
M          " @>8T  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " #]B(=6*]JIRTPJ  "OA@  &0              @(%)00  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /V(AU8#@\I#W 4  (4.
M   9              " @<QK  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ _8B'5BY01;A"!@  A \  !D              ("!WW$
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #]B(=6:@ET
M@<D#  !<"   &0              @(%8>   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( /V(AU9M -B*008  #P.   9
M  " @5A\  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M_8B'5J-R:)U?!   G@D  !D              ("!T((  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " #]B(=6<!7H3U<#  "!!P  &0
M            @(%FAP  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( /V(AU;/BF^+W!0  #X_   9              " @?2*  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ _8B'5I;NW[BP#
MS2$  !D              ("!!Z   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " #]B(=6^;.YD*\%  "1#@  &0              @('N
MK   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /V(AU:+
M$2OP"P0  )P(   9              " @=2R  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ _8B'5A:A Y.+!P  4A$  !D
M     ("!%K<  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /V(AU8VE#TVG3<  !+!   9              "
M@7+T  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ _8B'
M5@94E""6 P  V <  !D              ("!1BP! 'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " #]B(=6XTP?<3\#    "P  &0
M        @($3, $ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( /V(AU9",X2$- ,  -P&   9              " @8DS 0!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ _8B'5B__?%;; @  (P8
M !D              ("!]#8! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " #]B(=6O2FLAR@%  #L#   &0              @($&.@$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /V(AU:PW-!G
MT0(  $$&   9              " @64_ 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ _8B'5L=22R;O @  = 8  !D
M ("!;4(! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #]
MB(=6$,8A9D$*  !Y'0  &0              @(&310$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /V(AU;?:$(?\@8  +\1   9
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M970S.2YX;6Q02P$"% ,4    " #]B(=6QXJ71N\"   0!P  &0
M    @($R;0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M /V(AU8K@O=?60T  *6    9              " @5AP 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ _8B'5A=@]$;S @  G@L  !D
M             ("!Z'T! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " #]B(=610&%*>X#  !&$   &0              @($2@0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /V(AU:OZ>SSH (
M +$&   9              " @3>% 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ _8B'5DJ]&"/G!    R8  !D              ("!
M#H@! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #]B(=6
M>WI=]6X"  "H!0  &0              @($LC0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( /V(AU;Y<>(ZY (  -D'   9
M      " @=&/ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ _8B'5L@@I:*L @  !P<  !D              ("![)(! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #]B(=6+VB\Y\8"   N!P
M&0              @('/E0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( /V(AU8^82=H'P0  )(6   9              " @<R8 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ _8B'5F>8V&<W
M P  - D  !D              ("!(IT! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " #]B(=6'%-=J?("  #[!P  &0
M@(&0H $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( /V(
MAU:P$RZF$00  *(5   9              " @;FC 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ _8B'5ADU.P H P  P @  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( /V(AU;+PL\2)@0  +\9   9
M  " @<O9 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M_8B'5B%"8=Y8!   %!H  !D              ("!*-X! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " #]B(=6G_E[+"P$  "P$   &0
M            @(&WX@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( /V(AU:\6>DXU (  #<(   9              " @1KG 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ _8B'5J/' Y%G P
M< T  !D              ("!)>H! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " #]B(=6M'3ZAC($  #>#@  &0              @('#
M[0$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( /V(AU;?
MMS4XJ 0  +02   9              " @2SR 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ _8B'5N>^@VKO P  6Q   !D
M     ("!"_<! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /V(AU8RJOR(M0(  -P'   9              "
M@:T* @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ _8B'
M5I^8L?4] @  S@0  !D              ("!F0T" 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " #]B(=6HL;NSW<&  ";)   &0
M        @($-$ ( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( /V(AU;M$="@\04  "$L   9              " @;L6 @!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ _8B'5BQO\LKW!@  ISH
M !D              ("!XQP" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    " #]B(=6CRZ#P 4%   !&0  &0              @($1) (
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( /V(AU;C4DOB
M#@,  #$+   9              " @4TI @!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ _8B'5FP%9)W- @  \0@  !D
M ("!DBP" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " #]
MB(=6#,WN$3P"  "P!0  &0              @(&6+P( >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( /V(AU8(@X(T>@,  )\/   9
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M970X-"YX;6Q02P$"% ,4    " #]B(=6L&W^\:0"  !G"   &0
M    @(%I:0( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M /V(AU:TU?F2&P0  ,T0   9              " @41L @!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ _8B'5FH+4TYF P  ?Q<   T
M             ( !EG " 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #]B(=6
MEXJ[',     3 @  "P              @ $G= ( 7W)E;',O+G)E;'-02P$"
M% ,4    " #]B(=6;9$8CQT&  #&.   #P              @ $0=0( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ _8B'5E(UQJ.* @  N3(  !H
M         ( !6GL" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ _8B'5H/1K $N @  1#$  !,              ( !''X" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     %X 7@#)&0  >X "

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>356</ContextCount>
  <ElementCount>520</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>121</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash</Role>
      <ShortName>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Balance Sheet Detail</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetail</Role>
      <ShortName>Balance Sheet Detail</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Product Warranty</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarranty</Role>
      <ShortName>Product Warranty</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Segment Information and Revenue by Geography and Products</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts</Role>
      <ShortName>Segment Information and Revenue by Geography and Products</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://cutera.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables</Role>
      <ShortName>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/DerivativeInstruments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Balance Sheet Detail (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailTables</Role>
      <ShortName>Balance Sheet Detail (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/BalanceSheetDetail</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Product Warranty (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarrantyTables</Role>
      <ShortName>Product Warranty (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/ProductWarranty</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/DeferredRevenue</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables</Role>
      <ShortName>Segment Information and Revenue by Geography and Products (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/CommitmentsandContingencies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/Debt</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails</Role>
      <ShortName>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails</Role>
      <ShortName>Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/FairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Balance Sheet Detail - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailNarrativeDetails</Role>
      <ShortName>Balance Sheet Detail - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Balance Sheet Detail - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailInventoriesDetails</Role>
      <ShortName>Balance Sheet Detail - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails</Role>
      <ShortName>Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Detail - Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Detail - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Product Warranty - Summary of Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails</Role>
      <ShortName>Product Warranty - Summary of Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Deferred Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueNarrativeDetails</Role>
      <ShortName>Deferred Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails</Role>
      <ShortName>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Income Taxes - Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Defined Contribution Plan - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DefinedContributionPlanNarrativeDetails</Role>
      <ShortName>Defined Contribution Plan - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails</Role>
      <ShortName>Segment Information and Revenue by Geography and Products - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails</Role>
      <ShortName>Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails</Role>
      <ShortName>Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Financial Statement Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Commitments and Contingencies - Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails</Role>
      <ShortName>Commitments and Contingencies - Operating Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails</Role>
      <ShortName>Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails</Role>
      <ShortName>Debt - Outstanding Debt and Carrying Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Debt - Components of the Loss on Debt Extinguishment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails</Role>
      <ShortName>Debt - Components of the Loss on Debt Extinguishment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/SubsequentEvents</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="cutr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: cutr:ExtendedServiceContractOptionOneTerm, cutr:ExtendedServiceContractTerm, cutr:LesseeLeasesRemainingTerm, us-gaap:CapitalizedContractCostAmortizationPeriod, us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:ForeignCurrencyTransactionGainLossBeforeTax, us-gaap:NumberOfReportingUnits, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage -  cutr-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="cutr-20221231.htm">cutr-20221231.htm</File>
    <File>cuteraamendedandrestatedby.htm</File>
    <File>cutr-20221231.xsd</File>
    <File>cutr-20221231_cal.xml</File>
    <File>cutr-20221231_def.xml</File>
    <File>cutr-20221231_lab.xml</File>
    <File>cutr-20221231_pre.xml</File>
    <File>cutr-20221231xex1028four.htm</File>
    <File>cutr-20221231xex211listofs.htm</File>
    <File>cutr-20221231xexx1027thi.htm</File>
    <File>cutr-20221231xexx2311.htm</File>
    <File>cutr-20221231xexx3131.htm</File>
    <File>cutr-20221231xexx3141.htm</File>
    <File>cutr-20221231xexx3211.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cutr-20221231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1337">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>122
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cutr-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 40,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 1337,
    "http://xbrl.sec.gov/dei/2022": 38
   },
   "contextCount": 356,
   "dts": {
    "calculationLink": {
     "local": [
      "cutr-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cutr-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cutr-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cutr-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cutr-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cutr-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 805,
   "entityCount": 1,
   "hidden": {
    "http://cutera.com/20221231": 3,
    "http://fasb.org/us-gaap/2022": 22,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 29
   },
   "keyCustom": 78,
   "keyStandard": 442,
   "memberCustom": 55,
   "memberStandard": 58,
   "nsprefix": "cutr",
   "nsuri": "http://cutera.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cutera.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash",
     "shortName": "Cash, Cash Equivalents, Marketable Securities, and Restricted Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://cutera.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Derivative Instruments",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://cutera.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Balance Sheet Detail",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://cutera.com/role/BalanceSheetDetail",
     "shortName": "Balance Sheet Detail",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Product Warranty",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://cutera.com/role/ProductWarranty",
     "shortName": "Product Warranty",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Deferred Revenue",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://cutera.com/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://cutera.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Net Income (Loss) Per Share",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://cutera.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://cutera.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Defined Contribution Plan",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://cutera.com/role/DefinedContributionPlan",
     "shortName": "Defined Contribution Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Segment Information and Revenue by Geography and Products",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts",
     "shortName": "Segment Information and Revenue by Geography and Products",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LesseeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://cutera.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LesseeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://cutera.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://cutera.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables",
     "shortName": "Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://cutera.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://cutera.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Derivative Instruments (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://cutera.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Balance Sheet Detail (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://cutera.com/role/BalanceSheetDetailTables",
     "shortName": "Balance Sheet Detail (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Product Warranty (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://cutera.com/role/ProductWarrantyTables",
     "shortName": "Product Warranty (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Deferred Revenue (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://cutera.com/role/DeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://cutera.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://cutera.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables",
     "shortName": "Segment Information and Revenue by Geography and Products (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LeasesFinancialStatementInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://cutera.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LeasesFinancialStatementInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://cutera.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfCountriesInWhichEntityOperates",
      "reportCount": 1,
      "unitRef": "country",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ib1e9b45cb9574d1382cd7a4270da0967_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails",
     "shortName": "Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Summary of Cash and Cash Equivalents and Available-for-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails",
     "shortName": "Cash, Cash Equivalents, Marketable Securities, and Restricted Cash - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id720e09c88e443f2809964bf360c8189_I20220531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Fair Value of Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
     "shortName": "Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i8ac9e761079e46d09f596d92d01d71b4_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i221c5f5bf1c048b58ad83bbe86effde5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://cutera.com/role/DerivativeInstrumentsDetails",
     "shortName": "Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i221c5f5bf1c048b58ad83bbe86effde5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Balance Sheet Detail - Narrative (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
     "shortName": "Balance Sheet Detail - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Balance Sheet Detail - Inventories (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://cutera.com/role/BalanceSheetDetailInventoriesDetails",
     "shortName": "Balance Sheet Detail - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepositsAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails",
     "shortName": "Balance Sheet Detail - Other Current Assets and Prepaid Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepositsAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://cutera.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
     "shortName": "Balance Sheet Detail - Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Detail - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id98fc580362c485a9aa22ac1e8f9841d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Product Warranty - Summary of Warranties (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails",
     "shortName": "Product Warranty - Summary of Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i866a04e8824b4dbf9ff659afa11d7000_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cutr:CostsForExtendedServiceContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Deferred Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://cutera.com/role/DeferredRevenueNarrativeDetails",
     "shortName": "Deferred Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cutr:CostsForExtendedServiceContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id98fc580362c485a9aa22ac1e8f9841d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
     "shortName": "Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cutr:CapitalStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id98fc580362c485a9aa22ac1e8f9841d_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cutr:AdditionalSharesReservedSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "icf9eb37cd2f843bcb2780db55cc261c7_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i1d9d6c9df73b4b1591f546810a633a0f_D20200401-20200401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i2af1fdd05cd445a0ae8d99f2546c9649_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Income Taxes - Deferred Tax Assets (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://cutera.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id98fc580362c485a9aa22ac1e8f9841d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ib60f899800144726a0adde4f7415072f_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails",
     "shortName": "Net Income (Loss) Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i1fd96b24de6e4196b78b50d9a0fe49ae_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i670b164ba5d245a9a2b2c243a6c94701_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i5b771e0f32854640adb37fcb81cf460b_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i5b771e0f32854640adb37fcb81cf460b_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Defined Contribution Plan - Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://cutera.com/role/DefinedContributionPlanNarrativeDetails",
     "shortName": "Defined Contribution Plan - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i703988fcf2f641d0b7b217236b282e4b_D20221001-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails",
     "shortName": "Segment Information and Revenue by Geography and Products - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails",
     "shortName": "Segment Information and Revenue by Geography and Products - Schedule of Segment Reporting Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:ERPImplementation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
     "shortName": "Segment Information and Revenue by Geography and Products - Schedule of Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id82a22a9886c4a319a7f2dcb4b5cbdbd_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
     "shortName": "Commitments and Contingencies - Financial Statement Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails",
     "shortName": "Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Commitments and Contingencies - Lease Information (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails",
     "shortName": "Commitments and Contingencies - Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:PaymentsOfDerivativeIssuanceCostsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
     "shortName": "Commitments and Contingencies - Operating Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "iec6f3c33325946bb8a1100fd980e6608_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails",
     "shortName": "Commitments and Contingencies - Non-cancellable Operating Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "id4fabcd0c6b145328c06480322497ceb_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
     "shortName": "Debt - Outstanding Debt and Carrying Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i0e1b769004c940138fbdcc25ec85a289_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://cutera.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ibc17ad3b59664df49df18e44e735b529_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "cutr:InterestExpenseAndAmortizationOfDebtIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Debt - Components of the Loss on Debt Extinguishment (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
     "shortName": "Debt - Components of the Loss on Debt Extinguishment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i887cfc70722d4e35bd0fd39e04f0ec23_D20220501-20220531",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtConversionConvertedInstrumentAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://cutera.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ieec1fb784aae4900ae4e0cde895dc9e0_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "idbaf66959ab14c7789e42bdaa2cd69f7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "ic72b182a81cf43ee99eb4e8a9d3ec1a8_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20221231.htm",
      "contextRef": "i31da4d9b76804d9d903c33d31d6e483a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 121,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AccruedCappedCallCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Capped Call Costs",
        "label": "Accrued Capped Call Costs",
        "terseLabel": "Capped call costs accrued"
       }
      }
     },
     "localname": "AccruedCappedCallCosts",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AccruedInventoryInTransitCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory In Transit, Current",
        "label": "Accrued Inventory In Transit, Current",
        "terseLabel": "Liability for inventory in transit"
       }
      }
     },
     "localname": "AccruedInventoryInTransitCurrent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AdditionalSharesReservedSharesAvailableForGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.",
        "label": "Additional shares reserved, shares available for grant",
        "terseLabel": "Additional shares reserved (in shares)"
       }
      }
     },
     "localname": "AdditionalSharesReservedSharesAvailableForGrant",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for allowances for sales returns and doubtful accounts.",
        "label": "Allowances for Sales Returns and Doubtful Accounts [Policy Text Block]",
        "terseLabel": "Allowances for Sales Returns and Credit Losses"
       }
      }
     },
     "localname": "AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_AsiaExcludingJapanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia, Excluding Japan [Member]",
        "terseLabel": "Asia, excluding Japan"
       }
      }
     },
     "localname": "AsiaExcludingJapanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://cutera.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cutr_AviClearDeviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear Device",
        "label": "AviClear Device [Member]",
        "terseLabel": "AviClear Device"
       }
      }
     },
     "localname": "AviClearDeviceMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AviClearDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear Devices",
        "label": "AviClear Devices [Member]",
        "terseLabel": "AviClear devices"
       }
      }
     },
     "localname": "AviClearDevicesMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AviClearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear",
        "label": "AviClear [Member]",
        "terseLabel": "AviClear devices",
        "verboseLabel": "AviClear"
       }
      }
     },
     "localname": "AviClearMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AviClearOperatingLeaseLicenseFeeRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear Operating Lease License Fee Revenue",
        "label": "AviClear Operating Lease License Fee Revenue [Member]",
        "terseLabel": "AviClear operating lease license fee revenue"
       }
      }
     },
     "localname": "AviClearOperatingLeaseLicenseFeeRevenueMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AviClearOperatingLeaseRecurringRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear Operating Lease Recurring Revenue",
        "label": "AviClear Operating Lease Recurring Revenue [Member]",
        "terseLabel": "AviClear operating lease revenue"
       }
      }
     },
     "localname": "AviClearOperatingLeaseRecurringRevenueMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AviClearRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AviClear Revenue",
        "label": "AviClear Revenue [Member]",
        "terseLabel": "AviClear Revenue"
       }
      }
     },
     "localname": "AviClearRevenueMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CapitalStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Capital Stock Shares Authorized",
        "terseLabel": "Authorized capital (in shares)"
       }
      }
     },
     "localname": "CapitalStockSharesAuthorized",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_CapitalizedCloudComputingSetupCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the capitalized cloud computing set-up cost.",
        "label": "Capitalized Cloud Computing Set-up Cost [Member]",
        "terseLabel": "Capitalized Cloud Computing Set-up Cost"
       }
      }
     },
     "localname": "CapitalizedCloudComputingSetupCostMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CappedCallSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capped Call Securities",
        "label": "Capped Call Securities [Member]",
        "terseLabel": "Capped call"
       }
      }
     },
     "localname": "CappedCallSecuritiesMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-for-sale Debt Securities",
        "label": "Cash, Cash Equivalents And Available-for-sale Debt Securities",
        "totalLabel": "Total fair market value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecurities",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost",
        "label": "Cash, Cash Equivalents And Available-for-sale Debt Securities, Amortized Cost",
        "totalLabel": "Total amortized cost"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_CashSweepInvestmentFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Sweep Investment Funds",
        "label": "Cash Sweep Investment Funds [Member]",
        "terseLabel": "Cash Sweep Investment Funds"
       }
      }
     },
     "localname": "CashSweepInvestmentFundsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ChangeInRightofuseAssetAndLiabilityDueToModification": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the change in right-of-use asset and liability due to modification during the period.",
        "label": "Change in right-of-use asset",
        "terseLabel": "Change in right-of-use asset"
       }
      }
     },
     "localname": "ChangeInRightofuseAssetAndLiabilityDueToModification",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.",
        "label": "Contract With Customer Liability Decrease From Revenue Deferred",
        "negatedLabel": "Less: Revenue recognized from current period sales"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDecreaseFromRevenueDeferred",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.",
        "label": "Contract With Customer Liability Increase Advance Payments Received",
        "terseLabel": "Add: Payments received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of contract with customer liability.",
        "label": "Contract with Customer Liability [Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "label": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "terseLabel": "Training on use of system term (in days)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the first conversion trigger of debt.",
        "label": "Convertible Senior Notes Due 2026, First Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, First Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026FirstConversionTriggerMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to convertible senior notes due 2026.",
        "label": "Convertible Senior Notes Due 2026 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the second conversion trigger feature of debt.",
        "label": "Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, Second Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026SecondConversionTriggerMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2028FirstConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2028, First Conversion Trigger",
        "label": "Convertible Senior Notes Due 2028, First Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2028, First Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2028FirstConversionTriggerMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2028",
        "label": "Convertible Senior Notes Due 2028 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2028"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2028Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2028SecondConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2028, Second Conversion Trigger",
        "label": "Convertible Senior Notes Due 2028, Second Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2028, Second Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2028SecondConversionTriggerMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2029",
        "label": "Convertible Senior Notes Due 2029 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2029"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2029Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CostsForExtendedServiceContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred under service contracts.",
        "label": "Costs For Extended Service Contracts",
        "terseLabel": "Costs for extended service contracts"
       }
      }
     },
     "localname": "CostsForExtendedServiceContracts",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_CuteraCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cutera core",
        "label": "Cutera core [Member]",
        "terseLabel": "Cutera Core"
       }
      }
     },
     "localname": "CuteraCoreMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_DebtConversionConvertedInstrumentCashIssued": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 2.0,
       "parentTag": "cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Converted Instrument, Cash Issued",
        "label": "Debt Conversion, Converted Instrument, Cash Issued",
        "terseLabel": "Cash used for repurchase"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentCashIssued",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 1.0,
       "parentTag": "cutr_DebtConversionNetProceeds",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Converted Instrument, Value Of Cash And Shares Exchanged",
        "label": "Debt Conversion, Converted Instrument, Value Of Cash And Shares Exchanged",
        "totalLabel": "Total shares and cash"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtConversionNetProceeds": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Net Proceeds",
        "label": "Debt Conversion, Net Proceeds",
        "totalLabel": "Value of shares and cash exchanged"
       }
      }
     },
     "localname": "DebtConversionNetProceeds",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtConversionPercentageOfDebtConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Percentage Of Debt Converted",
        "label": "Debt Conversion, Percentage Of Debt Converted",
        "terseLabel": "Portion of 2026 Note principal exchanged"
       }
      }
     },
     "localname": "DebtConversionPercentageOfDebtConverted",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtConversionUnamortizedDebtIssuanceCostsConverted": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Unamortized Debt Issuance Costs, Converted",
        "label": "Debt Conversion, Unamortized Debt Issuance Costs, Converted",
        "terseLabel": "Portion of 2026 Note principal exchanged"
       }
      }
     },
     "localname": "DebtConversionUnamortizedDebtIssuanceCostsConverted",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtCovenantQuarterlyMinimumRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents quarterly minimum revenue under debt covenant.",
        "label": "Debt Covenant Quarterly Minimum Revenue",
        "terseLabel": "Quarterly minimum revenue"
       }
      }
     },
     "localname": "DebtCovenantQuarterlyMinimumRevenue",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentAdditionalAggregatePrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Additional Aggregate Principal Amount",
        "label": "Debt Instrument, Additional Aggregate Principal Amount",
        "terseLabel": "Additional principal"
       }
      }
     },
     "localname": "DebtInstrumentAdditionalAggregatePrincipalAmount",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentAnniversaryFeeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents anniversary fee amount for debt instrument.",
        "label": "Debt Instrument Anniversary Fee Amount",
        "terseLabel": "Anniversary fee amount"
       }
      }
     },
     "localname": "DebtInstrumentAnniversaryFeeAmount",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of required outstanding amount not subject to redemption of a convertible debt instrument.",
        "label": "Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption",
        "terseLabel": "Required outstanding amount not subject to redemption"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of qualifying accounts receivable for debt instrument.",
        "label": "cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable",
        "terseLabel": "Qualifying accounts receivable (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfQualifyingAccountsReceivable",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Consecutive Trading Days",
        "label": "Debt Instrument, Redeemable, Threshold Consecutive Trading Days",
        "terseLabel": "Redemption threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdConsecutiveTradingDays",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger",
        "label": "Debt Instrument, Redeemable, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Redemption threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtInstrumentRedeemableThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redeemable, Threshold Trading Days",
        "label": "Debt Instrument, Redeemable, Threshold Trading Days",
        "terseLabel": "Redemption threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableThresholdTradingDays",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "label": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "terseLabel": "Incremental repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionIncrementalRepurchaseAmount",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.",
        "label": "Deferred Tax Assets Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.",
        "label": "Deferred Tax Liabilities Deferred Contract Acquisition Costs",
        "negatedLabel": "Deferred contract acquisition costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredContractAcquisitionCosts",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.",
        "label": "Defined Contribution Plan Maximum Percentage Of Employee Voluntary Contribution",
        "terseLabel": "Maximum 401(k) employee contribution percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DemonstrationUnitsAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Demonstration Units, Amortization Period",
        "label": "Demonstration Units, Amortization Period",
        "terseLabel": "Estimated economic life of demonstration units (in years)"
       }
      }
     },
     "localname": "DemonstrationUnitsAmortizationPeriod",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.",
        "label": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationExcludingContractAcquisitionCosts",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DerivativeCapPricePremiumOverStockPricePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percent premium over the stock price for derivative caps.",
        "label": "Derivative, Cap Price, Premium Over Stock Price, Percent",
        "terseLabel": "Premium over stock price (percent)"
       }
      }
     },
     "localname": "DerivativeCapPricePremiumOverStockPricePercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "label": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "terseLabel": "Capped-call transaction term, consecutive trading days"
       }
      }
     },
     "localname": "DerivativeCappedCallTransactionTermConsecutiveTradingDays",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_ERPImplementation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ERP Implementation",
        "label": "ERP Implementation",
        "negatedTerseLabel": "ERP implementation"
       }
      }
     },
     "localname": "ERPImplementation",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ESPPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the Company's employee stock purchase plan (ESPP).",
        "label": "ESPP [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "ESPPMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.",
        "label": "Deferred true-up",
        "terseLabel": "Deferred true-up"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Excess Compensation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Excess Compensation, Percent",
        "terseLabel": "Excess compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExcessCompensationPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Extinguishment Of Loan, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Extinguishment Of Loan, Percent",
        "terseLabel": "Extinguishment of PPP loan"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.",
        "label": "Meals and entertainment",
        "terseLabel": "Meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.",
        "label": "Permanent differences",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.",
        "label": "General business credit",
        "terseLabel": "General business credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.",
        "label": "Effective Income Tax Rate Reconciliation Valuation Allowance Percent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationAllowancePercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Debt Extinguishment Costs, Percent",
        "label": "Effective Income Tax Reconciliation, Debt Extinguishment Costs, Percent",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2004 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2004 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_EquipmentAndFurnitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents office equipment and furniture.",
        "label": "Equipment and Furniture [Member]",
        "terseLabel": "Office equipment and furniture"
       }
      }
     },
     "localname": "EquipmentAndFurnitureMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 10 [Member]",
        "terseLabel": "Exercise Price Range 10"
       }
      }
     },
     "localname": "ExercisePriceRange10Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 1 [Member]",
        "terseLabel": "Exercise Price Range 1"
       }
      }
     },
     "localname": "ExercisePriceRange1Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 2 [Member]",
        "terseLabel": "Exercise Price Range 2"
       }
      }
     },
     "localname": "ExercisePriceRange2Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 3 [Member]",
        "terseLabel": "Exercise Price Range 3"
       }
      }
     },
     "localname": "ExercisePriceRange3Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 4 [Member]",
        "terseLabel": "Exercise Price Range 4"
       }
      }
     },
     "localname": "ExercisePriceRange4Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 5 [Member]",
        "terseLabel": "Exercise Price Range 5"
       }
      }
     },
     "localname": "ExercisePriceRange5Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 6 [Member]",
        "terseLabel": "Exercise Price Range 6"
       }
      }
     },
     "localname": "ExercisePriceRange6Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 7 [Member]",
        "terseLabel": "Exercise Price Range 7"
       }
      }
     },
     "localname": "ExercisePriceRange7Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange8Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 8 [Member]",
        "terseLabel": "Exercise Price Range 8"
       }
      }
     },
     "localname": "ExercisePriceRange8Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange9Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 9 [Member]",
        "terseLabel": "Exercise Price Range 9"
       }
      }
     },
     "localname": "ExercisePriceRange9Member",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExtendedServiceContractOptionOneTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option One, Term",
        "label": "Extended Service Contract, Option One, Term",
        "terseLabel": "Extended service contract, option one, term (in years)"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionOneTerm",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractOptionThreeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option Three, Term",
        "label": "Extended Service Contract, Option Three, Term",
        "terseLabel": "Extended service contract, option three, term (in years)"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionThreeTerm",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Term",
        "label": "Extended Service Contract, Term",
        "terseLabel": "Extended service contract term"
       }
      }
     },
     "localname": "ExtendedServiceContractTerm",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase (decrease) in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_InterestExpenseAndAmortizationOfDebtIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense And Amortization Of Debt Issuance Costs",
        "label": "Interest Expense And Amortization Of Debt Issuance Costs",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseAndAmortizationOfDebtIssuanceCosts",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LargestSupplierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Supplier",
        "label": "Largest Supplier [Member]",
        "terseLabel": "Largest Supplier"
       }
      }
     },
     "localname": "LargestSupplierMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LeaseInstallmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease installment costs",
        "label": "Lease installment costs [Member]",
        "terseLabel": "Lease installment cost"
       }
      }
     },
     "localname": "LeaseInstallmentCostsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance and operating lease.",
        "label": "Lease Right of Use Asset",
        "totalLabel": "Total leased assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LeasedEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased Equipment",
        "label": "Leased Equipment [Member]",
        "terseLabel": "Equipment leasing"
       }
      }
     },
     "localname": "LeasedEquipmentMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LeasesFinancialStatementInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the financial statement information for leases.",
        "label": "Leases, Financial Statement Information [Table Text Block]",
        "terseLabel": "Schedule of Financial Statement Information"
       }
      }
     },
     "localname": "LeasesFinancialStatementInformationTableTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_LegalFeesSeveranceAndOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Fees, Severance, and Other",
        "label": "Legal Fees, Severance, and Other",
        "negatedTerseLabel": "Legal fees, severance, and other"
       }
      }
     },
     "localname": "LegalFeesSeveranceAndOther",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LesseeLeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The renewal term for leases of lessee.",
        "label": "Lessee Lease Renewal Term",
        "terseLabel": "Remaining lease terms of finance leases"
       }
      }
     },
     "localname": "LesseeLeaseRenewalTerm",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LesseeLeasesRemainingTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining term of operating and finance leases for the lessee.",
        "label": "Lessee Leases Remaining Term",
        "terseLabel": "Remaining lease terms of operating leases"
       }
      }
     },
     "localname": "LesseeLeasesRemainingTerm",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LesseeLeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating and finance leases of lessee.",
        "label": "Lessee, Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability To Be Paid After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFive",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LessorDurationOfAutorenewalFeatures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Duration Of Autorenewal Features",
        "label": "Lessor, Duration Of Autorenewal Features",
        "terseLabel": "Duration of autorenewal features"
       }
      }
     },
     "localname": "LessorDurationOfAutorenewalFeatures",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the Loan and Security Agreement.",
        "label": "Loan and Security Agreement [Member]",
        "terseLabel": "Loan and Security Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LoyaltyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to loyalty",
        "label": "Loyalty [Member]",
        "terseLabel": "Loyalty"
       }
      }
     },
     "localname": "LoyaltyMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_NumberOfConsecutiveLeaseTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Consecutive Lease Terms",
        "label": "Number Of Consecutive Lease Terms",
        "terseLabel": "Number of consecutive lease terms"
       }
      }
     },
     "localname": "NumberOfConsecutiveLeaseTerms",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stack awards counted for every share granted or canceled when computed shares available for grant.",
        "label": "Number Of Stock Awards Counted For Every Share Granted Or Canceled",
        "terseLabel": "Share subtraction (in shares)"
       }
      }
     },
     "localname": "NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_OperatingLossCarryforwardsWithoutExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating loss carryforwards that have no expiration.",
        "label": "Operating Loss Carryforwards Without Expiration",
        "terseLabel": "Operating loss carryforwards without expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsWithoutExpiration",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation And Presentation Of Financial Statements",
        "label": "Organization, Consolidation And Presentation Of Financial Statements [Line Items]",
        "terseLabel": "Organization, Consolidation And Presentation Of Financial Statements [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation And Presentation Of Financial Statements",
        "label": "Organization, Consolidation And Presentation Of Financial Statements [Table]",
        "terseLabel": "Organization, Consolidation And Presentation Of Financial Statements [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_PaycheckProtectionProgramCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Paycheck Protection Program CARES Act [Member]",
        "terseLabel": "PPP loan"
       }
      }
     },
     "localname": "PaycheckProtectionProgramCARESActMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_PaymentsOfDerivativeIssuanceCostsGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of Derivative Issuance Costs, Gross",
        "label": "Payments of Derivative Issuance Costs, Gross",
        "terseLabel": "Payment of issuance costs of capped call, gross"
       }
      }
     },
     "localname": "PaymentsOfDerivativeIssuanceCostsGross",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_PercentageOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage amount of assets.",
        "label": "Percentage Of Assets",
        "terseLabel": "Percentage of assets in the United States"
       }
      }
     },
     "localname": "PercentageOfAssets",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_PurchaseOfCappedCall": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of Capped Call",
        "label": "Purchase of Capped Call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PurchaseOfCappedCall",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest of the World, Excluding United States, Asia and Europe [Member]",
        "terseLabel": "Rest of the world, other than United States, Asia and Europe"
       }
      }
     },
     "localname": "RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents restricted stock units and performance share units.",
        "label": "Restricted Stock Units and Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPerformanceShareUnitsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsAnnualGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Annual Grant",
        "label": "Restricted Stock Units, Annual Grant [Member]",
        "terseLabel": "Restricted Stock Units, Annual Grant"
       }
      }
     },
     "localname": "RestrictedStockUnitsAnnualGrantMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsNewHireMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, New Hire",
        "label": "Restricted Stock Units, New Hire [Member]",
        "terseLabel": "Restricted Stock Units, New Hire"
       }
      }
     },
     "localname": "RestrictedStockUnitsNewHireMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.",
        "label": "Revenue From Contract With Customer Including Assessed Tax Percent Of Total Revenues",
        "terseLabel": "Total net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for risks and uncertainties.",
        "label": "Risks and Uncertainties, Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_SalesAndMarketingAccrualsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales And Marketing Accruals, Current",
        "terseLabel": "Sales and marketing accruals"
       }
      }
     },
     "localname": "SalesAndMarketingAccrualsCurrent",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Stock awards canceled (in shares)",
        "terseLabel": "Stock awards canceled (expired or forfeited) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage",
        "terseLabel": "Additional shares authorized, percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Vested, aggregate fair value",
        "terseLabel": "Vested, aggregate fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches",
        "terseLabel": "Number of vesting tranches"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year",
        "terseLabel": "Percentage of awards officers are required to hold for a minimum of one year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant [Roll Forward]",
        "terseLabel": "Shares Available For Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term [Abstract]",
        "terseLabel": "Weighted-Average Remaining Contractual Life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross",
        "negatedLabel": "Stock awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted",
        "negatedLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.",
        "label": "Share Based Compensation By Share Based Payment Fully Vested Stock Awards Grant Date Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Award, Period To Determine Grant Amount",
        "label": "Share-based Payment Award, Period To Determine Grant Amount",
        "terseLabel": "Shares granted calculation, grant period (in days)"
       }
      }
     },
     "localname": "ShareBasedPaymentAwardPeriodToDetermineGrantAmount",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_SiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to Silicon Valley Bank.",
        "label": "Silicon Valley Bank [Member]",
        "terseLabel": "Silicon Valley Bank"
       }
      }
     },
     "localname": "SiliconValleyBankMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SkincareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Skincare [Member]",
        "terseLabel": "Skincare"
       }
      }
     },
     "localname": "SkincareMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_StandardProductWarrantyTermDirectSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Product Warranty Term, Direct Sales",
        "label": "Standard Product Warranty Term, Direct Sales",
        "terseLabel": "Warranty term, direct sales"
       }
      }
     },
     "localname": "StandardProductWarrantyTermDirectSales",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_StandardProductWarrantyTermDistributorSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Product Warranty Term, Distributor Sales",
        "label": "Standard Product Warranty Term, Distributor Sales",
        "terseLabel": "Warranty term, distributor sales (in months)"
       }
      }
     },
     "localname": "StandardProductWarrantyTermDistributorSales",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1998 Stock Plan [Member]",
        "terseLabel": "1998 Stock Plan"
       }
      }
     },
     "localname": "StockPlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_StockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Purchase Plan [Member]",
        "terseLabel": "Stock Purchase Plan"
       }
      }
     },
     "localname": "StockPurchasePlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Systems",
        "label": "Systems [Member]",
        "terseLabel": "Systems"
       }
      }
     },
     "localname": "SystemsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TheAmendedAndRestated2019EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the Amended and Restated 2019 Equity Incentive Plan (the \"Restarted Plan\").",
        "label": "The Amended and Restated 2019 Equity Incentive Plan [Member]",
        "terseLabel": "The Amended and Restated 2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TheAmendedAndRestated2019EquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TotalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Total Products [Member]",
        "terseLabel": "Total product revenue"
       }
      }
     },
     "localname": "TotalProductsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TwoThousandFourEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the equity incentive plan adopted by the Board of Directors in 2004.",
        "label": "Two Thousand Four Equity Incentive Plan [Member]",
        "terseLabel": "2004 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFourEquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2019 equity incentive plan.",
        "label": "Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Government Treasury Securities And Money Market Funds",
        "label": "US Government Treasury Securities And Money Market Funds [Member]",
        "terseLabel": "US Government Treasury Securities And Money Market Funds"
       }
      }
     },
     "localname": "USGovernmentTreasurySecuritiesAndMoneyMarketFundsMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_UnderwriterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the underwriter.",
        "label": "Underwriter [Member]",
        "terseLabel": "Underwriter"
       }
      }
     },
     "localname": "UnderwriterMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the underwritten public offering.",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten Public Offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Valuation Assumptions and Fair Value of Stock Options and ESPP Grants [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions and Fair Value of Stock Options and ESPP Grants"
       }
      }
     },
     "localname": "ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_VoceCapitalManagementLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voce Capital Management LLC",
        "label": "Voce Capital Management LLC [Member]",
        "terseLabel": "Voce Capital Management LLC"
       }
      }
     },
     "localname": "VoceCapitalManagementLLCMember",
     "nsuri": "http://cutera.com/20221231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r256",
      "r308",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r336",
      "r402",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r410",
      "r412",
      "r413",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r840",
      "r841",
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r256",
      "r308",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r336",
      "r402",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r410",
      "r412",
      "r413",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r840",
      "r841",
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r418",
      "r448",
      "r731",
      "r739",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r342",
      "r760",
      "r846",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r489",
      "r660",
      "r686",
      "r708",
      "r709",
      "r757",
      "r768",
      "r776",
      "r842",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r489",
      "r660",
      "r686",
      "r708",
      "r709",
      "r757",
      "r768",
      "r776",
      "r842",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r342",
      "r760",
      "r846",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r338",
      "r662",
      "r758",
      "r774",
      "r838",
      "r839",
      "r846",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r338",
      "r662",
      "r758",
      "r774",
      "r838",
      "r839",
      "r846",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r471",
      "r489",
      "r521",
      "r522",
      "r523",
      "r636",
      "r660",
      "r686",
      "r708",
      "r709",
      "r757",
      "r768",
      "r776",
      "r836",
      "r842",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r471",
      "r489",
      "r521",
      "r522",
      "r523",
      "r636",
      "r660",
      "r686",
      "r708",
      "r709",
      "r757",
      "r768",
      "r776",
      "r836",
      "r842",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r254",
      "r255",
      "r418",
      "r448",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r263",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r339",
      "r340",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r711",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r759",
      "r775",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r339",
      "r340",
      "r694",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r711",
      "r712",
      "r759",
      "r775",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r773"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $2,497 and $899, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r17",
      "r735"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Bonus and payroll-related accruals"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r215",
      "r682",
      "r691",
      "r692"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r26",
      "r29",
      "r149",
      "r624",
      "r687",
      "r688",
      "r799",
      "r800",
      "r801",
      "r814",
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r814",
      "r815",
      "r816",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r131",
      "r132",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r216",
      "r346",
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit loss, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesMember": {
     "auth_ref": [
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from loan and lease portfolio.",
        "label": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]",
        "terseLabel": "Allowance for credit losses, accounts receivable"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfAcquisitionCosts": {
     "auth_ref": [
      "r53",
      "r90"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Acquisition Costs",
        "terseLabel": "Amortization of contract acquisition costs"
       }
      }
     },
     "localname": "AmortizationOfAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r35",
      "r437",
      "r600",
      "r803"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r437",
      "r600",
      "r755",
      "r756",
      "r803"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "negatedTerseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetUnderConstructionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset in process of being built.",
        "label": "Asset under Construction [Member]",
        "terseLabel": "Assets under construction"
       }
      }
     },
     "localname": "AssetUnderConstructionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r179",
      "r191",
      "r211",
      "r250",
      "r316",
      "r328",
      "r334",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r570",
      "r573",
      "r587",
      "r773",
      "r840",
      "r841",
      "r902"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r205",
      "r220",
      "r250",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r570",
      "r573",
      "r587",
      "r773",
      "r840",
      "r841",
      "r902"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r348",
      "r361"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Marketable investments - U.S. Treasury"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss",
        "terseLabel": "Net unrealized loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r82",
      "r347",
      "r361",
      "r678"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cutr_CashCashEquivalentsAndAvailableForSaleDebtSecurities",
       "weight": 1.0
      },
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair market value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r157",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California Franchise Tax Board"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of capitalized contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized costs, amortization period (in years)"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Total capitalized costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r55",
      "r208",
      "r732"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents, Marketable Securities, and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r50",
      "r55",
      "r61"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cutr_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Cash, cash equivalents, and restricted cash as reported within the Consolidated Statements of Cash Flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r50",
      "r55",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r172"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount",
        "terseLabel": "Cash, FDIC insured amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r250",
      "r279",
      "r283",
      "r286",
      "r288",
      "r297",
      "r298",
      "r352",
      "r402",
      "r405",
      "r406",
      "r407",
      "r413",
      "r414",
      "r446",
      "r447",
      "r449",
      "r450",
      "r452",
      "r587",
      "r710",
      "r787",
      "r805",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r23",
      "r184",
      "r196"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13)."
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r814",
      "r815",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "verboseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r773"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 19,668,603 and 17,995,344 shares at December\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r31",
      "r229",
      "r231",
      "r236",
      "r679",
      "r683"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r69",
      "r70",
      "r170",
      "r171",
      "r342",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r69",
      "r70",
      "r170",
      "r171",
      "r342",
      "r693",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r69",
      "r70",
      "r170",
      "r171",
      "r342",
      "r696",
      "r914"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r189",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r69",
      "r70",
      "r170",
      "r171",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r69",
      "r70",
      "r170",
      "r171",
      "r342",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Description of Operations and Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Deferred Service Contract Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r454",
      "r455",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "terseLabel": "Accrual for loyalty program"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Less: Revenue recognized from beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Convertible debt at fair value"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r107",
      "r415",
      "r416",
      "r427",
      "r428",
      "r429",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible notes, net of unamortized debt issuance costs of $12,666 and $4,007, respectively"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r78",
      "r327",
      "r328",
      "r329",
      "r330",
      "r336",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Items not allocated to segments"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r38",
      "r662"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r808",
      "r879",
      "r881"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r808",
      "r879"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r554",
      "r562",
      "r808"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r808",
      "r879",
      "r881"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r68",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r58",
      "r60"
     ],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 1.0,
       "parentTag": "cutr_DebtConversionConvertedInstrumentValueOfCashAndSharesExchanged",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Value of shares issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r58",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Shares issued in debt conversion (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r249",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r431",
      "r438",
      "r439",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r180",
      "r181",
      "r190",
      "r256",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r601",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r181",
      "r190",
      "r442"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r108",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r20",
      "r114",
      "r115",
      "r117",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Convertible debt, conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r20",
      "r114",
      "r115",
      "r117",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Debt convertible to common shares (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Conversion threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r174",
      "r176",
      "r415",
      "r601",
      "r753",
      "r754"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r429",
      "r586",
      "r753",
      "r754"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r19",
      "r174",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate during period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r19",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r256",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r601",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r114",
      "r116",
      "r117",
      "r118",
      "r173",
      "r174",
      "r176",
      "r188",
      "r256",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r601",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term (in years)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r173",
      "r176",
      "r843"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r175",
      "r427",
      "r443",
      "r753",
      "r754"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "terseLabel": "Debt issuance cost accrued"
       }
      }
     },
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-Sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r808",
      "r880",
      "r881"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r175",
      "r843"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r143",
      "r808",
      "r880"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r539",
      "r540"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r53",
      "r143",
      "r555",
      "r561",
      "r562",
      "r808"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r791"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r792"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r808",
      "r880",
      "r881"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax asset before valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r877"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Net deferred tax asset",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r877"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax asset after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r139",
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Section 174 Costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Other accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r141",
      "r144",
      "r145",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r141",
      "r878"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer 401(k) discretionary contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r796"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Deposits Assets, Current",
        "terseLabel": "Deposits with vendors"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r53",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r53",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r886",
      "r887",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Gross notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCapPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.",
        "label": "Derivative, Cap Price",
        "terseLabel": "Cap price (in USD per share)"
       }
      }
     },
     "localname": "DerivativeCapPrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r158",
      "r159",
      "r162",
      "r163",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r167",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r221",
      "r222",
      "r586",
      "r741"
     ],
     "calculation": {
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities:"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r161",
      "r162",
      "r164",
      "r165",
      "r166",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r467",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r495",
      "r526",
      "r527",
      "r528",
      "r533",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r237",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r277",
      "r279",
      "r286",
      "r287",
      "r288",
      "r292",
      "r577",
      "r578",
      "r680",
      "r684",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per share, basic (USD per share)",
        "verboseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r237",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r279",
      "r286",
      "r287",
      "r288",
      "r292",
      "r577",
      "r578",
      "r680",
      "r684",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)",
        "verboseLabel": "Net income (loss) per share, diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Dilutive effect of incremental shares and share equivalents:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]",
        "terseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Computation of Net Income (Loss) per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r252",
      "r542",
      "r564"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r875",
      "r882"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r875",
      "r882"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r875",
      "r882"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Change in prior year reserves"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r875",
      "r882"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r113",
      "r202",
      "r233",
      "r234",
      "r235",
      "r264",
      "r265",
      "r266",
      "r268",
      "r274",
      "r276",
      "r296",
      "r353",
      "r453",
      "r529",
      "r530",
      "r531",
      "r557",
      "r558",
      "r576",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r624",
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": 2.0,
       "parentTag": "cutr_DebtConversionNetProceeds",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "negatedTerseLabel": "2026 Note principal exchanged",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Extinguishment of Debt [Line Items]",
        "terseLabel": "Extinguishment of Debt [Line Items]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r579",
      "r580",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r168",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets Measured and Recognized at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r429",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r580",
      "r633",
      "r634",
      "r635",
      "r753",
      "r754",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r429",
      "r473",
      "r478",
      "r580",
      "r633",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r429",
      "r473",
      "r478",
      "r580",
      "r634",
      "r753",
      "r754",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r429",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r633",
      "r634",
      "r635",
      "r753",
      "r754",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r583",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r605",
      "r611",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r607",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flow"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r603",
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Finance Lease Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities, non-current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r606",
      "r612"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Payments on finance lease obligation",
        "terseLabel": "Financing cash flow"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r602"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 2.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r605",
      "r611",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r615",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r614",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r349",
      "r350",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r440",
      "r451",
      "r575",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r750",
      "r824",
      "r825",
      "r826",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Cloud computing arrangement expected contract renewals (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r387",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r588",
      "r589",
      "r590",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency transaction gains"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r54",
      "r891",
      "r892"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Unrealized loss on foreign exchange forward"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign exchange forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office equipment and furniture"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r803",
      "r831",
      "r835"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedTerseLabel": "Loss on sale of property and equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r53",
      "r109",
      "r110"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain on extinguishment of PPP loan",
        "terseLabel": "Gain on extinguishment of PPP loan",
        "totalLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r209",
      "r372",
      "r677",
      "r751",
      "r773",
      "r829",
      "r830"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r375",
      "r751"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill additions during the year"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r53",
      "r373",
      "r378",
      "r383",
      "r751"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r491",
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r491",
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r37",
      "r250",
      "r316",
      "r327",
      "r333",
      "r336",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r587",
      "r749",
      "r840"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization": {
     "auth_ref": [
      "r388",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization",
        "terseLabel": "Capitalized computing accumulated amortization"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization": {
     "auth_ref": [
      "r388",
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization",
        "terseLabel": "Capitalized computing set-up costs"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization",
        "terseLabel": "Capitalized computing amortization expense"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostExpenseAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostImpairment": {
     "auth_ref": [
      "r388",
      "r392"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Impairment",
        "verboseLabel": "Impairment of capitalized cloud computing costs"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r251",
      "r563"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r32",
      "r177",
      "r185",
      "r200",
      "r316",
      "r327",
      "r333",
      "r336",
      "r681",
      "r749"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r251",
      "r563"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r393",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r252",
      "r543",
      "r547",
      "r553",
      "r559",
      "r565",
      "r567",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r253",
      "r275",
      "r276",
      "r314",
      "r541",
      "r560",
      "r566",
      "r685"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision",
        "totalLabel": "Tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r232",
      "r537",
      "r538",
      "r547",
      "r548",
      "r552",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid (refunded) for income taxes, net of (refunds) payments"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r183",
      "r198",
      "r793"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Foreign tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Change in deferred tax assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r288",
      "r494"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based payment arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense [Abstract]",
        "terseLabel": "Interest and other income (expense), net:"
       }
      }
     },
     "localname": "InterestExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r41",
      "r435",
      "r445",
      "r755",
      "r756"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedTerseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r278",
      "r284",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Payment of accrued interest"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r245",
      "r247",
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r794"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Demonstration inventories included in finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r88",
      "r736"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r218",
      "r733",
      "r773"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r207",
      "r217",
      "r294",
      "r365",
      "r366",
      "r367",
      "r661",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r88",
      "r738"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r87",
      "r795"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Valuation adjustment for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r88",
      "r737"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAndCash": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date.",
        "label": "Investments and Cash",
        "terseLabel": "Investments and cash"
       }
      }
     },
     "localname": "InvestmentsAndCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Accounting for Leases as a Lessee"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r618",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Accounting for Leases as a Lessor"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r619"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNoncancellableOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Operating Lease, Term of Contract",
        "terseLabel": "Lease term (in years)"
       }
      }
     },
     "localname": "LessorOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Outstanding letter of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r16",
      "r250",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r571",
      "r573",
      "r574",
      "r587",
      "r748",
      "r840",
      "r902",
      "r903"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r182",
      "r195",
      "r773",
      "r807",
      "r827",
      "r890"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r206",
      "r250",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r571",
      "r573",
      "r574",
      "r587",
      "r773",
      "r840",
      "r902",
      "r903"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r15",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Commitment fee amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r15",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r23",
      "r837"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated product liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r181",
      "r192",
      "r428",
      "r444",
      "r753",
      "r754"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-Term Debt",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r51",
      "r54"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r33",
      "r54",
      "r186",
      "r199",
      "r204",
      "r227",
      "r230",
      "r235",
      "r250",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r275",
      "r276",
      "r285",
      "r316",
      "r327",
      "r333",
      "r336",
      "r352",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r578",
      "r587",
      "r749",
      "r840"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total interest and other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReduction": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.",
        "label": "Notes Reduction",
        "terseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "NotesReduction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r316",
      "r327",
      "r333",
      "r336",
      "r749"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r895"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of comprehensive income that includes operating lease income.",
        "label": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseIncomeComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r295",
      "r617",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r295",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current",
        "verboseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r608",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r602"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 1.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r615",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r614",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r62",
      "r63",
      "r74",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r223",
      "r224"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax",
        "verboseLabel": "Net change in unrealized gain (loss) on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r223",
      "r224",
      "r225"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "totalLabel": "Total change in unrealized gain (loss) on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r228",
      "r231"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net change in unrealized gain on available-for-sale investments",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r27",
      "r30",
      "r85",
      "r226"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Less: Reclassification adjustment for net losses on investments recognized during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapital": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of ownership interest of different classes of partners in limited partnership.",
        "label": "Partners' Capital",
        "terseLabel": "Total capital spending"
       }
      }
     },
     "localname": "PartnersCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r244",
      "r742"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Financing Activities",
        "negatedLabel": "Purchase of capped call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Extinguishment of convertible notes"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of issuance costs of convertible notes"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDerivativeIssuanceCosts": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of a derivative security.",
        "label": "Payments of Derivative Issuance Costs",
        "negatedLabel": "Payment of issuance costs of capped call"
       }
      }
     },
     "localname": "PaymentsOfDerivativeIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Issuance costs on the public\u00a0offering",
        "terseLabel": "Stock issued, offering cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r241",
      "r883",
      "r884",
      "r885"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Acquisition of property, equipment and software"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Acquisition of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r471",
      "r472",
      "r478",
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Defined Contribution Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets and prepaid expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r219",
      "r368",
      "r369",
      "r734"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailOtherCurrentAssetsandPrepaidExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from convertible notes, net of unamortized debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Gross proceeds from equity offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from PPP loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r45",
      "r130"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r81",
      "r239",
      "r240"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of marketable investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from PPP loan"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales of marketable investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r17",
      "r98",
      "r99"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Product warranty"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranty"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarranty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r833",
      "r894",
      "r896"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r834",
      "r896"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r790",
      "r832",
      "r893"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "verboseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment",
        "verboseLabel": "Schedule of Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Transfers and Changes",
        "terseLabel": "Transfer of inventory to property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTransfersAndChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "verboseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r238",
      "r356"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r480",
      "r625",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r480",
      "r625",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r134",
      "r201",
      "r910"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenditures"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/FairValueofFinancialInstrumentsDetails",
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r788",
      "r804"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "netLabel": "Restricted cash",
        "terseLabel": "Current restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r695",
      "r789",
      "r804"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r119",
      "r194",
      "r690",
      "r692",
      "r773"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r202",
      "r264",
      "r265",
      "r266",
      "r268",
      "r274",
      "r276",
      "r353",
      "r529",
      "r530",
      "r531",
      "r557",
      "r558",
      "r576",
      "r687",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r307",
      "r308",
      "r326",
      "r331",
      "r332",
      "r338",
      "r339",
      "r342",
      "r466",
      "r467",
      "r662"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r470",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceBenchmarkMember": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer for specified product or service, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer, Product and Service Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceBenchmarkMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Deferred revenue balance, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Deferred revenue balance, recognition period (in months)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Deferred revenue balance (as a percent)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Net revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r613",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Assets acquired under finance lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r613",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Assets acquired under operating lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r342",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-Sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement Cost by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r161",
      "r162",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r64",
      "r67",
      "r279",
      "r283",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTable": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to debt extinguished, including the amount of gain (loss) on the debt extinguished, the income tax effect on the gain (loss), and the amount of gain (loss), net of the related income tax.",
        "label": "Schedule of Extinguishment of Debt [Table]",
        "terseLabel": "Schedule of Extinguishment of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfExtinguishmentOfDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of debt extinguished which may include, amount of gain (loss), the income tax effect and the per share amount of the aggregate gain (loss), net of the related income tax.",
        "label": "Schedule of Extinguishment of Debt [Table Text Block]",
        "terseLabel": "Schedule of Components of the Loss on Debt Extinguishment"
       }
      }
     },
     "localname": "ScheduleOfExtinguishmentOfDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r11",
      "r12",
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Product Warranty Accrual"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarrantyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r61",
      "r178",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Restricted Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r36",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r491",
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement Exercise Price Range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r120",
      "r123",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r771",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r304",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r342",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r396",
      "r397",
      "r751",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r316",
      "r319",
      "r330",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information and Revenue by Geography and Products"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofRevenuebyGeographyDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "negatedTerseLabel": "Stock-based compensation",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited(in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Awards granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding (in shares)",
        "periodStartLabel": "Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding (in dollars per share)",
        "periodStartLabel": "Outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant- Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional stock available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Options cancelled (expired or forfeited) (in shares)",
        "terseLabel": "Options cancelled (expired or forfeited) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options cancelled (expired or forfeited) (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance (in dollars per share)",
        "periodStartLabel": "Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r499",
      "r518",
      "r519",
      "r520",
      "r521",
      "r524",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Exercise price, lower range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Exercise price, upper range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r493",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Share-based Payment Arrangement, Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r491",
      "r496",
      "r497",
      "r498",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Share-based Payment Arrangement, Nonemployee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)",
        "verboseLabel": "Stock price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of stock, percent of market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Common stock issued, price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Less: Settlements made during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Add: Accruals for warranties issued during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Warranty Obligations"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r203",
      "r304",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r342",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r394",
      "r396",
      "r397",
      "r751",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsScheduleofSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r250",
      "r279",
      "r283",
      "r286",
      "r288",
      "r297",
      "r298",
      "r352",
      "r402",
      "r405",
      "r406",
      "r407",
      "r413",
      "r414",
      "r446",
      "r447",
      "r449",
      "r450",
      "r452",
      "r587",
      "r710",
      "r787",
      "r805",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtComponentsoftheLossonDebtExtinguishmentDetails",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r25",
      "r113",
      "r202",
      "r233",
      "r234",
      "r235",
      "r264",
      "r265",
      "r266",
      "r268",
      "r274",
      "r276",
      "r296",
      "r353",
      "r453",
      "r529",
      "r530",
      "r531",
      "r557",
      "r558",
      "r576",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r624",
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r296",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common stock in repayment of convertible notes"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "ESPP stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for employee purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of issuance costs and repayment of convertible notes (in shares)",
        "verboseLabel": "Issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for employee purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r113",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of issuance\u00a0costs and repayment of convertible notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r113",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r113",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r80",
      "r773",
      "r807",
      "r827",
      "r890"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r598",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r627",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Schedule of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Detail"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetail"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r763",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r763",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r349",
      "r350",
      "r440",
      "r451",
      "r575",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r824",
      "r825",
      "r826",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r746",
      "r765",
      "r767",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsMarketableSecuritiesandRestrictedCashSummaryofCashandCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized loss"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r536",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decreases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r299",
      "r300",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax assets valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r257",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r278",
      "r288"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r277",
      "r288"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1,2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118198657&loc=SL118198666-228104",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r777": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r778": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r779": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r781": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r782": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r783": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r784": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r785": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r786": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131251-203054",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>123
<FILENAME>0001628280-23-011123-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-011123-xbrl.zip
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M\DV\U+^=2BW5. PYH[:*$[$QX*TM-FX_3M^!)PY-/Y$.B&(L7F8<Q>7#90"
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ME2JO=O_$R6U58(&"IO=)N0OC?!ZJ2)YV%IXJ5<1+3;!C,)T&:98$9TNI/0$
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M<A$)XQHODZ\!#"M<^KYY!<XUA.%-+1DWG_OZ];?A>'AT<M03#O V$#DE4(4
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M$Q:A9#+%Q")3+0UD/&:O8R1OJ91,/5!V/X P#Y%JL($CFQ5H56(,:&PNV42
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M)):LH@E>!"#G, 2324:*TJN2Q%:9K -I=..5B.B")9=<T  )4:5D(9LH$!C
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M;<B8(196KPH ;#WOR):3]Z+F'@]]J#"^5B!V(F4Q>!6#A+92C4T&9<(8?#T
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M_585ID,I9_=K2I,I,4O'Y1@N&L_0UMZ^4T<>>@D@!LKQW&0]\2';XI4J<XQ
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MI9F#J5.>$$<CI]#\$'5NH TNJ19,-U/E,/Q;H'=J5MA/J?%)=% #\KDPW<)
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M2<C.!HJ'PM4#ZS3;"G2K,*B-G2T=$.:@*S1A,,-M&@2>4X+WD1B"'C1Y&HR
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M1Y(T\'\$[L"X9V:00O=;]BM _ %^N5X)V6QN@PYJ41=;:9LTPS$L8+)F=8G
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M)T9 IA$RT0SX/J8'&C:+VUP]PLJ,*V5.26O1;-H"TR;P/P6>3/<"R&,8':Z
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M"@LM@=3\#*Q&G<5D?,!J>ZV.NSVF#X74J==%U\>5=^_HA4S8Y+8.! 8=K5'
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M<%^D,S'+8@[&Q!BW+ 88?2M*1?O 5EW5N\##^R+[18;4H[><U__J2454NT;
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MUK1T(=S4*#!*Q()&++2J"'US43ENBU/8*<J0N5YIPU@#D8-A2!U4!6A?[%E
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M%?9:'+-OBY^R:SP] [L"NI>_;P0#MSQ).DN)I8LN+ZN?S'Q/GCB.TO7.*;(
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M'W!P(NBDK3%-4L.I&#_4_DVRF@PX*3ZAV]0;);&LN@+6@(&7P/XBOLSP'.[
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M,&.^$2BF$Z@1@Q)B4)Z-&)3#&,N(07E8@Q\Q*/=I)7'8'>B!T"#BK &.%XF
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M7^H%#>0_\2S1QG(_])MO8$Z2%[26?(@GG[]Y\>*++VE@O2M"+?'9FQ=./SQ
M-2M[J#9'4X2XG%E=3:=DL">&5!!9+4O8C1NR51IK/9+2N#!Y48C=QCNNS=Y#
M2W!K>IK6LH.A>DS["H;T'%V/RP596*R)U%;C'S;<[KN,TM^TM<@@K\VZJJ73
M)@T$FTL,?3K8%@LV)]WN,FA1/97MF]F0^K3H\-!DLK%J7_1&7X-%2C(!GHTU
M0MZ$VEBFQ\RB6Y!JF_%L3&DO-?.N2';,ITP1O9F"T\&H<L*WHC.,&S.75>C
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M7.Q"#@/6%7G,ZV">\=8['/DU^;-U$WLV.5RSR;]XABNH[;(D=V#*^Y"/9SX
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M"R*GYL(TMLQJ*X?1F,%! IFF"82"@[&ZU)<Y&8(HJ_DXD9AF:Z"B&!<'CB4
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M/Z7BBCU;K'T(M=[A8CEQDJI1%AVNE4B3;LWA%BDHD\Q(7;$.5C 1R><6V78
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M5DWR^6>O?_WAK/GLBY0;*)1<56:_32W9II5F[D&LB9G@8;";6LO-D5U*G7(
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M#KWQ %$GHHCC<50X5Z8E(4F.#811U@Y6UK0;IM*P2$Y)*^/>*+70"Q:RY%W
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MSHB'1GW0FXQ)$-+ /+%(;FN1C/(WRM]UY&^4$S><,$$PRLP^G56;==?Z;J#
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M-M.ZVZ7O><:M:A8V5JN-SV]R>=)NUEH C4FB4[%<"!VSK#X35QDN=8X.[2M
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M$/] 21KY!T?^2KI5:6J_9Z(6SGTGUX\B,&NGV=KFG*0Q12ME7VXJ_!;'Z6+
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MK 3588"!4\TRH6<%19*Q;S#U<C:-,%2VX8&<>"@A[-C7%4CDDP)-/-F'"(?
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M$<LV>/ LFU>:7R->,0K<\K4?4K^S@:==\]S /I4.6,Z!C.@@O!@"/6*HNTI
MT0D]^;#<:J,H2H@,(RFU61*T#&@X!E%5B(PHFS"J$A"1QP/<<CS$2K1NLZD1
M[B4@$4:V4$9A6I>Z370G&),;(WBM+X4"FLVD,;^-GU9D3^(IH-W9PM9M;J6
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M#^G6E?GG1A#Z*?5/7)10WU?>EJ ?/-\AVJ5^T8>UT.\,"-0JR:DQZ82J?!6
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M 1]*F)&TI"]UA^$;]>UG,5GI/=.NZ4/ZE@5YN '1WWW8]>SOR15 XZ!&+K^
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MR+KBJ;2J/\/OE6 >!J-9C_23PU'3U!7! DB065B!::;1Z?;HNBZ)&"9^%>N
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ME;:U;W29Z,LD9"?1_*9CS\7*I($DF&P*YZ_=-+,8KQ+#'4P#%9;@A(@GJ4E
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M97KD3O6&G^6CQ3+2NYK?[_..VVJHGY><+/."AP8;';2GQ-6%ROLXKSJ5P&4
M2[P2>@7*'MC=5=,+R*2O#GFQ#KE8,EZ$YT@LVF@EFMOXOU8"0#/<CR5WO@%
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M6+Q1Z-K64D2\8\Z! 1)N=7K5DR$#\LRH!UYAJ$\B7X)-H."-68H_#K'Q$@D
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M\'OVE'Y>$QS[Q)D,7)<@FU"G+Z?91I:7%*TC>6?NA@Y=IEAT()77!0)+NV'
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MAW.I-;$CB))'-Y[#!>DP=^$%R.Z,:!VYXH:<_B(W,S\.80TOP,*I&-\!.\0
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M65J3.VO!_@PC:\;#6<26<\^Q& AK:JJXC$(W=1++@:_,PNC.NO5@06?.@AF
MCXD^/)RVML'8H IA$ERE"\EZ ,3Y;!GS-^J'MZX7+WUV]\8+:/OTI;=R>:E
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M=PIIFGP=0W;;J[KVP!X]],+#2)1FL<[09  :B?+L%RM@/7<ZM90H^]7CK2(
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M()8LE^<GHNH@LO/%TQRUNCEZ!36X_(;Y*4OP3SCY%(B+VBGC2__)@Y;U/HP
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M;C*7/J?^16G\M_.OL$D,1E12_16-3G!D.8]>B+&'W2(Z]/_.LV&L2S;CQQ/
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ML&ML(6H#).V3D#%4_SVH7K]-H_XBZI:LC(S TN3B,I]J'"ACE*[OMC)(@%7
M[K1B9\[=U,>;08T@R^6M2"]5+Z6F#F]!R!IR>"YRH"(:RC9U1,&;8&CL]^5-
M/4QZ#*-E2,R*B:LU]Q4JTXK0]"!17F(!BV3UQ/.?A9H7Z-;A93K2LFW-2TQ_
M3-\)A9:A2@.1>:<Y!#M8Z;(223H.4C2+EUI8\Q.Y).OS)"$^"]>,^ :>,7G6
M^AXLE\=.Y$W473XJ^2C&7&O?YYE26[*(S2*V!/-K$H)2I]2H!7SNYL:!J(9
M*IF&:93,,Q-:U,MU*8Q^3WZ@EFF,E12ZM!6ZT8LU)YTJUT!+XQV)H$R1N237
M[*WU*Z%@ )9#3(!(%ZLE;^I&0"9=R,HY4@":/@8[EL=Y_IA>#*#?#MR&J>_B
M98),8*=\CR5:&)$JAUFKK,.$%=T>L-=+Z:CIE6R M.F+]U3:B2L<V:\0(=.4
M6V&;@$*AO8" *7N5&@+AV53A1:>(6XX7+;(%D70W]-G!)?EEF$\H4U1BGB18
M_E@!&IY8C@)]^W3N$4>NW=S@:8WHY@S@G7!*,$)W2)0;?@A!&V"2FR@IO+^$
ML'ERX6(J$OIDO9L2OT0OLF!."[^41-W20!K'VM4F?EF<)!!O/+V3=)J=9'XY
MAKF!DBO(F0Y]3JTUJPG\7EZ3U,-R71$)#3+= (9JI25DWIU*CQ6,*IP1AUZV
M*:2H98@!."YF5=:9("H#AR?W!0XK@?WUYTGTTZ^[?Z\^ 4:MH/[9HHPRS99$
MT<EWC# ^]-B,$_'2D4@9KLN;H\EX9-?$(Y\Y'EGLW&$"D28061*(M.Z)06I$
M]-+!1\O$'>M)Y";N:,CA>>*.C;?6]?CDBNU<Z]AD+O;K$Z!\*#$<9*KJV'2[
MK0<L)NNT6< ?1-9I;?3C%G<[XE8G*_ LO=9!-W[E:N=1%SHGVH6.#!$\R:7.
MB7:I\Z3W.2</O,^Q98D)AHNY!,LVESRUN>0Y^4Z7/(TWM/]_]K[UN6T<V?=?
M8>GLAZ2*=OA^.'-4Y=C.K._)6+ZV<_;NIRV0!&WNR*26I!Q[_OJ+!DB)>MF2
M2$F@B*V=Q+$D"D#_NM'OGJV_?RM*J@*,G^>/<F)HTNS((E6 ]I"8:.K55V91
M (\N'@O&+(/\*CUZAC%7 #\I3.$UO9SO-C&%ZBZ*D8GK\UT_(?DEP$G"+!I4
MWV=*#F"UKW3BOYJV$%WE(Z6,Q=[^>>IAE9>Y6-<SAH+",;38';GH&T:KXHIC
MKO@*6*?;Z;_9N4V]L(I2<6HM^L[F@)<G3!8#>B#-?S0<9Y5*/+ &1R@*IHUV
MH2$D](_#KS-[GG-FG$K7,]BHQ#!+I.)?I1.YB"92,VV<PYU+#VD.J P#?R/[
MV[I7]#.T,O%FOZ4L=<S&WK\+\5X][,E]1@PS_(+BO/IJ01^ZX>.58M?0E6NE
MHX0Y5*!Q,'20+4UZ>C54[&YZJO2^GT$%_76EG<_;DB#S0AR12(<%:Y_VZ&-%
MM:4(9/K--/I &;CR;: LH:$_9EUX"*'?XYQL%DEK\4G!Y>_)@.]$I8:F:="8
M_8+U ZRLD#'2^:3'ZO!MZC-9Y.1?3]/L MK5*XZKZ@NB+4O*+RN;#\*=SR*@
M95>8&<579KWAAY,N*]7YFG-.[B/F@#E%&12ZHA,-4;MBN+G']'H!;;9:4<W:
M[$(OI>)M]!#?5MV;,PTE66<O6LP]C/P(Y@(0$96D 2BW2UM SNOSE ?9O4#7
M &-:85/P]65.QJ3AVV0$&\T[*_K53#:U=&6%U'QG2?/WZC1!Z//":LONZ?\>
MKW%2R]<UHWL7GWQ!P_%$42F&XK))=F5LM_J,A54%2:E9L 8"\5NERBU)*Z5M
ME3YY3.TJ.Q2Q)L>EG3A)A:DT-Z;AUTK_0M:(=69O1?1T^JZT*BA /9E,YYOT
MJ"NZJ!T#6ZY,K7&/L":O,E)@+RDSKBC*:V]<:W4JC,ADV7DFBRLR6;A /[^9
M+&N5U%60=.AT%E%+QS/<5^2TS.%')+,<.PZZ5D0WIZWRGJ3B\I*DPJLYUZJP
MJ[NCL*N[J["K*\*N1QEV=?<4=NUB:IJMB-0T/M8B4M/:M?ANIZ:U2;=Z/Q/%
MG<]$F=R!2[-1YE^MF9'BBHR4KF>D6*W(2'%79*1L/N]:)*/L,!EE<LX[S4AQ
M.<A(<?G+2'%%1LJ>,E)</C-2W+F,%/?P&2GN1QDI]&NFF1^?%Q;/5X**VX$$
ME4/ZIND3SR(BF2)_C524ZU+(WL%=!%#Z Z5_8O+O*/N3RPT>8@ I=71-)L8.
M7N@LM^D%1>]Q(I? >?1"Y\%1<X2<$MDA>5M(.(5.O20 F@X)D0B_I\DOUER8
MZLK%=_JS0T_)/?>"HB&L:O8;EW]L.LCQ85GTQT/^GX\I^?[@I"!*2/_W=5\D
M D%"+1(P(#;9$)RJ1\=9@THIA<.$R8<1C9+',#*<ZE.E^@Z/NDTA@$CO5"J
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M+D(+:A)X&)J\37/":/U<-7E_R5U<M8@>RIRBA<=7\J&6/"-$T1!2F""^.N7
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M=2D0 .00@(U'(1L$H$W;P>F:R1$ 1:Q1^,UW&FMLD']HL%[6U=KY9R)PPR\
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MLL@]JJ@&'3#H.+4=H'MAQ<(U6JZB/'^#,EK3OOLUGO'Q;NL\7:Q0K+"C*^Q
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M>HX::I;OX$;X?)&5M9H>+<'%@HL%%T^X&&-?#3W;,1 BM[6BD#^QX@?8<<V
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M1DF&AJMU#Q'VW)O>D28$Q$'VG1@T]X1%!N&:'/9^I,D5D:;C!V/SBL<F8%P
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M OR"A\DHDR6REG&(_'R<PH3.(,KR-/+(D\@_X-C($?P)+3!QC-/'MQ,/93B
MP"2XXJ31$.7@A,OHK,]G'("OB[P*KC4X6)R2I^"8F*[@ 2++>89,OR2$_+\\
MQ8@!$GY'7HM2R2>'FA &R4[)SB1PL<%39+J18@?5%9+?1VEP CZDM^H^ BG[
MDQ ;?$W%2LD#'RK/H 51<3Y\FVP/OB%,AL/D%ZPT>\MRLM;)]LYV+<E6(GTY
M^<]?HHLA1BD<[A!^CV/YF 7]AL>#7WT\)*A)Q_?^>#C*9>D>^RG.I=N[P2&/
M2>;LG(I3N?M^6/" F.'K8%YQ<M 3*6Q("2/_"6ZK7T\1^8$*4O(M2^4L3:'&
M*8@K$'H^#D"@P_SEX3B@TK>4MU16(S_&LN0EP1M511):&RI3N2F1SXU3(DK+
MP7DI?J$GQZQ-67I"1%3#"\2\S).$O/Z<O"#"<,4/L&(/Q^26E$;1(WPED<AD
MX7 5LTOE!66$,5$*W\UD/!'0]^1*2MFG*_*>'H7]-2MD<E;<'L_C80Z7.5D,
M>=XHPCYFUSP:C0B-V;TOPTF\1'3[DZN%B?HA?HU8LT(XN/'H,44!+FZAXIO8
ME9&A0F/X%'TN7Y'+"Z+X7+&KZE(^$:P,,8U6D5NFN(3OV<?+&YJ<*R8:Y.>O
MY-GDX=!+&E9*OHLO;BAOFX.R!%%8(CC8$KP5/'_JE2OLS9XI.=04DTO<I\&C
M*GUXD\0/Y)UQY<8ZZ%'K?)W-I<S'L?!W39%S^8Y?#WHH_IM/A'"*PV@X!#&8
M2;_P< A_@RPC+XTS#"K[*,EH (L([:R4T?3?"6=G.M44A5*T0EL\Z+E,C%UR
MOX^?J4*T>)_"X7V*7C[3NWYB,!9^@?6-QLF7W1>O+/FF%+(6*E>]/T19%H41
M>1YA@N+S1>K*_$IGK%Q@A?)]Y1MF+=]'L,$1V+W%RU*8)L_T+:"ET(SA)",'
MB-(4Q61WY(SATJ0:'NB*H!"1;8.9CW.B6E(.G-Z*U<N2[!VLJ!'3%OD"XOQE
M*>F7O%R=_'$MW!%$V?U\\&,IP3A$'D%46+BG8"9R84T\(\@*BLOIR1,FS)]0
M3ODL&=-4H1+>Y+89#J?6T7J<>,]6,<^([?, /BPQD?PD'4&: &%JC(+_C FO
M@\$#A_OS]/ZTG%M#/:+DM(:)3Q.MB,GW+8TR#X%)>$$V1X@31T@F!XM3/"."
MP%ZC1)D*3FHW0C7"4P)QQD<P S.BBP-)R!<7CD:0*?#*(S'[H.)7+@RKJ8N1
MV9^,/,R>0L%S%(/PI@E<E:GML\X\-,P2!A[R'\C&1[)#8D?.R'V6#C"5Z'>7
M%]G$&4H.(,,4..2=]%38&?EIDC%[D1[? \U1@T_2=6* %3DJLO>@>@ 4VZ6U
M6D4^E;WP92\HC<A[B4!/B/TX>EK84N&5A/,@:E7U(=E2V[C"*VDR?GPB>T_)
M=BIG7*X!/X^&R1NFG@'I)DGS)^F<1B00N3 GOH(+%*, ?9:E\S$<_Q# 0'^$
M'[[AX6,T?I:E[RGPJBS]CE,"!T+2OR?DL_^3 "'_#QJAPG%[@R$ ,22K(!NZ
M)^Q.?G__*\K_8K]DM*:''$< Q_\A*PB2YU/I?G[U&8B + KP-&.PV&CIQ@58
M/S-+GAT$DGXEZ3#X!1^: (+0)\8Y>8&.94]>,+GA5F6ZTB!Y^C:7[8JQKX:>
M[1@(8<-5%/(G5OP .ZX9^"Y6_G6]K!+C^N;[0G?:\;.'TT%X0;^& .'_L_?F
MS6TCR;[H5T'HG7G3CJ#4V!?WN8Y0>^G1'+?M9]G=<?\Z40 *$J8I0@.0EC6?
M_F5F+2B X"93$BGQQCT]LD0"M61EY?++7YY-_D1U1HF96Y'"X"W-CMVF:)RC
M5]Y\VVXK4P\2$K4242DC1.*8,X$):'HQ&-J#$G[=&(FE$^L4U"^J[/I8PCSA
M$M8L8F+C4C9&&6G RH#SDG(^L?BXA&.-X^EIW3Y$X'X39A(GT4-!W(K_SB,A
M0G>#C-B#WA(;)LEHWM36P4"([.OU9\CV.RW;YZULMU)WC89&+2X[$"4,DV+L
M#]30I;2KQV R@/R#R8L&@Q8+^*;.&\)W#3U%[Z&EU!I47BYT6_QV>OI)W3"/
M*NE?&_ZQ> N;=254B9)H[XE(-,P/-T'/<#^%60@H4T[J.GI[3I!1Y,#^H6J)
M84,!ALHN1#1TBD;37V 1J'43-E<#7O6U4.#"\"X*O&#I=K@2EP.,% P'&!>,
MD\D&B?#5L6S_4\I'P76;C:MF5G,Y(3Q.5,*ZX#OB+3AE=?^L7@5E.\R7&K1V
MA1ZOF@ \77G01#;S_9I/&AA!3M9L]SMP Y=5CK<=&+OP;DR.C*=H:\_&.$>1
MC8#Q@&V$*D2ZY%5CK.P>NA<?)UBF :9<A2N2XJ4Q,J6'?V/C&4D-V@5ZIB,S
MX42+0/47L(X@;CHN4:4P0Y6B$38J[-Y5V:@4$>;AR0]$4SH#M5U.P2X'L=&?
MUQ^!WXBAR(.C.(5*_$N!OB7^F23JHJK $!R/1QB4+&9CD+YO0H$/<P_!9*[0
M.Q7'!><HC?LQK,LQ?CD_%K(\ZIP;\$# )< /HZ$O<G:S1MX];(R9KZF2L^X(
MC2/[]X8&@F-"!P-Q%""FF;B<P&/XQE5_)IGUH_42\(QO<JQ979)<=G:N\_%J
M,J-%I1C2%&;/8&Z<W YY]V4# ]/NAFF;BX>(XR(S@+R ?:.9P^[#32.RB.+0
MP5FLI_@/%9P2359E\3OQE8[T^I$B !.^EAE(0YD8&@3]RPRM>=F&#$>1<SB?
M>.]/V7=K:+/4QK0]76E2*&3'T]MK+EJ\ZF!")D< DH&@65&/#S)?T^*"?DBK
MNA8@$A6JT_(_I)#IZ31RF!_J%RT+])>.-(J1P(Y>"3DES8R>,;R_NN(T17KI
MB?5[N]\H$L8)Q1Y?E^ (537ED%&HX*R@,. SJ]8YK=!K&[@/:K2HQBB -*D4
MCSAK*LI-CZ3N%"I2AV8H*8U_(3TBL$+L+URC?\WR"ZG(4PSOD-('-7$K3@\L
M1;/XEGD4JXHHZCZ7S5](PO$5UJW&L$.+H5OH0/A]S""+(ML-_:#P[,P/DBSE
M>5'$<9%%#H]YPIZ(>49K)6)0YFKMWY7XI:,#BQDF#4Q9-Z)K< E58PP061/R
M[\GBT.LP,]?AQ'H'RJ^JY?$29H5A=,V]L554ZMWXS(QAHHUU;10XGG":;^?,
M$W&3Z+&2_S^RTIDXW6 ]6>BC"ZT%J@D4-_S$L\L)K/0%J0W1 7+42K1TG53P
M=OB^&.$=T^KFBW&5PK-:NTZ'O;);6+2&9V"/P4>7'_-Y7.]SKPIU%U>%'@H\
M=[9 [U#@^>B#?[H%GH-%#BN+%GH&2V 7+$S3S+;=W'?L)/63)(Q=FV<L=WB:
M[8Z)LE0_#B_&2FOL%2K+[%(&-X1UG)=-/3.M8W%]8R@"[MFRX8,V?SD1Q!7D
ML=;JML8+6-3IS3^6<IN,7)7T%@Q1, 1$@HLUE-6"I\ ;<GX%ABX&-J9=9YW<
M8OC@A-X)WVQ3:2,:+!<P4F$=8) ?_@U77=?1&\.&\MH2<1;Z*FL1E!6UAV[S
MN(QPI"K;AXB?&J&A\*4+]- F-"[Y 9TMP+\TN%.(4Y@JMC.QU.B+D9F%MO^%
M],*, <#SIV@SH2L/#LT4[1YMLTB[AV*ZX/YR\-OH5?CB)=8*><4S,&R:!L,%
M_#M8)"K., %A5&408P8FW24%)S!9R<%&$GX?ON"2$$^4";WFL$=D(4VLO_@M
M; J<%W+[T)>9KT\RS_']QHCA:!F9D+J:5&BDDF>VPJV9*X6R$R]+XH [J1?Z
M>9"EB8NL2DGLQ7Y1^',5HKNB,S9U:W@F*DA.\XI2!NWZ6=T%W#]/YVQB_7,V
MX1;(3"A.09M=,:9Y3@&C.F^L7RO,@:OTQ[O3\U_;W'K3S+JKTW[MZS4%>]7W
M3L^_ZJ]]J$[H]<>.-S+>?C:!$S:C93U^+>*"[RDN:/WTI;J&@^&YX8N71[]S
MAG%GI?RZGX3#-_C HY$,5T@8E(B@E[)[$L4?K2L^O:QRH5(HY,XF;5S."%1V
M/D@JO,10D(I%50@=H%B'*$0:?L9/K]^^?O_"?-2)!6NDU@4?V<: ,*A2E)@F
MMFXY@SLA!34TF5! "^U[ZPT(+/JB@N_("4;XG&0DI@'?P/07BC+J-W QP?_#
M%"TED4%53'*==9A>PHMG8NL8N<"4<%#1( )WPK\$%@(G>57E H93\VE=-==R
MQ&)>>AE9CD*O4A/@3LZN9B)TEO-"A]KPA=U)FWGJ=L[T5&,]+"2=,J/3="&6
M5VU\'R=ZU96;H5W!6"X::.*]L$&=K2[[X-;6N94Q+/F*'-,=*@::4[S3'-VX
M8GA_9KS\1O%CN.J^L7),3R5X">+]I(.L\BV7?)R#,CF^0O, ;\4<>Z2V'P+A
M 6$E7(%<])6/G%)5A#$."^/G(N;7;CI&'HR0(LFN8>.,M)2WU1XC65BB H<B
MZ#J[QJ2+&A&8E8T(8N0<@YZ@IMH=&9<%&"U7O+LU)]:GJAK+(@JYX#35I@0U
M"5* 01@,7F# &38>E&S6T*8AADC-J0<O4OK=.'EP1/[)X)ZN;^5I&I%\X>_9
M(G&GV.<)Z#S\D#QH9N"]QFQ23M$72ELS';:A- 28&=5DO:38'J:;S 4O<Q12
M6L%Y^2,=H.3V&*3DF.2V)^JH7L6B"8L9EPT-MHL9+!O<RR?6/ZH;+#?JE98J
M.<N%SL:_]01[+J*/4;<UQB/C:GI+62<_2UFK1JC72U@62Y0C-9=P'(XIX&\<
MX_W>78XAP''9"$=J6:J/Y'U. $2&2QT%\?E_@P4M8XH9W#WD_NB;%8Y+=25,
M9JU\*&-\H2.5&O;4OD@CET;+51O%7N?4&_U:J3#*+_6^<H.9N>.J*'1.FET@
M>E$FVO6BW%QRFNDM25#.X8!3_%CB7&&@>R@.8%Z>SBY@"*A/8VE@@LVH;470
MM-+^B\G^4W8EYDK_H/R8:>!)RR]V[1<OK3<MZ.!=#78+@OR.+4F6KI)PQH<^
M"YTOC!L4P>&72+MTA$\HT;G_QOOI6]-V$.@!>0^U*KILC<U5AI6\BT8H'_@8
MX0-?PB/Q[LQSWL=74.(-9RGDB]8;K0Q,API)!\]Z0AE,&.!L4J68N"51+R?7
MLVFC$[42L6N]Q_^UO 5S7#D#C?,;GL/ Z,D:D!5^DPY:8ZJ([\'TF-X@GDL,
MSJ$/BI]=\<5A;(F.HICFEYE[QXN[1AU;:[R#&(0RF?[>&#@#*K E'87O_,&%
M2D%+7/V 57L"0FP:&D8%K/ ZI*5&RX.U68NW3%1\D KJB5BCG".XDS#$91CZ
MU^V[Q[=RLLJ14 IVX2O7,WGF@>Z#)I#*U4CC<B SMY_:4KENTF,;TI>[570"
MVOM 1Z&'@[MV[+B/N2*JR03=H[NU.F<"O/*%?6^C.)%OOS@^)XQ-<:O""$8(
M"569^;U')?50M413R80 9JE([TM]J@U"93@0F GLPDE&)JNAKXT0P/"M*92Y
M6!&\T;1#7_-BK" #XB:A1^/?A1<D,O:D?MEW:\QN*&L@,$H2U\PF$T0/M!>1
M A11S'\VE5?*1,;%S/B)C'$)*(%P;>C%9 VAFA[VJ>DF4$X9>K#":)*^M27<
M:F?H3C&_=[A#-K&X,0P&ZR$T@@C5XD]SMK=K'X>[1I. O>T%.0J<-_H'642O
MJXE,Y]"N$>&9]5&>/*E2_,A^07]] X/Y1N /<2K_P?,+%#KUV->J6!8E793A
M:)GY> ._$JA,Y74XP8M[7Z7E!9X51K=(4YK.K%*3&:T-N8HB*F$X(1@:(96E
M5*S ;-(YR+IK"H[LI?F[ID6K7U4Y'S=S+^LX.U]UR%2;@L*.0;N&3$WCV05G
MQ$8FHR8$MX5ORU?B:55ESY=5,VT!I$M&(.1DZ!W:,T -T@]EBZ54MG,#"]C*
M#AGI\-V\DE]%54&EA)@_!2>+M DL;SG#.L#^HZY9F1\3()A@L4+'J:@Z1B-I
MH9K!+9772V9*JKX*M+!6(*P20MPFD37QV=*YH4LR$V45:-JCUPC+/YV.)808
M674:P=HSQ]-FQME4++2!G;JA^L=2\_X,;A.)VMST:/A7##TA.0R)I0:9Q,CU
M)2.J(Z'N18BTO:\0!%PB<"O'+ >Z40U>6N);W6O)R()P43J@)T(.XG4_G&O<
ME7-WUCFG<#J-X75W/!_X5)DO/V%2Z@4-Z)P&= "[;09V\PY@M]T8RP'LME^#
M?V9@MY7@M1Z,Q4D\+_)2+TN2R _<- YY$7@LXRPK;(X=NH;?LQ+^LA=4NAK=
M<C8'W^B"6\!9F%K_%^XS!8.1V39YI>Z?JV3: TA\R&\P6#P>4VZ(ED1X2@(O
MCY;?+<Q>VP&C;NEP9ZD(!%;!4/%;(I,MD@@"V&\ZN/CV9I9=]A]!Z?>M^+D+
MT\7S)L;]0L\^BTK,=V#3*]?K3S#67TN^QH7 LW"N-8&3I\SQPSQW/#]+0%/P
M+$G=),TSWX?A[2.EM5P<*FR[F)3[6:NO)D')")H'0EYFUR*_2XD=52%<5V-9
MCXGHV;P%H**9KQE0*H/-4[@^(E<D' 49"FLT6$(7#E(1*F4QS/2*.(F-]/G(
MB9(.!O\NHV;H(NDQ81EI9T =)Z+E9#'J+(V"5W+#&OBY(80#+RE801PDA&=!
M9VR*OD953LB=Q-]BBL=@_%KT:.WFJ665KFR[6NU[>OX?XG._4X4@:+B%9"BB
MFJG'A>*X16#'D9]F3N3G4<B\+& LR4$-Y':0V"O:T[K=RKKEVN!,A4>Q!2#\
M__P+^_Z)UZB9/Q9?*CA6\@$M9<JQV^H,N+7C.<J4OXTVG# HNR+(W#1E=N!G
MH&,<+P#C(D[A>F?,YBMZAS[DA..C5\Y\4]Z_"9ZRC2;-@R(!HR9C1<'\J A9
M'#L%_"L*<\_+0GM%?\>'G'0"DPX&MED$.FO>9BM'B\B&I_B2EF9/)F0%L!)!
MW'D/3ND)M]\5SC\M+Z5F]T]9F_;/)6MT-$8R'A.ZB>KX+Z1)(NL>!.1?TS(/
MEHB?6._$2C8<K*=)CFIV[H%=2):&YN >M'CYX><3[:B,$BY4DF5A &H0 3C)
MI@LT^/ [C._APYA6KU8&VZ7*WG6,4A4)M!<&6FK(FH !.O@MA29%F@=DLYK5
MF1F6K#G+2XQ*:;"F!+&HMPI 43DLQ[H,I6JO6F-0YC76?RY>UVHQQRTJ3Z S
M<7)BR/(-.HDTMY_#:[M0G#+J#BHHJ8C?K\85KJ[2<L+:](_9K&'!1K\4PQ'O
MH1VLBND-\=[!;">P*#\IXT P!"+QP?"S7FC";T;%(,0N8?UD\$F_0 )*. "4
MN).5\^U'D;MA*M3& "6GIK\SJ!0(?$O7-!74"$._:0_2_NF5=UU0RVI!,#.*
M F:_8 G[Q!/MWZ^N.)&/22@G&'IEW1&BN<$H)&Y+58+\+@(NA%\0)EIABA:.
MO-==1(J5S(,NW'JB<FBSKW.3)UGE%U2WS1%!F'&E -*%^NU$IK_@"4O6K$>\
M:$A>2Z;9&JG::ASBH\71J8\2+\MBRW? KCWO,>HO.6 #1Z<]<RL.C.@[C&D5
M\(5S$<VGS3X6A">2X$8R!C6+;X_NP@S-Z)W(0LEE)N7>WHK#3^U=>6-!S"G$
MQZ#4Z]*QZ+07B /UB1A^N(*VB13 8I(7 4]?2Z^XNZ17S(,GR%0$6$1V!)!]
M [I>D$CM(]07)<.BUN$*_: NAX)S*?>7DG-%8=G:<ZJZ8T@7O86%MZV-Y*:T
M@;$Q&K3KHW9W)A+Q@4TE5O.3:19)/MVUB]P>83X+V,R%XMF_BU0.7,L=(F$D
M,7@^3PAN\M#._5&U+R$5\KT4I%&Z^\FITLD2KR28>&0\D>O[67$.XTD"%Q(3
M['",!*]MAJ#B6F"%"D:\OM:8X:] 20HSJ=-7[ HD:RQI13 4I*Y89;E1F1/6
M1WRKQE.$-1-K;UU-RJS;? #U&[(,576G0PREJY5'T^T40V=SY=!PM:6O(T)$
MA$+0+QB)H"V3>G_(Q-@M0,TG3'D_.C7X#JZ)I>(&[)&7IR.D<,ZT;8<25IH5
M8?M8"F+>WF1J-[U&34:%OZ#H-DUO4D$I;\#;+D6\MZQE5RSD,^N:[-?@6%\B
M@9HT\B@:C'67QSIY0^"/;@NIMC>A,E#GWG-15S?DY9:-[#?%^[-8I]T4U?IP
M:7& $W%957*P^J&FE2@J."T1+R#-+%$XR(#;O2+V5"[D@H,Z5NNE"3WQDZKR
MM(,BTS=%S:\%OS&ND>A$L\ ^EI5X<]&!LJ%[ZP*9-F1HI)A-I$Z0U6;3H6'N
MX7*_,QCKR4$2M.ICDE;P((]-<590,E%[)Y@],!]:#Z9Y5 6;%MRVED?=\G)U
MS?<H/[3*LEG=M ]1P32,35V6U]<ML:(.6V%$37U<_U);^\9#1I*1@\JTQ.<G
MVLCM6?HGUI_X3%EWIY12*5.YNJ213 *6?U,T:/3::\'2R6Y%\SUEA+53'5XX
MD1\CJV0J$F2B2&KNB3*P(KQ2Z2G*3P^+O/!1._NMZ/)[FVI2YC>+!MK3L[@O
MJHH??V\\8@]/AGE!36^OL0IT?-N*D]Y5C$Y/&]-BKE2Y\EPX4%W=GFWE[+8Q
M%^W$>BVMTRYAC]FZH!,HHE)134J+\5@Y(HHM'="$&Z()_0.:<#?&<D 3[M?@
MGQF:<"4ZL(=-RCR6%F[$[1@^GWMNG+*\8'G G#SV7"];A"9<C6GJ4?0%2<+L
MR$_\./ ]EC//@>%EMI,D19C;WA[0;:W7@W8_+8A'"5!K$G7!'R[)PC<+5W?S
M6ZJQFB#_[SR6Z;1YI\6"\97.Y(U\5&,P&XMU$F]=./FN%8HO \M,KTB;#Q33
M(!)WE3*1^9^:X3X=XYXI>IXOEV9GX?G7R(B+KGHT/XT4A!6(E7 =P?09:'*T
M(Q*[X>DSFFT.F[0[.<FUCV5/H/4Y_+L.&LF>(6TO:>I[V^Q@<\Q#'\RE?3 ?
MN:EOFZ%8V)C\OOLY;[ANO#H(TO !L[PWC[HT':DA@-.:';<%9'&W5M5HN_VH
MU=2PCCN\/(_<>QO45FL)M$VL\2K=R>4":3HHKQV4(X4^_;LX:HOUEOC[%1)7
MI+H]>2X);3%7=MN:W\MPIHU(+K9 +$-W"IJO3II58N HM&ID/A8D[IZ$A:\Z
MW.N]V<E)K6W1B[[)T\NRSH^1=N#6:%B-:<+^;-&OHY;%0HKF_T[_D,Z 1-*P
M1<^O)=QX3-XU.-/$'0D26"IQDVXLB.#E;8-\&Y-> VB)/Y7IMNG"(14UG^/V
MPY9G<DK(?@@#P^Q"#QB)CDLB\P^"]5]G(,QQ*-=<I,VH$2KQ& H&'B/2,.HS
MFFHN5?UE&>2XQ#8"QK%2Q14#$YSD*D?82=PA/P62:[8X_EZ]DYE>Z\Y'>_)-
MI[ACX-USR$Z1D-/+M)/G8\-#_W81/-C:R=EMBB2Y1G"'1G*;Y8,=+U\G/Y<A
MM461RS=*L-6Z(4:*I.M4H: "<)VYPURRX_+[\669YWSRLCCV(_OH537A<GEQ
M*,NJ:T,6<N;:N9]'@<]9D.9AD80)EIA[=L#=56WJU/Y*D*8JM1+,2%\N07=\
M@6$?68*<%EX(>PE#?IG/:M <><,GNJ@J<L#SP6^((JA^*O%$ 4%;$1I.%AM0
M<D$0S^A?"F0G:#-E">A%S1L!ZVOW:JZ\1E>OB$U43035KT6@KJ?4$ <N9:3M
M+#]10T%4>*LHVY:%)I02M!L#399V3 G3IV_:DDTCTJK?UL99E[]W $NAO_HD
M5- 7B>#?R;DLMYBH#ZT!L>V5)8O"%56AH! FDE7)!+&):@Z!\<H5-N ^NU<.
ME5R^EV2YMVI#/LD!X8=PJA\+@2K[1 =J4&> ,='J"_?HE1/;?3VA 0_*EEI8
M.:/6C:VJZ.OJ!RH?NT*;2Y2MS>D+_>!I=<$IC*VANNHI/><!AJB^HSH%D&UG
M%,<)"TH!I]<P./0H-%1I:KQ#"<.>G?#APH%SPS3]IVKWNI,36]N^,&S;A?4T
M/QV=GW\Z>D&[O:P\AS6RE+%YN?:B7"/6$UM0\V+Z,AE<)?&K$OM-35\>)_=9
M>+&">#9VW?"^HVG+, *=Q0I. EP*"9!]24<5]JEWP=>\;3.@D9 &8;IH08Y%
MT;*M2%;6V>RJH?:G=!'H/RC%M/Y1/FSN#VZN]FJ4Z?]SWS:%C8=-1TVKM]G8
M77%^23'WB@6-6L$?W.0=UM?OJULV!G_I$QK@[&HGI[2^)TB0 @)1:"SP6$[P
M6DR0CCYU$*&2SM:4$%68.N7_]>3\A&S_UVS"<F9RFO:>.#*1'+J/E8@F=!N8
M8!F!,(0$ZN$;$JF*Z*/@$@"C03;]( 4UH^YD-]0\3<9;-!:>35'L!VN.)"(Y
M;XT,:A(I75<-AQ:.;)G]Q:?]'@3MHP0. _X\N\(2L3F;21(V6"IH"ZN'A#GB
M  F[2T%;Z 720&M:@+.8GEQ+=*/D?+'S%ZLGRF>"+:OA&D8;3W=K4"^E5A9R
MWUJB /F-$Q%5/AV/K=F$/ED;KX"987](U07*[!%A#E -);V=DZ<KX@5I! J$
MO  !"\^R>L:[;2DDS@=\;4%!@(6ZN!<$TJ8FDP:,QH!9&^- $E(:"NP&+>(B
M8A+!?2P;"<A?.[(5#@Y-[.J0/*^<Q@T,_;\6TLG,FKS')1/ZKLLR-W9#._*]
M.(ZSHL@<NPAX:#M9%/[OV1!1T''0IPY;ZLAT7)27D]G5<5X16! ?IWECPM9C
M\8Y>V2?>'&^,!2IJK!OW;#+-/,_=T"^8%W#;#UG&/"^)TC@(\L+.6)K0-.?H
M@3:>YOQ,?)S)/ ,. OC-3AVK>-\.\/ ^/#PXP,-W8RP'>/A^#?Z9P<-7PKU[
ML&V?%V[J)Z%3>*X?>PX+>1+9H9UYOA\Z4;P('KYMN'?'L72C':*?>*-ZYXJP
M*YBE5V5#%/3[YZ"<33+1&HS:+$AB!=% 740\C1R*V6I2\S8P&:I02 5)T(">
M*TP:V<*(3E,OD;0SQ;.NV6T-)C$V=R'@&+66IQX$F&,8J=9KLC'M(J1T"[36
M+5E;Q+6TZ4>JH9AHS-"8O$9S60VCL!.<[FX0=:9 \]A5#^SYLE+-@X4S(9XD
M3%DQ<G%&<&B(%I_KV&E,6 [,^(B ;H][7$GD>ZD'#N2TF)H_:YHJ(^AW&UE6
M-KQV(>16J.FHC=1<'EADN"J5&(!FNJG63"7&8<)YY-K,31+?BXK$9U[A<QZF
MD>O:6<?D[EF?[5HI0_0U+-FIL=!+<@)S><1P>1YQ_TXS\5$.2)1)&KF4,[+C
MF77^Y%@W',[*)CX'YYD#EUGL,\;]Q+;AO]S.<AXG09XEW%[;M1K>]0]\.N1P
MP"7IGM@+7:?-/:<D+K(@MKW0S>!J8PECZ#$Z/"Z2V'?RM3VGC681XRRB)0Y@
MUWTZ'5 U>MN1ND'VGX8M%+NZT3[F=AYG8>[%//:CPDD]/XUY4J0AK';@#.?X
M[K 4YB0V]I@37#!_R8)M-&,OR7+RCKGK>[F7!&G.O9RG/IP[/T]6L.H^R(QC
M^^B5<Y)L3] CM!0#L#Q!UOV0NTF<N4X1VBR.@]1FZ0I6W8>9M(/;'*YY+D86
M:'W53XITO!#^#5AS90=;=6S,Z)/(O'2Y"_6EO ;_O6:][[5TLQ9I<;8DIK95
MQ<W2+'3]+':*J/#3,&8L\6(_"=PTB]PT<+>AN#?<=_?HE7<RSY=]=V%/F9>'
M&;-S#[29[[#$C;RB<.,\2[,\B[>AU3><(GA(_HF[MFB3;5SS3D!4T&TB^X+H
MU"[5_CK2*'N,6\TEYWU$X4.W87C-FLO328[_@QWNOL%*@=>[J/M"O$DWA5W.
M=N%\958'?C!FOH>&J.$QE9-O'-47 1UQ9JUKB"S=U83?2@V*I$8YLOUA8Q%X
M&GQB7,(RY/(91OL\4IX$(@8-3X%_\F?0F(<G3B^)31H+A@4>AEK9=8BWT-54
MI9:4[Z"A\7;1?R'^V+L,XP++ !0U6F=,\V\5$Y>MS_7#3ZS7@OPFP[2*2%%1
MQ>O(X#P2_#\R$X*]L.NI66E,!+2*:79@JKJ3HC%GX>I>L7]5M<$J-:<WU-?-
MY<!77?(QC8;2DRF;_-5HFBSYC+^340J2(EH3EGG)B(7FBI6"M)U9V*J=NL6+
M-AH8/<#WE2I)B:G0L7PZL:9]HP9Z.'L!?-65V\H.7L$\<[^Z[!TKZS\P9_=[
MVX9=:+*%^BS8Q^XP.$_K#Y6<?*=[^YRU'17W3XV]:S.NE-5%9M*I!&5H5C=E
M8)I]7VY48WJ97I:(6RRWG8A;&?43]MWLT.$SG<J\U=7]NM*!.$2;J<B@(^-H
M-6NTXI0.OGYTYSD,N?USRD^;%,XIG]YP/E'/$"TQX55XG"5$]*H56J-ULI&(
MOBSAM(%.O554I(W4>!)  +)03JYGO<:9E.FF>A2!L6X?.))Y71@OF2.D94_/
M7ULQ]@H^ -0> </T'G?2<E[*C=3Q08DJ_O>LHOAA36!RVCUB]Q92)9ME4,,&
MU-O2(C4D%-3_+PLW\[!Y6]D\=]'F&5 S>4Q5CW<8O=QX_57%)]S=<0(#2?39
MX.Z.!K[0"L2J;Y.-*$6ITQ^9R1YWFB+9U#/X(6-NE>J' EJJKJNT$@S5:0=)
M*=4@J#DF$4ZZ=_+X5G)N8J["I+>94[>"SU W2#F&!QU3JJ3AF301NPS[HJ\?
M@<P)DD330KTMV%9!(>,O-21I7B$3&60SPXJ^$G]K++9JTMRN=CL*11BIA]H=
M%J4YU,6@1J'95N9732Z^*0S&NT1"214K(@D0WEUFR2*MNL2:U\(.;;1,RL9D
M+8_J2@F<5T/P&>I5F.*-1_VEU7"&1> 7G.Y!+]VO7O(6Z:799%XSZ8/=S*XQ
M6R41;R7VX,;MG51J_SIGJ/V: ?Y7)+ISB#J1EK\5AV[^<,MA*S$3];.FKI*5
M-I?(EWQ#_S7>81Q>V;M)@?=S68&FCIKH8S_"&G35&H^\H ++P$6^$?;N@K2)
M(?WX&ME=D&>7$W!:>9>+WEP#V%8FJ;G^)6LA\%G@T6'O/83][9_!?C;1:TK*
MS[ K.]IM6HZI#F9HP92E^AT6569R9:74O$Q2]!?>U?_DH/Q*:F&$A$^Q(+2A
MEO/&[K0E1V+3:Z$;)1%N739_H6(K*12,S>A4\+B=YJ.XNE3(=8IF.=4<P 5(
MP(C/?#JK)\WI)']3S=(I7)ZR<^_B2%[X1")Y>C'H;A(P$;D<(L G=O1]A=NX
M?Z<,?4#6F:+(A=1RBOJB;@;C1U+#B&#9=87' 2,%LO5P2]G7KI?D>-,B9D(D
MP,BHZ4")T%>/\:]7;3MAXUL\]Y=E,ZUJ,HG,]Y1=2+P1M:)O$M:DT&_D<("J
M*SA(4_AGOJ,5%QMNI-0U8Y),2W3%S;D9@IQ;)/D5*EL004-=<C":7ROX7]$;
M0-K!V#E%6=.JOV+[-I66@ \;6X:C TTH\BN4&E&O:9\NNLQ4\"C6B""I_GB/
MW@)L5!+%8F"NJB12MF@4Y0^SB8R]HOY^U.#BZVJ"(&21.?P,]X-0+/A3JU3G
M"&!M-TK#)&%.;C/?3N,X#6R797;HAIG+(^^)*.'.XA#D5@@JK@Y)A\B6X3^%
MM'R=R'8\T[UGD=2U1D/>L\QI9/!9/BW)2R)0'KLN<_P]]ID&Z^G$,LMER3XB
MFQ-/H.A%C3&!R[*@"*@N:9IPGLNS#:>EON"R_X#YNL%6VA3JF\!:@.QURU*$
M^D=&FTK81N,</GC!9)\4V7-^Z*IIDP%P(<W&@PWF#RSTR\H,PD.9P6Z,Y5!F
ML%^#?[IE!L-JJGOYO?KOM/ZY]^W!LH&5Y09]5ODT+3POSN*,)WZ<9K$;!T7F
MNF"YQ4YH%XO*$U8:/?MWR6L&D%GZ+RZ:K]9DS)C>D;BH53:Q$^N:XR<TKGL%
M!\+H@L[EEFTN]\1(\1J_%D:&]NFP':\:G-F\!M/VAG$F&*W1+#.J!T364]8/
ML.9R-(=6&"U 3TALU+PW,4S+N! -(8CV#+ *OD'@+7).5[D, )D0%OU: ;B_
MJ02<HK>*Y70F.\ ;!=UG$]TXK1NNNNP0TM,PE5^$#Q!8"/B!N#WDYG9[]E#]
MN'JA#+5.M95X8KU1\Q'C:;A\*.9KL7"""Q1'P7-9$ "3(/9"0FN0'4=FITS$
MP-](>C23$++58?9(K=N(NM5/;KNN&,ZSNW[G?_QZ8GV<6+]CCMER;$(T>B/K
M-9;(5_6DQ"KE"ZQI1\NPN9Q-K1Q;V</W-/3DW9NSUU06S*ZI[%U@8. 36@)D
MDK[NEZ'N@T+0B^.&:G'TI-ED FM)Q?;4(!79O7.+S$D28ZS4[_8B9$TSN[H6
M9# 7-1?18=J)=V7=3(]?EUB* V+T*XB']?^RJ^M?K"\U5KKKT"HQ$6C6TO:D
M2+DDOK :7 MPXN M?\!GX/#0XPBG2B,0H?TU7XF 6<J%S1\:ZHCV'2-#G):!
M^E[HT :.RAS>(BW30GS[FD;30N+]1!%>RC&)9@1MB8^$M>V?<)T.1&14Q13Q
M!" I !:!39:&D114M6U:-IM0=I"V))>Q%2,EIVJ4)+$!_>ZFJL<Y^ L&7^<<
M89>@YS3CY8/-Y!BF5M0028&-E"(O,<9$B9@*! 9&V'N)9$[2+^$Z@R"P+ATR
M1R$XI<3%S"U2&_KL+-<ZY F"+V%2F5T%9<R5^@,3(2F\T+'_MNBVGYB7E7E'
MONEAYI<6#"GJ!H67'X'^O<( ;]:2160JA44=*A9AM"<S?'H/IIWE&<]L/RK\
M*/&3P(DYXU[*_<C-@B0([16E)^[*@-DG7N,OP']U-";[V&V#9_'1*W^>A^%O
MHPWG$25%['D^Y[[G^(G#6<PBQW;SO.!^4N3QBH*2'Y]' O.8QY;_3="";[8E
M#LMC.\XBS\O\. ^2S/="+XU<)\CR*(E6E(G\\%02&Z;B#&U)%Q^/8D^%%%(.
M*<4\[AM&VQ!2[H8P\=AA!;=]SW82.XX#+V6ADP5YZ#OW+:2)<_0JF*\5VUA(
MP\2+PC@-602N59#F*1RX- I8'(&'9'OI?0MIXL(\YFL\[B*D>1Z!7UGD#HIG
M'+A)S@ILCI;S(@L#;M^[D((_&<S79JT4TA/K0Z5Z9ZRIVLVO"Q:EB49NKZN_
MM?K>S1S6IBR/,V30YW77R=S)F:WMZX-+7\J$'**F!%B7&XSE.&=5:W\-#NED
MJ@T2%6WO($%,\!5&]?'*;DP$UMF$/%7A9=Y<<L%Q#M:L?C4KJ5^R-(DD/+^E
MD^P!W13T=R([OZ!'#*;?6&KC;W(.)1I.E%&6+80K<KYSF#\"_<WYS+%G=TVU
M,9*[@YN@'MMZHV0%?J<<--:V;Z19W,CWF&]'L0VJG?E.PGT[]M.$IW&6.?S>
M+9+$/WKES)<W;ZSLTRP-@\)G7NK8?IB'"4L++RI"CWNA;0?\WI5] /.8K]>]
MB[*/?3=Q&$O]HBA\7G!0^7#K)A[S\C@ITOS>E7UX]&I U_<,[[\W4E>W?=QD
M\&=C+=VK_G[<8KVS"?+W5?7">I8D>B()9373O<P.&X,7:$A1N2:9_, M%7W=
M,ZHPF>22[@\K6TE?2Q =_3GEZ!\:V$6#E;3.Y6>(F$6&@5IUB_&]Z4QRS8CO
M%13E*2<C^1.RYLL&F!\&QH!1;\HM2Q!1WN4ZUH>JJO-RPFH,"\SJ9F',.T7<
M)5'[4[$@O*VI\(9"PD%LEB)"/IH9!R_7,1<16MD?:"R<7RJL05BJ 3$Q5F+!
MZTMU> 2-"UQKT@.A6(.^Y]J:/P$0Q!ZCWS'&A-=F17CL"H:EJ(*I.T@;RH-%
M3W%5)< JYU<4=-%1+0,ULYOVWP:EIH2_Q;#>5859"::O#]WIOFP/ L:]YS\G
M6(CJNA3'0Y\(@XB(2'8FA@QJ>-.X+$C6[A-JV1GT5QSS'0EPDIAH>Q:UT1@B
M%3%S2T.++-F(:EF0KD58G/>B91^JU4%MK[+YTDU+D3P))2/423&;"*N *B1F
M]36AK"L5=,9G#HV,F+1)<V'UV0ER"F->HS':=TA*JT7?-ME1S8;"&.86&@+D
M;Z8:_]2\F-5IV5P:#1;0=BW18J_$RTC4J D1?45A%WN+M3P@:,0#NP,W!'VD
M [6: AC[AH"*0W8HTF8FC0!8YC!N^!G9<DTEM2FYZK88@+2-\4Z.[#<<V*8,
M"TD"3OD24IU'HP;:RO0"VT:.C+4Y@QX3MPAG#X[Z]/;3F$VFIY,<N0ZNV\KH
M.1LRL)T^#B#G4<:*D,>>Q_TL#%/'"U,_!^NXR%)>N$_$YE0K1;*IEVG_;NG.
M/+B:1\\21;VW4E6=W-?=NE(X!\32[8ME%*:N5Z1!$KNAG^=NBB_S@SS/G BT
MQ9Q8OC%F9MRQ;8_W9AW:0VV'P-56S+ U_3>N;4Y1JS0RV/PZ9=1]!.1JR:("
MKF&4S>KI=Y<K*0HOSGP[#*/"AUU*D[Q 8IXP3S"H#AKMOX4%KI&46,=^C/AK
M=MWPE^J'7] 8'[/;E^6$9(^^](L<LX1?(MX05HP*(>69H.,A_MQ"$4]L 4><
MUO!_N7JS_/,)_>GG:3[_MS ZB8)DX9_M$V?AWY8]UH,!^8N_:C[V9QJR&#:L
M#.[D_SGRCO3BL>ROB[J:3?)C>>PSL("*0A7HO;0MA[96O>@NSW"OO^-3A@HB
M>XLOUOW>]=&<7J7=_2H.RGL\*%KF[[2&!?V_9?/'NL='FOR<,J;)OP<OEU]B
M/Y'R"H.BO$O/L<GNR]G+<TGWSO74(EHI2TUD9T5CT>J PJ1@B-:F!3DLJO)[
MC,OW8T*S^M#LG-#H:Y#F;[;)VZZVV+F)+S,W4H<GJ1]D:1)$?NYXL9OE$?/=
MR,Z9G831CY@;0D6]!^$;=.;1:6\-$2*/"Q;>YL]%LYU^*U^/D>0VYU14\B,Z
M;9_FO4Q&B\BS(S<,@BBQ?6;SV'$3)W+!1"N\@MG%@\FH?_0JVJZ$[J$V^4BM
MMTT7".L49_6DQ.#L0:>""\=<%B<LCV+&_2@MDBP*;3=, ]</'#_[(1=N(WD-
MCEYYSUZC_LZR2_AEW?/<#XH5G-TXLH,D<0*/AWYJ%RQB'D_3("]"M_"=X,$$
M-5Q+4'\FIWBPN=*A%G*M6LCH4 NY&V,YU$+NU^"?;BWD<"ND536*O2BH$WFA
MYQ>![\2.'_I!ZK$H"=R,.X%=Y$ZR*-JZ.@?2>T^2,==-8(H\\A./)4D01W Q
M>5GF%W[,=B=+LE0/?T5X@TC6(CAV6M::1O]Z,,T@@(B21-]H/[0HQ6"F^^4O
M*/U[5>D*%6H7:E*FZW(S032 >>8+)#1&_C"B*\&<<=$R-@_0%%N_8ZT(G]!#
MQ3BO65DW_31QVRL (_DJY[R'T(T%R0\-,!C>3<KU#Z+B-DU/WRE9M"R1:TYH
MX_0M-:Y9QO^_R=32@K,TQT)G%OH>9TGNIU[DI'Z6YG&>91MW,/FAJ<78JF2;
M[4P#!D/W\B((LLB//#^-$IZG=N1D"8^*PMNX5\D/32_!Z2WK/;.Z60\)]3=^
M669(.T01YES64LI&(.*7<ZU\\X$SM)NJ8.-N"&W_D]?C:I83RFM&*O.<3X]G
MUQ9VVE@%?MV1R2_5@\.W^^K;NE/]J)>KL22-D=6(9>KV )LK?Z>US?3:4J-Z
MP0LI ?5F)YH2\8_4+Y &*N]441LPZ4/DJ$>T09>[Y%5"I@6>L6C[^!G=!R?\
MANHV):847FFTIUOBI;MIY"7<8WF2A'Z>%DD<QTGFA*#]XM0IXG4X_+$-'\=<
M87X&,Y]<(/'7*:;55[CI/<!=X-A+.\ZM:IR'T*DPRC,8=>A'@9>F7ASDG@?&
MGI.&;*UV!%N;BD.6\<+6>?V#N"Z&K5O"G7?;(/7DIR/?5*7."+DIZ%MU_XA-
M+A8';&C/S>T\8)GO>07V3O5\YG"WB/R0LW4A7?^ ,<$H3EL)/Q<\5ZI+T%GG
M(*$F,Q3>*08.3EOKM-LR:^X"<EP=J%IGCD48V&$69 G6^:5Q!(H@8$D 1E#,
M,W"$UD7E/>P<J27Z_"6[&,VG^R$I<D"#M/>:3.N\;96WJ0&RK199#[N&_D9R
MLJT>60\[1XS:#S2<7T-.^GVS%.X69:/72&YU$TVMS>"B>BS8[ \N_/IK'FXD
M5UMWN^XPS[?BX*^:6+2ATADM+U][ #]M6VMAND!%^9WGQ__A=:77R&[7*-YH
M\[>%F;XGV5Y_VN#T3:HU),,,,G5C2OT@DPG_Q#J#OM_8XR$IJURRJ0@V<-F7
MVC28!(4]M8"XPE"22CB/!+%MC3&5&E]T ^(KWRL[%*F^T<87,8YU(E3='+';
M/>)Q$0R/XSN=]$W6143B@6L_$?BWFCL)2SM[2TQ_)]W\I9YN9SYE.Q_5GQAM
M>&R949";TH4SZ\8OVLE,9P)!/A6\;'TY%T@U%'AP0O"<&)=X4<UJ>->_9ZR>
M"K#?D&]<E'CNZ<:G/@ME865E#>=9U<7#6.$,3KDL?I=M'M@M4O.@.0&/%DW
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M%9[X/L^/&1;L71@H U7VA&I$@P*5+91)SR8%&8'=1'R^;$DHNGT)@'P/.C@
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MHCY^A_1A9PK2_!DF]_AB7./ "AQ8%VO=%U R&Q%^!\;?K75;\C%6B-6$T9:
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M6/$C<9F)^DO<^U( \.G>M/#BU&;>![A=/^K;%=N3\!9Y\N'C^Q9Y(B.IPX/
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MLVQI:AS53JW-AY]/?V05-CA:AY4\K.2CKN1V5L^V]D'E_5=_ ;<T^=T6G T
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M*C:P71%!):"X]:09T\[E9.Y\W*/F.,\N>3X;\X_%H X9T!)._]3OS4EL.1/
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MKBJ;!A%*!M^DB,"L@5-ZVI"0'Z0BW?1 _:FWY(QV9.,#1F#3:--JR?N[RS8
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M3#7VW%P]CE/X7U1^<_%RS[[TTSA:?8VZ/2G)QI?=WN;7MCU6];CT]GKJ]M?
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M&54(AN(1-\A?M\0OF2X91D#@VQO\R^N#T+,%JV1:??/Z7[](%]&C#.E@P><
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MK0%(" \]'W1O;"@CQ@2&A8(2I0+JTLA3EV0 $MLP@*L]#,!6,#5%,!W!8F,
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M[.-NROB2&HE6X)&012Y5/O&U9Y@26A$_#FEHJ.=SKFE-8C[*]3I]UF6T3D,
MCEV[>O58C"(_4"J*1*!B1GRA!?,\!?)1AKX,F5<7A4_18N3J6+T>6BS6$8N4
M<AF[AD6 /)_Y*@RD\2CU0P"G;\BKN?'*90 W4;%3?#O]9#=$O/O\\>/5>^H
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M\B((QXH.X.DVE:]N *(JC *?\\AXC$94\2 R-#(!=MQDD:J+I20Z?=H%J+0
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M[5"=/I/NQ;#YXMR"Z92"66/LU^N37?J < QW66;&&=[K)CI(!LDX,=GZ'MF
M';<93;*Q#;@>/MM./_)-Y@P-G':Q96R-[6B[:21PEF3CLI-VWB<;COGR.V5+
M!I\4;?/I5VH^K1K:>[IM.-TVG#Y+P^EK:)O\.VBE43X&"E0.SEIU0IVFS^ .
M?=-IM.^0U6LWWZ_).C<F)'$@?::U8<IUX5_CAI'Q%8_ 0'?_^;[:9>;4'OQ0
MXA(GE[V=1V5%=QVVA&/'2)>Q:RMI;_FUY=<E?HV4'^,()2J\D/E<*ZT]3X?$
M^+'R&8DLOU;(W#X)OV*JF-_UY*542>\Z&K[6W/5Y#)[X3: S$]D94&:8V9%=
M>^7\KME_0Z[0ZZ ;X8?R;T4,Z^W<@=P-HR*DE7U^T*GY!8]L_@UO1Y5'=\+>
M,9NNRP_O7+ >^B=5DTM?N5<:YU4@]F3:X2R(93BO&K!9(\1>@U?Y8?Q@4D>'
M83H!>#AZ&#FI@6=]-2L.Y84G4-=35WPJ#@.X[JXX)'MDU1F,=_H,5$);2W+!
MP'Q%E7 \8&*Z8-<7Q_+W6Q=AQS%L<);)>#\I?Q7VU2FE?$[\ SUOS&]C7>4>
MG.#66OGU1>$I1?I14(CY5;0K:)U\S6NPW*W6-9$#QY;JX?BY-=?K::[_[^)\
MRI?6,I'J]*4\5J)R:YK7$(3G-<UW 2%Q.WU%58U > UF^*_F*87CMI$S&W[1
MCR-8W?^TX?KSR/2/*299C)\_#H!?@(/>_7N2/#V:8?60)L'>'5V?5QQTT)KG
M3<+AR<3Z$7'H88#%.WQJ7VN@5[N#-3EZB&0.WHFT ?4Z6.C[!2D)!0.]RUL3
M_9)1^(HF^AH4;IM$# #<=^YV:Z ?XX:T-<1?/Z=T/T'-[> Y5K&'9&MT-PES
MI\N+S#&W!E:BTU>R3I[<-5C0'V;E#D9GQAD4-8=MK/MDXCB<C--M^<)X#F7I
MYW-UZ2PQRXOZQ\H5;LWH&D+P4.E\8@CZ"$%9*P@>R8RVW^WQ^G>B_'6EN-H)
M#)RC<;[JP:0(A6-QM1Z&NXQ[V$B@2VL)5P>[_*_I**N>)D!4I\_]KJ@Z2_SP
MHVV0U7[%<#V92;\?7#VWTV?\B)<W]:MJ:J _\(\C:8?FFF%5>H*>3 -,C^&N
M/(7J_$5 '= N(:L!];;'_$6@[V0"_1CH\T"ZNUVVIKMV'?O-7X/]K^.Q25OS
MO_[F_^^F>@:"1T':=WESC*G6]K\(VW\OK#+$*I4'U\FUAO\)% ;B!L_#T>&_
M)TF66&B%5YA<\YJ.P') =J[U8_G7M\6YW,V.Q:8\56<_>W\KUU0#MG[!18#Q
MV+<#E<"X!F]XL:M6NPXTV0^HM2C_ZV@4?4L&@RO+J#ESX&:.2\H#N!M&[X=C
M/;Q/@H$I8J7%2VL9!:M-U\Q2V)U1VHR:&F/N!#;X$3"'M:55)@FU"3>'(>83
M_HS]K2>9R0,SK5E])C&-:0Y O#NLV[LW6/BQAS&M,-?!%:N5'ZTQ?1$0/*W4
M/@8$J8L09/YE6=B-B;3_OG:4@?/#-).RLBIMQ\*\'H'J+:CJ<!LQ)ZULL'>-
M ,*;YC4._D'1W 9,?WK!]6G9O&7SYESD[,#FWE$ZJ-2&S7>8_H2_(_F387YG
MOC!JJ#A"YN4VRM,HCX/>IF8 ;_YJWI1#;>P1SWVPV+,[^X@.8'N3\>:/K P+
M>7VDVEE.Q)U-!<DI-O?O0UHNYTG?FYL@-?K/&YMU<*L'W_1SUOEI<593,KQ9
M(N+R_C?N,HY/MLL<1L \H]0>^BV UZ3X+EB3KLU:G(<4)<)?$N'%U!<!*'_!
M&(U=S64@!(U5$-(X#()_2AQ9C*PUBIVW/_^D&[N+49,7/VSRXL?HF=H-K.'^
M)2%I%4:B1."K,. Z8F"/"J.-BIC'X]@/O(B&+-=K\!D3W:&ORPV(=!G& ?,,
M*+9 Q8P;0GT:$1/+B'9>;Q;?NSC&OA)?S70RXB<]-I^ B,,05*3=Y*:!?)0V
M8R!?E, F4S,,X;&!&7\S9F@G[OW1^]QS8@,@T0-8EQY/QJ/TV4DL):Q["T""
MSXQ']NW+<_U,2;KI6QV=8IRS&.677>#D/N'U/':B87B-FMS7J,6^SIA!PALZ
M9_"_C4Z==Z L(J<=.=B.''PERI&6<GM2SKVZ88V[62J'7*Y>3;[P<(+RO7,$
MDWH6<GK_^V_+%O8N=O7=^+?\2#^7)[KPYFE<ZL:;L[D9SC/LN4<>3'Z2R-,Y
MSOT_=Y&JI[PBOFY&"F*C@XBY@:\%HT:#'QQ020(6!I$?A:%E)%(RTDKL]C49
MB;>,U#)2;1F):V 2&L6<AY))R@*I3!2XDH3*R#BFEI'<DI'<<S*2:!EI=T:Z
MAIQL!,^!5NDE9LF>PO)D0$/8,G#D/NQN#^IN&/UM!,2;OF^NG?\"G\M.W^V1
M0Y+_VI3M>H/Q0.OM-<'H@]+I\4,*[ELP7K(!Q$X/0840;)MXOC**_F[*P;(V
M-CG6R1!3B=O"@E>U,FS9Y"XL98\+YTW,']9'DX9V],0:MF(NFAELE:W:&H/:
MHO&UK8R38Y!T^JKGM=,9F@;$BF+Q<!OC]<2BAV)17%:'J5H;&G :\ PXC_G\
MH3:844\S8WI8O\[.:BL[460G]Q KH_4?6ROC( BR3I_T2#M9I&DX;(R141F1
M>"7:\VLB%*\AF/%Y/ K_O ET9GN1/>(LK_T'M3;7;']M*Z-Z9/#W$::'3N!M
MP< 40]<^/^C4_()G]W;NZ+ UU'KN$FAR^'4:B-PZE9=VB7(,G-K.3#VW;:5]
MN1@]NDWRVAC%3DZ'N6]M-*02P-Y]QV%)DR1[P$@55E=^_/C1&8QT.U3^-6R5
MG6W^Q7/Z$/\-3FAJ\[\P'W:!P]31!L2V#FJ]E<'1#9;C@'4-*#F.T6$]OFI#
MMV&[VJ+Q/&D?KRXP.:FCP+R&(,JO)A@[9M$^:7NXU^>R9H'=\+ 66<[VTMXJ
M];U.W^^QUA]M$!;K=5=3"8%59#X]FLQO$5IKA)[:+#D90ED=$7H= 9/09-GA
MMSK--?SK:H^L<0'PJ.8#CUO-$1PITZ,U:2/?^J#-,T<.!:#H]&7//U9SRA:%
M]43A&2(A&U%8Q>*0;1SD//#Z;93"K\.\$UV9LSI.]'ZSD9IKV9_;[JAR%UJ<
MV<([?IT[NO4LYF,FB6S'<#0(E.>Q0$X/107&L.RYJ_,5V_A'O0'9I(R1O: I
M7)LCTE;,O-XL1C.T#>J"20:O8? C-5&R7VGNM5CYKYX@\LED1J?AP]TP^M5\
M-8/1TTNE9X)8<Z/U-YN&Q,;D@>R!2<_:':IM -(@/-8\_K$'"JEM ;(:"FX#
M':?$T3_TH)B^H+'/OAZ&![6^;2 GG3O$L3-/38_JKCRIK?R$)9&DQU9K(MO(
M1FVQ6/.[E8H(Y)V^]'J^U\8S&@;#<\<S3@5([*[*>[PF(O$:PAAO'W ^L9,,
MG:<T&:7.,XX'2<$X3+]>70.0^E?F?L0SP@DN"_WZ*EQ8BEI>6+8>91,B'(<#
M=1T@[?7>0?6W+1!K+2?/T=MT=_@IA-^:UKIM4..T52SYD&(')RG>3)[:B$8]
M(QK38=)P3).G;::[=#$ZZ*ZZDFTPXU)@>+XKDPHP)#:HUJ8+-0F'-;\JJ8 ^
MSPK!.K72O888QO00CS*&I1C)4XP87IW*<VFCFLYMC&RWZ]^.["QQH.F')Y./
M.E]OR4M[/>D>H5+E: !HY,RF,[C U\9Q=4R/W9W/6*=/U?%:N;;<UG);G?3;
M*^?^[LYWME^M>\C56,MQI4'\TU@' P/_C9*O_9*BOT\>X0O"_L_PQW*-CSJ]
M3X8Y+=Q%I/]KDHV3^/GU-^7AINXR;$OWJPD-8C@7O91T';2YNL[XP3A8VZ:'
MSTX*S@P<:.1HY^MJ+A$^Y3\V<L@DBY;8PYB0Q('TF=:&*=>%?XT;1L97/ (.
M<?_Y?IW5=\.7N6'J5.GO=UEFQMGJ3?'BQ18PZTTT&M\4#YWRB)AC$='I<]I;
M91$'#F" &X,'6MH\C5*[4=@\_AI-PY'@/VA<#OQ9CYUD[$0C.+/A"'ON/ '[
M.N.1$QB@*6#@?TS4<[[ Q]>2=3A_"/;*3;Z!)\&CY[\-'IX,0W@<-D4.GBL=
MQ8&6^.J9K![!\BGEM\7OAW>/(%?&U0\(NZUZO=7@S/2 <-15%1H<:!R=@P9V
MF-]JG'1*@FB2@H"UZ,'+^,PQV$%T ZM;@N'.NGAI_Y0KF,%SCLO0KA01MA:B
M.C5XZ0\B#L03?*U!<*-XQ_?I@?-'[W-O#6OD\\@&B0Z2 ;PU1_#$OB?)03];
MB=U!OIA2'#WHK)K 41$<JY%2,8\% 9PT\87BTM?<!(SHO07.WV8[^-WL<8[V
MYF@+E$&V+'-[2<#$2B);O_HO..TL2NQGLZ[S[2$)'QS0#OK>V-Y>@1DDYBL0
M&4_K$3YT,TC^A!.^ 0$UO$'!M"B1G'L@>WX,N<32I:"+)^,)/ ,.9 CXRHK#
MRLSB$A8/*\RM$_AZ^);'$9Q2(4#SK\L)^%R*T8V &>L_$=+)$ $6AL@WSN-D
M,$Z>!L:)@7"C%/8.,!I,HA+[ ")XA]5RHZEE9*'WJ.]A(9/(ZBZ3=Q[!+ROZ
M[.+;4,YG&]K-+^X0U@3\9?=7;A:^ /X*_\.E:*#;8+!)Q">PP(V[AETF ]P+
M4#W)G&P2QTF8X*&:KTF$ PKP6[/)$VJC8L]@-V7 >K Q^!X'=P&FXI*Z@B.;
M+@+.ZY,9H/HH/M/%#^GR$]WR:-:M_]MH,H@*.L]8-QPA=8MO"_-Y31NE@$:6
ML]H+MY)8P]:^Q^2=CF<*%ZR<451\1;Y>($EIFO2F%IJUQQIA?XUW,KX>-!#I
MZ2D=?0<Y,@:^K23[9*Q]$9HH9+%D5/M*>'[,621"/XHB&N\J^PK78GC_MU&6
MO=5I^@SG\DVG4599[/ENI^_+WFHSZKU5..R+^&Y,!;A=+ Q=+6%O3$A./1+#
MULZQ2=+I,]Y;K?.=%^YQ/CS>[C>S0\!1W(_*53B#$18%SJ]C44=W'?U5)P-T
M1)!Y1G&,=F<AI8&'[ LY2^4B:Y\O3&)KO$Y $J%V  4#&W#N\]I%0&-@[I'S
M1\BP26KS (':*H?T^ '<Q_L'^ M5/>=N;Q@?ZC/8FYK-Q_N_D_'#:#)^ASNP
M,F[MD7K@&Y!M=A=*RM$8Z%O2^27J.M]0LN>T'*-_%8]-.I4*3BX0B+3G]:#!
M&!H69"[44 41DA;5.O99T:Q>Q\K:O/ T6P^G.<R\!;D):Q\FVGYLT8*S7ZFM
M25O5)01SFS#%HD@+RGQ" L]G@8JUIG[D"G=G!@;+[*W=ROSI[FEE^Q3;!JVF
M]>PMI0P#K&HN%(/_-\IH'0>&:>%1%M% >6?9),/)G9NEU+)/\%L!AA(P5A:L
MEP!L&3&YP)F'VQI(-T^-_[8B4P?Z&_(YV':/3R,P4[)) "_8RGLDYS@M#.72
MP\]%Z]3*7B,T\-DSPBW)D(+S@*5SQH,OQF"!Y[X9?0/!DCTD3X4?U[5_)V_
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MG+&NKW3N)<#/<N][.K[ST@'HR2YJ';NKRIO2S+P:Z6S\X('.FX\M?@JK2 ?
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MC\7O\MSF.7XU>LPOFN.:T[T]\:*?.C<?W_Z]\S-N QGIC;O\W0\;%_V-/R;
MY(KKWGWL_-P%F S=K?GT23D>UMK5KEGJ6C&_%CG7><^>NN_82/VK!6(;.&0N
M<#@!:(#( U,R RL0Y4LAB69%,* =X C@2G$*Y7$A;)UH7>\^+M!U*9V;*RF3
M.&%)(*@A6)Q)0\:#B$EF150P6S"O5EL4P/$6>6\US/WSE%)*VLWG]$& 68PZ
MX?=A9G+[:-G-C /Q@TYO_'VXK [.$&$T 80!K)E2XVOOI_1G[V8"\-, L\PZ
MU/HIA0^OOZ4W?9#2B/UI/@6DT[01&U93_",]++WK44'Y#K:XN_G=1UC=M]1^
MGWO8?\V=D_,/ .I/^N-*A<"&"V $(\, ;<-B0<(:3:W:!.@U@Z)1^MBQ+0-O
MC;$GN7<]RM*^0YSU&O+)D\[1&OPOJA+O'_GYKP_EEZN4BG!1$ <Z(3$+I68A
M$Z&O50SBEQ/E2TNU'RQU_9_5:^]=._Q2)#W*E@*'G Z+K&"5;)HX?@KGDU9^
MI1G>6CVWD(%E\_S<^YL= *[V"YYL[M,!J..9+GK8%RIP?K59<]DXV^:YN'>9
M,W%$.Q.G&6MI9^*<UN(O;";.DW;>@CCBVE(;^29* BW D-015LT*3BB/$ATF
M:_GA(\]>N8XGQ=RQ!YG(\"JDZCF#3$1P18+@ $,\Q#.?NG&(AW\5/G,VR(LL
M5I!#C$<YR&(#6.QVD*UO D@[2>5(<#S7 1C;#%W9'3@EXUV&SWD!;YNY*RWP
MZAB]<B"6>$80_>DM:D19[LW-C3OC\3:KP?#!HO/?I<1L,Q3IV2G)[3/J><8E
M5&P7 >/9GS-^YV=AZ1.UC7O7,S8.A-N/<%^UQ1/-Y%_.W-$\E($B3&M)A0E"
M2;EDANF0"V-#\50?8;;HORZ3!XMT_<$85_"_Z?CN!FSWX;W-WE>32Z]=R,V:
MK_K'SCG[OL2.F6%7K1C8?O)5Q"VEG2FE2>R,#\@9"Z T$O@JEDE"I"]53'WX
MZXFDP9>A- 64!C8R"\^P7K^EM#.EM"10@?&YX38,G4PCUE<"_HQ"[0<D>B(;
M]44H+2"='@69%L@FR;3SLN^VU:6K3(>#FGL7UI=L11*](GZB$E]J0P477(+N
M&02)IA$54A';1,TSH#C62/CM]( S1DQE8FV9P+ZBH>"1B'046!W:,/!#$T=/
MC;*H'S$WMW$,VC:.EX"5A@EA0Y4$(2/P"]&^361@HT#"_VC\5$.EHV,E;R)6
MGI=O<+6_>EF?6??3=5[R!GOZM_>TLM8&3!IM?ZT&_<[VUY:;;PH36[WKXY61
MOHS.)SH]YK,N5VJ)D[U0*?\,G1\&XQKNF6EYQ@7QC#V+K5^&9_CK_:8MSVAY
M1LLS#LLS]NQ'\#(\(UCO 6YYQDH[;J% A_J.(S0E$67'9SP-L7:%-:_P$MP!
MP)NP_<9/_6&>_^PEP,%F*D(/8?"WSZCY&9<9A-LWH>T)KK*W,[EQ(-Q>*5RU
MQ::H?B^=T+;<E_9C589?<-+?@8_NKML5S<ME4%='Y@:%:%I*.E-*VC-A[4"4
M)#L]3KI4TI:26DIZR;W]=+R,-"0E;.8&OQV$IA1FM81J.:OEYS9(>Q))9]N:
M(.<YF6H72MPSZ^S E!@2T!-E%QC 'J38O$SK%O_J2BX[-/[13D]UA5ANE-RB
M7V/1[WA)9,]0Z3=GB87UY2ZV6>\'RA(K?E9M4-/:W<GUCVQZ3HRW>>'.G:1*
M9)4$XF8\X"+T0YTH'D21%D*RA!+QPEH-[_3"+O67<R%VMB^:D8K0HNS>$7I
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M$/'SU9]=J4.X]@+TI%-<6N(X+^(P$2>4 FFP*!!1X -Y^"0R.@FUM41'1_(
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MZ<BPR!><4!XE.DRFML>'R3U **YA@.R\G?$EOK-FT@?UX;/]9@<3BP/?WOT
MKC;0_1O8U!#>FU^/QUD: 0LW7X>_#3,X@<$-:+#PH<U_??B;'=YF>G27QM?
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M,V]T;"A\DWL@$V'YNC_SLO(%Z'E)BUD!LT_O>CKWOMM^'_]=?LNJI<X\24]
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M!TSA6PJL=CST8ECG$% S=YZHS,8V_8;9Y%Z2_K &/AQ,,(4!KA[DUDNL]89
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MR$WIX@;C.VLF?5MP1FT0E_#B%-T*_YJ A5C )7)I7<,Y.OTO^'B2 T+DN3<
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M"2_D).'S1/3^PV^;W9Z_Z=CN$AF>&8\HN>O'=;5,3X^S'V]O,WN+0Z>69B[
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M3XU%;E/=%E+=M#;5;3_&TJ:Z'=;@CS?5[;&^Q]H4N94I;W,I<HI#X2[;-LU
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M9\9 /JX_WR]82$@V3U0U0\;+):<J_8ULRL+"<,]'GP),N3TH>E;>NYWC+GY
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MIZB/\S.)WO0.#Q9XAK\VGPHR5V0 +G']^BNL>?;X#O_J>_>JRWP'W$<@ 0?
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MNJYU,H!;X^"P?&2XS*YL/":4WM:";&-CWY<!V59U.QSL:D/-CPN\%$O5#1O
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MR3UQ8NJAW\4.W#O"(NHY(.U87F/*M:6L1/9@$UFL]D;,N@*W-U;.S\H9OK&
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MRE--$JX6>0 :$%-B+WGJZG-[]7T-JAG[[,9\]H9YFT5F6P9*P"4_GPKP/!-
M_FI[W]>'&I2^V%&R20NGXR7!N1+,;HC-2)M;=5TQ4HJ%Y$I4B47.'C5]U@"+
MMZ#W%_(ZPDWG0E%WK'9"8J20" 5,^)BQ%U0B*CY*\6B8)W13/!+^0CC83CHZ
M0:U##:+FM),04R2$CU#']F<5327J4HQ$A;I8'G9&9B44ZXNY"!]T 7$=717,
M'Z30A@KF37L@#8/LL%[;TX>!@UK/YWD77PIY?2Y*.9"B'$J70A@,"\QW<K&>
M6+QP?PT_\LRBE&+Z:'X2N4$82YN6$F,IK,$3DP_7[MKQKT0F4<$B.3G=5QS;
M!!Y+:BFQ*7W[N/>>.QP$C).' >JA<!K->?P?S9A)=/F,ZB;VV+S179X6-)7H
ME21_X.CE?- 2!D[B' G81KS .K=>(KSY@K5^V*6BHA(K.0_#Y@O8_01"\W&%
M+&\*2+-T=CR_0>3[X1-:!YA ._T;=@8783R)IK&?4KLC#O$>T8#0!]Z0ABH%
M34[4T/!YB;6$,:@\RD[4%^X]I<T72;^S3WC7)>U.3CSOT%]=W'_9>V9G]G+I
MP=84OQ&?@R 4;>=?P3?$%V$2G P@<_2/).5 (4'"T1>RF! ZL.P)X\EZ/@XB
M&I.!%=@+\G%04R'PA)F<5GB>4-\[ Y/9"UULZ<>!&U/>G('%0!]%7L3/%?U*
MPWCY<2"*>Q%9#*Q(%(_H$/]B9VZXL+W@&GY#0H.]ROZ,F&>+(V@@9?]C+^V@
MOCO5Y4WH35D:@:_DZ1\>)?7=TJAH0O^^QMB6\13V78PX_"PAWU@]$+I@Q;Y-
M;9]EG5/4ZKQCR3=!1&:$:O0JS7+UNQ?-SV,6P1:1IA[!U0.%H<%G/_""ETM<
M+(2O%8RG]RL&M&]Y.RO[W@GM%QJAM)+&$/&SGY\WK^A^7N7?W]HKK'(5^_[J
M-Y#F1))'3S9U&;_)>F%')+NV6SE@+\!)/7Q>@'O-*/UI(G*$0M]A7?.B1H.Z
M -,Z@N518U"%T0_6';"&I9:"2>&OOH!$+.)%<N"E<IBTZC:1FQ_:\U0C%( [
M1PN N%<A!7N7"K@YF+"4TG/NTR'5TZP]P1>:6PS9,9V9Q6<ZJU\>-@J9L!0\
MS,D(O@&M-1+/A,"<<P_W#T[%=?EK&-\ -3V>0:[O7!M*)HS C4UGT-K[>+GT
M/4+K.UE1V(1^H"K)GX"X(RXA"VS3PQPD&+,@P#+%W7SVJGJ-;T;DU9=\V2H^
M;FI&'YN$X>C1._>)3=?=[7=XS8/"IV1%4)C6C6B8T.O;F#IS:".8EK"5PC>*
M?+]20LL+&[M$EMM!(TQL/>-%2TPBOO"-IU,048H7BE!QVC/R$'XF_R ^+H6C
MQ$083\<!^5\ NZ$=]@+\7U"0EJ().EL ?'7MB9 EOM3!(F%?!JYB65;5,F&.
M"$,1VD<Q.X7X"];77%=S(WG,GYJ#]9=CBK?5YHASM<&U+5ECYQV(LC,GSG?8
MDT681R ,X*\9M1?GH[O+^Y$3U8N$=G439..&,$9(^7F^%<[:6]MS1U/86^!4
MO0(;K%(>VI R=5^62+/''\,+O)!^!2S914P.]P\_*#2"3E4CH ]7MA^M%$;K
M>B$3VIV\TY$^J 2[ S L ^9%R;,[E0*JKFBJ.+9?B46^L>RE35A_^0;X+O1]
M^!N+5&XX7Y3G2^VY([13MYW@5QYEA:7M@7JSF6IWMP5!$R95EHU/X878+&9"
MV\7"DVQ5 O)D^^A65JQ3<G&37*S%^21<P _A!8&E<^$%PH4U6J!S2\-VUR?U
M^@.0;#!%A@39:WX=)%$?C#'"OQ@W3?88X^E#&-E^0J#:2=$A!S-V+35JYUU[
MC?7.I/G][?[7$%H:X+</%.9M3%=Y^@K86GR!E70EG@_6V+*U)F?"6-Q_]P+'
M5L42-TN9T'*A<+W9'&;2-T;X,8$:'5U6N+UYYI+)RUEGE\\1]UUOO-0C[*!Q
M0&I7([W*KZ^:?PNA<?;2 Q7XQ0YL80+>W)S7"Z*JE@F"F9U(86"=8NR5W9$H
MI@&J@LWC-K>A[SFK!_(<??;!$JK>:FQ#\P4')4JYZ+A!,N_=>"H.]50[5DN*
M-IBL+[8Z8@YEA5._4,($8<Q25V:9_3!]Y7J*RSO"B$T==*I=@#7BA_SIT02#
M:D6S/64C+!XY#'.PWS1PD]<P ?/Z R)*7:-;W1"U<H]'^G$OLOXV**YS%QX%
M$>7JLGICHUG]]5=,Z7!GA6NTQL&N2^ _T3#"L/ 6IE&A^NM#S?'(WYM6N%3+
M"YN@B<I>6A@57EH8%U]:P%\NV7(IWBAXX*%^I;+JD(,A^JQN&WW:?@=^:I)<
MC%R7'W"V?1'%0SN!/I(DIB=Y>JO-XJ9T7OMH5NFC8 'ZT?AU8OY&.9#BWS<_
MWJNB9 3T,4!6N#T]2GI7>82DLOQKN_S7SR?EHCB:S2B9@2T,]B&8PDOXIMZW
MVIR0J7&E9&O.)3*9@W$T#RGF^*ZV-VLK=;WM:SAA=78Y7PAT!Y>6( +M"].@
MJ^U3/6$C=D^U3M^NXUX*@B:H-U3+X^G#G/P>4M_-KI6@&D9-#1 SO&^"H,8T
M7&K<X6A#S821..?G<JZ#VNVD1MRX.9W77AB2"!D;3R^ YR._UGP-YBEJX/.0
M10P8L1KGEV9U8\\[K1_D^DHBV%L[A+CU1WTK:AC<RVPWO99O2'R;2NO(@7T9
MXPLZQTYG<]Z(G*FFP+I14]#J=P2Z *P+V1B$60.*_CZ>_!^LB@\AGO86NSE-
MJVD;!J8.X9W'ON/R_PUX\>4?)4)X]W7C!DU(&++_K77(,9&)/HF!M'/J;=)X
M?7=/B4.YL0?:I*7_\N[V>K$4W]JUD[BDY!8*_T6=C\EIO_RD?[T^KRIN:O=J
MSYO=X[;$[?($FX*B"5*<[$MQ&WKNA[$K'C*!U>2>1/$2X50=Y=>M;T)O;\C,
M]J\(8?<$($&!@V5C',W7^[=QJ**ZBJEB7CBLQ]3+9T5I4U;*%B=J*SRCB7\\
MN<S:Z0T>38ZO[9GEZAEO]I8'B:H5O;JBJ7.AHL5M8FCF!,X8"^E%4F$\':&=
M)P[E7A%,UUIC-&K5??TN7I E)8YP$(*^A:T-K+'_YA\S!U&+W><V1$T5<'&Z
M/+FDJ7L8O:2X">OS)9C)X8J0AGU25C.A;[F1G)^;5=I6E36,Z!%/YG4>J@[6
MRN5,:+U.; +4 NC+HAG01<2CAJH1X0Z=/F2>/&AFO.QB5"HH&C$BM6[Y"^+@
M@7A^/2*YZ)#VI=WQLUJ"QKJ*\<8R_H=G=!YM'YW[N,@63&)T1:%#LW!O0"S!
M:&FS:NGI@+*A9[V^@95)GZ#%8&_>QA/?<\8P4S "H[B-H:QG@H:]"6VTLQ)0
M5J,9)43CI)>BE@D]N\98-6'1Y3.J<+)A3&),:Q*M1;,J9;L%)6,-T;9W7]-\
M16F8@W'WRL/<#HK[9W8=B)MXV8F1MDG1?DR33(5)ST(IYC(>3W%.=F/YU- U
M8J77Z86<;[:+L:FA:L3(/#R%#_,PQG<+KL*8-D]7IEW?! VOS-."!@DJYFUR
MO11I&&O7;9O2X!H?U@Z8YW"]J#H)^5+<7ONXS,;QQR#P4"P @2M"FIV<+*UJ
MJ'VKS&Y7O ,GO#<8[$WB9.V3YBG(&J%/Y?"VXNIY3043-"9F*8XY#"JWEES0
MA/87UJ>O'D@X(<$V:YP&#1-ZG28OU$MQ:%++E4J@D#:[DTR<5?1>/2EG?L,M
M9(P_]3,5IT09NI?"&#>77MJ"BMXWHF'H:B,KR,.F&O707 DOKFGR QGY"Q":
M JY/SH0[Z6,ZLX/$*8+S,/0]-XWCW1;>KAA/Y3>ZQ1VX*AGH@G('PN)&9_,5
MCD<\(=?MS<RM>G,#2Q;R8"\R5@7JKVV,\S.1F+.&IZL18D]A#C!5,CQU15./
MV99X(#:B+YOO97%O8PO'1B.R1ECB^0V$/.+*DQS:/!$I'OMH;$NTIOCJUH2.
MKPKP6]CX%-J%AW$'@CE;NO"!U=(U0E:RR(OJ8&A)01-LBMK (R## X\C]Y'[
M'Y,[.L(8:!O-5!(UUO.5MCR-QUX'Y;DDO)KS5HUHF!HRV-8IE\I'++)&OK0/
ML)+=:]L=ZP[AH@6>_U)W,E6[OA&J<FT1Y%LLL!$77KP80S-SKYQJW6A*QH3M
MBKRQ5.2_KJE@PJI1/")^1Q;B]2W=?+&;-5[_=*F&@BGJED(6"JPHG?(NZA[X
M;DH\?HX6+RQG3I,L5+Q-K/H%&_7:)].SS#Z8UR:F 6^M8L[453%AULB3^J2I
M%C@QJ3^U60LZOSVEHFC"B C])CL["JE<-%,\M:!DR 6=\N>/;D""88-[1<@6
M;RA5$C$!^PM\P3:YM(Y7;=$BP^"._8P/]12-L_1X^F^A'P=H<A?KU-V5[X:^
M"0;1-J\B\7.-VR^>>O0-,$Y@.^CPXT ^@14_^*ZXSU%5W(0YDD[K"X+WJ!1Q
MX8K")O3C1FS=89;X?N;$U$A86%7%A#Y=D$6(T2#.1F16*YP\5<PWO<JO/YG:
M'!WO]!RZL<'2-.,0SQ<?3N,D7SQT*+^'$).'\$OH>E//J8\>MR/VEW-WI:_I
MXNO*N-W%Z^+SN@P>G3-Z]>@!?^XCR4BBT)"E14W0C.L+49-%RZ1>M!:NS7RC
M>:+"W.CL7J3UN!KBV"RZ8;]!QY.[1M)EC:8N74U:QD9,9 ?&^Z8>C_<FS2'Y
M3)A(I\6C.O@5/FVT3"X<-SK&JTG+4.-!ADV1M+FF@@DXIUJ\D:_"0)]$>;[D
M(+9][A-NDVQ9JFQ"/UNO,A5Y6E(_>'W.RA?F^L-<\+_LP9@R,!@7]J>?_A]0
M2P,$%     @  (F'5DZ-M_CE,   W_$! !4   !C=71R+3(P,C(Q,C,Q7V-A
M;"YX;6SE?5MS6T>2YGO_"JWW=:M=]TO'=$_(DMWK"-M2R/)X]@F1595E89L"
M-  H2_/K-PL@*5Y $B#R@$?<B&Y9O CGJ\KOY*VR,O_MWS^]/WGV$1?+Z7SV
M]V_47^4WSW!6YG4Z^^/OW_SV]@<1O_GW?_SE+__V/X3XS^_>_/3LY;R<OL?9
MZMF+!<(*Z[,_IZMWSWZON/S7L[:8OW_V^WSQK^E'$.(?ZW_T8O[A\V+ZQ[O5
M,RVUN?[3Q=^J <Q!>@'!%V&=22(I:T66%66)K=C8_M<??RM!6XTQB9I4$U96
M$-FA$^BDJ0Y"S+&M/_1D.OO7W_H?&9;XC!8W6ZZ__/LW[U:K#W_[]ML___SS
MKY_RXN2O\\4?WVHIS;?GO_W-V:]_NO'[?YKU;ZN4TK?KGU[\ZG*Z[1?I8]6W
M__GS3[^6=_@>Q'2V7,&L] <LIW];KK_YT[S :KWG]^)Z=NMO]*_$^:^)_BVA
MM##JKY^6]9M__.79L\UV+.8G^ ;;L_[?W][\>/'(<KK"!?RUS-]_VW_T[8OY
M;#D_F=8NU^_@I$/^]1WB:DG UQ^T^OP!__[-<OK^PPF>?^_= MO?OZ&/6A
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M:_VA7T*@O_\PG?42\&U@G[<5+JY4R7U88)EN9#.KS]_/%ZOI?Z^_G/AB0@)
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M3>Y;8Z61V+\'RON&!7S@+@_HY&&T&@(]MUEIR(7UF7Q-<F$I+%<N5RL5>P>
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M@-LICRF?%HN&D=R J:@;DQUI U)S-BM$D:TY.Q(!P$9ZT9./YTN)C?OJP4[
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MQT5K 4UJ0:%52;E!*E8Q+_1N1&.RUQSLN'';FT\>[+KU-E!-8719>X$0R6F
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M%EPR&(047[HJD<U+KJ\N9&>$S;D0%.)G<%JIJM';QCW(8"N0059W,>4Z!!]
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M&4T!?<!8TE2,P7^#<IQY+O7@GN_LL)*?-I_]>/@_;8H.,FZ*KTB+?)UQ>M_
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MK&RLO8!L1W/<1G0E+?5P!'BC"L<:QLV?+KF_"_:>[.@NN!_&K*[%@5MK]QQ
M@;W7?]IW#,D':M!$% 9*O$U$G)=<$,V-MM))347M;?#QD>\.N_M1<F\/O?7
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M+H/V"VNLM;Q*QXC?_+!I#PX'-@?!=$E>8,J4>PV4!*HH24E(&Q1E-M,.I.X
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M].\Q--.SX9=296 @>.G/FLO9CZ5HKAMT1[DNMT.RB5)S:E/U._OW@WI\;#V
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MVFK.,:;!8FT3+GDTMG4TY!DX+Y82K47]E 5'#R)[-"+VO@=_.S*/G#><79,
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M[(>SJT?6.8=**D!?R-P/Q8!'[H$'%21&ZU7SY@];H'Q?I#A&_CV<.]\2%+8
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MC-U5K\_RY&#Y]G'=]0#1O2J>?7#UE%2X#=-I4@J[ZNQ9"G04^)"$,,R6$J.
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MT'MO FYX5;8!XQ^3<#V=+<;_@WEY0;@>.K>DZS>\21=G7<B >3E)O998^!B
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M5#&:G7]S4JGEJFYG*4Q.9=>9&6<7TX(8A8CED=\?PP4V_*FPOF$^["A2L-V
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MEO]C<LDI4?:QR.<'.\':C6Q =L(22 UKRS3P6[<11.F,L"#J 0&G+#N;0MO
MFQZ"Q?>_JC9@?A271_B=?;RB<^D/'V>"]W[SS-.Y'&#OC!<W Q,P1U&)A$D\
M!>;FW+7@(NYS42[^9EG/(K.B(":781=#55[]#ONN:EC"/08&* E'U@)I)"P3
M)%$\ S]>9PG(J0DBG$# :6(R(^PIQGFB/JHI;:@Q9N[8O5GZJE=HR;?.PXDV
MO@89!OG&N!U8P5@/.C0;1UVF* .G:-Z]<1PH76)X6KV_]CE0,^/4,@[SN&P=
M:FJV>BC];%5PM[3M]ZM"6 J.+$\*PTV'L4*9&RO.5.CT&!TD1C+MR#AFO:97
M>]R!JI9]*Q5]:><F?J=ZSR==/.?PO?*][)UG(8JND&42]0F.<1Q%FEE@=0":
MU9Q#S)ST/Y2['?R?[+SBZ5S;KEGCUM&/+54>YMDEM^ZOH4ROIK(JOE?D)MIE
M/2WZ,(15Q)%'U0PHV[NIA&08+632E$-_H 4C+/E2AVQ$R>./!97 TND"@[9\
MSW%Z7/'S-S&FGBKW?W/X256/!7KV0=/_I&(.T;)")T^\?",X,SMUO*'72+#:
M>,#E?*ZS5@&G"T?^B5@OH(C@IB1'$7]67IP068Y9<0;YCQ^ #&$*T Q7!-AJ
M@<!P5ZDA ]J'%H_<7,V*8$)/XSTFK^WY^]!C130L<771I;\HZL='<<C9(R.Y
M[$Y8,9(1VU-"6J:PW3&&3'@G5'$)*X'OTU+Y;&[GIGSW;]M#%?2J;EOFBW5'
MB1I5CT?L\KX?<U?V*'*5O7^#%5&$7(OK @#^+WOL92<Z$:R_40=A30B&.R*)
M)(519?-Q3),<&8^KBWI(XG_4\?+(@)VE"SZE43:&A6[5Y:8;DD.F=]8,UUZJ
MB"C22*^0RTD,>!>"X34\'>WUDC'4V]N2$M6N:GO7RMWY].LW8W]4X5;LM$NE
M'Z>]PY]$Z*?!C-\<DWG(I\VU (/ T^:1\8*I>T5HRLD,W*IR5""*O3/'DB=^
MG>U[_%'-3*SP#CUBUHY?J9LKUQ ,G8.PNTC&U384DAC#47+H)DE@^6.'>P*A
MC#X2S0-*6;378*REUB\O'_L=>/:0B;.@IV#J[L/%H@IAAJKZ^$_#P!X1GM@\
M8X;E!F(]%B"PIKAI'88<)\!MCI2\<3-DW+M#"2BKZY>N0-L_18<RW#2*+C[)
M:?R7_E,QPTGA7MWM?W-@\"(,OI,8_A3!_LJSSE+=F .,3XD1%W;K(E@%JQ,A
MDA4)>_2#PYX[^_TD4>?69N1YXF@:?%K/>7N+'X[LA(FN 'MZQF?K6_O]HM T
MY3O2]V=-1LN*,>\/SY[]5O"ZY=86Y&>=Q2'C(RMOCGD<A%4B&%%%*UQF-$\\
M'XP790)'JZ>G])2LW6D_&4T[@/1K:SS8RBUN;"G=:ZYXT.F! 3GMG<#E(]&%
M-ZS_R?YG%XXK&VP:Y/VX2XA42E/_,HKIW5_BW(6'<%#$3W_P)KT;+2\!W)DH
MJ,O$'<M>RX:'KOZ>L73OKW<OA.-K1'AW<=1"/!&QC&*;\'JPD@SXLOI5D.M*
M-Z&$)JV&95UOF)M;_S+/4R6L&HBW/;\N6AYU,-$Z4U=0? _N-DZ@0Y$WVF',
M;>[@YUQB1%6FVNVD$[(+66JS^3??N-)P?(!;KK/1XL%KUW7R/ONZA A"@D%3
M37#4,A@1SU$68&DCY6*+NM7\EU@[I1\S'3KS+=#+0PZ7SH0WQ&3$W6C,/2KM
MI&J+3F,6@Z'! >I/></XE\ZI6 .."2.Y8@ZJ:9MN%Q>%VD&B^U:^_;P%(;8[
MUDQ] 2E;9&O,NI[%U(QCJ8)-\#E7?9X*Q@>(82-QY&H2PVL(T3_+][J#*=+]
M^$IYE!9]/O-&AP5C[NCS6_:T^U%N[\2.Y=J[GMEY^,%W<<HG$8[, AV=P@/+
M!]D:H\?,[[K\M;\BMJ7/WF:B\=V:GMAN_V^Q;3ZENQ;%^+K>[>;3UE@/%_C=
MQDKE5I'"/:8WYM:6\<Q:UCRW  O'B .W&3CZ$*_&7BOV1M</%E3=AUL<>GO9
M95J0<"LJJ*+UF)?H!$3N9>XSW@,<V9(429IQ8#4"M^@D==Z7+<C+^2U(Y]0R
MYCBK0W[DK[O_BO*^9/Q\LMS 7:^\@NS1+^(+^P].1].UX" 816.1='PZ&(HU
M=4X8]P7F)+WN%.O^V-CQ3ZM_S<S<8J6[3,KB41%1Q0]79!VN%GY(M[O=,*7,
MEY;+C6 K8H<[++@%B!"D(/8CJ';V+B'DFG+$PFO/Q\]E8?4T9VL<B":MQ?K&
MBKY!)T;W"V9=_7#51:1JQ%$!<O+_^\GWCPD">P;T 8JQ!Z^D6)@+$W_'#AE!
M7<O RC;<F^SNT'_;$F'Z5]TFR/ +_# _74?/LKQ*]5F$_GZ-O7[ON*E8\'MD
M-"X$F=@*71YA^X&OX&L=.Q?MY<:>CC;BTO#2/).?8DI$E'@J#?7 6N*!?O:)
M]*?/+ZK:,QVCIKA:SQ+L8P&1I]A9I!)OUS3F&K?J^RA6!?!W(9;"I3'JC.?-
MUKZK"P4WU+^%G90MO[K;?,UX=.J8R_#;'\4%_)AMX=:]O=TA<ONN2B\4RON*
M>U79X[Z_$Z_5KLNZUWN]NM8@^RUKKY*;<Z'+2(E$U=$JU^8](:>S.KW.>(P-
M& G,2>FQIL$1:J8QRNX2/3B&<X[<5XYOCKM,4V]*SYHD5.QLH. ,"]]D7P[7
M37A)^<XM+C]QXU)0BCU8$P2W?\ 4CIT$E7@9QAVTQ8!+XMPJ \;F*)G6F@XG
MDBE'I';@:;_6OLVN7LO[?&S24TS+KJ;F2([NSOP;M,TL1P@FFNWDSYO9!PI6
M' W>-YQ,>I7U@\A8HDTDT6_I]:B]*+49-?LK=7 1?W[J0,&+(IUC5QX?D#:\
M9WC%,N3$$TH/&.X+"&I&!W3;!8XW%V^_<TGIQ@24"E=WLKN%OCF@/VX'UV8[
M]N89^=AU8&2/),C5F"^<.[Z7O9X. 6IY$D3V =X8LMF6(S_9AW\%7ZYDZ+K'
M^S ;]WD^?Q-'^+6)+7[NB*J>"6BU?;RK^+M)I**7[A3[4TQBA4<RCMQ,>5FY
M,@3&@0C(SJ&GQEA5W$?%WCU82YS,+ZP.8S+#JNV=WE#F+BMYITDQ70M4L.B[
M>K&B'U\47G%=GB4@A'#4:C#@>,"8M+WS4 @]!C*0+8@8(B3+UH/Q\795[(T
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M49[E)QKMM.O6SG5>1??@%6/+R!WR^+,,=+?9J=[I=$SSM'E>?!A:_\4A\NY
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MV5<V;FNOG;#,P#PXXN8?IVHE()]L+<^%%H9FP4\/77"&B@%5NQ,*67H-+77
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MQTZ%G202=TT,0"5$M_84B<.7!,1Q^#)HF&F2R<@?NQA#1AU7ER2:1S7\Y94
M3>_J*E,Q?[?KDQ)?6JYS-W7S6F9)9#9/4\@L4>]V P1P/IY$>8:O\>[T1\5S
M).J&Y,RC/$:,CT^IMKNIO/%WB<:$AG"/B7$_]1(4?CZJ TP_0NXN:_/$=>_
M*K)9$IL<H550!%";^_KX[GL?I'S\FJS6V_'L7(^JZ_=#;Z\IZ-:\5'F6><U4
M]?/MF^\1;XST=F!5$RL10'8;B>\M/?8QA2C@\S @+A:+\"?Z5TR_3IWECIP:
M.:HE+U,HTOU*L*KVQX8_5%09HM#8W"=17I$ .[*\/XX;*CR42M?!F!:1L#A[
MYH6Z-[\\N&H#SJ]:\6*)M7J B_OS]M>-\5)_Q5?^7G$:0U&J4 !&G\@2_Y^[
M&(^Q-C#(R&H$%(CM*<@Y:[> >WT17MH:Q4SD<N2ZD=6$YV?NPJ?/O[AI]5E8
M\?P*3<5I8#7 ZUIY/)VD! \$L+SL]&;0TC;4)7*(["Y_0]JLO.5VG/*\>_Y#
M)Q-T*@&XBV>)&+:3%$FWB#R<X5!437?%:\(C,O]T1P,NH<2G[,, ;;K0W(;W
MX+2QE[Y /_'PCR>5,K+.P*?D_>Q3[+@F!;H3E;QR%4AK12A@%AKHY0G X+F/
M]."N+YS;Z7YWE@#+>U<W0NMRB=F#7^Z%#_',6[(4(29YV!S <_I*2?\"ZHGU
M.[";I+\0B:'VL',/9.[ WC4%[V9E.A0\.U" P[_%U'##PNBH3G\2S[*L(DFQ
MCHH1G786J*YI<"Z,2?<1*'XIUJ,>R56PG[?U99&;,F/7#.\V;HRP!ZJU 38,
M,SIAE=*B/I%''?/@!?(_15!$%-.HS8=.RL[L]?WH8381NE=J*O!P_0_L.YR]
MI/DSKHT)CN#H2%!)VB-$S4(1,B]P6\URB,(T/??6[FB9?J3G3/*JRE[+_QX[
MHB@]S:8.-?7L=Q>[#7*R[8!G%6Z!-&OQ93?+N1<X?0;$N0D<7B%Z$H?/'-B>
MDWJ$E.;,3,$3,FA?HP)\M&H(455F4V?F&]Q[)/KBMTHOY&DMS(A,V6C<-(KQ
MBD"#AU L8;=N F"!CE<TI.]_RO1:VH$)!Z$0O@Q[?R/SG@ZI4:U#65]^R#TX
M^$FV\'<!^_#5OF$#:AWWW?0]?]]#>/T":\LF<H[@AM#5$+WE;=%@&8XVA=+:
M"L&H+C&6+9#UNL3]]\G&,>._UYA:KWUN3)^AY83^S4NNB)@I#OT=QQ+NX?#^
MI2MS^(1>8^T![R2H=%TU['F(2=W*$W*[,*I'@EL76Q;:R?ZP/,W]8/Z'JF.=
MP^C>Z1>,O^MS*):<-CV-2EAE1S"QNS?Y=V"!Z^#%W-JZ]S]F?\NJ[L!BS?](
MGG"O""^,QFPLUCSMO>ZK9R[\.+;U+*$ 7PE?::/A)Z?;Z_X5=ZVG-I"ZH"FO
M&N9%+^ZTQ=A%]FYQ\5>V83"^@?L,#.[$/>D)4#Q7/6K559AE>0V.)J:BKN,G
M)Z@\J[L&N\% \<HR?;F-\6\]FN5$S5O61%^HE^[+8T96*@>G7KY3J9(4^W\7
M@A> Q$*LRX2Q1/!;K#A](8I:AK,W+R?24(*VI6ZFF<J'I]3[+>[Q740]Y-DG
M?+\G99=MW-2>$F#(L_/_$"9[:.NK)J]9=B.LT_+T7[DU=1V?]&R RA_&/]U1
MC,POE[A/&)5_GSL=\C.=[QI\P9]1#NHP?:"1J2/7HCOA48J(;VOZZ#W82X!!
MQ:OOOPVM^CUIZW"/-LUZW[VL]^%^(R7"IU*O[ N,Q<SBG4A<1$V]]4EFV[_8
MU\'RPB:45:3U8DY[H4_MT_0O=C 8G\H?HN*N)-@U@&[AQ[==QGLIN#'N@T11
MY]]WUYH!=))R'?SN*[_$0DNC P+=DY,:+GNMOB>7[ M&!2 @V17'+B+=0(.>
MA$ARC4<>4._'D;"#@U5=""#*NG3FA\L#/L$*UQN<;P')B2H6(:(OTX4;I7E>
MP;-:A,!1VN"JRRML$+@X1P(/P[O2$A1%V(77 A =L@LI-#3/E)LMP)%ST:RN
MIZ1='%]=NZ[+MZZ_UT/ED*VI^I/$GHTHCA 3W*2C.+R["H6;.+8#NX&>NG2>
M!'3%I6$FVG!'1_037LWXOJOB"PK/-MCH%] U3A*^F3DWB5N1B17"GR=5;K>O
M)Y"X<;P@GHKJTH[W4*#KD^/T\JZ>Z+\$3$3-#ROY^X<IQW"Y68>'QOWE4[WJ
M]&2OX/V_NT5TUX'[1I,_])<^NT*-75%#FAXT!R0__O/*?.;8(@V>TM4Q*&K*
MR_&.N*V7O>>\VO/7,&?//18_GL"'\%,]78@J0L)ZTU&F'&<4R3^ZQ8;/14^E
M1NW/++4@^H=J-F?,/I<WX+TO+VITXDD?_>A%.5]$/&)W3PM03]T9-*4VXQG/
MH*C=PIJ0ONFQ)?F";0@QG(//:U]CQ,]^)D].E QT')&Q\MI[3BK!ZYXXA\"9
M1 /6Q%12G7<[.A+)#<XS[_Y8XJB#YC32ZE^<*LC5M@/[_B^&_=,Q5LYE+M:M
M\5GD=:W)PCOS;OM4[L;*A</%L0>@]IK!)&K$>BN#7=$"MZACP(O[Z1<1,=O#
M_A6MOQS*)=N"X15)S<5Q@A4\?Z.5L,_V;*:Q9%.86-P0HG:;);;I.KP#\UD7
M)8>EN4)J?_/5$N?86.$)]]^20OZ"0.&&H:ZM2*CI0=4<X[+)VU4X-WS;&]1&
MKC94WR9/T.&<[.\3ZSTKD/S9]PLHWMVP2O<C.P-_'2_FFX_X5)/OUK\N$3;8
M,>(/_^ G^LH%$WBMKJ&*K"P>#ZL\5GKWV)Y'O* IAV\9 KLVW! 9L$5,N:*G
MBAD0Y$3FASW<[,PV.C.;$XJAX1^=<)^RP]S[O+'?J@9\H4 OV%M^W*E>1?B
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MR5+KGPM31R[8V=^?;7GS/T<$5?9[U.VTR5%*SXHVTQ\WB9,<0\)9THU5Z0:
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M+U_60?D7:.E+\VU#M92QVKXE:0?PG_SV &)1#;(;2PUG?]5Z ,+GPN7F+XQ
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MO"[SS3FRG)]=RB:[F2W0L7;BTXF4RL&Y$R3HD":5?Y7.%4AZ03\JN30J1F?
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M(]>Z <-HXD=>X[93($=7?2IQWX),6L?;C(I75)K( 8IR-6[W5;[JGU0^_--
M<T20M$V(2[##95,E_Q*>4:Y2[Y# W<.:O>WR]-$F4G["AUX?W8;/]#BA)P\=
M2E)-IT60=5<VC87N#[B4@*LA[!#<RP-0#7ASE"E97T^K-6&$++ ?^D2;1Q%4
M(9> %#1YO%_QQK9Z?E3]N<']2!.ANW,ZW0VL]8IF(58=8)^9G0UF/1E6NLS6
M. .T<X:)Z .0Z6]%>D'9WR"&738P)S."UW1^ Z-$- 1@?V?%_BN-*N)%Y[0@
MB=(Y;E*4G>A3[4( 3Q'C:M-GT*8)C>&+E-[:-3N1%=Q6K/TUC+-RX0/I9T*R
MBL:_K@!-!!3UQ#N*;S=C3!:)_52A.CR8*B@U@NVP$R^M)KDV$*JDU-(E.]NS
MI@2Z3A/,?KT;-$YY_"6QSG2L_-'1UQN3$-PO]%\#DWC()OP;\O>[,@(J ;W#
MH-+1R$T%,+U$5)UEGT(YA^RTI!]B>M3U!34Z9PQ!.+<+P?&B2Q.#C0^H*A8<
M*&Y(?J$?!E)D>5-.WBFZ=]H'<?VTJDB[$G"&N6>'U@;!%4%J2_J@F&P<;),5
MCP6LZ."Z:?6+L=O]MZJ2_APV%]AEP#GM#>:&6ZKWC_#@+-V>5P59=M90#:HZ
M$9O29L>(=5?\Q&&1^'RG#R+[.SM*#T)R)9 2KW^E20K?2;6#D6WJ>L-A5 GK
M)2P;A"K10!*6<*IK8GR&[V[?PXV=8:T"3$VU4^2.P)6;/P;C%))Y?4&D*N!<
M(?T*NGZ&%A'*("GZTV7;:D>1G7<0Z@B&E=;#^J!/(<3KX"BZ ,DUFRC?+76:
MU)3:,)\;;A%BYYEW=T+]9T6!>P-F&F_T/:7NW _CP9NHW0TZ=T[C]#9=@CXM
MCHQ5[=%Z,[TH;*%W:W9GU3NH4\*K48)=;^H' Q5\Y+1L:RCZ<&]:.CR<8D*]
M K@O2=[ ,*B"V;C.N?)Y>_/28;=3W^V^76^ZN/-:/FDT)4KU^.F\>&DS*]Y9
MY&P:G7.C#-EI#L'EBY=LA5,$X4>KIW4B\&LKM3,,Z\GM3;D[ML[75:=1;E<S
M?PT\;)+<*6L8OTS^%%^V]1=%YZ PA=9\&8G]<E.?DZ40?4A*& @HI\H3A?OC
M"[ZU&9%$UIWR?/#9@QES_.K57[Z>291YJQ-K'I\I^^@&4YTLRH4!<9H0-S0@
MCR@C*>%Y-V$$)-^B"W;1)T1/<^+/<. 6=FY/ZOKP_:=9<O;%WD6J8S_:^V+B
M;4*_(HXC._UT%(KI'6"B X\FG?,=10FN%@#%M\+M$BT<5WZ-7"A<ESH[4908
M<;>/->O[>\M70U?FPR1Q:2OUIZY "E%SFOV,X>GOY7V&@:4>@'R13W-$NU'\
MOEDUS@>@KE.%H;46=RUT)5G#["YH5+24;SP7<S_V-HJU\8+K:^>X#MY4Y#&(
M3U64JS#M+9UO(ZDTU*M/2[BQHF"ADL5;_@K>^5"PZ2?%GV%VMM9?-&:^_3MD
M@/Y3#2K+&)&K2%P\(^Q5 6=F>K:/4=UH'_4D?6<0TL25?/6?#3R\KCF]5?ZV
M=ID!]W70:/&VC-I,S-*0_\5C[#-"5NQ=*"$D;GX;D"OIP<:['@:28!3=[\"M
M)?R?E(;W:1ZX-#[G-2OG7M@%"_[F'7LSN0*38$V6Z1"5[/1XYR!44PF5GYW,
MK,#T?,-5=!+I\P$.#73'Y:G4'X". D@#DG3UQ.]7)PQKC[JEZG'%2W.;Z1A&
MWCDM_(<FQ$+R^D>P1HJ6>  *0+'"=8% BGEH&<$N03TM9E_0QY6_(;?/$R(C
MCQ$WXS3DGA!*/3Z4EG6&,^2[TUP#%%!8W<0NJ<TV0F9Y"2LQ'T)7\4..0EJ&
MP:[*DSR]XYCNILT.YY-FK-VU$%4KPZ3ETN^FP^$!0BQ_%_ ,?G!1D\XQ6D@]
M-(WTC/#K@XA2]7&TJWCYL<=(/JI1>"Z,VXS<7.GYPKQQ)^9S>=UQ:JG"3HYG
MHH.5:;N[X._M3<8''UZB92)QN<AC]^G"](%%T9G' 1)6+:)VTT]0R1J2QF?N
M/Q NL;_O%7HG/=)JF-,$[?MK9"SM<4&D;&M] [HAJV\?<_EMSL54;X\K S+\
M4>6\3%K:?H'V"H)["B5:,$@IA1PU"?&&/47RMIF\7X#ZWO0]@W> 0T/DGP6$
M<*>HM'UU;Y:K.)P\>C1WF.\RSW%C&]DMSM.L!$@"FG@%-1M'P&XE(V&HXT 9
MP9UJ8Q$\8U=',D*G< =X/?3G#XB^>;2M(54]5=V>G*G8?&?N<D@_%#CIM:E+
M,:+/E%&"X-=)X)[2=GFGC> G[S.KYD*GWM*'\L?&MHZT^4E]&1=(J'F ^.7T
M4 [5^.$M;QX:]Q9)-(?.4NB<#XFYYH UQ2E49MM>BSM%+8YJ[A9.=K&[GCEE
M:Y?XV*7YN>)V2GKAW8_7//BJ)!G=2&36#T7T8(D6NC9P:Z(CKVAHFFMC7=:H
MV4S[R=#GZ]9K(K7//6)'-$QQ#<>N+([U5"[%WCVOM/'Q-*CJ-5R;<8=F (I'
M8=YOD,=J:05ZY\Q)QQ@Q-,EL,L@))5XXO^ S9K9R*A<3!O;BBU/N%#G7D#?W
M8,ALWS<1I/1%[RBB!\R*]"P#)XJ'=$@H,9BG <F]M\E5?J9PK"15HYJ1G^$:
M<\)/G4MG@=65SYL^.!5R\H@T>]78%; FH@]+-&?.LE4WI>B8+%E&@47T%*XO
MGIOQFJ9"2T)1?1:E\WY:+[_<W%80[(..7+YUS]CV;D)SM;-MR1;S+,(*(/U/
MO=90%#O:1TT8Z*2"5_4?/L3GL3J:*_GEQKOD7R[RB!\<XGJ,K5NV;I+5V*ZW
M8N_'UBI0^<'D*[38=LG0#3QX<YF CL=8QNK)_&QZ@DQX+($6C:@<PX0'-_E]
M6,J1M_\E<K'C^;'@#W?P5QBI"N-U51%#!Z#:Z:P6S4U=$HS0WT%QN)OLV^C*
M2OK04C]URI"#_'I+XQ6L(GKY-EO.I<+@C@&<W0SCR;'T0231TG)NB6Q,BDO4
M4PE5Y0GL8;C+@R]P#Y)FOWBW[Y-?E1^$3 1'.I3/OC7D.LPA=,48I3!X;G=O
MRXT1R7_2.Y!-"KVE>I?I4XMR &I)3>ASM*WL;32I*G/9R="^Z%SOX3,G3+E:
M XQ8 ^ND[%_LY3$P@LP\"Z--B]=3,'O73S'WA0CIG;,'?,8MV(V "I*?_=3O
M#3.A (&(]$H1,0D?Q>OQ?UV/^:TK(6/;1;_1Q1F1X0,0X9DO,'YR_ :JV #O
M%^K?EWFL*X%\^_:Y'JN(;WP?3CYT^FW%/HRM*:$*LN)*-L\L@?E#NW'(7F3"
M!+++O7*T FBU()DDYUHW3FN<>5Z4_8)C26T5]?(U_]2K@OO*HL+%S*IWE^CL
MR$[3=JF2+EZ,92_BW(NN0Z&J"L21IQ6G,AMZ>U2W3NR<[_'PE-B'S>V4SJ?G
M[.V?9ET>!1105 $ELA-SKMF\W)$^0)<A+<>F537GVA*GZPA-GR?>-W,*.<??
ML\RX\U'TB;#R6[;OP@^K*# D\P"X.WA^]]9X&XS4A!\BNUXFXDV()3THCO5
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MY!Z[CW\UR^ND\.+_ U+7_VK_K=U<6,#XD#.PV 63PWS&XQ;J(\*R5\X[).!
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M -I&N5_D]3,F?'KNR/+G39?\>'#M_:64SUQTCDS&Q[XEHK=.A0=0=.A3_$Z
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MK+$_CI4?J)V #<.;Y&FE$%]>$2,2DLYI0S'W30NZ*/9;5]N:_FU2F&,@_OM
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MPG:I38EC3JE%B4AESI3&PMF"1,6O_\M<X$R!MZ-GD\/M+XEBSS5/GL"E_WR
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MH0S 4=5'Z3Z@$U 9 CVTH/!.&RG0G7^+@P%H%$09,]WP;^(P\AV$*@9W)C
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M'79#(^:W,0#GX*U:3.H)N^@J*CY:)6B^"#F5]W7[MYBO]5J[_>,C'0E'V
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MEMNZ81B<%29(Y29H(EOA;VU/#D)5/H_)RKR:EAVV?V_H>WMA:DYZ7>_&?'S
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MR@9_T<'>^TJ8JBA;/MG5#$%/C#I A?/!1+2N '%A2@S EZQF9V($5C0'L<X
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MV6=N1/&:1OY:9S83A.8]!)C<A]Q*Z'IDR*2YF).+NBPG%T^)]CH=*W;_P)M
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M[V@\K #"<0AKPTP@2( Q ',(Q%=U0?];>YLK%MN95\1XUH!C,F^^IPO.VCB
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M=?;66*TT[R*[EB"!87_SR@O*RC77GB&G2T)+$H_"%LM)H&(42]C"$LQ2;78
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MD?\S5R?UY;R1^B[P""05(<0(E^/\/*8#C;&[@2;(<XLFN)Q!EYB2S?>BDO:
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MHMB'VK+3#.3&/<Y<_JP1=WCJP+R]_A?DX*WQ0_:R_]P6?Z U=DTOWF-L84W
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M5AFBN#=A8@P=JP9FAL)JPW+.W2XX^FV+W//TB+IQ5UK9V3,[C']F<.1T6!]
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M@[=EP$*]K+7@Q=P(6CJ,_OSM3L_N2VT3$P$,]_Z\K?3#L?=:3PO1D(\ 6CX
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M7[,_5?77+YT9/BL[P2UZ>T3O;)8[&#MFUB5@,V4M01.<VDY,1]'N($'WM?K
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M7"*,^Y@P'V(PU%=OM=\L/1G2JK/6YR.2[N_XNE,P>*.M%$RPG/NA'4XWX*5
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MYMJAITU92N[3U77G98Z]EI$^EOI,J7#]U]-O/\?VX8T"T!4E'+GD(=[&P&&
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M*-G#PT4F'B)[7(U?,_LC&$,N;D,B1N<T*$0L:)U/B,W(K#*F(1:MY@?:=L)
M\T?E]74QR[*&COJV/(%1W%$U"V=O)=73[<-7=W=1P15.\J86;;@/,*3212MF
M7(^!WJ8[D%437CCG=9=VL]_@1B'B<DMK:^?QH]L0N]KFCDYK#'724.LN_"&&
M$2G4 ]W+FX Q+F!S$0S/!<N^Y@(,E(SO%RE?/MO]KO!.0=5+@_Y;[YQV9-]:
M#'JW^Y1BVCZD_%;%JQ5,@Q<=QHX!:BC\]'4R!FJ%)&'NMT7][%M012&9"K\=
M<C:&L>K4@)9<RT28NU_*.07?^%"CQXN+O,-[3LU ?M< YBH\44%BLPY'5J5O
M48F);HGF1#)P)QF%&5:_XERL&SR2*Q;,;^^G-PWZXP)=(G+B"1Q5D$+O2@%^
MLQ5_+8IR4[8A05@9_W"X-%I[IIB.Z&<=4OCM,KYXJS')$B02!6?]3^<9_G-X
MK%(H5*FO8A!$AXEQ%"&.5!Q/4F4:'F28,Q==0B8(H"X761^:&W6=UB),5)&[
M'HP^&U&=G&*-7O_VD7YQPLKHXOMKM[)%Z002$SO;1T'T$><%2!4<N4@7QO>I
M9V055X7AOJ+&?F%?2Q6VJ@.%)_?HCYN-Y:N=M[1GM_8&"VP(=,,8MGA A_>0
M;3S+408>,G#3_:46A2>]-T9S%.LL@2[J>2/>ID?6A1O1SS!'&C*46W+B/5-N
M0(<PC"@B1SZ,E<N,HULP+7@B4'8DQ[Z#B<_@*2\L9Y"(*E?6GQA64R>0Z/=Q
M0=<U9'Z_U715:0T3K=<WV94-G1X5XIQFP+ VRA'X/1V&E"Q+O/B*\MYC@_@J
MD4F_]T$'U8-;%L_LW#-C3KF>&_F7LPU)OFHC!M2S&OG954XBOP8JX'6J%4L>
MQ%/@\@L16\,G+^@/TX/<<4X&[@\$Y!MQ/O[05G95]^VLX[ .8L,:?1?);=:.
M%<>LH>LSS7T4;1D6J35F)<[[AIX8V\K"\_=8*>V]FVE9?P^1"V,X((51H):2
M,]"Z*!=N)YQ4CE:?['!F3/1V:0= R<0>_2C?>)1)V,W+?AF^D>&S]F.I2E'G
M3-NSJ_25C.7ET'@,OY\$5IDW@V"X(K*)]85]X1^[U)DZ2=&*MDV2<@N!QR_\
M4$&5"A5KZJNY"6"LO'Z [-"'2>AK@M5C!A$SP_W&F%!@M \NH])?>$QUZW%T
MUVA,6&30_G6\!/M5Y4XGHW73=RJ[4H_;3'++0<]\:",Z5HU6!H990L7>@/^B
M+-!)E@@:0$,8B/2P"<Y12I3"A']=Z:I^B5F('\)XSXN$^P^E+/><#D-OS*_"
M&Q <.4M6!+>HZW \DG6=Z5!;"213$%FT[QV,S3["KG"3Y;;.D7]/T;4F[$7S
MDZ0T\C9Q=?IR%\LRFZS/#B%D>6H<8U>M#@Q53$)S9>Y[4\YSQ]M'O B$EL2W
M\R<(=YQ5\E*$1*M_BE;V,9$L:^Q0#8B#<"@D,GOW]?C2G9TVRNP+M[C)M"+O
MQO6806)]P2<BY;?)IV4(%\$MAB/=9M-8'8!=%2J<6VH5&T-Q@4H$^/L >8Z-
M8X<*O<=K+@H.A]C\P\QZO+I;6/KV[9A-BYTB?XF.H/H>P$DX]$$@B(+(Q$!Y
M5BM=FHV,(A&S$A-[X':E,T;<TJ>4U,UZ/8S<@UCT-Y\).IBY6J6^&RCF21"+
MA_+ X'%G&X)\CS*NWX;TBO..,$6^B._CXMEV/)FLFK<_]T:OHXG-\['Q7AP5
MOXI?Z_R.S: JGEO@?$Y,P.^%97PWRAF$TW*NT72JOWZCED'0-< 03Q($=TG>
M@!LK;AP>,0_+O5.8;F7VNK?N0^D>1CZ7/I6G],_\ZN1E)P+%7_S#6,6<.#I2
M=[VC9^0.@9_2UK.@>3"PK&-C&"11GG.VO9BLUHF,M"[,;D"*+RLRAE3[DPYD
M,^>[U^=_7)!ZJ/[*QZU@)EJ?\9M_0?C7"AC3[Z._3+\)$BY"IBM2(DX&Q="R
MCNOF3=(UJ=;&UP.S0PLP@-'Y[#H%O1-)9ZX)]??<^^LNM,0B@/J2Q_3H<BR?
MQCL.Q>&5.<=YTLR<.5^?^!_PM+:6L:O5CV6:IKVBKLHHL5[=2GLB?7CUY;]F
MB3KL4^A93+TB+8TA267AN<_01A$V,(:I] EF9)6&OQ;Y<72* 4YJ[<8Z](F,
MUN4/8CON.G$\N.6F8"0UY"BYD!3:F^J=J0'J 1I70/CGBI1YIQ4RQ'Q<]//Z
MRO#/SGA'CKPY#,O/NI2 0@VV93H1L2*-V2]\+%0Z'@Q4PNLZ:$P\C6@Q/,JX
MW?E28'.4E,:1ZV,% //,<<-9#)VGR4#V%X_L,%O0Z29*6QG$/E]6KG[<\ZZ]
MT25%[!JA/>^&AI+LA[P[AP8',?^1_A"XDGH*,0<M2;Q2:C"-Y.WYQ9HFR,5"
M=P.RGE-7.V 2_4A-;9[?D>#U84>5=^<%ZM0MC[A7.OX(XR@V(=5@P)$W+.5D
M\LY/J%/-=TPL9G<0628U+7CTT77TIT/-K'7.1V;1;W BW5':3S8*TV," E=H
M)I[ABP"T, , QX\D@1BP<&'6]![*.3)>L_^1%KVZ+)B-G@C[8>*4Y]CD))/X
MX8)U?8O0))QQC8#%D/#$1C=:/L/$C_N<$(V'H609-1F-^H9*@&%_$;1OY.SY
MQJF+N,^G'IYJ>JV@4I9Y#F>\UJ;^$=7\?L@%U,%74*H@V^AKL9$#5%@W 5@%
M4+TY1)"FU*>=89;]2+LQQ5)V#U?X\<,R-=U@]>G8NZ?VDC\RRGTT14\[&_82
M&3?@@^"OH$'JPSAI.#--=>RK27U#6H#ZM64TC(H,?G\QKI[E?#C+^_'=P .<
MSMI62-TN37%*.P&PO"D_!;^DY-1;75&Y&O09M;AW&R)P'%;- QE1$A;]G@ %
M*;(^<8Y-(62;C0K&:P]R9CH6CS'.O'F^++L0+)BD:K,^9]GZ[0;:/E?;,%7_
M0:5]S>QOUA:WE!!.S$*K<TL[CB94QV,H.BD-\XENO@S%'%.1/U47K&VNE:M,
M9H;L#%>Y\RI\^/;5'DWA?H/_=,TFPV6L?$B&JNAW//V 4">4XE.4TV0C3-I%
M@C!WJ7G2@'BJX.N(Y+5U@_8 X_T](1%"=HCP>$6>")EL[<<3/<_HXXE641'S
M(QUG*8DN/7GQ"7W*9[*>^LQ&=!V8T'S;42+Z^-];C_1.1]N]FD.E<^MV;,;^
MK_X57A]L]@,@#]PEVSR]5O4'D3I/&U\_WX"AQ7]:2GY08?F7*K_^S]F!ED"Y
MBE.Q;[^\27 89YDN.%0A,T=\-R>Z*@@/KVV@>+$:IQKU4 4\S4G#!/K-M::*
M+Y->[XB,)C!D_4OX<]J1)_)B&T)9VH:D-(-3:6U#GE^&,UQAVQ!%!/A'.EEO
M&_(LU'(;(E*V#7D/ \.KU$_P<]L9!&<OX1W_;K@*3X'(D2OD9?"YIRF&$P#[
M/_QX>D\^YG,]"+[OCV]#OB7S]G^"\Y+?$H"CF(<;(_+K%AP# J!KR)65!A4-
MTF.@#4[F-\-PQBR!O%@6G'5@['][&"&.W3\8KM E#./&-D1CI4C_&Q+PPS \
M$5O:("83!+_ O(GIY=_OQ&U#QHQ@@#8(9K->\#1V@XH]\3&.)PL:.PX*I!W9
MAFQ)\JO<?^<Y3IO^'Z2SLKP&'7GE'VYNLF)TM2/A2!'=G'JU;,>EW*\_NMZD
MM(R*#,3J]>8J=,)"\]!S>>4E:XR%]KDYUF>&R:)R?[!4A5[CKW,_"8P?%9%^
M"086GSD@WT\&I74),Q=$)M(Q5,-YD!V\KXD,5$@CZ_1M0X3CAT'.SLA]<5W$
M>2W64,IAZZ/"$L_=VP$;'9IS5M#R8S?%$]T 4F)2.7P'AM0"9S@0,WW3^A<$
M3F51L'>[5):KJ*Z[X;@HB[/8,RWF<Y]*N_\^&-+7.'9,:NP(3MW)?92%O4NJ
MFP0!#D*I8>7=Y5)=M #JF#,IWT[_1:2:Q2X?-T'IF8V:'@)@T,R13:!6<*3J
M6<\GX4@8H,,L=@.LF>9#'I]C%]2%G]!OFKSL97[]I6B4M*/NL:Q6.VP#J5SS
M@7ERC:7S"?9YE);,J.^&"X&P2!#0( ^E1C5TVAB*S[QCSE>,6(U$J?W]'O/;
M1;_4UU'K\;ISS3MP1AA'H9B21@.A]*Y_ (G7X>[+!> .AE:YLMEFD;-&<6!K
M=]Z.DW^](JU]I"52S*5=T8.C**&N9K=CJY@)8]UKY#Z&7V3#L_&S=F<G*U&J
M97- F-WOG4VUE0N.NZI+*IZ-2ER/,Y5*GO\X>CSRMPY/3  TEB9N(^\PID<M
MCYR6Q=N!,FAG&O;N[F#^>$;%0#D^DS4;49'NUZT76X_Y#)-78F]UW*[664=_
M;HE-W\F6=Q*B;:16!+WYY;YRS."K1<'TA16S?UGKJ;GQLW'Z^I*B#VP%K]G6
M=+L!&N V!.>)C+$#.1> 8C(<,+B%);^'AQM*H4ZV)\KZ NVA==X1%RP]#S0D
M'DK YMGCYH*?G-!-^=HFK=&BAP_#]%2#A'<-B!P%M!;P?02%E9V_!_$"D_'(
M"YD^,0>W+I]$G&ZQ=CJ[L_AJJ8M/ZYJ_#GW__SSHF!0#.E,WHKXP#4YZCJCG
M56U#1$<IL'Z$I-WKA7ALGVUT977L[FP1^H;^Z=?OK<Z*[,=Y9WL6GO!_?_>
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MT&9Q;&$;DFKE]?*7T7*]=!HNGJZ=X]+R:=,U1YOB7ZLY78:>)#!<\#-NK%'
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M,_A-:PTJM?]_]Y#RQJNK7)*IH3T0/A[$W^Z$<FW++!> 9P5;;8JM^G$C 3O
MGK78KUJC_G06[PT[T':E?;I-_ARY#1N"7$V;^D9%BT'@![5;]Z\VC_KIZ.VX
MR5N52<XN#$YSQ4\*'R8>2GCP"6A??[!MY6;P"U4CK53[ 6QR+G*U9CEAYNXC
MV!;PEI"'Y:<'D:OW:WW[42A7N?K/![7,N1?+./13DJA%A1^J107RF%24'?DP
MHE$:T@2%+!$FE'U1TMR(>J<H6&DE059I:<8MEV'M)VFG8(U,S7N<*OT6]?_
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MP>2V=?8%F2_10-L,AC-MM UO=EAQK<E3T F1_TN07-=S%$N/498FC,.4>;H
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M4EAW+B>9Y?K+"GK#;8"1 !U[8Z"C-G@&[%YS\-LH-22'8.9JG\!&]+0[!P-
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MU$&Q@."Y:V)SJWT$0S^GSLQ>\_^Q):M,/BFVNV%LLUT?Y'7H*I5+Z?D!\FD
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M\2=7AQVG>"7ZCT>.JL&$!RJG0/+P".8D$@?67\K6NFKM02?SCT)_('4_\V7
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M,9.8AX'G4[.#;4;RC+Z]2<^FM9KIJD.R5AVLJFX.&[K*;BL/UC*LV \X2Y+
M1SXD7J";D5 ?XB1E,(A"+PU$DJC?6\5NKX9[RJ!MI:PF--9.,2ZQ-8S5ND)L
M["!M\S:V?8Q;5=OEOP,_U H25P':7EG31F9-S#X*R1K==.7NS^NGW8__F:F9
M(6=W3Q_%_Z'N6YO<QK$L_PHB=F.G*D+HX0,DP9Y/67[4.M9=Z;6SNF.C/BCP
M3'-:*6:+4MKN7[\ 2$K,E$0!%,AD34R[TFF2]]X#\N "N(\GA88NQ1,%REV-
M%&F(F"D.4<M3B$F60)EQR@D71 BGUFQV8F=')OM##+!7UF0%_G;S]T&UCRS1
M=SP1\H;I9&="[G ./QBR0L?WT5"_T-<Y'+("XNSQD-W= SN5U$4:]D5:FE*^
MOXBUD,5VF0L2Y"*/81S$ND]DC"#E 8*!C 4.8HZ3'+L4*>T7YT1"$]0@O=,R
MVNHACOU*^G&UHQE_:(U,+VV!E4/AI;8F-/BIT=9CVH\=++ZZFO0+F[:]B97A
M1WU.[.X:'!*GN]JV,=N4A@*G#,94A!#))(08JY\R'"6,!#C,D' ,@CL\?6XN
M2J.<>TQ;!S ['A@,P\B??=MO>HSFK2<L]A>;UGGVU-%HQV:=B#\[<=' (N7M
MSI-9T31?_C+/1(:"((%Q+&/UF?($YA0+&.11QK.$!%&.G I8GY(RM\_UL-]:
M[P"QLG*<TT^#:?<)7PW1R)_R 9UF1Z)1T6.)YSX$?!5N/BECVG+,?68>%5GN
MO?AU0K[^;LKGW*Q-FV>F?KPK]:]N#Y5X^B/!0BE2GA,899)!A)#N9D8"*-(D
M0V%(4\*<MD!?UYRYD5AMC5FYB\8>7;5)ESR:1<#8E2^/'9?^>5Z)D4G;9WA9
MY\UZUWFS]*_550=H_D2Q9W[&>28A:5<:\Z>*5/,S<+X#V#QI-7"=W9Q!W)4W
M[%^[8B.:54+Q).IJJTL:82D1BR&.B%I[IU$,B:(-Y>/3.,^BD,21DU-_4>+<
MYD:C9E48 BPE>-SHR!9=X$JHWS\:TM/L5I5RJT;U/$\-Q-]R*>\3U;&7]^WI
MN9H'&FW!05U0Z^MQS6\+C:]]@(ORIMT;L#7_:+_ ^L9AU*,3WP[YM$U&G YK
M:<M'U$W^PB7&>1 E.85QQA0#L2B">8@3F =9&&1"YC1PBK6S%3PW(JK/V0[E
M4W5&K.!N?&,-NAWMC 'ER.QCJL@<=%Z O=;/:LOX[I3NBI0G,K(6.RDGN8+Q
MDIJ<[Q_<'&:C-U#>BOJ_']8?E*2U&NA"5,L@2[,P#A#D-(@AP@)!+$4 61ZB
M,-;I ''L%@77*V]^47 =Y9P[Q?3@:L<\UV,U6<\8HQ_XJ=7T9]V^T :[(?UB
M+F/BKVE,CZRI.\=<-OM$^QB+FX9Z-IOBB6A':1]@<2L/O_Q-;)<!BKF, PJS
MF$40"9'!G/, XHPRF48L2E#@YM-<$CDW;\:$#CUI15T]F(O@VOHN/B$;W6MI
M]5J ;B*^TM*GCV*+B#?OY*+ B?T26P"./1+K.T=:+=4UY3^8-4&XS)-8(*G[
M5^9YH)R3-(-$AAC&'-,D2A*$D5.TIYOXN7'-E^Z"24^_7"\"V*$VEW-?F8'#
MXFE5-1CL>:RMFN'XT+]^];_$.@G;5 NMY\+GM=PZ"8SSHNOT4X;2G12;C>!W
MY'N]V:1^:'_7G&<_VVU?\R;NK#J]'?^FK+9+P1')>)9!(5(!49!CF(=A"#-%
MB#)%22[<JHF,H>3LJ%/WW('4G/&QCJZN-#G"<-J2Z>L.TNB46YMB@F/;QH3Z
MY_T_-$8NGA_EZB.+UM %.'OB^Z8OFFD 0X\W%MYX? 05)V;[\4 ^GA-&E#4P
M\Z!\>"C7AK;J":ESD+KD,<\1XQ%,4X+4LIMR2'',( ME3$-$ QS3I9K7:&D[
M!_2)<Z&)KM#QV*+6MFVDUFF"-M@![H4[SD)"&-5I'CR$B,0Q)#A ,(P08B$*
M<S7G+A]-SZLO6[+93@OY2\'CP?Y+TUAN')0#S$7(60"#*).Z#@V!.$4,BCS*
MPRPC+*11@_*[M>56M%^,6[%_5H3M/ U?F(WL,30<8/1LUV+/0K$\9M18(.(K
MGZ9/U+39-!9&'^72V-PS;#[\M2SYMV*U6DH61I@2#*.$<XA2&4,<RPR&098@
MEL2"X=!E]=,^>&XKEE8OM^]_#Y/=MS[$^)&_ZXMV.W^^+XWT]*GN'SOI9_G2
MF)>?X-&_#_O<_E8^F:"_#^IK5M\OV? F;.8?1$<$;G_<,+;9D=7G<K5Z7VYT
M'."21#3*F(S41\D3B+!,(98T@A1QBM,XS +L%. R0(>Y?<2M"7JSMC6B#1(#
MK1F@L0/\H2T!C2F."?Q#!LR.(T8>AI'I9)01<*:@*S#TQ%9#-)B4V*Z Z"4'
M7O.HP7F^)IKVDWKWMCH&NHVI_>7'G7JBJ9U!9!BFN7)7>!JG$%$=@1Q'%,8T
M)I('*,[RP&W1;B%U?FOW3_O 8Z-VG5+1*KX 6O%!%4QLAB"5>1(IOQ'&,1-J
M"#"">:36F33D-&-YCJ+0:>?<\P!,TB^Z7-_#C\63V6I=WYLV&F;/:S30[689
MSU"./*L,1G%(JK<M+OX2P"]*G#HMW!:"$\GBUK<.#JX\6<*$1D$>B32#/.*:
M[06#%(<2$I$F3+$]Y]BI+[V/FC 3T$M3XF1+ONL,DZ>B<CYC.P=HD&%!2(@A
MTS,G8CR'6/ 0"D[B0(:$YCQVJ;7S9RFRXQ]).T*>?UF=:<KI3%-'9Q8%=!PK
MY_@MF5-MMLLOXEZ3\Z^BO-^0QZ\%(ZNWY0,IUDL4!'F"4P%%*A!$1!!()$EA
MAH*<!9'(E0]M0Z>]4N9&IET-P1^UCI8.6C^:_0S@#:.Q=PJ=X+'^\*W,[_OL
MU0,ZG[SZV^%S[W_V)!^[E7GMIVYWL:?8*!UN6I^OKU;E-WT.MA19GD9<IC"5
M%$.4!BFDL:3JCRR.XQ"G$8[<DE,LI%J]XI.FJ.QU!*15\LK I1-8RYR)*(V5
M1Z4\+8@D$C"/4P1#(7"&0Y9EPLEC]87TQ*F)H^-LYWYY1F]D*CX9OG5 \^8B
MFM?'8)W'9ZR0JA,27S="ZCP$%P.>>FYU[S3T;KTMU)I[1U<%>[\JR789)1BC
M7.8PB"B!*%$$@X.0*V\NRTWV<RBMN.7DT^?&(K6"H-80&!7MVPH=8]?/%U<C
M,C(SN(#AU$/HK-&#N@<=/VVROD%G#>EV##I_T3#GJPDT^O)5B.U'C;/Z]-NE
M5IZR&/-4AY>G:JFE^S7HD+<TCI4G(&@>N>U<G1<UMP^WC;XRJH)65\>5EP7"
M=AZ ']Q&_KR'0N8\WU]&P],TWR-HTMG]LL$O)W6+.X;&(E?;6ZDC2ZJ;-?\B
M-D\%$]67<L67A$2QX&IBSQA5BX9$S>Y8X$ M&@*&) ESC)D+69P7-3>RJ*N?
MZS*INI;)1CR)M6L.< ^N=A3A!ZV1*>)- Y%1TQSWMHH"K:G/,,U+:'@+TCPK
M:.(0S4L&'P=H7KSCVEH!'PM"BY7IXK7,E<<0$+US$^GR '&.8(ZYA#C#482R
M((LBQTRU$U+F1@P')<'JH*5CS\#3>-IN'5R)TNB;!7N 6@5_C)']?\)Z[PG_
M71FOE.-_PLSS:?VG+G;[XMENNUF^^[X5:RY:!GE3KDV[OKH4Y.U:W(G-PY*E
MB.641U#O+$(4BA#F81+ G&91&*=1+ ,KW\!:XMR8H-495+72.E7?:+T Y6-=
MB'$M%D"I\F R/GX(LK%-^+ ?AG[2& 7<L?<46EP;?<&;/:ZURN!6XZJU]@TF
M;SKW&N=Z6E"?B9XWN-:D[0Q43>#Z-L/*812'AIGM'S0)2SO;U3*V^XU#EW2F
M[H$.7-,%$7Y3YM1]<)9<Y+G,HPA&H:X'1P(&\SQ*81"F. ZH(O0X<5O1G9$T
M-[;N* K6Y59GDZV%6;GLU&VE^I=_JZ_"E%S1%5C,MH=>_E7ZDO\91HLT3<WR
MYG^B11!D"[4FK'0E9#7KKL[[-XZC8[LN](#YZ,O" ]Q:R04XJ.ES37@!"6]+
MPG-R)EX17C#W>$%XZ8:!O>AWNCW/K7RC"UCJ6G0?UO_X6K"O]3YVW=A#+6CB
M6&810C'D7!"(\C2"F*49#&C&LD0B@3.G^G%V8N?&/+76FD98J[=.5_FF-0>B
M/D I&]T=6\_;#8,=J_@'=V2*.>#ZYAC7YF#J]A*N[@WEG6#RU43>3NBTC>.=
M@#AJ%N]V]\!N0#I5N2[U]':W*=;WG^IB"B9Y^=W#XZK\(82YZ/;;6C'!U^)1
MAY(O0Y1+E 0<9DSG\@B"($Y3!!/&)0MT4C)W:^,S3(^Y$=F[+Y\^-54YFB)U
M@PL9#!T9.RJ; .^1N<THU]2> [4-H#;B4 RA-:0ND@#VIIC,*X^-:*X#TU<'
MF8%:3-OZY3JHCGJV7/FXJTL3F0JARS0*91HD,8PPBB"*DDPW3(P@#6.1R5@@
M[-;7]*6 N=%<M_S0 OS/X"]!$()'TM0!_BNXV6V_EAN]7/PK2 *U&#3_:WCP
MO]J/5B\5.[6+_@K"7"TA\2(-8O-O8;;(\V01(]1V2B!;M5)BIO'E__H?81K\
M5QPN@/X0S/7JA_"Z1>>+8;5=:PX?K-&7F-T2,4VI8=_E.L_9[[\@3/WXURH"
M\\RXGL(OSZ\;<+;PACP66[+J5)$Y?$_+-.9!RJ, YC'5>2"$0=W7"6(N%.-D
M6,C<_DRA3]+<..>@&6"UVNZ^U65X+<X*?($V]K??@%2[/DVIWH.FO@!S. _P
M!=Q$YP!W7P5X(-^+A]T#6!\V*!I8FQE)K<(>BFW3#)&*UNNG/]2,U.Q<_$<%
MF+I8?2-FEJ(_5N1;]1=/1P<VF/8>&?0^8+JC AL[GAT16-TPO$3[H1KR;^H5
M:<(614)%G,@,<IFI12_#B:)=M?Q5B]Z$AI0'L?H@'(NQGQ(T-^HUY<"[A;^U
MJ@.C0L^":^=L^8!L9.(=B-:@,NE]4'@LB'Y2S.2ES_N,/57DO/=Z']30.3LX
M%%0WW3S#)0MX+@..812JA2!"20@QX:ERV\(HPC+$ 7**"[66/#?R..@''K6"
M7OI0VX_#$%KQA.[4/--1>]'IWN"[[;(S5J,049_<5V0F"SCZJ<KF 0.W^ME7
MP7<K<2MOE%_*B]5.;Y)\$6RW,>%P[[ZSU8X+_EZ9J&MY[VH'^U:^(YMUL;ZO
M/HF-\;3NQ/?M+PJ"?RYEDO,@4>M02@.L%J,Z^#V*J.*\-$MBBG,:.9U>^E=Q
M;FS86JB7$ET;P<%(T%H)],L&.G;JFUI+]5YWO:IS/%;P_Q98GCB\ZMB.?1CA
M?UC!'W=$AX9H<X&QUZ/O.-Y@^#K,\*_@M.<<HP%\= 0RGJ0!>Y=OQ4.IYS(C
MX_=UL:UNZL@Q\XOZ=&8I\C!!.* PE0F"2/(,YBS(H8BC-$\80Q&W.BZQECBW
M6>!=M2T>=-D,(-3[5#X4#*P*:=B#=\T!.VW/L-!HJY&PV.[TC>_H7G$7/Z.O
M:0*]U[@Y)/:-I,,^J&]$)]H/O1I9MYU-%Y1Z=SBM'C3=3J>+7<]V/)UN'$#=
M']:*^D2U;8J9W:QY]_FZ"Z9:IS1QOSJ-KEI&&8K3A"$H$$X@TEFP)(LX9 F+
MLD0M!'A@M1\Z3/S<2+TU (C: @>&<8?>@KA'!71D%M]CV=8U5-H_YYI;">H-
MD#82W9@P*N8.%#\J]A/QO?<Q<./_P1#V3@;N3YUN9AAL\;-I8OA3!E=^[U:6
M?UM4;%56N^X&04["!$LB(:61K*N.TR!B,,(!8[J>2I(Z]<6X+')N<\/+?@O.
M1<8O06RW!^,7N)'G@*,>%0=UP1^C[(K8P^.OTO@E@5,7&K<$X$2=<=L[!\9<
MDNJK_I\N8/Y$5FKZJSXKEML43"VC]3\HHGO^B\Z52R*BC$<)@2*, X@BW7J"
M) $,DR!/TD!F6%?/M:^=?94V3N0T085MK=X",/4G$ <M%R9:9;,WHKZ 5.I7
MCZ5I!?ZMV'XMUF#[U:3(5N6JX&9/XXOR3$S[$9,8J)^NRYY]<\S<N6[ [?AP
MLF$<F2KK$31(O^N.X$%W4%^BA_3%+[MW> P*]8&LKPC2JW29-MS4!VQ'L:E>
M'GI-=XB/9575^\_K;;'>%>O[.GU).:35+T*6&[$OI2ZJ]^JOQ?UZ*5.!4T93
M2"+=32U%B?(?4P*IC$B>X8@SEKHWD!BBRMR\R4:M(<T0!HV$'9E.@^_H&P^F
MI<)/VHR?VY.ZUA)P, 508PLXM&#0^4:7!F9@[X5K,/7:GF&0(J_0P>$:P$XW
M>;CJB<.HLU.IZ$V=DGY#*U,'8YE%>4)1F$**=0M8GNE.:D+"* YE$H54)LBI
M!>QY47.COD:]*PJ+]<!JQW-^P!J9QSI**L>P >V/5E&/:^;+:'ABH!Y!DS+,
M98-?,HC%'<,8XG-=<_.ST)&M=?*C8J('O;-W2U?%O:$GO0^H_;J[XD&SEORB
M?EM))5S]V\=B+3ZHM5JU9$&8\RP@NK&$KD,1")AG5$+&\L1TI:>A4R27/]7F
MQD"-97IQU=@&.L:!@W4+T-H':@/U:KAK(OA#&PF,E8Y1]!Y'WH[T7F<\1R;)
MJ8?2F5S]H^Z)C#TJ-BEY^P?T)=F/(&%@N*^.Z:*D4BOZ\D$?!=7=+?3^[+VH
M.T >+OE$?NA?W>A.P'65M>KOHE(:ZI:1K;*E_M7M(6'['\K)_:JO>5*>\/W!
MY+9<VXZL=*&V<$E0Q,(H0C#)8^6NRCB ><XBF(8D0#D)$LZ<W-7YF#:WR:FV
MS&SSB9:QMB5X4K]V#!.>#<2VX<6S47A&$YRQ&/ZB309=6$ '%YVKVKVNP088
M<-J2E[J9T>'5>M=YM?2OU54'F!:@!0HT2'6FUPY6G@IHSG?\?45"S\>P:2.H
MYV/WN<CK^6DX*&*[FW[T67#Q8-3[L&8;8P59?1:/BI&^*C-N'G0QLF42\XQ%
M$JG5(@K4A!Y$$&,>0)[A*,\DB2-D5=9^J )SFW8[JNKCT4970(RR3I'&[F/1
M/SU.@?#(D]A1GN/!@ 7H(G^P =Q,@;Q3R/>H(S!9!+CWD7"-"1\,XX40<??G
M3ADQ/MCJ%P'DPY\S8&)I5L+MJ8F>K_Y1;+^^V57;\D%LE-353D]RNO^B^G_=
MBE$MEIG2XU::WD+- ZIEFK! A()#-6Y$33=9"',I).0HI(+1D#.,K*<;;VK-
M;1*J^S'IBMU.O9@\CY7%=/0J(S#-5B)XWYX8:ZN -@NT=H&]8:"US'2+;6S3
MT=3U$+;FO<KX.4QJKS*.$TUU-?TM]"[*IAXJ4@&BZU4P,_,5^['<JB%DY6I5
MKXA-Q !K$%AT&J/5_U)U]XS5/SYVMIO+_?:@7I(K.->5[E&K93RJ>PNMQ'U9
M<L7 ^WXJ:@'>"O-54<K[J/;.O/ZD33<?>T?HV2SM_^G#]H_?%VO]6GX4RAEX
MD5.P%$&:I8((M?X+ ]TB(X>81R%D&4VBC*882:L)V4+6W&;91E6PTKJ:]A=N
M&ZM]L-KM='H":^0)L<7)J*E7!\^3B?QM_%G X6DGKD_2I%MC%B:_W*NRN67@
M.=/NX8%L?MS*XP[JA_24 &<ABD,*,:8A1&&H Y:R!(J B2# +(ZI4Q]$&Z%S
M8XYNC9"]VF"OM^/YC WJEB<GGK$<^TRC5O<,BN-637% RM?NOXW(:??E'4 X
MVC%WN??JO>S&+2+WXE;^WQU9%?*']IN8Z3%3?19,%$_Z95ER$DL<I@&,$Q;K
M2',,<8+53P%G*4ECGG#[FLK#=)@;61UT!:115JUD6FW!3]W5D%M5DD$CY+S)
M/0;N(Q/;%5:,/P"#][K'&(B)]@ ^"[WV-WELCWLK]+SSK_Z/0ZWHFRYY>Q1\
M+<ZOP]9A#]SZT:^U#>YJ>\].N/.CKDF%VB='?M0CK=[?IOQQ&'*68,:@3#-]
MI$IR2%',8$!C&H2,LC1R6E+W2IO;;--DT>RU!:VZ XM,]T-MYQ9[ W#D:>,*
M[ :F(UW Q&O&T3E9KY!4=,'LTWE#EVYRHQ(NBN6->AK73WR_(O>*-E+,F1!Z
M.1U!Q.(04I(H_Y4&C*(L"D-);&CCZ,ESHXB]<D!K9T<'QW#U?_I7@3#R9VYI
MO_4G?=;6$Y]O)=A?[LNG_U3WU%^N^N'PP1X_:9*/\ZP![8=X_H+!&^+%5GPL
MG@3_H+R%];VNT:QWX;>_5T+N5A\+J?QD*1ABNI4K1APBR@3$1$B(.1'JB\PB
MF4G'G?&+0N?VJ;Y9E3L.F*DU:GSD3K#I/BJ9M6>D&[$6W\C*O<JET[A8;ZU[
M17O\/7:E+C3Z@H/"YGAYNP"USD K[76[W1HB?_ONET5.O0%O#<*)G7C[>X=T
M#SL4D/\BUD6Y^4VW<G^[$PK7]'VQJ;:'NO)WF^+^7FS^9CKJ+0,I<433#&*6
MZ%.]7'D5A'&8)31*\XP0$5JE:5RGQNS8K-.FO;8$&%. LD6W'$P7P)C3[;C0
M&.328VOPJ%ELC4TR%B-SW17# /ZHK;%<1%XY'BX-T:88E\DVRU:D20G1!:&D
M&0MV&(MM,Q:FQ#7UMB%V-83]S=$&/WW"SFG7(O"\K=K53QNZ.5:?2=^N.QKH
M;;K?A(YK(=^73-"8")3!3!+E7J,TA51D(8PE)F&,0KT =ML@NR!Q;A-1FYBE
MOB#"V$:W&2P:&UQWQRYA;;M#YA'!T7?)FO@3147=J42KNP!*80VK4MGG7IDE
M.M[VRR[)FWC/S-+\XWTSVQO=F*;:;)>'8^<U/][IMZP#8_^@&;W_7]Z] 6T
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M(JM# \3#L3(E<99%+(,($=TNFS)(91[!),XHCPA.P]2M",*8VLZ-+ _*=OJ
M.I+DN,-KQZNS&;0I%DV>2D^?'OM1VME,,CP^*T./INOTQ9['AOUD_>;1A;[.
M3/3NN]BPHM(._V]F+;H,$QQF:1K!*$P%1"S+(:8HABG)"&=89'ELE2DXFH9S
MFW$Z"KKOS(TWCM-,,U>-SI]H:NG8N0"UI?.93,X.PDPFD&/]_E23QEEX?4\4
MYP5-W-KG4U/<^=.F8.)6JKL?RO67K5HX-34PEBA)8Y9E"%(>2XB(R"%)!86)
MB!GA(DB3B5KU7%1U;M-%JS!XU!J;K5^M[:*M':-_\T V_Q1;\$16MM69)QAR
MAPGEU0=R_C/+_C7XU+X&M<7@2_TV-$;/H/&-]<"\=B.;RXK^.1K36 /NK=&,
MO<2KB^UUDC4^BSJ\M-/(IBZG_5NY_;*C_RW8]JX\M!]81BSED<QS*+(D57..
M^H,$20"3D+,HDIAPNZA/KUK-;7IIU0?E0?^FP0Q8EUM0U2;H_,O-WHC!=>&N
M&$V+H('7&*.19XZCUBC=)+/6K&=]TIK.*#J+&32V@;NRTU+E-09O<)F_:09Q
MHN/^NZ]M[Z:Z@/^ +\]D:3;YS_5+,$E%P.N'P:%&X!7"7JMJX/7X]-01]/!P
M]Y3&-_JI8O-(-ML?OZEW^N9[42US3A.6$@YQ&L<0(2PAR3F".. )RI(PDB2V
MF5'/"9C;Y-C5$6@EP1]:3<N"#V=A[)_*?( S\JSDC(M3,F>?\5>D;IY\[&2)
MFGU&==,R>Z\;MJWSG$U^5P.K8[[^+;@^7M#B/FW$0[%[N%ES<VE5[73E[#=E
MM:U^$[HK8Q3A,! P$V$"4903'8@;P4"B3.9)P(,HM@O$]:31_")N.R8T$W*C
MLNGDX7B<?.UXV6V\3#$&K^0C=T>CM0;\U-CSLPGBJ>]I!\D89<HU^-L_\82O
MITV2:[69="?$$W0OMSM\/=:]MNJ[];;8_M"56S>/Y<:L,DP!5T/VFQ]O2BZ6
M))""95$":2H#B.* 0IK0!#*>9WF&*1+4:K?"4M[<7*U:9?!,YT5=?5@W)FLT
M!UIU^R*M-KCWL^4(:([,ACZ =*KVZ@#/H!JP-L^?K#*L@['=>K$NMPUS\MZ0
MZJLB+OV?=VJ-^$16PK[TC-U#9O22:PW-/&Y^Z.@Z2O"6'2R>9NH+PB:=B.T,
M?SG/6MXU,,/X4>CO9WUO6HXUAQ+5DN(T2U"0Z9C_"**4A1"'.(0,(9Y@SG@6
MI4XIQB?%S&W2W&L)F/X.Y*K\YIA@?!I-.[:X'J.16>( 3],ML-718XYQ+P:^
MDHQ/"YDVR[C7T*,TX_ZKAY0?_JH/)3^L/Q?W7[>EW%5UH+[BF8\%H<5*3:]O
M=^*N_%O)"UG4/1&63'"2,$1@F.1<^=29\JF);H.2$I91DD2<6^U7#M9@;H11
MVP"*-=AH*V IH;*CKDW@4L5VR&!8'."-#?'87LDKHNM2'GADE*=OHZ5365D/
M^,957+7& ;XS':X?.O9UDV+]IL)>@W9_$>$A#YZP?O 5=C\O'7S-@X8YF>\>
M'E?E#R%,2$L=;-E4X4XXCE$D!8R1T+LT/()Y)A*8BC"*!(E3GEC-*!<ES6WF
M:$).W=S+\SC:>9A>T!F9]$_&[!U"J-J8\,O%XIU]SXOH>'(_S\N9U .]:.Y+
M)_3R#8.BTV2QU@%SZ^VFH#O]T$_J??@;^5X\[!ZZ+?]:\7\O5SOU*[W+<[AG
MF02$4(1SB/)(+5AI@B#.\Q!2FF-$)199BAV"T[PH-3?.:?0'* A_^N?/0#2Z
MUSU^&IT[+32= IO\C**%3_L*8S/Z>9NQ"'35 ]HFT [8P2IP*T%K%]@;]NS6
M5Q@VIW"TR8=O,O]9JF]8.\*\&=#GWY4>T(=F0)_WJ7W:C^.S.^@/XSZWGZF_
M2#2O(W A$,V/K"GCT+RB\R(,S>^S)TY9?4^*C:YRKM<+NX<V9:KN$Z<458_1
M:X?/9"N6(8L)"E$*><*56R^0A"1C"22IQ'',4II%5K/QA#K/;;(^:#>HB_N4
MHVVW^)C9&$ZXC!F8HJ3M-KT?3&&<UG*="]OT9NR\(MKZ&23$N@_5:Z?(.FC\
MYTB:=1\";VFT T0/K&*_6I7?="S1^W+SL22ZY88Y&/E85I6HFBV1,,U(*-2*
M4$JL^[RF!)(D%C .U,*0JMDI8DY;2S9"YS:)['4VY0S91O!B"U9&X87N3E5W
MC]D()HHGG?;L6)W>9ACL)@??X([-[J?:].QM6 !M@MDD-T8 ;<4(&U8NH/DJ
M$F\C<MH:\ X@')5X=[GW>JIZ6^[H5NY6;5.@S_OO[DU3BCQA(L-1'L!(R!RB
MF(60T#"!*<TI9@G%:9@/Y:R+TO\TY+4 EVJ;>Q@*=][R"O#(!+;O''90LD-@
M!O W-> ?#>!O?!>3'P3<""1V6?:KL9DU+'VT9O^0@;L)^C! AW8_;U-DW,#.
M04%;6T7P)1%8_5\:0I$'.HB$!)"B/(4L31"BC$5"(*>] 5<-YL9SK6+[6B1M
MK6G'E;[S2%BNV\?$=VP_S<!9*_^\K5G=55$LZGH?^R+O>R,\+J:'XN=K:>PL
M?]J%[E!XCI:M@Q\T,$+\4*6C*=V]VWXM-SH!9LDSF@8LX9#J+FF(IRG,$9$P
M"\(8$T$S$3J59^J1-3<V:\KHU$1&]FH.+\W7A[,=@WE";V2N>EY_J&U(L=?4
M8_C]93A\Q=[W2)HV\/ZRR4=1]Q:W#,T?ED*Y7OR.?&\CK@I1]13/;O]I&64\
M3% :09FP!"+!)"22Q# ,>$0#G-/8/7-XH"Y6'\ZD.<.M9J[)P4,'PXY[Q@5X
ML@ %8X/N@0@Z5BS 1<P'I/E>B9>W!-^A>DR<VGLE7,=)O=<^<.@Z4E&$/DFX
ME3JM[T'HC*?RX7$COHIU53R)YK=M EZ6(I(1C" /,P215$M)FJ0(4I9F649B
M&B&GW7U'^7/SNO;J-Y4,#WJ#6G&;1#XO V.[J!P-[M&7E!Z0'K"('(27MR6D
MF_2)%Y"#H#E>/@Y[S)5IE_I\=%V):ADPR5B6$\@QX6K)2!*(>:06CXKH<" B
MGLADN2VW9&5':$<2G"AK+V>\#^E.RP#E/J=0-'H.S+C< VE'0%?!,S+%'/(L
MWUW"9'B"Y4N[?>=6[I__.FF5+\T[FU%Y=*%[;;<F@*\Y\$8QB21"F5J?!3%$
M419"*JCZ0Z8A(5%(.;)JX'#TY+GY'(UR]L7;GN/4_YU>9?W(WV<;ENWO1/^L
MM5?49WO^O,D*LYTTHUN1[?0% U)'/I+-O:BV7W:/CZM";)K7BO$T9%Q]?H3G
M$B(4YI"$00IS-:-*E@2,4ZO*!>=%S.T[;)0$K98."0"G(>S_,OT ,_(G^A*3
MR]^J+3@.N0Y7@S11YH+U"^26:-!K?F_:P.D[ITL"Z-7\64A__Y5##Y;65;DJ
M>%W6:$>K@A=D4XCJ=F/:S7]8/RF1I@+$X5+!34TD=57=:G&9QE02W< PB+"
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M:;*HZT$PM4YK!JO/6<N#)6"GMUW5>*D+'G>FMO!:;-4O3#353RN3@+)/^E\
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MSM'=5Z&&1FOH<" T ':+8[9QP1R9I&KEP5[[IL[V7G]P5X)?!- F &,#T$:
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ML.[?2R;>D,=B2U9_(VM2G^1__/BFW2Y*J8X0CZ @)%-,*]4"$$D$91!Q'+$
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M4)A&**=)[)30ZR![;E1RH9_J C0&])9-OWI [ AG))@G<>Y[>I=V$!XA%F
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M0,FJ.=[J[W9P!?!V9.,=SI$II]%7%WMH- 8=E<%!9_^-))R@\M84R$;FQ/V
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M?<%!X070*@_L<'@1=#N/PR>4(U/"E2@Z^Q:VT'CR*"Z*F]2/L#7^I?=@?=^
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MY4&$D<PCZ3(##%5D;H1_Z*WYJ+4%/W02^>925PN_8V-'TU,@/O:QAF6JK#Y
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M'(:(AH@%22K<TDLOR)L;5>B#\-UV?VJ@2UDVAW8_?2RKZF?=KZH.KG \4+T
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MOBNJ<=FW)99FM"@R$A<$,I;E$&6$04PY@KDDJ2IBE?+,*9576+&FMI*U6MV
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M& #1@<G72 RV(IL+A VZ5NH;L)4[H!.R'U"AW)(=>QW74=D/B@/79<_7KPQ
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M8J[W?$6J(,%9#&E..":RR$3BE2CE3%]3XV$K&XC]K+9S6+H9;8$0&IAPC93
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M28"-P_(_J>&*U8OU2:+SMW-:UZ4JI7B[KBK=Y4QO4T@246.;9!PBDL20<E)
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MAD]%$4ESQ6&.LP(B&DM(6:X@R5@DD@QER*\VC5.O4Z.DB_F!KP#8T9H)#=O
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MIA#SXNHZ-]#8/ON=G!61EI]_<!9--]<@!$:1O_<]>*R,$["3,IPW< F'0([
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MY"52.L.0XHQ";%X0R,LT@QIE+,]28YY1YE.:\.KI7F9X@-J$[W8,T))T]"%
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MSVK%E]<V  XLN<_GN2]_W&">N+?D<[;V[FFQ4FQ>>7)WQGL'/]D*[;]5?MP
MK8)#OR9N]G2$4Q_9,G]Y_WE2D0_OM?\]U1UX GZI7H*F>)Q7BN[U":Z<_Z"U
MY //1>3&OZ&E'D7CWTA3X=KX-];P _-%-YR=7YXVZXWYBHP7_W4YGQM][#].
M$Y92:=OET;0L(,8%L>EM*90Z85PS@K%$7I6I4<0<FW^^.V>ME/%<E")-I=L:
M]/83%'G)"<#IO&5MWE,6_&'5!8V^(>M-HT[(6_,T=POYUZ!D=@(Z&/NRVV@]
M:DNK=BQ2R6]J]3P3JLT^M/T,IH5&A- L@9IEU1&C@F4A-93<?&1:$JFXTQ'C
MI8'&9LA;4<&ZEM5V4JTS;FT#58^"QRYPNPUS2,@BF]8M6HV8H)5S4G7]# 27
M1U5H(-@&J@7M"Y]?&:@#)IW%GUWW#U?RZ:#%JT)/E^O?W/'^;)D#S Y#5%'V
M*:*"*))AF#*2&-^;2ECR3$,J,DER;BQQIM[(]WXMZ=BL]KL^E27QYG%PQ[O_
M[/PU?>\)V&I\H0O:6WK?IV=E? [X@9Q_51_\--P1W? S _9;56Y7MOG!YN76
M?#^;FT75<^71#O[=/*_I_IRE#,FD4!"E,H,8)0K2 G,H-.&:EU0QE?B=/3B,
M.KYS@U;H":C$KD+!6\&-ZV0&[-F#VV42&&,I+9F W+:.P-).0I874$NE$4U$
M48C,9Y$./ 6#-5/\=?9LT_#,[ZOFL-6)7D38W=;4P&!&7AVOP-%[7?- )M *
MY3+BH&N-!P2'JX;/K3TB,6=YR,U0^QSD>SUUMWUVUU66U52EK$08*6.6!(58
M&(M4:LF@5)01F4FID#L%V/7RC,UD=30C $:I5VT(P)?]K,.=8DU"FP_M58")
M=0@6#3M=L4^(_[(SY1&G&G;&!@IGA9BY0#&O</AVAL8"##-<!"T<)J\";0$?
MVV_G]'\OU[:^<F\+=Q#S^_SP.%?;]_^]N?P]>YQMZF2C/8+[FP=;J5EK,LUX
M3E.>E%"*PJRG>:8@2X7Q]1$E:2H*8?9B/FY^%"G'MLKN25RUVWBJ"H[97J,(
MMB>]WR8ASC2[;2O>?/(BK[F-?OM1N<F)0XG76@*KIK'S.T4G8+\GR(W+5'OO
M8Z).1:"=3QP9!]TK187Y<'<5=["^Q0A\L^MX_.MLH3Z;-6L]+7!A=E2(0$H8
M@IA* GFA--0IDF5><I4K+[*-,^.,S;)7*9L[.<$?5E)0B>H9[#D'K)LE#@!7
M9%O:"ZD>90>=. 0K.#@]RL"E!IVJ'A<9=%_>,SS?D%U^T=7SU^LG>^!H+=%Z
M*A1!6+$2XD2;_Q29@"6VW<F)U%F.M) )\F,$[!C-Z4T?E/ZO/:];:C!K)#7.
MGQ'5_L;,\;,R-MF&-A?+C6]F9!?LCA'A*Z$<QFBT4EK(:@/2(EE)&C ,?!F.
M4.'?CI&&#?M>5ODHW.MP2\\RI;;#^:^V;]&6W&^:Y;3 "&&8%GEA;4@.&>;4
M[#D3011*9$*\4C_.C#,VMZ+F"]\*"^954ZYY(ZY_>]\SZ+J9B@"8Q8Z-;H&J
M1-SC_0Q8!].-0JBZE3.C#%MGTJWJ45W(A<O[602;/%#'R^;SY9_6SMCZD*_*
M)J"J=9/9-*6H+#.I!>3(YN/BTG81,#\J7&:\Y&E>E&Q:,]E\V[#5QLU*.(WM
M\_X?2A ]Y<NR/KS;,@R;U?,_%5OY&0VW"<A0B33)4D@3D4&<"0RYS',H4I8B
ME?(DUWDS 1\7CFY>)/C;\0<!WPP6$W8WRQT<R,AV_-O']Z#E.)D E,*$3L!6
M";#3HN$XJ?68!"]>]\(MD.5W&W/0=< +AL-5P>_F?FN$95A?KEZO/S:3^8MN
M(V13)@7".K7\CTI!G"("F<X22!4I:9F3C"CJXT!>'G)LOF0E8E6F47&YO1B+
MY$OEYH"SFT$*BUYD:U0+.P%'WJ65V!KW5N9PAL<=GT!6QV' 04V..P"']L;C
MSI#U#77ZJ[%LGXU^"\OA87.AUK?+^4R\3'%2Z@)K"BE!S+;ESB#%C$"%&"9(
M*4)P<7WE0J<,8S-'57\QR(]2WT,4*71/AIN)B@QQ; _J5,' 7DW!'[7$D3K"
M]H<N:O9_MP0CR.MW@L@M8]_M43WY&ZM$%?5ZF]_&!#\\J2G/<LQM:[ LU0CB
M$N70V#_;)*Q0LM1*B13Y]/2[-*"7;1NLS5\=K.O7!NPBQ&Y&+"1PD2U6(^I1
MY&YBFUQS574-"\B/Z A,*#[$2\,-RW_HJ/P1WZ'K?3U2O/<2%M[/ET^5+:O2
MH[ZIS=.C/5IH>N!RK BV7+ HRW*(*4*0JY)#F:-<Z"0KT]2)TM]KU+$Y3_N)
M9)7@8"LY,*+#I\?J8,PCO]<9_V[#$PW5R-;'$= ^K9V=D?7(CXZ!\& -GA_K
MK-<UV-PK(/93(BO@=XF1ZQIX>UC^<Z#$9U_@.M.;G1\V7!*SKWZO4I6];P[H
M/OZ#;2Q1V$N5\;SCC*9"H92+$C)1VJYK"3>>9,YM/Q<M.#%+@/0*VWF,/3:;
M?TSZW3A+#J><5\_#%>[F]>B^F>?Y:;86QI&WAS>@52,N;;<_@#$]U#,CO[VS
MV@V)D]]ZX1'A#B):!_G[\ITE/52VGG6:&E]5I*F"69((B)$N(&.%@CE!:9IG
M!J@<^^R070?^_]Y.V1GR_B<3UP+Y5N<3VZRY>@?=BA[WF*(+K(B'%2>'??,C
MBRXP7 XN.N_O16FG5F)FGKN:"?751H-1TNP^-*&8<J(AD5D)<5H26&8\A5G)
M9"[3DF9EXL%H=VZ<L7E5K:2@$A54L@*4>%&SG<748:\<!JG(%N8,2)=WP[Y,
M;)>PN$#$=O;V(7G8+NEP0,-V\?)(+&SK"T0^OY@K-^O/3<NG?ZG9W;VM('HV
MYNE.O1)[*IC*N2RUI?OG$/.,0IIR#I5,15:D*DE#G&Y&D7ULYJA1 -Q9#53=
M=4\NYW.V6MM&?&!MU?;,VACR5;CF;/7-)WC ,]ES9&]K5[:W&@';&*+&8 ):
M%$ # WAMM0>D@ L_>T.1P@64? 3'R5&GQ)LX+H((_9;&PQX%MH9EKT]!72-K
MU5AOJOY=TX25JI2%AD+:?K*ZX) 7"8<I5U2IG$G*4Y_US5> L2U2_V"K?ZM-
M%07;:S0#(/C]YV\_@^^KJ@^:9S#2>U+<5IJ84$=>+IRZP&PUZ#[O\[;Q?7$+
M9*B]AQ_4VO8%Y]!D]GZ.G]V3:C:]>9(S,^._+NMF*U-)2D)UF4*$D-GM*UNX
M47&XT$+R4N.LS(2+23OQ[+%9JT8\T,KG9I=.@=9M<JZ$(K(U<4;!V51TZ'O"
M"JR5^/EN^?P?YJ[: )B_[+[[4\\:Y)/N4*+]6KLNZ>> U.V2OK,?-T^;^Z4]
MA/C-S-S-#[.JE27.TI+F4.940IRI!')>Y#!-S;8Z55)+[-7I^/Q08_M,:TEM
MSS*PE74"K+3@#RNO)XU&!\9NGD,8Y")_U?U!\_8(+N,1:.WO&&C05?ZRPH?K
MN<,=_BOWQ\7&/.C3;*Y6[]E&W2U7+].L$$FF,@;-7VP3,I5;MF4$,\10SC-,
MTM2)9.?,\\=F&FH1024C:(5T7\9/(7AY*;\2E]@1>2](O-;T#L5[K>NGGC?8
MVMZAS/[ZWG59OS7^_=-J97;%GY2YA<V-3?CXPP9%U#NU4'JVF19IBFA.-$QQ
M+B"FN(0T(1@F@NLTR47)L=-QF^-X8_ND&SG]UO1+F+HM[ &1BOR1-Y*"1M1J
MF6^$!3\UXIX_"_!>X1V!";3,7QIMT+7>4?7#!=_U-L^3>EO$;M:HW[]-2R11
M)G$*"YR8;;I.-*3([-H3)+C(548+Y!1YW#UR;(;@]\7,GEE4E+>.F3][^'1_
M\?VTCOQ1__[;Y^\?/X!OWV^^?_P6X.#\2,>.1;JYN/X\FQ]V7^;>HX8Y+S\2
M?7LT?OPO/4/]\PHY)4^?3C2?ZU05DB19DL(\X;GQIQ&#)4DXS$N=98)A53*O
M VRW8<?V*=:Y>.N]NERQ?TJI:JD]P_IN$^ 8S \.:^1O_4(5[J1=S0/&[;T@
M"A6M=QMTV!B]%Q!'D7F_NWMN$98/#[-MQW/+3C S+\9"S-1Z6FB6")$6,&&*
M08S,'H$6.8.:9!(97T"IPHM>O6.LL9FA/5$K>A^Q+RSXZ;?E1@&4_>U\19 W
MV([[AC 0QMXS'*#W2LZ >X7+8(3:)W2,-.P>X;+*1_L#AUO\(X+-$>'+QQ_B
MWBXE-L@X14SE*.,<,BPQQ$KED!):FHV#I#G#E"#AY,*<&V!L5J*5$;1"5E%O
M]Z#@21 O1P6OA2:VP^&'BE=<L$OU7H'!DP\<+#+8I<Y^:+#SNC?OD-R9C,ER
M5M#<F(,D1V9;PU0*2Z$RB!*-=29%F@KN3XHYD/0^7]7PM)J#Y.4&>@UDAE"I
M20&%3FP-+9.0%Y*;?2[3F&M*L%D:/*DY1_L2#$?N^5=Z!=P\W!%.ZH ;]*#]
MM\>3C!UVSL;7G?LOE(0==BHB=NZ.D'Q=53M5-8VV^0B;S^WP5<> IE:N%&6B
M\S2%@A)E-S 8FN5)0$:P2I6D3!#W^L..@<:VD:DI'&8[62N^$X_ZPRY0+YR/
M!(0JLJ$^C=*Z#Q]/%UX>%#R!<!N(=><,?H$*-QVPZ*S<[+I_N-)-!RU>U6ZZ
M7-]S@VC/8&Q;%2715&.:&+P(S+BD$%.&C&%,<JA5RC&CI>;"J7/UJ8>/S1AN
MV_I4K9$>'HPG5IU'V3JWE7K<=5*ZLF_2*X =G>.>L,7V8"MX:KD">I4GE WE
M^NT_>EC_[(121T[4J6MZ>#HWS[/W<\56S;I"$4(YXP06Q"9LICJ')<YR2"BB
M4I1""[?H[(EGC^T3;J4#4MD6E:XY':= TZA BA6PU Q#+#().<LT+)'(,I7D
M2N-B:JP 7T:&;7^,^,#U!\S!V^L/0F0[MGUM>GAT!S!X.'']X1C(;[OX4O@Y
M:J?U[?3-#FX9SAT[+>LK#^S,)7VYNS;6/G[1[U=*SC9[V^&ZK<R495P)SJP/
M9GM,&8L.:5X*F+!<%"DA0I=>/>@N#3@VR[XG()A7LE>>6"6\+V?7!:C=7+*0
M $;?OU:B5MU"*F%?APM#-RYR1288(=>%X08FXG)3_IB R_&^4(WL;/M,K59F
M-%LSM%ZK;1R"46VV?5D&<8Y2B N60YZ:+:#4K) RSR5E7M4!'F./S>JT8H(-
M^P%8)2AXWK8"8ZT^US97.S\7;K8H$L*Q=X^.C=8F8#L-5:VAU28@^]<5($;K
MNG9^Y#?NO781DLL=V"X_(@BW8-ENY)(TPQ*;C2\5"&*I*61YGAGO"6>,I 4A
MV*V*H7.8L1FNDZ1YY57$@J7[1B\(3)&MSVF$XK,*EA[;G_-WOR6G8-FQ*;I\
M=?]TY>6B"I U1/'5<>*Z:>4H/RU7GYXV3RO5!G&G,LVR5!$*$VE)CG-.8)GF
M A:9Y)32G.;(B62DMP1C,PFUN("UO"] +U= 5R*#61OZMGDE52Z);W=&_PER
M<VVBPA[9Q-2R@TKX"6C$!\T\M I4TU"K %H=PJ9*]X(O8 *UW_B#IU7W@N=4
MLG6_!_FG8+]?/JO5#5^[]#P]NGY4GX>1"_S12A9@R3VK;:\4X==/&BPW^*0"
M^TG!IR_H2^[QS^7\:;%AJYJ 8#UEJD@*4IB-OT8)Q*A$D!9*0Y:II$R(R$OL
M3,YU<H2QK8L-F\56RIK7PO'HZ#R.E[_+J]&)[2%[ M.#Z..,\E=0?1P^<6"R
MCS,*'=-]G+NPGWO\P?:U$C/6M-ULV/OJ,ZB,%869:@5YF9L/NE "<E5PF)8I
M3W*S*TY3/5VH.UMQ^-W='^X8TND=IO4[?#1PS&#>3N*J/(WMR>SG[7;A[>;7
M7@O?4#2@.REM&.YQKK;H[8L\ ;\M%X^KI7P28?C]/& *Y*EVC32H3^J@\J'W
MZ7)+/\/RRW(I_YS-YY\?'MEL9<^<?UVNUU-2J$P70L-$Y\BV%$\@53R%*B,I
MRC.2,(I]-M>GAQF;I]!*"69;,?W,QADTW2S&]1A%-A:M@!.P$Q%8&<.9@VX,
M EF",X,,:@2Z%3W\_B]<W2.>_GDA+).V^J#J/S\O7O<&:CN9V0KV4F9ESF0*
M4UH4$!/C:K"4,BAT*BBBQAS(U"-5RF-HGY=_F#RJ71NLNJW8?">L1_#=!WV'
M<'PD1".;DU9JT(H-/B\.VXR!7Z/CZY'0%0GG@;*]OM\KZQ$_U3G.LQ;]GV2C
MS=]L'O3R_/L=JDMN#Q0[#U%\GC?<L4H/+5\=M/2YOV<]0'-$_T5__&$?_S1;
MW]O7T9[C\DW5P7)JZ[FE3#.8<,0@9KFP'25+F*,,)45BBPB\LM,<QAR;<[C?
M(?>UT/8W53^%NGFK)Y>T"_QN#F1@4".;_P!X^E<>N",4JB#!8<1AZQ3<(3@J
M7_"X]?KFW0=EHA]FZXJX[RO;J%MEWL'%9IH+A66!$U@F-O4C0]8QS10L,!6%
M*C(ME1-3=;_AQV:@VD[3U<+M6;+D";R;/8H'9V33=-"S^ZC<OI4>6/$GH%$@
M3J-N=^ B].IV&/S-VG6[ ]/5L=OC*4&RUM(FR2I%A4XRG4&2VX+T1&-(BU3!
MDFB%,XJY5$X!MNYAQF:B3N9DI5=EK:779*WU@"GVF=Q)A.)GK:579:VE(\A:
M2[VRU@ZO[O%Q6\8]>T+_K]GF_OW3>K-\4*MV5_;R?<5F"^,CW:Z6SS.II+W(
M=N'ZHK^]K#?JH>Y#."T51CE+""1"V]*?0D!*M3:@YRHS0U+$I;,9""#0V Q&
M*S58+L#3NMHKK"MQ@1G]H69)8B^NN6S!ILW!V P\&9'-4JL-L)*"5I_)-CSW
M,@';J6J5JJ^U:H$O&M2*39J&L@//ET>,;^!Y&RCV-]C\^:U# <'N7+%"C#/<
MVA80E5>K8,CG7AMJ_+*Y5ZNFPT5=(U+%#[ZK'YMW!HA_3Y%(28F$@EG.,<2%
MV> SS,PNGZ@$8ZWR-/,J4G,?>FQKX'Z@K)(=B*9U2U.P9I,U'BV!R4RV//J^
MC"7N\^(;B@R)]H 1R1KHMD=.+7@3CP16=E )'R4TZ8I8\ CEQ8'?*%#I"LCY
M>*7S$WJ:-75GU_"OZM'FY2SN''.W+]T^ID^C%A%L90R:UNT*1*@W_MPPP[[?
M%Y0]>ILO71\D/E4TX11$&-5%64)1<)LEGB%(2:%@*AC+N-FT(NX46N\>9FQ+
M[<GH2W%5?*JX)C[5 Z:WB$\5\>-3Q57QJ6($\:G"*SYU>/7 7/"?V&QE*[N5
M62V?'FH*UZ^S];\_K93ZO#"?HEI7,?*I3),R)0F&*M<$8IP7D*4E@:B0"$NM
M4I92+S<]ML1C,SE61JB-D&#62 E61DSP$S..O:7^MF<00Q%_.T^[HV,SILF,
M[2%=3_9MM:[X,138TWL"K.; J@Y:W:N#QQ'0?/O.TUL3?#O+^]>@]O:%/QBI
MM_? /7Q3FU-B^6]73[7;*Y5ZJ#9MYB5:WR_GLCF?97<V1F4+<ZO5\_MJ=G=G
M>?I422B2#-+,.K!:9K#,"@$QT:+0!+.\=#]9N4Z6T2TY1OYZTL"F5:!=:6QZ
M@SUDJ8A?'RL?;U-KX>$%7SEU#J[R<!,2>=FH\MQVFAACO]5E K;:@-M7LU/3
M\M8>^/>A9\?C+&6X61KH&"7Z;/EMD\+@V[F7NG*(X39<8;!XM2L+]$C_POT/
MS=N\_KP0R]7CTFX(Y+N7KY962QDH=M%X6YXG:5E 6I8:8DE*R#.F($*ERIDL
M4.X6IO$:=6SKV59PL"^Y=;:WLKL7^[MCW[U,14,T]H)T&4SP1] 3D%Y(]6(0
M<!]E,%8!;\7WF0;\;^X71FI<__57-:]J^9??V0][/FQMX&QQ]VFY.KV3F HD
M4YG3'"J4E!";R8"T*#@L&!9)BC.E<]52$[C%A_J*XO2%O:8LB&RUC.!J#:I#
MVU6M#-@LP4)M:GXNL%:;S5RU]1#JOYXL5P>SNR_/P]W>L^<6Y(DZ(\/8O$:%
M244_NB?[Y'2T9K<_#A>"N1;%0)&5WF(,&C"Y%JS#.,C5S^O)";\KX;M9R,J!
MM",:C^EC];5/%2U$FN<"EE(2B$M&(9>V_HXJK-/<.'I$3#?+#9N[&<]+ WHY
M=MMA(YI(.\9^"6J5ZK+>D_M__H\R1<7_:LWC3U+IF9CYQLLO3H2;)0P);V2+
M]^L!IK6  2GB':$(11%_:;AA*>(=E3^BB'>]KY^YV6>-^:+K(AACW:K&8M,D
MT07!C$.AA;0]*"@L19'#0@IC@#):Y-PKW:YKL+'M'_=EM;Z6M%&>+6-J=RL[
M?Z3=;$DH_"+;D4/HZ@!9"]W[,%T ?3 )9% ZAQK4F+@H?6A(G.[IZ;,L%W>V
M]**J^#6/N/DQ6T]YPDM5(@J)+,TVK\@9Y!E)(.+&;R&8%EA[43&?&F1L1L/*
M"*LB%"NEV3J8$< ?5E+/^O^3B#HZ'%?B%-O)L!!]]X/(W]/HP""4=W%JB&$]
MB@XEC[R(KFO[??2_+1>_MPU+DDS*DN<88LG,MTYP 1G1&4R4R(S_D%*1,Y]O
M?>_98_O$C6CF3[^O>1\JMX^X)P"1O]U:]PA=6$ZH&^@SW7_RH%_G"94./\I3
ME_3MWFOV:VPE;VLRSG\Q&XW:O-PNYS/Q,DV5R)%.2\BHL'$"7D#.<@X)*W0F
M$4FTXG[M?#M&&]OWVDH'OO#Y[*[R?KP[]W:!Z_8]!X,L\A?>R@D:04$KZ034
MLH(_FC_CU+NXP!2L*W#76 .W"790^[AOL,M-?9FE#WHU_;*RE*49)CG3NH0*
ME2G$F;$A/&42DB3AYO^2I07U"3V>'F9L <?C=G" *[U<J>N;PIW!V<VF7(]>
M[%/CHP9NZPFHA Q)%=T%0C"6Z).##$P0W:7H,3=TY]77%NK:H^4']:[Z"NJ_
MFX$^F#_6FYFX6=C&)VIVMSBH$BV30FDA%30[@L+R!::0:_-CEI5I5DJS6<!^
M90'7R3,V3V6_TK16HK4SS4]&I[X5O/TFS-&W&6X:8GL_#C,P :U"U1E)H])
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M(.#VJB>AP+2.@AZ2; ()K^=QL403U@G^ \H?7BPNY^OE]Q>+!!-0G)E &7'
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MEVMI 1;1CJ=KB(&2P$#)&)A+LK:3_'@+4[TD>4!_YFSIGF]+%FL_JW10+;[
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MN6G!"Z4OOW9EOEO90SYZW$-"81S >82< S/U>U7?IJ&1/-N9.KU3_]Y#P.T
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ME!)MG8-)-%((X2(!4[H\I3*?VTM+HK *XWFE?'RR,_0N>:V-3'K:H[2GNAI
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MX QW+'CM2W4W1C)<&!)\-(0:RRU3U&I5VQ6]CY[>[RX/?/8-VHTT&/=E3EP
M6IIJ!]Q=JKPEU=J6MB*6U:X?NY>@<4U1-5S<>6!930GMF9Q#C07/,C2'/ZBG
M>3F!NDI&Y>!*>-S\=TB?'LK-).=-2NAPBRS+8+J,04%IA)=,-)HF:Q6K?PEU
M-KG]+^T>O?3-9A$4)"^M*2ENE#(T+1,'OOP!&*A$8_'GXXNJ$8/V5)B\>TOW
M1!INSQP^][-R-_GA,\#Z);J9T]DYMO# I_0TA _1U50Z,"OO8TJE3)L!D4Q%
MXD.0A!MG/&<JIU@[_=]$.G"WEOV6P@ZY#4%8&0V&0I([%)+6"3>H\03%@WZ)
ME^@XU XN'T/?CY"L>PP.[WNW5%67[=F\[6W0/_QRZ>?K[^<8O/V/Z&GM[J6H
MDJF[O<:MPVPGW6L55<8SDK-&[0+JU!D7"0.5C631)1B@9>N#=%4H,MB5[Z%C
MW B=L@X8( $M,_,L(R[J7*:@6),5S][6OGQXF*IQC5)UQ!PH&JBIEO8LS=YL
M^?/"S-L?T3O O(>B2I9F^]G;WL,=3$J3L!>7J_7B I;7T DV4^D-'E>"ILW@
MH6  2/8IJ:R25JRVVW0B:;VJX Y]\'7I\\X92@4'JS2)+*,(P!D2I C$4H:G
MN$K4A/@0.!ZQWKBF9 A(W"J&&T#H[9F3[G53Z;6'"Y1+@O7W[B?=%!<_3]TW
M8;_WWJMOY<NS;$^O]?K6B%3CM5;"[/ITZGJ_7J^Y[878%5]VW0\[JJY*D&Z0
MS1+CUI<CLJLX<K0TE9"$^AAUH#8@(&LG@GI1W#MM=NKJSW=7W\FK! I6:$^2
ME['<9PEBC7<D92E#8H:Y6-LAZTGRR,FSI\/GG?S9$ZJZ/:N\\]K^'".[^\][
MVLRCE%0R@=>??RC_JDP(/E*2>>G4YB(0AZ@A(:+3KB-([FK;MWO(J=:[XE!,
M IIY =23[&(96"T,L1(]%96DS3%1X77M3-9]](QK=FIAXF@/B[X::,]@_ [K
M#7=O%JO2$[$SC>>8CL,?U-.(G$!=)7/RRB_GT_FGZT6N<6.C%-8H1H3O<HPI
M$2<])=PPJKG/*;K:U_S':.EK2/8_=Z=R!_D063)"E<EXX'I#'$1+M#=>&VU4
MW(__JC/9B FI@H-]^U%'\.T9CY>0RS/K+MZ=ALNK*9YGII8.?E3_%-/#%-:J
MZMSQ-KL^@.OILKO$.' :^6!\S.4=B4;?4D8IT<M$7U=K$3SU(F91>\,]@KS>
M*6Y<9[/*V_5G6+Y#GWMYO=QSF*-2U@?OKR'E9"ECI3>*)=*4.FH#D42E!!ZO
MR8"H/N_C3%I'KOP<"&MWLN)/H<GV#-L'^%08W.F%UA6&=WG#\/U76'Q:^B^?
MO_MR(=I=&YSWP.GQJ_1-9/7DJY*EW)+Q'KXLEMU#O.O 'S0&^ &QZ:TB,CE-
MK'.>!(>>M*3)<E5[_Q^CI7<]PM[G'MHDVG# ^""3F$,@4K), @<@'+>FBBX)
MD6K7KIU ULC-+&M@XTY!065EM&>QR@2PZ;K+9>'N?=&U$_X$\W/?7M[W<7U?
MXIQ*:25CT[7[N<DM2IJ9H%8BO^5@@AB)M4$2H7DI)E9!TMKC<FY3T.L^[PVL
M5K#IR+63LY0Q&F$E!B-9:8)Q2FEAY!52XJ6B>-ZZ_4J)(]=W!S]^7'O00WVW
M+N7Z2ZZ]3=^-$CXKV+H:0=PGLMI?NUHQ>#CHQ69O*'6&>*9$J2<K,VMT>5QD
MDM'2.Q:J7\$<I*1&WZ6#M;M:9ZJZ!$"Y>##:H^^,K'I(D7JJM.*U^XD<(67L
MPNO>^C_4^:BOR-O;_1\NPPK^]R5^R*NOYSX<N?,9O;LIW$=3K?!A;Y&;=T9!
M6"4$!KDR>\0(&!(B?IO @D4+KYRIWNOV""W]RYEO?^Y.RK!$T#HF(E@L1U9(
MQ%,#1 ='O3%!1UZ[P>I18L;N>U\!!W=KCVL(OD%K$3]#NIS!Z]?E-=U5[/\_
M+_ULFK]W#TNZ]@;G69%3/[NO=3F+AYY69[5<3ZZ7>W9HN6O<E5<V0E)#K$'(
M2>TE"6 C,9F:P +3B)E3MB8NN;,M\;N;+7DZ->=:H++"E:#?YOO7.G2H\L30
M=58)HW,H\Z=1"-[A'X9;D)H+FMA)]ND!(?0@<1RK-1".KNS74ZJM0>MV4A>G
MX;M1/6U7JG^"[E34:8.Q-"/!!W3615;$*:.)5RF8J(,RM/;U>1//T6XM7'R*
M:9KZ)>KJ[;*[2=DTH>N6O/E52*]0O^LKS7Z? $8A-CB4GI.EXY$K.4DNB=*6
MHQDP2?#:">(JA/\(#]@>@]P[W5.>7/L-M*;<=M+:,U/?-W_>'#2)!8'^LB.*
MIU)@F9 KJ31ATCFKJ0+DK3*F3Z-LW&D0XX-V /TU@,H_5N@.O5JMIQ<HK-7$
MB<B]+!4VL;A6ABEB<Z8D"$<!,H:-O':*X#8%XTYI&!]E/?0Q=DOQ]]/5GZ45
MPQ_S",LR8>+&5N]ODI S-T9'8D-I51B3)L&X1#RG+BGF?-R/!(_<R)R^YKB#
M&,8#UI"J:<!^_0Y_[5CDY6*.7\:-V([89PO(H&>$,]#H-1A1DE^YA'3&,I$$
MT-H6[K$TCCN$87P;.*A.&\#L R\L][D3V='H<3,*A2Q*EW$S:CP2C.$Y*<LX
M#T_\]O8<O XVU6%\O ZHSP;0>KB+YCY3AC)T;+U J<EN&C=^1:4A20HO<N0F
MJNJA^"F$C3OG87QLUM=> Y"\;GKX&_B2IBWB.N+-V,"8DIFP[# :DR(29X4D
MCBFF2\_%X 9KN?D0<>-.?1@?FL-H<>PHZ-ELMOBKM&1:_;)8?L#MMGH/Z\OE
MO+C?+Q>789TO9U<7#?M\.H7D)&2,&I&(3*P4<0A5IJ F9B)+2?&3PJ(>1)R$
M2O?CH?))E=> #47I1BC.2O?Z&^/#%TC#=%V^FC"MM62Z%/Z4&:8N96*I"R0[
M=$^$Y2ZXVG7F]Y!S6K:<_GB0K*VJ!E!7,OMS_)4[)CYSBON#<92/0Z>XM ,-
M-N%7T@<I%,VV^BS98[2<AK<?^'JFBI(: -O106=W^+(Z:@N"**]M&=QHB%52
M$^:TC4E+SGGMB1*GTG8:&'_@:Y=!E-@ .']=+-)?T]D,67J-0IQ_FH;9=N39
MG>@L\8Q.KB>,EBNE;"QQ.5%" 2R7S&11O4C@=.I. ^@/?&,SD"(;@"@*:I[\
M,NWU?MQ>OU/CN0,GD ]9IA90E%XH%YW!,U:FIP19_77>?02=!L0?\(:GOKH:
MP-[N>Z3];82;)1G#!6X>:XB,G*.06"2.4L^4HHGEVO;P'G).P]T/?%U32U6-
MH&ZQ/,R*\(D)9(,D="3*6SA/ G>*2-Q8B1IJ7/6!QO>0<QKJ?N!+EUJJ:@!U
MI>G>V]REF^XXM<R&W T)2Q;C+"4D"<(8DG("&IS4R9Q4,O^H3,PQ:D[#W(]\
MF5)'40U [CV*"PDH5T,OX2O,%EU(M>W)NO486!2<F@@D)>HQH#)HME%H1$B3
M%1.)4ET["W@"6:>!\ >^-JFMN@;0^"Q]Q1!_NIK./W4-2/<WE\\A@XV.<.$P
MM/=1$&]])%%GP9S,'!BOC,0'2#H-A3_@-<D0*FL @3<M;W=;1[V]&F[\NDO
M3[]"U]-ZN\E,I%F!-R1RC9LL<8SF'7[+(K62<><=K]TJXPPR3RO;_H%O3X96
M;0/HO6[ >L<K\=XR:BP191JXI,P0;Q3M*CJ#2,)K6CNQ?8R6TW#X0]^J5%!2
M V#;[]:YSPYND$"%IZ4):)=H F*Y2R30[*R*$;BH;18?(.DTZ/W =R@U5=8
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M-R@2I,TDAQB<2<EY6;O0Y@@IXU[\5K5=_47= &+VC&_YX^K.<>_P3R 3,,+
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MN(+&^@]WR+C[O@%A4$=ITX,DV$"\]&$Z^6.^/BZ)4D*Z,AS08I0GDDW@9$Y
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M\^=_M$X(722<2N. "XVA>B@;/T-9@):"]\B_QYBG,O9JTC\L8*L :MJ(=AM
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MS*Y#4=+=\CU-RLQ^8\ARG 2F"QG=+5,QN;($R=KJHY)?H&?8O3]]@ZJ:)AI
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M6',P7S> !I<%+V_A&"&7AG(\J%Q&L01%+0N)"Y17/40])6 8#U='IT\!<J"
M&SB!U]2ONWB%"XPM)P1C#@7",5:J=S((3"\\"5S8ZK7(#P@8'!V'*O1Q KNW
M= =V()_=Y-O*0H3GT4@A(1"OD=08P3B90/A$\ 3%^%9T2JI><1BW7SCLO=K
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M!-X$HO#9>,I<8#W%J'V5"J[<S_=R2_E^\MP7;'I%;^Y7YQKNM.$D@K9E#J+
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MQ=)=SS?7*U%A[HO)#E>A='-B5NQ]DJ"4T%$:YG3U72Y;2!FX-J2U<ZZ&PAK
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MNJ'<4KVP+P7=4'MN#S+'4]HYN.N+&,?E/W&73XQ4!^27! DFZ%QV!*%]"LY
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M:EUXL#]U':?GME=^)XNGZ^RU/VL#A[KF-FEJ#Q[7+A_M:4I?(/$L6U84>9[
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MK8/$&G-(-B.8(CFYA"J30> -R)18\#$I5?8:&O),S/SZA6,CH9'XYJ?RL@<
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M^/BRZO&0\[IY>X3>T'>,E$X\K]_.\CZ7C-L?U'\B^5?_S__Q_P-02P,$%
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M3#B@3#0<CP,(8\XVTDA)(X7AB,-H&\RM1,9I.9]#K2#_]+.*K5!MX4D)6[6
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MY4=C' 9G>%B.<SMUZ3.G.Q#UP@6?WL58W,Q6IG40<BJE]@90/H39D#UWJ=Z
MKNYR[J:[_*_+SZ6.QL\-Y<B,: TP,'Y],.MUG;7"1Q1&*4\F0F S"\K9:X.,
M&0CWL2(,4*P'W,[_$<P?&X8H1>W*.QQS MF)5%(JL?4L4ENQ;5%=@M)T1PC=
M_C(GO+[!D+!3!\+CAQY!*#NLW]O,ID8\/=F\5,Q X=)5#+B\0U6WHGP4V1(Q
M^,Z?G;N>M)0X.I4J*U??*!R;1=AK%+&@AE(^7\WZR8M3>*A:R9NCU=QBG)]2
M.:)7&@J+2V)#2[GL*$Z.5FHY253(B3(G6<'7"U94B"-*[SAX5'R?"D6NKCQ)
M&N8*+U2LH4JE@-"RF-AJ[K[)V<%^RL?Q/ZJ[L>:E@MQ$1\&W_0&\\'H]ZE,X
M!A4O2BR1M7B410CEXI)YU$,XZ?0L*DHZ*OWRO4H7UU&D1AG7?/9A;Y=SG +I
M/NL_QXJIY2 A1*NU35G_GZJLQ:4UE^>NE%4C05,^"D5)"/:TE8>Y\,T+JKMP
MJI\SBC"5U;GW.K7+L;M(Z.&=$V/?=;)3_9,B8&5R6H?M.&!?6IK#H=@3QT-:
M>!D(=^0B7*2-(XIWHR>].QZS-Q[Y&.(+JE1W=:%&5$CRM\86+7A_1*(9]@O.
M[-E"Y4:WS:P4; 7]^()XZKB7F9P]SXK,6#:X%8$$:CGG>E;LN7UA:;U2N]I>
MB9=E.O?899?55!?V#U]%RH*4XYBPH,)UV=90-4>G>%363&<^/VA18>][%A7V
MUHL*>W]'4>%KUD=?.%1(_#.14WRJ4R.:6?F%6)O9JB@L>+>XZA59A_99AT2/
M;5G$FKPDM>MPRV239K-MB&9S/K#ZR/?1]D3XP;S(J 7IK? /DQ&XV1\<_!C'
MR$H6*CM!2Y&*OI&\*IP/F0'7,1'U<_THXIVVN> 7@.;,50H(!0OTBN!MP@[/
MI0L-U65:<=Q-97N8PN/3:,%HC536**N,O@+J3)E'G(BEU+EP0"FECGV7"TR!
M *K"H7$&L"VXE:IQF2V97N\T&5/5[3BSTJ;J$LB-]!  RR3FK;BYS7Y.E.'E
M#Z4,+C=6,>,=OL4*"RJ:Z3P!9DY-P<5@I_HA'<-EFWF4RSR;V!RLY.0-"S)7
M69DLM$$'2)@H*5;Z8@5WN)=]67X_44903^?P_=F2@RO;=#EV<(6!<F:.)&KN
M#UZM8MWP"+L!%WZS6,+"ZUZSQ4H,[^@*PNO78$S!+I(+(7I*C8)&Q=7?U?XH
M*8+#RMWA&(=T2T$2@ JN!^_S'A X1N"MVD63+@GIU&4.^Z?/X&"DZ"1V:$?F
MOLQIG@3,;^>=Z2'JS&VN*_(9; LR%I63ZN0^^V&GCX4:7^2ASDWN\9=K8/;\
MBG3ORZIV>;/K;@ E'PS<Z(YO9 O\Y;RKWI!N?X'6T8H^B7_*7&  %12):A U
M5^NX@!H)*"P9JD]2)Z!([[P"I?!<2H,XZM /XDY27%E>Z? 5"M@H#PKA<]U7
M"(X;F^C2GA&0'E6'8D5UK2Q?K.@W];O9"3].Q,?RF>MDTQR )9Z4A=EN[-SX
M6[G&("D027O9:^ROK#!8SUBBAG:4NKDR=J31P/Z<2%-KV]?P7;Z6< B;D=1\
M.]JS3PH^CW3?DZWJ+KOW^LQI=I?(LBJXT[)=D\;Y7%Y<<=25XS2<THI%6Y&*
M-+TIC2CM=+9!NN!";=@<?'I)N6).9<?8E1SR;%7T[^+F5OUR<W/.@VX?3ZX^
MG)Q>C=39S?7=Y?GH]N3^\N8Z6>,YP5T^#,U+X!/GUKQ7+7E+9NMTIBL229CG
MH6.Z-(K=.R(35>B %\NEH0?+">2#N(Z@8BDG*NDCQ"FGC7,PWE$WN*,P2[<E
M%QU%[>:)FE3EG/GKRP%IKBWY.#*9FCR2>#5._?$C@F1&)'01,2$MF5LY4LK\
M#C4!BFVU$Y?YLJ"0)G>%[#"E\AK;KOR:<!7=</"FYFBB/EL:KBBT:[V;.JWL
MPNL<,0\/@C^/4..ZI >[XC$I/-_6%OPQH=H?)[>B@VT1OH*J,?PRI7=2*B(O
M)D'9^:FR9?\DU1OB&%A1]#96O@SCQQ4X#N=LEU#-B7 GM14T$T@>/JUVW7BI
MOS15R:5?*=>*(#J/2A;F2!&ID:J/$>:+@B]#HN0LFEE5MM.9FUA)\U8F5J)&
M>0>5UA$1,&&9YU+H@_T[A^;L(U-G3%,T#?8)QR3&<*SS&X4IG<35PWM/.V?@
MB#,]Y8NT+6+!7Y# B@!6)+#).;B9(!DFDK&=A!>W[)6\"^G*7(2. QKM0,G&
M(EQHH72#2ZYXBK@^=95Q*#>N-6$4))O;(F W4EE3/=B40V61O2 0)W!C[FH=
MF[89\)A>].^R\#.!/I:RY)TWBCP7S)2F4_,- <,%?:G!.HDY?RQA/HP*'>P/
M/4G1^.H9L&..T)R9Q!5[7'RI^^6R'[,RL?\]*Q/[ZY6)_;^C,N&GJ@..= H!
M%3?2S9 )3^Y'BC4R7N >D .-SLCP&.DHE9R7JGN>=$ARA]#+8)=&!D,:6'*P
MA'-\Z#IT[,@Z3^7<BB=-:FR@ LYSXGP\8NW,SMUBT"[NRG,9P9<UN>PZ$=\0
M[5N;II$:2S=AQK$O/A<U+^A8H<.R-9HOD)P03,L CP;/U=?_G?5L\70II6;!
M41Y-KILB)713) <>I!4NA@AA_4JK]&AXQ-[%,1S8CZX)JI"N!#R<FRT%]*!X
MX]:T';1VZ4%F:>R)../"#0VO^SG)QD,4;$,B8*+&#N6XQJ^4O6B04=ICC<_-
M>))R-2/SF(GJ6#Q0FTA[.Y?PX*&4",P!0*<04KUN'"2J%VWC/)8_ D?:OX &
MCESV!PD1'3:BLIZQ;B$5KFDTF1D06,GG)/](/'53%[81])=)CY>2B2>%#Q=+
MOE085T;KN5D.[5):Y^U9</0(!5.ICR<QI5%;C?@-OK$A4Z-&TUQL?V_N:N@Z
MSNUI^*_*<I==22V(O !] ^1K:%B:)H/HM&7ET777>NMAG2A.Q^E)/\Y$FB+E
MDGS)LRP+E]=22<!=""R5,8S8'MCA4$(DH(:J#"&?6.VL=IQD)LM^/<9@,?<0
M<<.W(7T7@CU#2.M\0"0VU(C<I%LAF3[ON8'[> ]7,T":KC.?"7$=MU<LIOF(
M0ES@"]Z!NJ-56=?;<@^,O1'\VI*.B:Q\<8.!E@/9=6NEXRER0AQ.C7%(43>>
M&NL'4&1ZHZP=UF%/W5 E28 /Q5"?5'1GBH6\+N/8HT<M+-<8[&9?Z(BA-24-
M.S_K_PU].ZGPD1F*[-EV27\X-F0TTE&7[**HJ]U+T"E?21L_NZ!#ATM(QC9<
MB9/4)BHE^7::C)V !Z.^[_]K?<2D>S5&&.NTD^R3'%A_M#S:9Q02^@[0N>[!
M6GI. -2R'O!&A3-A+?E/R#Q7P\X#VWYXO8&-C)[K#&\M3O7>#W'V),#6N<S8
MK./"WF:O&4Y X^R;N>P)8^%9X$FH55<-[&Q_(:'2%<=X]95",0G5/>*"#146
MHL="\E"3 Z-*!UR5H=*4KI;4S._9OGO98E-5FE\GZ\KZM#GW$6A8)R0KI%7[
MJ]YD0^DTQ7+R?@J586.F)FZ2AX-Q[;N[O+V$2MHX&B+L/2J&U=L27VJ@=AI+
M0[)$<5,Z'Y(AJJPE-4SB9>@,!YO$]J15]'$$@(X@ 00>G%&!:"FI=:E)(A@Z
MO,!!/1+E(!&Y#BXT.#])ELS?Q2F*E#O XRLW*E3#@G>Q30A,H@6$5B@ "#\H
MDN, -;!(1;Z4Z^STOJ#+2^5&GN/U]R4^S"RX@4-82*98.) ONU!<=U[<JZ7S
MH1Z[]H*M@ +X43,O[&3IG S'%?%E- \GYZGF'/A=A2CKXDBH$JDQ8V.9PHOJ
M$QMR8:F<RD%#'MTQ8>6"Y\(*[*BE92"G#- \O&SU:H TMS%3R9P':S;AVSTK
M\Q%!V62<@=\^Z1)^13-0#&%)O]TTL%,-GDEI24(F\].442XO*"!4#NB=)[#.
M<2*JD?71W9_-W[ [B#?QKYS$[Q]YFLTJR3]H<GWP/9/K@_7D^N#O2*Z?;CBN
M:" /86Z*:T\\ $UZ/5!G O)(Y/6ZLCL(%]>GR(Z*=CX6'YE&CX< %U!M[RKA
M?(K=4RFKKE;S^[/*A*D\V;6>FZB01A#8=V9=.R?0%VU((8+G-JNRL*DX Q[+
MI(E3OS>]N4=1K9M+Y/=FW.JRN"NRY6KC-DL&9F\&:N27H ;1.B=7C]OMR([/
MCVEE[6H7NB/'@]5UC:"C:I]%A-<&W4336B]LH9<]\.OP5Y=]\#N):F),O^9.
M^:',0&UPS6M0"O_^FUP$E]P5&;('F8/_^5$=R,OOZ4!>KCN0EW_/7U^XO%:?
M+N^O1W=WZA.]'GMSL?$]4\YFN)6RALJD%+/>0(\ZZ"OOTDWX;?XPH$L3P"&%
MX3^/<'IS>WOS:71+/VSZ\PFNR$7O9ZIK>(!#>DGRLSK7#X2J[XEKA^HCC=7^
MBC!G,XZR_;^ML&&-VY)>DKDS5-9W:YS-K)FH"YAXD5)Z>".-L3@3^/^JK2O_
MH;]'PG^>A/[^R?\"4$L#!!0    (  ")AU9M1.BI_P(  ,44   >    8W5T
M<BTR,#(R,3(S,7AE>#(Q,6QI<W1O9G,N:'1MU5AM;]HP$/Z^7^&F6KM)S1O0
M H$BK<!*!VM184+[-#F)"583.W*<IO37[T+"1M4QE:D;7CZ<XOA\]]QC^QQ?
M^Z!WTYU^'??10D8A&G^Y&%UUD::;YJS:-<W>M(<&T\\C5#,L&TT%9@F5E#,<
MFF;_6D/:0LK8,<TLRXRL:G 1F--;,S=5,T/.$V+XTM<Z[?P+2(+]SIOV@:ZC
M'O?2B#")/$&P)#Y*$\H"-/-)<H=TO=3J\G@I:+"0J&)5JFC&Q1V]QT6_I#(D
MG;6=MEFTV^;*2=OE_K+3]ND]HOZY1MUFHU&MDUJS9MFU>M/"+CD]K=0;\R8Y
M\RO$_F8#2!/4BS&)7(;D7(LHTQ<D]^_4*[%L9=27"\>VK+?:4STL E!UN90\
M<BS#:L02-.:<24 BP'+Q6CAX[N;)<!C;DN1!ZCBD 7,\"(Z([=9>:F=%8VEF
M/<#C(1?.H;5Z6GF//L<1#9?.\91&)$'7)$.W/,+L^"2!J=<3(NB\4$SH(W'L
M&C@IFKE%ATIPYA5?LI(XL!Q21M9$VI538*__L* NA6FU#?O/XGG"RU\(J(1?
M^R7\2>HFU*=84+#)YZB; A9\@JZ89Z!WO?[[5XAIQ[E^.1-=<.8*NHT!^P4,
M%*!]XG&!\W3@I,PG(M?2.D>']IG5>BZO<42V]6V3Z_#_763;\:N/_7>S,I&0
M91$7D%)3)L4R7[6P6KF(2^6\[T8$F-''55O1E:=UBKV&/J2)%& /HS$6<HE&
M-*)PCKS6[.TJ?\!1G;?)^':T+Y)VE1<D#&@:J4YI%S/LE]E?!=HV98%-=0;W
MO'EWE7T6A)CYZ.BPVFBA&0Y)HCK#5Q$D>IG_8N^9Z_^0NX]P[?$(FF"A7.8L
MH*E.X"41\,N]1)>1.U"!M4U98E.=PL%PWQMWFQQP2"I#$*I3^ G'F*&A,53N
MD%XA4YV^28PI0Q-CI!Q]*V3*TY=1^0BWL?SLVV<>W,"QE;+-FE?,BXJ?(T@(
M%\-[LK4*MBY__1R"W82'$/ZK%LY*613X5J7&SG=02P,$%     @  (F'5O.K
M'_'1$   _C8  !P   !C=71R+3(P,C(Q,C,Q>&5X>#$P,C=T:&DN:'1MU5O]
M;QO'T?X]?\56+0H*.-$B)=FUI1B0)256*\N%K#0(7KP_+.^6Y,;'6_8^)#-_
M?9^9V;W;(RE9#60$#6);Y-W.SO<\,[LZ>7_[X>KM=R?O+T[/WY[\:6]/G;NT
M69BB5C-3F%+7)E.3E?K9E9_MG5:71:KV]K#@]O+VZN)MVM3EWGA_/!Z-#T9?
MS)<OH_WQJWIN3U[(\^].7C#E[T[>?3S_14UFJ<M=^?W._=S69@=?GU_^2^G<
MSHKO=U)L:LKP956O<O/]SD*7,UOLY69:OQF9Q?&]S>KYF]'^T='QCO#[$ O[
M^Z/AK\N9<!M17.HLL\5LKW;+-V-0I TO/_RHJC(%#X\3VU&UK8E(E=O,C'84
ML_/]#O&SH^;&SN8U/AV\//)BO#WYX>/UK:KL;UB$]ST/4U?4>_3EF]&R/F:=
MO/$J4?CO]OWES;DZ_7!Q?8X_M_CBHU)7'T^OU>GUN?IT<?;3S>7M+^KTQYN+
M"WD!K\QM17^5F3J%^3(V8>W4E=.%TD6F/IFT*6V]4J>STAA^/*AIT5___+?Q
M>/^X7<6?1\>["L_8)/  6X 4OZW&A_5<97JEW%1]T*M$D;H2\A':96+J>V,*
M]>GRZO+LX[7ZU^G5U<4OZMWI]3_4P._T3A>?VTUHT=E/MQ<WIXFZO#X;)DHK
M=6YR?:]+HU)7+AV<T+JB6^[*TMV;LB5Q/W>543!K::J*N#X8'^ZK=WI5S1UH
MO'--;NYTF27J76FKB2Y,HL[@=%-7%A:[O3[<WS\:*G5S<79Y>WKU2:G3H2(F
MF;FPG9KK.[.N$%VKU)2UML6CBLXXC#2T!Z7]O<E7ZC7K;3^A+S5I7L*L1_$'
M6U;UTZT95-]QS.R3'.W^;+,RG:M#WG^4\#MX,&W*>DY+'N %^[DB=JVO<=/?
M<J7&KV3'=4?9U/, BQ98,3%JG:U$+5QFIY9^JIKE,N>]L(\K%8Q?TYX)&#?!
MJ9G#EJG@,4,*F'?>QG-L9[[4(G8*VUK6=,L.O(0I+ANX8F4JM33EPM8U.P$_
MZ6_"Q,^&L=]48.[?#?C#&M:J"$TR;2% NR_T9]/JOC1WMD($5/1DVP)2&'GZ
MM,GA6I6IB6E$*31G; &&SB-9-2W+B%3E/ ]AHV7IPDZPVN9&B/*F5J[ )NS]
M,!!K#@^P6J>(UDP7J4%:Q.[T',&RJ,A6DU]-6H=5Y$JVYGW(\BQB;GEELW2B
MU-(L85'0UMV+"CFAU$5M885.RHG)W3V$C-/A]<>?$Z31BYN+'S[>7#![V+1"
MTO;)Q,L'"F;F4 ZP7VIKG<M&CIUNYES&'^]TWNA)#G%[1!+/:&KLLI9 RF!G
MG7)N1#Y'G"$;D17(Z=//A;O/338C'Q6YR>MH<^@%WIZ;F28#JHEK"N_'2UVR
MN$0$;['Q.%Y=#JFK-TJ-ADB74UN(0J&',[TD25!=,M&_:BJ*:)BN< A,>CDX
M+]CK0KJ:8WM)<VS;A=$%N*O4S-XA4L5XBP>]?CSL:%5M>NB_,:)4P09X-7P]
MF.RJP3_;:#ISQ1T<T9*B+Q&-$WQ9(*-3N*ZMZK0*<7+C8]'67+ L-"4Y!CZ4
MZQ0/6W\4M4$H*,ZG"$4$O\[%$%D,,:F+%6RR8GTA,<!'VT]3A8^V2.U2Y_B4
MT,.%;1;POBFM2VB!Y?I1410EDK4RLUB*-R'#I(A05"=( "DDY& OHRL.#C4
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M6;[_!K/.]@%:FW1(%Z?-F+3+]@N/)6J*I?@R+]VK[^_MI]78X1JS!3MX_NK
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M&1_+7XWE$#I&D J]/N0+GQJ5O^[#)_L)UOE_ 5!+ P04    "   B8=6CVF
M2DP%   $%@  &0   &-U='(M,C R,C$R,S%X97AX,S(Q,2YH=&WM6%MOXC@4
M?M]?<89J9UJ)7(%2+E,I ZF*M@,5I-.9IY5)G&)-L+..*65__1X[H??NMM)N
MI](.#PARCL_-W_E\XOZ[X600?3L-8:&6&9R>?3H9#:!F.<YY8^ XPV@(Q]'G
M$VC:K@>1)+Q@B@E.,L<)QS6H+93*NXZS7J_M=<,6\L*)IHXVU70R(0IJ)RJI
M'?;U$_RF)#G\I?_.LF HXM62<@6QI$31!%8%XQ=PGM#B.UA6I340^4:RBX4"
MW_4;<"[D=W9)2KEB*J.'6SM]I_S?=XR3_EPDF\-^PBZ!)1]K;-^/XP9)DS;Q
M2+/5;G8Z^[Y_X'OQO#5OQ7[G=P^#=%"]7%.H348_UI:,6PNJ_7>;OMUNY:JW
M9HE:=#W7_;5F5 _[J> *_4E<7_XLS3PT1N0%VE,B[WH^6E+T2EDD8Q>\:U*L
ME::VZK'(A.SNN.;3TQ(K)4N6;;H?(K:D!8SI&J9B2?B'>H';8A54LK14+-B?
M%&-$)^;ONDRAC78RQNDV)<_72817"S9G"AJ^[=W-X'FQQUA\*G]0\(-P&HV.
M1H,@&DW&,#EZ,H$W$_#Q*#R"\&LX.(M&7T(,&:,/IQ",AU#*CD;C8#P8!2=;
MV9O/Z?1L.CL+QA%$$_ .X,R>V0,;9N' ;(K7:+GU-Y]#,(-@.#F-PB'<3F>;
M1,?=Q^V Z#B$63#]%(S#F37Y>A)^@V 0:8GONO[+NH?Q!!/N-O;S_[[SFX_F
M/.(0"\YIK D=UDPM0"TH$,Y7) -)<R$5H.1(R"5XKO4;B!0&*]PD4H<1CVT@
M,*0961-)T9)$?:)-U2$5TIC*,3"1 ,54$U2-Z7).Y?L=;]_M-;RZYG2_#J2
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M2P$"% ,4    " #]B(=6ETT<4(U.  #:7 , '@              @ $
M8W5T97)A86UE;F1E9&%N9')E<W1A=&5D8GDN:'1M4$L! A0#%     @ _8B'
M5C-G_:GQ]0, ]LHL !$              ( !R4X  &-U='(M,C R,C$R,S$N
M:'1M4$L! A0#%     @  (F'5J!1.R\:&@  XC@! !$              ( !
MZ40$ &-U='(M,C R,C$R,S$N>'-D4$L! A0#%     @  (F'5DZ-M_CE,
MW_$! !4              ( !,E\$ &-U='(M,C R,C$R,S%?8V%L+GAM;%!+
M 0(4 Q0    (  ")AU84]_&XD9D   N[!@ 5              "  4J0! !C
M=71R+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    "   B8=6O<+!-'&Y 0"X
M$0( %               @ $.*@4 8W5T<BTR,#(R,3(S,5]G,2YJ<&=02P$"
M% ,4    "   B8=68Q((=_^! 0!VU@\ %0              @ &QXP8 8W5T
M<BTR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @  (F'5K?.@]E Z   [80*
M !4              ( !XV4( &-U='(M,C R,C$R,S%?<')E+GAM;%!+ 0(4
M Q0    (  ")AU8V_!U0618   9%   <              "  59."0!C=71R
M+3(P,C(Q,C,Q>&5X,3 R.&9O=7(N:'1M4$L! A0#%     @  (F'5FU$Z*G_
M @  Q10  !X              ( !Z60) &-U='(M,C R,C$R,S%X97@R,3%L
M:7-T;V9S+FAT;5!+ 0(4 Q0    (  ")AU;SJQ_QT1   /XV   <
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>,S(Q,2YH=&U02P4&      \ #P 4!   GI,)

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
